PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	MacWilliams, B				MacWilliams, B			It's a dog's life for Siberian foxes	NATURE			English	News Item																			0	0	0	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2001	412	6850					845	845		10.1038/35091208	http://dx.doi.org/10.1038/35091208			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467EG	11528439	Bronze			2022-12-28	WOS:000170689000009
J	Senftleben, U; Cao, YX; Xiao, GT; Greten, FR; Krahn, G; Bonizzi, G; Chen, Y; Hu, YL; Fong, A; Sun, SC; Karin, M				Senftleben, U; Cao, YX; Xiao, GT; Greten, FR; Krahn, G; Bonizzi, G; Chen, Y; Hu, YL; Fong, A; Sun, SC; Karin, M			Activation by IKK alpha of a second, evolutionary conserved, NF-kappa B signaling pathway	SCIENCE			English	Article							MICE LACKING; BETA; PROTEINS; PHOSPHORYLATION; ALYMPHOPLASIA; DEFICIENT; INDUCTION; RESPONSES; SUBUNIT; CELLS	In mammals, the canonical nuclear factor kappaB (NF-kappaB) signaling pathway activated in response to infections is based on degradation Of I kappaB inhibitors. This pathway depends on the I kappaB kinase (IKK), which contains two catalytic subunits, IKK alpha and IKK beta. IKK beta is essential for inducible I kappaB phosphorylation and degradation, whereas IKK alpha is not. Here we show that IKK alpha is required for B cell maturation, formation of secondary lymphoid organs, increased expression of certain NF-kappaB target genes, and processing of the NF-kappa B2 (p100) precursor. IKK alpha preferentially phosphorylates NF-kappa B2, and this activity requires its phosphorylation by upstream kinases, one of which may be NF-kappaB-inducing kinase (NIK). IKK alpha is therefore a pivotal component of a second NF-kappaB activation pathway based on regulated NF-kappa B2 processing rather than I kappaB degradation.	Univ Calif San Diego, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; Univ Ulm, Anesthesiol Clin, D-89075 Ulm, Germany; Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA 17033 USA; Univ Ulm, Dept Dermatol, D-89081 Ulm, Germany	University of California System; University of California San Diego; Ulm University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Ulm University	Karin, M (corresponding author), Univ Calif San Diego, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, 9500 Gilman Dr, La Jolla, CA 92093 USA.		Greten, Florian R/AAF-5196-2020; Bonizzi, Giuseppina/AAD-9042-2022; Hu, Yinling/G-5682-2015	Greten, Florian R/0000-0002-3928-6080; Hu, Yinling/0000-0002-4795-8537	NIAID NIH HHS [AI45045, AI434477] Funding Source: Medline; NIEHS NIH HHS [ESO4151] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R37ES004151, R01ES004151] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Cao Y., UNPUB; Chu WM, 1999, IMMUNITY, V11, P721, DOI 10.1016/S1074-7613(00)80146-6; Franzoso G, 1998, J EXP MED, V187, P147, DOI 10.1084/jem.187.2.147; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995; Hu YL, 2001, NATURE, V410, P710, DOI 10.1038/35070605; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Ishikawa H, 1997, J EXP MED, V186, P999, DOI 10.1084/jem.186.7.999; Kaisho T, 2001, J EXP MED, V193, P417, DOI 10.1084/jem.193.4.417; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Lin L, 1998, CELL, V92, P819, DOI 10.1016/S0092-8674(00)81409-9; Ling L, 1998, P NATL ACAD SCI USA, V95, P3792, DOI 10.1073/pnas.95.7.3792; LIOU HC, 1994, MOL CELL BIOL, V14, P5349, DOI 10.1128/MCB.14.8.5349; Lu YR, 2001, GENE DEV, V15, P104, DOI 10.1101/gad.856901; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; MERCURIO F, 1993, GENE DEV, V7, P705, DOI 10.1101/gad.7.4.705; RICE NR, 1992, CELL, V78, P773; Rothwarf D.M., 1999, SCI STKE, V1999, pRE1; Senftleben U, 2001, IMMUNITY, V14, P217, DOI 10.1016/S1074-7613(01)00104-2; Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780; Silverman N, 2000, GENE DEV, V14, P2461, DOI 10.1101/gad.817800; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Yamada T, 2000, J IMMUNOL, V165, P804, DOI 10.4049/jimmunol.165.2.804; Yin L, 2001, SCIENCE, V291, P2162, DOI 10.1126/science.1058453; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360	29	1082	1140	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2001	293	5534					1495	1499		10.1126/science.1062677	http://dx.doi.org/10.1126/science.1062677			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465XV	11520989				2022-12-28	WOS:000170616000046
J	Barnes, DKA				Barnes, DKA			Resource availability Ancient homes for hard-up hermit crabs	NATURE			English	Article							SHELL UTILIZATION		Natl Univ Ireland Univ Coll Cork, Dept Zool & Anim Ecol, Cork, Ireland; Frontier, London EC2A 4QS, England	University College Cork	Barnes, DKA (corresponding author), British Antarctic Survey, High Cross,Maddingley Rd, Cambridge CB3 0ET, England.							Barnes DKA, 1998, J SHELLFISH RES, V17, P51; BARNES DKA, IN PRESS ECOLOGY BIO; BERTNESS MD, 1982, J EXP MAR BIOL ECOL, V64, P159, DOI 10.1016/0022-0981(82)90151-4; Burggren WW, 1988, BIOL LAND CRABS; FOTHERINGHAM N, 1976, ECOLOGY, V57, P570, DOI 10.2307/1936441; HAZLETT BA, 1980, BEHAV ECOL SOCIOBIOL, V6, P177, DOI 10.1007/BF00569198; KELLOGG CW, 1976, J EXP MAR BIOL ECOL, V22, P101, DOI 10.1016/0022-0981(76)90112-X; REESE ERNST S., 1962, ANIMAL BEHAVIOUR, V10, P347, DOI 10.1016/0003-3472(62)90058-1; RUTHERFORD JC, 1977, VELIGER, V19, P438	9	14	17	0	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2001	412	6849					785	786		10.1038/35090632	http://dx.doi.org/10.1038/35090632			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465ET	11518955				2022-12-28	WOS:000170577200026
J	Fukui, Y; Hashimoto, O; Sanui, T; Oono, T; Koga, H; Abe, M; Inayoshi, A; Noda, M; Oike, M; Shirai, T; Sasazuki, T				Fukui, Y; Hashimoto, O; Sanui, T; Oono, T; Koga, H; Abe, M; Inayoshi, A; Noda, M; Oike, M; Shirai, T; Sasazuki, T			Haematopoietic cell-specific CDM family protein DOCK2 is essential for lymphocyte migration	NATURE			English	Article							CHEMOKINE RECEPTOR; MYOBLAST CITY; T-CELLS; ACTIVATION; ORGANS; CDC42; PHAGOCYTOSIS; POLARIZATION; CHEMOTAXIS; EXPRESSION	Cell migration is a fundamental biological process involving membrane polarization and cytoskeletal dynamics(1), both of which are regulated by Rho family GTPases(2-5). Among these molecules, Rac is crucial for generating the actin-rich lamellipodial protrusion, a principal part of the driving force for movement(3,6). The CDM family proteins, Caenorhabditis elegans CED-5, human DOCK180 and Drosophila melanogaster Myoblast City (MBC), are implicated to mediate membrane extension by functioning upstream of Rac(7-12). Although genetic analysis has shown that CED-5 and Myoblast City are crucial for migration of particular types of cells(8,9,12), physiological relevance of the CDM family proteins in mammals remains unknown. Here we show that DOCK2, a haematopoietic cell-specific CDM family protein(13), is indispensable for lymphocyte chemotaxis. DOCK2-dercient mice (DOCK2(-/-)) exhibited migration defects of T and B lymphocytes, but not of monocytes, in response to chemokines, resulting in several abnormalities including T lymphocytopenia, atrophy of lymphoid follicles and loss of marginal-zone B cells. In DOCK2(-/-) lymphocytes, chemokine-induced Rac activation and actin polymerization were almost totally abolished. Thus, in lymphocyte migration DOCK2 functions as a central regulator that mediates cytoskeletal reorganization through Rac activation.	Kyushu Univ, Med Inst Bioregulat, Dept Immunobiol & Neurosci, Div Immunogenet,Higashi Ku, Fukuoka 8128582, Japan; Japan Sci & Technol Corp, CREST, Higashi Ku, Fukuoka 8128582, Japan; Kurume Univ, Sch Med, Res Ctr Innovat Canc Therapy, Kurume, Fukuoka 8300011, Japan; Juntendo Univ, Sch Med, Dept Pathol 2, Bunkyo Ku, Tokyo 1130033, Japan; Kyushu Univ, Grad Sch Med Sci, Dept Pharmacol, Higashi Ku, Fukuoka 8128582, Japan; Int Med Ctr Japan, Shinjuku Ku, Tokyo 1628655, Japan	Kyushu University; Japan Science & Technology Agency (JST); Kurume University; Juntendo University; Kyushu University; National Center for Global Health & Medicine - Japan	Sasazuki, T (corresponding author), Kyushu Univ, Med Inst Bioregulat, Dept Immunobiol & Neurosci, Div Immunogenet,Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.			Fukui, Yoshinori/0000-0003-2335-8745				Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Erickson MRS, 1997, J CELL BIOL, V138, P589, DOI 10.1083/jcb.138.3.589; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hasegawa H, 1996, MOL CELL BIOL, V16, P1770; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Kim CH, 1998, BLOOD, V91, P4434, DOI 10.1182/blood.V91.12.4434.412k45_4434_4443; Kiyokawa E, 1998, GENE DEV, V12, P3331, DOI 10.1101/gad.12.21.3331; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Nagase T, 1996, DNA Res, V3, P321, DOI 10.1093/dnares/3.5.321; Nakano H, 1998, BLOOD, V91, P2886, DOI 10.1182/blood.V91.8.2886.2886_2886_2895; Nishihara H, 1999, BBA-MOL CELL RES, V1452, P179, DOI 10.1016/S0167-4889(99)00133-0; Nolan KM, 1998, GENE DEV, V12, P3337, DOI 10.1101/gad.12.21.3337; OBERLEY LW, 1982, SUPEROXIDE DISMUTASE, V1, P1; Oliver AM, 1997, EUR J IMMUNOL, V27, P2366, DOI 10.1002/eji.1830270935; Onai N, 2000, BLOOD, V96, P2074; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Sotsios Y, 2000, IMMUNOL REV, V177, P217, DOI 10.1034/j.1600-065X.2000.17712.x; STOWERS L, 1995, P NATL ACAD SCI USA, V92, P5027, DOI 10.1073/pnas.92.11.5027; Thelen M, 2001, NAT IMMUNOL, V2, P129, DOI 10.1038/84224; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; Yoshida R, 1998, J BIOL CHEM, V273, P7118, DOI 10.1074/jbc.273.12.7118	30	350	360	0	8	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2001	412	6849					826	831		10.1038/35090591	http://dx.doi.org/10.1038/35090591			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465ET	11518968				2022-12-28	WOS:000170577200039
J	Shah, RR; Abbott, NL				Shah, RR; Abbott, NL			Principles for measurement of chemical exposure based on recognition-driven anchoring transitions in liquid crystals	SCIENCE			English	Article							SURFACE-CONFINED MONOLAYERS; PHASE PROBE MOLECULES; ACID; AMPLIFICATION; SENSORS; GOLD	The competitive binding of a molecule forming a liquid crystal and a targeted anatyte to a common molecular receptor presented at a solid surface possessing nanometer-scate topography is used to trigger an easily visualized surface-driven change in the orientation of a micrometer-thick film of liquid crystal. Diffusion of the targeted analyte from atmosphere to surface-immobilized receptor across the micrometer-thick film of liquid crystal is fast (on the order of seconds), and the competitive interaction of the targeted analyte and liquid crystal with the receptor provides a high level of tolerance to nontargeted species (water, ethanol, acetone, and hexanes). Systems that provide parts-per-billion (by volume) sensitivity to either organoamine or organophosphorus compounds are demonstrated, and their use for imaging of spatial gradients in concentration is reported. This approach does not require complex instrumentation and could provide the basis of wearable personalized sensors for measurement of real-time and cumulative exposure to environmental agents.	Univ Wisconsin, Dept Chem Engn, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Abbott, NL (corresponding author), Univ Wisconsin, Dept Chem Engn, 1415 Johnson Dr, Madison, WI 53706 USA.							Berger R, 1997, SCIENCE, V276, P2021, DOI 10.1126/science.276.5321.2021; Cisper ME, 1997, RAPID COMMUN MASS SP, V11, P1449; Coetzee JF, 1972, J SOLUTION CHEM, V1, P77, DOI 10.1007/BF00648418; Crooks RM, 1997, FARADAY DISCUSS, V107, P285, DOI 10.1039/a704586g; DAWOOD MR, 1992, J CLIN MICROBIOL, V30, P2279, DOI 10.1128/JCM.30.9.2279-2283.1992; DICKERT FL, 1992, SENSOR ACTUAT B-CHEM, V6, P25, DOI 10.1016/0925-4005(92)80025-S; Fritz J, 2000, SCIENCE, V288, P316, DOI 10.1126/science.288.5464.316; GUILBAUL.GG, 1969, J PHYS CHEM-US, V73, P2243, DOI 10.1021/j100727a024; Gupta VK, 1998, SCIENCE, V279, P2077, DOI 10.1126/science.279.5359.2077; Israelachvili J, 2000, INTERMOLECULAR SURFA; JEROME B, 1993, PHYS REV E, V48, P4556, DOI 10.1103/PhysRevE.48.4556; Jung LS, 1998, LANGMUIR, V14, P5636, DOI 10.1021/la971228b; KEPLEY LJ, 1992, ANAL CHEM, V64, P3191, DOI 10.1021/ac00048a018; MARCUS Y, 1991, J CHEM SOC DALTON, P2265, DOI 10.1039/dt9910002265; MARTELL AE, 1952, CHEM METAL CHELATE C; McQuade DT, 2000, CHEM REV, V100, P2537, DOI 10.1021/cr9801014; Niculescu M, 2000, ANAL CHEM, V72, P1591, DOI 10.1021/ac990848+; NUZZO RG, 1990, J AM CHEM SOC, V112, P558, DOI 10.1021/ja00158a012; PIERANSKI P, 1990, MOL CRYST LIQ CRYST, V179, P285, DOI 10.1080/00268949008055377; POZIOMEK EJ, 1974, MOL CRYST LIQ CRYST, V27, P175, DOI 10.1080/15421407408083128; Rittmann B., 2000, ENV BIOTECHNOLOGY PR; Shah RR, 2001, J PHYS CHEM B, V105, P4936, DOI 10.1021/jp004073g; Shah RR, 1999, J AM CHEM SOC, V121, P11300, DOI 10.1021/ja9844837; Skaife JJ, 1999, CHEM MATER, V11, P612, DOI 10.1021/cm9804822; THOMAS RC, 1995, J AM CHEM SOC, V117, P3830, DOI 10.1021/ja00118a019; Vo-Dinh T, 1999, FIELD ANAL CHEM TECH, V3, P346, DOI 10.1002/(SICI)1520-6521(1999)3:6<346::AID-FACT4>3.0.CO;2-Q; Wells M, 1996, LANGMUIR, V12, P1989, DOI 10.1021/la9507951; Yang HC, 1996, LANGMUIR, V12, P726, DOI 10.1021/la9505226	28	246	270	3	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2001	293	5533					1296	1299		10.1126/science.1062293	http://dx.doi.org/10.1126/science.1062293			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11509724				2022-12-28	WOS:000170492600033
J	Canup, RM; Asphaug, E				Canup, RM; Asphaug, E			Origin of the Moon in a giant impact near the end of the Earth's formation	NATURE			English	Article							HYPOTHESIS	The Moon is generally believed to have formed from debris ejected by a large off-centre collision with the early Earth(1,2). The impact orientation and size are constrained by the angular momentum contained in both the Earth's spin and the Moon's orbit, a quantity that has been nearly conserved over the past 4.5 billion years. Simulations of potential moon-forming impacts now achieve resolutions sufficient to study the production of bound debris. However, identifying impacts capable of yielding the Earth-Moon system has proved difficult(3-6). Previous works(4,5) found that forming the Moon with an appropriate impact angular momentum required the impact to occur when the Earth was only about half formed, a more restrictive and problematic model than that originally envisaged. Here we report a class of impacts that yield an iron-poor Moon, as well as the current masses and angular momentum of the Earth-Moon system. This class of impacts involves a smaller-and thus more likely-object than previously considered viable, and suggests that the Moon formed near the very end of Earth's accumulation.	SW Res Inst, Dept Space Studies, Boulder, CO 80302 USA; Univ Calif Santa Cruz, Dept Earth Sci, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Canup, RM (corresponding author), SW Res Inst, Dept Space Studies, 1050 Walnut St,Suite 426, Boulder, CO 80302 USA.	robin@boulder.swri.edu	Asphaug, Erik/AAC-9455-2020	Canup, Robin/0000-0002-2342-3458				Asphaug E, 1996, ICARUS, V121, P225, DOI 10.1006/icar.1996.0083; BENZ W, 1986, ICARUS, V66, P515, DOI 10.1016/0019-1035(86)90088-6; BENZ W, 1987, ICARUS, V71, P30, DOI 10.1016/0019-1035(87)90160-6; BENZ W, 1990, P NATO ADV RES WORKS, P1; Cameron A. G. W., 1976, LUNAR SCI, V7, P120; CAMERON AGW, 1991, ICARUS, V92, P204, DOI 10.1016/0019-1035(91)90046-V; Cameron AGW, 1997, ICARUS, V126, P126, DOI 10.1006/icar.1996.5642; Cameron AGW, 2001, METEORIT PLANET SCI, V36, P9, DOI 10.1111/j.1945-5100.2001.tb01806.x; CAMERON AGW, 2000, ORIGIN EARTH MOON, P133; Canup RM, 2001, ICARUS, V150, P288, DOI 10.1006/icar.2000.6581; CANUP RM, 2001, LUNAR SCI, V32; GREENBERG R, 1989, ORIGIN EVOLUTION PLA, P137; HERNQUIST L, 1989, ASTROPHYS J SUPPL S, V70, P419, DOI 10.1086/191344; HOOD LL, 2000, ORIGIN EARTH MOON, P397; Ida S, 1997, NATURE, V389, P353, DOI 10.1038/38669; Kokubo E, 2000, ICARUS, V148, P419, DOI 10.1006/icar.2000.6496; KOKUBO E, 2000, ORIGIN EARTH MOON, P145; LUCY LB, 1977, ASTRON J, V82, P1013, DOI 10.1086/112164; MELOSH HJ, 1997, LUNAR PLANET SCI C, V28, P935; MELOSH HJ, 1989, LUNAR PLANET SCI C, V20, P685; Melosh HJ., 2000, LUNAR PLANETARY SCI, P1903; Nelson AF, 1998, ASTROPHYS J, V502, P342, DOI 10.1086/305869; STEWART GR, 2000, ORIGIN EARTH MOON, P217; Tillotson J.H., 1962, GA3216	26	585	604	3	214	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2001	412	6848					708	712		10.1038/35089010	http://dx.doi.org/10.1038/35089010			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462ZB	11507633				2022-12-28	WOS:000170450200037
J	de la Fuente-Fernandez, R; Ruth, TJ; Sossi, V; Schulzer, M; Calne, DB; Stoessl, AJ				de la Fuente-Fernandez, R; Ruth, TJ; Sossi, V; Schulzer, M; Calne, DB; Stoessl, AJ			Expectation and dopamine release: Mechanism of the placebo effect in Parkinson's disease	SCIENCE			English	Article							HUMAN-BRAIN; COMPETITION; RACLOPRIDE; STRIATUM; BINDING	The power of placebos has long been recognized for improving numerous medical conditions such as Parkinson's disease (PID). Little is known, however, about the mechanism underlying the placebo effect. Using the ability of endogenous dopamine to compete for [C-11]raclopride binding as measured by positron emission tomography, we provide in vivo evidence for substantial release of endogenous dopamine in the striatum of PID, patients in response to placebo. Our findings indicate that the placebo effect in PID is powerful and is mediated through activation of the damaged nigrostriatal dopamine system.	Univ British Columbia, Ctr Neurodegenerat Disorders, Vancouver, BC V6T 2B5, Canada; Univ British Columbia, TRIUMF, Vancouver, BC V6T 2B5, Canada	University of British Columbia; University of British Columbia	Stoessl, AJ (corresponding author), Univ British Columbia, Ctr Neurodegenerat Disorders, Vancouver, BC V6T 2B5, Canada.		Stoessl, A Jon/J-9661-2015	Stoessl, A Jon/0000-0002-9778-7246				ALTMAN DG, 1991, PRACTICAL STAT MED R, P450; BEECHER HK, 1955, JAMA-J AM MED ASSOC, V159, P1602, DOI 10.1001/jama.1955.02960340022006; de la Fuente-Fernandez R, 2001, ANN NEUROL, V49, P298; DUVOISIN RC, 1971, MONOAMINES NOYAUX GR, P313; ERNST E, 1995, BMJ-BRIT MED J, V311, P551, DOI 10.1136/bmj.311.7004.551; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Fish JM, 1999, SCIENCE, V284, P914; FISHER LD, 1993, BIOSTATISTICS METHOD, P22; GANCHER ST, 1989, ANN NEUROL, V26, P232, DOI 10.1002/ana.410260209; Goetz CG, 2000, NEUROLOGY, V54, P710, DOI 10.1212/WNL.54.3.710; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Kaptchuk TJ, 1998, LANCET, V351, P1722, DOI 10.1016/S0140-6736(97)10111-8; Kirsch I., 1999, EXPECTANCIES SHAPE E; KISH SJ, 1988, NEW ENGL J MED, V318, P876, DOI 10.1056/NEJM198804073181402; KLEIJNEN J, 1994, LANCET, V344, P1347, DOI 10.1016/S0140-6736(94)90699-8; Koepp MJ, 1998, NATURE, V393, P266, DOI 10.1038/30498; Laruelle M, 2000, J CEREBR BLOOD F MET, V20, P423, DOI 10.1097/00004647-200003000-00001; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834, DOI 10.1097/00004647-199609000-00008; ROBBINS TW, 1992, SEMIN NEUROSCI, V4, P119; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SEEMAN P, 1989, SYNAPSE, V3, P96, DOI 10.1002/syn.890030113; Shetty N, 1999, CLIN NEUROPHARMACOL, V22, P207; STOESSL AJ, 1999, NEUROSCI NEWS, V2, P53; VOLKOW ND, 1993, J NUCL MED, V34, P609; VOLKOW ND, 1994, SYNAPSE, V16, P255, DOI 10.1002/syn.890160402; WISE R, 1980, TRENDS NEUROSCI, V3, P91, DOI 10.1016/0166-2236(80)90035-1; [No title captured]	27	699	708	2	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2001	293	5532					1164	1166		10.1126/science.1060937	http://dx.doi.org/10.1126/science.1060937			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498597				2022-12-28	WOS:000170432600067
J	Dalton, R				Dalton, R			Golf course threatens to leave hole in fossil records	NATURE			English	News Item																			0	1	1	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2001	412	6847					572	572		10.1038/35088189	http://dx.doi.org/10.1038/35088189			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460PP	11493881	Bronze			2022-12-28	WOS:000170318000005
J	Koscheev, AP; Gromov, MD; Mohapatra, RK; Ott, U				Koscheev, AP; Gromov, MD; Mohapatra, RK; Ott, U			History of trace gases in presolar diamonds inferred from ion-implantation experiments	NATURE			English	Article							NOBLE-GASES; ISOTOPIC FRACTIONATION; INTERSTELLAR DIAMONDS; METEORITES; GRAINS; ORIGIN; UREILITES; RELEASE; XENON	Diamond grains are the most abundant presolar grains found in primitive meteorites(1-3). They formed before the Solar System, and therefore provide a record of nuclear and chemical processes in stars and in the interstellar medium(1-3). Their origins are inferred from the unusual isotopic compositions of trace elements-mainly xenon(1-4)-which suggest that they came from supernovae. But the exact nature of the sources has been enigmatic, as has the method by which noble gases were incorporated into the grains. One observation is that different isotopic components are released at different temperatures when the grains are heated, and it has been suggested that these components have different origins. Here we report results of a laboratory study that shows that ion implantation (previously suggested on other grounds(5,6)) is a viable mechanism for trapping noble gases. Moreover, we rnd that ion implantation of a single isotopic composition can produce both low- and high-temperature release peaks from the same grains. We conclude that both isotopically normal and anomalous gases may have been implanted by multiple events separated in space and/or time, with thermal processing producing an apparent enrichment of the anomalous component in the high-temperature release peak. The previous assumption that the low- and high-temperature components were not correlated may therefore have led to an overestimate of the abundance of anomalous argon and krypton, while obscuring an enhancement of the light-in addition to the heavy-krypton isotopes.	Max Planck Inst Chem, Otto Hahn Inst, D-55128 Mainz, Germany; Karpov Inst Phys Chem, Moscow 103064, Russia	Max Planck Society; Karpov Institute of Physical Chemistry	Ott, U (corresponding author), Max Planck Inst Chem, Otto Hahn Inst, Becherweg 27, D-55128 Mainz, Germany.	ott@mpch-mainz.mpg.de	Mohapatra, Ratan/A-3512-2009; Ott, Ulrich/ABH-2337-2020	Mohapatra, Ratan/0000-0002-0999-1045; Ulrich, Ott/0000-0003-3574-9591				ANDERS E, 1993, METEORITICS, V28, P490, DOI 10.1111/j.1945-5100.1993.tb00274.x; BERNATOWICZ TJ, 1986, GEOCHIM COSMOCHIM AC, V50, P445, DOI 10.1016/0016-7037(86)90197-3; BERNATOWICZ TJ, 1987, GEOCHIM COSMOCHIM AC, V51, P1599, DOI 10.1016/0016-7037(87)90341-3; CLAYTON DD, 1989, ASTROPHYS J, V340, P613, DOI 10.1086/167422; Daulton TL, 1996, GEOCHIM COSMOCHIM AC, V60, P4853, DOI 10.1016/S0016-7037(96)00223-2; Frick U, 1977, P LUNAR PLANETARY SC, V8, P273; FRICK U, 1979, P LUN PLAN SCI C 10, V10, P1961; FUTAGAMI T, 1993, GEOCHIM COSMOCHIM AC, V57, P3177, DOI 10.1016/0016-7037(93)90302-D; Guillois O, 1999, ASTROPHYS J, V521, pL133, DOI 10.1086/312199; HOWARD WM, 1992, METEORITICS, V27, P404, DOI 10.1111/j.1945-5100.1992.tb00222.x; Huss GR, 2000, METEORIT PLANET SCI, V35, pA79; HUSS GR, 1994, METEORITICS, V29, P791, DOI 10.1111/j.1945-5100.1994.tb01094.x; Koscheev AP, 2000, METEORIT PLANET SCI, V35, pA92; KOSCHEEV AP, 2000, LUNAR PLANET SCI, V31; LEWIS RS, 1987, NATURE, V326, P160, DOI 10.1038/326160a0; Lyamkin A. I., 1988, Soviet Physics - Doklady, V33, P705; MATSUDA J, 1995, GEOCHIM COSMOCHIM AC, V59, P4939, DOI 10.1016/0016-7037(95)00333-9; MATSUDA J, 1991, GEOCHIM COSMOCHIM AC, V55, P2011, DOI 10.1016/0016-7037(91)90039-8; NUTH JA, 1992, ASTROPHYS SPACE SCI, V196, P117, DOI 10.1007/BF00645245; Ott U, 1996, ASTROPHYS J, V463, P344, DOI 10.1086/177247; OTT U, 1993, NATURE, V364, P25, DOI 10.1038/364025a0; Ozima M., 1993, METEORITICS, V28, P416; Ponganis KV, 1997, J GEOPHYS RES-PLANET, V102, P19335, DOI 10.1029/97JE01686; SCHELHAAS N, 1990, GEOCHIM COSMOCHIM AC, V54, P2869, DOI 10.1016/0016-7037(90)90021-C; TIELENS AGGM, 1987, ASTROPHYS J, V319, pL109, DOI 10.1086/184964; Verchovsky AB, 1998, SCIENCE, V281, P1165, DOI 10.1126/science.281.5380.1165; VERCHOVSKY AB, 2000, J C ABSTR, V5; WEIGEL A, 1998, LUNAR PLANET SCI, V29; Ziegler JF., 1985, TREATISE HEAVY ION S; Zinner E, 1997, AIP CONF PROC, P3, DOI 10.1063/1.53326	30	59	60	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2001	412	6847					615	617		10.1038/35088009	http://dx.doi.org/10.1038/35088009			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460PP	11493913				2022-12-28	WOS:000170318000033
J	Coulehan, JL; Platt, FW; Egener, B; Frankel, R; Lin, CT; Lown, B; Salazar, WH				Coulehan, JL; Platt, FW; Egener, B; Frankel, R; Lin, CT; Lown, B; Salazar, WH			"Let me see if I have this right ...": Words that help build empathy	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PHYSICIAN JOB-SATISFACTION; PRIMARY-CARE; MEDICAL INTERVIEW; PATIENT; COMMUNICATION; SYMPATHY; MODEL; VISITS; SKILL		SUNY Stony Brook, Dept Prevent Med, Stony Brook, NY 11794 USA; Univ Colorado, Hlth Sci Ctr, Denver, CO 80222 USA; Amer Acad Physician & Patient, Portland, OR 97210 USA; Highland Hosp, Rochester, NY 14620 USA; Mt Auburn Hosp, Cambridge, MA 02238 USA; Med Coll Georgia, Augusta, GA 30902 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Rochester; Harvard University; Mount Auburn Hospital; University System of Georgia; Augusta University	Coulehan, JL (corresponding author), SUNY Stony Brook, Dept Prevent Med, HSC L3-086, Stony Brook, NY 11794 USA.	jcoulehan@uhmc.sunysb.edu						BARRETTLENNARD GT, 1993, BRIT J MED PSYCHOL, V66, P3, DOI 10.1111/j.2044-8341.1993.tb01722.x; BASCH MF, 1983, J AM PSYCHOANAL ASS, V31, P101, DOI 10.1177/000306518303100104; Bates AS, 1998, MED CARE, V36, P610, DOI 10.1097/00005650-199804000-00016; BECKMAN HB, 1984, ANN INTERN MED, V101, P692, DOI 10.7326/0003-4819-101-5-692; BERTAKIS KD, 1991, J FAM PRACTICE, V32, P175; BOOK HE, 1988, AM J PSYCHIAT, V145, P420; BRANCH WT, 1993, JAMA-J AM MED ASSOC, V269, P1667, DOI 10.1001/jama.269.13.1667; Brock C D, 1993, Fam Med, V25, P245; BROTHERS LA, 1985, BRAIN RES, V359, P10, DOI 10.1016/0006-8993(85)91407-6; BUIE DH, 1981, J AM PSYCHOANAL ASS, V29, P281, DOI 10.1177/000306518102900201; CARSON RA, 1995, MED ETHIC S, P105; Charon R., 1993, EMPATHY PRACTICE MED, P147; Cohen-Cole SA, 1991, MED INTERVIEW 3 FUNC; Connelly J, 1999, ACAD MED, V74, P420, DOI 10.1097/00001888-199904000-00039; COULEHAN JL, 1995, LIT MED, V14, P222, DOI 10.1353/lm.1995.0027; COULEHAN JL, 2001, MED INTERVIEW MASTER; Donelan K, 1997, HEALTH AFFAIR, V16, P139, DOI 10.1377/hlthaff.16.5.139; Epstein RM, 1999, JAMA-J AM MED ASSOC, V282, P833, DOI 10.1001/jama.282.9.833; GALLOP R, 1990, J NERV MENT DIS, V178, P649, DOI 10.1097/00005053-199010000-00006; GRATTAN LM, 1989, AM J PSYCHIAT, V146, P1521; HALL JA, 1981, J HEALTH SOC BEHAV, V22, P18, DOI 10.2307/2136365; Halpern J., 1993, EMPATHY PRACTICE MED, P160; HUNTER KM, 1995, ACAD MED, V70, P787, DOI 10.1097/00001888-199509000-00014; KATZ RL, 1963, EMPATHY ITS NATURE U, P26; KLEINMAN A, 1978, ANN INTERN MED, V88, P251, DOI 10.7326/0003-4819-88-2-251; Konrad TR, 1999, MED CARE, V37, P1174, DOI 10.1097/00005650-199911000-00010; LARSEN KM, 1981, J FAM PRACTICE, V12, P481; LEVINSON W, 1995, J GEN INTERN MED, V10, P375, DOI 10.1007/BF02599834; Levinson W, 2000, JAMA-J AM MED ASSOC, V284, P1021, DOI 10.1001/jama.284.8.1021; LEVINSON W, 1993, MED CARE, V31, P285, DOI 10.1097/00005650-199304000-00001; Lief H. I., 1963, PSYCHOL BASIS MED PR, P12; Marvel MK, 1999, JAMA-J AM MED ASSOC, V281, P283, DOI 10.1001/jama.281.3.283; McMurray JE, 1997, J GEN INTERN MED, V12, P711, DOI 10.1046/j.1525-1497.1997.07145.x; Miller SZ, 1999, ACAD MED, V74, P800, DOI 10.1097/00001888-199907000-00014; MORE ES, 1994, EMPATHIC PRACTITIONE, P19; NIGHTINGALE SD, 1991, J GEN INTERN MED, V6, P420, DOI 10.1007/BF02598163; Novack DH, 1997, JAMA-J AM MED ASSOC, V278, P502, DOI 10.1001/jama.278.6.502; Pinderhughes EB., 1984, AM J PSYCHIAT, V4, P5; PLATT FW, 1994, J GEN INTERN MED, V9, P222, DOI 10.1007/BF02600129; Platt FW, 2001, ANN INTERN MED, V134, P1079, DOI 10.7326/0003-4819-134-11-200106050-00020; ROTER D, 1991, MED CARE, V29, P1083; Roter DL, 1997, JAMA-J AM MED ASSOC, V277, P350, DOI 10.1001/jama.277.4.350; SPIRO H, 1992, ANN INTERN MED, V116, P843, DOI 10.7326/0003-4819-116-10-843; Strayer J., 1987, EMPATHY ITS DEV, P218; Suchman A.L., 1998, PARTNERSHIPS HEALTHC; SUCHMAN AL, 1993, MED CARE, V31, P1083, DOI 10.1097/00005650-199312000-00002; Suchman AL, 1997, JAMA-J AM MED ASSOC, V277, P678, DOI 10.1001/jama.277.8.678; SUCHMAN AL, 1988, ANN INTERN MED, V108, P125, DOI 10.7326/0003-4819-108-1-125; WHITE J, 1994, J GEN INTERN MED, V9, P24, DOI 10.1007/BF02599139; WILMER HA, 1968, BRIT J MED PSYCHOL, V41, P243, DOI 10.1111/j.2044-8341.1968.tb02029.x; WISPE L, 1986, J PERS SOC PSYCHOL, V50, P314, DOI 10.1037/0022-3514.50.2.314; Wispe L., 1987, EMPATHY ITS DEV, P17; [No title captured]	53	184	187	0	22	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 7	2001	135	3					221	227		10.7326/0003-4819-135-3-200108070-00022	http://dx.doi.org/10.7326/0003-4819-135-3-200108070-00022			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	460FX	11487497				2022-12-28	WOS:000170298500016
J	Cataliotti, FS; Burger, S; Fort, C; Maddaloni, P; Minardi, F; Trombettoni, A; Smerzi, A; Inguscio, M				Cataliotti, FS; Burger, S; Fort, C; Maddaloni, P; Minardi, F; Trombettoni, A; Smerzi, A; Inguscio, M			Josephson junction arrays with Bose-Einstein condensates	SCIENCE			English	Article							QUANTUM	We report on the direct observation of an oscillating atomic current in a one-dimensional array of Josephson junctions realized with an atomic Bose-Einstein condensate. The array is created by a laser standing wave, with the condensates trapped in the valleys of the periodic potential and weakly coupled by the interwell barriers. The coherence of multiple tunneling between adjacent welts is continuously probed by atomic interference. The square of the small-amplitude oscillation frequency is proportional to the microscopic tunneling rate of each condensate through the barriers and provides a direct measurement of the Josephson critical current as a function of the intermediate barrier heights. Our superfluid array may allow investigation of phenomena so far inaccessible to superconducting Josephson junctions and lays a bridge between the condensate dynamics and the physics of discrete nonlinear media.	European Lab Nonlinear Spect LENS, I-50125 Florence, Italy; Ist Natl Fis Mat, I-50125 Florence, Italy; Univ Florence, Dipartimento Fis, I-50125 Florence, Italy; Univ Padua, Dipartimento Fis, I-35131 Padua, Italy; Int Sch Adv Studies, I-34014 Trieste, Italy	University of Florence; University of Padua; International School for Advanced Studies (SISSA)	Inguscio, M (corresponding author), European Lab Nonlinear Spect LENS, Lgo E Fermi 2, I-50125 Florence, Italy.		Fort, Chiara/B-9142-2018; Maddaloni, Pasquale/O-2937-2015; Minardi, Francesco/A-3528-2011; Cataliotti, Francesco Saverio/K-4772-2015	Fort, Chiara/0000-0001-8817-3077; Maddaloni, Pasquale/0000-0001-9971-406X; Minardi, Francesco/0000-0001-6161-8881; Cataliotti, Francesco Saverio/0000-0003-4458-7977; Inguscio, Massimo/0000-0001-8152-8103; Burger, Sven/0000-0002-3140-5380; Trombettoni, Andrea/0000-0002-1108-4727				ABDULLAEV FK, IN PRESS PHYS REV A; Anderson BP, 1998, SCIENCE, V282, P1686, DOI 10.1126/science.282.5394.1686; AVENEL O, 1988, PHYS REV LETT, V60, P416, DOI 10.1103/PhysRevLett.60.416; Barone A., 2000, Quantum Mesoscopic Phenomena and Mesoscopic Devices in Microelectronics, P301; BARONE A, 1982, PHYSICS APPL JOSEPHS; Burger S, 2001, PHYS REV LETT, V86, P4447, DOI 10.1103/PhysRevLett.86.4447; Dalfovo F, 1999, REV MOD PHYS, V71, P463, DOI 10.1103/RevModPhys.71.463; FAZIO R, IN PRESS PHYS REP; INGUSCIO M, 1999, BOSEEINSTEIN CONDENS; JOSEPHSON BD, 1962, PHYS LETT, V1, P251, DOI 10.1016/0031-9163(62)91369-0; Kozuma M, 1999, PHYS REV LETT, V82, P871, DOI 10.1103/PhysRevLett.82.871; Leggett AJ, 2001, REV MOD PHYS, V73, P307, DOI 10.1103/RevModPhys.73.307; Makhlin Y, 2001, REV MOD PHYS, V73, P357, DOI 10.1103/RevModPhys.73.357; MARTELLUCCI S, 2000, BOSEEINSTEIN CONDENS; Orzel C, 2001, SCIENCE, V291, P2386, DOI 10.1126/science.1058149; Pereverzev SV, 1997, NATURE, V388, P449, DOI 10.1038/41277; Sanchez A, 1998, SIAM REV, V40, P579, DOI 10.1137/S0036144597317418; Scott A.C., 1999, NONLINEAR SCI EMERGE; Smerzi A, 1997, PHYS REV LETT, V79, P4950, DOI 10.1103/PhysRevLett.79.4950; Trombettoni A, 2001, PHYS REV LETT, V86, P2353, DOI 10.1103/PhysRevLett.86.2353	21	740	751	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2001	293	5531					843	846		10.1126/science.1062612	http://dx.doi.org/10.1126/science.1062612			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11486083	Green Submitted			2022-12-28	WOS:000170241000039
J	Tapscott, SJ; Thornton, CA				Tapscott, SJ; Thornton, CA			Biomedicine - Reconstructing myotonic dystrophy	SCIENCE			English	Editorial Material							RNA-BINDING PROTEIN; TRINUCLEOTIDE REPEAT; CTG REPEAT; CONDUCTION ABNORMALITIES; REDUCES EXPRESSION; EXPANSION; MICE; FORM; TRANSCRIPTS; MODEL		Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; Univ Rochester, Sch Med & Dent, Dept Neurol, Rochester, NY 14642 USA	Fred Hutchinson Cancer Center; University of Rochester	Tapscott, SJ (corresponding author), Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA.	stapscot@fhcrc.org; charles_thornton@urmc.rochester.edu		Tapscott, Stephen/0000-0002-0319-0968				Berul CI, 1999, J CLIN INVEST, V103, pR1, DOI 10.1172/JCI5346; Breschel TS, 1997, HUM MOL GENET, V6, P1855, DOI 10.1093/hmg/6.11.1855; Davis BM, 1997, P NATL ACAD SCI USA, V94, P7388, DOI 10.1073/pnas.94.14.7388; Groh WJ, 1999, J CARDIOVASC ELECTR, V10, P1221, DOI 10.1111/j.1540-8167.1999.tb00299.x; Klesert TR, 1997, NAT GENET, V16, P402, DOI 10.1038/ng0897-402; Klesert TR, 2000, NAT GENET, V25, P105, DOI 10.1038/75490; Koob MD, 1999, NAT GENET, V21, P379, DOI 10.1038/7710; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; Lu XH, 1999, HUM MOL GENET, V8, P53, DOI 10.1093/hmg/8.1.53; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Moseley ML, 2000, HUM MOL GENET, V9, P2125, DOI 10.1093/hmg/9.14.2125; Napierala M, 1997, J BIOL CHEM, V272, P31079, DOI 10.1074/jbc.272.49.31079; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Saba S, 1999, J CARDIOVASC ELECTR, V10, P1214, DOI 10.1111/j.1540-8167.1999.tb00298.x; Sarkar PS, 2000, NAT GENET, V25, P110, DOI 10.1038/75500; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Tapscott SJ, 2000, SCIENCE, V289, P1701, DOI 10.1126/science.289.5485.1701; Thornton CA, 1997, NAT GENET, V16, P407, DOI 10.1038/ng0897-407; Tian B, 2000, RNA, V6, P79, DOI 10.1017/S1355838200991544; Timchenko LT, 1996, NUCLEIC ACIDS RES, V24, P4407, DOI 10.1093/nar/24.22.4407	21	42	44	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 3	2001	293	5531					816	817		10.1126/science.1063517	http://dx.doi.org/10.1126/science.1063517			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11486078				2022-12-28	WOS:000170241000032
J	Lewis, R; Nathan, N; Diarra, L; Belanger, F; Paquet, C				Lewis, R; Nathan, N; Diarra, L; Belanger, F; Paquet, C			Timely detection of meningococcal meningitis epidemics in Africa	LANCET			English	Article							SUB-SAHARAN AFRICA; NEISSERIA-MENINGITIDIS; VACCINATION; DISEASE; NIGER; THRESHOLDS; CHAD	Background Epidemics of meningococcal disease in Africa are commonly detected too late to prevent many cases. We assessed weekly meningitis incidence as a tool to detect epidemics in time to implement mass vaccination. Methods Meningitis incidence for 41 subdistricts in Mali was determined from cases recorded in health centres (1989-98) and from surveillance data (1996-98). For incidence thresholds of 5 to 20 cases per 100 000 inhabitants per week, we calculated sensitivity and specificity for detecting epidemics, and determined the time lapse between threshold and epidemic peak. Findings We recorded 9084 meningitis cases. Clinic-based weekly incidence of 5 and 10 cases per 100 000 inhabitants detected all meningitis epidemics (sensitivity 100%, 95% CI 93-100), with median threshold-to-peak time of 5 and 3 weeks. Under-reporting reduced sensitivity: only surveillance thresholds of 5 or 7 cases per 100 000 inhabitants per week detected all epidemics. Crossing the lower threshold before the 10th calendar week doubled epidemic risk relative to crossing it later (relative risk 2.1, 95% CI 1.4-3.2). At 10 cases per 100 000 inhabitants per week, specificity for outbreak prediction was 88%, 95% CI 83-91). For populations under 30 000, 3 to 5 cases in one or two weeks predicted epidemics with 85% to 97% specificity. Interpretation Low meningitis thresholds improve timely detection of epidemics. Ten cases per 100 000 inhabitants per week in one area confirm epidemic activity in a region, with few false alarms. An alert threshold of 5 cases per 100 000 inhabitants per week allows time to investigate, prepare for an epidemic, and initiate mass vaccination where appropriate. For populations under 30 000, the alert threshold is two cases in a week. High quality surveillance is essential.	Epicentre, F-75011 Paris, France; Direct Natl Sante Publ, Div Epidemiol, Bamako, Mali		Lewis, R (corresponding author), WHO, POB 24578, Kampala, Uganda.							BLAKEBROUGH IS, 1983, ANN TROP MED PARASIT, V77, P175, DOI 10.1080/00034983.1983.11811694; Campagne G, 2000, PEDIATR INFECT DIS J, V19, P144, DOI 10.1097/00006454-200002000-00013; Caugant DA, 1998, APMIS, V106, P505, DOI 10.1111/j.1699-0463.1998.tb01379.x; de Chabalier F, 2000, T ROY SOC TROP MED H, V94, P664, DOI 10.1016/S0035-9203(00)90224-4; de Chabalier F, 2000, T ROY SOC TROP MED H, V94, P251, DOI 10.1016/S0035-9203(00)90308-0; GREENWOOD BM, 1984, LANCET, V1, P1339; GREENWOOD BM, 1980, T ROY SOC TROP MED H, V74, P340, DOI 10.1016/0035-9203(80)90095-4; Guibourdenche M, 1996, EPIDEMIOL INFECT, V116, P115, DOI 10.1017/S095026880005233X; HASSANKING MKA, 1988, J INFECTION, V16, P55, DOI 10.1016/S0163-4453(88)96117-8; Kaninda AV, 2000, INT J EPIDEMIOL, V29, P933, DOI 10.1093/ije/29.5.933; Kaninda AV, 1997, LANCET, V350, P1708, DOI 10.1016/S0140-6736(05)64315-2; LAPEYSSONNIE L, 1963, Bull World Health Organ, V28 Suppl, P1; LENGELER C, 1995, ACTA TROP, V59, P211, DOI 10.1016/0001-706X(95)00081-O; Lewis R, 2000, LANCET, V355, P1185, DOI 10.1016/S0140-6736(05)72265-0; LEWIS R, IN PRESS CAHIERS SAN; Lewis RF, 1998, LANCET, V352, P823, DOI 10.1016/S0140-6736(05)60723-4; MacLennan J, 1999, VACCINE, V17, P3086, DOI 10.1016/S0264-410X(99)00139-5; *MED SANS FRONT, 2000, MAN EP MEN MEN; Miller MA, 1999, PEDIATR INFECT DIS J, V18, P1051, DOI 10.1097/00006454-199912000-00005; MOORE PS, 1992, CLIN INFECT DIS, V14, P515, DOI 10.1093/clinids/14.2.515; MOORE PS, 1992, INT J EPIDEMIOL, V21, P155, DOI 10.1093/ije/21.1.155; REINGOLD AL, 1985, LANCET, V2, P114; SPIEGEL A, 1990, B SOC PATHOL EXOT, V83, P642; Varaine F, 1997, T ROY SOC TROP MED H, V91, P3, DOI 10.1016/S0035-9203(97)90371-0; VARAINE F, 2000, 6 M INT COORD GROUP; Veeken H, 1998, B WORLD HEALTH ORGAN, V76, P135; Wenger J, 1997, LANCET, V350, P1709, DOI 10.1016/S0140-6736(05)64316-4; *WHO, 1995, CONTR EP MEN DIS; Woods CW, 2000, LANCET, V355, P30, DOI 10.1016/S0140-6736(99)03366-8; World Health Organisation, 2000, WKLY EPIDEMIOL REC, V75, P306; World Health Organization, 1997, WKLY EPIDEMIOL REC, V72, P313; ZENG G, 1988, INT J EPIDEMIOL, V17, P673, DOI 10.1093/ije/17.3.673	32	38	38	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 28	2001	358	9278					287	293		10.1016/S0140-6736(01)05484-8	http://dx.doi.org/10.1016/S0140-6736(01)05484-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	457AF	11498215				2022-12-28	WOS:000170114400012
J	Charrier, I; Mathevon, N; Jouventin, P				Charrier, I; Mathevon, N; Jouventin, P			Mother's voice recognition by seal pups - Newborns need to learn their mother's call before she can take off on a fishing trip.	NATURE			English	Article							ARCTOCEPHALUS-TROPICALIS; VOCAL RECOGNITION; AMSTERDAM ISLAND; FUR SEALS; GROWTH		Univ St Etienne, Lab Biol Anim, F-42023 St Etienne 2, France; CNRS, CEFE, UPR 9056, F-34213 Montpellier, France; CNRS, NAMC, UMR 8620, F-91400 Orsay, France	Universite Jean Monnet; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS)	Charrier, I (corresponding author), Univ St Etienne, Lab Biol Anim, F-42023 St Etienne 2, France.	mathevon@univ-st-etienne.fr		CHARRIER, Isabelle/0000-0003-4873-2342				Addae PC, 2000, APPL ANIM BEHAV SCI, V67, P77, DOI 10.1016/S0168-1591(99)00119-7; Gentry R.L., 1986, FUR SEALS MATERNAL S; Georges JY, 2000, ECOLOGY, V81, P295, DOI 10.2307/177427; Georges JY, 2000, J ZOOL, V251, P277, DOI 10.1111/j.1469-7998.2000.tb01078.x; Hofer M.A., 1981, P77; Insley SJ, 2000, NATURE, V406, P404, DOI 10.1038/35019064; JONES IL, 1987, ANIM BEHAV, V35, P1405, DOI 10.1016/S0003-3472(87)80013-1; KERLEY GIH, 1985, J ZOOL, V205, P315; RIEDMAN M, 1990, PINNIPEDS SEALS SEA; Roux J.-P., 1987, NOAA Technical Report NMFS, V51, P95; STIRLING I, 1975, J AUST MAMMAL SOC, V1, P389	11	93	97	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2001	412	6850					873	873		10.1038/35091136	http://dx.doi.org/10.1038/35091136			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467EG	11528465	Bronze			2022-12-28	WOS:000170689000031
J	Wilson, HR; Blake, R; Lee, SH				Wilson, HR; Blake, R; Lee, SH			Dynamics of travelling waves in visual perception	NATURE			English	Article							BINOCULAR-RIVALRY; STRIATE CORTEX; VISION; OSCILLATIONS; CONNECTIONS; INTEGRATION; FIELD	Nonlinear wave propagation is ubiquitous in nature, appearing in chemical reaction kinetics(1), cardiac tissue dynamics(1,2), cortical spreading depression(3) and slow wave sleep(4). The application of dynamical modelling has provided valuable insights into the mechanisms underlying such nonlinear wave phenomena in several domains(1,2,5,6). Wave propagation can also be perceived as sweeping waves of visibility that occur when the two eyes view radically different stimuli. Termed binocular rivalry, these fluctuating states of perceptual dominance and suppression are thought to provide a window into the neural dynamics that underlie conscious visual awareness(7,8). Here we introduce a technique to measure the speed of rivalry dominance waves propagating around a large, essentially one-dimensional annulus. When mapped onto visual cortex, propagation speed is independent of eccentricity. Propagation speed doubles when waves travel along continuous contours, thus demonstrating effects of collinear facilitation. A neural model with reciprocal inhibition between two layers of units provides a quantitative explanation of dominance wave propagation in terms of disinhibition. Dominance waves provide a new tool for investigating fundamental cortical dynamics.	York Univ, Biol & Ctr Vis Res, Toronto, ON M3J 1P3, Canada; Vanderbilt Univ, Dept Psychol, Nashville, TN 37203 USA	York University - Canada; Vanderbilt University	Wilson, HR (corresponding author), York Univ, Biol & Ctr Vis Res, 4700 Keele St, Toronto, ON M3J 1P3, Canada.		Lee, Sang-Hun/B-9898-2008					Alais D, 1999, VISION RES, V39, P4341, DOI 10.1016/S0042-6989(99)00146-7; Basarsky TA, 1998, J NEUROSCI, V18, P7189; BLAKE R, 1989, PSYCHOL REV, V96, P145, DOI 10.1037/0033-295X.96.1.145; BLAKE R, 1992, VISUAL NEUROSCI, V8, P469, DOI 10.1017/S0952523800004971; BLAKE R, 1990, PERCEPT PSYCHOPHYS, V48, P593, DOI 10.3758/BF03211605; Crick F, 1998, CEREB CORTEX, V8, P97, DOI 10.1093/cercor/8.2.97; DAS A, 1995, NATURE, V375, P780, DOI 10.1038/375780a0; Ermentrout GB, 2001, NEURON, V29, P33, DOI 10.1016/S0896-6273(01)00178-7; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; HITCHCOCK PF, 1980, BRAIN RES, V182, P176; HORTON JC, 1991, ARCH OPHTHALMOL-CHIC, V109, P816, DOI 10.1001/archopht.1991.01080060080030; Kamitani Y, 1999, NAT NEUROSCI, V2, P767, DOI 10.1038/11245; KIM U, 1995, J NEUROPHYSIOL, V74, P1301, DOI 10.1152/jn.1995.74.3.1301; Kovacs I, 1996, P NATL ACAD SCI USA, V93, P15508, DOI 10.1073/pnas.93.26.15508; LEHKY SR, 1988, PERCEPTION, V17, P215, DOI 10.1068/p170215; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; Logothetis NK, 1998, PHILOS T R SOC B, V353, P1801, DOI 10.1098/rstb.1998.0333; Logothetis NK, 1996, NATURE, V380, P621, DOI 10.1038/380621a0; MALACH R, 1993, P NATL ACAD SCI USA, V90, P10469, DOI 10.1073/pnas.90.22.10469; MCCORMICK DA, 1989, P NATL ACAD SCI USA, V86, P8098, DOI 10.1073/pnas.86.20.8098; Nagai Y, 2000, PHYS REV LETT, V84, P4248, DOI 10.1103/PhysRevLett.84.4248; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; Rinzel J, 1998, SCIENCE, V279, P1351, DOI 10.1126/science.279.5355.1351; Somers DC, 1998, CEREB CORTEX, V8, P204, DOI 10.1093/cercor/8.3.204; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; WALKER P, 1979, VISION RES, V19, P247, DOI 10.1016/0042-6989(79)90169-X; Wilson H.R., 1999, SPIKES DECISIONS ACT; Wilson HR, 2000, NAT NEUROSCI, V3, P170, DOI 10.1038/72115; Winfree A.T., 1987, TIME BREAKS 3 DIMENS; WOLFE JM, 1983, PERCEPTION, V12, P447, DOI 10.1068/p120447	30	207	208	2	18	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2001	412	6850					907	910		10.1038/35091066	http://dx.doi.org/10.1038/35091066			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467EG	11528478				2022-12-28	WOS:000170689000044
J	Koga, K; Gao, GT; Tanaka, H; Zeng, XC				Koga, K; Gao, GT; Tanaka, H; Zeng, XC			Formation of ordered ice nanotubes inside carbon nanotubes	NATURE			English	Article							NANOCAPILLARITY; MICROTUBULES; CAPILLARITY; NANORODS; WATER	Following their discovery(1), carbon nanotubes have attracted interest not only for their unusual electrical and mechanical properties, but also because their hollow interior can serve as a nanometre-sized capillary(2-7), mould(8-11) or template(12-14) in material fabrication. The ability to encapsulate a material in a nanotube also offers new possibilities for investigating dimensionally confined phase transitions(15). Particularly intriguing is the conjecture(16) that matter within the narrow confines of a carbon nanotube might exhibit a solid-liquid critical point(17) beyond which the distinction between solid and liquid phases disappears. This unusual feature, which cannot occur in bulk material, would allow for the direct and continuous transformation of liquid matter into a solid. Here we report simulations of the behaviour of water encapsulated in carbon nanotubes that suggest the existence of a variety of new ice phases not seen in bulk ice, and of a solid-liquid critical point. Using carbon nanotubes with diameters ranging from 1.1 nm to 1.4 nm and applied axial pressures of 50 MPa to 500 MPa, we rnd that water can exhibit a first-order freezing transition to hexagonal and heptagonal ice nanotubes, and a continuous phase transformation into solid-like square or pentagonal ice nanotubes.	Fukuoka Univ Educ, Dept Chem, Fukuoka 8114192, Japan; Univ Nebraska, Dept Chem, Lincoln, NE 68588 USA; Univ Nebraska, Ctr Mat & Anal, Lincoln, NE 68588 USA; Okayama Univ, Dept Chem, Okayama 7008530, Japan	Fukuoka University Education; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Okayama University	Koga, K (corresponding author), Fukuoka Univ Educ, Dept Chem, Fukuoka 8114192, Japan.		Gao, Guangtu/F-4541-2012; Tanaka, Hideki/B-1456-2011; Zeng, Xiao Cheng/C-1590-2013; Koga, Kenichiro/B-2635-2011	Zeng, Xiao Cheng/0000-0003-4672-8585; Koga, Kenichiro/0000-0002-1153-5831				AJAYAN PM, 1993, NATURE, V361, P333, DOI 10.1038/361333a0; AJAYAN PM, 1995, NATURE, V375, P564, DOI 10.1038/375564a0; BALL P, 1993, NATURE, V361, P297, DOI 10.1038/361297a0; DAI HJ, 1995, NATURE, V375, P769, DOI 10.1038/375769a0; DAVID VP, 1995, NATURE, V374, P602; DUJARDIN E, 1994, SCIENCE, V265, P1850, DOI 10.1126/science.265.5180.1850; Fan X, 2000, PHYS REV LETT, V84, P4621, DOI 10.1103/PhysRevLett.84.4621; Gao GT, 2000, J CHEM PHYS, V112, P8534, DOI 10.1063/1.481457; GOTO K, 1986, JPN J APPL PHYS 1, V25, P351, DOI 10.1143/JJAP.25.351; GUERRET-PIECOURT C, 1994, NATURE, V372, P761, DOI 10.1038/372761a0; HAMADA N, 1992, PHYS REV LETT, V68, P1579, DOI 10.1103/PhysRevLett.68.1579; Han WQ, 1997, SCIENCE, V277, P1287, DOI 10.1126/science.277.5330.1287; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kiang CH, 1999, J PHYS CHEM B, V103, P7449, DOI 10.1021/jp991424m; Koga K, 2000, J CHEM PHYS, V113, P5037, DOI 10.1063/1.1289554; Lobban C, 2000, J CHEM PHYS, V112, P7169, DOI 10.1063/1.481282; Meyer RR, 2000, SCIENCE, V289, P1324, DOI 10.1126/science.289.5483.1324; PEDERSON MR, 1992, PHYS REV LETT, V69, P2689, DOI 10.1103/PhysRevLett.69.2689; RAPAPORT DC, 1997, ART MOL DYNAMICS SIM, P48302; RUOFF RS, 1993, SCIENCE, V259, P346, DOI 10.1126/science.259.5093.346; STANLEY HE, 1971, INTRO PHASE TRANSITI, V2; Steele W.A., 1974, INTERACTION GASES SO; TSANG SC, 1994, NATURE, V372, P159, DOI 10.1038/372159a0; Ugarte D, 1996, SCIENCE, V274, P1897, DOI 10.1126/science.274.5294.1897	25	921	948	14	393	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2001	412	6849					802	805		10.1038/35090532	http://dx.doi.org/10.1038/35090532			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465ET	11518961	Green Published			2022-12-28	WOS:000170577200032
J	Levin, A				Levin, A			The Cochrane Collaboration	ANNALS OF INTERNAL MEDICINE			English	Article																			0	43	46	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 21	2001	135	4					309	312		10.7326/0003-4819-135-4-200108210-00035	http://dx.doi.org/10.7326/0003-4819-135-4-200108210-00035			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465KE	11511165				2022-12-28	WOS:000170587500027
J	Ford, N; 't Hoen, E				Ford, N; 't Hoen, E			The Global Health Fund: moral imperative or industry subsidy?	LANCET			English	Editorial Material									Med Sans Frontieres, London EC1R 5DJ, England	Doctors Without Borders	Ford, N (corresponding author), Med Sans Frontieres, 124-132 Clerkenwell Rd, London EC1R 5DJ, England.							Brugha R, 2001, BRIT MED J, V323, P152, DOI 10.1136/bmj.323.7305.152; *MED SANS FRONT, 2001, PILLS POCK EQ PRIC E	2	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 18	2001	358	9281					578	578		10.1016/S0140-6736(01)05711-7	http://dx.doi.org/10.1016/S0140-6736(01)05711-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464NB	11520549				2022-12-28	WOS:000170537700035
J	Bibby, TS; Nield, J; Barber, J				Bibby, TS; Nield, J; Barber, J			Iron deficiency induces the formation of an antenna ring around trimeric photosystem I in cyanobacteria	NATURE			English	Article							PHOTOSYNTHETIC REACTION-CENTER; EQUATORIAL PACIFIC-OCEAN; ISIA GENE; COMPLEX; SYNECHOCYSTIS-6803; CRYSTALLOGRAPHY; LIMITATION; RESOLUTION; BACTERIA; SYSTEM	Although iron is the fourth most abundant element in the Earth's crust, its concentration in the aquatic ecosystems-particularly the open oceans-is sufficiently low to limit photosynthetic activity and phytoplankton growth(1,2). Cyanobacteria, a major class of phytoplankton, respond to iron deficiency by expressing the 'iron-stress-induced' gene, isiA(ref. 3). The protein encoded by this gene has an amino-acid sequence that shows significant homology with one of the chlorophyll a-binding proteins (CP43) of photosystem II (PSII)(4,5). The precise function of the CP43-like protein, here called CP43', has not been elucidated, although there have been many suggestions(3,6). Here we show that CP43' associates with photosystem I (PSI) to form a complex that consists of a ring of 18 CP43' molecules around a PSI trimer. This significantly increases the size of the light-harvesting system of PSI. The utilization of a PSII-like protein as an extra antenna for PSI emphasises the flexibility of cyanobacterial light-harvesting systems, and seems to be a strategy which compensates for the lowering of phycobilisome and PSI levels in response to iron deficiency.	Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, Wolfson Labs, London SW7 2AY, England	Imperial College London	Barber, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, Wolfson Labs, London SW7 2AY, England.	j.barber@ic.ac.uk	Nield, Jon/C-5892-2013; Bibby, Thomas/C-9159-2014	Nield, Jon/0000-0001-9983-0239; Bibby, Thomas/0000-0003-1743-473X				Behrenfeld MJ, 1996, NATURE, V383, P508, DOI 10.1038/383508a0; BOEKEMA EJ, 1994, J BIOENERG BIOMEMBR, V26, P17, DOI 10.1007/BF00763217; Bricker TM, 1998, BBA-BIOENERGETICS, V1409, P50, DOI 10.1016/S0005-2728(98)00148-0; BURNAP RL, 1993, PLANT PHYSIOL, V103, P893, DOI 10.1104/pp.103.3.893; Cogdell RJ, 1999, J BACTERIOL, V181, P3869, DOI 10.1128/JB.181.13.3869-3879.1999; FALK S, 1995, PHOTOSYNTH RES, V45, P51, DOI 10.1007/BF00032235; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hankamer B, 1999, NAT STRUCT BIOL, V6, P560, DOI 10.1038/9341; Hankamer B, 1997, EUR J BIOCHEM, V243, P422, DOI 10.1111/j.1432-1033.1997.0422a.x; Krauss N, 1996, NAT STRUCT BIOL, V3, P965, DOI 10.1038/nsb1196-965; MARTIN JH, 1994, NATURE, V371, P123, DOI 10.1038/371123a0; MCDERMOTT G, 1995, NATURE, V374, P517, DOI 10.1038/374517a0; Park YI, 1999, MOL MICROBIOL, V32, P123, DOI 10.1046/j.1365-2958.1999.01332.x; ROGNER M, 1990, BIOCHIM BIOPHYS ACTA, V1015, P415, DOI 10.1016/0005-2728(90)90074-E; Schubert WD, 1997, J MOL BIOL, V272, P741, DOI 10.1006/jmbi.1997.1269; Sherman MB, 1998, ULTRAMICROSCOPY, V74, P179, DOI 10.1016/S0304-3991(98)00041-2; Straus N.A., 1994, MOL BIOL CYANOBACTER, P731, DOI DOI 10.1007/978-94-011-0227-8_25; TANG XS, 1994, BIOCHEMISTRY-US, V33, P4594, DOI 10.1021/bi00181a021; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	22	289	304	0	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2001	412	6848					743	745		10.1038/35089098	http://dx.doi.org/10.1038/35089098			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462ZB	11507643				2022-12-28	WOS:000170450200047
J	Maisel, WH; Sweeney, MO; Stevenson, WG; Ellison, KE; Epstein, LM				Maisel, WH; Sweeney, MO; Stevenson, WG; Ellison, KE; Epstein, LM			Recalls and safety alerts involving pacemakers and implantable cardioverter-defibrillator generators	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONGESTIVE-HEART-FAILURE; RANDOMIZED TRIAL; IMPACT; DEVICES; RISK; PERFORMANCE; MANAGEMENT; DISEASE; ATRIAL; DEATH	Context Unanticipated pacemaker and implantable cardioverter-defibrillator (ICD) generator malfunctions sometimes warrant recall by the US Food and Drug Administration (FDA). Despite increasingly frequent device implantation, pacemaker and ICD recalls and safety alerts (advisories) remain poorly characterized. Objectives To determine pacemaker and ICD generator advisory rates in the United States, to identify trends in these rates, and to examine their clinical and financial implications. Design and Setting Analysis of weekly FDA Enforcement Reports issued between January 1990 and December 2000 to identify all advisories involving pacemaker or ICD generators in the United States. Recalls and safety alerts involving lead malfunctions were not included. Main Outcome Measures Number of pacemakers and ICD generators in the United States subject to FDA recall or safety alert in 1990-2000; annual pacemaker and ICD advisory rates in the United States in 1990-2000; and estimated cost of device advisories. Results During the study period, 52 advisories (median [25th and 75th percentiles], 4 [4 and 7] per year) involving 408500 pacemakers and 114645 ICDs (523 145 total devices) were issued. Hardware malfunctions (35 advisories affecting 280641 devices) and computer errors (10 advisories affecting 216533 devices) accounted for 95 % of device recalls. Implantable cardioverter-clefibrillators were recalled more frequently than pacemakers (mean [SD], 16.4 [1.6] vs 6.7 [0.8] advisories per 100 person-years; P<.001). Between 1995 and 2000, the annual advisory rate increased for both pacemakers (P for trend <.001) and ICDs (P for trend =.02). An estimated 1.3 million device checks and analyses and 36187 device replacements resulted from the advisories and cost approximately $870 million. Conclusions Pacemaker and ICD recalls and safety alerts occur frequently, affect many patients, and appear to be increasing in number and rate. With the growing number of device implants and expanding indications for device therapy, the number of patients affected by device advisories will likely continue to increase.	Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Cardiac Arrhythmia Serv, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Maisel, WH (corresponding author), Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Cardiac Arrhythmia Serv, 75 Francis St, Boston, MA 02115 USA.		Epstein, Laurence/AAQ-7571-2021; Epstein, Laurence/ABB-1592-2020	Epstein, Laurence/0000-0001-5410-0291				*AM COLL CARD, 2000, GUID CPT 2000; Andersen HR, 1997, LANCET, V350, P1210, DOI 10.1016/S0140-6736(97)03425-9; Aydemir O, 1997, PACE, V20, P1628, DOI 10.1111/j.1540-8159.1997.tb03531.x; *BUR DAT MAN STRAT, 2001, PAYM RAT I PROV OUTL; Buxton AE, 1999, NEW ENGL J MED, V341, P1882, DOI 10.1056/NEJM199912163412503; Carpenter CM, 1998, J CARDIOVASC ELECTR, V9, P1008, DOI 10.1111/j.1540-8167.1998.tb00143.x; Centers for Medicare and Medicaid Services (Cms), 2000, FED REGISTER, V65, P47054; Connolly SJ, 2000, CIRCULATION, V101, P1297, DOI 10.1161/01.CIR.101.11.1297; Connolly SJ, 2000, NEW ENGL J MED, V342, P1385, DOI 10.1056/NEJM200005113421902; *FOOD DRUG ADM, 1997, FDA ENF REP; *FOOD DRUG ADM, 1999, FDA ENF REP; Godin JF, 1997, PACE, V20, P747, DOI 10.1111/j.1540-8159.1997.tb03899.x; Goldman BS, 1996, PACE, V19, P7, DOI 10.1111/j.1540-8159.1996.tb04785.x; Gras D, 1998, PACE, V21, P2249, DOI 10.1111/j.1540-8159.1998.tb01162.x; *GUID CORP, 1999, GUID PROD PERF REP; Higgins SL, 1999, AM J CARDIOL, V83, p79D; Kawanishi DT, 1996, PACE, V19, P1819, DOI 10.1111/j.1540-8159.1996.tb03232.x; Kawanishi DT, 1998, PACE, V21, P2322, DOI 10.1111/j.1540-8159.1998.tb01175.x; Lamas GA, 1998, NEW ENGL J MED, V338, P1097, DOI 10.1056/NEJM199804163381602; LANGEWIESCHE W, 1998, ATLANTIC MONTHLY, V281, P81; Levin PJ, 1997, J INVASIVE CARDIOL, V9, P138; LLEWELLYN MJ, 1989, PACE, V12, P1014, DOI 10.1111/j.1540-8159.1989.tb01918.x; MACGREGOR DC, 1977, J THORAC CARDIOV SUR, V74, P657, DOI 10.1016/S0022-5223(19)41201-4; McAnulty J, 1997, NEW ENGL J MED, V337, P1576; *MEDTR, 2000, MEDTR PROD PERF REP; *MEDTR, 1999, MEDTR PROD PERF REP; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; Nanthakumar K, 1998, PACE, V21, P87, DOI 10.1111/j.1540-8159.1998.tb01065.x; *NAT CTR HLTH STAT, 1997, HLTH US 1996 97 INJ, P217; *NAT CTR HLTH STAT, 1994, HLTH US 1993, P187; *NAT CTR HLTH STAT, 1999, HLTH US 1999 HLTH AG, P255; *NAT CTR HLTH STAT, 1998, HLTH US 1998 SOC STA, P311; *NAT CTR HLTH STAT, 1996, HLTH US 1995, P205; *NAT HOSP DISCH SU, 1998, VIT HLTH STAT 13, V133, P41; *NAT HOSP DISCH SU, 1999, VIT HLTH STAT 13, V144, P31; *NAT HOSP DISCH SU, 1999, VIT HLTH STAT 13, V140, P31; *NAT HOSP DISCH SU, 2000, ADV DATA, V316, P13; *NAT HOSP DISCH SU, 1995, VIT HLTH STAT 13, V121, P45; Reynolds DW, 1998, PACE, V21, P1646, DOI 10.1111/j.1540-8159.1998.tb00254.x; Saksena S, 1999, PACE, V22, P950, DOI 10.1111/j.1540-8159.1999.tb06821.x; Saxon LA, 1999, AM J CARDIOL, V83, p120D; Sears SE, 1999, CLIN CARDIOL, V22, P481; SIEBELS J, 1994, AM HEART J, V127, P1139, DOI 10.1016/0002-8703(94)90101-5; SILVERMAN BG, 1995, PUBLIC HEALTH REP, V110, P42; SNEED NV, 1994, HEART LUNG, V23, P317; SONG SL, 1994, PACE, V17, P692, DOI 10.1111/j.1540-8159.1994.tb02410.x; *ST JUD MED, 1998, PAC PROD PERF REP; *SULZ INT INC, 1997, SULZ INT PROD PERF R; *TEL PAC SYST, 1996, TEL PROD PERF REP AI; *TRENDS HLTH OLD A, 1995, VIT HLTH STAT 3, V30, P223; TYERS GFO, 1989, ANN THORAC SURG, V48, P390, DOI 10.1016/S0003-4975(10)62864-0; *US CENS BUR, 2000, ANN POP EST AG GROUP; *WAYS MEANS COMM, 1996, 1996 GREEN BOOK; 1998, FED REG, V63, P47601; 1999, FED REG, V64, P59379	55	137	137	1	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2001	286	7					793	799		10.1001/jama.286.7.793	http://dx.doi.org/10.1001/jama.286.7.793			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	462PU	11497532				2022-12-28	WOS:000170429600026
J	Cagnin, A; Brooks, DJ; Kennedy, AM; Gunn, RN; Myers, R; Turkheimer, FE; Jones, T; Banati, RB				Cagnin, A; Brooks, DJ; Kennedy, AM; Gunn, RN; Myers, R; Turkheimer, FE; Jones, T; Banati, RB			In-vivo measurement of activated microglia in dementia	LANCET			English	Article							H-3 PK11195 BINDING; ALZHEIMERS-DISEASE; PERIPHERAL BENZODIAZEPINE; EMISSION TOMOGRAPHY; FOCAL ISCHEMIA; BRAIN; PET; LESIONS; SITES; HIPPOCAMPUS	Background Activated microglia have a key role in the brain's immune response to neuronal degeneration. The transition of microglia from the normal resting state to the activated state is associated with an increased expression of receptors known as peripheral benzodiazepine binding sites, which are abundant on cells of mononuclear phagocyte lineage. We used brain imaging to study expression of these sites in healthy individuals and patients with Alzheimer's disease. Methods We studied 15 normal individuals (age 32-80 years), eight patients with Alzheimer's disease, and one patient with minimal cognitive impairment. Quantitative in-vivo measurements of glial activation were obtained with positron emission tomography (PET) and carbon-11-labelled (R)-PK11195, a specific ligand for the peripheral benzodiazepine binding site. Findings In normal individuals, regional [C-11](R)-PK11195 binding did not significantly change with age, except in the thalamus, where an age-dependent increase was found. By contrast, patients with Alzheimer's disease showed significantly increased regional [C-11](R)-PK11195 binding in the entorhinal, temporoparietal, and cingulate cortex. Interpretation In-vivo detection of increased [C-11](R)-PK11195 binding in Alzheimer-type dementia, including mild and early forms, suggests that microglial activation is an early event in the pathogenesis of the disease.	Hammersmith Hosp, Fac Med, Imperial Coll,Div Neurosci & Psychol Med, MRC Cyclotron Unit, London W12 0NN, England; Max Planck Inst Neurobiol, Dept Neuromorphol, Martinsried, Germany; Fac Med, Imperial Coll, Dept Neuropathol, Div Neurosci & Psychol Med, London, England	Imperial College London; Max Planck Society; Imperial College London	Banati, RB (corresponding author), Hammersmith Hosp, Fac Med, Imperial Coll,Div Neurosci & Psychol Med, MRC Cyclotron Unit, London W12 0NN, England.	richard.banati@csc.mrc.ac.uk	Turkheimer, Federico E/B-9485-2012; Gunn, Roger/H-1666-2012	Turkheimer, Federico E/0000-0002-3766-3815; Gunn, Roger/0000-0003-1181-5769; Brooks, David/0000-0003-2602-2518				Alzheimer A, 1911, Z GESAMTE NEUROL PSY, V4, P356, DOI 10.1007/BF02866241; Banati RB, 1997, J NEUROCYTOL, V26, P77, DOI 10.1023/A:1018567510105; Banati RB, 2000, BRAIN, V123, P2321, DOI 10.1093/brain/123.11.2321; Barger SW, 1997, NATURE, V388, P878, DOI 10.1038/42257; BLINZING.K, 1968, Z ZELLFORSCH MIK ANA, V85, P145, DOI 10.1007/BF00325030; Conway EL, 1998, NEUROSCIENCE, V82, P805; CUNNINGHAM VJ, 1993, J CEREBR BLOOD F MET, V13, P15, DOI 10.1038/jcbfm.1993.5; Dumont F, 1999, EUR J NUCL MED, V26, P194, DOI 10.1007/s002590050376; Esiri M. M., 1997, GREENFIELDS NEUROPAT, P153; GROOM GN, 1995, J NUCL MED, V36, P2207; Gunn RN, 1998, QUANTITATIVE FUNCTIONAL BRAIN IMAGING WITH POSITRON EMISSION TOMOGRAPHY, P401, DOI 10.1016/B978-012161340-2/50062-7; HAJNAL JV, 1995, J COMPUT ASSIST TOMO, V19, P677, DOI 10.1097/00004728-199509000-00001; Hertz L., 1993, PERIPHERAL BENZODIAZ, P27; Hu MTM, 2000, BRAIN, V123, P340, DOI 10.1093/brain/123.2.340; Hulette CM, 1998, J NEUROPATH EXP NEUR, V57, P1168, DOI 10.1097/00005072-199812000-00009; Killiany RJ, 2000, ANN NEUROL, V47, P430, DOI 10.1002/1531-8249(200004)47:4<430::AID-ANA5>3.0.CO;2-I; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; McGeer PL, 1995, BRAIN RES REV, V21, P195, DOI 10.1016/0165-0173(95)00011-9; Meguro K, 1999, BRAIN, V122, P1519, DOI 10.1093/brain/122.8.1519; Minoshima S, 1997, ANN NEUROL, V42, P85, DOI 10.1002/ana.410420114; MYERS R, 1991, NEUROSCI LETT, V133, P20, DOI 10.1016/0304-3940(91)90047-W; Niemann K, 2000, PSYCHIAT RES-NEUROIM, V99, P93, DOI 10.1016/S0925-4927(00)00059-7; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Price JL, 1999, ANN NEUROL, V45, P358, DOI 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; SETTE G, 1993, STROKE, V24, P2046, DOI 10.1161/01.STR.24.12.2046; SHAH F, 1994, NUCL MED BIOL, V21, P573, DOI 10.1016/0969-8051(94)90022-1; Tan J, 1999, SCIENCE, V286, P2352, DOI 10.1126/science.286.5448.2352; Veld BAI, 1998, NEUROBIOL AGING, V19, P607, DOI 10.1016/S0197-4580(98)00096-7	30	805	827	0	47	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 11	2001	358	9280					461	467		10.1016/S0140-6736(01)05625-2	http://dx.doi.org/10.1016/S0140-6736(01)05625-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463TB	11513911				2022-12-28	WOS:000170492400013
J	Matte, TD; Bresnahan, M; Begg, MD; Susser, E				Matte, TD; Bresnahan, M; Begg, MD; Susser, E			Influence of variation in birth weight within normal range and within sibships on IQ at age 7 years: cohort study	BRITISH MEDICAL JOURNAL			English	Article							CHILDREN; GROWTH	Objective To examine the relation between birth weight and measured intelligence at age 7 years in children within the normal range of birth weight and in siblings. Design Cohort study of siblings of the same sex. Setting 12 cities in the United States. Subjects 3484 children of 1683 mothers in a birth cohort study during the years 1959 through 1966. The sample was restricted to children born at greater than or equal to 37 weeks gestation and with birth weights of 1500-3999 g. Main outcome measure Full scale IQ at age 7 years. Results Mean IQ increased monotonically with birth weight in both sexes across the range of birth weight in a linear regression analysis of one randomly selected sibling per family (n = 1683) with adjustment for maternal age, race, education, socioeconomic status, and birth order. Within same sex sibling pairs, differences in birth weight were directly associated with differences in IQ in boys (812 pairs, predicted IQ difference per 100 g change in birth weight = 0.50, 95% confidence interval 0.28 to 0.71) but not girls (871 pairs, 0.10, - 0.09 to 0.30). The effect in boys remained after differences in birth order, maternal smoking, and head circumference were adjusted for and in an analysis restricted to children with birth weight greater than or equal to 2500 g. Conclusion The increase in childhood IQ with birth weight continues well into the normal birth weight range. For boys this relation holds within same sex sibships and therefore cannot be explained by confounding from family social environment.	New York Acad Med, Ctr Urban Epidemiol Studies, New York, NY 10029 USA; Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10032 USA; Columbia Univ, Mailman Sch Publ Hlth, Div Biostat, New York, NY 10032 USA	New York Academy of Medicine; Columbia University; Columbia University	Matte, TD (corresponding author), New York Acad Med, Ctr Urban Epidemiol Studies, 1216 5th Ave, New York, NY 10029 USA.							[Anonymous], 1999, NATL VITAL STAT REPO; BRESLAU N, 1995, EPIDEMIOL REV, V17, P96, DOI 10.1093/oxfordjournals.epirev.a036191; Breslau N, 1996, BIOL PSYCHIAT, V40, P389, DOI 10.1016/0006-3223(95)00399-1; BRESLAU N, 1994, ARCH PEDIAT ADOL MED, V148, P377, DOI 10.1001/archpedi.1994.02170040043007; Broman SH, 1984, HDB LONGITUDINAL RES, V1; *COLL PER PROJ EL, 1958, REC NAT I NEUR DIS S; Forsen T, 1999, BRIT MED J, V319, P1403, DOI 10.1136/bmj.319.7222.1403; HARDY JB, 1977, EPIDEMIOLOGY PREMATU; Hutchison JB, 1997, CELL MOL NEUROBIOL, V17, P603, DOI 10.1023/A:1022581902880; MCCORMICK MC, 1992, JAMA-J AM MED ASSOC, V267, P2204, DOI 10.1001/jama.267.16.2204; MYRIANTHOPOULOS NC, 1968, SOC SCI MED, V2, P283, DOI 10.1016/0037-7856(68)90004-8; NISWANDER NR, 1972, WOMEN THEIR PREGNANC; RECORD RG, 1969, ANN HUM GENET, V33, P71, DOI 10.1111/j.1469-1809.1969.tb01631.x; Richter CP, 1922, COMP PSYCHOL MONOGR, V1, P56; Sorensen HT, 1997, BRIT MED J, V315, P401, DOI 10.1136/bmj.315.7105.401; Stein Z., 1975, FAMINE HUM DEV DUTCH; Strauss RS, 1998, J PEDIATR-US, V133, P67, DOI 10.1016/S0022-3476(98)70180-5; Wechsler D., 2016, WECHSLER INTELLIGENC	18	218	221	1	8	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 11	2001	323	7308					310	314		10.1136/bmj.323.7308.310	http://dx.doi.org/10.1136/bmj.323.7308.310			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463HK	11498487	Green Published, Bronze			2022-12-28	WOS:000170470900018
J	Gratacos, M; Nadal, M; Martin-Santos, R; Pujana, MA; Gago, J; Peral, B; Armengol, L; Ponsa, I; Miro, R; Bulbena, A; Estivill, X				Gratacos, M; Nadal, M; Martin-Santos, R; Pujana, MA; Gago, J; Peral, B; Armengol, L; Ponsa, I; Miro, R; Bulbena, A; Estivill, X			A polymorphic genomic duplication on human chromosome 15 is a susceptibility factor for panic and phobic disorders	CELL			English	Article							JOINT HYPERMOBILITY SYNDROME; ANXIETY DISORDERS; LOCUS-CERULEUS; TRK FAMILY; RECEPTOR; CELLS; NEUROTROPHIN-3; REARRANGEMENTS; ASSOCIATION; HYPOTHESIS	Anxiety disorders are complex and common psychiatric illnesses associated with considerable morbidity and social cost. We have studied the molecular basis of the cooccurrence of panic and phobic disorders with joint laxity. We have identified an interstitial duplication of human chromosome 15q24-26 (named DUP25), which is significantly associated with panic/agoraphobia/social phobia/joint laxity in families, and with panic disorder in nonfamilial cases. Mosaicism, different forms of DUP25 within the same family, and absence of segregation of 15q24-26 markers with DUP25 and the psychiatric phenotypes suggest a non-Mendelian mechanism of disease-causing mutation. We propose that DUP25, which is present in 7% control subjects, is a susceptibility factor for a clinical phenotype that includes panic and phobic disorders and joint laxity.	IRO, Ctr Genet Med & Mol, E-08907 Barcelona, Catalonia, Spain; Hosp Mare Deu Esperanca, IMAS, Dept Psiquiatria, E-08083 Barcelona, Catalonia, Spain; IMIM, Unitat Recerca Psiquiatria, E-08083 Barcelona, Catalonia, Spain; Univ Autonoma Barcelona, Dept Biol Cellular Fisiol & Immunol, E-08193 Bellaterra, Catalonia, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Autonomous University of Barcelona	Estivill, X (corresponding author), IRO, Ctr Genet Med & Mol, E-08907 Barcelona, Catalonia, Spain.	estivill@iro.es	Peral, Belén/F-4562-2015; Bulbena, Antonio/AAG-5411-2019; Pujana, Miquel Angel/N-3127-2014; Estivill, Xavier/E-2957-2012; Estivill, Xavier/A-3125-2013	Peral, Belén/0000-0003-4984-4020; Bulbena, Antonio/0000-0003-2404-2478; Pujana, Miquel Angel/0000-0003-3222-4044; Estivill, Xavier/0000-0002-0723-2256; Nadal, Marga/0000-0002-5739-1693; Ponsa, Immaculada/0000-0003-3436-1907; miro, rosa/0000-0003-2508-5074				*AM PSYCH ASS, 1987, DSM3R DIAGN STAT MAN; ANASTASI J, 1990, AM J PATHOL, V136, P131; BARLOW DH, 1986, J NERV MENT DIS, V174, P63, DOI 10.1097/00005053-198602000-00001; Beighton PH, 1989, HYPERMOBILITY JOINTS; BRINK RA, 1968, SCIENCE, V159, P161, DOI 10.1126/science.159.3811.161; BULBENA A, 1993, PSYCHIAT RES, V46, P59, DOI 10.1016/0165-1781(93)90008-5; BULBENA A, 1988, LANCET, V2, P694; CELI FS, 1994, GENOMICS, V21, P304, DOI 10.1006/geno.1994.1270; COHEN ME, 1951, AM J HUM GENET, V3, P126; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; CROWE RR, 1983, ARCH GEN PSYCHIAT, V40, P1065; Crowe RR, 2001, AM J MED GENET, V105, P105, DOI 10.1002/1096-8628(20010108)105:1<105::AID-AJMG1072>3.0.CO;2-P; CURTIS D, 1994, ANN HUM GENET, V58, P151, DOI 10.1111/j.1469-1809.1994.tb01884.x; Deckert J, 1999, HUM MOL GENET, V8, P621, DOI 10.1093/hmg/8.4.621; Eichler EE, 1998, GENOME RES, V8, P758, DOI 10.1101/gr.8.8.758; ENG CM, 1991, GENOMICS, V9, P278, DOI 10.1016/0888-7543(91)90253-B; FOOTE SL, 1983, PHYSIOL REV, V63, P844, DOI 10.1152/physrev.1983.63.3.844; FRITZE J, 1995, J PSYCHIATR NEUROSCI, V20, P39; Giglio S, 2001, AM J HUM GENET, V68, P874, DOI 10.1086/319506; Gorman JM, 2000, AM J PSYCHIAT, V157, P493, DOI 10.1176/appi.ajp.157.4.493; HOPPER JL, 1987, GENET EPIDEMIOL, V4, P33, DOI 10.1002/gepi.1370040105; Ji YG, 2000, GENOME RES, V10, P597, DOI 10.1101/gr.10.5.597; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; KENDLER KS, 1993, PSYCHOL MED, V23, P397, DOI 10.1017/S003329170002849X; Kennedy JL, 1999, MOL PSYCHIATR, V4, P284, DOI 10.1038/sj.mp.4000507; KENYON K, 1993, J BIOL CHEM, V268, P18435; Knowles JA, 1998, AM J MED GENET, V81, P139, DOI 10.1002/(SICI)1096-8628(19980328)81:2<139::AID-AJMG4>3.0.CO;2-R; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leboyer M, 1998, TRENDS NEUROSCI, V21, P102, DOI 10.1016/S0166-2236(97)01187-9; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; MAIER W, 1993, J PSYCHIAT RES, V27, P79, DOI 10.1016/0022-3956(93)90019-X; Martin-Santos R, 1998, AM J PSYCHIAT, V155, P1578, DOI 10.1176/ajp.155.11.1578; MERLIO JP, 1992, NEUROSCIENCE, V51, P513, DOI 10.1016/0306-4522(92)90292-A; Nadal M, 1997, J MED GENET, V34, P50, DOI 10.1136/jmg.34.1.50; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; OTT J, 1991, ANAL HUMAN GENETIC L, P232; PAULS DL, 1980, AM J HUM GENET, V32, P639; Perna G, 1997, PSYCHIAT RES, V66, P69, DOI 10.1016/S0165-1781(97)85177-3; Pujana MA, 2001, GENOME RES, V11, P98, DOI 10.1101/gr.155601; SAMBROOK J, 1989, MOL CLONING, V2, P9; Schinder AF, 2000, TRENDS NEUROSCI, V23, P639, DOI 10.1016/S0166-2236(00)01672-6; SMITH MA, 1995, P NATL ACAD SCI USA, V92, P8788, DOI 10.1073/pnas.92.19.8788; van Overveld PGM, 2000, HUM MOL GENET, V9, P2879; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; VIELAND VJ, 1993, PSYCHIATR GENET, V3, P63, DOI 10.1097/00041444-199322000-00001; Wang ZW, 1998, AM J MED GENET, V81, P228, DOI 10.1002/(SICI)1096-8628(19980508)81:3<228::AID-AJMG5>3.0.CO;2-S; Weiller E, 1998, BRIT J PSYCHIAT, V173, P18, DOI 10.1192/S0007125000293471; Weissman MM, 1997, ARCH GEN PSYCHIAT, V54, P305; Weissman MM, 2000, AM J MED GENET, V96, P24, DOI 10.1002/(SICI)1096-8628(20000207)96:1<24::AID-AJMG7>3.0.CO;2-E	50	155	156	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 10	2001	106	3					367	379		10.1016/S0092-8674(01)00447-0	http://dx.doi.org/10.1016/S0092-8674(01)00447-0			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology	462RJ	11509185	Bronze			2022-12-28	WOS:000170433300014
J	Lo, WS; Duggan, L; Emre, NCT; Belotserkovskya, R; Lane, WS; Shiekhattar, R; Berger, SL				Lo, WS; Duggan, L; Emre, NCT; Belotserkovskya, R; Lane, WS; Shiekhattar, R; Berger, SL			Snf1 - a histone kinase that works in concert with the histone acetyltransferase Gcn5 to regulate transcription	SCIENCE			English	Article							IN-VIVO; SACCHAROMYCES-CEREVISIAE; H3 PHOSPHORYLATION; PROTEIN-KINASE; ADA-COMPLEX; YEAST; ACETYLATION; PHOSPHATASE; REPRESSION; ACTIVATION	Modification of histories is an important element in the regulation of gene expression. Previous work suggested a link between acetylation and phosphorylation, but questioned its mechanistic basis. We have purified a histone H3 serine-10 kinase complex from Saccharomyces cerevisiae and have identified its catalytic subunit as Snf1. The Snf1/AMPK family of kinases function in conserved signal transduction pathways. Our results show that Snf1 and the acetyltransferase Gcn5 function in an obligate sequence to enhance INO1 transcription by modifying histone H3 serine-10 and lysine-14. Thus, phosphorylation and acetylation are targeted to the same histone by promoter-specific regulation by a kinase/acetyltransferase pair, supporting models of gene regulation wherein transcription is controlled by coordinated patterns of histone modification.	Wistar Inst Anat & Biol, Mol Genet Program, Philadelphia, PA 19104 USA; Harvard Univ, Harvard Microchem & Proteom Anal Facil, Cambridge, MA 02138 USA	The Wistar Institute; Harvard University	Berger, SL (corresponding author), Wistar Inst Anat & Biol, Mol Genet Program, 3601 Spruce St,Room 389, Philadelphia, PA 19104 USA.		Emre, Tolga/A-1787-2016	Emre, Tolga/0000-0001-8021-5228; Berger, Shelley/0000-0001-5398-4400				Allard S, 1999, EMBO J, V18, P5108, DOI 10.1093/emboj/18.18.5108; Berger SL, 2001, SCIENCE, V292, P64; BRADBURY EM, 1992, BIOESSAYS, V14, P9; Brown CE, 2000, TRENDS BIOCHEM SCI, V25, P15, DOI 10.1016/S0968-0004(99)01516-9; Carlson M, 1999, CURR OPIN MICROBIOL, V2, P202, DOI 10.1016/S1369-5274(99)80035-6; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Clayton AL, 2000, EMBO J, V19, P3714, DOI 10.1093/emboj/19.14.3714; Eberharter A, 1999, MOL CELL BIOL, V19, P6621; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; Goto H, 1999, J BIOL CHEM, V274, P25543, DOI 10.1074/jbc.274.36.25543; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hayes JJ, 2001, CURR OPIN GENET DEV, V11, P124, DOI 10.1016/S0959-437X(00)00168-4; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; John S, 2000, GENE DEV, V14, P1196; Kuo MH, 1998, GENE DEV, V12, P627, DOI 10.1101/gad.12.5.627; Lo WS, 2000, MOL CELL, V5, P917, DOI 10.1016/S1097-2765(00)80257-9; MAHADEVAN LC, 1991, CELL, V65, P775, DOI 10.1016/0092-8674(91)90385-C; Pollard KJ, 1997, MOL CELL BIOL, V17, P6212, DOI 10.1128/MCB.17.11.6212; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Roberts SM, 1997, GENETICS, V147, P451; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Shirra MK, 1999, GENETICS, V152, P73; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Struhl K, 1998, CELL, V94, P1, DOI 10.1016/S0092-8674(00)81213-1; Thomson S, 1999, EMBO J, V18, P4779, DOI 10.1093/emboj/18.17.4779; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Wang L, 1998, GENE DEV, V12, P640, DOI 10.1101/gad.12.5.640; WOODS A, 1994, J BIOL CHEM, V269, P19509	29	287	298	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2001	293	5532					1142	1146		10.1126/science.1062322	http://dx.doi.org/10.1126/science.1062322			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498592				2022-12-28	WOS:000170432600062
J	Alexander, RM				Alexander, RM			Design by numbers	NATURE			English	Editorial Material									Univ Leeds, Sch Biol, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Alexander, RM (corresponding author), Univ Leeds, Sch Biol, Leeds LS2 9JT, W Yorkshire, England.							Alexander RM, 1996, OPTIMA ANIMALS; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; PARKER GA, 1990, NATURE, V348, P27, DOI 10.1038/348027a0; WEIBEL ER, 1998, PRINCIPLES ANIMAL DE	4	21	21	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2001	412	6847					591	591		10.1038/35088155	http://dx.doi.org/10.1038/35088155			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460PP	11493899	Bronze			2022-12-28	WOS:000170318000021
J	Ohman, MD; Hirche, HJ				Ohman, MD; Hirche, HJ			Density-dependent mortality in an oceanic copepod population	NATURE			English	Article							1997 SPRING BLOOM; PLANKTONIC MARINE COPEPOD; FREQUENCY TIME-SERIES; CALANUS-FINMARCHICUS; NORWEGIAN SEA; WEATHERSHIP M; DYNAMICS; PHYTOPLANKTON; PREDATION; BIOMASS	Planktonic copepods are primary consumers in the ocean and are perhaps the most numerous metazoans on earth. Secondary production by these zooplankton supports most food webs of the open sea, directly affecting pelagic fish populations and the biological pump of carbon into the deep ocean. Models of marine ecosystems are quite sensitive to the formulation of the term for zooplankton mortality(1-4), although there are few data available to constrain mortality rates in such models. Here we present the first evidence for nonlinear, density-dependent mortality rates of open-ocean zooplankton. A high-frequency time series reveals that per capita mortality rates of eggs of Calanus finmarchicus Gunnerus are a function of the abundance of adult females and juveniles. The temporal dynamics of zooplankton populations can be influenced as much by time-dependent mortality rates as by variations in 'bottom up' forcing. The functional form and rates chosen for zooplankton mortality in ecosystem models can alter the balance of pelagic ecosystems(1-3), modify elemental fluxes into the ocean's interior(5), and modulate interannual variability in pelagic ecosystems(6).	Stn Zool, F-06230 Villefranche Sur Mer, France; Alfred Wegener Inst Polar & Marine Res, D-27568 Bremerhaven, Germany	UDICE-French Research Universities; Sorbonne Universite; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Ohman, MD (corresponding author), Stn Zool, F-06230 Villefranche Sur Mer, France.	mohman@ucsd.edu	Ohman, Mark D/C-8763-2009	Ohman, Mark D/0000-0001-8136-3695				Aksnes DL, 1997, SARSIA, V82, P279, DOI 10.1080/00364827.1997.10413657; CAMPBELL RG, IN PRESS MAR ECOL PR; Carlotti F., 2000, P571, DOI 10.1016/B978-012327645-2/50013-X; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; DAAN R, 1988, MAR ECOL PROG SER, V47, P45, DOI 10.3354/meps047045; Edwards AM, 2000, J PLANKTON RES, V22, P1085, DOI 10.1093/plankt/22.6.1085; FASHAM MJR, 1995, DEEP-SEA RES PT I, V42, P1111, DOI 10.1016/0967-0637(95)00054-A; FASHAM MJR, 1993, GLOBAL CARBON CYCLE, P457; Gallego A, 1999, FISH OCEANOGR, V8, P77; Hainbucher Dagmar, 1999, Fisheries Oceanography, V8, P1, DOI 10.1046/j.1365-2419.1999.00009.x; HIRCHE HJ, IN PRESS MAR ECOL PR; Irigoien X, 1998, MAR ECOL PROG SER, V172, P127, DOI 10.3354/meps172127; LANDRY MR, 1978, INT REV GES HYDROBIO, V63, P77, DOI 10.1002/iroh.19780630106; LANDRY MR, 1981, MAR BIOL, V65, P77, DOI 10.1007/BF00397070; Li M, 2000, ESTUAR COAST SHELF S, V50, P467, DOI 10.1006/ecss.2000.0593; Lynch DR, 1998, MAR ECOL PROG SER, V169, P189, DOI 10.3354/meps169189; Meyer-Harms B, 1999, LIMNOL OCEANOGR, V44, P154, DOI 10.4319/lo.1999.44.1.0154; Miralto A, 1999, NATURE, V402, P173, DOI 10.1038/46023; Niehoff B, 1999, MAR ECOL PROG SER, V176, P81, DOI 10.3354/meps176081; OHMAN MD, 1994, LIMNOL OCEANOGR, V39, P21, DOI 10.4319/lo.1994.39.1.0021; OHMAN MD, 1998, EOS T AM GEOPHYS UN, V79, pOS155; PETERSON WT, 1994, LIMNOL OCEANOGR, V39, P1594, DOI 10.4319/lo.1994.39.7.1594; Planque B, 1998, ICES J MAR SCI, V55, P644, DOI 10.1006/jmsc.1998.0390; Richardson Katherine, 1999, Fisheries Oceanography, V8, P153, DOI 10.1046/j.1365-2419.1999.00007.x; ROTHSCHILD BJ, 1988, J PLANKTON RES, V10, P465, DOI 10.1093/plankt/10.3.465; SOLOW AR, 1995, J PLANKTON RES, V17, P1669, DOI 10.1093/plankt/17.8.1669; STEELE JH, 1992, J PLANKTON RES, V14, P157, DOI 10.1093/plankt/14.1.157; Uye S, 1998, J MARINE SYST, V15, P495, DOI 10.1016/S0924-7963(97)00052-3; WOOD SN, 1994, ECOL MONOGR, V64, P23, DOI 10.2307/2937054	29	193	195	0	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 9	2001	412	6847					638	641		10.1038/35088068	http://dx.doi.org/10.1038/35088068			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460PP	11493921	Green Published			2022-12-28	WOS:000170318000041
J	Craven, RB; Roehrig, JT				Craven, RB; Roehrig, JT			West Nile Virus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							LOW VOLUME APPLICATIONS; HALE COUNTY; NEW-YORK; ENCEPHALITIS; MALATHION; OUTBREAK; POPULATIONS; DIAGNOSIS; MOSQUITOS; EPIDEMIC		CDCP, Arbovirus Dis Branch,Natl Ctr Infect Dis, Div Vector Borne Infect Dis, US Dept HHS,PHS, Ft Collins, CO 80522 USA	Centers for Disease Control & Prevention - USA	Craven, RB (corresponding author), CDCP, Arbovirus Dis Branch,Natl Ctr Infect Dis, Div Vector Borne Infect Dis, US Dept HHS,PHS, POB 2087,Foothills Campus, Ft Collins, CO 80522 USA.	rbc1@cdc.gov		Roehrig, John/0000-0001-7581-0479				Anderson JF, 1999, SCIENCE, V286, P2331, DOI 10.1126/science.286.5448.2331; ANDIS MD, 1987, J AM MOSQUITO CONTR, V3, P125; Beaty BJ, 1989, DIAGNOSTIC PROCEDURE, P797; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P944; *CDCP, 1993, GUID ARB SURV US; *CDCP, 2000, MMWR-MORBID MORTAL W, V49, P820; CECCHINE G, 1996, REV SCI LIT IT PERTA, V8; Center for Disease Control and Prevention (CDC), 1999, MMWR-MORBID MORTAL W, V48, P890; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P845; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P178; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P37; CRAVEN RB, 1991, TXB HUMAN VIROLOGY, P645; CRAVEN RB, 1991, TXB HUMAN VIROLOGY, P649; Hayes CG, 1989, ARBOVIRUSES EPIDEMIO, VV, P59; Johnson AJ, 2000, J CLIN MICROBIOL, V38, P1827, DOI 10.1128/JCM.38.5.1827-1831.2000; Jordan I, 2000, J INFECT DIS, V182, P1214, DOI 10.1086/315847; Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000; Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333; LEISER LB, 1982, MOSQ NEWS, V42, P617; MARBERG K, 1956, AM J HYG, V64, P259, DOI 10.1093/oxfordjournals.aje.a119838; Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000; MITCHELL CJ, 1969, J MED ENTOMOL, V6, P155, DOI 10.1093/jmedent/6.2.155; MITCHELL CJ, 1970, J MED ENTOMOL, V7, P85, DOI 10.1093/jmedent/7.1.85; MONATH TP, 1991, TROPICAL MED, P206; Mount GA, 1996, J AM MOSQUITO CONTR, V12, P601; Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401; Peyton EL, 1999, J AM MOSQUITO CONTR, V15, P238; REISEN WK, 1985, J AM MOSQUITO CONTR, V1, P154; ROEHRIG JT, 2000, CLIN VIROLOGY MANUAL, P356; Shieh WJ, 2000, EMERG INFECT DIS, V6, P370, DOI 10.3201/eid0604.000407; Tardei G, 2000, J CLIN MICROBIOL, V38, P2232; Tsai TF, 1998, LANCET, V352, P767, DOI 10.1016/S0140-6736(98)03538-7	32	28	30	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2001	286	6					651	653		10.1001/jama.286.6.651	http://dx.doi.org/10.1001/jama.286.6.651			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459VE	11495600				2022-12-28	WOS:000170271500002
J	Day, M; Morris, RGM				Day, M; Morris, RGM			Memory consolidation and NMDA receptors: Discrepancy between genetic and pharmacological approaches	SCIENCE			English	Editorial Material							LONG-TERM POTENTIATION; SELECTIVE IMPAIRMENT; ANTAGONIST; BLOCKADE; AP5		Univ Edinburgh, Dept Neurosci, Edinburgh EH8 9JZ, Midlothian, Scotland	University of Edinburgh	Day, M (corresponding author), Univ Edinburgh, Dept Neurosci, 1 George Sq, Edinburgh EH8 9JZ, Midlothian, Scotland.		Morris, Richard G M/C-9982-2013					McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; MORRIS RGM, 1989, J NEUROSCI, V9, P3040; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; TEYLER TJ, 1987, ANNU REV NEUROSCI, V10, P131, DOI 10.1146/annurev.ne.10.030187.001023; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; 2001, SCIENCE, V291, P1902	10	24	27	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2001	293	5531					U1	U1						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11486056				2022-12-28	WOS:000170241000001
J	Drab, M; Verkade, P; Elger, M; Kasper, M; Lohn, M; Lauterbach, B; Menne, J; Lindschau, C; Mende, F; Luft, FC; Schedl, A; Haller, H; Kurzchalia, TV				Drab, M; Verkade, P; Elger, M; Kasper, M; Lohn, M; Lauterbach, B; Menne, J; Lindschau, C; Mende, F; Luft, FC; Schedl, A; Haller, H; Kurzchalia, TV			Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice	SCIENCE			English	Article							PLASMA-MEMBRANE; ENDOPLASMIC-RETICULUM; IN-VIVO; PROTEIN; TRANSPORT; CHOLESTEROL; CELLS; VIP21-CAVEOLIN; COMPONENT; MUSCLE	Caveolae are plasma membrane invaginations that may play an important role in numerous cellular processes including transport, signaling, and tumor suppression. By targeted disruption of caveolin-1, the main protein component of caveolae, we generated mice that lacked caveolae. The absence of this organelle impaired nitric oxide and calcium signaling in the cardiovascular system, causing aberrations in endothelium-dependent relaxation, contractility, and maintenance of myogenic tone. In addition, the lungs of knockout animals displayed thickening of alveolar septa caused by uncontrolled endothelial cell proliferation and fibrosis, resulting in severe physical limitations in caveolin-1-disrupted mice. Thus, caveolin-1 and caveolae play a fundamental role in organizing multiple signaling pathways in the cell.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; Humboldt Univ, Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; Hannover Med Sch, D-30625 Hannover, Germany; Tech Univ Dresden, Inst Anat, D-01307 Dresden, Germany	Max Planck Society; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Humboldt University of Berlin; Hannover Medical School; Technische Universitat Dresden	Kurzchalia, TV (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauer Str 108, D-01307 Dresden, Germany.		Schedl, Andreas/GOP-3427-2022; Verkade, Paul/N-7240-2014; Lindschau, Carsten/AAE-6721-2020; Schedl, Andreas/F-8823-2015; Drab, Marek/AAQ-1892-2020; Eckhardt, Erik/G-1567-2010; Drab, Marek/J-5196-2013; Lindschau, Carsten/G-1798-2011	Verkade, Paul/0000-0002-2497-1026; Schedl, Andreas/0000-0001-9380-7396; Drab, Marek/0000-0002-2771-1692; Lindschau, Carsten/0000-0003-1960-099X; Luft, Friedrich/0000-0002-8635-1199				Abrami L, 1998, J CELL BIOL, V140, P525, DOI 10.1083/jcb.140.3.525; ANDERSON RGW, 1992, SCIENCE, V255, P410, DOI 10.1126/science.1310359; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Babitt J, 1997, J BIOL CHEM, V272, P13242, DOI 10.1074/jbc.272.20.13242; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Bucci M, 2000, NAT MED, V6, P1362, DOI 10.1038/82176; FRA AM, 1995, P NATL ACAD SCI USA, V92, P8655, DOI 10.1073/pnas.92.19.8655; Galbiati F, 1998, EMBO J, V17, P6633, DOI 10.1093/emboj/17.22.6633; HALLER H, 1995, CIRC RES, V76, P21, DOI 10.1161/01.RES.76.1.21; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; KURZCHALIA TV, 1992, J CELL BIOL, V118, P1003, DOI 10.1083/jcb.118.5.1003; Kurzchalia TV, 1999, CURR OPIN CELL BIOL, V11, P424, DOI 10.1016/S0955-0674(99)80061-1; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; Lohn M, 2000, CIRC RES, V87, P1034, DOI 10.1161/01.RES.87.11.1034; MONIER S, 1995, MOL BIOL CELL, V6, P911, DOI 10.1091/mbc.6.7.911; MURATA M, 1995, P NATL ACAD SCI USA, V92, P10339, DOI 10.1073/pnas.92.22.10339; PALADE GE, 1960, ANAT REC, V136, P254; PALADE GE, 1953, J APPL PHYS, V24, P1424; PARTON RG, 1995, SCIENCE, V269, P1398, DOI 10.1126/science.7660120; Pluger S, 2000, CIRC RES, V87, pE53, DOI 10.1161/01.RES.87.11.e53; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Scheiffele P, 1998, J CELL BIOL, V140, P795, DOI 10.1083/jcb.140.4.795; Schnitzer JE, 1996, SCIENCE, V274, P239, DOI 10.1126/science.274.5285.239; Simons K, 2000, SCIENCE, V290, P1721, DOI 10.1126/science.290.5497.1721; Smart EJ, 1996, J BIOL CHEM, V271, P29427, DOI 10.1074/jbc.271.46.29427	25	1248	1288	1	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2001	293	5539					2449	2452		10.1126/science.1062688	http://dx.doi.org/10.1126/science.1062688			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	476PD	11498544				2022-12-28	WOS:000171237200046
J	Freeman, C; Evans, CD; Monteith, DT; Reynolds, B; Fenner, N				Freeman, C; Evans, CD; Monteith, DT; Reynolds, B; Fenner, N			Export of organic carbon from peat soils	NATURE			English	Article							MATTER; PEATLANDS; RIVERS		Univ Wales, Sch Biol Sci, Bangor LL57 2UW, Gwynedd, Wales; Ctr Ecol & Hydrol, Wallingford OX10 3BB, Oxon, England; UCL, Environm Change Res Ctr, London WC1H 0AP, England; Ctr Ecol & Hydrol, Bangor LL57 2UP, Gwynedd, Wales	Bangor University; UK Centre for Ecology & Hydrology (UKCEH); University of London; University College London; UK Centre for Ecology & Hydrology (UKCEH)	Freeman, C (corresponding author), Univ Wales, Sch Biol Sci, Bangor LL57 2UW, Gwynedd, Wales.	c.freeman@bangor.ac.uk	Monteith, Donald/C-1534-2008; Evans, Christopher D/F-2087-2010; Reynolds, Brian/G-6292-2011	Monteith, Donald/0000-0003-3219-1772; Evans, Christopher D/0000-0002-7052-354X; 				FREEMAN C, 1990, FRESHWATER BIOL, V24, P159, DOI 10.1111/j.1365-2427.1990.tb00315.x; Freeman C, 2001, NATURE, V409, P149, DOI 10.1038/35051650; GORHAM E, 1991, ECOL APPL, V1, P182, DOI 10.2307/1941811; Hope D, 1997, HYDROL PROCESS, V11, P325, DOI 10.1002/(SICI)1099-1085(19970315)11:3&lt;325::AID-HYP476&gt;3.0.CO;2-I; KRUG EC, 1983, SCIENCE, V221, P520, DOI 10.1126/science.221.4610.520; LUGO AE, 1989, ECOSYSTEMS WORLD, V15, P53; MONTEITH DT, 2000, UK ACID WATERS MONIT; PARKER DE, 1992, INT J CLIMATOL, V12, P317, DOI 10.1002/joc.3370120402; Raymond PA, 2001, NATURE, V409, P497, DOI 10.1038/35054034; WETZEL RG, 1992, HYDROBIOLOGIA, V229, P181, DOI 10.1007/BF00007000	10	745	783	12	402	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2001	412	6849					785	785		10.1038/35090628	http://dx.doi.org/10.1038/35090628			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465ET	11518954				2022-12-28	WOS:000170577200025
J	Haug, GH; Hughen, KA; Sigman, DM; Peterson, LC; Rohl, U				Haug, GH; Hughen, KA; Sigman, DM; Peterson, LC; Rohl, U			Southward migration of the intertropical convergence zone through the Holocene	SCIENCE			English	Article							TROPICAL ATLANTIC; CARIACO BASIN; EL-NINO; CLIMATE-CHANGE; OCEAN; VENEZUELA; TEMPERATURES; VARIABILITY; CIRCULATION; TIMESCALES	Titanium and iron concentration data from the anoxic Cariaco Basin, off the Venezuelan coast, can be used to infer variations in the hydrological cycle over northern South America during the past 14,000 years with subdecadal resolution. Following a dry Younger Dryas, a period of increased precipitation and riverine discharge occurred during the Holocene "thermal maximum." Since similar to 5400 years ago, a trend toward drier conditions is evident from the data, with high-amplitude fluctuations and precipitation minima during the time interval 3800 to 2800 years ago and during the "Little Ice Age." These regional changes in precipitation are best explained by shifts in the mean latitude of the Atlantic Intertropical Convergence Zone (ITCZ), potentially driven by Pacific-based climate variability. The Cariaco Basin record exhibits,strong correlations with climate records from distant regions, including the high-latitude Northern Hemisphere, providing evidence for global teleconnections among regional climates.	ETH Zentrum, Dept Earth Sci, CH-8092 Zurich, Switzerland; Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; Univ Bremen, Fachbereich Geowissensch, D-28334 Bremen, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Woods Hole Oceanographic Institution; Princeton University; University of Miami; University of Bremen	Haug, GH (corresponding author), ETH Zentrum, Dept Earth Sci, CH-8092 Zurich, Switzerland.		Röhl, Ursula/G-5986-2011; Sigman, Daniel M/A-2649-2008	Röhl, Ursula/0000-0001-9469-7053; Sigman, Daniel M/0000-0002-7923-1973				Baker PA, 2001, SCIENCE, V291, P640, DOI 10.1126/science.291.5504.640; BERGER A, 1991, QUATERNARY SCI REV, V10, P297, DOI 10.1016/0277-3791(91)90033-Q; Black DE, 1999, SCIENCE, V286, P1709, DOI 10.1126/science.286.5445.1709; BRADBURY JP, 1981, SCIENCE, V214, P1299, DOI 10.1126/science.214.4527.1299; BRIFFA KR, 1992, CLIM DYNAM, V7, P111, DOI 10.1007/BF00211153; Cane M, 1999, GEOPH MONOG SERIES, V112, P373; Chang P, 1997, NATURE, V385, P516, DOI 10.1038/385516a0; Clement AC, 2000, PALEOCEANOGRAPHY, V15, P731, DOI 10.1029/1999PA000466; Cook ER, 2000, CLIM DYNAM, V16, P79, DOI 10.1007/s003820050006; deMenocal P, 2000, SCIENCE, V288, P2198, DOI 10.1126/science.288.5474.2198; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; Fedorov AV, 2000, SCIENCE, V288, P1997, DOI 10.1126/science.288.5473.1997; HASTENRATH S, 1993, J GEOPHYS RES-ATMOS, V98, P5093, DOI 10.1029/92JD02646; Hodell DA, 2001, SCIENCE, V292, P1367, DOI 10.1126/science.1057759; HODELL DA, 1991, NATURE, V352, P790, DOI 10.1038/352790a0; Hughen KA, 1996, NATURE, V380, P51, DOI 10.1038/380051a0; KUTZBACH JE, 1988, SCIENCE, V241, P1043, DOI 10.1126/science.241.4869.1043; Lin HL, 1997, PALEOCEANOGRAPHY, V12, P415, DOI 10.1029/97PA00230; Maslin MA, 2000, SCIENCE, V290, P2285; Mayle FE, 2000, SCIENCE, V290, P2291, DOI 10.1126/science.290.5500.2291; MCGLONE MS, 1992, EL NINO HIST PALEOCL, P435; OBRIEN SR, 1995, SCIENCE, V270, P1962, DOI 10.1126/science.270.5244.1962; Peterson LC, 1991, PALEOCEANOGRAPHY, V6, P99, DOI 10.1029/90PA02497; Peterson L.C, 2000, P OCEAN DRILL PROGRA, V165, P85, DOI DOI 10.2973/ODP.PROC.SR.165.017.2000; Peterson LC, 2000, SCIENCE, V290, P1947, DOI 10.1126/science.290.5498.1947; Rind D, 1986, CLIM DYNAM, V1, P33; Rodbell DT, 1999, SCIENCE, V283, P516, DOI 10.1126/science.283.5401.516; ROHL U, 2000, P OCEAN DRILLING PRO, V0165; Sandweiss DH, 1996, SCIENCE, V273, P1531, DOI 10.1126/science.273.5281.1531; Stuiver M, 1998, RADIOCARBON, V40, P1041, DOI 10.1017/S0033822200019123; Thunell RC, 2000, LIMNOL OCEANOGR, V45, P300, DOI 10.4319/lo.2000.45.2.0300; Trenberth KE, 1998, J GEOPHYS RES-OCEANS, V103, P14291, DOI 10.1029/97JC01444; VanderHammen T, 1995, QUATERNARY SCI REV, V14, P841, DOI 10.1016/0277-3791(95)00066-6; Yarincik KM, 2000, PALEOCEANOGRAPHY, V15, P210	34	1249	1345	19	429	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2001	293	5533					1304	1308		10.1126/science.1059725	http://dx.doi.org/10.1126/science.1059725			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11509727				2022-12-28	WOS:000170492600036
J	Rietze, RL; Valcanis, H; Brooker, GF; Thomas, T; Voss, AK; Bartlett, PF				Rietze, RL; Valcanis, H; Brooker, GF; Thomas, T; Voss, AK; Bartlett, PF			Purification of a pluripotent neural stem cell from the adult mouse brain	NATURE			English	Article							CENTRAL-NERVOUS-SYSTEM; MAMMALIAN FOREBRAIN; IN-VIVO; NEURONS; EXPRESSION; ASTROCYTES; GENERATION; MARROW; BLOOD; MCD24	The adult mammalian central nervous system (CNS) contains a population of neural stem cells (NSCs)(1-4) with properties said to include the generation of non-neural progeny(5-7). However, the precise identity, location and potential of the NSC in situ remain unclear. We purified NSCs from the adult mouse brain by flow cytometry, and directly examined the cells' properties. Here we show that one type of NSC, which expresses the protein nestin but only low levels of PNA-binding and HSA proteins, is found in both ependymal and subventricular zones and accounts for about 63% of the total NSC activity. Furthermore, the selective depletion of the population of this stem cell in querkopf(8) mutant mice (which are deficient in production of olfactory neurons) suggests that it acts as a major functional stem cell in vivo. Most freshly isolated NSCs, when co-cultured with a muscle cell line, rapidly differentiated in vitro into myocytes that contain myosin heavy chain (MyHC). This demonstrates that a predominant, functional type of stem cell exists in the periventricular region of the adult brain with the intrinsic ability to generate neural and non-neural cells.	Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; Univ Melbourne, Howard Florey Inst Expt Physiol & Med, Parkville, Vic 3010, Australia	Walter & Eliza Hall Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Bartlett, PF (corresponding author), Walter & Eliza Hall Inst Med Res, Royal Parade, Parkville, Vic 3050, Australia.	bartlett@wehi.edu.au	Bartlett, Perry/F-3813-2012; Voss, Anne K/F-5110-2013	Voss, Anne K/0000-0002-3853-9381; Thomas, Tim/0000-0002-7623-8344				BARTLETT PF, 1982, P NATL ACAD SCI-BIOL, V79, P2722, DOI 10.1073/pnas.79.8.2722; Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Calaora V, 1996, NEUROSCIENCE, V73, P581, DOI 10.1016/0306-4522(96)00042-5; Chiasson BJ, 1999, J NEUROSCI, V19, P4462; Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Galli R, 2000, NAT NEUROSCI, V3, P986, DOI 10.1038/79924; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Gritti A, 1999, J NEUROSCI, V19, P3287; Gritti A, 1996, J NEUROSCI, V16, P1091; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; North KN, 1996, NEUROMUSCULAR DISORD, V6, P229, DOI 10.1016/0960-8966(96)00361-6; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; RICHARDS LJ, 1992, P NATL ACAD SCI USA, V89, P8591, DOI 10.1073/pnas.89.18.8591; SALNER AL, 1982, J NATL CANCER I, V68, P639; Shewan D, 1996, J NEUROSCI, V16, P2624; TAM PPL, 1992, DEVELOPMENT, V115, P703; Thomas T, 2000, DEVELOPMENT, V127, P2537	25	525	572	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 16	2001	412	6848					736	739		10.1038/35089085	http://dx.doi.org/10.1038/35089085			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462ZB	11507641				2022-12-28	WOS:000170450200045
J	Harbour, R; Miller, J				Harbour, R; Miller, J		Scottish Intercollegiate Guidelin	A new system for grading recommendations in evidence based guidelines	BRITISH MEDICAL JOURNAL			English	Article									Royal Coll Phys, Scottish Intercollegiate Guidelines Network, Edinburgh EH2 1JQ, Midlothian, Scotland	Royal College of Physicians	Harbour, R (corresponding author), Royal Coll Phys, Scottish Intercollegiate Guidelines Network, Edinburgh EH2 1JQ, Midlothian, Scotland.							CARRUTHERS SG, 1993, CAN MED ASSOC J, V149, P289; *COCHR METH WORK G, 1996, RETEST REC METH; ELWOOD JM, 1998, CRITICAL APPRAISAL E; Hadorn DC, 1996, J CLIN EPIDEMIOL, V49, P749, DOI 10.1016/0895-4356(96)00019-4; Liddle J., 1996, METHOD EVALUATING RE; Scottish Intercollegiate Guidelines Network, 2001, SIGN 50 GUID DEV HDB; United States Department of Health and Human Services Agency for Health Care Policy and Research, 1993, AHCPR PUBL, V1, P107	7	1098	1146	1	45	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 11	2001	323	7308					334	336		10.1136/bmj.323.7308.334	http://dx.doi.org/10.1136/bmj.323.7308.334			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463HK	11498496	Green Published			2022-12-28	WOS:000170470900025
J	Bellaiche, Y; Radovic, A; Woods, DF; Hough, CD; Parmentier, ML; O'Kane, CJ; Bryant, PJ; Schweisguth, F				Bellaiche, Y; Radovic, A; Woods, DF; Hough, CD; Parmentier, ML; O'Kane, CJ; Bryant, PJ; Schweisguth, F			The partner of inscuteable/discs-large complex is required to establish planar polarity during asymmetric cell division in Drosophila	CELL			English	Article							TUMOR-SUPPRESSOR GENE; PROTEIN-KINASE-C; SIGNALING POLARIZES; ELEGANS; LOCALIZATION; BAZOOKA; NUMB; DETERMINANTS; COLOCALIZES; ORIENTATION	Frizzled (Fz) signaling regulates cell polarity in both vertebrates and invertebrates. In Drosophila, Fz orients the asymmetric division of the sensory organ precursor cell (pl) along the antero-posterior axis of the notum. Planar polarization involves a remodeling of the apical-basal polarity of the pi cell. The Discs-large (Dlg) and Partner of Inscuteable (Pins) proteins accumulate at the anterior cortex, while Bazooka (Baz) relocalizes to the posterior cortex. Dig interacts directly with Pins and regulates the localization of Pins and Baz. Pins acts with Fz to localize Baz posteriorly, but Baz is not required to localize Pins anteriorly. Finally, Baz and the Dig/Pins complex are required for the asymmetric localization of Numb. Thus, the Dig/Pins complex responds to Fz signaling to establish planar asymmetry in the pl cell.	Ecole Normale Super, UMR 8544, F-75230 Paris 05, France; Univ Calif Irvine, Ctr Dev Biol, Irvine, CA 92697 USA; CCIPE, UPR 9023, F-34094 Montpellier 05, France; Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); University of California System; University of California Irvine; University of Cambridge	Bellaiche, Y (corresponding author), Ecole Normale Super, UMR 8544, 46 Rue Ulm, F-75230 Paris 05, France.	bellaich@wotan.ens.fr	O'Kane, Cahir/Q-6681-2019; O'Kane, Cahir J/C-4413-2011; Parmentier, Marie-Laure/N-9915-2017	O'Kane, Cahir/0000-0002-3488-2078; Parmentier, Marie-Laure/0000-0001-6133-3413; bellaiche, yohanns/0000-0003-1686-2943	NCI NIH HHS [CA 23928] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bellaiche Y, 2001, NAT CELL BIOL, V3, P50, DOI 10.1038/35050558; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Boyd L, 1996, DEVELOPMENT, V122, P3075; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; Cooper MTD, 1999, NATURE, V397, P526, DOI 10.1038/17395; De Vries L, 2000, P NATL ACAD SCI USA, V97, P14364, DOI 10.1073/pnas.97.26.14364; DRUBIN DG, 2000, CELL POLARITY; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; Fanto M, 2000, CURR BIOL, V10, P979, DOI 10.1016/S0960-9822(00)00645-X; Gho M, 1998, NATURE, V393, P178, DOI 10.1038/30265; Gho M, 1999, DEVELOPMENT, V126, P3573; Goode S, 1997, GENE DEV, V11, P2532, DOI 10.1101/gad.11.19.2532; HARTENSTEIN V, 1989, DEVELOPMENT, V107, P389; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Hung TJ, 1999, DEVELOPMENT, V126, P127; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Jones KH, 1996, GENETICS, V142, P205; Kaltschmidt JA, 2000, NAT CELL BIOL, V2, P7, DOI 10.1038/71323; Knoblich JA, 1999, CURR BIOL, V9, P155, DOI 10.1016/S0960-9822(99)80070-0; Kraut R, 1996, NATURE, V383, P50, DOI 10.1038/383050a0; Kuchinke U, 1998, CURR BIOL, V8, P1357, DOI 10.1016/S0960-9822(98)00016-5; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Lu BW, 1998, CELL, V95, P225, DOI 10.1016/S0092-8674(00)81753-5; Lu BW, 1999, MOL CELL, V4, P883, DOI 10.1016/S1097-2765(00)80218-X; Mlodzik M, 1999, EMBO J, V18, P6873, DOI 10.1093/emboj/18.24.6873; Muller HAJ, 2000, DEV DYNAM, V218, P52; Ohshiro T, 2000, NATURE, V408, P593, DOI 10.1038/35046087; Pai LM, 1997, DEVELOPMENT, V124, P2255; Parmentier ML, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-14-j0003.2000; Peng CY, 2000, NATURE, V408, P596, DOI 10.1038/35046094; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; QUI RC, 2000, CURR BIOL, V10, P697; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; Roegiers F, 2001, NAT CELL BIOL, V3, P58, DOI 10.1038/35050568; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Schubert CM, 2000, MOL CELL, V5, P671, DOI 10.1016/S1097-2765(00)80246-4; Shulman JM, 1998, TRENDS GENET, V14, P452, DOI 10.1016/S0168-9525(98)01584-4; STERNBERG PW, 1988, DEV BIOL, V130, P67, DOI 10.1016/0012-1606(88)90414-9; Strutt DI, 2001, MOL CELL, V7, P367, DOI 10.1016/S1097-2765(01)00184-8; Tada M, 2000, DEVELOPMENT, V127, P2227; Thorpe CJ, 1997, CELL, V90, P695, DOI 10.1016/S0092-8674(00)80530-9; Wallenfang MR, 2000, NATURE, V408, P89, DOI 10.1038/35040562; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Watts JL, 1996, DEVELOPMENT, V122, P3133; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; Woods DF, 1996, J CELL BIOL, V134, P1469, DOI 10.1083/jcb.134.6.1469; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5	52	178	181	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2001	106	3					355	366		10.1016/S0092-8674(01)00444-5	http://dx.doi.org/10.1016/S0092-8674(01)00444-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RJ	11509184	Bronze			2022-12-28	WOS:000170433300013
J	Munshi, N; Agalioti, T; Lomvardas, S; Merika, M; Chen, GY; Thanos, D				Munshi, N; Agalioti, T; Lomvardas, S; Merika, M; Chen, GY; Thanos, D			Coordination of a transcriptional switch by HMGI(Y) acetylation	SCIENCE			English	Article							IFN-BETA ENHANCEOSOME; GENE-EXPRESSION; RECRUITMENT; ACTIVATION; INDUCTION	Dynamic control of interferon-beta (IFN-beta) gene expression requires the regulated assembly and disassembly of the enhanceosome, a higher-order nucleoprotein complex formed in response to virus infection. The enhanceosome activates transcription by recruiting the histone acetyltransferase proteins CREB binding protein (CBP) and (p) under bar 300/(C) under bar BP-(a) under bar ssociated (f) under bar actors (PCAF)/GCN5, which, in addition to modifying histones, acetylate HMGI(Y), the architectural component required for enhanceosome assembly. We show that the accurate execution of the IFN-P transcriptional switch depends on the ordered acetylation of the high-mobility group I protein HMGI(Y) by PCAF/GCN5 and CBP, which acetylate HMGI(Y) at distinct lysine residues on endogenous promoters. Whereas acetylation of HMGI(Y) by CBP at lysine-65 destabilizes the enhanceosome, acetylation of HMGI(Y) by PCAF/GCN5 at lysine-71 potentiates transcription by stabilizing the enhanceosome and preventing acetylation by CBP.	Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University	Thanos, D (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA.		Munshi, Nikhil/ABE-2338-2021; Thanos, Dimitris/AAE-5720-2019	Lomvardas, Stavros/0000-0002-7668-3026; Agalioti, Theodora/0000-0002-5898-2751	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007367, R01GM054605] Funding Source: NIH RePORTER; NIGMS NIH HHS [1RO1GM54605, 5-T32-GM07367] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Kim TK, 1998, P NATL ACAD SCI USA, V95, P12191, DOI 10.1073/pnas.95.21.12191; Merika M, 1998, MOL CELL, V1, P277, DOI 10.1016/S1097-2765(00)80028-3; Munshi N, 1999, COLD SPRING HARB SYM, V64, P149, DOI 10.1101/sqb.1999.64.149; Munshi N, 1998, MOL CELL, V2, P457, DOI 10.1016/S1097-2765(00)80145-8; Parekh BS, 1999, MOL CELL, V3, P125, DOI 10.1016/S1097-2765(00)80181-1; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Yie JM, 1999, P NATL ACAD SCI USA, V96, P13108, DOI 10.1073/pnas.96.23.13108; Yie JM, 1999, EMBO J, V18, P3074, DOI 10.1093/emboj/18.11.3074	10	182	188	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2001	293	5532					1133	1136		10.1126/science.293.5532.1133	http://dx.doi.org/10.1126/science.293.5532.1133			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498590				2022-12-28	WOS:000170432600059
J	Kaptchuk, TJ; Eisenberg, DM				Kaptchuk, TJ; Eisenberg, DM			Varieties of healing. 2: A taxonomy of unconventional healing practices	ANNALS OF INTERNAL MEDICINE			English	Review							FOLK MEDICINE; ALTERNATIVE MEDICINE; HEALTH; RELIGION; CARE; TRANSFUSION; BELIEFS; THERAPY; CULTURE; FAITH	The first of two essays in this issue demonstrated that the United States has had a rich history of medical pluralism. This essay seeks to present an overview of contemporary unconventional medical practices in the United States. No clear definition of "alternative medicine" is offered because it is a residual category composed of heterogeneous healing methods. A descriptive taxonomy of contemporary unconventional healing could be more helpful. Two broad categories of unconventional medicine are described here: a more prominent, "mainstream" complementary and alternative medicine (CAM) and a more culture-bound, "parochial" unconventional medicine. The CAM component can be divided into professional groups, layperson-initiated popular health reform movements, New Age healing, alternative psychological therapies, and non-normative scientific enterprises. The parochial category can be divided into ethno-medicine, religious healing, and folk medicine. A topologic examination of U.S. health care can provide an important conceptual framework through which health care providers can understand the current situation in U.S. medical pluralism.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Kaptchuk, TJ (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, 330 Brookline Ave,W-K-400, Boston, MA 02215 USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U24AR043441] Funding Source: NIH RePORTER; NIAMS NIH HHS [U24 AR43441] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Albanese Catherine L., 1990, NATURE RELIG AM ALGO; ALBRECHT GL, 1982, RES SOCIOLOGY HLTH C, V2; AMUNDSEN DW, 1982, B HIST MED, V56, P326; ANDERSON J, 1997, NEWSDAY         1105, pB10; [Anonymous], 2000, LANCET, V356, P2023; [Anonymous], 1982, CRUSADERS FITNESS HI; Baer H A, 1992, Med Anthropol, V13, P369; Barnes LL, 1998, CULT MED PSYCHIAT, V22, P413, DOI 10.1023/A:1005403825213; BARRETT S, 1985, JAMA-J AM MED ASSOC, V254, P1041, DOI 10.1001/jama.254.8.1041; Braden C.S., 1963, SPIRITS REBELLION RI; Brown Karen McCarthy, 2001, M LOLA VODOU PRIESTE; BURROUGHS H, 1993, ALTERNATIVE HEALING; Cassileth BR, 1996, CANCER INVEST, V14, P396, DOI 10.3109/07357909609012168; CAVENDER AP, 1992, SOUTH MED J, V85, P170, DOI 10.1097/00007611-199202000-00012; Chopra Deepak, 1989, QUANTUM HEALING EXPL; COHEN C, 1992, PRIMARY CARE, V19, P87; COOK C, 1986, SOUTH MED J, V79, P1098, DOI 10.1097/00007611-198609000-00014; COOTER R, 1987, MED FRINGE MED ORTHO; COULEHAN JL, 1985, SOC SCI MED, V21, P383, DOI 10.1016/0277-9536(85)90218-7; Csordas T., 1994, SACRED SELF CULTURAL; Cumberland W.H., 1986, CARING CURING HLTH M; CURRY P, 1987, ASTROLOGY SCI SOC HI; Deutsch RM, 1977, NEW NUTS BERRIES; DICK HG, 1946, J HIST MED, V13, P300; Dossey L., 1991, MEANING MED; DOWLING SJ, 1984, J ROY SOC MED, V77, P634, DOI 10.1177/014107688407700803; Easthope G, 1986, HEALERS ALTERNATIVE; EISENBERG DM, 1993, ANN INTERN MED, V118, P964, DOI 10.7326/0003-4819-118-12-199306150-00009; Eisenberg DM, 1997, ANN INTERN MED, V127, P61, DOI 10.7326/0003-4819-127-1-199707010-00010; Eisenberg DM, 2000, JAMA-J AM MED ASSOC, V283, P885; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Ellwood Robert S, 1979, ALTERNATIVE ALTARS U; English-Lueck J., 1990, HLTH NEW AGE STUDY C; Ernst E, 1996, ARCH INTERN MED, V156, P2162, DOI 10.1001/archinte.156.19.2162; Ernst E, 1997, CIRCULATION, V96, P1031; Ernst E, 1999, FORSCH KOMPLEMENTMED, V6, P7, DOI 10.1159/000021201; Fadiman A., 1997, SPIRIT CATCHES YOU Y; FERNGREN GB, 1992, B HIST MED, V66, P1; FISCH S, 1968, MILBANK FUND Q, V46, P377, DOI 10.2307/3349335; Fox M, 1984, Med Anthropol, V8, P292; FUCHS M, 1975, MED CARE, V13, P915, DOI 10.1097/00005650-197511000-00004; Fuller R.C., 1982, MESMERISM AM CURE SO; Furnham A, 2000, COMPLEMENT THER MED, V8, P82, DOI 10.1054/ctim.2000.0355; FYE WB, 1986, CIRCULATION, V73, P21, DOI 10.1161/01.CIR.73.1.21; GEBHARD B, 1976, AM FOLK MED; GEVITZ N, 1995, MT SINAI J MED, V62, P127; Gevitz N., 1988, OTHER HEALERS UNORTH, P124; Gevitz N., 1982, DOS OSTEOPATHIC MED; GLIK DC, 1988, SOC SCI MED, V27, P1197, DOI 10.1016/0277-9536(88)90349-8; GOLDMAN B, 1991, CAN MED ASSOC J, V144, P218; GOLDSTEIN MS, 1987, J HEALTH SOC BEHAV, V28, P103, DOI 10.2307/2137125; GOOD BJ, 1981, 8 PUBL REG HLTH CAR; Gordon JS., 1996, MANIFESTO NEW MED; GORT EH, 1988, SOC SCI MED, V26, P1061, DOI 10.1016/0277-9536(88)90224-9; HAFNER AW, 1993, READERS GUIDE ALTERN; HAFNER AW, 1992, GUIDE AM MED ASS HIS; HAND W D, 1971, Journal of the History of Medicine and Allied Sciences, V26, P263; Harrell David E., 1978, ALL THINGS ARE POSSI; Harwood A, 1977, Cult Med Psychiatry, V1, P69; Harwood A, 1981, ETHNICITY MED CARE; HELMAN C G, 1978, Culture Medicine and Psychiatry, V2, P107, DOI 10.1007/BF00054580; HERINK R, 1980, PSYCHOTHERAPY HDB; HEXHAM I, 1992, PERSPECTIVES NEW AGE; Hufford DJ, 1997, PRIMARY CARE, V24, P723, DOI 10.1016/S0095-4543(05)70307-9; Jacobs C F, 1990, Med Anthropol, V12, P349; JOHNSON DM, 1986, SOCIOL ANAL, V47, P66, DOI 10.2307/3711279; JOHNSON KP, 1998, E CAYCE CONTEXT; Johnson Shirley M., 1997, Journal of the American Osteopathic Association, V97, P80; JONES RK, 1970, SOCIOLOGY, V4, P181, DOI 10.1177/003803857000400203; Judah J.S, 1967, HIST PHILOS METAPHYS; KANDEL RF, 1976, THESIS STATE U NEW Y; Kaptchuk TJ, 1998, ANN INTERN MED, V129, P1061, DOI 10.7326/0003-4819-129-12-199812150-00011; Kaptchuk TJ, 1998, ARCH INTERN MED, V158, P2215, DOI 10.1001/archinte.158.20.2215; Kaptchuk TJ, 1998, NUTRITION, V14, P471; KAPTCHUK TJ, 2001, FUNDAMENTALS COMPLEM; KAPTCHUK TJ, 2000, WEB THAT HAS NO WEAV; KAPTCHUK TJ, 1986, HEALING ARTS JOURNEY; KARASU TB, 1986, AM J PSYCHIAT, V143, P687; Kaufman M., 1971, HOMEOPATHY AM RISE F; Kelsey Morton T., 1973, HEALING CHRISTIANITY; Kemper K J, 1996, Pediatr Rev, V17, P279, DOI 10.1542/pir.17-8-279; Kerr H., 1983, OCCULT AM NEW HIST P; KING DE, 1988, J FAM PRACTICE, V27, P505; Kirmayer L. J, 1988, BIOMEDICINE EXAMINED; KIRSCHNER HE, 1991, LIVE FOOD JUICES; KLEINMAN AM, 1973, INQUIRY, V16, P206, DOI 10.1080/00201747308601685; KNAPP JE, 1990, NATL STUDY PROFESSIO; Ko CY, 1997, ARCH SURG-CHICAGO, V132, P829; KOENIG HG, 1988, J AM GERIATR SOC, V36, P362, DOI 10.1111/j.1532-5415.1988.tb02365.x; Kohl L, 1989, TAOIST MEDITATION LO; KRIEGER D, 1979, AM J NURS, V79, P660, DOI 10.2307/3462338; LAETZ T, 1991, JAMA-J AM MED ASSOC, V266, P2996, DOI 10.1001/jama.266.21.2996; LEIBOWITZ J, 1990, ALEXANDER TECHNIQUE; LERNER M, 1994, CHOICES HEALING INTE; LEVIN JS, 1986, SOC SCI MED, V23, P889, DOI 10.1016/0277-9536(86)90217-0; Levine HD, 1941, NEW ENGL J MED, V224, P487, DOI 10.1056/NEJM194103202241201; Linden Wolfgang, 1994, Annals of Behavioral Medicine, V16, P35; MANN MC, 1992, ANN INTERN MED, V117, P1042, DOI 10.7326/0003-4819-117-12-1042; MARTINEZ C, 1966, J AMER MED ASSOC, V196, P161, DOI 10.1001/jama.196.2.161; MATHEWS HF, 1987, SOUTHERN MED J, V80, P885, DOI 10.1097/00007611-198707000-00019; MCGUIRE MB, 1983, CULT MED PSYCHIAT, V7, P221, DOI 10.1007/BF00049311; McGuire Meredith, 1988, RITUAL HEALING SUBUR; Melton J.G., 1990, NEW AGE ENCY; MITCHELL BB, 1997, ACUPUNCTURE ORIENTAL; *NAT CTR HLTH STAT, 1975, OFF VIS OST PHYS JAN; National Institutes of Health, 1994, ALT MED EXP MED HOR; OConnor BB, 1995, STUDIES HLTH ILLNESS, Vxxiv; OPENHEIM J, 1988, OTHER WORLD SPIRITUA; OSHERSON S, 1981, SOCIAL CONTEXTS HLTH; PACHTER LM, 1994, JAMA-J AM MED ASSOC, V271, P690, DOI 10.1001/jama.271.9.690; *PAN DEF DESCR, 1997, ALTERN THER HEALTH M, V3, P49; Parker G.T., 1973, MIND CURE NEW ENGLAN; PIETRONI PC, 1992, BRIT MED J, V305, P564, DOI 10.1136/bmj.305.6853.564; RINZLER CA, 1991, FEED COLD STARVE FEV; ROTHSTEIN W, 1972, AM PHYSICIANS 19 CEN; RYWERANT Y, 1983, FELDENKRAIS METHOD; SAKETKHOO K, 1978, CHEST, V74, P408, DOI 10.1016/S0012-3692(15)37387-6; SAKS M, 1992, ALTERNATIVE MED BRIT; Schoepflin R., 1988, OTHER HEALERS UNORTH; SCOTT CS, 1974, PUBLIC HEALTH REP, V89, P524; Segen J. C., 1998, DICT ALTERNATIVE MED; SINGELENBERG R, 1990, SOC SCI MED, V31, P515, DOI 10.1016/0277-9536(90)90048-W; Snow L F, 1978, Cult Med Psychiatry, V2, P69, DOI 10.1007/BF00052450; TAPPEN FM, 1988, HEALING MASSAGE TECH; TROTTER R, 1981, CURANDERISMO MEXICAN; TURNER R, 1998, COMPLEMENTARY THERAP, V6, P141; *US C OFF TECHN AS, 1990, UNC CANC TREATM; Uva J L, 1991, JAMA, V266, P3065; VANPRAAG J, 1997, TALKING HEAVEN MEDIU; WARDWELL W, 1992, CHIROPRACTIC HIST EV; WARDWELL WI, 1994, PERSPECT BIOL MED, V37, P595; Weil A., 1995, SPONTANEOUS HEALING; YAHN G, 1979, JAMA-J AM MED ASSOC, V242, P2202, DOI 10.1001/jama.242.20.2202; YATES JW, 1981, MED PEDIATR ONCOL, V9, P121, DOI 10.1002/mpo.2950090204; Yuasa Yasuo., 1993, BODY SELF CULTIVATIO; Zefron L J, 1975, Nurs Forum, V14, P350, DOI 10.1111/j.1744-6198.1975.tb00596.x; [No title captured]	137	100	100	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 7	2001	135	3					196	204		10.7326/0003-4819-135-3-200108070-00012	http://dx.doi.org/10.7326/0003-4819-135-3-200108070-00012			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	460FX	11487487				2022-12-28	WOS:000170298500006
J	Wilkes, MM; Navickis, RJ				Wilkes, MM; Navickis, RJ			Patient survival after human albumin administration - A meta-analysis of randomized, controlled trials	ANNALS OF INTERNAL MEDICINE			English	Review							COLLOID OSMOTIC-PRESSURE; SEVERE OVARIAN HYPERSTIMULATION; VITRO FERTILIZATION PATIENTS; INTRAVENOUS ALBUMIN; SERUM-ALBUMIN; CARDIOPULMONARY BYPASS; PARENTERAL-NUTRITION; EXCHANGE-TRANSFUSION; MAJOR SURGERY; THERAPEUTIC PARACENTESIS	Purpose: To test the hypothesis that albumin administration is not associated with excess mortality. Data Sources: Computer searches of the MEDLINE and EMBASE databases, the Cochrane Library, and Internet documents; hand searching of medical journals; inquiries to investigators and medical directors; and review of reference lists. Study Selection: Randomized, controlled trials comparing albumin therapy with crystalloid therapy, no albumin, or lower doses of albumin. Data Extraction: Two investigators independently extracted data. The primary end point was relative risk for death. Criteria used to assess methodologic quality were blinding, method of allocation concealment, presence of mortality as a study end point, and crossover. Small-trial bias was also investigated. Data Synthesis: Fifty-five trials involving surgery or trauma, burns, hypoalbuminemia, high-risk neonates, ascites, and other indications were included. Albumin administration did not significantly affect mortality in any category of indications. For all trials, the relative risk for death was 1.11 (95% Cl, 0.95 to 1.28). Relative risk was lower among trials with blinding (0.73 [Cl, 0.48 to 1.12]; n = 7), mortality as an end point (1.00 [Cl, 0.84 to 1.18]; n = 17), no crossover (1.04 [Cl, 0.89 to 1.22]; n = 35), and 100 or more patients (0.94 [Cl, 0.77 to 1.14]; n = 10). In trials with two or more such attributes, relative risk was further reduced. Conclusions: overall, no effect of albumin on mortality was detected; any such effect may therefore be small. This finding supports the safety of albumin. The influence of methodologic quality on relative risk for death suggests the need for further well-designed clinical trials.	Hygeia Associates, Grass Valley, CA 95949 USA		Wilkes, MM (corresponding author), Hygeia Associates, 17988 Brewer Rd, Grass Valley, CA 95949 USA.	mwilkes@hygeiaassociates.com						ADAM R, 1991, TRANSPLANT P, V23, P2374; ALDERSON P, 2000, HUMAN ALBUMIN SOLUTI, P2; *ALPH THER CORP, 2000, PRESCR INF ALB HUM U; *BAYER CORP, 1998, PRESCR INF ALB HUM 5; Bell Ewan, 1999, Adverse Drug Reactions and Toxicological Reviews, V18, P149; Berlin JA, 1997, LANCET, V350, P185, DOI 10.1016/S0140-6736(05)62352-5; BLAND RD, 1976, AM J OBSTET GYNECOL, V124, P263, DOI 10.1016/0002-9378(76)90154-X; BLAND RD, 1973, ARCH DIS CHILD, V48, P800, DOI 10.1136/adc.48.10.800; BODENHAMER RM, 1985, ANN THORAC SURG, V40, P374, DOI 10.1016/S0003-4975(10)60072-0; BOLDT J, 1993, ANESTH ANALG, V76, P1185, DOI 10.1213/00000539-199376060-00002; BOLDT J, 1986, INFUS KLIN ERN, V13, P145; BOLDT J, 1992, ANESTH ANALG, V74, P219, DOI 10.1213/00000539-199202000-00008; BOUTROS AR, 1979, CRIT CARE MED, V7, P9, DOI 10.1097/00003246-197901000-00003; BRADBURN MJ, 1998, STATA TECH B, P86; BROWN RO, 1988, CRIT CARE MED, V16, P1177, DOI 10.1097/00003246-198812000-00002; Buhre W, 1997, BRIT J ANAESTH, V79, P311, DOI 10.1093/bja/79.3.311; CARLON GC, 1979, ANESTH ANALG, V58, P13; CHAN G, 1976, J PEDIATR-US, V88, P609, DOI 10.1016/S0022-3476(76)80020-0; Cole RP, 1999, BURNS, V25, P565; COMLEY A, 1968, ARCH DIS CHILD, V43, P151, DOI 10.1136/adc.43.228.151; COOK D, 1999, EVIDENCE BASED MED, V1, P19; DAWIDSON I, 1982, CRIT CARE MED, V10, P597, DOI 10.1097/00003246-198209000-00008; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; EBBESEN F, 1981, ACTA PAEDIATR SCAND, V70, P649, DOI 10.1111/j.1651-2227.1981.tb05762.x; Egger M, 1998, BMJ-BRIT MED J, V316, P61, DOI 10.1136/bmj.316.7124.61; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; EMERSON TE, 1989, CRIT CARE MED, V17, P690, DOI 10.1097/00003246-198907000-00020; EMERY EF, 1992, ARCH DIS CHILD-FETAL, V67, P1185, DOI 10.1136/adc.67.10_Spec_No.1185; Engelman DT, 1999, J THORAC CARDIOV SUR, V118, P866, DOI 10.1016/S0022-5223(99)70056-5; Ernest D, 1999, CRIT CARE MED, V27, P46, DOI 10.1097/00003246-199901000-00025; Erstad BL, 1996, PHARMACOTHERAPY, V16, P996; Erstad BL, 1999, AM J HEALTH-SYST PH, V56, P1451, DOI 10.1093/ajhp/56.14.1451; Ferguson ND, 1999, INTENS CARE MED, V25, P323, DOI 10.1007/s001340050844; FINLAYSON JS, 1980, SEMIN THROMB HEMOST, V6, P85, DOI 10.1055/s-2007-1005097; FOLEY EF, 1990, ARCH SURG-CHICAGO, V125, P739; GALLAGHER JD, 1985, ANESTH ANALG, V64, P753; GARCIACOMPEAN D, 1993, LIVER, V13, P233; Gentilini P, 1999, J HEPATOL, V30, P639, DOI 10.1016/S0168-8278(99)80194-9; Gibbs J, 1999, ARCH SURG-CHICAGO, V134, P36, DOI 10.1001/archsurg.134.1.36; GINES P, 1988, GASTROENTEROLOGY, V94, P1493, DOI 10.1016/0016-5085(88)90691-9; Goldwasser P, 1997, J CLIN EPIDEMIOL, V50, P693, DOI 10.1016/S0895-4356(97)00015-2; GOLUB R, 1994, CRIT CARE MED, V22, P613, DOI 10.1097/00003246-199404000-00017; GOODWIN CW, 1983, ANN SURG, V197, P520, DOI 10.1097/00000658-198305000-00004; GOSLINGA H, 1992, STROKE, V23, P181, DOI 10.1161/01.STR.23.2.181; Gotzsche PC, 2000, BRIT MED J, V321, P585, DOI 10.1136/bmj.321.7261.585; GREENHALGH DG, 1995, J TRAUMA, V39, P67, DOI 10.1097/00005373-199507000-00009; GREENOUGH A, 1993, EUR J PEDIATR, V152, P157, DOI 10.1007/BF02072495; GRUNDMANN R, 1985, ARCH SURG-CHICAGO, V120, P911; GRUNDMANN R, 1982, INTENS CARE MED, V8, P179, DOI 10.1007/BF01725735; GRUNDMANN R, 1986, LANGENBECK ARCH CHIR, V367, P235, DOI 10.1007/BF01263404; HALLOWELL P, 1978, ANN THORAC SURG, V25, P22, DOI 10.1016/S0003-4975(10)63481-9; HOEFT A, 1991, BRIT J ANAESTH, V66, P73, DOI 10.1093/bja/66.1.73; HONDEBRINK Y, 1997, INTENS CARE MED, V23, pS138; *IMM US INC, 1998, PRESCR INF ALB HUM 5; Isik AZ, 1996, EUR J OBSTET GYN R B, V70, P179, DOI 10.1016/S0301-2115(95)02603-7; JELENKO C, 1979, CRIT CARE MED, V7, P157, DOI 10.1097/00003246-197904000-00003; JONES MM, 1986, OBSTET GYNECOL, V68, P659; KANAREK KS, 1992, JPEN-PARENTER ENTER, V16, P49, DOI 10.1177/014860719201600149; KITCHEN WH, 1960, J PEDIATR-US, V57, P876, DOI 10.1016/S0022-3476(60)80137-0; Lennihan L, 2000, STROKE, V31, P383, DOI 10.1161/01.STR.31.2.383; LONDON MJ, 1992, J THORAC CARDIOV SUR, V104, P284; LOWE RJ, 1977, SURGERY, V81, P676; LUCA A, 1995, HEPATOLOGY, V22, P753, DOI 10.1016/0270-9139(95)90293-7; LUCAS CE, 1978, J TRAUMA, V18, P564, DOI 10.1097/00005373-197808000-00002; Magder S, 1999, J CRIT CARE, V14, P164, DOI 10.1016/S0883-9441(99)90030-8; MANTEL N, 1959, J NATL CANCER I, V22, P719; MARELLI D, 1989, J THORAC CARDIOV SUR, V98, P751; Margarson MP, 1998, ANAESTHESIA, V53, P789, DOI 10.1046/j.1365-2044.1998.00438.x; MATHRU M, 1980, ANESTH ANALG, V59, P655; McClelland DBL, 1998, TRANSFUSION, V38, P690, DOI 10.1046/j.1537-2995.1998.38798346639.x; MCNULTY SE, 1993, ANESTH ANALG, V76, P830; METILDI LA, 1984, SURG GYNECOL OBSTET, V158, P207; NIELSEN OM, 1989, DAN MED BULL, V36, P496; NIELSEN OM, 1985, ACTA CHIR SCAND, V151, P221; NILSSON E, 1980, ACTA CHIR SCAND, V146, P619; Oca MJ, 1999, PEDIAT RES, V45, P1265; OHQVIST G, 1981, SCAND J THORAC CARD, V15, P251, DOI 10.3109/14017438109100582; OHQVIST G, 1981, SCAND J THORAC CARD, V15, P257, DOI 10.3109/14017438109100583; POCKAJ BA, 1994, J IMMUNOTHER, V15, P22, DOI 10.1097/00002371-199401000-00003; Prien T, 1990, J Clin Anesth, V2, P317; RACKOW EC, 1983, CRIT CARE MED, V11, P839, DOI 10.1097/00003246-198311000-00001; Recinos P R, 1975, J Iowa Med Soc, V65, P426; REID DJ, 1988, CLIN PHARMACY, V7, P894; RENNIE M, 1998, BR J INTENS CARE, V8, P185; RING J, 1977, LANCET, V1, P466; Roberts I, 1998, BMJ-BRIT MED J, V317, P235; Rubin H, 1997, CRIT CARE MED, V25, P249, DOI 10.1097/00003246-199702000-00009; SADE RM, 1985, J THORAC CARDIOV SUR, V89, P713; Schmid CH, 1998, STAT MED, V17, P1923, DOI 10.1002/(SICI)1097-0258(19980915)17:17<1923::AID-SIM874>3.0.CO;2-6; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; SHAH DM, 1977, ARCH SURG-CHICAGO, V112, P1161; SHALEV E, 1995, HUM REPROD, V10, P1373, DOI 10.1093/HUMREP/10.6.1373; SHOHAM Z, 1994, FERTIL STERIL, V62, P137; SKILLMAN JJ, 1975, SURGERY, V78, P291; So KW, 1997, ARCH DIS CHILD-FETAL, V76, pF43, DOI 10.1136/fn.76.1.F43; Sort P, 1999, NEW ENGL J MED, V341, P403, DOI 10.1056/NEJM199908053410603; STEICHEN TJ, 1998, STATA TECH B, P84; TOLLOFSRUD S, 1995, ACTA ANAESTH SCAND, V39, P671, DOI 10.1111/j.1399-6576.1995.tb04146.x; TULLIS JL, 1977, JAMA-J AM MED ASSOC, V237, P355; Videm Vibeke, 1993, Perfusion, V8, P409, DOI 10.1177/026765919300800508; VIRGILIO RW, 1979, SURGERY, V85, P129; VIRGILIO RW, 1979, SURG FORUM, V30, P166; von Hoegen I, 2001, CRIT CARE MED, V29, P994, DOI 10.1097/00003246-200105000-00021; Webb AR, 2000, CRIT CARE, V4, pS26, DOI 10.1186/cc967; WILKINSON P, 1962, LANCET, V2, P1125; Woittiez A J, 1998, Ned Tijdschr Geneeskd, V142, P2161; WOJTYSIAK SL, 1992, CRIT CARE MED, V20, P164, DOI 10.1097/00003246-199202000-00005; WONG YK, 1972, ARCH DIS CHILD, V47, P241, DOI 10.1136/adc.47.252.241; WOOD B, 1970, ARCH DIS CHILD, V45, P59, DOI 10.1136/adc.45.239.59; WOODS MS, 1993, AM SURGEON, V59, P758; ZETTERSTROM H, 1981, ACTA ANAESTH SCAND, V25, P125, DOI 10.1111/j.1399-6576.1981.tb01622.x; ZETTERSTROM H, 1981, ACTA ANAESTH SCAND, V25, P133, DOI 10.1111/j.1399-6576.1981.tb01623.x; [No title captured]	113	288	330	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 7	2001	135	3					149	164		10.7326/0003-4819-135-3-200108070-00007	http://dx.doi.org/10.7326/0003-4819-135-3-200108070-00007			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460FX	11487482				2022-12-28	WOS:000170298500001
J	Pizzarello, S; Huang, YS; Becker, L; Poreda, RJ; Nieman, RA; Cooper, G; Williams, M				Pizzarello, S; Huang, YS; Becker, L; Poreda, RJ; Nieman, RA; Cooper, G; Williams, M			The organic content of the Tagish Lake meteorite	SCIENCE			English	Article							MURCHISON METEORITE; CARBONACEOUS CHONDRITE; C-13 NMR; ACIDS; HYDROCARBONS; DERIVATIVES; MATTER	The Tagish Lake meteorite felt last year on a frozen take in Canada and may provide the most pristine material of its kind. Analyses have now shown this carbonaceous chondrite to contain a suite of soluble organic compounds (similar to 100 parts per million) that includes mono- and dicarboxylic acids, dicarboximides, pyridine carboxylic acids, a sulfonic acid, and both aliphatic and aromatic hydrocarbons. The insoluble carbon exhibits exclusive aromatic character, deuterium enrichment, and fullerenes containing "planetary" helium and argon. The findings provide insight into an outcome of early solar chemical evolution that differs from any seen so far in meteorites.	Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; Univ Calif Santa Barbara, Inst Crustal Studies, Santa Barbara, CA 93106 USA; Univ Rochester, Dept Earth & Environm Sci, Rochester, NY 14627 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA	Arizona State University; Arizona State University-Tempe; Brown University; University of California System; University of California Santa Barbara; University of Rochester; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Pizzarello, S (corresponding author), Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA.							ALLAMANDOLA LJ, 1987, SCIENCE, V237, P56, DOI 10.1126/science.237.4810.56; Becker L, 2000, P NATL ACAD SCI USA, V97, P2979, DOI 10.1073/pnas.050519397; Brown PG, 2000, SCIENCE, V290, P320, DOI 10.1126/science.290.5490.320; CHYBA C, 1992, NATURE, V355, P125, DOI 10.1038/355125a0; CODY GD, 1999, LUNAR PLANET SCI, V30; COOPER GW, 1995, GEOCHIM COSMOCHIM AC, V59, P1003, DOI 10.1016/0016-7037(95)00018-6; Cooper GW, 1997, SCIENCE, V277, P1072, DOI 10.1126/science.277.5329.1072; CRONIN JR, 1993, GEOCHIM COSMOCHIM AC, V57, P4745, DOI 10.1016/0016-7037(93)90197-5; CRONIN JR, 1987, GEOCHIM COSMOCHIM AC, V51, P299, DOI 10.1016/0016-7037(87)90242-0; CRONIN JR, 1993, NATO ADV SCI INST SE, V416, P209; CRONIN JR, 1990, GEOCHIM COSMOCHIM AC, V54, P2859, DOI 10.1016/0016-7037(90)90020-L; Cronin JR., 1988, ORGANIC MATTER CARBO, P819; Gardinier A, 2000, EARTH PLANET SC LETT, V184, P9, DOI 10.1016/S0012-821X(00)00300-9; Gilmour I., 2001, LUNAR PLANET SCI, V32; HAN J, 1969, NATURE, V222, P364, DOI 10.1038/222364a0; KERRIDGE JF, 1987, GEOCHIM COSMOCHIM AC, V51, P2527, DOI 10.1016/0016-7037(87)90303-6; LAWLESS JG, 1979, NATURE, V282, P396, DOI 10.1038/282396a0; PELTZER ET, 1978, NATURE, V272, P443, DOI 10.1038/272443a0; Pizzarello S, 2001, METEORIT PLANET SCI, V36, P897, DOI 10.1111/j.1945-5100.2001.tb01929.x; STUDIER MH, 1972, GEOCHIM COSMOCHIM AC, V36, P189	20	197	201	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2001	293	5538					2236	2239		10.1126/science.1062614	http://dx.doi.org/10.1126/science.1062614			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475AL	11520948				2022-12-28	WOS:000171139400038
J	Renshaw, CE; Schulson, EM				Renshaw, CE; Schulson, EM			Universal behaviour in compressive failure of brittle materials	NATURE			English	Article							DUCTILE TRANSITION; EXPERIMENTAL DEFORMATION; FRACTURE; ICE; FAULTS; GROWTH; NUCLEATION; GRANITE; SOLIDS; ROCKS	Brittle failure limits the compressive strength of rock and ice when rapidly loaded under low to moderate confinement. Higher confinement or slower loading results in ductile failure once the brittle-ductile transition is crossed. Brittle failure begins when primary cracks initiate and slide, creating wing cracks at their tips(1-3). Under little to no confinement, wing cracks extend and link together, splitting the material into slender columns which then fail. Under low to moderate confinement, wing crack growth is restricted and terminal failure is controlled by the localization of damage along a narrow band. Early investigations proposed that localization results from either the linkage of wing cracks(1-3) or the buckling of microcolumns created between adjacent wing cracks(4,5). Observations of compressive failure in ice(6) suggest a mechanism whereby localization initiates owing to the bending-induced failure of slender microcolumns created between sets of secondary cracks emanating from one side of a primary crack. Here we analyse this mechanism, and show that it leads to a closed-form, quantitative model that depends only on independently measurable mechanical parameters. Our model predictions for both the brittle compressive strength and the brittle-ductile transition are consistent with data from a variety of crystalline materials, offering quantitative evidence for universal processes in brittle failure and for the broad applicability of the model.	Dartmouth Coll, Dept Earth Sci, Hanover, NH 03755 USA; Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College	Renshaw, CE (corresponding author), Dartmouth Coll, Dept Earth Sci, Hanover, NH 03755 USA.							ASHBY MF, 1986, ACTA METALL MATER, V34, P497, DOI 10.1016/0001-6160(86)90086-6; Bazant ZP, 1997, J ENG MECH, V123, P162; BRACE WF, 1963, J GEOPHYS RES, V68, P3709, DOI 10.1029/JZ068i012p03709; BRACE WF, 1967, FAILURE BREAKAGE ROC; Cooke ML, 1997, J GEOPHYS RES-SOL EA, V102, P22425, DOI 10.1029/97JB01829; GOTTSCHALK RR, 1990, J GEOPHYS RES-SOLID, V95, P21613, DOI 10.1029/JB095iB13p21613; GOWD TN, 1980, INT J ROCK MECH MIN, V17, P225, DOI 10.1016/0148-9062(80)91089-X; Hacker B.R., 1990, BRITTLE DUCTILE TRAN; Heard H C, 1960, GEOL SOC AM MEM, V79, P193, DOI DOI 10.1130/MEM79-P193; HELLAN K, 1984, INTRO FRACTURE MECH, P1; HORII H, 1985, J GEOPHYS RES-SOLID, V90, P3105, DOI 10.1029/JB090iB04p03105; HORII H, 1986, PHILOS T R SOC A, V319, P337, DOI 10.1098/rsta.1986.0101; ILIESCU D, 2000, THESIS DARTMOUTH COL, P1; KIRBY SH, 1980, J GEOPHYS RES, V85, P6353, DOI 10.1029/JB085iB11p06353; Mogi K., 1966, ROCK MECH ENG GEOL, V4, P41; NIXON WA, 1987, J PHYS-PARIS, V48, P313, DOI 10.1051/jphyscol:1987144; PENG S, 1972, INT J ROCK MECH MIN, V9, P37, DOI 10.1016/0148-9062(72)90050-2; Pollard D. D., 1987, FRACTURE MECH ROCK, P227; QI S, 1998, 14 INT S IC POTSD NE, P521; RECHES Z, 1994, J GEOPHYS RES-SOL EA, V99, P18159, DOI 10.1029/94JB00115; Riedel H, 1980, ASTM STP, P112; SCHULSON EM, 1995, J GEOPHYS RES-SOL EA, V100, P22383, DOI 10.1029/95JB02513; Schulson EM, 1999, J GEOPHYS RES-SOL EA, V104, P695, DOI 10.1029/1998JB900017; SCHULSON EM, 1990, ACTA METALL MATER, V38, P1963, DOI 10.1016/0956-7151(90)90308-4; SCHULSON EM, 1995, ACTA METALL MATER, V43, P3663; SHOCK RN, 1974, J GEOPHYS RES, V79, P1662; THOULESS MD, 1987, ACTA METALL MATER, V35, P1333, DOI 10.1016/0001-6160(87)90015-0; TULLIS J, 1977, J GEOPHYS RES, V82, P5705, DOI 10.1029/JB082i036p05705; Wang ZC, 1999, CAN MINERAL, V37, P525; Weiss J, 2000, PHILOS MAG A, V80, P279, DOI 10.1080/01418610008212053	30	138	147	6	69	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2001	412	6850					897	900		10.1038/35091045	http://dx.doi.org/10.1038/35091045			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467EG	11528475				2022-12-28	WOS:000170689000041
J	Bilham, R; Gaur, VK; Molnar, P				Bilham, R; Gaur, VK; Molnar, P			Earthquakes - Himalayan seismic hazard	SCIENCE			English	Editorial Material							AVERAGE RATE; DEFORMATION; CONSTRAINTS		Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; Indian Inst Astrophys, Bangalore 560034, Karnataka, India	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Department of Science & Technology (India); Indian Institute of Astrophysics (IIA)	Bilham, R (corresponding author), Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA.	bilham@colorado.edu		Bilham, Roger/0000-0002-5547-4102				Ambraseys N., 2000, CURR SCI, V79, P101; [Anonymous], 1990, J HIM GEOL; ARYA AS, 1992, CURR SCI INDIA, V62, P251; BAPAT A, 1983, CATALOG EARTHQUAKES; Bilham R, 1998, GEOL SOC SPEC PUBL, V146, P295, DOI 10.1144/GSL.SP.1999.146.01.18; Bilham R, 2001, GEOPHYS J INT, V144, P713, DOI 10.1046/j.1365-246x.2001.01365.x; Bilham R, 1998, CURR SCI INDIA, V74, P213; Bilham R, 2001, NATURE, V410, P806, DOI 10.1038/35071057; CHEN WP, 1977, J GEOPHYS RES, V82, P2945, DOI 10.1029/JB082i020p02945; Dunn J.A., 1939, GEOL SURV INDIA MEM, V73; IYENGAR RN, 1998, EARTHQUAKE HIST INDI; JACKSON M, 1994, J GEOPHYS RES-SOL EA, V99, P13897, DOI 10.1029/94JB00714; KHATTRI KN, 1987, TECTONOPHYSICS, V138, P79, DOI 10.1016/0040-1951(87)90067-9; LARSON K, 1999, J GEOPHYS RES, V104, P1177; Lave J, 2000, J GEOPHYS RES-SOL EA, V105, P5735, DOI 10.1029/1999JB900292; MIDDLEMISS CS, 1910, MEM GEOL SURV INDIA, V37; MOLNAR P, 1984, J GEOPHYS RES, V89, P6203, DOI 10.1029/JB089iB07p06203; Pandey M., 1988, J NEPAL GEOL SOC, V5, P22, DOI [10.3126/jngs.v5i1.32559, DOI 10.3126/JNGS.V5I1.32559]; PANDEY MR, 1995, GEOPHYS RES LETT, V22, P751, DOI 10.1029/94GL02971; Paul J, 2001, GEOPHYS RES LETT, V28, P647, DOI 10.1029/2000GL011832; RANA BSJ, 1935, NEPALKO MAHA BHUKAMP; Seeber L, 1981, M EWING SERIES AM GE, P259; [No title captured]	23	479	518	0	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2001	293	5534					1442	1444		10.1126/science.1062584	http://dx.doi.org/10.1126/science.1062584			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465XV	11520972				2022-12-28	WOS:000170616000029
J	Gotz, J; Chen, F; van Dorpe, J; Nitsch, RM				Gotz, J; Chen, F; van Dorpe, J; Nitsch, RM			Formation of neurofibrillary tangles in P301L tau transgenic mice induced by A beta 42 fibrils	SCIENCE			English	Article							PAIRED HELICAL FILAMENTS; ALZHEIMERS-DISEASE; MICROTUBULE-BINDING; PROTEIN; PHOSPHORYLATION; NEUROTOXICITY; AMYOTROPHY; PATHOLOGY; ISOFORMS; BRAIN	beta -Amyloid plaques and neurofibrillary tangles (NFTs) are the defining neuropathological hallmarks of Alzheimer's disease, but their pathophysiological relation is unclear. Injection of beta -amyloid A beta (42) fibrils into the brains of P301L mutant tau transgenic mice caused fivefold increases in the numbers of NFTs in cell bodies within the amygdala from where neurons project to the injection sites. Gallyas silver impregnation identified NFTs that contained tau phosphorylated at serine 212/threonine 214 and serine 422. NFTs were composed of twisted filaments and occurred in 6-month-old mice as early as 18 days after A beta (42) injections. Our data support the hypothesis that A beta (42) fibrils can accelerate NFT formation in vivo.	Univ Zurich, Div Psychiat Res, CH-8008 Zurich, Switzerland; Katholieke Univ Leuven, Ctr Human Genet, Expt Genet Grp, Louvain, Belgium	University of Zurich; KU Leuven	Nitsch, RM (corresponding author), Univ Zurich, Div Psychiat Res, August Forel Str 1, CH-8008 Zurich, Switzerland.	goetz@bli.unizh.ch; nitsch@bli.unizh.ch	Götz, Jürgen/C-2448-2014	Götz, Jürgen/0000-0001-8501-7896				Arnold SE, 1991, CEREB CORTEX, V1, P103, DOI 10.1093/cercor/1.1.103; BRAAK H, 1986, NEUROSCI LETT, V65, P351, DOI 10.1016/0304-3940(86)90288-0; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; BueeScherrer V, 1996, MOL BRAIN RES, V39, P79, DOI 10.1016/0169-328X(96)00003-4; BUSCIGLIO J, 1995, NEURON, V14, P879, DOI 10.1016/0896-6273(95)90232-5; Delacourte A, 1998, ANN NEUROL, V43, P193, DOI 10.1002/ana.410430209; DICKSON DW, 1995, NEUROBIOL AGING, V16, P285, DOI 10.1016/0197-4580(95)00013-5; GALLYAS F, 1971, ACTA MORPHOL HUNG, V19, P1; Geula C, 1998, NAT MED, V4, P827, DOI 10.1038/nm0798-827; GOEDERT M, 1995, NEUROSCI LETT, V189, P167, DOI 10.1016/0304-3940(95)11484-E; GOEDERT M, 1994, BIOCHEM J, V301, P871, DOI 10.1042/bj3010871; Gotz J, 2001, BRAIN RES REV, V35, P266, DOI 10.1016/S0165-0173(01)00055-8; Gotz J, 2001, J BIOL CHEM, V276, P529, DOI 10.1074/jbc.M006531200; Gotz J, 1998, P NATL ACAD SCI USA, V95, P12370, DOI 10.1073/pnas.95.21.12370; GOTZ J, UNPUB; GREENBERG SG, 1992, J BIOL CHEM, V267, P564; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; HSIAO KK, 1995, NEURON, V15, P1203, DOI 10.1016/0896-6273(95)90107-8; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; MCKEE AC, 1989, ANN NEUROL, V26, P652, DOI 10.1002/ana.410260511; Paxinos K.B.J., 1997, MOUSE BRAIN STEREOTA; PRICE DL, 1994, ANNU REV MED, V45, P435; Probst A, 2000, ACTA NEUROPATHOL, V99, P469, DOI 10.1007/s004010051148; Sergeant N, 1999, J NEUROCHEM, V72, P1243, DOI 10.1046/j.1471-4159.1999.0721243.x; SEUBERT P, 1995, J BIOL CHEM, V270, P18917, DOI 10.1074/jbc.270.32.18917; Spillantini MG, 1998, AM J PATHOL, V153, P1359, DOI 10.1016/S0002-9440(10)65721-5; Tanaka T, 1998, FEBS LETT, V426, P248, DOI 10.1016/S0014-5793(98)00346-9; Varadarajan S, 2000, J STRUCT BIOL, V130, P184, DOI 10.1006/jsbi.2000.4274; Velasco ME, 1998, BRAIN RES, V813, P329, DOI 10.1016/S0006-8993(98)01034-8	32	1180	1240	1	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2001	293	5534					1491	1495		10.1126/science.1062097	http://dx.doi.org/10.1126/science.1062097			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465XV	11520988				2022-12-28	WOS:000170616000045
J	Amer-Wahlin, I; Hellsten, C; Noren, H; Hagberg, H; Herbst, A; Kjellmer, I; Lilja, H; Lindoff, C; Mansson, M; Martensson, L; Olofsson, P; Sundstrom, AK; Marsal, K				Amer-Wahlin, I; Hellsten, C; Noren, H; Hagberg, H; Herbst, A; Kjellmer, I; Lilja, H; Lindoff, C; Mansson, M; Martensson, L; Olofsson, P; Sundstrom, AK; Marsal, K			Cardiotocography only versus cardiotocography plus ST analysis of fetal electrocardiogram for intrapartum fetal monitoring: a Swedish randomised controlled trial	LANCET			English	Article							ECG WAVE-FORM; NEONATAL ENCEPHALOPATHY; TERM; HYPOXIA; BLOOD	Background Previous studies indicate that analysis of the ST waveform of the fetal electrocardiogram provides information on the fetal response to hypoxia. We did a multicentre randomised controlled trial to test the hypothesis that intrapartum monitoring with cardiotocography combined with automatic ST-waveform analysis results in an improved perinatal outcome compared with cardiotocography alone. Methods At three Swedish labour wards, 4966 women with term fetuses in the cephalic presentation entered the trial during labour after a clinical decision had been made to apply a fetal scalp electrode for internal cardiotocography. They were randomly assigned monitoring with cardiotocography plus ST analysis (CTG+ST group) or cardiotocography only (CTG group). The main outcome measure was rate of umbilical-artery metabolic acidosis (pH <7.05 and base deficit >12 mmol/L). Secondary outcomes included operative delivery for fetal distress. Results were first analysed according to intention to treat, and secondly after exclusion of cases with severe malformations or with inadequate monitoring. Findings The CTG+ST group showed significantly lower rates of umbilical-artery metabolic acidosis than the cardiotocography group (15 of 2159 [0.7%] vs 31 of 2079 [2%], relative risk 0.47 [95% CI 0.25-0.86], p=0.02) and of operative delivery for fetal distress (193 of 2519 [8%] vs 227 of 2447 [9%], 0.83 [0.69-0.99], p=0.047) when all cases were included according to intention to treat. The differences were more pronounced after exclusion of 291 in the CTG+ST group and 283 in the CTG group with malformations or inadequate recording. Interpretation Intrapartum monitoring with cardiotocography combined with automatic ST-waveform analysis increases the ability of obstetricians to identify fetal hypoxia and to intervene more appropriately, resulting in an improved perinatal outcome.	Univ Lund Hosp, Dept Obstet & Gynecol, S-22185 Lund, Sweden; Lund Univ, Malmo Univ Hosp, Dept Obstet & Gynaecol, S-22100 Lund, Sweden; Gothenburg Univ, Sahlgrens Univ Hosp, Perinatal Ctr, S-41124 Gothenburg, Sweden	Lund University; Skane University Hospital; Lund University; Skane University Hospital; Sahlgrenska University Hospital; University of Gothenburg	Marsal, K (corresponding author), Univ Lund Hosp, Dept Obstet & Gynecol, S-22185 Lund, Sweden.	Karel.Marsal@gyn.lu.se		Herbst, Andreas/0000-0002-2540-7339; Hagberg, Henrik/0000-0003-3962-1448				ARULKUMARAN S, 1990, J PERINAT MED, V18, P13, DOI 10.1515/jpme.1990.18.1.13; COLEMAN J, 1957, SOCIOMETRY, V20, P253, DOI 10.2307/2785979; FREEMAN R, 1990, NEW ENGL J MED, V322, P624, DOI 10.1056/NEJM199003013220910; Granados A, 1997, INT J TECHNOL ASSESS, V13, P220, DOI 10.1017/S0266462300010370; GREENE KR, 1982, AM J OBSTET GYNECOL, V144, P950, DOI 10.1016/0002-9378(82)90190-9; HOKEGARD KH, 1981, ACTA PHYSIOL SCAND, V113, P1, DOI 10.1111/j.1748-1716.1981.tb06853.x; Hornbuckle J, 2000, BRIT J OBSTET GYNAEC, V107, P3, DOI 10.1111/j.1471-0528.2000.tb11571.x; LILJA H, 1989, INT J GYNECOL OBSTET, V30, P109, DOI 10.1016/0020-7292(89)90304-4; LOW JA, 1994, AM J OBSTET GYNECOL, V170, P1081, DOI 10.1016/S0002-9378(94)70101-6; Luzietti R, 1999, J PERINAT MED, V27, P431, DOI 10.1515/JPM.1999.058; MIRANDA CP, 1991, AM HEART J, V122, P1617, DOI 10.1016/0002-8703(91)90279-Q; Nelson KB, 1996, NEW ENGL J MED, V334, P613, DOI 10.1056/NEJM199603073341001; NIELSON JP, 1993, INTRAPARTUM FETAL SU; Parer JT, 2000, AM J OBSTET GYNECOL, V182, P982, DOI 10.1016/S0002-9378(00)70358-9; Rooth G., 1987, INT J GYNECOL OBSTET, V25, P159, DOI DOI 10.1016/0020-7292(87)90012-9; Rosen KG, 2000, PRENAT NEONAT MED, V5, P155; SARNAT HB, 1976, ARCH NEUROL-CHICAGO, V33, P696, DOI 10.1001/archneur.1976.00500100030012; SIGGAARD.O, 1971, SCAND J CLIN LAB INV, V27, P239, DOI 10.3109/00365517109080214; Spencer JAD, 1997, BRIT J OBSTET GYNAEC, V104, P25, DOI 10.1111/j.1471-0528.1997.tb10643.x; THACKER SB, 1995, OBSTET GYNECOL, V86, P613, DOI 10.1016/0029-7844(95)00232-G; WESTGATE J, 1994, BRIT J OBSTET GYNAEC, V101, P250, DOI 10.1111/j.1471-0528.1994.tb13119.x; WESTGATE J, 1993, AM J OBSTET GYNECOL, V169, P1151, DOI 10.1016/0002-9378(93)90273-L; Westgate JA, 1999, BRIT J OBSTET GYNAEC, V106, P774, DOI 10.1111/j.1471-0528.1999.tb08397.x; WIDMARK C, 1991, J DEV PHYSIOL, V15, P161	24	266	274	2	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 18	2001	358	9281					534	538		10.1016/S0140-6736(01)05703-8	http://dx.doi.org/10.1016/S0140-6736(01)05703-8			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464NB	11520523				2022-12-28	WOS:000170537700010
J	Herren, KR; Mackway-Jones, K; Richards, CR; Seneviratne, CJ; France, MW; Cotter, L				Herren, KR; Mackway-Jones, K; Richards, CR; Seneviratne, CJ; France, MW; Cotter, L			Is it possible to exclude a diagnosis of myocardial damage within six hours of admission to an emergency department? Diagnostic cohort study	BRITISH MEDICAL JOURNAL			English	Article							CARDIAC TROPONIN-T; CHEST-PAIN; INFARCTION; AUDIT; ACCIDENT; TRIAL; ROOM	Objective To assess the clinical efficacy and accuracy of an emergency department based six hour rule-out protocol for myocardial damage. Design Diagnostic cohort study. Setting Emergency department of an inner city university hospital. Participants 383 consecutive patients aged over 25 years with chest pain of less than 12 hours' duration who were at low to moderate risk of acute myocardial infarction. Intervention Serial measurements of creatine kinase MB mass and continuous ST segment monitoring for six hours with 12 leads. Main outcome measure Performance of the diagnostic test against a gold standard consisting of either a 48 hour measurement of troponin T concentration or screening for myocardial infarction according to the World Health Organization's criteria. Results Outcome of the gold standard test was available for 292 patients. On the diagnostic test for the protocol, 53 patients had positive results and 239 patients had negative results. There were 18 false positive results and one false negative result. Sensitivity was 97.2% (95% confidence interval 95.0% to 99.0%), specificity 93.0% (90.0% to 96.0%), the negative predictive value 99.6%, and the positive predictive value 66.0%. The positive likelihood ratio was 13.9 and the negative likelihood ratio 0.03. Conclusions The six hour rule-out protocol for myocardial infarction is accurate mad efficacious. It can be used in patients presenting to emergency departments with chest pain indicating a low to moderate risk of myocardial infarction.	Manchester Royal Infirm, Dept Emergency Med, Manchester M13 9WL, Lancs, England; Manchester Royal Infirm, Dept Clin Biochem, Manchester M13 9WL, Lancs, England; Manchester Royal Infirm, Manchester Heart Ctr, Manchester M13 9WL, Lancs, England	University of Manchester; University of Manchester; University of Manchester	Mackway-Jones, K (corresponding author), Manchester Royal Infirm, Dept Emergency Med, Oxford Rd, Manchester M13 9WL, Lancs, England.							CLEMENTS FM, 1988, CRIT CARE MED, V16, P710, DOI 10.1097/00003246-198807000-00013; Collinson PO, 2000, BRIT MED J, V320, P1702, DOI 10.1136/bmj.320.7251.1702; EMERSON PA, 1989, Q J MED, V70, P213; Farkouh ME, 1998, NEW ENGL J MED, V339, P1882, DOI 10.1056/NEJM199812243392603; FOTHERGILL NJ, 1993, ARCH EMERG MED, V10, P155; Hamm CW, 1997, NEW ENGL J MED, V337, P1648, DOI 10.1056/NEJM199712043372302; HUNT D, 1992, LANCET, V339, P753; KING SB, 1994, NEW ENGL J MED, V331, P1044, DOI 10.1056/NEJM199410203311602; KRUCOFF MW, 1986, AM J CARDIOL, V57, P916, DOI 10.1016/0002-9149(86)90730-7; LEE TH, 1987, AM J CARDIOL, V60, P219, DOI 10.1016/0002-9149(87)90217-7; LEE TH, 1987, ANN INTERN MED, V106, P181, DOI 10.7326/0003-4819-106-2-181; MAIR J, 1991, CLIN CHEM, V37, P845; Ohman EM, 1996, NEW ENGL J MED, V335, P1333, DOI 10.1056/NEJM199610313351801; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P532	14	28	28	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 18	2001	323	7309					372	374		10.1136/bmj.323.7309.372	http://dx.doi.org/10.1136/bmj.323.7309.372			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465GN	11509427	Bronze, Green Published			2022-12-28	WOS:000170581400018
J	Lam, TH; Ho, SY; Hedley, AJ; Mak, KH; Peto, R				Lam, TH; Ho, SY; Hedley, AJ; Mak, KH; Peto, R			Mortality and smoking in Hong Kong: case-control study of all adult deaths in 1998	BRITISH MEDICAL JOURNAL			English	Article							TOBACCO	Objective To assess the mortality currently associated,vith smoking in Hong Kong, and, since cigarette consumption reached its peak 20 years earlier in Hong Kong than in mainland China, to predict mortality in China 20 years hence. Design Case-control study. Past smoking habits of all Chinese adults in Hong Kong who died in 1998 (cases) were sought from those registering the death. Setting All the death registries in Hong Kong. Participants 27 507 dead cases (81% of all registered deaths) and 13 054 live controls aged greater than or equal to 35 years. Main outcome measures Mortality from all causes and from specific causes. Results In men aged 35-69 the adjusted risk ratios (and 95% confidence intervals) comparing smokers with non-smokers were 1.92 (1.70 to 2.16) for all deaths, 2.22 (1.94 to 2.55) for neoplastic deaths, 2.60 (2.10 to 3.21) for respiratory deaths (including tuberculosis, risk ratio 2.54), and 1.68 (1.43 to 1.97) for vascular deaths (each P < 0.0001). In women aged 35-69 the corresponding risk ratios were 1.62 (1.40 to 1.88) for all deaths, 1.60 (1.33 to 1.93) for neoplastic deaths, 3.13 (2.21 to 4.44) for respiratory deaths, and 1.55 (1.20 to 1.99) for vascular deaths (each P < 0.001). If these associations with smoking are largely or wholly causal then, among all registered deaths at ages 35-69 in 1998, tobacco caused about 33% (2534/7588) of all male deaths and 5% (169/3341) of all female deaths (hence 25% of all dead-is at these ages). At older ages tobacco seemed to be the cause of 15% (3017/20 420) of all deaths. Conclusions Among middle aged men the proportion of deaths caused by smoking is more than twice as big in Hong Kong now (33%) as in mainland China 10 years earlier. This supports predictions of a large increase in tobacco attributable mortality in China as a whole.	Univ Hong Kong, Dept Community Med, Hong Kong, Hong Kong, Peoples R China; Govt Hong Kong Special Adm Reg, Dept Hlth, Hong Kong, Hong Kong, Peoples R China; Univ Oxford, CTSU, Oxford OX2 6HE, England	University of Hong Kong; University of Oxford	Lam, TH (corresponding author), Univ Hong Kong, Dept Community Med, Patrick Manson Bldg S Wing,7 Sassoon Rd, Hong Kong, Hong Kong, Peoples R China.		Hedley, Anthony/C-4305-2009; Hedley, Anthony J/A-9113-2013; Lam, Tai Hing/C-4317-2009; Ho, Daniel Sai Yin/C-4307-2009	Lam, Tai Hing/0000-0002-2033-9971; Ho, Daniel Sai Yin/0000-0001-9485-0273				Liu BQ, 1998, BMJ-BRIT MED J, V317, P1411, DOI 10.1136/bmj.317.7170.1411; Peto R, 1999, NAT MED, V5, P15, DOI 10.1038/4691; Peto R., 2001, CRITICAL ISSUES GLOB, P154, DOI DOI 10.4314/NMP.V55I6.45441	3	115	119	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 18	2001	323	7309					361	362		10.1136/bmj.323.7309.361	http://dx.doi.org/10.1136/bmj.323.7309.361			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465GN	11509422	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000170581400013
J	Henneman, ML; Memmott, J				Henneman, ML; Memmott, J			Infiltration of a Hawaiian community by introduced biological control agents	SCIENCE			English	Article								To examine the community-wide effects of introduced biocontrol agents on Kauai Island, Hawaii, we constructed quantitative food webs showing interactions among plants, moths, and moth parasitoids in a native forest. Eighty-three percent of parasitoids reared from native moths were biological control agents, 14% were accidental immigrants, and 3% were native species. Although parasitism by biological control agents reached 28% in some species of moth, all biocontrol agents reared had been released before 1945. This study highlights the importance of considering the potential damage caused by an introduced control agent, in addition to that caused by the target alien species.	Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England	University of Bristol	Memmott, J (corresponding author), Univ Bristol, Sch Biol Sci, Woodland Rd, Bristol BS8 1UG, Avon, England.	Jane.Memmott@bristol.ac.uk						BEARDSLEY JOHN W., 1961, PROC HAWAIIAN ENT SOC, V17, P333; BENNETT FD, 1993, FLA ENTOMOL, V76, P54, DOI 10.2307/3496013; Boettner GH, 2000, CONSERV BIOL, V14, P1798, DOI 10.1046/j.1523-1739.2000.99193.x; CORNELL HV, 1993, AM NAT, V141, P847, DOI 10.1086/285512; COULSON J, 2001, RELEASES BENEFICIAL; Elliott N, 1996, OECOLOGIA, V105, P537, DOI 10.1007/BF00330017; FUNASAKI G Y, 1988, Proceedings of the Hawaiian Entomological Society, V28, P105; GAGNE WC, 1985, P 3 C EUR LEP CAMBR, P74; GLASSER JW, 1982, AM NAT, V119, P375, DOI 10.1086/283916; HADFIELD MG, 1993, AM ZOOL, V33, P610; HASSELL MP, 1973, J ANIM ECOL, V42, P693, DOI 10.2307/3133; HAWKINS BA, 1993, SCIENCE, V262, P1429, DOI 10.1126/science.262.5138.1429; HOWARTH FG, 1991, ANNU REV ENTOMOL, V36, P485, DOI 10.1146/annurev.en.36.010191.002413; Howarth Francis G., 2000, P369; Johnson DM, 1998, FLA ENTOMOL, V81, P12, DOI 10.2307/3495992; LAI P Y, 1986, Proceedings of the Hawaiian Entomological Society, V26, P89; LAI PY, 1983, LIST BIOL CONTROL IN; Louda SM, 1997, SCIENCE, V277, P1088, DOI 10.1126/science.277.5329.1088; MEMMOTT J, 1994, J ANIM ECOL, V63, P521, DOI 10.2307/5219; Memmott J, 2000, NONTARGET EFFECTS OF BIOLOGICAL CONTROL, P147; Messing RH, 2000, NONTARGET EFFECTS OF BIOLOGICAL CONTROL, P45; MURDOCH WW, 1985, AM NAT, V125, P344, DOI 10.1086/284347; SETTLE WH, 1990, ECOLOGY, V71, P1461, DOI 10.2307/1938283; Simberloff D, 1996, ECOLOGY, V77, P1965, DOI 10.2307/2265693; Simberloff D., 1992, Selection criteria and ecological consequences of importing natural enemies., P103; Strong DR, 2000, SCIENCE, V288, P1969, DOI 10.1126/science.288.5473.1969; Strong DR, 2001, EVALUATING INDIRECT ECOLOGICAL EFFECTS OF BIOLOGICAL CONTROL, P57, DOI 10.1079/9780851994536.0057; Thomas MB, 1998, TRENDS ECOL EVOL, V13, P325, DOI 10.1016/S0169-5347(98)01417-7; VANDRIESCHE RG, 1994, FLA ENTOMOL, V77, P20, DOI 10.2307/3495870; Williams F. X., 1931, HDB INSECTS OTHER IN; Zimmerman EC, 1978, MICROLEPIDOPTERA 2, V9, P883	31	221	233	4	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2001	293	5533					1314	1316		10.1126/science.1060788	http://dx.doi.org/10.1126/science.1060788			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11509730				2022-12-28	WOS:000170492600039
J	Brewer, TF; Heymann, SJ; Krumplitsch, SM; Wilson, ME; Colditz, GA; Fineberg, HV				Brewer, TF; Heymann, SJ; Krumplitsch, SM; Wilson, ME; Colditz, GA; Fineberg, HV			Strategies to decrease tuberculosis in US homeless populations - A computer simulation model	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NEW-YORK-CITY; DIRECTLY OBSERVED THERAPY; UNITED-STATES; ISONIAZID PROPHYLAXIS; HIV; SHELTER; TRANSMISSION; PREVENTION; RESISTANT	Context The rate of tuberculosis (TB) among US homeless persons maybe 20 times that of the general adult population. Studies suggest that the majority of urban homeless TB cases are attributable to ongoing transmission of TB. Optimal TB-control strategies in both chronically and transiently homeless populations are not known. Objective To examine the effects of TB-control strategies on projected TB cases and deaths in US homeless populations using a computer-based simulation model. Design, Setting, and Population The US general population and a theoretical population of 2 million homeless individuals in 1995 were divided into 18 clinical states based on the risk for or presence of TB and human immunodeficiency virus (HIV) infection in a semi-Markov model. Main Outcome Measures Prevalence of transiently and chronically homeless individuals with active TB and deaths from TB as a function of public health measures taken to control and eliminate TB, including improvement of treatment effectiveness, improvement in access to treatment, and vaccination with BCG. Results A 10% increase in access to treatment among homeless persons with active TB produced larger declines in predicted TB cases and deaths after 10 years (cases and deaths among chronically homeless persons decreased 12.5% and 19.8% and among transiently homeless persons dropped 35.9% and 32.4%, respectively) than improvements in the effectiveness of treatment programs (cases and deaths among chronically homeless per-sons declined 7.2% and 3.1% and among transiently homeless persons dropped 10.9% and 4.1%, respectively). A 10% increase in access to treatment among homeless persons with latent TB infection led to a 6.7% decline in TB among chronically homeless persons and a 5.7% decline among transiently homeless persons, while a 10% improvement in effectiveness of treatment for latent TB infection was associated with declines of 3.0% and 3.3%, respectively. When treatment for latent TB infection was modeled to be the same in vaccinated and nonvaccinated populations, BCG vaccination led to TB case declines of 15.4% and 21.5% in chronically and transiently homeless populations, respectively. Conclusions Overcoming barriers faced by homeless individuals in accessing TB treatment programs will be crucial to reducing the burden of TB in this high-risk group. Increased treatment access, improvement in the effectiveness of treatment programs, and BCG vaccination of HIV-negative homeless individuals have the best chance to markedly decrease TB morbidity and mortality.	Channing Labs, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Social Med, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Hlth & Social Behav, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Populat & Int Hlth, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA; Harvard Univ, Off Provost, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University	Brewer, TF (corresponding author), Channing Labs, 181 Longwood Ave, Boston, MA 02115 USA.	timothy.brewer@channing.harvard.edu	Colditz, Graham/A-3963-2009	Colditz, Graham/0000-0002-7307-0291; Heymann, Jody/0000-0003-0008-4198	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI001444] Funding Source: NIH RePORTER; NIAID NIH HHS [1K08 AI01444-01A1] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 1999, MMWR Recomm Rep, V48, P1; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; [Anonymous], 1992, MMWR Recomm Rep, V41, P13; Barnes PF, 1996, JAMA-J AM MED ASSOC, V275, P305, DOI 10.1001/jama.275.4.305; Barrow SM, 1999, AM J PUBLIC HEALTH, V89, P529, DOI 10.2105/AJPH.89.4.529; BLOWER SM, 1995, NAT MED, V1, P815, DOI 10.1038/nm0895-815; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Bock NN, 1998, INT J TUBERC LUNG D, V2, P124; Brewer TF, 1996, JAMA-J AM MED ASSOC, V276, P1898, DOI 10.1001/jama.276.23.1898; BRUDNEY K, 1991, AM REV RESPIR DIS, V144, P745, DOI 10.1164/ajrccm/144.4.745; Burman WJ, 1997, CHEST, V111, P1168, DOI 10.1378/chest.111.5.1168; BURT MR, 1999, HOMELESSNESS PROGRAM; CDC, 1999, REP TUB US 1998, P1; CDC (Centers for Disease Control and Prevention), 1993, MMWR RECOMM REP, V41, P1; *CDCP, 2001, NAT IMM SURV Q3 1999; *CDCP, 1996, REP TUB US 1995, P26; COHN DL, 1990, ANN INTERN MED, V112, P407, DOI 10.7326/0003-4819-76-3-112-6-407; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; COMBS DL, 1990, ANN INTERN MED, V112, P397, DOI 10.7326/0003-4819-76-3-112-6-397; Comstock GW, 1999, INT J TUBERC LUNG D, V3, P847; COMSTOCK GW, 1976, PUBLIC HEALTH REP, V91, P276; COUNTS GW, 1984, REV INFECT DIS, V6, P640; Curtis AB, 2000, INT J TUBERC LUNG D, V4, P308; DALEY CL, 1992, NEW ENGL J MED, V326, P231, DOI 10.1056/NEJM199201233260404; Diez E, 1996, TUBERCLE LUNG DIS, V77, P420, DOI 10.1016/S0962-8479(96)90114-8; ElSadr W, 1996, AM J PUBLIC HEALTH, V86, P1146, DOI 10.2105/AJPH.86.8_Pt_1.1146; Etkind S, 1991, Semin Respir Infect, V6, P273; FRIEDEN TR, 1995, NEW ENGL J MED, V333, P229, DOI 10.1056/NEJM199507273330406; Gallagher TC, 1997, MED CARE, V35, P814, DOI 10.1097/00005650-199708000-00007; GEITER L, 2000, ENDING NEGLECT ELIMI; Gelberg L, 2000, HEALTH SERV RES, V34, P1273; Gelberg L, 1996, J GEN INTERN MED, V11, P156, DOI 10.1007/BF02600268; Gelberg L, 1997, J GEN INTERN MED, V12, P25, DOI 10.1007/s11606-006-0004-4; GOBLE M, 1993, NEW ENGL J MED, V328, P527, DOI 10.1056/NEJM199302253280802; Gordin FM, 1996, AM J RESP CRIT CARE, V154, P1478, DOI 10.1164/ajrccm.154.5.8912768; HART PD, 1977, BRIT MED J, V2, P293, DOI 10.1136/bmj.2.6082.293; HIBBS JR, 1994, NEW ENGL J MED, V331, P304, DOI 10.1056/NEJM199408043310506; HOBBY GL, 1974, AM REV RESPIR DIS, V110, P95; Kann Laura, 1996, Morbidity and Mortality Weekly Report, V45, P1; Kimerling ME, 1999, INT J TUBERC LUNG D, V3, P613; KLINE SE, 1995, NEW ENGL J MED, V333, P222, DOI 10.1056/NEJM199507273330404; KOPANOFF DE, 1978, AM REV RESPIR DIS, V117, P991; LeBaron CW, 1998, ARCH PEDIAT ADOL MED, V152, P327; LINK B, 1995, AM J ORTHOPSYCHIAT, V65, P347, DOI 10.1037/h0079653; LoBue PA, 1999, CHEST, V115, P218, DOI 10.1378/chest.115.1.218; Markowitz N, 1997, ANN INTERN MED, V126, P123, DOI 10.7326/0003-4819-126-2-199701150-00005; Moss AR, 2000, AM J RESP CRIT CARE, V162, P460, DOI 10.1164/ajrccm.162.2.9910055; NAZARSTEWART V, 1992, AM REV RESPIR DIS, V146, P57, DOI 10.1164/ajrccm/146.1.57; NOLAN CM, 1991, AM REV RESPIR DIS, V143, P257, DOI 10.1164/ajrccm/143.2.257; PablosMendez A, 1997, AM J MED, V102, P164, DOI 10.1016/S0002-9343(96)00402-0; Park MM, 1996, AM J RESP CRIT CARE, V153, P317, DOI 10.1164/ajrccm.153.1.8542137; Phelan JC, 1999, AM J PUBLIC HEALTH, V89, P1334, DOI 10.2105/AJPH.89.9.1334; Pilote L, 1996, ARCH INTERN MED, V156, P161, DOI 10.1001/archinte.156.2.161; Polesky A, 1996, AM J RESP CRIT CARE, V154, P1473, DOI 10.1164/ajrccm.154.5.8912767; Rendleman NJ, 1999, AM J PREV MED, V17, P108, DOI 10.1016/S0749-3797(99)00052-5; ROSE DN, 1992, J GEN INTERN MED, V7, P589, DOI 10.1007/BF02599196; SALOMON N, 1995, CLIN INFECT DIS, V21, P1245, DOI 10.1093/clinids/21.5.1245; Salomon N, 1997, INT J TUBERC LUNG D, V1, P397; SEAHOLM SK, 1988, INT J BIOMED COMPUT, V23, P97, DOI 10.1016/0020-7101(88)90067-0; SELWYN PA, 1992, JAMA-J AM MED ASSOC, V268, P504, DOI 10.1001/jama.268.4.504; Shlay JC, 1996, SEX TRANSM DIS, V23, P304, DOI 10.1097/00007435-199607000-00011; SMALL PM, 1991, NEW ENGL J MED, V324, P289, DOI 10.1056/NEJM199101313240503; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; STLAWRENCE JS, 1995, AIDS EDUC PREV, V7, P22; TELZAK EE, 1995, NEW ENGL J MED, V333, P907, DOI 10.1056/NEJM199510053331404; TORRES RA, 1990, ARCH INTERN MED, V150, P2030, DOI 10.1001/archinte.150.10.2030; Tulsky JP, 2000, ARCH INTERN MED, V160, P697, DOI 10.1001/archinte.160.5.697; TURETT GS, 1995, CLIN INFECT DIS, V21, P1238, DOI 10.1093/clinids/21.5.1238; *US C MAYORS, 2001, STAT REP HUNG HOM AM; *WHO, 2000, WHO VACC PREV DIS M; Zhao FZ, 1996, LANCET, V347, P358, DOI 10.1016/S0140-6736(96)90537-1; ZOLOPA AR, 1994, JAMA-J AM MED ASSOC, V272, P455, DOI 10.1001/jama.272.6.455	72	24	25	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2001	286	7					834	842		10.1001/jama.286.7.834	http://dx.doi.org/10.1001/jama.286.7.834			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	462PU	11497538	Bronze			2022-12-28	WOS:000170429600032
J	Zabihi, N; Teichman, JMH				Zabihi, N; Teichman, JMH			Dealing with the pain of renal colic	LANCET			English	Editorial Material							URETERAL PRESSURE; INDOMETHACIN		Univ Texas, Hlth Sci Ctr, Dept Urol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Teichman, JMH (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Urol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.		Teichman, Joel/CAJ-0452-2022					Brater D. Craig, 1999, American Journal of Medicine, V107, p65S; CADNAPAPHORNCHAI P, 1978, PROSTAG OTH LIPID M, V16, P965, DOI 10.1016/0090-6980(78)90113-2; COLE RS, 1988, BRIT J UROL, V61, P19, DOI 10.1111/j.1464-410X.1988.tb09155.x; CORDELL WH, 1994, ANN EMERG MED, V23, P262, DOI 10.1016/S0196-0644(94)70038-9; ELSHERIF AE, 1995, J UROLOGY, V153, P1395, DOI 10.1016/S0022-5347(01)67411-1; HULAND H, 1981, INVEST UROL, V18, P274; KIMOTO Y, 1990, EUR J PHARMACOL, V175, P359, DOI 10.1016/0014-2999(90)90577-S; Lopes T, 2001, BJU INT, V87, P322, DOI 10.1046/j.1464-410x.2001.00068.x; MOODY TE, 1975, INVEST UROL, V13, P246; PERLMUTTER A, 1993, J UROLOGY, V149, P926, DOI 10.1016/S0022-5347(17)36261-4; SCHLONDORFF D, 1993, KIDNEY INT, V44, P643, DOI 10.1038/ki.1993.293; Segura JW, 1997, J UROLOGY, V158, P1915, DOI 10.1016/S0022-5347(01)64173-9; UDEN P, 1983, ACTA CHIR SCAND, V149, P497	13	14	14	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 11	2001	358	9280					437	438		10.1016/S0140-6736(01)05668-9	http://dx.doi.org/10.1016/S0140-6736(01)05668-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463TB	11513904				2022-12-28	WOS:000170492400006
J	Akimitsu, J; Takenawa, K; Suzuki, K; Harima, H; Kuramoto, Y				Akimitsu, J; Takenawa, K; Suzuki, K; Harima, H; Kuramoto, Y			High-temperature ferromagnetism in CaB2C2	SCIENCE			English	Article							ELECTRONIC-STRUCTURE	We report a high Curie-temperature ferromagnet, CaB2C2. Although the compound has neither transition metal nor rare earth ions, the ferromagnetic transition temperature T-c is about 770 Kelvin. Despite this high T-c, the magnitude of the ordered moment at room temperatures is on the order of 10(-4) Bohr magneton per formula unit, These properties are rather similar to those of doped divalent hexaborides, such as Ca1-xLaxB6. The calculated electronic states also show similarity near the Fermi level between CaB2C2 and divalent hexaborides. However, there is an important difference: CaB2C2 Crystallizes in a tetragonal structure, and there are no equivalent pockets in the energy bands for electrons and holes-in contrast with CaB6. Thus, the disputed threefold degeneracy, specific to the cubic structure, in the energy bands of divalent hexaborides turns out not to be essential for high-temperature ferromagnetism. It is the peculiar molecular orbitals near the Fermi level that appear to be crucial to the high-T-c ferromagnetism.	Aoyama Gakuin Univ, Dept Phys, Tokyo 1578572, Japan; Japan Sci & Technol Corp, CREST, Tokyo, Japan; Yokohama Natl Univ, Fac Environm & Informat Sci, Yokohama, Kanagawa 2408501, Japan; Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan; Tohoku Univ, Dept Phys, Sendai, Miyagi 9808578, Japan	Aoyama Gakuin University; Japan Science & Technology Agency (JST); Yokohama National University; Osaka University; Tohoku University	Akimitsu, J (corresponding author), Aoyama Gakuin Univ, Dept Phys, Tokyo 1578572, Japan.	jun@phys.aoyama.ac.jp		Suzuki, Kazuya/0000-0002-2231-4225				Albert B, 1999, INORG CHEM, V38, P6159, DOI 10.1021/ic9907821; Balents L, 2000, PHYS REV LETT, V84, P1264, DOI 10.1103/PhysRevLett.84.1264; Barzykin V, 2000, PHYS REV LETT, V84, P2207, DOI 10.1103/PhysRevLett.84.2207; HASEGAWA A, 1979, J PHYS C SOLID STATE, V12, P5431, DOI 10.1088/0022-3719/12/24/014; Massidda S, 1997, Z PHYS B CON MAT, V102, P83, DOI 10.1007/s002570050267; Onimaru T, 1999, J PHYS SOC JPN, V68, P2287, DOI 10.1143/JPSJ.68.2287; Tromp HJ, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.016401; van Duijn J, 2000, ANGEW CHEM INT EDIT, V39, P365, DOI 10.1002/(SICI)1521-3773(20000117)39:2<365::AID-ANIE365>3.0.CO;2-Q; Vonlanthen P, 2000, PHYS REV B, V62, P10076, DOI 10.1103/PhysRevB.62.10076; Young DP, 1999, NATURE, V397, P412, DOI 10.1038/17081; Zhitomirsky ME, 1999, NATURE, V402, P251, DOI 10.1038/46207	11	48	50	8	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2001	293	5532					1125	1127		10.1126/science.1061501	http://dx.doi.org/10.1126/science.1061501			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498587				2022-12-28	WOS:000170432600056
J	Schmidt-Mende, L; Fechtenkotter, A; Mullen, K; Moons, E; Friend, RH; MacKenzie, JD				Schmidt-Mende, L; Fechtenkotter, A; Mullen, K; Moons, E; Friend, RH; MacKenzie, JD			Self-organized discotic liquid crystals for high-efficiency organic photovoltaics	SCIENCE			English	Article								Self-organization of liquid crystalline and crystalline-conjugated materials has been used to create, directly from solution, thin films with structures optimized for use in photodiodes. The discotic liquid crystal hexa-peri-hexabenzocoronene was used in combination with a perylene dye to produce thin films with vertically segregated perylene and hexabenzocoronene, with large interfacial surface area. When incorporated into diode structures, these films show photovoltaic response with external quantum efficiencies of more than 34 percent near 490 nanometers. These efficiencies result from efficient photoinduced charge transfer between the hexabenzocoronene and perylene, as well as from effective transport of charges through vertically segregated perylene and hexabenzocoronene pi systems. This development demonstrates that complex structures can be engineered from novel materials by means of simple solution-processing steps and may enable inexpensive, high-performance, thin-film photovoltaic technology.	Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; Max Planck Inst Polymer Res, D-55128 Mainz, Germany; Cambridge Display Technol, Cambridge CB3 0HJ, England	University of Cambridge; Max Planck Society	Schmidt-Mende, L (corresponding author), Univ Cambridge, Cavendish Lab, Madingley Rd, Cambridge CB3 0HE, England.		Schmidt-Mende, Lukas/AAV-3847-2021; Schmidt-Mende, Lukas/H-4240-2011; chen, jia/F-8731-2011; Moons, Ellen/B-6252-2011	Schmidt-Mende, Lukas/0000-0001-6867-443X; Schmidt-Mende, Lukas/0000-0001-6867-443X; Moons, Ellen/0000-0002-1609-8909; Friend, Richard Henry/0000-0001-6565-6308				CHEN L, 2000, ADV MATER, V12, P18; Cleave V, 2001, ADV MATER, V13, P44, DOI 10.1002/1521-4095(200101)13:1<44::AID-ADMA44>3.3.CO;2-R; Dittmer JJ, 2000, SOL ENERG MAT SOL C, V61, P53, DOI 10.1016/S0927-0248(99)00096-3; Fechtenkotter A, 1999, ANGEW CHEM INT EDIT, V38, P3039, DOI 10.1002/(SICI)1521-3773(19991018)38:20<3039::AID-ANIE3039>3.3.CO;2-X; Granstrom M, 1998, NATURE, V395, P257, DOI 10.1038/26183; Halls JJM, 1999, PHYS REV B, V60, P5721, DOI 10.1103/PhysRevB.60.5721; Halls JJM, 1996, APPL PHYS LETT, V68, P3120, DOI 10.1063/1.115797; HALLS JJM, 1995, NATURE, V376, P498, DOI 10.1038/376498a0; MARK JE, 1996, PHYSICAL PROPERTIES, pCH16; Mizuguchi J, 1998, J APPL PHYS, V84, P4479, DOI 10.1063/1.368699; Schmitz-Hubsch T, 2000, SURF SCI, V445, P358, DOI 10.1016/S0039-6028(99)01081-X; Schon J. H., 2000, APPL PHYS LETT, V77, P23; Schon JH, 2000, NATURE, V403, P408, DOI 10.1038/35000172; Shaheen SE, 2001, APPL PHYS LETT, V78, P841, DOI 10.1063/1.1345834; STRUIJK WC, 2000, J AM CHEM SOC, V122, P45; TANG CW, 1986, APPL PHYS LETT, V48, P183, DOI 10.1063/1.96937; VANDECRAATS AM, 1999, ADV MATER, V11, P17; Yu G., 1995, SCIENCE, V270	18	2235	2283	10	639	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2001	293	5532					1119	1122		10.1126/science.293.5532.1119	http://dx.doi.org/10.1126/science.293.5532.1119			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498585	Green Submitted			2022-12-28	WOS:000170432600054
J	Vanclay, JK				Vanclay, JK			The effectiveness of parks	SCIENCE			English	Editorial Material									So Cross Univ, POB 157, Lismore, NSW 2480, Australia	Southern Cross University	Vanclay, JK (corresponding author), So Cross Univ, POB 157, Lismore, NSW 2480, Australia.	Jvanclay@scu.edu.au	Vanclay, Jerome/B-9266-2009	Vanclay, Jerome/0000-0002-5639-5481				Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125	1	36	38	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2001	293	5532					1007	1007		10.1126/science.293.5532.1007a	http://dx.doi.org/10.1126/science.293.5532.1007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498547				2022-12-28	WOS:000170432600001
J	Parmar, MKB; Griffiths, GO; Spiegelhalter, DJ; Souhami, RL; Altman, DG; van der Scheuren, E				Parmar, MKB; Griffiths, GO; Spiegelhalter, DJ; Souhami, RL; Altman, DG; van der Scheuren, E		CHART Steering Committee	Monitoring of large randomised clinical trials: a new approach with Bayesian methods	LANCET			English	Article							CELL LUNG-CANCER; CONVENTIONAL RADIOTHERAPY; MULTICENTER TRIAL; CHART; HEAD; NECK	Background In judging whether or not to continue enrolling patients into a randomised clinical trial, most data-monitoring and ethics committees (DMECs) rely on the p value for the difference in effect between the study groups. In the 1990s, two randomised controlled trials-one in patients with lung cancer and one in those with head and neck cancer-were instead monitored by Bayesian methods. We assessed the value of this approach in the monitoring of these clinical trials, Methods Before the trials opened, participating clinicians were asked their opinions on the expected difference between the study treatment (continuous hyperfractionated accelerated radiotherapy [CHART]) and conventional radiotherapy. These opinions were used to form an "enthusiastic" and a "sceptical" prior distribution. These prior distributions were combined with the trial data at each of the annual DMEC meetings. If, during monitoring, a result in favour of CHART was seen, the DMEC was to decide whether the results were sufficiently convincing to persuade a sceptic that CHART was worthwhile. Conversely, if there was apparently no or little difference, the DMEC was asked whether they thought the results sufficiently convincing to persuade an enthusiast that CHART was not worthwhile. Findings At each of the annual meetings, the DMEC concluded that there was insufficient evidence to convert either sceptics or enthusiasts, and that the trials should therefore remain open to recruitment. Neither trial was closed to recruitment earlier than planned. However if a conventional (p-value-based) stopping rule had been used, the lung-cancer trial would probably have been stopped. Interpretation This Bayesian approach to monitoring is simple to implement and straightforward for members of the DMEC to understand. In our opinion, it is more intuitively appealing than conventional approaches.	MRC, Clin Trials Unit, Canc Div, London NW1 2DA, England; Inst Publ Hlth, MRC, Biostat Unit, Cambridge, England; UCL, Royal Free & Univ Coll Med Sch, London WC1E 6BT, England; Inst Hlth Sci, Ctr Stat Med, ICRF Med Stat Grp, Oxford, England; Univ Hosp Gasthuisberg, Louvain, Belgium	Medical Research Council Clinical Trials Unit; MRC Biostatistics Unit; University of Cambridge; University of London; University College London; University of Oxford; KU Leuven; University Hospital Leuven	Griffiths, GO (corresponding author), MRC, Clin Trials Unit, Canc Div, 222 Euston Rd, London NW1 2DA, England.	gg@ctu.mrc.ac.uk		Griffiths, Gareth/0000-0002-9579-8021				Armitage P, 1999, CONTROL CLIN TRIALS, V20, P207, DOI 10.1016/S0197-2456(99)00005-7; *CLIN TRIAL SERV U, 1989, ISIS3 PROT 3 INT STU; DEMETS DL, 1994, STAT MED, V13, P1341, DOI 10.1002/sim.4780131308; DeMets DL, 1999, LANCET, V354, P1983, DOI 10.1016/S0140-6736(99)03464-9; Dische S, 1997, RADIOTHER ONCOL, V44, P123, DOI 10.1016/S0167-8140(97)00094-7; Fayers PM, 1997, STAT MED, V16, P1413, DOI 10.1002/(SICI)1097-0258(19970630)16:12<1413::AID-SIM578>3.0.CO;2-U; Freidlin B, 1999, CONTROL CLIN TRIALS, V20, P395, DOI 10.1016/S0197-2456(99)00017-3; *MED RES COUNC, 1989, AXIS PROT ADJ XRAY 5; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; PARMAR MKB, 1994, STAT MED, V13, P1297, DOI 10.1002/sim.4780131304; Saunders M, 1999, RADIOTHER ONCOL, V52, P137, DOI 10.1016/S0167-8140(99)00087-0; Saunders MI, 1996, BRIT J CANCER, V73, P1455, DOI 10.1038/bjc.1996.276; SPIEGELHALTER DJ, 1994, J R STAT SOC A STAT, V157, P357, DOI 10.2307/2983527; SPIEGELHALTER DJ, 1993, STAT MED, V12, P1501, DOI 10.1002/sim.4780121516; THORNTON JG, 1996, GROWTH RESTRICTION I; Whitehead J, 1997, DESIGN ANAL SEQUENTI	16	53	53	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 4	2001	358	9279					375	381		10.1016/S0140-6736(01)05558-1	http://dx.doi.org/10.1016/S0140-6736(01)05558-1			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459DE	11502318				2022-12-28	WOS:000170235100013
J	Dubrulle, J; McGrew, MJ; Pourquie, O				Dubrulle, J; McGrew, MJ; Pourquie, O			FGF signaling controls somite boundary position and regulates segmentation clock control of spatiotemporal Hox gene activation	CELL			English	Article							GROWTH-FACTOR RECEPTOR; VERTEBRATE SEGMENTATION; PRESOMITIC MESODERM; AVIAN EMBRYOS; MOUSE EMBRYO; CHICK-EMBRYO; EXPRESSION; SOMITOGENESIS; GASTRULATION; CELLS	Vertebrate segmentation requires a molecular oscillator, the segmentation clock, acting in presomitic mesoderm (PSM) cells to set the pace at which segmental boundaries are laid down. However, the signals that position each boundary remain unclear. Here, we report that FGF8 which is expressed in the posterior PSM, generates a moving wavefront at which level both segment boundary position and axial identity become determined. Furthermore, by manipulating boundary position in the chick embryo, we show that Hox gene expression is maintained in the appropriately numbered somite rather than at an absolute axial position. These results implicate FGF8 in ensuring tight coordination of the segmentation process and spatiotemporal Hox gene activation.	Univ Mediterranee AP Marseille, Dev Biol Inst Marseille, Lab Genet & Physiol Dev, CNRS,INSERM, F-13288 Marseille 09, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Pourquie, O (corresponding author), Univ Mediterranee AP Marseille, Dev Biol Inst Marseille, Lab Genet & Physiol Dev, CNRS,INSERM, Campus Luminy,Case 907, F-13288 Marseille 09, France.	pourquie@ibdm.univ-mrs.fr	Pourquié, Olivier/CAJ-5443-2022	Pourquié, Olivier/0000-0001-5189-1227				AOYAMA H, 1988, DEVELOPMENT, V104, P15; Araki I, 1999, DEVELOPMENT, V126, P5127; BURGESS R, 1995, DEV BIOL, V168, P296, DOI 10.1006/dbio.1995.1081; BURKE AC, 1995, DEVELOPMENT, V121, P333; Cohn MJ, 1997, NATURE, V387, P97, DOI 10.1038/387097a0; COOKE J, 1976, J THEOR BIOL, V58, P455, DOI 10.1016/S0022-5193(76)80131-2; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; Dale KJ, 2000, BIOESSAYS, V22, P72, DOI 10.1002/(SICI)1521-1878(200001)22:1<72::AID-BIES12>3.0.CO;2-S; DEUCHAR EM, 1967, J EMBRYOL EXP MORPH, V17, P349; DUBAND JL, 1987, J CELL BIOL, V104, P1361, DOI 10.1083/jcb.104.5.1361; DUBOULE D, 1995, CURR OPIN GENET DEV, V5, P525, DOI 10.1016/0959-437X(95)90058-O; Gaunt SJ, 1996, DEV DYNAM, V207, P270, DOI 10.1002/(SICI)1097-0177(199611)207:3<270::AID-AJA4>3.0.CO;2-E; GOULDING M, 1994, DEVELOPMENT, V120, P957; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Hirsinger E, 2000, INT REV CYTOL, V198, P1; Hirsinger E, 2001, DEVELOPMENT, V128, P107; Jiang YJ, 1998, CURR BIOL, V8, pR868, DOI 10.1016/S0960-9822(07)00547-7; Jouve C, 2000, DEVELOPMENT, V127, P1421; Kerszberg M, 2000, J THEOR BIOL, V205, P505, DOI 10.1006/jtbi.2000.2085; KEYNES RJ, 1988, DEVELOPMENT, V103, P413; KIENY M, 1972, DEV BIOL, V28, P142, DOI 10.1016/0012-1606(72)90133-9; Knezevic V, 1997, DEVELOPMENT, V124, P411; Kondo T, 1999, CELL, V97, P407, DOI 10.1016/S0092-8674(00)80749-7; McGrew MJ, 1998, CURR BIOL, V8, P979, DOI 10.1016/S0960-9822(98)70401-4; MEINHARDT H, 1986, SOMITES DEV EMBRYOS, P179; MENKES B, 1977, VERTEBRATE LIMB SOMI, V3, P405; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Nicolas JF, 1996, DEVELOPMENT, V122, P2933; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Nowicki JL, 2000, DEVELOPMENT, V127, P4265; PACKARD DS, 1978, J EXP ZOOL, V203, P295, DOI 10.1002/jez.1402030212; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Palmeirim I, 1998, DEV GENET, V23, P77, DOI 10.1002/(SICI)1520-6408(1998)23:1<77::AID-DVG8>3.0.CO;2-3; Partanen J, 1998, GENE DEV, V12, P2332, DOI 10.1101/gad.12.15.2332; PATSTONE G, 1993, DEV BIOL, V155, P107, DOI 10.1006/dbio.1993.1011; Pourquie O, 2000, CURR OPIN CELL BIOL, V12, P747, DOI 10.1016/S0955-0674(00)00163-0; Pownall ME, 1996, DEVELOPMENT, V122, P3881; SCHULTEMERKER S, 1995, CURR BIOL, V5, P62, DOI 10.1016/S0960-9822(95)00017-0; Sosic D, 1997, DEV BIOL, V185, P229, DOI 10.1006/dbio.1997.8561; STERN CD, 1992, DEVELOPMENT, P151; Stern CD, 1998, CURR TOP DEV BIOL, V36, P223; STERN CD, 1988, DEVELOPMENT, V104, P231; Sun X, 1999, GENE DEV, V13, P1834, DOI 10.1101/gad.13.14.1834; Szebenyi G, 1999, INT REV CYTOL, V185, P45; Vogel A, 1996, DEVELOPMENT, V122, P1737; YAMAGUCHI TP, 1992, DEV BIOL, V152, P75, DOI 10.1016/0012-1606(92)90157-C; YAMAGUCHI TP, 1994, GENE DEV, V8, P3032, DOI 10.1101/gad.8.24.3032; Yamamoto Y, 1999, DEV BIOL, V214, P60, DOI 10.1006/dbio.1999.9413; Zakany J, 2001, CELL, V106, P207, DOI 10.1016/S0092-8674(01)00436-6	49	498	523	3	28	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 27	2001	106	2					219	232		10.1016/S0092-8674(01)00437-8	http://dx.doi.org/10.1016/S0092-8674(01)00437-8			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	458KG	11511349	Green Published, Bronze			2022-12-28	WOS:000170193100011
J	Plass, R; Last, JA; Bartelt, NC; Kellogg, GL				Plass, R; Last, JA; Bartelt, NC; Kellogg, GL			Nanostructures - Self-assembled domain patterns	NATURE			English	Article							TRANSITIONS; SURFACE; LEED; PB		Sandia Natl Labs, Albuquerque, NM 87185 USA; Sandia Natl Labs, Livermore, CA 94551 USA	United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Sandia National Laboratories	Plass, R (corresponding author), Sandia Natl Labs, POB 5800, Albuquerque, NM 87185 USA.							ALERHAND OL, 1988, PHYS REV LETT, V61, P1973, DOI 10.1103/PhysRevLett.61.1973; HENRION J, 1972, SURF SCI, V29, P20, DOI 10.1016/0039-6028(72)90069-6; HURLEY MM, 1992, PHYS REV B, V46, P5783, DOI 10.1103/PhysRevB.46.5783; MARCHENKO VI, 1981, JETP LETT+, V33, P381; MCCONNELL HM, 1991, ANNU REV PHYS CHEM, V42, P171, DOI 10.1146/annurev.physchem.42.1.171; MEYER G, 1988, SURF SCI, V202, P125, DOI 10.1016/0039-6028(88)90065-9; NAGL C, 1994, SURF SCI, V321, P237, DOI 10.1016/0039-6028(94)90189-9; NG KO, 1995, PHYS REV B, V52, P2177, DOI 10.1103/PhysRevB.52.2177; SAGUI C, 1994, PHYS REV E, V49, P2225, DOI 10.1103/PhysRevE.49.2225; SEUL M, 1995, SCIENCE, V267, P476, DOI 10.1126/science.267.5197.476	10	157	157	0	36	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2001	412	6850					875	875		10.1038/35091143	http://dx.doi.org/10.1038/35091143			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467EG	11528467				2022-12-28	WOS:000170689000033
J	Landry, DW; Oliver, JA				Landry, DW; Oliver, JA			Mechanisms of disease: The pathogenesis of vasodilatory shock	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							NITRIC-OXIDE SYNTHASE; SENSITIVE POTASSIUM CHANNELS; DEPENDENT PROTEIN-KINASE; VASCULAR SMOOTH-MUSCLE; HUMAN SEPTIC SHOCK; VASOPRESSIN DEFICIENCY; ORTHOSTATIC HYPOTENSION; HEMORRHAGIC-SHOCK; LACTIC-ACIDOSIS; BLOOD-PRESSURE		Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY 10032 USA	Columbia University	Landry, DW (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Med, Phys & Surg Bldg,10-445,630 W 168th St, New York, NY 10032 USA.							ARCHER SL, 1994, P NATL ACAD SCI USA, V91, P7583, DOI 10.1073/pnas.91.16.7583; Argenziano M, 1997, CIRCULATION, V96, P286; Arnalich F, 1996, REGUL PEPTIDES, V65, P115, DOI 10.1016/0167-0115(96)00080-8; ARNAULD E, 1977, PFLUG ARCH EUR J PHY, V371, P193, DOI 10.1007/BF00586258; BACHYNSKI BN, 1986, OPHTHALMOLOGY, V93, P391; BAKER CH, 1990, CIRC SHOCK, V30, P81; BARTELSTONE HJ, 1965, AM J PHYSIOL, V208, P754, DOI 10.1152/ajplegacy.1965.208.4.754; BENEDICT CR, 1992, CIRC SHOCK, V38, P165; Bernard GR, 1997, NEW ENGL J MED, V336, P912, DOI 10.1056/NEJM199703273361303; BOCKA JJ, 1988, ANN EMERG MED, V17, P450, DOI 10.1016/S0196-0644(88)80234-8; BOLOTINA VM, 1994, NATURE, V368, P850, DOI 10.1038/368850a0; Brackett D J, 1983, Adv Shock Res, V9, P147; BRIERLEY JB, 1977, J NEUROL SCI, V31, P133, DOI 10.1016/0022-510X(77)90011-9; BYRNE JJ, 1966, NEW ENGL J MED, V275, P543, DOI 10.1056/NEJM196609082751007; Chen JM, 1999, CIRCULATION, V100, P244; Chen SJ, 1999, N-S ARCH PHARMACOL, V359, P493, DOI 10.1007/PL00005381; Cobb JP, 1999, CRIT CARE MED, V27, P855, DOI 10.1097/00003246-199905000-00002; COOKE CR, 1993, AM J KIDNEY DIS, V22, P44, DOI 10.1016/S0272-6386(12)70165-8; COWLEY AW, 1974, CIRC RES, V34, P505, DOI 10.1161/01.RES.34.4.505; CUMMING AD, 1988, AM J KIDNEY DIS, V11, P363; CUMMING AD, 1988, AM J KIDNEY DIS, V11, P23, DOI 10.1016/S0272-6386(88)80170-7; DAVIES NW, 1990, NATURE, V343, P375, DOI 10.1038/343375a0; ERRINGTON ML, 1972, J PHYSIOL-LONDON, V227, P395, DOI 10.1113/jphysiol.1972.sp010039; Fink MP, 1999, CRIT CARE MED, V27, P2019, DOI 10.1097/00003246-199909000-00050; Frajewicki V, 1997, AM J PHYSIOL-REG I, V273, pR1623, DOI 10.1152/ajpregu.1997.273.5.R1623; Gardiner SM, 1999, BRIT J PHARMACOL, V128, P1772, DOI 10.1038/sj.bjp.0702985; Garrard C S, 1993, Clin Auton Res, V3, P5, DOI 10.1007/BF01819137; Geisen K, 1996, HORM METAB RES, V28, P496, DOI 10.1055/s-2007-979841; Hollenberg SM, 1997, AM J PHYSIOL-REG I, V272, pR969, DOI 10.1152/ajpregu.1997.272.3.R969; HOLLENBERG SM, 1993, AM J PHYSIOL, V264, pH660, DOI 10.1152/ajpheart.1993.264.2.H660; Hollenberg SM, 2000, CIRC RES, V86, P774, DOI 10.1161/01.RES.86.7.774; Ikeda U, 1997, CARDIOVASC RES, V35, P168, DOI 10.1016/S0008-6363(97)00068-0; Jackson WF, 2000, HYPERTENSION, V35, P173, DOI 10.1161/01.HYP.35.1.173; Jaggar JH, 2000, AM J PHYSIOL-CELL PH, V278, pC235, DOI 10.1152/ajpcell.2000.278.2.C235; KAUFMANN H, 1991, LANCET, V338, P1542, DOI 10.1016/0140-6736(91)92370-H; KEUNG EC, 1991, J CLIN INVEST, V88, P1772, DOI 10.1172/JCI115497; Kilbourn R, 1999, CRIT CARE MED, V27, P857, DOI 10.1097/00003246-199905000-00003; Kristof AS, 1999, CRIT CARE MED, V27, P1121, DOI 10.1097/00003246-199906000-00033; LALAU JD, 1995, DIABETES CARE, V18, P779, DOI 10.2337/diacare.18.6.779; Landry DW, 1997, CIRCULATION, V95, P1122; LANDRY DW, 1992, J CLIN INVEST, V89, P2071, DOI 10.1172/JCI115820; LAUBACH VE, 1995, P NATL ACAD SCI USA, V92, P10688, DOI 10.1073/pnas.92.23.10688; Lindner KH, 1996, ANN INTERN MED, V124, P1061, DOI 10.7326/0003-4819-124-12-199606150-00006; MACMICKING JD, 1995, CELL, V81, P1170; Martin C, 2000, CRIT CARE MED, V28, P3198, DOI 10.1097/00003246-200009000-00014; Middleton S, 1944, AM J PHYSIOL, V141, P0132; Morales D, 1999, CIRCULATION, V100, P226, DOI 10.1161/01.CIR.100.3.226; MURPHY ME, 1995, J PHYSIOL-LONDON, V486, P47, DOI 10.1113/jphysiol.1995.sp020789; NAMBI P, 1986, P NATL ACAD SCI USA, V83, P8492, DOI 10.1073/pnas.83.22.8492; NEGROVILAR A, 1979, BRAIN RES, V169, P585, DOI 10.1016/0006-8993(79)90409-8; OCHOA JB, 1991, ANN SURG, V214, P621, DOI 10.1097/00000658-199111000-00013; PADFIELD PL, 1976, LANCET, V1, P1255; PARRILLO JE, 1993, NEW ENGL J MED, V328, P1471, DOI 10.1056/nejm199305203282008; Quayle JM, 1997, PHYSIOL REV, V77, P1165, DOI 10.1152/physrev.1997.77.4.1165; REMINGTON JW, 1950, AM J PHYSIOL, V161, P106, DOI 10.1152/ajplegacy.1950.161.1.106; RUTHERFORD RB, 1973, J SURG RES, V14, P538, DOI 10.1016/0022-4804(73)90124-8; Salzman AL, 1997, AM J PHYSIOL-HEART C, V272, pH688, DOI 10.1152/ajpheart.1997.272.2.H688; SCHNEIDER F, 1993, INTENS CARE MED, V19, P99, DOI 10.1007/BF01708370; SCHWARTZ J, 1981, ENDOCRINOLOGY, V109, P1778, DOI 10.1210/endo-109-5-1778; SMITH HJ, 1967, CIRCULATION, V35, P1084, DOI 10.1161/01.CIR.35.6.1084; SUFFREDINI AF, 1989, NEW ENGL J MED, V321, P280, DOI 10.1056/NEJM198908033210503; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; SYLVESTER JT, 1979, AM J PHYSIOL, V236, pH22, DOI 10.1152/ajpheart.1979.236.1.H22; Taylor BS, 2000, SHOCK, V13, P413, DOI 10.1097/00024382-200006000-00001; THIEMERMANN C, 1993, P NATL ACAD SCI USA, V90, P267, DOI 10.1073/pnas.90.1.267; Thorup C, 1999, AM J PHYSIOL-RENAL, V277, pF882, DOI 10.1152/ajprenal.1999.277.6.F882; Titheradge MA, 1999, BBA-BIOENERGETICS, V1411, P437, DOI 10.1016/S0005-2728(99)00031-6; Umino T, 1999, AM J PHYSIOL-RENAL, V276, pF433, DOI 10.1152/ajprenal.1999.276.3.F433; WAGNER HN, 1956, J CLIN INVEST, V35, P1412, DOI 10.1172/JCI103398; WAGNER HN, 1981, NEW ENGL J MED, V304, P1067; WAKATSUKI T, 1992, AM J PHYSIOL, V263, pH491, DOI 10.1152/ajpheart.1992.263.2.H491; WEI XQ, 1995, NATURE, V375, P408, DOI 10.1038/375408a0; Wilson M F, 1981, Adv Shock Res, V6, P15; WILSON RF, 1965, ARCH SURG-CHICAGO, V91, P121; YU MH, 1993, CRIT CARE MED, V21, P830, DOI 10.1097/00003246-199306000-00009; ZERBE RL, 1981, EUR J PHARMACOL, V72, P391, DOI 10.1016/0014-2999(81)90583-5; ZERBE RL, 1983, AM J MED, V74, P265, DOI 10.1016/0002-9343(83)90625-3	77	718	761	0	32	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 23	2001	345	8					588	595		10.1056/NEJMra002709	http://dx.doi.org/10.1056/NEJMra002709			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464ZH	11529214				2022-12-28	WOS:000170562900007
J	Sano, M; Kamino, A; Okamura, J; Shinkai, S				Sano, M; Kamino, A; Okamura, J; Shinkai, S			Ring closure of carbon nanotubes	SCIENCE			English	Article							WORMLIKE CHAINS	Lightly etched single-waited carbon nanotubes are chemically reacted to form rings. The rings appear to be fully closed as opposed to open coils, as ring-opening reactions did not change the structure of the observed rings. The average diameter of the rings was 540 nanometers with a narrow size distribution. The nanotubes in solution were modeled as wormlike polymer chains, yielding a persistence length of 800 nanometers. Nanotubes shorter than this length behave stiffly and stay nearly straight in solution. However, nanotubes longer than the Kuhn segment length of 1600 nanometers undergo considerable thermal fluctuation, suggesting a greater flexibility of these materials than is generally assumed.	Chemotransfigurat Project JST, Fukuoka 8390861, Japan	Japan Science & Technology Agency (JST)	Sano, M (corresponding author), Chemotransfigurat Project JST, Fukuoka 8390861, Japan.							Ahlskog M, 1999, CHEM PHYS LETT, V300, P202, DOI 10.1016/S0009-2614(98)01322-0; Ausman KD, 2000, J PHYS CHEM B, V104, P8911, DOI 10.1021/jp002555m; Bahr JL, 2001, CHEM COMMUN, P193, DOI 10.1039/b008042j; Brandrup J., 1989, POLYM HDB, V3rd ed.; Chen J, 1998, SCIENCE, V282, P95, DOI 10.1126/science.282.5386.95; Dai HJ, 1996, NATURE, V384, P147, DOI 10.1038/384147a0; DEHEER WA, 1995, SCIENCE, V270, P1179, DOI 10.1126/science.270.5239.1179; Flory P.J., 1969, STATISTICAL MECHANIC, P401; Ishida H, 2001, J ORG CHEM, V66, P2978, DOI 10.1021/jo001079t; Kim P, 1999, SCIENCE, V286, P2148, DOI 10.1126/science.286.5447.2148; Kong J, 2000, SCIENCE, V287, P622, DOI 10.1126/science.287.5453.622; Kuznetsova A, 2000, CHEM PHYS LETT, V321, P292, DOI 10.1016/S0009-2614(00)00341-9; Liu J, 1998, SCIENCE, V280, P1253, DOI 10.1126/science.280.5367.1253; Liu J, 1997, NATURE, V385, P780, DOI 10.1038/385780b0; Martel R, 1999, NATURE, V398, P299, DOI 10.1038/18589; Rinzler AG, 1998, APPL PHYS A-MATER, V67, P29, DOI 10.1007/s003390050734; Rueckes T, 2000, SCIENCE, V289, P94, DOI 10.1126/science.289.5476.94; Saito R, 1998, PHYS REV B, V57, P4145, DOI 10.1103/PhysRevB.57.4145; Saito R., 1998, PHYS PROPERTIES CARB; SHIMADA J, 1984, MACROMOLECULES, V17, P689, DOI 10.1021/ma00134a028; Vigolo B, 2000, SCIENCE, V290, P1331, DOI 10.1126/science.290.5495.1331; Wong SS, 1998, NATURE, V394, P52, DOI 10.1038/27873; YAMAKAWA H, 1972, J CHEM PHYS, V57, P2843, DOI 10.1063/1.1678675; Yu MF, 2000, PHYS REV LETT, V84, P5552, DOI 10.1103/PhysRevLett.84.5552	24	333	350	3	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2001	293	5533					1299	1301		10.1126/science.1061050	http://dx.doi.org/10.1126/science.1061050			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11509725				2022-12-28	WOS:000170492600034
J	Birch, JM; Dickinson, MH				Birch, JM; Dickinson, MH			Spanwise flow and the attachment of the leading-edge vortex on insect wings	NATURE			English	Article							UNSTEADY AERODYNAMIC PERFORMANCE; LOW REYNOLDS-NUMBERS; MANDUCA-SEXTA; FLIGHT; HAWKMOTH; MODEL; MECHANISM; ROTATION	The flow structure that is largely responsible for the good performance of insect wings has recently been identified as a leading-edge vortex(1,2). But because such vortices become detached from a wing in two-dimensional flow(1), an unknown mechanism must keep them attached to (three-dimensional) flapping wings. The current explanation, analogous to a mechanism operating on delta-wing aircraft, is that spanwise flow through a spiral vortex drains energy from the vortex core(3). We have tested this hypothesis by systematically mapping the flow generated by a dynamically scaled model insect while simultaneously measuring the resulting aerodynamic forces. Here we report that, at the Reynolds numbers matching the flows relevant for most insects, flapping wings do not generate a spiral vortex akin to that produced by delta-wing aircraft. We also rnd that limiting spanwise flow with fences and edge baffles does not cause detachment of the leading-edge vortex. The data support an alternative hypothesis-that downward flow induced by tip vortices limits the growth of the leading-edge vortex.	Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Dickinson, MH (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	flymanmd@socrates.berkeley.edu						Dickinson MH, 1999, SCIENCE, V284, P1954, DOI 10.1126/science.284.5422.1954; DICKINSON MH, 1994, J EXP BIOL, V192, P179; DICKINSON MH, 1993, J EXP BIOL, V174, P45; Dudley R., 2000, BIOMECHANICS INSECT; ELLINGTON CP, 1984, PHILOS T ROY SOC B, V305, P79, DOI 10.1098/rstb.1984.0052; Ellington CP, 1996, NATURE, V384, P626, DOI 10.1038/384626a0; KYIA M, 1977, J FLUID MECH, V82, P223; Liu H, 1998, J EXP BIOL, V201, P461; MAXWORTHY T, 1979, J FLUID MECH, V93, P47, DOI 10.1017/S0022112079001774; MAY RM, 1978, DIVERSITY INSECT FAU, P188; Milne-Thomson L. M., 2012, THEORETICAL AERODYNA; SARPKAYA T, 1975, J FLUID MECH, V68, P109, DOI 10.1017/S0022112075000717; Sunada S, 1997, J FLUID ENG-T ASME, V119, P129, DOI 10.1115/1.2819098; VandenBerg C, 1997, PHILOS T ROY SOC B, V352, P329, DOI 10.1098/rstb.1997.0024; Wang ZJ, 2000, PHYS REV LETT, V85, P2216, DOI 10.1103/PhysRevLett.85.2216; Willmott AP, 1997, PHILOS T ROY SOC B, V352, P303, DOI 10.1098/rstb.1997.0022; Willmott AP, 1997, J EXP BIOL, V200, P2723	17	417	435	6	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2001	412	6848					729	733		10.1038/35089071	http://dx.doi.org/10.1038/35089071			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462ZB	11507639				2022-12-28	WOS:000170450200043
J	Hyman, DJ; Pavlik, VN				Hyman, DJ; Pavlik, VN			Characteristics of patients with uncontrolled hypertension in the United States.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SYSTOLIC BLOOD-PRESSURE; CARE; AWARENESS	Background: Treatment of hypertension is one of the most common clinical responsibilities of U.S. physicians, yet only one fourth of patients with hypertension have their blood pressure adequately controlled. Methods: We analyzed data from the third National Health and Nutrition Examination Survey to assess the role of access to and use of health care in the control of hypertension. Hypertension was defined as a blood pressure of at least 140/90 mm Hg or the use of antihypertensive medication. Results: The study sample consisted of 16,095 adults who were at least 25 years old and for whom blood-pressure values were known. We estimated that 27 percent of the population had hypertension, but only 23 percent of those with hypertension were taking medications that controlled their condition. Among subjects with untreated or uncontrolled hypertension, the pattern was an elevation in the systolic blood pressure with a diastolic pressure of less than 90 mm Hg. The great majority had health insurance. Independent predictors of a lack of awareness of hypertension were an age of at least 65 years, male sex, non-Hispanic black race, and not having visited a physician within the preceding 12 months. The same variables, except for non-Hispanic black race, were independently associated with poor control of hypertension among those who were aware of their condition. An age of at least 65 years accounted for the greatest proportion of the attributable risk of the lack of awareness of hypertension and the lack of control of hypertension among those who were aware of their condition. Conclusions: Most cases of uncontrolled hypertension in the United States consist of isolated, mild systolic hypertension in older adults, most of whom have access to health care and relatively frequent contact with physicians. (N Engl J Med 2001;345:479-86.) Copyright (C) 2001 Massachusetts Medical Society.	Baylor Coll Med, Dept Med, Houston, TX 77030 USA; Baylor Coll Med, Dept Family & Community Med, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Hyman, DJ (corresponding author), Ben Taub Gen Hosp, Dept Med, 1504 Taub Loop, Houston, TX 77030 USA.	dhyman@bcm.tmc.edu						Aday L A, 1974, Health Serv Res, V9, P208; Alexander M, 1999, ARCH INTERN MED, V159, P2673, DOI 10.1001/archinte.159.22.2673; [Anonymous], 1991, JAMA, V265, P3255; [Anonymous], 1997, ARCH INTERN MED, V157, P2413; Berlowitz DR, 1998, NEW ENGL J MED, V339, P1957, DOI 10.1056/NEJM199812313392701; Black HR, 1998, ARCH INTERN MED, V158, P573; BURT VL, 1995, HYPERTENSION, V26, P60, DOI 10.1161/01.HYP.26.1.60; Coca A, 1998, J HYPERTENS, V16, pS45; Fagard RH, 1999, CLIN EXP HYPERTENS, V21, P491, DOI 10.3109/10641969909060982; GOLDMAN L, 1984, ANN INTERN MED, V101, P825, DOI 10.7326/0003-4819-101-6-825; HYMAN D, 2000, CLIN HYPERTENS, V2, P324; Hyman DJ, 2000, ARCH INTERN MED, V160, P2281, DOI 10.1001/archinte.160.15.2281; Izzo JL, 2000, HYPERTENSION, V35, P1021, DOI 10.1161/01.HYP.35.5.1021; Joffres MR, 1997, AM J HYPERTENS, V10, P1097; KLEINBAUM DG, 1982, EPIDEMIOLOGIC RES PR, P160; Meissner I, 1999, HYPERTENSION, V34, P466, DOI 10.1161/01.HYP.34.3.466; MOY E, 1995, ARCH INTERN MED, V155, P1497, DOI 10.1001/archinte.155.14.1497; *NAT COMM QUAL ASS, 1999, HEDIS 2000, V2; *NAT CTR HLTH STAT, 1994, VIT HLTH STAT, V1; Nelson C, 1999, VITAL HLTH STAT, V13; Port S, 2000, LANCET, V355, P175, DOI 10.1016/S0140-6736(99)07051-8; SHAH BV, 1997, SUDAAN USERS MANUAL, V1	22	564	587	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 16	2001	345	7					479	486		10.1056/NEJMoa010273	http://dx.doi.org/10.1056/NEJMoa010273			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	462QM	11519501				2022-12-28	WOS:000170431300001
J	Zurek, WH				Zurek, WH			Sub-Planck structure in phase space and its relevance for quantum decoherence	NATURE			English	Article							CHAOS; EVOLUTION	Heisenberg's principle(1) states that the product of uncertainties of position and momentum should be no less than the limit set by Planck's constant, (h) over bar /2. This is usually taken to imply that phase space structures associated with sub-Planck scales (<< (h) over bar) do not exist, or at least that they do not matter. Here I show that this common assumption is false: non-local quantum superpositions (or 'Schrodinger's cat' states) that are confined to a phase space volume characterized by the classical action A, much larger than (h) over bar, develop spotty structure on the sub-Planck scale, a = (h) over bar (2)/A. Structure saturates on this scale particularly quickly in quantum versions of classically chaotic systems-such as gases that are modelled by chaotic scattering of molecules-because their exponential sensitivity to perturbations(2) causes them to be driven into non-local 'cat' states. Most importantly, these sub-Planck scales are physically significant: a determines the sensitivity of a quantum system or environment to perturbations. Therefore, this scale controls the effectiveness of decoherence and the selection of preferred pointer states by the environment(3-8). It will also be relevant in setting limits on the sensitivity of quantum meters.	Los Alamos Natl Lab, Div Theory, Los Alamos, NM 87545 USA	United States Department of Energy (DOE); Los Alamos National Laboratory	Zurek, WH (corresponding author), Los Alamos Natl Lab, Div Theory, T-6,MS B288, Los Alamos, NM 87545 USA.	whz@LANL.gov						BERMAN GP, 1978, PHYSICA A, V91, P450, DOI 10.1016/0378-4371(78)90190-5; BERRY MV, 1979, J PHYS A-MATH GEN, V12, P625, DOI 10.1088/0305-4470/12/5/012; BRAGINSKY VB, 1996, REV MOD PHYS, V95, P703; Braun D, 2001, PHYS REV LETT, V86, P2913, DOI 10.1103/PhysRevLett.86.2913; CALDEIRA AO, 1983, PHYSICA A, V121, P587, DOI 10.1016/0378-4371(83)90013-4; CASATI G, 1995, QUANTUM CHAOS; CAVES CM, 1993, PHYSICAL ORIGINS TIM, P47; Giulini D., 1996, DECOHERENCE APPEARAN; Haake F., 2010, QUANTUM SIGNATURES C, DOI [10.1007/978-3-642-05428-0, DOI 10.1007/978-3-642-05428-0]; Habib S, 1998, PHYS REV LETT, V80, P4361, DOI 10.1103/PhysRevLett.80.4361; Hannay J. H., 1980, Physica D, V1D, P267, DOI 10.1016/0167-2789(80)90026-3; Heisenberg W., 1927, Z PHYS J PHYS, V43, P172; HILLERY M, 1984, PHYS REP, V106, P121, DOI 10.1016/0370-1573(84)90160-1; JOOS E, 1985, Z PHYS B, V59, P229; KARKUSZEWSKI Z, 2000, QUANTPH0010011; KORSCH HJ, 1981, PHYSICA D, V3, P627, DOI 10.1016/0167-2789(81)90045-2; Miller PA, 1999, PHYS REV E, V60, P1542, DOI 10.1103/PhysRevE.60.1542; PAZ JP, 2001, HOUCHES LECT SESSION, P533; ZUREK WH, 1981, PHYS REV D, V24, P1516, DOI 10.1103/PhysRevD.24.1516; ZUREK WH, 1994, PHYS REV LETT, V72, P2508, DOI 10.1103/PhysRevLett.72.2508; ZUREK WH, 1982, PHYS REV D, V26, P1862, DOI 10.1103/PhysRevD.26.1862; Zurek WH, 1998, PHYS SCRIPTA, VT76, P186, DOI 10.1238/Physica.Topical.076a00186; ZUREK WH, 2001, IN PRESS REV MOD PHY	24	236	237	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 16	2001	412	6848					712	717		10.1038/35089017	http://dx.doi.org/10.1038/35089017			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462ZB	11507634	Green Submitted			2022-12-28	WOS:000170450200038
J	Villareal, DT; Binder, EF; Williams, DB; Schechtman, KB; Yarasheski, KE; Kohrt, WN				Villareal, DT; Binder, EF; Williams, DB; Schechtman, KB; Yarasheski, KE; Kohrt, WN			Bone mineral density response to estrogen replacement in frail elderly women - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSTMENOPAUSAL OSTEOPOROSIS; VITAMIN-D; THERAPY; CALCIUM; BODY; HIP; AGE; SUPPLEMENTATION; PERFORMANCE; PREVENTION	Context Although hormone replacement therapy (HRT) is an established approach for osteoporosis prevention, little is known about the osteoprotective effects of HRT in frail elderly women. Objective To determine whether HRT increases bone mineral density (BMD) in frail elderly women. Design and Setting Randomized, double-blind, placebo-controlled trial conducted in a US university-based research center from September 1995 to August 2000. Participants Sixty-seven women aged 75 years or older with mild-to-moderate physical frailty. Intervention Participants were randomly assigned to receive conjugated estrogens, 0.625 mg/d, plus trimonthly medroxyprogesterone acetate, 5 mg/d for 13 days (n=45), or matching placebo (n=22), for 9 months. Main Outcome Measures The primary outcome measure was 9-month change in BMD of the lumbar spine and hip, measured by dual-energy x-ray absorptiometry. Secondary outcomes were changes in markers of bone turnover. Results Based on intention-to-treat analyses, HRT resulted in significantly larger increases in BMD of the lumbar spine than placebo (mean change, 4.3% vs 0.4%; between-group difference, 3.9%; 95% confidence interval [CI], 3.5%-4.3%) and total hip (mean change, 1.7% vs -0.1%; between-group difference, 1.8%; 95% Cl, 1.5%-2.1%). Compared with placebo, HRT resulted in significant decreases in serum bone-specific alkaline phosphatase levels (mean change, -24% vs 6%; between-group difference, -30%; 95% Cl, -26% to -33%) and urine N-telopeptide levels (mean change, -48% vs 4%; between-group difference, -52%; 95% CI, -47% to -55%). Conclusions In physically frail elderly women, 9 months of HRT significantly increased BMD compared with placebo in clinically important skeletal regions. Further studies are needed to determine whether these osteogenic effects of HRT in elderly women are associated with a reduction in osteoporotic fractures.	Washington Univ, Sch Med, Div Geriatr & Gerontol,Dept Internal Med, Claude Pepper Older Amer Independence Ctr, St Louis, MO 63108 USA; Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Div Geriatr Med, Denver, CO 80262 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Villareal, DT (corresponding author), Washington Univ, Sch Med, Div Geriatr & Gerontol,Dept Internal Med, Claude Pepper Older Amer Independence Ctr, 4488 Forest Pk Blvd, St Louis, MO 63108 USA.	dvillare@im.wustl.edu	Yarasheski, Kevin E/A-3025-2008; Yarasheski, Kevin/AAC-7450-2021	Yarasheski, Kevin/0000-0001-5436-2451	NCRR NIH HHS [K23 RR016191, K23 RR16191-01, RR00036] Funding Source: Medline; NIA NIH HHS [P60 AG013629, AG13629] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [K23RR016191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P60AG013629] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Allolio B, 1999, Osteoporos Int, V9 Suppl 2, pS9, DOI 10.1007/PL00004166; ARMAMENTOVILLAREAL R, 1995, J CLIN ENDOCR METAB, V80, P776, DOI 10.1210/jc.80.3.776; Binder EF, 2001, ANN INTERN MED, V134, P754, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00012; Binder EF, 1999, J GERONTOL A-BIOL, V54, pM353, DOI 10.1093/gerona/54.7.M353; Brown M, 2000, J GERONTOL A-BIOL, V55, pM350, DOI 10.1093/gerona/55.6.M350; Bush TL, 1996, JAMA-J AM MED ASSOC, V276, P1389, DOI 10.1001/jama.276.17.1389; CAULEY JA, 1995, ANN INTERN MED, V122, P9, DOI 10.7326/0003-4819-122-1-199501010-00002; CHRISTIANSEN C, 1990, J CLIN ENDOCR METAB, V71, P836, DOI 10.1210/jcem-71-4-836; COSMAN F, 1994, J CLIN ENDOCR METAB, V78, P939, DOI 10.1210/jc.78.4.939; CUMMINGS SR, 1993, LANCET, V341, P72, DOI 10.1016/0140-6736(93)92555-8; DawsonHughes B, 1997, NEW ENGL J MED, V337, P670, DOI 10.1056/NEJM199709043371003; ELDERS PJM, 1988, BONE MINER, V5, P11, DOI 10.1016/0169-6009(88)90003-7; ENSRUD KE, 1995, J BONE MINER RES, V10, P1778; FELSON DT, 1993, NEW ENGL J MED, V329, P1141, DOI 10.1056/NEJM199310143291601; Ferrucci L, 1999, J AM GERIATR SOC, V47, P639, DOI 10.1111/j.1532-5415.1999.tb01583.x; Friedman L.M., 1980, FUNDAMENTALS CLIN TR; Garnero P, 1996, J BONE MINER RES, V11, P1531; GENNARI C, 1990, J CLIN ENDOCR METAB, V71, P1288, DOI 10.1210/jcem-71-5-1288; Handa VL, 1996, J AM GERIATR SOC, V44, P1; Holloszy John O., 1995, P633; HUI SL, 1987, BONE MINER, V2, P141; Kohrt WM, 1998, J APPL PHYSIOL, V84, P1506, DOI 10.1152/jappl.1998.84.5.1506; KOHRT WM, 1995, OSTEOPOROSIS INT, V5, P150, DOI 10.1007/BF02106093; LINDSAY R, 1976, LANCET, V1, P1038; Lindsay R, 1998, ENDOCRIN METAB CLIN, V27, P399, DOI 10.1016/S0889-8529(05)70012-8; LINDSAY R, 1990, OBSTET GYNECOL, V76, P290; LUFKIN EG, 1992, ANN INTERN MED, V117, P1, DOI 10.7326/0003-4819-117-1-1; MARX CW, 1992, J BONE MINER RES, V7, P1275; MCKANE WR, 1995, J CLIN ENDOCR METAB, V80, P3458, DOI 10.1210/jc.80.12.3458; NILAS L, 1988, EUR J CLIN INVEST, V18, P529, DOI 10.1111/j.1365-2362.1988.tb01052.x; QUIGLEY MET, 1987, AM J OBSTET GYNECOL, V156, P1516; Recker RR, 1999, ANN INTERN MED, V130, P897, DOI 10.7326/0003-4819-130-11-199906010-00005; RESNICK NM, 1989, JAMA-J AM MED ASSOC, V261, P1025, DOI 10.1001/jama.261.7.1025; Riggs BL, 1998, J BONE MINER RES, V13, P763, DOI 10.1359/jbmr.1998.13.5.763; Riggs BL, 1998, J BONE MINER RES, V13, P168, DOI 10.1359/jbmr.1998.13.2.168; Rosen CJ, 1997, ENDOCRIN METAB CLIN, V26, P295, DOI 10.1016/S0889-8529(05)70248-6; Schneider DL, 1997, JAMA-J AM MED ASSOC, V277, P543, DOI 10.1001/jama.277.7.543; SEMAN E, 1997, AM J MED, V103, P745; Slemenda Charles, 1997, American Journal of Medicine, V103, p65S, DOI 10.1016/S0002-9343(97)90028-0; Villareal DT, 2000, CLIN ENDOCRINOL, V53, P561, DOI 10.1046/j.1365-2265.2000.01131.x	40	68	69	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2001	286	7					815	820		10.1001/jama.286.7.815	http://dx.doi.org/10.1001/jama.286.7.815			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	462PU	11497535	Bronze			2022-12-28	WOS:000170429600029
J	Collins, S				Collins, S			Changing the way we address severe malnutrition during famine	LANCET			English	Editorial Material							CHILDREN	This year, yet again, saw widespread food Insecurity and famine across the horn of Africa. Again, humanitarian agencies set up operations to implement various relief programmes. Nutritional interventions included general ration distribution to the whole of an affected population; blanket supplementary feeding to all members of an identified risk group; and targeted dry supplementary feeding centres for moderately malnourished and therapeutic feeding centres for the severely malnourished. As is usual in emergencies, many of the therapeutic feeding centres were hard to set up and did not achieve an adequate coverage of all the severely malnourished. This combination of delays and low coverage meant that many therapeutic feeding centres achieved little overall impact on mortality. I believe that the present focus on therapeutic feeding centres as the sole mode of treating severely malnourished people during famine is inappropriate and often counter-productive. A new concept of community-based therapeutic care is necessary to complement therapeutic feeding centres' interventions if famine relief programmes are to address the plight of the severely malnourished in an efficient and effective manner. During an emergency, the community-based therapeutic care approach could quickly provide good coverage and appropriate treatment for large numbers of severely malnourished people. The principles behind community-based therapeutic care are, however, developmental, empowering communities to cope more effectively with crisis and with transition back to normality. This is very different to the therapeutic feeding centres' approach that disempowers communities, requires very large amounts of external staff and resources, and undermines the Infrastructure. Although emergency community-based therapeutic care programmes could be large-scale and implemented quickly, they could also evolve into developmental Hearth model nutritional programmes without changing their conceptual basis. Conversely, Hearth programmes, although largely sustainable, could in times of crisis quickly scale-up into rapid effective emergency interventions. Creating such a continuum between emergency and developmental approaches has long been a holy grall of humanitarianism.	Valld Int, Llanidloes SY18 6PJ, Powys, Wales; Inst Child Hlth, Ctr Int Child Hlth, London WC1N 1EH, England	University of London; University College London	Collins, S (corresponding author), 37 Squires Court,Binfield Rd, London SW4 6TD, England.							Ashworth A, 1997, HEALTH POLICY PLANN, V12, P115, DOI 10.1093/heapol/12.2.115; Briend A, 1999, LANCET, V353, P1767, DOI 10.1016/S0140-6736(99)01078-8; Collins S, 1996, JAMA-J AM MED ASSOC, V276, P391, DOI 10.1001/jama.276.5.391; de Waal A., 1989, FAMINE KILLS DARFUR; Khanum S, 1998, AM J CLIN NUTR, V67, P940, DOI 10.1093/ajcn/67.5.940; KHANUM S, 1994, LANCET, V344, P1728; PHELPS L, 2001, UNPUB REPORT OXFAMS; *SPHER PROJ, 1999, PROJ TEAM SPHERE PRO; WOLLINKA O, 1997, HLTH NUTR MODEL APPL	9	78	79	0	12	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 11	2001	358	9280					498	501		10.1016/S0140-6736(01)05630-6	http://dx.doi.org/10.1016/S0140-6736(01)05630-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463TB	11513936				2022-12-28	WOS:000170492400036
J	Jones, RW				Jones, RW			Inflammation and Alzheimer's disease	LANCET			English	Editorial Material							CONTROLLED TRIAL		St Martins Hosp, Res Inst Care Elderly, Bath BA2 5RP, Avon, England		Jones, RW (corresponding author), St Martins Hosp, Res Inst Care Elderly, Bath BA2 5RP, Avon, England.							Aisen PS, 2000, NEUROLOGY, V54, P588, DOI 10.1212/WNL.54.3.588; Chao Chun C., 1998, Alzheimer's Disease Review, V3, P87; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; McGeer PL, 1995, BRAIN RES REV, V21, P195, DOI 10.1016/0165-0173(95)00011-9; McGeer PL, 1996, NEUROLOGY, V47, P425, DOI 10.1212/WNL.47.2.425; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; SAINATI SM, 2000, 6 INT STOCKH SPRINGF, P180; Scharf S, 1999, NEUROLOGY, V53, P197, DOI 10.1212/WNL.53.1.197; Stewart WF, 1997, NEUROLOGY, V48, P626, DOI 10.1212/WNL.48.3.626	10	34	34	1	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 11	2001	358	9280					436	437		10.1016/S0140-6736(01)05667-7	http://dx.doi.org/10.1016/S0140-6736(01)05667-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463TB	11513903				2022-12-28	WOS:000170492400005
J	Weiss, NS; Rossing, MA				Weiss, NS; Rossing, MA			Oestrogen-replacement therapy and risk of ovarian cancer	LANCET			English	Editorial Material									Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Weiss, NS (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.							AEDO AR, 1989, MATURITAS, V11, P147, DOI 10.1016/0378-5122(89)90007-8; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; COOK LS, 2000, WOMEN HLTH; Garg PP, 1998, OBSTET GYNECOL, V92, P472, DOI 10.1016/S0029-7844(98)00139-2; HELZLSOUER KJ, 1995, JAMA-J AM MED ASSOC, V274, P1926, DOI 10.1001/jama.274.24.1926; Rodriguez C, 2001, JAMA-J AM MED ASSOC, V285, P1460, DOI 10.1001/jama.285.11.1460; RODRIGUEZ G, 1999, H HARR OV CANC C STO; Rodriguez GC, 1998, J SOC GYNECOL INVEST, V5, P271, DOI 10.1016/S1071-5576(98)00017-3; WEISS NS, 1996, CANC EPIDEMIOLOGY PR	9	6	6	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 11	2001	358	9280					438	438		10.1016/S0140-6736(01)05669-0	http://dx.doi.org/10.1016/S0140-6736(01)05669-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463TB	11513905				2022-12-28	WOS:000170492400007
J	Hackett, JA; Feldser, DM; Greider, CW				Hackett, JA; Feldser, DM; Greider, CW			Telomere dysfunction increases mutation rate and genomic instability	CELL			English	Article							SINGLE-STRANDED-DNA; SACCHAROMYCES-CEREVISIAE; NONRECIPROCAL TRANSLOCATIONS; CHROMOSOMAL REARRANGEMENTS; FISSION YEAST; CAN1 LOCUS; REPLICATION; IDENTIFICATION; RECOMBINATION; MUTANTS	The increased tumor incidence in telomerase null mice suggests that telomere dysfunction induces genetic instability. To test this directly, we examined mutation rate in the absence of telomerase in S. cerevisiae. The mutation rate in the CAN1 gene increased 10- to 100-fold in est1 Delta strains as telomeres became dysfunctional. This increased mutation rate resulted from an increased frequency of terminal deletions. Chromosome fusions were recovered from est1 Delta strains, suggesting that the terminal deletions may occur by a breakage-fusion-bridge type mechanism. At one locus, chromosomes with terminal deletions gained a new telomere through a Rad52p-dependent, Rad51p-independent process consistent with break-induced replication. At a second locus, more complicated rearrangements involving multiple chromosomes were seen. These data suggest that telomerase can inhibit chromosomal instability.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Predoctoral Training Program Human Genet & Mol Bi, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Greider, CW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	cgreider@jhmi.edu		Greider, Carol/0000-0002-5494-8126	NIGMS NIH HHS [GM43080] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043080] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bosco G, 1998, GENETICS, V150, P1037; Boulton SJ, 1996, NUCLEIC ACIDS RES, V24, P4639, DOI 10.1093/nar/24.23.4639; Brachmann CB, 1998, YEAST, V14, P115; Cahill DP, 1999, TRENDS CELL BIOL, V9, pM57, DOI 10.1016/S0962-8924(99)01661-X; Chen C, 1998, MOL CELL, V2, P9, DOI 10.1016/S1097-2765(00)80109-4; Chen C, 1999, NAT GENET, V23, P81, DOI 10.1038/12687; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; Gasser SM, 2000, SCIENCE, V288, P1377, DOI 10.1126/science.288.5470.1377; GERRING SL, 1991, METHOD ENZYMOL, V194, P57; GOCKE E, 1979, GENETICS, V91, P53; Gravel S, 1998, SCIENCE, V280, P741, DOI 10.1126/science.280.5364.741; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; HABER JE, 1984, GENETICS, V106, P185; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; KRAMER KM, 1993, GENE DEV, V7, P2345, DOI 10.1101/gad.7.12a.2345; KRAMER KM, 1994, MOL CELL BIOL, V14, P1293, DOI 10.1128/MCB.14.2.1293; Le S, 1999, GENETICS, V152, P143; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; Lendvay TS, 1996, GENETICS, V144, P1399; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lewis LK, 2000, MUTAT RES-FUND MOL M, V451, P71, DOI 10.1016/S0027-5107(00)00041-5; Ling MF, 1995, NUCLEIC ACIDS RES, V23, P4924, DOI 10.1093/nar/23.23.4924; LOEB LA, 1991, CANCER RES, V51, P3075; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; Malkova A, 1996, P NATL ACAD SCI USA, V93, P7131, DOI 10.1073/pnas.93.14.7131; Malkova A, 2001, GENE DEV, V15, P1055, DOI 10.1101/gad.875901; Marsischky GT, 1996, GENE DEV, V10, P407, DOI 10.1101/gad.10.4.407; McClintock B, 1941, GENETICS, V26, P234; McEachern MJ, 2000, P NATL ACAD SCI USA, V97, P11409, DOI 10.1073/pnas.210388397; Morrow DM, 1997, GENETICS, V147, P371; Muller H.J., 1938, COLLECTING NET, V13, P181; Myung K, 2001, NATURE, V411, P1073, DOI 10.1038/35082608; Nadas A, 1996, ENVIRON MOL MUTAGEN, V28, P90; Naito T, 1998, NAT GENET, V20, P203, DOI 10.1038/2517; Nakamura TM, 1998, SCIENCE, V282, P493, DOI 10.1126/science.282.5388.493; NIGRO JM, 1992, MOL CELL BIOL, V12, P1357, DOI 10.1128/MCB.12.3.1357; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Shih IM, 2001, CANCER RES, V61, P818; SINGH D, 1994, INDIAN J CHEM TECHN, V1, P266; SUGAWARA N, 1992, MOL CELL BIOL, V12, P563, DOI 10.1128/MCB.12.2.563; Teo SH, 1997, EMBO J, V16, P4788, DOI 10.1093/emboj/16.15.4788; Thiagalingam S, 2001, P NATL ACAD SCI USA, V98, P2698, DOI 10.1073/pnas.051625398; WHELAN WL, 1979, GENETICS, V91, P35; ZAKIAN VA, 1989, ANNU REV GENET, V23, P579, DOI 10.1146/annurev.genet.23.1.579	48	290	299	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2001	106	3					275	286		10.1016/S0092-8674(01)00457-3	http://dx.doi.org/10.1016/S0092-8674(01)00457-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RJ	11509177	Bronze			2022-12-28	WOS:000170433300006
J	Rideout, WM; Eggan, K; Jaenisch, R				Rideout, WM; Eggan, K; Jaenisch, R			Nuclear cloning and epigenetic reprogramming of the genome	SCIENCE			English	Review							PREIMPLANTATION MOUSE EMBRYO; CLONED TRANSGENIC CALVES; DNA METHYLATION; TRANSCRIPTIONAL ACTIVITY; GENE-EXPRESSION; SOMATIC-CELLS; GERM-CELLS; STEM-CELLS; ENUCLEATED OOCYTES; FETAL FIBROBLASTS	Cloning of mammals by nuclear transfer (NT) results in gestational or neonatal failure with at most a few percent of manipulated embryos resulting in live births. Many of those that survive to term succumb to a variety of abnormalities that are likely due to inappropriate epigenetic reprogramming. Cloned embryos derived from donors, such as embryonic stem cells, that may require little or no reprogramming of early developmental genes develop substantially better beyond implantation than NT clones derived from somatic cells. Although recent experiments have demonstrated normal reprogramming of telomere length and X chromosome inactivation, epigenetic information established during gametogenesis, such as gametic imprints, cannot be restored after nuclear transfer. Survival of cloned animals to birth and beyond, despite substantial transcriptional dysregulation, is consistent with mammalian development being rather tolerant to epigenetic abnormalities, with lethality resulting only beyond a threshold of faulty gene reprogramming encompassing multiple loci.	MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Jaenisch, R (corresponding author), MIT, Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.		Eggan, Kevin/P-7119-2018					Adenot PG, 1997, DEVELOPMENT, V124, P4615; Aoki F, 1997, DEV BIOL, V181, P296, DOI 10.1006/dbio.1996.8466; Betts DH, 2001, P NATL ACAD SCI USA, V98, P1077, DOI 10.1073/pnas.031559298; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; Cho C, 2001, NAT GENET, V28, P82, DOI 10.1038/ng0501-82; Cibelli JB, 1998, SCIENCE, V280, P1256, DOI 10.1126/science.280.5367.1256; Constancia M, 1998, GENOME RES, V8, P881, DOI 10.1101/gr.8.9.881; Counter CM, 1998, P NATL ACAD SCI USA, V95, P14723, DOI 10.1073/pnas.95.25.14723; Daniels R, 2000, BIOL REPROD, V63, P1034, DOI 10.1095/biolreprod63.4.1034; De Sousa PA, 2001, BIOL REPROD, V65, P23, DOI 10.1095/biolreprod65.1.23; Dean W, 1998, DEVELOPMENT, V125, P2273; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; Doherty AS, 2000, BIOL REPROD, V62, P1526, DOI 10.1095/biolreprod62.6.1526; Eggan K, 2000, SCIENCE, V290, P1578, DOI 10.1126/science.290.5496.1578; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Gurdon J.B., 1979, International Review of Cytology Supplement, P161; Gurdon JB, 1999, SEMIN CELL DEV BIOL, V10, P239, DOI 10.1006/scdb.1998.0284; HENERY CC, 1995, DEV BIOL, V169, P448, DOI 10.1006/dbio.1995.1160; Hill JR, 2000, BIOL REPROD, V62, P1135, DOI 10.1095/biolreprod62.5.1135; Hill JR, 1999, THERIOGENOLOGY, V51, P1451, DOI 10.1016/S0093-691X(99)00089-8; HOWLETT SK, 1991, DEVELOPMENT, V113, P119; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; HUMPHERYS D, UNPUB; Jaenisch R, 1997, TRENDS GENET, V13, P323, DOI 10.1016/S0168-9525(97)01180-3; Jaenisch R, 2001, SCIENCE, V291, P2552, DOI 10.1126/science.1060463; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; Kang YK, 2001, NAT GENET, V28, P173, DOI 10.1038/88903; Kanka J, 1996, MOL REPROD DEV, V43, P135, DOI 10.1002/(SICI)1098-2795(199602)43:2&lt;135::AID-MRD1&gt;3.0.CO;2-S; Kato Y, 1999, DEVELOPMENT, V126, P1823; Kato Y, 2000, J REPROD FERTIL, V120, P231, DOI 10.1530/reprod/120.2.231; KAUFMAN MH, 1977, NATURE, V265, P53, DOI 10.1038/265053a0; Keefer CL, 2001, BIOL REPROD, V64, P849, DOI 10.1095/biolreprod64.3.849; Khosla S, 2001, BIOL REPROD, V64, P918, DOI 10.1095/biolreprod64.3.918; Kikyo N, 2000, SCIENCE, V289, P2360, DOI 10.1126/science.289.5488.2360; KIMURA Y, 1995, DEVELOPMENT, V121, P2397; KIMURA Y, 1995, BIOL REPROD, V53, P855, DOI 10.1095/biolreprod53.4.855; Kono T, 1996, NAT GENET, V13, P91, DOI 10.1038/ng0596-91; Kubota C, 2000, P NATL ACAD SCI USA, V97, P990, DOI 10.1073/pnas.97.3.990; Lanza RP, 2000, SCIENCE, V288, P665, DOI 10.1126/science.288.5466.665; Latham KE, 1999, INT REV CYTOL, V193, P71; LATHAM KE, 1994, DEV BIOL, V163, P341, DOI 10.1006/dbio.1994.1153; Lyon MF, 1999, CURR BIOL, V9, pR235, DOI 10.1016/S0960-9822(99)80151-1; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; McCreath KJ, 2000, NATURE, V405, P1066, DOI 10.1038/35016604; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; MONK M, 1987, DEVELOPMENT, V99, P371; NAGY A, 1990, DEVELOPMENT, V110, P815; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; PINTOCORREIA C, 1995, MOL REPROD DEV, V40, P292, DOI 10.1002/mrd.1080400305; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; RAZIN A, 1995, HUM MOL GENET, V4, P1751, DOI 10.1093/hmg/4.suppl_1.1751; Rideout WM, 2000, NAT GENET, V24, P109, DOI 10.1038/72753; RIDEOUT WM, UNPUB; SANFORD J, 1984, NUCLEIC ACIDS RES, V12, P2823, DOI 10.1093/nar/12.6.2823; SANFORD JP, 1987, GENE DEV, V1, P1039, DOI 10.1101/gad.1.10.1039; Schnieke AE, 1997, SCIENCE, V278, P2130, DOI 10.1126/science.278.5346.2130; SHEMER R, 1991, P NATL ACAD SCI USA, V88, P11300, DOI 10.1073/pnas.88.24.11300; Shiels PG, 1999, NATURE, V399, P316, DOI 10.1038/20580; Steger K, 1999, ANAT EMBRYOL, V199, P471, DOI 10.1007/s004290050245; Tada T, 1998, DEV GENES EVOL, V207, P551, DOI 10.1007/s004270050146; Tanaka M, 2001, DEVELOPMENT, V128, P655; Tian XC, 2000, NAT GENET, V26, P272, DOI 10.1038/81559; Tilghman SM, 1999, CELL, V96, P185, DOI 10.1016/S0092-8674(00)80559-0; Tucker KL, 1996, GENE DEV, V10, P1008, DOI 10.1101/gad.10.8.1008; Wakayama T, 2000, NATURE, V407, P318, DOI 10.1038/35030301; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wakayama T, 1999, P NATL ACAD SCI USA, V96, P14984, DOI 10.1073/pnas.96.26.14984; Wakayama T, 1999, NAT GENET, V22, P127, DOI 10.1038/9632; Warnecke PM, 1999, MOL CELL BIOL, V19, P164; Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442; Wells DN, 1999, BIOL REPROD, V60, P996, DOI 10.1095/biolreprod60.4.996; WIEKOWSKI M, 1993, DEV BIOL, V159, P366, DOI 10.1006/dbio.1993.1248; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Winger QA, 2000, MOL REPROD DEV, V56, P458, DOI 10.1002/1098-2795(200008)56:4&lt;458::AID-MRD3&gt;3.0.CO;2-L; WORRAD DM, 1994, DEVELOPMENT, V120, P2347; Young LE, 1998, REV REPROD, V3, P155, DOI 10.1530/revreprod/3.3.155; Young LE, 2001, NAT GENET, V27, P153, DOI 10.1038/84769; Zou X, 2001, Cloning, V3, P31, DOI 10.1089/152045501300189312	78	569	636	0	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2001	293	5532					1093	1098		10.1126/science.1063206	http://dx.doi.org/10.1126/science.1063206			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498580				2022-12-28	WOS:000170432600048
J	Rubin, C; Turner, AS; Bain, S; Mallinckrodt, C; McLeod, K				Rubin, C; Turner, AS; Bain, S; Mallinckrodt, C; McLeod, K			Anabolism - Low mechanical signals strengthen long bones	NATURE			English	Article							STRAIN; MAGNITUDE		SUNY Stony Brook, Dept Biomed Engn, Musculoskeletal Res Lab, Stony Brook, NY 11794 USA; Colorado State Univ, Dept Clin Sci, Ft Collins, CO 80523 USA; Skeletech Inc, Bothell, WA 98021 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Colorado State University	Rubin, C (corresponding author), SUNY Stony Brook, Dept Biomed Engn, Musculoskeletal Res Lab, Stony Brook, NY 11794 USA.	clinton.rubin@sunysb.edu						BAIN SD, 1990, J BONE MINER RES, V5, P1069; Blob RW, 1999, J EXP BIOL, V202, P1023; BURR DB, 1985, J BIOMECH, V18, P189, DOI 10.1016/0021-9290(85)90204-0; CARTER DR, 1981, MECHANICAL PROPERTIE, V45, P81; Fritton JC, 1997, ANN BIOMED ENG, V25, P831, DOI 10.1007/BF02684167; Fritton SP, 2000, J BIOMECH, V33, P317, DOI 10.1016/S0021-9290(99)00210-9; FROST HM, 1990, ANAT REC, V226, P403, DOI 10.1002/ar.1092260402; Huang RP, 1999, J GERONTOL A-BIOL, V54, pB352, DOI 10.1093/gerona/54.8.B352; Hylander WL, 1998, AM J PHYS ANTHROPOL, V107, P257, DOI 10.1002/(SICI)1096-8644(199811)107:3<257::AID-AJPA3>3.3.CO;2-Y; RUBIN CT, 1995, J BONE MINER RES, V10, P488; RUBIN CT, 1982, J EXP BIOL, V101, P187; SCHAFFLER MB, 1990, BONE, V11, P321, DOI 10.1016/8756-3282(90)90087-F; Wolff J., 1986, LAW BONE REMODELING	13	513	568	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 9	2001	412	6847					603	604		10.1038/35088122	http://dx.doi.org/10.1038/35088122			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460PP	11493908				2022-12-28	WOS:000170318000028
J	Tonomura, A; Kasai, H; Kamimura, O; Matsuda, T; Harada, K; Nakayama, Y; Shimoyama, J; Kishio, K; Hanaguri, T; Kitazawa, K; Sasase, M; Okayasu, S				Tonomura, A; Kasai, H; Kamimura, O; Matsuda, T; Harada, K; Nakayama, Y; Shimoyama, J; Kishio, K; Hanaguri, T; Kitazawa, K; Sasase, M; Okayasu, S			Observation of individual vortices trapped along columnar defects in high-temperature superconductors	NATURE			English	Article							VORTEX; ANISOTROPY; CRYSTALS	Many superconductors do not entirely expel magnetic flux-rather, magnetic flux can penetrate the superconducting state in the form of vortices. Moving vortices create resistance, so they must be 'pinned' to permit dissipationless current flow. This is a particularly important issue for the high-transition-temperature superconductors, in which the vortices move very easily(1). Irradiation of superconducting samples by heavy ions produces columnar defects, which are considered(2) to be the optimal pinning traps when the orientation of the column coincides with that of the vortex line. Although columnar defect pinning has been investigated using macroscopic techniques(3,4), it has hitherto been impossible to resolve individual vortices intersecting with individual defects. Here we achieve the resolution required to image vortex lines and columnar defects in Bi2Sr2CaCu2O8+delta (Bi-2212) thin films, using a 1-MV field-emission electron microscope(5). For our thin films, we rnd that the vortex lines at higher temperatures are trapped and oriented along tilted columnar defects, irrespective of the orientation of the applied magnetic field. At lower temperatures, however, vortex penetration always takes place perpendicular to the film plane, suggesting that intrinsic 'background' pinning in the material now dominates.	Hitachi Ltd, Adv Res Lab, Hatoyama, Saitama 3500395, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi, Saitama 3320012, Japan; Univ Tokyo, Dept Appl Chem, Tokyo 1138656, Japan; Univ Tokyo, Dept Adv Mat Sci, Sch Frontier Sci, Tokyo 1130033, Japan; Japan Atom Energy Res Inst, Dept Mat Sci, Tokai, Ibaraki 3191195, Japan	Hitachi Limited; Japan Science & Technology Agency (JST); University of Tokyo; University of Tokyo; Japan Atomic Energy Agency	Tonomura, A (corresponding author), Hitachi Ltd, Adv Res Lab, Hatoyama, Saitama 3500395, Japan.		Hanaguri, Tetsuo/I-6710-2012; Kishio, Kohji/AAL-2904-2020	Hanaguri, Tetsuo/0000-0003-2896-0081; Kishio, Kohji/0000-0002-2759-8618				CIVALE L, 1991, PHYS REV LETT, V67, P648, DOI 10.1103/PhysRevLett.67.648; Crabtree GW, 1997, PHYS TODAY, V50, P38, DOI 10.1063/1.881715; Fanesi S, 1999, PHYS REV B, V59, P1426, DOI 10.1103/PhysRevB.59.1426; HARADA K, 1992, NATURE, V360, P51, DOI 10.1038/360051a0; Hardy V, 1996, PHYS REV B, V54, P656, DOI 10.1103/PhysRevB.54.656; Kawasaki T, 2000, APPL PHYS LETT, V76, P1342, DOI 10.1063/1.126028; KLEIN L, 1993, PHYS REV B, V48, P3523, DOI 10.1103/PhysRevB.48.3523; KOTAKA Y, 1994, PHYSICA C, V235, P1529, DOI 10.1016/0921-4534(94)91989-5; SCHUSTER T, 1994, PHYS REV B, V50, P9499, DOI 10.1103/PhysRevB.50.9499; TINOMURA A, 1999, ELECT HOLOGRAPHY; YAO Z, 1994, NATURE, V371, P777, DOI 10.1038/371777a0	11	104	106	2	20	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2001	412	6847					620	622		10.1038/35088021	http://dx.doi.org/10.1038/35088021			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460PP	11493915				2022-12-28	WOS:000170318000035
J	Vladeck, BC				Vladeck, BC			Learn nothing, forget nothing - The Medicare commission redux.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Mt Sinai Sch Med, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Vladeck, BC (corresponding author), Mt Sinai Sch Med, New York, NY 10029 USA.							Aaron HJ, 1995, HEALTH AFFAIR, V14, P8, DOI 10.1377/hlthaff.14.4.8; Asch SM, 2000, JAMA-J AM MED ASSOC, V284, P2325, DOI 10.1001/jama.284.18.2325; *BOARD TRUST FED H, 2001, ANN REP BOARD TRUST, P2; Cooper BS, 2000, HEALTH AFFAIR, V19, P49, DOI 10.1377/hlthaff.19.5.49; *HLTH CAR FIN ADM, 2000, MED 2000 35 YEARS IM, P22; MAXWELL S, 2000, GROWTH MED OUT POCKE; Shaughnessy PW, 1997, MED CARE, V35, P1225, DOI 10.1097/00005650-199712000-00007; Vladeck BC, 1999, NEW ENGL J MED, V340, P1503, DOI 10.1056/NEJM199905133401911; Ware JE, 1996, JAMA-J AM MED ASSOC, V276, P1039, DOI 10.1001/jama.1996.03540130037027	9	5	5	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 9	2001	345	6					456	458		10.1056/NEJM200108093450611	http://dx.doi.org/10.1056/NEJM200108093450611			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460EJ	11496859				2022-12-28	WOS:000170295000011
J	Snyder, L; Sulmasy, DP				Snyder, L; Sulmasy, DP		Ethics Human Rights Comm Amer C	Physician-assisted suicide	ANNALS OF INTERNAL MEDICINE			English	Article							PATIENT REQUESTS; EUTHANASIA; OREGON; DEATH; PAIN; LIFE; GUIDELINES; ATTITUDES; MANAGEMENT; END	Medical professional codes have long prohibited physician involvement in assisting a patient's suicide. However, despite ethical and legal prohibitions, calls for the liberalization of this ban have grown in recent years. The medical profession should articulate its views on the arguments for and against changes in public policy and decide whether changes are prudent. In addressing such a contentious issue, physicians, policymakers, and society must fully consider the needs of patients, the vulnerability of particular patient groups, issues of trust and professionalism, and the complexities of end-of-life health care. Physician-assisted suicide is prominent among the issues that define our professional norms and codes of ethics. The American College of Physicians-American Society of Internal Medicine (ACP-ASIM) does not support the legalization of physician-assisted suicide. The routine practice of physician-assisted suicide raises serious ethical and other concerns. Legalization would undermine the patient-physician relationship and the trust necessary to sustain it; after the medical profession's role in society; and endanger the value our society places on life, especially on the lives of disabled, incompetent, and vulnerable individuals. The ACP-ASIM remains thoroughly committed to improving care for patients at the end of life.	Amer Coll Physicians, Amer Soc Internal Med, Philadelphia, PA 19106 USA	American College of Physicians	Snyder, L (corresponding author), Amer Coll Physicians, Amer Soc Internal Med, 190 N Independence Mall W, Philadelphia, PA 19106 USA.							Abrahm JL, 1999, ANN INTERN MED, V131, P37, DOI 10.7326/0003-4819-131-1-199907060-00009; ALPERS A, 1995, JAMA-J AM MED ASSOC, V274, P483, DOI 10.1001/jama.274.6.483; Angell M, 1997, NEW ENGL J MED, V336, P50, DOI 10.1056/NEJM199701023360108; ANNAS GJ, 1994, NEW ENGL J MED, V331, P1240, DOI 10.1056/NEJM199411033311822; Annas GJ, 1996, NEW ENGL J MED, V335, P683, DOI 10.1056/NEJM199608293350924; Bachman JG, 1996, NEW ENGL J MED, V334, P303, DOI 10.1056/NEJM199602013340506; Back AL, 1996, JAMA-J AM MED ASSOC, V275, P919, DOI 10.1001/jama.275.12.919; BAILE WF, 1993, CANCER, V72, P2786, DOI 10.1002/1097-0142(19931101)72:9<2786::AID-CNCR2820720942>3.0.CO;2-2; Baron CH, 1996, HARVARD J LEGIS, V33, P1; BATTIN MP, 1995, ACAD MED, V70, P583; BLENDON RJ, 1992, JAMA-J AM MED ASSOC, V267, P2658, DOI 10.1001/jama.267.19.2658; Block SD, 2000, ANN INTERN MED, V132, P209, DOI 10.7326/0003-4819-132-3-200002010-00007; BOSCHERT S, 1992, INTERNAL MED NE 1201, P3; BOSCHERT S, 1992, INTERNAL MED NE 1201, P20; BROCK DW, 1992, YALE J BIOL MED, V65, P121; BRODY H, 1992, NEW ENGL J MED, V327, P1384, DOI 10.1056/NEJM199211053271912; BUCHAN ML, 1995, J CLIN ETHIC, V6, P53; BYOCK I, 1997, DYING WELL PROSPECT, P245; Byock IR, 1997, MED ETHIC S, P107; CAIN C, 1998, DETROIT NEWS    1104, pA1; Callahan D, 1997, MED ETHIC S, P69; CALLAHAN D, 1992, HASTINGS CENT REP, V22, P52, DOI 10.2307/3562566; Caplan AL, 2000, ANN INTERN MED, V132, P476, DOI 10.7326/0003-4819-132-6-200003210-00009; CAPRON AM, 1992, HASTINGS CENT REP, V22, P30, DOI 10.2307/3562562; CASSEL CK, 1990, NEW ENGL J MED, V323, P750, DOI 10.1056/NEJM199009133231110; Chin AE, 1999, NEW ENGL J MED, V340, P577, DOI 10.1056/NEJM199902183400724; Chochinov HM, 1999, LANCET, V354, P816, DOI 10.1016/S0140-6736(99)80011-7; CHOCHINOV HM, 1995, AM J PSYCHIAT, V152, P1185; Christakis NA, 1996, NEW ENGL J MED, V335, P172, DOI 10.1056/NEJM199607183350306; CLEELAND CS, 1994, NEW ENGL J MED, V330, P592, DOI 10.1056/NEJM199403033300902; Coleman CH, 1996, J LAW MED ETHICS, V24, P217, DOI 10.1111/j.1748-720X.1996.tb01855.x; CONWELL Y, 1991, NEW ENGL J MED, V325, P1100, DOI 10.1056/NEJM199110103251511; COVINSKY KE, 1994, JAMA-J AM MED ASSOC, V272, P1839, DOI 10.1001/jama.272.23.1839; Emanuel EJ, 1996, LANCET, V347, P1805, DOI 10.1016/S0140-6736(96)91621-9; Emanuel Ezekiel, 1997, Atl Mon, V279, P73; Emanuel LL, 1998, JAMA-J AM MED ASSOC, V280, P643, DOI 10.1001/jama.280.7.643; Field MJ, 1997, APPROACHING DEATH IM; Fohr S A, 1998, J Palliat Med, V1, P315, DOI 10.1089/jpm.1998.1.315; Foley K, 1999, HASTINGS CENT REP, V29, P37, DOI 10.2307/3528194; FOLEY KM, 1991, J PAIN SYMPTOM MANAG, V6, P289, DOI 10.1016/0885-3924(91)90052-6; FRIED TR, 1993, ARCH INTERN MED, V153, P722, DOI 10.1001/archinte.153.6.722; GAYLIN W, 1988, JAMA-J AM MED ASSOC, V259, P2139; GERT B, 1994, HASTINGS CENT REP, V24, P13, DOI 10.2307/3562837; GILLESPIE M, 1999, KEVORKIAN FACE MURDE; Glick SM, 1997, AM J MED, V102, P294, DOI 10.1016/S0002-9343(97)00016-8; GOAD M, 2000, PORTLAND PRESS  1108, pA1; GROSS J, 1991, NY TIMES        1107, pB16; Hardwig J, 1997, HASTINGS CENT REP, V27, P34, DOI 10.2307/3527626; Heilig S, 1997, WESTERN J MED, V166, P370; Hendin H, 1999, J CLIN PSYCHIAT, V60, P46; Jochemsen H, 1999, J MED ETHICS, V25, P16, DOI 10.1136/jme.25.1.16; JONES WH, 1923, HIPPOCRATES, V1, P289; Jones WHS, 1923, HIPPOCRATES, P193; KAMISAR Y, 1993, HASTINGS CENT REP, V23, P32, DOI 10.2307/3563366; KAMISAR Y, 1958, MINN LAW REV, V42, P969; KASS LR, 1989, PUBLIC INTEREST, P25; Kissane DW, 1998, LANCET, V352, P1097, DOI 10.1016/S0140-6736(98)05406-3; Kitchens LW, 1998, ANN INTERN MED, V128, P576, DOI 10.7326/0003-4819-128-7-199804010-00012; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; KNAUS WA, 1995, ANN INTERN MED, V122, P191, DOI 10.7326/0003-4819-122-3-199502010-00007; Lee MA, 1996, NEW ENGL J MED, V334, P310, DOI 10.1056/NEJM199602013340507; Lo B, 1999, ANN INTERN MED, V130, P772, DOI 10.7326/0003-4819-130-9-199905040-00018; Lynn J, 1997, J AM GERIATR SOC, V45, P489, DOI 10.1111/j.1532-5415.1997.tb05176.x; MAX MB, 1990, ANN INTERN MED, V113, P885, DOI 10.7326/0003-4819-113-11-885; MILES SH, 1995, HASTINGS CENT REP, V25, P17, DOI 10.2307/3562108; Miller FG, 2000, ANN INTERN MED, V132, P470, DOI 10.7326/0003-4819-132-6-200003210-00008; MILLER FG, 1994, NEW ENGL J MED, V331, P119, DOI 10.1056/NEJM199407143310211; Nuland SB, 2000, NEW ENGL J MED, V342, P583, DOI 10.1056/NEJM200002243420811; *NY STAT TASK FORC, 1994, DEATH IS SOUGHT ASSI; ORENTLICHER D, 1992, JAMA-J AM MED ASSOC, V267, P2229; PELLEGRINO ED, 1993, JAMA-J AM MED ASSOC, V270, P874, DOI 10.1001/jama.270.7.874; PELLEGRINO ED, 1995, ANN INTERN MED, V122, P377, DOI 10.7326/0003-4819-122-5-199503010-00010; Phillips RS, 2000, J AM GERIATR SOC, V48, pS1, DOI 10.1111/j.1532-5415.2000.tb03118.x; PIJNENBORG L, 1993, LANCET, V341, P1196, DOI 10.1016/0140-6736(93)91014-D; PRATT DA, 1999, ALBANY LAW J SCI TEC, V9, P161; Quill TE, 1997, NEW ENGL J MED, V337, P1768, DOI 10.1056/NEJM199712113372413; QUILL TE, 1993, JAMA-J AM MED ASSOC, V270, P870, DOI 10.1001/jama.270.7.870; QUILL TE, 1995, ANN INTERN MED, V122, P368, DOI 10.7326/0003-4819-122-5-199503010-00008; SACHS GA, 1995, J AM GERIATR SOC, V43, P553, DOI 10.1111/j.1532-5415.1995.tb06106.x; SHAPIRO RS, 1994, ARCH INTERN MED, V154, P575, DOI 10.1001/archinte.154.5.575; Simons M, 2000, N Y Times Web, pA3; SIMONS M, 1995, NY TIMES        0909; SINGER PA, 1990, NEW ENGL J MED, V322, P1881, DOI 10.1056/NEJM199006283222610; SNYDER L, 1990, ANN INTERN MED, V112, P802, DOI 10.7326/0003-4819-112-11-802; Sullivan AD, 2000, NEW ENGL J MED, V342, P598, DOI 10.1056/NEJM200002243420822; Sulmasy DP, 1999, ARCH INTERN MED, V159, P545, DOI 10.1001/archinte.159.6.545; Sulmasy DP, 1998, J LAW MED ETHICS, V26, P55, DOI 10.1111/j.1748-720X.1998.tb01906.x; *TASK FORC IMPR CA, 1998, OR DEATH DIGN ACT GU; TOLLE SW, 1996, ETHICAL CHOICES CASE; TROLLOPE A, 1990, FIXED PERIOD NOVEL; van Delden JJM, 1999, J MED ETHICS, V25, P22, DOI 10.1136/jme.25.1.22; VANDELDEN JJM, 1993, HASTINGS CENT REP, V23, P24, DOI 10.2307/3562919; VANDERMAAS PJ, 1992, EUTHANASIA OTHER MED, P43; VONROENN JH, 1993, ANN INTERN MED, V119, P121, DOI 10.7326/0003-4819-119-2-199307150-00005; WANZER SH, 1989, NEW ENGL J MED, V320, P844, DOI 10.1056/NEJM198903303201306; Wolf S M, 1996, Duquesne Law Rev, V35, P455; Young EWD, 1997, WESTERN J MED, V166, P381; [No title captured]	98	37	37	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 7	2001	135	3					209	216		10.7326/0003-4819-135-3-200108070-00015	http://dx.doi.org/10.7326/0003-4819-135-3-200108070-00015			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	460FX	11487490				2022-12-28	WOS:000170298500009
J	Eichhorst, ST; Krammer, PH				Eichhorst, ST; Krammer, PH			Derangement of apoptosis in cancer	LANCET			English	Editorial Material							GENE; LYMPHOMA; CELLS		Univ Munich, Klinikum Grosshadern, Dept Med 2, D-8000 Munich, Germany; German Canc Res Ctr, Div Immunogenet, Tumorimmunol Program, D-69120 Heidelberg, Germany	University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ)	Eichhorst, ST (corresponding author), Univ Munich, Klinikum Grosshadern, Dept Med 2, D-8000 Munich, Germany.							Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Catlett IM, 2001, J IMMUNOL, V166, P6019, DOI 10.4049/jimmunol.166.10.6019; Dierlamm J, 1999, BLOOD, V93, P3601, DOI 10.1182/blood.V93.11.3601; Eichhorst ST, 2000, MOL CELL BIOL, V20, P7826, DOI 10.1128/MCB.20.20.7826-7837.2000; Kogan SC, 2001, J EXP MED, V193, P531, DOI 10.1084/jem.193.4.531; Krammer P H, 1999, Adv Immunol, V71, P163; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Medema JP, 1999, J EXP MED, V190, P1033, DOI 10.1084/jem.190.7.1033; Muller M, 1998, J EXP MED, V188, P2033, DOI 10.1084/jem.188.11.2033; Peter ME, 1998, CURR OPIN IMMUNOL, V10, P545, DOI 10.1016/S0952-7915(98)80222-7; Soengas MS, 2001, NATURE, V409, P207, DOI 10.1038/35051606; Stamatopoulos K, 2000, IMMUNOL TODAY, V21, P298, DOI 10.1016/S0167-5699(00)01650-9; Strand S, 1996, NAT MED, V2, P1361, DOI 10.1038/nm1296-1361; Takimoto R, 2000, ONCOGENE, V19, P1735, DOI 10.1038/sj.onc.1203489	14	11	14	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 4	2001	358	9279					345	346		10.1016/S0140-6736(01)05584-2	http://dx.doi.org/10.1016/S0140-6736(01)05584-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459DE	11502308				2022-12-28	WOS:000170235100003
J	Perkins, BA				Perkins, BA			Prospects for prevention of meningococcal meningitis	LANCET			English	Editorial Material							EPIDEMICS; THRESHOLDS		Ctr Dis Control & Prevent, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Perkins, BA (corresponding author), Ctr Dis Control & Prevent, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA.	BPerkins@CDC.GOV						de Chabalier F, 2000, T ROY SOC TROP MED H, V94, P251, DOI 10.1016/S0035-9203(00)90308-0; Kaninda AV, 2000, INT J EPIDEMIOL, V29, P933, DOI 10.1093/ije/29.5.933; MOORE PS, 1992, INT J EPIDEMIOL, V21, P155, DOI 10.1093/ije/21.1.155; *US AG INT DEV, 1994, DAT DEC MAK PROJ, P36; *WHO WORK GROUP, 1995, CONTR EP MEN DIS; Woods CW, 2000, LANCET, V355, P30, DOI 10.1016/S0140-6736(99)03366-8; World Health Organisation, 2000, WKLY EPIDEMIOL REC, V75, P306; World Health Organization, 1997, WKLY EPIDEMIOL REC, V72, P313	8	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 28	2001	358	9278					255	256		10.1016/S0140-6736(01)05492-7	http://dx.doi.org/10.1016/S0140-6736(01)05492-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	457AF	11498206				2022-12-28	WOS:000170114400003
J	Thompson, JS; Bixler, SA; Qian, F; Vora, K; Scott, ML; Cachero, TG; Hession, C; Schneider, P; Sizing, ID; Mullen, C; Strauch, K; Zafari, M; Benjamin, CD; Tschopp, J; Browning, JL; Ambrose, C				Thompson, JS; Bixler, SA; Qian, F; Vora, K; Scott, ML; Cachero, TG; Hession, C; Schneider, P; Sizing, ID; Mullen, C; Strauch, K; Zafari, M; Benjamin, CD; Tschopp, J; Browning, JL; Ambrose, C			BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF	SCIENCE			English	Article							NECROSIS-FACTOR FAMILY; CELL MATURATION ANTIGEN; A/WYSNJ MICE; MEMBER; SUPERFAMILY; APRIL; TACI; GROWTH; TALL-1; BCMA	B cell homeostasis has been shown to critically depend on BAFF, the B cell activation factor from the tumor necrosis factor (TNF) family. Although BAFF is already known to bind two receptors, BCMA and TACI, we have identified a third receptor for BAFF that we have termed BAFF-R. BAFF-R binding appears to be highly specific for BAFF, suggesting a unique role for this ligand-receptor interaction. Consistent with this, the BAFF-R locus is disrupted in A/WySnJ mice, which display a B cell phenotype qualitatively similar to that of the BAFF-deficient mice. Thus, BAFF-R appears to be the principal receptor for BAFF-mediated mature B cell survival.	Biogen Inc, Cambridge, MA 02142 USA; Univ Lausanne, Inst Biochem, CH-1066 Epalinges, Switzerland	Biogen; University of Lausanne	Ambrose, C (corresponding author), Biogen Inc, 12 Cambridge Ctr, Cambridge, MA 02142 USA.	christine_ambrose@biogen.com		Browning, Jeffrey/0000-0001-9168-5233; Schneider, Pascal/0000-0003-0677-9409				Batten M, 2000, J EXP MED, V192, P1453, DOI 10.1084/jem.192.10.1453; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Hahne M, 1998, J EXP MED, V188, P1185, DOI 10.1084/jem.188.6.1185; Hoag KA, 2000, IMMUNOGENETICS, V51, P924, DOI 10.1007/s002510000223; HUA XX, 1995, GENOMICS, V25, P667, DOI 10.1016/0888-7543(95)80009-B; Lentz VM, 1998, J IMMUNOL, V160, P3743; Lentz VM, 1996, J IMMUNOL, V157, P598; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Madry C, 1998, INT IMMUNOL, V10, P1693, DOI 10.1093/intimm/10.11.1693; Marsters SA, 2000, CURR BIOL, V10, P785, DOI 10.1016/S0960-9822(00)00566-2; MILLER DJ, 1991, EUR J IMMUNOL, V21, P1123, DOI 10.1002/eji.1830210506; MILLER DJ, 1992, EUR J IMMUNOL, V22, P373, DOI 10.1002/eji.1830220213; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Mukhopadhyay A, 1999, J BIOL CHEM, V274, P15978, DOI 10.1074/jbc.274.23.15978; Naismith JH, 1998, TRENDS BIOCHEM SCI, V23, P74, DOI 10.1016/S0968-0004(97)01164-X; QIAN F, UNPUB; Rennert P, 2000, J EXP MED, V192, P1677, DOI 10.1084/jem.192.11.1677; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Shu HB, 2000, P NATL ACAD SCI USA, V97, P9156, DOI 10.1073/pnas.160213497; Shu HB, 1999, J LEUKOCYTE BIOL, V65, P680, DOI 10.1002/jlb.65.5.680; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; Thompson JS, 2000, J EXP MED, V192, P129, DOI 10.1084/jem.192.1.129; von Bulow GU, 2001, IMMUNITY, V14, P573, DOI 10.1016/S1074-7613(01)00130-3; vonBulow GU, 1997, SCIENCE, V278, P138, DOI 10.1126/science.278.5335.138; Wu YM, 2000, J BIOL CHEM, V275, P35478, DOI 10.1074/jbc.M005224200; Xia XZ, 2000, J EXP MED, V192, P137, DOI 10.1084/jem.192.1.137; Xu SL, 2001, MOL CELL BIOL, V21, P4067, DOI 10.1128/MCB.21.12.4067-4074.2001; Zhang J, 2001, J IMMUNOL, V166, P6, DOI 10.4049/jimmunol.166.1.6	30	736	882	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2001	293	5537					2108	2111		10.1126/science.1061965	http://dx.doi.org/10.1126/science.1061965			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11509692				2022-12-28	WOS:000171028700079
J	Schiano, P; Clocchiatti, R; Ottolini, L; Busa, T				Schiano, P; Clocchiatti, R; Ottolini, L; Busa, T			Transition of Mount Etna lavas from a mantle-plume to an island-arc magmatic source	NATURE			English	Article							FEEDING SYSTEM; CONSTRAINTS; ELEMENT; GEOCHEMISTRY; VOLCANISM; ERUPTION; DYNAMICS; ORIGIN; BASALT	Mount Etna lies near the boundary between two regions that exhibit significantly different types of volcanism. To the north, volcanism in the Aeolian island arc is thought to be related to subduction of the Ionian lithosphere(1). On Sicily itself, however, no chemical(2,3) or seismological(4) evidence of subduction-related volcanism exists, and so it is thought that the volcanism-including that on Mount Etna itself-stems from the upwelling of mantle material(5), associated with various surface tectonic processes(1,6). But the paucity of geological evidence regarding the primary composition of magma from Mount Etna means that its source characteristics remain controversial. Here we characterize the trace-element composition of a series of lavas emitted by Mount Etna over the past 500 kyr and preserved as melt inclusions inside olivine phenocrysts. We show that the compositional change in primary magmas from Mount Etna reflects a progressive transition from a predominantly mantle-plume source to one with a greater contribution from island-arc (subduction-related) basalts. We suggest that this is associated with southward migration of the Ionian slab, which is becoming juxtaposed with a mantle plume beneath Sicily. This implies that the volcanism of Mount Etna has become more calc-alkaline, and hence more explosive, during its evolution.	Univ Clermont Ferrand, CNRS, Lab Magmas & Volcans, UMR 6524,OPGC, F-63038 Clermont Ferrand, France; CEA, CNRS, UMR 9956, Ctr Etud Nucl Saclay,Lab Pierre Sue, F-91191 Gif Sur Yvette, France; CNR, Ctr Studio Cristallochim & Cristallog, I-27100 Pavia, Italy; Univ Catania, Dipartimento Sci Geol, I-95129 Catania, Italy	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); Universite Clermont Auvergne (UCA); Universite Jean Monnet; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Consiglio Nazionale delle Ricerche (CNR); University of Catania	Schiano, P (corresponding author), Univ Clermont Ferrand, CNRS, Lab Magmas & Volcans, UMR 6524,OPGC, 5 Rue Kessler, F-63038 Clermont Ferrand, France.							ALBAREDE F, 2000, EOS, V81, P1271; ALLEGRE CJ, 1995, EARTH PLANET SC LETT, V129, P1, DOI 10.1016/0012-821X(94)00235-Q; ANDERSON H, 1987, GEOPHYS J INT, V91, P613, DOI 10.1111/j.1365-246X.1987.tb01661.x; BARBERI F, 1973, J GEOPHYS RES, V78, P5221, DOI 10.1029/JB078i023p05221; Bianchini G, 1998, EUR J MINERAL, V10, P301; BOTTAZZI P, 1994, SECONDARY ION MASS S, V9, P927; BUSA T, 1999, PERIOD MINERAL, V68, P163; Coltelli M, 1998, GEOLOGY, V26, P1095, DOI 10.1130/0091-7613(1998)026<1095:DOAPBE>2.3.CO;2; CONDOMINES M, 1995, EARTH PLANET SC LETT, V132, P25, DOI 10.1016/0012-821X(95)00052-E; FEIGENSON MD, 1983, CONTRIB MINERAL PETR, V84, P390, DOI 10.1007/BF01160290; FERRARI L, 1993, ACTA VULCANOL, V3, P1; Gillot P.Y., 1994, ACTA VULCANOL, V5, P81; Gioncada A, 1998, B VOLCANOL, V60, P286, DOI 10.1007/s004450050233; Gvirtzman Z, 1999, NATURE, V401, P782, DOI 10.1038/44555; HOFMANN AW, 1988, EARTH PLANET SC LETT, V90, P297, DOI 10.1016/0012-821X(88)90132-X; Hofmann AW, 1997, NATURE, V385, P219, DOI 10.1038/385219a0; KELLER J, 1974, CONTRIB MINERAL PETR, V45, P29; La Delfa S, 2001, J VOLCANOL GEOTH RES, V105, P121; Lanzafame G., 1997, ACTA VULCANOLOGICA, P113; Metrich N, 1996, GEOCHIM COSMOCHIM AC, V60, P4151, DOI 10.1016/S0016-7037(96)00229-3; MORRIS JD, 1983, GEOCHIM COSMOCHIM AC, V47, P2015, DOI 10.1016/0016-7037(83)90217-X; SCHIANO P, 1993, EARTH PLANET SC LETT, V119, P37, DOI 10.1016/0012-821X(93)90005-T; Tanguy JC, 1996, J VOLCANOL GEOTH RES, V71, P259, DOI 10.1016/0377-0273(95)00081-X; Tanguy JC, 1997, J VOLCANOL GEOTH RES, V75, P221, DOI 10.1016/S0377-0273(96)00065-0; TANGUY JC, 1978, CONTRIB MINERAL PETR, V66, P51, DOI 10.1007/BF00376085; Treuil M, 1984, B VOLCANOL, V47, P1125, DOI DOI 10.1007/BF01952368; TRUA T, 1997, THESIS U PISA; Turner S, 1998, GEOLOGY, V26, P1019, DOI 10.1130/0091-7613(1998)026<1019:UGTMMF>2.3.CO;2; WEAVER BL, 1991, EARTH PLANET SC LETT, V104, P381, DOI 10.1016/0012-821X(91)90217-6; Wendt JI, 1997, GEOLOGY, V25, P611, DOI 10.1130/0091-7613(1997)025<0611:EFACFT>2.3.CO;2	30	123	123	1	40	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2001	412	6850					900	904		10.1038/35091056	http://dx.doi.org/10.1038/35091056			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467EG	11528476				2022-12-28	WOS:000170689000042
J	Kourtzi, Z; Kanwisher, N				Kourtzi, Z; Kanwisher, N			Representation of perceived object shape by the human lateral occipital complex	SCIENCE			English	Article							RECOGNITION; AREAS; SELECTIVITY; ACTIVATION; CONTOURS; SURFACES	The human lateral occipital complex (LOC) has been implicated in object recognition, but it is unknown whether this region represents low-level image features or perceived object shape. We used an event-related functional magnetic resonance imaging adaptation paradigm in which the response to pairs of successively presented stimuli is tower when they are identical than when they are different. Adaptation across a change between the two stimuli in a pair provides evidence for a common neural representation invariant to that change. We found adaptation in the LOC when perceived shape was identical but contours differed, but not when contours were identical but perceived shape differed. These data indicate that the LOC represents not simple image features, but rather higher level shape information.	Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Massachusetts Gen Hosp, Nucl Magnet Resonance Ctr, Charlestown, MA 02128 USA	Max Planck Society; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital	Kourtzi, Z (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.	zoe.kourtzi@tuebingen.mpg.de		Kourtzi, Zoe/0000-0001-9441-7832	NATIONAL EYE INSTITUTE [R01EY013455] Funding Source: NIH RePORTER; NEI NIH HHS [EY13455] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bakin JS, 2000, J NEUROSCI, V20, P8188; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; Das A, 1999, NATURE, V399, P655, DOI 10.1038/21371; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 1998, NEURON, V21, P191, DOI 10.1016/S0896-6273(00)80526-7; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; HE ZJ, 1992, NATURE, V359, P231, DOI 10.1038/359231a0; Kanwisher N, 1996, COGNITIVE BRAIN RES, V5, P55, DOI 10.1016/S0926-6410(96)00041-9; KELLMAN PJ, 1983, COGNITIVE PSYCHOL, V15, P483, DOI 10.1016/0010-0285(83)90017-8; Kourtzi Z, 2000, J NEUROSCI, V20, P3310, DOI 10.1523/JNEUROSCI.20-09-03310.2000; KOURTZI Z, UNPUB; KOVACS G, 1995, J NEUROSCI, V15, P1984, DOI 10.1523/JNEUROSCI.15-03-01984.1995; Lisberger SG, 1999, J NEUROSCI, V19, P2224; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Marr D., 1982, VISION; Mattingley JB, 1997, SCIENCE, V275, P671, DOI 10.1126/science.275.5300.671; Mendola JD, 1999, J NEUROSCI, V19, P8560; MILLER EK, 1991, SCIENCE, V254, P1377, DOI 10.1126/science.1962197; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; NAKAYAMA K, 1989, PERCEPTION, V18, P55, DOI 10.1068/p180055; Nakayama K, 1995, VISUAL COGNITION INV, P1; Rosen BR, 1998, P NATL ACAD SCI USA, V95, P773, DOI 10.1073/pnas.95.3.773; SARY G, 1993, SCIENCE, V260, P995, DOI 10.1126/science.8493538; Sugita Y, 1999, NATURE, V401, P269, DOI 10.1038/45785; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Ullman S, 1998, COGNITION, V67, P21, DOI 10.1016/S0010-0277(98)00013-4; VONDERHEYDT R, 1984, SCIENCE, V224, P1260, DOI 10.1126/science.6539501; Zhou H, 2000, J NEUROSCI, V20, P6594, DOI 10.1523/JNEUROSCI.20-17-06594.2000	30	640	646	1	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2001	293	5534					1506	1509		10.1126/science.1061133	http://dx.doi.org/10.1126/science.1061133			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465XV	11520991				2022-12-28	WOS:000170616000049
J	Wand, AJ				Wand, AJ			On the dynamic origins of allosteric activation	SCIENCE			English	Editorial Material							CALMODULIN; NMR		Univ Penn, Johnson Res Fdn, Philadelphia, PA 19104 USA; Univ Penn, Dept Biochem Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Wand, AJ (corresponding author), Univ Penn, Johnson Res Fdn, Philadelphia, PA 19104 USA.	wand@mail.med.upenn.edu						AKKE M, 1993, J AM CHEM SOC, V115, P9832, DOI 10.1021/ja00074a073; COOPER A, 1984, EUR BIOPHYS J BIOPHY, V11, P103, DOI 10.1007/BF00276625; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Lee AL, 2000, NAT STRUCT BIOL, V7, P72; Li ZG, 1996, PROTEIN SCI, V5, P2647, DOI 10.1002/pro.5560051228; Malmendal A, 1999, J MOL BIOL, V293, P883, DOI 10.1006/jmbi.1999.3188; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Palmer AG, 1997, CURR OPIN STRUC BIOL, V7, P732, DOI 10.1016/S0959-440X(97)80085-1; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; Yang P, 1996, EUR J MINERAL, V8, P263	10	17	17	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2001	293	5534												1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465XV	11520951				2022-12-28	WOS:000170616000001
J	Elwin, G; Edwards, A; Eccles, M; Rovner, D				Elwin, G; Edwards, A; Eccles, M; Rovner, D			Decision analysis in patient care	LANCET			English	Review							PATIENTS PREFERENCES; ATRIAL-FIBRILLATION; SATISFACTION; ENCOUNTER; MEDICINE	To help patients to fully participate In shared decision making Is becoming an important goal in clinical practice and one which is receiving Increasing attention In terms of the requisite skills and technological development. We discuss the potential application of decision analysis-a specific technology that has been Introduced Into clinical practice but to date only within research contexts-and examine the usefulness and feasibility of the technique for patients, particularly In settings where clinical presentations are diverse and characterised by uncertainty.	Univ Wales Coll Med, Dept Gen Practice, Canolfan Iechyd Llanedeyrn Hlth Ctr, Cardiff CF23 9PN, S Glam, Wales; Univ Newcastle Upon Tyne, Ctr Hlth Serv Res, Newcastle Upon Tyne NE2 4AA, Tyne & Wear, England; Michigan State Univ, E Lansing, MI 48824 USA	Cardiff University; Newcastle University - UK; Michigan State University	Elwin, G (corresponding author), Univ Wales Coll Med, Dept Gen Practice, Canolfan Iechyd Llanedeyrn Hlth Ctr, Cardiff CF23 9PN, S Glam, Wales.		Elwyn, Glyn/B-4798-2009; Eccles, Martin P/AAD-4029-2020	Elwyn, Glyn/0000-0002-0917-6286; 				Charles C, 1997, SOC SCI MED, V44, P681, DOI 10.1016/S0277-9536(96)00221-3; Dowie J, 1996, J Health Serv Res Policy, V1, P104; Edwards A, 1998, FAM PRACT, V15, P296, DOI 10.1093/fampra/15.4.296; Edwards A, 2001, J HEALTH COMMUN, V6, P61, DOI 10.1080/10810730150501413; Edwards A, 1999, MED DECIS MAKING, V19, P428, DOI 10.1177/0272989X9901900411; Elwyn G, 2000, BRIT J GEN PRACT, V50, P892; Gafni A, 1998, SOC SCI MED, V47, P347, DOI 10.1016/S0277-9536(98)00091-4; GIGERENZA G, 1999, SIMPLE HEURISTICS MA; Guadagnoli E, 1998, SOC SCI MED, V47, P329, DOI 10.1016/S0277-9536(98)00059-8; Haynes RB, 1996, EVIDENCE BASED MED, V1, P196; Helfand M, 1997, MED DECIS MAKING, V17, P237; Holmes-Rovner M, 2001, BMJ-BRIT MED J, V322, P664, DOI 10.1136/bmj.322.7287.664; Howie JGR, 1998, FAM PRACT, V15, P165, DOI 10.1093/fampra/15.2.165; JUNGERMANN H, 1992, APPL PSYCHOL-INT REV, V41, P185, DOI 10.1111/j.1464-0597.1992.tb00697.x; KASSIRER JP, 1994, NEW ENGL J MED, V330, P1895, DOI 10.1056/NEJM199406303302611; LENERT LA, 1997, STANFORD CTR STUDY P; MULLEY AG, 1989, MED CARE, V27, pS269, DOI 10.1097/00005650-198903001-00021; Naylor C D, 1998, J Health Serv Res Policy, V3, P129; OCONNOR AM, 1995, MED DECIS MAKING, V15, P25, DOI 10.1177/0272989X9501500105; Protheroe J, 2000, BRIT MED J, V320, P1380, DOI 10.1136/bmj.320.7246.1380; REDELMEIER DA, 1995, MED DECIS MAKING, V15, P227, DOI 10.1177/0272989X9501500305; Robinson A, 2000, QUAL HEALTH CARE, V9, P238, DOI 10.1136/qhc.9.4.238; SCHWARTZ WB, 1979, NEW ENGL J MED, V300, P275; Tavakoli M, 1999, HOSP MED, V60, P444, DOI 10.12968/hosp.1999.60.6.1139; Thomson R, 2000, LANCET, V355, P956, DOI 10.1016/S0140-6736(00)90012-6; THORNTON JG, 1992, BRIT MED J, V304, P1099, DOI 10.1136/bmj.304.6834.1099; TORRANCE GW, 1986, J HEALTH ECON, V5, P1, DOI 10.1016/0167-6296(86)90020-2; Ubel PA, 1997, SOC SCI MED, V44, P647, DOI 10.1016/S0277-9536(96)00217-1; von Neumann J., 1947, THEORY GAMES EC BEHA, V2nd ed; Weinstein MC, 1980, CLIN DECISION ANAL; WILSON TD, 1993, PERS SOC PSYCHOL B, V19, P331, DOI 10.1177/0146167293193010	32	91	91	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 18	2001	358	9281					571	574		10.1016/S0140-6736(01)05709-9	http://dx.doi.org/10.1016/S0140-6736(01)05709-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	464NB	11520546				2022-12-28	WOS:000170537700033
J	Campbell, EG; Weissman, JS; Moy, E; Blumenthal, D				Campbell, EG; Weissman, JS; Moy, E; Blumenthal, D			Status of clinical research in academic health centers - Views from the research leadership	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Context The changing state of the health care system in the United States may be adversely affecting clinical research conducted in academic health centers (AHCs). Few formal data have been gathered about the nature and extent of the problems facing clinical research or the effects of remedies undertaken by AHCs. Objectives To assess the perceived quality and health of the clinical research enterprise and to determine challenges and adaptations to current environmental pressures. Design, Setting, and Participants Mailed survey conducted between December 1998 and March 1999 of a subsample of department chairs and senior research administrators (SRAs) in all US medical schools. Of the 712 potential respondents, 478 completed a questionnaire, yielding an overall response rate of 67.1% (64.8% for SRAs and 67.8% for department chairs). Main Outcome Measures Ratings of overall health/robustness of clinical research, quality of research in 5 domains, extent of challenges to performing research, and sense of urgency in responding to research challenges; formal strategies for research-related tasks and their effects. Results Slightly more than half (52%) of all respondents rated the health of the clinical research enterprise as good or excellent compared with 63% for nonclinical research (P<.001). Respondents were most likely to rate nonclinical research as high in quality (79%) compared with 70% for phase 3 clinical trials, 67% for translational research, 65% for phase 1 and 2 trials, and 57% for health services research (for all comparisons with nonclinical research, P<.001). Pressure on clinical faculty to see patients was perceived as a moderate-to-large problem for clinical research by the largest percentage of respondents (93%), followed by insufficient clinical revenues (89%), recruiting trained researchers (75%), lack of external support for clinical research (72%), competition from contract research organizations (48%), problems introduced by the institutional review board process (38%), and finding research participants (37%). In total, 81% of respondents considered the challenges facing clinical research in AHCs to be urgent or extremely urgent. Conclusions Academic leaders perceive clinical research activities in AHCs to be less healthy, of poorer quality, and facing greater challenges than nonclinical research activities. Many AHCs do not have policies or mechanisms to address challenges facing the clinical research mission. Even among those with such policies, more than half do not believe these policies have had large positive effects. Our findings support the view that the clinical research workforce and infrastructure may need to be expanded and strengthened to keep pace with advances in basic research.	Massachusetts Gen Hosp, Inst Hlth Policy, Dept Med, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; Assoc Amer Med Coll, Washington, DC USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Association of American Medical Colleges	Campbell, EG (corresponding author), Massachusetts Gen Hosp, Inst Hlth Policy, Dept Med, 50 Staniford St,9th Floor, Boston, MA 02114 USA.							ARHENS EH, 1994, CRISIS CLIN RES OVER; *ASS AM MED COLL, 2001, BREAK SCI BOTTL CLIN; BLUMENTHAL D, 2000, MANAGING ACAD HLTH C; Campbell EG, 1997, JAMA-J AM MED ASSOC, V278, P222, DOI 10.1001/jama.278.3.222; *COMM FUND TASK FO, 1999, BENCH BEDS PRES RES; *DEC RES INC, 1999, INT COMP EDG 9 2 HMO; Institute of Medicine, 2001, CROSSING QUALITY CHA; Institute of Medicine, 1994, CAR CLIN RES OBST OP; Meyer GS, 1996, JAMA-J AM MED ASSOC, V276, P672, DOI 10.1001/jama.276.9.672; Moy E, 1997, JAMA-J AM MED ASSOC, V278, P217, DOI 10.1001/jama.278.3.217; *NIH, 2001, 1999 RANK; *NIH, 1997, DIR PAN CLIN RES REP; Weissman JS, 1999, JAMA-J AM MED ASSOC, V281, P1093, DOI 10.1001/jama.281.12.1093	13	68	72	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2001	286	7					800	806		10.1001/jama.286.7.800	http://dx.doi.org/10.1001/jama.286.7.800			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	462PU	11497533	Bronze			2022-12-28	WOS:000170429600027
J	Jenuwein, T; Allis, CD				Jenuwein, T; Allis, CD			Translating the histone code	SCIENCE			English	Review							POSITION-EFFECT VARIEGATION; H3 PHOSPHORYLATION; EPIGENETIC STATES; CHROMATIN DOMAINS; DNA METHYLATION; GENE-EXPRESSION; TRITHORAX-GROUP; FISSION YEAST; LYSINE 9; IN-VIVO	Chromatin, the physiological template of all eukaryotic genetic information, is subject to a diverse array of posttranslational modifications that largely impinge on histone amino termini, thereby regulating access to the underlying DNA. Distinct histone amino-terminal modifications can generate synergistic or antagonistic interaction affinities for chromatin-associated proteins, which in turn dictate dynamic transitions between transcriptionally active or transcriptionally silent chromatin states. The combinatorial nature of histone amino-terminal modifications thus reveals a "histone code" that considerably extends the information potential of the genetic code. We propose that this epigenetic marking system represents a fundamental regulatory mechanism that has an impact on most, if not all, chromatin-templated processes, with far-reaching consequences for cell fate decisions and both normal and pathological development.	Vienna Bioctr, Res Inst Mol Pathol, A-1030 Vienna, Austria; Univ Virginia, Hlth Sci Ctr, Dept Biochem & Mol Biol, Charlottesville, VA 22908 USA	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Virginia	Jenuwein, T (corresponding author), Vienna Bioctr, Res Inst Mol Pathol, Dr Bohrgasse 7, A-1030 Vienna, Austria.	jenuwein@nt.imp.univie.ac.at; allis@virginia.edu			NIGMS NIH HHS [GM53512] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053512, R37GM053512] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahringer J, 2000, TRENDS GENET, V16, P351, DOI 10.1016/S0168-9525(00)02066-7; Akhtar A, 2000, NATURE, V407, P405, DOI 10.1038/35030169; Allard S, 1999, EMBO J, V18, P5108, DOI 10.1093/emboj/18.18.5108; ALLIS CD, 1980, CELL, V20, P55; ALLSHIRE RC, 1994, CELL, V76, P157, DOI 10.1016/0092-8674(94)90180-5; Baarends WM, 1999, DEV BIOL, V207, P322, DOI 10.1006/dbio.1998.9155; BALHORN R, 1984, EXP CELL RES, V150, P298, DOI 10.1016/0014-4827(84)90572-X; Baltimore D, 2001, NATURE, V409, P814, DOI 10.1038/35057267; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Brasher SV, 2000, EMBO J, V19, P1587, DOI 10.1093/emboj/19.7.1587; BROWN SW, 1966, SCIENCE, V151, P417, DOI 10.1126/science.151.3709.417; Cavalli G, 1999, SCIENCE, V286, P955, DOI 10.1126/science.286.5441.955; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Clarke AS, 1999, MOL CELL BIOL, V19, P2515; Clayton AL, 2000, EMBO J, V19, P3714, DOI 10.1093/emboj/19.14.3714; Cowieson NP, 2000, CURR BIOL, V10, P517, DOI 10.1016/S0960-9822(00)00467-X; DeRubertis F, 1996, NATURE, V384, P589; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; DISTECHE CM, 1995, TRENDS GENET, V11, P17, DOI 10.1016/S0168-9525(00)88981-7; Dou YL, 2000, MOL CELL, V6, P225, DOI 10.1016/S1097-2765(00)00024-1; Eisen A, 2001, J BIOL CHEM, V276, P3484, DOI 10.1074/jbc.M008159200; Eissenberg JC, 2000, CURR OPIN GENET DEV, V10, P204, DOI 10.1016/S0959-437X(00)00058-7; EISSENBERG JC, 1990, P NATL ACAD SCI USA, V87, P9923, DOI 10.1073/pnas.87.24.9923; El-Osta A, 2000, GENE EXPRESSION, V9, P63; Gregory RI, 2001, MOL CELL BIOL, V21, P5426, DOI 10.1128/MCB.21.16.5426-5436.2001; Grewal SIS, 1996, CELL, V86, P95, DOI 10.1016/S0092-8674(00)80080-X; Henchoz S, 1996, MOL CELL BIOL, V16, P5717; Holdeman R, 1998, DEVELOPMENT, V125, P2457; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Ivanova AV, 1998, NAT GENET, V19, P192, DOI 10.1038/566; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Jedrusik MA, 2001, DEVELOPMENT, V128, P1069; Jenuwein T, 1998, CELL MOL LIFE SCI, V54, P80, DOI 10.1007/s000180050127; Jenuwein T, 2001, TRENDS CELL BIOL, V11, P266, DOI 10.1016/S0962-8924(01)02001-3; JEPPESEN P, 1993, CELL, V74, P281, DOI 10.1016/0092-8674(93)90419-Q; Johnson CA, 1999, SEMIN CELL DEV BIOL, V10, P179, DOI 10.1006/scdb.1999.0299; Jones DO, 2000, BIOESSAYS, V22, P124, DOI 10.1002/(SICI)1521-1878(200002)22:2&lt;124::AID-BIES4&gt;3.0.CO;2-E; Kal AJ, 2000, GENE DEV, V14, P1058; Klar AJS, 1998, TRENDS GENET, V14, P299, DOI 10.1016/S0168-9525(98)01535-2; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; LIN RL, 1991, GENE DEV, V5, P1601, DOI 10.1101/gad.5.9.1601; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Lo WS, 2000, MOL CELL, V5, P917, DOI 10.1016/S1097-2765(00)80257-9; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Melcher M, 2000, MOL CELL BIOL, V20, P3728, DOI 10.1128/MCB.20.10.3728-3741.2000; Moazed D, 1996, CELL, V86, P667, DOI 10.1016/S0092-8674(00)80139-7; MULLER H. J., 1932, Proceedings. 6th Int. Congr. Genet., V1, P213; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Owen DJ, 2000, EMBO J, V19, P6141, DOI 10.1093/emboj/19.22.6141; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; PARO R, 1991, P NATL ACAD SCI USA, V88, P263, DOI 10.1073/pnas.88.1.263; PARO R, 1995, TRENDS GENET, V11, P295, DOI 10.1016/S0168-9525(00)89081-2; Paro R., 1996, EPIGENETIC MECH GENE, P507; PETERS AHF, UNPUB; Pham AD, 2000, SCIENCE, V289, P2357, DOI 10.1126/science.289.5488.2357; PILLUS L, 1995, CHROMATIN STRUCTURE, P123; PLATERO JS, 1995, EMBO J, V14, P3977, DOI 10.1002/j.1460-2075.1995.tb00069.x; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; REUTER G, 1992, BIOESSAYS, V14, P605, DOI 10.1002/bies.950140907; REUTER G, COMMUNICATION; Rice JC, 2001, CURR OPIN CELL BIOL, V13, P263, DOI 10.1016/S0955-0674(00)00208-8; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Roth DB, 2000, CELL, V103, P699, DOI 10.1016/S0092-8674(00)00173-2; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Rozenblatt-Rosen O, 1998, P NATL ACAD SCI USA, V95, P4152, DOI 10.1073/pnas.95.8.4152; Singh J, 1998, MOL CELL BIOL, V18, P5511, DOI 10.1128/MCB.18.9.5511; Smith ER, 1998, P NATL ACAD SCI USA, V95, P3561, DOI 10.1073/pnas.95.7.3561; Stallcup MR, 2001, ONCOGENE, V20, P3014, DOI 10.1038/sj.onc.1204325; Stankunas K, 1998, DEVELOPMENT, V125, P4055; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 2001, CURR BIOL, V11, P996, DOI 10.1016/S0960-9822(01)00294-9; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; THON G, 1992, GENETICS, V131, P287; TSCHIERSCH B, 1994, EMBO J, V13, P3822, DOI 10.1002/j.1460-2075.1994.tb06693.x; Tsukiyama T, 1997, CURR OPIN GENET DEV, V7, P182, DOI 10.1016/S0959-437X(97)80127-X; TURNER BM, 1992, CELL, V69, P375, DOI 10.1016/0092-8674(92)90417-B; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; van der Vlag J, 1999, NAT GENET, V23, P474, DOI 10.1038/70602; van Holde KE., 1989, SPRINGER SERIES MOL; van Lohuizen M, 1999, CURR OPIN GENET DEV, V9, P355, DOI 10.1016/S0959-437X(99)80053-7; Wallrath L, 1998, CURR OPIN GENET DEV, V8, P147, DOI 10.1016/S0959-437X(98)80135-4; Wang GZ, 2000, MOL CELL BIOL, V20, P6970, DOI 10.1128/MCB.20.18.6970-6983.2000; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; Winston F, 1999, NAT STRUCT BIOL, V6, P601, DOI 10.1038/10640; Wolffe AP, 2000, J STRUCT BIOL, V129, P102, DOI 10.1006/jsbi.2000.4217; Wolffe AP, 1996, TRENDS GENET, V12, P58, DOI 10.1016/0168-9525(96)81401-6; Zeitlin SG, 2001, J CELL SCI, V114, P653	93	7104	7401	32	1152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2001	293	5532					1074	1080		10.1126/science.1063127	http://dx.doi.org/10.1126/science.1063127			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498575	Green Submitted			2022-12-28	WOS:000170432600043
J	Keeling, RF; Visbeck, M				Keeling, RF; Visbeck, M			Palaeoceanography - Antarctic stratification and glacial CO2	NATURE			English	Article							CIRCULATION MODELS; OCEAN CIRCULATION; ATMOSPHERIC CO2; WATER; ICE		Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Lamont Doherty Earth Observ, Palisades, NY 10964 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; Columbia University	Keeling, RF (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.		Visbeck, Martin/G-2461-2011; Visbeck, Martin H/B-6541-2016	Visbeck, Martin/0000-0002-0844-834X; Visbeck, Martin H/0000-0002-0844-834X				Francois R, 1997, NATURE, V389, P929, DOI 10.1038/40073; Ganachaud A, 2000, NATURE, V408, P453, DOI 10.1038/35044048; Gnanadesikan A, 1999, SCIENCE, V283, P2077, DOI 10.1126/science.283.5410.2077; Gnanadesikan A, 1999, GEOPHYS RES LETT, V26, P1865, DOI 10.1029/1999GL900379; Keeling RF, 2001, PALEOCEANOGRAPHY, V16, P330, DOI 10.1029/2001PA000648; MORTLOCK RA, 1991, NATURE, V351, P220, DOI 10.1038/351220a0; PETIT JR, 1981, NATURE, V293, P391, DOI 10.1038/293391a0; Sigman DM, 2000, NATURE, V407, P859, DOI 10.1038/35038000; Stephens BB, 2000, NATURE, V404, P171, DOI 10.1038/35004556; Toggweiler J., 1993, GLOBAL CARBON CYCLE, P303; Toggweiler JR, 1999, PALEOCEANOGRAPHY, V14, P571, DOI 10.1029/1999PA900033; TRENBERTH KE, 1990, J PHYS OCEANOGR, V20, P1742, DOI 10.1175/1520-0485(1990)020<1742:TMACIG>2.0.CO;2; Visbeck M, 1997, J PHYS OCEANOGR, V27, P381, DOI 10.1175/1520-0485(1997)027<0381:SOETCI>2.0.CO;2	13	22	23	0	9	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2001	412	6847					605	606		10.1038/35088129	http://dx.doi.org/10.1038/35088129			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460PP	11493910				2022-12-28	WOS:000170318000030
J	Bruce, MG; Rosenstein, NE; Capparella, JM; Shutt, KA; Perkins, BA; Collins, M				Bruce, MG; Rosenstein, NE; Capparella, JM; Shutt, KA; Perkins, BA; Collins, M			Risk factors for meningococcal disease in college students	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CAMPUS BAR PATRONAGE; UNITED-STATES; BACTERIAL-MENINGITIS; INFECTIONS; OUTBREAK; EPIDEMIOLOGY; ASSOCIATION; MYCOPLASMA; CHILDREN; VACCINE	Context Elevated rates of meningococcal disease were noted among 18- to 22-year-olds in the mid-1990's. However, national data on rates of meningococcal disease in US college students were not collected until 1998. Objectives To determine rates of meningococcal disease in US college students and to identify risk factors for meningococcal disease in this population. Design, Setting, and Patients Prospective surveillance study with nested case-control study of US college students with meningococcal infection from September 1, 1998, to August 31, 1999. Fifty state health departments and 231 college health centers participated. Main Outcome Measures incidence of and risk factors for meningococcal disease in US college students. Results Ninety-six cases of meningococcal disease were identified. The incidence rate for undergraduates was 0.7 per 100000 persons vs 1.4 per 100000 for the general population of 18- to 23-year-old nonstudents (P<.001). Freshmen living in dormitories had the highest incidence rate at 5.1 per 100000. Of the 79 case-patients for whom information was available, 54 (68%) had illness due to vaccine-preventable meningococcal serogroups. On multivariable analysis of case-control study data, freshmen who lived in dormitories had an elevated risk of meningococcal disease (matched odds ratio, 3.6; 95% confidence interval, 1.6-8.5; P=.003) compared with other college students. Conclusions Freshmen who live in dormitories have an independent, elevated risk of meningococcal disease compared with other college students. Use of the currently vat available quadrivalent polysaccharide vaccine among college students could substantially decrease their risk of meningococcal disease.	CDCP, Meningitis & Special Pathogens Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Amer Coll Hlth Assoc, Baltimore, MD USA; Univ Penn, Student Hlth Serv, Philadelphia, PA 19104 USA	Centers for Disease Control & Prevention - USA; University of Pennsylvania	Rosenstein, NE (corresponding author), CDCP, Meningitis & Special Pathogens Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, 1600 Clifton Rd NE,Mailstop C-09, Atlanta, GA 30333 USA.			Shutt, Kathleen/0000-0003-3376-6152				Abramson JS, 2000, PEDIATRICS, V106, P1500, DOI 10.1542/peds.106.6.1500; ADAMS WG, 1993, JAMA-J AM MED ASSOC, V269, P221, DOI 10.1001/jama.269.2.221; *ADV COMM IMM PRAC, 2000, MMWR-MORBID MORTAL W, V49, P13; *AM COLL HLTH ASS, 2001, REC MEN MEN VACC; AYCOCK WL, 1950, BACTERIOL REV, V14, P115, DOI 10.1128/MMBR.14.2.115-160.1950; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; BRUNDAGE JF, 1987, EVOLUTION MENINGOCOC, P5; CARTWRIGHT KAV, 1991, LANCET, V338, P554, DOI 10.1016/0140-6736(91)91112-8; Cookson ST, 1998, J INFECT DIS, V178, P266, DOI 10.1086/517450; Douglas KA, 1997, J AM COLL HEALTH, V46, P55, DOI 10.1080/07448489709595589; Fischer M, 1997, PEDIATR INFECT DIS J, V16, P979, DOI 10.1097/00006454-199710000-00015; FRANCKE EL, 1981, SURG CLIN N AM, V61, P135; Froeschle JE, 1999, CLIN INFECT DIS, V29, P215, DOI 10.1086/520166; Hall CB, 1996, PEDIATRICS, V97, P404; HANEBERG B, 1983, NIPH (National Institute of Public Health) Annals (Oslo), V6, P169; Harrison LH, 1999, JAMA-J AM MED ASSOC, V281, P1906, DOI 10.1001/jama.281.20.1906; Imrey PB, 1996, AM J EPIDEMIOL, V143, P624, DOI 10.1093/oxfordjournals.aje.a008792; IMREY PB, 1995, J CLIN MICROBIOL, V33, P3133, DOI 10.1128/JCM.33.12.3133-3137.1995; JACKSON LA, 1995, JAMA-J AM MED ASSOC, V273, P383, DOI 10.1001/jama.273.5.383; Jackson Lisa A., 1993, Morbidity and Mortality Weekly Report, V42, P21; KRASINSKI K, 1987, AM J EPIDEMIOL, V125, P499, DOI 10.1093/oxfordjournals.aje.a114556; MARTONE WJ, 1999, CHANGING EPIDEMIOLOG, P1; Moodley JR, 1999, S AFR MED J, V89, P56; MOORE PS, 1990, JAMA-J AM MED ASSOC, V264, P1271, DOI 10.1001/jama.264.10.1271; Neal KR, 1999, EPIDEMIOL INFECT, V122, P351, DOI 10.1017/S0950268899002368; Nelson JD, 1996, NEW ENGL J MED, V335, P885, DOI 10.1056/NEJM199609193351210; Rosenstein NE, 1999, J INFECT DIS, V180, P1894, DOI 10.1086/315158; ROSS SC, 1984, MEDICINE, V63, P243, DOI 10.1097/00005792-198409000-00001; SAX LJ, 1998, AM FRESHMAN NATL NOR; Schuchat A, 1997, NEW ENGL J MED, V337, P970, DOI 10.1056/NEJM199710023371404; STANWELLSMITH RE, 1994, EPIDEMIOL INFECT, V112, P315, DOI 10.1017/S0950268800057733; STUART JM, 1988, COMMUNITY MED, V10, P139; Tappero JW, 1996, NEW ENGL J MED, V335, P833, DOI 10.1056/NEJM199609193351201; *UD DEP ED, 1999, NCES PUBL; *US CENS BUR, 1999, US CENS DAT 1998; WOODS CW, 1998, INF DIS SOC AM NOV 1; YOUNG LS, 1972, NEW ENGL J MED, V287, P5, DOI 10.1056/NEJM197207062870102; Yusuf HR, 1999, AM J PUBLIC HEALTH, V89, P712, DOI 10.2105/AJPH.89.5.712; 1997, MMWR MORB MORTAL WKL, V46, P13; 1999, COMMUN DIS REP, V9, P261	40	111	114	0	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2001	286	6					688	693		10.1001/jama.286.6.688	http://dx.doi.org/10.1001/jama.286.6.688			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459VE	11495618				2022-12-28	WOS:000170271500024
J	Gahan, LJ; Gould, F; Heckel, DG				Gahan, LJ; Gould, F; Heckel, DG			Identification of a gene associated with bit resistance in Heliothis virescens	SCIENCE			English	Article							BACILLUS-THURINGIENSIS TOXINS; CADHERIN SUPERFAMILY; QUANTITATIVE TRAITS; MENDELIAN FACTORS; RECEPTOR; MEMBERS; LEPIDOPTERA; NOCTUIDAE; ENDOTOXIN; CLONING	Transgenic crops producing insecticidal toxins from Bacillus thuringiensis (Bt) are widely used for pest control. Bt-resistant insect strains have been studied, but the molecular basis of resistance has remained elusive. Here, we show that disruption of a cadherin-superfamily gene by retrotransposon-mediated insertion was linked to high levels of resistance to the Et toxin Cry1Ac in the cotton pest Heliothis virescens. Monitoring the early phases of Bt resistance evolution in the field has been viewed as crucial but extremely difficult, especially when resistance is recessive. Our findings enable efficient DNA-based screening for resistant heterozygotes by directly detecting the recessive allele.	Univ Melbourne, Dept Genet, Ctr Environm Stress & Adaptat Res, Parkville, Vic 3052, Australia; N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA	University of Melbourne; University of North Carolina; North Carolina State University; Clemson University	Heckel, DG (corresponding author), Univ Melbourne, Dept Genet, Ctr Environm Stress & Adaptat Res, Parkville, Vic 3052, Australia.		Heckel, David G/K-2138-2013	Heckel, David G/0000-0001-8991-2150				Arkhipova IR, 1995, DROSOPHILA RETROTRAN; FERRE J, 1991, P NATL ACAD SCI USA, V88, P5119, DOI 10.1073/pnas.88.12.5119; *GENB, AF367363 GENB; *GENB, AF367362 GENB; GILL SS, 1995, J BIOL CHEM, V270, P27277, DOI 10.1074/jbc.270.45.27277; Gould F, 1997, P NATL ACAD SCI USA, V94, P3519, DOI 10.1073/pnas.94.8.3519; GOULD F, 1995, J ECON ENTOMOL, V88, P1545, DOI 10.1093/jee/88.6.1545; Heckel DG, 1997, J ECON ENTOMOL, V90, P75, DOI 10.1093/jee/90.1.75; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LANDER ES, 1989, GENETICS, V121, P185; Luo K, 1997, INSECT BIOCHEM MOLEC, V27, P735, DOI 10.1016/S0965-1748(97)00052-0; Marillonnet S, 1998, GENETICS, V150, P1245; Nagamatsu Y, 1999, FEBS LETT, V460, P385, DOI 10.1016/S0014-5793(99)01327-7; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; Suzuki ST, 1996, J CELL BIOCHEM, V61, P531, DOI 10.1002/(SICI)1097-4644(19960616)61:4<531::AID-JCB6>3.0.CO;2-P; Uemura T, 1998, CELL, V93, P1095, DOI 10.1016/S0092-8674(00)81452-X; US EPA, 1998, EPA PUBL; VADLAMUDI RK, 1995, J BIOL CHEM, V270, P5490, DOI 10.1074/jbc.270.10.5490; VANRIE J, 1990, SCIENCE, V247, P72, DOI 10.1126/science.2294593	19	451	530	5	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2001	293	5531					857	860		10.1126/science.1060949	http://dx.doi.org/10.1126/science.1060949			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11486086				2022-12-28	WOS:000170241000043
J	Kozloski, J; Hamzei-Sichani, F; Yuste, R				Kozloski, J; Hamzei-Sichani, F; Yuste, R			Stereotyped position of local synaptic targets in neocortex	SCIENCE			English	Article							RAT VISUAL-CORTEX; CEREBRAL-CORTEX; PROJECTION NEURONS; MORPHOLOGY; MONKEY; CAT; ORGANIZATION; CONNECTIONS; POTENTIALS; LAYER-5	The microcircuitry of the mammalian neocortex remains largely unknown. Although the neocortex could be composed of scores of precise circuits, an alternative possibility is that local connectivity is probabilistic or even random. To examine the precision and degree of determinism in the neocortical microcircuitry, we used optical probing to reconstruct microcircuits in layer 5 from mouse primary visual cortex. We stimulated "trigger" cells, isolated from a homogenous population of corticotectal pyramidal neurons, white optically detecting "follower" neurons directly driven by the triggers. Followers belonged to a few selective anatomical classes with stereotyped physiological and synaptic responses. Moreover, even the position of the followers appeared determined across animals. Our data reveal precisely organized cortical microcircuits.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Kozloski, J (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.							Abeles M., 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; [Anonymous], 1995, INTRO GEOLOGICAL DAT; Braitenberg V, 1998, CORTEX STAT GEOMETRY; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; Cajal S. R., 1904, TEXTURA SISTEMA NERV, V2; CAJAL SRY, 1923, RECUERDOS VIDA HIST; de No RL, 1922, TRAB LAB BIOL U MADR, V20, P41; DOUGLAS RJ, 1998, SYNAPTIC ORG BRAIN, pCH12; Fairen A., 1984, CEREB CORTEX, V1, P201; GILBERT CD, 1983, ANNU REV NEUROSCI, V6, P217, DOI 10.1146/annurev.ne.06.030183.001245; GILBERT CD, 1983, J NEUROSCI, V3, P1116; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; HUBENER M, 1988, NEUROSCI LETT, V94, P76, DOI 10.1016/0304-3940(88)90273-X; KASPER EM, 1994, J COMP NEUROL, V339, P495, DOI 10.1002/cne.903390404; KATZ LC, 1984, NATURE, V310, P498, DOI 10.1038/310498a0; Lorente de No R., 1949, PHYSL NERVOUS SYSTEM, P274; LUND JS, 1988, ANNU REV NEUROSCI, V11, P253, DOI 10.1146/annurev.ne.11.030188.001345; Marcoulides G.A., 1997, MULTIVARIATE STAT ME; Mountcastle V.B., 1998, PERCEPTUAL NEUROSCIE; MOUNTCASTLE VB, 1978, MINDFUL BRAIN, pCH1; Peterlin ZA, 2000, P NATL ACAD SCI USA, V97, P3619, DOI 10.1073/pnas.97.7.3619; Peters A., 1984, CEREB CORTEX; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Rumberger A, 1998, EXP BRAIN RES, V119, P375, DOI 10.1007/s002210050353; SCHOFIELD BR, 1987, J COMP NEUROL, V261, P85, DOI 10.1002/cne.902610107; Smetters D, 1999, METHODS, V18, P215, DOI 10.1006/meth.1999.0774; SOLNICK B, 1984, P NATL ACAD SCI-BIOL, V81, P3898, DOI 10.1073/pnas.81.12.3898; SOMOGYI P, 1982, NEUROSCIENCE, V7, P2577, DOI 10.1016/0306-4522(82)90086-0; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; SZENTAGOTHAI J, 1978, PROC R SOC SER B-BIO, V201, P219, DOI 10.1098/rspb.1978.0043; White E.L., 1989, CORTICAL CIRCUITS SY	32	141	143	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2001	293	5531					868	872		10.1126/science.293.5531.868	http://dx.doi.org/10.1126/science.293.5531.868			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11486089				2022-12-28	WOS:000170241000046
J	Hiroi, T; Zolensky, ME; Pieters, CM				Hiroi, T; Zolensky, ME; Pieters, CM			The Tagish Lake meteorite: A possible sample from a D-type asteroid	SCIENCE			English	Article							MAIN-BELT; BODIES; VESTA	A new type of carbonaceous chondrite, the Tagish Lake meteorite, exhibits a reflectance spectrum similar to spectra observed from the D-type asteroids, which are relatively abundant in the outer solar system beyond the main asteroid belt and have been inferred to be more primitive than any known meteorite. Until the Tagish Lake fait, these asteroids had no analog in the meteorite collections. The Tagish Lake meteorite is a carbon-rich (4 to 5 weight %), aqueously altered carbonaceous chondrite and contains high concentrations of presolar grains and carbonate minerals, which is consistent with the expectation that the D-type asteroids were originally made of primitive materials and did not experience any extensive heating.	Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; NASA, Earth Sci & Solar Syst Explorat Div, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA	Brown University; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER	Hiroi, T (corresponding author), Brown Univ, Dept Geol Sci, Providence, RI 02912 USA.			Zolensky, Michael/0000-0002-3181-1303				Bell J.F., 1989, ASTEROIDS, P921; BELL JF, 1988, LUNAR PLANET SCI, V19, P57; BINZEL RP, 1993, SCIENCE, V260, P186, DOI 10.1126/science.260.5105.186; Brown PG, 2000, SCIENCE, V290, P320, DOI 10.1126/science.290.5490.320; CASSIDY W, 1975, ICARUS, V25, P371, DOI 10.1016/0019-1035(75)90002-0; GAFFEY MJ, 1993, METEORITICS, V28, P161, DOI 10.1111/j.1945-5100.1993.tb00755.x; GOUNELLE M, 2001, LUNAR PLANET SCI, V32; LEBOFSKY LA, 1990, ICARUS, V83, P16, DOI 10.1016/0019-1035(90)90003-R; MCCORD TB, 1970, SCIENCE, V168, P1445, DOI 10.1126/science.168.3938.1445; MILANI A, 1994, ICARUS, V107, P219, DOI 10.1006/icar.1994.1020; NOBILI AM, 1989, ASTEROIDS, V2, P862; Opik E.J., 1951, P R IRISH ACAD A, V54, P165; TEDESCO EF, 1989, ASTEROIDS, V2, P1090; Tholen D., 1984, THESIS U ARIZONA TUS; VILAS F, 1985, ICARUS, V64, P503, DOI 10.1016/0019-1035(85)90071-5; Vokrouhlicky D, 2000, NATURE, V407, P606, DOI 10.1038/35036528; XU S, 1995, ICARUS, V115, P1, DOI 10.1006/icar.1995.1075; Yamada M, 1999, EARTH PLANETS SPACE, V51, P1255, DOI 10.1186/BF03351599; ZELLNER B, 1985, ICARUS, V61, P335	19	172	172	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2001	293	5538					2234	2236		10.1126/science.1063734	http://dx.doi.org/10.1126/science.1063734			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475AL	11520950				2022-12-28	WOS:000171139400037
J	Bar-Nahum, G; Nudler, E				Bar-Nahum, G; Nudler, E			Isolation and characterization of sigma(70)-retaining transcription elongation complexes from Escherichia coli	CELL			English	Article							CORE RNA-POLYMERASE; SIGMA-SUBUNIT; PROMOTER STRENGTH; TERNARY COMPLEXES; PROTEIN; INITIATION; TERMINATION; RELEASE; INVITRO; ENZYME	sigma (70) subunit is thought to be released from the core RNA polymerase (RNAP) upon the transition from initiation to elongation or shortly afterward. Here, we identify a population of RNAP from E. coli that retains sigma (70) throughout elongation. The relative amount of this population appears to depend on cellular growth and reaches its maximum during the stationary phase. The proportion of sigma (70)-retaining elongation complexes (EC-sigma (70)) is invariant with various promoters or distances from the transcription start site. EC-sigma (70) responds to pauses, intrinsic terminators, and the elongation factor NusA similarly to EC without sigma (70). However, EC-sigma (70) has a substantially higher ability to support multiple rounds of transcription at certain promoters, suggesting its profound role in gene expression and regulation in bacteria.	NYU, Med Ctr, Dept Biochem, New York, NY 10016 USA	New York University	Nudler, E (corresponding author), NYU, Med Ctr, Dept Biochem, New York, NY 10016 USA.			Nudler, Evgeny/0000-0002-8811-3071	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058750] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM58750] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRUNNER M, 1987, EMBO J, V6, P3139, DOI 10.1002/j.1460-2075.1987.tb02624.x; BURGESS RR, 1971, ANNU REV BIOCHEM, V40, P711, DOI 10.1146/annurev.bi.40.070171.003431; Ebright RH, 2000, J MOL BIOL, V304, P687, DOI 10.1006/jmbi.2000.4309; GILL SC, 1991, J MOL BIOL, V220, P307, DOI 10.1016/0022-2836(91)90015-X; GNATT AL, 2001, STRUCTURAL BASIS TRA, P3; Gourse RL, 1998, COLD SPRING HARB SYM, V63, P131, DOI 10.1101/sqb.1998.63.131; GREENBLATT J, 1981, CELL, V24, P421, DOI 10.1016/0092-8674(81)90332-9; Gross CA, 1998, COLD SPRING HARB SYM, V63, P141, DOI 10.1101/sqb.1998.63.141; GROSS CA, 1992, TRANSCRIPTIONAL REGU, P129; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; HANSEN UM, 1980, J BIOL CHEM, V255, P9564; HELMANN JD, 1988, ANNU REV BIOCHEM, V57, P839, DOI 10.1146/annurev.bi.57.070188.004203; Hengge-Aronis R, 1999, CURR OPIN MICROBIOL, V2, P148, DOI 10.1016/S1369-5274(99)80026-5; Jishage M, 1998, P NATL ACAD SCI USA, V95, P4953, DOI 10.1073/pnas.95.9.4953; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; KRUMMEL B, 1989, BIOCHEMISTRY-US, V28, P7829, DOI 10.1021/bi00445a045; Kusano S, 1997, GENES CELLS, V2, P433, DOI 10.1046/j.1365-2443.1997.13203301320330.x; LEIRMO S, 1987, BIOCHEMISTRY-US, V26, P2095, DOI 10.1021/bi00382a006; Liu KB, 1996, EMBO J, V15, P150, DOI 10.1002/j.1460-2075.1996.tb00343.x; LIU KB, 1995, P NATL ACAD SCI USA, V92, P5012, DOI 10.1073/pnas.92.11.5012; Maeda H, 2000, NUCLEIC ACIDS RES, V28, P3497, DOI 10.1093/nar/28.18.3497; Mukhopadhyay J, 2001, CELL, V106, P453, DOI 10.1016/S0092-8674(01)00464-0; NUDLER E, 1995, CELL, V81, P351, DOI 10.1016/0092-8674(95)90388-7; Nudler E, 1998, SCIENCE, V281, P424, DOI 10.1126/science.281.5375.424; Nudler E, 1999, J MOL BIOL, V288, P1, DOI 10.1006/jmbi.1999.2641; Nudler E, 1996, SCIENCE, V273, P211, DOI 10.1126/science.273.5272.211; OSUMIDAVIS PA, 1987, BIOCHIM BIOPHYS ACTA, V910, P130, DOI 10.1016/0167-4781(87)90065-0; PAVCO PA, 1990, J BIOL CHEM, V265, P9960; RAO L, 1994, J MOL BIOL, V235, P1421, DOI 10.1006/jmbi.1994.1098; Ring BZ, 1996, CELL, V86, P485, DOI 10.1016/S0092-8674(00)80121-X; SCHMIDT MC, 1984, BIOCHEMISTRY-US, V23, P197, DOI 10.1021/bi00297a004; SHIMAMOTO N, 1986, J BIOL CHEM, V261, P1859; STACKHOUSE TM, 1989, BIOCHEMISTRY-US, V28, P7781, DOI 10.1021/bi00445a038; Wassarman KM, 2000, CELL, V101, P613, DOI 10.1016/S0092-8674(00)80873-9; WU FYH, 1976, BIOCHEMISTRY-US, V15, P3254, DOI 10.1021/bi00660a014	35	96	99	1	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 24	2001	106	4					443	451		10.1016/S0092-8674(01)00461-5	http://dx.doi.org/10.1016/S0092-8674(01)00461-5			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	466UU	11525730	Bronze			2022-12-28	WOS:000170665200008
J	Zhang, Z; Carmichael, GG				Zhang, Z; Carmichael, GG			The fate of dsRNA in the nucleus: A p54(nrb)-containing complex retention of promiscuously mediates the nuclear A-to-I edited RNAs	CELL			English	Article							DOUBLE-STRANDED-RNA; SPLICING FACTOR PSF; CONSTITUTIVE TRANSPORT ELEMENT; DNA-BINDING PROTEIN; UNWINDING ACTIVITY; SCAFFOLD PROTEINS; TOPOISOMERASE-I; ANTISENSE RNA; ADENOSINE; EXPORT	How do cells discriminate between selectively edited mRNAs that encode new protein isoforms, and dsRNA-induced, promiscuously edited RNAs that encode nonfunctional, mutant proteins? We have developed a Xenopus oocyte model system which shows that a variety of hyperedited, inosine-containing RNAs are specifically retained in the nucleus. To uncover the mechanism of inosine-induced retention, HeLa cell nuclear extracts were used to isolate a multiprotein complex that binds specifically and cooperatively to inosine-containing RNAs. This complex contains the inosine-specific RNA binding protein p54(nrb), the splicing factor PSF, and the inner nuclear matrix structural protein matrin 3. We provide evidence that one function of the complex identified here is to anchor hyperedited RNAs to the nuclear matrix, while allowing selectively edited mRNAs to be exported.	Univ Connecticut, Ctr Hlth, Dept Microbiol, Farmington, CT 06030 USA	University of Connecticut	Carmichael, GG (corresponding author), Univ Connecticut, Ctr Hlth, Dept Microbiol, Farmington, CT 06030 USA.	carmichael@nso2.uchc.edu			NATIONAL CANCER INSTITUTE [R01CA045382] Funding Source: NIH RePORTER; NCI NIH HHS [CA32325, R01 CA045382] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akhmedov AT, 2000, NUCLEIC ACIDS RES, V28, P3022, DOI 10.1093/nar/28.16.3022; Ausubel FM, 1988, MOL REPROD DEV; BASS BL, 1988, CELL, V55, P1089, DOI 10.1016/0092-8674(88)90253-X; Bass BL, 2000, CELL, V101, P235, DOI 10.1016/S0092-8674(02)71133-1; BASS BL, 1987, CELL, V48, P607, DOI 10.1016/0092-8674(87)90239-X; Bass BL, 1997, TRENDS BIOCHEM SCI, V22, P157, DOI 10.1016/S0968-0004(97)01035-9; Basu A, 1997, MOL CELL BIOL, V17, P677, DOI 10.1128/MCB.17.2.677; BELGRADER P, 1991, J BIOL CHEM, V266, P9893; BRAUN IC, 2001, J BIOL CHEM, V19, P19; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Caputi M, 1999, EMBO J, V18, P4060, DOI 10.1093/emboj/18.14.4060; Carmichael GG, 2000, BLOOD CELL MOL DIS, V26, P57; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DONG BH, 1993, NUCLEIC ACIDS RES, V21, P4085, DOI 10.1093/nar/21.17.4085; EGEBJERG J, 1994, P NATL ACAD SCI USA, V91, P10270, DOI 10.1073/pnas.91.22.10270; Fischer U, 1999, NUCLEIC ACIDS RES, V27, P4128, DOI 10.1093/nar/27.21.4128; GOZANI O, 1994, EMBO J, V13, P3356, DOI 10.1002/j.1460-2075.1994.tb06638.x; Gruter P, 1998, MOL CELL, V1, P649, DOI 10.1016/S1097-2765(00)80065-9; HAMM J, 1990, CELL, V63, P109, DOI 10.1016/0092-8674(90)90292-M; Herb A, 1996, P NATL ACAD SCI USA, V93, P1875, DOI 10.1073/pnas.93.5.1875; Herold A, 2000, MOL CELL BIOL, V20, P8996, DOI 10.1128/MCB.20.23.8996-9008.2000; HIBINO Y, 1993, BIOCHIM BIOPHYS ACTA, V1174, P162, DOI 10.1016/0167-4781(93)90110-Y; HIBINO Y, 1993, BIOCHEM BIOPH RES CO, V197, P336, DOI 10.1006/bbrc.1993.2480; Hibino Y, 2000, BIOCHEM BIOPH RES CO, V279, P282, DOI 10.1006/bbrc.2000.3938; Hibino Y, 1998, BBA-GENE STRUCT EXPR, V1396, P88, DOI 10.1016/S0167-4781(97)00176-0; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; JONES KR, 1990, NEURON, V4, P711, DOI 10.1016/0896-6273(90)90197-N; Karhumaa P, 2000, J BIOL CHEM, V275, P16044, DOI 10.1074/jbc.275.21.16044; Kumar M, 1997, P NATL ACAD SCI USA, V94, P3542, DOI 10.1073/pnas.94.8.3542; Kumar M, 1998, MICROBIOL MOL BIOL R, V62, P1415, DOI 10.1128/MMBR.62.4.1415-1434.1998; LINDSEY LA, 1995, J BIOL CHEM, V270, P13415, DOI 10.1074/jbc.270.22.13415; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Lutz CS, 1998, RNA, V4, P1493, DOI 10.1017/S1355838298981183; Maquat LE, 2001, CELL, V104, P173, DOI 10.1016/S0092-8674(01)00202-1; Mathur M, 2001, MOL CELL BIOL, V21, P2298, DOI 10.1128/MCB.21.7.2298-2311.2001; Meissner M, 2000, J CELL BIOCHEM, V76, P559, DOI 10.1002/(SICI)1097-4644(20000315)76:4<559::AID-JCB4>3.0.CO;2-U; Miralles F, 2000, J CELL BIOL, V148, P271, DOI 10.1083/jcb.148.2.271; NISHIKURA K, 1992, ANN NY ACAD SCI, V660, P240, DOI 10.1111/j.1749-6632.1992.tb21076.x; Niswender CM, 1998, ANN NY ACAD SCI, V861, P38, DOI 10.1111/j.1749-6632.1998.tb10171.x; Otto H, 2001, EUR J BIOCHEM, V268, P420, DOI 10.1046/j.1432-1033.2001.01901.x; Pasquinelli AE, 1997, EMBO J, V16, P7500, DOI 10.1093/emboj/16.24.7500; PATTON JG, 1993, GENE DEV, V7, P393, DOI 10.1101/gad.7.3.393; POLSON AG, 1994, EMBO J, V13, P5701, DOI 10.1002/j.1460-2075.1994.tb06908.x; POLSON AG, 1991, BIOCHEMISTRY-US, V30, P11507, DOI 10.1021/bi00113a004; Reim I, 1999, CHROMOSOMA, V108, P162, DOI 10.1007/s004120050365; Reim I, 1999, EXP CELL RES, V253, P573, DOI 10.1006/excr.1999.4647; Saavedra C, 1997, CURR BIOL, V7, P619, DOI 10.1016/S0960-9822(06)00288-0; SACCOMANNO L, 1994, MOL CELL BIOL, V14, P5425, DOI 10.1128/MCB.14.8.5425; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Straub T, 1998, J BIOL CHEM, V273, P26261, DOI 10.1074/jbc.273.41.26261; Straub T, 2000, BIOCHEMISTRY-US, V39, P7552, DOI 10.1021/bi992898e; Tiscornia G, 2000, MOL CELL, V5, P959, DOI 10.1016/S1097-2765(00)80261-0; Traish AM, 1997, DIAGN MOL PATHOL, V6, P209, DOI 10.1097/00019606-199708000-00005; Urban RJ, 2000, MOL ENDOCRINOL, V14, P774, DOI 10.1210/me.14.6.774; WAGNER RW, 1989, P NATL ACAD SCI USA, V86, P2647, DOI 10.1073/pnas.86.8.2647; Yang YS, 1997, NUCLEIC ACIDS RES, V25, P2284, DOI 10.1093/nar/25.12.2284; YANG YS, 1993, MOL CELL BIOL, V13, P5593, DOI 10.1128/MCB.13.9.5593; ZHANG WW, 1993, BIOCHEM J, V290, P267, DOI 10.1042/bj2900267; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160	61	373	393	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 24	2001	106	4					465	475		10.1016/S0092-8674(01)00466-4	http://dx.doi.org/10.1016/S0092-8674(01)00466-4			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	466UU	11525732	Bronze			2022-12-28	WOS:000170665200010
J	Mukherjee, D; Nissen, SE; Topol, EJ				Mukherjee, D; Nissen, SE; Topol, EJ			Risk of cardiovascular events associated with selective COX-2 inhibitors	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; GASTROINTESTINAL TOLERABILITY; SYNTHASE CYCLOOXYGENASE; ANTIINFLAMMATORY DRUGS; RHEUMATOID-ARTHRITIS; BLOOD-PRESSURE; ROFECOXIB; CELECOXIB; NAPROXEN; OSTEOARTHRITIS	Atherosclerosis is a process with inflammatory features and selective cyclooxygenase 2 (COX-2) inhibitors may potentially have antiatherogenic effects by virtue of inhibiting inflammation. However, by decreasing vasodilatory and antiaggregatory prostacyclin production, COX-2 antagonists may lead to increased prothrombotic activity. To define the cardiovascular effects of COX-2 inhibitors when used for arthritis and musculoskeletal pain in patients without coronary artery disease, we performed a MEDLINE search to identify all English-language articles on use of COX-2 inhibitors published between 1998 and February 2001. We also reviewed relevant submissions to the US Food and Drug Administration by pharmaceutical companies. Our search yielded 2 major randomized trials, the Vioxx Gastrointestinal Outcomes Research Study (VIGOR; 8076 patients) and the Celecoxib Longterm Arthritis Safety Study (CLASS; 8059 patients), as well as 2 smaller trials with approximately 1000 patients each. The results from VIGOR showed that the relative risk of developing a confirmed adjudicated thrombotic cardiovascular event (myocardial infarction, unstable angina, cardiac thrombus, resuscitated cardiac arrest, sudden or unexplained death, ischemic stroke, and transient ischemic attacks) with rofecoxib treatment compared with naproxen was 2.38 (95% confidence interval 1.39-4.00; P=.002). There was no significant difference in cardiovascular event (myocardial infarction, stroke, and death) rates between celecoxib and nonsteroidal anti-inflammatory agents in CLASS. The annualized myocardial infarction rates for COX-2 inhibitors in both VIGOR and CLASS were significantly higher than that in the placebo group of a recent meta-analysis of 23407 patients in primary prevention trials (0.52%):0.74% with rofecoxib (P=.04 compared with the placebo group of the meta-analysis) and 0.80% with celecoxib (P=.02 compared with the placebo group of the meta-analysis). The available data raise a cautionary flag about the risk of cardiovascular events with COX-2 inhibitors. Further prospective trial evaluation may characterize and determine the magnitude of the risk.	Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Topol, EJ (corresponding author), Cleveland Clin Fdn, Dept Cardiovasc Med, F 25,9500 Euclid Ave, Cleveland, OH 44195 USA.	topole@ccf.org	Mukherjee, Debabrata/AAG-1486-2019	Mukherjee, Debabrata/0000-0002-5131-3694; Topol, Eric/0000-0002-1478-4729				[Anonymous], 2000, CAN MED ASSOC J, V163, P604; Belton O, 2000, CIRCULATION, V102, P840; Bensen WG, 2000, J RHEUMATOL, V27, P1876; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; BROCHIER ML, 1993, EUR HEART J, V14, P951, DOI 10.1093/eurheartj/14.7.951; Cataldo G, 1998, CORONARY ARTERY DIS, V9, P217, DOI 10.1097/00019501-199809040-00007; Catella-Lawson F, 1999, J PHARMACOL EXP THER, V289, P735; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; Day R, 2000, ARCH INTERN MED, V160, P1781, DOI 10.1001/archinte.160.12.1781; Ehrich EW, 2000, J RHEUMATOL, V27, P2635; *FDA, 2001, OPDRA POSTM SAF REV; *FDA, 2001, CARD SAF REV; *FDA ADV COMM, 2001, CARD SAF REV ROF; *FDA CLASS ADV COM, 2001, CLASS ADV COMM BRIEF; FU JY, 1990, J BIOL CHEM, V265, P16737; Goldstein JL, 2000, AM J GASTROENTEROL, V95, P1681; *IMS HLTH, 2000, IMS HLTH REP COX 2 D; Jahn J, 2000, BASIC RES CARDIOL, V95, P59; Kaplan-Machlis B, 1999, ANN PHARMACOTHER, V33, P979, DOI 10.1345/aph.18415; Koenig W, 2001, Cardiol Rev, V9, P31, DOI 10.1097/00045415-200101000-00007; KUJUBU DA, 1991, J BIOL CHEM, V266, P12866; Langman MJ, 1999, JAMA-J AM MED ASSOC, V282, P1929, DOI 10.1001/jama.282.20.1929; Libby P, 2001, CIRCULATION, V103, P1718, DOI 10.1161/01.CIR.103.13.1718; Lipsky PE, 1997, J RHEUMATOL, V24, P9; McAdam BF, 1999, P NATL ACAD SCI USA, V96, P272, DOI 10.1073/pnas.96.1.272; Megeff C E, 2000, J Fam Pract, V49, P108; Muscara MN, 2000, BRIT J PHARMACOL, V129, P1423, DOI 10.1038/sj.bjp.0703232; REILLY IAG, 1987, BLOOD, V69, P180; Sanmuganathan PS, 2001, HEART, V85, P265, DOI 10.1136/heart.85.3.265; Schmedtje JF, 1997, J BIOL CHEM, V272, P601; Shinmura K, 2000, P NATL ACAD SCI USA, V97, P10197, DOI 10.1073/pnas.97.18.10197; Silverstein FE, 2000, JAMA-J AM MED ASSOC, V284, P1247, DOI 10.1001/jama.284.10.1247; Taylor DW, 1999, LANCET, V353, P2179, DOI 10.1016/S0140-6736(99)05388-X; Van Hecken A, 2000, J CLIN PHARMACOL, V40, P1109; Vane JR, 1998, INFLAMM RES, V47, pS78; Wallberg-Jonsson S, 1999, J RHEUMATOL, V26, P2562; Watson DJ, 2000, ARCH INTERN MED, V160, P2998, DOI 10.1001/archinte.160.19.2998; Yusuf S, 2000, NEW ENGL J MED, V342, P145	39	1322	1378	2	114	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2001	286	8					954	959		10.1001/jama.286.8.954	http://dx.doi.org/10.1001/jama.286.8.954			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465EU	11509060				2022-12-28	WOS:000170577300030
J	Kessler, RC; Davis, RB; Foster, DF; Van Rompay, MI; Walters, EE; Wilkey, SA; Kaptchuk, TJ; Eisenberg, DM				Kessler, RC; Davis, RB; Foster, DF; Van Rompay, MI; Walters, EE; Wilkey, SA; Kaptchuk, TJ; Eisenberg, DM			Long-term trends in the use of complementary and alternative medical therapies in the United States	ANNALS OF INTERNAL MEDICINE			English	Article							SERVICES; CARE	Background: Although recent research has shown that many people in the United States use complementary and alternative medical (CAM) therapies, little is known about time trends in use. Objective: To present data on time trends in CAM therapy use in the United States over the past half-century. Design: Nationally representative telephone survey of 2055 respondents that obtained information on current use, lifetime use, and age at first use for 20 CAM therapies. Setting: The 48 contiguous U.S. states. Participants: Household residents 18 years of age and older. Measurement: Retrospective self-reports of age at first use for each of 20 CAM therapies. Results: Previously reported analyses of these data showed that more than one third of the U.S. population was currently using CAM therapy in the year of the interview (1997). Subsequent analyses of lifetime use and age at onset showed that 67.6% of respondents had used at least one CAM therapy in their lifetime. Lifetime use steadily increased with age across three age cohorts: Approximately 3 of every 10 respondents in the pre-baby boom cohort, 5 of 10 in the baby boom cohort, and 7 of 10 in the post-baby boom cohort reported using some type of CAM therapy by age 33 years. Of respondents who ever used a CAM therapy, nearly half continued to use many years later. A wide range of individual CAM therapies increased in use over time, and the growth was similar across all major sociodemographic sectors of the study sample. Conclusions: Use of CAM therapies by a large proportion of the study sample is the result of a secular trend that began at least a half century ago. This trend suggests a continuing demand for CAM therapies that will affect health care delivery for the foreseeable future.	Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Ctr Alternat Med Res & Educ, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Kessler, RC (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	kessler@hcp.med.harvard.edu	Van Rompay, Maria/G-9452-2012		NIAMS NIH HHS [U24 AR43441] Funding Source: Medline; NIMH NIH HHS [K05 MH00507] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U24AR043441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K05MH000507] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Astin JA, 1998, JAMA-J AM MED ASSOC, V279, P1548, DOI 10.1001/jama.279.19.1548; BERLINER HS, 1980, INT J HEALTH SERV, V10, P133, DOI 10.2190/XWR6-5QPX-GEGE-5GWR; CLAYTON D, 1993, STAT MODELS EPIDEMIO, P31; Delbanco T, 1998, JAMA-J AM MED ASSOC, V280, P1560, DOI 10.1001/jama.280.18.1560; Druss BG, 1999, JAMA-J AM MED ASSOC, V282, P651, DOI 10.1001/jama.282.7.651; EISENBERG DM, 1993, NEW ENGL J MED, V328, P246, DOI 10.1056/NEJM199301283280406; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Goldstein M. S., 1992, HLTH MOVEMENT PROMOT; HOLT D, 1979, J ROY STAT SOC A STA, V142, P33, DOI 10.2307/2344652; LEE ES, 1989, ANAL COMPLEXX SURVEY; Paramore LC, 1997, J PAIN SYMPTOM MANAG, V13, P83, DOI 10.1016/S0885-3924(96)00299-0; Pelletier KR, 1997, AM J HEALTH PROMOT, V12, P112, DOI 10.4278/0890-1171-12.2.112; ROTHSTEIN WG, 1985, AM PHYSICIANS 19 CEN; SAS, 1996, SAS US GUID REL 6 12; Shekelle PG, 1996, MED CARE, V34, P863, DOI 10.1097/00005650-199609000-00001; SHYROCK HS, 1971, METHODS MAT DEMOGRAP, V1; *US BUR CENS, 2001, US POP EST AG SEX RA; Wetzel MS, 1998, JAMA-J AM MED ASSOC, V280, P784, DOI 10.1001/jama.280.9.784; Whorton J C, 1986, Pharm Hist, V28, P14; WILLETT JB, 1993, J CONSULT CLIN PSYCH, V61, P952, DOI 10.1037/0022-006X.61.6.952; [No title captured]	21	487	495	0	41	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 21	2001	135	4					262	268		10.7326/0003-4819-135-4-200108210-00011	http://dx.doi.org/10.7326/0003-4819-135-4-200108210-00011			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	465KE	11511141				2022-12-28	WOS:000170587500005
J	Sheffield, JVL; Larson, EB				Sheffield, JVL; Larson, EB			Update in general internal medicine	ANNALS OF INTERNAL MEDICINE			English	Review									Univ Washington, Med Ctr, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Sheffield, JVL (corresponding author), Harborview Med Ctr, Box 359782,325 9th Ave, Seattle, WA 98104 USA.							DEMARI J, 1997, AM J PHYSIOL, V272, pF292; Heathcote EJ, 2000, NEW ENGL J MED, V343, P1673, DOI 10.1056/NEJM200012073432302; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Neal B, 2000, LANCET, V356, P1955; Salom MG, 1998, TRANSPLANTATION, V65, P1315, DOI 10.1097/00007890-199805270-00006; 2001, MMWR MORB MORTAL WKL, V50, P289; 1997, ARCH INTERN MED, V157, P2413	7	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 21	2001	135	4					269	278		10.7326/0003-4819-135-4-200108210-00012	http://dx.doi.org/10.7326/0003-4819-135-4-200108210-00012			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465KE	11511142				2022-12-28	WOS:000170587500006
J	Westermann, J; Engelhardt, B; Hoffmann, JC				Westermann, J; Engelhardt, B; Hoffmann, JC			Migration of T cells in vivo: Molecular mechanisms and clinical implications	ANNALS OF INTERNAL MEDICINE			English	Review							HIGH ENDOTHELIAL VENULES; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; INFLAMMATORY-BOWEL-DISEASE; CENTRAL-NERVOUS-SYSTEM; SPECIALIZED VASCULAR ENDOTHELIUM; SECONDARY LYMPHOID ORGANS; THORACIC-DUCT LYMPHOCYTES; 4 BETA 7; L-SELECTIN; B-LYMPHOCYTE	T cells play an important role In the pathogenesis of chronic and autoimmune Inflammatory diseases. They are found in high numbers in involved tissues, such as the lamina propria of the gut in patients with Crohn disease. Modifying T-cell number and function may therefore be of therapeutic value. In principle, two mechanisms may be responsible for the development of such T-cell Infiltrates: 1) an increased rate of T-cell immigration into involved tissues or 2) an increased proliferation rate, decreased T-cell death (apoptosis) rate, and prolonged retention of T cells already in the tissue. Based on the theory that T cells selectively target affected tissues through organ-specific adhesion-molecule pathways, current anti-adhesion-molecule therapy aims to interfere selectively with T-cell entry to stop tissue damage. However, the traffic of labeled T cells in unmanipulated animals shows that the entry of T-cell subsets into tissues is not organ-specific, even under conditions of differing adhesion molecule and chemokine receptor expression. In contrast, within various tissues, both movement and survival of T-cell subsets differ considerably. These observations suggest that the differential expression of adhesion molecules and chemokine receptors on T cells serves at least two functions in vivo. First, during migration of T cells out of the bloodstream, the different adhesion-molecule pathways provide redundancy, which guarantees that T-cell subsets are able to enter the different tissues in sufficient numbers (security). Second, adhesion molecules and chemokine receptors mediate T-cell interactions within the tissue that are characteristic for each subset and each microenvironment and determine the nature of the ensuing immune response (selectivity). Shifting the focus of anti-adhesion-molecule therapy toward the T cells in diseased tissue may lead to new treatment options.	Med Univ Lubeck, Inst Anat, D-23538 Lubeck, Germany; Max Planck Inst Physiol & Clin Res, WG Kerckhoff Inst, Bad Nauheim, Germany; Univ Saarlandes Kliniken, Med Klin, Homburg, Germany	University of Lubeck; Max Planck Society; Universitatsklinikum des Saarlandes	Westermann, J (corresponding author), Med Univ Lubeck, Inst Anat, Ratzeburger Allee 160, D-23538 Lubeck, Germany.	westermann@anat.mu-luebeck.de	Engelhardt, Britta/K-7267-2014	Engelhardt, Britta/0000-0003-3059-9846				Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Abbas AK, 2000, CELL, V100, P129, DOI 10.1016/S0092-8674(00)81689-X; Ager Ann, 1994, Trends in Cell Biology, V4, P326, DOI 10.1016/0962-8924(94)90234-8; Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; Aoudjit F, 1998, J IMMUNOL, V161, P2333; ARCHELOS JJ, 1993, ANN NEUROL, V34, P145, DOI 10.1002/ana.410340209; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; AUSTRUP F, 1995, EUR J IMMUNOL, V25, P1487, DOI 10.1002/eji.1830250602; BARGATZE RF, 1994, J EXP MED, V180, P1785, DOI 10.1084/jem.180.5.1785; BELL EB, 1995, INT IMMUNOL, V7, P1861, DOI 10.1093/intimm/7.11.1861; BERLIN C, 1995, CELL, V80, P413, DOI 10.1016/0092-8674(95)90491-3; Berlin-Rufenach C, 1999, J EXP MED, V189, P1467, DOI 10.1084/jem.189.9.1467; BJERKNES M, 1986, SCIENCE, V231, P402, DOI 10.1126/science.3941903; Bode U, 2001, EUR J IMMUNOL, V31, P2116, DOI 10.1002/1521-4141(200107)31:7<2116::AID-IMMU2116>3.0.CO;2-Q; Butcher EC, 1999, ADV IMMUNOL, V72, P209, DOI 10.1016/S0065-2776(08)60022-X; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; CAHILL R, 1974, Haematologia, V8, P321; Campbell JJ, 2000, CURR OPIN IMMUNOL, V12, P336, DOI 10.1016/S0952-7915(00)00096-0; Chaplin DD, 1998, CURR OPIN IMMUNOL, V10, P289, DOI 10.1016/S0952-7915(98)80167-2; Dailey MO, 1998, CRIT REV IMMUNOL, V18, P153, DOI 10.1615/CritRevImmunol.v18.i3.10; Davenport MP, 2000, IMMUNOL TODAY, V21, P315, DOI 10.1016/S0167-5699(00)01644-3; DEJOY SQ, 1990, CELL IMMUNOL, V130, P195, DOI 10.1016/0008-8749(90)90173-O; Diacovo TG, 1996, SCIENCE, V273, P252, DOI 10.1126/science.273.5272.252; Diaz-Gonzalez F, 1998, IMMUNOL TODAY, V19, P169, DOI 10.1016/S0167-5699(97)01216-4; Doerschuk CM, 1996, J IMMUNOL, V157, P4609; DRAYSON MT, 1986, TRANSPLANTATION, V41, P745, DOI 10.1097/00007890-198606000-00016; Drillenburg P, 2000, BLOOD, V95, P1900, DOI 10.1182/blood.V95.6.1900; Duchmann R, 1995, CLIN EXP IMMUNOL, V102, P448; Dulude G, 1999, J EXP MED, V189, P1329, DOI 10.1084/jem.189.8.1329; Economou JS, 1996, J CLIN INVEST, V97, P515, DOI 10.1172/JCI118443; Elson CO, 1998, ANN NY ACAD SCI, V859, P85, DOI 10.1111/j.1749-6632.1998.tb11113.x; Engelhardt B, 1998, J CLIN INVEST, V102, P2096, DOI 10.1172/JCI4271; Etzioni A, 1999, BLOOD, V94, P3281, DOI 10.1182/blood.V94.10.3281.422k37_3281_3288; Farstad IN, 1997, AM J PATHOL, V150, P187; Faveeuw C, 2000, INT IMMUNOL, V12, P241, DOI 10.1093/intimm/12.3.241; Finger EB, 1996, NATURE, V379, P266, DOI 10.1038/379266a0; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; FORD WL, 1975, PROG ALLERGY, V19, P1, DOI 10.1159/000313381; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; FOSSUM S, 1983, SCAND J IMMUNOL, V17, P539, DOI 10.1111/j.1365-3083.1983.tb00822.x; FOSSUM S, 1983, SCAND J IMMUNOL, V17, P551; FRIEDL P, 1994, IMMUNOLOGY, V82, P617; Fuss IJ, 1999, GASTROENTEROLOGY, V117, P1078, DOI 10.1016/S0016-5085(99)70392-6; Glennie MJ, 2000, IMMUNOL TODAY, V21, P403, DOI 10.1016/S0167-5699(00)01669-8; GORDON FH, 2000, GASTROENTEROLOGY, V116, pA638; Gunzer M, 2000, IMMUNITY, V13, P323, DOI 10.1016/S1074-7613(00)00032-7; Gustafsson D, 2000, ALLERGY, V55, P240, DOI 10.1034/j.1398-9995.2000.00391.x; Hamann A, 2000, EUR J IMMUNOL, V30, P3207, DOI 10.1002/1521-4141(200011)30:11<3207::AID-IMMU3207>3.0.CO;2-L; HAMANN A, 1994, J IMMUNOL, V152, P3282; Hesterberg PE, 1996, GASTROENTEROLOGY, V111, P1373, DOI 10.1053/gast.1996.v111.pm8898653; HICKEY WF, 1991, J NEUROSCI RES, V28, P254, DOI 10.1002/jnr.490280213; Hirschberg DL, 1998, J NEUROIMMUNOL, V89, P88, DOI 10.1016/S0165-5728(98)00118-0; Hoffmann JC, 1997, ANN RHEUM DIS, V56, P716, DOI 10.1136/ard.56.12.716; Hokari R, 1998, GASTROENTEROLOGY, V115, P618, DOI 10.1016/S0016-5085(98)70141-6; Holdsworth SR, 1999, KIDNEY INT, V55, P1198, DOI 10.1046/j.1523-1755.1999.00369.x; HOURIHAN H, 1993, J CELL SCI, V104, P1049; Hwang I, 2000, J EXP MED, V191, P1137, DOI 10.1084/jem.191.7.1137; Jonas P, 1998, INT J CANCER, V77, P402; Jutila MA, 1996, J IMMUNOL, V156, P289; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Krakowski ML, 2000, EUR J IMMUNOL, V30, P1002, DOI 10.1002/(SICI)1521-4141(200004)30:4<1002::AID-IMMU1002>3.0.CO;2-2; Kundig TM, 1996, IMMUNOL REV, V150, P63, DOI 10.1111/j.1600-065X.1996.tb00696.x; Laschinger M, 2000, J NEUROIMMUNOL, V102, P32, DOI 10.1016/S0165-5728(99)00156-3; Lee SJ, 1999, J NEUROIMMUNOL, V98, P77, DOI 10.1016/S0165-5728(99)00084-3; Lefrancois L, 1999, J EXP MED, V189, P1631, DOI 10.1084/jem.189.10.1631; Lemaire LCJM, 1998, SCAND J IMMUNOL, V47, P69; LEVINE JB, 1995, GASTROENTEROL CLIN N, V24, P633; Lin KC, 1998, CURR OPIN CHEM BIOL, V2, P453, DOI 10.1016/S1367-5931(98)80120-8; Lipp M, 2000, CURR TOP MICROBIOL, V251, P173; Luettig B, 1999, J IMMUNOL, V163, P4300; Luettig B, 2001, SCAND J IMMUNOL, V53, P563, DOI 10.1046/j.1365-3083.2001.00897.x; MACKAY CR, 1991, IMMUNOL TODAY, V12, P189, DOI 10.1016/0167-5699(91)90051-T; Mackay IR, 2000, BMJ-BRIT MED J, V321, P93, DOI 10.1136/bmj.321.7253.93; Mantovani A, 1999, IMMUNOL TODAY, V20, P254, DOI 10.1016/S0167-5699(99)01469-3; McIntyre BW, 1997, J IMMUNOL, V158, P4180; Melder RJ, 2000, MICROVASC RES, V59, P316, DOI 10.1006/mvre.1999.2223; MERKENSCHLAGER M, 1988, EUR J IMMUNOL, V18, P1653, DOI 10.1002/eji.1830181102; OHTSUKA A, 1993, BIOCHEM BIOPH RES CO, V193, P303, DOI 10.1006/bbrc.1993.1624; PABST R, 1994, RES IMMUNOL, V145, P289, DOI 10.1016/S0923-2494(94)80017-0; PABST R, 1988, IMMUNOL TODAY, V9, P43, DOI 10.1016/0167-5699(88)91258-3; PABST R, 1989, IMMUNOL REV, V108, P83, DOI 10.1111/j.1600-065X.1989.tb00014.x; Pilling D, 2000, CELL MOL BIOL, V46, P163; PITZALIS C, 1991, EUR J IMMUNOL, V21, P369, DOI 10.1002/eji.1830210218; Pitzalis C, 1996, ARTHRITIS RHEUM, V39, P137, DOI 10.1002/art.1780390118; Pospai D, 1998, DIGEST DIS SCI, V43, P412, DOI 10.1023/A:1018883112012; Powrie F, 1996, J EXP MED, V183, P2669, DOI 10.1084/jem.183.6.2669; Prendergast RA, 1998, INVEST OPHTH VIS SCI, V39, P754; Raivich G, 1998, J NEUROSCI, V18, P5804; Randolph DA, 1999, SCIENCE, V286, P2159, DOI 10.1126/science.286.5447.2159; RANNIE GH, 1977, CELL TISSUE KINET, V10, P523, DOI 10.1111/j.1365-2184.1977.tb00310.x; Reekers R, 1999, J ALLERGY CLIN IMMUN, V104, P466, DOI 10.1016/S0091-6749(99)70395-7; Robert C, 1999, NEW ENGL J MED, V341, P1817, DOI 10.1056/NEJM199912093412407; Rose JW, 1999, J NEUROIMMUNOL, V97, P110, DOI 10.1016/S0165-5728(99)00064-8; Rosenkranz AR, 1999, J CLIN INVEST, V103, P649, DOI 10.1172/JCI5183; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sallusto F, 1998, IMMUNOL TODAY, V19, P568, DOI 10.1016/S0167-5699(98)01346-2; Salmi M, 1997, ADV IMMUNOL, V64, P139, DOI 10.1016/S0065-2776(08)60889-5; Salmi M, 1998, INFLAMM BOWEL DIS, V4, P149; Sampson H A, 1995, Allergy, V50, P46; Schreiber S, 2000, GASTROENTEROLOGY, V118, pA568; Schwid SR, 1999, NEUROLOGY, V53, P444, DOI 10.1212/WNL.53.3.444; Seddon B, 2000, IMMUNOL TODAY, V21, P95, DOI 10.1016/S0167-5699(99)01559-5; SEDGLEY M, 1976, CELL TISSUE KINET, V9, P231, DOI 10.1111/j.1365-2184.1976.tb01271.x; Seiter S, 1998, CLIN IMMUNOL IMMUNOP, V89, P79, DOI 10.1006/clin.1998.4565; Shaw AS, 1997, IMMUNITY, V6, P361, DOI 10.1016/S1074-7613(00)80279-4; Shibahara T, 2000, GASTROENTEROLOGY, V118, P289, DOI 10.1016/S0016-5085(00)70211-3; SMITH ME, 1983, IMMUNOLOGY, V49, P83; SMITH ME, 1983, CELL IMMUNOL, V78, P161, DOI 10.1016/0008-8749(83)90269-1; SOO KS, 1995, CLIN EXP IMMUNOL, V100, P133; Sparshott SM, 1998, IMMUNOLOGY, V93, P447; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Stallmach A, 1999, GASTROENTEROLOGY, V117, P866, DOI 10.1016/S0016-5085(99)70345-8; Stekel DJ, 1997, IMMUNOL TODAY, V18, P216; Strober W, 1998, ANN INTERN MED, V128, P848, DOI 10.7326/0003-4819-128-10-199805150-00009; Takamoto M, 1998, IMMUNOLOGY, V95, P419, DOI 10.1046/j.1365-2567.1998.00616.x; Tang MLK, 1997, J IMMUNOL, V158, P5191; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; Tchilian EZ, 1997, IMMUNOLOGY, V92, P321, DOI 10.1046/j.1365-2567.1997.00351.x; Termeer CC, 1998, CLIN EXP IMMUNOL, V114, P422; Thornton AM, 2000, J IMMUNOL, V164, P183, DOI 10.4049/jimmunol.164.1.183; Tononi G, 1999, P NATL ACAD SCI USA, V96, P3257, DOI 10.1073/pnas.96.6.3257; TOYAMASORIMACHI N, 1993, EUR J IMMUNOL, V23, P439, DOI 10.1002/eji.1830230221; van Deventer SJH, 2000, SCAND J IMMUNOL, V51, P18; Van Parijs L, 1998, SCIENCE, V280, P243; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; VONANDRIAN UH, 1995, CELL, V82, P989, DOI 10.1016/0092-8674(95)90278-3; WALTER S, 1995, EUR J IMMUNOL, V25, P1199, DOI 10.1002/eji.1830250510; Wang WC, 1998, J IMMUNOL, V160, P961; Warnock RA, 2000, J EXP MED, V191, P77, DOI 10.1084/jem.191.1.77; WESTERMANN J, 1988, SCAND J IMMUNOL, V28, P203, DOI 10.1111/j.1365-3083.1988.tb02432.x; Westermann J, 1996, SCAND J IMMUNOL, V43, P297, DOI 10.1046/j.1365-3083.1996.d01-38.x; Westermann J, 1999, IMMUNOL TODAY, V20, P302, DOI 10.1016/S0167-5699(99)01474-7; WESTERMANN J, 1994, J IMMUNOL, V152, P1744; WESTERMANN J, 1992, EUR J IMMUNOL, V22, P2219, DOI 10.1002/eji.1830220906; WESTERMANN J, 1992, CLIN INVESTIGATOR, V70, P539; WESTERMANN J, 1993, J IMMUNOL, V150, P3843; WESTERMANN J, 1990, IMMUNOL TODAY, V11, P406, DOI 10.1016/0167-5699(90)90160-B; Westermann J, 1996, EUR J IMMUNOL, V26, P1866, DOI 10.1002/eji.1830260830; Westermann J, 1998, IMMUNOL TODAY, V19, P143, DOI 10.1016/S0167-5699(97)01210-3; Westermann J, 1996, IMMUNOL TODAY, V17, P278, DOI 10.1016/0167-5699(96)80545-7; Westermann J, 1997, EUR J IMMUNOL, V27, P3174, DOI 10.1002/eji.1830271214; WESTERMANN J, 1994, EUR J IMMUNOL, V24, P2312, DOI 10.1002/eji.1830241008; WESTERMANN J, 1994, SCAND J IMMUNOL, V39, P395, DOI 10.1111/j.1365-3083.1994.tb03391.x; Wildbaum G, 2000, J CLIN INVEST, V106, P671, DOI 10.1172/JCI8759; XU LL, 1995, J IMMUNOL, V155, P1184; Yacyshyn BR, 1998, GASTROENTEROLOGY, V114, P1133, DOI 10.1016/S0016-5085(98)70418-4; YANG XD, 1994, P NATL ACAD SCI USA, V91, P12604, DOI 10.1073/pnas.91.26.12604; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0; Young AJ, 1999, SEMIN IMMUNOL, V11, P73, DOI 10.1006/smim.1999.0163; Zhang ZX, 2000, NAT MED, V6, P782, DOI 10.1038/77513; Zidan M, 2000, SCAND J IMMUNOL, V51, P372	152	64	65	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 21	2001	135	4					279	295		10.7326/0003-4819-135-4-200108210-00013	http://dx.doi.org/10.7326/0003-4819-135-4-200108210-00013			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465KE	11511143				2022-12-28	WOS:000170587500007
J	Mehta, SR; Yusuf, S; Peters, RJG; Bertrand, ME; Lewis, BS; Natarajan, MK; Maimberg, K; Rupprecht, HJ; Zhao, F; Chrolavicius, S; Copland, I; Fox, KAA				Mehta, SR; Yusuf, S; Peters, RJG; Bertrand, ME; Lewis, BS; Natarajan, MK; Maimberg, K; Rupprecht, HJ; Zhao, F; Chrolavicius, S; Copland, I; Fox, KAA		Clopidogrel Unstable Angina Preven	Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study	LANCET			English	Article							BALLOON ANGIOPLASTY; STENT IMPLANTATION; ARTERY-DISEASE; PREVENTION; DIPYRIDAMOLE; RESTENOSIS; OUTCOMES; EVENTS; BIAS	Background Despite the use of aspirin, there is still a risk of ischaemic events after percutaneous coronary intervention (PCI). We aimed to find out whether, in addition to aspirin, pretreatment with clopidogrel followed by long-term therapy after PCI is superior to a strategy of no pretreatment and short-term therapy for only 4 weeks after PCI. Methods 2658 patients with non-ST-elevation acute coronary syndrome undergoing PCI in the CURE study had been randomly assigned double-blind treatment with clopidogrel (n=1313) or placebo (n=1345). Patients were pretreated with aspirin and study drug for a median of 6 days before PCI during the initial hospital admission, and for a median of 10 days overall. After PCI, most patients (>80%) in both groups received open-label thienopyridine for about 4 weeks, after which study drug was restarted for a mean of 8 months. The primary endpoint was a composite of cardiovascular death, myocardial infarction, or urgent target-vessel revascularisation within 30 days of PCI The main analysis was by intention to treat. Findings There were no drop-outs. 59 (4.5%) patients in the clopidogrel group had the primary endpoint, compared with 86 (6.4%) in the placebo group (relative risk 0.70 [95% CI 0.50-0.97], p=0.03). Long-term administration of clopidogrel after PCI was associated with a lower rate of cardiovascular death, myocardial infarction, or any revascularisation (p=0.03), and of cardiovascular death or myocardial infarction (p=0.047). Overall (including events before and after PCI) there was a 31% reduction cardiovascular death or myocardial infarction (p=0.002). There was less use of glycoprotein IIb/IIIa inhibitor in the clopidogrel group (P=0.001). At follow-up, there was no significant difference in major bleeding between the groups (p=0.64). Interpretation In patients with acute coronary syndrome receiving aspirin, a strategy of clopidogrel pretreatment followed by long-term therapy is beneficial in reducing major cardiovascular events, compared with placebo.	McMaster Univ, Med Ctr, Populat Hlth Res Inst, Div Cardiol, Hamilton, ON L8N 3Z5, Canada; McMaster Univ, Canadian Cardiovasc Collaborat Project Off, Hamilton, ON L8N 3Z5, Canada; Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; Hop Cardiol, Dept Cardiol, F-59037 Lille, France; Lady Davies Carmel Hosp, Haifa, Israel; Karolinska Hosp, S-10401 Stockholm, Sweden; Univ Mainz Klinikum, Mainz, Germany; Royal Edinburgh Infirm, Edinburgh, Midlothian, Scotland	McMaster University; Population Health Research Institute; McMaster University; University of Amsterdam; Academic Medical Center Amsterdam; Universite de Lille - ISITE; CHU Lille; Clalit Health Services; Carmel Medical Center; Karolinska Institutet; Karolinska University Hospital; Johannes Gutenberg University of Mainz; Royal Infirmary of Edinburgh	Mehta, SR (corresponding author), McMaster Univ, Med Ctr, Populat Hlth Res Inst, Div Cardiol, 1200 Main St W,HSC 3U5, Hamilton, ON L8N 3Z5, Canada.	smehta@mcmaster.ca	Fox, keith A A/I-3742-2013	Yusuf, Salim/0000-0003-4776-5601; Fox, Keith/0000-0002-0140-2752				ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; BARNATHAN ES, 1987, CIRCULATION, V76, P125, DOI 10.1161/01.CIR.76.1.125; Boersma E, 1999, CIRCULATION, V100, P2045, DOI 10.1161/01.CIR.100.20.2045; Bossavy JP, 1998, BLOOD, V92, P1518, DOI 10.1182/blood.V92.5.1518.417k22_1518_1525; CANNON CP, 2001, NEW ENGL J MED, V344, P1939; Chew DP, 2001, CIRCULATION, V103, P201; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; FUSTER V, 1992, NEW ENGL J MED, V326, P242, DOI 10.1056/NEJM199201233260406; Grewe PH, 2000, J AM COLL CARDIOL, V35, P157, DOI 10.1016/S0735-1097(99)00486-6; Hannan EL, 2000, J AM COLL CARDIOL, V36, P395, DOI 10.1016/S0735-1097(00)00752-X; Herbert JM, 1998, THROMB HAEMOSTASIS, V80, P512; Joffe MM, 1999, AM J EPIDEMIOL, V150, P327; Kong DF, 1998, CIRCULATION, V98, P2829, DOI 10.1161/01.CIR.98.25.2829; Moshfegh K, 2000, J AM COLL CARDIOL, V36, P699, DOI 10.1016/S0735-1097(00)00817-2; O'Neill WW, 2000, NEW ENGL J MED, V342, P1316, DOI 10.1056/NEJM200005043421803; Popma JJ, 2001, CHEST, V119, p321S, DOI 10.1378/chest.119.1_suppl.321S; ROSENBAUM PR, 1991, ANN INTERN MED, V115, P901, DOI 10.7326/0003-4819-115-11-901; Sakatani H, 1999, AM HEART J, V138, P962, DOI 10.1016/S0002-8703(99)70024-4; SAVAGE MP, 1995, CIRCULATION, V92, P3194, DOI 10.1161/01.CIR.92.11.3194; SCHWARTZ L, 1988, NEW ENGL J MED, V318, P1714, DOI 10.1056/NEJM198806303182603; SMITH SC, 2001, J AM COLL CARDIOL, V37; Tcheng JE, 2000, LANCET, V356, P2037; ten Berg JM, 2000, CIRCULATION, V102, P386; Topol EJ, 1998, CIRCULATION, V97, P211, DOI 10.1161/01.CIR.97.2.211; Topol EJ, 2001, NEW ENGL J MED, V344, P1888, DOI 10.1056/NEJM200106213442502; van Domburg RT, 2001, EUR HEART J, V22, P934, DOI 10.1053/euhj.2000.2420; Van Langenhove G, 2000, Circulation, V102, pE95; Wallentin L, 2000, LANCET, V356, P9, DOI 10.1016/S0140-6736(00)02427-2; Webb JG, 1999, J AM COLL CARDIOL, V34, P468, DOI 10.1016/S0735-1097(99)00196-5; Yusuf S, 2000, EUR HEART J, V21, P2033	30	2401	2532	0	73	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 18	2001	358	9281					527	533		10.1016/S0140-6736(01)05701-4	http://dx.doi.org/10.1016/S0140-6736(01)05701-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464NB	11520521				2022-12-28	WOS:000170537700008
J	Magnuson, JJ; Safina, C; Sissenwine, MP				Magnuson, JJ; Safina, C; Sissenwine, MP			Ecology and conservation - Whose fish are they anyway?	SCIENCE			English	Editorial Material							ATLANTIC		Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA; Natl Audubon Soc, Living Oceans Program, Islip, NY 11751 USA; NE Fisheries Sci Ctr, Woods Hole, MA 02543 USA	University of Wisconsin System; University of Wisconsin Madison; National Oceanic Atmospheric Admin (NOAA) - USA	Magnuson, JJ (corresponding author), Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA.							BOCK BA, 2001, SCIENCE, V293, P1310; ICCAT, 2000, ICCAT SCRS W ATL BLU; Lutcavage ME, 2000, MAR BIOL, V137, P347, DOI 10.1007/s002270000302; Lutcavage ME, 1999, CAN J FISH AQUAT SCI, V56, P173, DOI 10.1139/cjfas-56-2-173; National Research Council, 1994, ASS ATL BLUEF TUN; ROOKER J, IN PRESS MAR ECOL PR; Safina C., 1998, SONG BLUE OCEAN; Sissenwine MP, 1998, T AM FISH SOC, V127, P838, DOI 10.1577/1548-8659(1998)127<0838:ACOWAB>2.0.CO;2	8	20	20	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2001	293	5533					1267	1268		10.1126/science.1064052	http://dx.doi.org/10.1126/science.1064052			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11509715				2022-12-28	WOS:000170492600024
J	Thauer, RK				Thauer, RK			Enzymology - Nickel to the fore	SCIENCE			English	Editorial Material							CARBON-MONOXIDE DEHYDROGENASE; CLOSTRIDIUM-THERMOACETICUM; UREASE; SITES		Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany	Max Planck Society	Thauer, RK (corresponding author), Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany.							DIEKERT GB, 1979, ARCH MICROBIOL, V122, P117, DOI 10.1007/BF00408054; Dobbek H, 2001, SCIENCE, V293, P1281, DOI 10.1126/science.1061500; DRAKE HL, 1994, ACETOGENESIS, P273; Ermler U, 1998, CURR OPIN STRUC BIOL, V8, P749, DOI 10.1016/S0959-440X(98)80095-X; Garcin E, 1999, STRUCT FOLD DES, V7, P557, DOI 10.1016/S0969-2126(99)80072-0; Grabarse W, 2001, J MOL BIOL, V309, P315, DOI 10.1006/jmbi.2001.4647; Heo J, 2001, BIOCHEMISTRY-US, V40, P7604, DOI 10.1021/bi002554k; HOFFMANN R, 1995, SAME NOT SAME, P3; Kocsis E, 1999, J STRUCT BIOL, V128, P165, DOI 10.1006/jsbi.1999.4163; Loke HK, 2000, P NATL ACAD SCI USA, V97, P12530, DOI 10.1073/pnas.220404397; Maynard EL, 2001, J AM CHEM SOC, V123, P4697, DOI 10.1021/ja004017t; Meyer O, 2000, BIOL CHEM, V381, P865, DOI 10.1515/BC.2000.108; Pearson MA, 2000, BIOCHEMISTRY-US, V39, P8575, DOI 10.1021/bi000613o; Ralston CY, 2000, J AM CHEM SOC, V122, P10553, DOI 10.1021/ja0009469; SVETLICHNYI V, IN PRESS J BACTERIOL; ZERNER B, 1991, BIOORG CHEM, V19, P116, DOI 10.1016/0045-2068(91)90048-T	16	34	34	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2001	293	5533					1264	1265		10.1126/science.1064049	http://dx.doi.org/10.1126/science.1064049			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11509713				2022-12-28	WOS:000170492600022
J	Kuznicki, SM; Bell, VA; Nair, S; Hillhouse, HW; Jacubinas, RM; Braunbarth, CM; Toby, BH; Tsapatsis, M				Kuznicki, SM; Bell, VA; Nair, S; Hillhouse, HW; Jacubinas, RM; Braunbarth, CM; Toby, BH; Tsapatsis, M			A titanosilicate molecular sieve with adjustable pores for size-selective adsorption of molecules	NATURE			English	Article							RIGID-UNIT MODES; PHASE-TRANSITION; ETS-10; FLEXIBILITY; RHO; TEMPERATURE; DIFFRACTION; FRAMEWORK	Zeolites and related crystalline microporous oxides-tetrahedrally coordinated atoms covalently linked into a porous framework-are of interest for applications ranging from catalysis to adsorption and ion-exchange(1). In some of these materials (such as zeolite rho) adsorbates(2), ion-exchange, and dehydration and cation relocation(3,4) can induce strong framework deformations. Similar framework flexibility has to date not been seen in mixed octahedral/tetrahedral microporous framework materials, a newer and rapidly expanding class of molecular sieves(5-16). Here we show that the framework of the titanium silicate ETS-4, the first member of this class of materials(8), can be systematically contracted through dehydration at elevated temperatures to 'tune' the effective size of the pores giving access to the interior of the crystal. We show that this so-called 'molecular gate' effect can be used to tailor the adsorption properties of the materials to give size-selective adsorbents(17) suitable for commercially important separations of gas mixtures of molecules with similar size in the 4.0 to 3.0 Angstrom range, such as that of N-2/CH4, Ar/O-2 and N-2/O-2.	Engelhard Corp, Strateg Technol Grp, Iselin, NJ 08830 USA; Univ Massachusetts, Dept Chem Engn, Goessmann Lab 159, Amherst, MA 01003 USA; NIST, Ctr Neutron Res, Gaithersburg, MD 20899 USA	University of Massachusetts System; University of Massachusetts Amherst; National Institute of Standards & Technology (NIST) - USA	Kuznicki, SM (corresponding author), Engelhard Corp, Strateg Technol Grp, 101 Wood Ave, Iselin, NJ 08830 USA.	steve.kuznicki@engelhard.com	Tsapatsis, Michael/AAA-2527-2019; Toby, Brian H/F-3176-2013	Toby, Brian H/0000-0001-8793-8285; Nair, Sankar/0000-0001-5339-470X				ABRAMS L, 1995, TOPICS INCLUSION SCI, V6, P4; ANDERSON MW, 1995, PHILOS MAG B, V71, P813, DOI 10.1080/01418639508243589; Anderson MW, 1996, MICROPOROUS MATER, V6, P195, DOI 10.1016/0927-6513(95)00098-4; ANDERSON MW, 1994, NATURE, V367, P347, DOI 10.1038/367347a0; Bieniok A, 1998, MICROPOR MESOPOR MAT, V25, P193, DOI 10.1016/S1387-1811(98)00207-8; BIENIOK A, 1991, J SOLID STATE CHEM, V90, P173, DOI 10.1016/0022-4596(91)90183-I; Bordiga S, 2000, J CHEM PHYS, V112, P3859, DOI 10.1063/1.480533; Braunbarth C, 2000, CHEM MATER, V12, P1857, DOI 10.1021/cm9907211; Breck D. W., 1974, ZEOLITE MOL SIEVES; Cruciani G, 1998, MICROPOR MESOPOR MAT, V21, P143, DOI 10.1016/S1387-1811(97)00051-6; Depmeier W, 1999, MOL SIEVES, V2, P113, DOI [10.1007/3-540-69749-7_4, DOI 10.1007/3-540-69749-7_4]; Eldewik A., 1998, P INT ZEOLITE C, VIII, P1507; Hammonds KD, 1998, J PHYS CHEM B, V102, P1759, DOI 10.1021/jp980006z; Johnson GM, 1999, CHEM MATER, V11, P2780, DOI 10.1021/cm990179g; Kuznicki S., 1990, U.S. Patent, Patent No. [No. 4,938,939, 4938939]; Kuznicki S. M., 2000, Small-Pored Crystalline Titanium Molecular Sieve Zeolites and Their Use in Gas Separation Processes, Patent No. [US6068682, 6068682]; Kuznicki S.M., 1993, US Patent, Patent No. [5,244,650, 5244650]; Kuznicki S.M., 1989, U.S. Patent, Patent No. [4,853,202A, 4853202, US4853202 A]; KUZNICKI SM, 1993, Patent No. 5208006; Lamberti C, 1999, MICROPOR MESOPOR MAT, V30, P155, DOI 10.1016/S1387-1811(99)00022-0; LARSON AC, 1986, 86784 GSAS LAUR; LEBAIL A, 1988, MAT RES B, V23, P47; MCCUSKER LB, 1996, COMPREHENSIVE SUPRAM, P393; MENTZEN BF, 1995, MATER RES BULL, V30, P373, DOI 10.1016/0025-5408(95)00003-8; Merkov A.N., 1973, ZAP VSES MINERALOG O, V102, P54; MITARITEN M, 2001, P LAURANCE REID GAS, V51, P1; Nenoff T.M., 1996, J PHYS CHEM-US, V102, P14256; Philippou A, 1996, ZEOLITES, V16, P98, DOI 10.1016/0144-2449(95)00107-7; Rocha J, 2000, EUR J INORG CHEM, P801; Sandomirskii P. A., 1979, Soviet Physics - Crystallography, V24, P686; Wang XQ, 1999, CHEM COMMUN, P973, DOI 10.1039/a901280j; Young R.A., 1993, RIETVELD METHOD, DOI 10.1002/crat.2170300412	32	472	503	14	351	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 16	2001	412	6848					720	724		10.1038/35089052	http://dx.doi.org/10.1038/35089052			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462ZB	11507636				2022-12-28	WOS:000170450200040
J	Smaglik, P				Smaglik, P			Biologists officially welcome plan	NATURE			English	News Item																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 16	2001	412	6848					665	665		10.1038/35089190	http://dx.doi.org/10.1038/35089190			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462ZB	11507594	Bronze			2022-12-28	WOS:000170450200003
J	King, SL				King, SL			The most primitive sense	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2001	286	7					766	766		10.1001/jama.286.7.766	http://dx.doi.org/10.1001/jama.286.7.766			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	462PU	11497512				2022-12-28	WOS:000170429600001
J	Coker, R				Coker, R			Control of tuberculosis in Russia	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED TRIAL		Univ London London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Coker, R (corresponding author), Univ London London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, Keppel St, London WC1E 7HT, England.							Drobniewski F, 1996, TUBERCLE LUNG DIS, V77, P297, DOI 10.1016/S0962-8479(96)90092-1; DYE C, 1999, POTENTIAL IMPACT TUB; FARMER P, 1999, GLOBAL IMPACT DRUG R; Kamolratanakul P, 1999, T ROY SOC TROP MED H, V93, P552, DOI 10.1016/S0035-9203(99)90379-6; MAHER D, 1997, WHOTB97220; Perelman MI, 2000, INT J TUBERC LUNG D, V4, P1097; POLIVAKHO VV, 2000, PROBL TUBERK, V5, P32; Stern V., 1999, SENTENCED DIE PROBLE; Volmink J, 2000, LANCET, V355, P1345, DOI 10.1016/S0140-6736(00)02124-3; Walley JD, 2001, LANCET, V357, P664, DOI 10.1016/S0140-6736(00)04129-5; *WHO, 2000, NAT TUB PROGR MAN M; Zwarenstein M, 1998, LANCET, V352, P1340, DOI 10.1016/S0140-6736(98)04022-7; 2001, M WHO WORK GROUP DOT	13	16	16	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 11	2001	358	9280					434	435		10.1016/S0140-6736(01)05666-5	http://dx.doi.org/10.1016/S0140-6736(01)05666-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463TB	11513902				2022-12-28	WOS:000170492400004
J	Rahman, MM; Vermund, SH; Wahed, MA; Fuchs, GJ; Baqui, AH; Alvarez, JO				Rahman, MM; Vermund, SH; Wahed, MA; Fuchs, GJ; Baqui, AH; Alvarez, JO			Simultaneous zinc and vitamin A supplementation in Bangladeshi children: randomised double blind controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RESPIRATORY-INFECTIONS; PRESCHOOL-CHILDREN; YOUNG-CHILDREN; ACUTE DIARRHEA; MORTALITY; IMPACT; MORBIDITY; PREVALENCE; EFFICACY; PROTEIN	Objective To evaluate the effect of simultaneous zinc and vitamin A supplementation on diarrhoea and acute lower respiratory infections in children. Study design Randomised double blind placebo controlled trial. Setting Urban slums of Dhaka, Bangladesh. Participants and methods 800 children aged 12-35 months were randomly assigned to one of four intervention groups: 20 mg zinc once daily for 14 days; 200 000 IU vitamin A, single dose on day 14; both zinc and vitamin A; placebo. The children were followed up once a week for six months, and morbidity information was collected. Results The incidence and prevalence of diarrhoea were lower in the zinc and vitamin A groups than in the placebo group. Zinc and vitamin A interaction had a rate ratio (95% confidence interval) of 0.79 (0.66 to 0.94) for the prevalence of persistent diarrhoea and 0.80 (0.67 to 0.95) for dysentery. Incidence (1.62; 1.16 to 2.25) and prevalence (2.07; 1.76 to 2.44) of acute lower respirator,,, infection were significantly higher in the zinc group than in the placebo group. The interaction term had rate ratios of 0.75 (0.46 to 1.20) for incidence and 0.58 (0.46 to 0.73) for prevalence of acute lower respiratory infection. Conclusions Combined zinc and vitamin A synergistically reduced the prevalence of persistent diarrhoea and dysentery. Zinc was associated with a significant increase in acute lower respiratory infection, but this adverse effect was reduced by the interaction between zinc and vitamin A.	Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh; Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol & Int Hlth, Birmingham, AL 35294 USA	International Centre for Diarrhoeal Disease Research (ICDDR); University of Alabama System; University of Alabama Birmingham	Rahman, MM (corresponding author), Stanford Univ, Sch Med, Div Infect Dis & Geog Med, 300 Pasteur Dr,S-025, Stanford, CA 94305 USA.	mujib_99@vahoo.com	Fuchs, George/GLV-1285-2022; Vermund, Sten/AAD-3592-2020	Fuchs, George/0000-0002-8679-8265; Vermund, Sten/0000-0001-7289-8698				ABDELJABER MH, 1991, AM J PUBLIC HEALTH, V81, P1654, DOI 10.2105/AJPH.81.12.1654; BARRETO ML, 1994, LANCET, V344, P228, DOI 10.1016/S0140-6736(94)92998-X; BHANDARI N, 1994, BRIT MED J, V309, P1404, DOI 10.1136/bmj.309.6966.1404; CHENG L, 1993, EUR J CLIN NUTR, V47, P88; Christian P, 1998, AM J CLIN NUTR, V68, p435S, DOI 10.1093/ajcn/68.2.435S; Dibley MJ, 1996, J NUTR, V126, P434, DOI 10.1093/jn/126.2.434; Doherty CP, 1998, AM J CLIN NUTR, V68, P742, DOI 10.1093/ajcn/68.3.742; Faruque ASG, 1999, ACTA PAEDIATR, V88, P154, DOI 10.1080/08035259950170312; FAWZI WW, 1993, JAMA-J AM MED ASSOC, V269, P898, DOI 10.1001/jama.269.7.898; MUSTAFA MG, 1971, J LAB CLIN MED, V77, P563; RAHMAN MM, 2001, IN PRESS AM J CLIN N; RAHMATHULLAH L, 1990, NEW ENGL J MED, V323, P929, DOI 10.1056/NEJM199010043231401; RAHMATHULLAH L, 1991, AM J CLIN NUTR, V54, P568, DOI 10.1093/ajcn/54.3.568; RAMAKRISHNAN U, 1995, AM J CLIN NUTR, V61, P1295, DOI 10.1093/ajcn/61.6.1295; ROSS DA, 1993, LANCET, V342, P7, DOI 10.1016/0140-6736(93)91879-Q; Ruel MT, 1997, PEDIATRICS, V99, P808, DOI 10.1542/peds.99.6.808; Sazawal S, 1996, J NUTR, V126, P443, DOI 10.1093/jn/126.2.443; Sazawal S, 1997, AM J CLIN NUTR, V66, P413, DOI 10.1093/ajcn/66.2.413; SCHLESINGER L, 1993, ACTA PAEDIATR, V82, P734, DOI 10.1111/j.1651-2227.1993.tb12548.x; Sempertegui F, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.1.e1; SHINGWEKAR AG, 1979, CLIN CHIM ACTA, V93, P97, DOI 10.1016/0009-8981(79)90249-3; SMITH JC, 1973, SCIENCE, V181, P954, DOI 10.1126/science.181.4103.954; SOMMER A, 1986, LANCET, V1, P1169; STANKOVA L, 1976, J LAB CLIN MED, V88, P640; STANSFIELD SK, 1993, LANCET, V342, P578, DOI 10.1016/0140-6736(93)91410-N; Stephensen CB, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.5.e3; SUGARMAN B, 1983, REV INFECT DIS, V5, P137; WEST KP, 1991, LANCET, V338, P67, DOI 10.1016/0140-6736(91)90070-6	28	101	104	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 11	2001	323	7308					314	318		10.1136/bmj.323.7308.314	http://dx.doi.org/10.1136/bmj.323.7308.314			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463HK	11498488	Green Published, Bronze			2022-12-28	WOS:000170470900019
J	Harrison, LH; Pass, MA; Mendelsohn, AB; Egri, M; Rosenstein, NE; Bustamante, A; Razeq, J; Roche, JC				Harrison, LH; Pass, MA; Mendelsohn, AB; Egri, M; Rosenstein, NE; Bustamante, A; Razeq, J; Roche, JC			Invasive meningococcal disease in adolescents and young adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEISSERIA-MENINGITIDIS; BACTERIAL-MENINGITIS; UNITED-STATES; VACCINE; PREVENTION; INFECTION; RISK	Context Incidence of invasive meningococcal disease has increased recently in persons aged 15 through 24 years. Objective To characterize meningococcal infection in adolescents and young adults in Maryland during the 1990s. Design and Setting Population-based surveillance study for meningococcal disease from January 1, 1990, through December 31, 1999, in Maryland. Patients Maryland residents diagnosed as having invasive meningococcal disease. Main Outcome Measure Invasive meningococcal infection. Results Of 295 total cases, 71 (24.1%) occurred among persons aged 15 through 24 years. Sixteen (22.5%) of these cases were fatal. The annual incidence rate increased from 0.9 to 2.1 cases per 100000 among 15 through 24 year olds (P=.01). The proportion of all disease increased from 16.0% to 28.9% (P=.03). The incidence and proportion of cases subsequently decreased to 1.0 and 16.4% in 1998 through 1999, respectively. Infection in 15 through 24 year olds was more likely to be fatal than infection in those younger than age 15 years (22.5% vs 4.6%; P=.001). Infection in 15 through 24 year olds, compared with those aged 25 years or older, was more likely to be associated with male sex (66.2% vs 34.8%; P<.001) and serogroup C infection (46.9% vs 20.2%; P<.001), respectively. Infections were potentially preventable with the licensed meningococcal vaccine in 82.8% of 15 through 24 year olds, 68.1% of those younger than 15 years, and 76.8% of adults aged 25 years or older. Conclusions Incidence of meningococcal infection in 15 through 24 year olds in Maryland increased and then declined during the 1990s. Infection in this age group was associated with an unusually high case-fatality ratio, and the vast majority of cases were potentially vaccine preventable.	Univ Pittsburgh, Infect Dis Epidemiol Res Unit, Grad Sch Publ Hlth, Pittsburgh, PA 15261 USA; Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Int Hlth, Baltimore, MD USA; Univ Pittsburgh, Sch Med, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; Ctr Dis Control & Prevent, Meningitis & Special Pathogens Branch, Natl Ctr Infect Dis, Atlanta, GA USA; Maryland Dept Hlth & Mental Hyg, Labs Adm, Baltimore, MD USA; Maryland Dept Hlth & Mental Hyg, Epidemiol & Dis Control Program, Baltimore, MD USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Centers for Disease Control & Prevention - USA; Maryland Department of Health & Mental Hygiene; Maryland Department of Health & Mental Hygiene	Harrison, LH (corresponding author), Univ Pittsburgh, Infect Dis Epidemiol Res Unit, Grad Sch Publ Hlth, 521 Parran Hall,130 DeSoto St, Pittsburgh, PA 15261 USA.	lharriso@edc.gsph.pitt.edu		Mendelsohn, Aaron/0000-0002-0560-1177				Abramson JS, 2000, PEDIATRICS, V106, P1500, DOI 10.1542/peds.106.6.1500; *ADV COMM IMM PRAC, 2000, MMWR-MORBID MORTAL W, V49, P13; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; [Anonymous], 1998, MMWR-MORBID MORTAL W, V47, P229; ARTENSTEIN MS, 1970, NEW ENGL J MED, V282, P417, DOI 10.1056/NEJM197002192820803; Barquet N, 1999, ARCH INTERN MED, V159, P2329, DOI 10.1001/archinte.159.19.2329; Carrol ED, 2000, ARCH DIS CHILD, V83, P271, DOI 10.1136/adc.83.3.271; Cookson ST, 1998, J INFECT DIS, V178, P266, DOI 10.1086/517450; Diermayer M, 1999, JAMA-J AM MED ASSOC, V281, P1493, DOI 10.1001/jama.281.16.1493; DURAND ML, 1993, NEW ENGL J MED, V328, P21, DOI 10.1056/NEJM199301073280104; FINN R, IN PRESS SO MED J; Fischer M, 1997, PEDIATR INFECT DIS J, V16, P979, DOI 10.1097/00006454-199710000-00015; FISCHER M, 1998, 36 ANN M INF DIS SOC; Froeschle JE, 1999, CLIN INFECT DIS, V29, P215, DOI 10.1086/520166; GOLD R, 1971, B WORLD HEALTH ORGAN, V45, P279; HARRISON LH, 1995, JAMA-J AM MED ASSOC, V273, P419, DOI 10.1001/jama.273.5.419; Harrison LH, 1999, JAMA-J AM MED ASSOC, V281, P1906, DOI 10.1001/jama.281.20.1906; Harrison LH, 1998, J INFECT DIS, V177, P998, DOI 10.1086/515260; HARRISON LH, 1987, EVOLUTION MENINGOCOC, V1, P27; HUDSON PJ, 1986, PEDIATR INFECT DIS J, V5, P213, DOI 10.1097/00006454-198603000-00011; Imrey PB, 1996, AM J EPIDEMIOL, V143, P624, DOI 10.1093/oxfordjournals.aje.a008792; IMREY PB, 1995, J CLIN MICROBIOL, V33, P3133, DOI 10.1128/JCM.33.12.3133-3137.1995; JACKSON LA, 1995, JAMA-J AM MED ASSOC, V273, P383, DOI 10.1001/jama.273.5.383; Jackson Lisa A., 1993, Morbidity and Mortality Weekly Report, V42, P21; Knapp JS, 1999, MANUAL CLIN MICROBIO, P586; MOORE PS, 1992, CLIN INFECT DIS, V14, P515, DOI 10.1093/clinids/14.2.515; PELTOLA H, 1982, LANCET, V2, P595; Rosenstein N, 1998, JAMA-J AM MED ASSOC, V279, P435, DOI 10.1001/jama.279.6.435; Rosenstein NE, 1999, J INFECT DIS, V180, P1894, DOI 10.1086/315158; SAEZNIETO JA, 1982, J HYG-CAMBRIDGE, V89, P139, DOI 10.1017/S0022172400070637; Schuchat A, 1997, NEW ENGL J MED, V337, P970, DOI 10.1056/NEJM199710023371404; STEPHENS DS, 1995, ANN INTERN MED, V123, P937, DOI 10.7326/0003-4819-123-12-199512150-00007; Tappero JW, 1996, NEW ENGL J MED, V335, P833, DOI 10.1056/NEJM199609193351201; WOODS CW, 1998, 36 ANN M INF DIS SOC; 2001, FACT SHEET YOUTH RIS; 2000, MOR MORTAL WKLY REP, V49, P1	36	99	99	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2001	286	6					694	699		10.1001/jama.286.6.694	http://dx.doi.org/10.1001/jama.286.6.694			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459VE	11495619				2022-12-28	WOS:000170271500025
J	Schatz, IJ; Masaki, K; Yano, K; Chen, R; Rodriguez, BL; Curb, JD				Schatz, IJ; Masaki, K; Yano, K; Chen, R; Rodriguez, BL; Curb, JD			Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study	LANCET			English	Article							LOW SERUM-CHOLESTEROL; PHYSICAL-ACTIVITY; MEN; DISEASE; CANCER; RISK; DEATH	Background A generally held belief is that cholesterol concentrations should be kept low to lessen the risk of cardiovascular disease. However, studies of the relation between serum cholesterol and all-cause mortality in elderly people have shown contrasting results. To investigate these discrepancies, we did a longitudinal assessment of changes in both lipid and serum cholesterol concentrations over 20 years, and compared them with mortality. Methods Lipid and serum cholesterol concentrations were measured in 3572 Japanese/American men (aged 71-93 years) as part of the Honolulu Heart Program. We compared changes in these concentrations over 20 years with all-case mortality using three different Cox proportional hazards models. Findings Mean cholesterol fell significantly with increasing age. Age-adjusted mortality rates were 68.3, 48.9, 41.1, and 43.3 for the first to fourth quartiles of cholesterol concentrations, respectively. Relative risks for mortality were 0.72 (95% CI 0.60-0.87), 0.60 (0.49-0.74), and 0.65 (0.53-0.80), in the second, third, and fourth quartiles, respectively, with quartile 1 as reference. A Cox proportional hazard model assessed changes in cholesterol concentrations between examinations three and four. Only the group with low cholesterol concentration at both examinations had a significant association with mortality (risk ratio 1.64, 95% CI 1.13-2.36). Interpretation We have been unable to explain our results. These data cast doubt on the scientific justification for lowering cholesterol to very low concentrations (<4.65 mmol/L) in elderly people.	Univ Hawaii Manoa, John A Burns Sch Med, Dept Med, Clin Epidemiol & Geriatr Div, Honolulu, HI 96813 USA; Kuakini Med Ctr, Honolulu, HI USA	University of Hawaii System; University of Hawaii Manoa	Schatz, IJ (corresponding author), Univ Hawaii Manoa, John A Burns Sch Med, Dept Med, Clin Epidemiol & Geriatr Div, 1356 Lusitana St,7th Floor, Honolulu, HI 96813 USA.	schatzi@hawaii.edu			NATIONAL INSTITUTE ON AGING [N01AG042149] Funding Source: NIH RePORTER; NIA NIH HHS [N0I-AG-4-2149] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abbott RD, 1997, ANN EPIDEMIOL, V7, P417, DOI 10.1016/S1047-2797(97)00043-4; Burchfiel CM, 1996, ANN EPIDEMIOL, V6, P490, DOI 10.1016/S1047-2797(96)00103-2; BURCHFIEL CM, 1995, AM J EPIDEMIOL, V141, P360, DOI 10.1093/aje/141.4.360; Corti MC, 1997, ANN INTERN MED, V126, P753, DOI 10.7326/0003-4819-126-10-199705150-00001; EPSTEIN FH, 1992, ATHEROSCLEROSIS, V94, P1, DOI 10.1016/0021-9150(92)90182-G; ETTINGER WH, 1995, J GERONTOL A-BIOL, V50, pM137, DOI 10.1093/gerona/50A.3.M137; Grundy S, 1996, CIRCULATION, V93, P1067; IRIBARREN C, 1995, CIRCULATION, V92, P2396, DOI 10.1161/01.CIR.92.9.2396; JACOBS DR, 1993, ANNU REV PUBL HEALTH, V14, P95; KANNEL WB, 1979, ARCH INTERN MED, V139, P857, DOI 10.1001/archinte.139.8.857; KRITCHEVSKY SB, 1992, ANNU REV NUTR, V12, P391, DOI 10.1146/annurev.nu.12.070192.002135; LAW MR, 1992, BRIT J CANCER, V65, P307, DOI 10.1038/bjc.1992.63; Manolio T A, 1992, Ann Epidemiol, V2, P161, DOI 10.1016/1047-2797(92)90051-Q; PEDERSEN TR, 1994, LANCET, V344, P1383; Rantanen T, 1999, JAMA-J AM MED ASSOC, V281, P558, DOI 10.1001/jama.281.6.558; Sharp DS, 1996, AM J RESP CRIT CARE, V153, P805, DOI 10.1164/ajrccm.153.2.8564136; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Song YM, 2000, AM J EPIDEMIOL, V151, P739, DOI 10.1093/oxfordjournals.aje.a010272; WORTH RM, 1970, J CHRON DIS, V23, P389, DOI 10.1016/0021-9681(70)90022-6; YANO K, 1984, AM J EPIDEMIOL, V119, P653, DOI 10.1093/oxfordjournals.aje.a113787; YOUNG DR, 1995, J AM GERIATR SOC, V43, P845, DOI 10.1111/j.1532-5415.1995.tb05525.x	21	307	316	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 4	2001	358	9279					351	355		10.1016/S0140-6736(01)05553-2	http://dx.doi.org/10.1016/S0140-6736(01)05553-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	459DE	11502313				2022-12-28	WOS:000170235100008
J	Temple, LKF; McLeod, RS; Gallinger, S; Wright, JG				Temple, LKF; McLeod, RS; Gallinger, S; Wright, JG			Defining disease in the genomics era	SCIENCE			English	Editorial Material									Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Surg, Toronto, ON M5G 1X5, Canada; Univ Toronto, Hosp Sick Children, Dept Surg, Toronto, ON M5G 1X8, Canada; Univ Toronto, Hosp Sick Children, Dept Publ Hlth Sci, Toronto, ON M5G 1X8, Canada; Univ Toronto, Hosp Sick Children, Dept Hlth Policy Management & Evaluat, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Temple, LKF (corresponding author), Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Surg, Toronto, ON M5G 1X5, Canada.		Gallinger, Steven/E-4575-2013; McLeod, Robin/K-1476-2013						0	50	51	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2001	293	5531					807	808		10.1126/science.1062938	http://dx.doi.org/10.1126/science.1062938			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11486074				2022-12-28	WOS:000170241000026
J	Basu, AR; Jacobsen, SB; Poreda, RJ; Dowling, CB; Aggarwal, PK				Basu, AR; Jacobsen, SB; Poreda, RJ; Dowling, CB; Aggarwal, PK			Large groundwater strontium flux to the oceans from the bengal basin and the marine strontium isotope record	SCIENCE			English	Article							HIMALAYAN RIVERS; WEATHERING PROCESSES; BRAHMAPUTRA RIVER; SR; SR-87/SR-86; EVOLUTION; SEAWATER; TECTONICS; BARIUM; RA-226	Strontium concentration and isotopic data for subsurface flowing groundwaters of the Ganges-Brahmaputra (G-B) delta in the Bengal Basin demonstrate that this is a potentially significant source of strontium to the oceans, equal in magnitude to the dissolved strontium concentration carried to the oceans by the G-B river waters. The strontium concentrations of groundwaters are higher by a factor of about 10 than typical G-B river waters and they have similar Sr-87/Sr-86 ratio to the river waters. These new data suggest that the present contribution of the G-B system to the rise in Sr-87/Sr-86 ratio in seawater is higher by at least a factor of 2 to 5 than the average over the past 40 million years.	Univ Rochester, Dept Earth & Environm Sci, Rochester, NY 14627 USA; Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; Int Atom Energy Agcy, Isotope Hydrol Sect, A-1400 Vienna, Austria	University of Rochester; Harvard University; International Atomic Energy Agency	Basu, AR (corresponding author), Univ Rochester, Dept Earth & Environm Sci, 601 Elmwood Ave, Rochester, NY 14627 USA.	abasu@earth.rochester.edu	aggarwal, pradeep/C-8367-2016; Jacobsen, Stein/B-1759-2013; Jacobsen, Stein/ABA-1063-2021	aggarwal, pradeep/0000-0001-5970-1408; Jacobsen, Stein/0000-0003-2164-0720				Blum JD, 1998, GEOLOGY, V26, P411, DOI 10.1130/0091-7613(1998)026<0411:CVSWIT>2.3.CO;2; CARROLL J, 1993, GEOCHIM COSMOCHIM AC, V57, P2981, DOI 10.1016/0016-7037(93)90287-7; Derry LA, 1996, EARTH PLANET SC LETT, V142, P59, DOI 10.1016/0012-821X(96)00091-X; DOWLING CB, 2000, EOS S, V81, pF524; EDMOND JM, 1992, SCIENCE, V258, P1594, DOI 10.1126/science.258.5088.1594; Galy A, 1999, GEOCHIM COSMOCHIM AC, V63, P1905, DOI 10.1016/S0016-7037(99)00081-2; Galy A, 1999, CHEM GEOL, V159, P31, DOI 10.1016/S0009-2541(99)00033-9; GOLDSTEIN SJ, 1987, CHEM GEOL, V66, P245, DOI 10.1016/0168-9622(87)90045-5; Harris N, 1998, CHEM GEOL, V144, P205, DOI 10.1016/S0009-2541(97)00132-0; HARRIS NBW, 1995, GEOLOGY, V23, P721; JACOBSEN SB, 1988, EARTH PLANET SC LETT, V90, P315, DOI 10.1016/0012-821X(88)90133-1; Jacobsen SB, 1999, CHEM GEOL, V161, P37, DOI 10.1016/S0009-2541(99)00080-7; Korzun V. I., 1978, STUDIES REPORTS HYDR, V25; KRISHNASWAMI S, 1992, EARTH PLANET SC LETT, V109, P243, DOI 10.1016/0012-821X(92)90087-C; LITHGOWBERTELLONI C, 1993, GEOPHYS RES LETT, V20, P375, DOI 10.1029/93GL00168; Moore WS, 1996, NATURE, V380, P612, DOI 10.1038/380612a0; Moore WS, 1997, EARTH PLANET SC LETT, V150, P141, DOI 10.1016/S0012-821X(97)00083-6; PALMER MR, 1992, GEOCHIM COSMOCHIM AC, V56, P2099, DOI 10.1016/0016-7037(92)90332-D; Quade J, 1997, SCIENCE, V276, P1828, DOI 10.1126/science.276.5320.1828; RAYMO ME, 1992, NATURE, V359, P117, DOI 10.1038/359117a0; RICHTER FM, 1992, EARTH PLANET SC LETT, V109, P11, DOI 10.1016/0012-821X(92)90070-C; Sharma M, 1999, GEOCHIM COSMOCHIM AC, V63, P4005, DOI 10.1016/S0016-7037(99)00305-1; ZEKSTER IS, 1993, J HYDROL, V144, P405	23	134	141	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2001	293	5534					1470	1473		10.1126/science.1060524	http://dx.doi.org/10.1126/science.1060524			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465XV	11520982				2022-12-28	WOS:000170616000039
J	Hastie, ND				Hastie, ND			Life, sex, and WT1 isoforms - Three amino acids can make all the difference	CELL			English	Review							SUPPRESSOR GENE WT1; MESSENGER-RNAS; TUMOR; APOPTOSIS; BINDING; PROTEIN; ENCODES; DOMAIN		Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Hastie, ND (corresponding author), Western Gen Hosp, MRC, Human Genet Unit, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland.	nick.hastie@hgu.mrc.ac.uk						Burnette JM, 1999, GENETICS, V151, P1517; Davies RC, 1998, GENE DEV, V12, P3217, DOI 10.1101/gad.12.20.3217; English MA, 1999, J BIOL CHEM, V274, P13258, DOI 10.1074/jbc.274.19.13258; EPSTEIN JA, 1994, GENE DEV, V8, P2022, DOI 10.1101/gad.8.17.2022; Hammes A, 2001, CELL, V106, P319, DOI 10.1016/S0092-8674(01)00453-6; Herzer U, 1999, CURR BIOL, V9, P837, DOI 10.1016/S0960-9822(99)80369-8; Hossain A, 2001, J BIOL CHEM, V276, P16817, DOI 10.1074/jbc.M009056200; Kim J, 1999, MOL CELL BIOL, V19, P2289; Koopman P, 2001, CELL, V105, P843, DOI 10.1016/S0092-8674(01)00408-1; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee SB, 1999, CELL, V98, P663, DOI 10.1016/S0092-8674(00)80053-7; Little M, 1999, BIOESSAYS, V21, P191, DOI 10.1002/(SICI)1521-1878(199903)21:3<191::AID-BIES3>3.3.CO;2-#; Mayo MW, 1999, EMBO J, V18, P3990, DOI 10.1093/emboj/18.14.3990; Moore AW, 1999, DEVELOPMENT, V126, P1845; Penalva LOF, 2000, GENETICS, V155, P129; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Zhai G, 2001, BIOCHEMISTRY-US, V40, P2032, DOI 10.1021/bi001941r	18	80	82	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 24	2001	106	4					391	394		10.1016/S0092-8674(01)00469-X	http://dx.doi.org/10.1016/S0092-8674(01)00469-X			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	466UU	11525724	Green Published, Bronze			2022-12-28	WOS:000170665200001
J	Campbell, P				Campbell, P			Declaration of financial interests - Introducing a new policy for authors of research papers in Nature and Nature journals.	NATURE			English	Editorial Material																			0	21	23	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 23	2001	412	6849					751	751		10.1038/35090688	http://dx.doi.org/10.1038/35090688			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465ET	11518924	Bronze			2022-12-28	WOS:000170577200001
J	Hubacher, D; Lara-Ricalde, R; Taylor, DJ; Guerra-Infante, F; Guzman-Rodriguez, R				Hubacher, D; Lara-Ricalde, R; Taylor, DJ; Guerra-Infante, F; Guzman-Rodriguez, R			Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PELVIC-INFLAMMATORY-DISEASE; HYSTEROSALPINGOGRAPHY; FERTILITY; ASSOCIATION; TESTS	Background: Previous studies of intrauterine devices (IUDs), many of which are no longer in use, suggested that they might cause tubal infertility. The concern that IUDs that contain copper - currently the most commonly used type - may increase the risk of infertility in nulligravid women has limited the use of this highly effective method of birth control. Methods: We conducted a case-control study of 1895 women recruited between 1997 and 1999. We enrolled 358 women with primary infertility who had tubal occlusion documented by hysterosalpingography, as well as 953 women with primary infertility who did not have tubal occlusion (infertile controls) and 584 primigravid women (pregnant controls). We collected information on the women's past use of contraceptives, including copper IUDs, previous sexual relationships, and history of genital tract infections. Each woman's blood was tested for antibodies to Chlamydia trachomatis. We used stratified analyses and logistic regression to assess the association between the previous use of a copper IUD and tubal occlusion. Results: In analyses involving the women with tubal occlusion and the infertile controls, the odds ratio for tubal occlusion associated with the previous use of a copper IUD was 1.0 (95 percent confidence interval, 0.6 to 1.7). When the primigravid women served as the controls, the corresponding odds ratio was 0.9 (95 percent confidence interval, 0.5 to 1.6). Tubal infertility was not associated with the duration of IUD use, the reason for the removal of the IUD, or the presence or absence of gynecologic problems related to its use. The presence of antibodies to chlamydia was associated with infertility. Conclusions: The previous use of a copper IUD is not associated with an increased risk of tubal occlusion among nulligravid women, whereas infection with C. trachomatis is.	Family Hlth Int, Res Triangle Pk, NC 27709 USA; Natl Perinatol Inst, Mexico City, DF, Mexico		Hubacher, D (corresponding author), Family Hlth Int, POB 13950, Res Triangle Pk, NC 27709 USA.	dhubacher@fhi.org	Guerra-Infante, Fernando M./F-5844-2012	Guerra-Infante, Fernando M./0000-0001-8730-0484	NICHD NIH HHS [Y1-HD-7230-01] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ABMA JC, 1997, VITAL HLTH STAT 23, V19; *AM SOC REPR MED, 2000, OPT EV INF FEM COMM; [Anonymous], 1988, FERTIL STERIL, V49, P944, DOI 10.1016/s0015-0282(16)59942-7; [Anonymous], 1987, World Health Organ Tech Rep Ser, V753, P1; [Anonymous], 1995, Sex Transm Dis, V22, P71; Anwar M, 1993, Asia Oceania J Obstet Gynaecol, V19, P77; Brabin L, 1998, B WORLD HEALTH ORGAN, V76, P277; BUCHAN H, 1990, BRIT J OBSTET GYNAEC, V97, P780, DOI 10.1111/j.1471-0528.1990.tb02571.x; BURKMAN RT, 1981, OBSTET GYNECOL, V57, P269; CATES W, 1990, EPIDEMIOL REV, V12, P199, DOI 10.1093/oxfordjournals.epirev.a036054; CHERNESKY MA, 1999, SEXUALLY TRANSMITTED, P1281; CRAMER DW, 1985, NEW ENGL J MED, V312, P941, DOI 10.1056/NEJM198504113121502; DABEKAUSEN YAJM, 1994, FERTIL STERIL, V61, P833; DALING JR, 1985, NEW ENGL J MED, V312, P937, DOI 10.1056/NEJM198504113121501; DALING JR, 1992, NEW ENGL J MED, V326, P203; Doll H, 2001, BRIT J OBSTET GYNAEC, V108, P304, DOI 10.1111/j.1471-0528.2001.00075.x; EggertKruse W, 1997, HUM REPROD, V12, P1464, DOI 10.1093/humrep/12.7.1464; FARLEY TMM, 1992, LANCET, V339, P785, DOI 10.1016/0140-6736(92)91904-M; Gareen IF, 2000, EPIDEMIOLOGY, V11, P589, DOI 10.1097/00001648-200009000-00016; Grimes DA, 2000, LANCET, V356, P1013, DOI 10.1016/S0140-6736(00)02699-4; Hillis SD, 1999, OBSTET GYNECOL, V93, P889, DOI 10.1016/S0029-7844(98)00539-0; ISMAJOVICH B, 1986, INT J GYNECOL OBSTET, V24, P9, DOI 10.1016/0020-7292(86)90016-0; KARANDE VC, 1995, FERTIL STERIL, V63, P1167, DOI 10.1016/S0015-0282(16)57591-8; KRAMER RL, 1989, OBSTET GYNECOL, V73, P300; KRONMAL RA, 1991, J CLIN EPIDEMIOL, V44, P109, DOI 10.1016/0895-4356(91)90259-C; LALOS O, 1988, EUR J OBSTET GYN R B, V29, P129, DOI 10.1016/0028-2243(88)90139-6; LEE NC, 1991, OBSTET GYNECOL, V77, P425; LEE NC, 1983, OBSTET GYNECOL, V62, P1; Schlesselman JJ, 1982, CASE CONTROL STUDIES; Schmidt JE, 2000, FERTIL STERIL, V74, P892, DOI 10.1016/S0015-0282(00)01558-2; SKJELDESTAD F, 1988, Advances in Contraceptive Delivery Systems, V4, P179, DOI 10.1007/BF01849435; TaylorRobinson D, 1996, INT J STD AIDS, V7, P19, DOI 10.1258/0956462961917159; Thomas K, 2000, HUM REPROD, V15, P1079, DOI 10.1093/humrep/15.5.1079; TRIEMAN K, 1995, POPUL REP B, V22, P1; TRUSSELL J, 1995, AM J PUBLIC HEALTH, V85, P494, DOI 10.2105/AJPH.85.4.494; Tuuminen T, 2000, J MICROBIOL METH, V42, P265, DOI 10.1016/S0167-7012(00)00209-8; Urbach DR, 2001, AM J EPIDEMIOL, V153, P566, DOI 10.1093/aje/153.6.566; VESSEY M, 1976, Journal of Biosocial Science, V8, P373; VESSEY MP, 1981, BRIT MED J, V282, P855, DOI 10.1136/bmj.282.6267.855; Walsh T, 1998, LANCET, V351, P1005, DOI 10.1016/S0140-6736(97)09086-7; WESTROM L, 1975, AM J OBSTET GYNECOL, V121, P707, DOI 10.1016/0002-9378(75)90477-9; WESTROM L, 1999, SEXUALLY TRANSMITTED, P783; WILSON JC, 1989, AM J OBSTET GYNECOL, V160, P391, DOI 10.1016/0002-9378(89)90455-9	43	201	207	2	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 23	2001	345	8					561	567		10.1056/NEJMoa010438	http://dx.doi.org/10.1056/NEJMoa010438			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464ZH	11529209				2022-12-28	WOS:000170562900002
J	Blanck, HM; Khan, LK; Serdula, MK				Blanck, HM; Khan, LK; Serdula, MK			Use of nonprescription weight loss products - Results from a multistate survey	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DIETARY-SUPPLEMENTS; UNITED-STATES; DOUBLE-BLIND; PHENYLPROPANOLAMINE; PLACEBO; OBESITY	Context Lifestyle changes to lose weight can be difficult; hence, both prescription and nonprescription diet products are appealing. Usage patterns of the nonprescription products phenylpropanolamine (PPA) and ephedra are of particular interest because of recent safety concerns. Objective To estimate the prevalence of overall and specific nonprescription weight loss product use by demographic characteristics, prescription diet pill use, diabetic status, and lifestyle choices. Design and Setting The Behavioral Risk Factor Surveillance System, a random-digit telephone survey conducted in 1998 in 5 states. Florida, Iowa, Michigan, West Virginia, and Wisconsin. Participants Population-based sample of 14679 non institutionalized adults IS years or older. Main Outcome Measures Prevalence of nonprescription weight loss product use in 1996-1998. Results Seven percent reported overall nonprescription weight loss product use, 2% reported PPA use, and 1% reported ephedra product use. Overall use was especially common among young obese women (28.4%). Moreover, 7.9% of normal-weight women reported use. There was no difference in nonprescription weight loss product use by daily consumption of fruits and vegetables; however, more users than nonusers reported being physically active (for those who exercised greater than or equal to 30 minutes 5 times per week, odds ratio, 1.5, 95% confidence interval, 1.2-2.0). Among prescription weight loss product users, 33.8% also took nonprescription product. Conclusions With increasing rates of obesity, nonprescription product use is likely to increase. Clinicians should know about their patients' use of both prescription and nonprescription weight loss products.	Ctr Dis Control & Prevent, Div Nutr & Phys Act, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA; Ctr Dis Control & Prevent, Epidem Intelligence Serv, Div Appl Publ Hlth Training, Epidemiol Program Off, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Blanck, HM (corresponding author), Ctr Dis Control & Prevent, Div Nutr & Phys Act, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Hwy NE,MS K-26, Atlanta, GA 30341 USA.							Allison DB, 2001, CRIT REV FOOD SCI, V41, P1, DOI 10.1080/20014091091661; ASTRUP A, 1991, METABOLISM, V40, P323, DOI 10.1016/0026-0495(91)90117-F; ASTRUP A, 1992, INT J OBESITY, V16, P269; BRADLEY JG, 1991, POSTGRAD MED, V90, P43; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; *FDA, 2000, PUBL HLTH ADV SUBJ S; *FDA, 2000, DIET SUPPL CONT SPH; Greenway F, 1999, OBES RES, V7, P370, DOI 10.1002/j.1550-8528.1999.tb00420.x; Gurley BJ, 2000, AM J HEALTH-SYST PH, V57, P963, DOI 10.1093/ajhp/57.10.963; Haller CA, 2000, NEW ENGL J MED, V343, P1833, DOI 10.1056/NEJM200012213432502; Hankin J, 2000, J AM DIET ASSOC, V100, P419, DOI 10.1016/S0002-8223(00)00129-2; INSEL PA, 1991, BETA ADRENERGIC RECE, P295; Kernan WN, 2000, NEW ENGL J MED, V343, P1826, DOI 10.1056/NEJM200012213432501; LAKE CR, 1990, AM J MED, V89, P195, DOI 10.1016/0002-9343(90)90299-S; LEAVY AS, 1993, ANN INTERN MED 2, V119, P661; Lewis CJ, 2001, CRIT REV FOOD SCI, V41, P43, DOI 10.1080/20014091091724; Mokdad AH, 1999, JAMA-J AM MED ASSOC, V282, P1519, DOI 10.1001/jama.282.16.1519; NELSON DE, 1998, P SECT SURV METH AM; PENTEL P, 1984, JAMA-J AM MED ASSOC, V252, P1898, DOI 10.1001/jama.252.14.1898; Radimer KL, 2000, J AM DIET ASSOC, V100, P447, DOI 10.1016/S0002-8223(00)00137-1; Shah BV, 1997, SUDAAN USERS MANUAL; U.S. Department of Health and Human Services, 1996, 76200 US DEP HLTH HU; WILLARD HF, 1990, CHROMOSOMES TODAY, V10, P47; 2000, FED REG, V65, P17477; 1997, FED REG, V62, P30677; [No title captured]	26	97	103	0	10	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2001	286	8					930	935		10.1001/jama.286.8.930	http://dx.doi.org/10.1001/jama.286.8.930			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465EU	11509057	Bronze			2022-12-28	WOS:000170577300027
J	Illei, GG; Austin, HA; Crane, M; Collins, L; Gourley, MF; Yarboro, CH; Vaughan, EM; Kuroiwa, T; Danning, CL; Steinberg, AD; Klippel, JH; Balow, JE; Boumpas, DT				Illei, GG; Austin, HA; Crane, M; Collins, L; Gourley, MF; Yarboro, CH; Vaughan, EM; Kuroiwa, T; Danning, CL; Steinberg, AD; Klippel, JH; Balow, JE; Boumpas, DT			Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis	ANNALS OF INTERNAL MEDICINE			English	Article							STEM-CELL TRANSPLANTATION; MYCOPHENOLATE-MOFETIL THERAPY; CONTROLLED-TRIAL; INTRAVENOUS CYCLOPHOSPHAMIDE; AUTOIMMUNE-DISEASE; ERYTHEMATOSUS; GLOMERULONEPHRITIS; AZATHIOPRINE; PREDNISONE; REMISSION	Background: controlled trials in lupus nephritis have demonstrated that cyclophosphamide therapy is superior to corticosteroid therapy alone. The long-term effectiveness and side-effect profiles of pulse immunosuppressive regimens warrant further study. Objective: To define the long-term risk and benefit of monthly treatment with boluses of methylprednisolone, cyclophosphamide, or both. Design: Extended follow-up (median, 11 years) of a randomized, controlled trial. Setting: U.S. government research hospital. Patients: 82 patients with proliferative lupus nephritis. Measurements: Rates of treatment failure (defined as need for supplemental immunosuppressive therapy or doubling of serum creatinine concentration, or death) and adverse events. Results: In an intention-to-treat survival analysis, the likelihood of treatment failure was significantly lower in the cyclophosphamide (P = 0.04) and combination therapy (P = 0.002) groups than In the methylprednisolone group. Combination therapy and cyclophosphamide therapy alone did not differ statistically in terms of effectiveness or adverse events. Of patients who completed the protocol (n = 65), the proportion of patients who had doubling of serum creatinine concentration was significantly lower in the combination group than in the cyclophosphamide group (relative risk, 0.095 [95% Cl, 0.01 to 0.842]). Conclusion: With extended follow-up, pulse cyclophosphamide continued to show superior efficacy over pulse methylprednisolone alone for treatment of lupus nephritis. The combination of pulse cyclophosphamide and methylprednisolone appears to provide additional benefit over pulse cyclophosphamide alone and does not confer additional risk for adverse events.	NIAMSD, Arthrit & Rheumatism Branch, NIH, Bethesda, MD 20892 USA; NIDDKD, Skin Dis & Kidney Dis Sect, NIH, Bethesda, MD 20892 USA; Washington Hosp Ctr, Washington, DC 20010 USA; Mitretek Syst, Mclean, VA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); MedStar Washington Hospital Center	Illei, GG (corresponding author), NIAMSD, Arthrit & Rheumatism Branch, NIH, 10 Ctr Dr,Bldg 10,Room 9S-205, Bethesda, MD 20892 USA.	illeig@exchange.nih.gov						AUSTIN HA, 1986, NEW ENGL J MED, V314, P614, DOI 10.1056/NEJM198603063141004; BAKIR AA, 1994, AM J KIDNEY DIS, V24, P159, DOI 10.1016/S0272-6386(12)80177-6; Balow JE, 2000, SEMIN NEPHROL, V20, P32; BELMONT HM, 1995, LUPUS, V4, P104, DOI 10.1177/096120339500400205; Berden JHM, 1997, KIDNEY INT, V52, P538, DOI 10.1038/ki.1997.365; Bono L, 1999, QJM-INT J MED, V92, P211, DOI 10.1093/qjmed/92.4.211; BOUMPAS DT, 1993, ANN INTERN MED, V119, P366, DOI 10.7326/0003-4819-119-5-199309010-00003; BOUMPAS DT, 1992, LANCET, V340, P741, DOI 10.1016/0140-6736(92)92292-N; Brodsky RA, 1998, ANN INTERN MED, V129, P1031, DOI 10.7326/0003-4819-129-12-199812150-00007; CARETTE S, 1983, ANN INTERN MED, V99, P1, DOI 10.7326/0003-4819-99-1-1; DCruz D, 1997, CLIN EXP RHEUMATOL, V15, P275; DECKER JL, 1975, ANN INTERN MED, V83, P606, DOI 10.7326/0003-4819-83-5-606; Dooley MA, 1999, J AM SOC NEPHROL, V10, P833; Dooley MA, 1997, KIDNEY INT, V51, P1188, DOI 10.1038/ki.1997.162; Glicklich D, 1998, AM J KIDNEY DIS, V32, P318, DOI 10.1053/ajkd.1998.v32.pm9708620; Gourley MF, 1996, ANN INTERN MED, V125, P549, DOI 10.7326/0003-4819-125-7-199610010-00003; Gur-Lavi M, 1999, ARTHRITIS RHEUM, V42, P1777, DOI 10.1002/1529-0131(199908)42:8<1777::AID-ANR30>3.0.CO;2-C; Hochberg MC, 1996, ARTHRITIS RHEUM-US, V39, P1791; Huong DLT, 1999, MEDICINE, V78, P148; Ioannidis JPA, 2000, KIDNEY INT, V57, P258, DOI 10.1046/j.1523-1755.2000.00832.x; Lehman TJA, 2000, J PEDIATR-US, V136, P243, DOI 10.1016/S0022-3476(00)70109-0; LEWIS EJ, 1992, NEW ENGL J MED, V326, P1373, DOI 10.1056/NEJM199205213262101; Marmont AM, 1998, HAEMATOLOGICA, V83, P733; Moroni G, 1999, AM J KIDNEY DIS, V34, P530, DOI 10.1016/S0272-6386(99)70082-X; Moroni G, 1996, KIDNEY INT, V50, P2047, DOI 10.1038/ki.1996.528; Nagahama M, 2000, J CANCER RES CLIN, V126, P101, DOI 10.1007/PL00008480; Niaudet P, 2000, PEDIATR NEPHROL, V14, P158, DOI 10.1007/s004670050034; STEINBER.AD, 1971, ANN INTERN MED, V75, P165, DOI 10.7326/0003-4819-75-2-165; STEINBERG AD, 1991, ARTHRITIS RHEUM-US, V34, P945, DOI 10.1002/art.1780340803; STEINBERG AD, 1974, ARTHRITIS RHEUM, V17, P923, DOI 10.1002/art.1780170602; Traynor A, 1999, RHEUMATOLOGY, V38, P767, DOI 10.1093/rheumatology/38.8.767; Tyndall A, 1999, BONE MARROW TRANSPL, V24, P729, DOI 10.1038/sj.bmt.1701987; VALERI A, 1994, CLIN NEPHROL, V42, P71	33	346	379	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 21	2001	135	4					248	257		10.7326/0003-4819-135-4-200108210-00009	http://dx.doi.org/10.7326/0003-4819-135-4-200108210-00009			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465KE	11511139				2022-12-28	WOS:000170587500003
J	Cliffe, S; Tookey, PA; Nicoll, A				Cliffe, S; Tookey, PA; Nicoll, A			Antenatal detection of HIV: national surveillance and unlinked anonymous survey	BRITISH MEDICAL JOURNAL			English	Article							TRANSMISSION		Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London WC1N 1EH, England; Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, HIV & STI Div, London NW9 5EQ, England	University of London; University College London; Public Health England	Cliffe, S (corresponding author), Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, 30 Guilford St, London WC1N 1EH, England.		Tookey, Pat A/G-2732-2010	Tookey, Pat A/0000-0001-6258-0387				*COMM DIS SURV CTR, 2001, COMMUNICAB DIS REP, P11; Duong T, 1999, BRIT MED J, V319, P1227, DOI 10.1136/bmj.319.7219.1227; *INT WORK PART, 1998, RED MOTH CHILD TRANS; Ratcliffe J, 1998, AIDS, V12, P1381, DOI 10.1097/00002030-199811000-00021; *UK HLTH DEP, 1999, TARG AIM RED NUMB CH	5	20	20	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 18	2001	323	7309					376	377		10.1136/bmj.323.7309.376	http://dx.doi.org/10.1136/bmj.323.7309.376			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465GN	11509430	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000170581400021
J	Snaith, ML				Snaith, ML			Gout: diet and uric acid revisited	LANCET			English	Editorial Material							WEIGHT-LOSS; PLASMA; URATE		Univ Sheffield, Sch Med, Dept Rheumatol, Sheffield S10 2RX, S Yorkshire, England	University of Sheffield	Snaith, ML (corresponding author), Univ Sheffield, Sch Med, Dept Rheumatol, Sheffield S10 2RX, S Yorkshire, England.							Dessein PH, 2000, ANN RHEUM DIS, V59, P539, DOI 10.1136/ard.59.7.539; FACCHINI F, 1991, JAMA-J AM MED ASSOC, V266, P3008, DOI 10.1001/jama.266.21.3008; GERTLER MN, ANN INTERN MED, V34, P1421; GUTMAN AB, 1957, AM J MED, P23600; HAVELOCK E, 1904, STUDY BRIT GENIUS; MYERS AR, 1968, AM J MED, V45, P520, DOI 10.1016/0002-9343(68)90168-X; NICHOLLS A, 1972, LANCET, V2, P1223; Phillips M, 2000, ARTHRITIS RHEUM, V43, pS401; Porter Roy, 1998, GOUT PATRICIAN MALAD; RUNDLES RW, 1966, ANN INTERN MED, V64, P229, DOI 10.7326/0003-4819-64-2-229; SIMKIN PA, 1977, ANN INTERN MED, V86, P230, DOI 10.7326/0003-4819-86-2-230; TALBOTT JH, 1981, SEMIN ARTHRITIS RHEU, V11, P288, DOI 10.1016/0049-0172(81)90094-9; WROTMANN RL, 1997, ARTHRITIS ALLIED CON, P2078; WYNGAARDEN JB, 1974, AM J MED, V56, P651, DOI 10.1016/0002-9343(74)90632-9; YAMASHITA S, 1986, INT J OBESITY, V10, P255; YU TF, 1974, AM J MED, V56, P676, DOI 10.1016/0002-9343(74)90634-2	16	22	23	1	11	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 18	2001	358	9281					525	525		10.1016/S0140-6736(01)05745-2	http://dx.doi.org/10.1016/S0140-6736(01)05745-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464NB	11520519				2022-12-28	WOS:000170537700006
J	Graham, DJ; Drinkard, CR; Shatin, D; Tsong, Y; Burgess, MJ				Graham, DJ; Drinkard, CR; Shatin, D; Tsong, Y; Burgess, MJ			Liver enzyme monitoring in patients treated with troglitazone	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEPATIC-FAILURE	Context Soon after initial marketing in March 1997, troglitazone, the first thiazolidinedione antidiabetic agent, was found to cause life-threatening acute liver failure. The drug was removed from the market in March 2000. Objective To evaluate the effect of US Food and Drug Administration (FDA) risk management efforts, including repeated labeling changes and "Dear Healthcare Professional" letters, on periodic liver enzyme monitoring of patients taking troglitazone. Design, Setting, and Participants Claims data from a large, multistate managed care organization were used to establish 4 cohorts of patients (N = 7603) with at least 90 days of health plan enrollment before first troglitazone prescription during 4 consecutive periods spanning April 1997 to September 1999 and representing 4 progressively stringent liver monitoring recommendations. Main Outcome Measures Percentage of eligible troglitazone users in each cohort with baseline, monthly (for up to 6 months of continuous use), and complete (baseline and monthly) enzyme monitoring, based on computerized records of laboratory claims. Results Baseline testing increased from 15% before any FDA monitoring recommendations (cohort 1) to 44.6% following 4 separate FDA interventions (cohort 4; P<.001). In cohort 4, 33.4% of users had follow-up testing after 1 month of therapy, falling to 13% after 5 months of continuous use. in all cohorts, less than 5% received all recommended liver enzyme tests by the third month of continuous use. Conclusions The FDA risk management efforts did not achieve meaningful or sustained improvement in liver enzyme testing. Evaluation of the impact of regulatory actions is needed before such actions can be regarded as effective or sufficient.	US FDA, Off Postmarketing Drug Risk Assessment, Rockville, MD 20857 USA; US FDA, Off Biostat, Ctr Drug Evaluat & Res, Rockville, MD 20857 USA; United Hlth Grp, Ctr Hlth Care Policy & Evaluat, Minneapolis, MN USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); UnitedHealth Group Incorporated	Graham, DJ (corresponding author), US FDA, Off Postmarketing Drug Risk Assessment, 5600 Fishers Ln,HFD-400,Room 15B-32, Rockville, MD 20857 USA.				FDA HHS [FD-U-000149, FD-U-0001643-01/02] Funding Source: Medline	FDA HHS		ALVIR JMJ, 1993, NEW ENGL J MED, V329, P162, DOI 10.1056/NEJM199307153290303; Gitlin N, 1998, ANN INTERN MED, V129, P36, DOI 10.7326/0003-4819-129-1-199807010-00008; GRAHAM DJ, 1999, FDA MET END DRUGS AD; Herrine SK, 1999, ANN INTERN MED, V130, P163, DOI 10.7326/0003-4819-130-2-199901190-00021; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Honigfeld G, 1998, J CLIN PSYCHIAT, V59, P3; Jagannath S, 2000, ANN INTERN MED, V132, P677, DOI 10.7326/0003-4819-132-8-200004180-00021; Murphy EJ, 2000, DIGEST DIS SCI, V45, P549, DOI 10.1023/A:1005405526283; Neuschwander-Tetri BA, 1998, ANN INTERN MED, V129, P38, DOI 10.7326/0003-4819-129-1-199807010-00009; REZULIN, 1998, PHYSICIANS DESK REFE, P2218; Shibuya A, 1998, DIABETES CARE, V21, P2140, DOI 10.2337/diacare.21.12.2140; SIGMUND WR, 1998, IMPORTANT DRUG WARNI; SIGMUND WR, 1997, IMPORTANT DRUG WARNI; Smalley W, 2000, JAMA-J AM MED ASSOC, V284, P3036, DOI 10.1001/jama.284.23.3036; Stolberg Sheryl Gay, 1999, N Y Times Web, pA9; Walker A M, 1995, Arch Fam Med, V4, P24, DOI 10.1001/archfami.4.1.24	16	104	106	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2001	286	7					831	833		10.1001/jama.286.7.831	http://dx.doi.org/10.1001/jama.286.7.831			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	462PU	11497537	Bronze			2022-12-28	WOS:000170429600031
J	Bauchner, H; Sharfstein, J				Bauchner, H; Sharfstein, J			Failure to report ethical approval in child health research: review of published papers	BRITISH MEDICAL JOURNAL			English	Article							INFORMED CONSENT; BOARD APPROVAL	More than 500 journals Have adopted the uniform requirements of the International Committee of Medical Journal Editors, which stipulate that authors should "indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation:" One major purpose of institutional review is to ensure that informed consent is obtained when possible. We investigated how often research publications about child health report ethics committee approval or unformed consent.	Agcy Healthcare Res & Qual, Rockville, MD 20852 USA; Boston Univ, Sch Med, Dept Pediat, Div Gen Pediat, Boston, MA 02118 USA	Agency for Healthcare Research & Quality; Boston University	Bauchner, H (corresponding author), Agcy Healthcare Res & Qual, Rockville, MD 20852 USA.			Bauchner, Howard/0000-0002-8368-9805				Amdur RJ, 1997, JAMA-J AM MED ASSOC, V277, P909, DOI 10.1001/jama.277.11.909; Rennie D, 1997, JAMA-J AM MED ASSOC, V277, P922, DOI 10.1001/jama.277.11.922; Rikkert MGMO, 1996, BMJ-BRIT MED J, V313, P1117, DOI 10.1136/bmj.313.7065.1117; Sharp J, 2019, FACEBOOKS ROLE HLTH; Smith R, 1997, BRIT MED J, V314, P1059, DOI 10.1136/bmj.314.7087.1059	5	36	38	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 11	2001	323	7308					318	319		10.1136/bmj.323.7308.318	http://dx.doi.org/10.1136/bmj.323.7308.318			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463HK	11498489	Bronze, Green Published			2022-12-28	WOS:000170470900020
J	Hentze, MW				Hentze, MW			Protein synthesis - Believe it or not-translation in the nucleus	SCIENCE			English	Editorial Material							TRANSFER-RNAS; SURVEILLANCE; EXPORT		European Mol Biol Lab, Gene Express Programme, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Hentze, MW (corresponding author), European Mol Biol Lab, Gene Express Programme, Meyerhofstr 1, D-69117 Heidelberg, Germany.		Hentze, Matthias W/V-3980-2017	Hentze, Matthias W/0000-0002-4023-7876				Arts GJ, 1998, EMBO J, V17, P7430, DOI 10.1093/emboj/17.24.7430; Dostie J, 2000, J CELL BIOL, V148, P239, DOI 10.1083/jcb.148.2.239; GOIDL JA, 1978, TRENDS BIOCHEM SCI, V3, pN225; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Iborra FJ, 2001, SCIENCE, V293, P1139, DOI 10.1126/science.1061216; LAKE JA, 1994, P NATL ACAD SCI USA, V91, P2880, DOI 10.1073/pnas.91.8.2880; Li SL, 1998, IMMUNITY, V8, P135, DOI 10.1016/S1074-7613(00)80466-5; Lund E, 1998, SCIENCE, V282, P2082, DOI 10.1126/science.282.5396.2082; Mangiarotti G, 1999, BIOCHEMISTRY-US, V38, P3996, DOI 10.1021/bi9822022; Maquat LE, 2001, CELL, V104, P173, DOI 10.1016/S0092-8674(01)00202-1; MUHLEMANN O, IN PRESS MOL CELL	11	25	26	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2001	293	5532					1058	1059		10.1126/science.1063290	http://dx.doi.org/10.1126/science.1063290			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498567				2022-12-28	WOS:000170432600035
J	Rescigno, M; Borrow, P				Rescigno, M; Borrow, P			The host-pathogen interaction: New themes from dendritic cell biology	CELL			English	Review							MATURATION; VIRUS; INFECTION		Univ Milano Bicocca, Dept Biosci & Biotechnol U3, I-20126 Milan, Italy; Edward Jenner Inst Vaccine Res, Newbury RG20 7NN, Berks, England	University of Milano-Bicocca	Rescigno, M (corresponding author), Univ Milano Bicocca, Dept Biosci & Biotechnol U3, Piazza Sci 2, I-20126 Milan, Italy.		Rescigno, Maria/J-9704-2012	Rescigno, Maria/0000-0002-6464-509X; Borrow, Persephone/0000-0002-3877-9780				Cella M, 1999, J EXP MED, V189, P821, DOI 10.1084/jem.189.5.821; Engelmayer J, 1999, J IMMUNOL, V163, P6762; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Gewirtz AT, 2001, J CLIN INVEST, V107, P99, DOI 10.1172/JCI10501; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Kaisho T, 2001, TRENDS IMMUNOL, V22, P78, DOI 10.1016/S1471-4906(00)01811-1; Larsson M, 2001, TRENDS IMMUNOL, V22, P141, DOI 10.1016/S1471-4906(01)01860-9; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; MacDonald GH, 2000, J VIROL, V74, P914, DOI 10.1128/JVI.74.2.914-922.2000; Neutra MR, 1999, CURR TOP MICROBIOL, V236, P17; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Salio M, 1999, EUR J IMMUNOL, V29, P3245, DOI 10.1002/(SICI)1521-4141(199910)29:10<3245::AID-IMMU3245>3.3.CO;2-O; Stahl-Hennig C, 1999, SCIENCE, V285, P1261, DOI 10.1126/science.285.5431.1261; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Urban BC, 1999, NATURE, V400, P73, DOI 10.1038/21900	15	114	120	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 10	2001	106	3					267	270		10.1016/S0092-8674(01)00454-8	http://dx.doi.org/10.1016/S0092-8674(01)00454-8			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RJ	11509175	Bronze			2022-12-28	WOS:000170433300004
J	FitzGerald, GA; Patrono, C				FitzGerald, GA; Patrono, C			Drug therapy: The coxibs, selective inhibitors of cyclooxygenase-2.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; RANDOMIZED CONTROLLED TRIAL; PROSTAGLANDIN ENDOPEROXIDE SYNTHASE-1; HELICOBACTER-PYLORI INFECTION; PLACEBO-CONTROLLED TRIAL; RHEUMATOID-ARTHRITIS; GASTROINTESTINAL TOXICITY; INDUCIBLE CYCLOOXYGENASE; EICOSANOID BIOSYNTHESIS; INFLAMMATORY RESPONSE		Univ Penn, Dept Pharmacol, Ctr Expt Therapeut, Philadelphia, PA 19104 USA; Univ G dAnnunzio, Dept Med, Chieti, Italy; Univ G dAnnunzio, Ctr Excellence Aging, Chieti, Italy	University of Pennsylvania; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	FitzGerald, GA (corresponding author), Univ Penn, Dept Pharmacol, Ctr Expt Therapeut, 153 Johnson Pavil,3620 Hamilton Walk, Philadelphia, PA 19104 USA.	garret@spirit.gcrc.upenn.edu	FitzGerald, Garret A/A-4222-2010	Patrono, Carlo/0000-0002-6447-2424	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000040] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL062250, R01HL057847] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR00040] Funding Source: Medline; NHLBI NIH HHS [HL 62250, HL 57847] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adderley SR, 1999, J BIOL CHEM, V274, P5038, DOI 10.1074/jbc.274.8.5038; *ANT TRIAL COLL, IN PRESS BMJ; Bensen WG, 1999, MAYO CLIN PROC, V74, P1095, DOI 10.4065/74.11.1095; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Bourgeois P., 1994, European Journal of Rheumatology and Inflammation, V14, P39; BRADEN GA, 1991, CIRCULATION, V84, P679, DOI 10.1161/01.CIR.84.2.679; Cannon GW, 2000, ARTHRITIS RHEUM-US, V43, P978, DOI 10.1002/1529-0131(200005)43:5<978::AID-ANR4>3.0.CO;2-0; Catella-Lawson F, 1999, J PHARMACOL EXP THER, V289, P735; Chan CC, 1999, J PHARMACOL EXP THER, V290, P551; Clemett D, 2000, DRUGS, V59, P957, DOI 10.2165/00003495-200059040-00017; Crofford LJ, 2000, ARTHRITIS RHEUM, V43, P1891, DOI 10.1002/1529-0131(200008)43:8<1891::AID-ANR28>3.0.CO;2-R; CROFFORD LJ, 1994, J CLIN INVEST, V93, P1095, DOI 10.1172/JCI117060; Cryer B, 1998, AM J MED, V104, P413, DOI 10.1016/S0002-9343(98)00091-6; Cullen L, 1998, J PHARMACOL EXP THER, V287, P578; Davies NM, 2000, CLIN PHARMACOKINET, V38, P225, DOI 10.2165/00003088-200038030-00003; Day R, 2000, ARCH INTERN MED, V160, P1781, DOI 10.1001/archinte.160.12.1781; Depre M, 2000, EUR J CLIN PHARMACOL, V56, P167, DOI 10.1007/s002280050736; Dequeker J, 1998, BRIT J RHEUMATOL, V37, P946; DINCHUK JE, 1995, NATURE, V378, P406, DOI 10.1038/378406a0; Feldman M, 2000, ANN INTERN MED, V132, P134, DOI 10.7326/0003-4819-132-2-200001180-00008; Feldman M, 2000, ANN INTERN MED, V132, P1011, DOI 10.7326/0003-4819-132-2-200001180-00008; FITZGERALD GA, 1984, NEW ENGL J MED, V310, P1065, DOI 10.1056/NEJM198404263101701; FITZGERALD GA, 1981, J CLIN INVEST, V68, P1272, DOI 10.1172/JCI110373; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; Hawkey C, 1998, BRIT J RHEUMATOL, V37, P1142; Hawkey C, 2000, ARTHRITIS RHEUM-US, V43, P370, DOI 10.1002/1529-0131(200002)43:2<370::AID-ANR17>3.0.CO;2-D; Karim A, 1999, J RHEUMATOL, V26, P2539; Knijff-Dutmer EAJ, 1999, ANN RHEUM DIS, V58, P257, DOI 10.1136/ard.58.4.257; Komhoff M, 2000, KIDNEY INT, V57, P414; KUJUBU DA, 1992, J BIOL CHEM, V267, P7991; Kurumbail RG, 1997, NATURE, V385, P555, DOI 10.1038/385555b0; Langman MJ, 1999, JAMA-J AM MED ASSOC, V282, P1929, DOI 10.1001/jama.282.20.1929; LEE SH, 1992, J BIOL CHEM, V267, P25934; LOLL PJ, 1995, NAT STRUCT BIOL, V2, P637, DOI 10.1038/nsb0895-637; Malkowski MG, 2000, SCIENCE, V289, P1933, DOI 10.1126/science.289.5486.1933; Marnett LJ, 1999, J BIOL CHEM, V274, P22903, DOI 10.1074/jbc.274.33.22903; MASFERRER JL, 1990, J CLIN INVEST, V86, P1375, DOI 10.1172/JCI114850; McAdam BF, 1999, P NATL ACAD SCI USA, V96, P5890; McAdam BF, 1999, P NATL ACAD SCI USA, V96, P272, DOI 10.1073/pnas.96.1.272; McAdam BF, 2000, J CLIN INVEST, V105, P1473, DOI 10.1172/JCI9523; McCarthy CJ, 1999, AM J GASTROENTEROL, V94, P1218, DOI 10.1111/j.1572-0241.1999.01070.x; Mizuno H, 1997, GASTROENTEROLOGY, V112, P387, DOI 10.1053/gast.1997.v112.pm9024292; Morteau O, 2000, J CLIN INVEST, V105, P469, DOI 10.1172/JCI6899; Murata T, 1997, NATURE, V388, P678, DOI 10.1038/41780; Nantel F, 1999, FEBS LETT, V457, P475, DOI 10.1016/S0014-5793(99)01088-1; Newberry RD, 1999, NAT MED, V5, P900, DOI 10.1038/11341; Nicoll-Griffith DA, 2000, BIOORG MED CHEM LETT, V10, P2683, DOI 10.1016/S0960-894X(00)00538-2; OBANION MK, 1992, P NATL ACAD SCI USA, V89, P4888, DOI 10.1073/pnas.89.11.4888; Panara MR, 1998, CLIN PHARMACOL THER, V63, P672, DOI 10.1016/S0009-9236(98)90091-1; Panara MR, 1999, J PHARMACOL EXP THER, V290, P276; PASH JM, 1988, FASEB J, V2, P2613, DOI 10.1096/fasebj.2.10.2968288; PATRIGNANI P, 1994, J PHARMACOL EXP THER, V271, P1705; Patrignani P, 1997, J PHYSIOL PHARMACOL, V48, P623; PATRIGNANI P, 2000, P 11 INT C ADV PROST, P19; PATRONO C, 1987, KIDNEY INT, V32, P1, DOI 10.1038/ki.1987.164; Patrono C, 2001, CHEST, V119, p39S, DOI 10.1378/chest.119.1_suppl.39S; PATRONO C, 1980, THROMB RES, V17, P317, DOI 10.1016/0049-3848(80)90066-3; Paulson SK, 2000, DRUG METAB DISPOS, V28, P308; Porras A, 2000, CLIN PHARMACOL THER, V67, P137; Porto A, 1994, Eur J Rheumatol Inflamm, V14, P33; Pratico D, 2001, P NATL ACAD SCI USA, V98, P3358, DOI 10.1073/pnas.061607398; Prescott SM, 2000, J CLIN INVEST, V105, P1511, DOI 10.1172/JCI10241; Reuter BK, 1996, J CLIN INVEST, V98, P2076, DOI 10.1172/JCI119013; Riendeau D, 2001, J PHARMACOL EXP THER, V296, P558; Rocca B, 1999, J CLIN INVEST, V103, P1469, DOI 10.1172/JCI6400; Rodriguez LAG, 1998, ARCH INTERN MED, V158, P33, DOI 10.1001/archinte.158.1.33; Rodriguez LAG, 2001, ARTHRITIS RES, V3, P98, DOI 10.1186/ar146; Rodriguez LAG, 2000, EPIDEMIOLOGY, V11, P382, DOI 10.1097/00001648-200007000-00004; Sawaoka H, 1998, PROSTAG LEUKOTR ESS, V59, P313, DOI 10.1016/S0952-3278(98)90079-5; Schoenfeld Philip, 1999, American Journal of Medicine, V107, p48S; Schonbeck U, 1999, AM J PATHOL, V155, P1281, DOI 10.1016/S0002-9440(10)65230-3; Schwartz J, 2000, CLIN PHARMACOL THER, V67, P137; Schwartz JI, 2000, CLIN PHARMACOL THER, V67, P165; SEBALDT RJ, 1990, P NATL ACAD SCI USA, V87, P6974, DOI 10.1073/pnas.87.18.6974; SEIBERT K, 1994, P NATL ACAD SCI USA, V91, P12013, DOI 10.1073/pnas.91.25.12013; Shah AA, 2001, GUT, V48, P339, DOI 10.1136/gut.48.3.339; Sheng HM, 2000, J BIOL CHEM, V275, P6628, DOI 10.1074/jbc.275.9.6628; Shinmura K, 2000, P NATL ACAD SCI USA, V97, P10197, DOI 10.1073/pnas.97.18.10197; SILVERSTEIN FE, 1995, ANN INTERN MED, V123, P241, DOI 10.7326/0003-4819-123-4-199508150-00001; Silverstein FE, 2000, JAMA-J AM MED ASSOC, V284, P1247, DOI 10.1001/jama.284.10.1247; Simon LS, 1999, JAMA-J AM MED ASSOC, V282, P1921, DOI 10.1001/jama.282.20.1921; Simon LS, 1998, ARTHRITIS RHEUM-US, V41, P1591, DOI 10.1002/1529-0131(199809)41:9<1591::AID-ART9>3.0.CO;2-J; Singla AK, 2000, J PHARM PHARMACOL, V52, P467, DOI 10.1211/0022357001774255; Smith CJ, 1997, ADV EXP MED BIOL, V400, P99; Swan SK, 2000, ANN INTERN MED, V133, P1, DOI 10.7326/0003-4819-133-1-200007040-00002; Talley JJ, 2000, J MED CHEM, V43, P775, DOI 10.1021/jm990577v; Tang CY, 2000, J PHARMACOL EXP THER, V293, P453; Tegeder I, 1999, CLIN PHARMACOL THER, V65, P533, DOI 10.1016/S0009-9236(99)70073-1; Topper JN, 1996, P NATL ACAD SCI USA, V93, P10417, DOI 10.1073/pnas.93.19.10417; Van Hecken A, 2000, J CLIN PHARMACOL, V40, P1109; Wallberg-Jonsson S, 2000, J RHEUMATOL, V27, P71; WallbergJonsson S, 1997, J RHEUMATOL, V24, P445; Warner TD, 1999, P NATL ACAD SCI USA, V96, P9966; Warner TD, 1999, P NATL ACAD SCI USA, V96, P7563, DOI 10.1073/pnas.96.13.7563; WENNMALM A, 1988, AM J PHYSIOL, V255, pH15, DOI 10.1152/ajpheart.1988.255.1.H15; Whelton A, 2000, Am J Ther, V7, P159, DOI 10.1097/00045391-200007030-00004; Whelton A., 2001, AM J MED S1, V110, P33; XIE WL, 1991, P NATL ACAD SCI USA, V88, P2692, DOI 10.1073/pnas.88.7.2692; Zimmermann KC, 1998, MOL PHARMACOL, V54, P536, DOI 10.1124/mol.54.3.536	99	1165	1236	0	64	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 9	2001	345	6					433	442		10.1056/NEJM200108093450607	http://dx.doi.org/10.1056/NEJM200108093450607			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460EJ	11496855				2022-12-28	WOS:000170295000007
J	Leman, P; Strachan, D				Leman, P; Strachan, D			A case-control study of food poisoning seen at an accident and emergency department	LANCET			English	Article							CONSUMER	We investigated the hypothesis that sporadic food poisoning is a result of the consumption of food cooked or prepared outside the home. We did a case-control study, set in an urban emergency department, to find out the odds ratios for the risk of food poisoning associated with various patterns of consumption. We found that recent eating out (exposure on the day of or day before presentation) was associated with an odds ratio of 2.41 (95% Cl 1.29-4.50) for presenting with food poisoning.	St Thomas Hosp, Dept Accid & Emergency, London SE1 7EH, England; Univ London St Georges Hosp, Sch Med, Dept Publ Hlth Sci, London, England	Guy's & St Thomas' NHS Foundation Trust; St Georges University London	Leman, P (corresponding author), St Thomas Hosp, Dept Accid & Emergency, London SE1 7EH, England.							Bruhn CM, 1997, EMERG INFECT DIS, V3, P511, DOI 10.3201/eid0304.970415; Collins JE, 1997, EMERG INFECT DIS, V3, P471, DOI 10.3201/eid0304.970409; *DEP HLTH, 1992, PLCMO9214 DEP HLTH; Wheeler JG, 1999, BMJ-BRIT MED J, V318, P1046, DOI 10.1136/bmj.318.7190.1046	4	5	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 4	2001	358	9279					387	388		10.1016/S0140-6736(01)05582-9	http://dx.doi.org/10.1016/S0140-6736(01)05582-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459DE	11502323				2022-12-28	WOS:000170235100018
J	Wahlqvist, ML; Wattanapenpaiboon, N				Wahlqvist, ML; Wattanapenpaiboon, N			Hot foods - unexpected help with energy balance?	LANCET			English	Editorial Material									Monash Univ, Fac Med Nursing & Hlth Sci, Int Hlth & Dev Unit, Melbourne, Vic 3800, Australia	Monash University	Wahlqvist, ML (corresponding author), Monash Univ, Fac Med Nursing & Hlth Sci, Int Hlth & Dev Unit, Melbourne, Vic 3800, Australia.		Wahlqvist, Mark Lawrence/E-8800-2010					Cannon ME, 2001, MED J AUSTRALIA, V174, P520, DOI 10.5694/j.1326-5377.2001.tb143404.x; COLQUHOUN EQ, 1995, LIFE SCI, V57, P91, DOI 10.1016/0024-3205(95)00250-A; HENRY CJK, 1986, HUM NUTR-CLIN NUTR, V40C, P165; Kannar D, 2001, J AM COLL NUTR, V20, P225, DOI 10.1080/07315724.2001.10719036; McCrory MA, 1999, AM J CLIN NUTR, V69, P440; Organization WH, 1998, WELLB MEAS PRIM HLTH; Wahlqvist M.L., 1994, FUNCTIONAL FOODS DES, P71; Yoshioka M, 2001, BRIT J NUTR, V85, P203, DOI 10.1079/BJN2000224	8	32	32	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 4	2001	358	9279					348	349		10.1016/S0140-6736(01)05586-6	http://dx.doi.org/10.1016/S0140-6736(01)05586-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459DE	11502310				2022-12-28	WOS:000170235100005
J	Hofbauer, LC; Schoppet, M				Hofbauer, LC; Schoppet, M			Osteoprotegerin: a link between osteoporosis and arterial calcification?	LANCET			English	Editorial Material							BONE LOSS; LIGAND; OSTEOCLASTOGENESIS; DESTRUCTION; CELLS		Univ Marburg, Dept Med, Div Gastroenterol & Endocrinol, D-35033 Marburg, Germany; Univ Marburg, Dept Med, Div Cardiol, D-35033 Marburg, Germany	Philipps University Marburg; Philipps University Marburg	Hofbauer, LC (corresponding author), Univ Marburg, Dept Med, Div Gastroenterol & Endocrinol, D-35033 Marburg, Germany.		Hofbauer, Lorenz C/G-2490-2010	Hofbauer, Lorenz C/0000-0002-8691-8423				Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Bekker PJ, 2001, J BONE MINER RES, V16, P348, DOI 10.1359/jbmr.2001.16.2.348; Browner WS, 2001, J CLIN ENDOCR METAB, V86, P631, DOI 10.1210/jc.86.2.631; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Hak AE, 2000, ARTERIOSCL THROM VAS, V20, P1926, DOI 10.1161/01.ATV.20.8.1926; Hofbauer LC, 2001, BIOCHEM BIOPH RES CO, V280, P334, DOI 10.1006/bbrc.2000.4130; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Malyankar UM, 2000, J BIOL CHEM, V275, P20959, DOI 10.1074/jbc.C000290200; Min H, 2000, J EXP MED, V192, P463, DOI 10.1084/jem.192.4.463; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Teng YTA, 2000, J CLIN INVEST, V106, pR59, DOI 10.1172/JCI10763; Yano K, 1999, J BONE MINER RES, V14, P518, DOI 10.1359/jbmr.1999.14.4.518	16	100	111	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 28	2001	358	9278					257	259		10.1016/S0140-6736(01)05494-0	http://dx.doi.org/10.1016/S0140-6736(01)05494-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	457AF	11498208				2022-12-28	WOS:000170114400005
J	Ebisawa, K; Maeda, Y; Kaneda, H; Yamauchi, S				Ebisawa, K; Maeda, Y; Kaneda, H; Yamauchi, S			Origin of the hard X-ray emission from the galactic plane	SCIENCE			English	Article							SUPERNOVA-REMNANTS; RIDGE; ASCA; EXOSAT; LINE	The Galactic plane is a strong emitter of hard x-rays (2 to 10 kiloelectron volts), and the emission forms a narrow continuous ridge. The currently known hard x-ray sources are far too few to explain the ridge x-ray emission, and the fundamental question of whether the ridge emission is ultimately resolved into numerous dimmer discrete sources or truly diffuse emission has not yet been settled. In order to obtain a decisive answer, using the Chandra X-ray Observatory, we carried out the deepest hard x-ray survey of a Galactic plane region that is devoid of known x-ray point sources. We detected at least 36 new hard x-ray point sources in addition to strong diffuse emission within a 17' by 17' field of view. The surface density of the point sources is comparable to that at high Galactic latitudes after the effects of Galactic absorption are considered. Therefore, most of these point sources are probably extragalactic, presumably active galaxies seen through the Galactic disk. The Galactic ridge hard x-ray emission is diffuse, which indicates omnipresence within the Galactic plane of a hot plasma, the energy density of which is more than one order of magnitude higher than any other substance in the interstellar space.	NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Univ Space Res Assoc, Seabrook, MD 20706 USA; Penn State Univ, Dept Astron & Astrophys, Davey Lab 525, University Pk, PA 16802 USA; Inst Space & Astronaut Sci, Kanagawa 2298510, Japan; Iwate Univ, Fac Humanities & Social Sci, Morioka, Iwate 0208550, Japan	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Universities Space Research Association (USRA); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); Iwate University	Ebisawa, K (corresponding author), NASA, Goddard Space Flight Ctr, Code 662, Greenbelt, MD 20771 USA.			Ebisawa, Ken/0000-0002-5352-7178				BAMBA A, 2001, IN PRESS PUBL ASTRON, V53; DARNE TM, 2001, ASTROPHYS J, V547, P792; Giacconi R, 2001, ASTROPHYS J, V551, P624, DOI 10.1086/320222; HELFAND DJ, 1989, ASTROPHYS J, V341, P151, DOI 10.1086/167479; Kaneda H, 1997, ASTROPHYS J, V491, P638, DOI 10.1086/304965; Koyama K, 1997, PUBL ASTRON SOC JPN, V49, pL7, DOI 10.1093/pasj/49.3.L7; KOYAMA K, 1995, NATURE, V378, P255, DOI 10.1038/378255a0; KOYAMA K, 1986, PUBL ASTRON SOC JPN, V38, P503; KOYAMA K, 1986, PUBL ASTRON SOC JPN, V38, P121; MUKAI K, 1993, ASTROPHYS J, V418, P863, DOI 10.1086/173444; Sugizaki M, 2001, ASTROPHYS J SUPPL S, V134, P77, DOI 10.1086/320358; Tanaka Y, 1999, ASTRON NACHR, V320, P181, DOI 10.1002/1521-3994(199908)320:4/5<181::AID-ASNA181>3.0.CO;2-#; Tanuma S, 1999, PUBL ASTRON SOC JPN, V51, P161, DOI 10.1093/pasj/51.1.161; Ueda Y, 1999, ASTROPHYS J, V518, P656, DOI 10.1086/307291; Valinia A, 2000, ASTROPHYS J, V543, P733, DOI 10.1086/317133; WARWICK RS, 1985, NATURE, V317, P218, DOI 10.1038/317218a0; Watson MG, 1999, ASTR SOC P, V157, P291; WORRALL DM, 1982, ASTROPHYS J, V255, P111, DOI 10.1086/159809; Yamauchi S, 1996, PUBL ASTRON SOC JPN, V48, pL15, DOI 10.1093/pasj/48.2.L15	20	82	82	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2001	293	5535					1633	1635		10.1126/science.1063529	http://dx.doi.org/10.1126/science.1063529			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469FA	11498545	Green Submitted			2022-12-28	WOS:000170802900055
J	Hawthorne, DJ; Via, S				Hawthorne, DJ; Via, S			Genetic linkage of ecological specialization and reproductive isolation in pea aphids	NATURE			English	Article							SYMPATRIC SPECIATION; NATURAL-SELECTION; EVOLUTION; ANIMALS; RACES	The evolution of ecological specialization generates biological diversity and may lead to speciation(1-3). Genetic architecture can either speed or retard this process. If resource use and mate choice have a common genetic basis through pleiotropy or close linkage, the resulting genetic correlations can promote the joint evolution of specialization and reproductive isolation, facilitating speciation(4-6). Here we present a model of the role of genetic correlations in specialization and speciation, and test it by analysing the genetic architecture of key traits in two highly specialized host races of the pea aphid (Acyrthosiphon pisum pisum; Hemiptera : Aphididae). We found several complexes of pleiotropic or closely linked quantitative trait loci (QTL) that affect key traits in ways that would promote speciation: QTL with antagonistic effects on performance on the two hosts are linked to QTL that produce asortative mating (through habitat choice). This type of genetic architecture may be common in taxa that have speciated under divergent natural selection.	Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; Univ Maryland, Dept Biol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Via, S (corresponding author), Univ Maryland, Dept Entomol, College Pk, MD 20742 USA.	sv47@umail.umd.edu						BASTEN CJ, 1996, QTL CARTOGRAPHER VER; BUSH GL, 1994, TRENDS ECOL EVOL, V9, P285, DOI 10.1016/0169-5347(94)90031-0; Caillaud MC, 2000, AM NAT, V156, P606, DOI 10.1086/316991; Cho YG, 1996, GENOME, V39, P373, DOI 10.1139/g96-048; CHURCHILL GA, 1994, GENETICS, V138, P963; FELSENSTEIN J, 1981, EVOLUTION, V35, P124, DOI 10.1111/j.1558-5646.1981.tb04864.x; Filchak KE, 2000, NATURE, V407, P739, DOI 10.1038/35037578; Fry JD, 1996, AM NAT, V148, pS84, DOI 10.1086/285904; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; KONDRASHOV AS, 1986, BIOL J LINN SOC, V27, P201, DOI 10.1111/j.1095-8312.1986.tb01734.x; LANDE R, 1979, EVOLUTION, V33, P234, DOI [10.2307/2407380, 10.1111/j.1558-5646.1979.tb04678.x]; LANDE R, 1984, GENET RES, V44, P309, DOI 10.1017/S0016672300026549; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Littel RC, 1996, SAS SYSTEM MIXED MOD; Lynch Michael, 1998; ORR HA, 1995, GENETICS, V139, P1805; Orr HA, 1998, GENETICS, V149, P2099; Rice WR, 1987, EVOL ECOL, V1, P301, DOI 10.1007/BF02071555; RICE WR, 1993, EVOLUTION, V47, P1637, DOI [10.2307/2410209, 10.1111/j.1558-5646.1993.tb01257.x]; Schemske, 2000, EVOLUTION, V54, P1069, DOI DOI 10.1111/J.0014-3820.2000.TB00111.X; Schluter D, 1998, ENDLESS FORMS, P114; SUN RY, 1966, CAN J ZOOLOG, V44, P649, DOI 10.1139/z66-063; Thompson JD., 1994, COEVOLUTIONARY PROCE; Via S, 2000, EVOLUTION, V54, P1626, DOI 10.1111/j.0014-3820.2000.tb00707.x; Via S, 2001, TRENDS ECOL EVOL, V16, P381, DOI 10.1016/S0169-5347(01)02188-7; VIA S, 1985, EVOLUTION, V39, P505, DOI 10.1111/j.1558-5646.1985.tb00391.x; Via S, 1999, EVOLUTION, V53, P1446, DOI 10.1111/j.1558-5646.1999.tb05409.x; VIA S, 1991, EVOLUTION, V45, P827, DOI 10.1111/j.1558-5646.1991.tb04353.x; Whitlock MC, 1996, AM NAT, V148, pS65, DOI 10.1086/285902; [No title captured]	30	426	437	2	156	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 30	2001	412	6850					904	907		10.1038/35091062	http://dx.doi.org/10.1038/35091062			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467EG	11528477				2022-12-28	WOS:000170689000043
J	Galbiati, F; Razani, B; Lisanti, MP				Galbiati, F; Razani, B; Lisanti, MP			Emerging themes in lipid rafts and caveolae	CELL			English	Review							GPI-ANCHORED PROTEINS; PLASMA-MEMBRANE DOMAINS; DARBY CANINE KIDNEY; CELL-SURFACE; FORMING TOXIN; T-LYMPHOCYTES; COMPONENT; DYNAMIN; FAMILY; IDENTIFICATION		Yeshiva Univ Albert Einstein Coll Med, Albert Einstein Comprehens Canc Ctr, Dept Mol Pharmacol, Div Hormone Dependent Tumor Biol, Bronx, NY 10461 USA; Univ Pittsburgh, Sch Med, Dept Pharmacol, Pittsburgh, PA 15261 USA	Yeshiva University; Albert Einstein College of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lisanti, MP (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Albert Einstein Comprehens Canc Ctr, Dept Mol Pharmacol, Div Hormone Dependent Tumor Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.		Galbiati, Ferruccio/AAF-3527-2020; Lisanti, Michael P/C-6866-2013; Lisanti, Michael/B-6131-2018	Lisanti, Michael/0000-0003-2034-1382; Razani, Babak/0000-0002-7172-9240	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32-GM07288] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abrami L, 2000, TRENDS MICROBIOL, V8, P168, DOI 10.1016/S0966-842X(00)01722-4; Abrami L, 1999, J CELL BIOL, V147, P175, DOI 10.1083/jcb.147.1.175; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793; Brown DA, 1997, BIOCHEM BIOPH RES CO, V240, P1, DOI 10.1006/bbrc.1997.7575; Cavalli V, 2001, MOL CELL, V7, P421, DOI 10.1016/S1097-2765(01)00189-7; Chatterjee S, 2001, EMBO J, V20, P1583, DOI 10.1093/emboj/20.7.1583; de Marco MD, 2001, J BIOL CHEM, V276, P23009; Diep DB, 1998, J BIOL CHEM, V273, P2355, DOI 10.1074/jbc.273.4.2355; DRAB M, 2001, SCIENCE; Fujimoto T, 2001, J CELL BIOL, V152, P1079, DOI 10.1083/jcb.152.5.1079; Galbiati F, 2001, J BIOL CHEM, V276, P21425, DOI 10.1074/jbc.M100828200; GALBIATI F, 2001, IN PRESS TRENDS MOL; Gennis R. B., 1989, BIOMEMBRANES MOL STR, DOI [10.1007/978-1-4757-2065-5, DOI 10.1007/978-1-4757-2065-5]; Gkantiragas I, 2001, MOL BIOL CELL, V12, P1819, DOI 10.1091/mbc.12.6.1819; GLENNEY JR, 1992, P NATL ACAD SCI USA, V89, P10517, DOI 10.1073/pnas.89.21.10517; Hagiwara Y, 2000, HUM MOL GENET, V9, P3047, DOI 10.1093/hmg/9.20.3047; Hueber AO, 1997, CURR BIOL, V7, P705, DOI 10.1016/S0960-9822(06)00300-9; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Kabouridis PS, 2000, EUR J IMMUNOL, V30, P954, DOI 10.1002/1521-4141(200003)30:3<954::AID-IMMU954>3.3.CO;2-P; Kabouridis PS, 1997, EMBO J, V16, P4983, DOI 10.1093/emboj/16.16.4983; Kawasaki K, 2001, BIOPHYS J, V80, P738, DOI 10.1016/S0006-3495(01)76053-5; Kenworthy AK, 2000, MOL BIOL CELL, V11, P1645, DOI 10.1091/mbc.11.5.1645; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; Lang DM, 1998, J NEUROBIOL, V37, P502, DOI 10.1002/(SICI)1097-4695(199812)37:4<502::AID-NEU2>3.0.CO;2-S; LEE AG, 1977, BIOCHIM BIOPHYS ACTA, V472, P237, DOI 10.1016/0304-4157(77)90018-1; Madore N, 1999, EMBO J, V18, P6917, DOI 10.1093/emboj/18.24.6917; Martin-Belmonte F, 2000, MOL BIOL CELL, V11, P2033, DOI 10.1091/mbc.11.6.2033; Mayor S, 1998, EMBO J, V17, P4626, DOI 10.1093/emboj/17.16.4626; McNiven MA, 2000, TRENDS BIOCHEM SCI, V25, P115, DOI 10.1016/S0968-0004(99)01538-8; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; MOLDOVAN NI, 1995, EXP CELL RES, V219, P309, DOI 10.1006/excr.1995.1233; Ostermeyer AG, 2001, J CELL BIOL, V152, P1071, DOI 10.1083/jcb.152.5.1071; Paratcha G, 2001, NEURON, V29, P171, DOI 10.1016/S0896-6273(01)00188-X; PIERINI LM, 2001, IN PRESS P NATL ACAD; Pitts KR, 1999, MOL BIOL CELL, V10, P4403, DOI 10.1091/mbc.10.12.4403; Pol A, 2001, J CELL BIOL, V152, P1057, DOI 10.1083/jcb.152.5.1057; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Puertollano R, 1999, J CELL BIOL, V145, P141, DOI 10.1083/jcb.145.1.141; Puertollano R, 2001, MOL BIOL CELL, V12, P1869, DOI 10.1091/mbc.12.6.1869; RAZANI B, 2001, J BIOL CHEM; ROBERTS WG, 2000, MORPHOGENESIS ENDOTH; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Roy S, 1999, NAT CELL BIOL, V1, P98, DOI 10.1038/10067; Salzer U, 2001, BLOOD, V97, P1141, DOI 10.1182/blood.V97.4.1141; Schulte T, 1997, DEVELOPMENT, V124, P577; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Smart EJ, 1999, MOL CELL BIOL, V19, P7289; Sotgia F, 2000, J BIOL CHEM, V275, P38048, DOI 10.1074/jbc.M005321200; Stan RV, 1999, P NATL ACAD SCI USA, V96, P13203, DOI 10.1073/pnas.96.23.13203; STUERMER CAO, 2001, IN PRESS MOL BIOL CE; VANDERGOOT FG, 2001, METHODS MOL BIOL; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563	54	502	513	0	30	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 24	2001	106	4					403	411		10.1016/S0092-8674(01)00472-X	http://dx.doi.org/10.1016/S0092-8674(01)00472-X			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	466UU	11525727	Bronze			2022-12-28	WOS:000170665200004
J	Fox, CG; Chadwick, WW; Embley, RW				Fox, CG; Chadwick, WW; Embley, RW			Direct observation of a submarine volcanic eruption from a sea-floor instrument caught in a lava flow	NATURE			English	Article							DE-FUCA RIDGE; AXIAL-VOLCANO; GROUND DEFORMATION; 1998 ERUPTION; MORPHOLOGY; DISCHARGE	Our understanding of submarine volcanic eruptions has improved substantially in the past decade owing to the recent ability to remotely detect such events(1) and to then respond rapidly with synoptic surveys and sampling at the eruption site. But these data are necessarily limited to observations after the event(2). In contrast, the 1998 eruption of Axial volcano on the Juan de Fuca ridge(3,4) was monitored by in situ sea-floor instruments(5-7). One of these instruments, which measured bottom pressure as a proxy for vertical deformation of the sea floor, was overrun and entrapped by the 1998 lava flow. The instrument survived- being insulated from the molten lava by the solidified crust- and was later recovered. The data serendipitously recorded by this instrument reveal the duration, character and effusion rate of a sheet flow eruption on a mid-ocean ridge, and document over three metres of lava-flow inflation and subsequent drain-back. After the brief two-hour eruption, the instrument also measured gradual subsidence of 1.4 metres over the next several days, reflecting deflation of the entire volcano summit as magma moved into the adjacent rift zone. These findings are consistent with our understanding of submarine lava effusion, as previously inferred from seafloor observations, terrestrial analogues, and laboratory simulations(8-11).	Oregon State Univ, NOAA, Newport, OR 97365 USA; NOAA, PMEL, Newport, OR 97365 USA	National Oceanic Atmospheric Admin (NOAA) - USA; Oregon State University; National Oceanic Atmospheric Admin (NOAA) - USA	Chadwick, WW (corresponding author), Oregon State Univ, NOAA, 2115 SE OSU Dr, Newport, OR 97365 USA.	chadwick@pmel.noaa.gov	Chadwick, William W./R-7623-2019	Chadwick, William W./0000-0002-5129-4569				Baker ET, 1999, GEOPHYS RES LETT, V26, P3445, DOI 10.1029/1999GL002331; Chadwick WW, 1999, GEOPHYS RES LETT, V26, P3441, DOI 10.1029/1999GL900498; Chadwick WW, 1999, B VOLCANOL, V61, P194, DOI 10.1007/s004450050271; Dziak RP, 1999, GEOPHYS RES LETT, V26, P3429, DOI 10.1029/1999GL002332; Embley RW, 1999, GEOPHYS RES LETT, V26, P3425, DOI 10.1029/1999GL002328; Fox CG, 1999, GEOPHYS RES LETT, V26, P3437, DOI 10.1029/1999GL900491; FOX CG, 1993, MAR TECHNOL SOC J, V27, P22; FOX CG, 1990, J GEOPHYS RES-SOLID, V95, P12813, DOI 10.1029/JB095iB08p12813; GREGG TKP, 1995, GEOLOGY, V23, P73, DOI 10.1130/0091-7613(1995)023<0073:QOSLFM>2.3.CO;2; Gregg TKP, 1998, J GEOPHYS RES-SOL EA, V103, P27517, DOI 10.1029/98JB02465; Gregg TKP, 1996, GEOLOGY, V24, P981, DOI 10.1130/0091-7613(1996)024<0981:SLFIAM>2.3.CO;2; GRIFFITHS RW, 1992, J GEOPHYS RES-SOL EA, V97, P19729, DOI 10.1029/92JB01594; Lockwood J. P., 1987, US GEOL SURV PROF PA, V1350, P509; Perfit MR, 1998, GEOPH MONOG SERIES, V106, P59; ROWLAND SK, 1990, B VOLCANOL, V52, P615, DOI 10.1007/BF00301212; THORDARSON T, 1993, B VOLCANOL, V55, P233, DOI 10.1007/BF00624353; WADGE G, 1981, J VOLCANOL GEOTH RES, V11, P139, DOI 10.1016/0377-0273(81)90020-2; WEST ME, UNPUB NATURE; WOLFE EW, 1988, US GEOL SURV PROF PA, V1463, P1	20	64	64	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 16	2001	412	6848					727	729		10.1038/35089066	http://dx.doi.org/10.1038/35089066			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462ZB	11507638				2022-12-28	WOS:000170450200042
J	Petrie, M; McMurray, J				Petrie, M; McMurray, J			Changes in notions about heart failure	LANCET			English	Editorial Material							VENTRICULAR SYSTOLIC DYSFUNCTION; NATRIURETIC PEPTIDES; PREVALENCE; POPULATION; PROGNOSIS; COMMUNITY; MORTALITY		Univ Glasgow, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow	McMurray, J (corresponding author), Univ Glasgow, Glasgow G12 8QQ, Lanark, Scotland.	j.mcmurray@bio.gla.ac.uk	mcmurray, John/B-2467-2013	mcmurray, John/0000-0002-6317-3975; Petrie, Mark/0000-0002-6333-9496				Cleland JGF, 1999, EUR J HEART FAIL, V1, P211, DOI 10.1016/S1388-9842(99)00039-2; Dargie HJ, 2001, LANCET, V357, P1385, DOI 10.1016/s0140-6736(00)04560-8; Devereux RB, 2001, AM HEART J, V141, P439, DOI 10.1067/mhj.2001.113223; Devereux RB, 2000, AM J CARDIOL, V86, P1090, DOI 10.1016/S0002-9149(00)01165-6; GARDIN JM, 1995, CIRCULATION, V91, P1739, DOI 10.1161/01.CIR.91.6.1739; Hedberg P, 2001, EUR HEART J, V22, P676, DOI 10.1053/euhj.2000.2284; Kelly R, 2001, ANN CLIN BIOCHEM, V38, P94; Kitzman DW, 2001, AM J CARDIOL, V87, P413, DOI 10.1016/S0002-9149(00)01393-X; Kupari M, 1997, J INTERN MED, V241, P387, DOI 10.1046/j.1365-2796.1997.129150000.x; MacIntyre K, 2000, CIRCULATION, V102, P1126, DOI 10.1161/01.CIR.102.10.1126; MacMahon S, 1997, LANCET, V349, P375; McDonagh TA, 1997, LANCET, V350, P829, DOI 10.1016/S0140-6736(97)03033-X; McDonagh TA, 2001, HEART, V86, P21, DOI 10.1136/heart.86.1.21; Morgan S, 1999, BRIT MED J, V318, P368, DOI 10.1136/bmj.318.7180.368; Mosterd A, 1999, EUR HEART J, V20, P447, DOI 10.1053/euhj.1998.1239; NICKLAS JM, 1992, NEW ENGL J MED, V327, P685; Nielsen OW, 2001, HEART, V86, P172, DOI 10.1136/heart.86.2.172; Schunkert H, 1998, LANCET, V351, P372, DOI 10.1016/S0140-6736(05)78298-2; Senni M, 1998, CIRCULATION, V98, P2282, DOI 10.1161/01.CIR.98.21.2282; Swedberg K, 1999, J Card Fail, V5, P276, DOI 10.1016/S1071-9164(99)90013-1; Vasan RS, 2000, CIRCULATION, V101, P2118, DOI 10.1161/01.CIR.101.17.2118; Vasan RS, 1999, J AM COLL CARDIOL, V33, P1948, DOI 10.1016/S0735-1097(99)00118-7; VASAN RS, 1995, J AM COLL CARDIOL, V26, P1565, DOI 10.1016/0735-1097(95)00381-9	23	39	39	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 11	2001	358	9280					432	434		10.1016/S0140-6736(01)05664-1	http://dx.doi.org/10.1016/S0140-6736(01)05664-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463TB	11513900				2022-12-28	WOS:000170492400002
J	Banchereau, J; Schuler-Thurner, B; Palucka, AK; Schuler, G				Banchereau, J; Schuler-Thurner, B; Palucka, AK; Schuler, G			Dendritic cells as vectors for therapy	CELL			English	Review							T-CELLS; VACCINATION; MELANOMA; LYMPHOMA; ANTIGEN		Baylor Inst Immunol Res, Dallas, TX USA; Univ Erlangen Nurnberg, Dept Dermatol, Nurnberg, Germany	Baylor Scott & White Health; University of Erlangen Nuremberg	Banchereau, J (corresponding author), Baylor Inst Immunol Res, Dallas, TX USA.							Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bendandi M, 1999, NAT MED, V5, P1171, DOI 10.1038/13928; Caux C, 1996, J EXP MED, V184, P695, DOI 10.1084/jem.184.2.695; Dhodapkar MV, 2000, J CLIN INVEST, V105, pR9, DOI 10.1172/JCI9051; Dhodapkar MV, 2001, J EXP MED, V193, P233, DOI 10.1084/jem.193.2.233; Fong L, 2000, ANNU REV IMMUNOL, V18, P245, DOI 10.1146/annurev.immunol.18.1.245; Gilboa E, 1999, IMMUNITY, V11, P263, DOI 10.1016/S1074-7613(00)80101-6; Hsu FJ, 1996, NAT MED, V2, P52, DOI 10.1038/nm0196-52; Jonuleit H, 2000, J EXP MED, V192, P1213, DOI 10.1084/jem.192.9.1213; Larsson M, 2001, TRENDS IMMUNOL, V22, P141, DOI 10.1016/S1471-4906(01)01860-9; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; Nestle FO, 1998, NAT MED, V4, P328, DOI 10.1038/nm0398-328; Pulendran B, 2001, TRENDS IMMUNOL, V22, P41, DOI 10.1016/S1471-4906(00)01794-4; Qin ZH, 1998, NAT MED, V4, P627, DOI 10.1038/nm0598-627; Rosenberg SA, 1998, NAT MED, V4, P321, DOI 10.1038/nm0398-321; Simon RM, 2001, J CLIN ONCOL, V19, P1848, DOI 10.1200/JCO.2001.19.6.1848; Steinmann RM, 1999, ANNU REV IMMUNOL, V9, P271; Terabe M, 2000, NAT IMMUNOL, V1, P515, DOI 10.1038/82771; Thurner B, 1999, J EXP MED, V190, P1669, DOI 10.1084/jem.190.11.1669	19	332	374	0	21	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 10	2001	106	3					271	274		10.1016/S0092-8674(01)00448-2	http://dx.doi.org/10.1016/S0092-8674(01)00448-2			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RJ	11509176	Bronze			2022-12-28	WOS:000170433300005
J	Martienssen, RA; Colot, V				Martienssen, RA; Colot, V			DNA methylation and epigenetic inheritance in plants and filamentous fungi	SCIENCE			English	Review							DE-NOVO METHYLATION; CYTOSINE METHYLATION; ARABIDOPSIS-THALIANA; NEUROSPORA-CRASSA; RNA INTERFERENCE; METHYLTRANSFERASE HOMOLOG; SEED DEVELOPMENT; ENDOGENOUS GENE; MAIZE GENOME; C-ELEGANS	Plants and filamentous fungi share with mammals enzymes responsible for DNA methylation. in these organisms, DNA methylation is associated with gene silencing and transposon control. However, plants and fungi differ from mammals in the genomic distribution, sequence specificity, and heritability of methylation. We consider the rote that transposons play in establishing methylation patterns and the epigenetic consequences of their perturbation.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; INRA, CNRS, Unite Rech Genom Vegetale, F-91057 Evry, France	Cold Spring Harbor Laboratory; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay	Colot, V (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	martiens@cshl.org; colot@evry.inra.fr						Adams S, 2000, DEVELOPMENT, V127, P2493; Akhtar A, 2000, NATURE, V407, P405, DOI 10.1038/35030169; Amedeo P, 2000, NATURE, V405, P203, DOI 10.1038/35012108; BARKAN A, 1991, P NATL ACAD SCI USA, V88, P3502, DOI 10.1073/pnas.88.8.3502; BARRY C, 1993, P NATL ACAD SCI USA, V90, P4557, DOI 10.1073/pnas.90.10.4557; Bartee L, 2001, GENE DEV, V15, P1753, DOI 10.1101/gad.905701; Bartee L, 2001, NUCLEIC ACIDS RES, V29, P2127, DOI 10.1093/nar/29.10.2127; Belenkaya T, 1998, MOL GEN GENET, V259, P79, DOI 10.1007/s004380050791; Bender J, 1998, TRENDS BIOCHEM SCI, V23, P252, DOI 10.1016/S0968-0004(98)01225-0; Berg DE, 1989, MOBILE DNA; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Byrne M, 2001, CURR OPIN PLANT BIOL, V4, P38, DOI 10.1016/S1369-5266(00)00133-3; Cambareri EB, 1998, MOL CELL BIOL, V18, P5465, DOI 10.1128/MCB.18.9.5465; Cambareri EB, 1996, GENETICS, V143, P137; Cao XF, 2000, P NATL ACAD SCI USA, V97, P4979, DOI 10.1073/pnas.97.9.4979; Chandler VL, 2000, PLANT MOL BIOL, V43, P121, DOI 10.1023/A:1006499808317; Chen ZJ, 1997, GENE DEV, V11, P2124, DOI 10.1101/gad.11.16.2124; Cogoni C, 1996, EMBO J, V15, P3153, DOI 10.1002/j.1460-2075.1996.tb00678.x; Colot V, 1996, CELL, V86, P855, DOI 10.1016/S0092-8674(00)80161-0; Colot V, 1999, BIOESSAYS, V21, P402, DOI 10.1002/(SICI)1521-1878(199905)21:5<402::AID-BIES7>3.3.CO;2-2; Comai L, 2000, PLANT CELL, V12, P1551, DOI 10.1105/tpc.12.9.1551; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; Dong AP, 2001, NUCLEIC ACIDS RES, V29, P439, DOI 10.1093/nar/29.2.439; Dorer DR, 1997, GENETICS, V147, P1181; Dorweiler JE, 2000, PLANT CELL, V12, P2101, DOI 10.1105/tpc.12.11.2101; Faugeron G, 2000, CURR OPIN MICROBIOL, V3, P144, DOI 10.1016/S1369-5274(00)00066-7; FEDOROFF NV, 1989, MOBILE DNA, P375; Finnegan EJ, 2000, PLANT MOL BIOL, V43, P189, DOI 10.1023/A:1006427226972; Finnegan EJ, 2001, CURR BIOL, V11, pR99, DOI 10.1016/S0960-9822(01)00039-2; Finnegan EJ, 1996, P NATL ACAD SCI USA, V93, P8449, DOI 10.1073/pnas.93.16.8449; Furner IJ, 1998, GENETICS, V149, P651; Goyon C, 1996, NUCLEIC ACIDS RES, V24, P3348, DOI 10.1093/nar/24.17.3348; Habu Y, 2001, CURR OPIN GENET DEV, V11, P215, DOI 10.1016/S0959-437X(00)00182-9; Henikoff S, 1998, GENETICS, V149, P307; Irelan JT, 1997, GENETICS, V146, P509; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; Jacobsen SE, 2000, CURR BIOL, V10, P179, DOI 10.1016/S0960-9822(00)00324-9; Jacobsen SE, 1997, SCIENCE, V277, P1100, DOI 10.1126/science.277.5329.1100; Jeddeloh JA, 1998, GENE DEV, V12, P1714, DOI 10.1101/gad.12.11.1714; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Kakutani T, 1996, P NATL ACAD SCI USA, V93, P12406, DOI 10.1073/pnas.93.22.12406; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Kiger AA, 1999, GENETICS, V153, P799; KOUZMINOVA E, IN PRESS EMBO J; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee HS, 2001, P NATL ACAD SCI USA, V98, P6753, DOI 10.1073/pnas.121064698; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Luff B, 1999, MOL CELL, V3, P505, DOI 10.1016/S1097-2765(00)80478-5; Malagnac F, 1999, MOL MICROBIOL, V31, P331, DOI 10.1046/j.1365-2958.1999.01177.x; Malagnac F, 1997, CELL, V91, P281, DOI 10.1016/S0092-8674(00)80410-9; Martienssen R, 1998, TRENDS GENET, V14, P263, DOI 10.1016/S0168-9525(98)01518-2; Martienssen R, 1998, CURR OPIN GENET DEV, V8, P240, DOI 10.1016/S0959-437X(98)80147-0; Martienssen R, 1996, CURR BIOL, V6, P810, DOI 10.1016/S0960-9822(02)00601-2; Matzke M, 2001, SCIENCE, V293, P1080, DOI 10.1126/science.1063051; MATZKE M, 1996, TRENDS PLANT SCI, V1, P5586; Matzke MA, 2000, PLANT MOL BIOL, V43, P401, DOI 10.1023/A:1006484806925; Mauricio R, 2001, NAT REV GENET, V2, P370, DOI 10.1038/35072085; McCallum CM, 2000, NAT BIOTECHNOL, V18, P455, DOI 10.1038/74542; MCCLINTOCK B, 1951, COLD SPRING HARB SYM, V16, P13, DOI 10.1101/SQB.1951.016.01.004; McCombie WR, 2000, CELL, V100, P377, DOI 10.1016/S0092-8674(00)80673-X; Melquist S, 1999, GENETICS, V153, P401; Miao VPW, 2000, J MOL BIOL, V300, P249, DOI 10.1006/jmbi.2000.3864; Miura A, 2001, NATURE, V411, P212, DOI 10.1038/35075612; Morel JB, 2000, CURR BIOL, V10, P1591, DOI 10.1016/S0960-9822(00)00862-9; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; PAPA CM, IN PRESS PLANT CELL; Rabinowicz PD, 1999, NAT GENET, V23, P305, DOI 10.1038/15479; Raizada MN, 2001, PLANT J, V25, P79, DOI 10.1046/j.1365-313x.2001.00939.x; Ramsahoye BH, 2000, P NATL ACAD SCI USA, V97, P5237, DOI 10.1073/pnas.97.10.5237; RHOUNIM L, 1992, EMBO J, V11, P4451, DOI 10.1002/j.1460-2075.1992.tb05546.x; RICHARDS E, COMMUNICATION; Ronemus MJ, 1996, SCIENCE, V273, P654, DOI 10.1126/science.273.5275.654; ROSSIGNOL JL, 1994, EXPERIENTIA, V50, P307, DOI 10.1007/BF01924014; Rountree MR, 1997, GENE DEV, V11, P2383, DOI 10.1101/gad.11.18.2383; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; Scheid OM, 1998, P NATL ACAD SCI USA, V95, P632, DOI 10.1073/pnas.95.2.632; SCHWARTZ D, 1989, MAIZE GENET COOP NEW, V63, P42; Selker EU, 1999, CELL, V97, P157, DOI 10.1016/S0092-8674(00)80725-4; Selker EU, 1997, TRENDS GENET, V13, P296, DOI 10.1016/S0168-9525(97)01201-8; Settles AM, 2001, GENETICS, V157, P349; Singer T, 2001, GENE DEV, V15, P591, DOI 10.1101/gad.193701; Soppe WJJ, 2000, MOL CELL, V6, P791, DOI 10.1016/S1097-2765(05)00090-0; Springer PS, 2000, DEVELOPMENT, V127, P1815; Svoboda P, 2000, DEVELOPMENT, V127, P4147; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Vielle-Calzada JP, 2000, NATURE, V404, P91, DOI 10.1038/35003595; Vielle-Calzada JP, 1999, GENE DEV, V13, P2971, DOI 10.1101/gad.13.22.2971; Vinkenoog R, 2000, PLANT CELL, V12, P2271, DOI 10.1105/tpc.12.11.2271; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; Wassenegger M, 2000, PLANT MOL BIOL, V43, P203, DOI 10.1023/A:1006479327881; Wolffe AP, 1999, SCIENCE, V286, P481, DOI 10.1126/science.286.5439.481; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	95	383	437	1	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2001	293	5532					1070	1074		10.1126/science.293.5532.1070	http://dx.doi.org/10.1126/science.293.5532.1070			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498574				2022-12-28	WOS:000170432600042
J	Mechanic, D				Mechanic, D			How should hamsters run? Some observations about sufficient patient time in primary care	BRITISH MEDICAL JOURNAL			English	Article							GENERAL-PRACTICE; E-MAIL; CONTINUITY; PHYSICIANS		Rutgers State Univ, Inst Hlth Hlth Care Policy & Aging Res, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick	Mechanic, D (corresponding author), Rutgers State Univ, Inst Hlth Hlth Care Policy & Aging Res, New Brunswick, NJ 08901 USA.							AIREY C, 1999, NATL SURVEYS NHS PAT, pR10; Borowitz SM, 1998, JAMA-J AM MED ASSOC, V280, P1321, DOI 10.1001/jama.280.15.1321; Freeman G, 1997, BRIT MED J, V314, P1870, DOI 10.1136/bmj.314.7098.1870; Guthrie B, 2000, BRIT MED J, V321, P734, DOI 10.1136/bmj.321.7263.734; Kane B, 1998, J AM MED INFORM ASSN, V5, P104, DOI 10.1136/jamia.1998.0050104; Kao AC, 1998, J GEN INTERN MED, V13, P681, DOI 10.1046/j.1525-1497.1998.00204.x; KAPLAN SH, 1995, MED CARE, V33, P1176, DOI 10.1097/00005650-199512000-00002; LUDMERER KM, 1999, TIME HEAL AM MED ED, P370; Mechanic D, 1972, Med Care, V10, P402, DOI 10.1097/00005650-197209000-00004; MECHANIC D, 1975, MED CARE, V13, P189, DOI 10.1097/00005650-197503000-00001; MECHANIC D, 1968, MED CARE, V6, P245; Mechanic D, 2001, NEW ENGL J MED, V344, P198, DOI 10.1056/NEJM200101183440307; MECHANIC D, 1970, J HEALTH SOC BEHAV, V11, P87, DOI 10.2307/2948469; Morrison I, 2000, BRIT MED J, V321, P1541, DOI 10.1136/bmj.321.7276.1541; Remler DK, 2000, INQUIRY-J HEALTH CAR, V37, P304; ROTER DL, 1993, DOCTORS TALKING PATI; *ROYAL COLL GEN PR, 1999, 3 RCGP; SANDS DZ, 1999, AM J MANAG CARE; SCHERGER JE, 1999, HIPPOCRATES; Spielberg AR, 1998, JAMA-J AM MED ASSOC, V280, P1353, DOI 10.1001/jama.280.15.1353; WALKER J, 2000, GEN PRACTICE DEMANDI; WASSON J, 1992, JAMA-J AM MED ASSOC, V267, P1788, DOI 10.1001/jama.267.13.1788	22	62	63	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 4	2001	323	7307					266	268		10.1136/bmj.323.7307.266	http://dx.doi.org/10.1136/bmj.323.7307.266			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	461ZT	11485957	Bronze, Green Published			2022-12-28	WOS:000170394300021
J	Knight, SW; Bass, BL				Knight, SW; Bass, BL			A role for the RNase III enzyme DCR-1 in RNA interference and germ line development in Caenorhabditis elegans	SCIENCE			English	Article							DOUBLE-STRANDED-RNA; C-ELEGANS; GENETIC INTERFERENCE; POLYMERASE; ARABIDOPSIS; NEUROSPORA; EXPRESSION; HELICASE; SEQUENCE; VIRUS	An early event in RNA interference (RNAi) is the cleavage of the initiating double-stranded RNA (dsRNA) to short pieces, 21 to 23 nucleotides in length. Here we describe a null mutation in dicer-1 (dcr-1), a gene proposed to encode the enzyme that generates these short RNAs. We find that dcr-1(-/-) animals have defects in RNAi under some, but not all, conditions. Mutant animals have germ line defects that lead to sterility, suggesting that cleavage of dsRNA to short pieces is a requisite event in normal development.	Univ Utah, Dept Biochem, Salt Lake City, UT 84132 USA; Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	Bass, BL (corresponding author), Univ Utah, Dept Biochem, 50 N Med Dr,Room 211, Salt Lake City, UT 84132 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044073] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM044073] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bass BL, 2000, CELL, V101, P235, DOI 10.1016/S0092-8674(02)71133-1; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; BRENNER S, 1974, GENETICS, V77, P71; Cogoni C, 1999, SCIENCE, V286, P2342, DOI 10.1126/science.286.5448.2342; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Dalmay T, 2001, EMBO J, V20, P2069, DOI 10.1093/emboj/20.8.2069; DAVIDSON EH, 1979, SCIENCE, V204, P1052, DOI 10.1126/science.451548; Domeier ME, 2000, SCIENCE, V289, P1928, DOI 10.1126/science.289.5486.1928; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Grishok A, 2000, SCIENCE, V287, P2494, DOI 10.1126/science.287.5462.2494; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Ketting RF, 2000, NATURE, V404, P296, DOI 10.1038/35005113; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Mello C, 1995, CAENORHABDITIS ELEGA, P451; Montgomery MK, 1998, P NATL ACAD SCI USA, V95, P15502, DOI 10.1073/pnas.95.26.15502; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Parrish S, 2000, MOL CELL, V6, P1077, DOI 10.1016/S1097-2765(00)00106-4; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; SCHEDL T, 1997, C ELEGANS, V2, P241; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tabara H, 1998, SCIENCE, V282, P430, DOI 10.1126/science.282.5388.430; Tavernarakis N, 2000, NAT GENET, V24, P180, DOI 10.1038/72850; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Yochem J, 1998, GENETICS, V149, P1323; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	32	639	719	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2001	293	5538					2269	2271		10.1126/science.1062039	http://dx.doi.org/10.1126/science.1062039			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475AL	11486053	Green Accepted			2022-12-28	WOS:000171139400048
J	Ford, EB; Seager, S; Turner, EL				Ford, EB; Seager, S; Turner, EL			Characterization of extrasolar terrestrial planets from diurnal photometric variability	NATURE			English	Article							EARTH	The detection of massive planets orbiting nearby stars has become almost routine(1,2), but current techniques are as yet unable to detect terrestrial planets with masses comparable to the Earth's. Future space-based observatories to detect Earth-like planets are being planned. Terrestrial planets orbiting in the habitable zones of stars-where planetary surface conditions are compatible with the presence of liquid water-are of enormous interest because they might have global environments similar to Earth's and even harbour life. The light scattered by such a planet will vary in intensity and colour as the planet rotates; the resulting light curve will contain information about the planet's surface and atmospheric properties. Here we report a model that predicts features that should be discernible in the light curve obtained by low-precision photometry. For extrasolar planets similar to Earth, we expect daily flux variations of up to hundreds of per cent, depending sensitively on ice and cloud cover as well as seasonal variations. This suggests that the meteorological variability, composition of the surface (for example, ocean versus land fraction) and rotation period of an Earth-like planet could be derived from photometric observations. Even signatures of Earth-like plant life could be constrained or possibly, with further study, even uniquely determined.	Princeton Univ Observ, Princeton, NJ 08540 USA; Inst Adv Study, Princeton, NJ 08540 USA	Princeton University; Institute for Advanced Study - USA	Ford, EB (corresponding author), Princeton Univ Observ, Peyton Hall, Princeton, NJ 08540 USA.	eford@astro.princeton.edu	Ford, Eric B./AAB-5479-2019; Turner, Edwin L/A-4295-2011	Ford, Eric B./0000-0001-6545-639X; 				BEICHMAN CA, 1999, NASA JPL PUBL, V993, P1; BRICAUD A, 1995, J GEOPHYS RES-OCEANS, V100, P13321, DOI 10.1029/95JC00463; Brown TM, 2001, ASTROPHYS J, V552, P699, DOI 10.1086/320580; BUKATA RP, 1995, OPTICAL PROPERTIES R, P37; Butler RP, 1996, PUBL ASTRON SOC PAC, V108, P500, DOI 10.1086/133755; DEFRIES RS, 1994, INT J REMOTE SENS, V15, P3567, DOI 10.1080/01431169408954345; Goode PR, 2001, GEOPHYS RES LETT, V28, P1671, DOI 10.1029/2000GL012580; Hapke B., 1993, THEORY REFLECTANCE E; HOVENIER JW, 1989, ASTRON ASTROPHYS, V214, P391; JACQUEMOUD S, 1992, REMOTE SENS ENVIRON, V41, P123, DOI 10.1016/0034-4257(92)90072-R; JEROME JH, 1988, APPL OPTICS, V27, P4012, DOI 10.1364/AO.27.004012; KIRK JTO, 1991, LIMNOL OCEANOGR, V36, P455, DOI 10.4319/lo.1991.36.3.0455; Kondratyev K.Y., 1969, RAD ATMOSPHERE; Marcy G. W., 2000, Protostars and planets 4, P1285; MYNENI RB, 1995, REMOTE SENS ENVIRON, V51, P169, DOI 10.1016/0034-4257(94)00073-V; Nisenson P, 2001, ASTROPHYS J, V548, pL201, DOI 10.1086/319110; ROSSOW WB, 1991, B AM METEOROL SOC, V72, P2, DOI 10.1175/1520-0477(1991)072<0002:ICDP>2.0.CO;2; SAGAN C, 1993, NATURE, V365, P715, DOI 10.1038/365715a0; Schindler TL, 2000, ICARUS, V145, P262, DOI 10.1006/icar.2000.6340; SPERGEL DN, UNPUB APPL OPTICS; SPERGEL DN, 2001, ASTROPH0101142; VERBISCER AJ, 1990, ICARUS, V88, P418, DOI 10.1016/0019-1035(90)90092-N; VOKROUHLICKY D, 1995, ASTRON ASTROPHYS, V298, P307; WOESSNER P, 1987, REMOTE SENS ENVIRON, V21, P243, DOI 10.1016/0034-4257(87)90011-3; 2000, ESASCI200012, P1	25	158	159	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2001	412	6850					885	887		10.1038/35091009	http://dx.doi.org/10.1038/35091009			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467EG	11528471	Green Submitted			2022-12-28	WOS:000170689000037
J	Braithwaite, J				Braithwaite, J			Regulating nursing homes - The challenge of regulating care for older people in Australia	BRITISH MEDICAL JOURNAL			English	Article							CORPORATE		Australian Natl Univ, Res Sch Social Sci, Canberra, ACT 0200, Australia	Australian National University	Braithwaite, J (corresponding author), Australian Natl Univ, Res Sch Social Sci, Canberra, ACT 0200, Australia.			Braithwaite, John/0000-0001-8538-2404				Black Julia, 1997, RULES REGULATORS; BRAITHWAITE J, 1995, SOC LEGAL STUD, V4, P307, DOI 10.1177/096466399500400301; BRAITHWAITE J, 1993, HEALTH POLICY, V24, P19, DOI 10.1016/0168-8510(93)90085-4; BRAITHWAITE J, IN PRESS RESTORATIVE; BRAITHWAITE J, 1993, RAISING STANDARD RES; JENKINS A, 1993, CRIME LAW SOCIAL CH, V20, P221, DOI 10.1007/BF01308451; JOST TS, 1988, HOUSTON LAW REV, V25, P525; LOHR R, 2000, KEROSENE BATHS REVEA; MAKKAI T, 1993, INT J SOCIOL LAW, V21, P73; MCCALLUM J, 1996, AUSTR NEW AGED ISSUE; MCKIBBIN H, 1999, STANDARD, V2, P2; Osborne, 1992, REINVENTING GOVT; Power M., 1997, AUDIT SOC; TINGLE L, 2001, SYDNEY MORNING  0316, P2	14	28	28	2	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 25	2001	323	7310					443	446		10.1136/bmj.323.7310.443	http://dx.doi.org/10.1136/bmj.323.7310.443			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	469BX	11520849	Green Published			2022-12-28	WOS:000170793600028
J	Jacobson, MZ; Masters, GM				Jacobson, MZ; Masters, GM			Energy: Exploiting wind versus coal	SCIENCE			English	Editorial Material									Stanford Univ, Dept Civil & Environm Engn, Stanford, CA 94305 USA	Stanford University	Jacobson, MZ (corresponding author), Stanford Univ, Dept Civil & Environm Engn, Stanford, CA 94305 USA.	jacobson@ce.stanford.edu		Jacobson, Mark/0000-0002-4315-4128				MASTERS GM, UNPUB; Pope CA, 2000, AEROSOL SCI TECH, V32, P4, DOI 10.1080/027868200303885; REDLINGER RY, 2001, WIND ENERGY 21 CENTU	3	54	55	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2001	293	5534					1438	1438		10.1126/science.1063376	http://dx.doi.org/10.1126/science.1063376			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465XV	11520970				2022-12-28	WOS:000170616000025
J	Jeruzalmi, D; O'Donnell, M; Kuriyan, J				Jeruzalmi, D; O'Donnell, M; Kuriyan, J			Crystal structure of the processivity clamp loader gamma (gamma) complex of E-coli DNA polymerase III	CELL			English	Article							CHROMOSOMAL REPLICATION MACHINE; ONE HOLOENZYME PARTICLE; SLIDING CLAMPS; ACCESSORY PROTEINS; DELTA-SUBUNIT; BETA-CLAMP; MECHANISM; BINDING; ASSOCIATION; HYDROLYSIS	The gamma complex, an AAA+ ATPase, is the bacterial homolog of eukaryotic replication factor C (RFC) that loads the sliding clamp (beta, homologous to PCNA) onto DNA. The 2.7/3.0 Angstrom crystal structure of gamma complex reveals a pentameric arrangement of subunits, with stoichiometry delta':gamma (3):delta. The C-terminal domains of the subunits form a circular collar that supports an asymmetric arrangement of the N-terminal ATP binding domains of the gamma motor and the structurally related domains of the delta' stator and the delta wrench. The structure suggests a mechanism by which the gamma complex switches between a closed state, in which the beta -interacting element of delta is hidden by delta', and an open form similar to the crystal structure, in which delta is free to bind to beta.	Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Kuriyan, J (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10021 USA.	kuriyan@rockefeller.edu		O'Donnell, Michael/0000-0001-9002-4214	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045547, R01GM038839] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM-38839, R01 GM-45547] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmadian MR, 1997, NAT STRUCT BIOL, V4, P686, DOI 10.1038/nsb0997-686; ALBERTS BM, 1982, COLD SPRING HARB SYM, V47, P655, DOI 10.1101/SQB.1983.047.01.077; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bertram JG, 2000, J BIOL CHEM, V275, P28413, DOI 10.1074/jbc.M910441199; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; CULLMANN G, 1995, MOL CELL BIOL, V15, P4661; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; FLOWER AM, 1990, P NATL ACAD SCI USA, V87, P3713, DOI 10.1073/pnas.87.10.3713; Guenther B, 1997, CELL, V91, P335, DOI 10.1016/S0092-8674(00)80417-1; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Hingorani MM, 1998, J BIOL CHEM, V273, P24550, DOI 10.1074/jbc.273.38.24550; KELMAN Z, 1995, ANNU REV BIOCHEM, V64, P171, DOI 10.1146/annurev.bi.64.070195.001131; Kim S, 1996, J BIOL CHEM, V271, P21406, DOI 10.1074/jbc.271.35.21406; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P829, DOI 10.1107/S0907444996001783; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; Liu JY, 2000, MOL CELL, V6, P637, DOI 10.1016/S1097-2765(00)00062-9; May AP, 2001, J BIOL CHEM, V276, P21991, DOI 10.1074/jbc.R100013200; MCHENRY CS, 1982, J BIOL CHEM, V257, P2657; Moarefi I, 2000, J MOL BIOL, V296, P1215, DOI 10.1006/jmbi.1999.3511; Naktinis V, 1996, CELL, V84, P137, DOI 10.1016/S0092-8674(00)81000-4; NAKTINIS V, 1995, J BIOL CHEM, V270, P13358, DOI 10.1074/jbc.270.22.13358; Neuwald AF, 1999, GENOME RES, V9, P27; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; ODONNELL M, 1993, NUCLEIC ACIDS RES, V21, P1, DOI 10.1093/nar/21.1.1; ODONNELL ME, 1987, J BIOL CHEM, V262, P16558; ONRUST R, 1991, J BIOL CHEM, V266, P21681; ONRUST R, 1995, J BIOL CHEM, V270, P13366, DOI 10.1074/jbc.270.22.13366; ONRUST R, 1995, J BIOL CHEM, V270, P13348, DOI 10.1074/jbc.270.22.13348; OYAMA T, 2001, IN PRESS MOL CELL, V8; Pietroni P, 2001, J MOL BIOL, V309, P869, DOI 10.1006/jmbi.2001.4687; Pritchard AE, 2000, EMBO J, V19, P6536, DOI 10.1093/emboj/19.23.6536; Shamoo Y, 1999, CELL, V99, P155, DOI 10.1016/S0092-8674(00)81647-5; Shiomi Y, 2000, P NATL ACAD SCI USA, V97, P14127, DOI 10.1073/pnas.97.26.14127; Stewart J, 2001, J BIOL CHEM, V276, P19182, DOI 10.1074/jbc.M100592200; STILLMAN B, 1994, CELL, V78, P725, DOI 10.1016/S0092-8674(94)90362-X; STUDWELLVAUGHAN PS, 1991, J BIOL CHEM, V266, P19833; STUKENBERG PT, 1994, CELL, V78, P877, DOI 10.1016/S0092-8674(94)90662-9; STUKENBERG PT, 1991, J BIOL CHEM, V266, P11328; TSUCHIHASHI Z, 1990, P NATL ACAD SCI USA, V87, P2516, DOI 10.1073/pnas.87.7.2516; Turner J, 1999, EMBO J, V18, P771, DOI 10.1093/emboj/18.3.771; Vetter IR, 1999, Q REV BIOPHYS, V32, P1, DOI 10.1017/S0033583599003480; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; YOUNG MC, 1992, BIOCHEMISTRY-US, V31, P8675, DOI 10.1021/bi00152a001; Yu RC, 1998, NAT STRUCT BIOL, V5, P803, DOI 10.1038/1843; Yuzhakov A, 1996, CELL, V86, P877, DOI 10.1016/S0092-8674(00)80163-4; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X	50	244	249	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 24	2001	106	4					429	441		10.1016/S0092-8674(01)00463-9	http://dx.doi.org/10.1016/S0092-8674(01)00463-9			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	466UU	11525729	Bronze			2022-12-28	WOS:000170665200007
J	Fairhall, AL; Lewen, GD; Bialek, W; van Steveninck, RRD				Fairhall, AL; Lewen, GD; Bialek, W; van Steveninck, RRD			Efficiency and ambiguity in an adaptive neural code	NATURE			English	Article							INFORMATION-TRANSMISSION; SPIKE TRAINS; ADAPTATION; TIME; DYNAMICS; SYSTEM	We examine the dynamics of a neural code in the context of stimuli whose statistical properties are themselves evolving dynamically. Adaptation to these statistics occurs over a wide range of timescales-from tens of milliseconds to minutes. Rapid components of adaptation serve to optimize the information that action potentials carry about rapid stimulus variations within the local statistical ensemble, while changes in the rate and statistics of action-potential firing encode information about the ensemble itself, thus resolving potential ambiguities. The speed with which information is optimized and ambiguities are resolved approaches the physical limit imposed by statistical sampling and noise.	NEC Res Inst, Princeton, NJ 08540 USA	NEC Corporation	Fairhall, AL (corresponding author), NEC Res Inst, 4 Independence Way, Princeton, NJ 08540 USA.							ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; BORST A, 1987, BIOL CYBERN, V56, P209, DOI 10.1007/BF00365215; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Brown SP, 2001, NAT NEUROSCI, V4, P44, DOI 10.1038/82888; Carandini M, 1997, J NEUROSCI, V17, P8621; Clague H, 1997, J NEUROPHYSIOL, V77, P207, DOI 10.1152/jn.1997.77.1.207; DeWeese M, 1998, NEURAL COMPUT, V10, P1179, DOI 10.1162/089976698300017403; Fairhall AL, 2001, ADV NEUR IN, V13, P124; Feynman R.P., 1965, PATH INTEGRALS QUANT; Franceschini N., 1989, P360; Gerstner W, 1997, P NATL ACAD SCI USA, V94, P12740, DOI 10.1073/pnas.94.24.12740; GREEN DM, 1966, SIGNAL DETECTION THE; Hausen K., 1984, PHOTORECEPTION VISIO, P523, DOI [10.1007/978-1-4613-2743-1_15, DOI 10.1007/978-1-4613-2743-1_15]; Hopfield JJ, 1996, P NATL ACAD SCI USA, V93, P15440, DOI 10.1073/pnas.93.26.15440; Kim KJ, 2001, J NEUROSCI, V21, P287, DOI 10.1523/JNEUROSCI.21-01-00287.2001; LAND MF, 1974, J COMP PHYSIOL, V89, P331, DOI 10.1007/BF00695351; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; Markram H, 1998, NEUROBIOL LEARN MEM, V70, P101, DOI 10.1006/nlme.1998.3841; Meister M, 1999, NEURON, V22, P435, DOI 10.1016/S0896-6273(00)80700-X; Nelken I, 1999, NATURE, V397, P154, DOI 10.1038/16456; Perkel D, 1968, NEUROSCI RES PROG B, V6, P3; Reinagel P, 2000, J NEUROSCI, V20, P5392, DOI 10.1523/JNEUROSCI.20-14-05392.2000; Rieke F., 1997, SPIKES EXPLORING NEU; Schilstra C, 1999, J EXP BIOL, V202, P1481; Schneidman E, 2001, ADV NEUR IN, V13, P159; SEGUNDO JP, 1963, J EXP BIOL, V40, P643; SHAPLEY R, 1979, VISION RES, V19, P431, DOI 10.1016/0042-6989(79)90109-3; SIMONCELLI EP, 1999, ADV NEURAL INFORMATI, V11, P166; SMIRNAKIS S, 1997, NATURE, V386, P67; Strong SP, 1998, PHYS REV LETT, V80, P197, DOI 10.1103/PhysRevLett.80.197; THORSON J, 1974, SCIENCE, V183, P161, DOI 10.1126/science.183.4121.161; Toib A, 1998, J NEUROSCI, V18, P1893; VANHATEREN JH, 1992, J COMP PHYSIOL A, V171, P157, DOI 10.1007/BF00188924; VANSTEVENINCK RD, 1988, PROC R SOC SER B-BIO, V234, P379; vanSteveninck RRD, 1996, NATURE, V379, P642, DOI 10.1038/379642a0; VANSTEVENINCK RRD, 1986, BIOL CYBERN, V54, P223, DOI 10.1007/BF00318418; vanSteveninck RRD, 1996, NATURAL & ARTIFICIAL PARALLEL COMPUTATION, P21; Wainwright MJ, 1999, VISION RES, V39, P3960, DOI 10.1016/S0042-6989(99)00101-7; Wang YQ, 2000, PHYS REV E, V62, P1063, DOI 10.1103/PhysRevE.62.1063; Warland DK, 1991, READING SPIKES REAL; Wiener N., 1964, EXTRAPOLATION INTERP	45	546	554	1	41	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2001	412	6849					787	792		10.1038/35090500	http://dx.doi.org/10.1038/35090500			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465ET	11518957				2022-12-28	WOS:000170577200028
J	Lieberman, DA; Weiss, DG; Harford, WV; Ahnen, DJ; Provenzale, D; Sontag, SJ; Schnell, TG; Chejfec, G; Campbell, DR; Durbin, TE; Bond, JH; Nelson, DB; Ewing, SL; Triadafilopoulos, G; Ramirez, FC; Lee, JG; Collins, JF; Fennerty, B; Johnston, TK; Corless, CL; McQuaid, KR; Garewal, H; Sampliner, RE; Morales, TG; Fass, R; Smith, RE; Maheshwari, Y				Lieberman, DA; Weiss, DG; Harford, WV; Ahnen, DJ; Provenzale, D; Sontag, SJ; Schnell, TG; Chejfec, G; Campbell, DR; Durbin, TE; Bond, JH; Nelson, DB; Ewing, SL; Triadafilopoulos, G; Ramirez, FC; Lee, JG; Collins, JF; Fennerty, B; Johnston, TK; Corless, CL; McQuaid, KR; Garewal, H; Sampliner, RE; Morales, TG; Fass, R; Smith, RE; Maheshwari, Y		Veterans Affairs Cooperative Study	One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FLEXIBLE SIGMOIDOSCOPY; ASYMPTOMATIC ADULTS; HEMOCCULT; MORTALITY; SENSITIVITY; COLONOSCOPY; NEOPLASIA; TRIAL	Background: Fecal occult-blood testing and sigmoidoscopy have been recommended for screening for colorectal cancer, but the sensitivity of such combined testing for detecting neoplasia is uncertain. At 13 Veterans Affairs medical centers, we performed colonoscopy to determine the prevalence of neoplasia and the sensitivity of one-time screening with a fecal occult-blood test plus sigmoidoscopy. Methods: Asymptomatic subjects (age range, 50 to 75 years) provided stool specimens on cards from three consecutive days for fecal occult-blood testing, which were rehydrated for interpretation. They then underwent colonoscopy. Sigmoidoscopy was defined as examination of the rectum and sigmoid colon during colonoscopy, and sensitivity was estimated by determining how many patients with advanced neoplasia had an adenoma in the rectum or sigmoid colon. Advanced colonic neoplasia was defined as an adenoma 10 mm or more in diameter, a villous adenoma, an adenoma with high-grade dysplasia, or invasive cancer. Results: A total of 2885 subjects returned the three specimen cards for fecal occult-blood testing and underwent a complete colonoscopic examination. A total of 23.9 percent of subjects with advanced neoplasia had a positive test for fecal occult blood. As compared with subjects who had a negative test for fecal occult blood, the relative risk of advanced neoplasia in subjects who had a positive test was 3.47 (95 percent confidence interval, 2.76 to 4.35). Sigmoidoscopy identified 70.3 percent of all subjects with advanced neoplasia. Combined one-time screening with a fecal occult-blood test and sigmoidoscopy identified 75.8 percent of subjects with advanced neoplasia. Conclusions: One-time screening with both a fecal occult-blood test with rehydration and sigmoidoscopy fails to detect advanced colonic neoplasia in 24 percent of subjects with the condition.	Oregon Hlth Sci Univ, Portland Vet Affairs Med Ctr, Div Gastroenterol, Portland, OR 97207 USA; Vet Affairs Med Ctr, Perry Point, MD USA	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; VA Portland Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Lieberman, DA (corresponding author), Oregon Hlth Sci Univ, Portland Vet Affairs Med Ctr, Div Gastroenterol, P3-GI,POB 1034, Portland, OR 97207 USA.							AHLQUIST DA, 1993, JAMA-J AM MED ASSOC, V269, P1262, DOI 10.1001/jama.269.10.1262; ALLISON JE, 1990, ANN INTERN MED, V112, P328, DOI 10.7326/0003-4819-112-5-328; Berry DP, 1997, BRIT J SURG, V84, P1274; Byers T, 1997, CA-CANCER J CLIN, V47, P154, DOI 10.3322/canjclin.47.3.154; Eisen GM, 2000, GASTROINTEST ENDOSC, V51, P777, DOI 10.1053/ge.2000.v51.age516777; Imperiale TF, 2000, NEW ENGL J MED, V343, P169, DOI 10.1056/NEJM200007203430302; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; MANDEL JS, 1993, NEW ENGL J MED, V329, P672; NEWCOMB PA, 1992, JNCI-J NATL CANCER I, V84, P1572, DOI 10.1093/jnci/84.20.1572; Ransohoff DF, 1997, ANN INTERN MED, V126, P811, DOI 10.7326/0003-4819-126-10-199705150-00014; RANSOHOFF DF, 1994, NIH PUBLICATION, P207; Rasmussen M, 1999, SCAND J GASTROENTERO, V34, P73; Rex DK, 1997, GASTROENTEROLOGY, V112, P17, DOI 10.1016/S0016-5085(97)70213-0; Rex DK, 2000, AM J GASTROENTEROL, V95, P868, DOI 10.1111/j.1572-0241.2000.02059.x; SELBY JV, 1992, NEW ENGL J MED, V326, P653, DOI 10.1056/NEJM199203053261001; US Preventive Services Task Force United States. Office of Disease Prevention Health Promotion, 1996, GUID CLIN PREV SERV, P89; Vernon SW, 1997, JNCI-J NATL CANCER I, V89, P1406, DOI 10.1093/jnci/89.19.1406; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P594, DOI 10.1053/gast.1997.v112.agast970594; Winawer SJ, 1998, GASTROENTEROLOGY, V114, P625; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P1060; WINAWER SJ, 1993, J NATL CANCER I, V85, P1311, DOI 10.1093/jnci/85.16.1311	24	424	446	0	4	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 23	2001	345	8					555	560		10.1056/NEJMoa010328	http://dx.doi.org/10.1056/NEJMoa010328			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464ZH	11529208				2022-12-28	WOS:000170562900001
J	Brabin, L				Brabin, L			Hormonal markers of susceptibility to sexually transmitted infections: are we taking them seriously?	BRITISH MEDICAL JOURNAL			English	Article							HERPES-SIMPLEX VIRUS; CHLAMYDIA-TRACHOMATIS INFECTION; GENITAL HERPES; TYPE-2; WOMEN; RISK; TRANSMISSION		St Marys Hosp, Acad Unit Obstet & Gynaecol & Reprod Hlth Care, Manchester M13 0JH, Lancs, England	University of Manchester	Brabin, L (corresponding author), St Marys Hosp, Acad Unit Obstet & Gynaecol & Reprod Hlth Care, Manchester M13 0JH, Lancs, England.			Brabin, Loretta/0000-0003-4478-6503				Apter D, 1997, ANN NY ACAD SCI, V816, P9, DOI 10.1111/j.1749-6632.1997.tb52125.x; Brabin L, 2000, ACTA TROP, V75, P53, DOI 10.1016/S0001-706X(99)00093-5; BRABIN L, 1996, PREVENTION PELVIC IN, P160; Brown ZA, 1997, NEW ENGL J MED, V337, P509, DOI 10.1056/NEJM199708213370801; BURNSTEIN GR, 2001, SEX TRANSM INFECT, V77, P26; COTTINGHAM J, 1992, GENITOURIN MED, V68, P209; Fleming DT, 1997, NEW ENGL J MED, V337, P1105, DOI 10.1056/NEJM199710163371601; Greenblatt RM, 2000, J INFECT DIS, V181, P82, DOI 10.1086/315207; Hewitt R G, 2001, AIDS Read, V11, P29; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; Langenberg AGM, 1999, NEW ENGL J MED, V341, P1432, DOI 10.1056/NEJM199911043411904; MERTZ GJ, 1992, ANN INTERN MED, V116, P197, DOI 10.7326/0003-4819-116-3-197; Moscicki AB, 1998, J PEDIATR-US, V132, P277, DOI 10.1016/S0022-3476(98)70445-7; Moscicki AB, 2001, J INFECT DIS, V183, P865, DOI 10.1086/319261; Mosure DJ, 1996, AM J EPIDEMIOL, V144, P997, DOI 10.1093/oxfordjournals.aje.a008870; O'Farrell N, 2001, SEX TRANSM DIS, V28, P84, DOI 10.1097/00007435-200102000-00005; Obasi A, 1999, J INFECT DIS, V179, P16, DOI 10.1086/314555; Robbins AS, 2001, AM J PREV MED, V20, P90, DOI 10.1016/S0749-3797(00)00280-4; SIEGEL D, 1992, JAMA-J AM MED ASSOC, V268, P1702, DOI 10.1001/jama.268.13.1702; Smith SM, 2000, J INFECT DIS, V182, P708, DOI 10.1086/315776; Sonnex C, 1998, SEX TRANSM INFECT, V74, P11, DOI 10.1136/sti.74.1.11; Stephenson J, 2000, JAMA-J AM MED ASSOC, V284, P1913, DOI 10.1001/jama.284.15.1913; *UNDP UNFPA WHO WO, 2000, REPR HLTH RES WHO NE; Wang CC, 1999, J ACQ IMMUN DEF SYND, V21, P51, DOI 10.1097/00126334-199905010-00007; WASHINGTON AE, 1985, JAMA-J AM MED ASSOC, V253, P2246, DOI 10.1001/jama.253.15.2246	25	13	13	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 18	2001	323	7309					394	395		10.1136/bmj.323.7309.394	http://dx.doi.org/10.1136/bmj.323.7309.394			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465GN	11509437	Green Published			2022-12-28	WOS:000170581400032
J	Cunliffe, NA; Gondwe, JS; Kirkwood, CD; Graham, SM; Nhlane, NM; Thindwa, BDM; Dove, W; Broadhead, RL; Molyneux, ME; Hart, CA				Cunliffe, NA; Gondwe, JS; Kirkwood, CD; Graham, SM; Nhlane, NM; Thindwa, BDM; Dove, W; Broadhead, RL; Molyneux, ME; Hart, CA			Effect of concomitant HIV infection on presentation and outcome of rotavirus gastroenteritis in Malawian children	LANCET			English	Article							YOUNG-CHILDREN; ACUTE DIARRHEA; EPIDEMIOLOGY; SEVERITY; DISEASE; VACCINE; BLANTYRE; HEALTHY	Background Rotaviruses represent important causes of severe diarrhoea in early childhood. We examined the effect of HIV infection on the presentation and outcome of rotavirus gastroenteritis in Malawian children. Methods Children younger than 5 years who were treated for acute gastroenteritis at the Queen Elizabeth Central Hospital in Blantyre from July, 1997, to June, 1999, were enrolled. Children with rotavirus diarrhoea, with and without HIV infection, were followed up for up to 4 weeks after hospital discharge. Rotavirus disease severity (assessed with a 20-point score), duration of rotavirus shedding, and seroresponse to rotavirus were compared between HIV-infected and HIV-uninfected children. Findings 786 inpatients (median age 8 months, 271 [34%] of whom were HIV-1-infected) and 400 outpatients (median age 9 months, 65 [16%] of whom were HIV-infected) were enrolled. Rotavirus was detected less frequently among HIV-infected children (102 of 336 [30%]) than among HIV-uninfected children (348 of 850 [41%], (relative risk 0.71 [95% CI 0.53-0.87], p=0.0007). There were no differences in rotavirus disease severity for hospitalised children with and without HIV infection, but HIV-infected children were more likely to die during follow-up (11/50 [22%]) than HIV-uninfected children (0/61, p<0.0001). Of 29 HIV-infected and 45 HIV-uninfected children who completed follow-up, six (21%) HIV-infected children shed rotavirus, compared with two (4%) HIV-uninfected children (4.66 [1.01-21.51], p=0.05), but shedding was not associated with diarrhoea. Three-quarters of children exhibited a four-fold rise of serum IgG or lgA to rotavirus, which did not vary by HIV status. Interpretation. Malawian children with concomitant HIV infection resolved acute rotavirus infections. Rotavirus vaccine safety and immunogenicity in HIV-infected infants should now be determined.	Univ Liverpool, Dept Med Microbiol & Genitourinary Med, Liverpool L69 3GA, Merseyside, England; Univ Malawi, Wellcome Trust Res Labs, Coll Med, Blantyre, Malawi; Univ Liverpool, Coll Med, Blantyre, Malawi; Univ Malawi, Coll Med, Dept Paediat, Blantyre, Malawi; Royal Childrens Hosp, Dept Gastroenterol & Clin Nutr, Melbourne, Vic, Australia; Univ Liverpool, Sch Trop Med, Liverpool L69 3BX, Merseyside, England	University of Liverpool; University of Malawi; University of Malawi; University of Malawi; Royal Children's Hospital Melbourne; Liverpool School of Tropical Medicine; University of Liverpool	Cunliffe, NA (corresponding author), Univ Liverpool, Dept Med Microbiol & Genitourinary Med, Duncan Bldg,Daulby St, Liverpool L69 3GA, Merseyside, England.	N.A.Cunllffe@liverpool.ac.uk		Graham, Stephen/0000-0003-3525-2294; Cunliffe, Nigel/0000-0002-5449-4988				[Anonymous], 1999, MMWR Recomm Rep, V48, P1; BERN C, 1992, J CLIN MICROBIOL, V30, P3234, DOI 10.1128/JCM.30.12.3234-3238.1992; Bresee JS, 1999, VACCINE, V17, P2207, DOI 10.1016/S0264-410X(98)00376-4; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P1007; Cunliffe NA, 1998, B WORLD HEALTH ORGAN, V76, P525; Cunliffe NA, 1999, J MED VIROL, V57, P308, DOI 10.1002/(SICI)1096-9071(199903)57:3&lt;308::AID-JMV15&gt;3.0.CO;2-B; Cunliffe NA, 2001, J CLIN MICROBIOL, V39, P836, DOI 10.1128/JCM.39.3.836-843.2001; DAGAN R, 1990, PEDIATR INFECT DIS J, V9, P314, DOI 10.1097/00006454-199005000-00003; DEZOYSA I, 1985, B WORLD HEALTH ORGAN, V63, P569; Fontana M, 1996, J PEDIATR GASTR NUTR, V23, P492, DOI 10.1097/00005176-199611000-00026; FRANCO MA, 1995, J VIROL, V69, P7800, DOI 10.1128/JVI.69.12.7800-7806.1995; GILGER MA, 1992, J PEDIATR-US, V120, P912, DOI 10.1016/S0022-3476(05)81959-6; Glass RI, 1996, J INFECT DIS, V174, pS5, DOI 10.1093/infdis/174.Supplement_1.S5; Graham SM, 2000, LANCET, V355, P369, DOI 10.1016/S0140-6736(98)11074-7; GROHMANN GS, 1993, NEW ENGL J MED, V329, P14, DOI 10.1056/NEJM199307013290103; Iturriza-Gomara M, 2000, J CLIN MICROBIOL, V38, P4394; Joensuu J, 1997, LANCET, V350, P1205, DOI 10.1016/S0140-6736(97)05118-0; Kapikian A.Z., 1996, FIELDS VIROLOGY, P1657; KOTLOFF KL, 1994, JAMA-J AM MED ASSOC, V271, P448, DOI 10.1001/jama.271.6.448; Liste MB, 2000, J CLIN MICROBIOL, V38, P2873, DOI 10.1128/JCM.38.8.2873-2877.2000; McNeal MM, 1997, J VIROL, V71, P8735, DOI 10.1128/JVI.71.11.8735-8742.1997; Miller MA, 2000, HEALTH ECON, V9, P19, DOI 10.1002/(SICI)1099-1050(200001)9:1<19::AID-HEC487>3.0.CO;2-C; MIOTTI PG, 1992, J INFECT DIS, V165, P1116, DOI 10.1093/infdis/165.6.1116; Molbak K, 2000, VACCINE, V19, P393, DOI 10.1016/S0264-410X(00)00199-7; MONROE SS, 1993, J CLIN MICROBIOL, V31, P2866, DOI 10.1128/JCM.31.11.2866-2872.1993; OSHITANI H, 1994, J INFECT DIS, V169, P897, DOI 10.1093/infdis/169.4.897; PAVIA AT, 1992, PEDIATR INFECT DIS J, V11, P996, DOI 10.1097/00006454-199211120-00002; PerezSchael I, 1997, NEW ENGL J MED, V337, P1181, DOI 10.1056/NEJM199710233371701; Richardson S, 1998, LANCET, V351, P1844, DOI 10.1016/S0140-6736(97)11257-0; RUUSKA T, 1990, SCAND J INFECT DIS, V22, P259, DOI 10.3109/00365549009027046; SAULSBURY FT, 1980, J PEDIATR-US, V97, P61, DOI 10.1016/S0022-3476(80)80131-4; Taha T E, 2000, Pediatrics, V106, pE77, DOI 10.1542/peds.106.6.e77; THEA DM, 1993, NEW ENGL J MED, V329, P1696, DOI 10.1056/NEJM199312023292304	33	56	58	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 18	2001	358	9281					550	555		10.1016/S0140-6736(01)05706-3	http://dx.doi.org/10.1016/S0140-6736(01)05706-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464NB	11520526				2022-12-28	WOS:000170537700013
J	Naylor, CD				Naylor, CD			Clinical decisions: from art to science and back again	LANCET			English	Editorial Material							MEDICAL LITERATURE; USERS GUIDES		Univ Toronto, Fac Med, Toronto, ON M5S 1AB, Canada	University of Toronto	Naylor, CD (corresponding author), Univ Toronto, Fac Med, Toronto, ON M5S 1AB, Canada.							Greenhalgh T, 1999, BMJ-BRIT MED J, V318, P323, DOI 10.1136/bmj.318.7179.323; Holmes-Rovner M, 2001, BMJ-BRIT MED J, V322, P664, DOI 10.1136/bmj.322.7287.664; Naglie G, 1997, MED DECIS MAKING, V17, P136, DOI 10.1177/0272989X9701700203; NAYLOR CD, 1995, LANCET, V345, P840, DOI 10.1016/S0140-6736(95)92969-X; NAYLOR CD, 1992, P INT WORKSH FATS CH, P401; PETO R, 1995, J CLIN EPIDEMIOL, V48, P23, DOI 10.1016/0895-4356(94)00150-O; RICHARDSON WS, 1995, JAMA-J AM MED ASSOC, V273, P1610, DOI 10.1001/jama.273.20.1610; RICHARDSON WS, 1995, JAMA-J AM MED ASSOC, V273, P1292, DOI 10.1001/jama.273.16.1292	8	19	19	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 18	2001	358	9281					523	524						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464NB	11520517				2022-12-28	WOS:000170537700004
J	Speed, CA				Speed, CA			Fortnightly review - Corticosteroid injections in tendon lesions	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ROTATOR CUFF TENDINITIS; LATERAL EPICONDYLITIS; SHOULDER PAIN; DOUBLE-BLIND; TISSUE; TRIAMCINOLONE; DEGENERATION; ETIOLOGY; TRIAL		Univ Cambridge, Dept Med, Rheumatol Unit, Cambridge CB2 2QQ, England	University of Cambridge	Speed, CA (corresponding author), Univ Cambridge, Dept Med, Rheumatol Unit, Cambridge CB2 2QQ, England.	cas50@medschl.cam.ac.uk						ADEBAJO AO, 1990, J RHEUMATOL, V17, P1207; Alfredson H, 1999, KNEE SURG SPORT TR A, V7, P378, DOI 10.1007/s001670050184; Almekinders LC, 1998, MED SCI SPORT EXER, V30, P1183, DOI 10.1097/00005768-199808000-00001; APPELL HJ, 1990, SPORTS MED, V10, P42, DOI 10.2165/00007256-199010010-00005; Assendelft WJJ, 1996, BRIT J GEN PRACT, V46, P209; Balint P, 1997, BRIT J RHEUMATOL, V36, P1141; BAMJI AN, 1990, BRIT J RHEUMATOL, V29, P295; Benazzo Francesco, 1996, Bulletin Hospital for Joint Diseases, V54, P236; CHARD MD, 1994, ANN RHEUM DIS, V53, P30, DOI 10.1136/ard.53.1.30; *CONS ASS, 1995, DRUGS THER B, V33, P67; Curwin S., 1994, OXFORD TXB SPORTS ME; DaCruz D J, 1988, Br J Sports Med, V22, P64; Eustace JA, 1997, ANN RHEUM DIS, V56, P59, DOI 10.1136/ard.56.1.59; Gotoh M, 1998, J ORTHOP RES, V16, P618, DOI 10.1002/jor.1100160515; GOTTLIEB NL, 1980, JAMA-J AM MED ASSOC, V243, P1547, DOI 10.1001/jama.243.15.1547; GREEN S, 2000, COCHRANE DATABASE SY; HASLOCK I, 1995, BRIT J RHEUMATOL, V34, P449; Hay EM, 1999, BRIT MED J, V319, P964, DOI 10.1136/bmj.319.7215.964; JOSZA J, 1997, HUMAN TENDONS, P164; JOSZA J, 1997, HUMAN TENDONS, P491; JOSZA J, 1997, HUMAN TENDONS, P46; KANNUS P, 1991, J BONE JOINT SURG AM, V73A, P1507, DOI 10.2106/00004623-199173100-00009; KANNUS P, 1990, INT J SPORTS MED, V11, P397, DOI 10.1055/s-2007-1024826; KAPETANOS G, 1982, CLIN ORTHOP RELAT R, V163, P170; KETCHUM LD, 1971, PLAST RECONSTR SURG, V47, P471, DOI 10.1097/00006534-197105000-00011; Khan NA, 2000, SUSTAIN DEV, V8, P1, DOI 10.1002/(SICI)1099-1719(200002)8:1&lt;1::AID-SD126&gt;3.0.CO;2-C; LAMBERT MA, 1992, J HAND SURG-BRIT EUR, V17B, P69, DOI 10.1016/0266-7681(92)90014-S; MATTILA J, 1983, CLIN TRIALS J, V20, P18; MCCORMICK A, 1993, MORBIDITY STAT GE MB, V5; MURPHY D, 1995, J HAND SURG-AM, V20A, P628, DOI 10.1016/S0363-5023(05)80280-1; NYGREN A, 1995, SCAND J REHABIL MED, P107; PETRI M, 1987, ARTHRITIS RHEUM-US, V30, P1040, DOI 10.1002/art.1780300911; RILEY GP, 1994, ANN RHEUM DIS, V53, P359, DOI 10.1136/ard.53.6.359; Sackett DL, 1991, CLIN EPIDEMIOLOGY BA, V2nd; SPEED CA, 2000, CLIN EVIDENCE; UNVERFERTH LJ, 1973, J BONE JOINT SURG AM, V55, P1315; vanderWindt DAWM, 1996, BRIT J GEN PRACT, V46, P519; VECCHIO P, 1995, BRIT J RHEUMATOL, V34, P440; VECCHIO PC, 1993, BRIT J RHEUMATOL, V32, P743; Wong MEK, 1996, ORAL SURG ORAL MED O, V82, P475, DOI 10.1016/S1079-2104(96)80190-9; Zingas C, 1998, J HAND SURG-AM, V23A, P89, DOI 10.1016/S0363-5023(98)80095-6	41	84	91	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 18	2001	323	7309					382	386		10.1136/bmj.323.7309.382	http://dx.doi.org/10.1136/bmj.323.7309.382			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465GN	11509432	Green Published			2022-12-28	WOS:000170581400023
J	Amador, V; Monte, E; Garcia-Martinez, JL; Prat, S				Amador, V; Monte, E; Garcia-Martinez, JL; Prat, S			Gibberellins signal nuclear import of PHOR1, a photoperiod-responsive protein with homology to Drosophila armadillo	CELL			English	Article							BETA-CATENIN; GENETIC-ANALYSIS; SOLANUM-TUBEROSUM; REPEAT PROTEIN; PHYTOCHROME-B; TRANSDUCTION; ARABIDOPSIS; EXPRESSION; POTATO; PLANTS	S. tuberosum ssp. andigena potato plants require short days (SD) for tuberization. We have isolated PHOR1 (photoperiod-responsive 1), which shows upregulated expression in induced leaves (SD). PHOR1 encodes an arm repeat protein with homology to the Drosophila segment polarity protein armadillo. Antisense inhibition of PHOR1 produces a semidwarf phenotype similar to that of GA-deficient plants, and the antisense lines show reduced GA responsiveness combined with a higher endogenous GA content than wild-type plants. Feedback regulation of GA biosynthetic genes is also altered in these lines. Conversely, transgenic lines overexpressing PHOR1 show an enhanced response to GA. GA application induces rapid migration of PHOR1-GFP protein to the nucleus. Thus, PHOR1 appears to be a general component of GA signaling pathways that relocalizes to the nucleus in the presence of GA.	CSIC, Inst Biol Mol Barcelona, Dept Mol Genet, ES-08034 Barcelona, Spain; Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, Valencia 46022, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP)	Prat, S (corresponding author), CSIC, Inst Biol Mol Barcelona, Dept Mol Genet, Jordi Girona 18-26, ES-08034 Barcelona, Spain.		Elena, Monte/I-7221-2015; Prat, Salome/L-9240-2014	Prat, Salome/0000-0003-2684-5485; Monte, Elena/0000-0002-7340-9355				AMASINO RM, 1986, ANAL BIOCHEM, V152, P304, DOI 10.1016/0003-2697(86)90413-6; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Bethke PC, 1998, CURR OPIN PLANT BIOL, V1, P440, DOI 10.1016/S1369-5266(98)80270-7; Carrera E, 2000, PLANT J, V22, P247, DOI 10.1046/j.1365-313x.2000.00736.x; Cooley MB, 1999, PLANT PHYSIOL, V121, P1339, DOI 10.1104/pp.121.4.1339; Dale TC, 1998, BIOCHEM J, V329, P209; Ewing E. E., 1992, Horticultural Reviews, V14, P89; Ewing Elmer E., 1995, P698; Fagotto F, 1998, CURR BIOL, V8, P181, DOI 10.1016/S0960-9822(98)70082-X; FUJIOKA S, 1988, P NATL ACAD SCI USA, V85, P9031, DOI 10.1073/pnas.85.23.9031; GORLICH D, 1994, CELL, V79, P767, DOI 10.1016/0092-8674(94)90067-1; Gu TS, 1998, P NATL ACAD SCI USA, V95, P382, DOI 10.1073/pnas.95.1.382; Gu XJ, 1997, PLANT CELL, V9, P157, DOI 10.1105/tpc.9.2.157; Hedden P, 2000, CURR OPIN BIOTECH, V11, P130, DOI 10.1016/S0958-1669(00)00071-9; Hedden P, 1999, PLANT PHYSIOL, V119, P365, DOI 10.1104/pp.119.2.365; HOFGEN R, 1990, PLANT SCI, V66, P221, DOI 10.1016/0168-9452(90)90207-5; HOOLEY R, 1994, PLANT MOL BIOL, V26, P1529, DOI 10.1007/BF00016489; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Jackson SD, 1996, PHYSIOL PLANTARUM, V98, P407, DOI 10.1034/j.1399-3054.1996.980224.x; Jackson SD, 1996, PLANT J, V9, P159, DOI 10.1046/j.1365-313X.1996.09020159.x; Jacobsen SE, 1996, P NATL ACAD SCI USA, V93, P9292, DOI 10.1073/pnas.93.17.9292; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Kost B, 1998, PLANT J, V16, P393, DOI 10.1046/j.1365-313x.1998.00304.x; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lange T, 1998, PLANTA, V204, P409, DOI 10.1007/s004250050274; Lovegrove A, 2000, TRENDS PLANT SCI, V5, P102, DOI 10.1016/S1360-1385(00)01571-5; Miller JR, 1996, GENE DEV, V10, P2527, DOI 10.1101/gad.10.20.2527; Monte E, 1999, PLANT J, V19, P399, DOI 10.1046/j.1365-313X.1999.00537.x; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; PEIFER M, 1990, CELL, V63, P1167, DOI 10.1016/0092-8674(90)90413-9; Peng JR, 1997, GENE DEV, V11, P3194, DOI 10.1101/gad.11.23.3194; Pukatzki S, 1998, J BIOL CHEM, V273, P24131, DOI 10.1074/jbc.273.37.24131; Pysh LD, 1999, PLANT J, V18, P111, DOI 10.1046/j.1365-313X.1999.00431.x; Reichel C, 1996, P NATL ACAD SCI USA, V93, P5888, DOI 10.1073/pnas.93.12.5888; Shi LF, 1998, PLANT MOL BIOL, V38, P1053, DOI 10.1023/A:1006007315718; Silverstone AL, 1998, PLANT CELL, V10, P155, DOI 10.1105/tpc.10.2.155; Smith HMS, 1999, PLANT PHYSIOL, V119, P1157, DOI 10.1104/pp.119.4.1157; Sun TP, 2000, CURR OPIN PLANT BIOL, V3, P374, DOI 10.1016/S1369-5266(00)00099-6; Swain SM, 1996, PLANT PHYSIOL, V112, P11, DOI 10.1104/pp.112.1.11; TALON M, 1990, PLANTA, V182, P501, DOI 10.1007/BF02341024; Thomas SG, 1999, P NATL ACAD SCI USA, V96, P4698, DOI 10.1073/pnas.96.8.4698; Thornton TM, 1999, TRENDS PLANT SCI, V4, P424, DOI 10.1016/S1360-1385(99)01485-5; VANDENBERG JH, 1995, J PLANT PHYSIOL, V146, P467, DOI 10.1016/S0176-1617(11)82010-9; Willert K, 1998, CURR OPIN GENET DEV, V8, P95, DOI 10.1016/S0959-437X(98)80068-3	44	137	161	0	31	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 10	2001	106	3					343	354		10.1016/S0092-8674(01)00445-7	http://dx.doi.org/10.1016/S0092-8674(01)00445-7			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RJ	11509183	Bronze			2022-12-28	WOS:000170433300012
J	Mostashari, F; Bunning, ML; Kitsutani, PT; Singer, DA; Nash, D; Cooper, MJ; Katz, N; Liljebjelke, KA; Biggerstaff, BJ; Fine, AD; Layton, MC; Mullin, SM; Johnson, AJ; Martin, DA; Hayes, EB; Campbell, GL				Mostashari, F; Bunning, ML; Kitsutani, PT; Singer, DA; Nash, D; Cooper, MJ; Katz, N; Liljebjelke, KA; Biggerstaff, BJ; Fine, AD; Layton, MC; Mullin, SM; Johnson, AJ; Martin, DA; Hayes, EB; Campbell, GL			Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey	LANCET			English	Article							VIRUS-INFECTION; OUTBREAK; FEVER	Background In the summer of 1999, West Nile virus was recognised in the western hemisphere for the first time when it caused an epidemic of encephalitis and meningitis in the metropolitan area of New York City, NY, USA. Intensive hospital-based surveillance identified 59 cases, including seven deaths in the region. We did a household-based seroepidemiological survey to assess more clearly the public-health impact of the epidemic, its range of illness, and risk factors associated with infection. Methods We used cluster sampling to select a representative sample of households in an area of about 7.3 km(2) at the outbreak epicentre. All individuals aged 5 years or older were eligible for interviews and phlebotomy. Serum samples were tested for IgM and IgG antibodies specific for West Nile virus. Findings 677 individuals from 459 households participated. 19 were seropositive (weighted seroprevalence 2.6% [95% CI 1.2-4.1). Six (32%) of the seropositive individuals reported a recent febrile illness compared with 70 of 648 (11%) seronegative participants (difference 21% [0-47]). A febrile syndrome with fatigue, headache, myalgia, and arthralgia was highly associated with seropositivity (prevalence ratio 7.4 [1.5-36.6]). By extrapolation from the 59 diagnosed meningoencephalitis cases, we conservatively estimated that the New York outbreak consisted of 8200 (range 3500-13 000) West Nile viral infections, including about 1700 febrile infections. Interpretation During the 1999 West Nile virus outbreak, thousands of symptomless and symptomatic West Nile viral infections probably occurred, with fewer than 1% resulting in severe neurological disease.	New York City Dept Hlth, Communicable Dis Program, New York, NY 10013 USA; Ctr Dis Control & Prevent, Epidemiol Program Off, Publ Hlth Serv, US Dept HHS, Atlanta, GA USA; CDC, Div Vector Borne Infect Dis, Natl Ctr Infect Dis, Ft Collins, CO USA; CDC, Div Viral & Rickettsial Dis, NCID, Atlanta, GA 30333 USA; CDC, Div Quarantine, NCID, Atlanta, GA 30333 USA; CDC, Off Anal Epidemiol & Hlth Promot, Natl Ctr Hlth Stat, Hyattsville, MD USA	New York City Department of Health & Mental Hygiene; Centers for Disease Control & Prevention - USA; United States Public Health Service; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS)	Mostashari, F (corresponding author), New York City Dept Hlth, Communicable Dis Program, 125 Worth St,Box 22A, New York, NY 10013 USA.	mostashari@post.harvard.edu	Nash, Denis/AFI-7485-2022; Liljebjelke, Karen/ABC-9900-2020	Liljebjelke, Karen/0000-0002-8155-1626; Nash, Denis/0000-0002-3280-5386				Asnis DS, 2000, CLIN INFECT DIS, V30, P413, DOI 10.1086/313737; Beaty B.J., 1995, DIAGNOSTIC PROCEDURE, P189; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P845; Han LL, 1999, J INFECT DIS, V179, P230, DOI 10.1086/314566; Johnson AJ, 2000, J CLIN MICROBIOL, V38, P1827, DOI 10.1128/JCM.38.5.1827-1831.2000; LeGuenno B, 1996, LANCET, V348, P1315, DOI 10.1016/S0140-6736(05)65799-6; MARBERG K, 1956, AM J HYG, V64, P259, DOI 10.1093/oxfordjournals.aje.a119838; Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000; MCINTOSH BM, 1976, S AFR J SCI, V72, P295; NASH D, 2001, NEW ENGL J MED, V14, P1858; Nur YA, 1999, AM J TROP MED HYG, V61, P885, DOI 10.4269/ajtmh.1999.61.885; Platonov AE, 2001, EMERG INFECT DIS, V7, P128, DOI 10.3201/eid0701.010118; SMITHBURN K. C, 1940, AMER JOUR TROP MED, V20, P471; SPIGLAND I, 1957, J MED ASS ISRAEL, V54, P275; TAYLOR RM, 1956, AM J TROP MED HYG, V5, P579, DOI 10.4269/ajtmh.1956.5.579; Thomas DR, 1996, INT STAT REV, V64, P295, DOI 10.2307/1403787; THOMAS DR, 1987, J AM STAT ASSOC, V82, P630, DOI 10.2307/2289475; Tsai TF, 1998, LANCET, V352, P767, DOI 10.1016/S0140-6736(98)03538-7; Turner AG, 1996, INT J EPIDEMIOL, V25, P198, DOI 10.1093/ije/25.1.198; *US BUR CENS, 1997, EST POP COUNT RANK 1, P1	20	445	468	0	28	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 28	2001	358	9278					261	264		10.1016/S0140-6736(01)05480-0	http://dx.doi.org/10.1016/S0140-6736(01)05480-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	457AF	11498211				2022-12-28	WOS:000170114400008
J	Ballard, C; Fosssey, J; Chithramohan, R; Howard, R; Burns, A; Thompson, P; Tadros, G; Fairbairn, A				Ballard, C; Fosssey, J; Chithramohan, R; Howard, R; Burns, A; Thompson, P; Tadros, G; Fairbairn, A			Quality of care in private sector and NHS facilities for people with dementia: cross sectional survey	BRITISH MEDICAL JOURNAL			English	Article									Royal Coll Psychiatrists, London SW1X 8PG, England		Fairbairn, A (corresponding author), Royal Coll Psychiatrists, London SW1X 8PG, England.		Howard, Robert/E-4890-2010	Burns, Alistair/0000-0002-9837-0645; Ballard, Clive/0000-0003-0022-5632; Howard, Robert/0000-0002-3071-2338				Brooker D., 1995, J MENTAL HLTH, V4, P145, DOI DOI 10.1080/09638239550037686; COPELAND JRM, 1976, PSYCHOL MED, V6, P439, DOI 10.1017/S0033291700015889; *DEP HLTH, 1999, FIT FUT NAT REQ STAN; Kitwood T., 1997, EVALUATING DEMENTIA; LEAPER R, 1998, TRAINING QUALIFICATI	5	74	75	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 25	2001	323	7310					426	427		10.1136/bmj.323.7310.426	http://dx.doi.org/10.1136/bmj.323.7310.426			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469BX	11520838	Bronze, Green Published			2022-12-28	WOS:000170793600019
J	Gilbert, RE; Augood, C; Gupta, R; Ades, AE; Logan, S; Sculpher, M; van der Meulen, JHP				Gilbert, RE; Augood, C; Gupta, R; Ades, AE; Logan, S; Sculpher, M; van der Meulen, JHP			Screening for Down's syndrome: effects, safety, and cost effectiveness of first and second trimester strategies	BRITISH MEDICAL JOURNAL			English	Article							NUCHAL TRANSLUCENCY MEASUREMENT; MATERNAL AGE; WOMEN; AMNIOCENTESIS; MULTICENTER; PREFERENCES; THICKNESS; GESTATION; FETUSES; UK		Inst Child Hlth, Dept Paediat Epidemiol & Biostat, Systemat Reviews Training Unit, London WC1N 1EH, England; Univ York, Ctr Hlth Econ, York YO1 5DD, N Yorkshire, England; Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Hlth Serv Res Unit, London WC1E 7HT, England	University of London; University College London; University of York - UK; University of London; London School of Hygiene & Tropical Medicine	Gilbert, RE (corresponding author), Inst Child Hlth, Dept Paediat Epidemiol & Biostat, Systemat Reviews Training Unit, 30 Guilford St, London WC1N 1EH, England.			Gilbert, Ruth/0000-0001-9347-2709; van der Meulen, Jan/0000-0002-9451-2335; Logan, Stuart/0000-0002-9279-261X; Sculpher, Mark/0000-0003-3746-9913				Beazoglou T, 1998, PRENATAL DIAG, V18, P1241, DOI 10.1002/(SICI)1097-0223(199812)18:12<1241::AID-PD440>3.0.CO;2-M; BEWLEY S, 1995, BRIT J OBSTET GYNAEC, V102, P386, DOI 10.1111/j.1471-0528.1995.tb11290.x; Ganiats TG, 1996, MED DECIS MAKING, V16, P45, DOI 10.1177/0272989X9601600112; Gibb DM, 1998, BRIT MED J, V316, P259, DOI 10.1136/bmj.316.7127.259; Haddow JE, 1998, NEW ENGL J MED, V338, P955, DOI 10.1056/NEJM199804023381404; HECHT CA, 1994, PRENATAL DIAG, V14, P729, DOI 10.1002/pd.1970140814; HECKERLING PS, 1994, J CLIN EPIDEMIOL, V47, P1215, DOI 10.1016/0895-4356(94)90126-0; Hyett J, 1996, ULTRASOUND OBST GYN, V7, P245, DOI 10.1046/j.1469-0705.1996.07040245.x; Kuppermann M, 1999, PRENATAL DIAG, V19, P711, DOI 10.1002/(SICI)1097-0223(199908)19:8<711::AID-PD614>3.0.CO;2-V; MACINTOSH MCM, 1995, BRIT J OBSTET GYNAEC, V102, P798, DOI 10.1111/j.1471-0528.1995.tb10845.x; Mol BWJ, 1999, OBSTET GYNECOL, V94, P864, DOI 10.1016/S0029-7844(99)00496-2; Nicolaides KH, 1998, PRENATAL DIAG, V18, P519, DOI 10.1002/(SICI)1097-0223(199805)18:5<519::AID-PD398>3.0.CO;2-U; Pajkrt E, 2000, ULTRASOUND OBST GYN, V15, P297, DOI 10.1046/j.1469-0705.2000.00088.x; SHACKLEY M, 1993, TOURISM MANAGE, V15, P17; Snijders RJM, 1998, LANCET, V352, P343, DOI 10.1016/S0140-6736(97)11280-6; Torgerson DJ, 1996, BRIT MED J, V312, P35, DOI 10.1136/bmj.312.7022.35; Torrance GW, 1996, COST EFFECTIVENESS H, P276; van der Meulen JHP, 1999, BRIT J OBSTET GYNAEC, V106, P108; Wald N J, 1997, J Med Screen, V4, P181; Wald NJ, 1997, PRENATAL DIAG, V17, P821, DOI 10.1002/(SICI)1097-0223(199709)17:9<821::AID-PD154>3.3.CO;2-X; Wald NJ, 1999, LANCET, V354, P1264, DOI 10.1016/S0140-6736(99)03819-2; WALD NJ, 1992, BRIT J OBSTET GYNAEC, V99, P144, DOI 10.1111/j.1471-0528.1992.tb14474.x; Wald NJ, 1996, PRENATAL DIAG, V16, P143, DOI 10.1002/(SICI)1097-0223(199602)16:2<143::AID-PD825>3.0.CO;2-F; WALD NJ, 1988, BRIT MED J, V297, P883, DOI 10.1136/bmj.297.6653.883; Wald NJ, 1999, NEW ENGL J MED, V341, P461, DOI 10.1056/NEJM199908123410701	25	61	68	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 25	2001	323	7310					423	425		10.1136/bmj.323.7310.423	http://dx.doi.org/10.1136/bmj.323.7310.423			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469BX	11520837	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000170793600018
J	Lewis, J; Dickson, DW; Lin, WL; Chisholm, L; Corral, A; Jones, G; Yen, SH; Sahara, N; Skipper, L; Yager, D; Eckman, C; Hardy, J; Hutton, M; McGowan, E				Lewis, J; Dickson, DW; Lin, WL; Chisholm, L; Corral, A; Jones, G; Yen, SH; Sahara, N; Skipper, L; Yager, D; Eckman, C; Hardy, J; Hutton, M; McGowan, E			Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP	SCIENCE			English	Article							FAMILIAL ALZHEIMERS-DISEASE; AMYLOID PRECURSOR PROTEIN; PAIRED HELICAL FILAMENTS; BETA-PROTEIN; IN-VIVO; A-BETA; PRESENILIN-1; GENE; MUTATIONS; A-BETA-42(43)	JNPL3 transgenic mice expressing a mutant tau protein, which develop neurofibrillary tangles and progressive motor disturbance, were crossed with Tg2576 transgenic mice expressing mutant beta -amyloid precursor protein (APP), thus modulating the APP-A beta (beta -amyloid peptide) environment. The resulting double mutant (tau/APP) progeny and the Tg2576 parental strain developed A beta deposits at the same age; however, relative to JNPL3 mice, the double mutants exhibited neurofibrillary tangle pathology that was substantially enhanced in the limbic system and olfactory cortex. These results indicate that either APP or A beta influences the formation of neurofibrillary tangles. The interaction between A beta and tau pathologies in these mice supports the hypothesis that a similar interaction occurs in Alzheimer's disease.	Mayo Clin Jacksonville, Jacksonville, FL 32224 USA	Mayo Clinic	Hutton, M (corresponding author), Mayo Clin Jacksonville, Birdsall Bldg,4500 San Pablo Rd, Jacksonville, FL 32224 USA.	hutton.michael@mayo.edu	Hardy, John/C-2451-2009	Hardy, John/0000-0002-3122-0423; Skipper, Lisa/0000-0002-1524-9787; Dickson, Dennis W/0000-0001-7189-7917	NATIONAL INSTITUTE ON AGING [Z01AG000951, ZIAAG000951] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Callahan MJ, 2001, AM J PATHOL, V158, P1173, DOI 10.1016/S0002-9440(10)64064-3; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; DeTure M, 2001, ALZHEIMER'S DISEASE, P651, DOI 10.1002/0470846453.ch60; DICKSON DW, 1993, ACTA NEUROPATHOL, V85, P463; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P131; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; GRAVINA SA, 1995, J BIOL CHEM, V270, P7013, DOI 10.1074/jbc.270.13.7013; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; Hardy J, 1998, NAT NEUROSCI, V1, P355, DOI 10.1038/1565; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Haugabook SJ, 2001, FASEB J, V15, P16; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Jicha GA, 1999, J NEUROSCI, V19, P7486, DOI 10.1523/JNEUROSCI.19-17-07486.1999; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; JORM AF, 1987, ACTA PSYCHIAT SCAND, V76, P465, DOI 10.1111/j.1600-0447.1987.tb02906.x; Kawas C, 1999, ALZHEIMER DIS, P95; LANNFELT L, 1994, NEUROSCI LETT, V168, P254, DOI 10.1016/0304-3940(94)90463-4; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; LEWIS J, 2000, NEUROSCI NEWS, V3, P63; MASTERS CL, 1985, EMBO J, V4, P2757, DOI 10.1002/j.1460-2075.1985.tb04000.x; Mehta ND, 1998, ANN NEUROL, V43, P256, DOI 10.1002/ana.410430217; MIKOL J, 1980, ACTA NEUROPATHOL, V49, P57, DOI 10.1007/BF00692220; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; ROCCA WA, 1991, ANN NEUROL, V30, P381, DOI 10.1002/ana.410300310; ROSES AD, 1994, J NEUROPATH EXP NEUR, V53, P429, DOI 10.1097/00005072-199409000-00002; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; SELKOE DJ, 1994, J NEUROPATH EXP NEUR, V53, P438, DOI 10.1097/00005072-199409000-00003; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Vincent I, 1998, NEUROBIOL AGING, V19, P287, DOI 10.1016/S0197-4580(98)00071-2; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506	37	1151	1226	0	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2001	293	5534					1487	1491		10.1126/science.1058189	http://dx.doi.org/10.1126/science.1058189			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465XV	11520987				2022-12-28	WOS:000170616000044
J	Michaud, DS; Giovannucci, E; Willett, WC; Colditz, GA; Stampfer, MJ; Fuchs, CS				Michaud, DS; Giovannucci, E; Willett, WC; Colditz, GA; Stampfer, MJ; Fuchs, CS			Physical activity, obesity, height, and the risk of pancreatic cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-FAT DISTRIBUTION; NATIONAL DEATH INDEX; GROWTH-FACTOR-I; DIABETES-MELLITUS; ACTIVITY QUESTIONNAIRE; NUTRITIONAL FACTORS; INSULIN; MORTALITY; MEN; GLUCOSE	Context Diabetes mellitus and elevated postload plasma glucose levels have been associated with an increased risk of pancreatic cancer in previous studies. By virtue of their influence on insulin resistance, obesity and physical inactivity may increase risk of pancreatic cancer. Objective To examine obesity, height, and physical activity in relation to pancreatic cancer risk. Design and Setting Two US cohort studies conducted by mailed questionnaire, the Health Professionals Follow-Up Study (initiated in 1986) and the Nurses' Health Study (initiated in 1976), with 10 to 20 years of follow-up. Participants A total of 46648 men aged 40 to 75 years and 117041 women aged 30 to 55 years who were free of prior cancer at baseline and had complete data on height and weight. Main Outcome Measures Relative risk of pancreatic cancer, analyzed by self-reported body mass index (BMI), height, and level of physical activity. Results During follow-up, we documented 350 incident pancreatic cancer cases. Individuals with a BMI of at least 30 kg/m(2) had an elevated risk of pancreatic cancer compared with those with a BMI of less than 23 kg/m(2) (multivariable relative risk [RR], 1.72; 95% confidence interval [CI], 1.19-2.48), Height was associated with an increased pancreatic cancer risk (multivariable RR, 1.81; 95% CI, 1.31-2.52 for the highest vs lowest categories). An inverse relation was observed for moderate activity (multivariable RR, 0.45; 95% CI, 0.29-0.70 for the highest vs lowest categories; P for trend <.001). Total physical activity was not associated with risk among individuals with a BMI of less than 25 kg/m(2) but was inversely associated with risk among individuals with a BMI of at least 25 kg/m(2) (pooled multivariable RR, 0.59; 95% CI, 0.37-0.94 for the top vs bottom tertiles of total physical activity; P for trend=.04). Conclusion In 2 prospective cohort studies, obesity significantly increased the risk of pancreatic cancer. Physical activity appears to decrease the risk of pancreatic cancer, especially among those who are overweight.	Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; Harvard Univ, Sch Med, Boston, MA USA; Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Michaud, DS (corresponding author), NCI, 6120 Execut Blvd,EPS Room 7026, Rockville, MD 20852 USA.	michaudd@mail.nih.gov	Colditz, Graham/A-3963-2009; Michaud, Dominique S/I-5231-2014	Colditz, Graham/0000-0002-7307-0291; 	NATIONAL CANCER INSTITUTE [P01CA087969, R01CA086102] Funding Source: NIH RePORTER; NCI NIH HHS [CA 87969, CA 86102, CA 55075] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahlgren JD, 1996, SEMIN ONCOL, V23, P241; AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; ALBANES D, 1988, CANCER RES, V48, P1658; *AM CANC SOC INC, 2000, CANC FACTS FIG 2000; Baik I, 2000, AM J EPIDEMIOL, V152, P264, DOI 10.1093/aje/152.3.264; BERGMANN U, 1995, CANCER RES, V55, P2007; BOYLE P, 1989, INT J PANCREATOL, V5, P327, DOI 10.1007/BF02924298; Carey VJ, 1997, AM J EPIDEMIOL, V145, P614, DOI 10.1093/oxfordjournals.aje.a009158; CHAPMAN DG, 1968, BIOMETRICS, V24, P315, DOI 10.2307/2528037; ChasanTaber S, 1996, EPIDEMIOLOGY, V7, P81, DOI 10.1097/00001648-199601000-00014; Chow WH, 1999, BRIT J CANCER, V79, P640, DOI 10.1038/sj.bjc.6690101; Coughlin SS, 2000, CANCER CAUSE CONTROL, V11, P915, DOI 10.1023/A:1026580131793; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; DEMESQUITA HBB, 1992, INT J CANCER, V52, P24, DOI 10.1002/ijc.2910520106; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DESPRES JP, 1990, ARTERIOSCLEROSIS, V10, P497, DOI 10.1161/01.ATV.10.4.497; DiPietro L, 1998, J AM GERIATR SOC, V46, P875, DOI 10.1111/j.1532-5415.1998.tb02722.x; EVERHART J, 1995, JAMA-J AM MED ASSOC, V273, P1605, DOI 10.1001/jama.273.20.1605; Fisher WE, 1996, J SURG RES, V63, P310, DOI 10.1006/jsre.1996.0266; FRIEDMAN GD, 1993, INT J EPIDEMIOL, V22, P30, DOI 10.1093/ije/22.1.30; Fuchs CS, 1996, ARCH INTERN MED, V156, P2255, DOI 10.1001/archinte.156.19.2255; Gapstur SM, 2000, JAMA-J AM MED ASSOC, V283, P2552, DOI 10.1001/jama.283.19.2552; GHADIRIAN P, 1991, INT J CANCER, V47, P1, DOI 10.1002/ijc.2910470102; GIOVANNUCCI E, 1995, ANN INTERN MED, V122, P327, DOI 10.7326/0003-4819-122-5-199503010-00002; HENDERSON JR, 1981, GUT, V22, P158, DOI 10.1136/gut.22.2.158; HOWE GR, 1992, INT J CANCER, V51, P365, DOI 10.1002/ijc.2910510306; Ji BT, 1996, INT J CANCER, V66, P432; KALAPOTHAKI V, 1993, CANCER CAUSE CONTROL, V4, P375, DOI 10.1007/BF00051341; Kelley DE, 1999, MED SCI SPORT EXER, V31, pS619, DOI 10.1097/00005768-199911001-00021; KISSEBAH AH, 1982, J CLIN ENDOCR METAB, V54, P254, DOI 10.1210/jcem-54-2-254; KROTKIEWSKI M, 1983, J CLIN INVEST, V72, P1150, DOI 10.1172/JCI111040; LEVINE W, 1990, AM J EPIDEMIOL, V131, P254, DOI 10.1093/oxfordjournals.aje.a115495; LYON JL, 1993, CANCER EPIDEM BIOMAR, V2, P513; MANSON JE, 1987, JAMA-J AM MED ASSOC, V257, P353, DOI 10.1001/jama.257.3.353; Michaud DS, 2001, CANCER EPIDEM BIOMAR, V10, P429; MOLLER H, 1994, EUR J CANCER, V30A, P344, DOI 10.1016/0959-8049(94)90254-2; OHMURA E, 1990, CANCER RES, V50, P103; OSHIDA Y, 1989, J APPL PHYSIOL, V66, P2206, DOI 10.1152/jappl.1989.66.5.2206; RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; SHIBATA A, 1994, INT J CANCER, V58, P46, DOI 10.1002/ijc.2910580109; Silverman DT, 1998, JNCI-J NATL CANCER I, V90, P1710, DOI 10.1093/jnci/90.22.1710; Silverman DT, 1999, BRIT J CANCER, V80, P1830, DOI 10.1038/sj.bjc.6690607; Silverman DT, 2001, TERATOGEN CARCIN MUT, V21, P7, DOI 10.1002/1520-6866(2001)21:1<7::AID-TCM3>3.0.CO;2-A; Smith GD, 1998, BMJ-BRIT MED J, V317, P1351, DOI 10.1136/bmj.317.7169.1351; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; TAKEDA Y, 1991, J CANCER RES CLIN, V117, P416, DOI 10.1007/BF01612760; Wang MY, 1998, CANCER RES, V58, P38; Wareham NJ, 2000, AM J EPIDEMIOL, V152, P132, DOI 10.1093/aje/152.2.132; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991	50	435	446	1	31	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2001	286	8					921	929		10.1001/jama.286.8.921	http://dx.doi.org/10.1001/jama.286.8.921			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465EU	11509056	Bronze			2022-12-28	WOS:000170577300026
J	Toft, AD				Toft, AD			Subclinical hyperthyroidism.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							THYROTROPIN-SUPPRESSIVE THERAPY; THYROID ASSOCIATION GUIDELINES; SPORADIC NONTOXIC GOITER; BONE-MINERAL DENSITY; ATRIAL-FIBRILLATION; THYROXINE TREATMENT; EXERCISE CAPACITY; SERUM THYROTROPIN; RISK FACTOR; HYPOTHYROIDISM		Royal Edinburgh & Associated Hosp, Endocrine Clin, Edinburgh EH3 9YW, Midlothian, Scotland	Royal Infirmary of Edinburgh	Toft, AD (corresponding author), Royal Edinburgh & Associated Hosp, Endocrine Clin, Lauriston Pl, Edinburgh EH3 9YW, Midlothian, Scotland.							*AM ASS CLIN END, 1995, AM FAM PHYSICIAN, V51, P679; BELL GM, 1985, CLIN ENDOCRINOL, V22, P83, DOI 10.1111/j.1365-2265.1985.tb01068.x; BERGHOUT A, 1990, AM J MED, V89, P602, DOI 10.1016/0002-9343(90)90178-G; Biondi B, 1996, J CLIN ENDOCR METAB, V81, P4224, DOI 10.1210/jc.81.12.4224; Biondi B, 2000, J CLIN ENDOCR METAB, V85, P4701, DOI 10.1210/jc.85.12.4701; CARR D, 1988, CLIN ENDOCRINOL, V28, P325, DOI 10.1111/j.1365-2265.1988.tb01219.x; Cooper DS, 2001, NEW ENGL J MED, V345, P260, DOI 10.1056/NEJM200107263450406; Costagliola S, 1999, J CLIN ENDOCR METAB, V84, P90, DOI 10.1210/jc.84.1.90; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; Faber J, 1998, CLIN ENDOCRINOL, V48, P285; FOLDES J, 1993, CLIN ENDOCRINOL, V39, P521, DOI 10.1111/j.1365-2265.1993.tb02403.x; FORFAR JC, 1981, INT J CARDIOL, V1, P43, DOI 10.1016/0167-5273(81)90047-4; FRANKLYN JA, 1992, LANCET, V340, P9, DOI 10.1016/0140-6736(92)92423-D; Haddow JE, 1999, NEW ENGL J MED, V341, P549, DOI 10.1056/NEJM199908193410801; HEGEDUS L, 1988, BRIT MED J, V297, P661, DOI 10.1136/bmj.297.6649.661; Helfand M, 1999, ANN INTERN MED, V130, P246, DOI 10.7326/0003-4819-130-2-199901190-00018; Helfand M, 1998, ANN INTERN MED, V129, P144, DOI 10.7326/0003-4819-129-2-199807150-00020; Kalmijn S, 2000, CLIN ENDOCRINOL, V53, P733, DOI 10.1046/j.1365-2265.2000.01146.x; Kumeda Y, 2000, J CLIN ENDOCR METAB, V85, P4157, DOI 10.1210/jc.85.11.4157; Ladenson PW, 2000, ARCH INTERN MED, V160, P1573, DOI 10.1001/archinte.160.11.1573; Le Moli R, 1999, CLIN ENDOCRINOL, V50, P783; Mercuro G, 2000, J CLIN ENDOCR METAB, V85, P159, DOI 10.1210/jc.85.1.159; MUDDE AH, 1994, CLIN ENDOCRINOL, V41, P421, DOI 10.1111/j.1365-2265.1994.tb02571.x; MUDDE AH, 1992, CLIN ENDOCRINOL, V37, P35, DOI 10.1111/j.1365-2265.1992.tb02280.x; NAKAZAWA HK, 1982, AM J MED, V72, P903, DOI 10.1016/0002-9343(82)90850-6; NYSTROM E, 1989, CLIN ENDOCRINOL, V31, P143, DOI 10.1111/j.1365-2265.1989.tb01237.x; PARLE JV, 1991, CLIN ENDOCRINOL, V34, P77; SAWIN CT, 1994, NEW ENGL J MED, V331, P1249, DOI 10.1056/NEJM199411103311901; SINGER PA, 1995, JAMA-J AM MED ASSOC, V273, P808, DOI 10.1001/jama.273.10.808; SNYDER PJ, 1972, J CLIN INVEST, V51, P2077, DOI 10.1172/JCI107014; STAFFURTH JS, 1977, BRIT MED J, V2, P688, DOI 10.1136/bmj.2.6088.688; SURKS MI, 1990, JAMA-J AM MED ASSOC, V263, P1529, DOI 10.1001/jama.263.11.1529; TOFT AD, 1994, NEW ENGL J MED, V331, P174; TOFT AD, 1994, NEW ENGL J MED, V331, P1035; Uzzan B, 1996, J CLIN ENDOCR METAB, V81, P4278, DOI 10.1210/jc.81.12.4278; Vanderpump MPJ, 1996, BMJ-BRIT MED J, V313, P539; WIERSINGA WM, 1995, NETH J MED, V46, P197, DOI 10.1016/0300-2977(94)00089-R	37	147	167	0	6	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 16	2001	345	7					512	516		10.1056/NEJMcp010145	http://dx.doi.org/10.1056/NEJMcp010145			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	462QM	11519506				2022-12-28	WOS:000170431300006
J	Coid, J; Petruckevitch, A; Feder, G; Chung, WS; Richardson, J; Moorey, S				Coid, J; Petruckevitch, A; Feder, G; Chung, WS; Richardson, J; Moorey, S			Relation between childhood sexual and physical abuse and risk of revictimisation in women: a cross-sectional survey	LANCET			English	Article							DATE RAPE; ASSAULT; REVICTIMIZATION; IMPACT; VICTIMIZATION; CONSEQUENCES; EXPERIENCES; INPATIENTS; CHILDREN; VICTIMS	Background Women who are physically and sexually abused in childhood are at increased risk of victimisation in adulthood. Research has concentrated on sexual revictimisation, and has not included investigation of other abusive experiences, nor examination of prevalence and effects of abuse on adult revictimisation. We aimed to examine the relation between childhood trauma and adult revictimisation, and identify confounding factors. Methods We did a cross-sectional survey of 2592 women who were attending primary care practices in east London, UK, with self-administered anonymous questionnaires. We included questions on physical and sexual abuse in childhood; on domestic violence, rape, indecent assault, and other traumatic experiences in adulthood; and on alcohol and other drug abuse. We analysed associations between childhood and adulthood abuse with multiple logistic regression. Findings 1207 (55%) of 2192 eligible women were recruited and completed the questionnaire. Abusive experiences co-occurred in both childhood and adulthood. Repetition and severity of childhood abuse were independently associated with specific types of adult revictimisation. Unwanted sexual intercourse (<16 years) was associated with domestic violence in adulthood (odds ratio 3.54; 95% CI 1.52-8.25) and with rape (2.84; 1.09-7.35); and severe beatings by parents or carers with domestic violence (3.58; 2.06-6.20), rape (2.70; 1.27-5.74), and other trauma (3.85; 2.23-6.63). Interpretation Childhood abuse substantially increases risk of revictimisation in adulthood. Women who have experienced multiple childhood abuse are at most risk of adult revictimisation. Identification of women who have undergone childhood abuse is a prerequisite for prevention of further abuse.	St Bartholomews Hosp, Forens Psychiat Res Unit, London EC1A 7BE, England; Univ London Queen Mary & Westfield Coll, Dept Gen Practice, London E1 4NS, England; Maudsley Hosp & Inst Psychiat, London SE5 8AZ, England	University of London; Queen Mary University London; University of London; Queen Mary University London; South London & Maudsley NHS Trust; University of London; King's College London	Coid, J (corresponding author), St Bartholomews Hosp, Forens Psychiat Res Unit, William Harvey House,61 Bartholomew Close, London EC1A 7BE, England.			Feder, Gene/0000-0002-7890-3926				ALEXANDER PC, 1987, ARCH SEX BEHAV, V16, P235, DOI 10.1007/BF01541611; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; BECKERLAUSEN E, 1995, AM J ORTHOPSYCHIAT, V65, P560, DOI 10.1037/h0079670; BRIERE J, 1992, J CONSULT CLIN PSYCH, V60, P196, DOI 10.1037/0022-006X.60.2.196; Briere J., 1987, J INTERPERS VIOLENCE, V2, P367, DOI [10.1177/088626058700200403, DOI 10.1177/088626058700200403]; Cloitre M, 1996, J TRAUMA STRESS, V9, P473, DOI 10.1007/BF02103659; DEBLINGER E, 1989, CHILD ABUSE NEGLECT, V13, P403, DOI 10.1016/0145-2134(89)90080-X; DUTTON MA, 1994, J TRAUMA STRESS, V7, P237, DOI 10.1002/jts.2490070206; ELLIS EM, 1982, J ABNORM PSYCHOL, V91, P221, DOI 10.1037/0021-843X.91.3.221; FINKELHOR D, 1985, AM J ORTHOPSYCHIAT, V55, P530, DOI 10.1111/j.1939-0025.1985.tb02703.x; Follette VM, 1996, J TRAUMA STRESS, V9, P25, DOI 10.1007/BF02116831; FRANK E, 1980, J BEHAV ASSESS, V2, P39, DOI 10.1007/BF01321431; GIDYCZ CA, 1993, PSYCHOL WOMEN QUART, V17, P151, DOI 10.1111/j.1471-6402.1993.tb00441.x; GOLDSTON DB, 1989, J ABNORM PSYCHOL, V98, P314, DOI 10.1037/0021-843X.98.3.314; GORCEY M, 1986, SOC PSYCH PSYCH EPID, V21, P129, DOI 10.1007/BF00582682; Green B.L., 1991, J TRAUMA STRESS, V4, P137, DOI DOI 10.1002/JTS.2490040111; JACKSON JL, 1990, ARCH SEX BEHAV, V19, P211, DOI 10.1007/BF01541547; Kilpatrick DG, 1997, J CONSULT CLIN PSYCH, V65, P834, DOI 10.1037/0022-006X.65.5.834; KLUFT RP, 1990, PSYCHOL WOMEN Q, V19, P5; KOLKO DJ, 1988, CHILD ABUSE NEGLECT, V12, P529, DOI 10.1016/0145-2134(88)90070-1; KOSS MP, 1989, J CONSULT CLIN PSYCH, V57, P242, DOI 10.1037/0022-006X.57.2.242; Mandoki C A, 1989, Violence Vict, V4, P179; MAYALL A, 1995, J INTERPERS VIOLENCE, V10, P26, DOI 10.1177/088626095010001002; MAYFIELD D, 1974, AM J PSYCHIAT, V131, P1121; MCCAULEY J, 1995, ANN INTERN MED, V123, P737, DOI 10.7326/0003-4819-123-10-199511150-00001; Merrill LL, 1999, J TRAUMA STRESS, V12, P211, DOI 10.1023/A:1024789723779; MILLER J, 1978, AM J PSYCHIAT, V135, P1103; MUEHLENHARD CL, 1987, J COUNS PSYCHOL, V34, P186, DOI 10.1037/0022-0167.34.2.186; Russell D., 1984, SEXUAL EXPLOITATION, P29; Russell D. E. H., 1986, SECRET TRAUMA INCEST; Sanders B, 1999, J INTERPERS VIOLENCE, V14, P115, DOI 10.1177/088626099014002001; Stevenson M. R., 1992, J PSYCHOL HUM SEX, V4, P57, DOI [10.1300/J056v04n04_05, DOI 10.1300/J056V04N04_05]; Urquiza A J, 1994, Violence Vict, V9, P223; WYATT GE, 1992, J CONSULT CLIN PSYCH, V60, P167, DOI 10.1037/0022-006X.60.2.167	34	277	284	2	40	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 11	2001	358	9280					450	454		10.1016/S0140-6736(01)05622-7	http://dx.doi.org/10.1016/S0140-6736(01)05622-7			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	463TB	11513908				2022-12-28	WOS:000170492400010
J	Hippisley-Cox, J; Pringle, M; Coupland, C; Hammersley, V; Wilson, A				Hippisley-Cox, J; Pringle, M; Coupland, C; Hammersley, V; Wilson, A			Do single handed practices offer poorer care? Cross sectional survey of processes and outcomes	BRITISH MEDICAL JOURNAL			English	Article							GENERAL-PRACTICE; PRACTITIONERS; DEPRIVATION; RATES; SATISFACTION; SIZE	Objectives To determine whether there are important differences in performance between group practices and singlehanded general practitioners and the extent to which any differences are explained by practice characteristics such as deprivation. Design Cross sectional survey. Setting 206 singlehanded practices and 606 partnerships in Trent region, United Kingdom. Method Comparison of process and outcome measures derived from routinely collected data on hospital admissions and target payments for singlehanded practices and partnerships. Multivariate analysis was used to adjust for the confounding effects of general practice characteristics-deprivation (Townsend score), percentage of Asian residents, percentage of black residents, proportion of men over 75 years, proportion of women over 75 years, rurality, presence of a female general practitioner, and vocational training status. Results Differences in achievement of immunisation and cytology targets apparent on univariate analysis were not seen after adjustment for other general practice characteristics. Similarly, significant differences (> 15%; P < 0.01) for three types of hospital admission seen on univariate analysis were not present after adjustment for other practice characteristics. Conclusions This study provides no evidence that singlehanded general practitioners are underperforming clinically. Our results offer insight into the structural difference between the two types of practice and underline the importance of the effect of other practice characteristics on process and outcome measures.	Univ Nottingham, Div Gen Practice, Nottingham NG7 2RD, England; Univ Leicester, Leicester Gen Hosp, Dept Gen Practice & Primary Hlth Care, Leicester LE5 4PW, Leics, England	University of Nottingham; University Hospitals of Leicester NHS Trust; Leicester General Hospital; University of Leicester	Hippisley-Cox, J (corresponding author), Univ Nottingham, Div Gen Practice, Nottingham NG7 2RD, England.		Hippisley-Cox, Julia/AAY-2788-2020	Hippisley-Cox, Julia/0000-0002-2479-7283; Coupland, Carol/0000-0002-2327-3306				BAKER R, 1995, BRIT J GEN PRACT, V45, P654; Baker R, 1996, BRIT J GEN PRACT, V46, P601; Campbell JL, 1996, BRIT J GEN PRACT, V46, P465; CARLISLE R, 1998, BR J GEN PRACT, V48, P1477; CARLISLE RD, 1993, BRIT MED J, V306, P1383, DOI 10.1136/bmj.306.6889.1383; Carstairs V, 1991, DEPRIVATION HLTH; CURTIS SE, 1987, FAM PRACT, V4, P200, DOI 10.1093/fampra/4.3.200; *DEP HLTH, 2000, NHS PLANT PLAN INV P; Giuffrida A, 1999, BRIT MED J, V319, P94, DOI 10.1136/bmj.319.7202.94; GREEN JM, 1993, BRIT MED J, V307, P307; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; Hippisley-Cox J, 2000, BRIT MED J, V320, P842, DOI 10.1136/bmj.320.7238.842; HippisleyCox J, 1997, BRIT MED J, V314, P1458, DOI 10.1136/bmj.314.7092.1458; HUSAIN MH, 1981, BRIT MED J, V283, P1223, DOI 10.1136/bmj.283.6301.1223; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; LANGHAM S, 1995, BRIT J GEN PRACT, V45, P665; Lunt N, 1997, SOC SCI MED, V45, P341, DOI 10.1016/S0277-9536(96)00349-8; MORRIS R, 1991, J PUBLIC HEALTH MED, V13, P318; *NHS EX, 1998, NEW NHS MOD DEP NAT; *NHS EX, 1999, QUAL PERF NHS SUMM H; Pollock AM, 1998, BMJ-BRIT MED J, V317, P245, DOI 10.1136/bmj.317.7153.245; Reid FDA, 1999, BRIT MED J, V319, P98, DOI 10.1136/bmj.319.7202.98; Van den Hombergh P, 1998, BRIT J GEN PRACT, V48, P1743	23	44	45	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 11	2001	323	7308					320	323		10.1136/bmj.323.7308.320	http://dx.doi.org/10.1136/bmj.323.7308.320			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463HK	11498490	Green Published, Bronze			2022-12-28	WOS:000170470900021
J	Noera, G; Lamarra, M; Guarini, S; Bertolini, A				Noera, G; Lamarra, M; Guarini, S; Bertolini, A			Survival rate after early treatment for acute type-A aortic dissection with ACTH-(1-24)	LANCET			English	Article							SHOCK	Haemorrhagic shock, usually as a consequence of major trauma, is the most frequent cause of death among people younger than 40 years. Reports Indicate that melanocortin peptides are effective in reversing haemorrhagic shock. We found that in patients with aortic-dissection-induced haemorrhagic shock, the addition of an early intravenous bolus Injection of the melanocortin andrenocorticotrophic hormone (ACTH)-(1.24) to standard treatment significantly improved cardiovascular function and increased survival rate. Because administration of ACTH-(1.24) is simple, and because melanocortin peptides have no acute toxicity, their use in the early critical care of patients in shock should be more extensively assessed.	Univ Modena & Reggio Emilla, Dept Biomed Sci, Pharmacol Sect, I-41100 Modena, Italy; Villa Maria Cecilla Hosp, Cardiac Surg Unit, Ravenna, Italy	Universita di Modena e Reggio Emilia; Maria Cecilia Hospital	Guarini, S (corresponding author), Univ Modena & Reggio Emilla, Dept Biomed Sci, Pharmacol Sect, Via G Campi 287, I-41100 Modena, Italy.		GUARINI, SALVATORE/O-3139-2013	GUARINI, SALVATORE/0000-0002-1164-1706; Noera, Giorgio/0000-0002-2123-9964				BERTOLINI A, 1995, RESUSCITATION, V30, P29, DOI 10.1016/0300-9572(94)00863-B; MANDEL W, 1951, JAMA-J AM MED ASSOC, V146, P546, DOI 10.1001/jama.1951.03670060022005; NOERA G, 1991, RESUSCITATION, V22, P123, DOI 10.1016/0300-9572(91)90002-G; Regel G, 1996, WORLD J SURG, V20, P422, DOI 10.1007/s002689900067; Squadrito F, 1999, BRIT J PHARMACOL, V128, P816, DOI 10.1038/sj.bjp.0702848	5	35	36	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 11	2001	358	9280					469	470		10.1016/S0140-6736(01)05631-8	http://dx.doi.org/10.1016/S0140-6736(01)05631-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463TB	11513913				2022-12-28	WOS:000170492400015
J	Mannion, R; Goddard, M				Mannion, R; Goddard, M			Impact of published clinical outcomes data: case study in NHS hospital trusts	BRITISH MEDICAL JOURNAL			English	Article							PERFORMANCE DATA	Objective To examine the impact of the publication of clinical outcomes data on NHS Trusts in Scotland to inform the development of similar schemes elsewhere. Design Case studies including semistructured interviews and a review of background statistics. Setting Eight Scottish NHS acute trusts. Participants 48 trust staff comprising chief executives, medical directors, stroke consultants, breast cancer consultants, nurse managers, and junior doctors. Main outcome measures Staff views on the benefits and drawbacks of clinical outcome indicators provided by the clinical resource and audit group (CRAG) and perceptions of the impact of these data on clinical practice and continuous improvement of quality. Results The CRAG indicators had a low profile in the trusts and were rarely cited as informing internal quality improvement or used externally to identify best practice. The indicators were mainly used to support applications for further funding and service development. The poor effect was attributable to a lack of professional belief in the indicators, arising from perceived problems around quality of data and time lag between collection and presentation of data; limited dissemination; weak incentives to take action; a predilection for process rather than outcome indicators; and a belief that informal information is often more useful than quantitative data in the assessment of clinical performance. Conclusions Those responsible for developing clinical indicator programmes should develop robust datasets. They should also encourage a working environment and incentives such that these data are used to improve continuously.	Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England	University of York - UK	Mannion, R (corresponding author), Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England.			Mannion, Russell/0000-0002-0680-8049; Goddard, Maria Karen/0000-0002-1517-7461				BANISTER P, 1994, QUALITATIVE RES METH; Carstairs V., 1991, DEPRIVATION HLTH SCO; KENDRICK S, 1999, MANAGING QUALITY CON; Marshall M, 2000, J Health Serv Res Policy, V5, P1, DOI 10.1093/deafed/5.1.1; Marshall MN, 2000, JAMA-J AM MED ASSOC, V283, P1866, DOI 10.1001/jama.283.14.1866; Marshall MN, 2000, QUAL HEALTH CARE, V9, P53, DOI 10.1136/qhc.9.1.53; RAINWATER J, 1999, JT COMM J QUAL IMPRO, V24, P31	7	39	42	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 4	2001	323	7307					260	263		10.1136/bmj.323.7307.260	http://dx.doi.org/10.1136/bmj.323.7307.260			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	461ZT	11485954	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000170394300018
J	Elstein, D; Abrahamov, A; Hadas-Halpern, I; Zimran, A				Elstein, D; Abrahamov, A; Hadas-Halpern, I; Zimran, A			Gaucher's disease	LANCET			English	Editorial Material							MACROPHAGE-TARGETED GLUCOCEREBROSIDASE; REPLACEMENT THERAPY		Shaare Zedek Med Ctr, Gaucher Clin, IL-91031 Jerusalem, Israel	Hebrew University of Jerusalem; Shaare Zedek Medical Center	Elstein, D (corresponding author), Shaare Zedek Med Ctr, Gaucher Clin, POB 3235, IL-91031 Jerusalem, Israel.							ABRAHAMOV A, 1995, LANCET, V346, P1000, DOI 10.1016/S0140-6736(95)91688-1; Aerts JMFG, 1997, BAILLIERE CLIN HAEM, V10, P691, DOI 10.1016/S0950-3536(97)80034-0; BARTON NW, 1991, NEW ENGL J MED, V324, P1464, DOI 10.1056/NEJM199105233242104; Beutler E., 1995, METABOLIC MOL BASES, P2641; BRADY RO, 1993, ARCH NEUROL-CHICAGO, V50, P1212, DOI 10.1001/archneur.1993.00540110088009; Cox T, 2000, LANCET, V355, P1481, DOI 10.1016/S0140-6736(00)02161-9; Elstein D, 1998, LANCET, V351, P1544, DOI 10.1016/S0140-6736(98)10194-0; GRANOVSKYGRISARU S, 1995, AM J OBSTET GYNECOL, V172, P1284, DOI 10.1016/0002-9378(95)91494-3; ROSENTHAL DI, 1995, PEDIATRICS, V96, P629; SIDRANSKY E, 1992, PEDIATR RES, V32, P494, DOI 10.1203/00006450-199210000-00023; ZIMRAN A, 1995, J PEDIATR-US, V126, P596, DOI 10.1016/S0022-3476(95)70358-6	11	39	40	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 28	2001	358	9278					324	327		10.1016/S0140-6736(01)05490-3	http://dx.doi.org/10.1016/S0140-6736(01)05490-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	457AF	11498237				2022-12-28	WOS:000170114400033
J	Cohen-Fix, O				Cohen-Fix, O			The making and breaking of sister chromatid cohesion	CELL			English	Review							YEAST COHESIN; ANAPHASE; SEPARATION; DEGRADATION; SUBUNIT; SPINDLE; END		NIDDKD, Mol & Cellular Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Cohen-Fix, O (corresponding author), NIDDKD, Mol & Cellular Biol Lab, NIH, Bethesda, MD 20892 USA.	ornacf@helix.nih.gov			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK057803, Z01DK057803] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alexandru G, 2001, CELL, V105, P459, DOI 10.1016/S0092-8674(01)00362-2; Donaldson MM, 2001, J CELL BIOL, V153, P663, DOI 10.1083/jcb.153.4.663; Glover DM, 1998, GENE DEV, V12, P3777, DOI 10.1101/gad.12.24.3777; Hanna JS, 2001, MOL CELL BIOL, V21, P3144, DOI 10.1128/MCB.21.9.3144-3158.2001; Hirano T, 2000, ANNU REV BIOCHEM, V69, P115, DOI 10.1146/annurev.biochem.69.1.115; Jallepalli PV, 2001, CELL, V105, P445, DOI 10.1016/S0092-8674(01)00340-3; Jensen S, 2001, J CELL BIOL, V152, P27, DOI 10.1083/jcb.152.1.27; Kumada K, 1998, CURR BIOL, V8, P633, DOI 10.1016/S0960-9822(98)70250-7; Leismann O, 2000, GENE DEV, V14, P2192, DOI 10.1101/gad.176700; Mayer ML, 2001, MOL CELL, V7, P959, DOI 10.1016/S1097-2765(01)00254-4; MEI J, 2001, IN PRESS CURR BIOL; Rao H, 2001, NATURE, V410, P955, DOI 10.1038/35073627; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Tomonaga T, 2000, GENE DEV, V14, P2757, DOI 10.1101/gad.832000; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Wang ZH, 2000, SCIENCE, V289, P774, DOI 10.1126/science.289.5480.774; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039	19	33	33	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2001	106	2					137	140		10.1016/S0092-8674(01)00439-1	http://dx.doi.org/10.1016/S0092-8674(01)00439-1			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	458KG	11511341	Bronze			2022-12-28	WOS:000170193100003
J	Dell'Angelica, EC; Payne, GS				Dell'Angelica, EC; Payne, GS			Intracellular cycling of lysosomal enzyme receptors: Cytoplasmic tails' tales	CELL			English	Review							GOLGI; YEAST; PROTEINS; TRANSPORT; ENDOSOMES; PATHWAY		Univ Calif Los Angeles, Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Dell'Angelica, EC (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.							Black MW, 2000, J CELL BIOL, V151, P587, DOI 10.1083/jcb.151.3.587; Conibear E, 1998, BBA-MOL CELL RES, V1404, P211, DOI 10.1016/S0167-4889(98)00058-5; Costaguta G, 2001, MOL BIOL CELL, V12, P1885, DOI 10.1091/mbc.12.6.1885; Crump CM, 2001, EMBO J, V20, P2191, DOI 10.1093/emboj/20.9.2191; Deloche O, 2001, MOL BIOL CELL, V12, P475, DOI 10.1091/mbc.12.2.475; Diaz E, 1998, CELL, V93, P433, DOI 10.1016/S0092-8674(00)81171-X; Haft CR, 2000, MOL BIOL CELL, V11, P4105, DOI 10.1091/mbc.11.12.4105; Le Borgne R, 1998, BBA-MOL CELL RES, V1404, P195, DOI 10.1016/S0167-4889(98)00057-3; Meyer C, 2000, EMBO J, V19, P2193, DOI 10.1093/emboj/19.10.2193; Miwako I, 2001, J CELL SCI, V114, P1765; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Nothwehr SF, 2000, J CELL BIOL, V151, P297, DOI 10.1083/jcb.151.2.297; Puertollano R, 2001, SCIENCE, V292, P1712, DOI 10.1126/science.1060750; Puertollano R, 2001, CELL, V105, P93, DOI 10.1016/S0092-8674(01)00299-9; Takatsu H, 2001, J BIOL CHEM, V276, P28541, DOI 10.1074/jbc.C100218200; Tikkanen R, 2000, TRAFFIC, V1, P631, DOI 10.1034/j.1600-0854.2000.010807.x; Wan L, 1998, CELL, V94, P205, DOI 10.1016/S0092-8674(00)81420-8; Yeung BG, 1999, MOL BIOL CELL, V10, P3643, DOI 10.1091/mbc.10.11.3643; Zhu YX, 2001, SCIENCE, V292, P1716, DOI 10.1126/science.1060896	19	52	57	1	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 24	2001	106	4					395	398		10.1016/S0092-8674(01)00470-6	http://dx.doi.org/10.1016/S0092-8674(01)00470-6			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	466UU	11525725	Bronze			2022-12-28	WOS:000170665200002
J	Han, SY; Yu, Y; Chu, X; Chu, SI; Wang, Z				Han, SY; Yu, Y; Chu, X; Chu, SI; Wang, Z			Time-resolved measurement of dissipation-induced decoherence in a Josephson junction	SCIENCE			English	Article							QUANTUM COMPUTATION; TUNNEL-JUNCTIONS; STATES; SUPERPOSITION; QUANTIZATION; COMPUTER; SYSTEM; REGIME	We determined the dissipation-induced decoherence time (DIDT) of a superconducting Josephson tunnel junction by time-resolved measurements of its escape dynamics. Double-exponential behavior of the time-dependent escape probability was observed, suggesting the occurrence of a two-level decay-tunneling process in which energy relaxation from the excited to the ground level significantly affects the escape dynamics of the system. The observation of temporal double-exponential dependence enables direct measurements of the DIDT, a property critical to the study of quantum dynamics and the realization of macroscopic quantum coherence and quantum computing. We found that the DIDT was tau (d) > 11 mus at T = 0.55 K, demonstrating good prospects for implementing quantum computing with Josephson devices.	Univ Kansas, Dept Phys & Astron, Lawrence, KS 66045 USA; Univ Kansas, Dept Chem, Lawrence, KS 66045 USA; Minist Posts & Telecommun, Commun Res Lab, Kansai Adv Res Ctr, Nishi Ku, Kobe, Hyogo 65124, Japan	University of Kansas; University of Kansas; National Institute of Information & Communications Technology (NICT) - Japan	Han, SY (corresponding author), Univ Kansas, Dept Phys & Astron, Lawrence, KS 66045 USA.	han@ku.edu						Averin DV, 1998, SOLID STATE COMMUN, V105, P659, DOI 10.1016/S0038-1098(97)10001-1; BIALEK W, 1987, PHYS REV B, V35, P120, DOI 10.1103/PhysRevB.35.120; Bocko MF, 1997, IEEE T APPL SUPERCON, V7, P3638, DOI 10.1109/77.622206; Braun D, 2001, PHYS REV LETT, V86, P2913, DOI 10.1103/PhysRevLett.86.2913; CLARKE J, 1988, SCIENCE, V239, P992, DOI 10.1126/science.239.4843.992; Cosmelli C, 1999, PHYS REV LETT, V82, P5357, DOI 10.1103/PhysRevLett.82.5357; Flees DJ, 1999, J SUPERCOND, V12, P813, DOI 10.1023/A:1007797329201; Friedman JR, 2000, NATURE, V406, P43, DOI 10.1038/35017505; Han SY, 2001, PHYS REV LETT, V86, P4191, DOI 10.1103/PhysRevLett.86.4191; Kane BE, 1998, NATURE, V393, P133, DOI 10.1038/30156; Kauppinen JP, 1996, PHYS REV LETT, V77, P3889, DOI 10.1103/PhysRevLett.77.3889; LARKIN AI, 1986, ZH EKSP TEOR FIZ, V64, P185; LEGGETT AJ, 1987, REV MOD PHYS, V59, P1, DOI 10.1103/RevModPhys.59.1; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; MARTINIS JM, 1985, PHYS REV LETT, V55, P1543, DOI 10.1103/PhysRevLett.55.1543; Nakamura Y, 1999, NATURE, V398, P786, DOI 10.1038/19718; NIELSEN MA, 2000, QUANTUM COMPUTATION, pCH7; Orlando TP, 1999, PHYS REV B, V60, P15398, DOI 10.1103/PhysRevB.60.15398; Palma GM, 1996, P ROY SOC A-MATH PHY, V452, P567, DOI 10.1098/rspa.1996.0029; Plenio MB, 1997, P ROY SOC A-MATH PHY, V453, P2017, DOI 10.1098/rspa.1997.0109; Plenio MB, 1996, PHYS REV A, V53, P2986, DOI 10.1103/PhysRevA.53.2986; SCHMIDT JM, 1991, PHYS REV B, V43, P229, DOI 10.1103/PhysRevB.43.229; Shnirman A, 1997, PHYS REV LETT, V79, P2371, DOI 10.1103/PhysRevLett.79.2371; SHORE BW, 1990, SIMPLE ATOMS FIELDS, V1; Silvestrini P, 1997, PHYS REV LETT, V79, P3046, DOI 10.1103/PhysRevLett.79.3046; van der Wal CH, 2000, SCIENCE, V290, P773, DOI 10.1126/science.290.5492.773; Wang Z, 1999, APPL PHYS LETT, V75, P701, DOI 10.1063/1.124487; ZORIN AB, 1995, REV SCI INSTRUM, V66, P4296, DOI 10.1063/1.1145385; [No title captured]	29	70	77	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2001	293	5534					1457	1459		10.1126/science.1062266	http://dx.doi.org/10.1126/science.1062266			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465XV	11520978				2022-12-28	WOS:000170616000035
J	Vincent, S; Perkins, AL; Perrimon, N				Vincent, S; Perkins, AL; Perrimon, N			Doublesex surprises	CELL			English	Review							DROSOPHILA-MELANOGASTER		Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Pediat Surg Res Labs, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital	Perrimon, N (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, 200 Longwood Ave, Boston, MA 02115 USA.		vincent, stephane/M-7231-2016	vincent, stephane/0000-0003-2757-6926; Perrimon, Norbert/0000-0001-7542-472X				BAKER BS, 1980, GENETICS, V94, P383; Cline TW, 1996, ANNU REV GENET, V30, P637, DOI 10.1146/annurev.genet.30.1.637; Estrada B, 2001, DEVELOPMENT, V128, P331; Gorfinkiel N, 1999, MECH DEVELOP, V86, P113, DOI 10.1016/S0925-4773(99)00122-7; Guss KA, 2001, SCIENCE, V292, P1164, DOI 10.1126/science.1058312; Keisman EL, 2001, DEVELOPMENT, V128, P1643; Keisman EL, 2001, DEV CELL, V1, P215, DOI 10.1016/S1534-5807(01)00027-2; NOTHIGER R, 1977, ROUX ARCH DEV BIOL, V181, P367, DOI 10.1007/BF00848062; Sanchez L, 2001, DEVELOPMENT, V128, P1033; SCHUPBACH T, 1978, ROUX ARCH DEV BIOL, V185, P249, DOI 10.1007/BF00848355; Weatherbee SD, 1998, GENE DEV, V12, P1474, DOI 10.1101/gad.12.10.1474	11	18	18	2	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 24	2001	106	4					399	402		10.1016/S0092-8674(01)00468-8	http://dx.doi.org/10.1016/S0092-8674(01)00468-8			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	466UU	11525726	Bronze			2022-12-28	WOS:000170665200003
J	Hall, IR; McCave, IN; Shackleton, NJ; Weedon, GP; Harris, SE				Hall, IR; McCave, IN; Shackleton, NJ; Weedon, GP; Harris, SE			Intensified deep Pacfic inflow and ventilation in Pleistocene glacial times	NATURE			English	Article							SORTABLE SILT; OCEAN; CIRCULATION; WATER; SEDIMENT; CLIMATE; ATMOSPHERE; CARBON; SPEED; PROXY	The production of cold, deep waters in the Southern Ocean is an important factor in the Earth's heat budget(1). The supply of deep water to the Pacific Ocean is presently dominated by a single source, the deep western boundary current east of New Zealand. Here we use sediment records deposited under the influence of this deep western boundary current to reconstruct deep-water properties and speed changes during the Pleistocene epoch. In physical and isotope proxies we rnd evidence for intensified deep Pacific Ocean inflow and ventilation during the glacial periods of the past 1.2 million years. The changes in throughflow may be directly related to an increased production of Antarctic Bottom Water during glacial times. Possible causes for such an increased bottom-water production include increasing wind strengths in the Southern Ocean or an increase in annual sea-ice formation, leaving dense water after brine rejection and thereby enhancing deep convection. We infer also that the global thermohaline circulation was perturbed significantly during the mid-Pleistocene climate transition between 0.86 and 0.45 million years ago.	Cardiff Univ, Dept Earth Sci, Cardiff CF10 3YE, S Glam, Wales; Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; Univ Luton, Dept Environm Geog & Geol, Luton LU1 3JU, Beds, England; Sea Educ Assoc, Woods Hole, MA 02543 USA	Cardiff University; University of Cambridge; University of Bedfordshire	Hall, IR (corresponding author), Cardiff Univ, Dept Earth Sci, POB 914, Cardiff CF10 3YE, S Glam, Wales.	Hall@cardiff.ac.uk	Weedon, Graham P./B-7574-2008; McCave, Nick N/G-7323-2016; McCave, I. Nick/O-3992-2018; Hall, Ian R/C-2755-2009	Weedon, Graham P./0000-0003-1262-9984; McCave, Nick N/0000-0002-4702-5489; McCave, I. Nick/0000-0002-4702-5489; Hall, Ian R/0000-0001-6960-1419				Adkins JF, 1997, PALEOCEANOGRAPHY, V12, P337, DOI 10.1029/97PA00379; BARD E, 1994, EARTH PLANET SC LETT, V126, P275, DOI 10.1016/0012-821X(94)90112-0; BASSINOT FC, 1994, EARTH PLANET SC LETT, V126, P91, DOI 10.1016/0012-821X(94)90244-5; BERGER A, 1991, QUATERNARY SCI REV, V10, P297, DOI 10.1016/0277-3791(91)90033-Q; Bianchi GG, 1999, SEDIMENTOLOGY, V46, P1001; Bloomfield P., 1976, FOURIER ANAL TIME SE; Carter L, 1996, GEOLOGY, V24, P735, DOI 10.1130/0091-7613(1996)024<0735:RSRITA>2.3.CO;2; Carter L, 1999, MAR GEOL, V159, P221, DOI 10.1016/S0025-3227(98)00205-9; CHARLES CD, 1992, NATURE, V355, P416, DOI 10.1038/355416a0; Clarke A., 2001, OCEAN CIRCULATION CL, p[1, 11]; Dymond J, 1992, PALEOCEANOGRAPHY, V7, P163, DOI 10.1029/92PA00181; Hall IR, 1998, EARTH PLANET SC LETT, V164, P15, DOI 10.1016/S0012-821X(98)00209-X; IMBRIE J, 1980, SCIENCE, V207, P943, DOI 10.1126/science.207.4434.943; JANSEN JHF, 1986, SCIENCE, V232, P619, DOI 10.1126/science.232.4750.619; KROOPNICK P, 1974, DEEP-SEA RES, V21, P211, DOI 10.1016/0011-7471(74)90059-X; KROOPNICK PM, 1985, DEEP-SEA RES, V32, P57, DOI 10.1016/0198-0149(85)90017-2; Lean CMB, 1998, EARTH PLANET SC LETT, V163, P247, DOI 10.1016/S0012-821X(98)00191-5; MACKENSEN A, 1993, PALEOCEANOGRAPHY, V8, P587, DOI 10.1029/93PA01291; Mann ME, 1996, CLIMATIC CHANGE, V33, P409, DOI 10.1007/BF00142586; Marcantonio F, 2001, PALEOCEANOGRAPHY, V16, P260, DOI 10.1029/2000PA000540; MCCAVE IN, 1995, PALEOCEANOGRAPHY, V10, P593, DOI 10.1029/94PA03039; McCave IN, 1997, DEEP-SEA RES PT I, V44, P1203, DOI 10.1016/S0967-0637(97)00011-3; MCCAVE IN, 1995, NATURE, V374, P149, DOI 10.1038/374149a0; Mix A.C., 1995, Proceedings of the Ocean Drilling Program Scientific Results, V138, P371, DOI 10.2973/odp.proc.sr.138.120.1995; PARDOIGUZQUIZA E, 1994, COMPUT GEOSCI-UK, V20, P511, DOI 10.1016/0098-3004(94)90080-9; Rahmstorf S, 1997, J PHYS OCEANOGR, V27, P2040, DOI 10.1175/1520-0485(1997)027<2040:IOSHWO>2.0.CO;2; Raymo ME, 1997, PALEOCEANOGRAPHY, V12, P546, DOI 10.1029/97PA01019; Sikes EL, 2000, NATURE, V405, P555, DOI 10.1038/35014581; TOGGWEILER JR, 1993, GLOBAL CARBON CYCLE, P333; WARREN BA, 1973, DEEP-SEA RES, V20, P9, DOI 10.1016/0011-7471(73)90040-5; Yu EF, 1996, NATURE, V379, P689, DOI 10.1038/379689a0	31	167	177	5	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 23	2001	412	6849					809	812		10.1038/35090552	http://dx.doi.org/10.1038/35090552			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465ET	11518963				2022-12-28	WOS:000170577200034
J	Welch, KMA				Welch, KMA			A 47-year-old woman with tension-type headaches	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DOUBLE-BLIND; GENERAL-POPULATION; MIGRAINE; LIFE; AMITRIPTYLINE; EPIDEMIOLOGY; MEDICATION; THERAPY		Univ Kansas, Med Ctr, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center	Welch, KMA (corresponding author), Univ Kansas, Med Ctr, 3901 Rainbow Blvd,Suite 6002 Wescoe, Kansas City, KS 66160 USA.	kwelch2@kumc.edu						BENDTSEN L, 2000, HEADACHES, P573; BOLINE PD, 1995, J MANIP PHYSIOL THER, V18, P148; DEBENEDITTIS G, 1992, PAIN, V51, P35, DOI 10.1016/0304-3959(92)90006-W; DIENER HC, 1993, CEPHALALGIA, V13, P68, DOI 10.1177/0333102493013S1215; EDMEADS JG, 1980, HEADACHE, V28, P675; FOGELHOLM R, 1992, HEADACHE, V32, P509, DOI 10.1111/j.1526-4610.1992.hed3210509.x; Frishberg B, EVIDENCE BASED GUIDE; GRAFFRADFORD SB, 2000, HEADACHES, P657; HOLROYD KA, 1986, J BEHAV MED, V9, P515, DOI 10.1007/BF00845282; HOLROYD KA, 1991, J CONSULT CLIN PSYCH, V59, P387, DOI 10.1037/0022-006X.59.3.387; Holroyd KA, 2001, JAMA-J AM MED ASSOC, V285, P2208, DOI 10.1001/jama.285.17.2208; HOLROYD KA, 2000, HEADACHES, P643; Jensen R, 1996, CEPHALALGIA, V16, P175, DOI 10.1046/j.1468-2982.1996.1603175.x; JENSEN S, 2000, HEADACHES, P593; LANGEMARK M, 1987, CEPHALALGIA, V7, P249, DOI 10.1046/j.1468-2982.1987.0704249.x; Mathew NT, 1996, NEUROLOGY, V46, P1226, DOI 10.1212/WNL.46.5.1226; Mathew NT, 1997, NEUROL CLIN, V15, P167, DOI 10.1016/S0733-8619(05)70302-9; MATHEW NT, 2000, HEADACHES, P667; MICHULTKA DM, 1989, BEHAV RES THER, V27, P411, DOI 10.1016/0005-7967(89)90012-0; Mokri B, 1997, MAYO CLIN PROC, V72, P400, DOI 10.4065/72.5.400; MORLAND TJ, 1979, HEADACHE, V19, P382, DOI 10.1111/j.1526-4610.1979.hed1907382.x; NAGESH V, 2000, CEPHALALGIA, V20, P275; Ostergaard S, 1997, BMJ-BRIT MED J, V314, P1092, DOI 10.1136/bmj.314.7087.1092; Passchier J, 1996, HEADACHE, V36, P556, DOI 10.1046/j.1526-4610.1996.3609556.x; PEATFIELD RC, 2000, HEADACHES, P639; Porta M, 2000, Curr Rev Pain, V4, P31; RAMADAN NM, 2000, HEADACHES, P771; RAPAPORT A, 1985, CEPHALALGIA S3, V5, P448; Rasmussen B. K., 2000, HEADACHES, P545; RASMUSSEN BK, 1992, J EPIDEMIOL COMMUN H, V46, P443, DOI 10.1136/jech.46.4.443; RASMUSSEN BK, 1991, CEPHALALGIA, V11, P129, DOI 10.1046/j.1468-2982.1991.1103129.x; RASMUSSEN BK, 1991, J CLIN EPIDEMIOL, V44, P1147, DOI 10.1016/0895-4356(91)90147-2; RASMUSSEN BK, 1993, PAIN, V53, P65, DOI 10.1016/0304-3959(93)90057-V; REICH BA, 1989, HEADACHE, V29, P34, DOI 10.1111/j.1526-4610.1989.hed2901034.x; Rollnik JD, 2000, HEADACHE, V40, P300, DOI 10.1046/j.1526-4610.2000.00044.x; SAKAI F, 1995, BRAIN, V118, P523, DOI 10.1093/brain/118.2.523; SANDRINI G, 1994, CEPHALALGIA, V14, P451, DOI 10.1046/j.1468-2982.1994.1406451.x; SAPER JR, 1994, HEADACHE, V34, P497, DOI 10.1111/j.1526-4610.1994.hed3409497.x; SCHELLHAS KP, 1980, JAMA-J AM MED ASSOC, V244, P1450, DOI 10.1001/jama.244.13.1450; Schwartz BS, 1998, JAMA-J AM MED ASSOC, V279, P381, DOI 10.1007/s11916-010-0146-2; SILBERSTEIN SD, 1994, HEADACHE, V34, P1, DOI 10.1111/j.1526-4610.1994.hed3401001.x; SILVERMAN K, 1992, NEW ENGL J MED, V327, P1109, DOI 10.1056/NEJM199210153271601; SJAASTAD O, 1984, CEPHALALGIA, V4, P65, DOI 10.1046/j.1468-2982.1984.0401065.x; SJAASTAD O, 1990, HEADACHE, V30, P725, DOI 10.1111/j.1526-4610.1990.hed3011725.x; SOLOMON S, 1992, CEPHALALGIA, V12, P365, DOI 10.1111/j.1468-2982.1992.00365.x; SORGE F, 1988, CEPHALALGIA, V8, P1, DOI 10.1046/j.1468-2982.1988.0801001.x; WELCH KMA, 1993, NEW ENGL J MED, V329, P1476; WOBERBINGOL C, 1992, CEPHALALGIA, V12, P152, DOI 10.1046/j.1468-2982.1992.1203152.x	48	4	6	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2001	286	8					960	966		10.1001/jama.286.8.960	http://dx.doi.org/10.1001/jama.286.8.960			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465EU	11509061				2022-12-28	WOS:000170577300031
J	Gross, TJ; Hunninghake, GW				Gross, TJ; Hunninghake, GW			Medical progress: Idiopathic pulmonary fibrosis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							INTERSTITIAL LUNG-DISEASE; LOW-DOSE PREDNISOLONE; ALVEOLAR MACROPHAGES; INCREASED ENDOTHELIN-1; GENE-EXPRESSION; CYCLOPHOSPHAMIDE; PIRFENIDONE; THERAPY; CT; TRANSPLANTATION		Univ Iowa Hlth Care, Dept Internal Med, Div Pulm Crit Care & Occupat Med, Coll Med, Iowa City, IA 52242 USA; Vet Affairs Med Ctr, Iowa City, IA 52242 USA	University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Hunninghake, GW (corresponding author), Univ Iowa Hlth Care, Dept Internal Med, Div Pulm Crit Care & Occupat Med, Coll Med, Room C33-GH, Iowa City, IA 52242 USA.	gary-hunninghake@uiowa.edu	Gross, Thomas/AAO-9404-2021	Gross, Thomas/0000-0001-9617-6606				AKIRA M, 1993, RADIOLOGY, V189, P687, DOI 10.1148/radiology.189.3.8080483; Allen JT, 1999, AM J RESP CELL MOL, V21, P693, DOI 10.1165/ajrcmb.21.6.3719; *AM THOR SOC, 2000, AM J RESP CRIT CARE, V161, P646, DOI DOI 10.1164/AJRCCM.161.2.ATS3-00; Ayed AK, 2000, J ROY COLL SURG EDIN, V45, P159; Baecher-Allan Clare M., 1993, Regional Immunology, V5, P207; Bani D, 1997, GEN PHARMACOL-VASC S, V28, P13, DOI 10.1016/S0306-3623(96)00171-1; BAUGHMAN RP, 1992, CHEST, V102, P1090, DOI 10.1378/chest.102.4.1090; Baumgartner KB, 2000, AM J EPIDEMIOL, V152, P307, DOI 10.1093/aje/152.4.307; BITTERMAN PB, 1986, NEW ENGL J MED, V314, P1343, DOI 10.1056/NEJM198605223142103; Bjoraker JA, 1998, AM J RESP CRIT CARE, V157, P199, DOI 10.1164/ajrccm.157.1.9704130; BRIGGS DC, 1991, LANCET, V338, P661, DOI 10.1016/0140-6736(91)91235-M; BROEKELMANN TJ, 1991, P NATL ACAD SCI USA, V88, P6642, DOI 10.1073/pnas.88.15.6642; Chiaramonte MG, 1999, J CLIN INVEST, V104, P777, DOI 10.1172/JCI7325; CRYSTAL RG, 1976, ANN INTERN MED, V85, P769, DOI 10.7326/0003-4819-85-6-769; DAYTON CS, 1993, CHEST, V103, P69, DOI 10.1378/chest.103.1.69; Douglas WW, 1998, AM J RESP CRIT CARE, V158, P220, DOI 10.1164/ajrccm.158.1.9709089; Douglas WW, 2000, AM J RESP CRIT CARE, V161, P1172, DOI 10.1164/ajrccm.161.4.9907002; Epler G R, 1998, Curr Opin Pulm Med, V4, P93, DOI 10.1097/00063198-199803000-00006; Ferri C, 1997, BRIT J RHEUMATOL, V36, P360; FUKUDA Y, 1995, HUM PATHOL, V26, P53, DOI 10.1016/0046-8177(95)90114-0; Furuie H, 1997, EUR RESPIR J, V10, P787; Gay SE, 1998, AM J RESP CRIT CARE, V157, P1063, DOI 10.1164/ajrccm.157.4.9703022; Hancock A, 1998, AM J RESP CELL MOL, V18, P60, DOI 10.1165/ajrcmb.18.1.2627; HANLEY ME, 1991, AM REV RESPIR DIS, V144, P1102, DOI 10.1164/ajrccm/144.5.1102; Iyer SN, 1999, J PHARMACOL EXP THER, V289, P211; JOHNSON MA, 1989, THORAX, V44, P280, DOI 10.1136/thx.44.4.280; Kasper M, 1996, HISTOL HISTOPATHOL, V11, P463; KATZENSTEIN ALA, 1986, AM J SURG PATHOL, V10, P256, DOI 10.1097/00000478-198604000-00004; KATZENSTEIN ALA, 1994, AM J SURG PATHOL, V18, P136, DOI 10.1097/00000478-199402000-00003; Katzenstein ALA, 1998, AM J RESP CRIT CARE, V157, P1301, DOI 10.1164/ajrccm.157.4.9707039; Kazerooni EA, 1997, AM J ROENTGENOL, V169, P977, DOI 10.2214/ajr.169.4.9308447; Kehrer JP, 1997, TOXICOL LETT, V90, P125, DOI 10.1016/S0378-4274(96)03845-3; KLIJN JGM, 1990, J STEROID BIOCHEM, V37, P1089, DOI 10.1016/0960-0760(90)90471-V; Kolb M, 1998, EUR RESPIR J, V12, P1409, DOI 10.1183/09031936.98.12061409; KUHN C, 1989, AM REV RESPIR DIS, V140, P1693, DOI 10.1164/ajrccm/140.6.1693; Kunkel SL, 1996, SARCOIDOSIS VASC DIF, V13, P120; Lawrence DA, 1996, EUR CYTOKINE NETW, V7, P363; LEE JS, 1992, RADIOLOGY, V184, P451, DOI 10.1148/radiology.184.2.1620846; Lok SS, 1999, J HEART LUNG TRANSPL, V18, P884, DOI 10.1016/S1053-2498(99)00050-9; Mageto Y N, 1997, Curr Opin Pulm Med, V3, P336, DOI 10.1097/00063198-199709000-00004; Mapel DW, 1998, THORAX, V53, P469, DOI 10.1136/thx.53.6.469; MARCINIUK DD, 1994, CLIN CHEST MED, V15, P287; Marshall RP, 2000, AM J RESP CRIT CARE, V161, P1999, DOI 10.1164/ajrccm.161.6.9907004; Marshall RP, 1997, INT J BIOCHEM CELL B, V29, P107, DOI 10.1016/S1357-2725(96)00141-0; Marshall RP, 2000, THORAX, V55, P143, DOI 10.1136/thorax.55.2.143; Martinez JAB, 1997, AM J PHYSIOL-LUNG C, V273, pL676, DOI 10.1152/ajplung.1997.273.3.L676; Martinez TY, 2000, CHEST, V117, P1627, DOI 10.1378/chest.117.6.1627; Mason Robert J., 1999, American Journal of Respiratory and Critical Care Medicine, V160, P1771; MATHIESON JR, 1989, RADIOLOGY, V171, P111, DOI 10.1148/radiology.171.1.2928513; McCormick LL, 1999, J IMMUNOL, V163, P5693; Meyers BF, 1999, ANN SURG, V230, P362, DOI 10.1097/00000658-199909000-00009; Meyers BF, 2000, J THORAC CARDIOV SUR, V120, P99, DOI 10.1067/mtc.2000.106322; Michaelson JE, 2000, CHEST, V118, P788, DOI 10.1378/chest.118.3.788; Mietz H, 1998, BRIT J OPHTHALMOL, V82, P816, DOI 10.1136/bjo.82.7.816; Mullen J, 1998, J OCCUP ENVIRON MED, V40, P363, DOI 10.1097/00043764-199804000-00011; Muller NL, 1997, RADIOGRAPHICS, V17, P1016; Mutsaers SE, 1998, AM J RESP CELL MOL, V18, P611, DOI 10.1165/ajrcmb.18.5.2898; MYERS JL, 1988, CHEST, V94, P1309, DOI 10.1378/chest.94.6.1309; Nagai S, 1998, Curr Opin Pulm Med, V4, P256, DOI 10.1097/00063198-199809000-00003; Nava S, 1999, THORAX, V54, P390, DOI 10.1136/thx.54.5.390; Nicod LP, 1999, LANCET, V354, P268, DOI 10.1016/S0140-6736(99)00178-6; Nonn RA, 1998, AM J MED SCI, V315, P146, DOI 10.1097/00000441-199803000-00003; PANOS RJ, 1990, AM J MED, V88, P396, DOI 10.1016/0002-9343(90)90495-Y; Park SH, 1997, AM J RESP CRIT CARE, V156, P600, DOI 10.1164/ajrccm.156.2.9607123; Raghu G, 1999, AM J RESP CRIT CARE, V159, P1061, DOI 10.1164/ajrccm.159.4.9805017; Raghu G, 1999, CHEST, V116, P1168, DOI 10.1378/chest.116.5.1168; Rizzato G, 1999, Curr Opin Pulm Med, V5, P284, DOI 10.1097/00063198-199909000-00003; Romagnani S, 1999, INFLAMM BOWEL DIS, V5, P285, DOI 10.1097/00054725-199911000-00009; Ryu JH, 1998, MAYO CLIN PROC, V73, P1085, DOI 10.4065/73.11.1085; Samet JM, 2000, AM J RESP CRIT CARE, V161, P1; SCHWARTZ DA, 1991, J APPL PHYSIOL, V71, P1688, DOI 10.1152/jappl.1991.71.5.1688; SCHWARTZ DA, 1994, AM J RESP CRIT CARE, V149, P444, DOI 10.1164/ajrccm.149.2.8306043; SCHWARTZ DA, 1991, AM REV RESPIR DIS, V144, P504, DOI 10.1164/ajrccm/144.3_Pt_1.504; SCHWARTZ DA, 1994, AM J RESP CRIT CARE, V149, P450, DOI 10.1164/ajrccm.149.2.8306044; Seibold JR, 2000, ANN INTERN MED, V132, P871, DOI 10.7326/0003-4819-132-11-200006060-00004; Selman M, 1998, CHEST, V114, P507, DOI 10.1378/chest.114.2.507; Teder P, 2000, AM J RESP CELL MOL, V23, P7, DOI 10.1165/ajrcmb.23.1.f192; The BAL Cooperative Group Steering Committee, 1990, AM REV RESPIR DIS, V141, pS169; Tobin RW, 1998, AM J RESP CRIT CARE, V158, P1804, DOI 10.1164/ajrccm.158.6.9804105; Turner-Warwick M, 1998, THORAX, V53, pS3, DOI 10.1136/thx.53.2008.S3; TURNERWARWICK M, 1980, THORAX, V35, P593, DOI 10.1136/thx.35.8.593; TURNERWARWICK M, 1980, THORAX, V35, P171, DOI 10.1136/thx.35.3.171; Unemori EN, 1996, J CLIN INVEST, V98, P2739, DOI 10.1172/JCI119099; Vizza CD, 1998, CHEST, V113, P576, DOI 10.1378/chest.113.3.576; Wang RG, 1999, AM J PHYSIOL-LUNG C, V277, pL1158, DOI 10.1152/ajplung.1999.277.6.L1158; Ward PA, 1998, AM J RESP CRIT CARE, V157, pS123, DOI 10.1164/ajrccm.157.4.nhlbi-10; Wells, 1997, AM J RESP CRIT CARE, V156, P676; Wells AU, 1997, AM J RESP CRIT CARE, V155, P1367, DOI 10.1164/ajrccm.155.4.9105081; Whyte M, 2000, AM J RESP CRIT CARE, V162, P755, DOI 10.1164/ajrccm.162.2.9909053; Xaubet A, 1998, AM J RESP CRIT CARE, V158, P431, DOI 10.1164/ajrccm.158.2.9709008; YOUSEM SA, 1989, MAYO CLIN PROC, V64, P1373, DOI 10.1016/S0025-6196(12)65379-8; Ziesche R, 1999, NEW ENGL J MED, V341, P1264, DOI 10.1056/NEJM199910213411703; Ziesche R, 2000, NEW ENGL J MED, V342, P975; Zisman DA, 2000, CHEST, V117, P1619, DOI 10.1378/chest.117.6.1619	94	748	806	3	67	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 16	2001	345	7					517	525		10.1056/NEJMra003200	http://dx.doi.org/10.1056/NEJMra003200			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	462QM	11519507				2022-12-28	WOS:000170431300007
J	Waelbroeck, C; Duplessy, JC; Michel, E; Labeyrie, L; Paillard, D; Duprat, J				Waelbroeck, C; Duplessy, JC; Michel, E; Labeyrie, L; Paillard, D; Duprat, J			The timing of the last deglaciation in North Atlantic climate records	NATURE			English	Article							YOUNGER DRYAS EVENT; HEINRICH EVENTS; AGE CALIBRATION; GLACIAL PERIOD; RAPID CHANGES; C-14 AGE; OCEAN; SURFACE; RADIOCARBON; CIRCULATION	To determine the mechanisms governing the last deglaciation and the sequence of events that lead to deglaciation, it is important to obtain a temporal framework that applies to both continental and marine climate records. Radiocarbon dating has been widely used to derive calendar dates for marine sediments, but it rests on the assumption that the 'apparent age' of surface water (the age of surface water relative to the atmosphere) has remained constant over time(1,2). Here we present new evidence for variation in the apparent age of surface water (or reservoir age) in the North Atlantic ocean north of 40 degrees N over the past 20,000 years. In two cores we found apparent surface-water ages to be larger than those of today by 1,230 +/- 600 and 1,940 +/- 750 years at the end of the Heinrich 1 surge event (15,000 years BP) and by 820 +/- 430 to 1,010 +/- 340 years at the end of the Younger Dryas cold episode. During the warm Bolling-Allerod period, between these two periods of large reservoir ages, apparent surface-water ages were comparable to present values. Our results allow us to reconcile the chronologies from ice cores and the North Atlantic marine records over the entire deglaciation period. Moreover, the data imply that marine carbon dates from the North Atlantic north of 40 degrees N will need to be corrected for these highly variable effects.	Lab Sci Climat & Environm, F-91198 Gif Sur Yvette, France; Univ Paris 11, Dept Sci Terre, F-91104 Orsay, France; Univ Bordeaux 1, Dept Geol & Oceanog, CNRS, UMR 5805, F-33405 Talence, France	UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite de Bordeaux	Waelbroeck, C (corresponding author), Lab Sci Climat & Environm, Domaine CNRS,Bat 12, F-91198 Gif Sur Yvette, France.	Claire.Waelbroeck@lsce.cnrs-gif.fr	Paillard, Didier/G-4776-2012; Labeyrie, Laurent Denis/AAV-8405-2021	Paillard, Didier/0000-0002-9995-2794; Labeyrie, Laurent Denis/0000-0002-1554-2449; waelbroeck, claire/0000-0002-7256-5727				ALLEY RB, 1993, NATURE, V362, P527, DOI 10.1038/362527a0; AUSTIN WEN, 1995, RADIOCARBON, V37, P53, DOI 10.1017/S0033822200014788; BARD E, 1987, NATURE, V328, P791, DOI 10.1038/328791a0; BARD E, 1994, EARTH PLANET SC LETT, V126, P275, DOI 10.1016/0012-821X(94)90112-0; Bard E., 1987, CLIM DYNAM, V1, P101, DOI 10.1007/BF01054479; Bard E, 1988, PALEOCEANOGRAPHY, V3, P635, DOI 10.1029/PA003i006p00635; Bondevik S, 1999, QUATERNARY RES, V52, P104, DOI 10.1006/qres.1999.2048; Boyle EA, 1988, PALEOCEANOGRAPHY, V3, P471, DOI 10.1029/PA003i004p00471; Broecker W, 1992, CLIM DYNAM, V6, P265, DOI 10.1007/BF00193540; Dokken TM, 1999, NATURE, V401, P458, DOI 10.1038/46753; Duplessy JC, 1988, PALEOCEANOGRAPHY, V3, P343, DOI 10.1029/PA003i003p00343; DUPLESSY JC, 1992, NATURE, V358, P485, DOI 10.1038/358485a0; Johnsen SJ, 1997, J GEOPHYS RES-OCEANS, V102, P26397, DOI 10.1029/97JC00167; LABEYRIE L, 1995, PHILOS T ROY SOC B, V348, P255, DOI 10.1098/rstb.1995.0067; Labeyrie L, 1999, GEOPH MONOG SERIES, V112, P77; LABEYRIE LD, 1992, QUATERNARY SCI REV, V11, P401, DOI 10.1016/0277-3791(92)90022-Z; MALMGREN B, IN PRESS PALAEOCEANO; MIKOLAJEWICZ U, 1996, MAX PLANCK I METEO R, V189, P1; Muscheler R, 2000, NATURE, V408, P567, DOI 10.1038/35046041; SARNTHEIN M, 1994, PALEOCEANOGRAPHY, V9, P209, DOI 10.1029/93PA03301; SIANI G, 1999, THESIS U PARIS SUD; Sikes EL, 2000, NATURE, V405, P555, DOI 10.1038/35014581; Stocker TF, 1998, RADIOCARBON, V40, P359; Stocker TF, 1996, PALEOCEANOGRAPHY, V11, P773, DOI 10.1029/96PA02640; STUIVER M, 1993, RADIOCARBON, V35, P215, DOI 10.1017/S0033822200013904; Stuiver M, 1998, RADIOCARBON, V40, P1041, DOI 10.1017/S0033822200019123; Stuiver M., 1993, HOLOCENE, V3, P289, DOI DOI 10.1177/095968369300300401; Vidal L, 1997, EARTH PLANET SC LETT, V146, P13, DOI 10.1016/S0012-821X(96)00192-6; Voelker AHL, 1998, RADIOCARBON, V40, P517; Waelbroeck C, 1998, PALEOCEANOGRAPHY, V13, P272, DOI 10.1029/98PA00071	30	233	237	0	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 16	2001	412	6848					724	727		10.1038/35089060	http://dx.doi.org/10.1038/35089060			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462ZB	11507637				2022-12-28	WOS:000170450200041
J	Hammond, SM; Boettcher, S; Caudy, AA; Kobayashi, R; Hannon, GJ				Hammond, SM; Boettcher, S; Caudy, AA; Kobayashi, R; Hannon, GJ			Argonaute2, a link between genetic and biochemical analyses of RNAi	SCIENCE			English	Article							DOUBLE-STRANDED-RNA; C-ELEGANS; MESSENGER-RNA; INTERFERENCE; ARABIDOPSIS; POLYMERASE; HELICASE; NEUROSPORA; TRANSGENE; PROTEINS	Double-stranded RNA induces potent and specific gene silencing through a process referred to as RNA interference (RNAi) or posttranscriptional gene silencing (PTGS). RNAi is mediated by RNA-induced silencing complex (RISC), a sequence-specific, multicomponent nuclease that destroys messenger RNAs homologous to the silencing trigger. RISC is known to contain short RNAs (similar to 22 nucleotides) derived from the double-stranded RNA trigger, but the protein components of this activity are unknown. Here, we report the biochemical purification of the RNAi effector nuclease from cultured Drosophila cells. The active fraction contains a ribonucleoprotein complex of similar to 500 kilodaltons. Protein microsequencing reveals that one constituent of this complex is a member of the Argonaute family of proteins, which are essential for gene silencing in Caenorhabditis elegans, Neurospora, and Arabidopsis. This observation begins the process of forging links between genetic analysis of RNAi from diverse organisms and the biochemical model of RNAi that is emerging from Drosophila in vitro systems.	Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; Genet Inc, Cambridge, MA 02138 USA	Cold Spring Harbor Laboratory	Hannon, GJ (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, POB 100, Cold Spring Harbor, NY 11724 USA.		Hannon, Gregory/AAB-3568-2019	Caudy, Amy/0000-0001-6307-8137	NIGMS NIH HHS [R01-GM62534] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062534] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bohmert K, 1998, EMBO J, V17, P170, DOI 10.1093/emboj/17.1.170; Catalanotto C, 2000, NATURE, V404, P245, DOI 10.1038/35005169; Cerutti L, 2000, TRENDS BIOCHEM SCI, V25, P481, DOI 10.1016/S0968-0004(00)01641-8; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Cogoni C, 1999, SCIENCE, V286, P2342, DOI 10.1126/science.286.5448.2342; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Dalmay T, 2001, EMBO J, V20, P2069, DOI 10.1093/emboj/20.8.2069; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Kataoka Y, 2001, GENES CELLS, V6, P313, DOI 10.1046/j.1365-2443.2001.00427.x; KETTING R, UNPUB; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; Wu-Scharf D, 2000, SCIENCE, V290, P1159, DOI 10.1126/science.290.5494.1159; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	26	1099	1239	7	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2001	293	5532					1146	1150		10.1126/science.1064023	http://dx.doi.org/10.1126/science.1064023			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498593				2022-12-28	WOS:000170432600063
J	Kortenkamp, SJ; Wetherill, GW; Inaba, S				Kortenkamp, SJ; Wetherill, GW; Inaba, S			Runaway growth of planetary embryos facilitated by massive bodies in a protoplanetary disk	SCIENCE			English	Article							BODY	About 30% of detected extrasolar planets exist in multiple-star systems. The standard model of planet formation cannot easily accommodate such systems and has difficulty explaining the odd orbital characteristics of most extrasolar giant planets. We demonstrate that the formation of terrestrial-size planets may be insulated from these problems, enabling much of the framework of the standard model to be salvaged for use in complex systems. A type of runaway growth is identified that allows planetary embryos to form by a combination of nebular gas drag and perturbations from massive companions-be they giant planets, brown dwarfs, or other stars.	Univ Maryland, Dept Astron, College Pk, MD 20742 USA; Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA	University System of Maryland; University of Maryland College Park; Carnegie Institution for Science	Kortenkamp, SJ (corresponding author), Univ Maryland, Dept Astron, 1204 CSS Bldg,Stadium Dr, College Pk, MD 20742 USA.	kortenka@astro.umd.edu						ADACHI I, 1976, PROG THEOR PHYS, V56, P1756, DOI 10.1143/PTP.56.1756; Boss AP, 2000, ASTROPHYS J, V536, pL101, DOI 10.1086/312737; Butler RP, 1999, ASTROPHYS J, V526, P916, DOI 10.1086/308035; CANUP RM, 2000, ORIGIN EARTH MOON, P113; CANUP RM, 2000, ORIGIN EARTH MOON; Chambers JE, 1996, ICARUS, V119, P261, DOI 10.1006/icar.1996.0019; Inaba S, 2001, ICARUS, V149, P235, DOI 10.1006/icar.2000.6533; Kortenkamp SJ, 2000, ICARUS, V143, P60, DOI 10.1006/icar.1999.6241; KORTENKAMP SJ, 2000, ORIGIN EARTH MOON, P85; KORTENKAMP SJ, 2000, LUNAR PLAN SCI C, V31; LEVISON HF, 1994, ICARUS, V108, P18, DOI 10.1006/icar.1994.1039; MALHOTRA R, 1993, NATURE, V365, P819, DOI 10.1038/365819a0; MALHOTRA R, 1994, CELEST MECH DYN ASTR, V60, P373, DOI 10.1007/BF00691903; MANNINGS V, 2000, PROTOSTARS PLANETS, V4; Marzari F, 2000, ASTROPHYS J, V543, P328, DOI 10.1086/317091; Mathieu R. D., 2000, Protostars and planets 4, P703; Miller MC, 2001, ASTROPHYS J, V550, P863, DOI 10.1086/319813; Opik E.J., 1951, P R IRISH ACAD A, V54, P165; Richardson DC, 2000, ICARUS, V143, P45, DOI 10.1006/icar.1999.6243; Safronov V., 1972, EVOLUTION PROTOPLANE; STEWART GR, 1980, ICARUS, V44, P154, DOI 10.1016/0019-1035(80)90063-9; Weidenschilling S.J., 1993, PROTOSTARS PLANETS, P1031; Wuchterl G., 2000, Protostars and planets 4, P1081	26	45	46	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2001	293	5532					1127	1129		10.1126/science.1062391	http://dx.doi.org/10.1126/science.1062391			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498588				2022-12-28	WOS:000170432600057
J	Nelson, J				Nelson, J			Solar energy - Solar cells by self-assembly?	SCIENCE			English	Editorial Material							DONOR-ACCEPTOR HETEROJUNCTIONS; PHOTOVOLTAIC DEVICES; CHARGE SEPARATION; COMPOSITES; CONVERSION; NETWORK		Univ London Imperial Coll Sci Technol & Med, Dept Phys, Ctr Elect Mat & Devices, London SW7 2BZ, England	Imperial College London	Nelson, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Phys, Ctr Elect Mat & Devices, London SW7 2BZ, England.		Nelson, Jenny/CAF-2009-2022	Nelson, Jenny/0000-0003-1048-1330				Arango AC, 2000, ADV MATER, V12, P1689, DOI 10.1002/1521-4095(200011)12:22<1689::AID-ADMA1689>3.0.CO;2-9; Boden N, 1999, J MATER CHEM, V9, P2081, DOI 10.1039/a903005k; Dittmer JJ, 2000, SOL ENERG MAT SOL C, V61, P53, DOI 10.1016/S0927-0248(99)00096-3; Eckert JF, 2000, J AM CHEM SOC, V122, P7467, DOI 10.1021/ja9941072; Granstrom M, 1998, NATURE, V395, P257, DOI 10.1038/26183; Greenham NC, 1996, PHYS REV B, V54, P17628, DOI 10.1103/PhysRevB.54.17628; Hagfeldt A, 2000, ACCOUNTS CHEM RES, V33, P269, DOI 10.1021/ar980112j; HALLS JJM, 1995, NATURE, V376, P498, DOI 10.1038/376498a0; Schmidt-Mende L, 2001, SCIENCE, V293, P1119, DOI 10.1126/science.293.5532.1119; Shaheen SE, 2001, APPL PHYS LETT, V78, P841, DOI 10.1063/1.1345834; Takahashi K, 2000, SOL ENERG MAT SOL C, V61, P403, DOI 10.1016/S0927-0248(99)00163-4; van de Craats AM, 1999, ADV MATER, V11, P1469, DOI 10.1002/(SICI)1521-4095(199912)11:17<1469::AID-ADMA1469>3.0.CO;2-K; Yoshino K, 1997, IEEE T ELECTRON DEV, V44, P1315, DOI 10.1109/16.605474; YU G, 1995, SCIENCE, V270, P1789, DOI 10.1126/science.270.5243.1789; YU G, 1995, J APPL PHYS, V78, P4510, DOI 10.1063/1.359792	15	107	109	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2001	293	5532					1059	1060		10.1126/science.1062989	http://dx.doi.org/10.1126/science.1062989			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498568				2022-12-28	WOS:000170432600036
J	Robert, F				Robert, F			Isotope geochemistry - The origin of water on Earth	SCIENCE			English	Editorial Material							DEUTERIUM; METEORITE; HYDROGEN		CNRS, Museum Minerol, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS)	Robert, F (corresponding author), CNRS, Museum Minerol, 61 Rue Buffon, F-75005 Paris, France.	robert@mnhn.fr						Aikawa Y, 1999, ASTROPHYS J, V526, P314, DOI 10.1086/307973; Bockelee-Morvan D, 1998, ICARUS, V133, P147, DOI 10.1006/icar.1998.5916; BROWN PD, 1989, MON NOT R ASTRON SOC, V237, P661, DOI 10.1093/mnras/237.3.661; DELOULE E, 1995, GEOCHIM COSMOCHIM AC, V59, P4695, DOI 10.1016/0016-7037(95)00313-4; Deloule E, 1998, GEOCHIM COSMOCHIM AC, V62, P3367, DOI 10.1016/S0016-7037(98)00232-4; DHENDECOURT L, 2001, C DEUT U OBS MEUD FR; Drouart A, 1999, ICARUS, V140, P129, DOI 10.1006/icar.1999.6137; Geiss J, 1998, SPACE SCI REV, V84, P239, DOI 10.1023/A:1005039822524; Glassgold A. E., 2000, Protostars and planets 4, P429; HALBOUT J, 1990, GEOCHIM COSMOCHIM AC, V54, P1453, DOI 10.1016/0016-7037(90)90168-K; Leshin LA, 2000, GEOPHYS RES LETT, V27, P2017, DOI 10.1029/1999GL008455; Robert F, 2000, SPACE SCI REV, V92, P201, DOI 10.1023/A:1005291127595; Teixeira TC, 1999, ASTRON ASTROPHYS, V347, pL19	16	88	90	3	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2001	293	5532					1056	1058		10.1126/science.1064051	http://dx.doi.org/10.1126/science.1064051			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498566				2022-12-28	WOS:000170432600034
J	Pockley, P				Pockley, P			Commission plots transgenic future	NATURE			English	News Item																		Pockley P, 2000, NATURE, V404, P914, DOI 10.1038/35010234	1	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2001	412	6847					573	573		10.1038/35088195	http://dx.doi.org/10.1038/35088195			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460PP	11493883	Bronze			2022-12-28	WOS:000170318000007
J	Simpson, F				Simpson, F			Resistance to mantle flow inferred from the electromagnetic strike of the Australian upper mantle	NATURE			English	Article							ELECTRICAL ANISOTROPY; AZIMUTHAL ANISOTROPY; DEFORMATION; DISTORTION; INDUCTION; BENEATH; MODEL	Seismic anisotropy is thought to result from the strain-induced lattice-preferred orientation of mantle minerals, especially olivine(1,2), owing to shear waves propagating faster along the a-axis of olivine crystals than along the other axes. This anisotropy results in birefringence, or 'shear-wave splitting'(3), which has been investigated in numerous studies(1,4). Although olivine is also anisotropic with respect to electrical conductivity 5 (with the a-axis being most conductive), few studies of the electrical anisotropy of the upper mantle have been undertaken, and these have been limited to relatively shallow depths in the lithospheric upper mantle(6,7). Theoretical models of mantle flow have been used to infer that, for progressive simple shear imparted by the motion of an overriding tectonic plate, the a-axes of olivine crystals should align themselves parallel to the direction of plate motion(8,9). Here, however, we show that a significant discrepancy exists between the electromagnetic strike of the mantle below Australia and the direction of present-day absolute plate motion(10). We infer from this discrepancy that the a-axes of olivine crystals are not aligned with the direction of the present-day plate motion of Australia, indicating resistance to deformation of the mantle by plate motion.	Univ Gottingen, Inst Geophys, D-3400 Gottingen, Germany; Inst Geol & Nucl Sci, Lower Hutt, New Zealand	University of Gottingen; GNS Science - New Zealand	Simpson, F (corresponding author), Univ Gottingen, Inst Geophys, D-3400 Gottingen, Germany.							BAHR K, 1988, J GEOPHYS-Z GEOPHYS, V62, P119; BAHR K, 1991, PHYS EARTH PLANET IN, V66, P24, DOI 10.1016/0031-9201(91)90101-M; BAHR K, 1989, J GEOPHYS RES-SOLID, V94, P14195, DOI 10.1029/JB094iB10p14195; Bahr K, 2000, EARTH PLANET SC LETT, V178, P87, DOI 10.1016/S0012-821X(00)00070-4; Barruol G, 1997, J GEOPHYS RES-SOL EA, V102, P8329, DOI 10.1029/96JB03800; CHRISTENSEN NI, 1984, GEOPHYS J ROY ASTR S, V76, P89, DOI 10.1111/j.1365-246X.1984.tb05025.x; Debayle E, 1999, GEOPHYS J INT, V137, P747, DOI 10.1046/j.1365-246x.1999.00832.x; Debayle E, 2000, J GEOPHYS RES-SOL EA, V105, P25423, DOI 10.1029/2000JB900212; GRIPP AE, 1990, GEOPHYS RES LETT, V17, P1109, DOI 10.1029/GL017i008p01109; GROOM RW, 1989, J GEOPHYS RES-SOLID, V94, P1913, DOI 10.1029/JB094iB02p01913; KURTZ RD, 1993, GEOPHYS J INT, V113, P483, DOI 10.1111/j.1365-246X.1993.tb00901.x; MACKWELL SJ, 1990, J GEOPHYS RES-SOLID, V95, P5079, DOI 10.1029/JB095iB04p05079; MARESCHAL M, 1995, NATURE, V375, P134, DOI 10.1038/375134a0; MCKENZIE D, 1979, GEOPHYS J ROY ASTR S, V58, P689, DOI 10.1111/j.1365-246X.1979.tb04803.x; PARKINSON WD, 1959, GEOPHYS J ROY ASTR S, V2, P1, DOI 10.1111/j.1365-246x.1959.tb05776.x; RIBE NM, 1989, J GEOPHYS RES-SOLID, V94, P4213, DOI 10.1029/JB094iB04p04213; SCHMUCKER U, 1970, J GEOMAGN GEOELECTR, V22, P9, DOI 10.5636/jgg.22.9; SILVER PG, 1991, J GEOPHYS RES-SOL EA, V96, P16429, DOI 10.1029/91JB00899; Simpson F, 2000, J GEOPHYS RES-SOL EA, V105, P19321, DOI 10.1029/2000JB900106; VINNIK LP, 1995, NATURE, V375, P50, DOI 10.1038/375050a0; VINNIK LP, 1992, GEOPHYS J INT, V111, P433, DOI 10.1111/j.1365-246X.1992.tb02102.x	21	52	56	0	7	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2001	412	6847					632	635		10.1038/35088051	http://dx.doi.org/10.1038/35088051			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460PP	11493919				2022-12-28	WOS:000170318000039
J	Holt, S; Suder, A; Weatherall, M; Cheng, S; Shirtcliffe, P; Beasley, R				Holt, S; Suder, A; Weatherall, M; Cheng, S; Shirtcliffe, P; Beasley, R			Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysis	BRITISH MEDICAL JOURNAL			English	Article							TO-MODERATE ASTHMA; BECLOMETHASONE DIPROPIONATE; PRIMARY-CARE; METAANALYSIS; EFFICACY; BUDESONIDE; SALMETEROL; POWDER; EXACERBATIONS; AEROSOL	Objective To examine the dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma. Design Meta-analysis of placebo controlled, randomised clinical trials that presented data on at least one outcome measure of asthma and that used at least two different doses of fluticasone. Setting Medline, Embase, and GlaxoWellcome's internal clinical study registers. Main outcome measures FEV1, morning and evening peak expiratory flow, night awakenings, beta agonist use, and major exacerbations. Results Eight studies, with 2324 adolescents and adults with asthma, met the inclusion criteria. Data on doses of > 500 mug/day were limited. The dose-response curve for the raw data began to reach a plateau at around 100-200 mug/day and peaked by 500 mug/day. A negative exponential model for the data, without meta-analysis, indicated that 80% of the benefit at 1000 mug/day was achieved at doses of 70-170 mug/day and 90% by 100-250 mug/day. A quadratic meta-regression showed that the maximum achievable efficacy was obtained by doses of around 500 mug/day. The odds ratio for patients remaining in a study at a dose of 200 mug/day, compared with higher doses, was 0.73 (95% confidence interval 0.49 to 1.08). Comparison of the standardised difference in FEV, for an inhaled dose of 200 mug/day against higher doses showed a difference in FEV1 of 0.13 of a standard deviation (-0.02 to 0.29). Conclusions In adolescent and adult patients with asthma, most of the therapeutic benefit of inhaled fluticasone is achieved with a total daily dose of 100-250 mug, and the maximum effect is achieved with a dose of around 500 mug/day. However, these findings were limited by the lack of data on individual patients and by the paucity of dose-response studies that included doses of > 500 mug/day.	Wellington Sch Med, Wellington Asthma Res Grp, Wellington, New Zealand	University of Otago	Beasley, R (corresponding author), Wellington Sch Med, Wellington Asthma Res Grp, POB 7343, Wellington, New Zealand.		Weatherall, Mark/Y-6824-2019; Beasley, Richard/AAH-3908-2019	Weatherall, Mark/0000-0002-0051-9107; Beasley, Richard/0000-0003-0337-406X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AYRES JG, 1995, EUR RESPIR J, V8, P579; BARNES NC, 1993, EUR RESPIR J, V6, P877; *BRIT MED ASS ROY, 2000, BRIT NAT FORM, V147; Busse WW, 1999, J ALLERGY CLIN IMMUN, V104, P1215, DOI 10.1016/S0091-6749(99)70016-3; Busse WW, 1998, J ALLERGY CLIN IMMUN, V101, P457, DOI 10.1016/S0091-6749(98)70353-7; CHERVINSKY P, 1994, J ALLERGY CLIN IMMUN, V94, P676, DOI 10.1016/0091-6749(94)90174-0; DAgostino RB, 1995, CLIN PHARMACOL THER, V58, P605, DOI 10.1016/0009-9236(95)90016-0; Galant SP, 1996, ANN ALLERG ASTHMA IM, V77, P112, DOI 10.1016/S1081-1206(10)63496-5; GREENING AP, 1994, LANCET, V344, P219, DOI 10.1016/S0140-6736(94)92996-3; Johnson ES, 1999, ARCH INTERN MED, V159, P1248, DOI 10.1001/archinte.159.11.1248; Lawrence M, 1997, AM J RESP CRIT CARE, V156, P744, DOI 10.1164/ajrccm.156.3.9608058; Levy ML, 1996, THORAX, V51, P1087, DOI 10.1136/thx.51.11.1087; Lipworth BJ, 1999, ARCH INTERN MED, V159, P941, DOI 10.1001/archinte.159.9.941; *NAT ASTHM ED PREV, 1997, 2 NIH NAT ASTHM ED P; *NAT HEART LUNG BL, 1996, GLOB STRAT ASTHM MAN; Nelson HS, 1999, J ALLERGY CLIN IMMUN, V103, P267, DOI 10.1016/S0091-6749(99)70501-4; Noonan MJ, 1998, J ASTHMA, V35, P153, DOI 10.3109/02770909809068203; Pauwels RA, 1997, NEW ENGL J MED, V337, P1405, DOI 10.1056/NEJM199711133372001; Pearlman DS, 1997, ANN ALLERG ASTHMA IM, V78, P356, DOI 10.1016/S1081-1206(10)63196-1; Sheffer AL, 1996, J FAM PRACTICE, V42, P369; Shrewsbury S, 2000, BMJ-BRIT MED J, V320, P1368, DOI 10.1136/bmj.320.7246.1368; SMITH SJ, 1995, STAT MED, V14, P531, DOI 10.1002/sim.4780140513; van der Molen T, 1998, AM J RESP CRIT CARE, V158, P121, DOI 10.1164/ajrccm.158.1.9707035; Wasserman SI, 1996, J ASTHMA, V33, P265, DOI 10.3109/02770909609055367; Wolfe JD, 1996, CLIN THER, V18, P635, DOI 10.1016/S0149-2918(96)80214-1; Woolcock A, 1996, AM J RESP CRIT CARE, V153, P1481, DOI 10.1164/ajrccm.153.5.8630590; [No title captured], DOI DOI 10.1136/THX.52.2008.S1]	27	145	146	1	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 4	2001	323	7307					253	+		10.1136/bmj.323.7307.253	http://dx.doi.org/10.1136/bmj.323.7307.253			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	461ZT	11485952	Green Published, Bronze			2022-12-28	WOS:000170394300015
J	Lavery, JV; Boyle, J; Dickens, BM; Maclean, H; Singer, PA				Lavery, JV; Boyle, J; Dickens, BM; Maclean, H; Singer, PA			Origins of the desire for euthanasia and assisted suicide in people with HIV-1 or AIDS: a qualitative study	LANCET			English	Article							TERMINALLY ILL; NETHERLANDS; ATTITUDES; DEATH; CARE; CAREGIVERS	Background Euthanasia and assisted suicide, and policies to address them are the subjects of contentious debate in many countries. However, the question of why people desire euthanasia or assisted suicide has not been coherently answered. We aimed to answer this question in a specific group of patients. Methods We did a qualitative study of 32 people with HIV-1 or AIDS, who were enrolled in the HIV-1 Ontario Observational Database at Sunnybrook and Women's College Health Sciences Centre, Toronto, Ontario, Canada. We elicited participants' experiences of deliberation about euthanasia or assisted suicide, and the meaning of these experiences with in-depth, face-to-face interviews. We analysed our data with grounded theory methods. Findings Participants' desire for euthanasia and assisted suicide were affected by two main factors: disintegration, which resulted from symptoms and loss of function; and loss of community, which we defined as progressive diminishment of opportunities to initiate and maintain close personal relationships. These factors resulted in perceived loss of self. Euthanasia and assisted suicide were seen by participants as means of limiting loss of self. Interpretation These determinants of desire for euthanasia or assisted suicide in people with HIV-1 or AIDS have implications for the debate on these practices, and development of policies to regulate them.	Univ Toronto, Joint Ctr Bioeth, Toronto, ON, Canada; Queens Univ, Queens Hlth Policy Res Unit, Kingston, ON, Canada; Univ Toronto, Fac Law, Dept Philosophy, Toronto, ON M5S 1A1, Canada; Univ Toronto, Fac Publ Hlth Sci, Toronto, ON M5S 1A1, Canada; Univ Toronto, Ctr Res Womens Hlth, Toronto, ON M5S 1A1, Canada; Univ Toronto, Dept Med, Toronto, ON M5S 1A1, Canada; Univ Hlth Network, Toronto, ON, Canada	University of Toronto; Queens University - Canada; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Lavery, JV (corresponding author), NIH, Fogarty Int Ctr, Div Adv Studies & Policy Anal, Bldg 16, Bethesda, MD 20892 USA.		Lavery, James/E-5254-2012					Angell M, 1996, NEW ENGL J MED, V335, P1676, DOI 10.1056/NEJM199611283352209; Antonovsky A, 1987, UNRAVELING MYSTERY H, P15; ATKINSON JH, 1988, ARCH GEN PSYCHIAT, V45, P859; BARRETT RK, 1995, AIDS PATIENT CARE, V9, P240, DOI 10.1089/apc.1995.9.240; Breitbart W, 1996, AM J PSYCHIAT, V153, P238; CALLAHAN D, 1993, HASTINGS CENT REP, V23, P33, DOI 10.2307/3562588; Chin AE, 1999, NEW ENGL J MED, V340, P577, DOI 10.1056/NEJM199902183400724; Chochinov HM, 1998, PSYCHOSOMATICS, V39, P366, DOI 10.1016/S0033-3182(98)71325-8; Chochinov HM, 1999, LANCET, V354, P816, DOI 10.1016/S0140-6736(99)80011-7; CHOCHINOV HM, 1995, AM J PSYCHIAT, V152, P1185; DWORKIN R, 1993, LIFES DOMINION ARGUM, P210; Emanuel EJ, 1996, LANCET, V347, P1805, DOI 10.1016/S0140-6736(96)91621-9; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V284, P2460, DOI 10.1001/jama.284.19.2460; Ganzini L, 1998, NEW ENGL J MED, V339, P967, DOI 10.1056/NEJM199810013391406; Giacomini MK, 2000, JAMA-J AM MED ASSOC, V284, P357, DOI 10.1001/jama.284.3.357; Glaser B., 1992, BASICS GROUNDED THEO; GREEN G, 1995, AIDS CARE, V7, P169; Haverkate I, 2000, BRIT MED J, V321, P865, DOI 10.1136/bmj.321.7265.865; JECKER NS, 1993, J CLIN ETHIC, V4, P16; Kissane DW, 1998, LANCET, V352, P1097, DOI 10.1016/S0140-6736(98)05406-3; LAANE HM, 1995, AIDS CARE, V7, P163; Roscoe LA, 2000, NEW ENGL J MED, V343, P1735, DOI 10.1056/NEJM200012073432315; SCHNEIDER SG, 1991, J PERS SOC PSYCHOL, V61, P776, DOI 10.1037/0022-3514.61.5.776; Shortt S, 1999, J Health Serv Res Policy, V4, P230; Singer PA, 1999, JAMA-J AM MED ASSOC, V281, P163, DOI 10.1001/jama.281.2.163; Strauss A., 1990, BASICS QUALITATIVE R; VANDENBOOM F, 1995, AIDS CARE, V7, P175; vanderWal G, 1996, NEW ENGL J MED, V335, P1706; Walker RJ, 1996, HEALTH SOC WORK, V21, P49, DOI 10.1093/hsw/21.1.49; Yalom I.D., 1980, EXISTENTIAL PSYCHOTH	30	72	72	0	18	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 4	2001	358	9279					362	367		10.1016/S0140-6736(01)05555-6	http://dx.doi.org/10.1016/S0140-6736(01)05555-6			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	459DE	11502315				2022-12-28	WOS:000170235100010
J	Marin, O; Yaron, A; Bagri, A; Tessier-Lavigne, M; Rubenstein, JLR				Marin, O; Yaron, A; Bagri, A; Tessier-Lavigne, M; Rubenstein, JLR			Sorting of striatal and cortical interneurons regulated by semaphorin-neuropilin interactions	SCIENCE			English	Article							NEURONS; MIGRATION; RECEPTORS; GUIDANCE; ORIGIN; GENES	Most striatal and cortical interneurons arise from the basal telencephalon, later segregating to their respective targets. Here, we show that migrating cortical interneurons avoid entering the striatum because of a chemorepulsive signal composed at least in part of semaphorin 3A and semaphorin 3F. Migrating interneurons expressing neuropilins, receptors for semaphorins, are directed to the cortex; those lacking them go to the striatum. Loss of neuropilin function increases the number of interneurons that migrate into the striatum. These observations reveal a mechanism by which neuropilins mediate sorting of distinct neuronal populations into different brain structures, and provide evidence that, in addition to guiding axons, these receptors also control neuronal migration in the central nervous system.	Univ Calif San Francisco, Langley Porter Psychiat Inst, Nina Ireland Lab Dev Neurobiol, Dept Psychiat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Rubenstein, JLR (corresponding author), Univ Calif San Francisco, Langley Porter Psychiat Inst, Nina Ireland Lab Dev Neurobiol, Dept Psychiat, San Francisco, CA 94143 USA.	jlrr@cgl.ucsf.edu	Marin, Oscar/F-3856-2012	Marin, Oscar/0000-0001-6264-7027	NIDA NIH HHS [R01DA12462] Funding Source: Medline; NIMH NIH HHS [R01MH49428-01, K02MH01046-01, R01MH51561-01A1] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051561, R01MH049428, K02MH001046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012462] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Anderson S, 1999, CEREB CORTEX, V9, P646, DOI 10.1093/cercor/9.6.646; Anderson SA, 2001, DEVELOPMENT, V128, P353; Anderson SA, 1997, NEURON, V19, P27, DOI 10.1016/S0896-6273(00)80345-1; Chen H, 2000, NEURON, V25, P43, DOI 10.1016/S0896-6273(00)80870-3; Chisholm A, 1999, CURR OPIN NEUROBIOL, V9, P603, DOI 10.1016/S0959-4388(99)00021-5; Eickholt BJ, 1999, DEVELOPMENT, V126, P2181; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Kawasaki T, 1999, DEVELOPMENT, V126, P4895; Marin O, 2000, J NEUROSCI, V20, P6063; Parnavelas JG, 2000, TRENDS NEUROSCI, V23, P126, DOI 10.1016/S0166-2236(00)01553-8; Raper JA, 2000, CURR OPIN NEUROBIOL, V10, P88, DOI 10.1016/S0959-4388(99)00057-4; Tamagnone L, 2000, TRENDS CELL BIOL, V10, P377, DOI 10.1016/S0962-8924(00)01816-X; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	13	323	329	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 3	2001	293	5531					872	875		10.1126/science.1061891	http://dx.doi.org/10.1126/science.1061891			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11486090				2022-12-28	WOS:000170241000047
J	Wu, JF; Boyle, E; Sunda, W; Wen, LS				Wu, JF; Boyle, E; Sunda, W; Wen, LS			Soluble and colloidal iron in the olgotrophic North Atlantic and North Pacific	SCIENCE			English	Article							NATURAL ORGANIC-LIGANDS; PHYTOPLANKTON BLOOM; KINETIC APPROACH; WORLD OCEAN; SEAWATER; COMPLEXATION; CO2; FERTILIZATION; SOLUBILITY; HYDROXIDE	In the oligotrophic North Atlantic and North Pacific, ultrafiltration studies show that concentrations of soluble iron and soluble iron-binding organic ligands are much lower than previously presumed "dissolved" concentrations, which were operationally defined as that passing through a 0.4-micrometer pore filter. Our studies indicate that substantial portions of the previously presumed "dissolved" iron (and probably also iron-binding ligands) are present in colloidal size range. The soluble iron and iron-binding organic ligands are depleted at the surface and enriched at depth, similar to distributions of major nutrients. By contrast, colloidal iron shows a maximum at the surface and a minimum in the upper nutricline. Our results suggest that "dissolved" iron may be less bioavailable to phytoplankton than previously thought and that iron removal through colloid aggregation and settling should be considered in models of the oceanic iron cycle.	MIT, Cambridge, MA 02139 USA; NOAA, Beaufort Lab, Beaufort, NC 28516 USA; CNR, Natl Ctr Ocean Res, Taipei, Taiwan	Massachusetts Institute of Technology (MIT); National Oceanic Atmospheric Admin (NOAA) - USA	Wu, JF (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	jingfeng@mit.edu	Wu, Jingfeng/B-1301-2012; Wen, Liang-Saw/B-6245-2012	Wu, Jingfeng/0000-0003-0156-1507; WEN, LIANG-SAW/0000-0003-4731-275X				BASKARAN M, 1992, GEOCHIM COSMOCHIM AC, V56, P3375, DOI 10.1016/0016-7037(92)90385-V; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; BOYLE EA, 1977, GEOCHIM COSMOCHIM AC, V41, P1313, DOI 10.1016/0016-7037(77)90075-8; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P352, DOI 10.1029/98PA00920; BRULAND KW, 1991, LIMNOL OCEANOGR, V36, P1555, DOI 10.4319/lo.1991.36.8.1555; BRULAND KW, 1994, GEOCHIM COSMOCHIM AC, V58, P3172; Coale KH, 1996, NATURE, V383, P495, DOI 10.1038/383495a0; Coale KH, 1996, NATURE, V379, P621, DOI 10.1038/379621a0; DHUNGANA S, 2001, J BIOL INORG CH 0630; Falkowski PG, 1997, NATURE, V387, P272, DOI 10.1038/387272a0; GRAHAM WF, 1982, ATMOS ENVIRON, V16, P1089, DOI 10.1016/0004-6981(82)90198-6; Honeyman B. D., 1989, J MAR RES, V47, P950; Hutchins DA, 1999, NATURE, V400, P858, DOI 10.1038/23680; Johnson KS, 1997, MAR CHEM, V57, P137, DOI 10.1016/S0304-4203(97)00043-1; Kuma K, 1996, LIMNOL OCEANOGR, V41, P396, DOI 10.4319/lo.1996.41.3.0396; Liu XW, 1999, GEOCHIM COSMOCHIM AC, V63, P3487, DOI 10.1016/S0016-7037(99)00270-7; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; MOORE RM, 1985, GEOCHIM COSMOCHIM AC, V49, P2253, DOI 10.1016/0016-7037(85)90225-X; Prospero JM, 1996, BIOGEOCHEMISTRY, V35, P27, DOI 10.1007/BF02179824; RICH HW, 1990, LIMNOL OCEANOGR, V35, P652, DOI 10.4319/lo.1990.35.3.0652; RUE EL, 1995, MAR CHEM, V50, P117, DOI 10.1016/0304-4203(95)00031-L; Sunda WG, 1997, MAR CHEM, V57, P169, DOI 10.1016/S0304-4203(97)00045-5; VAN DEN BERG CMG, 1995, MAR CHEM, V50, P139, DOI 10.1016/0304-4203(95)00032-M; Volker C, 1999, MAR CHEM, V65, P227, DOI 10.1016/S0304-4203(99)00004-3; Watson AJ, 2000, NATURE, V407, P730, DOI 10.1038/35037561; WELLS ML, 1993, MAR CHEM, V41, P353, DOI 10.1016/0304-4203(93)90267-R; WELLS ML, 1983, J MAR RES, V41, P652; Wen LS, 1996, MAR CHEM, V55, P129, DOI 10.1016/S0304-4203(96)00052-7; Wiggert JD, 2000, DEEP-SEA RES PT II, V47, P1353, DOI 10.1016/S0967-0645(99)00147-2; Witter AE, 1998, MAR CHEM, V62, P241, DOI 10.1016/S0304-4203(98)00044-9; Wu JF, 1998, ANAL CHIM ACTA, V367, P183, DOI 10.1016/S0003-2670(98)00145-7; WU JF, 1995, MAR CHEM, V50, P159, DOI 10.1016/0304-4203(95)00033-N	32	349	364	6	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 3	2001	293	5531					847	849		10.1126/science.1059251	http://dx.doi.org/10.1126/science.1059251			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11486084				2022-12-28	WOS:000170241000040
J	Johnston, SD; Smye, M; Watson, RGP				Johnston, SD; Smye, M; Watson, RGP			Intestinal permeability and morphometric recovery in coeliac disease	LANCET			English	Editorial Material							CELIAC-DISEASE; PERSISTENT DEFECT; ABSORPTION TEST		Belfast City Hosp, Dept Gastroenterol, Belfast BT9 7AB, Antrim, North Ireland; Royal Victoria Hosp, Dept Clin Chem, Belfast BT12 6BA, Antrim, North Ireland; Queens Univ Belfast, Dept Med, Belfast BT7 1NN, Antrim, North Ireland	Belfast City Hospital; Queens University Belfast	Johnston, SD (corresponding author), Belfast City Hosp, Dept Gastroenterol, Belfast BT9 7AB, Antrim, North Ireland.							BJARNASON I, 1983, LANCET, V1, P323; BJARNASON I, 1994, SCAND J GASTROENTERO, V29, P630, DOI 10.3109/00365529409092484; BJARNASON I, 1984, GUT, V25, P145, DOI 10.1136/gut.25.2.145; CHADWICK VS, 1977, GASTROENTEROLOGY, V73, P247; Cummins AG, 2001, CLIN SCI, V100, P379, DOI 10.1042/CS20000193; Fasano A, 2000, LANCET, V355, P1518, DOI 10.1016/S0140-6736(00)02169-3; HAMILTON I, 1982, GUT, V23, P202, DOI 10.1136/gut.23.3.202; JUBY LD, 1987, J CLIN PATHOL, V40, P714, DOI 10.1136/jcp.40.7.714; LIM SG, 1993, SCAND J GASTROENTERO, V28, P573, DOI 10.3109/00365529309096090; Uil JJ, 1996, EUR J GASTROEN HEPAT, V8, P219, DOI 10.1097/00042737-199603000-00006	10	8	8	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 28	2001	358	9278					259	260		10.1016/S0140-6736(01)05495-2	http://dx.doi.org/10.1016/S0140-6736(01)05495-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	457AF	11498209				2022-12-28	WOS:000170114400006
J	Bender, J				Bender, J			A vicious cycle: RNA silencing and DNA methylation in plants	CELL			English	Review							DE-NOVO METHYLATION; GENE; ARABIDOPSIS; VIRUS		Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Bender, J (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, 615 N Wolfe St, Baltimore, MD 21205 USA.							Bartee L, 2001, GENE DEV, V15, P1753, DOI 10.1101/gad.905701; Dalmay T, 2000, PLANT CELL, V12, P369, DOI 10.1105/tpc.12.3.369; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Dalmay T, 2001, EMBO J, V20, P2069, DOI 10.1093/emboj/20.8.2069; Jones L, 1999, PLANT CELL, V11, P2291, DOI 10.1105/tpc.11.12.2291; Jones L, 2001, CURR BIOL, V11, P747, DOI 10.1016/S0960-9822(01)00226-3; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Mallory AC, 2001, PLANT CELL, V13, P571, DOI 10.1105/tpc.13.3.571; Morel JB, 2000, CURR BIOL, V10, P1591, DOI 10.1016/S0960-9822(00)00862-9; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Pelissier T, 1999, NUCLEIC ACIDS RES, V27, P1625, DOI 10.1093/nar/27.7.1625; Ratcliff FG, 1999, PLANT CELL, V11, P1207, DOI 10.1105/tpc.11.7.1207; Rountree MR, 1997, GENE DEV, V11, P2383, DOI 10.1101/gad.11.18.2383; Thomas CL, 2001, PLANT J, V25, P417, DOI 10.1046/j.1365-313x.2001.00976.x; Wassenegger M, 2000, PLANT MOL BIOL, V43, P203, DOI 10.1023/A:1006479327881; WASSENEGGER M, 1994, CELL, V76, P567, DOI 10.1016/0092-8674(94)90119-8	17	40	43	2	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 27	2001	106	2					129	132		10.1016/S0092-8674(01)00441-X	http://dx.doi.org/10.1016/S0092-8674(01)00441-X			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	458KG	11511339	Bronze			2022-12-28	WOS:000170193100001
J	Katzmann, DJ; Babst, M; Emr, SD				Katzmann, DJ; Babst, M; Emr, SD			Ubiquitin-dependent sorting into the multivesicular body pathway requires the function of a conserved endosomal protein sorting complex, ESCRT-I	CELL			English	Article							GROWTH-FACTOR-RECEPTOR; DOA4 DEUBIQUITINATING ENZYME; SACCHAROMYCES-CEREVISIAE; PREVACUOLAR COMPARTMENT; MULTIUBIQUITIN CHAIN; SYNTAXIN HOMOLOG; YEAST VACUOLE; C-CBL; TRANSPORT; MEMBRANE	The multivesicular body (MVB) pathway is responsible for both the biosynthetic delivery of lysosomal hydrolases and the downregulation of numerous activated cell surface receptors which are degraded in the lysosome. We demonstrate that ubiquitination serves as a signal for sorting into the MVB pathway. In addition, we characterize a 350 kDa complex, ESCRT-I (composed of Vps23, Vps28, and Vps37), that recognizes ubiquitinated MVB cargo and whose function is required for sorting into MVB vesicles. This recognition event depends on a conserved UBC-like domain in Vps23. We propose that ESCRT-I represents a conserved component of the endosomal sorting machinery that functions in both yeast and mammalian cells to couple ubiquitin modification to protein sorting and receptor downregulation in the MVB pathway.	Univ Calif San Diego, Sch Med, Div Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Emr, SD (corresponding author), Univ Calif San Diego, Sch Med, Div Cellular & Mol Med, La Jolla, CA 92093 USA.				NCI NIH HHS [CA 58689] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA058689] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amerik AY, 2000, MOL BIOL CELL, V11, P3365, DOI 10.1091/mbc.11.10.3365; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Babst M, 2000, TRAFFIC, V1, P248, DOI 10.1034/j.1600-0854.2000.010307.x; Babst M, 1997, EMBO J, V16, P1820, DOI 10.1093/emboj/16.8.1820; Becherer KA, 1996, MOL BIOL CELL, V7, P579, DOI 10.1091/mbc.7.4.579; Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227; Bishop N, 2001, J BIOL CHEM, V276, P11735, DOI 10.1074/jbc.M009863200; Burd CG, 1997, MOL BIOL CELL, V8, P1089, DOI 10.1091/mbc.8.6.1089; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Costaguta G, 2001, MOL BIOL CELL, V12, P1885, DOI 10.1091/mbc.12.6.1885; Cowles CR, 1997, EMBO J, V16, P2769, DOI 10.1093/emboj/16.10.2769; Cowles CR, 1997, CELL, V91, P109, DOI 10.1016/S0092-8674(01)80013-1; Darsow T, 1997, J CELL BIOL, V138, P517, DOI 10.1083/jcb.138.3.517; Darsow T, 2001, MOL BIOL CELL, V12, P37, DOI 10.1091/mbc.12.1.37; FELDER S, 1990, CELL, V61, P623, DOI 10.1016/0092-8674(90)90474-S; Fernandez-Borja M, 1999, CURR BIOL, V9, P55, DOI 10.1016/S0960-9822(99)80048-7; FRANZUSOFF A, 1989, EMBO J, V8, P2695, DOI 10.1002/j.1460-2075.1989.tb08410.x; FRENCH AR, 1994, J BIOL CHEM, V269, P15749; Futter CE, 1996, J CELL BIOL, V132, P1011, DOI 10.1083/jcb.132.6.1011; GRUENBERG J, 1995, CURR OPIN CELL BIOL, V7, P552, DOI 10.1016/0955-0674(95)80013-1; Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hong SJ, 1998, MOL GEN GENET, V259, P404, DOI 10.1007/s004380050830; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Kornilova E, 1996, J BIOL CHEM, V271, P30340, DOI 10.1074/jbc.271.48.30340; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Li Y, 1999, MOL CELL BIOL, V19, P3588; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Losko S, 2001, MOL BIOL CELL, V12, P1047, DOI 10.1091/mbc.12.4.1047; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; PIPER RC, 1995, J CELL BIOL, V131, P603, DOI 10.1083/jcb.131.3.603; Puertollano R, 2001, CELL, V105, P93, DOI 10.1016/S0092-8674(01)00299-9; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; ROBERTS CJ, 1989, J CELL BIOL, V108, P1363, DOI 10.1083/jcb.108.4.1363; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Sato TK, 2000, MOL CELL, V6, P661, DOI 10.1016/S1097-2765(00)00064-2; Sorkin Alexander, 1998, Frontiers in Bioscience, V3, pD729; SPORMANN DO, 1992, J BIOL CHEM, V267, P8021; Swaminathan S, 1999, MOL BIOL CELL, V10, P2583, DOI 10.1091/mbc.10.8.2583; TRAGLIA HM, 1989, MOL CELL BIOL, V9, P2989, DOI 10.1128/MCB.9.7.2989; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Wurmser AE, 1998, EMBO J, V17, P4930, DOI 10.1093/emboj/17.17.4930; Yokouchi M, 1999, J BIOL CHEM, V274, P31707, DOI 10.1074/jbc.274.44.31707	46	1054	1083	4	55	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 27	2001	106	2					145	155		10.1016/S0092-8674(01)00434-2	http://dx.doi.org/10.1016/S0092-8674(01)00434-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	458KG	11511343	Bronze			2022-12-28	WOS:000170193100005
J	Wang, HY; Ma, LG; Li, JM; Zhao, HY; Deng, XW				Wang, HY; Ma, LG; Li, JM; Zhao, HY; Deng, XW			Direct interaction of Arabidopsis cryptochromes with COP1 in light control development	SCIENCE			English	Article							BZIP PROTEIN; GENE; ENCODES; HY5	Arabidopsis seedling photomorphogenesis involves two antagonistically acting components, COP1 and HY5. COP1 specifically targets HY5 for degradation via the 26S proteasome in the dark through their direct physical interaction. Little is known regarding how light signals perceived by photoreceptors are transduced to regulate COP1. Arabidopsis has two related cryptochromes (cry1 and cry2) mediating various blue/ultraviolet-A light responses. Here we show that both photoactivated cryptochromes repress COP1 activity through a direct protein-protein contact and that this direct regulation is primarily responsible for the cryptochrome-mediated blue light regulation of seedling photomorphogenic development and genome expression profile.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Beijing Univ, Coll Life Sci, Peking Yale Joint Ctr Plant Mol Genet & Agrobiote, Beijing 100871, Peoples R China; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA	Yale University; Peking University; Yale University	Deng, XW (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	xingwang.deng@yale.edu	Deng, Xing Wang/ABF-4107-2020		NIGMS NIH HHS [GM59507, GM-47850] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM047850, R01GM047850, R37GM047850, R01GM059507] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; ANG LH, 1994, PLANT CELL, V6, P613, DOI 10.1105/tpc.6.5.613; Ang LH, 1998, MOL CELL, V1, P213, DOI 10.1016/S1097-2765(00)80022-2; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Chattopadhyay S, 1998, PLANT CELL, V10, P673, DOI 10.1105/tpc.10.5.673; Cosgrove DJ, 2001, PLANT PHYSIOL, V125, P131, DOI 10.1104/pp.125.1.131; DENG XW, 1992, CELL, V71, P791, DOI 10.1016/0092-8674(92)90555-Q; Deng XW, 1999, SEMIN CELL DEV BIOL, V10, P121, DOI 10.1006/scdb.1999.0287; Guo HW, 1999, PLANT J, V19, P279, DOI 10.1046/j.1365-313X.1999.00525.x; Holm M, 1999, PLANT MOL BIOL, V41, P151, DOI 10.1023/A:1006324115086; Lin CT, 1998, P NATL ACAD SCI USA, V95, P2686, DOI 10.1073/pnas.95.5.2686; Lin CT, 1996, PLANT J, V10, P893, DOI 10.1046/j.1365-313X.1996.10050893.x; MA L, IN PRESS PLANT CELL; Maurel C, 2001, PLANT PHYSIOL, V125, P135, DOI 10.1104/pp.125.1.135; MCNELLIS TW, 1994, PLANT CELL, V6, P1391, DOI 10.1105/tpc.6.10.1391; Mockler TC, 1999, DEVELOPMENT, V126, P2073; Osterlund MT, 2000, NATURE, V405, P462, DOI 10.1038/35013076; Osterlund MT, 1999, TRENDS CELL BIOL, V9, P113, DOI 10.1016/S0962-8924(99)01499-3; Oyama T, 1997, GENE DEV, V11, P2983, DOI 10.1101/gad.11.22.2983; Serino G, 1999, PLANT CELL, V11, P1967, DOI 10.1105/tpc.11.10.1967; Wei N, 1996, PLANT PHYSIOL, V112, P871, DOI 10.1104/pp.112.3.871; Wei N, 1999, TRENDS GENET, V15, P98, DOI 10.1016/S0168-9525(98)01670-9; Yang HQ, 2000, CELL, V103, P815, DOI 10.1016/S0092-8674(00)00184-7	23	371	410	4	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2001	294	5540					154	158		10.1126/science.1063630	http://dx.doi.org/10.1126/science.1063630			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480EJ	11509693				2022-12-28	WOS:000171448800050
J	Johnson, JP; Zagotta, WN				Johnson, JP; Zagotta, WN			Rotational movement during cyclic nucleotide-gated channel opening	NATURE			English	Article							LIGAND-BINDING DOMAIN; ACTIVATED CHANNELS; GATING MACHINERY; REARRANGEMENTS; STOICHIOMETRY; TRANSITION; MECHANISM; RESIDUE; NICKEL; CELLS	Cyclic nucleotide-gated (CNG) channels are crucial components of visual, olfactory and gustatory signalling pathways. They open in response to direct binding of intracellular cyclic nucleotides and thus contribute to cellular control of both the membrane potential and intracellular Ca2+ levels(1). Cytosolic Ni2+ potentiates the rod channel (CNG1) response to cyclic nucleotides(2-4) and inhibits the olfactory channel (CNG2) response(5). Modulation is due to coordination of Ni2+ by channel-specific histidines in the Clinker, between the S6 transmembrane segment and the cyclic nucleotide-binding domain. Here we report, using a histidine scan of the initial C-linker of the CNG1 channel, stripes of sites producing Ni2+ potentiation or Ni2+ inhibition, separated by 50 degrees on an a-helix. These results suggest a model for channel gating where rotation of the post-S6 region around the channel's central axis realigns the Ni2+-coordinating residues of multiple subunits. This rotation probably initiates movement of the S6 and pore opening.	Univ Washington, Sch Med, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Physiol & Biophys, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Zagotta, WN (corresponding author), Univ Washington, Sch Med, Howard Hughes Med Inst, Box 357290, Seattle, WA 98195 USA.			Johnson Jr., J.P./0000-0002-5762-5138	NEI NIH HHS [R01 EY010329, R01 EY010329-08] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010329] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Broillet MC, 2000, J BIOL CHEM, V275, P15135, DOI 10.1074/jbc.275.20.15135; Brown RL, 1998, BIOPHYS J, V75, P825, DOI 10.1016/S0006-3495(98)77571-X; Cortes DM, 2001, J GEN PHYSIOL, V117, P165, DOI 10.1085/jgp.117.2.165; Cowan J.A., 1997, INORGANIC BIOCH INTR; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Ermler U, 1998, CURR OPIN STRUC BIOL, V8, P749, DOI 10.1016/S0959-440X(98)80095-X; Flynn GE, 2001, NEURON, V30, P689, DOI 10.1016/S0896-6273(01)00324-5; GORDON SE, 1995, P NATL ACAD SCI USA, V92, P10222, DOI 10.1073/pnas.92.22.10222; Gordon SE, 1996, BIOCHEMISTRY-US, V35, P3994, DOI 10.1021/bi952607b; GORDON SE, 1995, NEURON, V14, P857, DOI 10.1016/0896-6273(95)90229-5; GORDON SE, 1995, NEURON, V14, P177; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; ILDEFONSE M, 1992, J MEMBRANE BIOL, V130, P91; KARPEN JW, 1993, J GEN PHYSIOL, V101, P1, DOI 10.1085/jgp.101.1.1; KNELLER DG, 1990, J MOL BIOL, V214, P171, DOI 10.1016/0022-2836(90)90154-E; Liu DT, 1998, NEURON, V21, P235, DOI 10.1016/S0896-6273(00)80530-9; Maroney MJ, 1999, CURR OPIN CHEM BIOL, V3, P188, DOI 10.1016/S1367-5931(99)80032-5; Matulef K, 1999, NEURON, V24, P443, DOI 10.1016/S0896-6273(00)80857-0; Paoletti P, 1999, J GEN PHYSIOL, V113, P17, DOI 10.1085/jgp.113.1.17; Perozo E, 1998, NAT STRUCT BIOL, V5, P459, DOI 10.1038/nsb0698-459; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; Shammat IM, 1999, NEURON, V23, P809, DOI 10.1016/S0896-6273(01)80038-6; Sunderman ER, 1999, J GEN PHYSIOL, V113, P601, DOI 10.1085/jgp.113.5.601; YAU KW, 1989, ANNU REV NEUROSCI, V12, P289, DOI 10.1146/annurev.ne.12.030189.001445; ZAGOTTA WN, 1989, P NATL ACAD SCI USA, V86, P7243, DOI 10.1073/pnas.86.18.7243; Zong XG, 1998, EMBO J, V17, P353, DOI 10.1093/emboj/17.2.353	26	88	90	1	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2001	412	6850					917	921		10.1038/35091089	http://dx.doi.org/10.1038/35091089			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467EG	11528481				2022-12-28	WOS:000170689000047
J	Raj, K; Ogston, P; Beard, P				Raj, K; Ogston, P; Beard, P			Virus-mediated killing of cells that lack p53 activity	NATURE			English	Article							ADENOASSOCIATED VIRUS; DNA-DAMAGE; E2 PROTEIN; PHOSPHORYLATION; REQUIREMENT; INHIBITION; MITOSIS; KINASE; CDC25C; PHASE	A major goal of molecular oncology is to identify means to kill cells lacking p53 function. Most current cancer therapy is based on damaging cellular DNA by irradiation or chemicals. Recent reports(1,2) support the notion that, in the event of DNA damage, the p53 tumour-suppressor protein is able to prevent cell death by sustaining an arrest of the cell cycle at the G2 phase. We report here that adeno-associated virus (AAV) selectively induces apoptosis in cells that lack active p53. Cells with intact p53 activity are not killed but undergo arrest in the G2 phase of the cell cycle. This arrest is characterized by an increase in p53 activity and p21 levels and by the targeted destruction of CDC25C. Neither cell killing nor arrest depends upon AAV-encoded proteins. Rather, AAV DNA, which is single-stranded with hairpin structures at both ends(3,4), elicits in cells a DNA damage response that, in the absence of active p53, leads to cell death. AAV inhibits tumour growth in mice. Thus viruses can be used to deliver DNA of unusual structure into cells to trigger a DNA damage response without damaging cellular DNA and to selectively eliminate those cells lacking p53 activity.	Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland	Swiss Institute Experimental Cancer Research	Beard, P (corresponding author), Swiss Inst Expt Canc Res, 155 Ch Boveresses, CH-1066 Epalinges, Switzerland.							BEAMISH H, 1994, INT J RADIAT BIOL, V65, P175, DOI 10.1080/09553009414550211; BERNS KI, 1995, BIOESSAYS, V17, P237, DOI 10.1002/bies.950170310; Blasina A, 1999, CURR BIOL, V9, P1135, DOI 10.1016/S0960-9822(99)80486-2; Bowman T, 1996, GENE DEV, V10, P826, DOI 10.1101/gad.10.7.826; Brown JM, 1999, CANCER RES, V59, P1391; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; DELAMAZA LM, 1981, JNCI-J NATL CANCER I, V67, P1323; Finkel E, 1999, SCIENCE, V286, P2256, DOI 10.1126/science.286.5448.2256; Fournier N, 1999, ONCOGENE, V18, P4015, DOI 10.1038/sj.onc.1202775; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; Ogston P, 2000, J VIROL, V74, P3494, DOI 10.1128/JVI.74.8.3494-3504.2000; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Rotman G, 1999, ONCOGENE, V18, P6135, DOI 10.1038/sj.onc.1203124; RUFFING M, 1992, J VIROL, V66, P6922, DOI 10.1128/JVI.66.12.6922-6930.1992; Saudan P, 2000, EMBO J, V19, P4351, DOI 10.1093/emboj/19.16.4351; SRIVASTAVA A, 1983, J VIROL, V45, P555, DOI 10.1128/JVI.45.2.555-564.1983; STRAUSFELD U, 1994, J BIOL CHEM, V269, P5989; WOZNIAK AJ, 1983, CANCER RES, V43, P120; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; YANG DZ, 1995, NAT STRUCT BIOL, V2, P577, DOI 10.1038/nsb0795-577	22	161	173	1	4	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2001	412	6850					914	917		10.1038/35091082	http://dx.doi.org/10.1038/35091082			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467EG	11528480				2022-12-28	WOS:000170689000046
J	Aizenberg, J; Tkachenko, A; Weiner, S; Addadi, L; Hendler, G				Aizenberg, J; Tkachenko, A; Weiner, S; Addadi, L; Hendler, G			Calcitic microlenses as part of the photoreceptor system in brittlestars	NATURE			English	Article							OPHIUROIDEA; ECHINODERMATA; BIOMINERALIZATION; LOCALIZATION	Photosensitivity in most echinoderms has been attributed to 'diffuse' dermal receptors(1-3). Here we report that certain single calcite crystals used by brittlestars for skeletal construction(4,5) are also a component of specialized photosensory organs, conceivably with the function of a compound eye. The analysis of arm ossicles in Ophiocoma(6) showed that in light-sensitive species, the periphery of the labyrinthic calcitic skeleton extends into a regular array of spherical microstructures that have a characteristic double-lens design. These structures are absent in light-indifferent species. Photolithographic experiments in which a photoresist film was illuminated through the lens array showed selective exposure of the photoresist under the lens centres. These results provide experimental evidence that the microlenses are optical elements that guide and focus the light inside the tissue. The estimated focal distance (4-7 mum below the lenses) coincides with the location of nerve bundles-the presumed primary photoreceptors. The lens array is designed to minimize spherical aberration and birefringence and to detect light from a particular direction. The optical performance is further optimized by phototropic chromatophores that regulate the dose of illumination reaching the receptors. These structures represent an example of a multifunctional biomaterial that fulfills both mechanical and optical functions.	Bell Labs, Lucent Technol, Murray Hill, NJ 07974 USA; Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; Natl Hist Museum Los Angeles Cty, Los Angeles, CA 90007 USA	Alcatel-Lucent; Lucent Technologies; AT&T; Weizmann Institute of Science	Aizenberg, J (corresponding author), Bell Labs, Lucent Technol, 600 Mt Ave, Murray Hill, NJ 07974 USA.		Tkachenko, Alexei V/I-9040-2012	Tkachenko, Alexei V/0000-0003-1291-243X				Aizenberg J, 1997, APPL PHYS LETT, V71, P3773, DOI 10.1063/1.120502; Ameye L, 1999, J HISTOCHEM CYTOCHEM, V47, P1189, DOI 10.1177/002215549904700911; Belcher AM, 1998, ACTA MATER, V46, P733, DOI 10.1016/S1359-6454(97)00253-X; CLARKSON ENK, 1975, NATURE, V254, P663, DOI 10.1038/254663a0; COBB JLS, 1990, COMP BIOCHEM PHYS A, V97, P329, DOI 10.1016/0300-9629(90)90619-4; COBB JLS, 1986, J NEUROCYTOL, V15, P97, DOI 10.1007/BF02057908; Cowles RP, 1910, J EXP ZOOL, V9, P387, DOI 10.1002/jez.1400090209; Doderlein L, 1898, DENKSCHR MED NAT GES, V8, P491; DONNAY G, 1969, SCIENCE, V166, P1147, DOI 10.1126/science.166.3909.1147; FLINT HT, 1936, GEOMETRICAL OPTICS; Gal J, 2000, VISION RES, V40, P843, DOI 10.1016/S0042-6989(99)00216-3; HENDLER G, 1984, PSZNI MAR ECOL, V5, P379, DOI 10.1111/j.1439-0485.1984.tb00131.x; HENDLER G, 1987, ZOOMORPHOLOGY, V107, P261, DOI 10.1007/BF00312172; Hyman L. H., 1955, INVERTEBRATES; Johnsen S, 1997, BIOL BULL, V193, P97, DOI 10.2307/1542739; Land M. F., 1981, COMP PHYSL EVOLUTI B, P471; Lowenstam H. A., 1989, BIOMINERALISATION, P123; Mann S, 1996, NATURE, V382, P313, DOI 10.1038/382313a0; MILLOTT N, 1975, ADV MAR BIOL, V13, P1, DOI 10.1016/S0065-2881(08)60279-5; Smith AB., 1980, SPEC PAP PALAEONTOL, V25, P1; Stubbs T.R., 1982, Echinoderms, P403; TOWE KM, 1973, SCIENCE, V179, P1007, DOI 10.1126/science.179.4077.1007; Wainwright S.A., 1976, MECH DESIGN ORGANISM; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Yoshida M., 1984, PHOTORECEPTION ECHIN, P743	25	468	494	9	232	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2001	412	6849					819	822		10.1038/35090573	http://dx.doi.org/10.1038/35090573			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465ET	11518966				2022-12-28	WOS:000170577200037
J	Lewis, S; Sherratt, TN; Hamer, KC; Wanless, S				Lewis, S; Sherratt, TN; Hamer, KC; Wanless, S			Evidence of intra-specific competition for food in a pelagic seabird	NATURE			English	Article							COLONY DISTRIBUTIONS; BRITISH-ISLES; POPULATION; SIZE; SEA	The factors affecting the population dynamics of seabirds have long intrigued biologists(1-5). Current data suggest that density-dependent depletion of prey during the breeding season may regulate population size(6-9). However, much of the evidence for this has been circumstantial, and the underlying mechanisms are unclear(5,10). Here, we show that the per capita population growth rates of northern gannet Morus bassanus at colonies in Britain and Ireland have declined with increasing population size. Furthermore, direct observations reveal that the mean foraging trip duration of breeding gannets is positively correlated with colony size, both among colonies of different sizes in the same year, and within colonies as they change in size. To understand this phenomenon, we have developed a model which demonstrates that disturbance of fish alone can readily generate conditions under which gannets at larger colonies have to travel further to obtain food.	Univ Durham, Dept Biol Sci, Durham DH1 3LE, England; Ctr Ecol & Hydrol, Banchory Res Stn, Hill Of Brathens AB31 4BW, Aberdeen, Scotland	Durham University; UK Centre for Ecology & Hydrology (UKCEH)	Sherratt, TN (corresponding author), Univ Durham, Dept Biol Sci, South Rd, Durham DH1 3LE, England.		Wanless, Sarah/K-2338-2012; Lewis, Sue/D-3380-2012	Wanless, Sarah/0000-0002-2788-4606; 				ASHMOLE N. P., 1963, IBIS, V103b, P458, DOI 10.1111/j.1474-919X.1963.tb06766.x; Birkhead T.R., 1985, P145; BIRT VL, 1987, MAR ECOL PROG SER, V40, P205, DOI 10.3354/meps040205; CAIRNS DK, 1989, AM NAT, V134, P141, DOI 10.1086/284970; COULSON JC, 1983, BIRD STUDY, V30, P9, DOI 10.1080/00063658309476769; CRAMP S, 1974, SEABIRDS BRITAIN IRE, P238; Croxall JP., 1987, SEABIRDS FEEDING ECO; CROXALL JP, 1991, BIRD POPULATION STUD, P272; Fisher J, 1943, J ANIM ECOL, V12, P173, DOI 10.2307/1376; Forbes LS, 2000, ECOGRAPHY, V23, P575, DOI 10.1034/j.1600-0587.2000.230508.x; Furness R. W., 1997, P INT S ROL FOR FISH, P147; FURNESS RW, 1984, NATURE, V311, P655, DOI 10.1038/311655a0; FURNESS RW, 1992, ARDEA, V80, P105; Garthe S, 1999, MAR ECOL PROG SER, V185, P93, DOI 10.3354/meps185093; GASTON AJ, 1983, CAN J ZOOL, V61, P2465, DOI 10.1139/z83-327; Hamer KC, 2000, MAR ECOL PROG SER, V200, P257, DOI 10.3354/meps200257; HAMER KC, IN PRESS MAR ECOL PR; HUNT GL, 1986, AUK, V103, P306, DOI 10.1093/auk/103.2.306; LACK D, 1966, POPULATION STUDIES B, P252; LLOYD C, 1991, STATUS SEABIRDS BRIT, P13; LOGERWELL EA, 1997, P INT S ROL FOR FISH, P191; MONAGHAN P, 1989, J FISH BIOL, V35, P339; Murray S., 1997, Scottish Birds, V19, P10; MURRAY S, 1986, Scottish Birds, V14, P74; NELSON J.B., 1978, SULIDAE GANNETS BOOB; NUR N, 2000, BIRD STUDY, V46, P575; POLLARD E, 1987, ECOLOGY, V68, P2046, DOI 10.2307/1939895; POTTS GR, 1980, J ANIM ECOL, V49, P465, DOI 10.2307/4258; UPTON AJ, 2000, 24 JNCC UK NAT CONS; WOOLLER RD, 1992, TRENDS ECOL EVOL, V7, P111, DOI 10.1016/0169-5347(92)90143-Y	30	315	326	1	102	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2001	412	6849					816	819		10.1038/35090566	http://dx.doi.org/10.1038/35090566			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465ET	11518965				2022-12-28	WOS:000170577200036
J	Sawka, AM; Young, WF; Thompson, GB; Grant, CS; Farley, DR; Leibson, C; van Heerden, JA				Sawka, AM; Young, WF; Thompson, GB; Grant, CS; Farley, DR; Leibson, C; van Heerden, JA			Primary aldosteronism: Factors associated with normalization of blood pressure after surgery	ANNALS OF INTERNAL MEDICINE			English	Article							PRIMARY HYPERALDOSTERONISM; UNILATERAL ADRENALECTOMY; PERSISTENT HYPERTENSION; DIAGNOSIS; PREVALENCE; ADENOMA	Background: Hypertension often persists after adrenalectomy for primary aldosteronism. Objective: To determine factors associated with resolution of hypertension after adrenalectomy for primary aldosteronism. Design: Retrospective cohort study. Setting: Tertiary care referral center in Rochester, Minnesota. Patients: All patients who underwent adrenalectomy for primary aldosteronism between I January 1993 and 31 December 1999. Measurements: Preoperative plasma renin activity, plasma and urinary aldosterone concentrations, and adrenal imaging. Followup blood pressure, measured at a clinic visit or at home, was reviewed. Results: 97 adrenalectomies were performed, and follow-up was available in 93 patients. Hypertension was resolved at follow-up (blood pressure < 140/90 mm Hg) without use of antihypertensive agents in 31 of 93 patients (33%). According to a stepwise multivariable logistic regression analysis adjusted for duration of follow-up, resolution of hypertension was independently associated with family history of hypertension in no more than 1 first-degree relative (odds ratio [OR], 10.9; P < 0.001) and preoperative use of two or fewer antihypertensive agents (OR, 4.7; P = 0.005). Additional factors associated with resolution of hypertension based on univariate analysis included younger age, shorter duration of hypertension, higher preoperative ratio of plasma aldosterone concentration to plasma renin activity, and higher urine aldosterone level (P < 0.05). Conclusions: Resolution of hypertension after adrenalectomy for primary aldosteronism is independently associated with a lack of family history of hypertension and preoperative use of two or fewer anti hypertensive agents.	Mayo Clin & Mayo Fdn, Div Metab Endocrinol & Nutr, Rochester, MN 55905 USA	Mayo Clinic	Young, WF (corresponding author), Mayo Clin & Mayo Fdn, Div Metab Endocrinol & Nutr, 200 1st St SW, Rochester, MN 55905 USA.		Sawka, Anna/AAA-4336-2020					BLUMENFELD JD, 1994, ANN INTERN MED, V121, P877, DOI 10.7326/0003-4819-121-11-199412010-00010; Celen O, 1996, ARCH SURG-CHICAGO, V131, P646; CONN JW, 1990, J LAB CLIN MED, V116, P253; FAVIA G, 1992, WORLD J SURG, V16, P680, DOI 10.1007/BF02067355; GORDON RD, 1994, CLIN EXP PHARMACOL P, V21, P315, DOI 10.1111/j.1440-1681.1994.tb02519.x; IRONY I, 1990, AM J HYPERTENS, V3, P576, DOI 10.1093/ajh/3.7.576; Lim PO, 1999, LANCET, V353, P40, DOI 10.1016/S0140-6736(05)74868-6; Lo CY, 1996, ANN SURG, V224, P125, DOI 10.1097/00000658-199608000-00003; Loh KC, 2000, J CLIN ENDOCR METAB, V85, P2854, DOI 10.1210/jc.85.8.2854; LUND JO, 1981, ACTA MED SCAND, P54; *NAT HIGH BLOOD PR, 1997, REP JOINT NAT COMM P; OBARA T, 1992, SURGERY, V112, P987; Proye CAG, 1998, SURGERY, V124, P1128, DOI 10.1067/msy.1998.93108; Shen WT, 1999, ARCH SURG-CHICAGO, V134, P628, DOI 10.1001/archsurg.134.6.628; STOWASSER M, 1994, CLIN EXP PHARMACOL P, V21, P319, DOI 10.1111/j.1440-1681.1994.tb02520.x; STREETEN DHP, 1979, AM J MED, V67, P403, DOI 10.1016/0002-9343(79)90786-1; Torpy DJ, 1999, VITAM HORM, V57, P177; Young W F Jr, 1999, Cardiol Rev, V7, P207, DOI 10.1097/00045415-199907000-00012; Young WF, 1997, ENDOCRINOLOGIST, V7, P213, DOI 10.1097/00019616-199707040-00003	19	232	242	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 21	2001	135	4					258	261		10.7326/0003-4819-135-4-200108210-00010	http://dx.doi.org/10.7326/0003-4819-135-4-200108210-00010			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465KE	11511140				2022-12-28	WOS:000170587500004
J	Street, K; Henderson, J				Street, K; Henderson, J			Are we treading a fine line?	BRITISH MEDICAL JOURNAL			English	Article							PEDIATRIC INTENSIVE-CARE; WITHDRAWAL; DEATH; MODES; UNIT		Bristol Royal Hosp Sick Children, Inst Child Hlth, Bristol BS2 8BJ, Avon, England	Bristol Royal Hospital For Children; University of Bristol	Street, K (corresponding author), Knapp Cottage, Knapp Rd E, Thornbury BS35 2HJ, S Gloucester, England.							BalfourLynn IM, 1996, J MED ETHICS, V22, P279, DOI 10.1136/jme.22.5.279; JECKER NS, 1991, HASTINGS CENT REP, V21, P5, DOI 10.2307/3563315; LEVETOWN M, 1994, JAMA-J AM MED ASSOC, V272, P1271, DOI 10.1001/jama.272.16.1271; MARTINOT A, 1995, ARCH PEDIATRIE, V2, P735, DOI 10.1016/0929-693X(96)81242-5; MINK RB, 1992, PEDIATRICS, V89, P961; *ROYAL COLL PAED C, 1997, WITHH WITHDR LIF SAV; RYAN CA, 1993, J PEDIATR, V124, P995; VERNON DD, 1993, CRIT CARE MED, V21, P1798, DOI 10.1097/00003246-199311000-00035	8	16	16	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 18	2001	323	7309					388	389		10.1136/bmj.323.7309.388	http://dx.doi.org/10.1136/bmj.323.7309.388			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465GN	11509434	Green Published			2022-12-28	WOS:000170581400027
J	Waddell, S; Quinn, WG				Waddell, S; Quinn, WG			Neurobiology - Learning how a fruit fly forgets	SCIENCE			English	Editorial Material							DROSOPHILA; SHIBIRE; DYNAMIN; MEMORY; BRAIN		MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Waddell, S (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.	waddell@mit.edu; cquinn@mit.edu	Oka, Yoshitaka/C-9670-2010	Oka, Yoshitaka/0000-0002-3482-3051; Waddell, Scott/0000-0003-4503-6229				CHEN MS, 1991, NATURE, V351, P583, DOI 10.1038/351583a0; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; DAVIS RL, 1995, MOL CELL BIOCHEM, V149, P271, DOI 10.1007/BF01076588; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Menzel R, 2001, LEARN MEMORY, V8, P53, DOI 10.1101/lm.38801; POODRY CA, 1973, DEV BIOL, V32, P373, DOI 10.1016/0012-1606(73)90248-0; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672	13	5	6	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2001	293	5533					1271	1272		10.1126/science.1064604	http://dx.doi.org/10.1126/science.1064604			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11509718				2022-12-28	WOS:000170492600027
J	Ylikorkala, A; Rossi, DJ; Korsisaari, N; Luukko, K; Alitalo, K; Henkemeyer, M; Makela, TP				Ylikorkala, A; Rossi, DJ; Korsisaari, N; Luukko, K; Alitalo, K; Henkemeyer, M; Makela, TP			Vascular abnormalities and deregulation of VEGF in Lkb1-deficient mice	SCIENCE			English	Article							ENDOTHELIAL GROWTH-FACTOR; EMBRYONIC LETHALITY; FACTOR EXPRESSION; GENE; KINASE; ACTIVATION; CARCINOMA; HYPOXIA; PROTEIN; FLK-1	The LKB1 tumor suppressor gene, mutated in Peutz-Jeghers syndrome, encodes a serine/threonine kinase of unknown function. Here we show that mice with a targeted disruption of Lkb1 die at midgestation, with the embryos showing neural tube defects, mesenchymal cell death, and vascular abnormalities. Extraembryonic development was also severely affected; the mutant placentas exhibited defective labyrinth layer development and the fetal vessels failed to invade the placenta. These phenotypes were associated,with tissue-specific deregulation of vascular endothelial growth factor (VEGF) expression, including a marked increase in the amount of VEGF messenger RNA. Moreover, VEGF production in cultured Lkb1(-/-) fibroblasts was elevated in both normoxic and hypoxic conditions. These findings place Lkb1 in the VEGF signaling pathway and suggest that the vascular defects accompanying Lkb1 loss are mediated at least in part by VEGF.	Univ Helsinki, Haartman Inst, Mol & Canc Biol Program, FIN-00014 Helsinki, Finland; Univ Helsinki, Biomedicum Helsinki, FIN-00014 Helsinki, Finland; Univ Bergen, Dept Anat & Cell Biol, N-5009 Bergen, Norway; Univ Helsinki, Cent Hosp, Diagnost Lab, Helsinki 00029, Finland; Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75235 USA	University of Helsinki; University of Helsinki; University of Bergen; University of Helsinki; Helsinki University Central Hospital; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Makela, TP (corresponding author), Univ Helsinki, Haartman Inst, Mol & Canc Biol Program, POB 63, FIN-00014 Helsinki, Finland.		makela, tomi/B-3734-2009; Alitalo, Kari K/J-5013-2014	makela, tomi/0000-0002-4869-8044; Alitalo, Kari K/0000-0002-7331-0902; Henkemeyer, Mark/0000-0002-7525-1061				Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; DUMONT DJ, 1995, DEV DYNAM, V203, P80, DOI 10.1002/aja.1002030109; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Giardiello FM, 2000, GASTROENTEROLOGY, V119, P1447, DOI 10.1053/gast.2000.20228; Gleadle JM, 1997, BLOOD, V89, P503, DOI 10.1182/blood.V89.2.503; Gnarra JR, 1997, P NATL ACAD SCI USA, V94, P9102, DOI 10.1073/pnas.94.17.9102; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; JOYNER AL, 1987, GENE DEV, V1, P29, DOI 10.1101/gad.1.1.29; KAIPAINEN A, 1993, J EXP MED, V178, P2077, DOI 10.1084/jem.178.6.2077; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; Luukko K, 1999, MECH DEVELOP, V83, P187, DOI 10.1016/S0925-4773(99)00050-7; Pal S, 1997, J BIOL CHEM, V272, P27509, DOI 10.1074/jbc.272.44.27509; Siemeister G, 1996, CANCER RES, V56, P2299; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; YAMAGUCHI TP, 1993, DEVELOPMENT, V118, P489; YLIKORKALA A, UNPUB	17	237	256	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2001	293	5533					1323	1326		10.1126/science.1062074	http://dx.doi.org/10.1126/science.1062074			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11509733				2022-12-28	WOS:000170492600042
J	Mawer, C; Ignatenko, NV; Wares, DF; Strelis, AK; Golubchikova, VT; Yanova, GV; Lyagoshina, TV; Sharaburova, OE; Banatvala, N				Mawer, C; Ignatenko, NV; Wares, DF; Strelis, AK; Golubchikova, VT; Yanova, GV; Lyagoshina, TV; Sharaburova, OE; Banatvala, N			Comparison of the effectiveness of WHO short-course chemotherapy and standard Russian antituberculous regimens in Tomsk, western Siberia	LANCET			English	Article							TREATMENT FAILURE; MDR-TB; TUBERCULOSIS	Background There has been a resurgence of tuberculosis in Russia in the past decade. Traditional Russian services for treatment of tuberculosis are very different from those in the west. We aimed to compare the effects of WHO short-course chemotherapy with standard Russian antituberculous regimens. Methods New tuberculosis patients aged 18 years or older were included in a trial and systematically allocated to traditional Russian tuberculosis treatments or WHO short-course chemotherapy in the two largest tuberculosis diagnostic and treatment centres of Tomsk Oblast, western Siberia. Standard WHO tuberculosis outcomes and rates of sputum conversion were used as primary outcomes. Analyses were by intention-to-treat. Findings 646 new cases were enrolled into the trial, of which 356 patients were given Russian tuberculosis treatment (155 smear positive) and 290 were given WHO short-course chemotherapy (155 smear positive). There was no statistical difference between the proportion cured or completing treatment (63% for both groups [difference in proportion=0%, 95% CI -11 to 11%]); or dying (short-course chemotherapy, 8% vs Russian, 11% [difference in proportion=-3%, 95% CI -9 to 4%]). There was no statistical difference with respect to sputum conversion rate at 6 months (91% vs 85% [difference in proportion=6%, 95% CI -2 to 13%]). Overall, outcomes were worse among patients with multidrug resistant isolates than non-resistant isolates. Interpretation WHO short-course chemotherapy treatment for tuberculosis can work well in Russia.	Suffolk Hlth, Dept Publ Hlth, Ipswich IP3 8NN, Suffolk, England; Med Emergency Relief Int, London SE1 1DB, England; Tomsk Oblast TB Dispensary, Tomsk, Russia; Siberian Med Univ, Cafedra Phthisiatry, Tomsk, Russia	Siberian State Medical University	Banatvala, N (corresponding author), Suffolk Hlth, Dept Publ Hlth, POB 55, Ipswich IP3 8NN, Suffolk, England.		Yanova, Galina/S-5085-2016	Yanova, Galina/0000-0003-2222-6281; Banatvala, Nick/0000-0001-8130-154X				Banatvala N, 1999, LANCET, V354, P56, DOI 10.1016/S0140-6736(05)75329-0; Barr DA, 1996, AM J PUBLIC HEALTH, V86, P307, DOI 10.2105/AJPH.86.3.307; CLOWES CI, 1997, TOMSK REGION TUBERCU; Drobniewski F, 1996, TUBERCLE LUNG DIS, V77, P199, DOI 10.1016/S0962-8479(96)90001-5; Drobniewski F, 1996, TUBERCLE LUNG DIS, V77, P297, DOI 10.1016/S0962-8479(96)90092-1; GARDNER MJ, 1989, BMJ; Kimerling ME, 1999, INT J TUBERC LUNG D, V3, P451; LYAGOSHINA TV, 1998, CLIN TUBERCULOSIS, P631; *MIN HLTH MED IND, 1988, BACT TECHN METH DIAG; *RUSS MIN HLTH MED, 1988, 527 MIN HLTH MED IND; *RUSS MIN HLTH MED, 2000, TUB STAT 1998; Spinaci S, 1999, INT J TUBERC LUNG D, V3, P365; *WHO, 1997, 97220 WHO; WHO, 1998, LAB SERV TUB CONTR 2; World Health Organization, 1998, LAB SERV TUB CONTR 3	15	27	27	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 11	2001	358	9280					445	449		10.1016/S0140-6736(01)05621-5	http://dx.doi.org/10.1016/S0140-6736(01)05621-5			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463TB	11513907				2022-12-28	WOS:000170492400009
J	Hammes, A; Guo, JK; Lutsch, G; Leheste, JR; Landrock, D; Ziegler, U; Gubler, MC; Schedl, A				Hammes, A; Guo, JK; Lutsch, G; Leheste, JR; Landrock, D; Ziegler, U; Gubler, MC; Schedl, A			Two splice variants of the Wilms' tumor 1 gene have distinct functions during sex determination and nephron formation	CELL			English	Article							TUMOR-SUPPRESSOR GENE; SRY-RELATED GENE; FRASIER-SYNDROME; SUBNUCLEAR LOCALIZATION; CAMPOMELIC DYSPLASIA; GLOMERULAR PROTEIN; WT1; EXPRESSION; MOUSE; MUTATIONS	Alternative splicing of Wt1 results in the insertion or omission of the three amino acids KTS between zinc fingers 3 and 4. In vitro experiments suggest distinct molecular functions for + and -KTS isoforms. We have generated mouse strains in which specific isoforms have been removed. Heterozygous mice with a reduction of +KTS levels develop glomerulosclerosis and represent a model for Frasier syndrome. Homozygous mutants of both strains die after birth due to kidney defects. Strikingly, mice lacking +KTS isoforms show a complete XY sex reversal due to a dramatic reduction of Sry expression levels. Our data demonstrate distinct functions for the two splice variants and place the +KTS variants as important regulators for Sty in the sex determination pathway.	MDC Mol Med, D-13092 Berlin, Germany; Hop Necker Enfants Malad, Dept Pediat Nephrol, F-75743 Paris 15, France	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Schedl, A (corresponding author), Newcastle Univ, Sch Biochem & Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	andreas.schedl@ncl.ac.uk	Schedl, Andreas/GOP-3427-2022; Schedl, Andreas/F-8823-2015	Schedl, Andreas/0000-0001-9380-7396; Hammes-Lewin, Annette/0000-0003-1663-8378; Gubler, Marie-Claire/0000-0002-3526-5661				Arango NA, 1999, CELL, V99, P409, DOI 10.1016/S0092-8674(00)81527-5; ARMSTRONG JF, 1993, MECH DEVELOP, V40, P85, DOI 10.1016/0925-4773(93)90090-K; Barbaux S, 1997, NAT GENET, V17, P467, DOI 10.1038/ng1297-467; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Bradley A, 1987, TERATOCARCINOMAS EMB, P113; Caricasole A, 1996, P NATL ACAD SCI USA, V93, P7562, DOI 10.1073/pnas.93.15.7562; daSilva SM, 1996, NAT GENET, V14, P62, DOI 10.1038/ng0996-62; Davies RC, 1998, GENE DEV, V12, P3217, DOI 10.1101/gad.12.20.3217; Davies RC, 2000, HUM MOL GENET, V9, P1177, DOI 10.1093/hmg/9.8.1177; De Santa Barbara P, 1998, MOL CELL BIOL, V18, P6653, DOI 10.1128/MCB.18.11.6653; Englert C, 1995, P NATL ACAD SCI USA, V92, P11960, DOI 10.1073/pnas.92.26.11960; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Gubler M C, 1999, Adv Nephrol Necker Hosp, V29, P299; HACKER A, 1995, DEVELOPMENT, V121, P1603; Herzer U, 1999, CURR BIOL, V9, P837, DOI 10.1016/S0960-9822(99)80369-8; Hogan B, 1994, MANIPULATING MOUSE E; Hossain A, 2001, J BIOL CHEM, V276, P16817, DOI 10.1074/jbc.M009056200; Ito S, 1999, PEDIATR NEPHROL, V13, P790, DOI 10.1007/s004670050702; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kennedy D, 1996, NAT GENET, V12, P329, DOI 10.1038/ng0396-329; KENT J, 1995, ONCOGENE, V11, P1781; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kikuchi H, 1998, J MED GENET, V35, P45, DOI 10.1136/jmg.35.1.45; Kim J, 1999, MOL CELL BIOL, V19, P2289; Klamt B, 1998, HUM MOL GENET, V7, P709, DOI 10.1093/hmg/7.4.709; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Ladomery MR, 1999, J BIOL CHEM, V274, P36520, DOI 10.1074/jbc.274.51.36520; Laity JH, 2000, P NATL ACAD SCI USA, V97, P11932, DOI 10.1073/pnas.97.22.11932; LARSSON SH, 1995, CELL, V81, P391, DOI 10.1016/0092-8674(95)90392-5; Lee SB, 1999, CELL, V98, P663, DOI 10.1016/S0092-8674(00)80053-7; Menke AL, 1998, INT REV CYTOL, V181, P151, DOI 10.1016/S0074-7696(08)60418-0; Miles C, 1998, P NATL ACAD SCI USA, V95, P13068, DOI 10.1073/pnas.95.22.13068; Moore AW, 1999, DEVELOPMENT, V126, P1845; Nachtigal MW, 1998, CELL, V93, P445, DOI 10.1016/S0092-8674(00)81172-1; Nagamine CM, 1999, DEV BIOL, V216, P182, DOI 10.1006/dbio.1999.9436; Patek CE, 1999, P NATL ACAD SCI USA, V96, P2931, DOI 10.1073/pnas.96.6.2931; Putaala H, 2000, J AM SOC NEPHROL, V11, P991, DOI 10.1681/ASN.V116991; Shih NY, 1999, SCIENCE, V286, P312, DOI 10.1126/science.286.5438.312; Shimamura R, 1997, CLIN CANCER RES, V3, P2571; Swain A, 1996, NAT GENET, V12, P404, DOI 10.1038/ng0496-404; Swain A, 1998, NATURE, V391, P761, DOI 10.1038/35799; Toyooka Y, 1998, INT J DEV BIOL, V42, P1143; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; WILKINSON DG, 1992, IN SITU HYBRIDIZATIO, P75; WILLNOW TE, 1994, METHOD CELL BIOL, V43, P305	45	382	396	2	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2001	106	3					319	329		10.1016/S0092-8674(01)00453-6	http://dx.doi.org/10.1016/S0092-8674(01)00453-6			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RJ	11509181	Bronze			2022-12-28	WOS:000170433300010
J	Amidzic, O; Riehle, HJ; Fehr, T; Wienbruch, C; Elbert, T				Amidzic, O; Riehle, HJ; Fehr, T; Wienbruch, C; Elbert, T			Pattern of focal gamma-bursts in chess players - Grandmasters call on regions of the brain not used so much by less skilled amateurs.	NATURE			English	Article							MEMORY		Univ Konstanz, D-78457 Constance, Germany	University of Konstanz	Amidzic, O (corresponding author), Univ Konstanz, Univ Str 10,Fac D30, D-78457 Constance, Germany.		Fehr, Thorsten/P-5058-2018; Elbert, Thomas/C-8556-2009	Fehr, Thorsten/0000-0002-2224-1740; Elbert, Thomas/0000-0003-1332-4939				Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; Elo Arpad E, 1978, RATING CHESSPLAYERS; Gobet F, 1998, COGNITION, V66, P115, DOI 10.1016/S0010-0277(98)00020-1; Pulvermuller F, 1999, TRENDS COGN SCI, V3, P250, DOI 10.1016/S1364-6613(99)01344-3; Singer W, 1997, TRENDS COGN SCI, V1, P252, DOI 10.1016/S1364-6613(97)01079-6; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195	6	55	57	3	8	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2001	412	6847					603	603		10.1038/35088119	http://dx.doi.org/10.1038/35088119			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	460PP	11493907	Green Published, Bronze			2022-12-28	WOS:000170318000027
J	Wilensky, GR				Wilensky, GR			Medicare reform - Now is the time.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Project HOPE, Bethesda, MD 20814 USA		Wilensky, GR (corresponding author), Project HOPE, Bethesda, MD 20814 USA.							Aaron HJ, 1995, HEALTH AFFAIR, V14, P8, DOI 10.1377/hlthaff.14.4.8; *BOARD TRUST FED O, 2001, STAT SOC SEC MED PRO; Butler SM, 1995, HEALTH AFFAIR, V14, P47, DOI 10.1377/hlthaff.14.4.47; *C BUDG OFF, 2001, BUDG EC OUTL FISC YE; Enthoven Alain, 1973, HLTH PLAN ONLY PRACT; *MED PAYM ADV COMM, 2001, REP C MED PAYM POL M; Wilensky GR, 1999, HEALTH AFFAIR, V18, P92, DOI 10.1377/hlthaff.18.1.92	7	12	12	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 9	2001	345	6					458	462		10.1056/NEJM200108093450612	http://dx.doi.org/10.1056/NEJM200108093450612			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460EJ	11496860				2022-12-28	WOS:000170295000012
J	Hundert, EM				Hundert, EM			A Golden Rule: Remember the gift	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	6	6	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2001	286	6					648	650		10.1001/jama.286.6.648	http://dx.doi.org/10.1001/jama.286.6.648			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459VE	11495599				2022-12-28	WOS:000170271500001
J	Ridker, PM; Danesh, J; Youngman, L; Collins, R; Stampfer, MJ; Peto, R; Hennekens, CH				Ridker, PM; Danesh, J; Youngman, L; Collins, R; Stampfer, MJ; Peto, R; Hennekens, CH			A prospective study of Helicobacter pylori seropositivity and the risk for future myocardial infarction among socioeconomically similar US men	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; CHLAMYDIA-PNEUMONIAE; CARDIOVASCULAR RISK; INFECTION; INFLAMMATION; MORTALITY	Background: The role of Helicobacter pylori as a determinant of cardiovascular disease is controversial. Objective: To determine whether previous exposure to H. pylori is associated with an increased risk for myocardial infarction. Design: Prospective case-control study. Setting: Physicians' Health Study. Participants: Initially healthy U.S. men. Measurements: Titers of IgG antibody against H. pylori and several inflammatory markers were measured in baseline blood samples obtained from 445 men who subsequently had a myocardial infarction (case-patients) and 445 men matched for age and smoking status who remained free of vascular disease (controls) during a mean follow-up of 8.9 years. Results: Baseline seropositivity was similar among case-patients and controls (43.4% vs. 44.3%; rate ratio, 0.96 [95% Cl, 0.7 to 1.3]). Minimal evidence of association was found between magnitude of seropositivity and subsequent risk and between seropositivity and levels of the inflammatory biomarkers. Conclusion: in a socioeconomically homogeneous population, we found limited evidence of association between H. pylori exposure and risk for future myocardial infarction.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Cardiovasc Dis Prevent, Boston, MA 02215 USA; Leducq Ctr Mol & Genet Epidemiol Cardiovasc Dis, Ctr Cardiovasc Dis Prevent, Boston, MA USA; Univ Miami, Miami, FL 33152 USA; Radcliffe Infirm, Clin Trial Serv Unit, Oxford OX2 6HE, England	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Miami; Radcliffe Infirmary; University of Oxford	Ridker, PM (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Cardiovasc Dis Prevent, 900 Commonwealth Ave E, Boston, MA 02215 USA.	pridker@partners.org			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058755] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL58755] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aromaa A., 1996, Gut, V39, pA91; Danesh J, 1997, LANCET, V350, P430, DOI 10.1016/S0140-6736(97)03079-1; Danesh J, 1999, BRIT MED J, V319, P1157, DOI 10.1136/bmj.319.7218.1157; Folsom AR, 1998, CIRCULATION, V98, P845, DOI 10.1161/01.CIR.98.9.845; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; Ma J, 1999, J AM COLL CARDIOL, V33, P1347, DOI 10.1016/S0735-1097(99)00007-8; MURRAY LJ, 1995, BRIT HEART J, V74, P497; Ossewaarde JM, 1998, EPIDEMIOL INFECT, V120, P93, DOI 10.1017/S0950268897008303; PATEL P, 1995, BRIT MED J, V311, P711, DOI 10.1136/bmj.311.7007.711; Ridker PM, 1999, ANN INTERN MED, V131, P573, DOI 10.7326/0003-4819-131-8-199910190-00004; Ridker PM, 1998, CIRCULATION, V97, P1671, DOI 10.1161/01.CIR.97.17.1671; Ridker PM, 1998, LANCET, V351, P88, DOI 10.1016/S0140-6736(97)09032-6; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ridker PM, 1999, AM J MED, V106, P376; Strachan DP, 1998, CIRCULATION, V98, P1286, DOI 10.1161/01.CIR.98.13.1286; Strandberg TE, 1997, BRIT MED J, V314, P1317, DOI 10.1136/bmj.314.7090.1317; Wald NJ, 1997, BMJ-BRIT MED J, V315, P1199, DOI 10.1136/bmj.315.7117.1199; Whincup P, 2000, CIRCULATION, V101, P1647; Whincup PH, 1996, HEART, V75, P568, DOI 10.1136/hrt.75.6.568; Witherell H, 1999, GASTROENTEROLOGY, V116, pA355	20	60	62	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 7	2001	135	3					184	188		10.7326/0003-4819-135-3-200108070-00010	http://dx.doi.org/10.7326/0003-4819-135-3-200108070-00010			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460FX	11487485				2022-12-28	WOS:000170298500004
J	Black, N				Black, N			Evidence based policy: proceed with care	BRITISH MEDICAL JOURNAL			English	Review									Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Black, N (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England.							ANTMAN EM, 1992, JAMA-J AM MED ASSOC, V268, P240, DOI 10.1001/jama.268.2.240; BLACK NA, 1989, J MANAG MED, V4, P38; Buxton M, 1996, J Health Serv Res Policy, V1, P35; Davis P, 1996, SOC SCI MED, V43, P865, DOI 10.1016/0277-9536(96)00130-X; Detmer D, 2000, J Health Serv Res Policy, V5, P197; FERLIE E, 2000, J HLTH SERV RES POLI, V5, P92; Florin D, 1999, SOC SCI MED, V49, P1269, DOI 10.1016/S0277-9536(99)00165-3; FLORIN D, 1996, BRIT MED J, V313, P895; Giddens A., 1987, SOC SCI; Haines A, 1998, BMJ-BRIT MED J, V317, P72, DOI 10.1136/bmj.317.7150.72; HAM C, 1995, BRIT MED J, V310, P71, DOI 10.1136/bmj.310.6972.71; Harries U, 1999, J PUBLIC HEALTH MED, V21, P29, DOI 10.1093/pubmed/21.1.29; KLEIN R, 1990, J HEALTH POLIT POLIC, V15, P501, DOI 10.1215/03616878-15-3-501; Lasswell H. D., 1951, POLICY SCI; Lilford R, 1999, J Health Serv Res Policy, V4, P164; Lilford R, 1998, J Health Serv Res Policy, V3, P159; Lomas J, 2000, HEALTH AFFAIR, V19, P236, DOI 10.1377/hlthaff.19.3.236; LOMAS J, 2000, CAN J POLICY RES, V1, P140; OUGHTON J, 2000, PUBLIC MANAG POLICY, V9, P12; POPE C, 1999, THESIS U LONDON LOND; Raine R, 1998, J Health Serv Res Policy, V3, P251; RIST R, 1994, HDB QUALITATIVE RES, P546; Robinson R, 2000, HEALTH ECON, V9, P1, DOI 10.1002/(SICI)1099-1050(200001)9:1<1::AID-HEC496>3.0.CO;2-5; Rosen R, 2000, J Health Serv Res Policy, V5, P103; Savoie I, 2000, J Health Serv Res Policy, V5, P76; Vella K, 2000, BRIT MED J, V320, P976, DOI 10.1136/bmj.320.7240.976; Webb A.L., 1986, PLANNING NEED SCARCI; WEISS CH, 1977, POLICY ANAL, V3, P531	28	353	356	0	37	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 4	2001	323	7307					275	278		10.1136/bmj.323.7307.275	http://dx.doi.org/10.1136/bmj.323.7307.275			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	461ZT	11485961	Green Published, Green Accepted			2022-12-28	WOS:000170394300024
J	Coker, R				Coker, R			Detention and mandatory treatment for tuberculosis patients in Russia	LANCET			English	Editorial Material									Univ London London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Coker, R (corresponding author), Univ London London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, Keppel St, London WC1E 7HT, England.							Coker R. J., 2000, CHAOS COERCION DETEN; COKER RJ, 1994, IN PRESS THORAX; Espinal MA, 2001, NEW ENGL J MED, V344, P1294, DOI 10.1056/NEJM200104263441706; FARMER P, 1999, GLOBAL IMPACT DRUG R; Gasner MR, 1999, NEW ENGL J MED, V340, P359, DOI 10.1056/NEJM199902043400506; GOSTIN LO, 1993, JAMA-J AM MED ASSOC, V269, P255, DOI 10.1001/jama.269.2.255; KRAUT AM, 1994, SILENT TRAVELLERS GE; MACLEOD RM, 1967, PUBLIC LAW, V107, P189; RISSE GB, 1988, AIDS BURDENS HIST, P33; RISSE GB, 1988, AIDS BURDENS HIST; SHILOVA MV, 2000, TUBERCULOSIS RUSSIA; Stern V., 1999, SENTENCED DIE PROBLE; *U CAL FJ CURR NAT, 1996, P C OCT 24 26 1996; Wares DF, 1997, LANCET, V350, P957, DOI 10.1016/S0140-6736(05)63295-3	14	8	8	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 4	2001	358	9279					349	350		10.1016/S0140-6736(01)05587-8	http://dx.doi.org/10.1016/S0140-6736(01)05587-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459DE	11502311				2022-12-28	WOS:000170235100006
J	Evans, J; Heron, J; Francomb, H; Oke, S; Golding, O				Evans, J; Heron, J; Francomb, H; Oke, S; Golding, O		Avon Longitudinal Study Parents	Cohort study of depressed mood during pregnancy and after childbirth	BRITISH MEDICAL JOURNAL			English	Article							POSTNATAL DEPRESSION; PSYCHIATRIC-DISORDER; ASSOCIATION; PREVALENCE; WOMEN	Objective To follow mothers' mood through pregnancy and after childbirth and compare reported symptoms of depression at each stage. Design Longitudinal cohort study. Setting Avon. Participants Pregnant women resident within Avon with an expected date of delivery between 1 April 1991 and 31 December 1992. Main outcome measures Symptom scores from the Edinburgh postnatal depression scale at 18 and 32 weeks of pregnancy and 8 weeks and 8 months postpartum. Proportion of women above a threshold indicating probable depressive disorder. Results Depression scores were higher at 32 weeks of pregnancy than 8 weeks postpartum (difference in means 0.88, 95% confidence interval 0.79 to 0.97). There was no difference in the distribution of total scores or scores for individual items at the four time points. 1222 (13.5%) women scored above threshold for probable depression at 32 weeks of pregnancy, 821 (9.1%) at 8 weeks postpartum, and 147 (1.6%) throughout. More mothers moved above the threshold for depression between 18 weeks and 32 weeks of pregnancy than between 32 weeks of pregnancy and 8 weeks postpartum. Conclusions Symptoms of depression are not more common or severe after childbirth than during pregnancy. Research and clinical efforts need to be moved towards understanding, recognising, and treating antenatal depression.	Univ Bristol, Div Psychiat, Bristol BS2 8DZ, Avon, England; Univ Bristol, Unit Paediat & Perinatal Epidemiol, Div Child Hlth, Bristol BS8 1TQ, Avon, England; Southmead Gen Hosp, N Bristol NHS Trust, Dept Womens Hlth & Care Newborn, Bristol BS10 5NB, Avon, England; Barrow Hosp, Mother & Baby Unit, Bristol BS48 3SG, Avon, England	University of Bristol; University of Bristol; North Bristol NHS Trust; Southmead Hospital	Evans, J (corresponding author), Univ Bristol, Div Psychiat, Bristol BS2 8DZ, Avon, England.		Heron, Jon/D-5884-2011	Heron, Jon/0000-0001-6199-5644; Golding, Jean/0000-0003-2826-3307; Evans, Jonathan/0000-0003-3171-640X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		COOPER PJ, 1995, BRIT J PSYCHIAT, V166, P191, DOI 10.1192/bjp.166.2.191; COOPER PJ, 1988, BRIT J PSYCHIAT, V152, P799, DOI 10.1192/bjp.152.6.799; COX JL, 1982, BRIT J PSYCHIAT, V140, P111, DOI 10.1192/bjp.140.2.111; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Crown S, 1979, MANUAL CROWN CRISP E; Fergusson DM, 1996, PAEDIATR PERINAT EP, V10, P279, DOI 10.1111/j.1365-3016.1996.tb00051.x; GREEN JM, 1991, BRIT J PSYCHIAT, V158, P865, DOI 10.1192/bjp.158.6.865a; GREEN JM, 1990, J REPROD INFANT PSYC, V0008; HARRIS B, 1992, BMJ-BRIT MED J, V305, P152, DOI 10.1136/bmj.305.6846.152; HEDEGAARD M, 1993, BMJ-BRIT MED J, V307, P234, DOI 10.1136/bmj.307.6898.234; HOBFOLL SE, 1995, J CONSULT CLIN PSYCH, V63, P445, DOI 10.1037/0022-006X.63.3.445; KENDELL RE, 1976, PSYCHOL MED, V6, P297, DOI 10.1017/S0033291700013854; Murray D, 1990, J REPROD INFANT PSYC, V8, P99, DOI DOI 10.1080/02646839008403615; Murray L, 1999, J CHILD PSYCHOL PSYC, V40, P1259, DOI 10.1111/1469-7610.00542; Mynors-Wallis LM, 2000, BMJ-BRIT MED J, V320, P26, DOI 10.1136/bmj.320.7226.26; OHARA MW, 1984, J ABNORM PSYCHOL, V93, P158, DOI 10.1037/0021-843X.93.2.158; OHARA MW, 1990, J ABNORM PSYCHOL, V99, P3, DOI 10.1037/0021-843X.99.1.3; PAGEL MD, 1990, SOC SCI MED, V30, P597, DOI 10.1016/0277-9536(90)90158-O; PITT B, 1968, BRIT J PSYCHIAT, V114, P1325, DOI 10.1192/bjp.114.516.1325; Sinclair D, 1998, BRIT J PSYCHIAT, V172, P58, DOI 10.1192/bjp.172.1.58; Spinelli MG, 1997, AM J PSYCHIAT, V154, P1028; Teixeira JMA, 1999, BRIT MED J, V318, P153, DOI 10.1136/bmj.318.7177.153; Thorpe K., 1993, J REPROD INFANT PSYC, V11, P119, DOI [10.1080/02646839308403204, DOI 10.1080/02646839308403204]; WATSON JP, 1984, BRIT J PSYCHIAT, V144, P453, DOI 10.1192/bjp.144.5.453	24	870	889	1	71	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 4	2001	323	7307					257	260		10.1136/bmj.323.7307.257	http://dx.doi.org/10.1136/bmj.323.7307.257			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	461ZT	11485953	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000170394300017
J	Middeldorp, S; Meinardi, JR; Koopman, MMW; van Pampus, ECM; Hamulyak, K; van der Meer, J; Prins, MH; Buller, HR				Middeldorp, S; Meinardi, JR; Koopman, MMW; van Pampus, ECM; Hamulyak, K; van der Meer, J; Prins, MH; Buller, HR			A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism	ANNALS OF INTERNAL MEDICINE			English	Article							ACTIVATED PROTEIN-C; DEEP-VEIN THROMBOSIS; COAGULATION-FACTOR-V; RISK-FACTORS; RESISTANCE; THROMBOPHILIA; POPULATION	Background: The factor V Leiden mutation is a common genetic defect associated with an increased risk for venous thromboembolism. The clinical implications for asymptomatic carriers of this mutation and, consequently, the usefulness of screening families in which a proband has both the mutation and venous thrombo embolism are unclear. Objective: To determine the incidence of venous thromboembolism in asymptomatic carriers of the factor V Leiden mutation. Design: Prospective cohort study. Setting: University hospitals in the Netherlands. Participants: 470 asymptomatic carriers of the factor V Leiden mutation (234 men, 236 women; mean age, 43 years [range, 15 to 88 years]), 12 of whom were homozygous. Carriers were identified by screening the first-degree relatives (>15 years of age) of 247 symptomatic probands. Measurements: Objectively diagnosed episodes of venous thromboembolism and the relationship between incidence and exposure to high-risk situations. Results: Nine venous thromboembolic events were observed in 1564 observation-years, resulting in an annual incidence of 0.58% (95% CI, 0.26% to 1.10%). The incidence of spontaneous venous thromboembolism was 0.26% (CI, 0.07% to 0.65%) per year; 3.5% (CI, 0.1% to 17.8%) per episode of surgery, trauma, or immobilization; 0.0% (CI, 0.0% to 19.5%) per pregnancy; 1.8% (CI, 0.4% to 5.2%) per year of oral contraceptive use; and 2.9% (CI, 0.8% to 15.3%) per year of use of hormone replacement therapy. Conclusions: The absolute annual incidence of spontaneous venous thromboembolism in asymptomatic carriers of the factor V Leiden mutation is low and does not justify routine screening of the families of symptomatic patients.	Acad Med Ctr, Dept Vasc Med, NL-1100 DE Amsterdam, Netherlands; Univ Groningen Hosp, Groningen, Netherlands; Univ Hosp Maastricht, Maastricht, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen; Maastricht University; Maastricht University Medical Centre (MUMC)	Middeldorp, S (corresponding author), Acad Med Ctr, Dept Vasc Med, F4-277,Box 22700, NL-1100 DE Amsterdam, Netherlands.		Middeldorp, Saskia/ABI-8197-2020	Middeldorp, Saskia/0000-0002-1006-6420				BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Dahlback B, 1996, LANCET, V347, P1346, DOI 10.1016/S0140-6736(96)91004-1; Desmarais S, 1996, LANCET, V347, P1374, DOI 10.1016/S0140-6736(96)91013-2; Frezzato M, 1996, AM J EPIDEMIOL, V143, P1257; GREENGARD JS, 1994, LANCET, V343, P1361, DOI 10.1016/S0140-6736(94)92497-X; HEIJBOER H, 1990, NEW ENGL J MED, V323, P1512, DOI 10.1056/NEJM199011293232202; KOSTER T, 1993, LANCET, V342, P1503, DOI 10.1016/S0140-6736(05)80081-9; Middeldorp S, 1998, ANN INTERN MED, V128, P15, DOI 10.7326/0003-4819-128-1-199801010-00003; Middeldorp S, 1998, SEMIN THROMB HEMOST, V24, P363, DOI 10.1055/s-2007-996024; NORDSTROM M, 1992, J INTERN MED, V232, P155, DOI 10.1111/j.1365-2796.1992.tb00565.x; REES DC, 1995, LANCET, V346, P1133, DOI 10.1016/S0140-6736(95)91803-5; RIDKER PM, 1995, NEW ENGL J MED, V332, P912, DOI 10.1056/NEJM199504063321403; Ridker PM, 1997, ANN INTERN MED, V126, P528, DOI 10.7326/0003-4819-126-7-199704010-00005; Rodeghiero F, 1999, ANN INTERN MED, V130, P643, DOI 10.7326/0003-4819-130-8-199904200-00004; Simioni P, 1999, ANN INTERN MED, V130, P538, DOI 10.7326/0003-4819-130-6-199903160-00012; Simioni P, 1999, THROMB HAEMOSTASIS, V81, P198, DOI 10.1055/s-0037-1614442; SVENSSON PJ, 1994, NEW ENGL J MED, V330, P517, DOI 10.1056/NEJM199402243300801; Vandenbroucke JP, 1996, BRIT MED J, V313, P1127, DOI 10.1136/bmj.313.7065.1127; VANDERMEER FJM, 1993, ARCH INTERN MED, V153, P1557, DOI 10.1001/archinte.153.13.1557; VOORBERG J, 1994, LANCET, V343, P1535, DOI 10.1016/S0140-6736(94)92939-4	20	138	140	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 4	2001	135	5					322	327		10.7326/0003-4819-135-5-200109040-00008	http://dx.doi.org/10.7326/0003-4819-135-5-200109040-00008			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	468WF	11529695				2022-12-28	WOS:000170780600002
J	Merlo, J; Liedholm, H; Lindblad, U; Bjorck-Linne, A; Falt, J; Lindberg, G; Melander, A				Merlo, J; Liedholm, H; Lindblad, U; Bjorck-Linne, A; Falt, J; Lindberg, G; Melander, A			Prescriptions with potential drug interactions dispensed at Swedish pharmacies in January 1999: cross sectional study	BRITISH MEDICAL JOURNAL			English	Article									Lund Univ, Malmo Univ Hosp, Dept Community Med, S-20502 Malmo, Sweden; Malmo Univ Hosp, NEPI Fdn Med Res Ctr, Malmo, Sweden	Lund University; Skane University Hospital; Lund University; Skane University Hospital	Merlo, J (corresponding author), Lund Univ, Malmo Univ Hosp, Dept Community Med, S-20502 Malmo, Sweden.		Merlo, Juan/E-2136-2011	Merlo, Juan/0000-0001-8379-9708				Rasbash J, 1999, USERS GUIDE MLWIN; SJOQVIST E, 1999, SWEDISH DRUG COMPEND, P1383; SJOQVIST F, 2000, SWEDISH DRUG COMPEND, P1481; STOCKLEY IH, 1996, DRUG INTERACTIONS SO; 1996, INFORMATION LAKEMEDE, V7, P27	5	61	65	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 25	2001	323	7310					427	428		10.1136/bmj.323.7310.427	http://dx.doi.org/10.1136/bmj.323.7310.427			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469BX	11520839	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000170793600020
J	Blinkhorn, S				Blinkhorn, S			Yes, but what's it for?	NATURE			English	Article									Psychometr Res & Dev Ltd, St Albans AL1 3HT, England		Blinkhorn, S (corresponding author), Psychometr Res & Dev Ltd, Brewmaster House, St Albans AL1 3HT, England.								0	2	2	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2001	412	6849					771	771		10.1038/35090659	http://dx.doi.org/10.1038/35090659			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465ET	11518944				2022-12-28	WOS:000170577200018
J	Dixon, J				Dixon, J			Reforming health care, Saskatchewan style	LANCET			English	Editorial Material							CANADA		Kings Fund, Hlth Care Policy Programme, London W1G 0AN, England		Dixon, J (corresponding author), Kings Fund, Hlth Care Policy Programme, London W1G 0AN, England.							[Anonymous], 2001, CARING MEDICARE SUST; DIXON J, 2001, POLITICAL Q      JAN; Evans RG, 2000, J HEALTH POLIT POLIC, V25, P889, DOI 10.1215/03616878-25-5-889; Morone JA, 2000, J HEALTH POLIT POLIC, V25, P959, DOI 10.1215/03616878-25-5-959; Naylor CD, 1999, HEALTH AFFAIR, V18, P9, DOI 10.1377/hlthaff.18.3.9; Rice T, 2000, J HEALTH POLIT POLIC, V25, P863, DOI 10.1215/03616878-25-5-863; Smee C, 2000, J HEALTH POLIT POLIC, V25, P945, DOI 10.1215/03616878-25-5-945	7	0	0	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 18	2001	358	9281					526	526		10.1016/S0140-6736(01)05746-4	http://dx.doi.org/10.1016/S0140-6736(01)05746-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	464NB	11520520				2022-12-28	WOS:000170537700007
J	Navin, TR; Beard, CB; Huang, L; del Rio, C; Lee, S; Pieniazek, NJ; Carter, JL; Le, T; Hightower, A; Rimland, D				Navin, TR; Beard, CB; Huang, L; del Rio, C; Lee, S; Pieniazek, NJ; Carter, JL; Le, T; Hightower, A; Rimland, D			Effect of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of P carinii pneumonia in patients with HIV-1: a prospective study	LANCET			English	Article							SULFONE PROPHYLAXIS; TRIMETHOPRIM-SULFAMETHOXAZOLE; AIDS PATIENTS; RESISTANCE; SEQUENCE	Background Investigators have reported that patients infected with Pneumocystis carinii containing mutations in the DHPS (dihydropteroate synthase) gene have a worse outcome than those infected with P carinii containing wildtype DHPS. We investigated patients with HIV-1 infection and P carinii pneumonia to determine if DHPS mutations were associated with poor outcomes in these patients. Methods We compared presence of mutations at the DHPS locus with survival and response of patients to cotrimoxazole or other drugs. Findings For patients initially given co-trimoxazole, nine (14%) of 66 with DHPS mutant died, compared with nine (25%) of 36 with wild type (risk ratio=0.55 [95% CI=0.24-1.25]; p=0.15). Ten (15%) of 66 patients with a DHPS mutant did not respond to treatment, compared with 13 (36%) of 36 patients with the wild type (0.42 [0.20-0.86]; p=0.02). For patients aged 40 years or older, four (14%) of 29 with the mutant and nine (56%) of 16 with the wild type died (0.25 [0.09-0.67]; p=0.005). Interpretation These results, by contrast with those of previous studies, suggest that patients with wild-type P carinii do not have a better outcome than patients with the mutant when given co-trimoxazole. Our results suggest that presence of a DHPS mutation should be only one of several criteria guiding the choice of initial drug treatment of P carinii pneumonia in patients with HIV-1 infection.	Ctr Dis Control & Prevent, Div Parasit Dis, Natl Ctr Infect Dis, US PHS,US Dept HHS, Atlanta, GA USA; Ctr Dis Control & Prevent, Div TB Eliminat, Natl Ctr HIV STD & TB Prevent, US PHS,US Dept HHS, Atlanta, GA USA; Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, San Francisco, CA USA; Univ Calif San Francisco, San Francisco Gen Hosp, Ctr AIDS Res, San Francisco, CA USA; Emory Univ, Sch Med, Dept Med, Atlanta, GA USA; Emory Univ, Sch Med, Ctr AIDS Res, Atlanta, GA USA; Vet Affairs Med Ctr, Atlanta, GA 30033 USA; Res Ctr AIDS & HIV Infect, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; United States Public Health Service; Centers for Disease Control & Prevention - USA; United States Public Health Service; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Emory University; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System	Navin, TR (corresponding author), Mailstop E-10,1600 Clifton Rd, Atlanta, GA 30333 USA.		Huang, Laurence/AAZ-7120-2021; del Rio, Carlos/B-3763-2012	Huang, Laurence/0000-0003-3888-2195; del Rio, Carlos/0000-0002-0153-3517				Achari A, 1997, NAT STRUCT BIOL, V4, P490, DOI 10.1038/nsb0697-490; Beard CB, 2000, EMERG INFECT DIS, V6, P265, DOI 10.3201/eid0603.000306; BROOKS DR, 1994, EUR J BIOCHEM, V224, P397, DOI 10.1111/j.1432-1033.1994.00397.x; FERMER C, 1995, J BACTERIOL, V177, P4669, DOI 10.1128/jb.177.16.4669-4675.1995; Helweg-Larsen J, 1999, LANCET, V354, P1347, DOI 10.1016/S0140-6736(99)03320-6; Huang L, 2000, J INFECT DIS, V182, P1192, DOI 10.1086/315824; Jones J L, 1999, MMWR CDC Surveill Summ, V48, P1; Kazanjian P, 1998, AIDS, V12, P873, DOI 10.1097/00002030-199808000-00009; Kazanjian P, 2000, J INFECT DIS, V182, P551, DOI 10.1086/315719; Lane BR, 1997, J INFECT DIS, V175, P482, DOI 10.1093/infdis/175.2.482; LOPEZ P, 1987, J BACTERIOL, V169, P4320, DOI 10.1128/jb.169.9.4320-4326.1987; Ma L, 1999, J INFECT DIS, V180, P1969, DOI 10.1086/315148; Martin JN, 1999, J INFECT DIS, V180, P1809, DOI 10.1086/315132; Mei Q, 1998, LANCET, V351, P1631, DOI 10.1016/S0140-6736(05)77687-X; 1999, AIDS REPORTING UPDAT	15	92	94	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 18	2001	358	9281					545	549		10.1016/S0140-6736(01)05705-1	http://dx.doi.org/10.1016/S0140-6736(01)05705-1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464NB	11520525	Green Submitted			2022-12-28	WOS:000170537700012
J	Abraham, RG; van den Bergh, S				Abraham, RG; van den Bergh, S			Astrophysics - The morphological evolution of galaxies	SCIENCE			English	Review							HUBBLE-DEEP-FIELDS; LDSS REDSHIFT SURVEYS; PRELIMINARY CLASSIFICATION; QUANTITATIVE MORPHOLOGY; PHYSICAL MORPHOLOGY; STELLAR POPULATION; PECULIAR GALAXIES; DISTANT GALAXIES; PARAMETERS; NORTH	Many galaxies have taken on their familiar appearance relatively recently. in the distant Universe, galaxy morphology deviates significantly (and systematically) from that of nearby galaxies at redshifts (z) as low as 0.3. This corresponds to a time similar to3.5 x 10(9) years in the past, which is only similar to 25% of the present age of the Universe. Beyond z = 0.5 (5 x 10(9) years in the past), spiral arms are less well developed and more chaotic, and barred spiral galaxies may become rarer. At z = 1, around 30% of the galaxy population is sufficiently peculiar that classification on Hubble's traditional "tuning fork" system is meaningless. On the other hand, some characteristics of galaxies have not changed much over time. The space density of luminous disk galaxies has not changed significantly since z = 1, indicating that although the general appearance of these galaxies has continuously changed over time, their overall numbers have been conserved.	Univ Toronto, Dept Astron & Astrophys, Toronto, ON M5S 3H8, Canada; Natl Res Council Canada, Herzberg Inst Astrophys, Dominion Astrophys Observ, Victoria, BC V9E 2E7, Canada	University of Toronto; National Research Council Canada	Abraham, RG (corresponding author), Univ Toronto, Dept Astron & Astrophys, 60 St George St, Toronto, ON M5S 3H8, Canada.	abraham@astro.utoronto.ca						Abraham R. G., 1999, IAU S, V186, P11; Abraham RG, 1996, ASTROPHYS J SUPPL S, V107, P1, DOI 10.1086/192352; Abraham RG, 1999, MON NOT R ASTRON SOC, V308, P569, DOI 10.1046/j.1365-8711.1999.02766.x; ABRAHAM RG, 1994, ASTROPHYS J, V432, P75, DOI 10.1086/174550; Abraham RG, 1999, ASTROPHYS SPACE SCI, V269, P323, DOI 10.1023/A:1017040812024; ABRAHAM RG, 1996, MNRAS, V279, P47; Balbi A, 2000, ASTROPHYS J, V545, pL1, DOI 10.1086/317323; BARNES JE, 1990, NATURE, V344, P379, DOI 10.1038/344379a0; Bershady MA, 2000, ASTRON J, V119, P2645, DOI 10.1086/301386; Block DL, 2001, ASTRON ASTROPHYS, V371, P393, DOI 10.1051/0004-6361:20010081; Bouwens R, 1998, ASTROPHYS J, V506, P579, DOI 10.1086/306289; Brinchmann J, 1998, ASTROPHYS J, V499, P112, DOI 10.1086/305621; Conselice CJ, 2000, ASTROPHYS J, V529, P886, DOI 10.1086/308300; Conselice CJ, 1999, ASTROPHYS SPACE SCI, V269, P585, DOI 10.1023/A:1017047802880; COWIE LL, 1995, NATURE, V377, P603, DOI 10.1038/377603a0; Cowie LL, 1996, ASTRON J, V112, P839, DOI 10.1086/118058; COWIE LL, 1995, ASTRON J, V110, P1576, DOI 10.1086/117631; de Bernardis P, 2000, NATURE, V404, P955, DOI 10.1038/35010035; DICKINSON M, 1998, DARK AGES GALAXIES W; DOI M, 1993, MON NOT R ASTRON SOC, V264, P832, DOI 10.1093/mnras/264.4.832; DRESSLER A, 1980, ASTROPHYS J, V236, P351, DOI 10.1086/157753; Driver S. P., 1998, APJ, V496, P93; DRIVER SP, 1995, ASTROPHYS J, V453, P48, DOI 10.1086/176369; Fuchs B, 1998, MON NOT R ASTRON SOC, V294, P513, DOI 10.1046/j.1365-8711.1998.01024.x; FUCHS B, IN PRESS; Giavalisco M, 1997, AIP CONF PROC, V408, P221, DOI 10.1063/1.53795; GLAZEBROOK K, 1995, MON NOT R ASTRON SOC, V275, pL19, DOI 10.1093/mnras/275.1.L19; Hibbard JE, 2000, ASTRON J, V119, P1130, DOI 10.1086/301263; Hibbard JE, 1997, ASTRON J, V114, P1741, DOI 10.1086/118603; Hogg DW, 1998, ASTRON J, V115, P1418, DOI 10.1086/300277; Hubble E, 1926, ASTROPHYS J, V64, P321, DOI 10.1086/143018; Le Fevre O, 2000, MON NOT R ASTRON SOC, V311, P565, DOI 10.1046/j.1365-8711.2000.03083.x; Lilly S, 1998, ASTROPHYS J, V500, P75, DOI 10.1086/305713; Marcum PM, 2001, ASTROPHYS J SUPPL S, V132, P129, DOI 10.1086/318953; Marleau FR, 1998, ASTROPHYS J, V507, P585, DOI 10.1086/306356; Menanteau F, 2001, MON NOT R ASTRON SOC, V322, P1, DOI 10.1046/j.1365-8711.2001.04028.x; MORGAN WW, 1959, PUBL ASTRON SOC PAC, V71, P394, DOI 10.1086/127415; MORGAN WW, 1958, PUBL ASTRON SOC PAC, V70, P364, DOI 10.1086/127243; NAIM A, 1995, MON NOT R ASTRON SOC, V274, P1107; Naim A, 1997, ASTROPHYS J, V476, P510, DOI 10.1086/303661; Naim A, 1997, ASTROPHYS J SUPPL S, V111, P357, DOI 10.1086/313022; NETTERFIELD CB, UNPUB; ODEWAHN SC, 1996, APJ, V472, P13; PASCARELLE SM, 1996, APJ, V456, P21; PEACOCK JA, 1999, COSMOLOGICAL PHYSICS; PETTINI M, IN PRESS; Steidel CC, 1999, ASTROPHYS J, V519, P1, DOI 10.1086/307363; Taniguchi Y, 2001, ASTROPHYS J, V547, P146, DOI 10.1086/318369; TOOMRE A, 1972, ASTROPHYS J, V178, P623, DOI 10.1086/151823; van den Bergh S, 2000, ASTRON J, V120, P2190, DOI 10.1086/316828; vandenBergh S, 1996, ASTRON J, V112, P359, DOI 10.1086/118020; Windhorst R, 1999, ASTROPHYS SPACE SCI, V269, P243, DOI 10.1023/A:1017059922502; [No title captured]	55	53	53	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2001	293	5533					1273	1278		10.1126/science.1060855	http://dx.doi.org/10.1126/science.1060855			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11509719				2022-12-28	WOS:000170492600028
J	Bertrand, CA				Bertrand, CA			Color by number: Imaging large data	SCIENCE			English	Article									Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bertrand, CA (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA.							Lawler A, 2001, SCIENCE, V292, P1044, DOI 10.1126/science.292.5519.1044; Paddock S, 2001, BIOTECHNIQUES, V30, P283, DOI 10.2144/01302bt01; RUSS C, 1999, IMAGE PROCESSING HDB; Smallcombe A, 2001, BIOTECHNIQUES, V30, P1240, DOI 10.2144/01306bt01	4	4	4	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2001	293	5533					1335	1336		10.1126/science.293.5533.1335	http://dx.doi.org/10.1126/science.293.5533.1335			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11509735				2022-12-28	WOS:000170492600045
J	Hauf, S; Waizenegger, IC; Peters, JM				Hauf, S; Waizenegger, IC; Peters, JM			Cohesin cleavage by separase required for anaphase and cytokinesis in human cells	SCIENCE			English	Article							SISTER-CHROMATID SEPARATION; FISSION YEAST; DEGRADATION; PROTEOLYSIS; CHROMOSOME; INHIBITOR; IDENTIFICATION; COMPLEXES; PROPHASE; MITOSIS	Cell division depends on the separation of sister chromatids in anaphase. In yeast, sister separation is initiated by cleavage of cohesin by the protease separase. In vertebrates, most cohesin is removed from chromosome arms by a cleavage-independent mechanism. Only residual amounts of cohesin are cleaved at the onset of anaphase, coinciding with its disappearance from centromeres. We have identified two separase cleavage sites in the human cohesin subunit SCC1 and have conditionally expressed noncleavable SCC1 mutants in human cells. our results indicate that cohesin cleavage by separase is essential for sister chromatid separation and for the completion of cytokinesis.	Res Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Peters, JM (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.		Hauf, Silke/H-7321-2012	Hauf, Silke/0000-0001-5938-721X				Alexandru G, 2001, CELL, V105, P459, DOI 10.1016/S0092-8674(01)00362-2; Buonomo SBC, 2000, CELL, V103, P387, DOI 10.1016/S0092-8674(00)00131-8; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Funabiki H, 1996, NATURE, V381, P438, DOI 10.1038/381438a0; HAUF S, UNPUB; Jallepalli PV, 2001, CELL, V105, P445, DOI 10.1016/S0092-8674(01)00340-3; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Leismann O, 2000, GENE DEV, V14, P2192, DOI 10.1101/gad.176700; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; McClintock B., 1941, COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, V9, P72; Nasmyth K, 2000, SCIENCE, V288, P1379, DOI 10.1126/science.288.5470.1379; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Stratmann R, 1996, CELL, V84, P25, DOI 10.1016/S0092-8674(00)80990-3; Tomonaga T, 2000, GENE DEV, V14, P2757, DOI 10.1101/gad.832000; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Vorlaufer E, 1998, MOL BIOL CELL, V9, P1817, DOI 10.1091/mbc.9.7.1817; Yanagida M, 1998, TRENDS CELL BIOL, V8, P144, DOI 10.1016/S0962-8924(98)01236-7; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418; Zur A, 2001, EMBO J, V20, P792, DOI 10.1093/emboj/20.4.792	22	372	383	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2001	293	5533					1320	1323		10.1126/science.1061376	http://dx.doi.org/10.1126/science.1061376			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11509732				2022-12-28	WOS:000170492600041
J	Rawlins, D; Pickering, K				Rawlins, D; Pickering, K			Ancient chronology - Astronomical orientation of the pyramids	NATURE			English	Article									Int Journal Sci Hist, DIO, Baltimore, MD 21211 USA; Analyst Int Corp, Minneapolis, MN 55435 USA		Rawlins, D (corresponding author), Int Journal Sci Hist, DIO, Box 19935, Baltimore, MD 21211 USA.	keithp@minn.net						DREYER JL, 1913, TYCHONIS BRAHE DANI, V11, P382; DREYER JLE, 1913, TYCHONIS BRAHE DANI, V12, P170; HAACK S, 1984, J HIST ASTRON ARCH S, V7, P119; Rawlins D., 1993, DIO, Viii, P3; RAWLINS D, 1981, ISIS, V73, P259; Rawlins Dennis, 1985, VISTAS ASTRON, V28, P255; Spence K, 2000, NATURE, V408, P320, DOI 10.1038/35042510; VONBECKERATH I, 1997, CHRONOLOGIE PHARONIS, P188	8	10	10	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2001	412	6848					699	699		10.1038/35089138	http://dx.doi.org/10.1038/35089138			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462ZB	11507629	Bronze			2022-12-28	WOS:000170450200033
J	Schatz, T; Schramm, U; Habs, D				Schatz, T; Schramm, U; Habs, D			Crystalline ion beams	NATURE			English	Article							LINEAR PAUL TRAP; STORAGE-RING; TEMPERATURE	By freezing out the motion between particles in a high-energy storage ring, it should be possible(1-4) to create threads of ions, offering research opportunities beyond the realm of standard accelerator physics. The usual heating due to intra-beam collisions should completely vanish, giving rise to a state of unprecedented brilliance. Despite a continuous improvement of beam cooling techniques, such as electron cooling and laser cooling, the ultimate goal(5) of beam crystallization has not yet been reached in high-energy storage rings. Electron-cooled dilute beams of highly charged ions show liquid-like order(6,7) with unique applications(8). An experiment(5) using laser cooling(9,10) suggested a reduction of intra-beam heating, although the results were ambiguous. Here we demonstrate the crystallization of laser-cooled Mg+ beams circulating in the radiofrequency quadrupole storage ring PALLAS(11,12) at a velocity of 2,800 m s(-1), which corresponds to a beam energy of 1 eV. A sudden collapse of the transverse beam size and the low longitudinal velocity spread clearly indicate the phase transition. The continuous ring-shaped crystalline beam shows exceptional stability, surviving for more than 3,000 revolutions without cooling.	LMU Munchen, Sekt Phys, D-85748 Garching, Germany	University of Munich	Schramm, U (corresponding author), LMU Munchen, Sekt Phys, D-85748 Garching, Germany.	ulrich.schramm@physik.uni-muenchen.de	Schramm, Ulrich/C-9393-2012	Schramm, Ulrich/0000-0003-0390-7671				BIRKL G, 1992, NATURE, V357, P310, DOI 10.1038/357310a0; BLUMEL R, 1988, NATURE, V334, P309, DOI 10.1038/334309a0; BRYANT PJ, 1993, CIRCULAR ACCELERATOR; Drewsen M, 1998, PHYS REV LETT, V81, P2878, DOI 10.1103/PhysRevLett.81.2878; DUBIN DHE, 1990, PHYS REV A, V42, P4972, DOI 10.1103/PhysRevA.42.4972; Eisenbarth U, 2000, HYPERFINE INTERACT, V127, P223, DOI 10.1023/A:1012699719074; HABS D, 1995, ANNU REV NUCL PART S, V45, P391, DOI 10.1146/annurev.ns.45.120195.002135; HASSE RW, 1990, ANN PHYS-NEW YORK, V203, P419, DOI 10.1016/0003-4916(90)90177-P; Hasse RW, 1999, PHYS REV LETT, V83, P3430, DOI 10.1103/PhysRevLett.83.3430; Lauer I, 1998, PHYS REV LETT, V81, P2052, DOI 10.1103/PhysRevLett.81.2052; Madsen N, 1999, PHYS REV LETT, V83, P4301, DOI 10.1103/PhysRevLett.83.4301; PARKHOMCHUK V, 1996, CRYSTALLINE BEAMS RE, P409; PESTRIKOV DV, 1996, CRYSTALLINE BEAMS RE, P275; Radon T, 2000, NUCL PHYS A, V677, P75, DOI 10.1016/S0375-9474(00)00304-3; RAHMAN A, 1986, PHYS REV LETT, V57, P1133, DOI 10.1103/PhysRevLett.57.1133; RAIZEN MG, 1992, PHYS REV A, V45, P6493, DOI 10.1103/PhysRevA.45.6493; Schatz T, 1999, AIP CONF PROC, V457, P269, DOI 10.1063/1.57465; SCHIFFER JP, 1985, Z PHYS A-HADRON NUCL, V321, P181, DOI 10.1007/BF01411964; Schiffer JP, 2000, P NATL ACAD SCI USA, V97, P10697, DOI 10.1073/pnas.190320397; SCHIFFER JP, 1996, CRYSTALLINE BEAMS RE, P217; SCHRAMM U, IN PRESS AIP C P, V576; SEURER M, 1996, CRYSTALLINE BEAMS RE, P311; SPREITER Q, 1995, NUCL INSTRUM METH A, V364, P239, DOI 10.1016/0168-9002(95)00493-9; Steck M, 1996, PHYS REV LETT, V77, P3803, DOI 10.1103/PhysRevLett.77.3803; Wei J, 1998, PHYS REV LETT, V80, P2606, DOI 10.1103/PhysRevLett.80.2606	25	108	109	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 16	2001	412	6848					717	720		10.1038/35089045	http://dx.doi.org/10.1038/35089045			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462ZB	11507635				2022-12-28	WOS:000170450200039
J	Wheeler, DA; Arathoon, EG; Pitts, M; Cedillos, RA; Bu, TE; Porras, GD; Herrera, G; Sosa, NR				Wheeler, DA; Arathoon, EG; Pitts, M; Cedillos, RA; Bu, TE; Porras, GD; Herrera, G; Sosa, NR			Availability of HIV care in Central America	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TYPE-1	Central America is an area with a growing human immunodeficiency virus (HIV) epidemic, but with marked limitations in its health care infrastructure. Estimated adult HIV infection rates range from 0.20% in Nicaragua to 2.01% in Belize. Hospitals and clinicians with experience in HIV care exist mainly, if not only, in capital cities and principal economic centers. Nationally sponsored social security systems in each country consistently offer a wider range of services than do ministry of health systems. Estimated access to the social security system ranges from 0% in Belize and 10% of the population in Honduras to 95% in Costa Rica. Combination antiretroviral therapy is not available through the ministries of health and zidovudine is only sporadically available for prevention of perinatal transmission. Combination therapy is available through the social security system in the countries of Guatemala, Panama, and Costa Rica only. A wide variety of antiretroviral agents are available through private pharmacies in all countries except Belize. With the exception of Costa Ricans, most people with HIV infection in Central America have limited access to HIV-specific health services and limited or no access to antiretroviral agents.	Infect Dis Physicians, Annandale, VA 22003 USA; Hosp San Juan Dios, Guatemala City, Guatemala; Natl AIDS Program, Belize City, Belize; Hosp Rosales, San Salvador, El Salvador; Hosp Escuela Tegucigalpa, Tegucigalpa, Honduras; Hosp Bautista, Managua, Nicaragua; Hosp Calderon Guardia, San Jose, Costa Rica; Complejo Hosp Metropolitano Arnulfo Arias Madrid, Panama City, Panama		Wheeler, DA (corresponding author), Infect Dis Physicians, 3289 Woodburn Rd,Suite 200, Annandale, VA 22003 USA.		Arathoon, Eduardo G./J-8751-2019	Arathoon, Eduardo G./0000-0002-6225-7413				AGUAIS J, 2000, 13 INT AIDS C JUL 13; Candal DH, 1997, AIDS RES HUM RETROV, V13, P1349, DOI 10.1089/aid.1997.13.1349; GONZALEZDIAZ E, 1999, INF DIS SOC AM ANN M; HASELTINE WA, 1998, ESTABLISHING PRIORIT; HERRERA G, 1999, 1 CENTR AM C SEX TRA; *J HOPK U AIDS SER, 1998, HOPK HIV REP S; *JOINT UN PROGR HI, 2000, REP GLOB HIV AIDS EP; Lara C, 1997, J CLIN MICROBIOL, V35, P783, DOI 10.1128/JCM.35.3.783-784.1997; *PAN AM HLTH ORG, 2000, AIDS SURV AM BIANN R; *PAN AM HLTH ORG W, 2000, BUILD BLOCKS GUID PR; QUATTRINI E, 2000, 13 INT AIDS C JUL 11; Schwartlander B, 1999, AIDS, V13, P2445, DOI 10.1097/00002030-199912030-00017; *U NAC AUT HOND, 1999, AN AC SIT NAC, P56; WEBER AE, 2000, 13 INT AIDS C JUL 10	14	12	13	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2001	286	7					853	860		10.1001/jama.286.7.853	http://dx.doi.org/10.1001/jama.286.7.853			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	462PU	11497545				2022-12-28	WOS:000170429600035
J	Tamm, I; Dorken, B; Hartmann, G				Tamm, I; Dorken, B; Hartmann, G			Antisense therapy in oncology: new hope for an old idea?	LANCET			English	Review							ANTI-APOPTOSIS GENE; RNA INHIBITS PROLIFERATION; PHASE-I; MESSENGER-RNA; CPG DNA; C-RAF; OLIGONUCLEOTIDE THERAPEUTICS; OLIGOMER COMPLEMENTARY; MALIGNANT-MELANOMA; PROTEIN EXPRESSION	There is a potential role for antisense oligonucleotides in the treatment of disease. The principle of antisense technology Is the sequence-specific binding of an antisense oligonucleotide to target mRNA, resulting in the prevention of gene translation. The specificity of hybridisation makes antisense treatment an attractive strategy to selectively modulate the expression of genes involved in the pathogenesis of diseases. One antisense drug has been approved for local treatment of cytomegalovirus-induced retinitis, and several antisense oligonucleotides are in clinical trials, including oligonucleotides that target the mRNA of BCL2, protein-kinase-C alpha, and RAF kinase. Antisense oligonucleotides are well tolerated and might have therapeutic activity. Here, we summarise treatment ideas in this field, summarise clinical trials that are being done, discuss the potential contribution of CpG motif-mediated effects, and look at promising molecular targets to treat human cancer with antisense oligonucleotides.	Humboldt Univ, Virchow Clin, Charite, Dept Haematol & Oncol, D-13353 Berlin, Germany; Univ Munich, Dept Internal Med, Div Clin Pharmacol, Munich, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munich	Tamm, I (corresponding author), Humboldt Univ, Virchow Clin, Charite, Dept Haematol & Oncol, Forsch Haus,Room 2-0315, D-13353 Berlin, Germany.	ingo.tamm@charite.de	Hartmann, Gunther/P-7492-2017	Hartmann, Gunther/0000-0003-1021-2018				Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Adida C, 1998, LANCET, V351, P882, DOI 10.1016/S0140-6736(05)70294-4; Agarwal N, 1999, BBA-GENE STRUCT EXPR, V1489, P85, DOI 10.1016/S0167-4781(99)00142-6; ALAVI JB, 2000, P AN M AM SOC CLIN, V19, pA167; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; ANFOSSI G, 1989, P NATL ACAD SCI USA, V86, P3379, DOI 10.1073/pnas.86.9.3379; Baens M, 1999, BLOOD, V94, p384A; Baker BF, 1999, BBA-GENE STRUCT EXPR, V1489, P3, DOI 10.1016/S0167-4781(99)00146-3; BOLLAG G, 1991, ANNU REV CELL BIOL, V7, P601, DOI 10.1146/annurev.cellbio.7.1.601; BOS JL, 1989, CANCER RES, V49, P4682; BRYSCH W, 1996, ANTISENSE THERAPEUTI, P159; Buolamwini JK, 1999, CURR OPIN CHEM BIOL, V3, P500, DOI 10.1016/S1367-5931(99)80073-8; CERRONI L, 1995, AM J DERMATOPATH, V17, P7, DOI 10.1097/00000372-199502000-00002; Chen G, 1996, J BIOL CHEM, V271, P28259, DOI 10.1074/jbc.271.45.28259; CHEN HX, 2000, P AN M AM SOC CLIN, V19, pA178; CHI KN, 2000, P AN M AM SOC CLIN, V19, pA330; Cioffi CL, 2000, METHOD ENZYMOL, V314, P363; Cioffi CL, 1997, MOL PHARMACOL, V51, P383; Clark RE, 2000, LEUKEMIA, V14, P347, DOI 10.1038/sj.leu.2401677; Cotter Finbarr E., 1999, Seminars in Hematology, V36, P9; Crooke ST, 1999, BBA-GENE STRUCT EXPR, V1489, P31, DOI 10.1016/S0167-4781(99)00148-7; Cunningham CC, 2000, CLIN CANCER RES, V6, P1626; de Smet MD, 1999, OCUL IMMUNOL INFLAMM, V7, P189, DOI 10.1076/ocii.7.3.189.4007; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Dierlamm J, 1999, BLOOD, V93, P3601, DOI 10.1182/blood.V93.11.3601; Eckhardt SG, 1999, J CLIN ONCOL, V17, P1095, DOI 10.1200/JCO.1999.17.4.1095; Gewirtz AM, 1998, BLOOD, V92, P712, DOI 10.1182/blood.V92.3.712.415a32_712_736; Gewirtz AM, 2000, J CLIN ONCOL, V18, P1809, DOI 10.1200/JCO.2000.18.9.1809; HARRIS NL, 1994, BLOOD, V84, P1361; Hartmann G, 1999, P NATL ACAD SCI USA, V96, P9305, DOI 10.1073/pnas.96.16.9305; Hartmann G, 2000, J IMMUNOL, V164, P944, DOI 10.4049/jimmunol.164.2.944; Hartmann G, 1996, MOL MED, V2, P429, DOI 10.1007/BF03401902; Hartmann G, 2000, J IMMUNOL, V164, P1617, DOI 10.4049/jimmunol.164.3.1617; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; HOLT JT, 1988, MOL CELL BIOL, V8, P963, DOI 10.1128/MCB.8.2.963; Islam A, 2000, ONCOGENE, V19, P617, DOI 10.1038/sj.onc.1203358; Jaattela M, 1999, EXP CELL RES, V248, P30, DOI 10.1006/excr.1999.4455; Jahrsdorfer B, 2001, J LEUKOCYTE BIOL, V69, P81; Jansen B, 2000, LANCET, V356, P1728, DOI 10.1016/S0140-6736(00)03207-4; Jansen B, 1998, NAT MED, V4, P232, DOI 10.1038/nm0298-232; Kasof GM, 2001, J BIOL CHEM, V276, P3238, DOI 10.1074/jbc.M003670200; Kawasaki H, 1998, CANCER RES, V58, P5071; Khuri FR, 2000, CLIN CANCER RES, V6, P1607; Klasa RJ, 2000, CLIN CANCER RES, V6, P2492; Koller E, 2000, TRENDS PHARMACOL SCI, V21, P142, DOI 10.1016/S0165-6147(00)01448-6; Kondo Y, 2000, ONCOGENE, V19, P2205, DOI 10.1038/sj.onc.1203538; Krieg AM, 2000, IMMUNOL TODAY, V21, P521, DOI 10.1016/S0167-5699(00)01719-9; Krieg AM, 2000, CURR TOP MICROBIOL, V247, P1; LANDRY J, 1989, J CELL BIOL, V109, P7, DOI 10.1083/jcb.109.1.7; Langdon SP, 1995, CLIN CANCER RES, V1, P1603; Levin AA, 1999, BBA-GENE STRUCT EXPR, V1489, P69, DOI 10.1016/S0167-4781(99)00140-2; Li FZ, 1999, NAT CELL BIOL, V1, P461, DOI 10.1038/70242; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; LI GC, 1991, P NATL ACAD SCI USA, V88, P1681, DOI 10.1073/pnas.88.5.1681; Lu CD, 1998, CANCER RES, V58, P1808; Mahon FX, 1995, EXP HEMATOL, V23, P1606; Monzo M, 1999, J CLIN ONCOL, V17, P2100, DOI 10.1200/JCO.1999.17.7.2100; Nemunaitis J, 1999, J CLIN ONCOL, V17, P3586, DOI 10.1200/JCO.1999.17.11.3586; O'Dwyer PJ, 1999, CLIN CANCER RES, V5, P3977; Olie RA, 2000, CANCER RES, V60, P2805; Oza AM, 2000, CLIN CANCER RES, V6, p4572S; PATERSON BM, 1977, P NATL ACAD SCI USA, V74, P4370, DOI 10.1073/pnas.74.10.4370; Reed JC, 1999, NAT CELL BIOL, V1, pE199, DOI 10.1038/70227; Reed John C., 1995, Current Opinion in Oncology, V7, P541, DOI 10.1097/00001622-199511000-00012; Rowley JD, 1999, SEMIN HEMATOL, V36, P59; SALEH M, 2000, P AN M AM SOC CLIN, V19, pA320; Sarela AI, 2000, GUT, V46, P645, DOI 10.1136/gut.46.5.645; Sharma HW, 1996, ANTICANCER RES, V16, P589; Sharma HW, 1996, ANTISENSE NUCLEIC A, V6, P3, DOI 10.1089/oli.1.1996.6.3; Simoes-Wust AP, 2000, INT J CANCER, V87, P582, DOI 10.1002/1097-0215(20000815)87:4<582::AID-IJC19>3.0.CO;2-P; SIMONS RW, 1983, CELL, V34, P683, DOI 10.1016/0092-8674(83)90401-4; SIU LL, 2000, P AN M AM SOC CLIN, V19, pA250; Smetsers TFCM, 1996, ANTISENSE NUCLEIC A, V6, P63, DOI 10.1089/oli.1.1996.6.63; STEPHENSON ML, 1978, P NATL ACAD SCI USA, V75, P285, DOI 10.1073/pnas.75.1.285; Stevenson JP, 1999, J CLIN ONCOL, V17, P2227, DOI 10.1200/JCO.1999.17.7.2227; Summerton J, 1999, BBA-GENE STRUCT EXPR, V1489, P141, DOI 10.1016/S0167-4781(99)00150-5; Suzuki A, 2000, ONCOGENE, V19, P3225, DOI 10.1038/sj.onc.1203665; Swana HS, 1999, NEW ENGL J MED, V341, P452, DOI 10.1056/NEJM199908053410614; Takahashi R, 1998, J BIOL CHEM, V273, P7787, DOI 10.1074/jbc.273.14.7787; Tamm I, 2000, CLIN CANCER RES, V6, P1796; Tamm I, 2000, BLOOD, V96, p462A; Tamm I, 1998, CANCER RES, V58, P5315; Tanaka K, 2000, CLIN CANCER RES, V6, P127; Tolcher AW, 2000, CLIN CANCER RES, V6, p4571S; Uozaki H, 1997, CANCER-AM CANCER SOC, V79, P2336, DOI 10.1002/(SICI)1097-0142(19970615)79:12<2336::AID-CNCR7>3.0.CO;2-J; Wang H, 1999, P NATL ACAD SCI USA, V96, P13989, DOI 10.1073/pnas.96.24.13989; Wang H, 1999, INT J ONCOL, V15, P653; Waters JS, 2000, J CLIN ONCOL, V18, P1812, DOI 10.1200/JCO.2000.18.9.1812; Weiner GJ, 2000, CURR TOP MICROBIOL, V247, P157; Whitesell L, 1991, Antisense Res Dev, V1, P343; WICKSTROM E, 1996, ANTISENSE THERAPY, P87; WICKSTROM EL, 1988, P NATL ACAD SCI USA, V85, P1028, DOI 10.1073/pnas.85.4.1028; Yuen A, 2000, CLIN CANCER RES, V6, p4572S; YUEN A, 2000, P AN M AM SOC CLIN, V19, pA459; Yuen AR, 1999, CLIN CANCER RES, V5, P3357; ZAMECNIK PC, 1978, P NATL ACAD SCI USA, V75, P280, DOI 10.1073/pnas.75.1.280; ZAMECNIK PC, 1999, ANTISENSE THERAPY, P5	98	211	285	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 11	2001	358	9280					489	497		10.1016/S0140-6736(01)05629-X	http://dx.doi.org/10.1016/S0140-6736(01)05629-X			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463TB	11513935				2022-12-28	WOS:000170492400035
J	Ferguson-Smith, AC; Surani, MA				Ferguson-Smith, AC; Surani, MA			Imprinting and the epigenetic asymmetry between parental genomes	SCIENCE			English	Editorial Material							DNA METHYLATION; ANTISENSE RNA; IGF2R GENE; CPG ISLAND; HISTONE H3; GERM-LINE; LYSINE 9; EXPRESSION; CTCF; UPSTREAM	Genomic imprinting confers a developmental asymmetry on the parental genomes, through epigenetic modifications in the germ line and embryo. These heritable modifications regulate the monoallelic activity of parental alleles resulting in their functional differences during development. Specific cis-acting regulatory elements associated with imprinted genes carry modifications involving chromatin structural changes and DNA methylation. Some of these modifications are initiated in the germ tine. Comparative genomic analysis at imprinted domains is emerging as a powerful toot for the identification of conserved elements amenable to more detailed functional analysis, and for providing insight into the emergence of imprinting during the evolution of mammalian species. Genomic imprinting therefore provides a model system for the analysis of the epigenetic control of genome function.	Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England; Univ Cambridge, Wellcome CRC Inst Canc & Dev Biol, Cambridge CB2 1QR, England; Univ Cambridge, Physiol Lab, Cambridge CB2 1QR, England	University of Cambridge; University of Cambridge; University of Cambridge	Ferguson-Smith, AC (corresponding author), Univ Cambridge, Dept Anat, Downing St, Cambridge CB2 3DY, England.	afsmith@mole.bio.cam.ac.uk; as10021@mole.bio.cam.ac.uk	Ferguson-Smith, Anne C/G-7534-2011	Ferguson-Smith, Anne/0000-0002-7608-5894; Surani, Azim/0000-0002-8640-4318				ALLEN ND, 1990, CELL, V61, P853, DOI 10.1016/0092-8674(90)90195-K; Arney KL, 2001, INT J DEV BIOL, V45, P533; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; BARLOW DP, 1993, SCIENCE, V260, P309, DOI 10.1126/science.8469984; BAYLIN S, IN PRESS SCIENCE; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bestor TH, 1996, NAT GENET, V12, P363, DOI 10.1038/ng0496-363; Birger Y, 1999, NATURE, V397, P84, DOI 10.1038/16291; BRANDEIS M, 1993, EMBO J, V12, P3669, DOI 10.1002/j.1460-2075.1993.tb06041.x; Chamberlain SJ, 2001, GENOMICS, V73, P316, DOI 10.1006/geno.2001.6543; Charlier C, 2001, NAT GENET, V27, P367, DOI 10.1038/86856; Charlier C, 2001, GENOME RES, V11, P850, DOI 10.1101/gr.172701; Constancia M, 2000, NAT GENET, V26, P203, DOI 10.1038/79930; Cranston MJ, 2001, GENOMICS, V73, P98, DOI 10.1006/geno.2001.6514; Davis TL, 2000, HUM MOL GENET, V9, P2885, DOI 10.1093/hmg/9.19.2885; Dean W, 2001, CURR BIOL, V11, pR527, DOI 10.1016/S0960-9822(01)00311-6; Eden S, 2001, EMBO J, V20, P3518, DOI 10.1093/emboj/20.13.3518; Ferguson-Smith AC, 2000, CURR BIOL, V10, pR872, DOI 10.1016/S0960-9822(00)00817-4; Grandjean V, 2001, FEBS LETT, V488, P165, DOI 10.1016/S0014-5793(00)02349-8; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Howell CY, 2001, CELL, V104, P829, DOI 10.1016/S0092-8674(01)00280-X; JAENISCH R, IN PRESS SCIENCE; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jones BK, 2001, HUM MOL GENET, V10, P807, DOI 10.1093/hmg/10.8.807; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Kato Y, 1999, DEVELOPMENT, V126, P1823; Killian JK, 2000, MOL CELL, V5, P707, DOI 10.1016/S1097-2765(00)80249-X; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Loebel DAF, 1996, GENOME RES, V6, P114, DOI 10.1101/gr.6.2.114; Lyle R, 2000, NAT GENET, V25, P19, DOI 10.1038/75546; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; NEUMANN B, 1995, NAT GENET, V9, P451, DOI 10.1038/ng0495-451b; O'Neill MJ, 2000, DEV GENES EVOL, V210, P18, DOI 10.1007/PL00008182; Ono R, 2001, GENOMICS, V73, P232, DOI 10.1006/geno.2001.6494; Oudejans CBM, 2001, GENOMICS, V73, P331, DOI 10.1006/geno.2001.6522; Paulsen M, 2000, HUM MOL GENET, V9, P1829, DOI 10.1093/hmg/9.12.1829; PAULSEN M, IN PRESS J PATHOL; PAULSEN M, UNPUB; Pickard B, 2001, MECH DEVELOP, V103, P35, DOI 10.1016/S0925-4773(01)00329-X; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Riesewijk AM, 1996, GENOMICS, V31, P158, DOI 10.1006/geno.1996.0027; RUBIN CM, 1994, NUCLEIC ACIDS RES, V22, P5121, DOI 10.1093/nar/22.23.5121; SANFORD JP, 1987, GENE DEV, V1, P1039, DOI 10.1101/gad.1.10.1039; Schmidt JV, 2000, GENE DEV, V14, P1997; Shemer R, 2000, NAT GENET, V26, P440, DOI 10.1038/82571; Smilinich NJ, 1999, P NATL ACAD SCI USA, V96, P8064, DOI 10.1073/pnas.96.14.8064; SURANI MA, 1993, PHILOS T R SOC B, V339, P165, DOI 10.1098/rstb.1993.0013; Szabo PE, 2000, CURR BIOL, V10, P607, DOI 10.1016/S0960-9822(00)00489-9; SZABO PE, 1995, GENE DEV, V9, P1857, DOI 10.1101/gad.9.15.1857; Tada M, 1997, EMBO J, V16, P6510, DOI 10.1093/emboj/16.21.6510; Tada T, 1998, DEV GENES EVOL, V207, P551, DOI 10.1007/s004270050146; Takada S, 2000, CURR BIOL, V10, P1135, DOI 10.1016/S0960-9822(00)00704-1; TAKADA S, UNPUB; Tanaka M, 1999, MECH DEVELOP, V87, P129, DOI 10.1016/S0925-4773(99)00158-6; Vrana PB, 1998, NAT GENET, V20, P362, DOI 10.1038/3833; Warnecke PM, 1998, GENOMICS, V51, P182, DOI 10.1006/geno.1998.5371; Werren JH, 2000, GENETICS, V155, P1469; Wutz A, 1997, NATURE, V389, P745, DOI 10.1038/39631; Wylie AA, 2000, GENOME RES, V10, P1711, DOI 10.1101/gr.161600; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	63	307	335	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2001	293	5532					1086	1089		10.1126/science.1064020	http://dx.doi.org/10.1126/science.1064020			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498578				2022-12-28	WOS:000170432600046
J	Noma, K; Allis, CD; Grewal, SIS				Noma, K; Allis, CD; Grewal, SIS			Transitions in distinct histone H3 methylation patterns at the heterochromatin domain boundaries	SCIENCE			English	Article							FISSION YEAST; PROTEIN; DIRECTIONALITY; EXPRESSION; CENTROMERE; REGION; LOCI	Eukaryotic genomes are organized into discrete structural and functional chromatin domains. Here, we show that distinct site-specific histone H3 methylation patterns define euchromatic and heterochromatic chromosomal domains within a 47-kilobase region of the mating-type locus in fission yeast. H3 methylated at lysine 9 (H3 Lys(9)), and its interacting Swi6 protein, are strictly localized to a 20-kilobase silent heterochromatic interval. In contrast, H3 methylated at lysine 4 (H3 LyS(4)) is specific to the surrounding euchromatic regions. Two inverted repeats flanking the silent interval serve as boundary elements to mark the borders between heterochromatin and euchromatin. Deletions of these boundary elements lead to spreading of H3 Lys(9) methylation and Swi6 into neighboring sequences. Furthermore, the H3 Lys(9) methylation and corresponding heterochromatin-associated complexes prevent H3 LyS(4) methylation in the silent domain.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Univ Virginia, Hlth Sci Ctr, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	Cold Spring Harbor Laboratory; University of Virginia	Grewal, SIS (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM053512, R01GM059772, R01GM053512] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM53512, GM59772] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ayoub N, 1999, GENETICS, V152, P495; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bell AC, 2001, SCIENCE, V291, P447, DOI 10.1126/science.291.5503.447; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bi X, 2001, CURR OPIN GENET DEV, V11, P199, DOI 10.1016/S0959-437X(00)00179-9; Cai HN, 2001, SCIENCE, V291, P493, DOI 10.1126/science.291.5503.493; Donze D, 1999, GENE DEV, V13, P698, DOI 10.1101/gad.13.6.698; Gerasimova TI, 2000, MOL CELL, V6, P1025, DOI 10.1016/S1097-2765(00)00101-5; Grewal SIS, 1997, GENETICS, V146, P1221; Grewal SIS, 2000, J CELL PHYSIOL, V184, P311, DOI 10.1002/1097-4652(200009)184:3<311::AID-JCP4>3.0.CO;2-D; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; KELLUM R, 1991, CELL, V64, P941, DOI 10.1016/0092-8674(91)90318-S; Muravyova E, 2001, SCIENCE, V291, P495, DOI 10.1126/science.291.5503.495; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nakayama J, 2000, CELL, V101, P307, DOI 10.1016/S0092-8674(00)80840-5; NAKAYAMA J, UNPUB; Partridge JF, 2000, GENE DEV, V14, P783; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; Sun FL, 1999, CELL, V99, P459, DOI 10.1016/S0092-8674(00)81534-2; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; THON G, 1993, GENETICS, V134, P1045; THON G, 1994, GENETICS, V138, P29; Wallrath L, 1998, CURR OPIN GENET DEV, V8, P147, DOI 10.1016/S0959-437X(98)80135-4; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781	25	577	600	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2001	293	5532					1150	1155		10.1126/science.1064150	http://dx.doi.org/10.1126/science.1064150			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498594				2022-12-28	WOS:000170432600064
J	Pouille, F; Scanziani, M				Pouille, F; Scanziani, M			Enforcement of temporal fidelity in pyramidal cells by somatic feed-forward inhibition	SCIENCE			English	Article							COINCIDENCE DETECTOR; CORTICAL NEURON; BRAIN-SLICES; INTERNEURONS; CA1; HIPPOCAMPUS; POTENTIALS; NOREPINEPHRINE; INTEGRATOR	The temporal resolution of neuronal integration depends on the time window within which excitatory inputs summate to reach the threshold for spike generation. Here, we show that in rat hippocampal pyramidal cells this window is very narrow (less than 2 milliseconds). This narrowness results from the short delay with which disynaptic feed-forward inhibition follows monosynaptic excitation. Simultaneous somatic and dendritic recordings indicate that feedforward inhibition is much stronger in the soma than in the dendrites, resulting in a broader integration window in the latter compartment. Thus, the subcellular partitioning of feed-forward inhibition enforces precise coincidence detection in the soma, while allowing dendrites to sum incoming activity over broader time windows.	Univ Zurich, Inst Brain Res, CH-8057 Zurich, Switzerland	University of Zurich	Scanziani, M (corresponding author), Univ Zurich, Inst Brain Res, Winterthurerstr 190, CH-8057 Zurich, Switzerland.							ABELES M, 1982, ISRAEL J MED SCI, V18, P83; ASTONJONES G, 1981, J NEUROSCI, V1, P887; Bergles DE, 1996, J NEUROSCI, V16, P572; DEBANNE D, 1995, J NEUROPHYSIOL, V73, P1282, DOI 10.1152/jn.1995.73.3.1282; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gulyas AI, 1999, J NEUROSCI, V19, P10082; Jaeger D, 1999, J NEUROSCI, V19, P6090, DOI 10.1523/JNEUROSCI.19-14-06090.1999; KNOWLES WD, 1981, J NEUROSCI, V1, P318; Konig P, 1996, TRENDS NEUROSCI, V19, P130, DOI 10.1016/S0166-2236(96)80019-1; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; MAJOR G, 1994, J NEUROSCI, V14, P4613; McQuiston AR, 1999, J NEUROSCI, V19, P5693, DOI 10.1523/JNEUROSCI.19-14-05693.1999; MILES R, 1984, J PHYSIOL-LONDON, V356, P97, DOI 10.1113/jphysiol.1984.sp015455; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; OTMAKHOV N, 1993, NEURON, V10, P1101, DOI 10.1016/0896-6273(93)90058-Y; Seutin V, 1997, NEUROPHARMACOLOGY, V36, P1653, DOI 10.1016/S0028-3908(97)00147-0; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; Shepherd G. M., 1998, SYNAPTIC ORG BRAIN; SOFTKY WR, 1993, J NEUROSCI, V13, P334; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; Sturm AK, 2001, BIOL CYBERN, V84, P153, DOI 10.1007/s004220000209; TEITELBAUM H, 1975, Science (Washington D C), V188, P1114, DOI 10.1126/science.175440; ZHANG S, 1994, J NEUROPHYSIOL, V72, P705, DOI 10.1152/jn.1994.72.2.705	23	801	811	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2001	293	5532					1159	1163		10.1126/science.1060342	http://dx.doi.org/10.1126/science.1060342			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498596				2022-12-28	WOS:000170432600066
J	Smallman, HS; MacLeod, DIA; Doyle, P				Smallman, HS; MacLeod, DIA; Doyle, P			Vision: Realignment of cones after cataract removal	NATURE			English	Article									Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA; Pacific Sci & Engn Grp, San Diego, CA 92122 USA; Dartmouth Coll, Dept Math, Hanover, NH 03755 USA	University of California System; University of California San Diego; Dartmouth College	Smallman, HS (corresponding author), Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA.							APPLEGATE RA, 1993, J OPT SOC AM A, V10, P1611, DOI 10.1364/JOSAA.10.001611; APPLEGATE RA, 1981, INVEST OPHTH VIS SCI, V21, P869; BONDS AB, 1978, INVEST OPHTH VIS SCI, V17, P754; Dennison D., 1979, Encyclopedia of Plant Physiology, New Series, Volume 7. Physiology of movements [Haupt, W.; Feinleib, M.E. (Editors)]., P506; ENOCH J M, 1961, Optom Wkly, V8, P329; ENOCH JM, 1981, PHILOS T R SOC B, V291, P323, DOI 10.1098/rstb.1981.0002; ENOCH JM, 1991, VISUAL OPTICS INSTRU, P280; FINE I, IN PRESS VISION RES; Kono M, 2001, VISION RES, V41, P103, DOI 10.1016/S0042-6989(00)00228-5; LATIES AM, 1968, NATURE, V218, P172, DOI 10.1038/218172a0; Laties AM, 1979, MOTILITY CELL FUNCTI, P285; MACLEOD DIA, 1974, VISION RES, V14, P369, DOI 10.1016/0042-6989(74)90235-1; Stiles WS, 1933, P R SOC LOND B-CONTA, V112, P428, DOI 10.1098/rspb.1933.0020	13	21	21	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2001	412	6847					604	605		10.1038/35088126	http://dx.doi.org/10.1038/35088126			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460PP	11493909				2022-12-28	WOS:000170318000029
J	Mishriki, YY				Mishriki, YY			Clinical picture: Oesophageal varix bleed	LANCET			English	Editorial Material									Lehigh Valley Hosp, Allentown, PA 18103 USA	Lehigh Valley Hospital	Mishriki, YY (corresponding author), Lehigh Valley Hosp, 1210 S Cedar Crest Blvd, Allentown, PA 18103 USA.								0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 28	2001	358	9278					293	293		10.1016/S0140-6736(01)05486-1	http://dx.doi.org/10.1016/S0140-6736(01)05486-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	457AF	11498216				2022-12-28	WOS:000170114400013
J	Yusupova, GZ; Yusupov, MM; Cate, JHD; Noller, HF				Yusupova, GZ; Yusupov, MM; Cate, JHD; Noller, HF			The path of messenger RNA through the ribosome	CELL			English	Article							DIRECTED CROSS-LINKING; BINDING; SITE; INITIATION; SUBUNIT; REGION; NUCLEOTIDES; TRANSLATION; COMPLEXES; SEQUENCE	Using X-ray crystallography, we have directly observed the path of mRNA in the 70S ribosome in Fourier difference maps at 7 Angstrom resolution. About 30 nucleotides of the mRNA are wrapped in a groove that encircles the neck of the 30S subunit. The Shine-Dalgarno helix is bound in a large cleft between the head and the back of the platform. At the interface, only about eight nucleotides (-1 to +7), centered on the junction between the A and P codons, are exposed, and bond almost exclusively to 16S rRNA. The mRNA enters the ribosome around position + 13 to + 15, the location of downstream pseudoknots that stimulate -1 translational frame shifting.	Univ Calif Santa Cruz, Sinsheimer Labs, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA; Whitehead Inst, Cambridge, MA 01242 USA	University of California System; University of California Santa Cruz; Massachusetts Institute of Technology (MIT); Whitehead Institute	Noller, HF (corresponding author), Univ Calif Santa Cruz, Sinsheimer Labs, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA.	harry@nuvolari.ucsc.edu	Yusupov, Marat/I-6126-2013; Yusupova, Gulnara/E-1877-2014	Yusupov, Marat/0000-0001-5544-0597; 				Agrawal RK, 1999, NAT STRUCT BIOL, V6, P643, DOI 10.1038/10695; Alam SL, 1999, P NATL ACAD SCI USA, V96, P14177, DOI 10.1073/pnas.96.25.14177; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BALAKIN A, 1990, BIOCHIM BIOPHYS ACTA, V1050, P119, DOI 10.1016/0167-4781(90)90151-Q; BELITSINA NV, 1981, FEBS LETT, V131, P289, DOI 10.1016/0014-5793(81)80387-0; BHANGU R, 1992, BIOCHEMISTRY-US, V31, P5937, DOI 10.1021/bi00140a033; BHANGU R, 1994, BIOCHEMISTRY-US, V33, P3063, DOI 10.1021/bi00176a040; BRETSCHER MS, 1968, NATURE, V220, P1088, DOI 10.1038/2201088a0; BRIERLEY I, 1989, CELL, V57, P537, DOI 10.1016/0092-8674(89)90124-4; BRIMACOMBE R, 1995, EUR J BIOCHEM, V230, P365; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; DOKUDOVSKAYA SS, 1993, BIOTECHNOL APPL BIOC, V18, P149; DONTSOVA O, 1992, EMBO J, V11, P3105, DOI 10.1002/j.1460-2075.1992.tb05383.x; FRANK J, 1995, NATURE, V376, P441, DOI 10.1038/376441a0; GAVRILOVA LP, 1976, J MOL BIOL, V101, P537, DOI 10.1016/0022-2836(76)90243-6; Greuer B, 1999, RNA, V5, P1521, DOI 10.1017/S1355838299991550; GUALERZI C, 1977, BIOCHEMISTRY-US, V16, P1684, DOI 10.1021/bi00627a025; HUTTENHOFER A, 1994, EMBO J, V13, P3892, DOI 10.1002/j.1460-2075.1994.tb06700.x; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; JUZUMIENE DI, 1995, J BIOL CHEM, V270, P12794, DOI 10.1074/jbc.270.21.12794; Lata KR, 1996, J MOL BIOL, V262, P43, DOI 10.1006/jmbi.1996.0497; MOAZED D, 1990, J MOL BIOL, V211, P135, DOI 10.1016/0022-2836(90)90016-F; MOAZED D, 1986, CELL, V47, P985, DOI 10.1016/0092-8674(86)90813-5; MOAZED D, 1987, NATURE, V327, P389, DOI 10.1038/327389a0; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; OTWINOWSKI Z, 1993, DATA COLLECTION PROC, P52; PESTKA S, 1967, J BIOL CHEM, V242, P4939; RINKEAPPEL J, 1994, NUCLEIC ACIDS RES, V22, P3018, DOI 10.1093/nar/22.15.3018; RINKEAPPEL J, 1993, NUCLEIC ACIDS RES, V21, P2853, DOI 10.1093/nar/21.12.2853; Ryter JM, 1998, EMBO J, V17, P7505, DOI 10.1093/emboj/17.24.7505; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Sergiev PV, 1997, RNA, V3, P464; SHATSKY IN, 1991, BIOCHIMIE, V73, P937, DOI 10.1016/0300-9084(91)90135-N; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; STEITZ JA, 1969, NATURE, V224, P957, DOI 10.1038/224957a0; VONAHSEN U, 1995, SCIENCE, V267, P234, DOI 10.1126/science.7528943; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	39	473	535	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2001	106	2					233	241		10.1016/S0092-8674(01)00435-4	http://dx.doi.org/10.1016/S0092-8674(01)00435-4			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	458KG	11511350	Bronze			2022-12-28	WOS:000170193100012
J	Eggert, US; Ruiz, N; Falcone, BV; Branstrom, AA; Goldman, RC; Silhavy, TJ; Kahne, D				Eggert, US; Ruiz, N; Falcone, BV; Branstrom, AA; Goldman, RC; Silhavy, TJ; Kahne, D			Genetic basis for activity differences between vancomycin and glycolipid derivatives of vancomycin	SCIENCE			English	Article							ESCHERICHIA-COLI; GLYCOPEPTIDE ANTIBIOTICS; LYTIC TRANSGLYCOSYLASE; MEMBRANE LOCALIZATION; RESISTANCE; IDENTIFICATION; CHROMOSOME; STRAINS; SYSTEM; GROWTH	Small molecules that affect specific protein functions can be valuable tools for dissecting complex cellular processes. Peptidoglycan synthesis and degradation is a process in bacteria that involves multiple enzymes under strict temporal and spatial regulation. We used a set of small molecules that inhibit the transglycosylation step of peptidoglycan synthesis to discover genes that help to regulate this process. We identified a gene responsible for the susceptibility of Escherichia coli cells to killing by glycolipid derivatives of vancomycin, thus establishing a genetic basis for activity differences between these compounds and vancomycin.	Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Adv Med Inc, San Francisco, CA 94080 USA	Princeton University; Princeton University	Kahne, D (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.	dkahne@princeton.edu		Ruiz, Natividad/0000-0002-6369-2206; Falcone, Brian/0000-0001-8506-0915; Silhavy, Thomas/0000-0001-7672-5153; Eggert, Ulrike/0000-0003-0932-5525				Alaimo PJ, 2001, CURR OPIN CHEM BIOL, V5, P360, DOI 10.1016/S1367-5931(00)00215-5; BARNA JCJ, 1984, ANNU REV MICROBIOL, V38, P339, DOI 10.1146/annurev.mi.38.100184.002011; Bernhardt TG, 2001, SCIENCE, V292, P2326, DOI 10.1126/science.1058289; Branstrom AA, 2000, FEMS MICROBIOL LETT, V191, P187, DOI 10.1111/j.1574-6968.2000.tb09338.x; BUGG TDH, 1991, BIOCHEMISTRY-US, V30, P2017, DOI 10.1021/bi00222a002; Ge M, 1999, SCIENCE, V284, P507, DOI 10.1126/science.284.5413.507; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; Kerns R, 2000, J AM CHEM SOC, V122, P12608, DOI 10.1021/ja0027665; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Lommatzsch J, 1997, J BACTERIOL, V179, P5465, DOI 10.1128/jb.179.17.5465-5470.1997; NAGARAJAN R, 1989, J ANTIBIOT, V42, P63, DOI 10.7164/antibiotics.42.63; Novak R, 1999, NATURE, V399, P590, DOI 10.1038/21202; SAMPSON BA, 1989, GENETICS, V122, P491; SCHREIBER SL, 1991, SCIENCE, V251, P283, DOI 10.1126/science.1702904; Silhavy T. J., 1984, EXPT GENE FUSIONS; SINGER M, 1989, MICROBIOL REV, V53, P1; TOMASZ A, 1970, NATURE, V227, P138, DOI 10.1038/227138a0; TUOMANEN E, 1986, J GEN MICROBIOL, V132, P1297; UMEDA M, 1991, GENE, V98, P1, DOI 10.1016/0378-1119(91)90096-T; VANHEIJENOORT Y, 1987, J GEN MICROBIOL, V133, P667; Vollmer W, 1999, J BIOL CHEM, V274, P6726, DOI 10.1074/jbc.274.10.6726; Williams DH, 1999, ANGEW CHEM INT EDIT, V38, P1173, DOI 10.1002/(SICI)1521-3773(19990503)38:9<1172::AID-ANIE1172>3.0.CO;2-C; YAMAGUCHI K, 1988, CELL, V53, P423, DOI 10.1016/0092-8674(88)90162-6; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zelenitsky SA, 1997, ANTIMICROB AGENTS CH, V41, P1407, DOI 10.1128/AAC.41.6.1407	25	112	116	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2001	294	5541					361	364		10.1126/science.1063611	http://dx.doi.org/10.1126/science.1063611			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482WZ	11520949				2022-12-28	WOS:000171601400040
J	Norell, MA; Makovicky, PJ; Currie, PJ				Norell, MA; Makovicky, PJ; Currie, PJ			Palaeontology - The beaks of ostrich dinosaurs	NATURE			English	Article									Amer Museum Nat Hist, New York, NY 10024 USA; Field Museum Nat Hist, Chicago, IL 60605 USA; Royal Tyrell Museum Palaeontol, Drumheller, AB T0J 0Y0, Canada	American Museum of Natural History (AMNH); Field Museum of Natural History (Chicago)	Norell, MA (corresponding author), Amer Museum Nat Hist, Cent Pk W & 79th St, New York, NY 10024 USA.	norell@amnh.org	Currie, Philip J/A-2628-2014	Currie, Philip J/0000-0001-6857-3161				CURRIE PJ, 1993, CRETACEOUS RES, V14, P127, DOI 10.1006/cres.1993.1011; Eberth D.A., 1997, ENCY DINOSAURS, P379; GOODMAN DC, 1962, FUNCTIONAL ANATOMY F, P1; JERZYKIEWICZ T, 1991, CRETACEOUS RES, V12, P345, DOI 10.1016/0195-6671(91)90015-5; Kobayashi Y, 1999, NATURE, V402, P480, DOI 10.1038/44999; Makovicky Peter J., 1998, American Museum Novitates, V3247, P1; Osborn HF, 1916, B AM MUS NAT HIST, V35, P733; Osmolska H., 1972, Palaeontologia Polonica, VNo. 27, P103; Padian K., 1997, ENCY DINOSAURS, P499; STERNBERG C. M., 1933, CANADIAN FIELD NATURALIST, V47, P79; Zweers G.A, 1977, Contributions vert. Evol., V3, P1	11	59	60	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2001	412	6850					873	874		10.1038/35091139	http://dx.doi.org/10.1038/35091139			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467EG	11528466				2022-12-28	WOS:000170689000032
J	Altman, DG; Schulz, KF				Altman, DG; Schulz, KF			Statistics notes - Concealing treatment allocation in randomised trials	BRITISH MEDICAL JOURNAL			English	Article							QUALITY		Inst Hlth Sci, Ctr Stat Med, Imperial Canc Res Fund, Med Stat Grp, Oxford OX3 7LF, England; Family Hlth Int, Res Triangle Pk, NC 27709 USA	University of Oxford	Altman, DG (corresponding author), Inst Hlth Sci, Ctr Stat Med, Imperial Canc Res Fund, Med Stat Grp, Oxford OX3 7LF, England.							Altman DG, 1999, BRIT MED J, V318, P1209; Altman DG, 1999, BRIT MED J, V319, P703, DOI 10.1136/bmj.319.7211.703; [Anonymous], 1948, BMJ-BRIT MED J, V2, P769; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Day SJ, 2000, BRIT MED J, V321, P504, DOI 10.1136/bmj.321.7259.504; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V274, P1456; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408	8	137	149	0	8	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 25	2001	323	7310					446	447		10.1136/bmj.323.7310.446	http://dx.doi.org/10.1136/bmj.323.7310.446			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469BX	11520850	Bronze, Green Published			2022-12-28	WOS:000170793600029
J	Coleman, T; Wynn, AT; Stevenson, K; Cheater, F				Coleman, T; Wynn, AT; Stevenson, K; Cheater, F			Qualitative study of pilot payment aimed at increasing general practitioners' antismoking advice to smokers	BRITISH MEDICAL JOURNAL			English	Article							1990 CONTRACT; SMOKING; HEALTH	Objectives To elicit general practitioners' and practice nurses' accounts of changes in their clinical practice or practice organisation made to claim a pilot health promotion payment. To describe attitudes towards the piloted and previous health promotion payments. Design Qualitative, semistructured interview study. Setting 13 general practices in Leicester. Participants 18 general practitioners and 13 practice nurses. Results Health professionals did not report substantially changing their clinical practice to claim the new payments and made only minimal changes in practice organisation. The new health promotion payment did not overcome general practitioners' resistance towards raising the issue of smoking when they felt that doing so could cause confrontation with patients. General practitioners who made the largest number of claims altered the way in which they recorded patients' smoking status rather than raising the topic of smoking more frequently with patients. Participants had strong negative views on die new payment, feeling it would also be viewed negatively by patients. They were, however, more positive about health promotion payments that rewarded "extra" effort-for example, setting up practice based smoking cessation clinics. Conclusions General practitioners and practice nurses were negative about a new health promotion payment, despite agreeing to pilot it. Health promotion payments do not automatically generate effective health promotion activity, and policymakers should consider careful piloting and evaluation of future changes in health promotion payments.	Leicester Gen Hosp, Leicester Warwick Med Sch, Dept Gen Practice & Primary Hlth Care, Leicester LE5 4PW, Leics, England; Univ Leeds, Sch Hlth Care Studies, Leeds LS2 9LN, W Yorkshire, England	University Hospitals of Leicester NHS Trust; Leicester General Hospital; University of Leicester; University of Leeds	Coleman, T (corresponding author), Leicester Gen Hosp, Leicester Warwick Med Sch, Dept Gen Practice & Primary Hlth Care, Gwendolen Rd, Leicester LE5 4PW, Leics, England.							BATES C, 2000, SMOKING CESSATION SU; BATES C, 2000, SMOKING CESSATION SE; BRITTEN N, 1995, BRIT MED J, V311, P251, DOI 10.1136/bmj.311.6999.251; Coleman T, 2001, BRIT MED J, V323, P435, DOI 10.1136/bmj.323.7310.435; Coleman T, 1996, BRIT J GEN PRACT, V46, P87; Coleman T, 2000, BRIT J GEN PRACT, V50, P207; COLEMAN T, 2000, PROSPECTIVE EVALUATI; *DEP HLTH, 1989, GEN PRACT NAT HLTH S; Dey P, 1999, BRIT J GEN PRACT, V49, P127; Dowell AC, 1996, FAM PRACT, V13, P357, DOI 10.1093/fampra/13.4.357; Fitzpatrick R, 1996, J Eval Clin Pract, V2, P123, DOI 10.1111/j.1365-2753.1996.tb00036.x; GIUFFRIDA A, 1998, COLLABORATION EFFECT; GOSDEN T, 1998, COLLABORATION EFFECT; GOSDEN T, 1998, COLLABRATION EFFECTI; GUIFFRIDA A, 1998, COLLABORATION EFFECT; HUGHES D, 1992, J HEALTH ECON, V11, P413, DOI 10.1016/0167-6296(92)90014-R; HUGHES D, 1993, HEALTH POLICY, V25, P39, DOI 10.1016/0168-8510(93)90101-T; Le Touze S, 1996, Nurs Times, V92, P32; LETOUZE S, 1995, EVALUATION NEW HLTH; LOWY A, 1993, BRIT MED J, V307, P413, DOI 10.1136/bmj.307.6901.413; REID GS, 1991, BRIT MED J, V303, P447, DOI 10.1136/bmj.303.6800.447; RITCHIE LD, 1992, BRIT MED J, V304, P816, DOI 10.1136/bmj.304.6830.816; STRAUSS A, 1998, BASIC QUALITATIVE RE; Strauss A., 1998, BASICS QUALITATIVE R; Tapper-Jones L, 1990, HLTH ED J, V49, P47; WILLIAMS A, 1988, BIOMEDICINE EXAMINED	26	20	21	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 25	2001	323	7310					432	435		10.1136/bmj.323.7310.432	http://dx.doi.org/10.1136/bmj.323.7310.432			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469BX	11520844	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000170793600024
J	Lilford, RJ; Braunholtz, D; Edwards, S; Stevens, A				Lilford, RJ; Braunholtz, D; Edwards, S; Stevens, A			Monitoring clinical trials - interim data should be publicly available	BMJ-BRITISH MEDICAL JOURNAL			English	Article							STOPPING RULES; GUIDELINES; COMMITTEES		Univ Birmingham, Dept Epidemiol & Publ Hlth, Birmingham B15 2TT, W Midlands, England; Univ Bristol, Ctr Eth Med, Bristol BS2 8BH, Avon, England	University of Birmingham; University of Bristol	Lilford, RJ (corresponding author), Univ Birmingham, Dept Epidemiol & Publ Hlth, Birmingham B15 2TT, W Midlands, England.	richard.lilford@doh.gsi.gov.uk		Stevens, Andrew/0000-0003-2079-3397				[Anonymous], 1989, NEW ENGL J MED, V321, P406; [Anonymous], 1988, LANCET, V2, P349; [Anonymous], 1996, INT C HARM TECHN REQ; ASHBY D, 1993, BRIT J CANCER, V68, P1047, DOI 10.1038/bjc.1993.481; BAUM M, 1994, STAT MED, V13, P1459, DOI 10.1002/sim.4780131322; BERRY DA, 1992, BAYESIAN STATISTICS, V4, P79; CROWLEY J, 1994, STAT MED, V13, P1391, DOI 10.1002/sim.4780131314; De Pauw M, 1994, Acta Urol Belg, V62, P31; FLEMING TR, 1993, STAT MED, V12, P565, DOI 10.1002/sim.4780120524; FREEDMAN LS, 1984, BIOMETRICS, V40, P575, DOI 10.2307/2530902; GEORGE SL, 1994, STAT MED, V13, P1313, DOI 10.1002/sim.4780131305; GREEN SJ, 1987, J CLIN ONCOL, V5, P1477, DOI 10.1200/JCO.1987.5.9.1477; HEITJAN DF, 1992, STAT MED, V11, P673, DOI 10.1002/sim.4780110511; HUGHES MD, 1993, STAT MED, V12, P1651, DOI 10.1002/sim.4780121802; HUGHES MD, 1993, STAT MED, V12, P901, DOI 10.1002/sim.4780121002; LEWIS RJ, 1993, ANN EMERG MED, V22, P1463, DOI 10.1016/S0196-0644(05)81997-3; Lilford RJ, 1995, J ROY SOC MED, V88, P552; MACHIN D, 1992, INTRO NEW TREATMENTS; *MRC, 1998, MRC QUID GOOD CLIN P, P22; POCOCK SJ, 1989, CONTROL CLIN TRIALS, V10, pS209; POCOCK SJ, 1993, STAT MED, V12, P1459, DOI 10.1002/sim.4780121512; SPIEGELHALTER DJ, 1994, J R STAT SOC A STAT, V157, P357, DOI 10.2307/2983527; Thornton JG, 1996, BRIT J OBSTET GYNAEC, V103, P611, DOI 10.1111/j.1471-0528.1996.tb09826.x; WALD N, 1991, LANCET, V338, P131	24	30	30	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 25	2001	323	7310					441	442		10.1136/bmj.323.7310.441	http://dx.doi.org/10.1136/bmj.323.7310.441			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469BX	11520848	Green Published			2022-12-28	WOS:000170793600027
J	Cui, Y; Wei, QQ; Park, HK; Lieber, CM				Cui, Y; Wei, QQ; Park, HK; Lieber, CM			Nanowire nanosensors for highly sensitive and selective detection of biological and chemical species	SCIENCE			English	Article								Boron-doped silicon nanowires (SiNWs) were used to create highly sensitive, real-time electrically based sensors for biological and chemical species. Amine- and oxide-functionalized SiNWs exhibit pH-dependent conductance that was linear over a large dynamic range and could be understood in terms of the change in surface charge during protonation and deprotonation. Biotin-modified SiNWs were used to detect streptavidin down to at least a picomolar concentration range. In addition, antigen-functionalized SiNWs show reversible antibody binding and concentration-dependent detection in real time. Lastly, detection of the reversible binding of the metabolic indicator Ca2+ was demonstrated, The small size and capability of these semiconductor nanowires for sensitive, label-free, real-time detection of a wide range of chemical and biological species could be exploited in array-based screening and in vivo diagnostics.	Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Lieber, CM (corresponding author), Harvard Univ, Dept Chem & Biol Chem, 12 Oxford St, Cambridge, MA 02138 USA.	cmt@cmliris.harvard.edu	Dee, Chang Fu/G-4842-2010; Chu, Yung-Ming/C-6318-2009; Cui, Yi/L-5804-2013; Park, Hongkun/R-9842-2019	Dee, Chang Fu/0000-0003-1015-9181; Cui, Yi/0000-0002-6103-6352; Park, Hongkun/0000-0001-9576-8829				BAGCI H, 1993, FEBS LETT, V322, P47, DOI 10.1016/0014-5793(93)81108-C; Bartlett P. N., 1996, HDB CHEM BIOL SENSOR, P139; BAYER EA, 1990, METHOD ENZYMOL, V184, P49; BERGVELD P, 1972, IEEE T BIO-MED ENG, VBM19, P342, DOI 10.1109/TBME.1972.324137; Blackburn G. F., 1987, BIOSENSORS FUNDAMENT, P481; Blake RC, 1999, ANAL BIOCHEM, V272, P123, DOI 10.1006/abio.1999.4176; BOLT GH, 1957, J PHYS CHEM-US, V61, P1166, DOI 10.1021/j150555a007; Collins PC, 2001, SCIENCE, V292, P706, DOI 10.1126/science.1058782; Cui Y, 2001, SCIENCE, V291, P851, DOI 10.1126/science.291.5505.851; Cui Y, 2001, APPL PHYS LETT, V78, P2214, DOI 10.1063/1.1363692; Cui Y, 2000, J PHYS CHEM B, V104, P5213, DOI 10.1021/jp0009305; Duan XF, 2001, NATURE, V409, P66, DOI 10.1038/35051047; Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z; HAFEMAN DG, 1988, SCIENCE, V240, P1182, DOI 10.1126/science.3375810; Huang Y, 2001, SCIENCE, V291, P630, DOI 10.1126/science.291.5504.630; Iler R. K, 1979, CHEM SILICA; KLEE CB, 1982, ADV PROTEIN CHEM, V35, P213, DOI 10.1016/S0065-3233(08)60470-2; Kong J, 2000, SCIENCE, V287, P622, DOI 10.1126/science.287.5453.622; Movileanu L, 2000, NAT BIOTECHNOL, V18, P1091, DOI 10.1038/80295; Seker F, 2000, CHEM REV, V100, P2505, DOI 10.1021/cr980093r; Tans SJ, 1998, NATURE, V393, P49, DOI 10.1038/29954; Vezenov DV, 1997, J AM CHEM SOC, V119, P2006, DOI 10.1021/ja963375m	22	5149	5451	55	2435	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2001	293	5533					1289	1292		10.1126/science.1062711	http://dx.doi.org/10.1126/science.1062711			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11509722				2022-12-28	WOS:000170492600031
J	Karcher, RL; Roland, JT; Zappacosta, F; Huddleston, MJ; Annan, RS; Carr, SA; Gelfand, V				Karcher, RL; Roland, JT; Zappacosta, F; Huddleston, MJ; Annan, RS; Carr, SA; Gelfand, V			Cell cycle regulation of myosin-V by calcium/calmodulin-dependent protein kinase II	SCIENCE			English	Article							MASS-SPECTROMETRY; ORGANELLE TRANSPORT; SELECTIVE DETECTION; MOTOR PROTEIN; MELANOPHORES; PHOSPHOPEPTIDES; PHOSPHORYLATION; MUTAGENESIS; DEGRADATION; ASSOCIATION	Organelle transport by myosin-V is down-regulated during mitosis, presumably by myosin-V phosphorylation. We used mass spectrometry phosphopeptide mapping to show that the tall of myosin-V was phosphorylated in mitotic Xenopus egg extract on a single serine residue localized in the carboxyl-terminal organelle-binding domain. Phosphorylation resulted in the release of the motor from the organelle. The phosphorylation site matched the consensus sequence of calcium/calmodulin-dependent protein kinase II (CaMKII), and inhibitors of CaMKII prevented myosin-V release. The modulation of cargo binding by phosphorylation is likely to represent a general mechanism regulating organelle transport by myosin-V.	Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA; GlaxoSmithKline, Dept Phys & Struct Chem, King Of Prussia, PA 19406 USA	University of Illinois System; University of Illinois Urbana-Champaign; GlaxoSmithKline	Gelfand, V (corresponding author), Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA.		Roland, Joseph/C-9592-2013; Gelfand, Vladimir I/D-2545-2013; Gelfand, Vladimir/M-1974-2019; Carr, Steven A./AAH-8366-2019	Gelfand, Vladimir I/0000-0002-6361-2798; Gelfand, Vladimir/0000-0002-6361-2798; Roland, Jr., J. Thomas/0000-0003-1181-4651	NIGMS NIH HHS [GM-52111] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052111, R55GM052111] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLAN VJ, 1991, J CELL BIOL, V113, P347, DOI 10.1083/jcb.113.2.347; Annan RS, 1996, ANAL CHEM, V68, P3413, DOI 10.1021/ac960221g; Annan RS, 2001, ANAL CHEM, V73, P393, DOI 10.1021/ac001130t; BENFENATI F, 1992, NATURE, V359, P417, DOI 10.1038/359417a0; BIEMANN K, 1990, METHOD ENZYMOL, V193, P886, DOI 10.1016/0076-6879(90)93460-3; Carr SA, 1996, ANAL BIOCHEM, V239, P180, DOI 10.1006/abio.1996.0313; Catlett NL, 1998, P NATL ACAD SCI USA, V95, P14799, DOI 10.1073/pnas.95.25.14799; Costa MCR, 1999, J BIOL CHEM, V274, P15811, DOI 10.1074/jbc.274.22.15811; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HUDDLESTON MJ, 1993, J AM SOC MASS SPECTR, V4, P710, DOI 10.1016/1044-0305(93)80049-5; ISHIDA A, 1995, BIOCHEM BIOPH RES CO, V212, P806, DOI 10.1006/bbrc.1995.2040; Joyal JL, 1997, J BIOL CHEM, V272, P15419, DOI 10.1074/jbc.272.24.15419; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; LINDSAY HD, 1995, J CELL SCI, V108, P3557; Niclas J, 1996, J CELL BIOL, V133, P585, DOI 10.1083/jcb.133.3.585; Nigg EA, 1998, CURR OPIN CELL BIOL, V10, P776, DOI 10.1016/S0955-0674(98)80121-X; Nilsson H, 1997, CELL MOTIL CYTOSKEL, V38, P397, DOI 10.1002/(SICI)1097-0169(1997)38:4<397::AID-CM9>3.3.CO;2-5; Ohi R, 1999, CURR OPIN CELL BIOL, V11, P267, DOI 10.1016/S0955-0674(99)80036-2; Patel R, 1999, J BIOL CHEM, V274, P7958, DOI 10.1074/jbc.274.12.7958; Prekeris R, 1997, J CELL BIOL, V137, P1589, DOI 10.1083/jcb.137.7.1589; Rogers SL, 1999, J CELL BIOL, V146, P1265, DOI 10.1083/jcb.146.6.1265; Rogers SL, 1997, P NATL ACAD SCI USA, V94, P3720, DOI 10.1073/pnas.94.8.3720; Rogers SL, 1998, CURR BIOL, V8, P161, DOI 10.1016/S0960-9822(98)70063-6; STARODUBOV S M, 1988, Ontogenez, V19, P279; Tuma MC, 1998, J CELL BIOL, V143, P1547, DOI 10.1083/jcb.143.6.1547; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; Walikonis RS, 2000, J NEUROSCI, V20, P4069; Warren G, 1996, CELL, V84, P395, DOI 10.1016/S0092-8674(00)81284-2; Wu XF, 1998, J CELL BIOL, V143, P1899, DOI 10.1083/jcb.143.7.1899	30	118	120	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2001	293	5533					1317	1320		10.1126/science.1061086	http://dx.doi.org/10.1126/science.1061086			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11509731				2022-12-28	WOS:000170492600040
J	Strom, BL; Schinnar, R; Ziegler, EE; Barnhart, KT; Sammel, MD; Macones, GA; Stallings, VA; Drulis, JM; Nelson, SE; Hanson, SA				Strom, BL; Schinnar, R; Ziegler, EE; Barnhart, KT; Sammel, MD; Macones, GA; Stallings, VA; Drulis, JM; Nelson, SE; Hanson, SA			Exposure to soy-based formula in infancy and endocrinological and reproductive outcomes in young adulthood	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHYTO-ESTROGENS; PHYTOESTROGENS; ISOFLAVONES; PROTEIN; BINDING; RELEVANCE; RECEPTORS; AFFINITY; DISEASE; CANCER	Context A large body of evidence documents the role of phytoestrogens in influencing hormone-dependent states. Infants fed soy formula receive high levels of phytoestrogens, in the form of soy isoflavones, during a stage of development at which permanent effects are theoretically possible. However, a paucity of data exists on the long-term effects of infant soy formulas. Objective To examine the association between infant exposure to soy formula and health in young adulthood, with an emphasis on reproductive health. Design, Setting, and Participants Retrospective cohort study conducted from March to August 1999 among adults aged 20 to 34 years who, as infants, participated during 1965-1978 in controlled feeding studies conducted at the University of Iowa, Iowa City (248 were fed soy formula and 563 were fed cow milk formula during infancy). Main Outcome Measures Self-reported pubertal maturation, menstrual and reproductive history, height and usual weight, and current health, compared based on type of formula exposure during infancy. Results No statistically significant differences were observed between groups in either women or men for more than 30 outcomes. However, women who had been fed soy formula reported slightly longer duration of menstrual bleeding (adjusted mean difference, 0.37 days; 95% confidence interval [CI], 0.06-0.68), with no difference in severity of menstrual flow. They also reported greater discomfort with menstruation (unadjusted relative risk for extreme discomfort vs no or mild pain, 1.77; 95% CI, 1.04-3.00). Conclusions Exposure to soy formula does not appear to lead to different general health or reproductive outcomes than exposure to cow milk formula. Although the few positive findings should be explored in future studies, our findings are reassuring about the safety of infant soy formula.	Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Med, Div Gen Internal Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Childrens Hosp, Div Gastroenterol & Nutr, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; Univ Iowa, Dept Pediat, Fomon Infant Nutr Unit, Iowa City, IA 52242 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Iowa	Strom, BL (corresponding author), Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, 824 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	bstrom@cceb.med.upenn.edu		Sammel, Mary/0000-0003-1248-4199	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD083279] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Acacio BD, 2000, FERTIL STERIL, V73, P595, DOI 10.1016/S0015-0282(99)00591-9; ADLERCREUTZ H, 1995, ENVIRON HEALTH PERSP, V103, P103, DOI 10.2307/3432518; ANDERSON JW, 1995, NEW ENGL J MED, V333, P276, DOI 10.1056/NEJM199508033330502; Anthony MS, 1996, J NUTR, V126, P43, DOI 10.1093/jn/126.1.43; Bennetts H. W., 1946, AUSTRALIAN VET JOUR, V22, P2, DOI 10.1111/j.1751-0813.1946.tb15473.x; CARTER MW, 1953, P SOC EXP BIOL MED, V84, P506, DOI 10.3181/00379727-84-20693; CASSIDY A, 1994, AM J CLIN NUTR, V60, P333, DOI 10.1093/ajcn/60.3.333; CHENG E, 1953, SCIENCE, V118, P164, DOI 10.1126/science.118.3058.164; DRANE H, 1975, FOOD COSMET TOXICOL, V13, P491, DOI 10.1016/S0015-6264(75)80216-1; DRANE HM, 1980, FOOD COSMET TOXICOL, V18, P425, DOI 10.1016/0015-6264(80)90201-1; FOLMAN Y, 1966, J ENDOCRINOL, V34, P215, DOI 10.1677/joe.0.0340215; FOMON SJ, 1984, PEDIATR RES, V18, P1233, DOI 10.1203/00006450-198412000-00001; FOMON SJ, 1986, J NUTR, V116, P1405, DOI 10.1093/jn/116.8.1405; FOMON SJ, 1971, ACTA PAEDIATR SCAND, P1; GAVALER JS, 1995, P SOC EXP BIOL MED, V208, P98; GREENLAND S, 1988, J CLIN EPIDEMIOL, V41, P1167, DOI 10.1016/0895-4356(88)90020-0; Huggett AC, 1997, LANCET, V350, P815, DOI 10.1016/S0140-6736(05)62613-X; Humfrey Charles D. N., 1998, Natural Toxins, V6, P51, DOI [10.1002/(SICI)1522-7189(199804)6:2<51::AID-NT11>3.3.CO;2-0, 10.1002/(SICI)1522-7189(199804)6:2<51::AID-NT11>3.0.CO;2-9]; Ingram D, 1997, LANCET, V350, P990, DOI 10.1016/S0140-6736(97)01339-1; Irvine CHG, 1998, P SOC EXP BIOL MED, V217, P247; IRVING C, 1995, NEW ZEAL MED J, V108, P208; KATZENELLENBOGEN BS, 1977, ENDOCRINOLOGY, V100, P1252, DOI 10.1210/endo-100-5-1252; Klein KO, 1998, NUTR REV, V56, P193, DOI 10.1111/j.1753-4887.1998.tb01748.x; Kleinbaum DG, 1982, EPIDEMIOLOGIC RES PR; Knight DC, 1996, OBSTET GYNECOL, V87, P897; McCullagh P., 1989, GEN LINEAR MODELS, V2nd; MEHTA CR, 1992, AM STAT, V46, P146, DOI 10.2307/2684185; Miller Rupert G., 1981, SIMULTANEOUS STAT IN, V2nd, DOI [DOI 10.1007/978-1-4613-8122-8, 10.1007/978-1-4613-8122-8_1]; MOULE G. R., 1963, Anim. Breed. Abstr., V31, P139; Murkies AL, 1998, J CLIN ENDOCR METAB, V83, P297, DOI 10.1210/jc.83.2.297; North K, 2000, BJU INT, V85, P107, DOI 10.1046/j.1464-410x.2000.00436.x; ROSENBLUM ER, 1992, ALCOHOL CLIN EXP RES, V16, P843, DOI 10.1111/j.1530-0277.1992.tb01879.x; Setchell KDR, 1997, LANCET, V350, P23, DOI 10.1016/S0140-6736(96)09480-9; SETCHELL KDR, 1987, GASTROENTEROLOGY, V93, P225, DOI 10.1016/0016-5085(87)91006-7; SETCHELL KDR, 1984, AM J CLIN NUTR, V40, P569, DOI 10.1093/ajcn/40.3.569; Setchell KDR, 1999, J NUTR, V129, p758S, DOI 10.1093/jn/129.3.758S; Sheehan DM, 1998, P SOC EXP BIOL MED, V217, P379, DOI 10.3181/00379727-217-44248; SHEMESH M, 1972, J REPROD FERTIL, V29, P1; SHUTT DA, 1972, J ENDOCRINOL, V52, P299, DOI 10.1677/joe.0.0520299; SHUTT DA, 1976, ENDEAVOUR, V35, P110, DOI 10.1016/0160-9327(76)90004-1; Siegel S., 1988, NONPARAMETRIC STAT B; SUTHERLAND RL, 1980, NATURE, V288, P273, DOI 10.1038/288273a0; TANG BY, 1980, J ENDOCRINOL, V85, P291, DOI 10.1677/joe.0.0850291; WHITTEN PL, 1995, P SOC EXP BIOL MED, V208, P82; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	49	224	234	0	31	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2001	286	7					807	814		10.1001/jama.286.7.807	http://dx.doi.org/10.1001/jama.286.7.807			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	462PU	11497534	Bronze			2022-12-28	WOS:000170429600028
J	Malterud, K				Malterud, K			Qualitative research: standards, challenges, and guidelines	LANCET			English	Article							GENERAL-PRACTICE; MEDICAL LITERATURE; USERS GUIDES; PRIMARY-CARE; HEALTH; DIALOGUE; RIGOUR; XXIII	Qualitative research methods could help us to improve our understanding of medicine. Rather than thinking of qualitative and quantitative strategies as incompatible, they should be seen as complementary. Although procedures for textual interpretation differ from those of statistical analysis, because of the different type of data used and questions to be answered, the underlying principles are much the same. In this article I propose relevance, validity, and reflexivity as overall standards for qualitative inquiry. I will discuss the specific challenges in relation to reflexivity, transferability, and shared assumptions of Interpretation, which are met by medical researchers who do this type of research, and I will propose guidelines for qualitative inquiry.	Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Sect Gen Practice, N-5009 Bergen, Norway; Univ Copenhagen, Dept Gen Practice, DK-1168 Copenhagen, Denmark; Univ Copenhagen, Res Inst, DK-1168 Copenhagen, Denmark	University of Bergen; University of Copenhagen; University of Copenhagen	Malterud, K (corresponding author), Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Sect Gen Practice, Ulriksdal 8C, N-5009 Bergen, Norway.		jittitaworn, wareerat/G-9191-2016					Blaxter M., 1996, MED SOCIOLOGY NEWS, V22, P68; BRITTEN N, 1995, FAM PRACT, V12, P104, DOI 10.1093/fampra/12.1.104; Chapple A, 1998, FAM PRACT, V15, P556, DOI 10.1093/fampra/15.6.556; ELDER NC, 1995, J FAM PRACTICE, V41, P279; Gardner K, 1999, BRIT MED J, V319, P418, DOI 10.1136/bmj.319.7207.418; Giacomini MK, 2000, JAMA-J AM MED ASSOC, V284, P478, DOI 10.1001/jama.284.4.478; Giacomini MK, 2000, JAMA-J AM MED ASSOC, V284, P357, DOI 10.1001/jama.284.3.357; Giorgi A., 1986, PHENOMENOLOGY PEDAGO, V4, P22; Giorgi A., 1985, PHENOMENOLOGY PSYCHO, P8; HAMBERG K, 1994, FAM PRACT, V11, P176, DOI 10.1093/fampra/11.2.176; Hammersley M., 1990, READING ETHNOGRAPHIC; Haraway D., 1991, MANIFESTLY HARAWAY; Hoddinott P, 1997, FAM PRACT, V14, P313, DOI 10.1093/fampra/14.4.313; Kuzel AJ., 1999, DOING QUALITATIVE RE, V2, P33, DOI DOI 10.1111/J.1365-2929.2006; Kvale S., 2007, INTERVIEWS INTRO QUA; Latour B., 1986, LAB LIFE CONSTRUCTIO; Lincoln Y, 1985, NATURALISTIC ENQUIRY; Lincoln Y.S., 1995, QUAL INQ, V1, P275, DOI [10.1177/107780049500100301, DOI 10.1177/107780049500100301]; MALTERUD K, 1993, FAM PRACT, V10, P201, DOI 10.1093/fampra/10.2.201; Malterud K, 2001, LANCET, V358, P397, DOI 10.1016/S0140-6736(01)05548-9; Malterud K, 1999, SCAND J PUBLIC HEALT, V27, P254, DOI 10.1177/14034948990270040901; MAYS N, 1995, BRIT MED J, V311, P109, DOI 10.1136/bmj.311.6997.109; Mays N., 2000, QUALITATIVE RES HLTH, V2nd, P89; Miles M., 2013, QUALITATIVE DATA ANA; MILLER WL, 1992, J FAM PRACTICE, V34, P289; Miller WL, 1999, DOING QUALITATIVE RE, P3; Morse J.M, 1992, QUAL HEALTH RES, V2, P3, DOI DOI 10.1177/104973239200200101; NAGEL T, 1986, VIEW NOWHERE; NESSA J, 1995, SCAND J PRIM HEALTH, V13, P83, DOI 10.3109/02813439508996741; Riessman C.K., 1993, NARRATIVE ANAL; SKELTON AM, 1995, FAM PRACT, V12, P44, DOI 10.1093/fampra/12.1.44; Soderlund A, 2000, SCAND J PRIM HEALTH, V18, P165, DOI 10.1080/028134300453377; Stensland P, 1997, SCAND J PRIM HEALTH, V15, P175, DOI 10.3109/02813439709035023; Strauss A., 1990, BASICS QUALITATIVE R; Tesch R., 1991, QUALITATIVE RES ANAL; van Maanen John, 1988, TALES FIELD WRITING; Yin R. K., 1984, CASE STUDY RES DESIG	37	2531	2565	6	441	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 11	2001	358	9280					483	488		10.1016/S0140-6736(01)05627-6	http://dx.doi.org/10.1016/S0140-6736(01)05627-6			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463TB	11513933				2022-12-28	WOS:000170492400033
J	Heckman, DS; Geiser, DM; Eidell, BR; Stauffer, RL; Kardos, NL; Hedges, SB				Heckman, DS; Geiser, DM; Eidell, BR; Stauffer, RL; Kardos, NL; Hedges, SB			Molecular evidence for the early colonization of land by fungi and plants	SCIENCE			English	Article							DETERMINING DIVERGENCE TIMES; EARLY EVOLUTION; ORIGIN; DIVERSIFICATION; CLOCK; LIFE	The colonization of land by eukaryotes probably was facilitated by a partnership (symbiosis) between a photosynthesizing organism (phototroph) and a fungus. However, the time when colonization occurred remains speculative. The first fossil land plants and fungi appeared 480 to 460 million years ago (Ma), whereas molecular clock estimates suggest an earlier colonization of land, about 600 Ma. Our protein sequence analyses indicate that green algae and major lineages of fungi were present 1000 Ma and that land plants appeared by 700 Ma, possibly affecting Earth's atmosphere, climate, and evolution of animals in the Precambrian.	Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA; Penn State Univ, Astrobiol Res Ctr, University Pk, PA 16802 USA; Penn State Univ, Dept Plant Pathol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Hedges, SB (corresponding author), Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA.	sbh1@psu.edu	Geiser, David/J-9950-2013					Alexopoulos C. J., 1996; Berbee ML, 2001, MYCOTA, V7, P229; Butterfield NJ, 2000, PALEOBIOLOGY, V26, P386, DOI 10.1666/0094-8373(2000)026<0386:BPNGNS>2.0.CO;2; Crowley TJ, 2001, SCIENCE, V292, P870, DOI 10.1126/science.1061664; Doolittle RF, 1996, SCIENCE, V271, P470, DOI 10.1126/science.271.5248.470; Evans RD, 1999, CRIT REV PLANT SCI, V18, P183, DOI 10.1016/S0735-2689(99)00384-6; Feng DF, 1997, P NATL ACAD SCI USA, V94, P13028, DOI 10.1073/pnas.94.24.13028; Gehrig H, 1996, J MOL EVOL, V43, P71, DOI 10.1007/BF02352301; Goremykin VV, 1997, PLANT SYST EVOL, V206, P337, DOI 10.1007/BF00987956; GRAY J, 1992, AM SCI, V80, P444; Hedges SB, 1996, NATURE, V381, P226, DOI 10.1038/381226a0; Hoffman PF, 1998, SCIENCE, V281, P1342, DOI 10.1126/science.281.5381.1342; HORODYSKI RJ, 1994, SCIENCE, V263, P494, DOI 10.1126/science.263.5146.494; James Timothy Y., 2000, Canadian Journal of Botany, V78, P336; Kenrick P, 1997, NATURE, V389, P33, DOI 10.1038/37918; KNOLL AH, 1992, SCIENCE, V256, P622, DOI 10.1126/science.1585174; Kroken SB, 1996, AM J BOT, V83, P1241, DOI 10.2307/2446108; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; KUMAR S, 1996, PHYLTEST PROGRAM TES; Kumar S., 1993, MEGA MOL EVOLUTIONAR; KUMP LR, 1988, NATURE, V335, P152, DOI 10.1038/335152a0; Moreira D, 2000, NATURE, V405, P69, DOI 10.1038/35011054; Nei M, 2001, P NATL ACAD SCI USA, V98, P2497, DOI 10.1073/pnas.051611498; PIROZYNSKI KA, 1975, BIOSYSTEMS, V6, P153, DOI 10.1016/0303-2647(75)90023-4; Redecker D, 2000, SCIENCE, V289, P1920, DOI 10.1126/science.289.5486.1920; REMY W, 1994, P NATL ACAD SCI USA, V91, P11841, DOI 10.1073/pnas.91.25.11841; RETALLACK GJ, 1994, PALEOBIOLOGY, V20, P523, DOI 10.1017/S0094837300012975; Schwartzman D., 1999, LIFE TEMPERATURE EAR; Selosse MA, 1998, TRENDS ECOL EVOL, V13, P15, DOI 10.1016/S0169-5347(97)01230-5; SIMON L, 1993, NATURE, V363, P67, DOI 10.1038/363067a0; TAKEZAKI N, 1995, MOL BIOL EVOL, V12, P823; Taylor TN, 1999, NATURE, V399, P648, DOI 10.1038/21349; TAYLOR TN, 1995, NATURE, V378, P244, DOI 10.1038/378244a0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang DYC, 1999, P ROY SOC B-BIOL SCI, V266, P163, DOI 10.1098/rspb.1999.0617; Watanabe Y, 2000, NATURE, V408, P574, DOI 10.1038/35046052; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	37	672	713	7	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2001	293	5532					1129	1133		10.1126/science.1061457	http://dx.doi.org/10.1126/science.1061457			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498589				2022-12-28	WOS:000170432600058
J	Matzke, M; Matzke, AJM; Kooter, JM				Matzke, M; Matzke, AJM; Kooter, JM			RNA: Guiding gene silencing	SCIENCE			English	Editorial Material							DOUBLE-STRANDED-RNA; DNA METHYLTRANSFERASES; MESSENGER-RNA; EVOLUTION; PLANTS; ARABIDOPSIS; METHYLATION; MECHANISMS; DISRUPTION; TRANSGENE	In diverse organisms, small RNAs derived from cleavage of double-stranded RNA can trigger epigenetic gene silencing in the cytoplasm and at the genome level. Small RNAs can guide posttranscriptional degradation of complementary messenger RNAs and, in plants, transcriptional gene silencing by methylation of homologous DNA sequences. RNA silencing is a potent means to counteract foreign sequences and could play an important role in plant and animal development.	Austrian Acad Sci, Inst Mol Biol, A-5020 Salzburg, Austria; Vrije Univ Amsterdam, Dept Dev Genet, Amsterdam, Netherlands	Austrian Academy of Sciences; Vrije Universiteit Amsterdam	Matzke, M (corresponding author), Austrian Acad Sci, Inst Mol Biol, Billrothstr 11, A-5020 Salzburg, Austria.		Matzke, Antonius/H-8698-2015					Akhtar A, 2000, NATURE, V407, P405, DOI 10.1038/35030169; Barstead R, 2001, CURR OPIN CHEM BIOL, V5, P63, DOI 10.1016/S1367-5931(00)00173-3; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Cao XF, 2000, P NATL ACAD SCI USA, V97, P4979, DOI 10.1073/pnas.97.9.4979; Carthew RW, 2001, CURR OPIN CELL BIOL, V13, P244, DOI 10.1016/S0955-0674(00)00204-0; Cerutti L, 2000, TRENDS BIOCHEM SCI, V25, P481, DOI 10.1016/S0968-0004(00)01641-8; Cogoni C, 2000, CURR OPIN GENET DEV, V10, P638, DOI 10.1016/S0959-437X(00)00134-9; DAVIDSON EH, 1979, SCIENCE, V204, P1051; Doudna JA, 2000, NAT STRUCT BIOL, V7, P954, DOI 10.1038/80729; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Erdmann VA, 2001, NUCLEIC ACIDS RES, V29, P189, DOI 10.1093/nar/29.1.189; Fagard M, 2000, ANNU REV PLANT PHYS, V51, P167, DOI 10.1146/annurev.arplant.51.1.167; Finnegan EJ, 2000, PLANT MOL BIOL, V43, P189, DOI 10.1023/A:1006427226972; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; HAMMOND SM, IN PRESS SCIENCE; Hirochika H, 2000, PLANT CELL, V12, P357, DOI 10.1105/tpc.12.3.357; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jacobsen SE, 1999, DEVELOPMENT, V126, P5231; Jones L, 2001, CURR BIOL, V11, P747, DOI 10.1016/S0960-9822(01)00226-3; Lafontaine DLJ, 1998, TRENDS BIOCHEM SCI, V23, P383, DOI 10.1016/S0968-0004(98)01260-2; Lee JT, 2000, CELL, V103, P17, DOI 10.1016/S0092-8674(00)00101-X; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Llave C, 2000, P NATL ACAD SCI USA, V97, P13401, DOI 10.1073/pnas.230334397; Mallory AC, 2001, PLANT CELL, V13, P571, DOI 10.1105/tpc.13.3.571; Matzke MA, 2000, PLANT MOL BIOL, V43, P401, DOI 10.1023/A:1006484806925; Matzke MA, 2001, CURR OPIN GENET DEV, V11, P221, DOI 10.1016/S0959-437X(00)00183-0; Mette MF, 2001, CURR BIOL, V11, P1119, DOI 10.1016/S0960-9822(01)00315-3; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; Miura A, 2001, NATURE, V411, P212, DOI 10.1038/35075612; Morel JB, 2000, CURR BIOL, V10, P1591, DOI 10.1016/S0960-9822(00)00862-9; Pannuti A, 2000, CURR OPIN GENET DEV, V10, P644, DOI 10.1016/S0959-437X(00)00136-2; Papaefthimiou I, 2001, NUCLEIC ACIDS RES, V29, P2395, DOI 10.1093/nar/29.11.2395; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Plasterk RHA, 2000, CURR OPIN GENET DEV, V10, P562, DOI 10.1016/S0959-437X(00)00128-3; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; Sijen T, 2001, CURR BIOL, V11, P436, DOI 10.1016/S0960-9822(01)00116-6; Singer T, 2001, GENE DEV, V15, P591, DOI 10.1101/gad.193701; SMITH SS, 1991, J MOL BIOL, V217, P39, DOI 10.1016/0022-2836(91)90609-A; TSUCHI T, 2001, CHEMBIOCHEM, V2, P239; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; Vance V, 2001, SCIENCE, V292, P2277, DOI 10.1126/science.1061334; Voinnet O, 2000, CELL, V103, P157, DOI 10.1016/S0092-8674(00)00095-7; Wang MB, 2001, RNA, V7, P16, DOI 10.1017/S1355838201001224; Wassenegger M, 2000, PLANT MOL BIOL, V43, P203, DOI 10.1023/A:1006479327881; Wu-Scharf D, 2000, SCIENCE, V290, P1159, DOI 10.1126/science.290.5494.1159; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	53	259	358	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2001	293	5532					1080	1083		10.1126/science.1063051	http://dx.doi.org/10.1126/science.1063051			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498576				2022-12-28	WOS:000170432600044
J	Wilson, FH; Disse-Nicodeme, S; Choate, KA; Ishikawa, K; Nelson-Willams, C; Desitter, I; Gunel, M; Milford, DV; Lipkin, GW; Achard, JM; Feely, MP; Dussol, B; Berland, Y; Unwin, RJ; Mayan, H; Simon, DB; Farfel, Z; Jeunemaitre, X; Lifton, RP				Wilson, FH; Disse-Nicodeme, S; Choate, KA; Ishikawa, K; Nelson-Willams, C; Desitter, I; Gunel, M; Milford, DV; Lipkin, GW; Achard, JM; Feely, MP; Dussol, B; Berland, Y; Unwin, RJ; Mayan, H; Simon, DB; Farfel, Z; Jeunemaitre, X; Lifton, RP			Human hypertension caused by mutations in WNK kinases	SCIENCE			English	Article							PSEUDOHYPOALDOSTERONISM TYPE-II; FAMILIAL HYPERKALEMIA; CHLORIDE REABSORPTION; MULTILOCUS LINKAGE; BLOOD-PRESSURE; DEFECT; LOCUS	Hypertension is a major public health problem of largely unknown cause. Here, we identify two genes causing pseudohypoaldosteronism type II, a Mendelian trait featuring hypertension, increased renal salt reabsorption, and impaired K+ and H+ excretion. Both genes encode members of the WNK family of serine-threonine kinases. Disease-causing mutations in WNK1 are large intronic deletions that increase WNK1 expression. The mutations in WNK4 are missense, which cluster in a short, highly conserved segment of the encoded protein. Both proteins localize to the distal nephron, a kidney segment involved in salt, K+, and pH homeostasis. WNK1 is cytoplasmic, whereas WNK4 localizes to tight junctions. The WNK kinases and their associated signaling pathway(s) may offer new targets for the development of anti hypertensive drugs.	Yale Univ, Sch Med, Boyer Ctr Mol Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Coll France, INSERM, U36, F-75005 Paris, France; Birmingham Childrens Hosp, Dept Nephrol, Birmingham B4 6NH, W Midlands, England; Queen Elizabeth Hosp, Dept Nephrol, Birmingham B15 2TT, W Midlands, England; Hop Amiens Sud, Serv Nephrol, Amiens, France; Gen Infirm, Unit Mol Vasc Med, Leeds LS1 3EX, W Yorkshire, England; Hop St Marguerite, Serv Nephrol & Hemodialyse, Marseille, France; UCL, Dept Nephrol, London W1W 7EY, England; UCL, Dept Physiol, London W1W 7EY, England; Tel Aviv Univ, Sheba Med Ctr, Fac Med, Dept Med E, IL-52621 Tel Hashomer, Israel; Tel Aviv Univ, Sheba Med Ctr, Fac Med, Biochem Pharmacol Lab, IL-52621 Tel Hashomer, Israel	Howard Hughes Medical Institute; Yale University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; University of Birmingham; University of Birmingham; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Leeds General Infirmary; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; University of London; University College London; University of London; University College London; Chaim Sheba Medical Center; Tel Aviv University; Chaim Sheba Medical Center; Tel Aviv University	Lifton, RP (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Howard Hughes Med Inst, 295 Congress Ave, New Haven, CT 06510 USA.	richard.ltifton@yale.edu	JEUNEMAITRE, Xavier/AAQ-4853-2021; achard, jean-michel/A-3392-2017	JEUNEMAITRE, Xavier/0000-0001-5925-381X; Wilson, Frederick/0000-0002-5019-0186				Baima J, 1999, HYPERTENSION, V34, P4, DOI 10.1161/01.HYP.34.1.4; BAZ M, 1990, PRESSE MED, V19, P1981; Disse-Nicodeme S, 2000, AM J HUM GENET, V67, P302, DOI 10.1086/303020; FARFEL Z, 1978, ARCH INTERN MED, V138, P1828, DOI 10.1001/archinte.138.12.1828; Gordon Richard D., 1995, P2111; Julier C, 1997, HUM MOL GENET, V6, P2077, DOI 10.1093/hmg/6.12.2077; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEE MR, 1980, LANCET, V1, P879; LEE MR, 1979, Q J MED, V48, P245; Levy D, 2000, HYPERTENSION, V36, P477, DOI 10.1161/01.HYP.36.4.477; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Madara JL, 1998, ANNU REV PHYSIOL, V60, P143, DOI 10.1146/annurev.physiol.60.1.143; Mansfield TA, 1997, NAT GENET, V16, P202, DOI 10.1038/ng0697-202; Mosterd A, 1999, NEW ENGL J MED, V340, P1221, DOI 10.1056/NEJM199904223401601; PAVER W K, 1964, Med J Aust, V2, P305; SCHAMBELAN M, 1981, KIDNEY INT, V19, P716, DOI 10.1038/ki.1981.72; SCHUSTER VL, 1987, AM J PHYSIOL, V253, pF203, DOI 10.1152/ajprenal.1987.253.2.F203; Simon DB, 1999, SCIENCE, V285, P103, DOI 10.1126/science.285.5424.103; TAKE C, 1991, NEW ENGL J MED, V324, P472, DOI 10.1056/NEJM199102143240707; Xu BE, 2000, J BIOL CHEM, V275, P16795, DOI 10.1074/jbc.275.22.16795	21	1085	1135	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2001	293	5532					1107	1112		10.1126/science.1062844	http://dx.doi.org/10.1126/science.1062844			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498583				2022-12-28	WOS:000170432600051
J	Eijkhout, HW; van der Meer, JWM; Kallenberg, CGM; Weening, RS; van Dissel, JT; Sanders, LAM; Strengers, PFW; Nienhuis, H; Schellekens, PTA				Eijkhout, HW; van der Meer, JWM; Kallenberg, CGM; Weening, RS; van Dissel, JT; Sanders, LAM; Strengers, PFW; Nienhuis, H; Schellekens, PTA		Inter-Univ Working Party Study Immune	The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia - A randomized, double-blind, multicenter crossover trial	ANNALS OF INTERNAL MEDICINE			English	Article							X-LINKED AGAMMAGLOBULINEMIA; COMMON VARIABLE IMMUNODEFICIENCY; GAMMA-GLOBULIN; THERAPY; COMPLICATIONS; DEFICIENCY; DISEASE	Background: In patients with hypogammaglobulinemia, substitution with immunoglobulin is the treatment of choice to reduce both frequency and severity of bacterial infections. Even with treatment, however, infections still occur in these patients. Objective: To determine whether doubling the standard dose of intravenous immunoglobulin would affect the incidence and duration of infections. Design: Multicenter, double-blind, randomized, crossover study. Setting: 15 outpatient clinics in the Netherlands. Patients: 43 patients with primary hypogammaglobulinemia, 41 of whom completed the protocol. Intervention: Patients received standard-dose immunoglobulin therapy for 9 months, followed by a 3-month washout period, and high-dose intravenous immunoglobulin therapy for 9 months, or vice versa. Measurements: The primary outcome measures were total number and duration of infections. Other measures were periods of fever, hospital admissions, use of antiboditics, absence from school or work, and trough levels of serum immunoglobulin. Side effects from the study medication were also recorded. Results: Compared with the standard dose of intravenous immunoglobulin (adults, 300 mg/kg of body weight every 4 weeks; children, 400 mg/kg every 4 weeks), high-dose therapy (adults, 600 mg/kg every 4 weeks; children, 800 mg/kg every 4 weeks) significantly reduced the number (3.5 vs. 2.5 per patient; P = 0.004) and duration (median, 33 days vs. 21 days; P = 0.015) of infections. Trough levels of IgG increased significantly during high-dose therapy. The incidence and type of side effects did not differ significantly for the two dosages. Conclusion: in patients with hypogammaglobulinemia, doubling the standard dose of intravenous immunoglobulin significantly reduced the number and duration of infections.	CLB, Dept Med, NL-1066 CX Amsterdam, Netherlands; Parexel Mirai, Amsterdam, Netherlands; Univ Nijmegen Hosp, NL-6500 HB Nijmegen, Netherlands; Univ Groningen Hosp, Groningen, Netherlands; Leiden Univ, Med Ctr, Leiden, Netherlands; Univ Hosp Children, Utrecht, Netherlands	Radboud University Nijmegen; University of Groningen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Eijkhout, HW (corresponding author), CLB, Dept Med, Plesmanlaan 125, NL-1066 CX Amsterdam, Netherlands.	H_Eijkhout@CLB.nl	van der Meer, Jos W.M./C-8521-2013	van der Meer, Jos W.M./0000-0001-5120-3690				BEAM TR, 1992, CLIN INFECT DIS, V15, pS5, DOI 10.1093/clind/15.Supplement_1.S5; BERNATOWSKA E, 1987, CLIN IMMUNOL IMMUNOP, V43, P153, DOI 10.1016/0090-1229(87)90123-1; BRUTON OC, 1952, PEDIATRICS, V9, P722; CUNNINGHAMRUNDLES C, 1984, ANN INTERN MED, V101, P435, DOI 10.7326/0003-4819-101-4-435; HERMASZEWSKI RA, 1993, Q J MED, V86, P31; HUSTON DP, 1991, J ALLERGY CLIN IMMUN, V87, P1, DOI 10.1016/0091-6749(91)90203-Z; JANEWAY CA, 1966, NEW ENGL J MED, V275, P826, DOI 10.1056/NEJM196610132751508; Kainulainen L, 1999, AM J RESP CRIT CARE, V159, P1199, DOI 10.1164/ajrccm.159.4.9807067; KERSTENS PJSM, 1992, EUR J CLIN MICROBIOL, V11, P842, DOI 10.1007/BF01960888; LIESE JG, 1992, AM J DIS CHILD, V146, P335, DOI 10.1001/archpedi.1992.02160150075025; LINDBERG K, 1993, SCAND J INFECT DIS, V25, P395, DOI 10.3109/00365549309008517; Ochs HD, 1996, MEDICINE, V75, P287, DOI 10.1097/00005792-199611000-00001; OCHS HD, 1984, AM J MED, V76, P78, DOI 10.1016/0002-9343(84)90324-3; PIROFSKY B, 1984, AM J MED, V76, P53, DOI 10.1016/0002-9343(84)90320-6; Pruzanski W, 1996, INFLAMMATION, V20, P353, DOI 10.1007/BF01486738; REMVIG L, 1991, J INTERN MED, V229, P73, DOI 10.1111/j.1365-2796.1991.tb00309.x; ROIFMAN CM, 1987, LANCET, V1, P1075; ROSEN FS, 1995, NEW ENGL J MED, V333, P431, DOI 10.1056/NEJM199508173330707; ROSEN FS, 1993, IMMUNODEFICIENCIES, P1; STIEHM ER, 1986, CLIN IMMUNOL IMMUNOP, V40, P69, DOI 10.1016/0090-1229(86)90070-X; Washington K, 1996, AM J SURG PATHOL, V20, P1240, DOI 10.1097/00000478-199610000-00010	21	183	189	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 7	2001	135	3					165	174		10.7326/0003-4819-135-3-200108070-00008	http://dx.doi.org/10.7326/0003-4819-135-3-200108070-00008			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460FX	11487483				2022-12-28	WOS:000170298500002
J	Carter, R				Carter, R			Ombudsman's fifth report	LANCET			English	Editorial Material									Lancet, London WC1X 8RR, England		Carter, R (corresponding author), Lancet, London WC1X 8RR, England.							Horton R, 1996, LANCET, V348, P6, DOI 10.1016/S0140-6736(05)64352-8; Sherwood T, 2000, LANCET, V356, P8, DOI 10.1016/S0140-6736(00)02426-0; Sherwood T, 1997, LANCET, V350, P4, DOI 10.1016/S0140-6736(05)66235-6; Sherwood T, 1999, LANCET, V354, P91, DOI 10.1016/S0140-6736(99)00229-9; Sherwood T, 1998, LANCET, V352, P7, DOI 10.1016/S0140-6736(05)79508-8	5	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 4	2001	358	9279					350	350		10.1016/S0140-6736(01)05588-X	http://dx.doi.org/10.1016/S0140-6736(01)05588-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459DE	11502312				2022-12-28	WOS:000170235100007
J	Drake, MJ; Mills, IW; Gillespie, JI				Drake, MJ; Mills, IW; Gillespie, JI			Model of peripheral autonomous modules and a myovesical plexus in normal and overactive bladder function	LANCET			English	Article							HUMAN URINARY-BLADDER; OBSTRUCTION; TISSUE; CELLS; PIG	Normal bladder function is controlled by the central nervous system (CNS) and any peripheral contribution to bladder control is believed to be small. Nevertheless, anatomically and functionally, such a contribution might exist. Taking account of this evidence, we propose that the detrusor muscle is arranged into modules, which are circumscribed areas of muscle active during the filling phase of the micturition cycle. These modules might be controlled by a peripheral myovesical plexus, consisting of intramural ganglia and interstitial cells. Detrusor overactivity is the occurrence of abnormal increases in pressure during bladder filling, which the patient cannot inhibit. This disorder is thought to be a consequence of abnormal expression of the micturition reflex or changes in the properties of the smooth muscle. We propose that detrusor overactivity results from exaggerated symptomatic expression of peripheral autonomous activity, resulting from a shift in the balance of excitation and inhibition in smooth muscle modules. These structures responsible for origin and spread of peripheral autonomous activity could be targeted to help develop new therapeutic strategies.	Univ Newcastle Upon Tyne, Sch Med, Tyne Micturit Res Grp, Sch Surg Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; St Marys Hosp, Dept Urol, London, England	Newcastle University - UK; Imperial College London	Drake, MJ (corresponding author), Univ Newcastle Upon Tyne, Sch Med, Tyne Micturit Res Grp, Sch Surg Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.		Drake, Marcus/C-4542-2014	Drake, Marcus/0000-0002-6230-2552				BRADING AF, 1994, BRIT J UROL, V73, P3, DOI 10.1111/j.1464-410X.1994.tb07447.x; Brading AF, 1997, UROLOGY, V50, P57, DOI 10.1016/S0090-4295(97)00591-8; Bristow SE, 1996, BRIT J UROL, V77, P333, DOI 10.1046/j.1464-410X.1996.08981.x; Charlton RG, 1999, BJU INT, V84, P953; COOLSAET BLRA, 1993, NEUROUROL URODYNAM, V12, P463, DOI 10.1002/nau.1930120504; DEGROAT WC, 1997, UROLOGY S6A, V50, pS36; Furness JB., 1987, ENTERIC NERVOUS SYST; Greenland JE, 2000, BJU INT, V85, P1109, DOI 10.1046/j.1464-410x.2000.00611.x; LENNON GM, 1993, BRIT J UROL, V72, P702, DOI 10.1111/j.1464-410X.1993.tb16251.x; Mills I. W., 1998, Neurourology and Urodynamics, V17, P352; Sanders KM, 1996, GASTROENTEROLOGY, V111, P492, DOI 10.1053/gast.1996.v111.pm8690216; Sergeant GP, 2000, J PHYSIOL-LONDON, V526, P359, DOI 10.1111/j.1469-7793.2000.t01-2-00359.x; SETHIA KK, 1990, J UROLOGY, V143, P1243, DOI 10.1016/S0022-5347(17)40246-1; SKEHAN AM, 1993, J UROLOGY, V149, P1156, DOI 10.1016/S0022-5347(17)36339-5; Smet PJ, 1996, NEUROSCIENCE, V71, P337, DOI 10.1016/0306-4522(95)00453-X; Smet PJ, 1996, J NEUROCYTOL, V25, P112, DOI 10.1007/BF02284790	16	115	125	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 4	2001	358	9279					401	403		10.1016/S0140-6736(01)05549-0	http://dx.doi.org/10.1016/S0140-6736(01)05549-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459DE	11502339				2022-12-28	WOS:000170235100034
J	Liquori, CL; Ricker, K; Moseley, ML; Jacobsen, JF; Kress, W; Naylor, SL; Day, JW; Ranum, LPW				Liquori, CL; Ricker, K; Moseley, ML; Jacobsen, JF; Kress, W; Naylor, SL; Day, JW; Ranum, LPW			Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9	SCIENCE			English	Article							TRINUCLEOTIDE REPEAT EXPANSION; BINDING-PROTEIN BINDS; FRAGILE-X-SYNDROME; REDUCES EXPRESSION; MESSENGER-RNA; CHROMOSOME 3Q; CTG REPEAT; MYOPATHY; LINKAGE; GENE	Myotonic dystrophy (DM), the most common form of muscular dystrophy in adults, can be caused by a mutation on either chromosome 19q13 (DM1) or 3q21 (DM2/PROMM). DM1 is caused by a CTG expansion in the 3' untranslated region of the dystrophia myotonica-protein kinase gene (DMPK). Several mechanisms have been invoked to explain how this mutation, which does not alter the protein-coding portion of a gene, causes the specific constellation of clinical features characteristic of DM. We now report that DM2 is caused by a CCTG expansion (mean similar to 5000 repeats) located in intron 1 of the zinc finger protein 9 (ZNF9) gene. Parallels between these mutations indicate that microsatellite expansions in RNA can be pathogenic and cause the multisystemic features of DM1 and DM2.	Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Neurol MMC 206, Minneapolis, MN 55455 USA; Univ Wurzburg, Dept Neurol, D-97070 Wurzburg, Germany; Univ Wurzburg, Inst Human Genet, D-97070 Wurzburg, Germany; Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, San Antonio, TX 78284 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Wurzburg; University of Wurzburg; University of Texas System; University of Texas Health San Antonio	Ranum, LPW (corresponding author), Univ Minnesota, Inst Human Genet, 420 Delaware St SE, Minneapolis, MN 55455 USA.			Day, John/0000-0002-0086-9529	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG002051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035870] Funding Source: NIH RePORTER; NCI NIH HHS [CA56266] Funding Source: Medline; NHGRI NIH HHS [HG002051] Funding Source: Medline; NINDS NIH HHS [NS35870] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alwazzan M, 1999, HUM MOL GENET, V8, P1491, DOI 10.1093/hmg/8.8.1491; BOUCHER CA, 1995, HUM MOL GENET, V4, P1919, DOI 10.1093/hmg/4.10.1919; Davis BM, 1997, P NATL ACAD SCI USA, V94, P7388, DOI 10.1073/pnas.94.14.7388; Day JW, 1999, NEUROMUSCULAR DISORD, V9, P19, DOI 10.1016/S0960-8966(98)00094-7; DEMUNAIN AL, 1994, ANN NEUROL, V35, P374, DOI 10.1002/ana.410350323; FLINK IL, 1995, GENE, V163, P279, DOI 10.1016/0378-1119(95)00421-2; FU YH, 1993, SCIENCE, V260, P235, DOI 10.1126/science.8469976; *GENB, AC022944 GENB; *GENB, M28372 GENB; *GENB, AC023598 GENB; *GENB, AF388525 GENB; *GENB, AF388526 GENB; *GENB, AF389886 GENB; *GENB, AC022993 GENB; *GENB, AF389887 GENB; Groenen P, 1998, BIOESSAYS, V20, P901, DOI 10.1002/(SICI)1521-1878(199811)20:11<901::AID-BIES5>3.0.CO;2-0; Harper P.S., 1989, MYOTONIC DYSTROPHY; Helderman-van den Enden ATJM, 1999, J MED GENET, V36, P253; Klesert TR, 1997, NAT GENET, V16, P402, DOI 10.1038/ng0897-402; Klesert TR, 2000, NAT GENET, V25, P105, DOI 10.1038/75490; Koob MD, 1999, NAT GENET, V21, P379, DOI 10.1038/7710; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Lu XH, 1999, HUM MOL GENET, V8, P53, DOI 10.1093/hmg/8.1.53; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Matsuura T, 2000, NAT GENET, V26, P191, DOI 10.1038/79911; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Moutou C, 1997, HUM MOL GENET, V6, P971, DOI 10.1093/hmg/6.7.971; OTTEN AD, 1995, P NATL ACAD SCI USA, V92, P5465, DOI 10.1073/pnas.92.12.5465; Pellizzoni L, 1997, J MOL BIOL, V267, P264, DOI 10.1006/jmbi.1996.0888; Pellizzoni L, 1998, J MOL BIOL, V281, P593, DOI 10.1006/jmbi.1998.1961; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; RAJAVASHISTH TB, 1989, SCIENCE, V245, P640, DOI 10.1126/science.2562787; Ranum LPW, 1998, NAT GENET, V19, P196, DOI 10.1038/570; RANUM LPW, UNPUB; Reddy S, 1996, NAT GENET, V13, P325, DOI 10.1038/ng0796-325; Ricker K, 1999, NEUROLOGY, V52, P170, DOI 10.1212/WNL.52.1.170; RICKER K, 1994, NEUROLOGY, V44, P1448, DOI 10.1212/WNL.44.8.1448; Sarkar PS, 2000, NAT GENET, V25, P110, DOI 10.1038/75500; Schneider C, 2000, NEUROLOGY, V55, P383, DOI 10.1212/WNL.55.3.383; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Steinert H., 1909, DTSCH Z NERVENHEILKU, V37, P58, DOI [10.1007/BF01671719, DOI 10.1007/BF01671719]; Takahashi N, 2000, BIOCHEM BIOPH RES CO, V277, P518, DOI 10.1006/bbrc.2000.3694; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Thornton CA, 1997, NAT GENET, V16, P407, DOI 10.1038/ng0897-407; THORNTON CA, 1994, ANN NEUROL, V35, P269, DOI 10.1002/ana.410350305; Timchenko LT, 1996, NUCLEIC ACIDS RES, V24, P4407, DOI 10.1093/nar/24.22.4407; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; WONG LJC, 1995, AM J HUM GENET, V56, P114	49	850	899	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2001	293	5531					864	867		10.1126/science.1062125	http://dx.doi.org/10.1126/science.1062125			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11486088				2022-12-28	WOS:000170241000045
J	Waitzkin, H; Iriart, C; Estrada, A; Lamadrid, S				Waitzkin, H; Iriart, C; Estrada, A; Lamadrid, S			Social medicine in Latin America: productivity and dangers facing the major national groups	LANCET			English	Article							CARE	There is little knowledge about Latin American social medicine in the English-speaking world. Social medicine groups exist in Argentina, Brazil, Chile, Colombia, Cuba, Ecuador, and Mexico. Dictatorships have created political and economic conditions which are more adverse in some countries than others; in certain instances, practitioners of social medicine have faced unemployment, arrest, torture, exile, and death. Social medicine groups have focused on the social determinants of illness and early death, the effects of social policies such as privatisation and public sector cutbacks, occupational and environmental causes of illness, critical epidemiology, mental health effects of political trauma, the impact of gender, and collaborations with local communities, labour organisations, and indigenous people. The groups' achievements and financial survival have varied, depending partly on the national context. Active professional associations have developed, both nationally and internationally. Several groups have achieved publication in journals and books, despite financial and technical difficulties that might be lessened through a new initiative sponsored by the US National Library of Medicine. The conceptual orientation and research efforts of these groups have tended to challenge current relations of economic and political power. Despite its dangers, Latin American social medicine has emerged as a productive field of work, whose findings have become pertinent throughout the world.	Univ New Mexico, Dept Family & Community Med, Div Community Med, Albuquerque, NM 87131 USA; Cent Org Argentine Workers, Buenos Aires, DF, Argentina; Grp Res & Training Social Med, Santiago, Chile; Univ Chile, Santiago, Chile	University of New Mexico; Universidad de Chile	Waitzkin, H (corresponding author), Univ New Mexico, Dept Family & Community Med, Div Community Med, Albuquerque, NM 87131 USA.	waitzkin@unm.edu			FIC NIH HHS [TW 01982] Funding Source: Medline; NLM NIH HHS [1G08 LM06688] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [F06TW001982] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [G08LM006688] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Agudelo S. F., 1997, Revista Panamericana de Salud Publica/Pan American Journal of Public Health, V2, P170; Agudelo SF, 1990, PALUDISMO AM LATINA; ARANGO Y, 1992, SALUD AUTOCUIDADO; Arouca ASS, 1975, DILEMA PREVENTIVISTA; AYRES J.R., 1995, EPIDEMIOLOGIA EMANCI; BELMARTINO S, 1998, CUADERNOS MED SOCIAL, V73, P61; BLANCO GJ, 2000, CHIAPAS EMERGENCIA S; Breilh J, 1988, EPIDEMIOLOGIA EC MED; BREILH J, 1995, NUEVOS CONCEPTOS TEC; BUCHANAN HS, 2001, IN PRESS DIGITAL LIB; CABELLO FC, 1993, SALUD CAMBIO, V4, P5; CAMPANA A, 1995, SALUD MENTAL CONCIEN; CAMPOS GWD, 1992, REFORMA REFORMA; COHEN H, 1994, POLITICAS SALUD MENT; COHN A, 1996, SAUDE BRASIL POLITIC; *COL CEAS, 1994, MUJ TRAB SAL; Cordeiro H., 1991, SISTEMA UNICO SAUDE; *CTR EST AS SAL, 1997, REF SAL PRIV SOL; DEALMEIDA N, 1992, EPIDEMIOLOGIA SIN NU; DONNANGELO M. C. F., 1975, MED SOC; ESCUDERO JC, 1992, SALUD CAMBIO CHILE, V3, P4; ESTRADA A, 1997, FAMILIA GENERO TERAP; ESTRADA A, 1998, ATENCION GERENCIADA; Fleury S, 2000, RESHAPING HLTH CARE; Franco T B, 1999, Cad Saude Publica, V15, P345, DOI 10.1590/S0102-311X1999000200019; GONCALVES RBM, 1994, TECNOLOGIA ORG SOCIA; Iriart Celia, 1994, TECNOBUROCRACIA SANI; LAURELL AC, 1977, INT J HEALTH SERV, V7, P401, DOI 10.2190/Q7AR-X9V1-KMV3-PCBX; Laurell AC, 1996, INT J HEALTH SERV, V26, P1, DOI 10.2190/PBX9-N89E-4QFE-046V; LAURELL AC, 1992, SOC SCI MED, V34, P603, DOI 10.1016/0277-9536(92)90188-V; LUZ M., 1988, NATURAL RACIONAL SOC; MARTINEZ FJM, 1996, ENTRE INFIERNO GLORI; MENENDEZ EL, 1992, CRISIS PUBLIC HLTH R; MERHY E, 1997, AGIR SAUDE DESAFIO P; Merhy EE, 1992, SAUDE PUBLICA COMO P; NERVI L, 1999, SALUD CAMBIO SOCIAL; NUNES ED, 1991, DEBATES MED SOCIAL; OCHOA FR, 1993, REV CUBANA SALUD PUB, V19, P36; PAIM JS, 1992, CRISIS PUBLIC HLTH R; POSSAS C, 1989, EPIDEMIOLOGIA SOC; SEIA H, 1997, SALUD PROBLEMA DEBAT, V15, P11; SHRAIBER L, 1989, ED MED CAPITALISMO; Stocker K, 1999, NEW ENGL J MED, V340, P1131, DOI 10.1056/NEJM199904083401425; TESTA M, 1992, CRISIS PUBLIC HLTH R; TESTA Mario, 1995, PENSAMIENTO ESTRATEG; VISILLAC E. F., 1996, SALUD AUTOGESTION LI; Waitzkin H, 1997, J FAM PRACTICE, V45, P250; WAITZKIN H, 2001, IN PRESS AM J PU OCT; ZAMUDIO L, 1978, BARRIO POPULAR MARGI	49	50	61	1	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 28	2001	358	9278					315	323		10.1016/S0140-6736(01)05488-5	http://dx.doi.org/10.1016/S0140-6736(01)05488-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	457AF	11498235				2022-12-28	WOS:000170114400031
J	Segal, HP				Segal, HP			Victor and victim - The true message of Frankenstein is about morality, not mad science.	NATURE			English	Editorial Material									Univ Maine, Dept Hist, Orono, ME 04469 USA	University of Maine System; University of Maine Orono	Segal, HP (corresponding author), Univ Maine, Dept Hist, Orono, ME 04469 USA.								0	3	3	0	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2001	412	6850					861	861		10.1038/35091129	http://dx.doi.org/10.1038/35091129			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467EG	11528455	Bronze			2022-12-28	WOS:000170689000023
J	Hugouvieux, V; Kwak, JM; Schroeder, JI				Hugouvieux, V; Kwak, JM; Schroeder, JI			An mRNA cap binding protein, ABH1, modulates early abscisic acid signal transduction in Arabidopsis	CELL			English	Article							CYTOPLASMIC CALCIUM; ANION CHANNELS; CYTOSOLIC CA-2+; GENE-EXPRESSION; ION CHANNELS; ETHYLENE; COMPLEX; MUTANT; ABA; GROWTH	The plant hormone abscisic acid (ABA) regulates important stress and developmental responses. We have isolated a recessive ABA hypersensitive mutant, abh1, that shows hormone specificity to ABA. ABH1 encodes the Arabidopsis homolog of a nuclear mRNA cap binding protein and functions in a heterodimeric complex to bind the mRNA cap structure. DNA chip analyses show that only a few transcripts are downregulated in abh1, several of which are implicated in ABA signaling. Consistent with these results, abh1 plants show ABA-hypersensitive stomatal closing and reduced wilting during drought. Interestingly, ABA-hypersensitive cytosolic calcium increases in abh1 guard cells demonstrate amplification of early ABA signaling. Thus, ABH1 represents a modulator of ABA signaling proposed to function by transcript alteration of early ABA signaling elements.	Univ Calif San Diego, Div Biol, Cell & Dev Biol Sect, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Mol Genet, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Schroeder, JI (corresponding author), Univ Calif San Diego, Div Biol, Cell & Dev Biol Sect, 9500 Gilman Dr, La Jolla, CA 92093 USA.	julian@biomail.ucsd.edu	Kwak, June M/G-8332-2011	Kwak, June M/0000-0001-6948-5155; Schroeder, Julian/0000-0002-3283-5972	NIGMS NIH HHS [R01 GM60396-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060396] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLAN AC, 1994, PLANT CELL, V6, P1319; Allen GJ, 1999, PLANT CELL, V11, P1785, DOI 10.1105/tpc.11.9.1785; Allen GJ, 1999, PLANT J, V19, P735, DOI 10.1046/j.1365-313x.1999.00574.x; Allen GJ, 2000, SCIENCE, V289, P2338, DOI 10.1126/science.289.5488.2338; Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; ARMSTRONG F, 1995, P NATL ACAD SCI USA, V92, P9520, DOI 10.1073/pnas.92.21.9520; Beaudoin N, 2000, PLANT CELL, V12, P1103, DOI 10.1105/tpc.12.7.1103; Bethke PC, 1998, CURR OPIN PLANT BIOL, V1, P440, DOI 10.1016/S1369-5266(98)80270-7; Bonetta D, 2000, PLANTA, V211, P182, DOI 10.1007/s004250000283; Bueno P, 1998, PLANT SCI, V138, P27, DOI 10.1016/S0168-9452(98)00154-X; CARY AJ, 1995, PLANT PHYSIOL, V107, P1075, DOI 10.1104/pp.107.4.1075; Cutler S, 1996, SCIENCE, V273, P1239, DOI 10.1126/science.273.5279.1239; Ephritikhine G, 1999, PLANT J, V18, P303, DOI 10.1046/j.1365-313X.1999.00454.x; Finkelstein RR, 2000, PLANT CELL, V12, P599, DOI 10.1105/tpc.12.4.599; Flaherty SM, 1997, P NATL ACAD SCI USA, V94, P11893, DOI 10.1073/pnas.94.22.11893; Fortes P, 2000, MOL CELL, V6, P191, DOI 10.1016/S1097-2765(00)00020-4; Fortes P, 1999, MOL CELL BIOL, V19, P6543; Foster R, 1999, PLANT J, V17, P363, DOI 10.1046/j.1365-313X.1999.00384.x; FURUICHI Y, 1977, NATURE, V266, P235, DOI 10.1038/266235a0; Ghassemian M, 2000, PLANT CELL, V12, P1117, DOI 10.1105/tpc.12.7.1117; GILMOUR SJ, 1992, PLANT MOL BIOL, V18, P13, DOI 10.1007/BF00018452; GILROY S, 1990, NATURE, V346, P769, DOI 10.1038/346769a0; GIRAUDAT J, 1992, PLANT CELL, V4, P1251, DOI 10.1105/tpc.4.10.1251; Grabov A, 1998, P NATL ACAD SCI USA, V95, P4778, DOI 10.1073/pnas.95.8.4778; Guan LQM, 2000, PLANT J, V22, P87, DOI 10.1046/j.1365-313x.2000.00723.x; Gutierrez RA, 1999, TRENDS PLANT SCI, V4, P429, DOI 10.1016/S1360-1385(99)01484-3; GUZMAN P, 1990, PLANT CELL, V2, P513, DOI 10.1105/tpc.2.6.513; IZAURRALDE E, 1994, CELL, V78, P657, DOI 10.1016/0092-8674(94)90530-4; IZAURRALDE E, 1995, NATURE, V376, P709, DOI 10.1038/376709a0; KARSSEN CM, 1989, ANN BOT-LONDON, V63, P71, DOI 10.1093/oxfordjournals.aob.a087730; KATAOKA N, 1995, NUCLEIC ACIDS RES, V23, P3638, DOI 10.1093/nar/23.18.3638; KOOMNEEF M, 1998, PLANT PHYSIOL BIOCH, V36, P83, DOI DOI 10.1016/S0981-9428(98)80093-4; KOOMNEEF M, 1994, PHYSIOL PLANTARUM, P313; Leung J, 1997, PLANT CELL, V9, P759, DOI 10.1105/tpc.9.5.759; Leung J, 1998, ANNU REV PLANT PHYS, V49, P199, DOI 10.1146/annurev.arplant.49.1.199; Lewis JD, 1997, EUR J BIOCHEM, V247, P461, DOI 10.1111/j.1432-1033.1997.00461.x; Li JX, 2000, SCIENCE, V287, P300, DOI 10.1126/science.287.5451.300; Lin XY, 1999, NATURE, V402, P761, DOI 10.1038/45471; LINCOLN C, 1990, PLANT CELL, V2, P1071, DOI 10.1105/tpc.2.11.1071; MacIntosh GC, 2001, P NATL ACAD SCI USA, V98, P1018, DOI 10.1073/pnas.98.3.1018; MacRobbie EAC, 1998, PHILOS T ROY SOC B, V353, P1475, DOI 10.1098/rstb.1998.0303; MARCOTTE WR, 1992, BIOCHEM SOC T, V20, P93, DOI 10.1042/bst0200093; MCAINSH MR, 1990, NATURE, V343, P186, DOI 10.1038/343186a0; NAMBARA E, 1992, PLANT J, V2, P435, DOI 10.1111/j.1365-313X.1992.00435.x; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Pei ZM, 1997, PLANT CELL, V9, P409, DOI 10.1105/tpc.9.3.409; Pei ZM, 1998, SCIENCE, V282, P287, DOI 10.1126/science.282.5387.287; Schroeder JI, 2001, NATURE, V410, P327, DOI 10.1038/35066500; SCHROEDER JI, 1990, P NATL ACAD SCI USA, V87, P9305, DOI 10.1073/pnas.87.23.9305; SCHROEDER JI, 1989, NATURE, V338, P427, DOI 10.1038/338427a0; Schwartz SH, 1997, PLANT PHYSIOL, V114, P161, DOI 10.1104/pp.114.1.161; Seki M, 2001, PLANT CELL, V13, P61, DOI 10.1105/tpc.13.1.61; SHATKIN AJ, 1976, CELL, V9, P645, DOI 10.1016/0092-8674(76)90128-8; Sheen J, 1998, P NATL ACAD SCI USA, V95, P975, DOI 10.1073/pnas.95.3.975; SHIMOTOHNO K, 1977, P NATL ACAD SCI USA, V74, P2734, DOI 10.1073/pnas.74.7.2734; Sonenberg N, 1998, CURR OPIN CELL BIOL, V10, P268, DOI 10.1016/S0955-0674(98)80150-6; STASWICK PE, 1992, P NATL ACAD SCI USA, V89, P6837, DOI 10.1073/pnas.89.15.6837; Staxen I, 1999, P NATL ACAD SCI USA, V96, P1779, DOI 10.1073/pnas.96.4.1779; Steber CM, 1998, GENETICS, V149, P509; Takahashi S, 2000, PLANT CELL PHYSIOL, V41, P898, DOI 10.1093/pcp/pcd010; UEMURA H, 1992, J BACTERIOL, V174, P5526, DOI 10.1128/JB.174.17.5526-5532.1992; Vranova E, 2000, J EXP BOT, V51, P1763, DOI 10.1093/jexbot/51.351.1763; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; WILHELM KS, 1993, PLANT MOL BIOL, V23, P1073, DOI 10.1007/BF00021822; Wilson KF, 1999, J BIOL CHEM, V274, P4166, DOI 10.1074/jbc.274.7.4166; Yalovsky S, 2000, PLANT CELL, V12, P1257, DOI 10.1105/tpc.12.8.1257; Ziegelhoffer EC, 2000, P NATL ACAD SCI USA, V97, P7633, DOI 10.1073/pnas.130189397	67	322	333	1	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 24	2001	106	4					477	487		10.1016/S0092-8674(01)00460-3	http://dx.doi.org/10.1016/S0092-8674(01)00460-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	466UU	11525733	Bronze			2022-12-28	WOS:000170665200011
J	Lee, VMY				Lee, VMY			Biomedicine - Tauists and beta aptists united - Well almost!	SCIENCE			English	Editorial Material							FAMILIAL ALZHEIMERS-DISEASE; AMYLOID PRECURSOR PROTEIN; TRANSGENIC MICE; NEURONAL LOSS; IN-VIVO; TAU; GENE; MISSENSE; DEMENTIA; MUTATIONS		Univ Penn, Sch Med, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Lee, VMY (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA.	vmylee@mail.med.upenn.edu						Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; Duff K, 2000, NEUROBIOL DIS, V7, P87, DOI 10.1006/nbdi.1999.0279; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Hall GF, 2000, J CELL SCI, V113, P1373; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Irizarry MC, 1997, J NEUROPATH EXP NEUR, V56, P965, DOI 10.1097/00005072-199709000-00002; Irizarry MC, 1997, J NEUROSCI, V17, P7053; Ishihara T, 1999, NEURON, V24, P751, DOI 10.1016/S0896-6273(00)81127-7; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382	18	38	40	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2001	293	5534					1446	1447		10.1126/science.1064684	http://dx.doi.org/10.1126/science.1064684			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465XV	11520974				2022-12-28	WOS:000170616000031
J	Vocadlo, DJ; Davies, GJ; Laine, R; Withers, SG				Vocadlo, DJ; Davies, GJ; Laine, R; Withers, SG			Catalysis by hen egg-white lysozyme proceeds via a covalent intermediate	NATURE			English	Article							CRYSTALLOGRAPHIC EVIDENCE; BETA-GLUCOSIDASE; HYDROLYSIS; DISTORTION; MECHANISM; INSIGHTS; ACID	Hen egg-white lysozyme (HEWL) was the first enzyme to have its three-dimensional structure determined by X-ray diffraction techniques(1). A catalytic mechanism, featuring a long-lived oxo-carbenium-ion intermediate, was proposed on the basis of model-building studies(2). The `Phillips' mechanism is widely held as the paradigm for the catalytic mechanism of beta -glycosidases that cleave glycosidic linkages with net retention of configuration of the anomeric centre. Studies with other retaining beta -glycosidases, however, provide strong evidence pointing to a common mechanism for these enzymes that involves a covalent glycosyl-enzyme intermediate, as previously postulated(3). Here we show, in three different cases using electrospray ionization mass spectrometry, a catalytically competent covalent glycosyl-enzyme intermediate during the catalytic cycle of HEWL. We also show the three-dimensional structure of this intermediate as determined by Xray diffraction. We formulate a general catalytic mechanism for all retaining beta -glycosidases that includes substrate distortion, formation of a covalent intermediate, and the electrophilic migration of C1 along the reaction coordinate.	Univ British Columbia, Prot Engn Network Ctr Excellence, Vancouver, BC V6T 1Z1, Canada; Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada; Univ York, Dept Chem, Struct Biol Lab, York YO10 5DD, N Yorkshire, England; Louisiana State Univ, Dept Biol, Baton Rouge, LA 70808 USA; Louisiana State Univ, Dept Chem, Baton Rouge, LA 70808 USA	University of British Columbia; University of British Columbia; University of York - UK; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University	Withers, SG (corresponding author), Univ British Columbia, Prot Engn Network Ctr Excellence, Vancouver, BC V6T 1Z1, Canada.	withers@chem.ubc.ca	Laine, Roger A/B-9434-2014; Laine, Roger/ABE-2473-2020; Withers, Stephen G/I-7229-2019; Vocadlo, David J/E-5508-2014; Davies, Gideon J/A-9042-2011	Laine, Roger A/0000-0001-5984-4409; Withers, Stephen G/0000-0002-6722-5701; Vocadlo, David J/0000-0001-6897-5558; Davies, Gideon J/0000-0002-7343-776X				AMYES TL, 1989, J AM CHEM SOC, V111, P7888, DOI 10.1021/ja00202a033; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BALLARDIE FW, 1977, BIOORG CHEM, V6, P483, DOI 10.1016/0045-2068(77)90047-5; BLAKE CCF, 1965, NATURE, V206, P757, DOI 10.1038/206757a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burmeister WP, 1997, STRUCTURE, V5, P663, DOI 10.1016/S0969-2126(97)00221-9; CHIPMAN DM, 1968, J BIOL CHEM, V243, P487; DAHLQUIS.FW, 1969, BIOCHEMISTRY-US, V8, P4214, DOI 10.1021/bi00838a045; Davies G. J., 1998, INCOMPREHENSIVE BIOL, P119; Davies GJ, 1998, BIOCHEMISTRY-US, V37, P11707, DOI 10.1021/bi981315i; Fedorov A, 2001, BIOCHEMISTRY-US, V40, P853, DOI 10.1021/bi002499f; FINK AL, 1980, BIOCHEMISTRY-US, V19, P811, DOI 10.1021/bi00545a030; HOLLER E, 1975, BIOCHEMISTRY-US, V14, P2377, DOI 10.1021/bi00682a017; KOSHLAND DE, 1953, BIOL REV, V28, P416, DOI 10.1111/j.1469-185X.1953.tb01386.x; Kuroki R, 1999, P NATL ACAD SCI USA, V96, P8949, DOI 10.1073/pnas.96.16.8949; MALCOLM BA, 1989, P NATL ACAD SCI USA, V86, P133, DOI 10.1073/pnas.86.1.133; Mark BL, 2001, J BIOL CHEM, V276, P10330, DOI 10.1074/jbc.M011067200; Matsumura I, 1996, BIOCHEMISTRY-US, V35, P1881, DOI 10.1021/bi951671q; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Notenboom V, 1998, NAT STRUCT BIOL, V5, P812, DOI 10.1038/1852; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PHILLIPS DC, 1967, P NATL ACAD SCI USA, V57, P484; RANDMEIR T, 1969, BIOCHEMISTRY-US, V8, P4206, DOI 10.1021/bi00838a044; ROSENBERG S, 1981, BIOCHEMISTRY-US, V20, P3196, DOI 10.1021/bi00514a032; SINNOTT ML, 1973, BIOCHEM J, V133, P89, DOI 10.1042/bj1330089; STRYNADKA NCJ, 1991, J MOL BIOL, V220, P401, DOI 10.1016/0022-2836(91)90021-W; Sulzenbacher G, 1996, BIOCHEMISTRY-US, V35, P15280, DOI 10.1021/bi961946h; Tews I, 1996, NAT STRUCT BIOL, V3, P638, DOI 10.1038/nsb0796-638; WANG Q, 1995, BIOCHEMISTRY-US, V34, P14554, DOI 10.1021/bi00044a034	29	509	524	1	193	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 23	2001	412	6849					835	838		10.1038/35090602	http://dx.doi.org/10.1038/35090602			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465ET	11518970	Green Accepted			2022-12-28	WOS:000170577200041
J	Stein, DJ				Stein, DJ			Handwriting and obsessive-compulsive disorder	LANCET			English	Editorial Material									Univ Stellenbosch, Dept Psychiat, MRC, Unit Anxiety Disorders, ZA-7505 Tygerberg, South Africa; Univ Florida, Gainesville, FL USA	Stellenbosch University; State University System of Florida; University of Florida	Stein, DJ (corresponding author), Univ Stellenbosch, Dept Psychiat, MRC, Unit Anxiety Disorders, ZA-7505 Tygerberg, South Africa.		Stein, Dan/A-1752-2008	Stein, Dan/0000-0001-7218-7810				ALTEN EH, 1939, MED REC, V150, P71; BEYERSTEIN BL, 1992, WRITE STUFF EVALUATI; CJ Murray, 1996, GLOBAL BURDEN DIS CO, VI; GROSS LJ, 1975, TEX REP BIOL MED, V33, P371; Grossberg S, 2000, NEURAL NETWORKS, V13, P999, DOI 10.1016/S0893-6080(00)00065-4; Kuenstler U, 1999, PSYCHIAT RES-NEUROIM, V90, P31, DOI 10.1016/S0925-4927(98)00054-7; Mavrogiorgou P, 2001, J NEUROL NEUROSUR PS, V70, P605, DOI 10.1136/jnnp.70.5.605; Rauch SL, 1997, J NEUROPSYCH CLIN N, V9, P568; Schilder P, 1938, AM J PSYCHIAT, V94, P1397, DOI 10.1176/ajp.94.6.1397; SMITH KU, 1956, J APPL PSYCHOL, V40, P302, DOI 10.1037/h0041211; Stein D, 1997, ESSENTIAL PAPERS OBS; Stein D J, 2000, Curr Psychiatry Rep, V2, P341, DOI 10.1007/s11920-000-0079-2; STEIN DJ, 1993, PSYCHIAT ANN, V23, P389, DOI 10.3928/0048-5713-19930701-10; Stein DJ, 1994, CURRENT INSIGHTS OBS; Volmat R, 1983, Acta Psychiatr Belg, V83, P220	15	2	3	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 18	2001	358	9281					524	525		10.1016/S0140-6736(01)05744-0	http://dx.doi.org/10.1016/S0140-6736(01)05744-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	464NB	11520518				2022-12-28	WOS:000170537700005
J	Brown, T; Sibbett, W; Wright, EM				Brown, T; Sibbett, W; Wright, EM			Laser physics - Getting to grips with light	SCIENCE			English	Editorial Material							OPTICAL FREQUENCY-MEASUREMENT; PHASE-CONTROL; PULSES; LINE		Univ St Andrews, Sch Phys & Astron, Ultrafast Photon Collaborat, St Andrews KY16 9SS, Fife, Scotland; Univ Arizona, Ctr Opt Sci, Tucson, AZ 85721 USA	University of St Andrews; University of Arizona	Brown, T (corresponding author), Univ St Andrews, Sch Phys & Astron, Ultrafast Photon Collaborat, St Andrews KY16 9SS, Fife, Scotland.	ctab@st-andrews.ac.uk						Diddams SA, 2000, OPT PHOTONICS NEWS, V11, P16, DOI 10.1364/OPN.11.10.000016; Hopkins JM, 2000, SCI AM, V283, P72, DOI 10.1038/scientificamerican0900-72; Jones DJ, 2000, SCIENCE, V288, P635, DOI 10.1126/science.288.5466.635; Morgner U, 1999, OPT LETT, V24, P411, DOI 10.1364/OL.24.000411; Morgner U, 2001, PHYS REV LETT, V86, P5462, DOI 10.1103/PhysRevLett.86.5462; Poppe A, 2001, APPL PHYS B-LASERS O, V72, P373, DOI 10.1007/s003400000526; Shelton RK, 2001, SCIENCE, V293, P1286, DOI 10.1126/science.1061754; Stenger J, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.021802; Telle HR, 1999, APPL PHYS B-LASERS O, V69, P327, DOI 10.1007/s003400050813; Udem T, 1999, PHYS REV LETT, V82, P3568, DOI 10.1103/PhysRevLett.82.3568	10	0	0	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2001	293	5533					1265	+		10.1126/science.1064465	http://dx.doi.org/10.1126/science.1064465			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11509714				2022-12-28	WOS:000170492600023
J	des Etangs, AL; Vidal-Madjar, A; Roberge, A; Feldman, PD; Deleuil, M; Andre, M; Blair, WP; Bouret, JC; Desert, JM; Ferlet, R; Friedman, S; Hebrard, G; Lemoine, M; Moos, HW				des Etangs, AL; Vidal-Madjar, A; Roberge, A; Feldman, PD; Deleuil, M; Andre, M; Blair, WP; Bouret, JC; Desert, JM; Ferlet, R; Friedman, S; Hebrard, G; Lemoine, M; Moos, HW			Deficiency of molecular hydrogen in the disk of beta Pictoris	NATURE			English	Article							HST-GHRS OBSERVATIONS; CIRCUMSTELLAR DISK; CO; GAS; BODIES; SPACE; CI	Molecular hydrogen (H-2) is by far the most abundant material from which stars, protoplanetary disks and giant planets form, but it is difficult to detect directly. Infrared emission lines from H-2 have recently been reported(1) towards beta Pictoris, a star harbouring a young planetary system(2). This star is surrounded by a dusty 'debris disk' that is continuously replenished either by collisions between asteroidal objects(3) or by evaporation of ices on Chiron-like objects(4). A gaseous disk has also been inferred from absorption lines in the stellar spectrum(5-8). Here we present the far-ultraviolet spectrum of beta Pictoris, in which H-2 absorption lines are not seen. This allows us to set a very low upper limit on the column density of H-2 : N(H-2) less than or equal to 10(18) cm(-2). This non-detection is puzzling when compared to the quantity of H-2 inferred from the infrared observations, but it does show that H-2 is not in the disk on the direct line of sight. Carbon monoxide (CO) has been seen in absorption against the star(8-10), yielding a ratio of CO/H-2 >6 x 10(-4). As CO would be destroyed under ambient conditions in about 200 years (refs 9, 11), our result demonstrates that the CO in the disk arises from evaporation of planetesimals.	CNRS, Inst Astrophys Paris, F-75014 Paris, France; Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA; Lab Astrophys Marseille, F-13376 Marseille 2, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Johns Hopkins University; UDICE-French Research Universities; Aix-Marseille Universite	des Etangs, AL (corresponding author), CNRS, Inst Astrophys Paris, 98 Bis Bld Arago, F-75014 Paris, France.	lecaveli@iap.fr	Roberge, Aki/D-2782-2012; Lecavelier des Etangs, Alain/GLU-6503-2022; Lemoine, Martin/AAE-6416-2019	Roberge, Aki/0000-0002-2989-3725; Lecavelier des Etangs, Alain/0000-0002-5637-5253; Lemoine, Martin/0000-0002-2395-7812; Deleuil, Magali/0000-0001-6036-0225				Backman D. E., 1993, PROTOSTARS PLANETS, P1253; BEUST H, 1990, ASTRON ASTROPHYS, V236, P202; CARRUTHERS GR, 1970, ASTROPHYS J, V161, pL81, DOI 10.1086/180575; DELEUIL M, IN PRESS ASTROPHYS J; desEtangs AL, 1996, ASTRON ASTROPHYS, V307, P542; DESETANGS AL, 1999, PLANETS OUTSIDE SOLA, P95; FERLET R, 1987, ASTRON ASTROPHYS, V185, P267; HOBBS LM, 1985, ASTROPHYS J, V293, pL29, DOI 10.1086/184485; Jolly A, 1998, ASTRON ASTROPHYS, V329, P1028; Kamp I, 2000, ASTRON ASTROPHYS, V353, P276; Lagrange AM, 1998, ASTRON ASTROPHYS, V330, P1091; Liseau R, 1998, ASTRON ASTROPHYS, V334, P935; Magnani L, 1998, ASTROPHYS J, V504, P290, DOI 10.1086/306062; Moos HW, 2000, ASTROPHYS J, V538, pL1, DOI 10.1086/312795; Navascues DBY, 1999, ASTROPHYS J, V520, pL123, DOI 10.1086/312162; Roberge A, 2000, ASTROPHYS J, V538, P904, DOI 10.1086/309157; ROBERGE A, 1908, ASTROPHYS J, V551, pL97; SHULL JM, 1982, ANNU REV ASTRON ASTR, V20, P163, DOI 10.1146/annurev.aa.20.090182.001115; SPITZER L, 1973, ASTROPHYS J, V181, pL116, DOI 10.1086/181197; Thi WF, 2001, NATURE, V409, P60, DOI 10.1038/35051033; VANDISHOECK EF, 1988, ASTROPHYS J, V334, P771, DOI 10.1086/166877; Vidal-Madjar A, 1998, PLANET SPACE SCI, V46, P629, DOI 10.1016/S0032-0633(97)00192-X; VIDALMADJAR A, 1994, ASTRON ASTROPHYS, V290, P245; VIDALMADJAR A, 1986, ASTRON ASTROPHYS, V167, P325	24	94	95	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2001	412	6848					706	708		10.1038/35089006	http://dx.doi.org/10.1038/35089006			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462ZB	11507632				2022-12-28	WOS:000170450200036
J	Geijsen, N; Uings, IJ; Pals, C; Armstrong, J; McKinnon, M; Raaijmakers, JAM; Lammers, JWJ; Koenderman, L; Coffer, PJ				Geijsen, N; Uings, IJ; Pals, C; Armstrong, J; McKinnon, M; Raaijmakers, JAM; Lammers, JWJ; Koenderman, L; Coffer, PJ			Cytokine-specific transcriptional regulation through an IL-5R alpha interacting protein	SCIENCE			English	Article							INTERLEUKIN-5 RECEPTOR; IL-5 RECEPTOR; ALPHA-CHAIN; CELL; PDZ; MICE; DIFFERENTIATION; RECOGNITION; EXPRESSION; ACTIVATOR	Cytokine receptors consist of multiple subunits, which are often shared between different receptors, resulting in the functional redundancy sometimes observed between cytokines. The interleukin 5 (IL-5) receptor consists of an IL-5-specific alpha -subunit (IL-5R alpha) and a signal-transducing beta -subunit (betac) shared with the IL-3 and granulocyte-macrophage colony-stimulating factor (GM-CSF) receptors. In this study, we sought to find a rote for the cytoplasmic domain of IL-5R alpha. We show that syntenin, a protein containing PSD-95/Discs large/zO-1 (PDZ) domains, associates with the cytoplasmic tail of the IL-5R alpha. Syntenin was found to directly associate with the transcription factor Sox4. Association of syntenin with IL-5R alpha was required for IL-5-mediated activation of Sox4. These studies identify a mechanism of transcriptional activation by cytokine-specific receptor subunits.	Univ Utrecht, Med Ctr, Heart Lung Ctr Utrecht, Dept Pulm Dis, NL-3584 CX Utrecht, Netherlands; Glaxo Wellcome Med Res Ctr, Cell Biol Unit, Stevenage SG1 2NY, Herts, England	Utrecht University; Utrecht University Medical Center; GlaxoSmithKline	Coffer, PJ (corresponding author), Univ Utrecht, Med Ctr, Heart Lung Ctr Utrecht, Dept Pulm Dis, G03-550,Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.		Coffer, Paul/AAF-7970-2020; Koenderman, Leo/AAE-7870-2020; Coffer, Paul J/A-5769-2009	Koenderman, Leo/0000-0002-5636-6453; 				Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; Hiroi T, 1999, J IMMUNOL, V162, P821; HITOSHI Y, 1990, J IMMUNOL, V144, P4218; Kopf M, 1996, IMMUNITY, V4, P15, DOI 10.1016/S1074-7613(00)80294-0; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Lin D, 1999, J BIOL CHEM, V274, P3726, DOI 10.1074/jbc.274.6.3726; LOPEZ AF, 1988, J EXP MED, V167, P219, DOI 10.1084/jem.167.1.219; Moon BG, 2001, IMMUNOLOGY, V102, P289, DOI 10.1046/j.1365-2567.2001.01196.x; MURATA Y, 1992, J EXP MED, V175, P341, DOI 10.1084/jem.175.2.341; Schilham MW, 1996, NATURE, V380, P711, DOI 10.1038/380711a0; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Takatsu K, 1998, CYTOKINE GROWTH F R, V9, P25, DOI 10.1016/S1359-6101(97)00034-8; TAVERNIER J, 1991, CELL, V66, P1175, DOI 10.1016/0092-8674(91)90040-6; VANDEWETERING M, 1993, EMBO J, V12, P3847, DOI 10.1002/j.1460-2075.1993.tb06063.x; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; WETZEL GD, 1989, EUR J IMMUNOL, V19, P1701, DOI 10.1002/eji.1830190926; Yoshida T, 1996, IMMUNITY, V4, P483, DOI 10.1016/S1074-7613(00)80414-8	18	100	109	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2001	293	5532					1136	1138		10.1126/science.1059157	http://dx.doi.org/10.1126/science.1059157			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498591				2022-12-28	WOS:000170432600060
J	deVeber, G; Andrew, M; Adams, C; Bjornson, B; Booth, F; Buckley, DJ; Camfield, CS; David, M; Humphreys, P; Langevin, P; MacDonald, EA; Gillett, J				deVeber, G; Andrew, M; Adams, C; Bjornson, B; Booth, F; Buckley, DJ; Camfield, CS; David, M; Humphreys, P; Langevin, P; MacDonald, EA; Gillett, J		Canadian Pediat Ischemic Stroke St	Cerebral sinovenous thrombosis in children.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SAGITTAL SINUS THROMBOSIS; ARTERIAL ISCHEMIC STROKE; FACTOR-V LEIDEN; VENOUS THROMBOSIS; VEIN-THROMBOSIS; INFANTS; CHILDHOOD; ANGIOGRAPHY; DEFICIENCY; DISORDERS	Background: Cerebral sinovenous thrombosis in children is a serious disorder, and information is needed about its prevention and treatment. Methods: The Canadian Pediatric Ischemic Stroke Registry was initiated in 1992 at the 16 pediatric tertiary care centers in Canada. Children (newborn to 18 years of age) with symptoms and radiographic confirmation of sinovenous thrombosis were included. Results: During the first six years of the registry, 160 consecutive children with sinovenous thrombosis were enrolled, and the incidence of the disorder was 0.67 case per 100,000 children per year. Neonates were most commonly affected. Fifty-eight percent of the children had seizures, 76 percent had diffuse neurologic signs, and 42 percent had focal neurologic signs. Risk factors included head and neck disorders (in 29 percent), acute systemic illnesses (in 54 percent), chronic systemic diseases (in 36 percent), and prothrombotic states (in 41 percent). Venous infarcts occurred in 41 percent of the children. Fifty-three percent of the children received antithrombotic agents. Neurologic deficits were present in 38 percent of the children, and 8 percent died; half the deaths were due to sinovenous thrombosis. Predictors of adverse neurologic outcomes were seizures at presentation and venous infarcts. Conclusions: Sinovenous thrombosis in children affects primarily neonates and results in neurologic impairment or death in approximately half the cases. The occurrence of venous infarcts or seizures portends a poor outcome. (N Engl J Med 2001;345:417-23.) Copyright (C) 2001 Massachusetts Medical Society.	Hosp Sick Children, Div Neurol, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Div Hematol Oncol, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Populat Hlth Sci Program, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Pediat, Toronto, ON, Canada; Univ Calgary, Dept Pediat, Calgary, AB T2N 1N4, Canada; Univ British Columbia, Dept Pediat, Vancouver, BC V6T 1W5, Canada; Univ Manitoba, Dept Pediat, Winnipeg, MB R3T 2N2, Canada; Mem Univ Newfoundland, Dept Pediat, St Johns, NF A1C 5S7, Canada; Dalhousie Univ, Dept Pediat, Halifax, NS, Canada; Univ Montreal, Dept Hematol Oncol, Montreal, PQ, Canada; Univ Ottawa, Dept Pediat, Ottawa, ON K1N 6N5, Canada; CHU Laval, Dept Pediat Neurol, St Foy, PQ, Canada; Queens Univ, Dept Pediat, Kingston, ON K7L 3N6, Canada; Univ Western Ontario, Dept Pediat, London, ON N6A 3K7, Canada; Univ Western Ontario, Dept Clin Neurosci, London, ON N6A 3K7, Canada; McMaster Univ, Dept Pediat, Hamilton, ON, Canada; McGill Univ, Dept Neurol, Montreal, PQ H3A 2T5, Canada; McGill Univ, Dept Pediat, Montreal, PQ H3A 2T5, Canada; McGill Univ, Dept Neurosurg, Montreal, PQ H3A 2T5, Canada; Univ Alberta, Dept Pediat, Edmonton, AB, Canada; Univ Saskatchewan, Dept Pediat, Saskatoon, SK, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Calgary; University of British Columbia; University of Manitoba; Memorial University Newfoundland; Dalhousie University; Universite de Montreal; University of Ottawa; Laval University; Queens University - Canada; Western University (University of Western Ontario); Western University (University of Western Ontario); McMaster University; McGill University; McGill University; McGill University; University of Alberta; University of Saskatchewan	deVeber, G (corresponding author), Hosp Sick Children, Div Neurol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.		Bjornson, Bruce Hal/A-8616-2010	Bjornson, Bruce Hal/0000-0002-1465-6196; /0000-0002-9584-0576				BARAM TZ, 1988, ANN NEUROL, V24, P792, DOI 10.1002/ana.410240617; BARRON TF, 1992, PEDIATR NEUROL, V8, P112, DOI 10.1016/0887-8994(92)90030-3; BEZINQUE SL, 1995, PEDIATR RADIOL, V25, P175, DOI 10.1007/BF02021526; Bonduel M, 1999, ARCH NEUROL-CHICAGO, V56, P967, DOI 10.1001/archneur.56.8.967; Bousser MG, 1997, MAJOR PROBLEMS NEURO, V33; BROWN MT, 1991, NEUROLOGY, V41, P455, DOI 10.1212/WNL.41.3.455; *CANSIM, STAT CAN; CANTU C, 1993, STROKE, V24, P1880, DOI 10.1161/01.STR.24.12.1880; Casey SO, 1996, RADIOLOGY, V198, P163, DOI 10.1148/radiology.198.1.8539371; de Bruijn SFTM, 1999, STROKE, V30, P484, DOI 10.1161/01.STR.30.3.484; Deschiens MA, 1996, STROKE, V27, P1724, DOI 10.1161/01.STR.27.10.1724; deVeber G, 1998, ARCH NEUROL-CHICAGO, V55, P1539, DOI 10.1001/archneur.55.12.1539; deVeber GA, 2000, J CHILD NEUROL, V15, P316, DOI 10.1177/088307380001500508; DINDAR F, 1974, CAN MED ASSOC J, V111, P545; EINHAUPL KM, 1991, LANCET, V338, P597, DOI 10.1016/0140-6736(91)90607-Q; Einhaupl KM, 1990, CEREBRAL SINUS THROM, P149, DOI 10.1007/978- 1-4684-8199-0_14; HICKEY WF, 1982, AM J MED, V73, P740; JUSTICH E, 1984, EUR J RADIOL, V4, P294; LEE BCP, 1984, AM J NEURORADIOL, V5, P281; LUDWIG B, 1980, NEURORADIOLOGY, V20, P145, DOI 10.1007/BF00341779; Maiti B., 1997, Journal of the Neurological Sciences, V150, pS147, DOI 10.1016/S0022-510X(97)85563-3; Martinelli I, 1998, NEW ENGL J MED, V338, P1793, DOI 10.1056/NEJM199806183382502; MEDLOCK MD, 1992, NEUROSURGERY, V31, P870, DOI 10.1227/00006123-199211000-00007; Nagaraja D, 1999, NEUROL INDIA, V47, P43; *PRACT MAN INF, 1997, INT CLASS DIS 9 REV; PRATS JM, 1992, NEUROLOGY, V42, P2303, DOI 10.1212/WNL.42.12.2303-a; RAO KCVG, 1981, RADIOLOGY, V140, P391, DOI 10.1148/radiology.140.2.7255715; RICH C, 1993, STROKE, V24, P603, DOI 10.1161/01.STR.24.4.603; *SAS I, 1998, STATV VERS 5 1; SCOTTI LN, 1974, RADIOLOGY, V112, P393, DOI 10.1148/112.2.393; SHEVELL MI, 1989, PEDIATR NEUROL, V5, P161, DOI 10.1016/0887-8994(89)90065-9; UZIEL Y, 1995, J PEDIATR-US, V126, P722, DOI 10.1016/S0022-3476(95)70399-3; VANKUIJCK MAP, 1994, NEUROPEDIATRICS, V25, P16, DOI 10.1055/s-2008-1071575; vonScheven E, 1996, J PEDIATR-US, V129, P339, DOI 10.1016/S0022-3476(96)70064-1; YUH WTC, 1994, AM J NEURORADIOL, V15, P309; Zuber M, 1996, STROKE, V27, P1721, DOI 10.1161/01.STR.27.10.1721	36	714	746	0	10	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 9	2001	345	6					417	423		10.1056/NEJM200108093450604	http://dx.doi.org/10.1056/NEJM200108093450604			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460EJ	11496852				2022-12-28	WOS:000170295000004
J	McCarty, KF; Nobel, JA; Bartelt, NC				McCarty, KF; Nobel, JA; Bartelt, NC			Vacancies in solids and the stability of surface morphology	NATURE			English	Article							POINT-DEFECTS; RELAXATION; DIFFUSION; STEPS	Determining how thermal vacancies are created and destroyed in solids is crucial for understanding many of their physical properties, such as solid-state diffusion. Surfaces are known to be good sources and sinks for bulk vacancies, but directly determining where the exchange between the surface and the bulk occurs is difficult. Here we show that vacancy generation (and annihilation) on the (110) surface of an ordered nickel-aluminium intermetallic alloy does not occur over the entire surface, but only near atomic step edges. This has been determined by oscillating the sample's temperature and observing in real time the response of the surface structure as a function of frequency (a version of Angstrom's method of measuring thermal conductivity(1)) using low-energy electron microscopy. Although the surface-exchange process is slow compared with bulk diffusion, the vacancy-generation rate nevertheless controls the dynamics of the alloy surface morphology. These observations, demonstrating that surface smoothing can occur through bulk vacancy transport rather than surface diffusion, should have important implications for the stability of fabricated nanoscale structures.	Sandia Natl Labs, Livermore, CA 94551 USA	United States Department of Energy (DOE); Sandia National Laboratories	McCarty, KF (corresponding author), Sandia Natl Labs, Livermore, CA 94551 USA.	mccarty@sandia.gov	McCarty, Kevin/F-9368-2012	McCarty, Kevin/0000-0002-8601-079X				Angstr?m, 1863, PHILOS MAG, V25, P130, DOI DOI 10.1080/14786446308643429; BAI B, 1999, MRS S P, V552; BAUER E, 1994, REP PROG PHYS, V57, P895, DOI 10.1088/0034-4885/57/9/002; BLAKELY JM, 1961, T FARADAY SOC, V57, P1164, DOI 10.1039/tf9615701164; Bradley AJ, 1937, PROC R SOC LON SER-A, V159, P0056, DOI 10.1098/rspa.1937.0056; DAVIS HL, 1985, PHYS REV LETT, V54, P566, DOI 10.1103/PhysRevLett.54.566; Giesen M, 1999, SURF SCI, V431, P109, DOI 10.1016/S0039-6028(99)00448-3; Hagen M, 1998, PHILOS MAG A, V77, P447, DOI 10.1080/01418619808223764; HERRING C, 1952, STRUCTURE PROPERTIES; HOEHNE K, 1971, PHYS STATUS SOLIDI A, V5, P577, DOI 10.1002/pssa.2210050306; Ibach H, 1996, SURF SCI, V364, P453, DOI 10.1016/0039-6028(96)00635-8; Jeong HC, 1999, SURF SCI REP, V34, P171, DOI 10.1016/S0167-5729(98)00010-7; Korzhavyi PA, 2000, PHYS REV B, V61, P6003, DOI 10.1103/PhysRevB.61.6003; MAIYA PS, 1967, J APPL PHYS, V38, P698, DOI 10.1063/1.1709399; Meyer B, 1999, PHYS REV B, V60, P717, DOI 10.1103/PhysRevB.60.717; Meyer B, 1999, PHYS REV B, V59, P6072, DOI 10.1103/PhysRevB.59.6072; Mishin Y, 1997, PHILOS MAG A, V75, P169, DOI 10.1080/01418619708210289; MULLINS WW, 1959, J APPL PHYS, V30, P77, DOI 10.1063/1.1734979; Smirnov A. A., 1991, Soviet Physics - Doklady, V36, P479; Tanaka S, 1997, PHYS REV LETT, V78, P3342, DOI 10.1103/PhysRevLett.78.3342; WASILEWSKI RJ, 1968, J PHYS CHEM SOLIDS, V29, P39, DOI 10.1016/0022-3697(68)90252-7; ZINKEALLMANG M, 1992, SURF SCI REP, V16, P377, DOI 10.1016/0167-5729(92)90006-W	22	102	105	4	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 9	2001	412	6847					622	625		10.1038/35088026	http://dx.doi.org/10.1038/35088026			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460PP	11493916				2022-12-28	WOS:000170318000036
J	Feltbower, RG; Moorman, AV; Dovey, G; Kinsey, S; McKinney, PA				Feltbower, RG; Moorman, AV; Dovey, G; Kinsey, S; McKinney, PA			Incidence of childhood acute lymphoblastic leukaemia in Yorkshire, UK	LANCET			English	Article							LEUKEMIA	Between 1980 and 1998, in the north-west of England, a significant rise in childhood acute lymphoblastic leukaemia was caused by an Increase in the precursor B-cell form of this disease. We analysed data on children who were diagnosed with leukaemia in Yorkshire, UK, between 1974 and 1997. The incidence of acute lymphoblastic leukaemia remained stable, although a non-significant yearly increase of 2.4% was noted for the precursor B-cell form of this disease from 1980 onwards. The precursor B-cell form accounted for 80% of all acute lymphoblastic leukaemia. Our data are not consistent with increasing Incidence for precursor B-cell acute lymphoblastic leukaemia, although numbers of children with acute myeloid leukaemia are rising.	Paediat Epidemiol Grp, Leeds LS2 9LN, W Yorkshire, England; Leukaemia Res Fund Ctr Clin Epidemiol, Leeds LS2 9LN, W Yorkshire, England; Unit Epidemiol & Hlth Serv Res, Leeds LS2 9LN, W Yorkshire, England; St James Univ Hosp, Childrens Day Hosp, Leeds LS9 7TF, W Yorkshire, England	University of Leeds; University of Leeds; University of Leeds; Saint James's University Hospital	McKinney, PA (corresponding author), Paediat Epidemiol Grp, 30 Hyde Terrace, Leeds LS2 9LN, W Yorkshire, England.	p.a.mckinney@leeds.ac.uk	Moorman, Anthony/F-5518-2010; Moorman, Anthony/G-1468-2014	Moorman, Anthony/0000-0002-9781-6107				BLAIR V, 1994, EUR J CANCER, V30A, P1490, DOI 10.1016/0959-8049(94)00274-9; COEBERGH JWW, 1989, BRIT J CANCER, V59, P100, DOI 10.1038/bjc.1989.20; DRAPER GJ, 1994, CANCER SURV, V20, P493; McKinney PA, 1998, BRIT J CANCER, V78, P974, DOI 10.1038/bjc.1998.612; McNally RJQ, 2000, LANCET, V356, P485, DOI 10.1016/S0140-6736(00)02562-9	5	22	22	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 4	2001	358	9279					385	387		10.1016/S0140-6736(01)05581-7	http://dx.doi.org/10.1016/S0140-6736(01)05581-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459DE	11502322				2022-12-28	WOS:000170235100017
J	Kasting, JF				Kasting, JF			Earth history - The rise of atmospheric oxygen	SCIENCE			English	Editorial Material							OXIDATION-STATE; EARLY EVOLUTION; SULFUR; ROCKS; LIFE		Penn State Univ, Dept Geosci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Kasting, JF (corresponding author), Penn State Univ, Dept Geosci, University Pk, PA 16802 USA.		Kasting, James/AAF-6851-2020					Berndt ME, 1996, GEOLOGY, V24, P351, DOI 10.1130/0091-7613(1996)024<0351:ROCDSO>2.3.CO;2; BRASIER MD, 2001, EARTH SYSTEM PROCESS, P66; Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; Canil D, 1997, NATURE, V389, P842, DOI 10.1038/39860; CANNAT M, 1993, J GEOPHYS RES-SOL EA, V98, P4163, DOI 10.1029/92JB02221; Catling DC, 2001, SCIENCE, V293, P839, DOI 10.1126/science.1061976; CLOUD P, 1972, AM J SCI, V272, P537, DOI 10.2475/ajs.272.6.537; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; HU G, COMMUNICATION; KASTING JF, 1993, J GEOL, V101, P245, DOI 10.1086/648219; KASTING JF, 1989, ORIGINS LIFE EVOL B, V19, P95, DOI 10.1007/BF01808144; KUMP LR, 1992, GEOCHIM COSMOCHIM AC, V56, P3217, DOI 10.1016/0016-7037(92)90299-X; KUMP LR, 2001, GEOL GEOCHEM GEOPHYS; MOJZSIS SJ, 2001, 11 ANN VM GOLDSCHM C; Ohmoto H, 1996, GEOLOGY, V24, P1135, DOI 10.1130/0091-7613(1996)024<1135:EIPGPF>2.3.CO;2; Pavlov AA, 2000, J GEOPHYS RES-PLANET, V105, P11981, DOI 10.1029/1999JE001134; RYE R, 1995, NATURE, V378, P603, DOI 10.1038/378603a0; SCHOPF JW, 1993, SCIENCE, V260, P640, DOI 10.1126/science.260.5108.640; SEYFRIED WE, 1985, GEOCHIM COSMOCHIM AC, V49, P2545, DOI 10.1016/0016-7037(85)90123-1; Walker, 1977, EVOLUTION ATMOSPHERE, V32, P71; WALKER JCG, 1983, EARTHS EARLIEST BIOS, P260	21	147	151	3	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2001	293	5531					819	820		10.1126/science.1063811	http://dx.doi.org/10.1126/science.1063811			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11486080				2022-12-28	WOS:000170241000034
J	McCammon, C				McCammon, C			Geophysics - Deep diamond mysteries	SCIENCE			English	Editorial Material							FERRIC IRON; INCLUSIONS		Univ Bayreuth, Bayer Geoinst, D-95440 Bayreuth, Germany	University of Bayreuth	McCammon, C (corresponding author), Univ Bayreuth, Bayer Geoinst, POB 101251, D-95440 Bayreuth, Germany.	catherine.mccammon@uni-bayreuth.de	McCammon, Catherine/B-4983-2010	McCammon, Catherine/0000-0001-5680-9106				Davies R., 1999, P 7 INT KIMB C, P148; DEINES P, 1980, GEOCHIM COSMOCHIM AC, V44, P943, DOI 10.1016/0016-7037(80)90284-7; Finger LW, 2000, AM MINERAL, V85, P1804; Haggerty SE, 1999, SCIENCE, V285, P851, DOI 10.1126/science.285.5429.851; Harris J, 1997, NATURE, V387, P486, DOI 10.1038/387486a0; Harte B., 1999, MANTLE PETROLOGY FIE, P125; Hutchison M. T., 1999, P 7 INT KIMB C, P372; Joswig W, 1999, EARTH PLANET SC LETT, V173, P1, DOI 10.1016/S0012-821X(99)00210-1; Kaminsky FV, 2001, CONTRIB MINERAL PETR, V140, P734, DOI 10.1007/s004100000221; KESSON SE, 1992, EARTH PLANET SC LETT, V111, P229, DOI 10.1016/0012-821X(92)90181-T; McCammon C, 1997, SCIENCE, V278, P434, DOI 10.1126/science.278.5337.434; McCammon C, 1997, NATURE, V387, P694, DOI 10.1038/42685; RINGWOOD AE, 1991, GEOCHIM COSMOCHIM AC, V55, P2083, DOI 10.1016/0016-7037(91)90090-R; Scott Smith B.S., 1984, DEV PETROLOGY, P121; Stachel T, 2000, CONTRIB MINERAL PETR, V140, P16, DOI 10.1007/s004100000174	15	24	25	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 3	2001	293	5531					813	814		10.1126/science.1063295	http://dx.doi.org/10.1126/science.1063295			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11486076				2022-12-28	WOS:000170241000030
J	Derkatch, IL; Bradley, ME; Hong, JY; Liebman, SW				Derkatch, IL; Bradley, ME; Hong, JY; Liebman, SW			Prions affect the appearance of other prions: The story of [PIN+]	CELL			English	Article							DE-NOVO APPEARANCE; YEAST SACCHAROMYCES-CEREVISIAE; RELEASE FACTOR; PSI+ PRION; IN-VITRO; PROTEIN HSP104; FORMING DOMAIN; SUP35 PROTEIN; PROPAGATION; PSI(+)	Prions are self-propagating protein conformations. Recent research brought insight into prion propagation, but how they first appear is unknown. We previously established that the yeast non-Mendelian trait [PIN+] is required for the de novo appearance of the [PSI+] prion. Here, we show that the presence of prions formed by Rnq1 or Ure2 is sufficient to make cells [PIN+]. Thus, [PIN+] can be caused by more than one prion. Furthermore, an unbiased functional screen for [PIN+] prions uncovered the known prion gene, URE2, the proposed prion gene, NEW1, and nine novel candidate prion genes all carrying prion domains. Importantly, the de novo appearance of Rnq1::GFP prion aggregates also requires the presence of other prions, suggesting the existence of a general mechanism by which the appearance of prions is enhanced by heterologous prion aggregates.	Univ Illinois, Dept Biol Sci, Mol Biol Lab, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Liebman, SW (corresponding author), Univ Illinois, Dept Biol Sci, Mol Biol Lab, 900 S Ashland Ave, Chicago, IL 60607 USA.	suel@uic.edu			NIGMS NIH HHS [GM 56350, R01 GM056350] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056350] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altschul SF, 1996, METHOD ENZYMOL, V266, P460; Bailleul PA, 1999, GENETICS, V153, P81; Caughey B, 2000, NAT MED, V6, P751, DOI 10.1038/77476; Caughey B, 1995, CHEM BIOL, V2, P807, DOI 10.1016/1074-5521(95)90087-X; Chernoff YO, 1999, MOL CELL BIOL, V19, P8103; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; CHERNOFF YO, 1993, CURR GENET, V24, P268, DOI 10.1007/BF00351802; Coustou V, 1997, P NATL ACAD SCI USA, V94, P9773, DOI 10.1073/pnas.94.18.9773; COX B, 1994, CURR BIOL, V4, P744, DOI 10.1016/S0960-9822(00)00167-6; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Derkatch IL, 1998, P NATL ACAD SCI USA, V95, P2400, DOI 10.1073/pnas.95.5.2400; Derkatch IL, 1997, GENETICS, V147, P507; Derkatch IL, 1996, GENETICS, V144, P1375; Derkatch IL, 2000, EMBO J, V19, P1942, DOI 10.1093/emboj/19.9.1942; Fernandez-Bellot E, 2000, EMBO J, V19, P3215, DOI 10.1093/emboj/19.13.3215; Friesen MJ, 2000, J BIOL CHEM, V275, P26370, DOI 10.1074/jbc.M003299200; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; INGEVECHTOMOV SG, 1988, GENETIKA+, V24, P2110; Jackson GS, 1999, SCIENCE, V283, P1935, DOI 10.1126/science.283.5409.1935; Johan K, 1998, P NATL ACAD SCI USA, V95, P2558, DOI 10.1073/pnas.95.5.2558; King CY, 1997, P NATL ACAD SCI USA, V94, P6618, DOI 10.1073/pnas.94.13.6618; Kisilevsky R, 1999, AMYLOID, V6, P98, DOI 10.3109/13506129909007309; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Liebman SW, 1999, J BIOL CHEM, V274, P1181, DOI 10.1074/jbc.274.3.1181; MASISON DC, 1995, SCIENCE, V270, P93, DOI 10.1126/science.270.5233.93; Masison DC, 1997, P NATL ACAD SCI USA, V94, P12503, DOI 10.1073/pnas.94.23.12503; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Moriyama H, 2000, MOL CELL BIOL, V20, P8916, DOI 10.1128/MCB.20.23.8916-8922.2000; NEHLIN JO, 1989, GENE, V85, P313, DOI 10.1016/0378-1119(89)90423-X; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; Osherovich LZ, 2001, CELL, V106, P183, DOI 10.1016/S0092-8674(01)00440-8; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Paushkin SV, 1997, SCIENCE, V277, P381, DOI 10.1126/science.277.5324.381; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; Pellizzoni L, 1999, P NATL ACAD SCI USA, V96, P11167, DOI 10.1073/pnas.96.20.11167; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rose MD., 1990, METHODS YEAST GENETI; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Santoso A, 2000, CELL, V100, P277, DOI 10.1016/S0092-8674(00)81565-2; Schlumpberger M, 2000, PROTEIN SCI, V9, P440; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Sherman F., 1986, METHODS YEAST GENETI; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Taylor KL, 1999, SCIENCE, V283, P1339, DOI 10.1126/science.283.5406.1339; TERAVANESYAN MD, 1994, GENETICS, V137, P671; Thual C, 1999, J BIOL CHEM, V274, P13666, DOI 10.1074/jbc.274.19.13666; Tuite MF, 2000, CELL, V100, P289, DOI 10.1016/S0092-8674(00)80663-7; TUITE MF, 1981, GENETICS, V98, P691; Wickner RB, 1999, MICROBIOL MOL BIOL R, V63, P844, DOI 10.1128/MMBR.63.4.844-861.1999; Wickner RB, 2000, J STRUCT BIOL, V130, P310, DOI 10.1006/jsbi.2000.4250; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner RB, 1995, YEAST, V11, P1671, DOI 10.1002/yea.320111609; Zhou P, 1999, EMBO J, V18, P1182, DOI 10.1093/emboj/18.5.1182; Zhou P, 2001, MOL MICROBIOL, V39, P37, DOI 10.1046/j.1365-2958.2001.02224.x	57	469	487	5	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2001	106	2					171	182		10.1016/S0092-8674(01)00427-5	http://dx.doi.org/10.1016/S0092-8674(01)00427-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	458KG	11511345	Bronze			2022-12-28	WOS:000170193100007
J	Wade, S; Kilgour, T				Wade, S; Kilgour, T			Extracts from "Clinical evidence" - Infantile colic	BMJ-BRITISH MEDICAL JOURNAL			English	Review							DOUBLE-BLIND; DICYCLOMINE; MANAGEMENT; COMMUNITY; TRIAL		Archer St Clin, Darlington DL3 6LT, Durham, England; City Hosp, Sunderland SR4 7TP, England		Wade, S (corresponding author), Archer St Clin, Darlington DL3 6LT, Durham, England.	sally@wade85.fsnet.co.uk						BARR RG, 1991, PEDIATRICS, V87, P623; CAMPBELL JPM, 1989, J ROY COLL GEN PRACT, V39, P11; Canivet C, 1996, ACTA PAEDIATR, V85, P454, DOI 10.1111/j.1651-2227.1996.tb14060.x; Crowcroft NS, 1997, BMJ-BRIT MED J, V314, P1325, DOI 10.1136/bmj.314.7090.1325; DANIELSSON B, 1985, ACTA PAEDIATR SCAND, V74, P446, DOI 10.1111/j.1651-2227.1985.tb11001.x; Fleiss J.L., 1986, DESIGN ANAL CLIN EXP; FORSYTH BWC, 1989, J PEDIATR-US, V115, P521, DOI 10.1016/S0022-3476(89)80274-4; Garrison MM, 2000, PEDIATRICS, V106, P184; GRUNSEIT F, 1977, CURR MED RES OPIN, V5, P258, DOI 10.1185/03007997709110175; Hill DJ, 1995, J ALLERGY CLIN IMMUN, V96, P886, DOI 10.1016/S0091-6749(95)70224-5; HWANG CP, 1985, BRIT MED J, V291, P1014, DOI 10.1136/bmj.291.6501.1014; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kearney PJ, 1998, J HUM NUTR DIET, V11, P281, DOI 10.1046/j.1365-277X.1998.00108.x; Lucas A, 1998, EARLY HUM DEV, V53, P9, DOI 10.1016/S0378-3782(98)00032-2; Lucassen PLBJ, 2000, PEDIATRICS, V106, P1349, DOI 10.1542/peds.106.6.1349; Lucassen PLBJ, 1998, BMJ-BRIT MED J, V316, P1563, DOI 10.1136/bmj.316.7144.1563; Markestad T, 1997, ARCH DIS CHILD, V76, P356, DOI 10.1136/adc.76.4.356; MCKENZIE S, 1991, ARCH DIS CHILD, V66, P1416, DOI 10.1136/adc.66.12.1416; METCALF TJ, 1994, PEDIATRICS, V94, P29; PARKIN PC, 1993, PEDIATRICS, V92, P197; STAHLBERG MR, 1986, ARCH DIS CHILD, V61, P1232, DOI 10.1136/adc.61.12.1232; STJAMESROBERTS I, 1991, J CHILD PSYCHOL PSYC, V32, P951; TAUBMAN B, 1988, PEDIATRICS, V81, P756; WEIZMAN Z, 1993, J PEDIATR-US, V123, P670, DOI 10.1016/S0022-3476(05)80982-5; WILLIAMS J, 1984, BRIT MED J, V288, P901, DOI 10.1136/bmj.288.6421.901	25	29	31	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 25	2001	323	7310					437	440		10.1136/bmj.323.7310.437	http://dx.doi.org/10.1136/bmj.323.7310.437			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469BX	11520846	Green Published			2022-12-28	WOS:000170793600026
J	Shin, JS; Abraham, SN				Shin, JS; Abraham, SN			Cell biology - Caveolae - Not just craters in the cellular landscape	SCIENCE			English	Editorial Material							TRANSCYTOSIS; CHOLESTEROL; TOXIN; ENTRY		Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Microbiol, Durham, NC 27710 USA	Duke University; Duke University	Shin, JS (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA.	Abrah006@mc.duke.edu	Oka, Yoshitaka/C-9670-2010	Oka, Yoshitaka/0000-0002-3482-3051				Abrami L, 2000, TRENDS MICROBIOL, V8, P168, DOI 10.1016/S0966-842X(00)01722-4; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Baorto DM, 1997, NATURE, V389, P636, DOI 10.1038/39376; Bomsel M, 2000, MOL BIOL CELL, V11, p497A; Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647; Hansen GH, 1999, GASTROENTEROLOGY, V116, P610, DOI 10.1016/S0016-5085(99)70183-6; Lauer S, 2000, EMBO J, V19, P3556, DOI 10.1093/emboj/19.14.3556; Lencer WI, 1999, BBA-MOL CELL RES, V1450, P177, DOI 10.1016/S0167-4889(99)00070-1; Middleton J, 1997, CELL, V91, P385, DOI 10.1016/S0092-8674(00)80422-5; Mordue DG, 1999, J EXP MED, V190, P1783, DOI 10.1084/jem.190.12.1783; Ricci V, 2000, MOL BIOL CELL, V11, P3897, DOI 10.1091/mbc.11.11.3897; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Shin JS, 2000, SCIENCE, V289, P785, DOI 10.1126/science.289.5480.785; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408	14	59	63	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2001	293	5534					1447	1448		10.1126/science.1061079	http://dx.doi.org/10.1126/science.1061079			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465XV	11520975				2022-12-28	WOS:000170616000032
J	Wiens, DA; Snider, NO				Wiens, DA; Snider, NO			Repeating deep earthquakes: Evidence for fault reactivation at great depth	SCIENCE			English	Article							TONGA SUBDUCTION ZONE; FOCUS EARTHQUAKES; BOLIVIAN EARTHQUAKE; AFTERSHOCK SEQUENCE; RUPTURE; CALIFORNIA; MECHANISM; MICROEARTHQUAKES; INTERMEDIATE; DEFORMATION	We have identified three groups of deep earthquakes showing nearly identical waveforms in the Tonga stab. Relocation with a cross-correlation method shows that each cluster is composed of 10 to 30 earthquakes along a plane 10 to 30 kilometers in length. Some of the earthquakes are colocated, demonstrating repeated rupture of the same fault, and one pair of events shows identical rupture complexity, suggesting that the temporal and spatial rupture pattern was repeated. Recurrence intervals show an inverse time distribution, indicating a strong temporal control over fault reactivation. Runaway thermal shear instabilities may explain temporally clustered earthquakes with similar waveforms located along slip zones weakened by shear heating. Earthquake doublets that occur within a few hours are consistent with events recurring before the thermal energy of the initial rupture can diffuse away.	Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA	Washington University (WUSTL)	Wiens, DA (corresponding author), Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA.		Wiens, Douglas A/J-9259-2016	Wiens, Douglas A/0000-0002-5169-4386				Antolik M, 1999, J GEOPHYS RES-SOL EA, V104, P863, DOI 10.1029/1998JB900042; Aster R, 2000, ADVANCES IN SEISMIC EVENT LOCATION, P231; BOATWRIGHT J, 1980, B SEISMOL SOC AM, V70, P1; DZIEWONSKI AM, 1981, J GEOPHYS RES, V86, P2825, DOI 10.1029/JB086iB04p02825; GIARDINI D, 1984, NATURE, V307, P505, DOI 10.1038/307505a0; GREEN HW, 1989, NATURE, V341, P733, DOI 10.1038/341733a0; GREEN HW, 1990, NATURE, V348, P720, DOI 10.1038/348720a0; GREEN HWI, 1995, ANN REV EARTH PLANET, V24, P169; HOBBS BE, 1988, J GEOPHYS RES-SOLID, V93, P10521, DOI 10.1029/JB093iB09p10521; HULL J, 1988, J STRUCT GEOL, V10, P431, DOI 10.1016/0191-8141(88)90020-X; ISACKS BL, 1967, B SEISMOL SOC AM, V57, P935; JORDAN TH, 1981, B SEISMOL SOC AM, V71, P1105; Kameyama M, 1997, GEOPHYS RES LETT, V24, P2523, DOI 10.1029/97GL02648; Kanamori H, 1998, SCIENCE, V279, P839, DOI 10.1126/science.279.5352.839; KARATO S, IN PRESS PHYS EARTH; Kisslinger C, 1996, ADV GEOPHYS, V38, P1, DOI 10.1016/S0065-2687(08)60019-9; MEADE C, 1991, SCIENCE, V252, P68, DOI 10.1126/science.252.5002.68; Nadeau RM, 1999, SCIENCE, V285, P718, DOI 10.1126/science.285.5428.718; OGAWA M, 1987, J GEOPHYS RES-SOLID, V92, P13801, DOI 10.1029/JB092iB13p13801; POUPINET G, 1984, J GEOPHYS RES, V89, P5719, DOI 10.1029/JB089iB07p05719; Roth EG, 1999, J GEOPHYS RES-SOL EA, V104, P4795, DOI 10.1029/1998JB900052; Rubin AM, 1999, NATURE, V400, P635, DOI 10.1038/23196; Scholz C. H., 1990, MECH EARTHQUAKES FAU; Shearer PM, 1997, J GEOPHYS RES-SOL EA, V102, P8269, DOI 10.1029/96JB03228; SILVER PG, 1995, SCIENCE, V268, P69, DOI 10.1126/science.268.5207.69; TIBI R, 2000, THESIS FREE U BERLIN; VIDALE JE, 1994, NATURE, V368, P624, DOI 10.1038/368624a0; Waldhauser F, 1999, GEOPHYS RES LETT, V26, P3525, DOI 10.1029/1999GL010462; WIENS DA, 1994, NATURE, V372, P540, DOI 10.1038/372540a0; Wiens DA, 1997, GEOPHYS RES LETT, V24, P2059, DOI 10.1029/97GL01957; WIENS DA, IN PRESS PHYS EARTH; Wiens DA., 1995, IRIS NEWSL, V14, P1	32	35	44	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2001	293	5534					1463	1466		10.1126/science.1063042	http://dx.doi.org/10.1126/science.1063042			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465XV	11520980				2022-12-28	WOS:000170616000037
J	Tice, JA; Ross, E; Coxson, PG; Rosenberg, I; Weinstein, MC; Hunink, MGM; Goldman, PA; Williams, L; Goldman, L				Tice, JA; Ross, E; Coxson, PG; Rosenberg, I; Weinstein, MC; Hunink, MGM; Goldman, PA; Williams, L; Goldman, L			Cost-effectiveness of vitamin therapy to lower plasma homocysteine levels for the prevention of coronary heart disease - Effect of grain fortification and beyond	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FOLIC-ACID SUPPLEMENTATION; CARDIOVASCULAR RISK FACTOR; SERUM TOTAL HOMOCYSTEINE; VASCULAR-DISEASE; ARTERY DISEASE; MYOCARDIAL-INFARCTION; CONTROLLED TRIAL; CLINICAL-TRIALS; HOMOCYST(E)INE LEVELS; SECONDARY PREVENTION	Context A high homocysteine level has been identified as an independent modifiable risk factor for coronary heart disease (CHD) events and death. Since January 1998, the US Food and Drug Administration has required that all enriched grain products contain 140 mug of folic acid per 100 g, a level considered to decrease homocysteine levels. Objectives To examine the potential effect of grain fortification with folic acid on CHID events and to estimate the cost-effectiveness of additional vitamin supplementation (folic acid and cyanocobalamin) for CHID prevention. Design and Setting Cost-effectiveness analysis using the Coronary Heart Disease Policy Model, a validated, state-transition model of CHD events in adults aged 35 through 84 years. Data from the third National Health and Nutrition Examination Survey (NHANES III) were used to estimate age- and sex-specific differences in homocysteine levels. Intervention Hypothetical comparison between a diet that includes enriched grain products projected to increase folic acid intake by 100 mug/d with the same diet without folic acid fortification; and a comparison between vitamin therapy that consists of 1 mg of folic acid and 0.5 mg of cyanocobalamin and the diet that includes grains fortified with folic acid. Main Outcome Measures Incidence of myocardial infarction and death from CHID, quality-adjusted life-years (QALYs) saved, and medical costs. Results Grain fortification with folic acid was predicted to decrease CHID events by 8% in women and 13% in men, with comparable reductions in CHID mortality. The model projected that, compared with grain fortification alone, treating all patients with known CHID with folic acid and cyanocobalamin over a 10-year period would result in 310000 fewer deaths and lower costs. Over the same 10-year period, providing vitamin supplementation in addition to grain fortification to all men aged 45 years or older without known CHID was projected to save more than 300000 QALYs, to save more than US $2 billion, and to be the preferred strategy. For women without CHD, the preferred vitamin supplementation strategy would be to treat all women older than 55 years, a strategy projected to save more than 140000 QALYs over 10 years. Conclusions Folic acid and cyanocobalamin supplementation may be cost-effective among many population subgroups and could have a major epidemiologic benefit for primary and secondary prevention of CHID if ongoing clinical trials confirm that homocysteine-lowering therapy decreases CHID event rates.	Univ Calif San Francisco, Dept Med, Div Gen Internal Med, San Francisco, CA 94143 USA; Tufts Univ, Div Clin Nutr, Boston, MA 02111 USA; Tufts Univ, Div Gen Internal Med, Boston, MA 02111 USA; Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; Erasmus Med Ctr, Dept Radiol, Rotterdam, Netherlands; Erasmus Med Ctr, Dept Epidemiol & Biostat, Rotterdam, Netherlands	University of California System; University of California San Francisco; Tufts University; Tufts University; Harvard University; Harvard T.H. Chan School of Public Health; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Tice, JA (corresponding author), Univ Calif San Francisco, Dept Med, Div Gen Internal Med, San Francisco, CA 94143 USA.			Tice, Jeffrey/0000-0002-9857-2028				ALFTHAN G, 1994, ATHEROSCLEROSIS, V106, P9, DOI 10.1016/0021-9150(94)90078-7; ARNESEN E, 1995, INT J EPIDEMIOL, V24, P704, DOI 10.1093/ije/24.4.704; Avins AL, 1998, JAMA-J AM MED ASSOC, V279, P445, DOI 10.1001/jama.279.6.445; BERGMARK C, 1993, EUR J VASCULAR SURG, V7, P391, DOI 10.1016/S0950-821X(05)80255-5; Bostom AG, 1997, ARTERIOSCL THROM VAS, V17, P2554, DOI 10.1161/01.ATV.17.11.2554; Bostom AG, 1997, ANN INTERN MED, V127, P1089, DOI 10.7326/0003-4819-127-12-199712150-00006; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; BRATTSTROM L, 1990, ATHEROSCLEROSIS, V81, P51, DOI 10.1016/0021-9150(90)90058-Q; Brattstrom L, 1998, BMJ-BRIT MED J, V316, P894, DOI 10.1136/bmj.316.7135.894; BRATTSTROM LE, 1988, SCAND J CLIN LAB INV, V48, P215, DOI 10.3109/00365518809167487; Bronstrup A, 1998, AM J CLIN NUTR, V68, P1104; Caro J, 1997, BRIT MED J, V315, P1577, DOI 10.1136/bmj.315.7122.1577; Chauveau P, 1996, MINER ELECTROL METAB, V22, P106; Cheng SWK, 1997, ANN VASC SURG, V11, P217, DOI 10.1007/s100169900037; CLARKE R, 1991, NEW ENGL J MED, V324, P1149, DOI 10.1056/NEJM199104253241701; Cuskelly G. J., 1995, IRISH J MED SCI, V164; DALERY K, 1995, AM J CARDIOL, V75, P1107, DOI 10.1016/S0002-9149(99)80739-5; den Heijer M, 1998, ARTERIOSCL THROM VAS, V18, P356, DOI 10.1161/01.ATV.18.3.356; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DICKINSON CJ, 1995, QJM-INT J MED, V88, P357; ELVEBACK LR, 1981, MAYO CLIN PROC, V56, P665; Evans RW, 1997, ARTERIOSCL THROM VAS, V17, P1947, DOI 10.1161/01.ATV.17.10.1947; Fenech M, 1998, CARCINOGENESIS, V19, P1163, DOI 10.1093/carcin/19.7.1163; Folsom AR, 1998, CIRCULATION, V98, P204, DOI 10.1161/01.CIR.98.3.204; Food and Drug Administration, 1996, FED REGISTER, V61, P8781; FRANKEN DG, 1994, J INHERIT METAB DIS, V17, P159, DOI 10.1007/BF00735426; FRANKEN DG, 1994, ARTERIOSCLER THROMB, V14, P465, DOI 10.1161/01.ATV.14.3.465; FRISON L, 1992, STAT MED, V11, P1685, DOI 10.1002/sim.4780111304; GENEST JJ, 1990, J AM COLL CARDIOL, V16, P1114, DOI 10.1016/0735-1097(90)90542-W; GOLDMAN L, 1991, JAMA-J AM MED ASSOC, V265, P1145, DOI 10.1001/jama.265.9.1145; Graham IM, 1997, JAMA-J AM MED ASSOC, V277, P1775, DOI 10.1001/jama.277.22.1775; Guttormsen AB, 1996, J CLIN INVEST, V98, P2174, DOI 10.1172/JCI119024; Hankey GJ, 1999, LANCET, V354, P407, DOI 10.1016/S0140-6736(98)11058-9; HEINONEN OP, 1994, NEW ENGL J MED, V330, P1029; Hennekens CH, 1996, NEW ENGL J MED, V334, P1145, DOI 10.1056/NEJM199605023341801; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Hunink MGM, 1997, JAMA-J AM MED ASSOC, V277, P535, DOI 10.1001/jama.277.7.535; ISRAELSSON B, 1988, ATHEROSCLEROSIS, V71, P227, DOI 10.1016/0021-9150(88)90147-5; Jacques PF, 1999, NEW ENGL J MED, V340, P1449, DOI 10.1056/NEJM199905133401901; Janssen MJFM, 1996, MINER ELECTROL METAB, V22, P110; Johannesson M, 1997, NEW ENGL J MED, V336, P332, DOI 10.1056/NEJM199701303360503; Koehler KM, 1997, J AM DIET ASSOC, V97, P167, DOI 10.1016/S0002-8223(97)00044-8; Kuzminski AM, 1998, BLOOD, V92, P1191, DOI 10.1182/blood.V92.4.1191.416k15_1191_1198; LANDGREN F, 1995, J INTERN MED, V237, P381, DOI 10.1111/j.1365-2796.1995.tb01190.x; Malinow MR, 1998, NEW ENGL J MED, V338, P1009, DOI 10.1056/NEJM199804093381501; MALINOW MR, 1990, CIRCULATION, V81, P2004, DOI 10.1161/01.CIR.81.6.2004; MALINOW MR, 1989, CIRCULATION, V79, P1180, DOI 10.1161/01.CIR.79.6.1180; Malinow MR, 1997, ARTERIOSCL THROM VAS, V17, P1157, DOI 10.1161/01.ATV.17.6.1157; MCCULLY KS, 1969, AM J PATHOL, V56, P111; *MED EC CO INC, 1997, DRUG TOP RED BOOK; MOLGAARD J, 1992, J INTERN MED, V231, P273; Morris S, 1997, HEALTH ECON, V6, P589, DOI 10.1002/(SICI)1099-1050(199711)6:6<589::AID-HEC286>3.0.CO;2-D; Moustapha A, 1998, CIRCULATION, V97, P138, DOI 10.1161/01.CIR.97.2.138; *NAT CTR HLTH STAT, 1989, VIT STAT US 1986, V2; *NAT CTR HLTH STAT, 1981, VIT STA US A, V2; *NAT HLTH NUTR EX, 1990, NAT HLTH NUTR EX SUR; National Health and Nutrition Examination Survey III, 1998, NAT HLTH NUTR EX SUR; NAURATH HJ, 1995, LANCET, V346, P85, DOI 10.1016/S0140-6736(95)92113-3; Nygard O, 1997, NEW ENGL J MED, V337, P230, DOI 10.1056/NEJM199707243370403; OKEEFE CA, 1995, J NUTR, V125, P2717; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; PANCHARUNITI N, 1994, AM J CLIN NUTR, V59, P940, DOI 10.1093/ajcn/59.4.940; PERRY IJ, 1995, LANCET, V346, P1395, DOI 10.1016/S0140-6736(95)92407-8; Rasmussen K, 1996, CLIN CHEM, V42, P630; ROBINSON K, 1995, CIRCULATION, V92, P2825, DOI 10.1161/01.CIR.92.10.2825; Russell LB, 1998, NEW ENGL J MED, V339, P1158, DOI 10.1056/NEJM199810153391612; SALTZMAN E, 1994, CLIN RES, V42, pA172; SanthoshKumar CR, 1997, EUR J CLIN NUTR, V51, P188, DOI 10.1038/sj.ejcn.1600385; Schorah CJ, 1998, EUR J CLIN NUTR, V52, P407, DOI 10.1038/sj.ejcn.1600576; Schwartz SM, 1997, CIRCULATION, V96, P412; STAMPFER MJ, 1992, JAMA-J AM MED ASSOC, V268, P877, DOI 10.1001/jama.268.7.877; Stehouwer CDA, 1998, ARTERIOSCL THROM VAS, V18, P1895, DOI 10.1161/01.ATV.18.12.1895; Stephens NG, 1996, LANCET, V347, P781, DOI 10.1016/S0140-6736(96)90866-1; STINNETT A, 1996, COST EFFECTIVENESS H, P348; TAYLOR LM, 1991, J VASC SURG, V13, P128, DOI 10.1016/0741-5214(91)90020-U; Torrance GW, 1996, COST EFFECTIVENESS H, P276; Tsevat J, 2001, AM HEART J, V141, P727, DOI 10.1067/mhj.2001.114805; Tucker KL, 1996, JAMA-J AM MED ASSOC, V276, P1879, DOI 10.1001/jama.276.23.1879; U.S. Department of Health and Human Services, 1990, NIH PUBL; UBBINK JB, 1991, KLIN WOCHENSCHR, V69, P527, DOI 10.1007/BF01649290; UBBINK JB, 1994, J NUTR, V124, P1927, DOI 10.1093/jn/124.10.1927; UBBINK JB, 1995, CLIN CHEM, V41, P1033; UBBINK JB, 1993, CLIN INVESTIGATOR, V71, P993, DOI 10.1007/BF00180030; *US BUR CENS, 1990, US POP EST AG SE S P, V25; VANDENBERG M, 1994, J VASC SURG, V20, P933, DOI 10.1016/0741-5214(94)90230-5; VERHOEF P, 1994, STROKE, V25, P1924, DOI 10.1161/01.STR.25.10.1924; Verhoef P, 1996, AM J EPIDEMIOL, V143, P845, DOI 10.1093/oxfordjournals.aje.a008828; VONECKARDSTEIN A, 1994, ARTERIOSCLER THROMB, V14, P460, DOI 10.1161/01.ATV.14.3.460; Wald NJ, 1998, ARCH INTERN MED, V158, P862, DOI 10.1001/archinte.158.8.862; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; WEINSTEIN MC, 1987, AM J PUBLIC HEALTH, V77, P1417, DOI 10.2105/AJPH.77.11.1417; Wilcken DEL, 1997, J INHERIT METAB DIS, V20, P295, DOI 10.1023/A:1005373209964; WILCKEN DEL, 1988, METABOLISM, V37, P697, DOI 10.1016/0026-0495(88)90093-5; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Woodside JV, 1998, AM J CLIN NUTR, V67, P858, DOI 10.1093/ajcn/67.5.858; Woodside JV, 1997, P NUTR SOC, V56, P479, DOI 10.1079/PNS19970048; WU LL, 1994, CLIN CHEM, V40, P552; 1996, FED REG, V61, P59489; 1993, FED REG, V58, P53305	99	71	76	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2001	286	8					936	943		10.1001/jama.286.8.936	http://dx.doi.org/10.1001/jama.286.8.936			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465EU	11509058	Bronze			2022-12-28	WOS:000170577300028
J	Dobbek, H; Svetlitchnyi, V; Gremer, L; Huber, R; Meyer, O				Dobbek, H; Svetlitchnyi, V; Gremer, L; Huber, R; Meyer, O			Crystal structure of a carbon monoxide dehydrogenase reveals a [Ni-4Fe-5S] cluster	SCIENCE			English	Article							IRON-SULFUR PROTEINS; RUBRUM CO-DEHYDROGENASE; RHODOSPIRILLUM-RUBRUM; ANGSTROM; NICKEL; FE; RESOLUTION; REDUCTION; OXIDATION	The homodimeric nickel-containing CO dehydrogenase from the anaerobic bacterium Carboxydothermus hydrogenoformans catalyzes the oxidation of CO to CO2. A crystal structure of the reduced enzyme has been solved at 1.6 angstrom resolution. This structure represents the prototype for Ni-containing CO dehydrogenases from anaerobic bacteria and archaea. It contains five metal clusters of which clusters B, B', and a subunit-bridging, surface-exposed cluster D are cubane-type [4Fe-4S] clusters. The active-site clusters C and C' are novel, asymmetric [Ni-4Fe-5S] clusters. Their integral Ni ion, which is the likely site of CO oxidation, is coordinated by four sulfur ligands with square planar geometry.	Max Planck Inst Biochem, Abt Strukturforsch, D-82152 Martinsried, Germany; Univ Bayreuth, Bayreuther Zentrum Mol Biowissensch, D-95440 Bayreuth, Germany; Univ Bayreuth, Lehrstuhl Mikrobiol, D-95440 Bayreuth, Germany	Max Planck Society; University of Bayreuth; University of Bayreuth	Dobbek, H (corresponding author), Max Planck Inst Biochem, Abt Strukturforsch, Klopferspitz 18A, D-82152 Martinsried, Germany.		Gremer, Lothar/H-9128-2013	Gremer, Lothar/0000-0001-7065-5027				Arendsen AF, 1998, J BIOL INORG CHEM, V3, P81, DOI 10.1007/s007750050210; Arendsen AF, 1999, ADV INORG CHEM, V47, P219, DOI 10.1016/S0898-8838(08)60079-3; BACON D, 1988, J MOL GRAPHICS, V6, P219, DOI 10.1016/S0263-7855(98)80030-1; Beinert H, 2000, J BIOL INORG CHEM, V5, P2, DOI 10.1007/s007750050002; BONAM D, 1987, J BIOL CHEM, V262, P2980; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Coyle C.L, 1988, BIOINORGANIC CHEM NI, P1; CRANE BR, 1995, SCIENCE, V270, P59, DOI 10.1126/science.270.5233.59; DELATTRE O, 1997, EUR J ORTHOP SURG TR, V7, P1; DeRose VJ, 1998, J AM CHEM SOC, V120, P8767, DOI 10.1021/ja9731480; Dobbek H, 1999, P NATL ACAD SCI USA, V96, P8884, DOI 10.1073/pnas.96.16.8884; Ermler U, 1998, CURR OPIN STRUC BIOL, V8, P749, DOI 10.1016/S0959-440X(98)80095-X; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FERRY JG, 1995, ANNU REV MICROBIOL, V49, P305, DOI 10.1146/annurev.mi.49.100195.001513; Gonzalez JM, 2000, FEMS MICROBIOL LETT, V191, P243, DOI 10.1111/j.1574-6968.2000.tb09346.x; Hanzelmann P, 2000, J MOL BIOL, V301, P1221, DOI 10.1006/jmbi.2000.4023; Heo J, 1999, J AM CHEM SOC, V121, P11045, DOI 10.1021/ja990397a; Heo JY, 2000, BIOCHEMISTRY-US, V39, P7956, DOI 10.1021/bi992958g; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hu ZG, 1996, J AM CHEM SOC, V118, P830, DOI 10.1021/ja9528386; Johnson MK, 1998, CURR OPIN CHEM BIOL, V2, P173, DOI 10.1016/S1367-5931(98)80058-6; KUMAR M, 1993, J AM CHEM SOC, V115, P11646, DOI 10.1021/ja00077a093; Meyer O, 2000, BIOL CHEM, V381, P865, DOI 10.1515/BC.2000.108; NICHOLLS A, 1993, BIOPHYS J, V64, pA166; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; Ragsdale SW, 1996, CHEM REV, V96, P2515, DOI 10.1021/cr950058+; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Spangler NJ, 1998, J BIOL CHEM, V273, P4059, DOI 10.1074/jbc.273.7.4059; Staples CR, 1999, J AM CHEM SOC, V121, P11034, DOI 10.1021/ja990396i; Sticht H, 1998, PROG BIOPHYS MOL BIO, V70, P95, DOI 10.1016/S0079-6107(98)00027-3; SVETLICHNY VA, 1991, SYST APPL MICROBIOL, V14, P254, DOI 10.1016/S0723-2020(11)80377-2; SVETLITCHNYI V, IN PRESS J BACTERIOL; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; TURK D, 1992, THESIS TU MUNCHEN MU	36	391	430	3	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2001	293	5533					1281	1285		10.1126/science.1061500	http://dx.doi.org/10.1126/science.1061500			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11509720				2022-12-28	WOS:000170492600029
J	Boekema, EJ; Hifney, A; Yakushevska, AE; Piotrowski, M; Keegstra, W; Berry, S; Michel, KP; Pistorius, EK; Kruip, J				Boekema, EJ; Hifney, A; Yakushevska, AE; Piotrowski, M; Keegstra, W; Berry, S; Michel, KP; Pistorius, EK; Kruip, J			A giant chlorophyll-protein complex induced by iron defciency in cyanobacteria	NATURE			English	Article							LIGHT-HARVESTING COMPLEX; PHOTOSYSTEM-II COMPLEX; SYNECHOCOCCUS SP; ISIA GENE; STRESS; PURIFICATION; ORGANIZATION; LIMITATION; SUBUNITS	Cyanobacteria are abundant throughout most of the world's water bodies and contribute significantly to global primary productivity through oxygenic photosynthesis. This reaction is catalysed by two membrane-bound protein complexes, photosystem I (PSI) and photosystem II (PSII), which both contain chlorophyll-binding subunits functioning as an internal antenna(1). In addition, phycobilisomes act as peripheral antenna systems, but no additional light-harvesting systems have been found under normal growth conditions. Iron deficiency, which is often the limiting factor for cyanobacterial growth in aquatic ecosystems(2), leads to the induction of additional proteins such as IsiA (ref. 3). Although IsiA has been implicated in chlorophyll storage, energy absorption and protection against excessive light, its precise molecular function and association to other proteins is unknown. Here we report the purification of a specific PSI-IsiA supercomplex, which is abundant under conditions of iron limitation. Electron microscopy shows that this supercomplex consists of trimeric PSI surrounded by a closed ring of 18 IsiA proteins binding around 180 chlorophyll molecules. We provide a structural characterization of an additional chlorophyll-containing, membrane-integral antenna in a cyanobacterial photosystem.	Univ Bielefeld, D-33501 Bielefeld, Germany; Univ Groningen, Groningen Biomol Sci, NL-9747 AG Groningen, Netherlands; Univ Groningen, Inst Biotechnol, NL-9747 AG Groningen, Netherlands; Ruhr Univ Bochum, D-44780 Bochum, Germany	University of Bielefeld; University of Groningen; University of Groningen; Ruhr University Bochum	Pistorius, EK (corresponding author), Univ Bielefeld, D-33501 Bielefeld, Germany.	e.pistorius@biologie.uni-bielefeld.de; jochen.kruip@ruhr-uni-bochum.de	Piotrowski, Markus/F-5419-2010	Piotrowski, Markus/0000-0002-6347-3337; hifney, Awatief/0000-0002-1247-1876				Behrenfeld MJ, 1996, NATURE, V383, P508, DOI 10.1038/383508a0; BOEKEMA EJ, 1995, P NATL ACAD SCI USA, V92, P175, DOI 10.1073/pnas.92.1.175; Boekema EJ, 2001, BIOCHEMISTRY-US, V40, P1029, DOI 10.1021/bi0015358; BURNAP RL, 1993, PLANT PHYSIOL, V103, P893, DOI 10.1104/pp.103.3.893; DEKKER JP, 1988, BIOCHIM BIOPHYS ACTA, V936, P307, DOI 10.1016/0005-2728(88)90006-0; Exss-Sonne P, 2000, PHOTOSYNTH RES, V63, P145, DOI 10.1023/A:1006322925324; Garczarek L, 2000, P NATL ACAD SCI USA, V97, P4098, DOI 10.1073/pnas.070040897; GUIKEMA JA, 1983, PLANT PHYSIOL, V73, P250, DOI 10.1104/pp.73.2.250; HARAUZ G, 1988, METHOD ENZYMOL, V164, P35; HIYAMA T, 1972, BIOCHIM BIOPHYS ACTA, V267, P160, DOI 10.1016/0005-2728(72)90147-8; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; KARRASCH S, 1995, EMBO J, V14, P631, DOI 10.1002/j.1460-2075.1995.tb07041.x; LaRoche J, 1996, P NATL ACAD SCI USA, V93, P15244; LAUDENBACH DE, 1988, J BACTERIOL, V170, P5018, DOI 10.1128/jb.170.11.5018-5026.1988; Lelong C, 1996, EMBO J, V15, P2160, DOI 10.1002/j.1460-2075.1996.tb00569.x; LEONHARDT K, 1992, J GEN MICROBIOL, V138, P1613, DOI 10.1099/00221287-138-8-1613; MCDERMOTT G, 1995, NATURE, V374, P517, DOI 10.1038/374517a0; NITSCHKE W, 1991, TRENDS BIOCHEM SCI, V16, P241, DOI 10.1016/0968-0004(91)90095-D; PAKRASI HB, 1985, P NATL ACAD SCI USA, V82, P6903, DOI 10.1073/pnas.82.20.6903; Park YI, 1999, MOL MICROBIOL, V32, P123, DOI 10.1046/j.1365-2958.1999.01332.x; STRAUS NA, 1994, ADV PHOTOSYNTHESIS, V1, P731; VANHEEL M, 1981, ULTRAMICROSCOPY, V6, P187, DOI 10.1016/0304-3991(81)90059-0; Wenk SO, 2000, J CHROMATOGR B, V737, P131, DOI 10.1016/S0378-4347(99)00525-3; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	24	270	289	1	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2001	412	6848					745	748		10.1038/35089104	http://dx.doi.org/10.1038/35089104			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462ZB	11507644	Green Published			2022-12-28	WOS:000170450200048
J	Klarreich, E				Klarreich, E			Wellcome Trust sets out fresh misconduct standards	NATURE			English	News Item																			0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 16	2001	412	6848					667	667		10.1038/35089196	http://dx.doi.org/10.1038/35089196			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462ZB	11507596	Bronze			2022-12-28	WOS:000170450200005
J	Ohl, FW; Scheich, H; Freeman, WJ				Ohl, FW; Scheich, H; Freeman, WJ			Change in pattern of ongoing cortical activity with auditory category learning	NATURE			English	Article							FREQUENCY-MODULATED TONES; OLFACTORY EEG; CORTEX; DISCRIMINATION; REPRESENTATION; SYSTEMS	Humans are able to classify novel items correctly by category(1,2); some other animals have also been shown to do this(3-7). During category learning, humans group perceptual stimuli by abstracting qualities from similarity relationships of their physical properties(1,2,8). Forming categories is fundamental to cognition(9) and can be independent of a 'memory store' of information about the items or a prototype(10). The neurophysiological mechanisms underlying the formation of categories are unknown. Using an animal model of category learning(6), in which frequency-modulated tones are distinguished into the categories of 'rising' and 'falling' modulation, we demonstrate here that the sorting of stimuli into these categories emerges as a sudden change in an animal's learning strategy. Electro-corticographical recording from the auditory cortex(11) shows that the transition is accompanied by a change in the dynamics of cortical stimulus representation. We suggest that this dynamic change represents a mechanism underlying the recognition of the abstract quality (or qualities) that defines the categories.	Leibniz Inst Neurobiol, D-39118 Magdeburg, Germany; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Leibniz Institut fur Neurobiologie (LIN); University of California System; University of California Berkeley	Ohl, FW (corresponding author), Leibniz Inst Neurobiol, Brenneckstr 6, D-39118 Magdeburg, Germany.	frank.ohl@ifn-magdeburg.de						Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Barrie JM, 1996, J NEUROPHYSIOL, V76, P520, DOI 10.1152/jn.1996.76.1.520; CREUTZFELDT O, 1989, EXP BRAIN RES, V77, P451, DOI 10.1007/BF00249600; Feldman J, 2000, NATURE, V407, P630, DOI 10.1038/35036586; Freeman W.J., 2000, NEURODYNAMICS EXPLOR, DOI 10.1007/978-1-4471-0371-4; FREEMAN WJ, 1987, BEHAV NEUROSCI, V101, P766, DOI 10.1037/0735-7044.101.6.766; FREEMAN WJ, 1982, PSYCHOPHYSIOLOGY, V19, P44, DOI 10.1111/j.1469-8986.1982.tb02598.x; FREEMAN WJ, 1994, PHYSICA D, V75, P151, DOI 10.1016/0167-2789(94)90280-1; HART J, 1985, NATURE, V316, P439, DOI 10.1038/316439a0; HEIL P, 1992, J COMP NEUROL, V322, P548, DOI 10.1002/cne.903220409; HERRNSTEIN RJ, 1990, COGNITION, V37, P133, DOI 10.1016/0010-0277(90)90021-B; HUOTILAINEN M, 1995, NEUROREPORT, V6, P841, DOI 10.1097/00001756-199504190-00004; KNOWLTON BJ, 1993, SCIENCE, V262, P1747, DOI 10.1126/science.8259522; KOMATSU LK, 1992, PSYCHOL BULL, V112, P500, DOI 10.1037/0033-2909.112.3.500; KUHL PK, 1975, SCIENCE, V190, P69, DOI 10.1126/science.1166301; LEA SEG, 1984, ANIMAL COGNITION, P263; Marshuetz C, 2000, J COGNITIVE NEUROSCI, P146; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; MCCARTHY RA, 1988, NATURE, V334, P428, DOI 10.1038/334428a0; Medin D.L., 1998, PERCEPTION COGNITION, P403, DOI DOI 10.1016/B978-012301160-2/50015-0; MOODY DB, 1995, METHODS COMP PSYCHOA, P293; Ohl FW, 1999, LEARN MEMORY, V6, P347; Ohl FW, 1997, P NATL ACAD SCI USA, V94, P9440, DOI 10.1073/pnas.94.17.9440; Ohl FW, 2000, J NEUROPHYSIOL, V83, P3123, DOI 10.1152/jn.2000.83.5.3123; Orlov T, 2000, NATURE, V404, P77, DOI 10.1038/35003571; PEARCE JM, 1991, CURRENT TOPICS IN ANIMAL LEARNING : BRAIN, EMOTION, AND COGNITION, P141; SAMMON JW, 1969, IEEE T COMPUT, VC 18, P401, DOI 10.1109/T-C.1969.222678; Schreiner CE, 2000, ANNU REV NEUROSCI, V23, P501, DOI 10.1146/annurev.neuro.23.1.501; Wetzel W, 1998, BEHAV BRAIN RES, V91, P29, DOI 10.1016/S0166-4328(97)00099-5; WOODRUFF G, 1981, NATURE, V293, P568, DOI 10.1038/293568a0	30	246	249	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2001	412	6848					733	736		10.1038/35089076	http://dx.doi.org/10.1038/35089076			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	462ZB	11507640				2022-12-28	WOS:000170450200044
J	Robert, KA; Thompson, MB				Robert, KA; Thompson, MB			Sex determination - Viviparous lizard selects sex of embryos	NATURE			English	Article							REPTILES; TEMPERATURES		Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; Univ Sydney, Inst Wildlife Res, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Robert, KA (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	krobert@bio.usyd.edu.au	Thompson, Mike/ABA-8716-2020; Robert, Kylie/C-5181-2009	Robert, Kylie/0000-0002-8554-8440; Thompson, Michael/0000-0002-2496-992X				BULL JJ, 1980, Q REV BIOL, V55, P3, DOI 10.1086/411613; Ciofi C, 1997, APPL ANIM BEHAV SCI, V51, P251, DOI 10.1016/S0168-1591(96)01108-2; Cogger HG, 1986, REPTILES AMPHIBIANS; CREE A, 1995, NATURE, V375, P543, DOI 10.1038/375543a0; Harlow Peter S., 1996, Herpetological Review, V27, P71; JANZEN FJ, 1994, P NATL ACAD SCI USA, V91, P7487, DOI 10.1073/pnas.91.16.7487; JANZEN FJ, 1991, Q REV BIOL, V66, P149, DOI 10.1086/417143; Olsson M, 2001, J EVOLUTION BIOL, V14, P120, DOI 10.1046/j.1420-9101.2001.00255.x; SCHWARZKOPF L, 1991, OECOLOGIA, V88, P562, DOI 10.1007/BF00317720; Whetton PH, 2001, CLIMATE RES, V16, P181, DOI 10.3354/cr016181; YNTEMA CL, 1980, HERPETOLOGICA, V36, P33; YNTEMA CL, 1981, J MORPHOL, V167, P297, DOI 10.1002/jmor.1051670304	12	79	87	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 16	2001	412	6848					698	699		10.1038/35089135	http://dx.doi.org/10.1038/35089135			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462ZB	11507628				2022-12-28	WOS:000170450200032
J	Evans, DB; Tandon, A; Murray, CJL; Lauer, JA				Evans, DB; Tandon, A; Murray, CJL; Lauer, JA			Comparative efficiency of national health systems: cross national econometric analysis	BRITISH MEDICAL JOURNAL			English	Article							COST-EFFECTIVENESS; MORTALITY; DECLINE; REFORM	Objective To improve the evidence base for health policy by devising a method to measure and monitor the performance of health systems. Design Estimation of the relation between levels of population health and the inputs used to produce health. Setting 191 countries. Main outcome measure Health system efficiency (performance), Results Estimated efficiency varied from nearly fully efficient to nearly fully inefficient. Countries with a history of civil conflict or high prevalence of HIV and AIDS were less efficient. Performance increased with health expenditure per capita. Conclusions Increasing the resources for health systems is critical to improving health in poor countries, but important gains can be made in most countries by using existing resources more efficiently.	WHO, Global Programme Evidence Hlth Policy, CH-1211 Geneva 27, Switzerland	World Health Organization	Evans, DB (corresponding author), WHO, Global Programme Evidence Hlth Policy, CH-1211 Geneva 27, Switzerland.			Lauer, Jeremy A/0000-0003-0652-0691				Ahmad OB, 2000, B WORLD HEALTH ORGAN, V78, P1175; CALDWELL JC, 1979, POP STUD-J DEMOG, V33, P395, DOI 10.2307/2173888; CALDWELL JC, 1985, GOOD HLTH LOW COST, P181; Collins C, 1999, HEALTH POLICY, V47, P69, DOI 10.1016/S0168-8510(99)00003-2; DeRosario J M, 1999, J Healthc Qual, V21, P37; Durham G, 1999, Aust Health Rev, V22, P100; EVANS DB, 2000, 7 WHO; EVANS DB, 2000, 29 WHO; Feldman R, 2000, J Health Care Finance, V26, P15; Halstead S, 1985, GOOD HLTH LOW COST; HSIAO W, 2000, WHAT SHOULD MACROECO; Hussein AK, 1997, E AFR MED J, V74, P751; Maynard A, 1995, INT J HEALTH PLAN M, V10, P247, DOI 10.1002/hpm.4740100403; MOORE M, 1996, 7 WHO; Murray CJL, 2000, HEALTH ECON, V9, P235, DOI 10.1002/(SICI)1099-1050(200004)9:3<235::AID-HEC502>3.0.CO;2-O; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P663; Ron A, 1999, SOC SCI MED, V48, P939, DOI 10.1016/S0277-9536(98)00394-3; Tandon A, 2000, 30 WHO; TENGS T, 1997, 204 NCPA; TENGS TO, 1995, RISK ANAL, V15, P369, DOI 10.1111/j.1539-6924.1995.tb00330.x; World Health Organization, 2000, WORLD HLTH REP 2000	21	130	134	4	16	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 11	2001	323	7308					307	310		10.1136/bmj.323.7308.307	http://dx.doi.org/10.1136/bmj.323.7308.307			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	463HK	11498486	Green Published, Bronze			2022-12-28	WOS:000170470900017
J	Van Gool, WA; Weinstein, HC; Scheltens, PK; Walstra, GJM				Van Gool, WA; Weinstein, HC; Scheltens, PK; Walstra, GJM			Effect of hydroxychloroquine on progression of dementia in early Alzheimer's disease: an 18-month randomised, double-blind, placebo-controlled study	LANCET			English	Article							CONTROLLED TRIAL; THERAPY; ASSOCIATION; CHLOROQUINE; PREVALENCE; DIAGNOSIS; SYSTEM; ONSET; BRAIN	Background Results of epidemiological studies, neuropathological observations, and in-vitro experiments all suggest that inflammatory mechanisms contribute to the destructive lesions in Alzheimer's disease. We aimed to establish the effect of the anti-inflammatory drug hydroxychloroquine on the progression of dementia. Methods We did a double-blind, parallel-group, multicentre trial in which we randomly assigned 168 patients with early Alzheimer's disease to hydroxychloroquine (200 or 400 mg dependent on bodyweight), or placebo for 18 months. Outcome measures were related to activities of daily living, cognitive function, and behavioural abnormalities. Analysis was by intention to treat. Results At 18 months, mean scores for the interview for deterioration in daily life in dementia in patients on hydroxychloroquine (22.6 [SD 11.4]) did not differ from those for patients on placebo (21.3 [10.5]). Also, mean scores on the cognitive subscale of the Alzheimer's disease assessment scale were closely similar in hydroxychloroquine (26.4 [14.9]) and placebo (25.7 [14.3]) treated patients, as were behavioural changes, measured by the revised memory and behavioural problems checklist (36.3 [12.0] and 34.2 [12.4], respectively). Explorative analyses did not suggest any specific subgroup that benefited from hydroxychloroquine. The frequency and nature of serious adverse events and side-effects were much the same in both groups. 155 (92%) patients completed all assessments over the entire study. Interpretation Anti-inflammatory treatment with hydroxychloroquine for 18 months does not slow the rate of decline in minimal or mild Alzheimer's disease.	Acad Med Ctr, Dept Neurol, NL-1100 DE Amsterdam, Netherlands; St Lucas Andreas Ziekenhuis, Dept Neurol, Amsterdam, Netherlands; Vrije Univ, Acad Ziekenhuis, Dept Neurol, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Sint Lucas Andreas Hospital; Vrije Universiteit Amsterdam	Van Gool, WA (corresponding author), Acad Med Ctr, Dept Neurol, POB 22700, NL-1100 DE Amsterdam, Netherlands.		Van Gool, Willem A/G-5985-2012; Weinstein, Henry C/ABG-4587-2020; Scheltens, Philip/AAL-9631-2020	Weinstein, Henry C/0000-0002-3534-4618; Scheltens, Philip/0000-0002-1046-6408; Van Gool, Willem/0000-0003-3174-8233				Aisen PS, 2000, NEUROLOGY, V54, P588, DOI 10.1212/WNL.54.3.588; AISEN PS, 1994, AM J PSYCHIAT, V151, P1105; Anthony JC, 2000, NEUROLOGY, V54, P2066, DOI 10.1212/WNL.54.11.2066; Block JA, 1998, LANCET, V351, P771, DOI 10.1016/S0140-6736(05)78925-X; BREITNER J, 2000, NEUROSCIENCE NEWS, V3, P33; BREITNER JCS, 1995, NEUROBIOL AGING, V16, P523, DOI 10.1016/0197-4580(95)00049-K; COLEMAN PD, 1987, NEUROBIOL AGING, V16, P873; Giulian D, 1999, AM J HUM GENET, V65, P13, DOI 10.1086/302477; GOOD MI, 1982, J CLIN PSYCHOPHARM, V2, P40, DOI 10.1097/00004714-198202000-00005; Grimaldi LME, 2000, ANN NEUROL, V47, P361, DOI 10.1002/1531-8249(200003)47:3<361::AID-ANA12>3.3.CO;2-E; Hofman A, 1997, LANCET, V349, P151, DOI 10.1016/S0140-6736(96)09328-2; JIANG H, 1994, J IMMUNOL, V152, P50; KUHLMAN JJ, 1991, J FORENSIC SCI, V36, P1572; MCCHESNEY EW, 1983, AM J MED, V75, P11, DOI 10.1016/0002-9343(83)91265-2; McGeer PL, 1995, BRAIN RES REV, V21, P195, DOI 10.1016/0165-0173(95)00011-9; McGeer PL, 1996, NEUROLOGY, V47, P425, DOI 10.1212/WNL.47.2.425; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Nicoll JAR, 2000, ANN NEUROL, V47, P365, DOI 10.1002/1531-8249(200003)47:3<365::AID-ANA13>3.0.CO;2-G; ROSEN WG, 1984, AM J PSYCHIAT, V141, P1356; ROTH M, 1986, BRIT J PSYCHIAT, V149, P698, DOI 10.1192/bjp.149.6.698; SAINATI SM, 2000, 6 INT STOCKH SPRINGF, P180; Schafer Andrew I., 1999, American Journal of Medicine, V106, p25S, DOI 10.1016/S0002-9343(99)00114-X; Scharf S, 1999, NEUROLOGY, V53, P197, DOI 10.1212/WNL.53.1.197; Sharma OP, 1998, ARCH NEUROL-CHICAGO, V55, P1248, DOI 10.1001/archneur.55.9.1248; SNYDER SW, 1994, EXP NEUROL, V128, P136, DOI 10.1006/exnr.1994.1121; Stern Y, 1997, JAMA-J AM MED ASSOC, V277, P806, DOI 10.1001/jama.277.10.806; TERI L, 1992, PSYCHOL AGING, V7, P622, DOI 10.1037/0882-7974.7.4.622; Teunisse S, 1996, J NEUROL, V243, P522, DOI 10.1007/BF00886874; TEUNISSE S, 1995, DEV DEMENTIA FUNCTIO, P85; Yasojima K, 1999, AM J PATHOL, V154, P927, DOI 10.1016/S0002-9440(10)65340-0; YOUNG D, 1995, CLIN THER, V17, P231, DOI 10.1016/0149-2918(95)80021-2	32	166	173	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 11	2001	358	9280					455	460		10.1016/S0140-6736(01)05623-9	http://dx.doi.org/10.1016/S0140-6736(01)05623-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463TB	11513909				2022-12-28	WOS:000170492400011
J	Mellman, I; Steinman, RM				Mellman, I; Steinman, RM			Dendritic cells: Specialized and regulated antigen processing machines	CELL			English	Review							CLASS-II COMPLEXES; DEVELOPMENTAL REGULATION; TRANSPORT; RECEPTOR; ACCUMULATION; PROTEOLYSIS; ENDOCYTOSIS		Yale Univ, Sch Med, Ludwig Inst Canc Res, Dept Cell Biol, New Haven, CT 06520 USA; Rockefeller Univ, Cellular Physiol & Immunol Lab, New York, NY 10021 USA	Ludwig Institute for Cancer Research; Yale University; Rockefeller University	Mellman, I (corresponding author), Yale Univ, Sch Med, Ludwig Inst Canc Res, Dept Cell Biol, 333 Cedar St, New Haven, CT 06520 USA.	ira.mellkan@yale.edu	Steinman, Ralph/F-7729-2012; Mellman, Ira/ABG-5896-2020					Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; de Baey A, 2000, J EXP MED, V191, P743, DOI 10.1084/jem.191.4.743; Fiebiger E, 2001, J EXP MED, V193, P881, DOI 10.1084/jem.193.8.881; Garrett WS, 2000, CELL, V102, P325, DOI 10.1016/S0092-8674(00)00038-6; Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47; Huang FP, 2000, J EXP MED, V191, P435, DOI 10.1084/jem.191.3.435; Inaba K, 2000, J EXP MED, V191, P927, DOI 10.1084/jem.191.6.927; Inaba K, 1998, J EXP MED, V188, P2163, DOI 10.1084/jem.188.11.2163; Kaisho T, 2001, TRENDS IMMUNOL, V22, P78, DOI 10.1016/S1471-4906(00)01811-1; Liu YJ, 2001, CELL, V106, P259, DOI 10.1016/S0092-8674(01)00456-1; Mahnke K, 2000, J CELL BIOL, V151, P673, DOI 10.1083/jcb.151.3.673; Manoury B, 2001, CURR BIOL, V11, P447, DOI 10.1016/S0960-9822(01)00118-X; Pierre P, 1998, CELL, V93, P1135, DOI 10.1016/S0092-8674(00)81458-0; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; Rodriguez A, 1999, NAT CELL BIOL, V1, P362, DOI 10.1038/14058; Thery C, 1999, J CELL BIOL, V147, P599, DOI 10.1083/jcb.147.3.599; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522; Valladeau J, 2000, IMMUNITY, V12, P71, DOI 10.1016/S1074-7613(00)80160-0; Vermaelen KY, 2001, J EXP MED, V193, P51, DOI 10.1084/jem.193.1.51; West MA, 2000, CURR BIOL, V10, P839, DOI 10.1016/S0960-9822(00)00595-9	21	1719	1816	2	134	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2001	106	3					255	258		10.1016/S0092-8674(01)00449-4	http://dx.doi.org/10.1016/S0092-8674(01)00449-4			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RJ	11509172	Bronze			2022-12-28	WOS:000170433300001
J	Lemay, SG; Janssen, JW; van den Hout, M; Mooij, M; Bronikowski, MJ; Willis, PA; Smalley, RE; Kouwenhoven, LP; Dekker, C				Lemay, SG; Janssen, JW; van den Hout, M; Mooij, M; Bronikowski, MJ; Willis, PA; Smalley, RE; Kouwenhoven, LP; Dekker, C			Two-dimensional imaging of electronic wavefunctions in carbon nanotubes	NATURE			English	Article								The drive towards the development of molecular electronics is placing increasing demands on the level of control that must be exerted on the electronic structure of materials. Proposed device architectures ultimately rely on tuning the interactions between individual electronic states, which amounts to controlling the detailed spatial structure of the electronic wavefunctions in the constituent molecules(1,2). Few experimental tools are available to probe this spatial structure directly, and the shapes of molecular wavefunctions are usually only known from theoretical investigations. Here we present scanning tunnelling spectroscopy measurements of the two-dimensional structure of individual wavefunctions in metallic single-walled carbon nanotubes; these measurements reveal spatial patterns that can be directly understood from the electronic structure of a single graphite sheet, and which represent an elegant illustration of Bloch's theorem(3) at the level of individual wavefunctions. We also observe energy-dependent interference patterns in the wavefunctions and exploit these to directly measure the linear electronic dispersion relation of the metallic single-walled carbon nanotube.	Delft Univ Technol, Dept Appl Phys, NL-2628 CJ Delft, Netherlands; Delft Univ Technol, DIMES, NL-2628 CJ Delft, Netherlands; Rice Univ, Rice Quantum Inst, Ctr Nanoscale Sci & Technol, Dept Chem, Houston, TX 77251 USA; Rice Univ, Rice Quantum Inst, Ctr Nanoscale Sci & Technol, Dept Phys, Houston, TX 77251 USA	Delft University of Technology; Delft University of Technology; Rice University; Rice University	Lemay, SG (corresponding author), Delft Univ Technol, Dept Appl Phys, Lorentzweg 1, NL-2628 CJ Delft, Netherlands.	lemay@mb.tn.tudelft.nl	Lemay, Serge G./AAZ-9887-2021; Willis, Peter A/I-6621-2012	Lemay, Serge G./0000-0002-0404-3169; Willis, Peter A/0000-0001-5394-1101; Dekker, Cees/0000-0001-6273-071X				AVIRAM A, 1974, CHEM PHYS LETT, V29, P277, DOI 10.1016/0009-2614(74)85031-1; Bloch F, 1929, Z PHYS, V52, P555, DOI 10.1007/BF01339455; Bronikowski MJ, 2001, J VAC SCI TECHNOL A, V19, P1800, DOI 10.1116/1.1380721; CROMMIE MF, 1993, NATURE, V363, P524, DOI 10.1038/363524a0; Dreselhaus G., 2000, SCI APPL NANOTUBES, P275; Egger R, 1997, PHYS REV LETT, V79, P5082, DOI 10.1103/PhysRevLett.79.5082; HASEGAWA Y, 1993, PHYS REV LETT, V71, P1071, DOI 10.1103/PhysRevLett.71.1071; Joachim C, 2000, NATURE, V408, P541, DOI 10.1038/35046000; Kane C, 1997, PHYS REV LETT, V79, P5086, DOI 10.1103/PhysRevLett.79.5086; Kane CL, 1999, PHYS REV B, V59, P12759, DOI 10.1103/PhysRevB.59.R12759; Liang WJ, 2001, NATURE, V411, P665, DOI 10.1038/35079517; Rubio A, 1999, PHYS REV LETT, V82, P3520, DOI 10.1103/PhysRevLett.82.3520; TERSOFF J, 1985, PHYS REV B, V31, P805, DOI 10.1103/PhysRevB.31.805; Venema LC, 1997, APPL PHYS LETT, V71, P2629, DOI 10.1063/1.120161; Venema LC, 2000, PHYS REV B, V62, P5238, DOI 10.1103/PhysRevB.62.5238; Venema LC, 1999, SCIENCE, V283, P52, DOI 10.1126/science.283.5398.52; Wildoer JWG, 1998, NATURE, V391, P59, DOI 10.1038/34139	17	179	183	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 9	2001	412	6847					617	620		10.1038/35088013	http://dx.doi.org/10.1038/35088013			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460PP	11493914				2022-12-28	WOS:000170318000034
J	Simons-Morton, DG; Blair, SN; King, AC; Morgan, TM; Applegate, WB; O'Toole, M; Haskell, WL; Albright, CL; Cohen, SJ; Ribisl, PM; Shih, JH				Simons-Morton, DG; Blair, SN; King, AC; Morgan, TM; Applegate, WB; O'Toole, M; Haskell, WL; Albright, CL; Cohen, SJ; Ribisl, PM; Shih, JH		Writing Grp Activity Counseling Tr	Effects of physical activity counseling in primary care - The activity counseling trial: A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ALL-CAUSE MORTALITY; ACTIVITY PROGRAMS; HEALTH-PROMOTION; CARDIORESPIRATORY FITNESS; CARDIAC REHABILITATION; CLINICAL CARDIOLOGY; EXERCISE; MEN; INTERVENTION; DISEASE	Context Physical activity is important for health, yet few studies have examined the effectiveness of physical activity patient counseling in primary care. Objective To compare the effects of 2 physical activity counseling interventions with current recommended care and with each other in a. primary care setting. Design The Activity Counseling Trial, a randomized controlled trial with recruitment in 1995-1997, with 24 months of follow-up. Setting Eleven primary care facilities affiliated with 3 US clinical research centers. Participants Volunteer sample of 395 female and 479 male inactive primary care patients aged 35 to 75 years without clinical cardiovascular disease. Interventions Participants were randomly assigned to 1 of 3 groups: advice (n=292), which included physician advice and written educational materials (recommended care); assistance (n=293),,which included all the components received by the advice group plus interactive mail and behavioral counseling at physician visits; or counseling (n=289), which included the assistance and advice group components plus regular telephone counseling and behavioral classes. Main Outcome Measures Cardiorespiratory fitness, measured by maximal oxygen uptake ((V)over dotO(2)max) and self-reported total physical activity, measured by a 7-day Physical Activity Recall, compared among the 3 groups and analyzed separately for men and women at 24 months. Results At 24 months, 91.4% of the sample had completed physical activity and 77.6% had completed cardiorespiratory fitness measurements. For women at 24 months, (V)over dotO(2)max was significantly higher in the assistance group than in the advice group (mean difference, 80.7 mL/min; 99.2% confidence interval [CI], 8.1-153.2 mL/min) and in the counseling group than in the advice group (mean difference, 73.9 mL/min; 99.2% CI, 0.9-147.0 mL/min), with no difference between the counseling and assistance groups and no significant differences in reported total physical activity. For men, there were no significant between-group differences in cardiorespiratory fitness or total physical activity. Conclusions Two patient counseling interventions differing in type and number of contacts were equally effective in women in improving cardiorespiratory fitness over 2 years compared with recommended care. In men, neither of the 2 counseling interventions was more effective than recommended care.	NHLBI, Clin Applicat & Prevent Program, Div Epidemiol & Clin Applicat, Bethesda, MD 20892 USA; Univ Texas, SW Med Ctr, Inst Aerobics Res, Dallas, TX USA; San Diego State Univ, San Diego, CA 92182 USA; Brown Univ, Providence, RI 02912 USA; Stanford Univ, Sch Med, Palo Alto, CA 94304 USA; Univ Tennessee, Memphis, TN USA; Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC 27109 USA; Penn Med Labs, Washington, DC USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; California State University System; San Diego State University; Brown University; Stanford University; University of Tennessee System; University of Tennessee Health Science Center; Wake Forest University; Wake Forest Baptist Medical Center	Simons-Morton, DG (corresponding author), NHLBI, Clin Applicat & Prevent Program, Div Epidemiol & Clin Applicat, 6701 Rockledge Dr,MSC 7936, Bethesda, MD 20892 USA.	simonsd@nhlbi.nih.gov	Sallis, James F/D-3001-2014	Sallis, James F/0000-0003-2555-9452; King, Abby/0000-0002-7949-8811	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC045138, N01HC045135, N01HC045136, N01HC045137] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HC-45136, N01-HC-45135, N01-HC-45138, N01-HC-45137] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Albright CL, 2000, AM J PREV MED, V18, P225, DOI 10.1016/S0749-3797(99)00155-5; [Anonymous], 1990, Med Sci Sports Exerc, V22, P265; [Anonymous], 1996, JAMA, V276, P241; [Anonymous], 1995, GUID EX TEST PRESCR; Bandura A., 1986, SOCIAL FDN THOUGHT A; Black HR, 1997, ARCH INTERN MED, V157, P2413; Blair SN, 1998, MED SCI SPORT EXER, V30, P1097, DOI 10.1097/00005768-199807000-00012; BLAIR SN, 1995, JAMA-J AM MED ASSOC, V273, P1093, DOI 10.1001/jama.273.14.1093; BLAIR SN, 1985, AM J EPIDEMIOL, V122, P794, DOI 10.1093/oxfordjournals.aje.a114163; Blair SN, 1996, JAMA-J AM MED ASSOC, V276, P205, DOI 10.1001/jama.276.3.205; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; BULL FCL, 1995, AUST J PUBLIC HEALTH, V19, P300; Calfas KJ, 1996, PREV MED, V25, P225, DOI 10.1006/pmed.1996.0050; Dishman RK, 1996, MED SCI SPORT EXER, V28, P706, DOI 10.1097/00005768-199606000-00010; Dunn AL, 1999, JAMA-J AM MED ASSOC, V281, P327, DOI 10.1001/jama.281.4.327; EKELUND LG, 1988, NEW ENGL J MED, V319, P1379, DOI 10.1056/NEJM198811243192104; Fletcher GF, 1996, CIRCULATION, V94, P857, DOI 10.1161/01.CIR.94.4.857; FLETCHER GF, 1992, CIRCULATION, V86, P340, DOI 10.1161/01.CIR.86.1.340; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; GODIN G, 1990, AM J HLTH PROMOT, V4, P225; Goldman HM, 1999, SCANNING, V21, P40, DOI 10.1002/sca.4950210106; GRUNDY SM, 1993, JAMA-J AM MED ASSOC, V269, P3015, DOI 10.1001/jama.269.23.3015; HARRIS SS, 1989, JAMA-J AM MED ASSOC, V261, P3588, DOI 10.1001/jama.261.24.3588; JENNRICH RI, 1986, BIOMETRICS, V42, P805, DOI 10.2307/2530695; KING AC, 1991, JAMA-J AM MED ASSOC, V266, P1535, DOI 10.1001/jama.266.11.1535; KING AC, 1995, CIRCULATION, V91, P2596, DOI 10.1161/01.CIR.91.10.2596; King AC, 2000, J GERONTOL A-BIOL, V55, pM74; King AC, 1998, MED SCI SPORT EXER, V30, P1086, DOI 10.1097/00005768-199807000-00011; Kriska A.M., 1997, MED SCI SPORTS EXERC, V29, P5, DOI [DOI 10.1097/00005768-199706001-00003, https://doi.org/10.1097/00005768-199706001-00003]; LEWIS CE, 1991, ANN INTERN MED, V114, P54, DOI 10.7326/0003-4819-114-1-54; LIE H, 1985, EUR HEART J, V6, P147, DOI 10.1093/oxfordjournals.eurheartj.a061829; Little R. J. A., 1987, STAT ANAL MISSING DA; Long BJ, 1996, AM J PREV MED, V12, P73, DOI 10.1016/S0749-3797(18)30348-9; Marcus BH, 1997, PREV MED, V26, P382, DOI 10.1006/pmed.1997.0158; Margitic S, 1999, PREV MED, V29, P277, DOI 10.1006/pmed.1999.0543; *NAT HEART LUNG BL, 1993, NIH PUBL; Norris SL, 2000, PREV MED, V30, P513, DOI 10.1006/pmed.2000.0673; *OB ED IN EXP PAN, 1998, OBES RES S2, V6, pS51; ORLEANS CT, 1985, PREV MED, V14, P636, DOI 10.1016/0091-7435(85)90083-0; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Pollock ML, 1998, MED SCI SPORT EXER, V30, P975, DOI 10.1097/00005768-199806000-00032; Pruitt L. A., 2000, Medicine and Science in Sports and Exercise, V32, pS328; ROSEN MA, 1984, PREV MED, V13, P535, DOI 10.1016/0091-7435(84)90022-7; RUSSELL NK, 1993, AM J PUBLIC HEALTH, V83, P979, DOI 10.2105/AJPH.83.7.979; SALLIS JF, 1985, AM J EPIDEMIOL, V121, P91, DOI 10.1093/oxfordjournals.aje.a113987; SHERMAN SE, 1993, J GEN INTERN MED, V8, P243, DOI 10.1007/BF02600089; Simons-Morton DG, 1998, MED SCI SPORT EXER, V30, P1084, DOI 10.1097/00005768-199807000-00010; Simons-Morton DG, 2000, PREV MED, V31, P513, DOI 10.1006/pmed.2000.0733; Simons-Morton DG, 1998, AM J PREV MED, V15, P413, DOI 10.1016/S0749-3797(98)00078-6; U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; *US DEP HHS, 1997, HLTH PEOPL 2010; Wee CC, 1999, JAMA-J AM MED ASSOC, V282, P1583, DOI 10.1001/jama.282.16.1583; WELLS KB, 1986, AM J PUBLIC HEALTH, V76, P1009, DOI 10.2105/AJPH.76.8.1009; WELLS KB, 1984, JAMA-J AM MED ASSOC, V252, P2846, DOI 10.1001/jama.252.20.2846; WOODWELL DA, 1999, ADV DATA, V305, P1	56	282	285	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2001	286	6					677	687						11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459VE	11495617				2022-12-28	WOS:000170271500023
J	Fridkin, SK; Edwards, JR; Courval, JM; Hill, H; Tenover, FC; Lawton, R; Gaynes, RP; McGowan, JE				Fridkin, SK; Edwards, JR; Courval, JM; Hill, H; Tenover, FC; Lawton, R; Gaynes, RP; McGowan, JE		Intensive Care Antimicrobial Resis	The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 US adult intensive care units	ANNALS OF INTERNAL MEDICINE			English	Article							ANTIMICROBIAL RESISTANCE; NOSOCOMIAL INFECTIONS; OUTBREAK; EPIDEMIOLOGY; SURVEILLANCE; HOSPITALS; SEVERITY; FAECIUM; IMPACT; RISK	Background: Patient-specific risk factors for acquisition of vancomycin-resistant enterococci (VRE) among hospitalized patients are becoming well defined. However, few studies have reported data on the institutional risk factors, including rates of antimicrobial use, that predict rates of VRE. Identifying modifiable institutional factors can advance quality-improvement efforts to minimize hospital-acquired infections with VRE. Objective: To determine the independent importance of any association between antimicrobial use and risk factors for nosocomial infection on rates of VRE in intensive care units (ICUs). Design: Prospective ecologic study. Setting: 126 adult ICUs from 60 U.S. hospitals from January 1996 through July 1999. Patients: All patients admitted to participating ICUs. Measurements: Monthly use of antimicrobial agents (defined daily doses per 1000 patient-days), nosocomial infection rates, and susceptibilities of all tested enterococci isolated from clinical cultures. Results: Prevalence of VRE (median, 10%; range, 0% to 59%) varied by type of ICU and by teaching status and size of the hospital. Prevalence of VRE was strongly associated with VRE prevalence among inpatient non-ICU areas and outpatient areas in the hospital, ventilator-days per 1000 patient-days, and rate of parenteral vancomycin use. In a weighted linear regression model controlling for type of ICU and rates of VRE among non-ICU inpatient areas rates of vancomycin use (P < 0.001) and third-generation cephalosporin use (P = 0.02) were independently associated with VRE prevalence. Conclusions: Higher rates of vancomycin or third-generation cephalosporin use were associated with increased prevalence of VRE, independent of other ICU characteristics and the endemic VRE prevalence elsewhere in the hospital. Decreasing the use rates of these antimicrobial agents could reduce rates of VRE in ICUs.	Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Centers for Disease Control & Prevention - USA; Emory University; Rollins School Public Health	Fridkin, SK (corresponding author), Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Natl Ctr Infect Dis, MS A-35,1600 Clifton Rd, Atlanta, GA 30333 USA.	skf0@cdc.gov	mcgowan, john e/G-5404-2011					[Anonymous], 1995, INFECT CONT HOSP EP, V16, P105; [Anonymous], 1993, MMWR-MORBID MORTAL W, V42, P597; Archibald L, 1997, CLIN INFECT DIS, V24, P211, DOI 10.1093/clinids/24.2.211; BOYCE JM, 1994, J CLIN MICROBIOL, V32, P1148, DOI 10.1128/JCM.32.5.1148-1153.1994; CULLEN DJ, 1984, CRIT CARE MED, V12, P155, DOI 10.1097/00003246-198403000-00001; Duncan RA, 1997, INFECT CONT HOSP EP, V18, P260; EMORI TG, 1991, AM J INFECT CONTROL, V19, P19, DOI 10.1016/0196-6553(91)90157-8; Evans ME, 1996, INFECT CONT HOSP EP, V17, P356; Fridkin SK, 1999, CLIN INFECT DIS, V28, P1119, DOI 10.1086/514752; Fridkin SK, 1999, CLIN INFECT DIS, V29, P245, DOI 10.1086/520193; FRIDKIN SK, IN PRESS CLIN INFECT; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Goldmann DA, 1996, JAMA-J AM MED ASSOC, V275, P234, DOI 10.1001/jama.275.3.234; Hamilton C. Dukes, 1997, Clinical Infectious Diseases, V25, P425; HANDWERGER S, 1993, CLIN INFECT DIS, V16, P750, DOI 10.1093/clind/16.6.750; JOHNSON SV, 1995, PHARMACOTHERAPY, V15, P579, DOI 10.1002/j.1875-9114.1995.tb02866.x; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Montecalvo MA, 1996, ARCH INTERN MED, V156, P1458, DOI 10.1001/archinte.156.13.1458; MORGENSTERN H, 1995, ANNU REV PUBL HEALTH, V16, P61, DOI 10.1146/annurev.pu.16.050195.000425; MORRIS JG, 1995, ANN INTERN MED, V123, P250, DOI 10.7326/0003-4819-123-4-199508150-00002; PETROFSKY MV, 1997, INFECT CONT HOSP EP, V18, pP33; Quale J, 1996, CLIN INFECT DIS, V23, P1020, DOI 10.1093/clinids/23.5.1020; Salemi C, 1998, Clin Perform Qual Health Care, V6, P12; SHAY DK, 1995, J INFECT DIS, V172, P993, DOI 10.1093/infdis/172.4.993; Singer MV, 1998, INFECT CONT HOSP EP, V19, P248; Steward CD, 2000, DIAGN MICR INFEC DIS, V38, P59, DOI 10.1016/S0732-8893(00)00161-9; Stroud L, 1996, INFECT CONT HOSP EP, V17, P576; Watanakunakorn C, 1997, INFECT CONT HOSP EP, V18, P767; Wenzel RP, 1999, CLIN INFECT DIS, V28, P1126, DOI 10.1086/514753	29	201	216	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 7	2001	135	3					175	183		10.7326/0003-4819-135-3-200108070-00009	http://dx.doi.org/10.7326/0003-4819-135-3-200108070-00009			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460FX	11487484				2022-12-28	WOS:000170298500003
J	Farmer, P; Leandre, F; Mukherjee, JS; Claude, MS; Nevil, P; Smith-Fawzi, MC; Koenig, SP; Castro, A; Becerra, MC; Sachs, J; Attaran, A; Kim, JY				Farmer, P; Leandre, F; Mukherjee, JS; Claude, MS; Nevil, P; Smith-Fawzi, MC; Koenig, SP; Castro, A; Becerra, MC; Sachs, J; Attaran, A; Kim, JY			Community-based approaches to HIV treatment in resource-poor settings	LANCET			English	Editorial Material							IMMUNODEFICIENCY-VIRUS TYPE-1; WEIGHT-LOSS; TUBERCULOSIS; TRANSMISSION; PROGRESSION; INFECTION; MORTALITY; SURVIVAL; DISEASES; AIDS		Harvard Univ, Sch Med, Dept Social Med, Boston, MA 02115 USA; Ctr Thomas J White, Cange, Haiti; Harvard Univ, Ctr Int Dev, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University	Farmer, P (corresponding author), Harvard Univ, Sch Med, Dept Social Med, Boston, MA 02115 USA.	paul_farmer@hms.harvard.edu	Castro, Arachu/L-6664-2014	Castro, Arachu/0000-0003-0428-9174				[Anonymous], 1992, AIDS WORLD; BLATT SP, 1995, J INFECT DIS, V171, P837, DOI 10.1093/infdis/171.4.837; *CDCP, 1996, MMWR-MORBID MORTAL W, V45, P468; *CENTR INT AG, 2001, WORLD FACTB 2000; CHAN ISF, 1995, AIDS, V9, P1145, DOI 10.1097/00002030-199510000-00005; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; DESCHAMPS MM, 1993, J ACQ IMMUN DEF SYND, V6, P446; Farmer P, 1991, Semin Respir Infect, V6, P254; Farmer P, 1998, BRIT MED J, V317, P671, DOI 10.1136/bmj.317.7159.671; Farmer P, 1998, INT J TUBERC LUNG D, V2, P869; Farmer P, 1997, AIDS Clin Care, V9, P83; Farmer P, 1997, ANTHR INFECT DIS, P413; Farmer Paul, 1996, WOMEN POVERTY AIDS S; Farmer Paul E., 2000, CATHOLIC ETHICISTS H, P108; FARMER PE, 2000, J RESP DIS, V21, P53; FARMER PE, 2000, EMERGENCE AIDS IMPAC, P139; Farmer PE, 2000, NATL AIDS B, V13, P6; FARMER PE, 2000, LUNG BIOL HEALTH DIS, V144, P447; Freedberg KA, 2001, NEW ENGL J MED, V344, P824, DOI 10.1056/NEJM200103153441108; FUCHS D, 1993, EUR J HAEMATOL, V50, P90; Garber AM, 2000, HANDB ECON, V17, P181; GARRETT L, 2000, NEWSDAY         1129; Gebo KA, 1999, AIDS, V13, P963, DOI 10.1097/00002030-199905280-00013; GELLMAN B, 2000, WASHINGTON POST 0705, P1; GRAHAM NMH, 1993, AM J EPIDEMIOL, V137, P439, DOI 10.1093/oxfordjournals.aje.a116692; GUPTA R, 2000, P M CAMBR MA JUL 5 6; *INT FED RED CROSS, 2000, WORLD DIS REP 2000; *JOINT UN PROGR HI, 2000, REP GLOB HIV AIDS EP; *JOINT UN PROGR HI, 2000, AIDS EP UPD; Mayaud P, 1998, LANCET, V351, P29; McNeil D G Jr, 2000, N Y Times Web; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Moore RD, 1999, AIDS, V13, P1933, DOI 10.1097/00002030-199910010-00017; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; *PAN I, 2000, OUR MEANS COST TREAT; Pecoul B, 1999, JAMA-J AM MED ASSOC, V281, P361, DOI 10.1001/jama.281.4.361; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Raviglione MC, 1997, LANCET, V350, P624, DOI 10.1016/S0140-6736(97)04146-9; SUMARTOJO E, 1993, AM REV RESPIR DIS, V147, P1311, DOI 10.1164/ajrccm/147.5.1311; United Nations Development Program, 2000, HUM DEV REP 2000; Wheeler DA, 1998, J ACQ IMMUN DEF SYND, V18, P80, DOI 10.1097/00042560-199805010-00012; *WORLD BANK, 1997, 366 WDP; 1973, BMJ, V4, P568	43	337	345	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 4	2001	358	9279					404	409		10.1016/S0140-6736(01)05550-7	http://dx.doi.org/10.1016/S0140-6736(01)05550-7			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459DE	11502340				2022-12-28	WOS:000170235100035
J	Freemantle, N; Behmane, D; de Joncheere, K				Freemantle, N; Behmane, D; de Joncheere, K			Pricing and reimbursement of pharmaceuticals in the Baltic States	LANCET			English	Editorial Material									Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England; Med Pricing & Reimbursement Agcy, Riga, Latvia; WHO, Reg Off Europe, DK-2100 Copenhagen, Denmark	University of Birmingham; World Health Organization	Freemantle, N (corresponding author), Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England.			Freemantle, Nick/0000-0001-5807-5740				BLOOR K, 1996, HLTH CARE UK 1995 96, P173; Jacobzone S., 2000, PHARM POLICIES OECD	2	8	8	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 28	2001	358	9278					260	260		10.1016/S0140-6736(01)05496-4	http://dx.doi.org/10.1016/S0140-6736(01)05496-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	457AF	11498210				2022-12-28	WOS:000170114400007
J	Chamoun, Z; Mann, RK; Nellen, D; von Kessler, DP; Bellotto, M; Beachy, PA; Basler, K				Chamoun, Z; Mann, RK; Nellen, D; von Kessler, DP; Bellotto, M; Beachy, PA; Basler, K			Skinny Hedgehog, an acyltransferase required for palmitoylation and activity of the Hedgehog signal	SCIENCE			English	Article							DROSOPHILA; POLARITY; PROTEIN; IDENTIFICATION; MUTATIONS; GENES; CHROMOSOME; WINGLESS; PATTERN; RNA	One of the most dominant influences in the patterning of multicellular embryos is exerted by the Hedgehog (Hh) family of secreted signaling proteins. Here, we identify a segment polarity gene in Drosophila, melanogaster, Skinny hedgehog (ski), and show that its product is required in Hh-expressing cells for production of appropriate signaling activity in embryos and in the imaginal precursors of adult tissues. The ski gene encodes an apparent acyltransferase, and we provide genetic and biochemical evidence that Hh proteins from ski mutant cells retain carboxyl-terminal cholesterol modification but lack amino-terminal palmitate modification. Our results suggest that ski encodes an enzyme that acts within the secretory pathway to catalyze amino-terminal palmitoylation of Hh, and further demonstrate that this lipid modification is required for the embryonic and larval patterning activities of the Hh signal.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Univ Zurich, Inst Mol Biol, CH-8057 Zurich, Switzerland; Univ Zurich, Inst Zool, CH-8057 Zurich, Switzerland	Howard Hughes Medical Institute; Johns Hopkins University; University of Zurich; University of Zurich	Beachy, PA (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	pbeachy@jhmi.edu; basler@molbio.unizh.ch		Basler, Konrad/0000-0003-3534-1529				BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; Burke R, 1999, CELL, V99, P803, DOI 10.1016/S0092-8674(00)81677-3; CAPDEVILA J, 1994, EMBO J, V13, P71, DOI 10.1002/j.1460-2075.1994.tb06236.x; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Chen CH, 1999, CELL, V98, P305, DOI 10.1016/S0092-8674(00)81960-1; Chou TB, 1996, GENETICS, V144, P1673; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Deak P, 1997, GENETICS, V147, P1697; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Kadowaki T, 1996, GENE DEV, V10, P3116, DOI 10.1101/gad.10.24.3116; Kawakami Y, 2001, J IMMUNOL, V166, P2871, DOI 10.4049/jimmunol.166.4.2871; Kohtz JD, 2001, DEVELOPMENT, V128, P2351; Lardizabal KD, 2000, PLANT PHYSIOL, V122, P645, DOI 10.1104/pp.122.3.645; Lee JD, 2001, DEV BIOL, V233, P122, DOI 10.1006/dbio.2001.0218; LEE JJ, 1994, SCIENCE, V266, P1528, DOI 10.1126/science.7985023; Li BL, 1999, J BIOL CHEM, V274, P11060, DOI 10.1074/jbc.274.16.11060; Neumann C, 1997, BIOESSAYS, V19, P721, DOI 10.1002/bies.950190813; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; PORTER JA, 1995, NATURE, V374, P363, DOI 10.1038/374363a0; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Porter JA, 1996, CELL, V86, P21, DOI 10.1016/S0092-8674(00)80074-4; Strigini M, 1997, DEVELOPMENT, V124, P4697; TABATA T, 1994, CELL, V76, P89, DOI 10.1016/0092-8674(94)90175-9; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; VANDENHEUVEL M, 1993, EMBO J, V12, P5293, DOI 10.1002/j.1460-2075.1993.tb06225.x; WAHI M, 1995, GENETICS, V140, P79; WOHLWILL AD, 1991, GENETICS, V128, P763	28	326	340	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2001	293	5537					2080	2084		10.1126/science.1064437	http://dx.doi.org/10.1126/science.1064437			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11486055				2022-12-28	WOS:000171028700072
J	Edwards, MB; Taylor, KM				Edwards, MB; Taylor, KM			Cohort survey of heart valve replacement patients: does the valve card scheme have room for improvement?	BRITISH MEDICAL JOURNAL			English	Article							FRACTURE; REGISTRY		Hammersmith Hosp, Dept Cardiothorac Surg, United Kingdom Heart Valve Registry, London W12 0NN, England	Imperial College London	Edwards, MB (corresponding author), Hammersmith Hosp, Dept Cardiothorac Surg, United Kingdom Heart Valve Registry, London W12 0NN, England.		EDWARDS, MARIA-BENEDICTA/L-9777-2019					Baumgartner FJ, 1997, TEX HEART I J, V24, P122; DYER C, 1988, GUARDIAN        0917, P20; Edwards MB, 1999, J HEART VALVE DIS, V8, P697; Taylor K, 1997, HEART, V77, P295, DOI 10.1136/hrt.77.4.295; VANDERGRAAF Y, 1992, LANCET, V339, P257, DOI 10.1016/0140-6736(92)91328-6	5	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 25	2001	323	7310					429	430		10.1136/bmj.323.7310.429	http://dx.doi.org/10.1136/bmj.323.7310.429			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469BX	11520841	Bronze, Green Published			2022-12-28	WOS:000170793600022
J	Cheung, AY; Wu, HM				Cheung, AY; Wu, HM			Plant biology - Pollen tube guidance right on target	SCIENCE			English	Editorial Material							GROWTH; GLYCOPROTEIN		Univ Massachusetts, Dept Biochem & Mol Biol, Cell & Mol Biol Program, Plant Biol Grad Program, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Cheung, AY (corresponding author), Univ Massachusetts, Dept Biochem & Mol Biol, Cell & Mol Biol Program, Plant Biol Grad Program, Amherst, MA 01003 USA.	acheung@biochem.umass.edu						CHEUNG AY, 1995, CELL, V82, P383, DOI 10.1016/0092-8674(95)90427-1; FAURE JE, COMMUNICATION; HEPLER PK, IN PRESS ANN REV CEL; Herrero M, 2000, ANN BOT-LONDON, V85, P79, DOI 10.1006/anbo.1999.1014; Higashiyama T, 2001, SCIENCE, V293, P1480, DOI 10.1126/science.1062429; Higashiyama T, 1998, PLANT CELL, V10, P2019, DOI 10.1105/tpc.10.12.2019; Lord E, 2000, TRENDS PLANT SCI, V5, P368, DOI 10.1016/S1360-1385(00)01744-1; Palanivelu R, 2000, TRENDS CELL BIOL, V10, P517, DOI 10.1016/S0962-8924(00)01849-3; Russell SD, 1996, SEX PLANT REPROD, V9, P337, DOI 10.1007/BF02441952; Shimizu KK, 2000, DEVELOPMENT, V127, P4511; Wolters-Arts M, 1998, NATURE, V392, P818, DOI 10.1038/33929; WU HM, 1995, CELL, V82, P395, DOI 10.1016/0092-8674(95)90428-X	12	33	38	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2001	293	5534					1441	1442		10.1126/science.1065051	http://dx.doi.org/10.1126/science.1065051			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465XV	11520971				2022-12-28	WOS:000170616000028
J	Etienne-Manneville, S; Hall, A				Etienne-Manneville, S; Hall, A			Integrin-mediated activation of Cdc42 controls cell polarity in migrating astrocytes through PKC zeta	CELL			English	Article							SACCHAROMYCES-CEREVISIAE GENE; PROTEIN-KINASE-C; RHO GTPASES; T-CELLS; BINDING; RAC; ADHESION; PHOSPHORYLATION; MEMBRANE; DYNACTIN	We describe here a signal transduction pathway controlling the establishment of mammalian cell polarity. Scratching a confluent monolayer of primary rat astrocytes leads to polarization of cells at the leading edge. The microtubule organizing center, the microtubule cytoskeleton, and the Golgi reorganize to face the new free space, and directed cell protrusion and migration specifically occur perpendicularly to the scratch. We show here that the interaction of integrins with extracellular matrix at the newly formed cell front leads to the activation and polarized recruitment of Cdc42, which in turn recruits and activates a cytoplasmic mPar6/PKC zeta complex. Localized PKC zeta activity, acting through the microtubule motor protein dynein, is required for all aspects of induced polarity in these cells.	UCL, MRC, Lab Mol Cell Biol, London WC1E 6BT, England; UCL, CRC, Oncogene & Signal Transduct Grp, Cell Biol Unit, London WC1E 6BT, England; UCL, Dept Biochem & Mol Biol, London WC1E 6BT, England	University of London; University College London; University of London; University College London; University of London; University College London	Hall, A (corresponding author), UCL, MRC, Lab Mol Cell Biol, Gower St, London WC1E 6BT, England.	alan.hall@ucl.ac.uk	Etienne-Manneville, Sandrine/C-5879-2015	Etienne-Manneville, Sandrine/0000-0001-6651-3675				Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bloom K, 2001, CURR BIOL, V11, pR326, DOI 10.1016/S0960-9822(01)00176-2; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; COBB BS, 1994, MOL CELL BIOL, V14, P147, DOI 10.1128/MCB.14.1.147; Cook TA, 1998, J CELL BIOL, V141, P175, DOI 10.1083/jcb.141.1.175; Cox EA, 2001, MOL BIOL CELL, V12, P265, DOI 10.1091/mbc.12.2.265; Daub H, 2001, J BIOL CHEM, V276, P1677, DOI 10.1074/jbc.C000635200; DIAZMECO MT, 1994, EMBO J, V13, P2842, DOI 10.1002/j.1460-2075.1994.tb06578.x; Doe CQ, 2001, NAT CELL BIOL, V3, pE7, DOI 10.1038/35050684; Etienne-Manneville S, 1999, J IMMUNOL, V163, P668; Guo S, 1996, CURR OPIN GENET DEV, V6, P408, DOI 10.1016/S0959-437X(96)80061-X; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hung TJ, 1999, DEVELOPMENT, V126, P127; Ishizaki T, 2001, NAT CELL BIOL, V3, P8; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Johansson AS, 2000, J CELL SCI, V113, P3267; JOHNSON DI, 1990, J CELL BIOL, V111, P143, DOI 10.1083/jcb.111.1.143; Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Kjoller L, 2001, J CELL BIOL, V152, P1145, DOI 10.1083/jcb.152.6.1145; Koonce MP, 1999, EMBO J, V18, P6786, DOI 10.1093/emboj/18.23.6786; Kroschewski R, 1999, NAT CELL BIOL, V1, P8, DOI 10.1038/8977; Lamarche N, 1996, CELL, V87, P519, DOI 10.1016/S0092-8674(00)81371-9; Leng LJ, 1998, BLOOD, V91, P4206, DOI 10.1182/blood.V91.11.4206.411k30_4206_4215; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Lowin-Kropf B, 1998, J CELL BIOL, V140, P861, DOI 10.1083/jcb.140.4.861; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; Qiu RG, 2000, CURR BIOL, V10, P697, DOI 10.1016/S0960-9822(00)00535-2; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; STOWERS L, 1995, P NATL ACAD SCI USA, V92, P5027, DOI 10.1073/pnas.92.11.5027; Suzuki A, 2001, J CELL BIOL, V152, P1183, DOI 10.1083/jcb.152.6.1183; TANAKA E, 1995, J CELL BIOL, V128, P139, DOI 10.1083/jcb.128.1.139; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9; ZIMAN M, 1991, MOL CELL BIOL, V11, P3537, DOI 10.1128/MCB.11.7.3537	41	811	832	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 24	2001	106	4					489	498		10.1016/S0092-8674(01)00471-8	http://dx.doi.org/10.1016/S0092-8674(01)00471-8			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	466UU	11525734	Bronze			2022-12-28	WOS:000170665200012
J	Jung, H; Karato, S				Jung, H; Karato, S			Water-induced fabric transitions in olivine	SCIENCE			English	Article							WAVE VELOCITIES; MANTLE; DEFORMATION; ANISOTROPY; BENEATH; ZONE; FLOW	The interpretation of seismic anisotropy in Earth's upper mantle has traditionally been based on the fabrics (lattice-preferred orientation) of relatively water-poor olivine. Here we show that when a large amount of water is added to olivine, the relation between flow geometry and seismic anisotropy undergoes marked changes. Some of the puzzling observations of seismic anisotropy in the upper mantle, including the anomalous anisotropy in the central Pacific and the complicated anisotropy in subduction zones, can be attributed to the enrichment of water in these regions.	Univ Minnesota, Dept Geol & Geophys, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Karato, S (corresponding author), Yale Univ, Dept Geol & Geophys, POB 6666, New Haven, CT 06520 USA.	shun-ichiro.karato@yale.edu						BELL DR, 1992, SCIENCE, V255, P1391, DOI 10.1126/science.255.5050.1391; Ben Ismail W, 1998, TECTONOPHYSICS, V296, P145; Bystricky M, 2000, SCIENCE, V290, P1564, DOI 10.1126/science.290.5496.1564; CARTER NL, 1970, GEOL SOC AM BULL, V81, P2181, DOI 10.1130/0016-7606(1970)81[2181:HTFODA]2.0.CO;2; CHOPRA PN, 1984, J GEOPHYS RES, V89, P7861, DOI 10.1029/JB089iB09p07861; Ekstrom G, 1998, NATURE, V394, P168, DOI 10.1038/28148; FRESE K, 2001, DEFORM MECH RHEOL TE, V53, P54; FROST HJ, 1982, DEFORMATION MECH MAP, P167; Green D.H., 1998, EARTHS MANTLE COMPOS, P311, DOI DOI 10.1017/CB09780511573101.010; Hirth G, 1996, EARTH PLANET SC LETT, V144, P93, DOI 10.1016/0012-821X(96)00154-9; Jin DH, 1998, J STRUCT GEOL, V20, P195, DOI 10.1016/S0191-8141(97)00059-X; Jung H, 2001, J STRUCT GEOL, V23, P1337, DOI 10.1016/S0191-8141(01)00005-0; KARATO S, 1986, NATURE, V319, P309, DOI 10.1038/319309a0; KARATO S, 1995, P JPN ACAD B-PHYS, V71, P61, DOI 10.2183/pjab.71.61; KARATO S, 1989, TECTONOPHYSICS, V168, P255, DOI 10.1016/0040-1951(89)90221-7; Karato S, 1998, EARTH PLANET SC LETT, V157, P193, DOI 10.1016/S0012-821X(98)00034-X; KARATO S, IN PRESS PHILOS MA A; Karato S, 1999, P 12 INT C TEXT MAT, P1546; Kohlstedt DL, 1996, CONTRIB MINERAL PETR, V123, P345, DOI 10.1007/s004100050161; LITTLEJOHN AL, 1974, CAN J EARTH SCI, V11, P1288, DOI 10.1139/e74-121; MACKWELL SJ, 1985, J GEOPHYS RES-SOLID, V90, P1319, DOI 10.1029/JB090iB13p11319; Margheriti L, 1996, GEOPHYS RES LETT, V23, P2721, DOI 10.1029/96GL02519; MEI S, 2001, J GEOPHYS RES, V105, P21461; MERCIER JCC, 1980, J GEOPHYS RES, V85, P6293, DOI 10.1029/JB085iB11p06293; Mockel J.R., 1969, LEIDSE GEOL MEDED, V42, P61; MONTAGNER JP, 1986, J GEOPHYS RES-SOLID, V91, P511, DOI 10.1029/JB091iB01p00511; Montagner JP, 2000, PROBLEMS IN GEOPHYSICS FOR THE NEW MILLENNIUM, P217; NATAF HC, 1986, J GEOPHYS RES-SOLID, V91, P7261, DOI 10.1029/JB091iB07p07261; Nicolas A., 1987, FORMATION ANISOTROPY, DOI DOI 10.1029/GD016P0111; PATERSON MS, 1982, B MINERAL, V105, P20; SCHILLING JG, 1980, PHILOS T R SOC A, V297, P147, DOI 10.1098/rsta.1980.0208; Smith GP, 2001, SCIENCE, V292, P713, DOI 10.1126/science.1058763; YOSHINO G, 1961, J SCI HIROSHIMA U C, V3, P343; Zhang SQ, 2000, TECTONOPHYSICS, V316, P133, DOI 10.1016/S0040-1951(99)00229-2; ZHANG SQ, 1995, NATURE, V375, P774, DOI 10.1038/375774a0	35	665	695	4	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2001	293	5534					1460	1463		10.1126/science.1062235	http://dx.doi.org/10.1126/science.1062235			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465XV	11520979				2022-12-28	WOS:000170616000036
J	Kim, T; Tao-Cheng, JH; Eiden, LE; Loh, YP				Kim, T; Tao-Cheng, JH; Eiden, LE; Loh, YP			Chromogranin A, an "on/off" switch controlling dense-core secretory granule biogenesis	CELL			English	Article							TERMINAL DOMAINS; CELLS; EXPRESSION; AGGREGATION; PROTEIN; GENE; PH; VESICLES; PEPTIDES; PATHWAY	We present evidence that regulation of dense-core secretory granule biogenesis and hormone secretion in endocrine cells is dependent on chromogranin A (CGA). Downregulation of CGA expression in a neuroendocrine cell line, PC12, by antisense RNAs led to profound loss of dense-core secretory granules, impairment of regulated secretion of a transfected prohormone, and reduction of secretory granule proteins. Transfection of bovine CGA into a CGA-deficient PC12 clone rescued the regulated secretory phenotype. Stable transfection of CGA into a CGA-deficient pituitary cell line, 6T3, lacking a regulated secretory pathway, restored regulated secretion. Overexpression of CGA induced dense-core granules, immunoreactive for CGA, in nonendocrine fibroblast CV-1 cells. We conclude that CGA is an "on/off" switch that alone is sufficient to drive dense-core secretory granule biogenesis and hormone sequestration in endocrine cells.	NICHHD, Dev Neurobiol Lab, Cellular Neurobiol Sect, NIH, Bethesda, MD 20892 USA; NINDS, EM Facil, Bethesda, MD 20892 USA; NIMH, Lab Cellular & Mol Regulat, Mol Neurosci Sect, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Loh, YP (corresponding author), NICHHD, Dev Neurobiol Lab, Cellular Neurobiol Sect, NIH, Bethesda, MD 20892 USA.	ypl@codon.nih.gov		Eiden, Lee/0000-0001-7524-944X	NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002386, Z01MH002386] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BENEDUM UM, 1987, EMBO J, V6, P1203, DOI 10.1002/j.1460-2075.1987.tb02355.x; CASTRO MG, 1989, MOL CELL ENDOCRINOL, V65, P165, DOI 10.1016/0303-7207(89)90177-9; Cool DR, 1997, CELL, V88, P73, DOI 10.1016/S0092-8674(00)81860-7; Corradi N, 1996, J BIOL CHEM, V271, P27116, DOI 10.1074/jbc.271.43.27116; Cowley DJ, 2000, J BIOL CHEM, V275, P7743, DOI 10.1074/jbc.275.11.7743; ERICKSON JD, 1993, J NEUROCHEM, V61, P2314, DOI 10.1111/j.1471-4159.1993.tb07476.x; FISCHERCOLBRIE R, 1987, ANN NY ACAD SCI, V493, P120, DOI 10.1111/j.1749-6632.1987.tb27189.x; FISCHERCOLBRIE R, 1987, J NEUROCHEM, V48, P262, DOI 10.1111/j.1471-4159.1987.tb13157.x; Galas MC, 1997, J BIOL CHEM, V272, P2788, DOI 10.1074/jbc.272.5.2788; GERDES HH, 1989, J BIOL CHEM, V264, P12009; Glombik MM, 2000, BIOCHIMIE, V82, P315, DOI 10.1016/S0300-9084(00)00195-4; GORR SU, 1989, AM J PHYSIOL, V257, pE247, DOI 10.1152/ajpendo.1989.257.2.E247; HEISLER S, 1984, J NEUROCHEM, V42, P1659, DOI 10.1111/j.1471-4159.1984.tb12757.x; HENDY GN, 1995, CLIN INVEST MED, V18, P47; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; HUTTNER WB, 1991, TRENDS BIOCHEM SCI, V16, P27, DOI 10.1016/0968-0004(91)90012-K; IACANGELO AL, 1991, MOL ENDOCRINOL, V5, P1651, DOI 10.1210/mend-5-11-1651; IACANGELO AL, 1995, REGUL PEPTIDES, V58, P65, DOI 10.1016/0167-0115(95)00069-N; Jain RK, 2000, J BIOL CHEM, V275, P27032; LOH YP, 1985, J BIOL CHEM, V260, P7194; MATSUUCHI L, 1991, J CELL BIOL, V112, P843, DOI 10.1083/jcb.112.5.843; Ozawa H, 1995, CELL STRUCT FUNCT, V20, P415, DOI 10.1247/csf.20.415; Pance A, 1999, J NEUROCHEM, V73, P21, DOI 10.1046/j.1471-4159.1999.0730021.x; SCHAFER MKH, 1994, PEPTIDES, V15, P263, DOI 10.1016/0196-9781(94)90012-4; Tanner VA, 1996, J HISTOCHEM CYTOCHEM, V44, P1481, DOI 10.1177/44.12.8985140; Watanabe T, 1998, ENDOCRINOLOGY, V139, P2765, DOI 10.1210/en.139.6.2765; WINKLER H, 1992, NEUROSCIENCE, V49, P497, DOI 10.1016/0306-4522(92)90222-N; WU HJ, 1991, J BIOL CHEM, V266, P13130; Yoo SH, 1996, J BIOL CHEM, V271, P17041, DOI 10.1074/jbc.271.29.17041; YOO SH, 1995, J BIOL CHEM, V270, P12578, DOI 10.1074/jbc.270.21.12578	30	337	352	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 24	2001	106	4					499	509		10.1016/S0092-8674(01)00459-7	http://dx.doi.org/10.1016/S0092-8674(01)00459-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	466UU	11525735	Bronze			2022-12-28	WOS:000170665200013
J	Van Eck, S; Goriely, S; Jorissen, A; Plez, B				Van Eck, S; Goriely, S; Jorissen, A; Plez, B			Discovery of three lead-rich stars	NATURE			English	Article							S-PROCESS NUCLEOSYNTHESIS; METAL-POOR STAR; AGB STARS; NEUTRON-CAPTURE; CH STARS; EVOLUTION; CARBON; BARIUM; GIANT	About half of the stable nuclei heavier than iron are believed to be synthesized during the late stages of evolution of stars with masses in the range 0.8-8 solar masses. These elements are then expelled into the interstellar medium through stellar winds after being 'dredged up' towards the surface of the stars. These processes occur when the star is in the 'asymptotic giant branch' (AGB) phase of its life. Nuclei (mainly iron) deep inside the star slowly capture neutrons and progressively build up heavier elements (the 's-process'). For AGB stars that formed early in the history of the Galaxy, and that therefore have very low abundances of elements heavier than helium ('metals'), models(1) predict that the s-process will accumulate synthesized material with atomic weights in the Pb-Bi region. Such stars will therefore have large overabundances of lead relative to other heavy elements. Here we report the discovery of large amounts of lead in three metal-poor stars (HD187861, HD196944 and HD224959). Our analysis shows that these stars are more enriched in lead than in any other element heavier than iron. The excellent agreement between the observed and predicted abundances reinforces our current understanding of the detailed operation of the s-process deep in the interiors of AGB stars.	Free Univ Brussels, Inst Astron & Astrophys, B-1050 Brussels, Belgium; Univ Montpellier 2, GRAAL, F-34095 Montpellier 05, France; European So Observ, Santiago 19, Chile	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite de Montpellier; European Southern Observatory	Van Eck, S (corresponding author), Free Univ Brussels, Inst Astron & Astrophys, Blvd Triomphe,CP 226, B-1050 Brussels, Belgium.		Goriely, Stephane/AAE-1742-2021; Plez, Bertrand/G-6697-2011	Plez, Bertrand/0000-0002-0398-4434				Alvarez R, 1998, ASTRON ASTROPHYS, V330, P1109; Aoki W, 2000, ASTROPHYS J, V536, pL97, DOI 10.1086/312740; Biemont E, 2000, MON NOT R ASTRON SOC, V312, P116, DOI 10.1046/j.1365-8711.2000.03094.x; Fujimoto MY, 2000, ASTROPHYS J, V529, pL25, DOI 10.1086/312453; Gallino R, 1998, ASTROPHYS J, V497, P388, DOI 10.1086/305437; Goriely S, 2000, ASTRON ASTROPHYS, V362, P599; Goriely S, 1999, ASTRON ASTROPHYS, V346, P798; Herwig F, 1997, ASTRON ASTROPHYS, V324, pL81; KAPPELER F, 1989, REP PROG PHYS, V52, P945, DOI 10.1088/0034-4885/52/8/002; Langer N, 1999, ASTRON ASTROPHYS, V346, pL37; Luque J., 1999, SRI International Report MP 99-009.; MCCLURE RD, 1990, ASTROPHYS J, V352, P709, DOI 10.1086/168573; Sneden C, 2000, ASTROPHYS J, V533, pL139, DOI 10.1086/312631; Sneden C, 1998, ASTROPHYS J, V496, P235, DOI 10.1086/305366; Travaglio C, 1999, ASTROPHYS J, V521, P691, DOI 10.1086/307571; VANTURE AD, 1992, ASTRON J, V104, P1997, DOI 10.1086/116375; Zacs L, 1998, ASTRON ASTROPHYS, V337, P216	17	115	115	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2001	412	6849					793	795		10.1038/35090514	http://dx.doi.org/10.1038/35090514			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465ET	11518958				2022-12-28	WOS:000170577200029
J	Mysak, LA				Mysak, LA			Oceanography - Patterns of Arctic circulation	SCIENCE			English	Editorial Material							OSCILLATION; OCEAN		McGill Univ, Dept Atmospher & Ocean Sci, Montreal, PQ H3A 2K6, Canada; McGill Univ, Ctr Climate & Global Change Res, Montreal, PQ H3A 2K6, Canada	McGill University; McGill University	Mysak, LA (corresponding author), McGill Univ, Dept Atmospher & Ocean Sci, Montreal, PQ H3A 2K6, Canada.							Dickson RR, 2000, J CLIMATE, V13, P2671, DOI 10.1175/1520-0442(2000)013<2671:TAORTT>2.0.CO;2; Dyke AS, 1997, ARCTIC, V50, P1; Gobeil C, 2001, SCIENCE, V293, P1301, DOI 10.1126/science.1059725; MACDONALD RG, COMMUNICATION; Polyakov IV, 2000, GEOPHYS RES LETT, V27, P4097, DOI 10.1029/2000GL011909; Proshutinsky AY, 1997, J GEOPHYS RES-OCEANS, V102, P12493, DOI 10.1029/97JC00738; Thompson DWJ, 1998, GEOPHYS RES LETT, V25, P1297, DOI 10.1029/98GL00950; TREMBLAY LB, 1997, GEOPHYS RES LETT, V24, P2207; Venegas SA, 2000, J CLIMATE, V13, P3412, DOI 10.1175/1520-0442(2000)013<3412:ITADTO>2.0.CO;2; Walsh JE, 1996, J CLIMATE, V9, P480, DOI 10.1175/1520-0442(1996)009<0480:RDOSLP>2.0.CO;2; WANNER H, IN PRESS SURV GEOPHY	11	53	58	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2001	293	5533					1269	1270		10.1126/science.1064217	http://dx.doi.org/10.1126/science.1064217			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11509716				2022-12-28	WOS:000170492600025
J	Nossal, GJV				Nossal, GJV			A purgative mastery	NATURE			English	Editorial Material									Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia	University of Melbourne	Nossal, GJV (corresponding author), Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia.							Kamradt T, 2001, NEW ENGL J MED, V344, P655, DOI 10.1056/NEJM200103013440907; MILLER JFA, IN PRESS TRANSPLANTA; Schwartz R., 1999, FUNDAMENTAL IMMUNOLO, P701	3	18	19	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 16	2001	412	6848					685	686		10.1038/35089152	http://dx.doi.org/10.1038/35089152			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462ZB	11507616				2022-12-28	WOS:000170450200022
J	Ioannidis, JPA; Haidich, AB; Pappa, M; Pantazis, N; Kokori, SI; Tektonidou, MG; Contopoulos-Ioannidis, DG; Lau, J				Ioannidis, JPA; Haidich, AB; Pappa, M; Pantazis, N; Kokori, SI; Tektonidou, MG; Contopoulos-Ioannidis, DG; Lau, J			Comparison of evidence of treatment effects in randomized and nonrandomized studies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							DESIGN AFFECTS OUTCOMES; METAANALYSIS; THERAPY; PREVENTION; EFFICACY; CANCER; SUPPLEMENTATION; PUBLICATION; MAMMOGRAPHY; DISEASE	Context There is substantial debate about whether the results of nonrandomized studies are consistent with the results of randomized controlled trials on the same topic. Objectives To compare results of randomized and non randomized studies that evaluated medical interventions and to examine characteristics that may explain discrepancies between randomized and non-randomized studies. Data Sources MEDLINE (1966-March 2000), the Cochrane Library (Issue 3, 2000), and major journals were searched. Study Selection Forty-five diverse topics were identified for which both randomized trials (n = 240) and nonrandomized studies (n = 168) had been performed and had been considered in meta-analyses of binary outcomes. Data Extraction Data on events per patient in each study arm and design and characteristics of each study considered in each meta-analysis were extracted and synthesized separately for randomized and nonrandomized studies. Data Synthesis Very good correlation was observed between the summary odds ratios of randomized and nonrandomized studies (r = 0.75; P<.001); however, nonrandomized studies tended to show larger treatment effects (28 vs 11; P = .009). Between-study heterogeneity was frequent among randomized trials alone (23%) and very frequent among nonrandomized studies alone (41%). The summary results of the 2 types of designs differed beyond chance in 7 cases (16%). Discrepancies beyond chance were less common when only prospective studies were considered (8%). Occasional differences in sample size and timing of publication were also noted between discrepant randomized and nonrandomized studies. In 28 cases (62%), the natural logarithm of the odds ratio differed by at least 50%, and in 15 cases (33%), the odds ratio varied at least 2-fold between nonrandomized studies and randomized trials. Conclusions Despite good correlation between randomized trials and nonrandomized studies-in particular, prospective studies-discrepancies beyond chance do occur and differences in estimated magnitude of treatment effect are very common.	Univ Ioannina, Sch Med, Clin Trials & Evidence Based Med Unit, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; Univ Athens, Sch Med, Dept Hyg & Epidemiol, GR-11527 Athens, Greece; Laikon Gen Hosp, GR-11527 Athens, Greece; George Washington Univ, Sch Med, Dept Pediat, Washington, DC 20052 USA; Tufts Univ, Sch Med, Dept Med, Div Clin Care Res, Boston, MA 02111 USA	University of Ioannina; Athens Medical School; National & Kapodistrian University of Athens; Laiko General Hospital; George Washington University; Tufts University	Lau, J (corresponding author), Tufts Univ New England Med Ctr, Div Clin Care Res, Box 63,750 Washington St, Boston, MA 02111 USA.	JLau1@lifespan.org	Haidich, Anna Bettina/L-9426-2019; Ioannidis, John P. A./G-9836-2011; Kokoris, Stella/GYA-1957-2022; Tektonidou, Maria/AAF-1642-2019	Haidich, Anna Bettina/0000-0001-5100-8799; Tektonidou, Maria/0000-0003-2238-0975; Pantazis, Nikos/0000-0002-4196-5066; Kokoris, Styliani/0000-0002-1635-7309				ABRUTYN E, 1991, JAMA-J AM MED ASSOC, V266, P2262, DOI 10.1001/jama.266.16.2262; Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501; [Anonymous], 1994, Am J Reprod Immunol, V32, P55; Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; BEROYZ G, 1994, LANCET, V343, P619; Black NA, 1996, BRIT J UROL, V78, P497, DOI 10.1046/j.1464-410X.1996.01422.x; BROSSEAU L, 2000, LOW LEVEL LASER THER; CALLAHAN CM, 1991, ANN INTERN MED, V114, P216, DOI 10.7326/0003-4819-114-3-216; Camma C, 1996, DIGEST DIS SCI, V41, P1248, DOI 10.1007/BF02088245; Carroll D, 1996, BRIT J ANAESTH, V77, P798, DOI 10.1093/bja/77.6.798; CHALMERS TC, 1977, NEW ENGL J MED, V297, P1091, DOI 10.1056/NEJM197711172972004; Chinoy MA, 1999, INJURY, V30, P157, DOI 10.1016/S0020-1383(99)00074-1; COLDITZ GA, 1989, STAT MED, V8, P441, DOI 10.1002/sim.4780080408; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Cook RL, 1998, SEX TRANSM DIS, V25, P144, DOI 10.1097/00007435-199803000-00007; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; FOUQUE D, 1992, BMJ-BRIT MED J, V304, P216, DOI 10.1136/bmj.304.6821.216; GIFFORD DS, 1995, OBSTET GYNECOL, V85, P1047, DOI 10.1016/0029-7844(95)00053-T; GLASZIOU PP, 1993, BMJ-BRIT MED J, V306, P366, DOI 10.1136/bmj.306.6874.366; Gotzsche PC, 2000, LANCET, V355, P129, DOI 10.1016/S0140-6736(99)06065-1; Grullon KE, 1997, OBSTET GYNECOL, V90, P860, DOI 10.1016/S0029-7844(97)00405-5; Hart RG, 2000, ARCH NEUROL-CHICAGO, V57, P326, DOI 10.1001/archneur.57.3.326; HOMMES DW, 1992, ANN INTERN MED, V116, P279, DOI 10.7326/0003-4819-116-4-279; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; IMPERIALE T F, 1991, Journal of the American Medical Association, V266, P260, DOI 10.1001/jama.266.2.260; INSUA JT, 1994, ANN INTERN MED, V121, P355, DOI 10.7326/0003-4819-121-5-199409010-00008; Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P281, DOI 10.1001/jama.279.4.281; Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P1089, DOI 10.1001/jama.279.14.1089; Ioannidis JPA, 2001, ANN EMERG MED, V37, P461, DOI 10.1067/mem.2001.114904; Ioannidis JPA, 2001, BRIT MED J, V322, P879, DOI 10.1136/bmj.322.7291.879; KASISKE BL, 1993, JAMA-J AM MED ASSOC, V269, P395, DOI 10.1001/jama.269.3.395; KERLIKOWSKE K, 1995, JAMA-J AM MED ASSOC, V273, P149, DOI 10.1001/jama.273.2.149; Kunz R, 1998, BRIT MED J, V317, P1185, DOI 10.1136/bmj.317.7167.1185; Lau J, 1998, LANCET, V351, P123, DOI 10.1016/S0140-6736(97)08468-7; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; MANTEL N, 1959, J NATL CANCER I, V22, P719; McAlister FA, 1998, BRIT J SURG, V85, P171; MILLER JN, 1989, STAT MED, V8, P455, DOI 10.1002/sim.4780080409; PATEL MK, 2000, POLYSACCHARIDE VACCI; Pocock SJ, 2000, NEW ENGL J MED, V342, P1907, DOI 10.1056/NEJM200006223422511; Pocock SJ., 2013, CLIN TRIALS PRACTICA; Psaty BM, 1997, JAMA-J AM MED ASSOC, V277, P739, DOI 10.1001/jama.277.9.739; PYORALA S, 1995, J CLIN ENDOCR METAB, V80, P2795, DOI 10.1210/jc.80.9.2795; Ramsey MJ, 2000, LARYNGOSCOPE, V110, P335, DOI 10.1097/00005537-200003000-00001; REIMOLD SC, 1992, AM HEART J, V124, P924, DOI 10.1016/0002-8703(92)90974-Z; ROTHMAN KJ, 1986, CONTROL CLIN TRIALS, V7, P177; SACKS H, 1982, AM J MED, V72, P233, DOI 10.1016/0002-9343(82)90815-4; Schatzkin A, 2000, NEW ENGL J MED, V342, P1149, DOI 10.1056/NEJM200004203421601; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; SRISURAPANONT M, 2000, OPIOID ANTAGONISTS A; TANGKANAKUL C, 2000, LOCAL GEN ANAESTHESI; Towler B, 1998, BRIT MED J, V317, P559, DOI 10.1136/bmj.317.7158.559; VANDEKERCKHOVE P, 2000, OIL SOLUBLE WATER SO; VANDENBROUCKEGRAULS CMJE, 1991, LANCET, V338, P859, DOI 10.1016/0140-6736(91)91510-2; WATSON A, 2000, TECHNIQUES PELVIC SU; WELLS PS, 1994, ARCH INTERN MED, V154, P67, DOI 10.1001/archinte.154.1.67; Yusuf S, 2000, NEW ENGL J MED, V342, P154, DOI 10.1056/NEJM200001203420302	58	617	626	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2001	286	7					821	830		10.1001/jama.286.7.821	http://dx.doi.org/10.1001/jama.286.7.821			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	462PU	11497536				2022-12-28	WOS:000170429600030
J	Krugman, RD; Cohn, F				Krugman, RD; Cohn, F			Time to end health professional neglect of cycle of violence	LANCET			English	Editorial Material									Univ Colorado, Sch Med, Deans Off, Denver, CO 80262 USA; Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of California System; University of California Irvine	Krugman, RD (corresponding author), Univ Colorado, Sch Med, Deans Off, Denver, CO 80262 USA.							Brown JR, 1996, CELL, V86, P297, DOI 10.1016/S0092-8674(00)80101-4; KEMPE CH, 1962, JAMA-J AM MED ASSOC, V181, P17, DOI 10.1001/jama.1962.03050270019004; ROSENBERG DA, 1991, ANNU REV MED, V42, P217, DOI 10.1146/annurev.med.42.1.217; U.S. Advisory Board on Child Abuse and Neglect, 1991, CREAT CAR COMM BLUEP; U.S. Advisory Board on Child Abuse and Neglect, 1990, CHILD AB NEGL CRIT 1	5	2	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 11	2001	358	9280					434	434		10.1016/S0140-6736(01)05665-3	http://dx.doi.org/10.1016/S0140-6736(01)05665-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463TB	11513901				2022-12-28	WOS:000170492400003
J	Lawrance, RA; Dorsch, MF; Sapsford, R; Mackintosh, AF; Greenwood, DC; Jackson, BM; Morrell, C; Robinson, MB; Hall, AS				Lawrance, RA; Dorsch, MF; Sapsford, R; Mackintosh, AF; Greenwood, DC; Jackson, BM; Morrell, C; Robinson, MB; Hall, AS		EMMACE Study Grp	Use of cumulative mortality data in patients with acute myocardial infarction for early detection of variation in clinical practice: observational study	BRITISH MEDICAL JOURNAL			English	Article							CARDIAC-SURGERY; HEART-SURGERY; TRIAL	Objectives Use of cumulative mortality adjusted for case mix in patients with acute myocardial infarction for early detection of variation in clinical practice. Design Observational study. Setting 20 hospitals across the former Yorkshire region. Participants All 2153 consecutive patients with confirmed acute myocardial infarction identified during three months. Main outcome measures Variable life-adjusted displays showing cumulative differences between observed and expected mortality of patients; expected mortality calculated from risk model based on admission characteristics of age. heart rate, and systolic blood pressure. Results The performance of two individual hospitals over three months was examined as an example. One, the smallest district hospital in the region, had a series of 30 consecutive patients but had five more deaths than predicted. The variable life-adjusted display showed minimal variation from that predicted for the first 15 patients followed by a run of unexpectedly high mortality. The second example was the main tertiary referral centre for the region, which admitted 188 consecutive patients. The display showed a period of apparently poor performance followed by substantial improvement, where the plot rose steadily from a cumulative net lives saved of - 4 to 7. These variations in patient outcome are unlikely to have been revealed during conventional audit practice. Conclusions Variable life-adjusted display has been integrated. into surgical care as a graphical display of risk-adjusted survival for individual surgeons or centres. In combination with a simple risk model, it may have a role in monitoring performance and outcome in patients with acute myocardial infarction.	Leeds Gen Infirm, BHF Heart Res Ctr, Leeds LS2 9JT, W Yorkshire, England; St James Univ Hosp, Leeds LS9 7TF, W Yorkshire, England; Univ Leeds, Nuffield Inst Hlth, Leeds LS2 9PL, W Yorkshire, England	Leeds General Infirmary; University of Leeds; Saint James's University Hospital; University of Leeds	Hall, AS (corresponding author), Leeds Gen Infirm, BHF Heart Res Ctr, Leeds LS2 9JT, W Yorkshire, England.		Greenwood, Darren C/C-3220-2008; Hall, Alistair/K-1953-2019	Greenwood, Darren C/0000-0001-7035-3096; Hall, Alistair/0000-0003-0306-7887				ANDERSON RG, 1996, FEDERAL RESERVE BANK, V0078; BIRKHEAD J, 2000, EHEART, V84; de Mol BA, 1998, LANCET, V351, P144, DOI 10.1016/S0140-6736(05)78110-1; DELEVAL MR, 1994, J THORAC CARDIOV SUR, V107, P914; *DEP HLTH, 2000, NAT SERV FRAM COR HE; DORSCH MF, IN PRESS HEART; Ecochard E, 2000, HEART, V84, P5, DOI 10.1136/heart.84.1.5; IEZZONI LI, 1992, MED CARE, V30, P347, DOI 10.1097/00005650-199204000-00005; LAWRANCE RA, 2000, EHEART, V84; LEE KL, 1995, CIRCULATION, V91, P1659, DOI 10.1161/01.CIR.91.6.1659; Lovegrove J, 1997, LANCET, V350, P1128, DOI 10.1016/S0140-6736(97)06507-0; NASHEF SAM, 1992, BRIT MED J, V305, P1066, DOI 10.1136/bmj.305.6861.1066; Nashef SAM, 1998, LANCET, V351, P143, DOI 10.1016/S0140-6736(05)78111-3; PARSONNET V, 1989, CIRCULATION 2, V76, P3; Poloniecki J, 1998, BRIT MED J, V316, P1697, DOI 10.1136/bmj.316.7146.1697; Sergeant P, 1997, LANCET, V350, P1114, DOI 10.1016/S0140-6736(97)22042-8; Sherlaw-Johnson C, 2000, HEART, V84, P79, DOI 10.1136/heart.84.1.79; WILLIAMS SM, 1992, BRIT MED J, V304, P1359, DOI 10.1136/bmj.304.6838.1359	18	39	39	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 11	2001	323	7308					324	327		10.1136/bmj.323.7308.324	http://dx.doi.org/10.1136/bmj.323.7308.324			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463HK	11498491	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000170470900022
J	Lanzavecchia, A; Sallusto, F				Lanzavecchia, A; Sallusto, F			Regulation of T cell immunity by dendritic cells	CELL			English	Review							SIGNAL		Inst Biomed Res, CH-6500 Bellinzona, Switzerland	Universita della Svizzera Italiana	Lanzavecchia, A (corresponding author), Inst Biomed Res, Via Vincenzo Vela 6, CH-6500 Bellinzona, Switzerland.							Cella M, 2000, NAT IMMUNOL, V1, P305, DOI 10.1038/79747; Dhodapkar MV, 2001, J EXP MED, V193, P233, DOI 10.1084/jem.193.2.233; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47; Huang FP, 2000, J EXP MED, V191, P435, DOI 10.1084/jem.191.3.435; Inaba K, 1998, J EXP MED, V188, P2163, DOI 10.1084/jem.188.11.2163; Jonuleit H, 2000, J EXP MED, V192, P1213, DOI 10.1084/jem.192.9.1213; Kadowaki N, 2000, J EXP MED, V192, P219, DOI 10.1084/jem.192.2.219; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kalinski P, 1999, IMMUNOL TODAY, V20, P561, DOI 10.1016/S0167-5699(99)01547-9; Kedl RM, 2000, J EXP MED, V192, P1105, DOI 10.1084/jem.192.8.1105; Lane P, 2000, J EXP MED, V191, P201, DOI 10.1084/jem.191.2.201; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; Lanzavecchia A, 2000, SCIENCE, V290, P92, DOI 10.1126/science.290.5489.92; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734; Schulz O, 2000, IMMUNITY, V13, P453, DOI 10.1016/S1074-7613(00)00045-5; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730	19	761	850	1	23	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 10	2001	106	3					263	266		10.1016/S0092-8674(01)00455-X	http://dx.doi.org/10.1016/S0092-8674(01)00455-X			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RJ	11509174	Bronze			2022-12-28	WOS:000170433300003
J	Nelson, G; Hoon, MA; Chandrashekar, J; Zhang, YF; Ryba, NJP; Zuker, CS				Nelson, G; Hoon, MA; Chandrashekar, J; Zhang, YF; Ryba, NJP; Zuker, CS			Mammalian sweet taste receptors	CELL			English	Article							PUTATIVE PHEROMONE RECEPTORS; PROTEIN-COUPLED RECEPTORS; GLUTAMATE RECEPTORS; MULTIGENE FAMILY; MICE; EXPRESSION; RESPONSES; G-ALPHA(16); PREFERENCE; HAMSTER	The sense of taste provides animals with valuable information about the quality and nutritional value of food. Previously, we identified a large family of mammalian taste receptors involved in bitter taste perception (the T2Rs). We now report the characterization of mammalian sweet taste receptors. First, transgenic rescue experiments prove that the Sac locus encodes T1R3, a member of the T1R family of candidate taste receptors. Second, using a heterologous expression system, we demonstrate that T1R2 and T1R3 combine to function as a sweet receptor, recognizing sweet-tasting molecules as diverse as sucrose, saccharin, dulcin, and acesulfame-K. Finally, we present a detailed analysis of the patterns of expression of T1Rs and T2Rs, thus providing a view of the representation of sweet and bitter taste at the periphery.	Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Zuker, CS (corresponding author), Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA.	czuker@flyeye.ucsd.edu		Chandrashekar, jayaram/0000-0001-6412-0114; Ryba, Nicholas/0000-0002-2060-8393	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000561] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Bachmanov AA, 1997, MAMM GENOME, V8, P545, DOI 10.1007/s003359900500; BAKER EK, 1994, EMBO J, V13, P4886, DOI 10.1002/j.1460-2075.1994.tb06816.x; Boughter JD, 1997, J NEUROSCI, V17, P2852; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; CAPELESS CG, 1995, CHEM SENSES, V20, P291, DOI 10.1093/chemse/20.3.291; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Danilova V, 1998, J NEUROPHYSIOL, V80, P2102, DOI 10.1152/jn.1998.80.4.2102; Dwyer ND, 1998, CELL, V93, P455, DOI 10.1016/S0092-8674(00)81173-3; FULLER JL, 1974, J HERED, V65, P33, DOI 10.1093/oxfordjournals.jhered.a108452; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Kitagawa M, 2001, BIOCHEM BIOPH RES CO, V283, P236, DOI 10.1006/bbrc.2001.4760; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; LEFKOWITZ RJ, 1992, COLD SPRING HARB SYM, V57, P127, DOI 10.1101/SQB.1992.057.01.016; Li X, 2001, MAMM GENOME, V12, P13, DOI 10.1007/s003350010236; Lindemann B, 1996, PHYSIOL REV, V76, P719, DOI 10.1152/physrev.1996.76.3.719; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; Max M, 2001, NAT GENET, V28, P58, DOI 10.1038/88270; MCBURNEY DH, 1979, PSYCHOL BULL, V86, P151, DOI 10.1037/0033-2909.86.1.151; MISTRETTA CM, 1995, NEUROL DIS, V32, P635; Mody SM, 2000, MOL PHARMACOL, V57, P13; Montmayeur JP, 2001, NAT NEUROSCI, V4, P492, DOI 10.1038/87440; Nagarajan S, 1996, J MED CHEM, V39, P4167, DOI 10.1021/jm960349q; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; NINOMIYA Y, 1984, BRAIN RES, V302, P305, DOI 10.1016/0006-8993(84)90244-0; Ninomiya Y, 1997, AM J PHYSIOL-REG I, V272, pR1002, DOI 10.1152/ajpregu.1997.272.3.R1002; OFFERMANNS S, 1995, J BIOL CHEM, V270, P15175, DOI 10.1074/jbc.270.25.15175; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; Sainz E, 2001, J NEUROCHEM, V77, P896, DOI 10.1046/j.1471-4159.2001.00292.x; Salahpour A, 2000, TRENDS ENDOCRIN MET, V11, P163, DOI 10.1016/S1043-2760(00)00260-5; SCHIFFMAN SS, 1981, PHARMACOL BIOCHEM BE, V15, P377, DOI 10.1016/0091-3057(81)90266-5; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(01)00263-X; SMITH DV, 1993, MECH TASTE TRANSDUCT, P295; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; TSIEN RY, 1985, CELL CALCIUM, V6, P145, DOI 10.1016/0143-4160(85)90041-7	38	1257	1343	7	253	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2001	106	3					381	390		10.1016/S0092-8674(01)00451-2	http://dx.doi.org/10.1016/S0092-8674(01)00451-2			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RJ	11509186	Bronze			2022-12-28	WOS:000170433300015
J	Wakioka, T; Sasaki, A; Kato, R; Shouda, T; Matsumoto, A; Miyoshi, K; Tsuneoka, M; Komiya, S; Baron, R; Yoshimura, A				Wakioka, T; Sasaki, A; Kato, R; Shouda, T; Matsumoto, A; Miyoshi, K; Tsuneoka, M; Komiya, S; Baron, R; Yoshimura, A			Spred is a Sprouty-related suppressor of Ras signalling	NATURE			English	Article							DROSOPHILA SPROUTY; KINASE-ACTIVITY; RAF-1; EXPRESSION; ACTIVATION; DIFFERENTIATION; PHOSPHORYLATION; INHIBITOR; CLONING; HOMOLOG	Cellular proliferation, and differentiation of cells in response to extracellular signals, are controlled by the signal transduction pathway of Ras, Raf and MAP (mitogen-activated protein) kinase. The mechanisms that regulate this pathway are not well known. Here we describe two structurally similar tyrosine kinase substrates, Spred-1 and Spred-2. These two proteins contain a cysteine-rich domain related to Sprouty (the SPR domain) at the carboxy terminus. In Drosophila, Sprouty inhibits the signalling by receptors of fibroblast growth factor (FGF) and epidermal growth factor (EGF) by suppressing the MAP kinase pathway(2-7). Like Sprouty, Spred inhibited growth-factor-mediated activation of MAP kinase. The Ras-MAP kinase pathway is essential in the differentiation of neuronal cells and myocytes. Expression of a dominant negative form of Spred and Spred-antibody microinjection revealed that endogenous Spred regulates differentiation in these types of cells. Spred constitutively associated with Ras but did not prevent activation of Ras or membrane translocation of Raf. Instead, Spred inhibited the activation of MAP kinase by suppressing phosphorylation and activation of Raf. Spred may represent a class of proteins that modulate Ras-Raf interaction and MAP kinase signalling.	Kyushu Univ, Med Inst Bioregulat, Div Mol & Cellular Immunol, Higashi Ku, Fukuoka 8128582, Japan; Kagoshima Univ, Fac Med, Dept Orthopaed, Kagoshima 899, Japan; Kurume Univ, Inst Life Sci, Kurume, Fukuoka 8390861, Japan; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA	Kyushu University; Kagoshima University; Kurume University; Yale University	Yoshimura, A (corresponding author), Kyushu Univ, Med Inst Bioregulat, Div Mol & Cellular Immunol, Higashi Ku, Fukuoka 8128582, Japan.		Yoshimura, Akihiko/K-5515-2013	Sasaki, Atsuo/0000-0003-2963-4501				Bennett AM, 1997, SCIENCE, V278, P1288, DOI 10.1126/science.278.5341.1288; Casci T, 1999, CELL, V96, P655, DOI 10.1016/S0092-8674(00)80576-0; de Maximy AA, 1999, MECH DEVELOP, V81, P213, DOI 10.1016/S0925-4773(98)00241-X; DeMille MMC, 1996, GENE, V183, P103, DOI 10.1016/S0378-1119(96)00506-9; ELLEDGE SJ, 1991, P NATL ACAD SCI USA, V88, P1731, DOI 10.1073/pnas.88.5.1731; GILLE H, 1995, EMBO J, V14, P951, DOI 10.1002/j.1460-2075.1995.tb07076.x; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mason CS, 1999, EMBO J, V18, P2137, DOI 10.1093/emboj/18.8.2137; Minowada G, 1999, DEVELOPMENT, V126, P4465; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; Prehoda KE, 1999, CELL, V97, P471, DOI 10.1016/S0092-8674(00)80757-6; Reich A, 1999, DEVELOPMENT, V126, P4139; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; ROSE DW, 1992, J CELL BIOL, V119, P1405, DOI 10.1083/jcb.119.6.1405; Suzuki A, 2001, J EXP MED, V193, P471, DOI 10.1084/jem.193.4.471; Tefft JD, 1999, CURR BIOL, V9, P219, DOI 10.1016/S0960-9822(99)80094-3; WARNE PH, 1993, NATURE, V364, P352, DOI 10.1038/364352a0; Wu ZG, 2000, MOL CELL BIOL, V20, P3951, DOI 10.1128/MCB.20.11.3951-3964.2000; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Yeung K, 1999, NATURE, V401, P173, DOI 10.1038/43686; Yokouchi M, 1997, ONCOGENE, V15, P7, DOI 10.1038/sj.onc.1201163	23	344	361	0	11	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2001	412	6847					647	651		10.1038/35088082	http://dx.doi.org/10.1038/35088082			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460PP	11493923				2022-12-28	WOS:000170318000043
J	Klemperer, W				Klemperer, W			Astronomy - The complex story of H-2	SCIENCE			English	Editorial Material							MOLECULAR-HYDROGEN; CHEMISTRY; LINES		Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA	Harvard University	Klemperer, W (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.							Biham O, 2001, ASTROPHYS J, V553, P595, DOI 10.1086/320975; de Lange A, 2001, PHYS REV LETT, V86, P2988, DOI 10.1103/PhysRevLett.86.2988; GEBALLE TR, 1993, ASTR SOC P, V41, P147; HERBST E, 1995, ANNU REV PHYS CHEM, V46, P27, DOI 10.1146/annurev.physchem.46.1.27; MAHAN BH, 1970, ACCOUNTS CHEM RES, V8, P55; McCall BJ, 1999, ASTROPHYS J, V522, P338, DOI 10.1086/307637; MORTON DC, 1975, ASTROPHYS J, V197, P85, DOI 10.1086/153490; Rychlewski J, 1999, ADV QUANTUM CHEM, V31, P173; SPITZER L, 1974, ASTROPHYS J SUPPL S, V28, P373, DOI 10.1086/190323; STARK J, 1927, WIEN HARMS HDB EXPT, V21, P442	10	1	1	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2001	293	5531					815	816		10.1126/science.1062991	http://dx.doi.org/10.1126/science.1062991			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11486077				2022-12-28	WOS:000170241000031
J	Salooja, N; Szydlo, RM; Socie, G; Rio, B; Chatterjee, R; Ljungman, P; Van Lint, MT; Powles, R; Jackson, G; Hinterberger-Fischer, M; Kolb, HJ; Apperley, JF				Salooja, N; Szydlo, RM; Socie, G; Rio, B; Chatterjee, R; Ljungman, P; Van Lint, MT; Powles, R; Jackson, G; Hinterberger-Fischer, M; Kolb, HJ; Apperley, JF		European Grp Blood & Marrow Transp	Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey	LANCET			English	Article							TOTAL-BODY IRRADIATION; CHRONIC MYELOID-LEUKEMIA; RADIATION WORKERS; LYMPHOMA; CYCLOPHOSPHAMIDE; CHEMOTHERAPY; FERTILITY; CHILDREN; FAILURE; EMBRYOS	Background Some patients treated by transplantation of haemopoietic stem cells (peripheral blood or bone marrow) become permanently infertile, but others retain or recover fertility. We assessed the outcome of conception in women, and partners of men previously treated by autologous or allogeneic stem cell transplantation (SCT). Methods We sent questionnaires to 229 centres of the European Group for Blood and Marrow Transplantation. We sought details about the original disease, transplant procedure, and outcome of conception for both male and female patients. Findings 199 centres gave information relating to 19 412 allogeneic and 17 950 autologous transplant patients. 232 (0.6%) patients conceived after SCT. Crude annual birth rate for 4-month survivors of SCT was lower than the national average for England and Wales at 1.7 per 1000 patients. 312 conceptions were reported in 113 patients (74 allograft) and partners of 119 patients (93 allograft). Most pregnancies were uncomplicated and resulted in 271 livebirths. 28 (42%) of 67 allograft recipients had caesarean section compared with 16% in the normal population (difference=26% [95% CI 15-38]), 12 (20%) of 59 had preterm delivery compared with a normal rate of 6% (14% [4-24]), and 12 (23%) of 52 had low birthweight singleton offspring compared with a normal rate of 6% (17% [6-29]). Interpretation Pregnancy after SCT is likely to have a successful outcome. Pregnancies in allograft patients who have received total body irradiation should be treated as high risk for maternal and fetal complications.	Hammersmith Hosp, Imperial Coll Sci & Med, Dept Haematol, London W12 0NN, England; Hop St Louis, Dept Hematol BMT, Paris, France; Hop Hotel Dieu, Serv Hematol, Paris, France; UCL Hosp, Dept Haematol, London, England; Huddinge Univ Hosp, Dept Hematol, S-14186 Huddinge, Sweden; Osped San Martino Genova, Dept Hematol, Genoa, Italy; Royal Marsden Hosp, Leukaemia Myeloma Units, Surrey, England; Royal Victoria Infirm, Dept Haematol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; Donauspital, L Boltzmann Inst, Dept Internal Med 2, Vienna, Austria; Univ Munich, Klinikum Grosshadern, Med Klin 3, D-8000 Munich, Germany	Imperial College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; University College London Hospitals NHS Foundation Trust; University of London; University College London; Karolinska Institutet; University of Genoa; IRCCS AOU San Martino IST; Royal Marsden NHS Foundation Trust; Newcastle University - UK; Donauspital; University of Munich	Apperley, JF (corresponding author), Hammersmith Hosp, Imperial Coll Sci & Med, Dept Haematol, Du Cane Rd, London W12 0NN, England.	j.apperley@ic.ac.uk	Szydlo, Richard/C-6678-2012; Ljungman, Per/M-4946-2019	Szydlo, Richard/0000-0003-1102-8298; 				APPERLEY JF, 1995, BLOOD REV, V9, P93, DOI 10.1016/S0268-960X(95)90030-6; ATKINSON HG, 1994, LANCET, V344, P199, DOI 10.1016/S0140-6736(94)92804-5; Blondel B., 1997, Journal de Gynecologie Obstetrique et Biologie de la Reproduction, V26, P770; BorgnaPignatti C, 1996, BONE MARROW TRANSPL, V18, P235; CHATTERJEE R, 1994, BONE MARROW TRANSPL, V13, P519; CHATTERJEE R, 1994, BONE MARROW TRANSPL, V13, P511; Deeg HJ, 1998, BLOOD, V91, P3637; *DEP HLTH, 1997, B DEP HLTH, V28; Draper GJ, 1997, BRIT MED J, V315, P1181, DOI 10.1136/bmj.315.7117.1181; *EUROCAT, 1997, 7 EUROCAT; Everett C, 1997, BRIT MED J, V315, P32, DOI 10.1136/bmj.315.7099.32; GARDNER MJ, 1992, BRIT MED J, V305, P715, DOI 10.1136/bmj.305.6855.715; GARDNER MJ, 1990, BRIT MED J, V300, P423, DOI 10.1136/bmj.300.6722.423; Gulati SC, 1998, J CLIN ONCOL, V16, P1978, DOI 10.1200/JCO.1998.16.5.1978; Jackson GH, 1997, LEUKEMIA LYMPHOMA, V28, P127, DOI 10.3109/10428199709058338; LEE S, 1995, J ASSIST REPROD GEN, V12, P294, DOI 10.1007/BF02212935; Letendre L, 1997, MED PEDIATR ONCOL, V28, P147; Lipton JH, 1997, J CLIN ONCOL, V15, P3347, DOI 10.1200/JCO.1997.15.11.3347; NEEL JV, 1990, AM J HUM GENET, V46, P1053; *NORD MED COMM, 1993, BRITHS INF MORT NORD; *OFF NAT STAT, 1998, SER MB3, V12; *OFF NAT STAT, 1997, SER FMI, V24; Parker L, 1999, LANCET, V354, P1407, DOI 10.1016/S0140-6736(99)04138-0; RIO B, 1994, BONE MARROW TRANSPL, V13, P487; Sanders JE, 1996, BLOOD, V87, P3045, DOI 10.1182/blood.V87.7.3045.bloodjournal8773045; Sankila R, 1998, NEW ENGL J MED, V338, P1339, DOI 10.1056/NEJM199805073381902; Singhal S, 1996, BONE MARROW TRANSPL, V18, P1049; TANBO T, 1995, OBSTET GYNECOL, V86, P188, DOI 10.1016/0029-7844(95)00159-O	28	237	247	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 28	2001	358	9278					271	276		10.1016/S0140-6736(01)05482-4	http://dx.doi.org/10.1016/S0140-6736(01)05482-4			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	457AF	11498213				2022-12-28	WOS:000170114400010
J	Vasiliauskas, D; Stern, CD				Vasiliauskas, D; Stern, CD			Patterning the embryonic axis: FGF signaling and how vertebrate embryos measure time	CELL			English	Review							CENTRAL-NERVOUS-SYSTEM; RETINOIC ACID CAUSES; XENOPUS; CLOCK; GENES; NODE; WNT		Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA	Columbia University	Stern, CD (corresponding author), UCL, Dept Anat & Dev Biol, Gower St, London WC1E 6BT, England.	c.stern@ucl.ac.uk	Stern, Claudio/AAZ-7381-2021; Stern, Claudio D/C-6265-2008; Vasiliauskas, Daniel/AAV-1981-2020	Stern, Claudio/0000-0002-9907-889X; Stern, Claudio D/0000-0002-9907-889X; Vasiliauskas, Daniel/0000-0002-0570-2322				ANG SL, 1993, DEVELOPMENT, V118, P139; COOKE J, 1976, J THEOR BIOL, V58, P455, DOI 10.1016/S0022-5193(76)80131-2; Dale KJ, 2000, BIOESSAYS, V22, P72, DOI 10.1002/(SICI)1521-1878(200001)22:1<72::AID-BIES12>3.0.CO;2-S; DURSTON AJ, 1989, NATURE, V340, P140, DOI 10.1038/340140a0; Foley AC, 1997, DEVELOPMENT, V124, P2983; Glinka A, 1997, NATURE, V389, P517, DOI 10.1038/39092; HOGAN BLM, 1992, NATURE, V359, P237, DOI 10.1038/359237a0; KESSEL M, 1991, CELL, V67, P89, DOI 10.1016/0092-8674(91)90574-I; MARSHALL H, 1994, NATURE, V370, P567, DOI 10.1038/370567a0; Mathis L, 2001, NAT CELL BIOL, V3, P559, DOI 10.1038/35078535; MAVILIO F, 1988, DIFFERENTIATION, V37, P73, DOI 10.1111/j.1432-0436.1988.tb00798.x; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; McGrew LL, 1997, MECH DEVELOP, V69, P105, DOI 10.1016/S0925-4773(97)00160-3; PAPALOPULU N, 1991, DEVELOPMENT, V113, P1145; Slack J. M. W., 1991, REGIONAL SPECIFICATI; Stern CD, 2001, NAT REV NEUROSCI, V2, P92, DOI 10.1038/35053563; vanderHoeven F, 1996, CELL, V85, P1025, DOI 10.1016/S0092-8674(00)81303-3	17	61	61	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 27	2001	106	2					133	136		10.1016/S0092-8674(01)00442-1	http://dx.doi.org/10.1016/S0092-8674(01)00442-1			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	458KG	11511340	Bronze			2022-12-28	WOS:000170193100002
J	Coleman, T; Wynn, AT; Barrett, S; Wilson, A; Adams, S				Coleman, T; Wynn, AT; Barrett, S; Wilson, A; Adams, S			Intervention study to evaluate pilot health promotion payment aimed at increasing general practitioners' antismoking advice to smokers	BRITISH MEDICAL JOURNAL			English	Article									Leicester Gen Hosp, Leicester Warwick Med Sch, Dept Gen Practice & Primary Hlth Care, Leicester LE5 1PW, Leics, England; Univ Nottingham, Sch Human Dev, Acad Div Child Hlth, Childrens Res Tumour & Disabil Res Ctr, Nottingham NG7 2UH, England; Univ Leicester, Dept Med, Div Cardiol, Leicester LE3 9QP, Leics, England	University Hospitals of Leicester NHS Trust; Leicester General Hospital; University of Leicester; University of Nottingham; University of Leicester	Coleman, T (corresponding author), Leicester Gen Hosp, Leicester Warwick Med Sch, Dept Gen Practice & Primary Hlth Care, Leicester LE5 1PW, Leics, England.			Coleman, Tim/0000-0002-7303-4805				Coleman T, 1999, BRIT J GEN PRACT, V49, P557; Coleman T, 2001, BRIT MED J, V323, P432, DOI 10.1136/bmj.323.7310.432; *DEP HLTH, 1989, GEN PRACT NAT HLTH S; GIUFFRIDA A, 2000, COLLABORATION EFFECT; [No title captured]	5	25	25	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 25	2001	323	7310					435	436		10.1136/bmj.323.7310.435	http://dx.doi.org/10.1136/bmj.323.7310.435			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469BX	11520845	Bronze, Green Published			2022-12-28	WOS:000170793600025
J	Pledger, G; Stringer, MD				Pledger, G; Stringer, MD			Childhood deaths from acute appendicitis in England and Wales 1963-97: observational population based study	BRITISH MEDICAL JOURNAL			English	Article									Oaktree Cottage Mitford, Morpeth NE61 3PN, Northd, England; Leeds Teaching Hosp NHS Trust, Dept Paediat Surg, Leeds LS9 7TF, W Yorkshire, England	University of Leeds	Pledger, G (corresponding author), Oaktree Cottage Mitford, Morpeth NE61 3PN, Northd, England.							Barker DJP, 1998, MOTHERS BABIES HLTH; *DEP HLTH, 1963, HOSP IN PAT ENQ HOSP; PLEDGER HG, 1969, BMJ-BRIT MED J, V4, P466, DOI 10.1136/bmj.4.5681.466; PLEDGER HG, 1987, BMJ-BRIT MED J, V295, P1233, DOI 10.1136/bmj.295.6608.1233; WILLIAMS N, 1991, ARCH DIS CHILD, V66, P1270, DOI 10.1136/adc.66.11.1270	5	13	13	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 25	2001	323	7310					430	431		10.1136/bmj.323.7310.430	http://dx.doi.org/10.1136/bmj.323.7310.430			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469BX	11520842	Bronze, Green Published			2022-12-28	WOS:000170793600023
J	Kodama, R; Norreys, PA; Mima, K; Dangor, AE; Evans, RG; Fujita, H; Kitagawa, Y; Krushelnick, K; Miyakoshi, T; Miyanaga, N; Norimatsu, T; Rose, SJ; Shozaki, T; Shigemori, K; Sunahara, A; Tampo, M; Tanaka, KA; Toyama, Y; Yamanaka, Y; Zepf, M				Kodama, R; Norreys, PA; Mima, K; Dangor, AE; Evans, RG; Fujita, H; Kitagawa, Y; Krushelnick, K; Miyakoshi, T; Miyanaga, N; Norimatsu, T; Rose, SJ; Shozaki, T; Shigemori, K; Sunahara, A; Tampo, M; Tanaka, KA; Toyama, Y; Yamanaka, Y; Zepf, M			Fast heating of ultrahigh-density plasma as a step towards laser fusion ignition	NATURE			English	Article							GENERATED FAST ELECTRONS; HOT-ELECTRONS; TARGETS; COMPRESSION; INSTABILITY; PULSE; LIGHT; REAR	Modern high-power lasers can generate extreme states of matter that are relevant to astrophysics(1), equation-of-state studies(2) and fusion energy research(3,4). Laser-driven implosions of spherical polymer shells have, for example, achieved an increase in density of 1,000 times relative to the solid state(5). These densities are large enough to enable controlled fusion, but to achieve energy gain a small volume of compressed fuel (known as the 'spark') must be heated to temperatures of about 10(8) K (corresponding to thermal energies in excess of 10 keV). In the conventional approach to controlled fusion, the spark is both produced and heated by accurately timed shock waves(4), but this process requires both precise implosion symmetry and a very large drive energy. In principle, these requirements can be significantly relaxed by performing the compression and fast heating separately(6-10); however, this 'fast ignitor' approach(7) also suffers drawbacks, such as propagation losses and deflection of the ultra-intense laser pulse by the plasma surrounding the compressed fuel. Here we employ a new compression geometry that eliminates these problems; we combine production of compressed matter in a laser-driven implosion with picosecond-fast heating by a laser pulse timed to coincide with the peak compression. Our approach therefore permits efficient compression and heating to be carried out simultaneously, providing a route to efficient fusion energy production.	Osaka Univ, Inst Laser Engn, Suita, Osaka 5650871, Japan; Rutherford Appleton Lab, Didcot OX11 0QX, Oxon, England; Univ London Imperial Coll Sci Technol & Med, Blackett Lab, London SW7 2BZ, England; Univ York, Dept Phys, York YO1 5DD, N Yorkshire, England; Osaka Univ, Fac Engn, Suita, Osaka 5650871, Japan	Osaka University; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; Imperial College London; University of York - UK; Osaka University	Kodama, R (corresponding author), Osaka Univ, Inst Laser Engn, 2-6 Yamada Oka, Suita, Osaka 5650871, Japan.		Mima, Kunioki/H-9014-2016; Krushelnick, Karl/AAZ-3028-2020; Miyanaga, Noriaki/F-1340-2015; Shigemori, Keisuke/GPK-4304-2022; Shigemori, Keisuke/B-3262-2013; Tanaka, Kazuo A/AAL-2115-2020; Kodama, Ryosuke/G-2627-2016; SUNAHARA, ATSUSHI/K-2914-2019; Zepf, Matt/M-1232-2014; Norimatsu, Takayoshi/I-5710-2015; Toyama, Yusuke/H-8023-2012; Tampo, Motonobu/I-2897-2012	Miyanaga, Noriaki/0000-0002-9902-5392; Shigemori, Keisuke/0000-0002-3978-8427; SUNAHARA, ATSUSHI/0000-0001-7543-5226; Toyama, Yusuke/0000-0003-3230-1062; Rose, Steven/0000-0001-6808-6355				Atzeni S, 1999, PHYS PLASMAS, V6, P3316, DOI 10.1063/1.873571; AZECHI H, 1991, LASER PART BEAMS, V9, P193, DOI 10.1017/S0263034600003281; BRUNEL F, 1987, PHYS REV LETT, V59, P52, DOI 10.1103/PhysRevLett.59.52; Davies JR, 1999, PHYS REV E, V59, P6032, DOI 10.1103/PhysRevE.59.6032; Duda BJ, 1999, PHYS REV LETT, V83, P1978, DOI 10.1103/PhysRevLett.83.1978; Hain S, 1999, LASER PART BEAMS, V17, P245, DOI 10.1017/S0263034699172100; Honda M, 2000, PHYS REV LETT, V85, P2128, DOI 10.1103/PhysRevLett.85.2128; Ichimaru S, 1999, PHYS PLASMAS, V6, P2649, DOI 10.1063/1.873221; Kato Y, 1997, PLASMA PHYS CONTR F, V39, P145, DOI 10.1088/0741-3335/39/5A/015; Key MH, 1998, PHYS PLASMAS, V5, P1966, DOI 10.1063/1.872867; Kodama R, 2000, PHYS REV LETT, V84, P674, DOI 10.1103/PhysRevLett.84.674; Kodama R, 1999, REV SCI INSTRUM, V70, P625, DOI 10.1063/1.1149383; KODAMA R, IN PRESS PHYS PLASMA; KRUER WL, 1985, PHYS FLUIDS, V28, P430, DOI 10.1063/1.865171; LEFEBVRE E, 1995, PHYS REV LETT, V74, P2002, DOI 10.1103/PhysRevLett.74.2002; LINDL JD, 1992, PHYS TODAY, V45, P32, DOI 10.1063/1.881318; MALKA G, 1996, PHYS REV LETT, V74, P4655; Norreys PA, 2000, PHYS PLASMAS, V7, P3721, DOI 10.1063/1.1287419; NUCKOLLS J, 1972, NATURE, V239, P139, DOI 10.1038/239139a0; PERRY MD, 1994, SCIENCE, V264, P917, DOI 10.1126/science.264.5161.917; Piriz AR, 1998, PHYS PLASMAS, V5, P2721, DOI 10.1063/1.872960; Pukhov A, 1997, PHYS REV LETT, V79, P2686, DOI 10.1103/PhysRevLett.79.2686; Remington BA, 1999, SCIENCE, V284, P1488, DOI 10.1126/science.284.5419.1488; Santala MIK, 2000, PHYS REV LETT, V84, P1459, DOI 10.1103/PhysRevLett.84.1459; Sunahara A, 1999, FUSION ENG DES, V44, P163, DOI 10.1016/S0920-3796(98)00362-7; TABAK M, 1994, PHYS PLASMAS, V1, P1626, DOI 10.1063/1.870664; Tanaka KA, 2000, PHYS PLASMAS, V7, P2014, DOI 10.1063/1.874023; Tatarakis M, 1998, PHYS REV LETT, V81, P999, DOI 10.1103/PhysRevLett.81.999; Wharton KB, 1998, PHYS REV LETT, V81, P822, DOI 10.1103/PhysRevLett.81.822	29	795	832	8	177	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2001	412	6849					798	802		10.1038/35090525	http://dx.doi.org/10.1038/35090525			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465ET	11518960				2022-12-28	WOS:000170577200031
J	Jones, MI; Greenfield, SM; Bradley, CP				Jones, MI; Greenfield, SM; Bradley, CP			Prescribing new drugs: qualitative study of influences on consultants and general practitioners	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INFORMATION-SOURCES; BEHAVIOR	Objective To explore consultants' and general practitioners' perceptions of the factors that influence their decisions to introduce new drugs into their clinical practice. Design Qualitative study using semistructured interviews. Monitoring of hospital and general practice prescribing data for eight new drugs. Setting Teaching hospital and nearby general hospital plus general practices in Birmingham. Participants 38 consultants and 56 general practitioners who regularly referred to the teaching hospital. Main outcome measures Reasons for prescribing a new drug; sources of information used for new drugs; extent of contact between consultants and general practitioners; and amount of study drugs used in hospitals and by general practitioners. Results Consultants usually prescribed new drugs only in their specialty, used few new drugs, and used scientific evidence to inform their decisions. General practitioners generally prescribed more new drugs and for a wider range of conditions, but their approach varied considerably both between general practitioners and between drugs for the same general practitioner. Drug company representatives were an important source of in-formation for general practitioners. Prescribing data were consistent with statements made by respondents. Conclusions The factors influencing the introduction of new drugs, particularly in primary care, are more multiple and complex than suggested by early theories of drug innovation. Early experience of using a new drug seems to strongly influence future use.	Univ Birmingham, Sch Med, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Jones, MI (corresponding author), Univ Birmingham, Sch Med, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England.	M.I.Jones@bham.ac.uk		Bradley, Colin/0000-0002-3595-9567				Allery LA, 1997, BMJ-BRIT MED J, V314, P870; Armstrong D, 1996, BRIT MED J, V312, P949; *AUD COMM, 2000, PCG AG PROGR PRIM CA; AVORN J, 1982, AM J MED, V73, P4, DOI 10.1016/0002-9343(82)90911-1; Barrie AR, 1997, BRIT MED J, V315, P1512, DOI 10.1136/bmj.315.7121.1512; Berkwits M, 1998, SOC SCI MED, V47, P1539, DOI 10.1016/S0277-9536(98)00232-9; Bryman A., 1994, ANAL QUALITATIVE DAT; Coleman J. S., 1966, MED INNOVATION DIFFU; *DEP HLTH, 1999, 1 CLASS SERV QUAL NE; DUERDEN M, 1996, FRIEND FOE WORKING D; GRIFFIN JP, 1993, J ROY COLL PHYS LOND, V27, P121; Jones M, 1999, J CLIN PHARM THER, V24, P451, DOI 10.1046/j.1365-2710.1999.00255.x; Jones MI, 2001, FAM PRACT, V18, P333, DOI 10.1093/fampra/18.3.333; Jones MI, 2000, INT J PHARM PRACTICE, V8, P285; Lincoln YS., 2008, COLLECTING INTERPRET; PEAY MY, 1990, SOC SCI MED, V31, P467, DOI 10.1016/0277-9536(90)90042-Q; STRICKLANDHODGE B, 1982, J ROY SOC MED, V75, P341; STRICKLANDHODGE B, 1988, J ROY SOC MED, V81, P207, DOI 10.1177/014107688808100407; STRICKLANDHODGE B, 1980, J ROY SOC MED, V73, P857, DOI 10.1177/014107688007301208; TAYLOR RJ, 1991, BRIT J GEN PRACT, V41, P244; Tomlin Z, 1999, BMJ-BRIT MED J, V318, P1532, DOI 10.1136/bmj.318.7197.1532; Walshe K, 1998, PUBLIC MONEY MANAGE, V18, P15, DOI 10.1111/1467-9302.00136; Williamson P M, 1975, J R Coll Gen Pract, V25, P383; Wood M, 1998, SOC SCI MED, V47, P1729, DOI 10.1016/S0277-9536(98)00250-0	24	87	90	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 18	2001	323	7309					378	381		10.1136/bmj.323.7309.378	http://dx.doi.org/10.1136/bmj.323.7309.378			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465GN	11509431	Bronze, Green Published			2022-12-28	WOS:000170581400022
J	Levitan, IB; Cibulsky, SM				Levitan, IB; Cibulsky, SM			Biochemistry - TRP ion channels - Two proteins in one	SCIENCE			English	Editorial Material							POTASSIUM CHANNEL; ACETYLCHOLINE-RECEPTOR; CALCIUM CHANNELS; TYROSINE KINASE; SRC; PHOSPHORYLATION; MODULATION; NEURONS; BINDING; PKA		Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA	University of Pennsylvania	Levitan, IB (corresponding author), Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA.		Oka, Yoshitaka/C-9670-2010	Oka, Yoshitaka/0000-0002-3482-3051				Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; CHUNG SK, 1991, SCIENCE, V253, P560, DOI 10.1126/science.1857986; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Davare MA, 1999, J BIOL CHEM, V274, P30280, DOI 10.1074/jbc.274.42.30280; FERRIS CD, 1992, J BIOL CHEM, V267, P7036; Fuhrer C, 1996, J BIOL CHEM, V271, P32474, DOI 10.1074/jbc.271.50.32474; Gao TY, 1997, NEURON, V19, P185, DOI 10.1016/S0896-6273(00)80358-X; Gray PC, 1998, NEURON, V20, P1017, DOI 10.1016/S0896-6273(00)80482-1; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; Holmes TC, 1996, SCIENCE, V274, P2089, DOI 10.1126/science.274.5295.2089; Levitan IB, 1999, ADV SEC MESS PHOSPH, V33, P3; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; REHM H, 1989, BIOCHEMISTRY-US, V28, P6455, DOI 10.1021/bi00441a044; REINHART PH, 1995, J NEUROSCI, V15, P4572; ROSENMUND C, 1994, NATURE, V368, P853, DOI 10.1038/368853a0; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; SWOPE SL, 1994, J BIOL CHEM, V269, P29817; Wang J, 1999, J Neurosci, V19, pRC4; Yamaguchi H, 2001, MOL CELL, V7, P1047, DOI 10.1016/S1097-2765(01)00256-8; Yu XM, 1997, SCIENCE, V275, P674, DOI 10.1126/science.275.5300.674	22	22	23	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2001	293	5533					1270	1271		10.1126/science.1062504	http://dx.doi.org/10.1126/science.1062504			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11509717				2022-12-28	WOS:000170492600026
J	Shelton, RK; Ma, LS; Kapteyn, HC; Murnane, MM; Hall, JL; Ye, J				Shelton, RK; Ma, LS; Kapteyn, HC; Murnane, MM; Hall, JL; Ye, J			Phase-coherent optical pulse synthesis from separate femtosecond lasers	SCIENCE			English	Article							TI-SAPPHIRE LASER; MODE-LOCKED LASER; SUBFEMTOSECOND PULSES; FREQUENCY-MEASUREMENT; GENERATION; SCATTERING; EVOLUTION	We generated a coherently synthesized optical pulse from two independent mode-locked femtosecond lasers, providing a route to extend the coherent bandwidth available for ultrafast science. The two separate lasers (one centered at 760 nanometers wavelength, the other at 810 nanometers) are tightly synchronized and phase-locked. Coherence between the two lasers is demonstrated via spectral interferometry and second-order field cross-correlation. Measurements reveal a coherently synthesized pulse that has a temporally narrower second-order autocorrelation width and that exhibits a larger amplitude than the individual laser outputs. This work represents a new and flexible approach to the synthesis of coherent tight.	Natl Inst Stand & Technol, Boulder, CO 80309 USA; Univ Colorado, Dept Phys, Boulder, CO 80309 USA; E China Normal Univ, Dept Phys, Shanghai 200062, Peoples R China	National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder; East China Normal University	Ye, J (corresponding author), Natl Inst Stand & Technol, 325 Broadway, Boulder, CO 80309 USA.		Ye, Jun/C-3312-2011; Kapteyn, Henry C/H-6559-2011	Ye, Jun/0000-0003-0076-2112; Kapteyn, Henry C/0000-0001-8386-6317; HALL, JOHN/0000-0001-6137-8945				ALFANO RR, 1989, SUPERCONTINUUM LASER, P13602; ALLAN DW, 1966, PR INST ELECTR ELECT, V54, P221, DOI 10.1109/PROC.1966.4634; ANDERSON MH, 1995, SCIENCE, V269, P198, DOI 10.1126/science.269.5221.198; Apolonski A, 2000, PHYS REV LETT, V85, P740, DOI 10.1103/PhysRevLett.85.740; ASAKI MT, 1993, OPT LETT, V18, P977, DOI 10.1364/OL.18.000977; BYER RL, IN PRESS J MOD OPT; CORKUM PB, 1994, OPT LETT, V19, P1870, DOI 10.1364/OL.19.001870; Crooker SA, 1996, REV SCI INSTRUM, V67, P2068, DOI 10.1063/1.1147016; Diddams SA, 2000, PHYS REV LETT, V84, P5102, DOI 10.1103/PhysRevLett.84.5102; Diels J. C., 1996, ULTRASHORT LASER PUL; Fittinghoff DN, 1996, OPT LETT, V21, P884, DOI 10.1364/OL.21.000884; HOLLBERG L, IN PRESS IEEE J QUAN; Jones DJ, 2000, SCIENCE, V288, P635, DOI 10.1126/science.288.5466.635; JUDSON RS, 1992, PHYS REV LETT, V68, P1500, DOI 10.1103/PhysRevLett.68.1500; Kaindl RA, 2000, J OPT SOC AM B, V17, P2086, DOI 10.1364/JOSAB.17.002086; KAPLAN AE, 1994, PHYS REV LETT, V73, P1243, DOI 10.1103/PhysRevLett.73.1243; Ma LS, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.021802; Ranka JK, 2000, OPT LETT, V25, P25, DOI 10.1364/OL.25.000025; Sackett CA, 2000, NATURE, V404, P256, DOI 10.1038/35005011; Schoenlein RW, 1996, SCIENCE, V274, P236, DOI 10.1126/science.274.5285.236; SPENCE DE, 1991, OPT LETT, V16, P42, DOI 10.1364/OL.16.000042; Telle HR, 1999, APPL PHYS B-LASERS O, V69, P327, DOI 10.1007/s003400050813; Udem T, 1999, OPT LETT, V24, P881, DOI 10.1364/OL.24.000881; Udem T, 1999, PHYS REV LETT, V82, P3568, DOI 10.1103/PhysRevLett.82.3568; Ye J, 2000, OPT LETT, V25, P1675, DOI 10.1364/OL.25.001675; Ye J, 1999, OPT LETT, V24, P1838, DOI 10.1364/OL.24.001838; ZHOU JP, 1994, OPT LETT, V19, P1149, DOI 10.1364/OL.19.001149	27	218	227	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2001	293	5533					1286	1289		10.1126/science.1061754	http://dx.doi.org/10.1126/science.1061754			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11509721	Green Published			2022-12-28	WOS:000170492600030
J	Takamoto, DY; Aydil, E; Zasadzinski, JA; Ivanova, AT; Schwartz, DK; Yang, TL; Cremer, PS				Takamoto, DY; Aydil, E; Zasadzinski, JA; Ivanova, AT; Schwartz, DK; Yang, TL; Cremer, PS			Stable ordering in Langmuir-Blodgett films	SCIENCE			English	Article							X-RAY-DIFFRACTION; STEARIC-ACID; WATER; REFLECTIVITY; MONOLAYERS; GENERATION; MOLECULES; SURFACE; SALTS	Defects in the layering of Langmuir-Blodgett (LB) films can be eliminated by depositing from the appropriate monolayer phase at the air-water interface. LB films deposited from the hexagonal phase of cadmium arachidate (CdA(2)) at pH 7 spontaneously transform into the bulk soap structure, a centrosymmetric bilayer with an orthorhombic herringbone packing. A large wavelength folding mechanism accelerates the conversion between the two structures, leading to a disruption of the desired layering. At pH > 8.5, though it is more difficult to draw LB films, almost perfect layering is obtained due to the inability to convert from the as-deposited structure to the equilibrium one.	Univ Calif Santa Barbara, Dept Chem & Mat Engn, Santa Barbara, CA 93106 USA; Tulane Univ, Dept Chem, New Orleans, LA 70118 USA; Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA	University of California System; University of California Santa Barbara; Tulane University; Texas A&M University System; Texas A&M University College Station	Zasadzinski, JA (corresponding author), Univ Calif Santa Barbara, Dept Chem & Mat Engn, Santa Barbara, CA 93106 USA.		Aydil, Eray/M-5503-2019; Schwartz, Daniel K/H-5153-2012; Yang, Tinglu/N-3569-2013	Schwartz, Daniel K/0000-0001-5397-7200; Yang, Tinglu/0000-0003-0872-8218; Aydil, Eray/0000-0002-8377-9480	NHLBI NIH HHS [HL51177] Funding Source: Medline; NIGMS NIH HHS [GM47334] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047334] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ashwell GJ, 1999, J MATER CHEM, V9, P1991, DOI 10.1039/a902604e; Corkery RW, 1997, LANGMUIR, V13, P3591, DOI 10.1021/la9701743; Ganguly P, 1997, LANGMUIR, V13, P6582, DOI 10.1021/la970626b; GARNAES J, 1992, NATURE, V357, P54, DOI 10.1038/357054a0; Gragson DE, 1998, J PHYS CHEM B, V102, P3847, DOI 10.1021/jp9806011; Harkins WD, 1938, J CHEM PHYS, V6, P298, DOI 10.1063/1.1750252; Kaganer VM, 1999, REV MOD PHYS, V71, P779, DOI 10.1103/RevModPhys.71.779; Kitaigorodskii A. I., 1962, ORGANIC CHEM CRYSTAL; Kuzmenko I, 1998, LANGMUIR, V14, P3882, DOI 10.1021/la970819z; LEVEILLER F, 1994, LANGMUIR, V10, P819, DOI 10.1021/la00015a037; LEVEILLER F, 1991, SCIENCE, V252, P1532, DOI 10.1126/science.252.5012.1532; Miranda PB, 1998, CHEM PHYS LETT, V286, P1, DOI 10.1016/S0009-2614(97)01476-0; PENNER TL, 1994, NATURE, V367, P49, DOI 10.1038/367049a0; ROBERTS GG, 1990, LANGMUIRBLODGETT FIL; Schwartz D. K., 1997, Surface Science Reports, V27, P241, DOI 10.1016/S0167-5729(97)00003-4; SCHWARTZ DK, 1992, J PHYS CHEM-US, V96, P10444, DOI 10.1021/j100204a059; SCHWARTZ DK, 1993, J AM CHEM SOC, V115, P7374, DOI 10.1021/ja00069a040; SCHWARTZ DK, 1993, PHYS REV E, V47, P452, DOI 10.1103/PhysRevE.47.452; SCHWARTZ DK, 1992, SCIENCE, V257, P508, DOI 10.1126/science.257.5069.508; SHEN YR, 1989, ANNU REV PHYS CHEM, V40, P327, DOI 10.1146/annurev.pc.40.100189.001551; TIPPMANNKRAYER P, 1992, THIN SOLID FILMS, V210, P577, DOI 10.1016/0040-6090(92)90346-D; WIESLER DG, 1995, THIN SOLID FILMS, V266, P69, DOI 10.1016/0040-6090(95)06603-9; YAZDANIAN M, 1992, LANGMUIR, V8, P630, DOI 10.1021/la00038a055; ZASADZINSKI JA, 1994, SCIENCE, V263, P1726, DOI 10.1126/science.8134836	24	95	98	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2001	293	5533					1292	1295		10.1126/science.1060018	http://dx.doi.org/10.1126/science.1060018			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11509723				2022-12-28	WOS:000170492600032
J	Liu, YJ				Liu, YJ			Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity	CELL			English	Review							BLOOD; PROGENITOR; INDUCTION		DNAX Res Inst Mol & Cellular Biol Inc, Palo Alto, CA 94304 USA	Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.	Liu, YJ (corresponding author), DNAX Res Inst Mol & Cellular Biol Inc, 901 Calif Ave, Palo Alto, CA 94304 USA.							Bendriss-Vermare N, 2001, J CLIN INVEST, V107, P835, DOI 10.1172/JCI11734; Bjorck P, 1998, J IMMUNOL, V161, P5795; Caux C, 1997, BLOOD, V90, P1458, DOI 10.1182/blood.V90.4.1458.1458_1458_1470; Dhodapkar MV, 2001, J EXP MED, V193, P233, DOI 10.1084/jem.193.2.233; Fossum S, 1989, Curr Top Pathol, V79, P101; Ito T, 2001, J IMMUNOL, V166, P2961, DOI 10.4049/jimmunol.166.5.2961; Ito T, 1999, J IMMUNOL, V163, P1409; Jonuleit H, 2000, J EXP MED, V192, P1213, DOI 10.1084/jem.192.9.1213; Kaisho T, 2001, TRENDS IMMUNOL, V22, P78, DOI 10.1016/S1471-4906(00)01811-1; Kalinski P, 1999, IMMUNOL TODAY, V20, P561, DOI 10.1016/S0167-5699(99)01547-9; Liu YJ, 2001, NAT IMMUNOL, V2, P585, DOI 10.1038/89726; Pulendran B, 2001, TRENDS IMMUNOL, V22, P41, DOI 10.1016/S1471-4906(00)01794-4; Rissoan MC, 1999, SCIENCE, V283, P1183, DOI 10.1126/science.283.5405.1183; Shortman K, 2000, IMMUNOL CELL BIOL, V78, P161, DOI 10.1046/j.1440-1711.2000.00901.x; Spits H, 2000, J EXP MED, V192, P1775, DOI 10.1084/jem.192.12.1775; Steinman RM, 2000, J EXP MED, V191, P411, DOI 10.1084/jem.191.3.411; Strunk D, 1997, J EXP MED, V185, P1131, DOI 10.1084/jem.185.6.1131; Traver D, 2000, SCIENCE, V290, P2152, DOI 10.1126/science.290.5499.2152	18	779	869	1	42	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 10	2001	106	3					259	262		10.1016/S0092-8674(01)00456-1	http://dx.doi.org/10.1016/S0092-8674(01)00456-1			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RJ	11509173	Bronze			2022-12-28	WOS:000170433300002
J	Akiyama, T; Powell, JL; Mitchell, LB; Ehlert, FA; Baessler, C				Akiyama, T; Powell, JL; Mitchell, LB; Ehlert, FA; Baessler, C		Antiarrhythmics Versus Defibrillat	Resumption of driving after life-threatening ventricular tachyarrhythmia.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS; RECOMMENDATIONS; RESTRICTIONS; TACHYCARDIA; ACCIDENTS; EPILEPSY; PATIENT; SAFETY	Background: Although the privilege of driving must be respected, it may be necessary to restrict driving when it poses a threat to others. The risks associated with allowing patients with life-threatening ventricular tachyarrhythmias to drive have not been quantified. Methods: The Antiarrhythmics versus Implantable Defibrillators (AVID) trial compared antiarrhythmic-drug therapy with the implantation of defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. In the current study, we sent patients who participated in the AVID trial a questionnaire, to be completed anonymously, requesting information about driving habits and experiences. Results: The questionnaire was returned by 758 of 909 patients (83 percent). Of these, 627 patients drove during the year before their index episode of ventricular tachyarrhythmia. A total of 57 percent of these patients resumed driving within 3 months after randomization in the AVID trial, 78 percent within 6 months, and 88 percent within 12 months. While driving, 2 percent had a syncopal episode, 11 percent had dizziness or palpitations that necessitated stopping the vehicle, 22 percent had dizziness or palpitations that did not necessitate stopping the vehicle, and 8 percent of the 295 patients with an implantable cardioverter-defibrillator received a shock. Fifty patients reported having at least 1 accident, for a total of 55 accidents during 1619 patient-years of follow-up after the resumption of driving (3.4 percent per patient-year). Only 11 percent of these accidents were preceded by symptoms of possible arrhythmia (0.4 percent per patient-year). Conclusions: Most patients with ventricular tachyarrhythmias resume driving early. Although it is common for them to have symptoms of possible arrhythmia while driving, accidents are uncommon and occur with a frequency that is lower than the annual accident rate of 7.1 percent in the general driving population of the United States. (N Engl J Med 2001;345:391-7.) Copyright (C) 2001 Massachusetts Medical Society.	Univ Washington, AVID Clin Trial Ctr, Seattle, WA 98105 USA; Univ Rochester, Med Ctr, Rochester, NY 14642 USA; Univ Calgary, Calgary, AB, Canada; Columbia Univ, St Lukes Roosevelt Hosp Ctr, New York, NY USA; Med Coll Penn Hahnemann Univ, Philadelphia, PA USA	University of Washington; University of Washington Seattle; University of Rochester; University of Calgary; Columbia University; Mount Sinai St. Luke's; Mount Sinai West; Drexel University	Powell, JL (corresponding author), Univ Washington, AVID Clin Trial Ctr, 1107 NE 45th St,Rm 505, Seattle, WA 98105 USA.				NHLBI NIH HHS [N01-HC-25117] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025117] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ANDERSON MH, 1994, AM HEART J, V127, P1185, DOI 10.1016/0002-8703(94)90108-2; [Anonymous], 1996, CAN J CARDIOL, V12, P1164; BAESSLER C, 1998, PACE, V21, P839; Canadian Cardiovascular Society, 1996, CAN J CARDIOL, V12, P1175; CHRISTIAN MS, 1988, BRIT MED J, V297, P1021, DOI 10.1136/bmj.297.6655.1021; Conti JB, 1997, PACE, V20, P2200, DOI 10.1111/j.1540-8159.1997.tb04237.x; CURTIS AB, 1995, J AM COLL CARDIOL, V26, P180, DOI 10.1016/0735-1097(95)00133-K; DHALA A, 1995, AM J CARDIOL, V75, P516, DOI 10.1016/S0002-9149(99)80595-5; DICARLO LA, 1992, PACE, V15, P1131, DOI 10.1111/j.1540-8159.1992.tb03115.x; Epstein AE, 1996, CIRCULATION, V94, P1147, DOI 10.1161/01.CIR.94.5.1147; FINCH NJ, 1993, JAMA-J AM MED ASSOC, V270, P1587, DOI 10.1001/jama.270.13.1587; GRATTAN E, 1968, BMJ-BRIT MED J, V1, P75, DOI 10.1136/bmj.1.5584.75; HANSOTIA P, 1991, NEW ENGL J MED, V324, P22, DOI 10.1056/NEJM199101033240105; HERNER B, 1966, BRIT J IND MED, V23, P37; HOSSACK DW, 1974, MED J AUSTRALIA, V1, P164, DOI 10.5694/j.1326-5377.1974.tb50782.x; Jung W, 1997, EUR HEART J, V18, P1210; KRUMHOLZ A, 1991, JAMA-J AM MED ASSOC, V265, P622, DOI 10.1001/jama.265.5.622; LARSEN GC, 1994, JAMA-J AM MED ASSOC, V271, P1335, DOI 10.1001/jama.271.17.1335; LEITCH JW, 1992, CIRCULATION, V85, P1064, DOI 10.1161/01.CIR.85.3.1064; McAnulty J, 1997, NEW ENGL J MED, V337, P1576; MYERBURG RJ, 1964, AM HEART J, V68, P586, DOI 10.1016/0002-8703(64)90266-2; *NAT HIGHW TRAFF S, 1998, TRAFF SAF FACTS 1997, P98; OSTROM M, 1987, J FORENSIC SCI, V32, P988; PARSONS M, 1986, Q J MED, V227, P295; SHELDON R, 1995, AM J CARDIOL, V75, P955, DOI 10.1016/S0002-9149(99)80699-7; STRICKBERGER SA, 1991, ANN INTERN MED, V115, P560, DOI 10.7326/0003-4819-115-7-560; SUTTON R, 1995, CLIN CARDIAC PACING, P284; WALLER JA, 1965, NEW ENGL J MED, V273, P1413, DOI 10.1056/NEJM196512232732605; WHARTON JM, 1995, CLIN CARDIAC PACING, P304	29	77	77	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 9	2001	345	6					391	397		10.1056/NEJM200108093450601	http://dx.doi.org/10.1056/NEJM200108093450601			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460EJ	11496849				2022-12-28	WOS:000170295000001
J	Faust, SN; Levin, M; Harrison, OB; Goldin, RD; Lockhart, MS; Kondaveeti, S; Laszik, Z; Esmon, CT; Heyderman, RS				Faust, SN; Levin, M; Harrison, OB; Goldin, RD; Lockhart, MS; Kondaveeti, S; Laszik, Z; Esmon, CT; Heyderman, RS			Dysfunction of endothelial protein C activation in severe meningococcal sepsis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DISSEMINATED INTRAVASCULAR COAGULATION; ADHESION MOLECULE EXPRESSION; COLI SEPTIC SHOCK; PURPURA FULMINANS; TISSUE FACTOR; NEISSERIA-MENINGITIDIS; PATHWAY INHIBITOR; ANTITHROMBIN-III; LIPOOLIGOSACCHARIDE STRUCTURE; SOLUBLE THROMBOMODULIN	Background: Impairment of the protein C anticoagulation pathway is critical to the thrombosis associated with sepsis and to the development of purpura fulminans in meningococcemia. We studied the expression of thrombomodulin and the endothelial protein C receptor in the dermal microvasculature of children with severe meningococcemia and purpuric or petechial lesions. Methods: We assessed the integrity of the endothelium and the expression of thrombomodulin and the endothelial protein C receptor in biopsy specimens of purpuric lesions from 21 children with meningococcal sepsis (median age, 41 months), as compared with control skin-biopsy specimens. Results: The expression of endothelial thrombomodulin and of the endothelial protein C receptor was lower in the patients with meningococcal sepsis than in the controls, both in vessels with thrombosis and in vessels without thrombosis. On electron microscopical examination, the endothelial cells were generally intact in both thrombosed and nonthrombosed vessels. Plasma thrombomodulin levels in the children with meningococcal sepsis (median, 6.4 ng per liter) were higher than those in the controls (median, 3.6 ng per liter; P=0.002). Plasma levels of protein C antigen, protein S antigen, and antithrombin antigen were lower than those in the controls. In two patients treated with unactivated protein C concentrate, activated protein C was undetectable at the time of admission, and plasma levels remained low. Conclusions: In severe meningococcal sepsis, protein C activation is impaired, a finding consistent with down-regulation of the endothelial thrombomodulin-endothelial protein C receptor pathway. (N Engl J Med 2001;345:408-16.) Copyright (C) 2001 Massachusetts Medical Society.	St Marys Hosp, Imperial Coll Sch med, Dept Paediat, London W2 1PG, England; St Marys Hosp, Imperial Coll Sch med, Dept Pathol, London W2 1PG, England; Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA; Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK USA; Howard Hughes Med Inst, Oklahoma City, OK USA; Univ Bristol, Dept Pathol, Bristol, Avon, England; Univ Bristol, Dept Microbiol, Bristol, Avon, England	Imperial College London; Imperial College London; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Howard Hughes Medical Institute; University of Bristol; University of Bristol	Levin, M (corresponding author), St Marys Hosp, Imperial Coll Sch med, Dept Paediat, Norfolk Pl, London W2 1PG, England.		Faust, Saul/J-9779-2014	Faust, Saul/0000-0003-3410-7642; Levin, Michael/0000-0003-2767-6919; Goldin, Robert/0000-0001-5184-4519; Harrison, Odile/0000-0002-1623-0295	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL054804] Funding Source: NIH RePORTER; NHLBI NIH HHS [P50 HL54804] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Achtman M, 1995, MENINGOCOCCAL DIS, P159; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; BRANDTZAEG P, 1990, THROMB RES, V57, P271, DOI 10.1016/0049-3848(90)90326-8; BRANDTZAEG P, 1989, THROMB RES, V55, P459, DOI 10.1016/0049-3848(89)90054-6; BRANDTZAEG P, 1995, MENINGOCOCCAL DIS, P71; CATTORETTI G, 1993, J PATHOL, V171, P83, DOI 10.1002/path.1711710205; CREASEY AA, 1993, J CLIN INVEST, V91, P2850, DOI 10.1172/JCI116529; de Jonge E, 1998, DRUGS, V55, P767, DOI 10.2165/00003495-199855060-00004; de Kleijn ED, 1998, EUR J PEDIATR, V157, P869, DOI 10.1007/s004310050958; DEUTZTERLOUW PP, 1990, CLIN CHIM ACTA, V186, P321, DOI 10.1016/0009-8981(90)90318-M; Dixon GLJ, 1999, INFECT IMMUN, V67, P5626, DOI 10.1128/IAI.67.11.5626-5633.1999; DREYFUS M, 1991, NEW ENGL J MED, V325, P1565, DOI 10.1056/NEJM199111283252207; Duncan A, 1997, LANCET, V350, P1565, DOI 10.1016/S0140-6736(05)64007-X; EDGAR P, 1989, J CLIN PATHOL, V42, P985, DOI 10.1136/jcp.42.9.985; ELEY B, 2000, TXB PEDIAT DERMATOLO, V2, P1574; Esmon CT, 1999, THROMB HAEMOSTASIS, V82, P251; Esmon CT, 1997, THROMB HAEMOSTASIS, V78, P70; Faust SN, 2000, BEST PRACT RES CL HA, V13, P179, DOI 10.1053/beha.2000.0067; FOURRIER F, 1990, INTENS CARE MED, V16, P121, DOI 10.1007/BF01699858; FOURRIER F, 1993, CHEST, V104, P882, DOI 10.1378/chest.104.3.882; FUKUDOME K, 1994, J BIOL CHEM, V269, P26486; Furuno T, 1997, INT ARCH ALLERGY IMM, V112, P262, DOI 10.1159/000237464; GRUBER A, 1992, BLOOD, V79, P2340; HARRIS OB, 2000, 12 INT PATH NEISS C, P18; Hazelzet JA, 1996, THROMB HAEMOSTASIS, V76, P932; Hermans PWM, 1999, LANCET, V354, P556, DOI 10.1016/S0140-6736(99)02220-5; HESSELVIK JF, 1991, THROMB HAEMOSTASIS, V65, P126; Heyderman RS, 1997, MICROB PATHOGENESIS, V22, P265, DOI 10.1006/mpat.1996.0112; HEYDERMAN RS, 1992, THROMB RES, V67, P677, DOI 10.1016/0049-3848(92)90071-H; HEYDERMAN RS, 2000, TXB PEDIAT DERMATOLO, V1, P384; Hibberd ML, 1999, LANCET, V353, P1049, DOI 10.1016/S0140-6736(98)08350-0; HSU SM, 1981, AM J CLIN PATHOL, V75, P734, DOI 10.1093/ajcp/75.5.734; IBA T, 1995, SURG TODAY, V25, P585, DOI 10.1007/BF00311430; Ikegami K, 1998, J TRAUMA, V44, P789, DOI 10.1097/00005373-199805000-00008; KLEIN NJ, 1992, J CELL SCI, V102, P821; Klein NJ, 1996, J INFECT DIS, V173, P172, DOI 10.1093/infdis/173.1.172; Kornelisse RF, 1996, J INFECT DIS, V173, P1148, DOI 10.1093/infdis/173.5.1148; Krafte-Jacobs B, 1998, CRIT CARE MED, V26, P933, DOI 10.1097/00003246-199805000-00032; Kurosawa S, 1997, J CLIN INVEST, V100, P411, DOI 10.1172/JCI119548; Kurosawa S, 1998, BLOOD, V91, P725, DOI 10.1182/blood.V91.2.725; Kurosawa S, 2000, J IMMUNOL, V165, P4697, DOI 10.4049/jimmunol.165.8.4697; Laszik Z, 1997, CIRCULATION, V96, P3633; Levi M, 1999, THROMB HAEMOSTASIS, V82, P695; LEVIN M, 1995, J PEDIATR-US, V127, P355, DOI 10.1016/S0022-3476(95)70063-3; LORENTE JA, 1993, CHEST, V103, P1536, DOI 10.1378/chest.103.5.1536; Mavrommatis AC, 2000, CRIT CARE MED, V28, P451, DOI 10.1097/00003246-200002000-00027; MOORE KL, 1987, J CLIN INVEST, V79, P124, DOI 10.1172/JCI112772; NADEL S, 1995, MENINGOCOCCAL DIS, P207; OSTERUD B, 1983, THROMB HAEMOSTASIS, V49, P5; PARAMO JA, 1990, THROMB HAEMOSTASIS, V64, P3; POLLACK MM, 1988, CRIT CARE MED, V16, P1110, DOI 10.1097/00003246-198811000-00006; Pollard AJ, 1999, ARCH DIS CHILD, V80, P290, DOI 10.1136/adc.80.3.290; POWARS D, 1993, CLIN INFECT DIS, V17, P254, DOI 10.1093/clinids/17.2.254; Rintala E, 1998, CRIT CARE MED, V26, P965, DOI 10.1097/00003246-199805000-00038; Sadler JE, 1997, THROMB HAEMOSTASIS, V78, P392; SHETH SB, 1991, AM J HEMATOL, V36, P14, DOI 10.1002/ajh.2830360104; Shimura M, 1996, AM J HEMATOL, V52, P165; Smith OP, 1997, LANCET, V350, P1590, DOI 10.1016/S0140-6736(97)06356-3; SORIA J, 1985, THROMB HAEMOSTASIS, V53, P293; SOTTO MN, 1976, J INFECT DIS, V133, P506, DOI 10.1093/infdis/133.5.506; TAYLOR FB, 1991, CIRC SHOCK, V33, P127; TAYLOR FB, 1987, J CLIN INVEST, V79, P918, DOI 10.1172/JCI112902; THOMSON APJ, 1991, CRIT CARE MED, V19, P26, DOI 10.1097/00003246-199101000-00010; VANDEUREN M, 1993, BMJ-BRIT MED J, V306, P1229, DOI 10.1136/bmj.306.6887.1229; White B, 2000, BLOOD, V96, P3719, DOI 10.1182/blood.V96.12.3719.h8003719_3719_3724; ZENZ W, 1995, PEDIATRICS, V96, P44	66	480	508	0	14	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 9	2001	345	6					408	416		10.1056/NEJM200108093450603	http://dx.doi.org/10.1056/NEJM200108093450603			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460EJ	11496851				2022-12-28	WOS:000170295000003
J	Harvey, R; Lane, A; Murray, L; Harvey, I; Nair, P; Donovan, J				Harvey, R; Lane, A; Murray, L; Harvey, I; Nair, P; Donovan, J			Effect of Helicobacter pylori infection on blood pressure: a community based cross sectional study	BRITISH MEDICAL JOURNAL			English	Article							CORONARY HEART-DISEASE; ASSOCIATION		N Bristol NHS Trust, Frenchay Hosp, Bristol BS16 1LE, Avon, England; Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England	North Bristol NHS Trust; University of Bristol	Harvey, R (corresponding author), N Bristol NHS Trust, Frenchay Hosp, Bristol BS16 1LE, Avon, England.				Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BARNES RJ, 1991, BRIT J GEN PRACT, V41, P286; Danesh J, 1999, BRIT MED J, V319, P1157, DOI 10.1136/bmj.319.7218.1157; Lip GYH, 1996, BRIT MED J, V312, P250; PATEL P, 1995, BRIT MED J, V311, P711, DOI 10.1136/bmj.311.7007.711; Whincup PH, 1996, HEART, V75, P568, DOI 10.1136/hrt.75.6.568	5	19	20	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 4	2001	323	7307					264	265		10.1136/bmj.323.7307.264	http://dx.doi.org/10.1136/bmj.323.7307.264			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	461ZT	11485956	Bronze, Green Published			2022-12-28	WOS:000170394300020
J	Catling, DC; Zahnle, KJ; McKay, CP				Catling, DC; Zahnle, KJ; McKay, CP			Biogenic methane, hydrogen escape, and the irreversible oxidation of early Earth	SCIENCE			English	Article							ATMOSPHERIC OXYGEN; REDOX STATES; EVOLUTION; DOLOMITE; MANTLE; GA; PHOTOSYNTHESIS; GREENHOUSE; PALEOSOLS; ISOTOPES	The low O-2 content of the Archean atmosphere implies that methane should have been present at levels similar to 10(2) to 10(3) parts per million volume (ppmv) (compared with 1.7 ppmv today) given a plausible biogenic source. CH4 is favored as the greenhouse gas that countered the lower luminosity of the early Sun. But abundant CH4 implies that hydrogen escapes to space (up arrow space) orders of magnitude faster than today. Such reductant loss oxidizes the Earth. Photosynthesis splits water into O-2 and H, and methanogenesis transfers the H into CH4. Hydrogen escape after CH4 photolysis, therefore, causes a net gain of oxygen [CO2 + 2H(2)O CH4 --> 2O(2) --> CO2 + O-2 + 4H(up arrow space)]. Expected irreversible oxidation (similar to 10(12) to 10(13) moles oxygen per year) may help explain how Earth's surface environment became irreversibly oxidized.	NASA, Ames Res Ctr, Div Space Sci, Moffett Field, CA 94035 USA; SETI Inst, Mountain View, CA 94043 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Catling, DC (corresponding author), NASA, Ames Res Ctr, Div Space Sci, Mail Stop 245-3, Moffett Field, CA 94035 USA.	catling@humbabe.arc.nasa.gov	Catling, David C/D-2082-2009	Catling, David/0000-0001-5646-120X				Anbar AD, 2001, J GEOPHYS RES-PLANET, V106, P3219, DOI 10.1029/2000JE001272; BAHCALL JN, 1988, REV MOD PHYS, V60, P297, DOI 10.1103/RevModPhys.60.297; Bau M, 1999, EARTH PLANET SC LETT, V174, P43, DOI 10.1016/S0012-821X(99)00261-7; BERNER RA, 1989, AM J SCI, V289, P333, DOI 10.2475/ajs.289.4.333; Berner RA, 2000, SCIENCE, V287, P1630, DOI 10.1126/science.287.5458.1630; Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; BUDYKO ML, 1985, HIST EARTHS ATMOSPHE; BUICK R, 1990, SEDIMENTOLOGY, V37, P247, DOI 10.1111/j.1365-3091.1990.tb00958.x; BUICK R, 1992, SCIENCE, V255, P74, DOI 10.1126/science.11536492; Canil D, 1999, GEOCHIM COSMOCHIM AC, V63, P557, DOI 10.1016/S0016-7037(98)00287-7; CHAMBERLAIN JW, 1987, THEORY PLANETARY ATM, P34; DELANO JW, IN PRESS ORIGIN LIFE; Des Marais DJ, 2000, SCIENCE, V289, P1703; DIX GR, 1995, PRECAMBRIAN RES, V70, P253, DOI 10.1016/0301-9268(94)00044-R; EUGSTER HP, 1972, P INT GEOL C, V24, P3; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Francois LM, 1986, PALEOCEANOGRAPHY, V1, P355, DOI 10.1029/PA001i004p00355; FYFE WS, 1978, FLUIDS EARTHS CRUST, pCH7; Green MG, 2000, TECTONOPHYSICS, V322, P69, DOI 10.1016/S0040-1951(00)00058-5; Hayes J. M., 1994, EARLY LIFE EARTH, P220; Holland H. D., 1978, CHEM ATMOSPHERE OCEA; Holland HD., 1984, CHEM EVOLUTION ATMOS; Holland HD., 1999, GEOCHEM NEWS, V100, P20; HUNTEN DM, 1973, J ATMOS SCI, V30, P1481, DOI 10.1175/1520-0469(1973)030<1481:TEOLGF>2.0.CO;2; KASTING JF, 1993, J GEOL, V101, P245, DOI 10.1086/648219; Kasting JF, 2001, ORIGINS LIFE EVOL B, V31, P271, DOI 10.1023/A:1010600401718; Kump LR, 2001, GEOCHEM GEOPHY GEOSY, V2; MARAIS DJD, 1992, NATURE, V359, P605, DOI 10.1038/359605a0; Melezhik VA, 1999, EARTH-SCI REV, V48, P71, DOI 10.1016/S0012-8252(99)00044-6; MELNIK YP, 1982, PRECAMBRIAN BANDED I, P68; OWEN T, 1979, NATURE, V277, P640, DOI 10.1038/277640a0; Pavlov AA, 2000, J GEOPHYS RES-PLANET, V105, P11981, DOI 10.1029/1999JE001134; PAVLOV AA, IN PRESS J GEOPHYS R; Prasad N, 1996, CATENA, V27, P105, DOI 10.1016/0341-8162(96)00003-3; Rye R, 2000, GEOLOGY, V28, P483, DOI 10.1130/0091-7613(2000)28<483:LAWAGE>2.0.CO;2; RYE R, 1995, NATURE, V378, P603, DOI 10.1038/378603a0; Rye R, 1998, AM J SCI, V298, P621, DOI 10.2475/ajs.298.8.621; SCHIDLOWSKI M, 1987, ANNU REV EARTH PL SC, V15, P47, DOI 10.1146/annurev.ea.15.050187.000403; Shen YA, 2001, NATURE, V410, P77, DOI 10.1038/35065071; Taylor H.P., 1977, J GEOL SOC LONDON, V133, P509, DOI [10.1144/gsjgs.133.6.0509, DOI 10.1144/GSJGS.133.6.0509]; VISCONTI G, 1975, J ATMOS SCI, V32, P1631, DOI 10.1175/1520-0469(1975)032<1631:TETOAP>2.0.CO;2; WALTER FM, 1991, SUN TIME, P633; WEDEPOHL KH, 1995, GEOCHIM COSMOCHIM AC, V59, P1217, DOI 10.1016/0016-7037(95)00038-2	46	309	331	9	129	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 3	2001	293	5531					839	843		10.1126/science.1061976	http://dx.doi.org/10.1126/science.1061976			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11486082				2022-12-28	WOS:000170241000038
J	Ranke, MB; Saenger, P				Ranke, MB; Saenger, P			Turner's syndrome	LANCET			English	Review							GROWTH-HORMONE TREATMENT; SHORT STATURE; X-CHROMOSOME; LIVER ABNORMALITIES; GLUCOSE-METABOLISM; BEHAVIOR PROBLEMS; ADULT HEIGHT; Y-CHROMOSOME; GIRLS; WOMEN	Before chromosomal analysis became available, the diagnosis of Turner's syndrome was based on the characteristics Independently described by Otto Ullrich and Henry Turner, such as short stature, gonadal dysgenesis, typical, visible dysmorphic stigmata, and abnormalities in organs, which present in individuals with a female phenotype. Today, Turner's syndrome or Ullrich-Turner's syndrome may be defined as the combination of characteristic physical features and complete or part absence of one of the X chromosomes, frequently accompanied by cell-line mosaicism. The increasing interest In Turner's syndrome over the past two decades has been motivated both by the quest for a model by which the multi-faceted features of this disorder can be understood, and the endeavour to provide life-long support to the patient. New developments in research allow patients with Turner's syndrome to have multidisciplinary care.	Univ Tubingen, Childrens Hosp, Paediat Endocrinol Sect, D-72076 Tubingen, Germany; Yeshiva Univ Albert Einstein Coll Med, Montefiore Med Ctr, Dept Pediat, Div Pediat Endocrinol, New York, NY 10033 USA	Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Montefiore Medical Center; Yeshiva University	Ranke, MB (corresponding author), Univ Tubingen, Childrens Hosp, Paediat Endocrinol Sect, D-72076 Tubingen, Germany.	mlranke@med.uni-tuebingen.de						Albareda MM, 1999, EUR J GASTROEN HEPAT, V11, P1037, DOI 10.1097/00042737-199909000-00015; Baird DT, 1999, ENDOCRINOLOGY, V140, P462, DOI 10.1210/en.140.1.462; Belin V, 1998, NAT GENET, V19, P67, DOI 10.1038/ng0198-67; Binder G, 2000, J CLIN ENDOCR METAB, V85, P245, DOI 10.1210/jc.85.1.245; Bishop DVM, 2000, NEUROPSYCHOLOGIA, V38, P712, DOI 10.1016/S0028-3932(99)00118-9; CLARK C, 1990, CAN J NEUROL SCI, V17, P140, DOI 10.1017/S0317167100030341; Clement-Jones M, 2000, HUM MOL GENET, V9, P695, DOI 10.1093/hmg/9.5.695; CONWAY GS, 2000, OPTIMIZING HLTH CARE, P295; DEKERDANET M, 1994, CLIN ENDOCRINOL, V41, P673; Donaldson MDC, 1997, HORM RES, V48, P35, DOI 10.1159/000191327; DOWNEY J, 1989, J NERV MENT DIS, V177, P191, DOI 10.1097/00005053-198904000-00002; El Abd S, 1999, AM J MED GENET, V88, P510; Garden AS, 1996, CLIN ENDOCRINOL, V45, P589, DOI 10.1046/j.1365-2265.1996.00849.x; GOLDBERG JD, 1990, AM J MED GENET, V35, P174, DOI 10.1002/ajmg.1320350206; Gravholt CH, 1996, BMJ-BRIT MED J, V312, P16, DOI 10.1136/bmj.312.7022.16; Gravholt CH, 1998, DIABETES CARE, V21, P1062, DOI 10.2337/diacare.21.7.1062; Gravholt CH, 1998, J CLIN EPIDEMIOL, V51, P147, DOI 10.1016/S0895-4356(97)00237-0; Gravholt CH, 2000, J CLIN ENDOCR METAB, V85, P3199, DOI 10.1210/jc.85.9.3199; GRAVHOLT CH, 2000, OPTIMIZING HLTH CARE, P285; HABERECHT M, 2000, OPTIMIZING HLTH CARE, P79; HAVERKAMP F, 2000, OPTIMIZING HLTH CARE, P97; HEIKKILA M, 2000, OPTIMIZING HLTH CARE, P29; HOOK EB, 1978, NEW ENGL J MED, V299, P1036, DOI 10.1056/NEJM197811092991903; HOVATTA O, 2000, OPTIMIZING HLTH CARE, P247; Hsu LYF, 1998, GENETIC DISORDERS FE, V4th, P179; Jacobs P, 1997, ANN HUM GENET, V61, P471, DOI 10.1017/S0003480097006507; KULKARNI R, 1989, PRENATAL DIAG, V9, P439, DOI 10.1002/pd.1970090610; LIN AE, 2000, OPTIMIZING HLTH CARE, P115; MANUEL M, 1976, AM J OBSTET GYNECOL, V124, P293, DOI 10.1016/0002-9378(76)90160-5; MATHUR A, 1991, AM J HUM GENET, V48, P682; MCCAULEY E, 1987, CHILD DEV, V58, P464, DOI 10.2307/1130523; MCCAULEY E, 1995, J DEV BEHAV PEDIATR, V16, P82; MCCAULEY E, 1986, J AM ACAD CHILD PSY, V25, P105, DOI 10.1016/S0002-7138(09)60606-3; MONEY J, 1970, BEHAV GENET, V1, P43, DOI 10.1007/BF01067370; Murphy DGM, 1997, BIOL PSYCHIAT, V41, P285, DOI 10.1016/S0006-3223(95)00660-5; OGATA T, 1993, HUM GENET, V91, P551; OGATA T, 2000, OPTIMIZING HLTH CARE, P9; PASQUINO AM, 2000, OPTIMIZING HLTH CARE, P231; RADETTI G, 1995, ACTA PAEDIATR, V84, P909, DOI 10.1111/j.1651-2227.1995.tb13791.x; RANKE MB, 1994, HORM RES, V42, P90, DOI 10.1159/000184154; Ranke MB, 1995, INT CONGR SER, V1089, P161; Rao E, 1997, NAT GENET, V16, P54, DOI 10.1038/ng0597-54; REISS AL, 1995, ANN NEUROL, V38, P731, DOI 10.1002/ana.410380507; Romans SM, 1998, AM J MED GENET, V79, P140, DOI 10.1002/(SICI)1096-8628(19980901)79:2<140::AID-AJMG10>3.0.CO;2-J; ROSENFELD RG, 1988, J PEDIATR-US, V113, P393, DOI 10.1016/S0022-3476(88)80290-7; ROVET JF, 1994, GROWTH STATURE ADAPT, P165; Ruiz C, 1999, CLIN CHEM, V45, P2259; Saegnger P, 2000, OPTIMIZING HLTH CARE, P125; Saenger P, 1996, NEW ENGL J MED, V335, P1749, DOI 10.1056/NEJM199612053352307; Salerno M, 1999, EUR J PEDIATR, V158, P618, DOI 10.1007/s004310051163; Sas T., 1999, Hormone Research (Basel), V51, P58; Sas T, 2000, CLIN ENDOCRINOL, V52, P741, DOI 10.1046/j.1365-2265.2000.01007.x; Sas TCJ, 1999, J CLIN ENDOCR METAB, V84, P4607, DOI 10.1210/jc.84.12.4607; Scourfield J, 1999, BRIT J PSYCHIAT, V175, P559, DOI 10.1192/bjp.175.6.559; Skuse DH, 1997, NATURE, V387, P705, DOI 10.1038/42706; SONIS W, 1983, HYPERACTIVITY TURNER; STABLER B, 1999, GROWTH HORMONE THERA, P365; Sybert VP, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.1.e11; SYLVEN L, 1993, ACTA ENDOCRINOL-COP, V129, P188, DOI 10.1530/acta.0.1290188; Tarani L, 1998, GYNECOL ENDOCRINOL, V12, P83, DOI 10.3109/09513599809024955; TILLY JL, 2000, OPTIMIZING HLTH CARE, P43; VERP MS, 1987, CANCER GENET CYTOGEN, V25, P191, DOI 10.1016/0165-4608(87)90180-4; VITTAY P, 1980, CLIN GENET, V18, P387; Williams J K, 1992, J Pediatr Nurs, V7, P14; ZINN AR, 1993, INT CONGR SER, V1014, P49; Zinn AR, 2000, OPTIMIZING HLTH CARE, P19	66	201	214	1	21	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 28	2001	358	9278					309	314		10.1016/S0140-6736(01)05487-3	http://dx.doi.org/10.1016/S0140-6736(01)05487-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	457AF	11498234				2022-12-28	WOS:000170114400030
J	Osherovich, LZ; Weissman, JS				Osherovich, LZ; Weissman, JS			Multiple GIn/Asn-rich prion domains confer susceptibility to induction of the yeast [PSI+] prion	CELL			English	Article							TRANSLATION TERMINATION EFFICIENCY; AMYLOID-LIKE FIBRILS; SACCHAROMYCES-CEREVISIAE; NEURODEGENERATIVE DISEASES; HUNTINGTONS-DISEASE; GLUTAMINE REPEATS; CELL-DEATH; POLYGLUTAMINE; PROPAGATION; INHERITANCE	The yeast prion [PSI+] results from self-propagating aggregates of Sup35p. De novo formation of [PSI+] requires an additional non-Mendelian trait, thought to result from a prion form of one or more unknown proteins. We find that the Gln/Asn-rich prion domains of two proteins, New1p and Rnq1p, can control susceptibility to [PSI+] induction as well as enhance aggregation of a human glutamine expansion disease protein. [PSI+] inducibility results from gain-of-function properties of New1p and Rnq1p aggregates rather than from inactivation of the normal proteins. These studies suggest a molecular basis for the epigenetic control of [PSI+] inducibility and may reveal a broader role for this phenomenon in the physiology of protein aggregation.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Osherovich, LZ (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Mol & Cellular Pharmacol, 513 Parnassus Ave, San Francisco, CA 94143 USA.	lxoshe@itsa.ucsf.edu		Weissman, Jonathan/0000-0003-2445-670X				Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Carmichael J, 2000, P NATL ACAD SCI USA, V97, P9701, DOI 10.1073/pnas.170280697; Chernoff YO, 1999, MOL CELL BIOL, V19, P8103; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Derkatch IL, 1997, GENETICS, V147, P507; Derkatch IL, 1996, GENETICS, V144, P1375; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Derkatch IL, 2000, EMBO J, V19, P1942, DOI 10.1093/emboj/19.9.1942; Eaglestone SS, 1999, EMBO J, V18, P1974, DOI 10.1093/emboj/18.7.1974; FESCHENKO MS, 1992, J BIOL CHEM, V267, P4097; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; Jung GM, 2001, CURR MICROBIOL, V43, P7, DOI 10.1007/s002840010251; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Kushnirov VV, 1998, CELL, V94, P13, DOI 10.1016/S0092-8674(00)81216-7; Lindquist S, 1995, COLD SPRING HARB SYM, V60, P451, DOI 10.1101/SQB.1995.060.01.050; Liu JJ, 1999, NATURE, V400, P573, DOI 10.1038/23048; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Newnam GP, 1999, MOL CELL BIOL, V19, P1325; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; Perutz MF, 1999, TRENDS BIOCHEM SCI, V24, P58, DOI 10.1016/S0968-0004(98)01350-4; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; ROSE MD, 1987, CELL, V48, P1047, DOI 10.1016/0092-8674(87)90712-4; Santoso A, 2000, CELL, V100, P277, DOI 10.1016/S0092-8674(00)81565-2; Satyal SH, 2000, P NATL ACAD SCI USA, V97, P5750, DOI 10.1073/pnas.100107297; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Serio TR, 1999, ANNU REV CELL DEV BI, V15, P661, DOI 10.1146/annurev.cellbio.15.1.661; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Sondheimer N, 2001, EMBO J, V20, P2435, DOI 10.1093/emboj/20.10.2435; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; TUITE MF, 1981, GENETICS, V98, P691; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Wickner RB, 1999, MICROBIOL MOL BIOL R, V63, P844, DOI 10.1128/MMBR.63.4.844-861.1999; Wickner RB, 2000, CURR BIOL, V10, pR335, DOI 10.1016/S0960-9822(00)00460-7; Zhou P, 2001, MOL MICROBIOL, V39, P37, DOI 10.1046/j.1365-2958.2001.02224.x	42	257	269	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2001	106	2					183	194		10.1016/S0092-8674(01)00440-8	http://dx.doi.org/10.1016/S0092-8674(01)00440-8			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	458KG	11511346	Bronze			2022-12-28	WOS:000170193100008
J	Zakany, J; Kmita, M; Alarcon, P; de la Pompa, JL; Duboule, D				Zakany, J; Kmita, M; Alarcon, P; de la Pompa, JL; Duboule, D			Localized and transient transcription of Hox genes suggests a link between patterning and the segmentation clock	CELL			English	Article							SOMITE BOUNDARY FORMATION; LUNATIC FRINGE; DELTA-HOMOLOG; REGULATORY CONTROLS; HOMEOBOX GENE; BODY PLAN; MOUSE; EXPRESSION; COMPLEX; MURINE	During development, Hox gene transcription is activated in presomitic mesoderm with a time sequence that follows the order of the genes along the chromosome. Here, we show that Hoxd1 and other Hox genes display dynamic stripes of expression within presomitic mesoderm. The underlying transcriptional bursts may reflect the mechanism that coordinates Hox gene activation with somitogenesis. This mechanism appears to depend upon Notch signaling, as mice deficient for RBPJk, the effector of the Notch pathway, showed severely reduced Hoxd gene expression in presomitic mesoderm. These results suggest a molecular link between Hox gene activation and the segmentation clock. Such a linkage would efficiently keep in phase the production of novel segments with their morphological specification.	Univ Geneva, Dept Zool & Anim Biol, CH-1211 Geneva 4, Switzerland; Hosp Duran & Reynals, Inst Recerca Oncol, Dept Mol Oncol, Barcelona, Spain; EMBL, Mouse Biol Program, Rome, Italy	University of Geneva; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals; European Molecular Biology Laboratory (EMBL)	Duboule, D (corresponding author), Univ Geneva, Dept Zool & Anim Biol, Quai Ernest Ansermet 30, CH-1211 Geneva 4, Switzerland.		De La Pompa, José Luis/F-9719-2014	De La Pompa, José Luis/0000-0001-6761-7265; Kmita, Marie/0000-0003-4021-0478; duboule, denis/0000-0001-9961-2960				Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Barrantes ID, 1999, CURR BIOL, V9, P470, DOI 10.1016/S0960-9822(99)80212-7; Cohen B, 1997, NAT GENET, V16, P283, DOI 10.1038/ng0797-283; CONDIE BG, 1993, DEVELOPMENT, V119, P579; CONLON RA, 1995, DEVELOPMENT, V121, P1533; Dale KJ, 2000, BIOESSAYS, V22, P72, DOI 10.1002/(SICI)1521-1878(200001)22:1<72::AID-BIES12>3.0.CO;2-S; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; DESCHAMPS J, 1993, DEV BIOL, V156, P473, DOI 10.1006/dbio.1993.1093; DUBOULE D, 1995, CURR OPIN GENET DEV, V5, P525, DOI 10.1016/0959-437X(95)90058-O; DUBOULE D, 1989, EMBO J, V8, P1497, DOI 10.1002/j.1460-2075.1989.tb03534.x; DUBOULE D, 1994, DEVELOPMENT, P135; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Dunwoodie SL, 1997, DEVELOPMENT, V124, P3065; Evrard YA, 1998, NATURE, V394, P377, DOI 10.1038/28632; Forsberg H, 1998, CURR BIOL, V8, P1027, DOI 10.1016/S0960-9822(07)00424-1; FROHMAN MA, 1992, MECH DEVELOP, V38, P55, DOI 10.1016/0925-4773(92)90038-L; GAUNT SJ, 1988, DEVELOPMENT, V104, P169; Gerard M, 1997, DEV BIOL, V190, P32, DOI 10.1006/dbio.1997.8679; Gossler A, 1998, CURR TOP DEV BIOL, V38, P225; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; Herault Y, 1999, DEV BIOL, V208, P157, DOI 10.1006/dbio.1998.9179; HUNT P, 1991, NATURE, V353, P861, DOI 10.1038/353861a0; Jiang YJ, 2000, NATURE, V408, P475, DOI 10.1038/35044091; Johnston SH, 1997, DEVELOPMENT, V124, P2245; Jouve C, 2000, DEVELOPMENT, V127, P1421; Kmita M, 2000, NAT GENET, V26, P451, DOI 10.1038/82593; Kmita M, 2000, GENE DEV, V14, P198; Kondo T, 1999, CELL, V97, P407, DOI 10.1016/S0092-8674(00)80749-7; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Kusumi K, 1998, NAT GENET, V19, P274, DOI 10.1038/961; Mann RS, 1997, BIOESSAYS, V19, P661, DOI 10.1002/bies.950190804; McGrew MJ, 1998, CURR BIOL, V8, P979, DOI 10.1016/S0960-9822(98)70401-4; Medina-Martinez O, 2000, DEV BIOL, V222, P71, DOI 10.1006/dbio.2000.9683; OKA C, 1995, DEVELOPMENT, V121, P3291; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Saga Y, 1997, GENE DEV, V11, P1827, DOI 10.1101/gad.11.14.1827; Stern CD, 2000, CURR TOP DEV BIOL, V47, P107; STUBBS L, 1990, GENOMICS, V7, P422, DOI 10.1016/0888-7543(90)90177-V; Suemori H, 2000, DEV BIOL, V220, P333, DOI 10.1006/dbio.2000.9651; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Takahashi Y, 2000, NAT GENET, V25, P390, DOI 10.1038/78062; Tam PPL, 2000, CURR TOP DEV BIOL, V47, P1; Tan DP, 1996, P NATL ACAD SCI USA, V93, P8247, DOI 10.1073/pnas.93.16.8247; vanderHoeven F, 1996, CELL, V85, P1025, DOI 10.1016/S0092-8674(00)81303-3; Zakany J, 1999, NATURE, V401, P761, DOI 10.1038/44511; Zakany J, 1997, EMBO J, V16, P4393, DOI 10.1093/emboj/16.14.4393; Zakany J, 1996, NATURE, V384, P69, DOI 10.1038/384069a0; Zhang NA, 1998, NATURE, V394, P374, DOI 10.1038/28625	48	150	154	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 27	2001	106	2					207	217		10.1016/S0092-8674(01)00436-6	http://dx.doi.org/10.1016/S0092-8674(01)00436-6			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	458KG	11511348	Bronze			2022-12-28	WOS:000170193100010
J	Schiemann, B; Gommerman, JL; Vora, K; Cachero, TG; Shulga-Morskaya, S; Dobles, M; Frew, E; Scott, ML				Schiemann, B; Gommerman, JL; Vora, K; Cachero, TG; Shulga-Morskaya, S; Dobles, M; Frew, E; Scott, ML			An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway	SCIENCE			English	Article							NECROSIS-FACTOR FAMILY; FACTOR RECEPTOR SUPERFAMILY; MOUSE BONE-MARROW; AUTOIMMUNE-DISEASE; MEMBER; MICE; GROWTH; APRIL; IDENTIFICATION; LYMPHOCYTES	The B cell activating factor BAFF (BtyS/TALL-1/zTNF4) is a tumor necrosis factor (TNF)-related ligand that promotes B cell survival and binds to three receptors (BCMA, TACI, and the recently described BAFF-R). Here we report an absolute requirement for BAFF in normal B cell development. Examination of secondary lymphoid organs from BAFF-deficient mice revealed an almost complete loss of follicular and marginal zone B lymphocytes. In contrast, mice lacking BCMA had normal-appearing B lymphocyte compartments. BAFF therefore plays a crucial role in B cell development and can function through receptors other than BCMA.	Biogen Inc, Cambridge, MA 02142 USA	Biogen	Scott, ML (corresponding author), Biogen Inc, 14 Cambridge Ctr, Cambridge, MA 02142 USA.	martin_scott@biogen.com		Gommerman, Jennifer/0000-0003-4576-6168				Batten M, 2000, J EXP MED, V192, P1453, DOI 10.1084/jem.192.10.1453; Cheema GS, 2001, ARTHRITIS RHEUM-US, V44, P1313, DOI 10.1002/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S; Clarke SH, 1998, J EXP MED, V187, P1325, DOI 10.1084/jem.187.8.1325; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; GRAS MP, 1995, INT IMMUNOL, V7, P1093, DOI 10.1093/intimm/7.7.1093; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Hahne M, 1998, J EXP MED, V188, P1185, DOI 10.1084/jem.188.6.1185; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; HARDY RR, 1994, IMMUNOL REV, V137, P91, DOI 10.1111/j.1600-065X.1994.tb00660.x; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; KALLED S, UNPUB; Khare SD, 2000, P NATL ACAD SCI USA, V97, P3370, DOI 10.1073/pnas.050580697; Lentz VM, 1996, J IMMUNOL, V157, P598; Li YS, 1996, IMMUNITY, V5, P527, DOI 10.1016/S1074-7613(00)80268-X; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Madry C, 1998, INT IMMUNOL, V10, P1693, DOI 10.1093/intimm/10.11.1693; Martin F, 2001, CURR OPIN IMMUNOL, V13, P195, DOI 10.1016/S0952-7915(00)00204-1; Meffre E, 2000, NAT IMMUNOL, V1, P379, DOI 10.1038/80816; MILLER DJ, 1991, EUR J IMMUNOL, V21, P1123, DOI 10.1002/eji.1830210506; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Mukhopadhyay A, 1999, J BIOL CHEM, V274, P15978, DOI 10.1074/jbc.274.23.15978; Nemazee D, 2000, Adv Immunol, V74, P89; Rennert P, 2000, J EXP MED, V192, P1677, DOI 10.1084/jem.192.11.1677; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Shu HB, 1999, J LEUKOCYTE BIOL, V65, P680, DOI 10.1002/jlb.65.5.680; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; von Bulow GU, 2001, IMMUNITY, V14, P573, DOI 10.1016/S1074-7613(01)00130-3; vonBulow GU, 1997, SCIENCE, V278, P138, DOI 10.1126/science.278.5335.138; Vora KA, 1999, J EXP MED, V189, P471, DOI 10.1084/jem.189.3.471; Xu SL, 2001, MOL CELL BIOL, V21, P4067, DOI 10.1128/MCB.21.12.4067-4074.2001; Yu G, 2000, NAT IMMUNOL, V1, P252, DOI 10.1038/79802; Zhang J, 2001, J IMMUNOL, V166, P6, DOI 10.4049/jimmunol.166.1.6	33	863	942	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2001	293	5537					2111	2114		10.1126/science.1061964	http://dx.doi.org/10.1126/science.1061964			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11509691				2022-12-28	WOS:000171028700080
J	Green, MA; Zhao, JH; Wang, AH; Reece, PJ; Gal, M				Green, MA; Zhao, JH; Wang, AH; Reece, PJ; Gal, M			Efficient silicon light-emitting diodes	NATURE			English	Article							SOLAR-CELLS; QUANTUM EFFICIENCY; RADIATION; DEVICES	Considerable effort is being expended on the development of efficient silicon light-emitting devices compatible with silicon-based integrated circuit technology(1). Although several approaches are being explored(1-6), all presently suffer from low emission efficiencies, with values in the 0.01-0.1% range regarded as high(2). Here we report a large increase in silicon light-emitting diode power conversion efficiency to values above 1% near room temperature-close to the values of representative direct bandgap emitters of a little more than a decade ago(7,8). Our devices are based on normally weak one- and two-phonon assisted sub-bandgap light-emission processes. Their design takes advantage of the reciprocity between light absorption and emission by maximizing absorption at relevant sub-bandgap wavelengths while reducing the scope for parasitic non-radiative recombination within the diode. Each feature individually is shown to improve the emission efficiency by a factor of ten, which accounts for the improvement by a factor of one hundred on the efficiency of baseline devices.	Univ New S Wales, Ctr Generat Photovolt 3, Sydney, NSW 2052, Australia; Univ New S Wales, Photovolt Special Res Ctr, Sydney, NSW 2052, Australia; Univ New S Wales, Sch Phys, Sydney, NSW 2052, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Green, MA (corresponding author), Univ New S Wales, Ctr Generat Photovolt 3, Sydney, NSW 2052, Australia.	m.green@unsw.edu.au	Green, Martin A/H-7567-2012	Green, Martin A/0000-0002-8860-396X; Reece, Peter/0000-0003-4852-3735				ARAUJO GL, 1994, SOL ENERG MAT SOL C, V33, P213, DOI 10.1016/0927-0248(94)90209-7; Ball P, 2001, NATURE, V409, P974, DOI 10.1038/35059301; CAMPBELL P, 1987, J APPL PHYS, V62, P243, DOI 10.1063/1.339189; Goetzberger A., 1981, Fifteenth IEEE Photovoltaic Specialists Conference - 1981, P867; GREEN MA, 1995, PROG PHOTOVOLTAICS, V3, P189, DOI 10.1002/pip.4670030303; Hirschman KD, 1996, NATURE, V384, P338, DOI 10.1038/384338a0; Kirchhoff G, 1860, ANN PHYS CHEM, V109, P275, DOI DOI 10.1002/ANDP.18601850205; KRAMER J, 1993, SENSOR ACTUAT A-PHYS, V37-8, P527, DOI 10.1016/0924-4247(93)80091-T; Leong D, 1997, NATURE, V387, P686, DOI 10.1038/42667; Luque A, 1997, PHYS REV LETT, V78, P5014, DOI 10.1103/PhysRevLett.78.5014; MEYER M, 2000, COMPOUND SEMICOND, V6, P26; NEISSER A, 1998, THESIS TU BERLIN; Ng WL, 2001, NATURE, V410, P192, DOI 10.1038/35065571; ONG TC, 1983, IEEE ELECTR DEVICE L, V4, P460, DOI 10.1109/EDL.1983.25802; Planck M., 1959, THEORY HEAT RAD; SCHLANGENOTTO H, 1974, PHYS STATUS SOLIDI A, V21, P357, DOI 10.1002/pssa.2210210140; SCHNITZER I, 1993, APPL PHYS LETT, V63, P2174, DOI 10.1063/1.110575; SCHNITZER I, 1993, APPL PHYS LETT, V62, P131, DOI 10.1063/1.109348; SHOCKLEY W, 1961, J APPL PHYS, V32, P510, DOI 10.1063/1.1736034; Thomas GA, 2000, PHYS TODAY, V53, P30, DOI 10.1063/1.1325229; Trupke T, 1998, SOL ENERG MAT SOL C, V53, P103, DOI 10.1016/S0927-0248(98)00016-6; Vescan L, 1999, EUR MAT RES, V77, P485; VOUK MA, 1977, J PHYS C SOLID STATE, V10, P3689, DOI 10.1088/0022-3719/10/18/031; WASSERRAB T, 1978, Z NATURFORSCH A, V33, P1097, DOI 10.1515/zna-1978-0920; Windisch R, 2000, IEEE T ELECTRON DEV, V47, P1492, DOI 10.1109/16.848298; WURFEL P, 1982, J PHYS C SOLID STATE, V15, P3967, DOI 10.1088/0022-3719/15/18/012; WURFEL P, 1995, APPL PHYS A-MATER, V60, P67, DOI 10.1007/BF01577615; YABLONOVITCH E, 1982, J OPT SOC AM, V72, P899, DOI 10.1364/JOSA.72.000899; Zhao J, 2001, SOL ENERG MAT SOL C, V66, P27, DOI 10.1016/S0927-0248(00)00155-0; ZHENG B, 1994, APPL PHYS LETT, V64, P2842, DOI 10.1063/1.111977	30	487	512	0	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 23	2001	412	6849					805	808		10.1038/35090539	http://dx.doi.org/10.1038/35090539			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465ET	11518962				2022-12-28	WOS:000170577200033
J	Elliott, P; Briggs, D; Morris, S; de Hoogh, C; Hurt, C; Jensen, TK; Maitland, I; Richardson, S; Wakefield, J; Jarup, L				Elliott, P; Briggs, D; Morris, S; de Hoogh, C; Hurt, C; Jensen, TK; Maitland, I; Richardson, S; Wakefield, J; Jarup, L			Risk of adverse birth outcomes in populations living near landfill sites	BRITISH MEDICAL JOURNAL			English	Article							HAZARDOUS-WASTE SITES; CONGENITAL-MALFORMATIONS; RETROSPECTIVE ANALYSIS; NEURAL-TUBE; HEALTH; EXPOSURE; ENGLAND; DEFECTS; MORTALITY; PROXIMITY	Objective To investigate the risk of adverse birth outcomes associated with residence near landfill sites in Great Britain. Design Geographical study of risks of adverse birth outcomes in populations living within 2 km of 9565 landfill sites operational at some time between 1982 and 1997 (from a total of 19 196 sites) compared with those living further away. Setting Great Britain. Subjects Over 8.2 million live births, 43 471 stillbirths, and 124 597 congenital anomalies (including terminations). Main outcome measures All congenital anomalies combined, sonic specific anomalies, and prevalence of low and very low birth weight (<2500 g and <1500 g). Results For all anomalies combined, relative risk of residence near landfill sites (all waste types) was 0.92 (99% confidence interval 0.907 to 0.923) unadjusted, and 1.01 (1.005 to 1.023) adjusted for confounders. Adjusted risks were 1.05 (1.01 to 1.10) for neural tube defects, 0.96 (0.93 to 0.99) for cardiovascular defects, 1.07 (1.04 to 1.10) for hypospadias and epispadias (with no excess of surgical correction), 1.08 (1.01 to 1.15) for abdominal wall defects, 1.19 (1.05 to 1.34) for surgical correction of gastroschisis and exomphalos, and 1.05 (1.047 to 1.055) and 1.04 (1.03 to 1.05) for low and very low birth weight respectively. There was no excess risk of stillbirth. Findings for special (hazardous) waste sites did not differ systematically from those for non-special sites. For some specific anomalies, higher risks were found in the period before opening compared with after opening of a landfill site, especially hospital admissions for abdominal wall defects. Conclusions We found small excess risks of congenital anomalies and low and very low birth weight in populations living near landfill sites. No causal mechanisms are available to explain these findings, and alternative explanations include data artefacts and residual confounding. Further studies are needed to help differentiate between the various possibilities.	Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, Small Area Hlth Stat Unit, London W2 1PG, England	Imperial College London	Elliott, P (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, Small Area Hlth Stat Unit, St Marys Campus, London W2 1PG, England.		Richardson, Sylvia T/G-4691-2015	Richardson, Sylvia T/0000-0003-1998-492X; Hurt, Chris/0000-0003-1206-8355				AFFLICK EF, 1997, AM J EPIDEMIOL, V145, P148; BALARAJAN R, 1989, Archives of Disease in Childhood, V64, P1457, DOI 10.1136/adc.64.10.1457; BRIGGS D, 2001, 20011 SAHSU; CARSTAIRS V, 1989, BRIT MED J, V299, P886, DOI 10.1136/bmj.299.6704.886; Croen LA, 1997, EPIDEMIOLOGY, V8, P347, DOI 10.1097/00001648-199707000-00001; *DEP ENV, 2001, DIG ENV STAT; Dolk H, 1998, LANCET, V352, P423, DOI 10.1016/S0140-6736(98)01352-X; ElFadel M, 1997, J ENVIRON MANAGE, V50, P1, DOI 10.1006/jema.1995.0131; ELLIOTT P, 2001, BIRTH OUTCOMES SELEC; Fielder HMP, 2000, BRIT MED J, V320, P19, DOI 10.1136/bmj.320.7226.19; GESCHWIND SA, 1992, AM J EPIDEMIOL, V135, P1197, DOI 10.1093/oxfordjournals.aje.a116226; Hamar GB, 1996, J EXPO ANAL ENV EPID, V6, P247; Johnson Barry L., 1997, Reviews on Environmental Health, V12, P235; LECK I, 1995, J EPIDEMIOL COMMUN H, V49, P171, DOI 10.1136/jech.49.2.171; LYNBERG MC, 1994, AM J EPIDEMIOL, V140, P244, DOI 10.1093/oxfordjournals.aje.a117243; Marshall EG, 1997, ARCH ENVIRON HEALTH, V52, P416, DOI 10.1080/00039899709602220; NEUTRA R, 1991, ENVIRON HEALTH PERSP, V94, P31, DOI 10.2307/3431289; *OFF POP CENS SURV, 1992, STAT REV NOT CONG MA; PARSONS L, 1990, BRIT J OBSTET GYNAEC, V97, P237, DOI 10.1111/j.1471-0528.1990.tb01788.x; ROHT LH, 1985, AM J EPIDEMIOL, V122, P418, DOI 10.1093/oxfordjournals.aje.a114123; SCHULMAN J, 1993, ARCH ENVIRON HEALTH, V48, P114, DOI 10.1080/00039896.1993.9938404; SHAW GM, 1992, ARCH ENVIRON HEALTH, V47, P147, DOI 10.1080/00039896.1992.10118769; SOLIMAN MRI, 1993, TOXICOL IND HEALTH, V9, P901, DOI 10.1177/074823379300900511; Tan KH, 1996, BRIT MED J, V313, P903; TORFS CP, 1994, TERATOLOGY, V50, P44, DOI 10.1002/tera.1420500107; *US EPA, 1999, REV RISK ASS AIR CHA, V1; VIANNA NJ, 1984, SCIENCE, V226, P1217, DOI 10.1126/science.6505690; Vrijheid M, 2000, ENVIRON HEALTH PERSP, V108, P101, DOI 10.2307/3454635; Ward RS, 1996, WASTE MANAGE RES, V14, P243; Wasserman CR, 1996, TERATOLOGY, V53, P261, DOI 10.1002/(SICI)1096-9926(199604)53:4<261::AID-TERA9>3.3.CO;2-8; *WHO, 2001, METH ASS RISK HLTH E; *WORK GROUP REG GE, 1995, 43 OPCS WORK GROUP R; [No title captured]	33	212	216	0	16	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 18	2001	323	7309					363	368		10.1136/bmj.323.7309.363	http://dx.doi.org/10.1136/bmj.323.7309.363			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465GN	11509424	Green Published, Bronze			2022-12-28	WOS:000170581400014
J	van Roggen, JFG; Smit, VTHBM				van Roggen, JFG; Smit, VTHBM			Hydatidiform mole.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Leiden Univ, Med Ctr, NL-2300 RC Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van Roggen, JFG (corresponding author), Leiden Univ, Med Ctr, NL-2300 RC Leiden, Netherlands.		Smit, Vincent/AAD-1811-2022	Smit, Vincent/0000-0003-3730-5652					0	1	1	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 16	2001	345	7					503	503		10.1056/NEJMicm970501	http://dx.doi.org/10.1056/NEJMicm970501			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	462QM	11519504				2022-12-28	WOS:000170431300004
J	Dvorak, AM				Dvorak, AM			Mesothelioma.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Dvorak, AM (corresponding author), Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.								0	0	0	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 9	2001	345	6					424	424		10.1056/NEJM200108093450605	http://dx.doi.org/10.1056/NEJM200108093450605			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460EJ	11496853				2022-12-28	WOS:000170295000005
J	Witmer, LM				Witmer, LM			Nostril position in dinosaurs and other vertebrates and its significance for nasal function	SCIENCE			English	Article								Many dinosaurs have enormous and complicated bony nasal apertures. Functional interpretation requires knowledge of the Location of the external opening in the skin. Traditionally, the fleshy nostril of dinosaurs has been placed in the back of the bony opening, but studies of extant dinosaur relatives suggest that it is located far forward. Narial blood supply and cavernous tissue corroborate the rostra[ position in dinosaurs. A rostra[ nostril was, and remains, a virtually invariant rule of construction among Amniota, which has consequences for (I) nasal airstreaming, and hence various physiological parameters, and (ii) the collection of behaviorally relevant circumoral odorants.	Ohio Univ, Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA	University System of Ohio; Ohio University	Witmer, LM (corresponding author), Ohio Univ, Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA.	witmer@exchange.oucom.ohiou.edu						Aas-Hansen O, 2000, AM J PHYSIOL-REG I, V279, pR1190; BAKKER RT, 1971, NATURE, V229, P172, DOI 10.1038/229172a0; BANG B G, 1971, Acta Anatomica, V79, P1; BAUMEL JJ, 1983, ZOOMORPHOLOGY, V102, P215, DOI 10.1007/BF00310349; BELLAIRS AD, 1949, J ANAT, V83, P116; BELLAIRS AD, 1953, J ANAT, V87, P367; Brochu CA, 2000, J VERTEBR PALEONTOL, V20, P1, DOI 10.1671/0272-4634(2000)020[0001:ADREFT]2.0.CO;2; Bruner HL, 1907, AM J ANAT, V7, P1, DOI 10.1002/aja.1000070102; Cope ED, 1878, AM NAT, V12, P71, DOI [10.1086/272033., DOI 10.1086/272033]; DAWES J D K, 1952, J Laryngol Otol, V66, P583, DOI 10.1017/S0022215100048143; DAWES JDK, 1953, J ANAT, V87, P311; Hatcher J. B., 1907, MONOGRAPHS US GEOLOG, VXLIX, DOI DOI 10.5962/BHL.TITLE.60500; HUNTLEY AC, 1984, J EXP BIOL, V113, P447; LAURENT RS, 1994, J EXP BIOL, V194, P329; MALAN M. E., 1946, ANN UNIV STELLENBOSCH REEKS A, V24A, P69; Marsh O., 1883, AM J SCI, V26, P81; Marsh O. C., 1884, AM J SCI 3, V158, P161, DOI DOI 10.2475/AJS.S3-27.158.161; OSBORN HF, 1898, B AM MUS NAT HIST, V10, P219; OSTROM JH, 1961, AM MUSEUM NATURAL HI, V122, P33; Owen R., 1875, PALAEONTOGRAPHICAL S, V29, P15; PARSONS TS, 1970, BIOLOGY REPTILIA, V2, P99; PRATT CWM, 1948, P ZOOL SOC LOND, V118, P171; REHOREK SJ, 2001, 2001 ANN M AM SOC IC; Ruben JA, 1996, ANIMALS TEMPERATURE, P347; Schmidt-Nielsen K., 1997, ANIMAL PHYSL; Sedlmayr Jayc C., 1999, Journal of Vertebrate Paleontology, V19, p74A; STEBBINS RC, 1948, AM J ANAT, V83, P183, DOI 10.1002/aja.1000830202; Walker WF, 1959, COPEIA, V1959, P257, DOI [10.2307/1440406, DOI 10.2307/1440406]; Ward S, 1999, J EXP BIOL, V202, P1589; Witmer L. M., 1999, Journal of Vertebrate Paleontology, V19, p85A; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; WITMER LM, 1995, J MORPHOL, V225, P269, DOI 10.1002/jmor.1052250304; Witmer LM, 1999, J ZOOL, V249, P249, DOI 10.1017/S0952836999009991; Witmer LM, 2001, NAT HIST, V110, P64; WITMER LM, 1997, MEM SOC VERTEBR PALE, V17, P173	35	37	37	2	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 3	2001	293	5531					850	853		10.1126/science.1062681	http://dx.doi.org/10.1126/science.1062681			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11486085				2022-12-28	WOS:000170241000041
J	Johnson, DC				Johnson, DC			A role for phosphodiesterase type-4 inhibitors in COPD?	LANCET			English	Editorial Material							OBSTRUCTIVE PULMONARY-DISEASE; TRIAL		Massachusetts Gen Hosp, Pulm & Crit Care Unit, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Johnson, DC (corresponding author), Massachusetts Gen Hosp, Pulm & Crit Care Unit, Boston, MA 02114 USA.	djohnson5@partners.org						Altose MD, 2000, NEW ENGL J MED, V343, P1902; American Thoracic Society, 1995, AM J RESP CRIT CARE, V152, P77; Bundschuh DS, 2001, J PHARMACOL EXP THER, V297, P280; Burge PS, 2000, BMJ-BRIT MED J, V320, P1297, DOI 10.1136/bmj.320.7245.1297; CAMILLI AE, 1987, AM REV RESPIR DIS, V135, P794, DOI 10.1164/arrd.1987.135.4.794; Casaburi R, 2000, CHEST, V118, P1294, DOI 10.1378/chest.118.5.1294; D'Urzo AD, 2001, CHEST, V119, P1347, DOI 10.1378/chest.119.5.1347; Jeffery PK, 1998, THORAX, V53, P129, DOI 10.1136/thx.53.2.129; NIEWOEHNER DE, 1974, NEW ENGL J MED, V291, P755, DOI 10.1056/NEJM197410102911503; Sandford AJ, 2001, AM J RESP CRIT CARE, V163, P469, DOI 10.1164/ajrccm.163.2.2006158; Sethi S, 2000, CHEST, V117, p286S, DOI 10.1378/chest.117.5_suppl_1.286S; SIAFAKAS NM, 1995, EUR RESPIR J, V8, P1398, DOI 10.1183/09031936.95.08081398; US Department of Health and Human Services, 1984, DHHS PUBL; ZuWallack RL, 2001, CHEST, V119, P1661, DOI 10.1378/chest.119.6.1661; [No title captured], DOI DOI 10.1136/THX.52.2008.S1]	15	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 28	2001	358	9278					256	257		10.1016/S0140-6736(01)05493-9	http://dx.doi.org/10.1016/S0140-6736(01)05493-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	457AF	11498207				2022-12-28	WOS:000170114400004
J	Dedi, R; Bhandari, S; Turney, JH; Brownjohn, AM; Eardley, I				Dedi, R; Bhandari, S; Turney, JH; Brownjohn, AM; Eardley, I			Lesson of the week - Causes of haematuria in adult polycystic kidney disease	BRITISH MEDICAL JOURNAL			English	Review							HEMATURIA; CYTOLOGY		Gen Infirm, Dept Renal Med, Leeds LS1 3EX, W Yorkshire, England; Gen Infirm, Dept Urol, Leeds LS1 3EX, W Yorkshire, England; Royal Infirm, Hull Hosp NHS Trust, Dept Renal Med, Kingston Upon Hull HU3 2JZ, N Humberside, England; Royal Infirm, E Yorkshire Hosp NHS Trust, Dept Renal Med, Kingston Upon Hull HU3 2JZ, N Humberside, England	Leeds General Infirmary; Leeds General Infirmary	Dedi, R (corresponding author), Gen Infirm, Dept Renal Med, Leeds LS1 3EX, W Yorkshire, England.			bhandari, sunil/0000-0002-0996-9622				Bastacky S, 1999, CANCER CYTOPATHOL, V87, P118, DOI 10.1002/(SICI)1097-0142(19990625)87:3<118::AID-CNCR4>3.0.CO;2-N; BERLAC PA, 1992, J UROLOGY, V147, P1510, DOI 10.1016/S0022-5347(17)37610-3; DELANEY VB, 1985, AM J KIDNEY DIS, V5, P104, DOI 10.1016/S0272-6386(85)80004-4; GABOW PA, 1992, AM J KIDNEY DIS, V20, P140, DOI 10.1016/S0272-6386(12)80541-5; GABOW PA, 1993, NEW ENGL J MED, V329, P332, DOI 10.1056/NEJM199307293290508; Gupta S, 2000, ACTA RADIOL, V41, P280, DOI 10.1034/j.1600-0455.2000.041003280.x; KEITH DS, 1994, J AM SOC NEPHROL, V4, P1661; Khadra MH, 2000, J UROLOGY, V163, P524, DOI 10.1016/S0022-5347(05)67916-5; MALONE PR, 1986, BRIT J UROL, V58, P520, DOI 10.1111/j.1464-410X.1986.tb05458.x; TORRES VE, 1988, AM J KIDNEY DIS, V11, P318, DOI 10.1016/S0272-6386(88)80137-9; ZEIER M, 1988, NEPHRON, V49, P177, DOI 10.1159/000185052	11	8	8	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 18	2001	323	7309					386	387		10.1136/bmj.323.7309.386	http://dx.doi.org/10.1136/bmj.323.7309.386			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465GN	11509433	Green Published			2022-12-28	WOS:000170581400024
J	Geddes, DM				Geddes, DM			Of isolates and isolation: Pseudomonas aeruginosa in adults with cystic fibrosis	LANCET			English	Editorial Material							COLONIZATION		Royal Brompton Natl Heart & Lung Hosp, Dept Cyst Fibrosis, London SW3 6NP, England	Imperial College London	Geddes, DM (corresponding author), Royal Brompton Natl Heart & Lung Hosp, Dept Cyst Fibrosis, Sydney St, London SW3 6NP, England.							Davis PB, 1997, PEDIATR RES, V41, P161, DOI 10.1203/00006450-199702000-00001; HUDSON VL, 1993, J PEDIATR-US, V122, P854, DOI 10.1016/S0022-3476(09)90007-5; Jones AM, 2001, EUR RESPIR J, V17, P295, DOI 10.1183/09031936.01.17202950; KEREM E, 1990, J PEDIATR-US, V116, P714, DOI 10.1016/S0022-3476(05)82653-8; Ojeniyi B, 2000, PEDIATR PULM, V29, P177, DOI 10.1002/(SICI)1099-0496(200003)29:3<177::AID-PPUL4>3.0.CO;2-U; PAMUKCU A, 1995, PEDIATR PULM, V19, P10, DOI 10.1002/ppul.1950190103; SPELLER DE, 1990, PRINCIPLES BACTERIOL, P142; VALERIUS NH, 1991, LANCET, V338, P725, DOI 10.1016/0140-6736(91)91446-2	8	21	21	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 18	2001	358	9281					522	523		10.1016/S0140-6736(01)05742-7	http://dx.doi.org/10.1016/S0140-6736(01)05742-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464NB	11520516				2022-12-28	WOS:000170537700003
J	Stables, RH				Stables, RH			Clopidogrel in invasive management of non-ST-elevation ACS	LANCET			English	Editorial Material							ACUTE CORONARY SYNDROMES; UNSTABLE ANGINA; MYOCARDIAL-INFARCTION; SEGMENT ELEVATION; CLINICAL OUTCOMES; STRATIFICATION; BENEFIT; RISK		Royal Liverpool Univ Hosp, Liverpool L7 8XP, Merseyside, England; Ctr Cardiothorac, Liverpool L7 8XP, Merseyside, England	Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool	Stables, RH (corresponding author), Royal Liverpool Univ Hosp, Liverpool L7 8XP, Merseyside, England.			Stables, Rodney Hilton/0000-0002-9244-7015				*ACC AHA TASK FORC, 2001, J AM COLL CARDIOL, V37, P2001; Bazzino O, 1998, NEW ENGL J MED, V338, P1488; Bertrand ME, 2000, EUR HEART J, V21, P1406, DOI 10.1053/euhj.2000.2301; Braunwald E, 2000, J AM COLL CARDIOL, V36, P970, DOI 10.1016/S0735-1097(00)00889-5; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; Collinson J, 2000, EUR HEART J, V21, P1450, DOI 10.1053/euhj.1999.1995; Hamm CW, 1999, NEW ENGL J MED, V340, P1623, DOI 10.1056/NEJM199905273402103; Heeschen C, 2000, EUR HEART J, V21, P1159, DOI 10.1053/euhj.1999.1986; Heeschen C, 1999, LANCET, V354, P1757, DOI 10.1016/S0140-6736(99)10285-X; Kleiman NS, 2000, CIRCULATION, V101, P751, DOI 10.1161/01.CIR.101.7.751; *NAT I CLIN EXC, 2000, GUID US GLYC IIB III; Steinhubl SR, 2001, CIRCULATION, V103, P1403, DOI 10.1161/01.CIR.103.10.1403; Topol EJ, 1998, LANCET, V352, P87, DOI 10.1016/S0140-6736(98)85010-1; Wallentin L, 2000, LANCET, V356, P9, DOI 10.1016/S0140-6736(00)02427-2; Yusuf S, 2001, NEW ENGL J MED, V345, P494	15	8	8	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 18	2001	358	9281					520	521		10.1016/S0140-6736(01)05741-5	http://dx.doi.org/10.1016/S0140-6736(01)05741-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464NB	11520515				2022-12-28	WOS:000170537700002
J	King, C; Siegel, M				King, C; Siegel, M			The master settlement agreement with the tobacco industry and cigarette advertising in magazines.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EFFECTIVE FREQUENCY; ADVERTISEMENTS; SMOKING; ADS	Background: In 1998, the attorneys general of 46 states signed a Master Settlement Agreement with the four largest tobacco companies in the United States. The agreement prohibits tobacco advertising that targets people younger than 18 years of age. Methods: We analyzed the trends in expenditures for advertising for 15 specific brands of cigarettes and the exposure of young people to cigarette advertising in 38 magazines between 1995 and 2000. We defined cigarette brands as "youth'' brands if they were smoked by more than 5 percent of the smokers in the 8th, 10th, and 12th grades in 1998; all others were considered to be "adult'' brands. We classified magazines as youth-oriented magazines if at least 15 percent of their readers or at least 2 million of their readers were 12 to 17 years old. "Reach,'' a standard measure of exposure to advertising, was defined as the number of young persons who read at least one issue of a magazine containing an advertisement for a particular brand of cigarette during a given year. Results: In 2000 dollars, the overall advertising expenditures for the 15 brands of cigarettes in the 38 magazines were $238.2 million in 1995, $219.3 million in 1998, $291.1 million in 1999, and $216.9 million in 2000. Expenditures for youth brands in youth-oriented magazines were $56.4 million in 1995, $58.5 million in 1998, $67.4 million in 1999, and $59.6 million in 2000. Expenditures for adult brands in youth-oriented magazines were $72.2 million, $82.3 million, $108.6 million, and $67.6 million, respectively. In 2000, magazine advertisements for youth brands of cigarettes reached more than 80 percent of young people in the United States an average of 17 times each. Conclusions: The Master Settlement Agreement with the tobacco industry appears to have had little effect on cigarette advertising in magazines and on the exposure of young people to these advertisements. (N Engl J Med 2001;345:504-11.) Copyright (C) 2001 Massachusetts Medical Society.	Boston Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02118 USA; Harvard Univ, Sch Business, Boston, MA 02163 USA	Boston University; Harvard University	Siegel, M (corresponding author), Boston Univ, Sch Publ Hlth, Dept Social & Behav Sci, 715 Albany St,TW2, Boston, MA 02118 USA.			King, Charles/0000-0001-8665-3376				AGOSTINI JM, 1961, J ADVERTISING RES, V1, P11; AGOSTINI JM, 1962, J ADVERTISING RES, V2, P24; ALBRIGHT CL, 1988, HEALTH EDUC QUART, V15, P225, DOI 10.1177/109019818801500207; ALBRIGHT CL, 1988, HLTH ED Q, V15, P349; ALTMAN DG, 1987, J COMMUN, V37, P95, DOI 10.1111/j.1460-2466.1987.tb01010.x; Basil M, 1991, HEALTH COMMUN, V3, P75; Batra R, 1996, ADVERTISING MANAGEME; Biener L, 2000, AM J PUBLIC HEALTH, V90, P407, DOI 10.2105/AJPH.90.3.407; *DEP HLTH HUM SERV, 1994, PREV TOB US YOUNG PE; *FED TRAD COMM, 2001, CIG REP 1999; FREEMAN H, 1993, TOBACCO USE AM CRISI, P32; GREENE JD, 1970, J ADVERTISING RES, V10, P12; Hastings G, 2000, BRIT MED J, V321, P366, DOI 10.1136/bmj.321.7257.366; HUANG PP, 1992, TOB CONTROL, V1, P249; HUTCHINGS R, 1981, P NAT C SMOK HLTH DE, P249; Johnston L, 1999, CIGARETTE BRAND PREF; JOHNSTON LD, 2000, NIH PUBLICATION; Jones JP, 1997, J ADVERTISING RES, V37, P14; King C, 1998, JAMA-J AM MED ASSOC, V279, P516, DOI 10.1001/jama.279.7.516; King C 3rd, 1999, Nicotine Tob Res, V1, P331, DOI 10.1080/14622299050011461; KING KW, 1991, J PUBLIC POLICY MARK, V10, P63, DOI 10.1177/074391569101000106; KINNEAR TC, 1990, PRINCIPLES MARKETING; Kotler P., 1976, MARKETING MANAGEMENT; Krugman DM, 2000, J PUBLIC POLICY MARK, V19, P183, DOI 10.1509/jppm.19.2.183.17124; KRUGMAN HE, 1972, J ADVERTISING RES, V12, P11; KRUPKA LR, 1990, J DRUG EDUC, V20, P15, DOI 10.2190/6BWW-RG2B-CV80-XYXN; LIEBMAN L, 1974, J ADVERTISING RES, V14, P23; Longman KA, 1997, J ADVERTISING RES, V37, P44; Lynch BS., 1994, GROWING TOBACCO FREE; METHERINGHAM RA, 1964, J ADVERTISING RES, V4, P23; *NAT ASS ATT GEN, 2000, MULT SETT TOB IND; PAPAZIAN E, 2000, MAGAZINE DIMENSIONS; Pierce JP, 1998, JAMA-J AM MED ASSOC, V279, P511; POLLAY RW, 1993, ADV CONSUM RES, V20, P266; Sanchez L, 2000, JAMA-J AM MED ASSOC, V283, P2106, DOI 10.1001/jama.283.16.2106; Sargent JD, 2000, PREV MED, V30, P320, DOI 10.1006/pmed.1999.0629; Warner K.E., 1992, TOB CONTROL, V1, P25; WARNER KE, 1985, HEALTH EDUC QUART, V12, P115, DOI 10.1177/109019818501200111; WARNER KE, 1986, SELLING SMOKE CIGARE; 2000, MMWR MORB MORTAL WKL, V49, P49; 2000, NY TIMES        0606, pC27; 2000, LOS ANGELES TIM 0606, pC3	42	82	82	0	4	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 16	2001	345	7					504	511		10.1056/NEJMsa003149	http://dx.doi.org/10.1056/NEJMsa003149			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	462QM	11519505	Bronze			2022-12-28	WOS:000170431300005
J	Murray, JS; Jayarajasingh, R; Perros, P				Murray, JS; Jayarajasingh, R; Perros, P			Lesson of the week - Deterioration of symptoms after start of thyroid hormone replacement	BRITISH MEDICAL JOURNAL			English	Review							HYPOTHYROIDISM; INSUFFICIENCY; DISEASE		Freeman Rd Hosp, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England; Med Sch Newcastle Upon Tyne, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle Freeman Hospital; Newcastle University - UK; Newcastle University - UK	Perros, P (corresponding author), Freeman Rd Hosp, High Heaton, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England.							BARNETT AH, 1982, POSTGRAD MED J, V58, P690, DOI 10.1136/pgmj.58.685.690; BURKE CW, 1985, CLIN ENDOCRINOL META, V14, P947, DOI 10.1016/S0300-595X(85)80084-0; DAVIS J, 1986, BRIT MED J, V292, P1595, DOI 10.1136/bmj.292.6535.1595; GHARIB H, 1972, LANCET, V2, P734; Oelkers W, 1996, NEW ENGL J MED, V335, P1206, DOI 10.1056/NEJM199610173351607; ORTH DN, 1992, TXB ENDOCRINOLOGY, P489; PARLE JV, 1991, CLIN ENDOCRINOL, V34, P77; TUNBRIDGE WMG, 1977, CLIN ENDOCRINOL, V7, P481, DOI 10.1111/j.1365-2265.1977.tb01340.x; Vanderpump MPJ, 1996, BMJ-BRIT MED J, V313, P539; Weetman AP, 1997, BRIT MED J, V314, P1175, DOI 10.1136/bmj.314.7088.1175	10	26	27	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 11	2001	323	7308					332	333		10.1136/bmj.323.7308.332	http://dx.doi.org/10.1136/bmj.323.7308.332			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463HK	11498494	Green Published			2022-12-28	WOS:000170470900024
J	Jones, PA; Takai, D				Jones, PA; Takai, D			The role of DNA methylation in mammalian epigenetics	SCIENCE			English	Editorial Material							DE-NOVO METHYLATION; CPG ISLAND; METHYLTRANSFERASE GENE; HISTONE DEACETYLASE; DENOVO METHYLATION; CELL-LINES; BINDING; TRANSCRIPTION; CHROMOSOME; COMPLEX	Genes constitute only a small proportion of the total mammalian genome, and the precise control of their expression in the presence of an overwhelming background of noncoding DNA presents a substantial problem for their regulation. Noncoding DNA, containing introns, repetitive elements, and potentially active transposable elements, requires effective mechanisms for its tong-term silencing. Mammals appear to have taken advantage of the possibilities afforded by cytosine methylation to provide a heritable mechanism for altering DNA-protein interactions to assist in such silencing. Genes can be transcribed from methylation-free promoters even though adjacent transcribed and nontranscribed regions are extensively methylated. Gene promoters can be used and regulated white keeping noncoding DNA, including transposable elements, suppressed. Methylation is also used for Long-term epigenetic silencing of X-linked and imprinted genes and can either increase or decrease the level of transcription, depending on whether the methylation inactivates a positive or negative regulatory element.	Univ So Calif, Keck Sch Med, Dept Biochem, USC Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA; Univ So Calif, Keck Sch Med, Dept Mol Biol, USC Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California	Jones, PA (corresponding author), Univ So Calif, Keck Sch Med, Dept Biochem, USC Norris Comprehens Canc Ctr, 1441 Eastlake Ave,MS 8302L, Los Angeles, CA 90089 USA.	jones_p@ccnt.hsc.usc.edu	jia, xu/A-8386-2016		NCI NIH HHS [R01 CA82422] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA082422] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Baylin SB, 1998, ADV CANCER RES, V72, P141; BESTOR T, 1988, J MOL BIOL, V203, P971, DOI 10.1016/0022-2836(88)90122-2; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Carotti D, 1998, BIOCHEMISTRY-US, V37, P1101, DOI 10.1021/bi971031i; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; CHRISTMAN JK, 1995, P NATL ACAD SCI USA, V92, P7347, DOI 10.1073/pnas.92.16.7347; Constancia M, 2000, NAT GENET, V26, P203, DOI 10.1038/79930; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; Delgado S, 1998, EMBO J, V17, P2426, DOI 10.1093/emboj/17.8.2426; Eden S, 2001, EMBO J, V20, P3518, DOI 10.1093/emboj/20.13.3518; Fatemi M, 2001, J MOL BIOL, V309, P1189, DOI 10.1006/jmbi.2001.4709; Fuks F, 2001, EMBO J, V20, P2536, DOI 10.1093/emboj/20.10.2536; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gonzalgo ML, 1998, CANCER RES, V58, P1245; GRIGG G, 1994, BIOESSAYS, V16, P431, DOI 10.1002/bies.950160612; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Han L, 2001, MOL CELL BIOL, V21, P3416, DOI 10.1128/MCB.21.10.3416-3424.2001; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Hendrich B, 2001, GENE DEV, V15, P710, DOI 10.1101/gad.194101; HENDRIKS RW, 1992, GENOMICS, V14, P598, DOI 10.1016/S0888-7543(05)80157-0; ISSA JPJ, 1994, NAT GENET, V7, P536, DOI 10.1038/ng0894-536; JAHNER D, 1985, NATURE, V315, P594, DOI 10.1038/315594a0; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Jones PA, 1999, TRENDS GENET, V15, P34, DOI 10.1016/S0168-9525(98)01636-9; JONES PA, 1990, P NATL ACAD SCI USA, V87, P6117, DOI 10.1073/pnas.87.16.6117; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lin IG, 2000, MOL CELL BIOL, V20, P2343, DOI 10.1128/MCB.20.7.2343-2349.2000; MACLEOD D, 1994, GENE DEV, V8, P2282, DOI 10.1101/gad.8.19.2282; MAGEWU AN, 1994, MOL CELL BIOL, V14, P4225, DOI 10.1128/MCB.14.6.4225; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; O'Neill RJW, 1998, NATURE, V393, P68, DOI 10.1038/29985; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; PRENDERGAST GC, 1991, SCIENCE, V251, P186, DOI 10.1126/science.1987636; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; RIDEOUT WM, 1990, SCIENCE, V249, P1288, DOI 10.1126/science.1697983; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Rountree MR, 1997, GENE DEV, V11, P2383, DOI 10.1101/gad.11.18.2383; TAKAI D, UNPUB; Turker MS, 1999, SEMIN CANCER BIOL, V9, P329, DOI 10.1006/scbi.1999.0133; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Yeivin A, 1993, EXS, V64, P523; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	47	1413	1536	6	281	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2001	293	5532					1068	1070		10.1126/science.1063852	http://dx.doi.org/10.1126/science.1063852			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498573				2022-12-28	WOS:000170432600041
J	Park, Y; Kuroda, MI				Park, Y; Kuroda, MI			Epigenetic aspects of X-chromosome dosage compensation	SCIENCE			English	Editorial Material							INACTIVATION CENTER; ACETYL TRANSFERASE; MALE DROSOPHILA; MSL COMPLEX; HISTONE H3; RNA PAINTS; CHROMATIN; EVOLUTION; SEX; GENES	The X chromosomes of mammals and fruit flies exhibit unusual properties that have evolved to deal with the different dosages of X-linked genes in mates (XY) and females (XX). The X chromosome dosage-compensation mechanisms discovered in these species are evolutionarily unrelated, but exhibit surprising parallels in their regulatory strategies. These features include the importance of noncoding RNAs, and epigenetic spreading of chromatin-modifying activities.	Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Howard Hughes Medical Institute	Park, Y (corresponding author), Baylor Coll Med, Howard Hughes Med Inst, 1 Baylor Plaza, Houston, TX 77030 USA.							Akhtar A, 2000, MOL CELL, V5, P367, DOI 10.1016/S1097-2765(00)80431-1; Amrein H, 1997, CELL, V88, P459, DOI 10.1016/S0092-8674(00)81886-3; Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; Bone JR, 1996, GENETICS, V144, P705; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; BROWN CJ, 1994, NATURE, V368, P154, DOI 10.1038/368154a0; Charlesworth B, 1996, CURR BIOL, V6, P149, DOI 10.1016/S0960-9822(02)00448-7; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Clayton AL, 2000, EMBO J, V19, P3714, DOI 10.1093/emboj/19.14.3714; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Clerc P, 1998, NAT GENET, V19, P249, DOI 10.1038/924; Cline TW, 1996, ANNU REV GENET, V30, P637, DOI 10.1146/annurev.genet.30.1.637; Cooper D.W., 1993, Seminars in Developmental Biology, V4, P117, DOI 10.1006/sedb.1993.1014; Csankovszki G, 2001, J CELL BIOL, V153, P773, DOI 10.1083/jcb.153.4.773; Csankovszki G, 1999, NAT GENET, V22, P323, DOI 10.1038/11887; Debrand E, 1999, MOL CELL BIOL, V19, P8513; Franke A, 1999, MOL CELL, V4, P117, DOI 10.1016/S1097-2765(00)80193-8; Gu WG, 2000, EMBO J, V19, P5202, DOI 10.1093/emboj/19.19.5202; Herzing LBK, 1997, NATURE, V386, P272, DOI 10.1038/386272a0; Hilfiker A, 1997, EMBO J, V16, P2054, DOI 10.1093/emboj/16.8.2054; Jin Y, 2000, J CELL BIOL, V149, P1005, DOI 10.1083/jcb.149.5.1005; Kageyama Y, 2001, EMBO J, V20, P2236, DOI 10.1093/emboj/20.9.2236; Kelley RL, 2000, CURR OPIN GENET DEV, V10, P555, DOI 10.1016/S0959-437X(00)00127-1; Kelley RL, 1999, CELL, V98, P513, DOI 10.1016/S0092-8674(00)81979-0; KRIVSHENKO J, 1959, GENETICS, V44, P1027; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; Larsson J, 2001, P NATL ACAD SCI USA, V98, P6273, DOI 10.1073/pnas.111581298; Lee JT, 2000, CELL, V103, P17, DOI 10.1016/S0092-8674(00)00101-X; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Lee JT, 1997, NATURE, V386, P275, DOI 10.1038/386275a0; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; MARIN I, 1996, NATURE, V383; Meller VH, 1997, CELL, V88, P445, DOI 10.1016/S0092-8674(00)81885-1; Meller VH, 2000, CURR BIOL, V10, P136, DOI 10.1016/S0960-9822(00)00311-0; Meyer BJ, 2000, TRENDS GENET, V16, P247, DOI 10.1016/S0168-9525(00)02004-7; Morey C, 2001, HUM MOL GENET, V10, P1403, DOI 10.1093/hmg/10.13.1403; Pannuti A, 2000, CURR OPIN GENET DEV, V10, P644, DOI 10.1016/S0959-437X(00)00136-2; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; RASMUSSEN TP, 2001, CHROMOSOMA      0720; Rice WR, 1996, BIOSCIENCE, V46, P331, DOI 10.2307/1312947; Sado T, 2001, DEVELOPMENT, V128, P1275; Smith ER, 2000, MOL CELL BIOL, V20, P312, DOI 10.1128/MCB.20.1.312-318.2000; Solter D, 1997, GENE DEV, V11, P153, DOI 10.1101/gad.11.2.153; TURNER BM, 1992, CELL, V69, P375, DOI 10.1016/0092-8674(92)90417-B; Wakefield MJ, 1997, P NATL ACAD SCI USA, V94, P9665, DOI 10.1073/pnas.94.18.9665; Wang YM, 2001, CELL, V105, P433, DOI 10.1016/S0092-8674(01)00325-7; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8	47	83	88	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2001	293	5532					1083	1085		10.1126/science.1063073	http://dx.doi.org/10.1126/science.1063073			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498577				2022-12-28	WOS:000170432600045
J	Harries, AD; Nyangulu, DS; Hargreaves, NJ; Kaluwa, O; Salaniponi, FM				Harries, AD; Nyangulu, DS; Hargreaves, NJ; Kaluwa, O; Salaniponi, FM			Preventing antiretroviral anarchy in sub-Saharan Africa	LANCET			English	Editorial Material							TUBERCULOSIS; AIDS	Combination antiretroviral therapy has dramatically improved the survival of patients living with HIV and AIDS In Industrialised countries of the world. Despite this enormous benefit, there are some major problems and obstacles to be overcome.(1) Treatment of HIV-infection is likely to be lifelong.(2) Unfortunately, many HIV-Infected individuals cannot tolerate the toxic effects of the drugs, or have difficulty complying with treatment which involves large numbers of pills and complicated dosing schedules. Poor adherence to treatment leads to the emergence of drug-resistant viral strains that need new combinations of drugs or new drugs altogether.	Natl TB Control Programme, Community Hlth Sci Unit, Lilongwe, Malawi; Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England; Natl AIDS Control Programme, Lilongwe, Malawi	Liverpool School of Tropical Medicine	Harries, AD (corresponding author), British High Commiss, POB 30042, Lilongwe 3, Malawi.	adharries@malawi.net	Franzeck, Fabian C/B-5055-2011					Attaran A, 2001, LANCET, V357, P57, DOI 10.1016/S0140-6736(00)03576-5; Bosman MCJ, 2000, INT J TUBERC LUNG D, V4, P606; Carr A, 2000, LANCET, V356, P1423, DOI 10.1016/S0140-6736(00)02854-3; Fauci AS, 1999, NEW ENGL J MED, V341, P1046, DOI 10.1056/NEJM199909303411406; HARRIES AD, 1996, WHOTB96200; Harrington M, 2000, LANCET, V355, P2147, DOI 10.1016/S0140-6736(00)02388-6; Horton R, 2000, LANCET, V356, P1541, DOI 10.1016/S0140-6736(00)03122-6; Kumar S, 2001, LANCET, V357, P616, DOI 10.1016/S0140-6736(05)71411-2; MAHER D, 1997, WHOTB97220; Mukadi YD, 2001, AIDS, V15, P143, DOI 10.1097/00002030-200101260-00002; Pozniak AL, 1999, AIDS, V13, P435, DOI 10.1097/00002030-199903110-00001; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Raviglione MC, 1997, LANCET, V350, P624, DOI 10.1016/S0140-6736(97)04146-9; *UNAIDS, 2000, AIDS EP UPD; Volmink J, 2000, LANCET, V355, P1345, DOI 10.1016/S0140-6736(00)02124-3; *WHO, 2000, GLOB TUB CONTR WHO R; *WHO, 2001, WHOHIS200004; Wood E, 2000, LANCET, V355, P2095, DOI 10.1016/S0140-6736(00)02375-8; World Health Organization, 1994, WHOTB94179	19	180	186	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 4	2001	358	9279					410	414		10.1016/S0140-6736(01)05551-9	http://dx.doi.org/10.1016/S0140-6736(01)05551-9			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459DE	11502341				2022-12-28	WOS:000170235100036
J	Furlong, EEM; Andersen, EC; Null, B; White, KP; Scott, MP				Furlong, EEM; Andersen, EC; Null, B; White, KP; Scott, MP			Patterns of gene expression during Drosophila mesoderm Development	SCIENCE			English	Article							DORSAL VENTRAL POLARITY; TWIST GENE; MYOBLAST FUSION; PROTEIN; INDUCTION; EMBRYO; PATHWAY; COMPLEX; CELLS; TOLL	The transcription factor Twist initiates Drosophila mesoderm development, resulting in the formation of heart, somatic muscle, and other cell types. Using a Drosophila embryo sorter, we isolated enough homozygous twist mutant embryos to perform DNA microarray experiments. Transcription profiles of twist loss-of-function embryos, embryos with ubiquitous twist expression, and wild-type embryos were compared at different developmental stages. The results implicate hundreds of genes, many with vertebrate homologs, in stage-specific processes in mesoderm development. One such gene, gleeful, related to the vertebrate Gli genes, is essential for somatic muscle development and sufficient to cause neural cells to express a muscle marker.	Stanford Univ, Sch Med, Howard Hughes Med Inst,Beckman Ctr B300, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst,Beckman Ctr B300, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Scott, MP (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst,Beckman Ctr B300, Dept Dev Biol, 279 Campus Dr, Stanford, CA 94305 USA.			Andersen, Erik/0000-0003-0229-9651; Furlong, Eileen/0000-0002-9544-8339	Howard Hughes Medical Institute Funding Source: Medline; NHGRI NIH HHS [K22 HG00045-02] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K22HG000045] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ARMAND P, 1994, MOL CELL BIOL, V14, P4145, DOI 10.1128/MCB.14.6.4145; BATE M, 1993, DEV DROSOPHILA METAN, V2, P1013; Baylies MK, 1996, SCIENCE, V272, P1481, DOI 10.1126/science.272.5267.1481; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Borkowski OMD, 1995, DEVELOPMENT, V121, P4183; Campos-Ortega J.A., 1997, EMBRYONIC DEV DROSOP, V2nd, P9; Cann GM, 1999, ANAT EMBRYOL, V200, P239, DOI 10.1007/s004290050276; Casal J, 1996, P NATL ACAD SCI USA, V93, P10327, DOI 10.1073/pnas.93.19.10327; Casso David, 2000, Mechanisms of Development, V91, P451, DOI 10.1016/S0925-4773(00)00248-3; Chuang PT, 2000, CURR OPIN GENET DEV, V10, P515, DOI 10.1016/S0959-437X(00)00121-0; Doberstein SK, 1997, J CELL BIOL, V136, P1249, DOI 10.1083/jcb.136.6.1249; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FRASCH M, 1995, NATURE, V374, P464, DOI 10.1038/374464a0; Furlong EEM, 2001, NAT BIOTECHNOL, V19, P153, DOI 10.1038/84422; Gross I, 1996, NUCLEIC ACIDS RES, V24, P1238, DOI 10.1093/nar/24.7.1238; HOPWOOD ND, 1989, CELL, V59, P893, DOI 10.1016/0092-8674(89)90612-0; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; LAKEY A, 1993, EMBO J, V12, P2863, DOI 10.1002/j.1460-2075.1993.tb05948.x; LEPTIN M, 1991, GENE DEV, V5, P1568, DOI 10.1101/gad.5.9.1568; LEPTIN M, 1990, DEVELOPMENT, V110, P73; LEVINE M, 1988, CELL, V52, P785, DOI 10.1016/0092-8674(88)90418-7; Lewis KE, 1999, DEV BIOL, V216, P469, DOI 10.1006/dbio.1999.9519; REUTER R, 1993, DEVELOPMENT, V119, P1135; SCHNEIDER DS, 1991, GENE DEV, V5, P797, DOI 10.1101/gad.5.5.797; Spring J, 2000, DEV BIOL, V228, P363, DOI 10.1006/dbio.2000.9956; STAEHLINGHAMPTON K, 1994, NATURE, V372, P783; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Taylor MV, 2000, CURR BIOL, V10, pR646, DOI 10.1016/S0960-9822(00)00664-3; TAYLOR MV, 1995, MECH DEVELOP, V50, P29, DOI 10.1016/0925-4773(94)00323-F; THISSE B, 1987, NUCLEIC ACIDS RES, V15, P3439, DOI 10.1093/nar/15.8.3439; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vincent S, 1998, MOL CELL, V2, P515, DOI 10.1016/S1097-2765(00)80151-3; Wang SM, 1997, GENE, V187, P83, DOI 10.1016/S0378-1119(96)00727-5; WOLF C, 1991, DEV BIOL, V143, P363, DOI 10.1016/0012-1606(91)90086-I; Yin ZZ, 1997, DEVELOPMENT, V124, P4971	35	207	210	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2001	293	5535					1629	1633		10.1126/science.1062660	http://dx.doi.org/10.1126/science.1062660			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469FA	11486054				2022-12-28	WOS:000170802900054
J	Deitsch, KW; Calderwood, MS; Wellems, TE				Deitsch, KW; Calderwood, MS; Wellems, TE			Malaria - Cooperative silencing elements in var genes	NATURE			English	Article							PLASMODIUM-FALCIPARUM; ANTIGENIC VARIATION; ERYTHROCYTES; TRANSCRIPTION; EXPRESSION; SWITCHES		NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Deitsch, KW (corresponding author), NIAID, Parasit Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000483, ZIAAI000483] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Chen QJ, 1998, NATURE, V394, P392, DOI 10.1038/28660; Deitsch KW, 1999, MOL BIOCHEM PARASIT, V101, P107, DOI 10.1016/S0166-6851(99)00062-6; Deitsch KW, 2001, NUCLEIC ACIDS RES, V29, P850, DOI 10.1093/nar/29.3.850; Firestein R, 2000, MOL CELL BIOL, V20, P4900, DOI 10.1128/MCB.20.13.4900-4909.2000; Newbold CI, 1999, CURR OPIN MICROBIOL, V2, P420, DOI 10.1016/S1369-5274(99)80074-5; Scherf A, 1998, EMBO J, V17, P5418, DOI 10.1093/emboj/17.18.5418; Scherf A, 2001, CELL MICROBIOL, V3, P125, DOI 10.1046/j.1462-5822.2001.00109.x; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1	10	172	174	0	11	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2001	412	6850					875	876		10.1038/35091146	http://dx.doi.org/10.1038/35091146			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467EG	11528468				2022-12-28	WOS:000170689000034
J	Mollereau, B; Dominguez, M; Webel, R; Colley, NJ; Keung, B; de Celis, JF; Desplan, C				Mollereau, B; Dominguez, M; Webel, R; Colley, NJ; Keung, B; de Celis, JF; Desplan, C			Two-step process for photoreceptor formation in Drosophila	NATURE			English	Article							CELL-FATE; RHODOPSIN; EYE; R7; EXPRESSION; PROTEIN; GENE; IDENTIFICATION; RECEPTOR; COMPLEX	The formation of photoreceptor cells (PRCs) in Drosophila serves as a paradigm for understanding neuronal determination and differentiation. During larval stages, a precise series of sequential inductive processes leads to the recruitment of eight distinct PRCs (R1-R8)(1). But, final photoreceptor differentiation, including rhabdomere morphogenesis and opsin expression, is completed four days later, during pupal development(2,3). It is thought that photoreceptor cell fate is irreversibly established during larval development, when each photoreceptor expresses a particular set of transcriptional regulators and sends its projection to different layers of the optic lobes. Here, we show that the spalt (sal) gene complex(4-7) encodes two transcription factors that are required late in pupation for photoreceptor differentiation. In the absence of the sal complex, rhabdomere morphology and expression of opsin genes in the inner PRCs R7 and R8 are changed to become identical to those of outer R1-R6 PRCs. However, these cells maintain their normal projections to the medulla part of the optic lobe, and not to the lamina where outer PRCs project. These data indicate that photoreceptor differentiation occurs as a two-step process. First, during larval development, the photoreceptor neurons become committed and send their axonal projections to their targets in the brain. Second, terminal differentiation is executed during pupal development and the photoreceptors adopt their final cellular properties.	NYU, Dept Biol, New York, NY 10003 USA; UMH, CSIC, Inst Neurociencias, San Juan Alicante 03550, Spain; Univ Wisconsin, Dept Ophthalmol, Madison, WI 53792 USA; Univ Wisconsin, Dept Visual Sci & Genet, Madison, WI 53792 USA; Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain	New York University; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	de Celis, JF (corresponding author), NYU, Dept Biol, New York, NY 10003 USA.		Dominguez, Maria/G-2171-2014; Mollereau, Bertrand/S-4447-2017; de+Celis, Jose/AAE-8142-2019	Dominguez, Maria/0000-0002-3329-7862; Mollereau, Bertrand/0000-0003-4710-8185; de Celis, Jose F./0000-0003-4808-9844; Desplan, Claude/0000-0002-6914-1413	NEI NIH HHS [R01 EY008768] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY008768] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Barrio R, 1999, DEV BIOL, V215, P33, DOI 10.1006/dbio.1999.9434; BEGEMANN G, 1995, DEVELOPMENT, V121, P225; Cadavid ALM, 2000, DEVELOPMENT, V127, P1727; CAGAN RL, 1989, DEV BIOL, V136, P346, DOI 10.1016/0012-1606(89)90261-3; Chang HY, 2000, SCIENCE, V290, P1978, DOI 10.1126/science.290.5498.1978; Chou WH, 1996, NEURON, V17, P1101, DOI 10.1016/S0896-6273(00)80243-3; Chou WH, 1999, DEVELOPMENT, V126, P607; COLLEY NJ, 1991, CELL, V67, P255, DOI 10.1016/0092-8674(91)90177-Z; COLLEY NJ, 1995, P NATL ACAD SCI USA, V92, P3070, DOI 10.1073/pnas.92.7.3070; deCelis JF, 1996, NATURE, V381, P421, DOI 10.1038/381421a0; Dominguez M, 1998, CURR BIOL, V8, P1039, DOI 10.1016/S0960-9822(98)70441-5; Elstob PR, 2001, DEVELOPMENT, V128, P723; FORTINI ME, 1991, CELL TISSUE RES, V265, P185, DOI 10.1007/BF00318153; Freeman M, 1997, DEVELOPMENT, V124, P261; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Hardie R.C., 1985, Progress in Sensory Physiology, V5, P1; Kauffmann RC, 1996, GENE DEV, V10, P2167, DOI 10.1101/gad.10.17.2167; KIMMEL BE, 1990, GENE DEV, V4, P712, DOI 10.1101/gad.4.5.712; KUHNLEIN RP, 1994, EMBO J, V13, P168, DOI 10.1002/j.1460-2075.1994.tb06246.x; Kumar JP, 1997, DEV BIOL, V188, P43, DOI 10.1006/dbio.1997.8636; Kumar JP, 1995, DEVELOPMENT, V121, P4359; Mollereau B, 2000, MECH DEVELOP, V93, P151, DOI 10.1016/S0925-4773(00)00287-2; Papatsenko D, 1997, DEVELOPMENT, V124, P1665; PERRY MM, 1968, J MORPHOL, V124, P227, DOI 10.1002/jmor.1051240208; PORTER JA, 1993, J CELL BIOL, V122, P601, DOI 10.1083/jcb.122.3.601; Rusten TE, 2001, DEVELOPMENT, V128, P711; Sheng GJ, 1997, GENE DEV, V11, P1122, DOI 10.1101/gad.11.9.1122; Stowers RS, 1999, GENETICS, V152, P1631; TOMLINSON A, 1987, DEV BIOL, V123, P264, DOI 10.1016/0012-1606(87)90448-9; VENKATESH TR, 1985, TRENDS NEUROSCI, V8, P251, DOI 10.1016/0166-2236(85)90098-0	30	101	101	0	8	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2001	412	6850					911	913		10.1038/35091076	http://dx.doi.org/10.1038/35091076			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467EG	11528479				2022-12-28	WOS:000170689000045
J	Chiosis, G; Boneca, IG				Chiosis, G; Boneca, IG			Selective cleavage of D-Ala-D-Lac by small molecules: Re-sensitizing resistant bacteria to vancomycin	SCIENCE			English	Article							BIOSYNTHESIS; MECHANISM; PLASMID	Pathogenic enterococci are becoming resistant to currently available antibiotics, including vancomycin, the drug of last resort for Gram-positive infections. Enterococci pose a significant public health threat, not least because of the risk of transferring vancomycin resistance to the ubiquitous Staphylococcus aureus. Vancomycin resistance is manifested by cell wall peptidoglycan precursors with altered termini that cannot bind the antibiotic. Small molecules with well-oriented nucleophile-electrophile assembly and complementary chirality to the peptidoglycan termini were identified as catalytic and selective cleavers of the peptidoglycan precursor depsipeptide. These molecules were tested in combination with vancomycin and were found to re-sensitize vancomycin-resistant bacteria to the antibiotic.	Columbia Univ, Dept Chem, New York, NY 10027 USA; Rockefeller Univ, Microbiol Lab, New York, NY 10021 USA	Columbia University; Rockefeller University	Chiosis, G (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.	chiosisg@mskmail.mskcc.org; bonecai@pasteur.fr	Boneca, Ivo G/H-1677-2014	Boneca, Ivo G/0000-0001-8122-509X				Abraham EP, 1940, NATURE, V146, P837, DOI 10.1038/146837a0; Arthur M, 1996, MOL MICROBIOL, V21, P33, DOI 10.1046/j.1365-2958.1996.00617.x; BUGG TDH, 1991, BIOCHEMISTRY-US, V30, P10408, DOI 10.1021/bi00107a007; deJonge BLM, 1996, MICROB DRUG RESIST, V2, P225, DOI 10.1089/mdr.1996.2.225; French GL, 1998, CLIN INFECT DIS, V27, pS75, DOI 10.1086/514910; Ge M, 1999, SCIENCE, V284, P507, DOI 10.1126/science.284.5413.507; HANDWERGER S, 1990, ANTIMICROB AGENTS CH, V34, P358, DOI 10.1128/AAC.34.2.358; JACOB AE, 1974, J BACTERIOL, V117, P360, DOI 10.1128/JB.117.2.360-372.1974; NESTLER HP, 1994, J ORG CHEM, V59, P4723, DOI 10.1021/jo00096a008; OHLMEYER MHJ, 1993, P NATL ACAD SCI USA, V90, P10922, DOI 10.1073/pnas.90.23.10922; Perl Trish M., 1999, American Journal of Medicine, V106, p26S, DOI 10.1016/S0002-9343(98)00354-4; REYNOLDS PE, 1989, EUR J CLIN MICROBIOL, V8, P943, DOI 10.1007/BF01967563; Sundram UN, 1996, J AM CHEM SOC, V118, P13107, DOI 10.1021/ja9621298; Tenover FC, 2001, EMERG INFECT DIS, V7, P327, DOI 10.3201/eid0702.010237; WALSH CT, 1993, SCIENCE, V261, P308, DOI 10.1126/science.8392747; Woodford N, 1998, J MED MICROBIOL, V47, P849, DOI 10.1099/00222615-47-10-849; WRIGHT GD, 1992, ACCOUNTS CHEM RES, V25, P468, DOI 10.1021/ar00022a006; Xu R, 1999, J AM CHEM SOC, V121, P4898, DOI 10.1021/ja990240i	18	52	54	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2001	293	5534					1484	1487		10.1126/science.1060324	http://dx.doi.org/10.1126/science.1060324			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465XV	11520986				2022-12-28	WOS:000170616000043
J	Dhanasekaran, SM; Barrette, TR; Ghosh, D; Shah, R; Varambally, S; Kurachi, K; Pienta, KJ; Rubin, MA; Chinnaiyan, AM				Dhanasekaran, SM; Barrette, TR; Ghosh, D; Shah, R; Varambally, S; Kurachi, K; Pienta, KJ; Rubin, MA; Chinnaiyan, AM			Delineation of prognostic biomarkers in prostate cancer	NATURE			English	Article							MOLECULAR CLASSIFICATION; EXPRESSION; PROGRESSION; GENETICS	Prostate cancer is the most frequently diagnosed cancer in American men(1,2). Screening for prostate-specific antigen (PSA) has led to earlier detection of prostate cancer(3), but elevated serum PSA levels may be present in non-malignant conditions such as benign prostatic hyperlasia (BPH). Characterization of gene-expression profiles that molecularly distinguish prostatic neoplasms may identify genes involved in prostate carcinogenesis, elucidate clinical biomarkers, and lead to an improved classification of prostate cancer(4-6). Using microarrays of complementary DNA, we examined gene-expression profiles of more than 50 normal and neoplastic prostate specimens and three common prostate-cancer cell lines. Signature expression profiles of normal adjacent prostate (NAP), BPH, localized prostate cancer, and metastatic, hormone-refractory prostate cancer were determined. Here we establish many associations between genes and prostate cancer. We assessed two of these genes-hepsin, a transmembrane serine protease, and pim-1, a serine/threonine kinase-at the protein level using tissue microarrays consisting of over 700 clinically stratified prostate-cancer specimens. Expression of hepsin and pim-1 proteins was significantly correlated with measures of clinical outcome. Thus, the integration of cDNA microarray, high-density tissue microarray, and linked clinical and pathology data is a powerful approach to molecular profiling of human cancer.	Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Biostat, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Chinnaiyan, AM (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	arul@umich.edu	; Pienta, Kenneth/E-7679-2015	Dhanasekaran, saravana mohan/0000-0002-0489-2224; Pienta, Kenneth/0000-0002-4138-2186; Varambally, Sooryanarayana/0000-0002-2277-1127; Rubin, Mark/0000-0002-8321-9950; Ghosh, Debashis/0000-0001-6618-1316				Abate-Shen C, 2000, GENE DEV, V14, P2410, DOI 10.1101/gad.819500; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Barry MJ, 2001, NEW ENGL J MED, V344, P1373, DOI 10.1056/NEJM200105033441806; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; BUTTYAN R, 1987, PROSTATE, V11, P327, DOI 10.1002/pros.2990110405; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Elek J, 2000, IN VIVO, V14, P173; Emmert-Buck MR, 2000, AM J PATHOL, V156, P1109, DOI 10.1016/S0002-9440(10)64979-6; GLEASON DF, 1992, HUM PATHOL, V23, P273, DOI 10.1016/0046-8177(92)90108-F; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Liotta L, 2000, NAT REV GENET, V1, P48, DOI 10.1038/35049567; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Perrone EE, 2000, JNCI-J NATL CANCER I, V92, P937, DOI 10.1093/jnci/92.11.937; Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591; Rubin MA, 2000, CLIN CANCER RES, V6, P1038; Ruijter E, 1999, ENDOCR REV, V20, P22, DOI 10.1210/er.20.1.22; Shurbaji MS, 1996, HUM PATHOL, V27, P917, DOI 10.1016/S0046-8177(96)90218-X; Tomita K, 2000, CANCER RES, V60, P3650; TSUJI A, 1991, J BIOL CHEM, V266, P16948	20	1328	1471	2	154	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 23	2001	412	6849					822	826		10.1038/35090585	http://dx.doi.org/10.1038/35090585			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465ET	11518967	Green Published			2022-12-28	WOS:000170577200038
J	Kalidas, MT; Kantarjian, H; Talpaz, M				Kalidas, MT; Kantarjian, H; Talpaz, M			Chronic myelogenous leukemia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CHRONIC MYELOID-LEUKEMIA; BONE-MARROW-TRANSPLANTATION; ABL TYROSINE KINASE; CHRONIC GRANULOCYTIC-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; CHRONIC MYELOCYTIC-LEUKEMIA; INTERFERON-ALPHA; HYDROXYUREA THERAPY; CHRONIC PHASE; CHROMOSOME		Univ Texas, MD Anderson Canc Ctr, Dept Bioimmunotherapy, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Talpaz, M (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Bioimmunotherapy, 1515 Holcombe Blvd,Box 422, Houston, TX 77030 USA.	mtalpaz@mail.mdanderson.org		Talpaz, Moshe/0000-0003-3361-3981				ALLAN NC, 1995, LANCET, V345, P1392, DOI 10.1016/S0140-6736(95)92596-1; ARTHUR CK, 1988, BLOOD, V71, P1179; CLIFT RA, 1993, BLOOD, V82, P1954; CLIFT RA, 1982, LANCET, V2, P621; Collins RH, 1997, J CLIN ONCOL, V15, P433, DOI 10.1200/JCO.1997.15.2.433; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Druker BJ, 2000, J CLIN INVEST, V105, P3, DOI 10.1172/JCI9083; FEFER A, 1979, NEW ENGL J MED, V300, P333, DOI 10.1056/NEJM197902153000702; FIALKOW PJ, 1977, AM J MED, V63, P125, DOI 10.1016/0002-9343(77)90124-3; GILES FJ, 2000, AM SOC CLIN ONC PROG, V19, pA46; GRATWOHL A, 1993, BONE MARROW TRANSPL, V12, P509; Guilhot F, 1997, NEW ENGL J MED, V337, P223, DOI 10.1056/NEJM199707243370402; HAUT A, 1961, BLOOD, V17, P1; HEHLMANN R, 1993, BLOOD, V82, P398, DOI 10.1182/blood.V82.2.398.bloodjournal822398; HEHLMANN R, 1994, BLOOD, V84, P4064, DOI 10.1182/blood.V84.12.4064.bloodjournal84124064; Horowitz MM, 1996, BONE MARROW TRANSPL, V17, pS5; HUGHES TP, 1991, BLOOD, V77, P874; Kantarjian H, 2000, BLOOD, V96, p470A; Kantarjian HM, 2000, CANCER-AM CANCER SOC, V89, P1647, DOI 10.1002/1097-0142(20001015)89:8<1647::AID-CNCR1>3.0.CO;2-U; KANTARJIAN HM, 1995, ANN INTERN MED, V122, P254, DOI 10.7326/0003-4819-122-4-199502150-00003; Kantarjian HM, 1998, HEMATOL ONCOL CLIN N, V12, P31, DOI 10.1016/S0889-8588(05)70496-2; Kantarjian HM, 1997, LEUKEMIA, V11, P1617, DOI 10.1038/sj.leu.2400796; KENNEDY BJ, 1992, SEMIN ONCOL, V19, P21; KENNEDY BJ, 1972, CANCER-AM CANCER SOC, V29, P1052, DOI 10.1002/1097-0142(197204)29:4<1052::AID-CNCR2820290454>3.0.CO;2-7; KLOKE O, 1993, BRIT J HAEMATOL, V83, P399, DOI 10.1111/j.1365-2141.1993.tb04663.x; KURZROCK R, 1988, NEW ENGL J MED, V319, P990; Louwagie A, 1996, BONE MARROW TRANSPL, V17, pS19; Mahon FX, 1998, BLOOD, V92, P4059, DOI 10.1182/blood.V92.11.4059.423k34_4059_4065; Minot GR., 1924, JAMA-J AM MED ASSOC, V82, P1489, DOI [10.1001/jama.1924.02650450001001, DOI 10.1001/JAMA.1924.02650450001001]; Molldrem JJ, 2000, NAT MED, V6, P1018, DOI 10.1038/79526; *MRC WORK PART THE, 1968, BMJ-BRIT MED J, V1, P201; Mughal TI, 2000, BLOOD, V96, p141A; NOWELL PC, 1960, SCIENCE, V132, P1497; OBRIEN S, 1995, BLOOD, V86, P3322, DOI 10.1182/blood.V86.9.3322.bloodjournal8693322; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; SAVAGE DG, 1994, INT J HEMATOL, V60, P1; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Silver RT, 1999, BLOOD, V94, P1517; SOKAL JE, 1984, BLOOD, V63, P789, DOI 10.1182/blood.V63.4.789.789; SPECCHIA G, 1995, LEUKEMIA LYMPHOMA, V18, P37, DOI 10.3109/10428199509075301; TALPAZ M, 1991, ANN INTERN MED, V114, P532, DOI 10.7326/0003-4819-114-7-532; TALPAZ M, 1983, BLOOD, V62, P689; Talpaz M, 2000, BLOOD, V96, p469A; Tura S, 1998, BLOOD, V92, p317A; TURA S, 1994, NEW ENGL J MED, V330, P820	48	48	54	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2001	286	8					895	898		10.1001/jama.286.8.895	http://dx.doi.org/10.1001/jama.286.8.895			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465EU	11509034				2022-12-28	WOS:000170577300001
J	Peretz, D; Williamson, RA; Kaneko, K; Vergara, J; Leclerc, E; Schmitt-Ulms, G; Mehlhorn, IR; Legname, G; Wormald, MR; Rudd, PM; Dwek, RA; Burton, DR; Prusiner, SB				Peretz, D; Williamson, RA; Kaneko, K; Vergara, J; Leclerc, E; Schmitt-Ulms, G; Mehlhorn, IR; Legname, G; Wormald, MR; Rudd, PM; Dwek, RA; Burton, DR; Prusiner, SB			Antibodies inhibit prion propagation and clear cell cultures of prion infectivity	NATURE			English	Article							DOMINANT-NEGATIVE INHIBITION; MONOCLONAL-ANTIBODIES; HAMSTER PRP; PROTEIN PRP; SCRAPIE; CONVERSION; REPLICATION; PATHOLOGY; MODEL	Prions are the transmissible pathogenic agents responsible for diseases such as scrapie and bovine spongiform encephalopathy. In the favoured model of prion replication, direct interaction between the pathogenic prion protein (PrPSc) template and endogenous cellular prion protein (PrPC) is proposed to drive the formation of nascent infectious prions(1,2). Reagents specifically binding either prion-protein conformer may interrupt prion production by inhibiting this interaction. We examined the ability of several recombinant antibody antigen-binding fragments (Fabs) to inhibit prion propagation in cultured mouse neuroblastoma cells (ScN2a) infected with PrPSc. Here we show that antibodies binding cell-surface PrPC inhibit PrPSc formation in a dose-dependent manner. In cells treated with the most potent antibody, Fab D18, prion replication is abolished and pre-existing PrPSc is rapidly cleared, suggesting that this antibody may cure established infection. The potent activity of Fab D18 is associated with its ability to better recognize the total population of PrPC molecules on the cell surface, and with the location of its epitope on PrPC. Our observations support the use of antibodies in the prevention and treatment of prion diseases and identify a region of PrPC for drug targeting.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Oxford, Dept Biochem, Glycobiol Inst, Oxford OX1 3QU, England	Scripps Research Institute; Scripps Research Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Oxford	Williamson, RA (corresponding author), Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA.	anthony@scripps.edu; burton@scripps.edu	Wormald, Mark R/G-2785-2011; Legname, Giuseppe/C-1723-2012	Wormald, Mark R/0000-0002-4853-2773; Legname, Giuseppe/0000-0003-0716-4393				Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; BORCHELT DR, 1990, J CELL BIOL, V110, P743, DOI 10.1083/jcb.110.3.743; BUTLER DA, 1988, J VIROL, V62, P1558, DOI 10.1128/JVI.62.5.1558-1564.1988; CAUGHEY B, 1993, J VIROL, V67, P643, DOI 10.1128/JVI.67.2.643-650.1993; Caughey WS, 1998, P NATL ACAD SCI USA, V95, P12117, DOI 10.1073/pnas.95.21.12117; Chabry J, 1999, J VIROL, V73, P6245, DOI 10.1128/JVI.73.8.6245-6250.1999; CHUONG CM, 1982, P NATL ACAD SCI-BIOL, V79, P4234, DOI 10.1073/pnas.79.13.4234; Idusogie EE, 2000, J IMMUNOL, V164, P4178, DOI 10.4049/jimmunol.164.8.4178; James TL, 1997, P NATL ACAD SCI USA, V94, P10086, DOI 10.1073/pnas.94.19.10086; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; KOCISKO DA, 1995, P NATL ACAD SCI USA, V92, P3923, DOI 10.1073/pnas.92.9.3923; Leclerc E, 2001, EMBO J, V20, P1547, DOI 10.1093/emboj/20.7.1547; Peretz D, 1997, J MOL BIOL, V273, P614, DOI 10.1006/jmbi.1997.1328; Perrier V, 2000, P NATL ACAD SCI USA, V97, P6073, DOI 10.1073/pnas.97.11.6073; Petrescu AJ, 1999, GLYCOBIOLOGY, V9, P343, DOI 10.1093/glycob/9.4.343; PRIOLA SA, 1995, J VIROL, V69, P7754, DOI 10.1128/JVI.69.12.7754-7758.1995; Priola SA, 2001, J VIROL, V75, P4673, DOI 10.1128/JVI.75.10.4673-4680.2001; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; RACE RE, 1987, J GEN VIROL, V68, P1391, DOI 10.1099/0022-1317-68-5-1391; Rudd PM, 2001, BIOCHEMISTRY-US, V40, P3759, DOI 10.1021/bi002625f; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; SCOTT M, 1993, CELL, V73, P979, DOI 10.1016/0092-8674(93)90275-U; Supattapone S, 1999, P NATL ACAD SCI USA, V96, P14529, DOI 10.1073/pnas.96.25.14529; Supattapone S, 1999, CELL, V96, P869, DOI 10.1016/S0092-8674(00)80596-6; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Williamson RA, 1996, P NATL ACAD SCI USA, V93, P7279, DOI 10.1073/pnas.93.14.7279; Williamson RA, 1998, J VIROL, V72, P9413, DOI 10.1128/JVI.72.11.9413-9418.1998; Xu DL, 2000, CELL IMMUNOL, V200, P16, DOI 10.1006/cimm.2000.1617; Zulianello L, 2000, J VIROL, V74, P4351, DOI 10.1128/JVI.74.9.4351-4360.2000	29	431	467	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2001	412	6848					739	743		10.1038/35089090	http://dx.doi.org/10.1038/35089090			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462ZB	11507642				2022-12-28	WOS:000170450200046
J	Yusuf, S; Fox, KAA; Tognoni, G; Mehta, SR; Chrolavicius, S; Anand, S; Avezum, A; Awan, N; Bertrand, M; Budaj, A; Ceremuzynski, L; Col, J; Commerford, PJ; Diaz, R; Flather, M; Franzosi, MG; Gersh, B; Grossman, W; Halon, DA; Hunt, D; Joyner, C; Karatzas, N; Keltai, M; Kopecky, S; Lewis, BS; Maggioni, A; Malmberg, K; Moccetti, T; Morais, J; Natarajan, M; Paolasso, E; Peters, R; Piegas, L; Pipilis, A; Pogue, J; Ramos-Corrales, M; Rupprecht, HJ; Sitkei, E; Valentin, V; Varigos, J; Widimsky, P; Wittlinger, T; Blumenthal, M; Bouthier, J; Gaudin, C; Hess, T; Khurmi, N; Sotty, M; Copland, I; Cracknell, B; Demers, C; Eikelboom, J; Morris, B; Pasquale, J; Yacyshyn, V; Zhao, F; Wyse, G; Cairns, J; Hart, R; Hirsh, J; Gent, M; Ryan, T; Wittes, J; Guerrero, RA; Arias, V; Bello, FH; Bono, JO; Bujan, L; Caccavo, A; Fernandez, AA; Fuselli, JJ; Gambarte, AJ; Hasbani, EG; Marzetti, E; Mon, G; Nordaby, R; Quijano, G; Salvati, A; San Martin, E; Schygiel, P; Liprandi, AS; Torre, H; Tuero, E; Amerena, J; Bett, JHN; Botha, J; Buncle, A; Careless, D; Ewart, A; Fagan, A; Fitzpatrick, D; Garrahy, P; Gunawardane, K; Hamer, A; Hill, A; Jepson, N; Lane, G; LeGood, H; Nelson, G; Sallaberger, M; Tulloch, G; Owensby, D; Padley, J; Rees, D; Roberts, K; Rosen, D; Sampson, J; Singh, B; Singh, C; Taylor, R; Thomson, A; Walsh, W; De Raedt, H; Rankin, J; Abrantes, JA; de Albuquerque, DC; Blacher, C; Bodanese, LC; Carvalho, AC; Coutinho, M; Dutra, O; Esteves, JP; Leaes, P; Lima, NS; Lobo, N; Neto, JAM; Marino, RL; Nicolau, JC; Pedrosa, RC; Pereira, I; Rabelo, W; Rabelo, A; Ramos, RF; Rocha, RM; Schramm, EC; Serrano, CV; Souza, VP; Timerman, A; Vaz, R; Xavier, SS; Auger, P; Barbin, K; Bata, I; Bergeron, L; Bhargava, RK; Bogaty, P; Bolduc, P; Boyne, T; Boyer, L; Bozek, B; Calmusky, T; Chan, YK; Cole, D; D'Astous, M; David, M; Davies, T; Desjardins, L; Dohaney, PB; Doody, M; Dumont, F; Fortin, C; Fung, A; Galdreault, G; Gervais, PB; Giannoccaro, JP; Gosselin, G; Grandmont, D; Grover, A; Gupta, M; Hink, H; Hiscock, JG; Hutton, D; Hynd, JWH; Iless, A; Kent, C; Kitching, A; Kouz, S; Kwok, K; LaForest, M; Lee, H; Lefkowitz, C; Lubelsky, B; Ma, P; Marquis, JF; McCallum, A; Major, R; May, B; Mercier, M; Montigny, M; Morris, A; Nawaz, S; Norris, J; Pallie, S; Panju, A; Parekh, P; Patterson, C; Pesant, Y; Pilon, C; Rajakumar, ARJ; Rebane, T; Ricci, J; Ruel, M; Schuld, R; Starra, R; Thornley, M; Weeks, AS; Winkler, LH; Wisenberg, G; Witt, I; Woo, K; Yu, E; Zadra, R; Zaniol, D; Bocek, P; Branny, M; Cepelak, V; Gregor, P; Groch, L; Jansky, P; Svitil, P; Vaclavicek, A; Husted, S; Ziegler, B; Karhu, A; Mustonen, J; Nieminen, M; Nissinen, K; Peuhkurinen, K; Tuomainen, P; Ylitalo, A; Adam, M; Amat, G; Asward, K; Bessede, G; Dambrine, P; Decoulx, E; D'Hautefeuille, B; Dujardin, J; Fouche, R; Fournier, P; Haftel, Y; Ketelers, JY; Lallemant, R; Lang, M; Leroy, F; Richard, M; Dippold, W; Gronholz, J; Harenberg, J; Hilpert, C; Horacek, T; Moritz, A; Neuss, H; Nitsche, K; Ochs, HR; Plumer-Schmidt, M; Pollock, B; Post, G; Sauer, M; Schmidt, A; Schmitt, H; Schulze, HO; Schuster, P; von Leitner, ER; Christakos, S; Karidis, K; Kifnidis, K; Papadopoulos, K; Symconidis, D; Tirologos, A; Garai, B; Gesztesi, T; Heltai, K; Herczeg, B; Janosi, A; Kadar, A; Kalo, E; Karpati, P; Kiss, B; Nagy, A; Okros, M; Poor, F; Regos, L; Sebo, J; Sitkei, E; Soltesz, P; Stefan, J; Szaboki, F; Timar, S; Varallyay, Z; Veres, K; Daly, K; Cotter, G; Marmor, A; Nazzal, D; Omary, M; Reisin, L; Rosenfeld, T; Shargorodsky, M; Shasha, S; Smulovitz, A; Vered, Z; Zimlichman, R; Beria, G; Bernardi, D; Bonfanti, E; Ceci, V; De Caterina, R; De Servi, S; DelPinto, M; Di Chiara, A; Di Pasquale, G; Filippucci, L; Galli, M; Gardinale, E; Landoni, MT; Martoni, A; Mauri, F; Maurea, N; Meneghetti, P; Mennuni, M; Murrone, A; Pani, A; Paolini, E; Passarelli, P; Pettinati, G; Pontillo, B; Rossi, L; Rossi, R; Santini, M; Sabino, G; Tricoci, P; Turazza, FM; Diaz, AC; Garcia-Sosa, A; Santamaria, IH; Pons, JL; Medecigo, JN; Rojo, FJR; Diaz, CJS; Castro, JT; Morales, EV; Baldew, S; Basart, DCG; Bijsterfeld, N; Bronzwaer, P; Chardon, A; den Hartoog, M; Heijmen, H; Heijmeriks, J; Jochemsen, G; Klomps, H; Landsaat, P; Michels, H; Moons, A; Pieterse, M; Sadee, A; van Beek, G; Van Hessen, M; Verheul, J; Viergever, E; Audeau, M; Hills, M; Ikram, H; Johnstone, M; Smart, A; Erikssen, J; Morstel, T; Winther, J; Achremczyk, P; Baranowska, A; Burduk, P; Cichon, D; Czepiel, A; Danielewicz, H; Danielewicz, P; Dworzanski, W; Gessek, J; Gorecki, A; Gorny, J; Janik, K; Jedrzejowski, A; Kania, G; Kawka-Urbanek, T; Klaudel, J; Kopcik, D; Kozlowski, A; Krasowski, W; Ladach, A; Laniec, M; Maciejewicz, J; Maciejewski, P; Majcher, Z; Malinowski, S; Marczyk, T; Miekus, P; Myczka, T; Ogorek, M; Piepiorka, M; Religa, K; Reszka, Z; Rozwodowska, M; Smielak-Korombel, W; Smiglak, D; Spyra, J; Stec, S; Susol, D; Szpajer, M; Szymanski, P; Szymcyyk-Muszytowska, G; Tomzynski, M; Ujda, M; Wasek, W; Waszyrowski, T; Wojewoda, P; Wnorowska, A; Wrobel, P; Zadrozny, J; Zebrowski, A; Zielinski, Z; Bastos, JM; Cardoso, P; Carrageta, M; Catarino, C; Ferreira, R; Gomes, MV; Aboo, A; Bobak, L; Brown, B; Cassim, S; Harripersadh, S; Manga, P; Maritz, F; Marx, J; Myburgh, D; Nell, H; Okreglicki, A; Theron, H; Orcajo, NA; Colomina, F; Echanove, I; Guerrer, JG; Gomez-Martinez, E; Lekuona, I; Miralles, L; Pasaval, C; Rovira, A; San Jose, J; Llorian, AR; Valentin, V; Abdon, N; Bartholdson, B; Basilier, E; Johansson, I; Kristensson, B; Larsson, K; Lindell, P; Moller, B; Rasmanis, G; Stjerna, A; Tolhagen, K; Caduff, B; Noseda, G; Rossi, A; Schmidt, D; Zerega, J; Carr, K; Detrano, R; Geer, R; Grewal, G; Hermany, P; Lakkis, N; Lewis, WR; Pacheco, TR; Papuchis, G; Puma, J; Runckey, S; Thadani, U; Whitaker, J; Adgey, YJA; Blackman, D; Brack, M; Bridges, A; Cohen, A; Currie, P; Duffy, S; Findlay, I; Goodfellow, J; Gray, K; Hogg, D; Holdright, D; Hughes, D; Irvine, N; Jennings, K; Keeling, P; Ludman, P; Mathew, T; McIntyre, P; Oliver, R; Palmer, N; Rodrigues, E; Smyth, L; Sprigings, D; Stephens, J; Timmis, A; Vincent, R				Yusuf, S; Fox, KAA; Tognoni, G; Mehta, SR; Chrolavicius, S; Anand, S; Avezum, A; Awan, N; Bertrand, M; Budaj, A; Ceremuzynski, L; Col, J; Commerford, PJ; Diaz, R; Flather, M; Franzosi, MG; Gersh, B; Grossman, W; Halon, DA; Hunt, D; Joyner, C; Karatzas, N; Keltai, M; Kopecky, S; Lewis, BS; Maggioni, A; Malmberg, K; Moccetti, T; Morais, J; Natarajan, M; Paolasso, E; Peters, R; Piegas, L; Pipilis, A; Pogue, J; Ramos-Corrales, M; Rupprecht, HJ; Sitkei, E; Valentin, V; Varigos, J; Widimsky, P; Wittlinger, T; Blumenthal, M; Bouthier, J; Gaudin, C; Hess, T; Khurmi, N; Sotty, M; Copland, I; Cracknell, B; Demers, C; Eikelboom, J; Morris, B; Pasquale, J; Yacyshyn, V; Zhao, F; Wyse, G; Cairns, J; Hart, R; Hirsh, J; Gent, M; Ryan, T; Wittes, J; Guerrero, RA; Arias, V; Bello, FH; Bono, JO; Bujan, L; Caccavo, A; Fernandez, AA; Fuselli, JJ; Gambarte, AJ; Hasbani, EG; Marzetti, E; Mon, G; Nordaby, R; Quijano, G; Salvati, A; San Martin, E; Schygiel, P; Liprandi, AS; Torre, H; Tuero, E; Amerena, J; Bett, JHN; Botha, J; Buncle, A; Careless, D; Ewart, A; Fagan, A; Fitzpatrick, D; Garrahy, P; Gunawardane, K; Hamer, A; Hill, A; Jepson, N; Lane, G; LeGood, H; Nelson, G; Sallaberger, M; Tulloch, G; Owensby, D; Padley, J; Rees, D; Roberts, K; Rosen, D; Sampson, J; Singh, B; Singh, C; Taylor, R; Thomson, A; Walsh, W; De Raedt, H; Rankin, J; Abrantes, JA; de Albuquerque, DC; Blacher, C; Bodanese, LC; Carvalho, AC; Coutinho, M; Dutra, O; Esteves, JP; Leaes, P; Lima, NS; Lobo, N; Neto, JAM; Marino, RL; Nicolau, JC; Pedrosa, RC; Pereira, I; Rabelo, W; Rabelo, A; Ramos, RF; Rocha, RM; Schramm, EC; Serrano, CV; Souza, VP; Timerman, A; Vaz, R; Xavier, SS; Auger, P; Barbin, K; Bata, I; Bergeron, L; Bhargava, RK; Bogaty, P; Bolduc, P; Boyne, T; Boyer, L; Bozek, B; Calmusky, T; Chan, YK; Cole, D; D'Astous, M; David, M; Davies, T; Desjardins, L; Dohaney, PB; Doody, M; Dumont, F; Fortin, C; Fung, A; Galdreault, G; Gervais, PB; Giannoccaro, JP; Gosselin, G; Grandmont, D; Grover, A; Gupta, M; Hink, H; Hiscock, JG; Hutton, D; Hynd, JWH; Iless, A; Kent, C; Kitching, A; Kouz, S; Kwok, K; LaForest, M; Lee, H; Lefkowitz, C; Lubelsky, B; Ma, P; Marquis, JF; McCallum, A; Major, R; May, B; Mercier, M; Montigny, M; Morris, A; Nawaz, S; Norris, J; Pallie, S; Panju, A; Parekh, P; Patterson, C; Pesant, Y; Pilon, C; Rajakumar, ARJ; Rebane, T; Ricci, J; Ruel, M; Schuld, R; Starra, R; Thornley, M; Weeks, AS; Winkler, LH; Wisenberg, G; Witt, I; Woo, K; Yu, E; Zadra, R; Zaniol, D; Bocek, P; Branny, M; Cepelak, V; Gregor, P; Groch, L; Jansky, P; Svitil, P; Vaclavicek, A; Husted, S; Ziegler, B; Karhu, A; Mustonen, J; Nieminen, M; Nissinen, K; Peuhkurinen, K; Tuomainen, P; Ylitalo, A; Adam, M; Amat, G; Asward, K; Bessede, G; Dambrine, P; Decoulx, E; D'Hautefeuille, B; Dujardin, J; Fouche, R; Fournier, P; Haftel, Y; Ketelers, JY; Lallemant, R; Lang, M; Leroy, F; Richard, M; Dippold, W; Gronholz, J; Harenberg, J; Hilpert, C; Horacek, T; Moritz, A; Neuss, H; Nitsche, K; Ochs, HR; Plumer-Schmidt, M; Pollock, B; Post, G; Sauer, M; Schmidt, A; Schmitt, H; Schulze, HO; Schuster, P; von Leitner, ER; Christakos, S; Karidis, K; Kifnidis, K; Papadopoulos, K; Symconidis, D; Tirologos, A; Garai, B; Gesztesi, T; Heltai, K; Herczeg, B; Janosi, A; Kadar, A; Kalo, E; Karpati, P; Kiss, B; Nagy, A; Okros, M; Poor, F; Regos, L; Sebo, J; Sitkei, E; Soltesz, P; Stefan, J; Szaboki, F; Timar, S; Varallyay, Z; Veres, K; Daly, K; Cotter, G; Marmor, A; Nazzal, D; Omary, M; Reisin, L; Rosenfeld, T; Shargorodsky, M; Shasha, S; Smulovitz, A; Vered, Z; Zimlichman, R; Beria, G; Bernardi, D; Bonfanti, E; Ceci, V; De Caterina, R; De Servi, S; DelPinto, M; Di Chiara, A; Di Pasquale, G; Filippucci, L; Galli, M; Gardinale, E; Landoni, MT; Martoni, A; Mauri, F; Maurea, N; Meneghetti, P; Mennuni, M; Murrone, A; Pani, A; Paolini, E; Passarelli, P; Pettinati, G; Pontillo, B; Rossi, L; Rossi, R; Santini, M; Sabino, G; Tricoci, P; Turazza, FM; Diaz, AC; Garcia-Sosa, A; Santamaria, IH; Pons, JL; Medecigo, JN; Rojo, FJR; Diaz, CJS; Castro, JT; Morales, EV; Baldew, S; Basart, DCG; Bijsterfeld, N; Bronzwaer, P; Chardon, A; den Hartoog, M; Heijmen, H; Heijmeriks, J; Jochemsen, G; Klomps, H; Landsaat, P; Michels, H; Moons, A; Pieterse, M; Sadee, A; van Beek, G; Van Hessen, M; Verheul, J; Viergever, E; Audeau, M; Hills, M; Ikram, H; Johnstone, M; Smart, A; Erikssen, J; Morstel, T; Winther, J; Achremczyk, P; Baranowska, A; Burduk, P; Cichon, D; Czepiel, A; Danielewicz, H; Danielewicz, P; Dworzanski, W; Gessek, J; Gorecki, A; Gorny, J; Janik, K; Jedrzejowski, A; Kania, G; Kawka-Urbanek, T; Klaudel, J; Kopcik, D; Kozlowski, A; Krasowski, W; Ladach, A; Laniec, M; Maciejewicz, J; Maciejewski, P; Majcher, Z; Malinowski, S; Marczyk, T; Miekus, P; Myczka, T; Ogorek, M; Piepiorka, M; Religa, K; Reszka, Z; Rozwodowska, M; Smielak-Korombel, W; Smiglak, D; Spyra, J; Stec, S; Susol, D; Szpajer, M; Szymanski, P; Szymcyyk-Muszytowska, G; Tomzynski, M; Ujda, M; Wasek, W; Waszyrowski, T; Wojewoda, P; Wnorowska, A; Wrobel, P; Zadrozny, J; Zebrowski, A; Zielinski, Z; Bastos, JM; Cardoso, P; Carrageta, M; Catarino, C; Ferreira, R; Gomes, MV; Aboo, A; Bobak, L; Brown, B; Cassim, S; Harripersadh, S; Manga, P; Maritz, F; Marx, J; Myburgh, D; Nell, H; Okreglicki, A; Theron, H; Orcajo, NA; Colomina, F; Echanove, I; Guerrer, JG; Gomez-Martinez, E; Lekuona, I; Miralles, L; Pasaval, C; Rovira, A; San Jose, J; Llorian, AR; Valentin, V; Abdon, N; Bartholdson, B; Basilier, E; Johansson, I; Kristensson, B; Larsson, K; Lindell, P; Moller, B; Rasmanis, G; Stjerna, A; Tolhagen, K; Caduff, B; Noseda, G; Rossi, A; Schmidt, D; Zerega, J; Carr, K; Detrano, R; Geer, R; Grewal, G; Hermany, P; Lakkis, N; Lewis, WR; Pacheco, TR; Papuchis, G; Puma, J; Runckey, S; Thadani, U; Whitaker, J; Adgey, YJA; Blackman, D; Brack, M; Bridges, A; Cohen, A; Currie, P; Duffy, S; Findlay, I; Goodfellow, J; Gray, K; Hogg, D; Holdright, D; Hughes, D; Irvine, N; Jennings, K; Keeling, P; Ludman, P; Mathew, T; McIntyre, P; Oliver, R; Palmer, N; Rodrigues, E; Smyth, L; Sprigings, D; Stephens, J; Timmis, A; Vincent, R		Clopidrogel Unstable Angina Preven	Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNSTABLE ANGINA	Background: Despite current treatments, patients who have acute coronary syndromes without ST-segment elevation have high rates of major vascular events. We evaluated the efficacy and safety of the antiplatelet agent clopidogrel when given with aspirin in such patients. Methods: We randomly assigned 12,562 patients who had presented within 24 hours after the onset of symptoms to receive clopidogrel (300 mg immediately, followed by 75 mg once daily) (6259 patients) or placebo (6303 patients) in addition to aspirin for 3 to 12 months. Results: The first primary outcome -- a composite of death from cardiovascular causes, nonfatal myocardial infarction, or stroke -- occurred in 9.3 percent of the patients in the clopidogrel group and 11.4 percent of the patients in the placebo group (relative risk with clopidogrel as compared with placebo, 0.80; 95 percent confidence interval, 0.72 to 0.90; P<0.001). The second primary outcome -- the first primary outcome or refractory ischemia -- occurred in 16.5 percent of the patients in the clopidogrel group and 18.8 percent of the patients in the placebo group (relative risk, 0.86, P<0.001). The percentages of patients with in-hospital refractory or severe ischemia, heart failure, and revascularization procedures were also significantly lower with clopidogrel. There were significantly more patients with major bleeding in the clopidogrel group than in the placebo group (3.7 percent vs. 2.7 percent; relative risk, 1.38; P=0.001), but there were not significantly more patients with episodes of life-threatening bleeding (2.1 percent vs. 1.8 percent, P=0.13) or hemorrhagic strokes. Conclusions: The antiplatelet agent clopidogrel has beneficial effects in patients with acute coronary syndromes without ST-segment elevation. However, the risk of major bleeding is increased among patients treated with clopidogrel. (N Engl J Med 2001;345:494-502.) Copyright (C) 2001 Massachusetts Medical Society.	McMaster Univ, Hamilton Gen Hosp, Populat Hlth Res Inst, Canadian Cardiovasc Collaborat Project Off, Hamilton, ON L8L 2X2, Canada	McMaster University; Population Health Research Institute	Yusuf, S (corresponding author), McMaster Univ, Hamilton Gen Hosp, Populat Hlth Res Inst, Canadian Cardiovasc Collaborat Project Off, 237 Barton St E, Hamilton, ON L8L 2X2, Canada.	yusufs@mcmaster.ca	Widimsky, Petr/P-8088-2016; bastos, jose/AAH-2656-2020; Cairns, John/AAI-8744-2021; Pedrosa, Rozangela Curi/AAN-3409-2020; De Caterina, Raffaele/K-3857-2016; Klaudel, Jacek/GLU-4779-2022; De+Servi, Stefano/AAT-2631-2021; Fox, keith A A/I-3742-2013; Serrano, Carlos Vicente/I-2729-2013; Avezum, Alvaro AA/K-6137-2016; Rozwodowska, Małgorzata MR/G-5143-2014; Rocha, Ricardo Mourilhe/ABC-5053-2020; Nicolau, Jose C/E-1487-2012; Valencia Morales, Eduardo/GXV-3309-2022; Stec, Sebastian M/D-4186-2014; Coutinho, Mario SSA/A-3269-2013; Murrone, Adriano/AAD-5266-2022; Eikelboom, John/AAG-6117-2019; Maurea, Nicola/AAC-2341-2022; Turazza, Fabio/AAB-8736-2020; Lima, Thaísa/AAG-6483-2021; Avezum, Alvaro/AAP-7687-2020	Widimsky, Petr/0000-0001-5686-7752; bastos, jose/0000-0002-9526-3123; Pedrosa, Rozangela Curi/0000-0003-1732-8363; De Caterina, Raffaele/0000-0003-1637-574X; Klaudel, Jacek/0000-0002-0406-7240; Avezum, Alvaro AA/0000-0002-3073-6890; Rocha, Ricardo Mourilhe/0000-0003-2501-302X; Nicolau, Jose C/0000-0002-9680-3689; Valencia Morales, Eduardo/0000-0002-3398-4654; Coutinho, Mario SSA/0000-0002-8025-9084; Eikelboom, John/0000-0003-4126-1285; Turazza, Fabio/0000-0002-2348-5309; Budaj, Andrzej/0000-0002-6395-2098; Yusuf, Salim/0000-0003-4776-5601				ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; [Anonymous], 1994, BMJ-BRIT MED J, V308, P81, DOI DOI 10.1136/BMJ.308.6921.81; *ANT TRIAL COLL, IN PRESS BMJ; Chew DP, 2001, CIRCULATION, V103, P201; *FRAGM FAST REV IN, 1999, LANCET, V354, P1478; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; *PRAT REC INH ISCH, 1998, NEW ENGL J MED, V338, P1488; RAO AK, 1988, J AM COLL CARDIOL, V11, P1; Simoons ML, 2001, LANCET, V357, P1915; Tonkin AM, 2000, LANCET, V356, P1871, DOI 10.1016/S0140-6736(00)03257-8; Topol CE, 2000, LANCET, V355, P337; Topol E, 1998, NEW ENGL J MED, V339, P436; Wallentin L, 1996, LANCET, V347, P561; Wallentin L, 1999, LANCET, V354, P701; Yeghiazarians Y, 2000, NEW ENGL J MED, V342, P101, DOI 10.1056/NEJM200001133420207; Yusuf S, 2001, J AM COLL CARDIOL, V37, P475; Yusuf S, 2000, EUR HEART J, V21, P2033; Yusuf S, 2000, NEW ENGL J MED, V342, P145; YUSUF S, 1988, JAMA-J AM MED ASSOC, V260, P2259, DOI 10.1001/jama.260.15.2259	19	4804	5063	1	212	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 16	2001	345	7					494	502						9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	462QM	11519503				2022-12-28	WOS:000170431300003
J	Saphire, EO; Parren, PWHI; Pantophlet, R; Zwick, MB; Morris, GM; Rudd, PM; Dwek, RA; Stanfield, RL; Burton, DR; Wilson, IA				Saphire, EO; Parren, PWHI; Pantophlet, R; Zwick, MB; Morris, GM; Rudd, PM; Dwek, RA; Stanfield, RL; Burton, DR; Wilson, IA			Crystal structure of a neutralizing human IgG against HIV-1: A template for vaccine design	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODY; ENVELOPE GLYCOPROTEIN; GP120; INFECTION; LIBRARIES; EFFICIENT; PROTEINS; RECEPTOR; EPITOPE	We present the crystal structure at 2.7 angstrom resolution of the human antibody lgG1 b12. Antibody b12 recognizes the CD4-binding site of human immunodeficiency virus-1 (HIV-1) gp120 and is one of only two known antibodies against gp120 capable of broad and potent neutralization of primary HIV-1 isolates. A key feature of the antibody-combining site is the protruding, finger-like long CDR H3 that can penetrate the recessed CD4-binding site of gp120. A docking model of b12 and gp120 reveals severe structural constraints that explain the extraordinary challenge in eliciting effective neutralizing antibodies similar to b12. The structure, together with mutagenesis studies, provides a rationale for the extensive cross-reactivity of b12 and a valuable framework for the design of HIV-1 vaccines capable of eliciting b12-like activity.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Univ Oxford, Dept Biochem, Oxford Glycobiol Inst, Oxford OX1 3QU, England	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; University of Oxford	Burton, DR (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Stanfield, Robyn/AAH-3190-2019; Saphire, Erica/A-7055-2009; Morris, Garrett Matthew/F-2465-2019	Morris, Garrett Matthew/0000-0003-1731-8405; Parren, Paul/0000-0002-4365-3859; Saphire, Erica Ollmann/0000-0002-1206-7451	NIAID NIH HHS [AI40377, AI33292] Funding Source: Medline; NIGMS NIH HHS [GM46192] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033292, R29AI040377, R37AI033292] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; BARBAS CF, 1993, J MOL BIOL, V230, P812, DOI 10.1006/jmbi.1993.1203; Binley JM, 1998, AIDS RES HUM RETROV, V14, P191, DOI 10.1089/aid.1998.14.191; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Burton DR, 1997, P NATL ACAD SCI USA, V94, P10018, DOI 10.1073/pnas.94.19.10018; Burton DR, 2001, CURR TOP MICROBIOL, V260, P109; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; DSouza MP, 1997, J INFECT DIS, V175, P1056, DOI 10.1086/516443; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Gauduin MC, 1997, NAT MED, V3, P1389, DOI 10.1038/nm1297-1389; GELDERBLOM HR, 1987, VIROLOGY, V156, P171, DOI 10.1016/0042-6822(87)90449-1; JONES TA, 1982, COMPUTATIONAL CRYSTA, P303; Kunert R, 1998, AIDS RES HUM RETROV, V14, P1115, DOI 10.1089/aid.1998.14.1115; Kwong PD, 2000, STRUCTURE, V8, P1329, DOI 10.1016/S0969-2126(00)00547-5; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; MENENDEZ A, UNPUB; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MICHAELSEN TE, 1994, P NATL ACAD SCI USA, V91, P9243, DOI 10.1073/pnas.91.20.9243; Mo HM, 1997, J VIROL, V71, P6869, DOI 10.1128/JVI.71.9.6869-6874.1997; Moore JP, 1996, J VIROL, V70, P1863, DOI 10.1128/JVI.70.3.1863-1872.1996; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Myszka DG, 2000, P NATL ACAD SCI USA, V97, P9026, DOI 10.1073/pnas.97.16.9026; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parren PWHI, 1999, AIDS, V13, pS137; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Poignard P, 1999, IMMUNITY, V10, P431, DOI 10.1016/S1074-7613(00)80043-6; ROBEN P, 1994, J VIROL, V68, P4821, DOI 10.1128/JVI.68.8.4821-4828.1994; SANNA PP, 1995, P NATL ACAD SCI USA, V92, P6439, DOI 10.1073/pnas.92.14.6439; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; SANZ I, 1991, J IMMUNOL, V147, P1720; Saphire EO, 2001, ACTA CRYSTALLOGR D, V57, P168, DOI 10.1107/S0907444900017376; Smith TJ, 1996, NATURE, V383, P350, DOI 10.1038/383350a0; TRKOLA A, 1995, J VIROL, V69, P6609, DOI 10.1128/JVI.69.11.6609-6617.1995; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; YANG WP, 1995, J MOL BIOL, V254, P392, DOI 10.1006/jmbi.1995.0626; ZWICK MBV, UNPUB	44	732	802	0	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2001	293	5532					1155	1159		10.1126/science.1061692	http://dx.doi.org/10.1126/science.1061692			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498595				2022-12-28	WOS:000170432600065
J	Hussain, A; Smith, R				Hussain, A; Smith, R			Declaring financial competing interests: survey of five general medical journals	BRITISH MEDICAL JOURNAL			English	Article							CONFLICT-OF-INTEREST		BMJ, London WC1H 9JR, England		Hussain, A (corresponding author), Raigmore Hosp, Inverness IV2 3UJ, Scotland.							ANGELL M, 1993, LANCET, V341, P742; Krimsky S, 1996, Sci Eng Ethics, V2, P395, DOI 10.1007/BF02583927; MONMANEY T, 1999, LOS ANGELES TIM 1021; Smith R, 1998, BMJ-BRIT MED J, V317, P291, DOI 10.1136/bmj.317.7154.291; Stelfox HT, 1998, NEW ENGL J MED, V338, P101, DOI 10.1056/NEJM199801083380206	5	47	47	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 4	2001	323	7307					263	264		10.1136/bmj.323.7307.263	http://dx.doi.org/10.1136/bmj.323.7307.263			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	461ZT	11485955	Bronze, Green Published			2022-12-28	WOS:000170394300019
J	Griffitts, JS; Whitacre, JL; Stevens, DE; Aroian, RV				Griffitts, JS; Whitacre, JL; Stevens, DE; Aroian, RV			Bt toxin resistance from loss of a putative carbohydrate-modifying enzyme	SCIENCE			English	Article							PESTICIDAL CRYSTAL PROTEINS; BACILLUS-THURINGIENSIS; CAENORHABDITIS-ELEGANS; AMINOPEPTIDASE-N; IDENTIFICATION; RECEPTOR; LECTIN; FOLD	The development of resistance is the main threat to the long-term use of toxins from Bacillus thuringiensis (Bt) in transgenic plants. Here we report the cloning of a Bt toxin resistance gene, Caenorhabditis elegans bre-5, which encodes a putative beta -1,3-galactosyltransferase. Lack of bre-5 in the intestine led to resistance to the Bt toxin Cry5B. Wild-type but not bre-5 mutant animals were found to uptake toxin into their gut cells, consistent with bre-5 mutants lacking toxin-binding sites on their apical gut. bre-5 mutants displayed resistance to Cry14A, a Bt toxin lethal to both nematodes and insects; this indicates that resistance by loss of carbohydrate modification is relevant to multiple Bt toxins.	Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Aroian, RV (corresponding author), Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.							Amado M, 1999, BBA-GEN SUBJECTS, V1473, P35, DOI 10.1016/S0304-4165(99)00168-3; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Burton SL, 1999, J MOL BIOL, V287, P1011, DOI 10.1006/jmbi.1999.2649; Crickmore N, 1998, MICROBIOL MOL BIOL R, V62, P807, DOI 10.1128/MMBR.62.3.807-813.1998; de Maagd RA, 2001, TRENDS GENET, V17, P193, DOI 10.1016/S0168-9525(01)02237-5; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; GRIFFITTS JS, UNPUB; Jenkins JL, 1999, FEBS LETT, V462, P373, DOI 10.1016/S0014-5793(99)01559-8; Kostich M, 2000, J CELL SCI, V113, P2595; Lee X, 1998, J BIOL CHEM, V273, P6312, DOI 10.1074/jbc.273.11.6312; MARROQUIN L, UNPUB; Marroquin LD, 2000, GENETICS, V155, P1693; MCGAUGHEY WH, 1998, ISRAEL J ENTOMOL, V2, P1; Panin VM, 1998, SEMIN CELL DEV BIOL, V9, P609, DOI 10.1006/scdb.1998.0263; PAYNE J, 1995, Patent No. 5589382; PAYNE JM, 1994, Patent No. 9416079; Plasterk RHA, 2000, CURR OPIN GENET DEV, V10, P562, DOI 10.1016/S0959-437X(00)00128-3; Sankaranarayanan R, 1996, NAT STRUCT BIOL, V3, P596, DOI 10.1038/nsb0796-596; Sasser J. N., 1987, Vistas on Nematology: A Commemoration of the Twenty-fifth Anniversary of the Society of Nematologists, P7; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; SPANGLER BD, 1992, MICROBIOL REV, V56, P622, DOI 10.1128/MMBR.56.4.622-647.1992; TABASHNIK BE, 1994, P ROY SOC B-BIOL SCI, V255, P7, DOI 10.1098/rspb.1994.0002; WHITACRE JF, UNPUB; Yochem J, 1998, GENETICS, V149, P1323	24	165	197	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2001	293	5531					860	864		10.1126/science.1062441	http://dx.doi.org/10.1126/science.1062441			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11486087				2022-12-28	WOS:000170241000044
J	Cathebras, P; Sauron, C; Morel, F; Stasia, MJ				Cathebras, P; Sauron, C; Morel, F; Stasia, MJ			An unusual case of sarcoidosis	LANCET			English	Editorial Material							CHRONIC GRANULOMATOUS-DISEASE		Hop Nord St Etienne, Dept Internal Med, F-42055 St Etienne 2, France; Hop Michallon, Enzymol Lab, Grenoble, France	CHU de St Etienne; CHU Grenoble Alpes	Cathebras, P (corresponding author), Hop Nord St Etienne, Dept Internal Med, F-42055 St Etienne 2, France.	pascal.cathebras@chu-st-etienne.fr		STASIA, Marie jose/0000-0003-4466-4880				EZEKOWITZ RAB, 1991, NEW ENGL J MED, V324, P509, DOI 10.1056/NEJM199102213240801; Liese JG, 1996, LANCET, V347, P220, DOI 10.1016/S0140-6736(96)90403-1; SCHAPIRO BL, 1991, NEW ENGL J MED, V325, P1786, DOI 10.1056/NEJM199112193252506; Segal BH, 2000, MEDICINE, V79, P170, DOI 10.1097/00005792-200005000-00004; Winkelstein JA, 2000, MEDICINE, V79, P155, DOI 10.1097/00005792-200005000-00003	5	8	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 28	2001	358	9278					294	294		10.1016/S0140-6736(01)05485-X	http://dx.doi.org/10.1016/S0140-6736(01)05485-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	457AF	11498217				2022-12-28	WOS:000170114400014
J	Bray, D				Bray, D			Reasoning for results	NATURE			English	Editorial Material									Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Cambridge	Bray, D (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.							Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; HUSZAGH VA, 1989, NATURE, V338, P109, DOI 10.1038/338109a0; Mayr E, 1997, THIS IS BIOL; Noble D, 2001, PHILOS T ROY SOC A, V359, P1127, DOI 10.1098/rsta.2001.0820	5	25	25	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2001	412	6850					863	863		10.1038/35091132	http://dx.doi.org/10.1038/35091132			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467EG	11528456				2022-12-28	WOS:000170689000024
J	Sale, JE; Calandrini, DM; Takata, M; Takeda, S; Neuberger, MS				Sale, JE; Calandrini, DM; Takata, M; Takeda, S; Neuberger, MS			Ablation of XRCC2/3 transforms immunoglobulin V gene conversion into somatic hypermutation	NATURE			English	Article							DOUBLE-STRAND BREAKS; LIGHT-CHAIN GENE; HOMOLOGOUS RECOMBINATION; CHROMOSOME STABILITY; REPAIR GENES; DNA; PROMOTES; CHICKEN; DIVERSIFICATION; MAINTENANCE	After gene rearrangement, immunoglobulin V genes are further diversified by either somatic hypermutation or gene conversion(1). Hypermutation (in man and mouse) occurs by the fixation of individual, non-templated nucleotide substitutions. Gene conversion (in chicken) is templated by a set of upstream V pseudogenes. Here we show that if the RAD51 paralogues(2) XRCC2, XRCC3 or RAD51B are ablated the pattern of diversification of the immunoglobulin V gene in the chicken DT40 B-cell lymphoma line(3) exhibits a marked shift from one of gene conversion to one of somatic hypermutation. Non-templated, single-nucleotide substitutions are incorporated at high frequency specifically into the V domain, largely at G/C and with a marked hotspot preference. These mutant DT40 cell lines provide a tractable model for the genetic dissection of immunoglobulin hypermutation and the results support the idea that gene conversion and somatic hypermutation constitute distinct pathways for processing a common lesion in the immunoglobulin V gene. The marked induction of somatic hypermutation that is achieved by ablating the RAD51 paralogues is probably a consequence of modifying the recombination-mediated repair of such initiating lesions.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Kawasaki Med Sch, Okayama 7010192, Japan; Kyoto Univ, Fac Med, CREST Res Project, Sakyo Ku, Kyoto 6068501, Japan	MRC Laboratory Molecular Biology; Kawasaki Medical School; Japan Science & Technology Agency (JST); Kyoto University	Sale, JE (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	msn@mrc-lmb.cam.ac.uk		Takata, Minoru/0000-0002-4926-3675; Takeda, Shunichi/0000-0002-7924-7991; Sale, Julian/0000-0002-5031-3780				BABA TW, 1985, VIROLOGY, V144, P139, DOI 10.1016/0042-6822(85)90312-5; Bezzubova O, 1997, CELL, V89, P185, DOI 10.1016/S0092-8674(00)80198-1; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Brenneman MA, 2000, MUTAT RES-DNA REPAIR, V459, P89, DOI 10.1016/S0921-8777(00)00002-1; Bross L, 2000, IMMUNITY, V13, P589, DOI 10.1016/S1074-7613(00)00059-5; BUERSTEDDE JM, 1990, EMBO J, V9, P921, DOI 10.1002/j.1460-2075.1990.tb08190.x; Cui X, 1999, MUTAT RES-DNA REPAIR, V434, P75, DOI 10.1016/S0921-8777(99)00010-5; Deans B, 2000, EMBO J, V19, P6675, DOI 10.1093/emboj/19.24.6675; Diaz M, 2001, PHILOS T R SOC B, V356, P67, DOI 10.1098/rstb.2000.0750; Griffin CS, 2000, NAT CELL BIOL, V2, P757, DOI 10.1038/35036399; HONJO T, 1995, IMMUNOGLOBULIN GENES; Johnson RD, 1999, NATURE, V401, P397, DOI 10.1038/43935; KIM S, 1990, MOL CELL BIOL, V10, P3224, DOI 10.1128/MCB.10.6.3224; Liu N, 1998, MOL CELL, V1, P783, DOI 10.1016/S1097-2765(00)80078-7; MAIZELS N, 1995, CELL, V83, P9, DOI 10.1016/0092-8674(95)90227-9; MCCORMACK WT, 1993, MOL CELL BIOL, V13, P821, DOI 10.1128/MCB.13.2.821; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Rada C, 1998, IMMUNITY, V9, P135, DOI 10.1016/S1074-7613(00)80595-6; REYNAUD CA, 1989, CELL, V59, P171, DOI 10.1016/0092-8674(89)90879-9; REYNAUD CA, 1987, CELL, V48, P379, DOI 10.1016/0092-8674(87)90189-9; Sale JE, 1998, IMMUNITY, V9, P859, DOI 10.1016/S1074-7613(00)80651-2; Sayegh CE, 1999, EMBO J, V18, P6319, DOI 10.1093/emboj/18.22.6319; Takata M, 2000, MOL CELL BIOL, V20, P6476, DOI 10.1128/MCB.20.17.6476-6482.2000; Takata M, 2001, MOL CELL BIOL, V21, P2858, DOI 10.1128/MCB.21.8.2858-2866.2001; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Weill JC, 1996, IMMUNOL TODAY, V17, P92, DOI 10.1016/0167-5699(96)80586-X; XU B, 1994, SCIENCE, V265, P1590, DOI 10.1126/science.8079173; Yamaguchi-Iwai Y, 1998, MOL CELL BIOL, V18, P6430, DOI 10.1128/MCB.18.11.6430	30	185	196	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2001	412	6850					921	926		10.1038/35091100	http://dx.doi.org/10.1038/35091100			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467EG	11528482				2022-12-28	WOS:000170689000048
J	Lovley, DR				Lovley, DR			Bioremediation - Anaerobes to the rescue	SCIENCE			English	Editorial Material							PETROLEUM-CONTAMINATED AQUIFER; IN-SITU; BENZENE		Univ Massachusetts, Dept Microbiol, Amherst, MA 01337 USA	University of Massachusetts System; University of Massachusetts Amherst	Lovley, DR (corresponding author), Univ Massachusetts, Dept Microbiol, Amherst, MA 01337 USA.	dlovley@microbio.umass.edu						Alexander M., 1999, BIODEGRADATION BIORE; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Anderson RT, 2000, ENVIRON SCI TECHNOL, V34, P2261, DOI 10.1021/es991211a; Beja O, 2000, ENVIRON MICROBIOL, V2, P516, DOI 10.1046/j.1462-2920.2000.00133.x; Chapelle F, 2001, GROUND WATER MICROBI; Cunningham JA, 2001, ENVIRON SCI TECHNOL, V35, P1663, DOI 10.1021/es001722t; Fennell DE, 2001, ENVIRON SCI TECHNOL, V35, P1830, DOI 10.1021/es0016203; Lee MD, 1998, ANNU REV MICROBIOL, V52, P423, DOI 10.1146/annurev.micro.52.1.423; Lloyd JR, 2001, CURR OPIN BIOTECH, V12, P248, DOI 10.1016/S0958-1669(00)00207-X; Lovley DR, 2000, BIODEGRADATION, V11, P107, DOI 10.1023/A:1011191220463; Nisbet EG, 2001, NATURE, V409, P1083, DOI 10.1038/35059210; Rooney-Varga JN, 1999, APPL ENVIRON MICROB, V65, P3056; Smith RL, 2001, ENVIRON SCI TECHNOL, V35, P196, DOI 10.1021/es001360p; Snoeyenbos-West OL, 2000, MICROBIAL ECOL, V39, P153, DOI 10.1007/s002480000018; Wilson MS, 1999, APPL ENVIRON MICROB, V65, P80	15	151	162	4	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2001	293	5534					1444	1446		10.1126/science.1063294	http://dx.doi.org/10.1126/science.1063294			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465XV	11520973				2022-12-28	WOS:000170616000030
J	Homma, K; Yoshimura, M; Saito, J; Ikebe, R; Ikebe, M				Homma, K; Yoshimura, M; Saito, J; Ikebe, R; Ikebe, M			The core of the motor domain determines the direction of myosin movement	NATURE			English	Article							SMOOTH-MUSCLE MYOSIN; ACTIN-BASED MOTOR; UNCONVENTIONAL MYOSINS; COMPLEX; KINESIN; VI; CONFORMATION; ELEGANS; FAMILY; CHAIN	Myosins constitute a superfamily of at least 18 known classes of molecular motors that move along actin filaments(1-3). Myosins move towards the plus end of F-actin filaments; however, it was shown recently that a certain class of myosin, class VI myosin, moves towards the opposite end of F-actin, that is, in the minus direction(4). As there is a large, unique insertion in the myosin VI head domain between the motor domain and the light-chain-binding domain (the lever arm), it was thought that this insertion alters the angle of the lever-arm switch movement, thereby changing the direction of motility(4). Here we determine the direction of motility of chimaeric myosins that comprise the motor domain and the lever-arm domain (containing an insert) from myosins that have movement in the opposite direction. The results show that the motor core domain, but neither the large insert nor the converter domain, determines the direction of myosin motility.	Univ Massachusetts, Sch Med, Dept Physiol, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Ikebe, M (corresponding author), Univ Massachusetts, Sch Med, Dept Physiol, 55 Lake Ave N, Worcester, MA 01655 USA.							AVRAHAM KB, 1995, NAT GENET, V11, P369, DOI 10.1038/ng1295-369; Baker JP, 1997, J MOL BIOL, V272, P523, DOI 10.1006/jmbi.1997.1232; CHIEN YH, 1984, MOL CELL BIOL, V4, P507, DOI 10.1128/MCB.4.3.507; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; Endow SA, 2000, NATURE, V406, P913, DOI 10.1038/35022617; Endow SA, 1998, SCIENCE, V281, P1200, DOI 10.1126/science.281.5380.1200; HASSON T, 1994, J CELL BIOL, V127, P425, DOI 10.1083/jcb.127.2.425; Hasson T, 1997, J CELL BIOL, V137, P1287, DOI 10.1083/jcb.137.6.1287; Hodge T, 2000, J CELL SCI, V113, P3353; Homma K, 2000, J BIOL CHEM, V275, P34766, DOI 10.1074/jbc.M003132200; Houdusse A, 1999, CELL, V97, P459, DOI 10.1016/S0092-8674(00)80756-4; IKEBE M, 1985, J BIOL CHEM, V260, P3146; Kelleher JF, 2000, CURR BIOL, V10, P1489, DOI 10.1016/S0960-9822(00)00828-9; KELLERMAN KA, 1992, J CELL BIOL, V119, P823, DOI 10.1083/jcb.119.4.823; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; MERMALL V, 1994, NATURE, V369, P560, DOI 10.1038/369560a0; Mooseker MS, 1995, ANNU REV CELL DEV BI, V11, P633, DOI 10.1146/annurev.cellbio.11.1.633; Sablin EP, 1998, NATURE, V395, P813, DOI 10.1038/27463; Sakamoto T, 2000, BIOCHEM BIOPH RES CO, V272, P586, DOI 10.1006/bbrc.2000.2819; Sata M, 1996, BIOCHEMISTRY-US, V35, P11113, DOI 10.1021/bi960435s; Smith CA, 1996, BIOCHEMISTRY-US, V35, P5404, DOI 10.1021/bi952633+; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Titus MA, 1997, TRENDS CELL BIOL, V7, P119, DOI 10.1016/S0962-8924(97)01019-2; Walker ML, 2000, NATURE, V405, P804, DOI 10.1038/35015592; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835; Zhu T, 1996, BIOCHEMISTRY-US, V35, P513, DOI 10.1021/bi952053c	26	60	61	1	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2001	412	6849					831	834		10.1038/35090597	http://dx.doi.org/10.1038/35090597			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465ET	11518969				2022-12-28	WOS:000170577200040
J	Block, BA; Dewar, H; Blackwell, SB; Williams, TD; Prince, ED; Farwell, CJ; Boustany, A; Teo, SLH; Seitz, A; Walli, A; Fudge, D				Block, BA; Dewar, H; Blackwell, SB; Williams, TD; Prince, ED; Farwell, CJ; Boustany, A; Teo, SLH; Seitz, A; Walli, A; Fudge, D			Migratory movements, depth preferences, and thermal biology of Atlantic bluefin tuna	SCIENCE			English	Article							GULF-OF-MEXICO; THUNNUS-THYNNUS; SATELLITE; FISH; TEMPERATURE; TRACKING; EAST	The deployment of electronic data storage tags that are surgically implanted or satellite-linked provides marine researchers with new ways to examine the movements, environmental preferences, and physiology of pelagic vertebrates. We report the results obtained from tagging of Atlantic bluefin tuna with implantable archival and pop-up satellite archival tags. The electronic tagging data provide insights into the seasonal movements and environmental preferences of this species. Bluefin tuna dive to depths of >1000 meters and maintain a warm body temperature. Western-tagged bluefin tuna make trans-Atlantic migrations and they frequent spawning grounds in the Gulf of Mexico and eastern Mediterranean. These data are critical for the future management and conservation of bluefin tuna in the Atlantic.	Stanford Univ, Hopkins Marine Stn, Tuna Res & Conservat Ctr, Pacific Grove, CA 93950 USA; Pfleger Inst Environm Res, Oceanside, CA 92054 USA; Monterey Bay Aquarium, Monterey, CA 93940 USA; Natl Marine Fisheries Serv, Miami, FL 33149 USA	Stanford University; Monterey Bay Aquarium Research Institute; National Oceanic Atmospheric Admin (NOAA) - USA	Block, BA (corresponding author), Stanford Univ, Hopkins Marine Stn, Tuna Res & Conservat Ctr, Pacific Grove, CA 93950 USA.	bblock@stanford.edu	Fudge, Douglas/I-6860-2016	Fudge, Douglas/0000-0001-9569-1374				Altringham JD, 1997, J EXP BIOL, V200, P2617; BAGLIN RE, 1982, FISH B-NOAA, V80, P121; BAYLIFF WH, 1991, B IATTC, V20, P1; Block BA, 1998, MAR TECHNOL SOC J, V32, P37; Block BA, 1998, P NATL ACAD SCI USA, V95, P9384, DOI 10.1073/pnas.95.16.9384; CAREY FG, 1966, P NATL ACAD SCI USA, V56, P1464, DOI 10.1073/pnas.56.5.1464; CAREY FG, 1984, J EXP BIOL, V109, P1; DELONG RL, 1992, MAR MAMMAL SCI, V8, P155, DOI 10.1111/j.1748-7692.1992.tb00375.x; Gunn J., 2001, TUNA PHYSL ECOLOGY E, P167, DOI 10.1016/S1546-5098(01)19006-0; Hill Roger D., 1994, P227; Kitagawa T, 2000, MAR ECOL PROG SER, V206, P251, DOI 10.3354/meps206251; Koudil M, 2000, CR ACAD SCI III-VIE, V323, P377, DOI 10.1016/S0764-4469(00)00144-X; LEBOEUF BJ, 2000, ECOL MONOGR, V353, P70; Lutcavage ME, 1999, CAN J FISH AQUAT SCI, V56, P173, DOI 10.1139/cjfas-56-2-173; MAGGIO T, 2000, MATTANZA; Magnuson J. J., 1994, ASSESSMENT ATLANTIC; Marcinek DJ, 2001, MAR BIOL, V138, P869, DOI 10.1007/s002270000492; MATHER FJ, 1995, 370 NOAA NMFSSFSC; MCGOWAN MF, 1989, FISH B-NOAA, V87, P615; Metcalfe JD, 1997, NATURE, V387, P665, DOI 10.1038/42622; Nemerson D, 2000, FISH B-NOAA, V98, P118; NISHIDA T, 1998, 107 ICCAT; RODRIGUEZRODA J, 1967, INVEST PESQ, V31, P349; Schaefer Kurt M., 2001, Fish Physiology, V19, P225; SCOTT GP, 1993, B MAR SCI, V53, P912; Sissenwine MP, 1998, T AM FISH SOC, V127, P838, DOI 10.1577/1548-8659(1998)127<0838:ACOWAB>2.0.CO;2; Welch DW, 1999, CAN J FISH AQUAT SCI, V56, P1317, DOI 10.1139/cjfas-56-7-1317	27	485	506	5	276	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2001	293	5533					1310	1314		10.1126/science.1061197	http://dx.doi.org/10.1126/science.1061197			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11509729				2022-12-28	WOS:000170492600038
J	Sagoe-Moses, C; Pearson, RD; Perry, J; Jagger, J				Sagoe-Moses, C; Pearson, RD; Perry, J; Jagger, J			Risks to health care workers in developing countries.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEPATITIS-B; UNSAFE INJECTIONS; VIRUS-INFECTION; UNITED-STATES; NEEDLESTICK INJURIES; DEVELOPING-WORLD; TRANSMISSION; EPIDEMIOLOGY; PREVALENCE; DEVICES		Minist Hlth, Accra, Ghana; Univ Virginia Hlth Syst, Charlottesville, VA 22908 USA	University of Virginia	Sagoe-Moses, C (corresponding author), Minist Hlth, Accra, Ghana.				PHS HHS [21204] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ADEGBOYE AA, 1994, INFECT CONT HOSP EP, V15, P27; Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; ANGLIM AM, 1995, INFECT CONT HOSP EP, V16, P570; [Anonymous], 1991, Fed Regist, V56, P64004; AOUN H, 1989, NEW ENGL J MED, V321, P693, DOI 10.1056/NEJM198909073211020; BATTERSBY A, 1998, VITAL HLTH BRIEFING; *FOOD DRUG ADM, 1999, GLASS CAP TUB JOINT; Ippolito G, 1999, CLIN INFECT DIS, V28, P365, DOI 10.1086/515101; IPPOLITO G, 1994, JAMA-J AM MED ASSOC, V272, P607, DOI 10.1001/jama.272.8.607; JAGGER J, 1988, NEW ENGL J MED, V319, P284, DOI 10.1056/NEJM198808043190506; Jagger J, 1998, JAMA-J AM MED ASSOC, V280, P31, DOI 10.1001/jama.280.1.31; JAGGER J, 1990, INFECT CONT HOSP EP, V11, P584; JAGGER J, 1998, ADV EXPOS PREV, V3, P25; JAGGER J, 1998, ADV EXPOSURE PREV, V3, P34; *JOINT UN PROGR, 2000, NAT AIDS PROGR GUID; *JOINT UN PROGR HI, 1999, UNAIDS9953E; Kane A, 1999, B WORLD HEALTH ORGAN, V77, P801; KhuriBulos NA, 1997, AM J INFECT CONTROL, V25, P322, DOI 10.1016/S0196-6553(97)90024-9; Lymer UB, 1997, J HOSP INFECT, V35, P223, DOI 10.1016/S0195-6701(97)90210-3; Mahoney FJ, 1997, ARCH INTERN MED, V157, P2601, DOI 10.1001/archinte.157.22.2601; Martinson FEA, 1996, J MED VIROL, V48, P278, DOI 10.1002/(SICI)1096-9071(199603)48:3&lt;278::AID-JMV11&gt;3.0.CO;2-9; MCCORMICK RD, 1991, AM J MED S3B, V91, P301; McQuillan GM, 1999, AM J PUBLIC HEALTH, V89, P14, DOI 10.2105/AJPH.89.1.14; Mfugale D., 2001, HLTH WORKERS RISK HI; Miller MA, 1999, B WORLD HEALTH ORGAN, V77, P808; PERRY J, 2000, ADV EXPOSURE PREV, V5, P44; Perry JHR, 2000, ADV EXPOSURE PREV, V5, P39; RICHARDLENOBLE D, 1995, AM J TROP MED HYG, V53, P338, DOI 10.4269/ajtmh.1995.53.338; Simonsen L, 1999, B WORLD HEALTH ORGAN, V77, P789; VANSTAA A, 1997, WHODAP964, V15, P43; *WHO, 1998, WHO EST HLTH PERS, V27, P2001; *WHO, 1999, WHOVB9925 UNICEFUNFP; *WHO, 1998, WHOEPILHIS9605; *WORLD BANK GROUP, 2000, WORLD BANK HIV AIDS; 1984, LANCET, V2, P1376; 1993, WKLY EPIDEMIOL REC, V68, P267; 1987, MWR MORB MORTAL WK S, V36, P3; 1993, WKLY EPIDEMIOL REC, V68, P253; 1993, WKLY EPIDEMIOL REC, V68, P245	39	107	118	0	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 16	2001	345	7					538	541		10.1056/NEJM200108163450711	http://dx.doi.org/10.1056/NEJM200108163450711			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	462QM	11519511				2022-12-28	WOS:000170431300011
J	Stebbins, CE; Galan, JE				Stebbins, CE; Galan, JE			Structural mimicry in bacterial virulence	NATURE			English	Review							PROTEIN-TYROSINE-PHOSPHATASE; GTPASE-ACTIVATING PROTEIN; SALMONELLA-TYPHIMURIUM; CRYSTAL-STRUCTURE; MAMMALIAN-CELLS; YERSINIA; ACTIN; INVASIN; TOXINS; LISTERIA	An important mechanism underlying the strategies used by microbial pathogens to manipulate cellular functions is that of functional mimicry of host activities. In some cases, mimicry is achieved through virulence factors that are direct homologues of host proteins. In others, convergent evolution has produced new effectors that, although having no obvious amino-acid sequence similarity to host factors, are revealed by structural studies to display mimicry at the molecular level.	Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, New Haven, CT 06536 USA	Yale University	Galan, JE (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, 333 Cedar St, New Haven, CT 06536 USA.	jorge.galan@yale.edu	Stebbins, Erec/N-2565-2018	Stebbins, Erec/0000-0001-6229-5308				Alouf JE, 2000, METH MOL B, V145, P1; Black DS, 1997, EMBO J, V16, P2730, DOI 10.1093/emboj/16.10.2730; Bourdet-Sicard R, 2000, MICROBES INFECT, V2, P813, DOI 10.1016/S1286-4579(00)90366-6; Braun L, 2000, EMBO J, V19, P1458, DOI 10.1093/emboj/19.7.1458; Chen YJ, 1996, EMBO J, V15, P3853, DOI 10.1002/j.1460-2075.1996.tb00759.x; Cossart P, 1998, EMBO J, V17, P3797, DOI 10.1093/emboj/17.14.3797; Fu YX, 1999, NATURE, V401, P293, DOI 10.1038/45829; Galan JE, 2000, P NATL ACAD SCI USA, V97, P8754, DOI 10.1073/pnas.97.16.8754; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; GALYOV EE, 1993, NATURE, V361, P730, DOI 10.1038/361730a0; Goehring UM, 1999, J BIOL CHEM, V274, P36369, DOI 10.1074/jbc.274.51.36369; Goosney DL, 2000, ANNU REV CELL DEV BI, V16, P173, DOI 10.1146/annurev.cellbio.16.1.173; GUAN KL, 1990, SCIENCE, V249, P553, DOI 10.1126/science.2166336; Haag F, 1998, J BIOL REG HOMEOS AG, V12, P53; Hamburger ZA, 1999, SCIENCE, V286, P291, DOI 10.1126/science.286.5438.291; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; Hardt WD, 1998, P NATL ACAD SCI USA, V95, P2574, DOI 10.1073/pnas.95.5.2574; Hayward RD, 1999, EMBO J, V18, P4926, DOI 10.1093/emboj/18.18.4926; Isberg RR, 2000, MICROBES INFECT, V2, P793, DOI 10.1016/S1286-4579(00)90364-2; ISBERG RR, 1990, CELL, V60, P861, DOI 10.1016/0092-8674(90)90099-Z; Kaniga K, 1996, MOL MICROBIOL, V21, P633, DOI 10.1111/j.1365-2958.1996.tb02571.x; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; Lerm M, 2000, FEMS MICROBIOL LETT, V188, P1; Marino M, 1999, MOL CELL, V4, P1063, DOI 10.1016/S1097-2765(00)80234-8; Montecucco C, 1996, EXPERIENTIA, V52, P1026, DOI 10.1007/BF01952098; Nassar N, 1998, NAT STRUCT BIOL, V5, P1047, DOI 10.1038/4156; Norris FA, 1998, P NATL ACAD SCI USA, V95, P14057, DOI 10.1073/pnas.95.24.14057; Orth K, 2000, SCIENCE, V290, P1594, DOI 10.1126/science.290.5496.1594; Persson C, 1997, EMBO J, V16, P2307, DOI 10.1093/emboj/16.9.2307; Reyrat JM, 1999, MOL MICROBIOL, V34, P197, DOI 10.1046/j.1365-2958.1999.01592.x; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; Shen Y, 2000, CELL, V103, P501, DOI 10.1016/S0092-8674(00)00141-0; Stebbins CE, 2000, MOL CELL, V6, P1449, DOI 10.1016/S1097-2765(00)00141-6; Stender S, 2000, MOL MICROBIOL, V36, P1206, DOI 10.1046/j.1365-2958.2000.01933.x; STUCKEY JA, 1994, NATURE, V370, P571, DOI 10.1038/370571a0; TRAN VG, 1991, J BIOL CHEM, V266, P24367; VANNHIEU GT, 1993, EMBO J, V12, P1887, DOI 10.1002/j.1460-2075.1993.tb05837.x; VanNhieu GT, 1997, EMBO J, V16, P2717, DOI 10.1093/emboj/16.10.2717; von Pawel-Rammingen U, 2000, MOL MICROBIOL, V36, P737, DOI 10.1046/j.1365-2958.2000.01898.x; Wurtele M, 2001, NAT STRUCT BIOL, V8, P23; Zhou D, 1999, SCIENCE, V283, P2092, DOI 10.1126/science.283.5410.2092	44	239	252	1	16	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 16	2001	412	6848					701	705		10.1038/35089000	http://dx.doi.org/10.1038/35089000			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462ZB	11507631				2022-12-28	WOS:000170450200035
J	Hippisley-Cox, J; Pringle, M				Hippisley-Cox, J; Pringle, M			General practice workload implications of the national service framework for coronary heart disease: cross sectional survey	BRITISH MEDICAL JOURNAL			English	Article									Univ Nottingham, Div Gen Practice, Nottingham NG7 2RD, England	University of Nottingham	Hippisley-Cox, J (corresponding author), Univ Nottingham, Div Gen Practice, Nottingham NG7 2RD, England.		Hippisley-Cox, Julia/AAY-2788-2020	Hippisley-Cox, Julia/0000-0002-2479-7283				Campbell NC, 1998, BMJ-BRIT MED J, V316, P1430, DOI 10.1136/bmj.316.7142.1430; Department of Health, 2000, NAT SERV FRAM COR AR; Hippisley-Cox J, 2001, BMJ-BRIT MED J, V322, P832, DOI 10.1136/bmj.322.7290.832; Ramsay LE, 1999, BMJ-BRIT MED J, V319, P630, DOI 10.1136/bmj.319.7210.630; SMITH GD, 1993, BMJ-BRIT MED J, V306, P1367, DOI 10.1136/bmj.306.6889.1367	5	31	31	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 4	2001	323	7307					269	270		10.1136/bmj.323.7307.269	http://dx.doi.org/10.1136/bmj.323.7307.269			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	461ZT	11485958	Bronze, Green Published			2022-12-28	WOS:000170394300022
J	Alabadi, D; Oyama, T; Yanovsky, MJ; Harmon, FG; Mas, P; Kay, SA				Alabadi, D; Oyama, T; Yanovsky, MJ; Harmon, FG; Mas, P; Kay, SA			Reciprocal regulation between TOC1 and LHY/CCA1 within the Arabidopsis circadian clock	SCIENCE			English	Article							TRANSCRIPTION FACTOR; MOLECULAR-BASES; EXPRESSION; THALIANA; GENE; RHYTHMS; MUTANT	The interactive regulation between clock genes is central for oscillator function. Here, we show interactions between the Arabidopsis clock genes LATE ELONGATED HYPOCOTYL (LHY), CIRCADIAN CLOCK ASSOCIATED 1 (CCA1), and TIMING OF CAB EXPRESSION 1 (TOC1). The MYB transcription factors LHY and CCA1 negatively regulate TOC1 expression. We show that both proteins bind to a region in the TOC1 promoter that is critical for its clock regulation. Conversely, TOC1 appears to participate in the positive regulation of LHY and CCA1 expression. Our results indicate that these interactions form a loop critical for clock function in Arabidopsis.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Inst Childhood & Neglected Dis, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Kay, SA (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.		Mas, Paloma/B-8215-2016; Rosa, Bruce/F-6393-2010; Alabadi, David/AAS-3408-2020; Kay, Steve A/F-6025-2011	Mas, Paloma/0000-0002-3780-8041; Alabadi, David/0000-0001-8492-6713; Kay, Steve A/0000-0002-0402-2878	NIGMS NIH HHS [GM56006] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALABADI D, UNPUB; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Glossop NRJ, 1999, SCIENCE, V286, P766, DOI 10.1126/science.286.5440.766; Green RM, 1999, P NATL ACAD SCI USA, V96, P4176, DOI 10.1073/pnas.96.7.4176; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Hicks KA, 1996, SCIENCE, V274, P790, DOI 10.1126/science.274.5288.790; Martinez-Garcia JF, 2000, SCIENCE, V288, P859, DOI 10.1126/science.288.5467.859; Matsushika A, 2000, PLANT CELL PHYSIOL, V41, P1002, DOI 10.1093/pcp/pcd043; McWatters HG, 2000, NATURE, V408, P716, DOI 10.1038/35047079; MILLAR AJ, 1995, SCIENCE, V267, P1161, DOI 10.1126/science.7855595; Sakai H, 2000, PLANT J, V24, P703, DOI 10.1046/j.1365-313x.2000.00909.x; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Singh KB, 1998, PLANT PHYSIOL, V118, P1111, DOI 10.1104/pp.118.4.1111; Somers DE, 1999, PLANT PHYSIOL, V121, P9, DOI 10.1104/pp.121.1.9; Somers DE, 1998, DEVELOPMENT, V125, P485; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Wang ZY, 1997, PLANT CELL, V9, P491, DOI 10.1105/tpc.9.4.491; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6	20	827	891	14	201	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2001	293	5531					880	883		10.1126/science.1061320	http://dx.doi.org/10.1126/science.1061320			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11486091				2022-12-28	WOS:000170241000049
J	Sonenberg, N; Newgard, CB				Sonenberg, N; Newgard, CB			Protein synthesis - The perks of balancing glucose	SCIENCE			English	Editorial Material							TRANSLATIONAL CONTROL; KINASE; PEK		McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; McGill Univ, McGill Canc Ctr, Montreal, PQ H3G 1Y6, Canada; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Touchstone Ctr Diabet Res, Dallas, TX 75390 USA	McGill University; McGill University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Sonenberg, N (corresponding author), McGill Univ, Dept Biochem, 3655 Drummond St, Montreal, PQ H3G 1Y6, Canada.							Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hinnebusch AG, 2000, COLD SPRING HARBOR M, V39, P185; Liu CY, 2000, J BIOL CHEM, V275, P24881, DOI 10.1074/jbc.M004454200; PROSTKO CR, 1993, MOL CELL BIOCHEM, V128, P255, DOI 10.1007/BF01076776; RON D, COMMUNICATION; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Shi YG, 1999, J BIOL CHEM, V274, P5723, DOI 10.1074/jbc.274.9.5723; Sood R, 2000, BIOCHEM J, V346, P281, DOI 10.1042/0264-6021:3460281	13	18	18	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 3	2001	293	5531					818	819		10.1126/science.1062937	http://dx.doi.org/10.1126/science.1062937			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11486079				2022-12-28	WOS:000170241000033
J	Barabasi, AL; Freeh, VW; Jeong, HW; Brockman, JB				Barabasi, AL; Freeh, VW; Jeong, HW; Brockman, JB			Parasitic computing	NATURE			English	Article							WEB	Reliable communication on the Internet is guaranteed by a standard set of protocols, used by all computers(1). Here we show that these protocols can be exploited to compute with the communication infrastructure, transforming the Internet into a distributed computer in which servers unwittingly perform computation on behalf of a remote node. In this model, which we call 'parasitic computing', one machine forces target computers to solve a piece of a complex computational problem merely by engaging them in standard communication. Consequently, the target computers are unaware that they have performed computation for the benefit of a commanding node. As experimental evidence of the principle of parasitic computing, we harness the power of several web servers across the globe, which-unknown to them-work together to solve an NP complete problem(2).	Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA; Univ Notre Dame, Dept Comp Sci & Engn, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame	Barabasi, AL (corresponding author), Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA.		Jeong, Hawoong/AAR-2524-2021; Barabasi, Albert-Laszlo/S-6474-2017; Jeong, Hawoong/C-1587-2011; Jeong, Hawoong/A-2469-2009	Jeong, Hawoong/0000-0002-2491-8620; Jeong, Hawoong/0000-0002-2491-8620; Barabasi, Albert/0000-0002-4028-3522				ALDERMAN LM, 1994, SCIENCE, V266, P1021; Boole G., 1854, INVESTIGATION LAWS T; Cohen R, 2001, PHYS REV LETT, V86, P3682, DOI 10.1103/PhysRevLett.86.3682; Cohen R, 2000, PHYS REV LETT, V85, P4626, DOI 10.1103/PhysRevLett.85.4626; FOSTER I, 2000, NATURE WEB MATTERS; Garey M.R., 1979, COMPUTERS INTRACTABI; Lawrence S, 1999, NATURE, V400, P107, DOI 10.1038/21987; Lawrence S, 1998, SCIENCE, V280, P98, DOI 10.1126/science.280.5360.98; Ouyang Q, 1997, SCIENCE, V278, P446, DOI 10.1126/science.278.5337.446; Peterson L., 2011, COMPUTER NETWORKS SY; SCHONING U, 1999, P 40 ANN IEEE S FDN, P410; STEVENS WR, 1994, TCP IP ILLUSTRATED, P144; Stone J, 1998, IEEE ACM T NETWORK, V6, P529, DOI 10.1109/90.731187; STONE J, 2000, P ACM SIGCOMM, P309	14	42	43	0	13	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2001	412	6850					894	897		10.1038/35091039	http://dx.doi.org/10.1038/35091039			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467EG	11528474				2022-12-28	WOS:000170689000040
J	Kokoouline, V; Greene, CH; Esry, BD				Kokoouline, V; Greene, CH; Esry, BD			Mechanism for the destruction of H-3(+) ions by electron impact	NATURE			English	Article							QUANTUM-DEFECT THEORY; COULOMBIC 3-BODY SYSTEMS; RYDBERG STATE DYNAMICS; DISSOCIATIVE RECOMBINATION; STORAGE-RING; H-3+; SERIES; D-3(+); HCO+	The rate at which the simplest triatomic ion (H-3(+)) dissociates following recombination with a low-energy electron has been measured in numerous experiments(1-10). This process is particularly important for understanding observations of H-3(+) in diffuse interstellar clouds(11-13). But, despite extensive efforts(14,15), no theoretical treatment has yet proved capable of predicting the measured dissociative recombination rates at low energy, even to within an order of magnitude. Here we show that the Jahn-Teller symmetry-distortion effect(16-19)-almost universally neglected in the theoretical description of electron-molecule collisions-generates recombination at a much faster rate than any other known mechanism. Our estimated rate constant overlaps the range of values spanned by experiments. We treat the low-energy collision process as a curve-crossing problem, which was previously thought inapplicable(20) to low-energy recombination in H-3(+). Our calculation reproduces the measured propensity for three-body versus two-body breakup of the neutral fragments(3), as well as the vibrational distribution(4) of the H-2 product molecules.	Univ Colorado, Dept Phys, Boulder, CO 80309 USA; Univ Colorado, Joint Inst Lab Astrophys, Boulder, CO 80309 USA; Kansas State Univ, Dept Phys, Manhattan, KS 66506 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Kansas State University	Greene, CH (corresponding author), Univ Colorado, Dept Phys, Boulder, CO 80309 USA.		Esry, Brett D/H-7511-2013; Greene, Chris H/C-3821-2011	Esry, Brett D/0000-0003-3207-8526; Greene, Chris H/0000-0002-2096-6385; Kokoouline, Viatcheslav/0000-0002-9945-0858				AMANO T, 1990, J CHEM PHYS, V92, P6492, DOI 10.1063/1.458594; BATES DR, 1992, J PHYS B-AT MOL OPT, V25, P5479, DOI 10.1088/0953-4075/25/24/025; BORDAS MC, 1991, PHYS REV A, V44, P1817, DOI 10.1103/PhysRevA.44.1817; Cecchi-Pestellini C, 2000, MON NOT R ASTRON SOC, V313, pL6, DOI 10.1046/j.1365-8711.2000.03320.x; DATZ S, 1995, PHYS REV LETT, V74, P896, DOI 10.1103/PhysRevLett.74.896; Esry BD, 1996, PHYS REV A, V54, P394, DOI 10.1103/PhysRevA.54.394; Geballe TR, 2000, PHILOS T R SOC A, V358, P2503, DOI 10.1098/rsta.2000.0663; GIUSTI A, 1980, J PHYS B-AT MOL OPT, V13, P3867, DOI 10.1088/0022-3700/13/19/025; Glosik J, 2000, CHEM PHYS LETT, V331, P209, DOI 10.1016/S0009-2614(00)01183-0; GREENE CH, 1985, ADV ATOM MOL PHYS, V21, P51, DOI 10.1016/S0065-2199(08)60141-4; Jaquet R, 1998, J CHEM PHYS, V108, P2837, DOI 10.1063/1.475703; Jensen MJ, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.052701; Jungen Ch., 1996, MOL APPL QUANTUM DEF; LARSSON M, 1993, PHYS REV LETT, V70, P430, DOI 10.1103/PhysRevLett.70.430; Larsson M, 2000, PHILOS T ROY SOC A, V358, P2433, DOI 10.1098/rsta.2000.0658; Laube S, 1998, J PHYS B-AT MOL OPT, V31, P2111, DOI 10.1088/0953-4075/31/9/023; LIN CD, 1995, PHYS REP, V257, P2; McCall BJ, 1998, SCIENCE, V279, P1910, DOI 10.1126/science.279.5358.1910; Mistrik I, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.033410; Oka T, 2000, PHILOS T R SOC A, V358, P2363, DOI 10.1098/rsta.2000.0653; OMALLEY TF, 1966, PHYS REV, V150, P14, DOI 10.1103/PhysRev.150.14; Orel AE, 2000, PHILOS T ROY SOC A, V358, P3293, DOI 10.1098/rsta.2000.2000; OREL AE, 1993, PHYS REV LETT, V71, P4315, DOI 10.1103/PhysRevLett.71.4315; Schneider IF, 2000, PHYS REV LETT, V85, P3785, DOI 10.1103/PhysRevLett.85.3785; STAIB A, 1990, Z PHYS D ATOM MOL CL, V16, P275, DOI 10.1007/BF01437531; STEPHENS JA, 1995, J CHEM PHYS, V102, P1579, DOI 10.1063/1.468890; STEPHENS JA, 1994, PHYS REV LETT, V72, P1624, DOI 10.1103/PhysRevLett.72.1624; Strasser D, 2001, PHYS REV LETT, V86, P779, DOI 10.1103/PhysRevLett.86.779; SUNDSTROM G, 1994, SCIENCE, V263, P785, DOI 10.1126/science.263.5148.785; TANABE T, 2000, DISSOCIATIVE RECOMBI, V4, P170; ZHOU Y, 1993, J PHYS B-AT MOL OPT, V26, P3937, DOI 10.1088/0953-4075/26/21/026	31	168	168	1	17	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2001	412	6850					891	894		10.1038/35091025	http://dx.doi.org/10.1038/35091025			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467EG	11528473				2022-12-28	WOS:000170689000039
J	Higashiyama, T; Yabe, S; Sasaki, N; Nishimura, Y; Miyagishima, S; Kuroiwa, H; Kuroiwa, T				Higashiyama, T; Yabe, S; Sasaki, N; Nishimura, Y; Miyagishima, S; Kuroiwa, H; Kuroiwa, T			Pollen tube attraction by the synergid cell	SCIENCE			English	Article							NAKED EMBRYO SAC; TORENIA-FOURNIERI; DOUBLE FERTILIZATION; FEMALE GAMETOPHYTE; NICOTIANA-ALATA; AXON GUIDANCE; IN-VITRO; GROWTH; ARABIDOPSIS; ORGANIZATION	In flowering plants, guidance of the pollen tube to the embryo sac (the haploid female gametophyte) is critical for successful fertilization. The target embryo sac may attract the pollen tube as the final step of guidance in the pistil. We show by laser Ceti ablation that two synergid cells adjacent to the egg cell attract the pollen tube. A single synergid cell was sufficient to generate an attraction signal, and two cells enhanced it. After fertilization, the embryo sac no longer attracts the pollen tube, despite the persistence of one synergid cell. This cessation of attraction might be involved in blocking polyspermy.	Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan; Ochanomizu Univ, Dept Biol, Tokyo 1128610, Japan	University of Tokyo; Ochanomizu University	Higashiyama, T (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan.	higashi@biol.s.u-tokyo.ac.jp	Higashiyama, Tetsuya/C-2882-2012	Higashiyama, Tetsuya/0000-0002-7346-360X; Miyagishima, Shin-ya/0000-0002-9111-0832; Nishimura, Yoshiki/0000-0001-8686-9206				CASS DD, 1974, PROTOPLASMA, V81, P49, DOI 10.1007/BF02055773; CHEUNG AY, 1995, CELL, V82, P383, DOI 10.1016/0092-8674(95)90427-1; Drews GN, 1998, PLANT CELL, V10, P5, DOI 10.1105/tpc.10.1.5; DUMAS C, 1984, INT REV CYTOL, V90, P239, DOI 10.1016/S0074-7696(08)61491-6; Goodhill GJ, 1997, EUR J NEUROSCI, V9, P1414, DOI 10.1111/j.1460-9568.1997.tb01496.x; GUILFORD VIVIAN B., 1952, BULL TORREY BOT CLUB, V79, P6, DOI 10.2307/2482102; Higashiyama T, 1997, PLANTA, V203, P101, DOI 10.1007/s004250050170; Higashiyama T, 1998, PLANT CELL, V10, P2019, DOI 10.1105/tpc.10.12.2019; Higashiyama T, 2000, PLANT PHYSIOL, V122, P11, DOI 10.1104/pp.122.1.11; HIGASHIYAMA T, UNPUB; HUANG BQ, 1992, INT REV CYTOL, V140, P233, DOI 10.1016/S0074-7696(08)61099-2; HULSKAMP M, 1995, PLANT CELL, V7, P57, DOI 10.1105/tpc.7.1.57; Lord E, 2000, TRENDS PLANT SCI, V5, P368, DOI 10.1016/S1360-1385(00)01744-1; Lush WM, 1999, TRENDS PLANT SCI, V4, P413, DOI 10.1016/S1360-1385(99)01473-9; Lush WM, 1998, PLANT PHYSIOL, V118, P733, DOI 10.1104/pp.118.3.733; Maheshwari P., 1950, INTRO EMBRYOLOGY ANG; MOL R, 1986, PLANT CELL REP, V3, P202; Palanivelu R, 2000, TRENDS CELL BIOL, V10, P517, DOI 10.1016/S0962-8924(00)01849-3; Pruitt RE, 1999, CURR OPIN PLANT BIOL, V2, P419, DOI 10.1016/S1369-5266(99)00015-1; Ray S, 1997, DEVELOPMENT, V124, P2489; Russell SD, 1996, SEX PLANT REPROD, V9, P337, DOI 10.1007/BF02441952; RUSSELL SD, 1992, INT REV CYTOL, V140, P357, DOI 10.1016/S0074-7696(08)61102-X; Shimizu KK, 2000, DEVELOPMENT, V127, P4511; Wilhelmi LK, 1996, SCIENCE, V274, P1535, DOI 10.1126/science.274.5292.1535; Wilhelmi LK, 1997, PLANT PHYSIOL, V113, P307, DOI 10.1104/pp.113.2.307; Wolters-Arts M, 1998, NATURE, V392, P818, DOI 10.1038/33929; Wu HM, 2000, PLANT J, V22, P165, DOI 10.1046/j.1365-313x.2000.00731.x; WU HM, 1995, CELL, V82, P395, DOI 10.1016/0092-8674(95)90428-X	28	303	338	6	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2001	293	5534					1480	1483		10.1126/science.1062429	http://dx.doi.org/10.1126/science.1062429			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465XV	11520985				2022-12-28	WOS:000170616000042
J	Velebit, V; Schneider, P				Velebit, V; Schneider, P			Carotid-body tumor	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Hop Tour, Geneva, Switzerland		Velebit, V (corresponding author), Hop Tour, Geneva, Switzerland.								0	0	2	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 23	2001	345	8					587	587		10.1056/NEJMicm960533	http://dx.doi.org/10.1056/NEJMicm960533			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464ZH	11529213				2022-12-28	WOS:000170562900006
J	Garfield, R				Garfield, R			Economic sanctions on Yugoslavia	LANCET			English	Editorial Material									Columbia Univ, Sch Nursing, New York, NY 10032 USA	Columbia University	Garfield, R (corresponding author), Columbia Univ, Sch Nursing, Box 6,630 W 168th St, New York, NY 10032 USA.							GARFIELD R, 2001, EC SANCT HLTH WELF F; Garfield R., 1999, IMPACT EC SANCTIONS; *WORLD BANK, 2001, FED REP YUG BREAK PA	3	9	9	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 18	2001	358	9281					580	580		10.1016/S0140-6736(01)05713-0	http://dx.doi.org/10.1016/S0140-6736(01)05713-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464NB	11520550				2022-12-28	WOS:000170537700037
J	Lindholm, LH; Anderson, H; Ekbom, T; Hansson, L; Lanke, J; Dahlof, B; de Faire, U; Forsen, K; Hedner, T; Linjer, E; Schersten, B; Wester, PO; Moller, TR				Lindholm, LH; Anderson, H; Ekbom, T; Hansson, L; Lanke, J; Dahlof, B; de Faire, U; Forsen, K; Hedner, T; Linjer, E; Schersten, B; Wester, PO; Moller, TR			Relation between drug treatment and cancer in hypertensives in the Swedish Trial in Old Patients with Hypertension 2: a 5-year, prospective, randomised, controlled trial	LANCET			English	Article							ISOLATED SYSTOLIC HYPERTENSION; CALCIUM-CHANNEL BLOCKERS; BLOOD-PRESSURE; ANTIHYPERTENSIVE DRUGS; ACTIVE TREATMENT; RISK; MORTALITY; MEN; MORBIDITY; PLACEBO	Background Is cancer related to hypertension and blood pressure? Do anti hypertensive drugs promote cancer? Do antihypertensive drugs protect against cancer? We previously analysed the frequency of cardiovascular mortality and morbidity in elderly people who participated in the Swedish Trial in Old Patients with Hypertension 2 (STOP-Hypertension-2). We have also looked at the frequency of cancer in these patients. Methods We randomly assigned 6614 elderly patients with hypertension (mean age 76 years, median time of follow-up 5.3 years) to one of three treatment strategies: conventional drugs (diuretics or beta -blockers), calcium antagonists, or ACE inhibitors. We matched the patients to the Swedish Cancer Registry and compared our findings with expected values based on age, sex, and calendar-year-specific reference frequencies for the general Swedish population. We also compared the number of cancers between the three treatment groups. Findings At baseline, 607 (9%) patients had previous malignant disease. Diagnoses were closely similar to the distribution of cancer types that might be seen in elderly patients. During follow-up, there were 625 new cases of cancer in 590 patients. The frequency of cancer did not differ significantly between the treatment strategies, including all cancers and those at individual sites. The standardised incidence ratios (SIRs) for all cancers were also close to unity: 0.92 (95% CI 0.80-1.06) for conventional drugs, 0.96 (0.83-1.10) for calcium antagonists, and 0.99 (0.86-1.13) for ACE inhibitors. Interpretations No difference in cancer risk was seen between patients randomly assigned to conventional drugs, calcium antagonists, or ACE inhibitors. Thus, the general message to the practising physician is that more attention should be given to getting the blood pressure down than to the risk of cancer.	Umea Univ, Dept Publ Hlth & Clin Med, SE-90185 Umea, Sweden; Lund Univ, Dept Canc Epidemiol, Lund, Sweden; Malmo Univ Hosp, Dept Community Med, Malmo, Sweden; Uppsala Univ, Dept Publ Hlth & Social Sci, Uppsala, Sweden; Sahlgrens Univ Hosp, Dept Med, S-41345 Gothenburg, Sweden; Sahlgrens Univ Hosp, Dept Clin Pharmacol, S-41345 Gothenburg, Sweden; Lund Univ, Dept Stat, S-22100 Lund, Sweden; Karolinska Univ Hosp, Dept Med, Stockholm, Sweden; Lund Univ, Dept Community Hlth Sci Dalby Lund, S-22100 Lund, Sweden	Umea University; Lund University; Lund University; Skane University Hospital; Uppsala University; Sahlgrenska University Hospital; Sahlgrenska University Hospital; Lund University; Karolinska Institutet; Karolinska University Hospital; Lund University	Lindholm, LH (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, SE-90185 Umea, Sweden.							Dahlof B, 1993, Blood Press, V2, P136, DOI 10.3109/08037059309077541; DAHLOF B, 1991, LANCET, V338, P1281, DOI 10.1016/0140-6736(91)92589-T; DYER AR, 1975, LANCET, V1, P1051; FILIPOVSKY J, 1993, INT J OBESITY, V17, P197; Gong LS, 1996, J HYPERTENS, V14, P1237, DOI 10.1097/00004872-199610000-00013; GROVE JS, 1991, AM J EPIDEMIOL, V134, P942, DOI 10.1093/oxfordjournals.aje.a116178; Hamet P, 1996, HYPERTENSION, V28, P321, DOI 10.1161/01.HYP.28.3.321; Hansson L, 1999, LANCET, V354, P1751, DOI 10.1016/S0140-6736(99)10327-1; HELLSTROM J, 1958, Br J Urol, V30, P13, DOI 10.1111/j.1464-410X.1958.tb03498.x; Hole DJ, 1998, J HYPERTENS, V16, P119, DOI 10.1097/00004872-199816010-00017; HOLE DJ, 1993, BRIT MED J, V306, P609, DOI 10.1136/bmj.306.6878.609; Jick H, 1997, LANCET, V349, P525, DOI 10.1016/S0140-6736(97)80084-0; Lever AF, 1998, LANCET, V352, P179, DOI 10.1016/S0140-6736(98)03228-0; Lever AF, 1999, CLIN EXP HYPERTENS, V21, P937, DOI 10.3109/10641969909061022; LINDHOLM L, 1986, ENVIRON RES, V40, P202, DOI 10.1016/S0013-9351(86)80097-4; Lindholm Lars H., 1996, Blood Pressure, V5, P300, DOI 10.3109/08037059609078063; Liu LS, 1998, J HYPERTENS, V16, P1823, DOI 10.1097/00004872-199816120-00016; MATTSSON B, 1984, THESIS KAROLINSKA I; *NORW SWED EXP GRO, 1994, BLOOD PRESSURE, V3, P219; *ONC CTR SWED, 1995, ATL CANC INC SWED, P1; Pahor M, 1996, LANCET, V348, P493, DOI 10.1016/S0140-6736(96)04277-8; Pahor M, 1996, AM J HYPERTENS, V9, P695, DOI 10.1016/0895-7061(96)00186-0; Peeters PHM, 1998, J HYPERTENS, V16, P941, DOI 10.1097/00004872-199816070-00007; Peeters PHM, 2000, J HYPERTENS, V18, P249, DOI 10.1097/00004872-200018030-00002; Rosengren A, 1998, J HYPERTENS, V16, P933, DOI 10.1097/00004872-199816070-00006; Shapiro JA, 1999, AM J EPIDEMIOL, V149, P521; Soler M, 1999, HYPERTENSION, V34, P320, DOI 10.1161/01.HYP.34.2.320; Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6; Wannamethee G, 1996, INT J EPIDEMIOL, V25, P22, DOI 10.1093/ije/25.1.22	29	92	95	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 18	2001	358	9281					539	544		10.1016/S0140-6736(01)05704-X	http://dx.doi.org/10.1016/S0140-6736(01)05704-X			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464NB	11520524				2022-12-28	WOS:000170537700011
J	Stene, LC; Magnus, P; Lie, RT; Sovik, O; Joner, G				Stene, LC; Magnus, P; Lie, RT; Sovik, O; Joner, G		Norwegian Childhood Diabet Study	Maternal and paternal age at delivery, birth order, and risk of childhood onset type 1 diabetes: population based cohort study	BRITISH MEDICAL JOURNAL			English	Article							ENVIRONMENTAL-FACTORS; MELLITUS; DETERMINANTS; YORKSHIRE; UK	Objective To estimate the associations of maternal and paternal age at delivery and of birth order with the risk of childhood onset type I diabetes. Design Cohort study by record linkage of the medical birth registry and the national childhood diabetes registry in Norway. Setting Norway. Subjects All live births in Norway between 1974 and 1998 (1.4 million people) were followed for a maximum of 15 years, contributing 8.2 million person years of observation during 1989-98. 1824 cases of type I diabetes diagnosed between 1989 and 1998 were identified. Main outcome measures Incidence of type I diabetes. Results There was no association between maternal age at delivery and type 1 diabetes among firstborn children, but among fourthborn children there was a 43.2% increase in incidence of diabetes for each five year increase in maternal age (95% confidence interval 6.4% to 92.6%). Each increase in birth order was associated with a 17.9% reduction in incidence (3.2% to 30.4%) when maternal age was 20-24 years, but the association was weaker when maternal age was 30 years or more. Paternal age was not associated with type 1 diabetes after maternal age was adjusted for. Conclusions Intrauterine factors and early life environment may influence the risk of type I diabetes. The relation of maternal age and birth order to risk of type I diabetes is complex.	Aker Hosp, Ctr Diabet Res, N-0407 Oslo, Norway; Univ Oslo, Ulleval Hosp, Ctr Diabet Res, Dept Paediat, N-0407 Oslo, Norway; Natl Publ Hlth Inst, Dept Populat Hlth Sci, Epidemiol Sect, N-0403 Oslo, Norway; Haukeland Hosp, Med Birth Registry Norway, N-5021 Bergen, Norway; Haukeland Hosp, Dept Paediat, N-5021 Bergen, Norway	University of Oslo; University of Oslo; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital	Stene, LC (corresponding author), Aker Hosp, Ctr Diabet Res, N-0407 Oslo, Norway.							Akerblom HK, 1998, DIABETES METAB REV, V14, P31, DOI 10.1002/(SICI)1099-0895(199803)14:1&lt;31::AID-; Bache I, 1999, DIABETES CARE, V22, P1063, DOI 10.2337/diacare.22.7.1063; BERENDES HW, 1991, REPROD PERINATAL EPI, P28; Bingley PJ, 2000, BMJ-BRIT MED J, V321, P420, DOI 10.1136/bmj.321.7258.420; BYRNES G, 2000, FLAWED ANAL INVALIDA; DAHLQUIST G, 1992, DIABETOLOGIA, V35, P671, DOI 10.1007/BF00400261; DAHLQUIST G, 1991, DIABETOLOGIA, V34, P757, DOI 10.1007/BF00401524; Dahlquist GG, 1999, DIABETES CARE, V22, P1698, DOI 10.2337/diacare.22.10.1698; FLOOD TM, 1982, DIABETES CARE, V5, P571, DOI 10.2337/diacare.5.6.571; Green A, 2000, LANCET, V355, P873; Jones ME, 1998, INT J EPIDEMIOL, V27, P444, DOI 10.1093/ije/27.3.444; McKinney PA, 2000, DIABETIC MED, V17, P236, DOI 10.1046/j.1464-5491.2000.00220.x; McKinney PA, 1999, DIABETES CARE, V22, P928, DOI 10.2337/diacare.22.6.928; MORINPAPUNEN L, 1984, MED BIOL, V62, P323; PATTERSON CC, 1994, DIABETES CARE, V17, P376, DOI 10.2337/diacare.17.5.376; PRESTON D. L., 1993, EPICURE USERS GUIDE; SKJAERVEN R, 1988, AM J EPIDEMIOL, V128, P1352, DOI 10.1093/oxfordjournals.aje.a115088; SOLTESZ G, 1994, ACTA PAEDIATR, V83, P730, DOI 10.1111/j.1651-2227.1994.tb13128.x; Stene LC, 2001, BMJ-BRIT MED J, V322, P889, DOI 10.1136/bmj.322.7291.889; Tai TY, 1998, DIABETES RES CLIN PR, V42, P197, DOI 10.1016/S0168-8227(98)00105-3; Wadsworth EJK, 1997, DIABETIC MED, V14, P390, DOI 10.1002/(SICI)1096-9136(199705)14:5<390::AID-DIA364>3.0.CO;2-E; WAGENER DK, 1983, DIABETOLOGIA, V25, P82	22	69	71	0	10	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 18	2001	323	7309					369	371		10.1136/bmj.323.7309.369	http://dx.doi.org/10.1136/bmj.323.7309.369			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465GN	11509426	Bronze, Green Published			2022-12-28	WOS:000170581400015
J	Walker, F; Walker, DA; Nielsen, M				Walker, F; Walker, DA; Nielsen, M			Flash pulmonary oedema	LANCET			English	Editorial Material							RENAL-ARTERY STENOSIS; EDEMA; REVASCULARIZATION; HYPERTENSION; DISEASE		Southampton Gen Hosp, Southampton, Hants, England	University of Southampton	Walker, F (corresponding author), Southampton Gen Hosp, Tremona Rd, Southampton, Hants, England.			Walker, David/0000-0002-7140-6855				DIAMOND JR, 1993, AM J KIDNEY DIS, V21, P328, DOI 10.1016/S0272-6386(12)80756-6; JACOBSON HR, 1988, KIDNEY INT, V34, P729, DOI 10.1038/ki.1988.240; KOCH KM, 1968, J CLIN INVEST, V47, P1696, DOI 10.1172/JCI105860; MESSINA LM, 1992, J VASC SURG, V15, P73, DOI 10.1016/0741-5214(92)70015-D; PICKERING TG, 1988, LANCET, V2, P551	5	14	15	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 18	2001	358	9281					556	556		10.1016/S0140-6736(01)05708-7	http://dx.doi.org/10.1016/S0140-6736(01)05708-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464NB	11520528				2022-12-28	WOS:000170537700015
J	Bahr, R				Bahr, R			Recent advances - Sports medicine	BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED TRIAL; MIDDLE-AGED MEN; PHYSICAL-ACTIVITY; CARDIORESPIRATORY FITNESS; ANKLE SPRAINS; RISK-FACTORS; CARDIOVASCULAR-DISEASE; OSTEOPOROTIC FRACTURES; ELDERLY PEOPLE; KNEE INJURY		Norwegian Univ Sport & Phys Educ, Oslo Sports Trauma Res Ctr, N-0806 Oslo, Norway	Norwegian School of Sport Sciences	Bahr, R (corresponding author), Norwegian Univ Sport & Phys Educ, Oslo Sports Trauma Res Ctr, N-0806 Oslo, Norway.		Bahr, Roald/B-6964-2014	Bahr, Roald/0000-0001-5725-4237				ARENDT E, 1995, AM J SPORT MED, V23, P694, DOI 10.1177/036354659502300611; Blair SN, 1996, JAMA-J AM MED ASSOC, V276, P205, DOI 10.1001/jama.276.3.205; Blair SN, 1999, MED SCI SPORT EXER, V31, pS646, DOI 10.1097/00005768-199911001-00025; Boden BP, 2000, PHYSICIAN SPORTSMED, V28, P53, DOI 10.3810/psm.2000.04.841; Caraffa A, 1996, Knee Surg Sports Traumatol Arthrosc, V4, P19, DOI 10.1007/BF01565992; *CDCP, 1996, JAMA-J AM MED ASSOC, V276, P522, DOI DOI 10.1001/JAMA.1996.03540070018010; Dunn AL, 1999, JAMA-J AM MED ASSOC, V281, P327, DOI 10.1001/jama.281.4.327; Evans WJ, 1999, MED SCI SPORT EXER, V31, P12, DOI 10.1097/00005768-199901000-00004; Farrell SW, 1998, MED SCI SPORT EXER, V30, P899, DOI 10.1097/00005768-199806000-00019; FIATARONE MA, 1994, NEW ENGL J MED, V330, P1769, DOI 10.1056/NEJM199406233302501; Haapanen N, 1997, INT J EPIDEMIOL, V26, P739, DOI 10.1093/ije/26.4.739; Hartard M, 1996, AM J PHYS MED REHAB, V75, P21, DOI 10.1097/00002060-199601000-00006; Heidt RS, 2000, AM J SPORT MED, V28, P659, DOI 10.1177/03635465000280050601; Heinonen A, 1996, LANCET, V348, P1343, DOI 10.1016/S0140-6736(96)04214-6; Hewett TE, 1999, AM J SPORT MED, V27, P699, DOI 10.1177/03635465990270060301; Hurley BF, 2000, SPORTS MED, V30, P249, DOI 10.2165/00007256-200030040-00002; Kannus P, 1999, BMJ-BRIT MED J, V318, P205; Natri A, 1999, SPORTS MED, V28, P35, DOI 10.2165/00007256-199928010-00004; NELSON ME, 1994, JAMA-J AM MED ASSOC, V272, P1909, DOI 10.1001/jama.272.24.1909; PATRICK K, 1994, PHYSICIAN SPORTSMED, V22, P45, DOI 10.1080/00913847.1994.11947706; Pescatello LS, 2000, BRIT J SPORT MED, V34, P86, DOI 10.1136/bjsm.34.2.86; Rosengren A, 1997, ANN EPIDEMIOL, V7, P69, DOI 10.1016/S1047-2797(96)00106-8; SITLER M, 1994, AM J SPORT MED, V22, P454, DOI 10.1177/036354659402200404; SURVE I, 1994, AM J SPORT MED, V22, P601, DOI 10.1177/036354659402200506; Thacker SB, 1999, AM J SPORT MED, V27, P753, DOI 10.1177/03635465990270061201; TROPP H, 1985, AM J SPORT MED, V13, P259, DOI 10.1177/036354658501300408; Verhagen EALM, 2000, CLIN J SPORT MED, V10, P291, DOI 10.1097/00042752-200010000-00012; Wedderkopp N, 1999, SCAND J MED SCI SPOR, V9, P41; Wei M, 1999, JAMA-J AM MED ASSOC, V282, P1547, DOI 10.1001/jama.282.16.1547; Weinsier RL, 1998, AM J MED, V105, P145, DOI 10.1016/S0002-9343(98)00190-9	30	12	14	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 11	2001	323	7308					328	331		10.1136/bmj.323.7308.328	http://dx.doi.org/10.1136/bmj.323.7308.328			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463HK	11498493	Green Published			2022-12-28	WOS:000170470900023
J	Dhar, SK; Yoshida, K; Machida, Y; Khaira, P; Chaudhuri, B; Wohlschlegel, JA; Leffak, M; Yates, J; Dutta, A				Dhar, SK; Yoshida, K; Machida, Y; Khaira, P; Chaudhuri, B; Wohlschlegel, JA; Leffak, M; Yates, J; Dutta, A			Replication from oriP of Epstein-Barr virus requires human ORC and is inhibited by geminin	CELL			English	Article							ORIGIN RECOGNITION COMPLEX; DNA-REPLICATION; DROSOPHILA HOMOLOG; CELL-CYCLE; INITIATION; PROTEINS; XENOPUS; YEAST; ASSOCIATION; SEPARATION	A hypomorphic mutation made in the ORC2 gene of a human cancer cell line through homologous recombination decreased Orc2 protein levels by 90%. The G1 phase of the cell cycle was prolonged, but there was no effect on the utilization of either the c-Myc or beta -globin cellular origins of replication. Cells carrying this mutation failed to support the replication of a plasmid bearing the oriP replicator of Epstein Barr virus (EBV), and this defect was rescued by reintroduction of Orc2. Orc2 specifically associates with oriP in cells, most likely through its interaction with EBNA1. Geminin, an inhibitor of the mammalian replication initiation complex, inhibits replication from oriP. Therefore, ORC and the human replication initiation apparatus is required for replication from a viral origin of replication.	Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Wright State Univ, Dept Biochem & Mol Biol, Dayton, OH 45435 USA; Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University System of Ohio; Wright State University Dayton; Roswell Park Cancer Institute	Dutta, A (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	adutta@rics.bwh.harvard.edu	Machida, Yuichi/AAO-3533-2021; Dutta, Anindya/P-3203-2016	Machida, Yuichi/0000-0003-1414-0568; Dutta, Anindya/0000-0002-4319-0073	NCI NIH HHS [CA43122, CA60499] Funding Source: Medline; NIGMS NIH HHS [GM53819] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA043122, R01CA060499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053819] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aladjem MI, 1998, SCIENCE, V281, P1005, DOI 10.1126/science.281.5379.1005; Austin RJ, 1999, GENE DEV, V13, P2639, DOI 10.1101/gad.13.20.2639; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; BLOW JJ, 1986, CELL, V47, P577, DOI 10.1016/0092-8674(86)90622-7; Carpenter PB, 1996, NATURE, V379, P357, DOI 10.1038/379357a0; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; CHEN CL, 1993, J VIROL, V67, P6303, DOI 10.1128/JVI.67.10.6303-6308.1993; Chesnokov I, 1999, GENE DEV, V13, P1289, DOI 10.1101/gad.13.10.1289; Cocker JH, 1996, NATURE, V379, P180, DOI 10.1038/379180a0; DERSHOWITZ A, 1993, MOL CELL BIOL, V13, P391, DOI 10.1128/MCB.13.1.391; Diffley JFX, 1995, J CELL SCI, P67; Dutta A, 1997, ANNU REV CELL DEV BI, V13, P293, DOI 10.1146/annurev.cellbio.13.1.293; EHRENHOFERMURRAY AE, 1995, SCIENCE, V270, P1671, DOI 10.1126/science.270.5242.1671; FOSS M, 1993, SCIENCE, V262, P1838, DOI 10.1126/science.8266071; FRAPPIER L, 1991, J BIOL CHEM, V266, P7819; GAHN TA, 1989, CELL, V58, P527, DOI 10.1016/0092-8674(89)90433-9; GAVIN KA, 1995, SCIENCE, V270, P1667, DOI 10.1126/science.270.5242.1667; GILBERT DM, 1995, J BIOL CHEM, V270, P9597, DOI 10.1074/jbc.270.16.9597; GOSSEN M, 1995, SCIENCE, V270, P1674, DOI 10.1126/science.270.5242.1674; HARRISON S, 1994, J VIROL, V68, P1913, DOI 10.1128/JVI.68.3.1913-1925.1994; IP YT, 1988, J BIOL CHEM, V263, P14044; Kamath S, 2001, NUCLEIC ACIDS RES, V29, P809, DOI 10.1093/nar/29.3.809; Landis G, 1997, P NATL ACAD SCI USA, V94, P3888, DOI 10.1073/pnas.94.8.3888; LASKEY R, 1996, DNA REPLICATION EUKA, P119; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Malott M, 1999, MOL CELL BIOL, V19, P5685; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; MIDDLETON T, 1992, J VIROL, V66, P489, DOI 10.1128/JVI.66.1.489-495.1992; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; Pak DTS, 1997, CELL, V91, P311, DOI 10.1016/S0092-8674(00)80415-8; Pinto S, 1999, NEURON, V23, P45, DOI 10.1016/S0896-6273(00)80752-7; Quintana DG, 1997, J BIOL CHEM, V272, P28247, DOI 10.1074/jbc.272.45.28247; Stillman B, 1996, SCIENCE, V274, P1659, DOI 10.1126/science.274.5293.1659; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Tao L, 2000, J CELL BIOCHEM, V78, P442, DOI 10.1002/1097-4644(20000901)78:3<442::AID-JCB9>3.0.CO;2-1; Tatsumi Y, 2000, J BIOL CHEM, V275, P5904, DOI 10.1074/jbc.275.8.5904; Thome KC, 2000, J BIOL CHEM, V275, P35233, DOI 10.1074/jbc.M005765200; Tugal T, 1998, J BIOL CHEM, V273, P32421, DOI 10.1074/jbc.273.49.32421; WALDMAN T, 1995, CANCER RES, V55, P5187; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; YATES JL, 1985, NATURE, V313, P812, DOI 10.1038/313812a0; Yates JL, 2000, J VIROL, V74, P4512, DOI 10.1128/JVI.74.10.4512-4522.2000; YATES JL, 1991, J VIROL, V65, P483, DOI 10.1128/JVI.65.1.483-488.1991; YATES JL, 1988, CANC CELLS, P197	44	232	239	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2001	106	3					287	296		10.1016/S0092-8674(01)00458-5	http://dx.doi.org/10.1016/S0092-8674(01)00458-5			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RJ	11509178	Bronze			2022-12-28	WOS:000170433300007
J	Menz, RI; Walker, JE; Leslie, AGW				Menz, RI; Walker, JE; Leslie, AGW			Structure of bovine mitochondrial Fl-ATPase with nucleotide bound to all three catalytic sites: Implications for the mechanism of rotary catalysis	CELL			English	Article							F-1-ATPASE; SYNTHASE; HYDROLYSIS; ROTATION; COMPLEXES; BINDING; CONFORMATION; F(1)-ATPASE; REFINEMENT; TRYPTOPHAN	The crystal structure of a novel aluminium fluoride inhibited form of bovine mitochondrial F-1-ATPase has been determined at 2 Angstrom resolution. In contrast to all previously determined structures of the bovine enzyme, all three catalytic sites are occupied by nucleotide. The subunit that did not bind nucleotide in previous structures binds ADP and sulfate (mimicking phosphate), and adopts a "half-closed" conformation. This structure probably represents the posthydrolysis, pre-product release step on the catalytic pathway. A catalytic scheme for hydrolysis (and synthesis) at physiological rates and a mechanism for the ATP-driven rotation of the gamma subunit are proposed based on the crystal structures of the bovine enzyme.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; MRC, Dunn Human Nutr Unit, Cambridge CB2 2XY, England	MRC Laboratory Molecular Biology; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research	Leslie, AGW (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	jew@mrc-dunn.cam.ac.uk; andrew@mrc-imb.cam.ac.uk		Walker, John/0000-0001-7929-2162				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Amano T, 1996, J BIOL CHEM, V271, P18128, DOI 10.1074/jbc.271.30.18128; AMANO T, 1994, FEBS LETT, V348, P93, DOI 10.1016/0014-5793(94)00588-5; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boyer PD, 2000, BBA-BIOENERGETICS, V1458, P252, DOI 10.1016/S0005-2728(00)00077-3; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; BOYER PD, 1993, BIOCHIM BIOPHYS ACTA, V1140, P215, DOI 10.1016/0005-2728(93)90063-L; Braig K, 2000, STRUCTURE, V8, P567, DOI 10.1016/S0969-2126(00)00145-3; CROSS RL, 1982, J BIOL CHEM, V257, P2101; DeckersHebestreit G, 1996, ANNU REV MICROBIOL, V50, P791, DOI 10.1146/annurev.micro.50.1.791; Dou C, 1997, BIOCHEMISTRY-US, V36, P3719, DOI 10.1021/bi962353+; DUNCAN TM, 1995, P NATL ACAD SCI USA, V92, P10964, DOI 10.1073/pnas.92.24.10964; ELSHAWI MK, 1990, J BIOL CHEM, V265, P4402; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FELDMAN RI, 1983, J BIOL CHEM, V258, P2178; Fersht A., 1999, STRUCTURE MECH PROTE; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; ISSARTEL JP, 1991, BIOCHEMISTRY-US, V30, P4726, DOI 10.1021/bi00233a013; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Le NP, 2000, BIOCHEMISTRY-US, V39, P2778, DOI 10.1021/bi992530h; Leslie A., 1992, JOINT CCP4 EACMB NEW; Lobau S, 1997, J BIOL CHEM, V272, P3648, DOI 10.1074/jbc.272.6.3648; LUTTER R, 1993, J MOL BIOL, V229, P787, DOI 10.1006/jmbi.1993.1081; Masaike T, 2000, J EXP BIOL, V203, P1; McCarty RE, 2000, ANNU REV PLANT PHYS, V51, P83, DOI 10.1146/annurev.arplant.51.1.83; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nadanaciva S, 2000, BIOCHEMISTRY-US, V39, P9583, DOI 10.1021/bi000941o; Nadanaciva S, 1999, BIOCHEMISTRY-US, V38, P15493, DOI 10.1021/bi9917683; Nadanaciva S, 1999, BIOCHEMISTRY-US, V38, P7670, DOI 10.1021/bi990663x; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Ren HM, 2000, BBA-BIOENERGETICS, V1458, P221, DOI 10.1016/S0005-2728(00)00075-X; Rodgers AJW, 2000, NAT STRUCT BIOL, V7, P1051; ROSING J, 1977, J BIOL CHEM, V252, P2478; Sabbert D, 1996, NATURE, V381, P623, DOI 10.1038/381623a0; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Stryer L., 1995, BIOCHEMISTRY-US, V4th ed.; TRONRUD DE, 1987, ACTA CRYSTALLOGR A, V43, P489, DOI 10.1107/S0108767387099124; Tsunoda SP, 1999, J BIOL CHEM, V274, P5701, DOI 10.1074/jbc.274.9.5701; Walker JE, 1998, ANGEW CHEM INT EDIT, V37, P2309, DOI 10.1002/(SICI)1521-3773(19980918)37:17<2308::AID-ANIE2308>3.0.CO;2-W; Weber J, 1997, BBA-BIOENERGETICS, V1319, P19, DOI 10.1016/S0005-2728(96)00121-1; Weber J, 2000, BBA-BIOENERGETICS, V1458, P300, DOI 10.1016/S0005-2728(00)00082-7; WEBER J, 1993, J BIOL CHEM, V268, P20126; Weber J, 1996, J BIOL CHEM, V271, P18711, DOI 10.1074/jbc.271.31.18711; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513	46	386	392	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2001	106	3					331	341		10.1016/S0092-8674(01)00452-4	http://dx.doi.org/10.1016/S0092-8674(01)00452-4			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RJ	11509182	Bronze			2022-12-28	WOS:000170433300011
J	Breiling, A; Turner, BM; Bianchi, ME; Orlando, V				Breiling, A; Turner, BM; Bianchi, ME; Orlando, V			General transcription factors bind promoters repressed by Polycomb group proteins	NATURE			English	Article							DROSOPHILA-MELANOGASTER; IN-VIVO; CHROMATIN; COMPLEX; INTERACTS; TRITHORAX	To maintain cell identity during development and differentiation, mechanisms of cellular memory have evolved that preserve transcription patterns in an epigenetic manner. The proteins of the Polycomb group (PcG) are part of such a mechanism, maintaining gene silencing. They act as repressive multiprotein complexes that may render target genes inaccessible to the transcriptional machinery(1,2), inhibit chromatin remodelling(3,4), influence chromosome domain topology(5) and recruit histone deacetylases (HDACs)(6). PcG proteins have also been found to bind to core promoter regions(7), but the mechanism by which they regulate transcription remains unknown. To address this, we used formaldehyde-crosslinked chromatin immunoprecipitation (X-ChIP) to map TATA-binding protein (TBP), transcription initiation factor IIB (TFIIB) and IIF (TFIIF), and dHDAC1 (RPD3) across several Drosophila promoter regions. Here we show that binding of PcG proteins to repressed promoters does not exclude general transcription factors (GTFs) and that depletion of PcG proteins by double-stranded RNA interference leads to de-repression of developmentally regulated genes. We further show that PcG proteins interact in vitro with GTFs. We suggest that PcG complexes maintain silencing by inhibiting GTF-mediated activation of transcription.	San Raffaele Sci Inst, DIBIT, I-20132 Milan, Italy; Univ Birmingham, Sch Med, Chromatin & Gene Express Grp, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Orlando, V (corresponding author), San Raffaele Sci Inst, DIBIT, Via Olgettina 58, I-20132 Milan, Italy.		Bianchi, Marco Emilio/K-3417-2018	Bianchi, Marco Emilio/0000-0002-5329-6445; Breiling, Achim/0000-0002-7928-299X				Barlow AL, 2001, EXP CELL RES, V265, P90, DOI 10.1006/excr.2001.5162; Beuchle D, 2001, DEVELOPMENT, V128, P993; Breiling A, 1999, MOL CELL BIOL, V19, P8451; Cavalli G, 1999, SCIENCE, V286, P955, DOI 10.1126/science.286.5441.955; CHINWALLA V, 1995, EMBO J, V14, P2056, DOI 10.1002/j.1460-2075.1995.tb07197.x; GREGORY RI, IN PRESS MOL CELL BI; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; Hansen SK, 1997, CELL, V91, P71, DOI 10.1016/S0092-8674(01)80010-6; Imhof A, 1997, CURR BIOL, V7, P689, DOI 10.1016/S0960-9822(06)00296-X; Johnson CA, 2001, J BIOL CHEM, V276, P4539, DOI 10.1074/jbc.C000824200; Kuras L, 1999, NATURE, V399, P609, DOI 10.1038/21239; Kyba M, 1998, MOL CELL BIOL, V18, P2712, DOI 10.1128/MCB.18.5.2712; Lupo R, 2001, MOL CELL, V7, P127, DOI 10.1016/S1097-2765(01)00161-7; Orlando V, 1998, EMBO J, V17, P5141, DOI 10.1093/emboj/17.17.5141; PARO R, 1992, MECH DEVELOP, V40, P37; Paro R., 1996, EPIGENETIC MECH GENE, P507; Pirrotta V, 1997, CURR OPIN GENET DEV, V7, P249, DOI 10.1016/S0959-437X(97)80135-9; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Strutt H, 1997, EMBO J, V16, P3621, DOI 10.1093/emboj/16.12.3621; Strutt H, 1997, MOL CELL BIOL, V17, P6773, DOI 10.1128/MCB.17.12.6773; Tsai SC, 2000, NAT GENET, V26, P349, DOI 10.1038/81671; van der Vlag J, 1999, NAT GENET, V23, P474, DOI 10.1038/70602; Waltzer L, 1998, NATURE, V395, P521, DOI 10.1038/26785; WEEKS JR, 1993, GENE DEV, V7, P2329, DOI 10.1101/gad.7.12a.2329; Wei Q, 2000, DEV BIOL, V228, P239, DOI 10.1006/dbio.2000.9938; White DA, 1999, METHODS, V19, P417, DOI 10.1006/meth.1999.0878	28	201	203	0	8	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2001	412	6847					651	655		10.1038/35088090	http://dx.doi.org/10.1038/35088090			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460PP	11493924				2022-12-28	WOS:000170318000044
J	Malterud, K				Malterud, K			The art and science of clinical knowledge: evidence beyond measures and numbers	LANCET			English	Article							GENERAL-PRACTICE; WOMEN PATIENTS; MEDICINE; CONSULTATION; DIAGNOSIS; DIALOGUES	Medical doctors claim that their discipline is founded on scientific knowledge. Yet, although the ideas of evidence based medicine are widely accepted, clinical decisions and methods of patient care are based on much more than just the results of controlled experiments. Clinical knowledge consists of interpretive action and interaction-factors that involve communication, opinions, and experiences. The traditional quantitative research methods represent a confined access to clinical knowing, since they incorporate only questions and phenomena that can be controlled, measured, and counted. The tacit knowing of an experienced practitioner should also be investigated, shared, and contested. Qualitative research methods are strategies for the systematic collection, organisation, and interpretation of textual material obtained from talk or observation, which allow the exploration of social events as experienced by individuals in their natural context. Qualitative inquiry could contribute to a broader understanding of medical science.	Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Sect Gen Practice, N-5009 Bergen, Norway; Univ Copenhagen, Dept Gen Practice, DK-1168 Copenhagen, Denmark; Univ Copenhagen, Res Inst, DK-1168 Copenhagen, Denmark	University of Bergen; University of Copenhagen; University of Copenhagen	Malterud, K (corresponding author), Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Sect Gen Practice, Ulriksdal 8C, N-5009 Bergen, Norway.							Barbour R S, 1999, J Health Serv Res Policy, V4, P39; Bogdewic SP, 1999, DOING QUALITATIVE RE, P47; BURKETT GL, 1983, J FAM PRACTICE, V6, P625; DREYFUS HL, 1986, SOC RES, V53, P57; ELMORE JG, 1994, NEW ENGL J MED, V331, P1493, DOI 10.1056/NEJM199412013312206; FOSS L, 1989, J MED PHILOS, V14, P165, DOI 10.1093/jmp/14.2.165; Gandhi IG, 1997, FAM PRACT, V14, P49, DOI 10.1093/fampra/14.1.49; Gardner K, 1999, BRIT MED J, V319, P418, DOI 10.1136/bmj.319.7207.418; Hollnagel H, 1999, SCAND J PRIM HEALTH, V17, P3, DOI 10.1080/028134399750002809; HORTON R, 1995, LANCET, V346, P3, DOI 10.1016/S0140-6736(95)92644-5; JONES R, 1995, BRIT MED J, V311, P2, DOI 10.1136/bmj.311.6996.2; KORAN LM, 1975, NEW ENGL J MED, V293, P642, DOI 10.1056/NEJM197509252931307; Krueger RA., 2009, FOCUS GROUPS PRACTIC; Kvale S., 2007, INTERVIEWS INTRO QUA; Latour B., 1986, LAB LIFE CONSTRUCTIO; LEDER D, 1990, THEOR MED, V11, P9, DOI 10.1007/BF00489234; LEVENSTEIN JH, 1986, FAM PRACT, V3, P24, DOI 10.1093/fampra/3.1.24; Lincoln Y, 1985, NATURALISTIC ENQUIRY; Malterud K, 1999, THEOR MED BIOETH, V20, P275, DOI 10.1023/A:1009905523228; MALTERUD K, 1995, THEOR MED, V16, P183, DOI 10.1007/BF00998544; Malterud K, 1995, FAM PRACT, V12, P476, DOI 10.1093/fampra/12.4.476; Malterud K, 1999, SCAND J PRIM HEALTH, V17, P49; Malterud K, 1999, SCAND J PUBLIC HEALT, V27, P254, DOI 10.1177/14034948990270040901; McWhinney I R, 1989, Fam Med, V21, P296; Miles M., 2013, QUALITATIVE DATA ANA; MILLER WL, 1992, J FAM PRACTICE, V34, P289; Mishler EG, 1984, DISCOURSE MED DIALEC; Montgomery Hunter K, 1991, DOCTORS STORIES NARR; NESSA J, 1995, SCAND J PRIM HEALTH, V13, P83, DOI 10.3109/02813439508996741; Polanyi M., 1983, TACIT DIMENSION; Pope C., 2020, QUALITATIVE RES HLTH; Sackett D. L., 1997, EVIDENCE BASED MED P; Sassower R, 1987, Theor Med, V8, P221, DOI 10.1007/BF00539757; Schon D. A., 1991, REFLECTIVE PRACTITIO; SKELTON AM, 1995, FAM PRACT, V12, P44, DOI 10.1093/fampra/12.1.44; Soderlund A, 2000, SCAND J PRIM HEALTH, V18, P165, DOI 10.1080/028134300453377; STEIN HF, 1991, QUAL HEALTH RES, V1, P6; Stensland P, 1999, SCAND J PRIM HEALTH, V17, P75, DOI 10.1080/028134399750002683; Stensland P, 1997, SCAND J PRIM HEALTH, V15, P175, DOI 10.3109/02813439709035023; Whyte W.F., 1991, PARTICIPATORY ACTION; Widdershoven-Heerding I, 1987, Theor Med, V8, P179, DOI 10.1007/BF00539754; WULFF HR, 1986, J MED PHILOS, V11, P123, DOI 10.1093/jmp/11.2.123; 1991, LANCET, V337, P401	43	466	470	1	38	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 4	2001	358	9279					397	400		10.1016/S0140-6736(01)05548-9	http://dx.doi.org/10.1016/S0140-6736(01)05548-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459DE	11502338				2022-12-28	WOS:000170235100033
J	Hubalek, Z				Hubalek, Z			Comparative symptomatology of West Nile fever	LANCET			English	Editorial Material							OUTBREAK; EPIDEMIC		Inst Vertebrate Biol, Med Zool Lab, Valtice 69142, Czech Republic		Hubalek, Z (corresponding author), Inst Vertebrate Biol, Med Zool Lab, Klasterni 2, Valtice 69142, Czech Republic.	zhubalek@brno.cas.cz	Hubalek, Zdenek/G-1111-2014; Hubalek, Zdenek/AAF-8071-2019	Hubalek, Zdenek/0000-0003-4732-0987; 				Asnis DS, 2000, CLIN INFECT DIS, V30, P413, DOI 10.1086/313737; BULETSA BA, 1989, ZH NEVROPATOL PSIKH, V89, P29; Downs WG, 1973, ARTHROPOD BORNE VIRU; HANNOUN C, 1969, ARBOVIRUSES CALIFORN, P379; Hubalek Z, 1999, EMERG INFECT DIS, V5, P594, DOI 10.3201/eid0504.990430; MARBERG K, 1956, AM J HYG, V64, P259, DOI 10.1093/oxfordjournals.aje.a119838; MCINTOSH BM, 1976, S AFR J SCI, V72, P295; Nur YA, 1999, AM J TROP MED HYG, V61, P885, DOI 10.4269/ajtmh.1999.61.885; Platonov AE, 2001, EMERG INFECT DIS, V7, P128, DOI 10.3201/eid0701.010118; Rohlf F.J., 1993, NTSYS PC; Tsai TF, 1998, LANCET, V352, P767, DOI 10.1016/S0140-6736(98)03538-7	11	18	19	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 28	2001	358	9278					254	255		10.1016/S0140-6736(01)05491-5	http://dx.doi.org/10.1016/S0140-6736(01)05491-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	457AF	11498205				2022-12-28	WOS:000170114400002
J	Litt, MD; Simpson, M; Gaszner, M; Allis, CD; Felsenfeld, G				Litt, MD; Simpson, M; Gaszner, M; Allis, CD; Felsenfeld, G			Correlation between histone lysine methylation and developmental changes at the chicken beta-globin locus	SCIENCE			English	Article							ENHANCER-BLOCKING ACTIVITY; INSULATOR; EXPRESSION; GENE	Methylation of histories at specific residues plays an important role in transcriptional regulation. Chromatin immunoprecipitation of dimethytated lysine 9 on histone H3 across 53 kilobases of the chicken beta -globin locus during erythropoiesis shows an almost complete anticorrelation between regions of elevated lysine 9 methylation and acetylation. Lysine 9 is methylated most over constitutive condensed chromatin and developmentally inactive globin genes. In contrast, lysine 4 methylation of histone H3 correlates with H3 acetylation. These results lead us to propose a mechanism by which the insulator in the beta -globin locus can protect the globin genes from being silenced by adjacent condensed chromatin.	NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Virginia	Felsenfeld, G (corresponding author), NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	gxf@vger.niddk.nih.gov			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK034001] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; ALLIS CD, COMMUNICATION; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Chung JH, 1997, P NATL ACAD SCI USA, V94, P575, DOI 10.1073/pnas.94.2.575; Davie JR, 1999, J CELL BIOCHEM, P141; Donze D, 2001, EMBO J, V20, P520, DOI 10.1093/emboj/20.3.520; FELSENFELD G, 1993, GENE, V135, P119, DOI 10.1016/0378-1119(93)90056-9; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Litt MD, 2001, EMBO J, V20, P2224, DOI 10.1093/emboj/20.9.2224; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Pikaart MI, 1998, GENE DEV, V12, P2852, DOI 10.1101/gad.12.18.2852; Prioleau MN, 1999, EMBO J, V18, P4035, DOI 10.1093/emboj/18.14.4035; Recillas-Targa F, 1999, P NATL ACAD SCI USA, V96, P14354, DOI 10.1073/pnas.96.25.14354; RECILLASTARGA F, COMMUNICATION; Rice JC, 2001, CURR OPIN CELL BIOL, V13, P263, DOI 10.1016/S0955-0674(00)00208-8; Saitoh N, 2000, EMBO J, V19, P2315, DOI 10.1093/emboj/19.10.2315; Spencer VA, 1999, GENE, V240, P1, DOI 10.1016/S0378-1119(99)00405-9; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X	21	497	516	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2001	293	5539					2453	2455		10.1126/science.1064413	http://dx.doi.org/10.1126/science.1064413			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	476PD	11498546	Green Submitted			2022-12-28	WOS:000171237200047
J	Sundar, S; Agrawal, G; Rai, M; Makharia, MK; Murray, HW				Sundar, S; Agrawal, G; Rai, M; Makharia, MK; Murray, HW			Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: randomised trial	BRITISH MEDICAL JOURNAL			English	Article							LIPID COMPLEX; AMBISOME; ANTIMONY; THERAPY	Objective To test short course, low dose liposomal amphotericin B as single or daily infusion treatment in Indian visceral leishmaniasis (kala-azar). Design Randomised, open label study. Setting Inpatient unit for leishmaniasis in Bihar, India. Participants 91 adults and children with splenic aspirate positive for infection. Interventions Total dose of 5 mg/kg of liposomal amphotericin B given as a single infusion (n = 46) or as once daily infusions of 1 mg/kg for five days (n = 45). Main outcome measures Clinical and parasitological cure assessed 14 days after treatment and long term definitive cure (healthy, no relapse) at six months. Results All but one person in each group had an initial apparent cure. During six months of follow up, three patients in the single dose group and two in the five dose group relapsed. Complete response (definitive cure) was therefore achieved in 84 of 91 subjects (92%): 42 of 46 patients in the single dose group (91%, 95% confidence interval 79% to 98%) and 42 of 45 in the five dose group (93%, 82% to 99%). Response rates in the two groups were not significantly different. Conclusion Low dose liposomal amphotericin B (5 mg/kg), given either as a five day course or as a single infusion, seems to be effective for visceral leishmaniasis and wan-ants further testing.	Banaras Hindu Univ, Kala Azar Med Res Ctr, Dept Med, Inst Med Sci, Varanasi 211005, Uttar Pradesh, India; Cornell Univ, Weill Med Coll, Dept Med, New York, NY 10021 USA	Banaras Hindu University (BHU); Cornell University	Sundar, S (corresponding author), Banaras Hindu Univ, Kala Azar Med Res Ctr, Dept Med, Inst Med Sci, Varanasi 211005, Uttar Pradesh, India.		Murray, Heather/GQY-8016-2022					Berman JD, 1998, B WORLD HEALTH ORGAN, V76, P25; Bora D, 1999, NATL MED J INDIA, V12, P62; Davidson RN, 1996, CLIN INFECT DIS, V22, P938, DOI 10.1093/clinids/22.6.938; DIETZE R, 1995, T ROY SOC TROP MED H, V89, P309, DOI 10.1016/0035-9203(95)90557-X; diMartino L, 1997, J PEDIATR-US, V131, P271, DOI 10.1016/S0022-3476(97)70165-3; Herwaldt BL, 1999, NEW ENGL J MED, V341, P1840, DOI 10.1056/NEJM199912093412411; Jha TK, 1998, BRIT MED J, V316, P1200, DOI 10.1136/bmj.316.7139.1200; Lal S, 1996, MANUAL VISCERAL LEIS, P167; *MED EC, 1999, DRUG TOP REDB; Meyerhoff A, 1999, CLIN INFECT DIS, V28, P42, DOI 10.1086/515085; Murray  H W, 2000, Int J Infect Dis, V4, P158, DOI 10.1016/S1201-9712(00)90078-X; Sundar S, 1997, ANN INTERN MED, V127, P133, DOI 10.7326/0003-4819-127-2-199707150-00007; Sundar S, 1998, ANN TROP MED PARASIT, V92, P755, DOI 10.1080/00034989858998; Sundar S, 2000, CLIN INFECT DIS, V31, P1104, DOI 10.1086/318121; SUNDAR S, IN PRESS AM J TROP M; Thakur CP, 1999, T ROY SOC TROP MED H, V93, P319, DOI 10.1016/S0035-9203(99)90037-8; Thakur CP, 1996, T ROY SOC TROP MED H, V90, P319, DOI 10.1016/S0035-9203(96)90271-0	17	133	135	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 25	2001	323	7310					419	422		10.1136/bmj.323.7310.419	http://dx.doi.org/10.1136/bmj.323.7310.419			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469BX	11520836	Green Published, Bronze			2022-12-28	WOS:000170793600016
J	Gattinoni, L; Tognoni, G; Pesenti, A; Taccone, P; Mascheroni, D; Labarta, V; Malacrida, R; Di Giulio, P; Fumagalli, R; Pelosi, P; Brazzi, L; Latini, R				Gattinoni, L; Tognoni, G; Pesenti, A; Taccone, P; Mascheroni, D; Labarta, V; Malacrida, R; Di Giulio, P; Fumagalli, R; Pelosi, P; Brazzi, L; Latini, R		Prone-Supine Study Grp	Effect of prone positioning on the survival of patients with acute respiratory failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE LUNG INJURY; OXYGENATION	Background: Although placing patients with acute respiratory failure in a prone (face down) position improves their oxygenation 60 to 70 percent of the time, the effect on survival is not known. Methods: In a multicenter, randomized trial, we compared conventional treatment (in the supine position) of patients with acute lung injury or the acute respiratory distress syndrome with a predefined strategy of placing patients in a prone position for six or more hours daily for 10 days. We enrolled 304 patients, 152 in each group. Results: The mortality rate was 23.0 percent during the 10-day study period, 49.3 percent at the time of discharge from the intensive care unit, and 60.5 percent at 6 months. The relative risk of death in the prone group as compared with the supine group was 0.84 at the end of the study period (95 percent confidence interval, 0.56 to 1.27), 1.05 at the time of discharge from the intensive care unit (95 percent confidence interval, 0.84 to 1.32), and 1.06 at six months (95 percent confidence interval, 0.88 to 1.28). During the study period the mean (+/-SD) increase in the ratio of the partial pressure of arterial oxygen to the fraction of inspired oxygen, measured each morning while patients were supine, was greater in the prone than the supine group (63.0+/-66.8 vs. 44.6+/-68.2, P=0.02). The incidence of complications related to positioning (such as pressure sores and accidental extubation) was similar in the two groups. Conclusions: Although placing patients with acute respiratory failure in a prone position improves their oxygenation, it does not improve survival.	Univ Milan, Osped Maggiore Milano, Ist Ricovero & Cura Carattere Sci, Ist Anestesia & Rianimaz, Milan, Italy; Univ Milano Bicocca, Osped S Gerardo, Ist Anestesia & Rianimaz, Monza, Italy; Ist Ric Farmacol Mario Negri, Milan, Italy; Lugano Civ Hosp, Dept Intens Care & Anesthesia, Lugano, Switzerland	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; San Gerardo Hospital; University of Milano-Bicocca; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Gattinoni, L (corresponding author), Osped Maggiore Policlin IRCCS, Ist Anestesia & Rianimaz, Via Francesco Sforza 35, I-20122 Milan, Italy.		Pesenti, Antonio/H-7483-2012; Brazzi, Luca/AAS-4978-2020; Fumagalli, Roberto/AAB-9746-2019; Latini, Roberto/AAB-1410-2020; Rocco, Patricia/I-7460-2012	Pesenti, Antonio/0000-0003-2593-729X; Brazzi, Luca/0000-0001-7059-0622; Fumagalli, Roberto/0000-0003-0398-1329; Latini, Roberto/0000-0002-3729-4650; Rocco, Patricia/0000-0003-1412-7136; Gattinoni, Luciano/0000-0001-5380-2494; Pelosi, Paolo/0000-0001-5055-3023				ALBERT RK, 1987, AM REV RESPIR DIS, V135, P628; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Broccard A, 2000, CRIT CARE MED, V28, P295, DOI 10.1097/00003246-200002000-00001; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; DOUGLAS WW, 1977, AM REV RESPIR DIS, V115, P559; Human Medicines Evaluation Unit, 1996, ICH TOP E6 GUID GOOD, P17; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; LEGALL JR, 1994, JAMA-J AM MED ASSOC, V271, P1321; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; *NAT PRESS ULC ADV, 1989, DECUBITUS, V2, P24; PAPPERT D, 1994, CHEST, V106, P1511, DOI 10.1378/chest.106.5.1511; Pelosi P, 1998, AM J RESP CRIT CARE, V157, P387, DOI 10.1164/ajrccm.157.2.97-04023; PIEHL MA, 1976, CRIT CARE MED, V4, P13, DOI 10.1097/00003246-197601000-00003; POCOCK SJ, 1983, CLIN TRIALS PRACTICA, P231; SLUTSKY AS, 1994, INTENS CARE MED, V20, P378	15	690	765	1	22	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 23	2001	345	8					568	573		10.1056/NEJMoa010043	http://dx.doi.org/10.1056/NEJMoa010043			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464ZH	11529210				2022-12-28	WOS:000170562900003
J	Heyland, DK; Novak, F; Drover, JW; Jain, A; Su, XY; Suchner, U				Heyland, DK; Novak, F; Drover, JW; Jain, A; Su, XY; Suchner, U			Should immunonutrition become routine in critically ill patients? A systematic review of the evidence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMMUNE-ENHANCING DIET; ENTERAL NUTRITION; RANDOMIZED-TRIAL; ARGININE SUPPLEMENTATION; ARTIFICIAL NUTRITION; CLINICAL-TRIAL; DOUBLE-BLIND; FISH-OIL; CANCER; SURGERY	Context Several nutrients have been shown to influence immunologic and inflammatory responses in humans. Whether these effects translate into an improvement in clinical outcomes in critically ill patients remains unclear. Objective To examine the relationship between enteral nutrition supplemented with immune-enhancing nutrients and infectious complications and mortality rates in critically ill patients. Data Sources The databases of MEDLINE, EMBASE, Biosis, and CINAHL were searched for articles published from 1990 to 2000. Additional data sources included the Cochrane Controlled Trials Register from 1990 to 2000, personal files, abstract proceedings, and relevant reference fists of articles identified by database review. Study Selection A total of 326 titles, abstracts, and articles were reviewed. Primary studies were included If they were randomized trials of critically ill or surgical patients that evaluated the effect of enteral nutrition supplemented with some combination of arginine, glutamine, nucleotides, and omega-3 fatty acids on infectious complication and mortality rates compared with standard enteral nutrition, and included clinically important outcomes, such as mortality. Data Extraction Methodological quality of individual studies was scored and necessary data were abstracted in duplicate and independently. Data Synthesis Twenty-two randomized trials with a total of 2419 patients compared the use of immunonutrition with standard enteral nutrition in surgical and critically Ill patients. With respect to mortality, immunonutrition was associated with a pooled risk ratio (RR) of 1.10 (95% confidence interval [CI], 0.93-1.31). Immunonutrition was associated with lower infectious complications (RR, 0.66; 95% CI, 0.54-0.80). Since there was significant heterogeneity across studies, we examined several a priori subgroup analyses. We found that studies using commercial formulas with high arginine content were associated with a significant reduction in infectious complications and a trend toward a lower mortality rate compared with other immune-enhancing diets. Studies of surgical patients were associated with a significant reduction in infectious complication rates compared with studies of critically Ill patients. In studies of critically ill patients, studies with a high-quality score were associated with increased mortality and a significant reduction in infectious complication rates compared with studies with a low-quality score. Conclusion Immunonutrition may decrease infectious complication rates but it is not associated with an overall mortality advantage. However, the treatment effect varies depending on the intervention, the patient population, and the methodological quality of the study.	Queens Univ, Kingston Gen Hosp, Dept Med, Kingston, ON K7L 2V7, Canada; Queens Univ, Kingston Gen Hosp, Dept Surg, Kingston, ON K7L 2V7, Canada; Univ Munich, Grosshadern Univ Hosp, Dept Anesthesiol, Munich, Germany	Queens University - Canada; Queens University - Canada; University of Munich	Heyland, DK (corresponding author), Queens Univ, Kingston Gen Hosp, Dept Med, Angada 3,76 Stuart St, Kingston, ON K7L 2V7, Canada.	dkh2@post.queensu.ca	Novak, Frantisek/F-4268-2017; Suchner, Ulrich/AAC-7723-2020; Xia, Xianfeng/F-9169-2011	Novak, Frantisek/0000-0001-5582-3977; 				Alexander JW, 1998, NUTRITION, V14, P627, DOI 10.1016/S0899-9007(98)00004-5; Atkinson S, 1998, CRIT CARE MED, V26, P1164, DOI 10.1097/00003246-199807000-00013; Bastian L, 1998, Langenbecks Arch Chir Suppl Kongressbd, V115, P1083; Bastian L, 1998, UNFALLCHIRURG, V101, P105, DOI 10.1007/s001130050242; Beale RJ, 1999, CRIT CARE MED, V27, P2799, DOI 10.1097/00003246-199912000-00032; BOWER RH, 1995, CRIT CARE MED, V23, P436, DOI 10.1097/00003246-199503000-00006; Braga M, 1996, EUR J SURG, V162, P105; Braga M, 1996, ARCH SURG-CHICAGO, V131, P1257; Braga M, 1999, ARCH SURG-CHICAGO, V134, P428, DOI 10.1001/archsurg.134.4.428; Braga M, 1998, NUTRITION, V14, P831, DOI 10.1016/S0899-9007(98)00103-8; BRAGA M, 1995, INFUSIONSTHERAPIE, V22, P280; Braga M, 1998, CRIT CARE MED, V26, P24, DOI 10.1097/00003246-199801000-00012; BRAGA M, 1999, JPEN J PARENTER ENTE, V23, pS2; BROWN RO, 1994, PHARMACOTHERAPY, V14, P314; CERRA FB, 1990, NUTRITION, V6, P84; CHENDRASEKHAR A, 1997, CRIT CARE MED, V25, pA135; DALY JM, 1990, CRIT CARE MED, V18, pS86; DALY JM, 1992, SURGERY, V112, P56; DALY JM, 1995, ANN SURG, V221, P327, DOI 10.1097/00000658-199504000-00002; DEMPSEY DT, 1988, AM J CLIN NUTR, V47, P352, DOI 10.1093/ajcn/47.2.352; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Di Carlo V, 1999, DIGEST SURG, V16, P320, DOI 10.1159/000018742; DiGiovine B, 1999, AM J RESP CRIT CARE, V160, P976, DOI 10.1164/ajrccm.160.3.9808145; Engel JM, 1997, ANASTH INTENSIV NOTF, V32, P234, DOI 10.1055/s-2007-995043; Evoy D, 1998, NUTRITION, V14, P611, DOI 10.1016/S0899-9007(98)00005-7; FAGON JY, 1994, INFECT CONT HOSP EP, V15, P428; Fleming TR, 1996, ANN INTERN MED, V125, P605, DOI 10.7326/0003-4819-125-7-199610010-00011; Gadek JE, 1999, CRIT CARE MED, V27, P1409, DOI 10.1097/00003246-199908000-00001; Galban C, 2000, CRIT CARE MED, V28, P643, DOI 10.1097/00003246-200003000-00007; Gianotti L, 2000, PANCREAS, V21, P344, DOI 10.1097/00006676-200011000-00004; Gianotti L, 1999, JPEN-PARENTER ENTER, V23, P314, DOI 10.1177/0148607199023006314; Gianotti L, 1997, ARCH SURG-CHICAGO, V132, P1222, DOI 10.1001/archsurg.1997.01430350072012; Gianotti Luca, 1998, Rivista Italiana di Nutrizione Parenterale ed Enterale, V16, P173; GONCE SJ, 1990, JPEN-PARENTER ENTER, V14, P237, DOI 10.1177/0148607190014003237; GOTTSCHLICH MM, 1990, JPEN-PARENTER ENTER, V14, P225, DOI 10.1177/0148607190014003225; GREGOIRE G, 1995, J CLIN EPIDEMIOL, V48, P159, DOI 10.1016/0895-4356(94)00098-B; Hasselmann M., 1997, INTENS CARE MED, V23, pS136; HEDGES LV, 1982, PSYCHOL BULL, V92, P490, DOI 10.1037/0033-2909.92.2.490; Heslin MJ, 1997, ANN SURG, V226, P567, DOI 10.1097/00000658-199710000-00016; Heyland DK, 1999, AM J RESP CRIT CARE, V159, P1249, DOI 10.1164/ajrccm.159.4.9807050; Heyland DK, 1998, JAMA-J AM MED ASSOC, V280, P2013, DOI 10.1001/jama.280.23.2013; Heys SD, 1999, ANN SURG, V229, P467, DOI 10.1097/00000658-199904000-00004; HOUDIJK AP, 1999, JPEN J PARENTER E S5, V23, P52; Houdijk APJ, 1998, LANCET, V352, P772, DOI 10.1016/S0140-6736(98)02007-8; Jones C, 1999, NUTRITION, V15, P108, DOI 10.1016/S0899-9007(98)00172-5; Kenler AS, 1996, ANN SURG, V223, P316, DOI 10.1097/00000658-199603000-00013; Kudsk KA, 1996, ANN SURG, V224, P531, DOI 10.1097/00000658-199610000-00011; Leleiko NS, 1995, NUTRITION, V11, P725; LIEBERMAN MD, 1990, NUTRITION, V6, P88; LORENTE JA, 1993, CRIT CARE MED, V21, P1287, DOI 10.1097/00003246-199309000-00010; MEAKINS JL, 1979, ANN SURG, V190, P286, DOI 10.1097/00000658-197909000-00003; Mendez C, 1997, J TRAUMA, V42, P933, DOI 10.1097/00005373-199705000-00026; MOORE FA, 1994, J TRAUMA, V37, P607, DOI 10.1097/00005373-199410000-00014; Morais A A, 1995, Rev Hosp Clin Fac Med Sao Paulo, V50, P276; NAYLOR AF, 1967, BIOMETRICS, V23, P349, DOI 10.2307/2528167; Ogawa K, 2000, SURGERY, V127, P329, DOI 10.1067/msy.2000.103498; RODRIGO CM, 1997, NUTR HOSP, V12, P80; Rothman J., 1986, MODERN EPIDEMIOLOGY; ROTHMAN KJ, 1979, EPIDEMIOLOGICAL ANAL; Saffle JR, 1997, J TRAUMA, V42, P793, DOI 10.1097/00005373-199705000-00008; SAITO H, 1987, ARCH SURG-CHICAGO, V122, P784; Schilling J, 1996, NUTRITION, V12, P423, DOI 10.1016/S0899-9007(96)00096-2; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Senkal M, 1999, ARCH SURG-CHICAGO, V134, P1309, DOI 10.1001/archsurg.134.12.1309; Senkal M, 1997, CRIT CARE MED, V25, P1489, DOI 10.1097/00003246-199709000-00015; Snyderman CH, 1999, LARYNGOSCOPE, V109, P915, DOI 10.1097/00005537-199906000-00014; Sugimoto K, 1999, CRIT CARE MED, V27, pA91, DOI 10.1097/00003246-199912001-00236; TALABISKA DG, 1993, FASEB J, V7, pA378; TEPASKE R, 1999, EUSIS K OSL; Weimann A, 1998, NUTRITION, V14, P165, DOI 10.1016/S0899-9007(97)00429-2; WHITEHEAD A, 1991, STAT MED, V10, P1665, DOI 10.1002/sim.4780101105; WILMORE DW, 1991, NEW ENGL J MED, V325, P695, DOI 10.1056/NEJM199109053251005; WILMORE DW, 1996, BRIT J SURG, V83, P305; Wu DY, 1998, P NUTR SOC, V57, P503, DOI 10.1079/PNS19980074	74	591	623	2	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2001	286	8					944	953		10.1001/jama.286.8.944	http://dx.doi.org/10.1001/jama.286.8.944			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465EU	11509059				2022-12-28	WOS:000170577300029
J	Kawata, S; Sun, HB; Tanaka, T; Takada, K				Kawata, S; Sun, HB; Tanaka, T; Takada, K			Finer features for functional microdevices - Micromachines can be created with higher resolution using two-photon absorption.	NATURE			English	Article							3-DIMENSIONAL MICROFABRICATION; PHOTOPOLYMERIZATION; STORAGE		Osaka Univ, Dept Appl Phys, Suita, Osaka 5650871, Japan	Osaka University	Kawata, S (corresponding author), Osaka Univ, Dept Appl Phys, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	kawata@ap.eng.osaka-u.ac.jp	Kawata, Satoshi/N-7228-2013; Sun, Hong-Bo/D-3689-2012	Sun, Hong-Bo/0000-0003-2127-8610				ASHKIN A, 1970, PHYS REV LETT, V24, P156, DOI 10.1103/PhysRevLett.24.156; Cumpston BH, 1999, NATURE, V398, P51, DOI 10.1038/17989; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; FLORY PJ, 1952, PRINCIPALS POLYM CHE; Inouye Y, 1998, JPN J APPL PHYS 2, V37, pL684, DOI 10.1143/JJAP.37.L684; Maruo S, 1997, OPT LETT, V22, P132, DOI 10.1364/OL.22.000132; Maruo S, 1998, J MICROELECTROMECH S, V7, P411, DOI 10.1109/84.735349; PARTHENOPOULOS DA, 1989, SCIENCE, V245, P843, DOI 10.1126/science.245.4920.843; Sun HB, 2000, OPT LETT, V25, P1110, DOI 10.1364/OL.25.001110; Sun HB, 1999, APPL PHYS LETT, V74, P786, DOI 10.1063/1.123367; Sun HB, 2001, APPL PHYS LETT, V79, P1, DOI 10.1063/1.1381035; WU ES, 1992, P SOC PHOTO-OPT INS, V1674, P776, DOI 10.1117/12.130367	12	2352	2501	48	995	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 16	2001	412	6848					697	698		10.1038/35089130	http://dx.doi.org/10.1038/35089130			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462ZB	11507627				2022-12-28	WOS:000170450200031
J	Davies, MK; Hobbs, FDR; Davis, RC; Kenkre, JE; Roalfe, AK; Hare, R; Wosornu, D; Lancashire, RJ				Davies, MK; Hobbs, FDR; Davis, RC; Kenkre, JE; Roalfe, AK; Hare, R; Wosornu, D; Lancashire, RJ			Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study	LANCET			English	Article							DIAGNOSIS; MORBIDITY; CAPTOPRIL; MORTALITY; TIME	Background Accurate data for prevalence rates for heart failure due to various causes, and for left-ventricular systolic dysfunction in all adults are unavailable. Our aim was to assess prevalence of left-ventricular systolic dysfunction and heart failure in a large representative adult population in England. Methods Of 6286 randomly selected patients aged 45 years and older, 3960 (63%) participated in the study. They came from 16 randomly selected general practices. We assessed patients by history and examination, electrocardiography, and echocardiography. Prevalence of left-ventricular systolic dysfunction (defined as ejection fraction <40%) and heart failure was calculated for the overall population on the basis of strict criteria and, when necessary, adjudication by a panel. Findings Left-ventricular systolic dysfunction was diagnosed in 72 (1.8% [95% CI 1.4-2.3]) participants, half of whom had no symptoms. Borderline left-ventricular function (ejection fraction 40-50%) was seen in 139 patients (3.5% [3.0-4.1]). Definite heart failure was seen in 92 (2.3%, [1.9-2.8]) and was associated with an ejection fraction of less than 40% in 38 (41%) patients, atrial fibrillation in 30 (33%), and valve disease in 24 (26%). Probable heart failure was seen in a further 32 (0.8% [0.6-1.1]) patients. In total, 124 (3.1% [2.6-3.7]) patients aged 45 years or older had definite or probable heart failure. Interpretation Heart failure is often misdiagnosed or underdiagnosed in primary care. Our results suggest that assessment of left-ventricular function in patients with suspected heart failure could lead to more effective diagnosis and treatment of this disorder.	Univ Birmingham, Sch Med, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England; Univ Birmingham, Sch Med, Dept Publ Hlth & Epidemiol, Birmingham B15 2TT, W Midlands, England; Selly Oak Hosp, Dept Cardiol, Selly Oak, W Midlands, England	University of Birmingham; University of Birmingham	Hobbs, FDR (corresponding author), Univ Birmingham, Sch Med, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England.	f.d.r.hobbs@bham.ac.uk		hobbs, richard/0000-0001-7976-7172				Caruana L, 2000, BRIT MED J, V321, P215, DOI 10.1136/bmj.321.7255.215; CLELAND JG, 1995, EUR HEART J, V16, P741; Davie AP, 1997, EUR HEART J, V18, P981; *DEP HLTH, 2000, NAT SERV FRAM COR HE; ERIKSSON H, 1995, J INTERN MED, V237, P135, DOI 10.1111/j.1365-2796.1995.tb01153.x; FOLLAND ED, 1979, CIRCULATION, V60, P760, DOI 10.1161/01.CIR.60.4.760; GARG R, 1995, JAMA-J AM MED ASSOC, V273, P1450, DOI 10.1001/jama.273.18.1450; GILLUM RF, 1993, AM HEART J, V126, P1042, DOI 10.1016/0002-8703(93)90738-U; Hjalmarson A, 1999, LANCET, V353, P2001; Hobbs FDR, 2000, EUR HEART J, V21, P1877, DOI 10.1053/euhj.2000.2170; Lechat P, 1999, LANCET, V353, P9; MARANTZ PR, 1988, CIRCULATION, V77, P607, DOI 10.1161/01.CIR.77.3.607; McDonagh TA, 1997, LANCET, V350, P829, DOI 10.1016/S0140-6736(97)03033-X; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; Morgan S, 1999, BRIT MED J, V318, P368, DOI 10.1136/bmj.318.7180.368; Mosterd A, 1999, EUR HEART J, V20, P447, DOI 10.1053/euhj.1998.1239; NICKLAS JM, 1992, NEW ENGL J MED, V327, P685; NORRIS RM, 1984, AM J CARDIOL, V53, P408, DOI 10.1016/0002-9149(84)90003-1; PARAMESHWAR J, 1992, BRIT J GEN PRACT, V42, P287; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Pitt B, 1997, LANCET, V349, P747, DOI 10.1016/S0140-6736(97)01187-2; REMES J, 1992, EUR HEART J, V13, P588, DOI 10.1093/oxfordjournals.eurheartj.a060220; REMES J, 1991, EUR HEART J, V12, P315, DOI 10.1093/oxfordjournals.eurheartj.a059896; Remme WJ, 1997, EUR HEART J, V18, P736; Schunkert H, 1998, LANCET, V351, P372, DOI 10.1016/S0140-6736(05)78298-2; SUTTON GC, 1990, AM HEART J, V120, P1538, DOI 10.1016/0002-8703(90)90055-3; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; Townsend PP., 1988, HLTH DEPRIVATION INE; Vasan RS, 2001, NEW ENGL J MED, V344, P56, DOI 10.1056/NEJM200101043440111; WHEELDON NM, 1993, Q J MED, V86, P17	30	365	373	0	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 11	2001	358	9280					439	444		10.1016/S0140-6736(01)05620-3	http://dx.doi.org/10.1016/S0140-6736(01)05620-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463TB	11513906				2022-12-28	WOS:000170492400008
J	Kriss, GA; Shull, JM; Oegerle, W; Zheng, W; Davidsen, AF; Songaila, A; Tumlinson, J; Cowie, LL; Deharveng, JM; Friedman, SD; Giroux, ML; Green, RF; Hutchings, JB; Jenkins, EB; Kruk, JW; Moos, HW; Morton, DC; Sembach, KR; Tripp, TM				Kriss, GA; Shull, JM; Oegerle, W; Zheng, W; Davidsen, AF; Songaila, A; Tumlinson, J; Cowie, LL; Deharveng, JM; Friedman, SD; Giroux, ML; Green, RF; Hutchings, JB; Jenkins, EB; Kruk, JW; Moos, HW; Morton, DC; Sembach, KR; Tripp, TM			Resolving the structure of ionized helium in the intergalactic medium with the Far Ultraviolet Spectroscopic Explorer	SCIENCE			English	Article							COLD DARK-MATTER; LY-ALPHA FOREST; ABSORPTION; CLOUDS; MODEL; EVOLUTION; SPECTRUM; HYDROGEN; OPACITY; QUASARS	The neutral hydrogen (H I) and ionized helium (He II) absorption in the spectra of quasars are unique probes of structure in the early universe. We present Far-Ultraviolet Spectroscopic Explorer observations of the line of sight to the quasar HE2347-4342 in the 1000 to 1187 angstrom band at a resolving power of 15,000. We resolve the He II Lyman alpha (Ly alpha) absorption as a discrete forest of absorption lines in the redshift range 2.3 to 2.7. About 50 percent of these features have H I counterparts with column densities N-HI > 10(12.3) per square centimeter that account for most of the observed opacity in He II Ly alpha. The He if to H I column density ratio ranges from 1 to >1000, with an average of similar to 80. Ratios of <100 are consistent with photoionization of the absorbing gas by a hard ionizing spectrum resulting from the integrated light of quasars, but ratios of >100 in many locations indicate additional contributions from starburst galaxies or heavily filtered quasar radiation. The presence of He II Ly alpha absorbers with no H I counterparts indicates that structure is present even in low-density regions, consistent with theoretical predictions of structure formation through gravitational instability.	Space Telescope Sci Inst, Baltimore, MD 21218 USA; Johns Hopkins Univ, Ctr Astrophys Sci, Dept Phys & Astron, Baltimore, MD 21218 USA; Univ Colorado, Dept Astrophys & Planetary Sci, JILA, Boulder, CO 80309 USA; NASA, Goddard Space Flight Ctr, Astron & Solar Phys Lab, Greenbelt, MD 20771 USA; Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; Astron Spatiale Lab, F-13376 Marseille 12, France; Kitt Peak Natl Observ, Natl Opt Astron Observ, Tucson, AZ 85726 USA; Princeton Univ Observ, Princeton, NJ 08544 USA; Natl Res Council Canada, Herzberg Inst Astrophys, Victoria, BC V8X 4M6, Canada	Space Telescope Science Institute; Johns Hopkins University; University of Colorado System; University of Colorado Boulder; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Hawaii System; National Optical Astronomy Observatory; Princeton University; National Research Council Canada	Kriss, GA (corresponding author), Space Telescope Sci Inst, 3700 San Martin Dr, Baltimore, MD 21218 USA.		Oegerle, William/C-9070-2012; Kruk, Jeffrey/G-4047-2012; Jenkins, Edward/P-5684-2014	Jenkins, Edward/0000-0003-1892-4423; Kriss, Gerard/0000-0002-2180-8266				BI HG, 1995, ASTROPHYS J, V452, P90, DOI 10.1086/176282; BI HG, 1993, ASTROPHYS J, V405, P479, DOI 10.1086/172380; Bi HG, 1997, ASTROPHYS J, V479, P523, DOI 10.1086/303908; CARDELLI JA, 1989, ASTROPHYS J, V345, P245, DOI 10.1086/167900; CEN R, 1994, APJ, V437, P9; Cen RY, 1999, ASTROPHYS J, V514, P1, DOI 10.1086/306949; Croft RAC, 1997, ASTROPHYS J, V488, P532, DOI 10.1086/304723; Dave R, 1999, ASTROPHYS J, V511, P521, DOI 10.1086/306722; Davidsen AF, 1996, NATURE, V380, P47, DOI 10.1038/380047a0; FEIGELSON ED, 1985, ASTROPHYS J, V293, P192, DOI 10.1086/163225; GUNN JE, 1965, ASTROPHYS J, V142, P1633, DOI 10.1086/148444; Heap SR, 2000, ASTROPHYS J, V534, P69, DOI 10.1086/308719; Hernquist L, 1996, ASTROPHYS J, V457, pL51, DOI 10.1086/309899; HU EM, 1995, ASTRON J, V110, P1526, DOI 10.1086/117625; HUI MA, 1997, ASTRON J, V486, P599; JAKOBSEN P, 1994, NATURE, V370, P35, DOI 10.1038/370035a0; JAKOBSEN P, 1993, ASTROPHYS J, V417, P528, DOI 10.1086/173331; KRISS GA, 1994, ASTR SOC P, V61, P437; LYNDS R, 1971, ASTROPHYS J, V164, pL73, DOI 10.1086/180695; Madau P, 1999, ASTROPHYS J, V514, P648, DOI 10.1086/306975; MiraldaEscude J, 1996, ASTROPHYS J, V471, P582, DOI 10.1086/177992; Moos HW, 2000, ASTROPHYS J, V538, pL1, DOI 10.1086/312795; PRESS WH, 1993, ASTROPHYS J, V418, P585, DOI 10.1086/173419; Reimers D, 1997, ASTRON ASTROPHYS, V327, P890; Sahnow DJ, 2000, ASTROPHYS J, V538, pL7, DOI 10.1086/312794; Schlegel DJ, 1998, ASTROPHYS J, V500, P525, DOI 10.1086/305772; Shull JM, 2000, ASTROPHYS J, V538, pL73, DOI 10.1086/312782; SMETTE A, IN PRESS ASTROPHYS J; Songaila A, 1998, ASTRON J, V115, P2184, DOI 10.1086/300387; SONGAILA A, 1995, NATURE, V375, P124, DOI 10.1038/375124a0; Zhang Y, 1997, ASTROPHYS J, V485, P496, DOI 10.1086/304446; ZHANG Y, 1995, ASTROPHYS J, V453, pL57; Zheng W, 1997, ASTROPHYS J, V475, P469, DOI 10.1086/303560; Zheng W, 1998, ASTRON J, V115, P391, DOI 10.1086/300230	34	122	122	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2001	293	5532					1112	1116		10.1126/science.1062693	http://dx.doi.org/10.1126/science.1062693			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498584	Green Submitted			2022-12-28	WOS:000170432600052
J	Struhl, K				Struhl, K			Gene regulation - A paradigm for precision	SCIENCE			English	Editorial Material							IFN-BETA ENHANCEOSOME; TRANSCRIPTION; RECRUITMENT; EXPRESSION; ACTIVATION		Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Struhl, K (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.							Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Falvo JV, 2000, MOL CELL BIOL, V20, P4814, DOI 10.1128/MCB.20.13.4814-4825.2000; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; MANIATIS T, 1992, TRANSCRIPTIONAL REGU, P1193; Merika M, 1998, MOL CELL, V1, P277, DOI 10.1016/S1097-2765(00)80028-3; Merika M, 2001, CURR OPIN GENET DEV, V11, P205, DOI 10.1016/S0959-437X(00)00180-5; Munshi N, 1998, MOL CELL, V2, P457, DOI 10.1016/S1097-2765(00)80145-8; Munshi N, 2001, SCIENCE, V293, P1133, DOI 10.1126/science.293.5532.1133; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; STRUHL K, 1991, NEURON, V7, P177, DOI 10.1016/0896-6273(91)90256-Y; Struhl K, 1999, CELL, V98, P1, DOI 10.1016/S0092-8674(00)80599-1; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; van Heeckeren WJ, 1998, MOL CELL BIOL, V18, P7317, DOI 10.1128/MCB.18.12.7317; Yie JM, 1999, P NATL ACAD SCI USA, V96, P13108, DOI 10.1073/pnas.96.23.13108; Yie JM, 1999, EMBO J, V18, P3074, DOI 10.1093/emboj/18.11.3074	15	48	50	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2001	293	5532					1054	1055		10.1126/science.1064050	http://dx.doi.org/10.1126/science.1064050			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498564				2022-12-28	WOS:000170432600032
J	Compton, CH; Gubb, J; Nieman, R; Edelson, J; Amit, O; Bakst, A; Ayres, JG; Creemers, JPHM; Schultze-Werninghaus, G; Brambilla, C; Barnes, NC				Compton, CH; Gubb, J; Nieman, R; Edelson, J; Amit, O; Bakst, A; Ayres, JG; Creemers, JPHM; Schultze-Werninghaus, G; Brambilla, C; Barnes, NC		Int Study Grp	Cilomilast, a selective phosphodiesterase-4 inhibitor for treatment of patients with chronic obstructive pulmonary disease: a randomised, dose-ranging study	LANCET			English	Article							ARIFLO(TM) SB 207499; PDE4 INHIBITOR; COPD; THEOPHYLLINE	Background Chronic obstructive pulmonary disease (COPD) is a common, progressive respiratory disease that causes great morbidity and mortality despite treatment. There is evidence for airway inflammation in COPD. Cilomilast is an orally active, potent, selective phosphodiesterase type 4 inhibitor, which in vitro can affect cells thought to be of clinical importance in COPD. Our aim was to assess the safety, efficacy, and dose response of cilomilast in the treatment of patients with this disease. Methods We did a 6-week, randomised, dose-ranging study in 424 patients with COPD (forced expiratory volume in 1 s [FEV1] 46.8% of predicted, FEV1/forced vital capacity [FVC] 54.6%, and postsalbutamol reversibility 5.4%). We randomly assigned individuals at 60 European centres to receive cilomilast 5 (n=109), 10 (n=102), or 15 (n=107) mg twice daily, or placebo (n=106). The main outcome measure was trough FEV1 before and after use of a bronchodilator. Analyses were by intention to treat. Findings Cilomilast 15 mg twice daily significantly improved FEV1 compared with placebo (mean 130 mL vs -30 mL [95% CI 90-240] at week 6, p<0.0001). FVC and peak expiratory flow were also improved (p=0.001 and p<0.0001, respectively). Quality of life measures did not differ significantly between the groups. There were no significant differences in serious adverse events between the groups. Interpretation Cilomilast 15 mg twice daily might be an effective maintenance treatment for COPD. Further clinical studies are underway.	SmithKline Beecham Pharmaceut, Harlow CM19 5AD, Essex, England; SmithKline Beecham Pharmaceut, Collegeville, PA USA; Birmingham Heartlands Hosp, Birmingham B9 5ST, W Midlands, England; Poliklin Longziekten, Eindhoven, Netherlands; Med Klin & Poliklin Allergol, Bochum, Germany; CHU Tronche, Serv Pneumophysiol D2, Grenoble, France; London Chest Hosp, Dept Thorac Med, London E2 9JX, England; London Chest Hosp, Dept Resp Med, London E2 9JX, England	GlaxoSmithKline; GlaxoSmithKline; Heart of England NHS Foundation Trust; University of Birmingham; CHU Grenoble Alpes; University of London; Queen Mary University London; University of London; Queen Mary University London	Compton, CH (corresponding author), SmithKline Beecham Pharmaceut, Harlow CM19 5AD, Essex, England.	christopher_h_compton@sbphrd.com						[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; [Anonymous], [No title captured]; Barnes PJ, 1998, TRENDS PHARMACOL SCI, V19, P415, DOI 10.1016/S0165-6147(98)01245-0; BIAGGIONI I, 1991, J PHARMACOL EXP THER, V258, P588; Boushey HA, 1999, NEW ENGL J MED, V340, P1990, DOI 10.1056/NEJM199906243402509; Cazzola M, 1999, THORAX, V54, P730, DOI 10.1136/thx.54.8.730; CELLI BR, 1995, AM J RESP CRIT CARE, V152, pS77; CRAPO RO, 1981, AM REV RESPIR DIS, V123, P659; Fernandes LB, 1996, CLIN EXP PHARMACOL P, V23, P980, DOI 10.1111/j.1440-1681.1996.tb01153.x; GREENING A, 1997, EUR RESPIR REV, V7, P243; Griswold DE, 1999, AM J RESP CRIT CARE, V159, pA90; Griswold DE, 1998, J PHARMACOL EXP THER, V287, P705; Hattotuwa K, 1999, AM J RESP CRIT CARE, V159, pA523; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; HOYERT DL, 1999, NATL VITAL STAT REPO, V47, P84; Jeffery PK, 1998, THORAX, V53, P129, DOI 10.1136/thx.53.2.129; JONES PW, 1992, AM REV RESPIR DIS, V145, P1321, DOI 10.1164/ajrccm/145.6.1321; Mapp CE, 2000, NEW ENGL J MED, V343, P1960, DOI 10.1056/NEJM200012283432609; Murdoch RD, 1999, AM J RESP CRIT CARE, V159, pA525; MURRAY CJL, 1996, GLOBAL BURDEN DIS, P361; *OFF POP CENS SURV, 1993, MORT STAT CAUS ENGL; Osman LM, 1997, THORAX, V52, P67; Scanlon PD, 2000, AM J RESP CRIT CARE, V161, P381, DOI 10.1164/ajrccm.161.2.9901044; SIAFAKAS NM, 1995, EUR RESPIR J, V8, P1398, DOI 10.1183/09031936.95.08081398; Torphy TJ, 1998, AM J RESP CRIT CARE, V157, P351, DOI 10.1164/ajrccm.157.2.9708012; Torphy TJ, 1999, PULM PHARMACOL THER, V12, P131, DOI 10.1006/pupt.1999.0181; Underwood DC, 1998, J PHARMACOL EXP THER, V287, P988; [No title captured], DOI DOI 10.1136/THX.52.2008.S1]; 1983, CLIN RESP PHYSL S, V19	29	158	173	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 28	2001	358	9278					265	270		10.1016/S0140-6736(01)05481-2	http://dx.doi.org/10.1016/S0140-6736(01)05481-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	457AF	11498212				2022-12-28	WOS:000170114400009
J	Marie, Y; Sanson, M; Mokhtari, K; Leuraud, P; Kujas, M; Delattre, JY; Poirier, J; Zalc, B; Khe, HX				Marie, Y; Sanson, M; Mokhtari, K; Leuraud, P; Kujas, M; Delattre, JY; Poirier, J; Zalc, B; Khe, HX			OLIG2 as a specific marker of oligodendroglial tumour cells	LANCET			English	Article								OLIG2 is a recently Identified transcription factor involved In the specification of cells In the oligodendroglial lineage. We Investigated the expression of OLIG2 by In-situ hybridisation In 21 brain tumours: nine grade II and III oligodendrogliomas, three grade II oligoastrocytomas, and nine non-oligodendroglial tumours (four grade IV astrocytomas, two meningiomas, a dysembryoplastic neuroepithelial tumour, and two metastases). OLIG2-positive cells corresponding to neoplastic oligodendrocytes were present in all oligodendrogliomas and oligoastrocytomas. By contrast, OLIG2 expression was not detected in the non-oligodendroglial tumours. Thus, oligodendroglioma probably arise from oligodendrocyte precursor cells. OLIG2 should prove a useful marker for the diagnosis of oligodendroglial tumours.	Grp Hosp Pitie Salpetriere, Federat Neurol Mazarin, F-75651 Paris 13, France; INSERM, U495, Lab Biol Interact Neurone Glie, Paris, France; UPMC, Paris, France; Grp Hosp Pitie Salpetriere, Lab Histoembryol Cytogenet, F-75634 Paris, France; Grp Hosp Pitie Salpetriere, Lab Neuropathol R Escourolle, F-75634 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Khe, HX (corresponding author), Grp Hosp Pitie Salpetriere, Federat Neurol Mazarin, F-75651 Paris 13, France.		Messier, Claude/A-2322-2008; Hoang-Xuan, Khe/O-7527-2017	Messier, Claude/0000-0002-4791-1763; 				Coons SW, 1997, CANCER, V79, P1381, DOI 10.1002/(SICI)1097-0142(19970401)79:7<1381::AID-CNCR16>3.0.CO;2-W; Fortin D, 1999, NEUROSURGERY, V45, P1279, DOI 10.1097/00006123-199912000-00001; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; REIFENBERGER J, 1994, AM J PATHOL, V145, P1175; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3	5	122	129	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 28	2001	358	9278					298	300		10.1016/S0140-6736(01)05499-X	http://dx.doi.org/10.1016/S0140-6736(01)05499-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	457AF	11498220				2022-12-28	WOS:000170114400017
J	Reddy, A; Caler, EV; Andrews, NW				Reddy, A; Caler, EV; Andrews, NW			Plasma membrane repair is mediated by Ca2+-regulated exocytosis of lysosomes	CELL			English	Article							REGULATES CA2+-DEPENDENT EXOCYTOSIS; EPITHELIAL-CELLS; PC12 CELLS; FIBROBLASTS; SYNAPTOTAGMINS; RELEASE; MACROMOLECULES; CONTRACTION; DISRUPTIONS; MECHANISM	Plasma membrane wounds are repaired by a mechanism involving Ca2+-regulated exocytosis. Elevation in intracellular [Ca2+] triggers fusion of lysosomes with the plasma membrane, a process regulated by the lysosomal synaptotagmin isoform Syt VII. Here, we show that Ca2+-regulated exocytosis of lysosomes is required for the repair of plasma membrane disruptions. Lysosomal exocytosis and membrane resealing are inhibited by the recombinant Syt VII C(2)A domain or anti-Syt VII C(2)A antibodies, or by antibodies against the cytosolic domain of Lamp-1, which specifically aggregate lysosomes. We further demonstrate that lysosomal exocytosis mediates the resealing of primary skin fibroblasts wounded during the contraction of collagen matrices. These findings reveal a fundamental, novel role for lysosomes: as Ca2+-regulated exocytic compartments responsible for plasma membrane repair.	Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, New Haven, CT 06520 USA	Yale University	Andrews, NW (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, 333 Cedar St, New Haven, CT 06520 USA.			Andrews, Norma/0000-0002-0611-2412	NIAID NIH HHS [AI34867] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034867, R01AI034867] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andrews NW, 2000, TRENDS CELL BIOL, V10, P316, DOI 10.1016/S0962-8924(00)01794-3; Bakker AC, 1997, J CELL SCI, V110, P2227; Bi GQ, 1995, J CELL BIOL, V131, P1747, DOI 10.1083/jcb.131.6.1747; BODEMANN H, 1972, J MEMBRANE BIOL, V8, P1, DOI 10.1007/BF01868092; BUSSONMABILLOT S, 1984, BIOL CELL, V51, P53, DOI 10.1111/j.1768-322X.1984.tb00283.x; Butcher BA, 2000, MOL BIOCHEM PARASIT, V107, P207, DOI 10.1016/S0166-6851(00)00189-4; Caler EV, 2001, J EXP MED, V193, P1097, DOI 10.1084/jem.193.9.1097; CHANG DC, 1990, BIOPHYS J, V58, P1, DOI 10.1016/S0006-3495(90)82348-1; Chavez RA, 1996, J CELL BIOL, V133, P1177, DOI 10.1083/jcb.133.6.1177; CHEN WT, 1981, J CELL SCI, V49, P1; Coorssen JR, 1996, EMBO J, V15, P3787, DOI 10.1002/j.1460-2075.1996.tb00752.x; Dai J, 1995, COLD SPRING HARB SYM, V60, P567, DOI 10.1101/SQB.1995.060.01.060; Davis AF, 1999, NEURON, V24, P363, DOI 10.1016/S0896-6273(00)80850-8; Detrait ER, 2000, J NEUROSCI RES, V62, P566, DOI 10.1002/1097-4547(20001115)62:4<566::AID-JNR11>3.3.CO;2-W; Eddleman CS, 1997, P NATL ACAD SCI USA, V94, P4745, DOI 10.1073/pnas.94.9.4745; Gerona RRL, 2000, J BIOL CHEM, V275, P6328, DOI 10.1074/jbc.275.9.6328; Grinnell F, 2000, TRENDS CELL BIOL, V10, P362, DOI 10.1016/S0962-8924(00)01802-X; GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401; HART NH, 1987, J EXP ZOOL, V244, P17, DOI 10.1002/jez.1402440104; HARTER C, 1992, J CELL BIOL, V117, P311, DOI 10.1083/jcb.117.2.311; Kasai H, 1999, P NATL ACAD SCI USA, V96, P945, DOI 10.1073/pnas.96.3.945; LEE B, 1985, BIOCHIM BIOPHYS ACTA, V815, P128, DOI 10.1016/0005-2736(85)90482-1; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; LIEBER MR, 1982, J BIOL CHEM, V257, P1660; Lin YC, 1997, MOL BIOL CELL, V8, P59, DOI 10.1091/mbc.8.1.59; LIPPINCOTTSCHWARTZ J, 1991, CELL, V67, P601, DOI 10.1016/0092-8674(91)90534-6; Martinez I, 2000, J CELL BIOL, V148, P1141, DOI 10.1083/jcb.148.6.1141; MCNEIL PL, 1987, J CELL SCI, V88, P669; McNeil PL, 2000, J CELL SCI, V113, P1891; MCNEIL PL, 1989, GASTROENTEROLOGY, V96, P1238, DOI 10.1016/S0016-5085(89)80010-1; MCNEIL PL, 1992, AM J PATHOL, V140, P1097; McNeil PL, 1997, J CELL BIOL, V137, P1, DOI 10.1083/jcb.137.1.1; MCNEIL PL, 1984, J CELL BIOL, V98, P1556, DOI 10.1083/jcb.98.4.1556; MIKOSHIBA K, 1995, P NATL ACAD SCI USA, V92, P10703, DOI 10.1073/pnas.92.23.10703; Miyake K, 1995, J CELL BIOL, V131, P1737, DOI 10.1083/jcb.131.6.1737; MOCHITATE K, 1991, EXP CELL RES, V193, P198, DOI 10.1016/0014-4827(91)90556-A; Mota MM, 2001, SCIENCE, V291, P141, DOI 10.1126/science.291.5501.141; Ninomiya Y, 1996, J BIOL CHEM, V271, P17751, DOI 10.1074/jbc.271.30.17751; Rodriguez A, 1996, J CELL BIOL, V134, P349, DOI 10.1083/jcb.134.2.349; Rodriguez A, 1999, J BIOL CHEM, V274, P16754, DOI 10.1074/jbc.274.24.16754; Rodriguez A, 1997, J CELL BIOL, V137, P93, DOI 10.1083/jcb.137.1.93; Schiavo G, 1998, BIOCHEM BIOPH RES CO, V248, P1, DOI 10.1006/bbrc.1998.8527; STEINHARDT RA, 1994, SCIENCE, V263, P390, DOI 10.1126/science.7904084; Sudhof TC, 1996, NEURON, V17, P379, DOI 10.1016/S0896-6273(00)80171-3; Sugita S, 2000, BIOCHEMISTRY-US, V39, P2940, DOI 10.1021/bi9920984; SWANSON JA, 1987, SCIENCE, V238, P548, DOI 10.1126/science.2443981; Terasaki M, 1997, J CELL BIOL, V139, P63, DOI 10.1083/jcb.139.1.63; Togo T, 1999, J CELL SCI, V112, P719; Togo T, 2000, MOL BIOL CELL, V11, P4339, DOI 10.1091/mbc.11.12.4339; TOMASEK JJ, 1992, ANAT REC, V232, P359, DOI 10.1002/ar.1092320305; ULLRICH B, 1995, NEUROPHARMACOLOGY, V34, P1371, DOI 10.1016/0028-3908(95)00132-P; WALL DA, 1985, J CELL BIOL, V101, P1651, DOI 10.1083/jcb.101.5.1651	52	723	738	2	31	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 27	2001	106	2					157	169		10.1016/S0092-8674(01)00421-4	http://dx.doi.org/10.1016/S0092-8674(01)00421-4			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	458KG	11511344	Bronze			2022-12-28	WOS:000170193100006
J	Gill, TM; Desai, MM; Gahbauer, EA; Holford, TR; Williams, CS				Gill, TM; Desai, MM; Gahbauer, EA; Holford, TR; Williams, CS			Restricted activity among community-living older persons: Incidence, precipitants, and health care utilization	ANNALS OF INTERNAL MEDICINE			English	Article							BASE-LINE VULNERABILITY; RANDOMIZED-TRIAL; PREVENTING DISABILITY; FUNCTIONAL DEPENDENCE; ADULTS; SYMPTOMS; PEOPLE; DISEASE; EVENTS; FALLS	Background: Restricted activity is a potentially important indicator of health and functional status. Yet, relatively little is known about the incidence, precipitants, or health care utilization associated with restricted activity among older persons. Objective: To more accurately estimate the rate of restricted activity among community-living older persons, to identify the health-related and non-health-related problems that lead to restricted activity, and to determine whether restricted activity is associated with increased health care utilization. Design: Prospective cohort study. Setting: New Haven, Connecticut. Participants: 754 nondisabled members of a large health plan, 70 years of age or older, who were categorized according to their risk for disability (low, intermediate, or high). Measurements: Occurrence of restricted activity (defined as having stayed in bed for at least half a day or having cut down on one's usual activities because of an illness, injury, or another problem), problems leading to restricted activity, and health care utilization were ascertained during monthly telephone interviews for up to 2 years. Results: In median follow-up of 15 months, 76.6% of participants reported restricted activity during at least 1 month and 39.3% reported restricted activity during 2 consecutive months. The rates of restricted activity per 100 person-months were 19.0 episodes for all participants and 16.9, 27.3, and 22.7 episodes for participants at low, intermediate, and high risk for disability, respectively. Of the 24 prespecified health-related and non-health-related problems, the rates per 100 person-months of restricted activity ranged from 0.1 episode for "problem with alcohol" to 65.5 episodes for "been fatigued." On average, participants identified 4.5 different problems as a cause for their restricted activity, Health care utilization was substantially greater during months with restricted activity than months without restricted activity. The corresponding rates per 100 person-months were 63.8 and 45.1 for physician office visits, 12.5 and 1.0 for emergency department visits, 14.1 and 0.3 for hospital admissions, and 67.6 and 45.1 for any health care utilization (P<0.001 for each pairwise comparison). Conclusions: Restricted activity is common among community-living older persons, regardless of risk for disability, and it is usually attributable to several concurrent health-related problems. Although restricted activity is associated with a. substantial increase in health care utilization, older persons with restricted activity often do not seek medical attention.	Yale Univ, Sch Med, Dorothy Adler Geriat Assessment Ctr, New Haven, CT 06504 USA; Dept Vet Affairs, Connecticut Healthcare Syst, West Haven, CT USA	Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Gill, TM (corresponding author), Yale Univ, Sch Med, Dorothy Adler Geriat Assessment Ctr, 20 York St, New Haven, CT 06504 USA.		Fazli, Ghazal/AAE-8320-2022; Gill, Thomas M./H-7043-2019	Gill, Thomas M./0000-0002-6450-0368; Desai, Mayur/0000-0001-6616-0945	NATIONAL INSTITUTE ON AGING [R01AG017560, K23AG000759] Funding Source: NIH RePORTER; NIA NIH HHS [K23AG00759, 1RO1AG17560-01A1] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Baker DW, 1998, SOC SCI MED, V47, P1601, DOI 10.1016/S0277-9536(98)00215-9; BRODY EM, 1983, GERONTOLOGIST, V23, P75, DOI 10.1093/geront/23.1.75; BRODY EM, 1983, J AM GERIATR SOC, V31, P489, DOI 10.1111/j.1532-5415.1983.tb05124.x; Feinstein AR, 1987, CLINIMETRICS; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fried LP, 1997, J AM GERIATR SOC, V45, P92, DOI 10.1111/j.1532-5415.1997.tb00986.x; Gill TM, 1999, J GERONTOL A-BIOL, V54, pM377, DOI 10.1093/gerona/54.7.M377; Glynn RJ, 1996, BMJ-BRIT MED J, V312, P364; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; Haas J, 1998, NEW ENGL J MED, V338, P1694, DOI 10.1056/NEJM199806043382312; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Inouye SK, 1996, JAMA-J AM MED ASSOC, V275, P852, DOI 10.1001/jama.275.11.852; Institute of Medicine, 1996, HLTH OUTC OLD PEOPL; Jones R, 2000, BMJ-BRIT MED J, V320, P596, DOI 10.1136/bmj.320.7235.596; KOSOROK MR, 1992, AM J PUBLIC HEALTH, V82, P1263, DOI 10.2105/AJPH.82.9.1263; Leveille SG, 1998, J AM GERIATR SOC, V46, P1191, DOI 10.1111/j.1532-5415.1998.tb04533.x; Leveille SG, 2000, J GERONTOL B-PSYCHOL, V55, pS41; Lorig KR, 1999, MED CARE, V37, P5, DOI 10.1097/00005650-199901000-00003; *NAT CTR HLTH STAT, 1986, DHHS PUBL; Nevitt MC, 2000, ARCH INTERN MED, V160, P77, DOI 10.1001/archinte.160.1.77; RAKOWSKI W, 1988, MED CARE, V26, P278, DOI 10.1097/00005650-198803000-00005; Reuben DB, 1999, J AM GERIATR SOC, V47, P269, DOI 10.1111/j.1532-5415.1999.tb02988.x; Rothman K., 1998, MODERN EPIDEMIOLOGY; *SAS I, 1996, SAS SOFTW SYST VERS; SCHOLES D, 1991, AM J PUBLIC HEALTH, V81, P485, DOI 10.2105/AJPH.81.4.485; STUKEL TA, 1994, STAT MED, V13, P1781, DOI 10.1002/sim.4780131709; Szklo M, 1998, EPIDEMIOL REV, V20, P81, DOI 10.1093/oxfordjournals.epirev.a017974; TINETTI ME, 1995, JAMA-J AM MED ASSOC, V273, P1348, DOI 10.1001/jama.273.17.1348; TINETTI ME, 1994, J GERONTOL, V49, pM140, DOI 10.1093/geronj/49.3.M140; *US DHEW, 1979, DHEW PUBL; VERBRUGGE LM, 1985, SOC SCI MED, V20, P855, DOI 10.1016/0277-9536(85)90343-0; VERBRUGGE LM, 1987, MED CARE, V25, P539, DOI 10.1097/00005650-198706000-00008; WAGNER EH, 1994, AM J PUBLIC HEALTH, V84, P1800, DOI 10.2105/AJPH.84.11.1800; WAGNER EH, 1993, J AM GERIATR SOC, V41, P241, DOI 10.1111/j.1532-5415.1993.tb06700.x	34	247	248	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 4	2001	135	5					313	321		10.7326/0003-4819-135-5-200109040-00007	http://dx.doi.org/10.7326/0003-4819-135-5-200109040-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	468WF	11529694				2022-12-28	WOS:000170780600001
J	El Goresy, A; Chen, M; Dubrovinsky, L; Gillet, P; Graup, G				El Goresy, A; Chen, M; Dubrovinsky, L; Gillet, P; Graup, G			An ultradense polymorph of rutile with seven-coordinated titanium from the Ries crater	SCIENCE			English	Article							HIGH-PRESSURE; PHASE-TRANSITION; TIO2; SILICA	We report the discovery of an ultradense post-rutile polymorph of titanium dioxide in shocked gneisses of the Ries crater in Germany. The microscopic diagnostic feature is intense blue internal reflections in crossed polarizers in reflected light. X-ray diffraction studies revealed a monoclinic lattice, isostructural with the baddeleyite ZrO2 polymorph, and the titanium cation is coordinated with seven oxygen anions. The cell parameters are as follows: a = 4.606(2) angstroms, b = 4.986(3) angstroms, c = 4.933(3) angstroms, beta (angle between c and a axes) = 99.17(6)degrees; space group P2(1)/c; density = 4.72 grams per cubic centimeter, where the numbers in parentheses are standard deviations in the last significant digits. This phase is 11% denser than rutile. The mineral is sensitive to x-ray irradiation and tends to invert to rutile. The presence of baddeleyite-type TiO2 in the shocked rocks indicates that the peak shock pressure was between 16 and 20 gigapascals, and the post-shock temperature was much lower than 500 degreesC.	Max Planck Inst Chem, D-55128 Mainz, Germany; Chinese Acad Sci, Guangzhou Inst Geochem, Guangzhou 510640, Peoples R China; Uppsala Univ, Inst Earth Sci, Theoret Geochem Program, S-75236 Uppsala, Sweden; Ecole Normale Super Lyon, Lab Sci Terre, F-69364 Lyon, France	Max Planck Society; Chinese Academy of Sciences; Guangzhou Institute of Geochemistry, CAS; Uppsala University; Ecole Normale Superieure de Lyon (ENS de LYON)	El Goresy, A (corresponding author), Max Planck Inst Chem, J Joachim Becher Weg 27, D-55128 Mainz, Germany.	goresy@mpch-mainz.mpg.de		Dubrovinsky, Leonid/0000-0002-3717-7585				AHUJA R, 2001, UNPUB; CHAO ECT, 1967, SCIENCE, V156, P192, DOI 10.1126/science.156.3772.192; DECARLI PS, 2001, LUNAR PLANET SCI, V32; DECARLI PS, 2000, CATASTROPHIC EVENTS; DUBROVINSKAIA NA, UNPUB; Dubrovinsky LS, 2001, NATURE, V410, P653, DOI 10.1038/35070650; El Goresy A, 2000, SCIENCE, V288, P1632, DOI 10.1126/science.288.5471.1632; El Goresy A, 2001, AM MINERAL, V86, P611; ELGORESY A, IN PRESS EARTH PLANE; Gerward L, 1997, J APPL CRYSTALLOGR, V30, P259, DOI 10.1107/S0021889896011454; Haines J, 1996, SCIENCE, V271, P629, DOI 10.1126/science.271.5249.629; Haines J, 1996, J PHYS-CONDENS MAT, V8, P1631, DOI 10.1088/0953-8984/8/11/009; Hwang SL, 2000, SCIENCE, V288, P321, DOI 10.1126/science.288.5464.321; KUSABA K, 1988, PHYS CHEM MINER, V15, P238, DOI 10.1007/BF00307512; LEGER JM, 1994, HIGH-PRESSURE SCIENCE AND TECHNOLOGY - 1993, PTS 1 AND 2, P363, DOI 10.1063/1.46117; LINDE RK, 1969, J CHEM PHYS, V50, P319, DOI 10.1063/1.1670796; LIU LG, 1978, SCIENCE, V199, P422, DOI 10.1126/science.199.4327.422; Masaitis VL, 1998, METEORIT PLANET SCI, V33, P349, DOI 10.1111/j.1945-5100.1998.tb01639.x; MCQUEEN RG, 1967, SCIENCE, V155, P1401, DOI 10.1126/science.155.3768.1401; Okuno M, 1999, PHYS CHEM MINER, V26, P304, DOI 10.1007/s002690050190; Olsen JS, 1999, J PHYS CHEM SOLIDS, V60, P229, DOI 10.1016/S0022-3697(98)00274-1; RAMDOHR P, 1975, ERZMINERLIEN VERWACH; STAHLE V, 1999, METEORIT PLANET SCI; STAHLE V, UNPUB; STOFFLER D, 1974, FORTSCHR MINERAL, V51, P256; Stu┬ffler D., 1972, FORTSCHRITTE MINERAL, V49, P50; SYONO Y, 1987, SHOCK INDUCED PHASE	27	84	85	0	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2001	293	5534					1467	1470						4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465XV	11520981				2022-12-28	WOS:000170616000038
J	Isshiki, T; Pearson, B; Holbrook, S; Doe, CQ				Isshiki, T; Pearson, B; Holbrook, S; Doe, CQ			Drosophila neuroblasts sequentially express transcription factors which specify the temporal identity of their neuronal progeny	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; IKAROS GENE FAMILY; EMBRYONIC NEUROBLASTS; SEGMENTATION GENE; DOMAIN GENE; GLIAL-CELLS; CNS; HUNCHBACK; SPECIFICATION; KRUPPEL	Neural precursors often generate distinct cell types in a specific order, but the intrinsic or extrinsic cues regulating the timing of cell fate specification are poorly understood. Here we show that Drosophila neural precursors (neuroblasts) sequentially express the transcription factors Hunchback --> Kruppel --> Pdm --> Castor, with differentiated progeny maintaining the transcription factor profile present at their birth. Hunchback is necessary and sufficient for first-born cell fates, whereas Kruppel is necessary and sufficient for second-born cell fates; this is observed in multiple lineages and is independent of the cell type involved. We propose that Hunchback and Kruppel control early-born temporal identity in neuroblast cell lineages.	Univ Oregon 1254, Howard Hughes Med Inst, Inst Neurosci, Inst Mol Biol, Eugene, OR 97403 USA	Howard Hughes Medical Institute; University of Oregon	Doe, CQ (corresponding author), Univ Oregon 1254, Howard Hughes Med Inst, Inst Neurosci, Inst Mol Biol, Eugene, OR 97403 USA.		Isshiki, Takako/L-5255-2013	Pearson, Bret/0000-0002-3473-901X	NICHD NIH HHS [HD27056] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD027056] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bossing T, 1996, DEV BIOL, V179, P41, DOI 10.1006/dbio.1996.0240; BROADUS J, 1995, MECH DEVELOP, V53, P393, DOI 10.1016/0925-4773(95)00454-8; Brody T, 2000, DEV BIOL, V226, P34, DOI 10.1006/dbio.2000.9829; Cepko CL, 1999, CURR OPIN NEUROBIOL, V9, P37, DOI 10.1016/S0959-4388(99)80005-1; Cortes M, 1999, CURR OPIN IMMUNOL, V11, P167, DOI 10.1016/S0952-7915(99)80028-4; CUI X, 1995, DEVELOPMENT, V121, P3233; CUI X, 1992, DEVELOPMENT, V116, P943; DOE CQ, 1985, DEV BIOL, V111, P206, DOI 10.1016/0012-1606(85)90446-4; Durand B, 2000, BIOESSAYS, V22, P64; Farkas G, 2000, GENE, V253, P117, DOI 10.1016/S0378-1119(00)00240-7; Fay DS, 1999, DEV BIOL, V205, P240, DOI 10.1006/dbio.1998.9096; FRANTZ GD, 1994, J NEUROSCI, V14, P472; FRANTZ GD, 1994, J NEUROSCI, V14, P5725; FURST A, 1985, DEV BIOL, V109, P184, DOI 10.1016/0012-1606(85)90359-8; GAUL U, 1987, CELL, V50, P639, DOI 10.1016/0092-8674(87)90037-7; Graba Y, 1997, BIOESSAYS, V19, P379, DOI 10.1002/bies.950190505; Harris WA, 1997, CURR OPIN GENET DEV, V7, P651, DOI 10.1016/S0959-437X(97)80013-5; Hoch M, 1998, EMBO J, V17, P5766, DOI 10.1093/emboj/17.19.5766; Honma Y, 1999, FEBS LETT, V447, P76, DOI 10.1016/S0014-5793(99)00265-3; HULSKAMP M, 1994, GENETICS, V138, P125; Iwasa JH, 2000, DEV GENES EVOL, V210, P277, DOI 10.1007/s004270050315; Kambadur R, 1998, GENE DEV, V12, P246, DOI 10.1101/gad.12.2.246; Lane ME, 1996, CELL, V87, P1225, DOI 10.1016/S0092-8674(00)81818-8; Lundell MJ, 1998, DEVELOPMENT, V125, P463; MARGOLIS JS, 1995, DEVELOPMENT, V121, P3067; MCCONNELL SK, 1995, J NEUROSCI, V15, P6987; MELLERICK DM, 1992, NEURON, V9, P789, DOI 10.1016/0896-6273(92)90234-5; Muller C, 2001, CURR OPIN GENET DEV, V11, P167, DOI 10.1016/S0959-437X(00)00175-1; Ohnuma S, 1999, CELL, V99, P499, DOI 10.1016/S0092-8674(00)81538-X; Perron M, 1998, DEV BIOL, V199, P185, DOI 10.1006/dbio.1998.8939; PROKOP A, 1994, DEVELOPMENT, V120, P2567; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Romani S, 1996, MECH DEVELOP, V60, P95, DOI 10.1016/S0925-4773(96)00603-X; Schmid A, 1999, DEVELOPMENT, V126, P4653; Skeath JB, 1998, DEVELOPMENT, V125, P1857; SOMMER RJ, 1992, P NATL ACAD SCI USA, V89, P10782, DOI 10.1073/pnas.89.22.10782; WEIGMANN K, 1995, DEVELOPMENT, V121, P3713; Wimmer EA, 2000, SCIENCE, V287, P2476, DOI 10.1126/science.287.5462.2476; YANG XH, 1993, GENE DEV, V7, P504, DOI 10.1101/gad.7.3.504	39	463	466	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 24	2001	106	4					511	521		10.1016/S0092-8674(01)00465-2	http://dx.doi.org/10.1016/S0092-8674(01)00465-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	466UU	11525736	Bronze			2022-12-28	WOS:000170665200014
J	Wang, JF; Gudiksen, MS; Duan, XF; Cui, Y; Lieber, CM				Wang, JF; Gudiksen, MS; Duan, XF; Cui, Y; Lieber, CM			Highly polarized photoluminescence and photodetection from single indium phosphide nanowires	SCIENCE			English	Article							QUANTUM WIRES; SEMICONDUCTOR NANOWIRES; ANISOTROPY; DOTS	We have characterized the fundamental photoluminescence (PL) properties of individual, isolated indium phosphide (InP) nanowires to define their potential for optoelectronics. Polarization-sensitive measurements reveal a striking anisotropy in the PL intensity recorded parallel and perpendicular to the long axis of a nanowire. The order-of-magnitude polarization anisotropy was quantitatively explained in terms of the large dielectric contrast between these freestanding nanowires and surrounding environment, as opposed to quantum confinement effects. This intrinsic anisotropy was used to create polarization-sensitive nanoscale photodetectors that may prove useful in integrated photonic circuits, optical switches and interconnects, near-field imaging, and high-resolution detectors.	Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Lieber, CM (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.	cml@cmliris.harvard.edu	Cui, Yi/L-5804-2013; Duan, Xiangfeng/AAQ-9674-2020; Duan, Xiangfeng/E-7522-2011; Chu, Yung-Ming/C-6318-2009; Wang, Jianfang/O-1810-2013	Cui, Yi/0000-0002-6103-6352; Duan, Xiangfeng/0000-0002-4321-6288; Duan, Xiangfeng/0000-0002-4321-6288; Wang, Jianfang/0000-0002-2467-8751				Akiyama H, 1996, PHYS REV B, V53, pR4229, DOI 10.1103/PhysRevB.53.R4229; Bass M, 1995, HDB OPTICS; Chen CJ, 1999, APPL PHYS LETT, V74, P862, DOI 10.1063/1.123391; Cui Y, 2001, SCIENCE, V291, P851, DOI 10.1126/science.291.5505.851; Cui Y, 2000, J PHYS CHEM B, V104, P5213, DOI 10.1021/jp0009305; Duan XF, 2000, ADV MATER, V12, P298, DOI 10.1002/(SICI)1521-4095(200002)12:4<298::AID-ADMA298>3.0.CO;2-Y; Duan XF, 2001, NATURE, V409, P66, DOI 10.1038/35051047; Empedocles SA, 1996, PHYS REV LETT, V77, P3873, DOI 10.1103/PhysRevLett.77.3873; Gudiksen MS, 2001, J PHYS CHEM B, V105, P4062, DOI 10.1021/jp010540y; Gudiksen MS, 2000, J AM CHEM SOC, V122, P8801, DOI 10.1021/ja002008e; GUDIKSEN MS, 1984, ELECTRODYNAMICS CONT, P34; Hasen J, 1997, NATURE, V390, P54, DOI 10.1038/36299; Huang Y, 2001, SCIENCE, V291, P630, DOI 10.1126/science.291.5504.630; ILS P, 1995, PHYS REV B, V51, P4272, DOI 10.1103/PhysRevB.51.4272; SOMEYA T, 1995, PHYS REV LETT, V74, P3664, DOI 10.1103/PhysRevLett.74.3664; URA S, 1988, J LIGHTWAVE TECHNOL, V6, P1028, DOI 10.1109/50.4095; Vouilloz F, 1998, PHYS REV B, V57, P12378, DOI 10.1103/PhysRevB.57.12378	17	1711	1785	26	592	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2001	293	5534					1455	1457		10.1126/science.1062340	http://dx.doi.org/10.1126/science.1062340			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465XV	11520977				2022-12-28	WOS:000170616000034
J	Bawden, GW; Thatcher, W; Stein, RS; Hudnut, KW; Peltzer, G				Bawden, GW; Thatcher, W; Stein, RS; Hudnut, KW; Peltzer, G			Tectonic contraction across Los Angeles after removal of groundwater pumping effects	NATURE			English	Article							METROPOLITAN REGION; SOUTHERN-CALIFORNIA; INTERFEROMETRY; EARTHQUAKES; HAZARDS; RADAR	After the 1987 Whittier Narrows(1) and 1994 Northridge(2) earthquakes revealed that blind thrust faults represent a significant threat to metropolitan Los Angeles(3), a network of 250 continuously recording global positioning system (GPS) stations(4,5) was deployed to monitor displacements associated with deep slip on both blind and surface faults. Here we augment this GPS data with interferometric synthetic aperture radar imagery to take into account the deformation associated with groundwater pumping and strike-slip faulting. After removing these non-tectonic signals, we are left with 4.4 mm yr(-1) of uniaxial contraction across the Los Angeles basin, oriented N 36 degrees E (perpendicular to the major strike-slip faults in the area). This indicates that the contraction is primarily accommodated on thrust faults(6) rather than on the northeast-trending strike-slip faults. We have found that widespread groundwater and oil pumping obscures and in some cases mimics the tectonic signals expected from the blind thrust faults. In the 40-km-long Santa Ana basin, groundwater withdrawal and re-injection produces 12 mm yr(-1) of long-term subsidence, accompanied by an unprecedented seasonal oscillation of 55 mm in the vertical direction and 7 mm horizontally.	US Geol Survey, Menlo Pk, CA 94025 USA; US Geol Survey, Pasadena, CA 91106 USA; Univ Calif Los Angeles, Los Angeles, CA 90095 USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; University of California System; University of California Los Angeles	Bawden, GW (corresponding author), US Geol Survey, 345 Middlefield Rd, Menlo Pk, CA 94025 USA.		Peltzer, Gilles/V-8108-2019; Hudnut, Kenneth W/AAB-4549-2020; Hudnut, Kenneth W/B-1945-2009	Hudnut, Kenneth W/0000-0002-3168-4797; Hudnut, Kenneth W/0000-0002-3168-4797				Argus DF, 1999, GEOLOGY, V27, P703, DOI 10.1130/0091-7613(1999)027<0703:SATOML>2.3.CO;2; BOCK Y, 1997, 1408001A0899 SCEC, V2; CARPENTER MC, 1993, 497H58 US GEOL SURV; CLARKE DD, 1987, ASS PETROL GEOL, V58, P135; DOLAN JF, 1995, SCIENCE, V267, P199, DOI 10.1126/science.267.5195.199; Ferretti A, 2000, IEEE T GEOSCI REMOTE, V38, P2202, DOI 10.1109/36.868878; GALLOWAY D, 1999, 1182177 US GEOL SURV; Galloway DL, 1998, WATER RESOUR RES, V34, P2573, DOI 10.1029/98WR01285; HAUKSSON E, 1995, J GEOPHYS RES-SOL EA, V100, P12335, DOI 10.1029/95JB00865; HAUKSSON E, 1989, J GEOPHYS RES-SOLID, V94, P9569, DOI 10.1029/JB094iB07p09569; IRELAND RL, 1982, 82370134 US GEOL SUR; JACKSON DD, 1995, B SEISMOL SOC AM, V85, P379; Massonnet D, 1998, REV GEOPHYS, V36, P441, DOI 10.1029/97RG03139; MILLS W, 1999, 371 OR COUNT WAT DIS; POLAND JF, 1956, W1109 US GEOL SURV; PRESCOTT WH, 1996, EOS T AGU, V77, P417; Shaw JH, 1996, J GEOPHYS RES-SOL EA, V101, P8623, DOI 10.1029/95JB03453; Shaw JH, 1999, SCIENCE, V283, P1516, DOI 10.1126/science.283.5407.1516; Walls C, 1998, NATURE, V394, P356, DOI 10.1038/28590; Zhang J, 1997, J GEOPHYS RES-SOL EA, V102, P18035, DOI 10.1029/97JB01380	20	241	253	1	34	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2001	412	6849					812	815		10.1038/35090558	http://dx.doi.org/10.1038/35090558			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465ET	11518964				2022-12-28	WOS:000170577200035
J	Okazaki, R; Takaoka, N; Nagao, K; Sekiya, M; Nakamura, T				Okazaki, R; Takaoka, N; Nagao, K; Sekiya, M; Nakamura, T			Noble-gas-rich chondrules in an enstatite meteorite	NATURE			English	Article							E-CHONDRITES; COMPONENTS; ELEMENTS; SOLAR	Chondrules are silicate spherules that are found in abundance in the most primitive class of meteorites, the chondrites. Chondrules are believed to have formed by rapid cooling of silicate melt early in the history of the Solar System(1), and their properties should reflect the composition of (and physical conditions in) the solar nebula at the time when the Sun and planets were forming. It is usually believed that chondrules lost all their noble gases at the time of melting(2-4). Here we report the discovery of significant amounts of trapped noble gases in chondrules in the enstatite chondrite Yamato-791790, which consists of highly reduced minerals. The elemental ratios Ar-36/Xe-132 and Kr-84/Xe-132 are similar to those of 'subsolar' gas(5,6), which has the highest Ar-36/Xe-132 ratio after that of solar-type noble gases(7). The most plausible explanation for the high noble-gas concentration and the characteristic elemental ratios is that solar gases were implanted into the chondrule precursor material, followed by incomplete loss of the implanted gases through diffusion over time.	Univ Tokyo, Grad Sch Sci, Earthquake Chem Lab, Bunkyo Ku, Tokyo 1130033, Japan; Kyushu Univ 33, Fac Sci, Dept Earth & Planetary Sci, Fukuoka 8128581, Japan	University of Tokyo; Kyushu University	Okazaki, R (corresponding author), Univ Tokyo, Grad Sch Sci, Earthquake Chem Lab, Bunkyo Ku, Tokyo 1130033, Japan.							ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; CRABB J, 1981, GEOCHIM COSMOCHIM AC, V45, P2443, DOI 10.1016/0016-7037(81)90097-1; CRABB J, 1982, GEOCHIM COSMOCHIM AC, V46, P2351, DOI 10.1016/0016-7037(82)90207-1; DODD RT, 1981, METEORITES PETROLOGI; Eberhardt P., 1972, P LUNAR PLANET SCI C, P1821; GOSWAMI JN, 1984, SPACE SCI REV, V37, P111, DOI 10.1007/BF00213959; HEWINS RH, 1996, CHONDRULES PROTOPLAN, P257; HIYAGON H, 1981, THESIS U TOKYO; KIM JS, 1994, METEORITICS, V29, P482; Kimura M., 1999, ANTARCT METEORITE RE, V12, P1; KIRSTEN T, 1968, J GEOPHYS RES, V73, P2807, DOI 10.1029/JB073i008p02807; LEWIS RS, 1975, SCIENCE, V190, P1251, DOI 10.1126/science.190.4221.1251; MIURA YN, 1997, ANTARCTIC METEORITES, V22, P118; Nakamura T, 1999, GEOCHIM COSMOCHIM AC, V63, P241, DOI 10.1016/S0016-7037(98)00275-0; OKAZAKI R, 2000, THESIS KYUSHU U; Okazaki R, 2000, ANTARCT METEOR RES, V13, P153; Ozima M., 1983, NOBLE GAS GEOCHEMIST; PEPIN RO, 1991, ICARUS, V92, P2, DOI 10.1016/0019-1035(91)90036-S; Rubin AE, 2000, EARTH-SCI REV, V50, P3, DOI 10.1016/S0012-8252(99)00067-7; Shu FH, 2001, ASTROPHYS J, V548, P1029, DOI 10.1086/319018; WACKER JF, 1983, EARTH PLANET SC LETT, V62, P147, DOI 10.1016/0012-821X(83)90078-X; WIELER R, 1992, GEOCHIM COSMOCHIM AC, V56, P2907, DOI 10.1016/0016-7037(92)90367-R; [No title captured]	23	36	36	0	7	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2001	412	6849					795	798		10.1038/35090520	http://dx.doi.org/10.1038/35090520			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465ET	11518959				2022-12-28	WOS:000170577200030
J	Mohle-Boetani, JC; Farrar, JA; Werner, SB; Minassian, D; Bryant, R; Abbott, S; Slutsker, L; Vugia, DJ				Mohle-Boetani, JC; Farrar, JA; Werner, SB; Minassian, D; Bryant, R; Abbott, S; Slutsker, L; Vugia, DJ		Investigation Team	Escherichia coli O157 and Salmonella infections associated with sprouts in California, 1996-1998	ANNALS OF INTERNAL MEDICINE			English	Article							OUTBREAK	Background: In California, from 1996 through 1998, more than 50% of multicounty outbreaks with confirmed food vehicles were related to alfalfa or clover sprouts. Objective: To summarize investigations of sprout-associated outbreaks. Design: Matched case-control studies. Setting: California. Patients: Outbreak-associated patients and matched population controls. Measurements: Matched odds ratios and 95% Cis; traceback and environmental investigations of sprout and seed growers; and pulsed-field gel electrophoresis of isolates from patients, sprouts, and seeds. Results: Five sprout-associated outbreaks of salmonellosis and one outbreak of infection with nonmotile Shiga toxin-producing Escherichia coli O157 occurred. Six hundred patients had culture-confirmed disease, and two died. It is estimated that these outbreaks caused 22 800 cases of gastrointestinal illness or urinary tract infection. In the case-control studies, odds ratios for the association between illness and alfalfa sprout consumption ranged from 5.0 to proportional to (all were statistically significant). Three sprout growers were implicated, and each was associated with two outbreaks. Outbreak strains of Salmonella were isolated from sprouts supplied by two sprout growers and from seeds used by the third sprout grower. Conclusions: As currently produced, sprouts can be a hazardous food. Seeds can be contaminated before sprouting, and no method can eliminate all pathogens from seeds. Seed and sprout growers should implement measures to decrease contamination. The general public should recognize the risks of eating sprouts, and populations at high risk for complications from salmonellosis or E coli O157 infection should avoid sprout consumption.	Calif Dept Hlth Serv, Berkeley, CA 94704 USA; Los Angeles Cty Dept Hlth Serv, Los Angeles, CA USA; Ctr Dis Control & Prevent, Atlanta, GA USA	California Department of Health Care Services; Centers for Disease Control & Prevention - USA	Mohle-Boetani, JC (corresponding author), Dis Invest & Surveillance Branch, Div Communicable Dis Control, 2151 Berkeley Way,Room 708, Berkeley, CA 94704 USA.	jmohlebo@dhs.ca.gov	Mohle-Boetani, Janet/AAH-4221-2019					Abbott SL, 1999, J CLIN MICROBIOL, V37, P4177, DOI 10.1128/JCM.37.12.4177-4178.1999; Andre AD, 1995, INT J AVIAT PSYCHOL, V5, P1, DOI 10.1207/s15327108ijap0501_1; Backer HD, 2000, PUBLIC HEALTH REP, V115, P339, DOI 10.1093/phr/115.4.339; Buck P., 1998, 47 ANN EP INT SERV C; *CDCP, 1999, FOODB DIS ACT SURV N, P6; *CDCP, 1995, EPI INFO VERS 6 04B; GLYNN MK, 1998, 36 ANN M INF DIS SOC; Inami GB, 1999, J FOOD PROTECT, V62, P662, DOI 10.4315/0362-028X-62.6.662; Kurtzweil P, 1999, FDA Consum, V33, P18; Mahon BE, 1997, J INFECT DIS, V175, P876, DOI 10.1086/513985; MARTIN D, 1991, EPIDEMIOLOGY, V2, P359, DOI 10.1097/00001648-199109000-00008; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Michino H, 1999, AM J EPIDEMIOL, V150, P787, DOI 10.1093/oxfordjournals.aje.a010082; OMAHONEY M, 1990, J PUBLIC HEALTH MED, V12, P91; PONKA A, 1995, LANCET, V345, P462, DOI 10.1016/S0140-6736(95)90451-4; Puohiniemi R, 1997, J CLIN MICROBIOL, V35, P2487, DOI 10.1128/JCM.35.10.2487-2491.1997; SWAMINATHAN B, 1993, DIAGNOSTIC MOL MICRO; Taormina PJ, 1999, EMERG INFECT DIS, V5, P626, DOI 10.3201/eid0505.990503; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Van Beneden CA, 1999, JAMA-J AM MED ASSOC, V281, P158, DOI 10.1001/jama.281.2.158; 1997, MMWR MORB MORTAL WKL, V46, P741	21	88	90	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 21	2001	135	4					239	247		10.7326/0003-4819-135-4-200108210-00008	http://dx.doi.org/10.7326/0003-4819-135-4-200108210-00008			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465KE	11511138				2022-12-28	WOS:000170587500002
J	Hall, NF; Gale, CR; Syddall, H; Phillips, DIW; Martyn, CN				Hall, NF; Gale, CR; Syddall, H; Phillips, DIW; Martyn, CN			Risk of macular degeneration in users of statins: cross sectional study	BRITISH MEDICAL JOURNAL			English	Article									Univ Southampton, Southampton Gen Hosp, MRC, Environm Epidemiol Unit, Southampton SO16 6YD, Hants, England	University of Southampton	Martyn, CN (corresponding author), Univ Southampton, Southampton Gen Hosp, MRC, Environm Epidemiol Unit, Southampton SO16 6YD, Hants, England.		Gale, Catharine R/B-1653-2012	Gale, Catharine/0000-0002-3361-8638	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bressler NM, 2000, BRIT MED J, V321, P1425, DOI 10.1136/bmj.321.7274.1425; Dithmar S, 2000, INVEST OPHTH VIS SCI, V41, P2035; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1128; Kureishi Y, 2000, NAT MED, V6, P1004, DOI 10.1038/79510; Pignone M, 2000, BRIT MED J, V321, P983, DOI 10.1136/bmj.321.7267.983	5	98	101	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 18	2001	323	7309					375	376		10.1136/bmj.323.7309.375	http://dx.doi.org/10.1136/bmj.323.7309.375			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465GN	11509429	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000170581400020
J	Cheney, RE; Rodriguez, OC				Cheney, RE; Rodriguez, OC			Cell biology - A switch to release the motor	SCIENCE			English	Editorial Material							MYOSIN-V; ASSOCIATION; MOVEMENT; YEAST; CYCLE		Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Cheney, RE (corresponding author), Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA.			Cheney, Richard/0000-0001-6565-7888	NIDCD NIH HHS [R29 DC003299] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R29DC003299] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Costa MCR, 1999, J BIOL CHEM, V274, P15811, DOI 10.1074/jbc.274.22.15811; Espreafico EM, 1998, P NATL ACAD SCI USA, V95, P8636, DOI 10.1073/pnas.95.15.8636; Finger FP, 1998, J CELL BIOL, V142, P609, DOI 10.1083/jcb.142.3.609; Karcher RL, 2001, SCIENCE, V293, P1317, DOI 10.1126/science.1061086; Lapierre LA, 2001, MOL BIOL CELL, V12, P1843, DOI 10.1091/mbc.12.6.1843; Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024; Mermall V, 1998, SCIENCE, V279, P527, DOI 10.1126/science.279.5350.527; Niclas J, 1996, J CELL BIOL, V133, P585, DOI 10.1083/jcb.133.3.585; Rogers SL, 1999, J CELL BIOL, V146, P1265, DOI 10.1083/jcb.146.6.1265; Wu XF, 1998, CELL MOTIL CYTOSKEL, V40, P286, DOI 10.1002/(SICI)1097-0169(1998)40:3<286::AID-CM7>3.0.CO;2-B; Wu XF, 1998, J CELL BIOL, V143, P1899, DOI 10.1083/jcb.143.7.1899; Wu XF, 2001, J CELL SCI, V114, P1091; Yin HW, 2000, NATURE, V406, P1013, DOI 10.1038/35023024	13	7	7	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2001	293	5533					1263	1264		10.1126/science.1064602	http://dx.doi.org/10.1126/science.1064602			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11509712				2022-12-28	WOS:000170492600021
J	Sano, Y; Inamura, K; Miyake, A; Mochizuki, S; Yokoi, H; Matsushime, H; Furuichi, K				Sano, Y; Inamura, K; Miyake, A; Mochizuki, S; Yokoi, H; Matsushime, H; Furuichi, K			Immunocyte Ca2+ influx system mediated by LTRPC2	SCIENCE			English	Article							TRP; DROSOPHILA; CHANNELS; PROTEIN; GENE; FAMILY; CD38	We characterized an activation mechanism of the human LTRPC2 protein, a member of the transient receptor potential family of ion channels, and demonstrated that LTRPC2 mediates Call influx into immunocytes. Intracellular pyrimidine nucleotides, adenosine 5'-diphosphoribose (ADPR), and nicotinamide adenine dinucleotide (NAD), directly activated LTRPC2, which functioned as a Ca2+-permeable nonselective cation channel and enabled Ca2+ influx into cells. This activation was suppressed by intracellular adenosine triphosphate. These results reveal that ADPR and NAD act as intracellular messengers and may have an important role in Ca2+ influx by activating LTRPC2 in immunocytes.	Yamanouchi Pharmaceut Co Ltd, Inst Drug Discovery Res, Mol Med Labs, Tsukuba, Ibaraki 3058585, Japan	Astellas Pharmaceuticals	Sano, Y (corresponding author), Yamanouchi Pharmaceut Co Ltd, Inst Drug Discovery Res, Mol Med Labs, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, Japan.	sano.yorikata@yamanouchi.co.jp						Agam K, 2000, J NEUROSCI, V20, P5748, DOI 10.1523/JNEUROSCI.20-15-05748.2000; Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; Duncan LM, 1998, CANCER RES, V58, P1515; FINKEL TH, 1991, IMMUNOL TODAY, V12, P79, DOI 10.1016/0167-5699(91)90162-M; Guse AH, 2000, J MOL MED, V78, P26, DOI 10.1007/s001090000076; Guse AH, 1998, CRIT REV IMMUNOL, V18, P419, DOI 10.1615/CritRevImmunol.v18.i5.20; Han MK, 2000, J BIOL CHEM, V275, P20799, DOI 10.1074/jbc.M001189200; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; Hofmann T, 2000, J MOL MED, V78, P14, DOI 10.1007/s001090050378; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; KATO I, 1995, J BIOL CHEM, V270, P30045, DOI 10.1074/jbc.270.50.30045; LEWIS CA, 1979, J PHYSIOL-LONDON, V286, P417, DOI 10.1113/jphysiol.1979.sp012629; Mehta K, 1996, FASEB J, V10, P1408, DOI 10.1096/fasebj.10.12.8903511; Missiaen L, 2000, CELL CALCIUM, V28, P1, DOI 10.1054/ceca.2000.0131; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; Nagamine K, 1998, GENOMICS, V54, P124, DOI 10.1006/geno.1998.5551; Prawitt D, 2000, HUM MOL GENET, V9, P203, DOI 10.1093/hmg/9.2.203; Putney JW, 1999, BIOESSAYS, V21, P38; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; SANO Y, UNPUB; Sestini S, 2000, ARCH BIOCHEM BIOPHYS, V379, P277, DOI 10.1006/abbi.2000.1888; WEISS A, 1991, ANNU REV GENET, V25, P487, DOI 10.1146/annurev.ge.25.120191.002415; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Wilding M, 1998, AM J PHYSIOL-CELL PH, V275, pC1277, DOI 10.1152/ajpcell.1998.275.5.C1277	25	359	380	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2001	293	5533					1327	1330		10.1126/science.1062473	http://dx.doi.org/10.1126/science.1062473			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11509734				2022-12-28	WOS:000170492600043
J	Adam, D				Adam, D			Chemistry journal reacts to dispute	NATURE			English	News Item																			0	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 16	2001	412	6848					669	669		10.1038/35089212	http://dx.doi.org/10.1038/35089212			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462ZB	11507601	Bronze			2022-12-28	WOS:000170450200010
J	Digicaylioglu, M; Lipton, SA				Digicaylioglu, M; Lipton, SA			Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappa B signalling cascades	NATURE			English	Article							NITRIC-OXIDE; TRANSCRIPTION FACTOR; CYTOKINE RECEPTORS; INDUCED APOPTOSIS; OXIDATIVE STRESS; GENE-EXPRESSION; CELLS; ACTIVATION; INHIBITION; HIPPOCAMPAL	Erythropoietin, a kidney cytokine regulating haematopoiesis (the production of blood cells), is also produced in the brain after oxidative or nitrosative stress(1,2). The transcription factor hypoxia-inducible factor-1 (HIF-1) upregulates EPO following hypoxic stimuli(3,4). Here we show that preconditioning with EPO protects neurons in models of ischaemic and degenerative damage due to excitotoxins(4,5) and consequent generation of free radicals, including nitric oxide (NO). Activation of neuronal EPO receptors (EPORs) prevents apoptosis induced by NMDA (N-methyl-D-aspartate) or NO by triggering cross-talk between the signalling pathways of Janus kinase-2 (Jak2) and nuclear factor-kappaB (NF-kappaB). We show that EPOR-mediated activation of Jak2 leads to phosphorylation of the inhibitor of NF-kappaB (I kappaB), subsequent nuclear translocation of the transcription factor NF-kappaB, and NF-kappaB-dependent transcription of neuroprotective genes. Transfection of cerebrocortical neurons with a dominant interfering form of Jak2 or an I kappaB alpha super-repressor blocks EPO-mediated prevention of neuronal apoptosis. Thus neuronal EPORs activate a neuroprotective pathway that is distinct from previously well characterized Jak and NF-kappaB functions. Moreover, this EPO effect may underlie neuroprotection mediated by hypoxic-schaemic preconditioning.	Burnham Inst, Ctr Neurosci & Aging Res, La Jolla, CA 92037 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp,Program Neurosci, Cerebrovasc & NeuroSci Res Inst, Boston, MA 02115 USA	Sanford Burnham Prebys Medical Discovery Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Lipton, SA (corresponding author), Burnham Inst, Ctr Neurosci & Aging Res, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Digicaylioglu, Murat H/D-3302-2009	Lipton, Stuart/0000-0002-3490-1259				ANAGNOSTOU A, 1990, P NATL ACAD SCI USA, V87, P5978, DOI 10.1073/pnas.87.15.5978; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Bernaudin M, 2000, GLIA, V30, P271, DOI 10.1002/(SICI)1098-1136(200005)30:3<271::AID-GLIA6>3.3.CO;2-8; Bonfoco E, 1996, NEUROREPORT, V8, P273, DOI 10.1097/00001756-199612200-00054; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Briscoe J, 1996, EMBO J, V15, P799, DOI 10.1002/j.1460-2075.1996.tb00415.x; DAWSON VL, 1993, J NEUROSCI, V13, P2651; DIGICAYLIOGLU M, 1995, P NATL ACAD SCI USA, V92, P3717, DOI 10.1073/pnas.92.9.3717; Gage AT, 1996, BRAIN RES, V719, P172, DOI 10.1016/0006-8993(96)00092-3; Gregory T, 1999, BLOOD, V94, P87, DOI 10.1182/blood.V94.1.87.413k41_87_96; Grilli M, 1996, SCIENCE, V274, P1383, DOI 10.1126/science.274.5291.1383; IHLE JN, 1995, ANNU REV IMMUNOL, V13, P369, DOI 10.1146/annurev.iy.13.040195.002101; Iimuro Y, 1998, J CLIN INVEST, V101, P802, DOI 10.1172/JCI483; Imbert V, 1996, CELL, V86, P787, DOI 10.1016/S0092-8674(00)80153-1; Lezoualc'h F, 1998, J NEUROSCI, V18, P3224; LIN YZ, 1995, J BIOL CHEM, V270, P14255, DOI 10.1074/jbc.270.24.14255; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; MASUDA S, 1993, J BIOL CHEM, V268, P11208; Mattson MP, 1997, J NEUROSCI RES, V49, P681, DOI 10.1002/(SICI)1097-4547(19970915)49:6<681::AID-JNR3>3.0.CO;2-3; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; Morishita E, 1997, NEUROSCIENCE, V76, P105, DOI 10.1016/s0306-4522(96)00306-5; ONeill LAJ, 1997, TRENDS NEUROSCI, V20, P252, DOI 10.1016/S0166-2236(96)01035-1; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Schmidt H. H. W., 1996, METHODS NITRIC OXIDE, P491; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; VAN AD, 1996, SCIENCE, V274, P787; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; ZHUANG HM, 1994, J BIOL CHEM, V269, P21411	30	778	859	0	47	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2001	412	6847					641	647		10.1038/35088074	http://dx.doi.org/10.1038/35088074			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460PP	11493922				2022-12-28	WOS:000170318000042
J	Back, AL; Pearlman, RA				Back, AL; Pearlman, RA			Desire for physician-assisted suicide: requests for a better death?	LANCET			English	Editorial Material							TERMINALLY ILL; PATIENT REQUESTS; HASTENED DEATH; CARE; EUTHANASIA; ATTITUDES; CANCER; LIFE; END		Univ Washington, Vaterans Affairs Puget Sound Hlth Care Syst, Seattle, WA 98108 USA	University of Washington; University of Washington Seattle	Back, AL (corresponding author), Univ Washington, Vaterans Affairs Puget Sound Hlth Care Syst, Seattle, WA 98108 USA.							Angell M, 1997, NEW ENGL J MED, V336, P50, DOI 10.1056/NEJM199701023360108; Back AL, 1996, JAMA-J AM MED ASSOC, V275, P919, DOI 10.1001/jama.275.12.919; BLOCH SD, 1994, ARCH INTERN MED, V154, P2039, DOI 10.1001/archinte.154.18.2039; Breitbart W, 2000, JAMA-J AM MED ASSOC, V284, P2907, DOI 10.1001/jama.284.22.2907; CHOCHINOV HM, 1995, AM J PSYCHIAT, V152, P1185; Dworkin G, 1998, EUTHANASIA PHYSICIAN; Foley KM, 1997, NEW ENGL J MED, V336, P54, DOI 10.1056/NEJM199701023360109; Ganzini L, 1998, NEW ENGL J MED, V339, P967, DOI 10.1056/NEJM199810013391406; Meier DE, 1998, NEW ENGL J MED, V338, P1193, DOI 10.1056/NEJM199804233381706; Rosenfeld B, 2000, CANCER, V88, P2868, DOI 10.1002/1097-0142(20000615)88:12<2868::AID-CNCR30>3.0.CO;2-K; Singer PA, 1999, JAMA-J AM MED ASSOC, V281, P163, DOI 10.1001/jama.281.2.163; Steinhauser KE, 2000, ANN INTERN MED, V132, P825, DOI 10.7326/0003-4819-132-10-200005160-00011; Sullivan AD, 2000, NEW ENGL J MED, V342, P598, DOI 10.1056/NEJM200002243420822; van der Maas PJ, 1996, NEW ENGL J MED, V335, P1699, DOI 10.1056/NEJM199611283352227	14	8	8	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 4	2001	358	9279					344	345		10.1016/S0140-6736(01)05583-0	http://dx.doi.org/10.1016/S0140-6736(01)05583-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459DE	11502307				2022-12-28	WOS:000170235100002
J	Donaldson, M				Donaldson, M			What is the role of growth-hormone therapy in short children who were small for gestational age?	LANCET			English	Editorial Material							SHORT STATURE; FINAL HEIGHT; RETARDATION; BIRTH; TERM		Royal Hosp Sick Children, Dept Child Hlth, Glasgow GS3 8SJ, Lanark, Scotland	University of Glasgow	Donaldson, M (corresponding author), Royal Hosp Sick Children, Dept Child Hlth, Glasgow GS3 8SJ, Lanark, Scotland.							Coutant R, 1998, J CLIN ENDOCR METAB, V83, P1070, DOI 10.1210/jc.83.4.1070; de Zegher F, 2000, J CLIN ENDOCR METAB, V85, P2816, DOI 10.1210/jc.85.8.2816; DEWAAL WJ, 1994, CLIN ENDOCRINOL, V41, P621; DEZEGHER F, 1990, BIOL NEONATE, V58, P188; KARLBERG J, 1995, PEDIATR RES, V38, P733, DOI 10.1203/00006450-199511000-00017; Zucchini S, 2001, ARCH DIS CHILD, V84, P340, DOI 10.1136/adc.84.4.340	6	5	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 4	2001	358	9279					347	348		10.1016/S0140-6736(01)05585-4	http://dx.doi.org/10.1016/S0140-6736(01)05585-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459DE	11502309				2022-12-28	WOS:000170235100004
J	Devireddy, LR; Teodoro, JG; Richard, FA; Green, MR				Devireddy, LR; Teodoro, JG; Richard, FA; Green, MR			Induction of apoptosis by a secreted lipocatin that is transcriptionally regulated by IL-3 deprivation	SCIENCE			English	Article							ACUTE-PHASE PROTEIN; CELL-DEATH; HEMATOPOIETIC-CELLS; INDUCED EXPRESSION; GENE; SURVIVAL; ENDONUCLEASE; ACTIVATION; WITHDRAWAL; LINES	Many hematopoietic cells undergo apoptosis when deprived of specific cytokines, and this process requires de novo RNA/protein synthesis. Using DNA microarrays to analyze interleukin-3 (IL-3)- dependent murine FL5.12 pro-B cells, we found that the gene undergoing maximal transcriptional induction after cytokine withdrawal is 24p3, which encodes a secreted lipocalin. Conditioned medium from IL-3-deprived FL5.12 cells contained 24p3 and induced apoptosis in naive FL5.12 cells even when IL-3 was present. 24p3 also induced apoptosis in a wide variety of leukocytes but not other cell types. Apoptotic sensitivity correlated with the presence of a putative 24p3 cell surface receptor. We conclude that IL-3 deprivation activates 24p3 transcription, leading to synthesis and secretion of 24p3, which induces apoptosis through an autocrine pathway.	Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Gene Funct & Express, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Green, MR (corresponding author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Gene Funct & Express, 373 Plantat St, Worcester, MA 01605 USA.		Teodoro, Joe/AFT-2440-2022	Teodoro, Joe/0000-0002-3713-6839				Blalock WL, 1999, LEUKEMIA, V13, P1109, DOI 10.1038/sj.leu.2401493; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Chen G, 1999, J BIOL CHEM, V274, P7, DOI 10.1074/jbc.274.1.7; Chu ST, 1996, BIOCHEM J, V316, P545, DOI 10.1042/bj3160545; COHEN JJ, 1984, J IMMUNOL, V132, P38; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Endres R, 1997, IMMUNITY, V7, P419, DOI 10.1016/S1074-7613(00)80363-5; Flower DR, 1996, BIOCHEM J, V318, P1; GALILI U, 1982, CANCER RES, V42, P1433; GarayRojas E, 1996, GENE, V170, P173, DOI 10.1016/0378-1119(95)00896-9; GREENBERGER JS, 1983, P NATL ACAD SCI-BIOL, V80, P2931, DOI 10.1073/pnas.80.10.2931; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; JOHNSON DE, 1998, FRONT BIOSCI, V3, P313; Khaled AR, 1999, P NATL ACAD SCI USA, V96, P14476, DOI 10.1073/pnas.96.25.14476; Lenardo M, 1999, ANNU REV IMMUNOL, V17, P221, DOI 10.1146/annurev.immunol.17.1.221; Liu QS, 1997, MOL REPROD DEV, V46, P507, DOI 10.1002/(SICI)1098-2795(199704)46:4&lt;507::AID-MRD9&gt;3.0.CO;2-S; LIU QS, 1995, J BIOL CHEM, V270, P22565, DOI 10.1074/jbc.270.38.22565; MCCUBREY J, 1989, ONCOGENE RES, V4, P97; MISHIZAWA M, 1992, FEBS LETT, V299, P36; NIELSEN BS, 1996, GUT, V38, P41; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; Rathmell JC, 1999, ANNU REV IMMUNOL, V17, P781, DOI 10.1146/annurev.immunol.17.1.781; RODRIGUEZTARDUCHY G, 1990, EMBO J, V9, P2997, DOI 10.1002/j.1460-2075.1990.tb07492.x; RODRIGUEZTARDUCHY G, 1992, J IMMUNOL, V149, P535; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Vander Heiden MG, 1999, MOL CELL, V3, P159; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; WATSON J, 1979, J EXP MED, V150, P1510, DOI 10.1084/jem.150.6.1510; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3	31	312	333	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2001	293	5531					829	834		10.1126/science.1061075	http://dx.doi.org/10.1126/science.1061075			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11486081				2022-12-28	WOS:000170241000036
J	He, XW; Rines, DR; Espelin, CW; Sorger, PK				He, XW; Rines, DR; Espelin, CW; Sorger, PK			Molecular analysis of kinetochore-microtubule attachment in budding yeast	CELL			English	Article							SPINDLE POLE BODY; CELL-CYCLE ARREST; SACCHAROMYCES-CEREVISIAE; CHROMOSOME SEGREGATION; MITOTIC SPINDLE; PRECOCIOUS SEPARATION; CENTROMERE PROTEIN; FISSION YEAST; XENOPUS EGGS; PLUS-END	The complex series of movements that mediates chromosome segregation during mitosis is dependent on the attachment of microtubules to kinetochores, DNA-protein complexes that assemble on centromeric DNA. We describe the use of live-cell imaging and chromatin immunoprecipitation in S. cerevisiae to identify ten kinetochore subunits, among which are yeast homologs of microtubule binding proteins in animal cells. By analyzing conditional mutations in several of these proteins, we show that they are required for the imposition of tension on paired sister kinetochores and for correct chromosome movement. The proteins include both molecular motors and microtubule associated proteins (MAPs), implying that motors and MAPs function together in binding chromosomes to spindle microtubules.	MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Sorger, PK (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.			Rines, Daniel/0000-0002-1830-2926; Sorger, Peter/0000-0002-3364-1838	NIGMS NIH HHS [GM19483, GM51464] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051464] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERLIN V, 1990, J CELL BIOL, V111, P2573, DOI 10.1083/jcb.111.6.2573; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; Bloom K, 2000, NAT CELL BIOL, V2, pE96, DOI 10.1038/35014089; Brunner D, 2000, CELL, V102, P695, DOI 10.1016/S0092-8674(00)00091-X; Cheeseman IM, 2001, J CELL BIOL, V152, P197, DOI 10.1083/jcb.152.1.197; Diamantopoulos GS, 1999, J CELL BIOL, V144, P99, DOI 10.1083/jcb.144.1.99; DOHENY KF, 1993, CELL, V73, P761, DOI 10.1016/0092-8674(93)90255-O; Donaldson AD, 1996, J CELL BIOL, V132, P887, DOI 10.1083/jcb.132.5.887; Dujardin D, 1998, J CELL BIOL, V141, P849, DOI 10.1083/jcb.141.4.849; Freeman L, 2000, J CELL BIOL, V149, P811, DOI 10.1083/jcb.149.4.811; GARD DL, 1987, J CELL BIOL, V105, P2203, DOI 10.1083/jcb.105.5.2203; Gardner RD, 2001, GENETICS, V157, P1493; Gheber L, 1999, J BIOL CHEM, V274, P9564, DOI 10.1074/jbc.274.14.9564; GOH PY, 1993, J CELL BIOL, V121, P503, DOI 10.1083/jcb.121.3.503; Goshima G, 2000, CELL, V100, P619, DOI 10.1016/S0092-8674(00)80699-6; He XW, 2000, CELL, V101, P763, DOI 10.1016/S0092-8674(00)80888-0; Hildebrandt ER, 2000, BBA-MOL CELL RES, V1496, P99, DOI 10.1016/S0167-4889(00)00012-4; Hofmann C, 1998, J CELL BIOL, V143, P1029, DOI 10.1083/jcb.143.4.1029; HOYT MA, 1992, J CELL BIOL, V118, P109, DOI 10.1083/jcb.118.1.109; Hunter AW, 2000, J CELL SCI, V113, P4379; Hyland KM, 1999, J CELL BIOL, V145, P15, DOI 10.1083/jcb.145.1.15; Hyman AA, 1995, ANNU REV CELL DEV BI, V11, P471, DOI 10.1146/annurev.cb.11.110195.002351; Janke C, 2001, EMBO J, V20, P777, DOI 10.1093/emboj/20.4.777; Jones MH, 1999, MOL BIOL CELL, V10, P2377, DOI 10.1091/mbc.10.7.2377; Kaplan KB, 2001, NAT CELL BIOL, V3, P429, DOI 10.1038/35070123; Kim JH, 1999, J CELL BIOL, V145, P1381, DOI 10.1083/jcb.145.7.1381; Korinek WS, 2000, SCIENCE, V287, P2257, DOI 10.1126/science.287.5461.2257; Megee PC, 1999, MOL CELL, V4, P445, DOI 10.1016/S1097-2765(00)80347-0; Meluh PB, 1999, METHOD ENZYMOL, V304, P414; Meluh PB, 1997, GENE DEV, V11, P3401, DOI 10.1101/gad.11.24.3401; Meluh PB, 1998, CELL, V94, P607, DOI 10.1016/S0092-8674(00)81602-5; Miller RK, 2000, MOL BIOL CELL, V11, P2949, DOI 10.1091/mbc.11.9.2949; Miller RK, 1998, J CELL BIOL, V140, P377, DOI 10.1083/jcb.140.2.377; Nabeshima K, 1998, MOL BIOL CELL, V9, P3211, DOI 10.1091/mbc.9.11.3211; Ortiz J, 1999, GENE DEV, V13, P1140, DOI 10.1101/gad.13.9.1140; OSBORNE MA, 1994, J CELL BIOL, V125, P853, DOI 10.1083/jcb.125.4.853; Rieder CL, 1998, TRENDS CELL BIOL, V8, P310, DOI 10.1016/S0962-8924(98)01299-9; ROOF DM, 1992, J CELL BIOL, V118, P95, DOI 10.1083/jcb.118.1.95; Sassoon I, 1999, GENE DEV, V13, P545, DOI 10.1101/gad.13.5.545; SKIBBENS RV, 1993, J CELL BIOL, V122, P859, DOI 10.1083/jcb.122.4.859; Spittle C, 2000, J BIOL CHEM, V275, P20748, DOI 10.1074/jbc.M002597200; STOLER S, 1995, GENE DEV, V9, P573, DOI 10.1101/gad.9.5.573; STRUNNIKOV AV, 1995, J CELL BIOL, V128, P749, DOI 10.1083/jcb.128.5.749; Tanaka TU, 2000, NAT CELL BIOL, V2, P492, DOI 10.1038/35019529; Tanaka TU, 1999, CELL, V98, P847, DOI 10.1016/S0092-8674(00)81518-4; Tavormina PA, 1998, GENETICS, V148, P1701; Tournebize R, 2000, NAT CELL BIOL, V2, P13, DOI 10.1038/71330; VASQUEZ RJ, 1994, J CELL BIOL, V127, P985, DOI 10.1083/jcb.127.4.985; Wang PJJ, 1997, J CELL BIOL, V139, P1271, DOI 10.1083/jcb.139.5.1271; Wigge PA, 2001, J CELL BIOL, V152, P349, DOI 10.1083/jcb.152.2.349; Wigge PA, 1998, J CELL BIOL, V141, P967, DOI 10.1083/jcb.141.4.967; Zeng XM, 1999, J CELL BIOL, V146, P415, DOI 10.1083/jcb.146.2.415; Zheng L, 1999, MOL CELL BIOL, V19, P5417; Zheng L, 2000, MOL CELL BIOL, V20, P3529, DOI 10.1128/MCB.20.10.3529-3537.2000	54	213	216	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 27	2001	106	2					195	206		10.1016/S0092-8674(01)00438-X	http://dx.doi.org/10.1016/S0092-8674(01)00438-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	458KG	11511347	Bronze			2022-12-28	WOS:000170193100009
J	Merrow, M; Roenneberg, T				Merrow, M; Roenneberg, T			Circadian clocks: Running on redox	CELL			English	Review							MPER1; NPAS2		Inst Med Psychol, D-80336 Munich, Germany		Merrow, M (corresponding author), Inst Med Psychol, Goethestr 31, D-80336 Munich, Germany.	martha@imp.med.uni-muenchen.de						Albrecht U, 2001, J BIOL RHYTHM, V16, P100, DOI 10.1177/074873001129001791; Aschoff J., 1981, BIOL RHYTHMS, P311; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Emery P, 2000, NATURE, V404, P456, DOI 10.1038/35006558; Garcia JA, 2000, SCIENCE, V288, P2226, DOI 10.1126/science.288.5474.2226; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; JAY TM, 1985, BRAIN RES, V342, P297, DOI 10.1016/0006-8993(85)91129-1; Krishnan B, 2001, NATURE, V411, P313, DOI 10.1038/35077094; McWatters HG, 2000, NATURE, V408, P716, DOI 10.1038/35047079; Merrow M, 1999, NATURE, V399, P584, DOI 10.1038/21190; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Roenneberg T, 1999, J BIOL RHYTHM, V14, P449, DOI 10.1177/074873099129001019; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; SCHWARTZ WJ, 1977, SCIENCE, V197, P1089, DOI 10.1126/science.887940; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; WAGNER E, 1975, BIOSYSTEMS, V7, P68, DOI 10.1016/0303-2647(75)90044-1; Wever R.A., 1979, CIRCADIAN SYSTEM MAN; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4	19	35	36	2	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2001	106	2					141	143		10.1016/S0092-8674(01)00443-3	http://dx.doi.org/10.1016/S0092-8674(01)00443-3			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	458KG	11511342	Bronze			2022-12-28	WOS:000170193100004
J	O'Boyle, CP; Cole, RP				O'Boyle, CP; Cole, RP			Rationing in the NHS: audit of outcome and acceptance of restriction criteria for minor operations	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Salisbury Dist Hosp, Odstock Ctr Burns Plast & Maxillofacial Surg, Salisbury SP2 8BJ, Wilts, England	Salisbury District Hospital	O'Boyle, CP (corresponding author), Salisbury Dist Hosp, Odstock Ctr Burns Plast & Maxillofacial Surg, Salisbury SP2 8BJ, Wilts, England.	ciaranoboyle@saintly.com	O'Boyle, Ciaran P/J-5853-2019	O'Boyle, Ciaran/0000-0001-9650-2133				Asch DA, 1997, NEW ENGL J MED, V336, P1668, DOI 10.1056/NEJM199706053362309; Charatan FB, 1996, BRIT MED J, V313, P1506, DOI 10.1136/bmj.313.7071.1506a; Latham SR, 1999, CLIN PLAST SURG, V26, P115; MCWILLIAM LJ, 1991, BRIT MED J, V303, P1177, DOI 10.1136/bmj.303.6811.1177; Timmons MJ, 2000, ANN ROY COLL SURG, V82, P332	5	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 25	2001	323	7310					428	429		10.1136/bmj.323.7310.428	http://dx.doi.org/10.1136/bmj.323.7310.428			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469BX	11520840	Green Published, Bronze			2022-12-28	WOS:000170793600021
J	Casares, F; Mann, RS				Casares, F; Mann, RS			The ground state of the ventral appendage in Drosophila	SCIENCE			English	Article							DISTAL-LESS; HOX GENE; PROXIMODISTAL AXIS; ANTENNAL IDENTITY; LEG DEVELOPMENT; NOTCH; EVOLUTION; SEGMENTATION; HOMOTHORAX; DOMAINS	In Drosophila melanogaster, the antennae, legs, genitalia, and analia make up a serially homologous set of ventral appendages that depend on different selector genes for their unique identities. The diversity among these structures implies that there is a common ground state that selector genes modify to generate these different appendage morphologies. Here we show that the ventral appendage that forms in the absence of selector gene activity is leglike but consists of only two segments along its proximo-distal axis: a proximal segment and a distal tarsus. These results raise the possibility that, during evolution, leglike appendages could have developed without selector gene activity.	Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University	Mann, RS (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 701 W 168 St, New York, NY 10032 USA.	rsm10@columbia.edu	Casares, Fernando/M-5451-2019	Casares, Fernando/0000-0002-2181-3858	NIGMS NIH HHS [R01 GM058575] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058575] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abu-Shaar M, 1998, DEVELOPMENT, V125, P3821; BEEMAN RW, 1989, DEV BIOL, V133, P196, DOI 10.1016/0012-1606(89)90311-4; Bishop SA, 1999, DEVELOPMENT, V126, P2993; BOUDREAUX BH, 1987, ARTHROPOD PHYLOGENY; Brown S, 2000, P NATL ACAD SCI USA, V97, P4510, DOI 10.1073/pnas.97.9.4510; Casares F, 1998, NATURE, V392, P723, DOI 10.1038/33706; de Celis JF, 1998, DEVELOPMENT, V125, P4617; Dong PDS, 2000, DEVELOPMENT, V127, P209; Duncan DM, 1998, GENE DEV, V12, P1290, DOI 10.1101/gad.12.9.1290; Estrada B, 2001, DEVELOPMENT, V128, P331; Gehring W., 1966, ARCH JULIUS KALAUSST, V41, P44; Gellon G, 1998, BIOESSAYS, V20, P116, DOI 10.1002/(SICI)1521-1878(199802)20:2<116::AID-BIES4>3.3.CO;2-N; Gorfinkiel N, 1997, GENE DEV, V11, P2259, DOI 10.1101/gad.11.17.2259; Grenier JK, 1997, CURR BIOL, V7, P547, DOI 10.1016/S0960-9822(06)00253-3; HANNAH-ALAVA ALOHA, 1958, J MORPH, V103, P281, DOI 10.1002/jmor.1051030205; Hughes CL, 2000, DEVELOPMENT, V127, P3683; Mann RS, 2000, ANNU REV CELL DEV BI, V16, P243, DOI 10.1146/annurev.cellbio.16.1.243; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Moreno E, 1999, NATURE, V400, P873, DOI 10.1038/23709; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Rauskolb C, 1999, DEV BIOL, V210, P339, DOI 10.1006/dbio.1999.9273; Snodgrass R, 1935, PRINCIPLES INSECT MO, P83; STRUHL G, 1981, NATURE, V292, P635, DOI 10.1038/292635a0; STRUHL G, 1982, P NATL ACAD SCI-BIOL, V79, P7380, DOI 10.1073/pnas.79.23.7380; VILLANO JL, 1995, DEVELOPMENT, V121, P2767; Weatherbee SD, 1999, CELL, V97, P283, DOI 10.1016/S0092-8674(00)80737-0; Wu J, 1999, DEVELOPMENT, V126, P109	27	76	79	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2001	293	5534					1477	1480		10.1126/science.1062542	http://dx.doi.org/10.1126/science.1062542			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465XV	11520984				2022-12-28	WOS:000170616000041
J	Drazner, MH; Rame, JE; Stevenson, LW; Dries, DL				Drazner, MH; Rame, JE; Stevenson, LW; Dries, DL			Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DILATED CARDIOMYOPATHY; CRITICALLY ILL; HEMODYNAMIC CORRELATIONS; INTEROBSERVER AGREEMENT; CARDIAC TRANSPLANTATION; MYOCARDIAL-INFARCTION; PHYSICAL-EXAMINATION; DOPPLER EVALUATION; CATHETERIZATION; SURVIVAL	Background: The independent prognostic value of elevated jugular venous pressure or a third heart sound in patients with heart failure is not well established. Methods: We performed a retrospective analysis of the Studies of Left Ventricular Dysfunction treatment trial, in which 2569 patients with symptomatic heart failure or a history of it were randomly assigned to receive enalapril or placebo. The mean (+/-SD) follow-up was 32+/-15 months. The presence of elevated jugular venous pressure or a third heart sound was ascertained by physical examination on entry into the trial. The risks of hospitalization for heart failure and progression of heart failure as defined by death from pump failure and the composite end point of death or hospitalization for heart failure were compared in patients with these findings on physical examination and patients without these findings. Results: In multivariate analyses that were adjusted for other markers of the severity of heart failure, elevated jugular venous pressure was associated with an increased risk of hospitalization for heart failure (relative risk, 1.32; 95 percent confidence interval, 1.08 to 1.62; P<0.01), death or hospitalization for heart failure (relative risk, 1.30; 95 percent confidence interval, 1.11 to 1.53; P<0.005), and death from pump failure (relative risk, 1.37; 95 percent confidence interval, 1.07 to 1.75; P<0.05). The presence of a third heart sound was associated with similarly increased risks of these outcomes. Conclusions: In patients with heart failure, elevated jugular venous pressure and a third heart sound are each independently associated with adverse outcomes, including progression of heart failure. Assessment for these findings is clinically meaningful.	Univ Texas, SW Med Ctr, Donald W Reynolds Cardiovasc Clin Res Ctr, Heart Failure Res Unit, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Div Cardiol, Dallas, TX 75390 USA; Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Harvard University; Brigham & Women's Hospital	Drazner, MH (corresponding author), Univ Texas, SW Med Ctr, Donald W Reynolds Cardiovasc Clin Res Ctr, Heart Failure Res Unit, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.		Rame, J. Eduardo/ABF-2208-2021	Rame, J. Eduardo/0000-0002-2936-1702				Aaronson KD, 1997, CIRCULATION, V95, P2660, DOI 10.1161/01.CIR.95.12.2660; Adolph RJ, 1998, CHEST, V114, P1235, DOI 10.1378/chest.114.5.1235; Azevedo ER, 2000, CIRCULATION, V101, P2053, DOI 10.1161/01.CIR.101.17.2053; Badgett RG, 1997, JAMA-J AM MED ASSOC, V277, P1712, DOI 10.1001/jama.277.21.1712; BRAUNWALD E, 1997, HEART DIS TXB CARDIO, V1, P445; BUTMAN SM, 1993, J AM COLL CARDIOL, V22, P968, DOI 10.1016/0735-1097(93)90405-P; CAMPANA C, 1993, J HEART LUNG TRANSPL, V12, P756; CHAKKO S, 1991, AM J MED, V90, P353, DOI 10.1016/0002-9343(91)90576-J; CONNORS AF, 1983, NEW ENGL J MED, V308, P263, DOI 10.1056/NEJM198302033080508; COOK DJ, 1990, AM J MED SCI, V299, P175, DOI 10.1097/00000441-199003000-00006; CRAIGE E, 1988, NEW ENGL J MED, V318, P1611, DOI 10.1056/NEJM198806163182409; CURRIE PJ, 1985, J AM COLL CARDIOL, V6, P750, DOI 10.1016/S0735-1097(85)80477-0; DAVISON R, 1974, AM HEART J, V87, P279, DOI 10.1016/0002-8703(74)90064-7; Drazner MH, 1999, J HEART LUNG TRANSPL, V18, P1126, DOI 10.1016/S1053-2498(99)00070-4; Dries DL, 1999, NEW ENGL J MED, V340, P609, DOI 10.1056/NEJM199902253400804; Dries DL, 1998, J AM COLL CARDIOL, V32, P695, DOI 10.1016/S0735-1097(98)00297-6; Dries DL, 1999, NEW ENGL J MED, V341, P298; EISENBERG PR, 1984, CRIT CARE MED, V12, P549, DOI 10.1097/00003246-198407000-00001; FLETCHER RH, 1992, ANN INTERN MED, V117, P786, DOI 10.7326/0003-4819-117-9-786; FOLLAND ED, 1992, NEW ENGL J MED, V327, P458, DOI 10.1056/NEJM199208133270703; GADSBOLL N, 1989, EUR HEART J, V10, P1017, DOI 10.1093/oxfordjournals.eurheartj.a059414; GLOVER DR, 1987, BRIT HEART J, V57, P125; HARLAN WR, 1977, ANN INTERN MED, V86, P133, DOI 10.7326/0003-4819-86-2-133; ISHIMITSU T, 1985, J AM COLL CARDIOL, V5, P268, DOI 10.1016/S0735-1097(85)80046-2; ISHMAIL AA, 1987, CHEST, V91, P870, DOI 10.1378/chest.91.6.870; Joshi N, 1999, SOUTH MED J, V92, P756, DOI 10.1097/00007611-199908000-00002; KAYE DM, 1994, J AM COLL CARDIOL, V23, P570, DOI 10.1016/0735-1097(94)90738-2; KEOGH AM, 1990, AM J CARDIOL, V65, P903, DOI 10.1016/0002-9149(90)91434-8; Leri A, 1998, J CLIN INVEST, V101, P1326, DOI 10.1172/JCI316; Levin A, 1998, ANN INTERN MED, V128, P334, DOI 10.7326/0003-4819-128-4-199802150-00057; LIKOFF MJ, 1987, AM J CARDIOL, V59, P634; Lucas C, 2000, AM HEART J, V140, P840, DOI 10.1067/mhj.2000.110933; Mangione S, 1998, JAMA-J AM MED ASSOC, V279, P1444; McGee SR, 1998, AM HEART J, V136, P10, DOI 10.1016/S0002-8703(98)70175-9; MORLEY D, 1994, AM J CARDIOL, V73, P379, DOI 10.1016/0002-9149(94)90012-4; PATEL R, 1993, WESTERN J MED, V158, P606; PINAMONTI B, 1993, J AM COLL CARDIOL, V22, P808, DOI 10.1016/0735-1097(93)90195-7; Pozzoli M, 1997, CIRCULATION, V95, P1222; POZZOLI M, 1990, EUR HEART J, V11, P500, DOI 10.1093/oxfordjournals.eurheartj.a059742; RIHAL CS, 1994, CIRCULATION, V90, P2772, DOI 10.1161/01.CIR.90.6.2772; SHAH PM, 1969, AM HEART J, V78, P823, DOI 10.1016/0002-8703(69)90450-5; STCLAIR EW, 1992, ANN INTERN MED, V117, P751, DOI 10.7326/0003-4819-117-9-751; Stein JH, 1997, AM J CARDIOL, V80, P1615, DOI 10.1016/S0002-9149(97)00776-5; STEVENSON LW, 1990, AM J CARDIOL, V66, P1348, DOI 10.1016/0002-9149(90)91166-4; STEVENSON LW, 1989, JAMA-J AM MED ASSOC, V261, P884, DOI 10.1001/jama.261.6.884; *STUD LEFT VENTR D, 1990, AM J CARDIOL, V66, P1026; UNVERFERTH DV, 1984, AM J CARDIOL, V54, P147, DOI 10.1016/0002-9149(84)90320-5; VANDEWERF F, 1984, CIRCULATION, V69, P1070, DOI 10.1161/01.CIR.69.6.1070; Weitz HH, 2000, AM J MED, V108, P669, DOI 10.1016/S0002-9343(00)00385-5; WESTMAN EC, 1995, J GEN INTERN MED, V10, P455, DOI 10.1007/BF02599919; XIE GY, 1994, J AM COLL CARDIOL, V24, P132, DOI 10.1016/0735-1097(94)90553-3; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; YUSUF S, 1990, AM J CARDIOL, V66, P315	54	414	435	0	10	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 23	2001	345	8					574	581		10.1056/NEJMoa010641	http://dx.doi.org/10.1056/NEJMoa010641			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464ZH	11529211				2022-12-28	WOS:000170562900004
J	Reynolds, EH				Reynolds, EH			Todd, Hughlings Jackson, and the electrical basis of epilepsy	LANCET			English	Review								John Hughlings Jackson is widely credited with the first electrical theory of epilepsy (1873), which was confirmed by the experimental studies of Hitzig and Ferrier. His views are summarised In his famous Lumleian lectures to the Royal College of Physicians In 1890. Robert Bentley Todd, however, had earlier developed an electrical theory of epilepsy, which he presented In his own brilliant Lumleian lectures to the Royal College of Physicians in 1849. Todd was Influenced by the electrical discoveries of his contemporary, Michael Faraday, and thought of the brain as having battery like properties that led to the sudden discharge of electrical energy (nervous force) in epilepsy. Unlike Hughlings Jackson, Todd was an anatomist and physiologist as well as a physician, and he did his own electrical experiments In rabbits to prove his theory, something Hughlings Jackson, who relied on Ferrier for scientific and experimental support, could never have done. There Is no mention of Todd's Lumleian lectures In Hughlings Jackson's later lectures and writings, nor In those of Hitzig or Ferrier. Todd's remarkable observations and lectures, and his electrical theory of epilepsy deserve to be drawn to the attention of the medical and scientific community.	Kings Coll London, Weston Educ Ctr, Inst Epileptol, London SE5 9PJ, England	University of London; King's College London	Reynolds, EH (corresponding author), Kings Coll London, Weston Educ Ctr, Inst Epileptol, Denmark Hill Campus, London SE5 9PJ, England.	reynolds@buckles.u-net.com						Brazier M. A. B., 1988, HIST NEUROPHYSIOLOGY; Collier J, 1934, LANCET, V2, P855; Ferrier D, 1873, Br Med J, V1, P457; Gloor Pierre, 1974, EPILEPSY, P353; Hitzig E, 1900, BRAIN, V23, P545, DOI 10.1093/brain/23.4.545; Jackson J. H., 1890, LANCET, V1, P685; JACKSON JH, 1876, W RIDING LUNATIC ASY, V4, P266; JACKSON JH, 1890, LANCET, V1, P735; JACKSON JH, 1873, REP W RIDING LUNATIC, V3, P315; JACKSON JH, 1890, LANCET, V1, P785; JACKSON JH, 1866, MED TIMES GASETTE, V1, P442; Lyons JB, 1982, HIST ASPECTS NEUROSC, P137; LYONS JB, 2000, NEUROLOGICAL EPONYMS, P100; REYNOLDS EH, 1988, ARCH NEUROL-CHICAGO, V45, P675, DOI 10.1001/archneur.1988.00520300095027; Todd RB, 1849, LONDON MED GAZ, V8; Todd RB, 1849, LONDON MED GAZ, V8, P815; Todd RB, 1849, LONDON MED GAZ, V8, P724; Todd RB, 1849, LONDON MED GAZ, V8, P766; Todd RB, 1849, LONDON MED GAZ, V8, p[661, 724, 766, 815, 837]; York GK, 2000, NEUROLOGICAL EPONYMS, P94	20	15	16	1	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 18	2001	358	9281					575	577		10.1016/S0140-6736(01)05710-5	http://dx.doi.org/10.1016/S0140-6736(01)05710-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464NB	11520547				2022-12-28	WOS:000170537700034
J	Snell, B				Snell, B			Inappropriate drug donations: the need for reforms	LANCET			English	Editorial Material									Macfarlane Burnet Ctr Med Res, Int Hlth Unit, Fairfield, Vic 3078, Australia		Snell, B (corresponding author), Macfarlane Burnet Ctr Med Res, Int Hlth Unit, POB 254, Fairfield, Vic 3078, Australia.							Forte GB, 1998, NEW ENGL J MED, V338, P1473; WHO, 1999, GUID SAF DISP UNW PH; World Health Organization, 1999, GUID DRUG DON	3	7	8	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 18	2001	358	9281					578	580		10.1016/S0140-6736(01)05712-9	http://dx.doi.org/10.1016/S0140-6736(01)05712-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464NB	11520548				2022-12-28	WOS:000170537700036
J	Cifuentes, L; Borja-Aburto, VH; Gouveia, N; Thurston, G; Davis, DL				Cifuentes, L; Borja-Aburto, VH; Gouveia, N; Thurston, G; Davis, DL			Climate change: Hidden health benefits of greenhouse gas mitigation	SCIENCE			English	Editorial Material							AIR-POLLUTION; INFANT-MORTALITY		Carnegie Mellon Univ, H John Heinz III Sch Publ Policy & Management, Pittsburgh, PA 15213 USA; NYU, Sch Med, Nelson Inst Environm Med, Tuxedo Pk, NY 10987 USA; Univ Sao Paulo, Fac Med, Dept Prevent Med, Sao Paulo, Brazil; Direcc Gen Salud Ambiental, Mexico City, DF, Mexico; Pontificia Univ Catolica Chile, Santiago, Chile	Carnegie Mellon University; New York University; Universidade de Sao Paulo; Pontificia Universidad Catolica de Chile	Davis, DL (corresponding author), Carnegie Mellon Univ, H John Heinz III Sch Publ Policy & Management, Pittsburgh, PA 15213 USA.	ddavis@andrew.cmu.edu	Cifuentes, Luis Abdon/C-7081-2009; Gouveia, Nelson C/C-4580-2013	Cifuentes, Luis Abdon/0000-0001-7416-5607; Gouveia, Nelson C/0000-0003-0625-0265	NIEHS NIH HHS [ES00260] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		*ABT ASS INC, 2000, PART REL HLTH BEN RE; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Bernard SM, 2001, ENVIRON HEALTH PERSP, V109, P199, DOI 10.2307/3435010; Bobak M, 1999, EPIDEMIOLOGY, V10, P666, DOI 10.1097/00001648-199911000-00004; Cifuentes L, 2001, ENVIRON HEALTH PERSP, V109, P419, DOI 10.2307/3434790; Davis DL, 1997, LANCET, V350, P1341, DOI 10.1016/S0140-6736(97)10209-4; *EPA NCEA, 1996, EPA600P93004AC NCEA; Farrow RS, 2001, IMPROVING REGULATION: CASES IN ENVIRONMENT HEALTH AND SAFETY, P429; Friedman MS, 2001, JAMA-J AM MED ASSOC, V285, P897, DOI 10.1001/jama.285.7.897; Intergovernmental Panel on Climate Change, 2001, CLIM CHANG 2001 SCI; Krewski D, 2000, REANALYSIS HARVARD 1; Kunzli N, 2000, LANCET, V356, P795, DOI 10.1016/S0140-6736(00)02653-2; LEVY J, 2001, RISK PERSPECT, V9, P2; Loomis D, 1999, EPIDEMIOLOGY, V10, P118, DOI 10.1097/00001648-199903000-00006; Maisonet M, 2001, ENVIRON HEALTH PERSP, V109, P351, DOI 10.2307/3434782; National Research Council, 2001, CLIM CHANG SCI AN SO; *ONT MED ASS, 2000, ILLN COSTS AIR POLL; Samet JM, 2000, NEW ENGL J MED, V343, P1742, DOI 10.1056/NEJM200012143432401; U.S. Environmental Protection Agency (EPA), 1996, EPA600P95001CF NCEA; [WHO] World Health Organization, 1997, HLTH ENV SUST DEV 5	20	110	112	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2001	293	5533					1257	1259		10.1126/science.1063357	http://dx.doi.org/10.1126/science.1063357			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11509711				2022-12-28	WOS:000170492600018
J	Gobeil, C; Macdonald, RW; Smith, JN; Beaudin, L				Gobeil, C; Macdonald, RW; Smith, JN; Beaudin, L			Atlantic water flow pathways revealed by lead contamination in Arctic basin sediments	SCIENCE			English	Article							NORTH-ATLANTIC; ISOTOPIC COMPOSITION; TRACE-METALS; OCEAN; CIRCULATION; POLLUTION; AEROSOLS; RATIOS; SEA; ICE	Contaminant lead in sediments underlying boundary currents in the Arctic Ocean provides an image of current organization and stability during the past 50 years. The sediment distributions of lead, stable lead isotope ratios, and lead-210 in the major Arctic Ocean basins reveal close coupling of the Eurasian Basin with the North Atlantic during the 20th century. They indicate that the Atlantic water boundary current in the Eurasian Basin has been a prominent pathway, that contaminant lead from the Laptev Sea supplies surface water in the transpolar drift, and that the Canadian and Eurasian basins have been historically decoupled.	Inst Maurice Lamontagne, Mont Joli, PQ G5H 3Z4, Canada; Bedford Inst Oceanog, Dartmouth, NS B2Y 4A2, Canada; Fisheries Oceans Canada Inst Ocean Sci, Sidney, BC V8L 4B2, Canada	Fisheries & Oceans Canada; Bedford Institute of Oceanography; Fisheries & Oceans Canada	Gobeil, C (corresponding author), Inst Maurice Lamontagne, Mont Joli, PQ G5H 3Z4, Canada.	GobeilC@dfo-mpo.gc.ca	Macdonald, Robie W/A-7896-2012	Macdonald, Robie W/0000-0002-1141-8520; Gobeil, Charles/0000-0002-9805-2970				AKEREDOLU FA, 1994, ATMOS ENVIRON, V28, P1557, DOI 10.1016/1352-2310(94)90214-3; Alleman LY, 1999, GEOPHYS RES LETT, V26, P1477, DOI 10.1029/1999GL900287; BOYLE EA, 1986, J GEOPHYS RES-OCEANS, V91, P8573, DOI 10.1029/JC091iC07p08573; Darby DA, 1997, DEEP-SEA RES PT II, V44, P1745, DOI 10.1016/S0967-0645(97)00039-8; Eicken H, 2000, GEOPHYS RES LETT, V27, P1919, DOI 10.1029/1999GL011132; Erel Y, 2001, ENVIRON SCI TECHNOL, V35, P292, DOI 10.1021/es0013172; HAMELIN B, 1990, GEOCHIM COSMOCHIM AC, V54, P37, DOI 10.1016/0016-7037(90)90193-O; HONG SM, 1994, SCIENCE, V265, P1841, DOI 10.1126/science.265.5180.1841; HOPPER JF, 1991, TELLUS B, V43, P45, DOI 10.1034/j.1600-0889.1991.00004.x; LIVINGSTON HD, 1988, PHILOS T R SOC, V25, P161; MacDonald RW, 2000, SCI TOTAL ENVIRON, V254, P93, DOI 10.1016/S0048-9697(00)00434-4; Monna F, 1997, ENVIRON SCI TECHNOL, V31, P2277, DOI 10.1021/es960870+; Morison J, 1998, DEEP-SEA RES PT I, V45, P15, DOI 10.1016/S0967-0637(97)00025-3; MUROZUMI M, 1969, GEOCHIM COSMOCHIM AC, V33, P1247, DOI 10.1016/0016-7037(69)90045-3; NG A, 1982, GEOCHIM COSMOCHIM AC, V46, P2307; PATTERSON CC, 1987, MAR CHEM, V22, P137, DOI 10.1016/0304-4203(87)90005-3; Proshutinsky AY, 1997, J GEOPHYS RES-OCEANS, V102, P12493, DOI 10.1029/97JC00738; Rigor I, 1992, ARCOS NEWSL, V44, P1; RUDELS B, 1994, GEOPHYS MONOGR SER, V85, P33, DOI DOI 10.1029/GM085P0033; SCHAUER U, IN PRESS ANN GEOPHYS; Schaule B. K., 1983, Trace Metals in Sea Water. Proceedings of the NATO Advanced Research Institute, P487; Schoster F, 2000, INT J EARTH SCI, V89, P486, DOI 10.1007/s005310000120; Smethie WM, 2000, J GEOPHYS RES-OCEANS, V105, P1105, DOI 10.1029/1999JC900233; Smith JN, 1998, DEEP-SEA RES PT I, V45, P959, DOI 10.1016/S0967-0637(97)00107-6; Smith JN, 1999, J GEOPHYS RES-OCEANS, V104, P29663, DOI 10.1029/1999JC900244; STURGES WT, 1993, ATMOS ENVIRON A-GEN, V27, P2865, DOI 10.1016/0960-1686(93)90317-R; VERON A, 1987, NATURE, V326, P278, DOI 10.1038/326278a0; Veron AJ, 1999, DEEP-SEA RES PT II, V46, P919, DOI 10.1016/S0967-0645(99)00009-0; Veron AJ, 1997, J GEOPHYS RES-ATMOS, V102, P28049, DOI 10.1029/97JD01527	29	45	47	2	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2001	293	5533					1301	1304		10.1126/science.1062167	http://dx.doi.org/10.1126/science.1062167			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11509726				2022-12-28	WOS:000170492600035
J	Cartwright, J				Cartwright, J			Stranger than fiction - The tale of the epic voyage made to establish the metric system is an intriguing and exciting one.	NATURE			English	Editorial Material									CSIC, Lab Crystallog Studies, E-18071 Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC)	Cartwright, J (corresponding author), CSIC, Lab Crystallog Studies, E-18071 Granada, Spain.		Cartwright, Julyan/C-1387-2016	Cartwright, Julyan/0000-0001-7392-0957					0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 16	2001	412	6848					683	683		10.1038/35089149	http://dx.doi.org/10.1038/35089149			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462ZB	11507615	Bronze			2022-12-28	WOS:000170450200021
J	Fuchs, M; Gerber, J; Drapkin, R; Sif, S; Ikura, T; Ogryzko, V; Lane, WS; Nakatani, Y; Livingston, DM				Fuchs, M; Gerber, J; Drapkin, R; Sif, S; Ikura, T; Ogryzko, V; Lane, WS; Nakatani, Y; Livingston, DM			The p400 complex is an essential E1A transformation target	CELL			English	Article							CHROMATIN REMODELING COMPLEX; HISTONE ACETYLASE COMPLEX; ESSENTIAL COFACTOR; C-MYC; ACETYLTRANSFERASE COMPLEX; SWI/SNF COMPLEX; PROTEIN; TRANSCRIPTION; BINDING; ONCOPROTEINS	Here, we report the identification of a new E1A binding protein complex that is essential for E1A-mediated transformation. Its core component is a SWI2/SNF2-related, 400 kDa protein (p400). Other components include the myc- and p/CAF-associated cofactor, TRRAP/PAF400, the DNA helicases TAP54 alpha/beta, actin-like proteins, and the human homolog of the Drosophila Enhancer of Polycomb protein. An E1A mutant, defective in p400 binding, is also defective in transformation. Certain p400 fragments partially rescued this phenotype, underscoring the role of E1A-p400 complex formation in the E1A transforming process. Furthermore, E1A and c-myc each alter the subunit composition of p400 complexes, implying that physiological p400 complex formation contributes to transformation suppression.	Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Ohio State Univ, Sch Med, Columbus, OH 43210 USA; Harvard Univ, Microchem & Proteom Anal Facil, Cambridge, MA 02138 USA; Inst Andre Lwoff, Villejuif, France	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University System of Ohio; Ohio State University; Harvard University	Livingston, DM (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.		Ogryzko, Vasily/M-6665-2015; Drapkin, Ronny/E-9944-2016; Sif, Said/AAE-5554-2019	Ogryzko, Vasily/0000-0002-8548-1389; Drapkin, Ronny/0000-0002-6912-6977; Sif, Said/0000-0001-6268-1145	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007627] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32-HL07627-16] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allard S, 1999, EMBO J, V18, P5108, DOI 10.1093/emboj/18.18.5108; BARBEAU D, 1994, ONCOGENE, V9, P359; BAYLEY ST, 1994, INT J ONCOL, V5, P425; Cairns BR, 1998, MOL CELL, V2, P639, DOI 10.1016/S1097-2765(00)80162-8; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; Drapkin R, 1996, P NATL ACAD SCI USA, V93, P6488, DOI 10.1073/pnas.93.13.6488; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Galarneau L, 2000, MOL CELL, V5, P927, DOI 10.1016/S1097-2765(00)80258-0; Goodman RH, 2000, GENE DEV, V14, P1553; Grand F, 1999, CANCER RES, V59, P3870; HOWE JA, 1992, VIROLOGY, V186, P15, DOI 10.1016/0042-6822(92)90057-V; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; JELSMA TN, 1989, VIROLOGY, V171, P120, DOI 10.1016/0042-6822(89)90518-7; Johnston H, 1999, J BIOL CHEM, V274, P16370, DOI 10.1074/jbc.274.23.16370; Kung AL, 2000, NAT MED, V6, P1335, DOI 10.1038/82146; LAND H, 1995, METHOD ENZYMOL, V254, P37; Margolis RL, 1997, HUM GENET, V100, P114, DOI 10.1007/s004390050476; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; McMahon SB, 2000, MOL CELL BIOL, V20, P556, DOI 10.1128/MCB.20.2.556-562.2000; NEVINS JR, 1992, SCIENCE, V258, P424; Ogryzko VV, 1998, CELL, V94, P35, DOI 10.1016/S0092-8674(00)81219-2; PAUSE A, 1992, EMBO J, V11, P2643, DOI 10.1002/j.1460-2075.1992.tb05330.x; Peterson CL, 1998, J BIOL CHEM, V273, P23641, DOI 10.1074/jbc.273.37.23641; Phelan ML, 1999, MOL CELL, V3, P247, DOI 10.1016/S1097-2765(00)80315-9; Saleh A, 1998, J BIOL CHEM, V273, P26559, DOI 10.1074/jbc.273.41.26559; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; SHIMONO Y, 1939, J BIOL CHEM, P275; Sif S, 1998, GENE DEV, V12, P2842, DOI 10.1101/gad.12.18.2842; Sinclair DAR, 1998, GENETICS, V148, P211; Vassilev A, 1998, MOL CELL, V2, P869, DOI 10.1016/S1097-2765(00)80301-9; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; WHYTE P, 1988, J VIROL, V62, P257, DOI 10.1128/JVI.62.1.257-265.1988; Wood MA, 2000, MOL CELL, V5, P321, DOI 10.1016/S1097-2765(00)80427-X; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	36	245	251	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 10	2001	106	3					297	307		10.1016/S0092-8674(01)00450-0	http://dx.doi.org/10.1016/S0092-8674(01)00450-0			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RJ	11509179	Bronze			2022-12-28	WOS:000170433300008
J	Walker, JR; Corpina, RA; Goldberg, J				Walker, JR; Corpina, RA; Goldberg, J			Structure of the Ku heterodimer bound to DNA and its implications for double-strand break repair	NATURE			English	Article							DEPENDENT PROTEIN-KINASE; KU80-DEFICIENT CELLS; END; COMPLEX; BINDING; SUBUNIT; RECOMBINATION; ASSOCIATION; STABILITY; PATHWAY	The Ku heterodimer (Ku70 and Ku80 subunits) contributes to genomic integrity through its ability to bind DNA double-strand breaks and facilitate repair by the non-homologous end-joining pathway. The crystal structure of the human Ku heterodimer was determined both alone and bound to a 55-nucleotide DNA element at 2.7 and 2.5 Angstrom resolution, respectively. Ku70 and Ku80 share a common topology and form a dyad-symmetrical molecule with a preformed ring that encircles duplex DNA. The binding site can cradle two full turns of DNA while encircling only the central 3-4 base pairs (bp). Ku makes no contacts with DNA bases and few with the sugar-phosphate backbone, but it fits sterically to major and minor groove contours so as to position the DNA helix in a defined path through the protein ring. These features seem well designed to structurally support broken DNA ends and to bring the DNA helix into phase across the junction during end processing and ligation.	Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Goldberg, J (corresponding author), Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, 1275 York Ave, New York, NY 10021 USA.	jonathan@ximpact4.ski.mskcc.org		/0000-0002-5255-895X				Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baumann P, 1998, P NATL ACAD SCI USA, V95, P14066, DOI 10.1073/pnas.95.24.14066; Boulton SJ, 1996, EMBO J, V15, P5093, DOI 10.1002/j.1460-2075.1996.tb00890.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Calsou P, 1999, J BIOL CHEM, V274, P7848, DOI 10.1074/jbc.274.12.7848; Cary RB, 1997, P NATL ACAD SCI USA, V94, P4267, DOI 10.1073/pnas.94.9.4267; Chen S, 2001, J BIOL CHEM, V276, P24323, DOI 10.1074/jbc.M010544200; CHOU CH, 1992, J EXP MED, V175, P1677, DOI 10.1084/jem.175.6.1677; Critchlow SE, 1998, TRENDS BIOCHEM SCI, V23, P394, DOI 10.1016/S0968-0004(98)01284-5; DEVRIES E, 1989, J MOL BIOL, V208, P65, DOI 10.1016/0022-2836(89)90088-0; Difilippantonio MJ, 2000, NATURE, V404, P510, DOI 10.1038/35006670; Dynan WS, 1998, NUCLEIC ACIDS RES, V26, P1551, DOI 10.1093/nar/26.7.1551; Feldmann E, 2000, NUCLEIC ACIDS RES, V28, P2585, DOI 10.1093/nar/28.13.2585; Ferguson DO, 2000, P NATL ACAD SCI USA, V97, P6630, DOI 10.1073/pnas.110152897; Gell D, 1999, NUCLEIC ACIDS RES, V27, P3494, DOI 10.1093/nar/27.17.3494; GHOSH G, 1995, NATURE, V373, P303, DOI 10.1038/373303a0; Giffin W, 1996, NATURE, V380, P265, DOI 10.1038/380265a0; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; Gu YS, 1997, P NATL ACAD SCI USA, V94, P8076, DOI 10.1073/pnas.94.15.8076; Haber JE, 2000, TRENDS GENET, V16, P259, DOI 10.1016/S0168-9525(00)02022-9; HTUN H, 1989, SCIENCE, V243, P1571, DOI 10.1126/science.2648571; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; Liang F, 1996, J BIOL CHEM, V271, P14405, DOI 10.1074/jbc.271.24.14405; Lieber MR, 1999, GENES CELLS, V4, P77, DOI 10.1046/j.1365-2443.1999.00245.x; McElhinny SAN, 2000, MOL CELL BIOL, V20, P2996, DOI 10.1128/MCB.20.9.2996-3003.2000; MULLER CW, 1995, NATURE, V373, P311, DOI 10.1038/373311a0; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nussenzweig A, 1997, P NATL ACAD SCI USA, V94, P13588, DOI 10.1073/pnas.94.25.13588; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAILLARD S, 1993, PROTEINS, V15, P330, DOI 10.1002/prot.340150310; Ramsden DA, 1998, EMBO J, V17, P609, DOI 10.1093/emboj/17.2.609; ROTH DB, 1986, MOL CELL BIOL, V6, P4295, DOI 10.1128/MCB.6.12.4295; Singleton BK, 1999, MOL CELL BIOL, V19, P3267; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; Stewart J, 2001, J BIOL CHEM, V276, P19182, DOI 10.1074/jbc.M100592200; TACCIOLI GE, 1994, SCIENCE, V265, P1442, DOI 10.1126/science.8073286; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; THODE S, 1990, CELL, V60, P921, DOI 10.1016/0092-8674(90)90340-K; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Yoo S, 1999, NUCLEIC ACIDS RES, V27, P4679, DOI 10.1093/nar/27.24.4679; Yoo S, 1999, J BIOL CHEM, V274, P20034, DOI 10.1074/jbc.274.28.20034; Zhao JK, 1999, BIOCHEMISTRY-US, V38, P2152, DOI 10.1021/bi9825246; Zhu CM, 1996, CELL, V86, P379, DOI 10.1016/S0092-8674(00)80111-7	44	834	874	2	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 9	2001	412	6847					607	614		10.1038/35088000	http://dx.doi.org/10.1038/35088000			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460PP	11493912				2022-12-28	WOS:000170318000032
J	Merrer, J; De Jonghe, B; Golliot, F; Lefrant, JY; Raffy, B; Barre, E; Rigaud, JP; Casciani, D; Misset, B; Bosquet, C; Outin, H; Brun-Buisson, C; Nitenberg, G				Merrer, J; De Jonghe, B; Golliot, F; Lefrant, JY; Raffy, B; Barre, E; Rigaud, JP; Casciani, D; Misset, B; Bosquet, C; Outin, H; Brun-Buisson, C; Nitenberg, G		French Catheter Study Grp Intensiv	Complications of femoral and subclavian venous catheterization in critically ill patients - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DEEP-VEIN THROMBOSIS; 200 CONSECUTIVE PATIENTS; PULMONARY-EMBOLISM; UPPER-EXTREMITY; DIAGNOSIS; INFECTION; SEPSIS; PREVENTION; METAANALYSIS; MULTICENTER	Context Whether venous catheterization at the femoral site is associated with an increased risk of complications compared with that at the subclavian site is debated. Objective To compare mechanical, infectious, and thrombotic complications of femoral and subclavian venous catheterization. Design and Setting Concealed, randomized controlled clinical trial conducted between December 1997 and July 2000 at 8 intensive care units (ICUs) in France. Patients Two hundred eighty-nine adult patients receiving a first central venous catheter. Interventions Patients were randomly assigned to undergo central venous catheterization at the femoral site (n=145) or subclavian site (n=144). Main Outcome Measures Rate and severity of mechanical, infectious, and thrombotic complications, compared by catheterization site in 289, 270, and 223 patients, respectively. Results Femoral catheterization was associated with a higher incidence rate of overall infectious complications (19.8% vs 4.5%; P<.001; incidence density of 20 vs 3.7 per 1000 catheter-days) and of major infectious complications (clinical sepsis with or without bloodstream infection, 4.4% vs 1.5%; P=.07; incidence density of 4.5 vs 1.2 per 1000 catheter-days), as well as of overall thrombotic complications (21.5% vs 1.9%; P<.001) and complete thrombosis of the vessel (6% vs 0%; P=.01); rates of overall and major mechanical complications were similar between the 2 groups (17.3% vs 18.8%; P=.74 and 1.4% vs 2.8%; P=.44, respectively). Risk factors for mechanical complications were duration of insertion (odds ratio [OR], 1.05; 95% confidence interval [CI], 1.03-1.08 per additional minute; P<.001); insertion in 2 of the centers (OR, 4.52; 95% CI, 1.81-11.23; P=.001); and insertion during the night (OR, 2.06; 95% Cl, 1.04-4.08; P=.03). The only factor associated with infectious complications was femoral catheterization (hazard ratio [HR], 4.83; 95% CI, 1.96-11.93; P<.001); antibiotic administration via the catheter decreased risk of infectious complications (HR, 0.41; 95% CI, 0.18-0.93; P=.03). Femoral catheterization was the only risk factor for thrombotic complications (OR, 14.42; 95% CI, 3.33-62.57; P<.001). Conclusion Femoral venous catheterization is associated with a greater risk of infectious and thrombotic complications than subclavian catheterization in ICU patients.	Ctr Hop Poissy St Germain Laye, Serv Reanimat Med, F-78303 Poissy, France; Ctr Hop Poissy St Germain Laye, Serv Reanimat Chirurg, F-78303 Poissy, France; Ctr Coordinat & Lutte Contre Infect Nosocomiales, Paris, France; Hop St Joseph, Serv Reanimat Polyvalente, F-75674 Paris, France; Ctr Hosp Univ Nimes, Dept Urgence Reanimat, Nimes, France; Ctr Hosp Mantes La Jolie, Serv Reanimat Polyvalente, Mantes La Jolie, France; Ctr Hosp Dieppe, Serv Reanimat Med, Dieppe, France; Ctr Hosp Villeneuve St George, Serv Reanimat Polyvalente, Villeneuve St Georges, France; CHU Strasbourg, Serv Reanimat Med, F-67000 Strasbourg, France; CHU Henri Mondor, Serv Reanimat Med, F-94010 Creteil, France; Inst Gustave Roussy, Serv Reanimat Med Chirurg, Villejuif, France	Hopital Paris Saint-Joseph; UDICE-French Research Universities; Universite Paris Cite; Universite de Montpellier; CHU de Nimes; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UNICANCER; Gustave Roussy	Merrer, J (corresponding author), Ctr Hop Poissy St Germain Laye, Serv Reanimat Med, 10 Rue Champ Gaillard, F-78303 Poissy, France.		Misset, Benoit/P-7817-2018	Misset, Benoit/0000-0001-6466-0065				BECKER DM, 1991, ARCH INTERN MED, V151, P1934, DOI 10.1001/archinte.151.10.1934; BRISMAR B, 1981, ANN SURG, V194, P779, DOI 10.1097/00000658-198112000-00021; BRUNBUISSON C, 1987, ARCH INTERN MED, V147, P873, DOI 10.1001/archinte.147.5.873; COLLIGNON P, 1988, INTENS CARE MED, V14, P227, DOI 10.1007/BF00717995; Durbec O, 1997, CRIT CARE MED, V25, P1986, DOI 10.1097/00003246-199712000-00014; Durbec O, 1997, CRIT CARE MED, V25, P1982, DOI 10.1097/00003246-199712000-00013; FAGON JY, 1993, INTENS CARE MED, V19, P137, DOI 10.1007/BF01720528; GETZEN LC, 1979, AM J SURG, V138, P875, DOI 10.1016/0002-9610(79)90314-3; GIL RT, 1989, ARCH INTERN MED, V149, P1139, DOI 10.1001/archinte.149.5.1139; Goetz AM, 1998, INFECT CONT HOSP EP, V19, P842; HAIRE WD, 1991, J ULTRAS MED, V10, P493, DOI 10.7863/jum.1991.10.9.493; Hirsh J, 1996, CIRCULATION, V93, P2212, DOI 10.1161/01.CIR.93.12.2212; HORATTAS MC, 1988, SURGERY, V104, P561; HUISMAN MV, 1989, CHEST, V95, P498, DOI 10.1378/chest.95.3.498; Joynt GM, 2000, CHEST, V117, P178, DOI 10.1378/chest.117.1.178; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; MANSFIELD PF, 1994, NEW ENGL J MED, V331, P1735, DOI 10.1056/NEJM199412293312602; Mermel LA, 2000, ANN INTERN MED, V132, P391, DOI 10.7326/0003-4819-132-5-200003070-00009; MONREAL M, 1991, CHEST, V99, P280, DOI 10.1378/chest.99.2.280; Pearson ML, 1996, INFECT CONT HOSP EP, V17, P438; PLATE G, 1985, BRIT J SURG, V72, P912, DOI 10.1002/bjs.1800721123; Prandoni P, 1997, ARCH INTERN MED, V157, P57, DOI 10.1001/archinte.157.1.57; Raad I, 1997, ANN INTERN MED, V127, P267, DOI 10.7326/0003-4819-127-4-199708150-00002; Randolph AG, 1996, CRIT CARE MED, V24, P2053, DOI 10.1097/00003246-199612000-00020; Randolph AG, 1998, CRIT CARE MED, V26, P1452, DOI 10.1097/00003246-199808000-00038; RYAN JA, 1974, NEW ENGL J MED, V290, P757, DOI 10.1056/NEJM197404042901401; SITZMANN JV, 1985, ANN SURG, V202, P766, DOI 10.1097/00000658-198512000-00017; Timsit JF, 1998, CHEST, V114, P207, DOI 10.1378/chest.114.1.207; Timsit JF, 1999, ANN INTERN MED, V130, P729, DOI 10.7326/0003-4819-130-9-199905040-00004; Timsit JF, 1996, JAMA-J AM MED ASSOC, V276, P1416, DOI 10.1001/jama.276.17.1416; TROTTIER SJ, 1995, CRIT CARE MED, V23, P52, DOI 10.1097/00003246-199501000-00011; WILLIAMS JF, 1991, CRIT CARE MED, V19, P550, DOI 10.1097/00003246-199104000-00016	32	784	833	0	17	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2001	286	6					700	707		10.1001/jama.286.6.700	http://dx.doi.org/10.1001/jama.286.6.700			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459VE	11495620	Bronze			2022-12-28	WOS:000170271500026
J	Kaptchuk, TJ; Eisenberg, DM				Kaptchuk, TJ; Eisenberg, DM			Varieties of healing. 1: Medical pluralism in the United States	ANNALS OF INTERNAL MEDICINE			English	Article							ALTERNATIVE MEDICINE; COMPLEMENTARY; TRENDS; CARE	Medicine has become interested in unconventional healing practices, ostensibly because of recent demographic research that reveals a thriving medical market of multiple options. This essay presents a historical overview of medical pluralism in the United States. Consistent evidence is examined suggesting that unconventional medicine has been a persistent presence in U.S. health care. Despite parallels with the past, the recent widespread interest in alternative medicine also represents a dramatic reconfiguration of medical pluralism-from historical antagonism to what might arguably be described as a topical acknowledgment of postmodern medical diversity. This recent shift may have less to do with acknowledging "new" survey data than with representing shifts in medicine's institutional authority in a consumer-driven health care environment. This essay is an introduction to a discussion of a taxonomy of contemporary U.S. medical pluralism, which also appears in this issue.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Kaptchuk, TJ (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, 330 Brookline Ave,W-K-400, Boston, MA 02215 USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U24AR043441] Funding Source: NIH RePORTER; NIAMS NIH HHS [U24 AR43441] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ARMSTRONG D, 1991, GREAT AM MED SHOW; Astin JA, 1998, ARCH INTERN MED, V158, P2303, DOI 10.1001/archinte.158.21.2303; Astin JA, 1998, JAMA-J AM MED ASSOC, V279, P1548, DOI 10.1001/jama.279.19.1548; Bagley CM, 1999, ANN INTERN MED, V131, P229, DOI 10.7326/0003-4819-131-3-199908030-00018; BAKX K, 1991, SOCIOL HEALTH ILL, V13, P20, DOI 10.1111/1467-9566.ep11340307; Barzansky B, 2000, JAMA-J AM MED ASSOC, V284, P1114, DOI 10.1001/jama.284.9.1114; BEARDSLEY EJ, 1924, J MED SOC NEW JERSEY, V21, P275; BERMAN ALEX, 1951, BULL HIST MED, V25-25, P405; BRINSMADE TC, 1958, TMSSNY, P257; BRODY JE, 1999, NY TIMES HLTH F 0209; CANT SL, 1991, SOCIOLOGY HLTH ILLNE, V13, P139; Cassedy J. H., 1991, MED AM; COLLINS SD, 1944, INCIDENCE ILLNESS VO; COWART VS, 1988, JAMA-J AM MED ASSOC, V259, P3229; CRAMP AJ, 1929, NEW ENGL J MED, V201, P1297; CRAMP AJ, 1921, NOSTRUMS QUACKERY PS; EASTHOPE G, 1993, AUST NZ J SOCIOL, V29, P289; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Ernst E, 1996, J ROY COLL PHYS LOND, V30, P410; Ernst Robert, 1991, WEAKNESS IS CRIME LI; ESTES JW, 1991, B HIST MED, V65, P162; Falk IS, 1933, INCIDENCE ILLNESS RE; FANER AW, 1992, GUIDE AM MED ASS HIS; FITZ RH, 1894, T ASSOC AM PHYSICIAN, V8, P1; Fontanarosa PB, 1998, JAMA-J AM MED ASSOC, V280, P1618, DOI 10.1001/jama.280.18.1618; GABE J, 1994, CHALLENGING MED; GEVITZ N, 1989, PERSPECT BIOL MED, V32, P281; GoldbeckWood S, 1996, BRIT MED J, V313, P131, DOI 10.1136/bmj.313.7050.131a; HAEHL R, 1995, S HAHNEMANN HIS LIFE, V2; HAHNEMANN S, 1980, ORGANON MED; HOLMES OW, 1842, HOMOEOPATHY ITS KIND; IDLER EL, 1989, CULT MED PSYCHIAT, V13, P1, DOI 10.1007/BF00052680; JONES RK, 1985, SICKNESS SECTARIANIS; Kaptchuk TJ, 1998, ANN INTERN MED, V129, P1061, DOI 10.7326/0003-4819-129-12-199812150-00011; KAPTCHUK TJ, 1996, COMPLEMENTARY MED OB; KAPTCHUK TJ, 1986, HEALING ARTS JOURNEY; Kett J, 1968, FORMATION AM MED PRO; KING D, 1858, QUACKERY UNMASKED CO; KLEINMAN AM, 1973, INQUIRY, V16, P206, DOI 10.1080/00201747308601685; *LANDM HEALTHC, 1998, LANDM REP PUBL PERC; LESLIE C, 1980, SOC SCI MED-MED ANTH, V14, P191, DOI 10.1016/0160-7987(80)90044-7; MOORE JS, 1993, CHIROPRACTIC AM HIST; MURPHY LR, 1991, ENTER PHYSICIAN TRAN; Nissenbaum Stephen, 1980, SEX DIET DEBILITY JA; Paramore LC, 1997, J PAIN SYMPTOM MANAG, V13, P83, DOI 10.1016/S0885-3924(96)00299-0; Pelletier KR, 1997, AM J HEALTH PROMOT, V12, P112, DOI 10.4278/0890-1171-12.2.112; PORTER R, 1982, HLTH SALE QUACKERY E; PRESS I, 1980, SOC SCI MED-MED ANTH, V14, P45, DOI 10.1016/0160-7987(80)90040-X; ROBERTS JB, 1896, J AM MED SOC, V26, P299; ROEBUCK JB, 1972, J HEALTH SOC BEHAV, V13, P162, DOI 10.2307/2136898; ROREM CR, 1932, COST MED; ROTHESTEIN WG, 1985, AM PHYSICIANS 19 CEN; Sergeant MJ, 2000, ANN INTERN MED, V132, P675, DOI 10.7326/0003-4819-132-8-200004180-00013; Starr P, 1982, SOCIAL TRANSFORMATIO; Stokstad E, 2000, SCIENCE, V288, P1568, DOI 10.1126/science.288.5471.1568; VANDENNOORT S, 1983, ARCH NEUROL-CHICAGO, V40, P673, DOI 10.1001/archneur.1983.04050100013004; WAITE FC, 1940, OHIO STATE ARCHAEOLO, V49, P322; WARNER JH, 1987, MED FRINGE MED ORTHO; Whorton J C, 1975, Bull Hist Med, V49, P466; Williams SJ, 1996, SOC SCI MED, V42, P1609, DOI 10.1016/0277-9536(95)00313-4; WROBEL A, 1987, PSEUDO SCI SOC 19 CE; Young J.H, 1967, MED MESSIAHS SOCIAL; Young JH., 1961, TOADSTOOL MILLIONAIR; 1836, BOSTON MED SURG J, V15, P241; 1829, BOSTON MED SURG J, V366; [No title captured]; 1837, BOSTON MED SURG J, V17, P322; 1962, JAMA, V180, P53	68	97	98	0	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 7	2001	135	3					189	195		10.7326/0003-4819-135-3-200108070-00011	http://dx.doi.org/10.7326/0003-4819-135-3-200108070-00011			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	460FX	11487486				2022-12-28	WOS:000170298500005
J	Corrao, G; Corazza, GR; Bagnardi, V; Brusco, G; Ciacci, C; Cottone, M; Guidetti, CS; Usai, P; Cesari, P; Pelli, MA; Loperfido, S; Volta, U; Calabro, A; Certo, M				Corrao, G; Corazza, GR; Bagnardi, V; Brusco, G; Ciacci, C; Cottone, M; Guidetti, CS; Usai, P; Cesari, P; Pelli, MA; Loperfido, S; Volta, U; Calabro, A; Certo, M		Club Tenue Study Grp	Mortality in patients with coeliac disease and their relatives: a cohort study	LANCET			English	Article							GLUTEN-FREE DIET; T-CELL LYMPHOMA; CELIAC-DISEASE; DERMATITIS-HERPETIFORMIS; ENTEROPATHY; MALIGNANCY; SURVIVAL; SPRUE; FEATURES	Background Although previous studies have shown increased mortality in patients with coeliac disease and their relatives, no data are available in relation to different patterns of clinical presentation. We assessed mortality in patients with coeliac disease and their first-degree relatives. Methods We enrolled, in a prospective cohort study, 1072 adult patients with coeliac disease consecutively diagnosed in 11 gastroenterology units between 1962 and 1994, and their 3384 first-degree relatives. We compared the number of deaths up to 1998 with expected deaths and expressed the comparison as standardised mortality ratio (SMR) and relative survival ratio. Findings 53 coeliac patients died compared with 25.9 expected deaths (SMR 2.0 [95% CI 1.5-2.7]). A significant excess of mortality was evident during the first 3 years after diagnosis of coeliac disease and in patients who presented with malabsorption symptoms (2.5 [1.8-3.4]), but not in those diagnosed because of minor symptoms (1.1 [0.5-2.2]) or because of antibody screening (1.2 [0.1-7.0]). SMR increased with increasing delay in diagnosis and for patients with poor compliance with gluten-free diet. Non-Hodgkin lymphoma was the main cause of death. No excess of deaths was recorded in relatives with coeliac disease. Interpretation. Prompt and strict dietary treatment decreases mortality in coeliac patients. Prospective studies are needed to clarify the progression of mild or symptomless coeliac disease and its relation to intestinal lymphoma.	Univ Milano Bicocca, Cattedra Stat Med, I-20126 Milan, Italy; Univ Pavia, IRCCS Policlin San Matteo, Cattedra Gastroenterol, I-27100 Pavia, Italy; Univ Naples Federico II, Cattedra Gastroenterol, Naples, Italy; Univ Palermo, Clin Med R, I-90133 Palermo, Italy; Univ Turin, Cattedra Gastroenterol, I-10124 Turin, Italy; Univ Cagliari, Med Clin, I-09124 Cagliari, Italy; Casa Cura Poliambulanza Brescia, Unita Gastroenterol, Brescia, Italy; Univ Perugia, Cattedra Gastroenterol, I-06100 Perugia, Italy; Osped Treviso, Div Gastroenterol, Verona, Italy; Univ Bologna, Cattedra Med Interna, I-40126 Bologna, Italy; Univ Florence, Cattedra Gastroenterol, I-50121 Florence, Italy; Univ Cattolica Roma, Cattedra Med Interna, Rome, Italy	University of Milano-Bicocca; IRCCS Fondazione San Matteo; University of Pavia; University of Naples Federico II; University of Palermo; University of Turin; University of Cagliari; University of Perugia; University of Bologna; University of Florence; Catholic University of the Sacred Heart	Corrao, G (corresponding author), Univ Milano Bicocca, Cattedra Stat Med, I-20126 Milan, Italy.		Corazza, Gino Roberto/K-8500-2016; carolina, ciacci/A-2594-2012	Corazza, Gino Roberto/0000-0001-9532-0573; carolina, ciacci/0000-0002-7426-1145; Cottone, Mario/0000-0003-1523-7556; Volta, Umberto/0000-0003-3405-3808				AshtonKey M, 1997, AM J PATHOL, V151, P493; Auricchio S, 1988, GASTROENTEROL INT, V1, P25; BAKER PG, 1975, BRIT MED J, V1, P486, DOI 10.1136/bmj.1.5956.486; Berti I, 2000, GASTROENTEROLOGY, V118, pA696, DOI 10.1016/S0016-5085(00)84916-1; Bottaro G, 1999, AM J GASTROENTEROL, V94, P691, DOI 10.1111/j.1572-0241.1999.00938.x; Breslow NE., 1987, STAT METHODS CANC RE, P81; CATASSI C, 1994, LANCET, V343, P200, DOI 10.1016/S0140-6736(94)90989-X; COLLIN P, 1994, GUT, V35, P1215, DOI 10.1136/gut.35.9.1215; Collin P, 1996, GUT, V38, P528, DOI 10.1136/gut.38.4.528; Collin P, 1997, SCAND J GASTROENTERO, V32, P1129, DOI 10.3109/00365529709002992; CORAZZA G, 1992, GASTROENTEROLOGY, V103, P1517, DOI 10.1016/0016-5085(92)91172-Z; Cottone M, 1999, DIGEST DIS SCI, V44, P2538, DOI 10.1023/A:1026655609906; FREEMAN HJ, 1977, AM J MED, V63, P585, DOI 10.1016/0002-9343(77)90204-2; Greco L, 1997, ITAL J GASTROENTEROL, V29, P305; Hin H, 1999, BMJ-BRIT MED J, V318, P164, DOI 10.1136/bmj.318.7177.164; HOLMES GKT, 1989, GUT, V30, P333, DOI 10.1136/gut.30.3.333; HOWELL WM, 1995, HUM IMMUNOL, V43, P29, DOI 10.1016/0198-8859(94)00130-I; LOGAN RFA, 1983, BMJ-BRIT MED J, V286, P95, DOI 10.1136/bmj.286.6359.95; LOGAN RFA, 1989, GASTROENTEROLOGY, V97, P265, DOI 10.1016/0016-5085(89)90060-7; Mustalahti K, 2000, GASTROENTEROLOGY, V118, pA369, DOI 10.1016/S0016-5085(00)83582-9; NIELSEN OH, 1985, SCAND J GASTROENTERO, V20, P13, DOI 10.3109/00365528509089626; STOKES PL, 1976, BRIT J PREV SOC MED, V30, P17; SWERDLOW AJ, 1993, BRIT J DERMATOL, V129, P140, DOI 10.1111/j.1365-2133.1993.tb03516.x; SWINSON CM, 1980, BRIT MED J, V281, P1258, DOI 10.1136/bmj.281.6250.1258; THOMSEN BL, 1991, STAT MED, V10, P733, DOI 10.1002/sim.4780100508; TRIER JS, 1991, NEW ENGL J MED, V325, P1709, DOI 10.1056/NEJM199112123252406; WRIGHT DH, 1995, BAILLIERE CLIN GASTR, V9, P351, DOI 10.1016/0950-3528(95)90035-7	27	414	427	0	24	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 4	2001	358	9279					356	361		10.1016/S0140-6736(01)05554-4	http://dx.doi.org/10.1016/S0140-6736(01)05554-4			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459DE	11502314				2022-12-28	WOS:000170235100009
J	Staedke, SG; Kamya, MR; Dorsey, G; Gasasira, A; Ndeezi, G; Charlebois, ED; Rosenthal, PJ				Staedke, SG; Kamya, MR; Dorsey, G; Gasasira, A; Ndeezi, G; Charlebois, ED; Rosenthal, PJ			Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trial	LANCET			English	Article							PYRIMETHAMINE-SULFADOXINE; PLASMODIUM-FALCIPARUM; IN-VIVO; DRUG-RESISTANCE; CHLOROQUINE; ANTIMALARIAL; CHILDREN; SENSITIVITY; EFFICACY	Background Increasing Plasmodium falciparum resistance to chloroquine in sub-Saharan Africa necessitates use of alternative antimalarial agents. Affordable alternative treatments include sulfadoxine/pyrimethamine and amodiaquine. Combination of antimalarial agents can increase therapeutic efficacy and delay emergence of drug resistance. We compared the efficacy of sulfadoxine/ pyrimethamine, amodiaquine, and an amodiaquine/ sulfadoxine/pyrimethamine combination for treatment of uncomplicated malaria in a region of high chloroquine resistance. Methods Patients with symptoms of uncomplicated falciparum malaria and confirmed disease in Kampala, Uganda, were randomly assigned to receive sulfadoxine/pyrimethamine (25 mg/kg sulfadoxine, and 1.25 mg/kg pyrimethamine) plus placebo; amodiaquine (25 mg/kg) plus placebo; or amodiaquine plus sulfadoxine/pyrimethamine. Patients were followed up for 14 days, and clinical and parasitological outcomes were assessed. Findings 90% (400/445) of patients enrolled in the study successfully completed 14 days of follow-up. Treatment failure based on clinical criteria occurred in 13 of 131 (10%) patients on sulfadoxine/ pyrimethamine, nine of 131 (7%) on amodiaquine, and four of 138 (3%) on amodiaquine/sulfadoxine/pyrimethamine. Based on parasitological criteria, treatment failed in 26%, 16%, and 10% of these patients, respectively. Amodiaquine/sulfadoxine/pyrimethamine was significantly more effective than sulfadoxine/pyrimethamine alone in children aged younger than 5 years (clinical failure in 3.5% vs 13.9%, respectively, risk difference 10.4% [95% CI, 1.6-19-3] p=0.021; parasitological failure in 12.8% vs 26.4%, risk difference 13.6% [1.2-26.0] p=0.041). Interpretation Sulfadoxine/pyrimethamine, amodiaquine, and amodiaquine/sulfadoxine/pyrimethamine were all effective for treatment of uncomplicated falciparum malaria in Uganda. The amodiaquine/sulfadoxine/ pyrimethamine combination was the most effective, and could be the optimum low-cost alternative to chloroquine in Africa.	Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, San Francisco, CA 94143 USA; Makerere Univ, Sch Med, Kampala, Uganda; Univ Calif San Francisco, San Francisco Gen Hosp, Epictr, San Francisco, CA 94143 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Makerere University; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Staedke, SG (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Box 0811,3rd & Parnassus Ave, San Francisco, CA 94143 USA.	staedke@itsa.ucsf.edu			PHS HHS [R03 A143301, T32A107641-01] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bloland PB, 1999, ANN TROP MED PARASIT, V93, P5, DOI 10.1080/00034989958753; Bloland PB, 1996, LANCET, V348, P1659, DOI 10.1016/S0140-6736(05)65723-6; Brasseur P, 1999, T ROY SOC TROP MED H, V93, P645, DOI 10.1016/S0035-9203(99)90083-4; CAMPBELL CC, 1991, J INFECT DIS, V163, P1207, DOI 10.1093/infdis/163.6.1207; Dorsey G, 2000, AM J TROP MED HYG, V62, P686, DOI 10.4269/ajtmh.2000.62.686; Gorissen E, 2000, TROP MED INT HEALTH, V5, P459, DOI 10.1046/j.1365-3156.2000.00570.x; KAMUGISHA J, 1994, TROP GEOGR MED, V46, P364; Kamya MR, 2001, T ROY SOC TROP MED H, V95, P50, DOI 10.1016/S0035-9203(01)90331-1; Krishna S, 1996, CLIN PHARMACOKINET, V30, P263, DOI 10.2165/00003088-199630040-00002; Marsh K, 1998, LANCET, V352, P924, DOI 10.1016/S0140-6736(05)61510-3; McIntosh HM, 1998, ANN TROP MED PARASIT, V92, P265, DOI 10.1080/00034989859825; MOUNT DL, 1989, B WORLD HEALTH ORGAN, V67, P295; Muller O, 1996, TROP MED INT HEALTH, V1, P124, DOI 10.1046/j.1365-3156.1996.d01-13.x; Olliaro P, 1996, LANCET, V348, P1196, DOI 10.1016/S0140-6736(96)06217-4; Onyiorah E, 1996, T ROY SOC TROP MED H, V90, P307, DOI 10.1016/S0035-9203(96)90265-5; PHILLIPSHOWARD PA, 1990, J ROY SOC MED, V83, P82, DOI 10.1177/014107689008300208; PINICHPONGSE S, 1982, B WORLD HEALTH ORGAN, V60, P907; Price RN, 1996, LANCET, V347, P1654, DOI 10.1016/S0140-6736(96)91488-9; Ronn AM, 1996, T ROY SOC TROP MED H, V90, P179, DOI 10.1016/S0035-9203(96)90129-7; Trape JF, 1998, CR ACAD SCI III-VIE, V321, P689, DOI 10.1016/S0764-4469(98)80009-7; van Dillen J, 1999, T ROY SOC TROP MED H, V93, P185, DOI 10.1016/S0035-9203(99)90304-8; Von Seidlein L, 1998, AM J TROP MED HYG, V58, P638; WATKINS WM, 1993, T ROY SOC TROP MED H, V87, P75, DOI 10.1016/0035-9203(93)90431-O; WERNSDORFER WH, 1994, ACTA TROP, V56, P143, DOI 10.1016/0001-706X(94)90060-4; White N, 1999, PHILOS T R SOC B, V354, P739, DOI 10.1098/rstb.1999.0426; White NJ, 1999, LANCET, V353, P1965, DOI 10.1016/S0140-6736(98)07367-X; White NJ, 1996, LANCET, V348, P1184, DOI 10.1016/S0140-6736(05)65475-X; *WHO, 1996, ASS THER EFF ANT DRU; *WHO, 1994, ANT DRUG POL DAT REQ; Wolday D, 1995, T ROY SOC TROP MED H, V89, P654, DOI 10.1016/0035-9203(95)90431-X; [No title captured]	31	92	95	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 4	2001	358	9279					368	374		10.1016/S0140-6736(01)05557-X	http://dx.doi.org/10.1016/S0140-6736(01)05557-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459DE	11502317				2022-12-28	WOS:000170235100012
J	Wallace, WHB; Blacklay, A; Eiser, C; Davies, H; Hawkins, M; Levitt, GA; Jenney, MEM				Wallace, WHB; Blacklay, A; Eiser, C; Davies, H; Hawkins, M; Levitt, GA; Jenney, MEM		Late Effects Comm United Kingdom	Developing strategies for long term follow up of survivors of childhood cancer	BRITISH MEDICAL JOURNAL			English	Review							ACUTE LYMPHOBLASTIC-LEUKEMIA; ALKYLATING-AGENTS; ABDOMINAL IRRADIATION; LATE CARDIOTOXICITY; HODGKINS-DISEASE; FINAL HEIGHT; CHEMOTHERAPY; CONSEQUENCES; RADIOTHERAPY; ADJUSTMENT		Royal Hosp Sick Children, Edinburgh EH9 1LF, Midlothian, Scotland; Princess Wales Childrens Hosp, Birmingham B4 6NH, W Midlands, England; Univ Sheffield, Sheffield S10 2TP, S Yorkshire, England; Sheffield Childrens Hosp, Sheffield S10 2TH, S Yorkshire, England; Univ Birmingham, Dept Epidemiol & Publ Hlth, Birmingham B15 2TT, W Midlands, England; Great Ormond St Hosp Children, London WC1N 3JH, England; Llandough Hosp, Penarth CF64 2XX, S Glam, Wales	University of Sheffield; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; University of Birmingham; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Wallace, WHB (corresponding author), Royal Hosp Sick Children, Edinburgh EH9 1LF, Midlothian, Scotland.			wallace, william, hamish/0000-0001-8080-5674				CRITCHLEY HOD, 1992, BRIT J OBSTET GYNAEC, V99, P392, DOI 10.1111/j.1471-0528.1992.tb13755.x; DAVIES HA, 1995, ACTA PAEDIATR, V84, P45, DOI 10.1111/j.1651-2227.1995.tb13862.x; Eiser C, 1998, J CHILD PSYCHOL PSYC, V39, P621, DOI 10.1111/1469-7610.00362; Eiser C, 2000, J PEDIATR PSYCHOL, V25, P449, DOI 10.1093/jpepsy/25.6.449; Eiser C, 1997, Sarcoma, V1, P39; GOORIN AM, 1990, J PEDIATR-US, V116, P144, DOI 10.1016/S0022-3476(05)81668-3; HANCOCK SL, 1993, JAMA-J AM MED ASSOC, V270, P1949, DOI 10.1001/jama.270.16.1949; Hawkins MM, 1996, J NATL CANCER I, V88, P270, DOI 10.1093/jnci/88.5.270; HAWKINS MM, 1992, BRIT MED J, V304, P951, DOI 10.1136/bmj.304.6832.951; HAWKINS MM, 1987, BRIT J CANCER, V56, P339, DOI 10.1038/bjc.1987.200; Hill JM, 1998, CANCER-AM CANCER SOC, V82, P208; KISSEN GKN, 1995, THERAPY BASED GUIDEL; Mackie EJ, 1996, MED PEDIATR ONCOL, V27, P74, DOI 10.1002/(SICI)1096-911X(199608)27:2<74::AID-MPO2>3.0.CO;2-Q; MULHERN PK, 1994, PEDIAT PSYCHOONCOLOG; Neugut AI, 1999, MULTIPLE PRIMARY CAN; NOLL RB, 1993, J PEDIATR PSYCHOL, V18, P351, DOI 10.1093/jpepsy/18.3.351; Noll RB, 1997, J PEDIATR PSYCHOL, V22, P827, DOI 10.1093/jpepsy/22.6.827; Nysom K, 1998, J CLIN ONCOL, V16, P3752, DOI 10.1200/JCO.1998.16.12.3752; Nysom K, 1998, PROG PEDIATR CARDIOL, V8, P121, DOI 10.1016/S1058-9813(98)00008-3; QUIGLEY C, 1989, NEW ENGL J MED, V321, P143, DOI 10.1056/NEJM198907203210303; Sanders JE, 1996, BLOOD, V87, P3045, DOI 10.1182/blood.V87.7.3045.bloodjournal8773045; SHALET SM, 1988, HORM RES, V30, P53, DOI 10.1159/000181029; SHALET SM, 1985, MED PEDIATR ONCOL, V13, P65, DOI 10.1002/mpo.2950130204; SKLAR C, 1993, J PEDIATR-US, V123, P59, DOI 10.1016/S0022-3476(05)81537-9; SORENSEN K, 1995, J CLIN ONCOL, V13, P1546, DOI 10.1200/JCO.1995.13.7.1546; Sorensen K, 1997, J CLIN ONCOL, V15, P61, DOI 10.1200/JCO.1997.15.1.61; SULMONT V, 1990, ACTA PAEDIATR SCAND, V79, P542, DOI 10.1111/j.1651-2227.1990.tb11509.x; TRUESDELL S, 1994, SURVIVORS CHILDHOOD; TUCKER MA, 1987, J NATL CANCER I, V78, P459, DOI 10.1093/jnci/78.3.459; TUCKER MA, 1987, NEW ENGL J MED, V317, P588, DOI 10.1056/NEJM198709033171002; WALLACE WHB, 1993, MED PEDIATR ONCOL, V21, P333, DOI 10.1002/mpo.2950210505; WALLACE WHB, 1989, BRIT J RADIOL, V62, P995, DOI 10.1259/0007-1285-62-743-995; Waring AB, 2000, HOSP MED, V61, P550, DOI 10.12968/hosp.2000.61.8.1398	33	156	159	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 4	2001	323	7307					271	274		10.1136/bmj.323.7307.271	http://dx.doi.org/10.1136/bmj.323.7307.271			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	461ZT	11485960	Green Published			2022-12-28	WOS:000170394300023
J	Ambros, V				Ambros, V			Development - Dicing up RNAs	SCIENCE			English	Editorial Material							CAENORHABDITIS-ELEGANS; REGULATORY RNA; LIN-14		Dartmouth Coll, Sch Med, Dept Genet, Hanover, NH 03755 USA	Dartmouth College	Ambros, V (corresponding author), Dartmouth Coll, Sch Med, Dept Genet, Hanover, NH 03755 USA.							Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; KNIGHT SW, 2001, SCIENCE         0802; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Parrish S, 2000, MOL CELL, V6, P1077, DOI 10.1016/S1097-2765(00)00106-4; PARRISH S, IN PRESS RNA; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	15	18	28	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2001	293	5531					811	+		10.1126/science.1064400	http://dx.doi.org/10.1126/science.1064400			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11486075				2022-12-28	WOS:000170241000029
J	Foster, JE; Holmes, SF; Erie, DA				Foster, JE; Holmes, SF; Erie, DA			Allosteric binding of nucleoside triphosphates to RNA polymerase regulates transcription elongation	CELL			English	Article							RIBONUCLEIC-ACID POLYMERASE; TERMINATION; ENZYME; DNA; MECHANISM; SITES; CONFORMATIONS; FIDELITY; MODEL	The regulation of transcription elongation and termination appears to be governed by the ability of RNA polymerase elongation complexes to adopt multiple conformational states; however, the factors controlling the distribution between these states remain elusive. We used transient-state kinetics to investigate the incorporation of single nucleotides. We demonstrate that E. coli RNA polymerase contains an allosteric binding site in addition to the catalytic site. Binding of the templated nucleoside triphosphate (NTP), but not nontemplated NTPs, to this site increases the rate of nucleotide incorporation. The data suggest that RNA polymerase can exist in a state that catalyzes synthesis slowly (unactivated) and one that catalyzes synthesis rapidly (activated), with the transition from the slow to the fast state being induced by binding of the templated NTP to the allosteric site.	Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Erie, DA (corresponding author), Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA.				NIGMS NIH HHS [GM-54316] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON KS, 1988, BIOCHEMISTRY-US, V27, P7395, DOI 10.1021/bi00419a034; ARMSTRONG VW, 1979, BIOCHEMISTRY-US, V18, P4120, DOI 10.1021/bi00586a010; Artsimovitch I, 2000, P NATL ACAD SCI USA, V97, P7090, DOI 10.1073/pnas.97.13.7090; BARSHOP BA, 1983, ANAL BIOCHEM, V130, P134, DOI 10.1016/0003-2697(83)90660-7; Buc H, 2000, SCIENCE, V287, P2437, DOI 10.1126/science.287.5462.2437; BURGESS RR, 1975, BIOCHEMISTRY-US, V14, P4634, DOI 10.1021/bi00692a011; Conaway JW, 1999, ANNU REV BIOCHEM, V68, P301, DOI 10.1146/annurev.biochem.68.1.301; Coulombre B, 1999, MICROBIOL MOL BIOL R, V63, P457, DOI 10.1128/MMBR.63.2.457-478.1999; Davenport RJ, 2000, SCIENCE, V287, P2497, DOI 10.1126/science.287.5462.2497; DEMERCOYROL L, 1990, BIOCHEM J, V269, P651, DOI 10.1042/bj2690651; ERIE DA, 1993, SCIENCE, V262, P867, DOI 10.1126/science.8235608; ERIE DA, 1992, ANNU REV BIOPH BIOM, V21, P379, DOI 10.1146/annurev.bb.21.060192.002115; Gelles J, 1998, CELL, V93, P13, DOI 10.1016/S0092-8674(00)81140-X; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; Guthold M, 2001, CHEMBIOCHEM, V2, P167; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Landick R, 1999, SCIENCE, V284, P598, DOI 10.1126/science.284.5414.598; LEVIN JR, 1987, J MOL BIOL, V196, P61, DOI 10.1016/0022-2836(87)90511-0; MATSUZAKI H, 1994, J MOL BIOL, V235, P1173, DOI 10.1006/jmbi.1994.1072; Mooney RA, 1999, CELL, V98, P687, DOI 10.1016/S0092-8674(00)81483-X; MOORE DS, 1995, BASIC PRACTICE STAT, P630; NEFF NF, 1980, BIOCHEMISTRY-US, V19, P3005, DOI 10.1021/bi00554a027; NIERMAN WC, 1980, J BIOL CHEM, V255, P4495; POLYAKOV A, 1995, CELL, V83, P365, DOI 10.1016/0092-8674(95)90114-0; SCHULZ AR, 1994, ENZYME KINETICS DIST, P133; Segel IH., 1975, ENZYME KINETICS, P227; SHOEMAKER DP, 1981, EXPT PHYSICAL CHEM, P727; TELESNITSKY APW, 1989, J MOL BIOL, V205, P315, DOI 10.1016/0022-2836(89)90343-4; Thomas MJ, 1998, CELL, V93, P627, DOI 10.1016/S0092-8674(00)81191-5; Uptain SM, 1997, P NATL ACAD SCI USA, V94, P13548, DOI 10.1073/pnas.94.25.13548; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; von Hippel PH, 1998, SCIENCE, V281, P660, DOI 10.1126/science.281.5377.660; YANG XJ, 1989, P NATL ACAD SCI USA, V86, P5301, DOI 10.1073/pnas.86.14.5301; Yarnell WS, 1999, SCIENCE, V284, P611, DOI 10.1126/science.284.5414.611; Yin H, 1999, P NATL ACAD SCI USA, V96, P13124, DOI 10.1073/pnas.96.23.13124; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9; ZIMMERLE CT, 1989, BIOCHEM J, V258, P381, DOI 10.1042/bj2580381	39	93	95	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 27	2001	106	2					243	252		10.1016/S0092-8674(01)00420-2	http://dx.doi.org/10.1016/S0092-8674(01)00420-2			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	458KG	11511351	Bronze, Green Published			2022-12-28	WOS:000170193100013
J	Kanitakis, J; Faure, M; Claudy, A				Kanitakis, J; Faure, M; Claudy, A			Clinical picture: Eyelid metastasis	LANCET			English	Editorial Material									Hop Edouard Herriot, Dept Dermatol, F-69437 Lyon 03, France	CHU Lyon	Kanitakis, J (corresponding author), Hop Edouard Herriot, Dept Dermatol, F-69437 Lyon 03, France.		Kanitakis, Jean/Q-3450-2019	Kanitakis, Jean/0000-0003-0469-257X					0	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 7	2001	358	9275					33	33		10.1016/S0140-6736(00)05255-7	http://dx.doi.org/10.1016/S0140-6736(00)05255-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449WV	11496919	Bronze			2022-12-28	WOS:000169710900014
J	LeCouter, J; Kowalski, J; Foster, J; Hass, P; Zhang, ZM; Dillard-Telm, L; Frantz, G; Rangell, L; DeGuzman, L; Keller, GA; Peale, F; Gurney, A; Hillan, KJ; Ferrara, N				LeCouter, J; Kowalski, J; Foster, J; Hass, P; Zhang, ZM; Dillard-Telm, L; Frantz, G; Rangell, L; DeGuzman, L; Keller, GA; Peale, F; Gurney, A; Hillan, KJ; Ferrara, N			Identification of an angiogenic mitogen selective for endocrine gland endothelium	NATURE			English	Article							GROWTH-FACTOR; VASCULAR-PERMEABILITY; CORPUS-LUTEUM; EXPRESSION; CELLS; GENE; VEGF; MICROENVIRONMENT; DIFFERENTIATION; PROLIFERATION	The known endothelial mitogens stimulate growth of vascular endothelial cells without regard to their tissue of origin. Here we report a growth factor that is expressed largely in one type of tissue and acts selectively on one type of endothelium. This molecule, called endocrine-gland-derived vascular endothelial growth factor (EG-VEGF), induced proliferation, migration and fenestration (the formation of membrane discontinuities) in capillary endothelial cells derived from endocrine glands. However, EG-VEGF had little or no effect on a variety of other endothelial and non-endothelial cell types tested. Similar to VEGF, EG-VEGF possesses a HIF-1 binding site, and its expression is induced by hypoxia. Both EG-VEGF and VEGF resulted in extensive angiogenesis and cyst formation when delivered in the ovary. However, unlike VEGF, EG-VEGF failed to promote angiogenesis in the cornea or skeletal muscle. Expression of human EG-VEGF messenger RNA is restricted to the steroidogenic glands, ovary, testis, adrenal and placenta and is often complementary to the expression of VEGF, suggesting that these molecules function in a coordinated manner. EG-VEGF is an example of a class of highly specific mitogens that act to regulate proliferation and differentiation of the vascular endothelium in a tissue-specific manner.	Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA; Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; Genentech Inc, Dept Toxicol Pathol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Ferrara, N (corresponding author), Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA.	nf@gene.com						AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Aird WC, 1997, J CELL BIOL, V138, P1117, DOI 10.1083/jcb.138.5.1117; Aravind L, 1998, CURR BIOL, V8, pR477, DOI 10.1016/S0960-9822(98)70309-4; Arbiser JL, 1997, P NATL ACAD SCI USA, V94, P861, DOI 10.1073/pnas.94.3.861; Basset DL, 1943, AM J ANAT, V73, P251, DOI 10.1002/aja.1000730206; Boisbouvier J, 1998, J MOL BIOL, V283, P205, DOI 10.1006/jmbi.1998.2057; BREIER G, 1992, DEVELOPMENT, V114, P521; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Collin O, 1996, INT J ANDROL, V19, P221, DOI 10.1111/j.1365-2605.1996.tb00466.x; Dellian M, 1996, AM J PATHOL, V149, P59; Dor Y, 2001, AM J PHYSIOL-CELL PH, V280, pC1367, DOI 10.1152/ajpcell.2001.280.6.C1367; Esser S, 1998, J CELL BIOL, V140, P947, DOI 10.1083/jcb.140.4.947; Farrara N, 2000, CURR OPIN BIOTECH, V11, P617, DOI 10.1016/S0958-1669(00)00153-1; Ferrara N, 1998, NAT MED, V4, P336, DOI 10.1038/nm0398-336; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Ferrara N, 1999, NAT MED, V5, P1359, DOI 10.1038/70928; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Gerber HP, 1999, DEVELOPMENT, V126, P1149; Gille H, 2001, J BIOL CHEM, V276, P3222, DOI 10.1074/jbc.M002016200; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; GOLDZIEHER JW, 1962, J CLIN ENDOCR METAB, V22, P325, DOI 10.1210/jcem-22-3-325; GOSPODAROWICZ D, 1984, J CELL BIOL, V99, P947, DOI 10.1083/jcb.99.3.947; JOUBERT FJ, 1980, H-S Z PHYSIOL CHEM, V361, P1787, DOI 10.1515/bchm2.1980.361.2.1787; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Klagsbrun M, 1992, Semin Cancer Biol, V3, P81; Krupnik VE, 1999, GENE, V238, P301, DOI 10.1016/S0378-1119(99)00365-0; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; Miao HQ, 1999, J CELL BIOL, V146, P233, DOI 10.1083/jcb.146.1.233; MONACCI WT, 1993, AM J PHYSIOL, V264, pC995, DOI 10.1152/ajpcell.1993.264.4.C995; PALADE GE, 1979, ACTA PHYSIOL SCAND, P11; Pettersson A, 2000, LAB INVEST, V80, P99, DOI 10.1038/labinvest.3780013; PHILLIPS HS, 1990, ENDOCRINOLOGY, V127, P965, DOI 10.1210/endo-127-2-965; PHILLIPS HS, 1990, SCIENCE, V250, P290, DOI 10.1126/science.1688328; RAVINDRANATH N, 1992, ENDOCRINOLOGY, V131, P254, DOI 10.1210/en.131.1.254; Roberts WG, 1997, CANCER RES, V57, P765; Ryan AM, 1999, TOXICOL PATHOL, V27, P78, DOI 10.1177/019262339902700115; Schweitz H, 1999, FEBS LETT, V461, P183, DOI 10.1016/S0014-5793(99)01459-3; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Simionescu N., 1988, CELL TISSUE BIOL, P355; STEWART PA, 1981, DEV BIOL, V84, P183, DOI 10.1016/0012-1606(81)90382-1; VANTILBEURGH H, 1992, NATURE, V359, P159, DOI 10.1038/359159a0; Wechselberger C, 1999, FEBS LETT, V462, P177, DOI 10.1016/S0014-5793(99)01473-8; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; ZETTER BR, 1980, NATURE, V285, P41, DOI 10.1038/285041a0	46	426	486	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2001	412	6850					877	884		10.1038/35091000	http://dx.doi.org/10.1038/35091000			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467EG	11528470				2022-12-28	WOS:000170689000036
J	Pockley, P				Pockley, P			Funding bonanza for astronomy and biotech in Australia	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2001	412	6850					846	846		10.1038/35091214	http://dx.doi.org/10.1038/35091214			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467EG	11528440	Bronze			2022-12-28	WOS:000170689000010
J	Colley, DG; LoVerde, PT; Savioli, L				Colley, DG; LoVerde, PT; Savioli, L			Infectious disease: Medical helminthology in the 21st century	SCIENCE			English	Editorial Material							COGNITIVE FUNCTION		CDC, Div Parasit Dis, NCID, Atlanta, GA 30341 USA; SUNY Buffalo, Sch Med & Biomed Sci, Buffalo, NY 14214 USA; WHO, CH-1211 Geneva, Switzerland	Centers for Disease Control & Prevention - USA; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; World Health Organization	Colley, DG (corresponding author), CDC, Div Parasit Dis, NCID, Atlanta, GA 30341 USA.	Dcolley@cdc.gov						ADAMS EJ, 1994, J NUTR, V124, P1199, DOI 10.1093/jn/124.8.1199; Burglin TR, 1998, INT J PARASITOL, V28, P395, DOI 10.1016/S0020-7519(97)00208-7; Cioli D, 1998, PARASITOL TODAY, V14, P418, DOI 10.1016/S0169-4758(98)01323-4; Crompton DWT, 1999, J PARASITOL, V85, P397, DOI 10.2307/3285768; Davis RE, 1999, P NATL ACAD SCI USA, V96, P8687, DOI 10.1073/pnas.96.15.8687; FENNER F, 1998, ERADICATION INFECT D, P3; Guerrant DI, 1999, AM J TROP MED HYG, V61, P707, DOI 10.4269/ajtmh.1999.61.707; Henderson D A, 1998, Bull World Health Organ, V76 Suppl 2, P17; Ismail M, 1999, AM J TROP MED HYG, V60, P932, DOI 10.4269/ajtmh.1999.60.932; MCGARVEY ST, 1993, AM J TROP MED HYG, V48, P547, DOI 10.4269/ajtmh.1993.48.547; MOORE SR, IN PRESS INT J EPIDE; Nokes C, 1999, AM J TROP MED HYG, V60, P556, DOI 10.4269/ajtmh.1999.60.556; NOKES C, 1992, P ROY SOC B-BIOL SCI, V247, P77, DOI 10.1098/rspb.1992.0011; Sangster NC, 1999, PARASITOL TODAY, V15, P141, DOI 10.1016/S0169-4758(99)01413-1; VANDERWERF MJ, COMMUNICATION	15	71	74	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2001	293	5534					1437	1438		10.1126/science.1060733	http://dx.doi.org/10.1126/science.1060733			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465XV	11520969				2022-12-28	WOS:000170616000024
J	Mukhopadhyay, J; Kapanidis, AN; Mekler, V; Kortkhonjia, E; Ebright, YW; Ebright, RH				Mukhopadhyay, J; Kapanidis, AN; Mekler, V; Kortkhonjia, E; Ebright, YW; Ebright, RH			Translocation of sigma(70) with RNA polymerase during transcription: Fluorescence resonance energy transfer assay for movement relative to DNA	CELL			English	Article							LAC UV5 PROMOTER; ESCHERICHIA-COLI; TERNARY COMPLEXES; NUCLEIC-ACIDS; INITIATION; SUBUNIT; PROTEIN; ELONGATION; ORGANIZATION; PURIFICATION	Using fluorescence resonance energy transfer, we show that, in the majority of transcription complexes, sigma (70) is not released from RNA polymerase upon transition from initiation to elongation, but, instead, remains associated with RNA polymerase and translocates with RNA polymerase. The results argue against the presumption that there are necessary subunit-composition differences, and corresponding necessary mechanistic differences, in initiation and elongation. The methods of this report should be generalizable to monitor movement of any molecule relative to any nucleic acid.	Rutgers State Univ, Dept Chem, Waksman Inst, Howard Hughes Med Inst, Piscataway, NJ 08854 USA	Howard Hughes Medical Institute; Rutgers State University New Brunswick	Ebright, RH (corresponding author), Rutgers State Univ, Dept Chem, Waksman Inst, Howard Hughes Med Inst, POB 939, Piscataway, NJ 08854 USA.		Ebright, Richard/O-3321-2019	Ebright, Richard/0000-0001-8915-7140	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041376] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM41376] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bar-Nahum G, 2001, CELL, V106, P443, DOI 10.1016/S0092-8674(01)00461-5; Bown JA, 1999, J BIOL CHEM, V274, P2263, DOI 10.1074/jbc.274.4.2263; BURGESS RR, 1975, BIOCHEMISTRY-US, V14, P4634, DOI 10.1021/bi00692a011; Callaci S, 1998, J BIOL CHEM, V273, P32995, DOI 10.1074/jbc.273.49.32995; CARPOUSIS AJ, 1985, J MOL BIOL, V183, P165, DOI 10.1016/0022-2836(85)90210-4; CECH CL, 1980, BIOCHEMISTRY-US, V19, P2440, DOI 10.1021/bi00552a023; Chong SR, 1996, J BIOL CHEM, V271, P22159, DOI 10.1074/jbc.271.36.22159; Chong SR, 1997, GENE, V192, P271, DOI 10.1016/S0378-1119(97)00105-4; Christie GE, 1996, J BACTERIOL, V178, P6991, DOI 10.1128/jb.178.23.6991-6993.1996; CHUI MM, 1995, J COLLOID INTERF SCI, V174, P336, DOI 10.1006/jcis.1995.1399; CLEGG RM, 1992, METHOD ENZYMOL, V211, P353; Daube SS, 1999, P NATL ACAD SCI USA, V96, P8390, DOI 10.1073/pnas.96.15.8390; Ebright RH, 2000, J MOL BIOL, V304, P687, DOI 10.1006/jmbi.2000.4309; GILL SC, 1991, J MOL BIOL, V220, P307, DOI 10.1016/0022-2836(91)90015-X; GREENBLATT J, 1981, CELL, V24, P421, DOI 10.1016/0092-8674(81)90332-9; Gross CA, 1998, COLD SPRING HARB SYM, V63, P141, DOI 10.1101/sqb.1998.63.141; HANSEN UM, 1980, J BIOL CHEM, V255, P9564; HSU TP, 1984, POLYMER, V25, P1419, DOI 10.1016/0032-3861(84)90103-4; Kashlev M, 1996, METHOD ENZYMOL, V274, P326; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; KRUMMEL B, 1989, BIOCHEMISTRY-US, V28, P7829, DOI 10.1021/bi00445a045; Kubori T, 1996, J MOL BIOL, V256, P449, DOI 10.1006/jmbi.1996.0100; LEVIN JR, 1987, J MOL BIOL, V196, P85, DOI 10.1016/0022-2836(87)90512-2; Lilley DMJ, 2000, CURR OPIN CHEM BIOL, V4, P507, DOI 10.1016/S1367-5931(00)00124-1; Minakhin L, 2001, P NATL ACAD SCI USA, V98, P892, DOI 10.1073/pnas.98.3.892; Muir TW, 1998, P NATL ACAD SCI USA, V95, P6705, DOI 10.1073/pnas.95.12.6705; Naryshkin N, 2000, CELL, V101, P601, DOI 10.1016/S0092-8674(00)80872-7; Niu W, 1996, CELL, V87, P1123, DOI 10.1016/S0092-8674(00)81806-1; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; OSUMIDAVIS PA, 1987, BIOCHIM BIOPHYS ACTA, V910, P130, DOI 10.1016/0167-4781(87)90065-0; Owens JT, 1998, P NATL ACAD SCI USA, V95, P6021, DOI 10.1073/pnas.95.11.6021; Pluen A, 1998, ELECTROPHORESIS, V19, P1548, DOI 10.1002/elps.1150191005; Ring BZ, 1996, CELL, V86, P485, DOI 10.1016/S0092-8674(00)80121-X; Sambrook J, 2001, MOL CLONING LAB MANU, V3rd; SHIMAMOTO N, 1986, J BIOL CHEM, V261, P1859; STRANEY DC, 1985, CELL, V43, P449, DOI 10.1016/0092-8674(85)90175-8; STRANEY DC, 1987, J MOL BIOL, V193, P267, DOI 10.1016/0022-2836(87)90218-X; SUH WC, 1992, BIOCHEMISTRY-US, V31, P7815, DOI 10.1021/bi00149a011; TRAVERS AA, 1969, NATURE, V222, P537, DOI 10.1038/222537a0; WANG DG, 1995, CELL, V81, P341, DOI 10.1016/0092-8674(95)90387-9	41	144	153	2	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 24	2001	106	4					453	463		10.1016/S0092-8674(01)00464-0	http://dx.doi.org/10.1016/S0092-8674(01)00464-0			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	466UU	11525731	Bronze			2022-12-28	WOS:000170665200009
J	Wu, YT; Marsh, JW				Wu, YT; Marsh, JW			Selective transcription and modulation of resting T cell activity by preintegrated HIV DNA	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; QUIESCENT CD4 LYMPHOCYTES; NEF GENE; MESSENGER-RNA; IN-VITRO; REPLICATION; ACTIVATION; INFECTION; EXPRESSION; PROTEIN	The quiescent nature of most peripheral T cells poses an effective limitation to human immunodeficiency virus (HIV) replication and, in particular, to viral integration into the host chromatin. Two HIV proteins, Nef and Tat, increase T cell activity, but a requirement of integration for viral gene expression would preclude a rote for these proteins in resting cells. Here, we report that HIV infection leads to selective transcription of the nef and tat genes before integration. This preintegration transcription in quiescent cells leads to increased T cell activation and viral replication.	NIMH, Mol Biol Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Marsh, JW (corresponding author), NIMH, Mol Biol Lab, Bethesda, MD 20892 USA.	jon@codon.nih.gov			NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002629, ZIAMH002629] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AIKEN C, 1995, J VIROL, V69, P5048, DOI 10.1128/JVI.69.8.5048-5056.1995; [Anonymous], UNPUB; CARA A, 1995, VIROLOGY, V208, P242, DOI 10.1006/viro.1995.1148; CHOWERS MY, 1994, J VIROL, V68, P2906, DOI 10.1128/JVI.68.5.2906-2914.1994; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Davis CB, 1997, J EXP MED, V186, P1793, DOI 10.1084/jem.186.10.1793; ENGELMAN A, 1995, J VIROL, V69, P2729, DOI 10.1128/JVI.69.5.2729-2736.1995; ENGLUND G, 1995, J VIROL, V69, P3216, DOI 10.1128/JVI.69.5.3216-3219.1995; FOLKS TM, 1986, J EXP MED, V164, P280, DOI 10.1084/jem.164.1.280; JONES KA, 1994, ANNU REV BIOCHEM, V63, P717, DOI 10.1146/annurev.bi.63.070194.003441; Kinoshita S, 1998, CELL, V95, P595, DOI 10.1016/S0092-8674(00)81630-X; Korin YD, 1998, J VIROL, V72, P3161, DOI 10.1128/JVI.72.4.3161-3168.1998; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; MILLER MD, 1995, J VIROL, V69, P579, DOI 10.1128/JVI.69.1.579-584.1995; MILLER MD, 1994, J EXP MED, V179, P101, DOI 10.1084/jem.179.1.101; Ott M, 1997, SCIENCE, V275, P1481, DOI 10.1126/science.275.5305.1481; Pandori MW, 1996, J VIROL, V70, P4283, DOI 10.1128/JVI.70.7.4283-4290.1996; PURCELL DFJ, 1993, J VIROL, V67, P6365, DOI 10.1128/JVI.67.11.6365-6378.1993; RHEE SS, 1994, J IMMUNOL, V152, P5128; Schrager JA, 1999, P NATL ACAD SCI USA, V96, P8167, DOI 10.1073/pnas.96.14.8167; SIEKEVITZ M, 1987, SCIENCE, V238, P1575, DOI 10.1126/science.2825351; SIEKEVITZ M, 1987, P NATL ACAD SCI USA, V84, P5389, DOI 10.1073/pnas.84.15.5389; SPINA CA, 1995, J VIROL, V69, P2977, DOI 10.1128/JVI.69.5.2977-2988.1995; SPINA CA, 1994, J EXP MED, V179, P115, DOI 10.1084/jem.179.1.115; STEVENSON M, 1990, EMBO J, V9, P1551, DOI 10.1002/j.1460-2075.1990.tb08274.x; TONGSTARKSEN SE, 1987, P NATL ACAD SCI USA, V84, P6845, DOI 10.1073/pnas.84.19.6845; Unutmaz D, 1999, J EXP MED, V189, P1735, DOI 10.1084/jem.189.11.1735; Wang JK, 2000, P NATL ACAD SCI USA, V97, P394, DOI 10.1073/pnas.97.1.394; WISKERCHEN M, 1995, J VIROL, V69, P376, DOI 10.1128/JVI.69.1.376-386.1995; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353	31	284	294	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2001	293	5534					1503	1506		10.1126/science.1061548	http://dx.doi.org/10.1126/science.1061548			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465XV	11520990				2022-12-28	WOS:000170616000048
J	Scuteri, A; Bos, AJG; Brant, LJ; Talbot, L; Lakatta, EG; Fleg, JL				Scuteri, A; Bos, AJG; Brant, LJ; Talbot, L; Lakatta, EG; Fleg, JL			Hormone replacement therapy and longitudinal changes in blood pressure in postmenopausal women	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; ESTROGEN REPLACEMENT; NITRIC-OXIDE; HYPERTENSION; MENOPAUSE; ESTRADIOL; AGE; PREVENTION; HEALTH; GENDER	Background: The incidence of hypertension in postmenopausal women exceeds that in age-matched men. Longitudinal studies relating hormone replacement therapy (HRT) to blood pressure changes are sparse. Objective: To investigate the association between HRT and longitudinal changes In blood pressure In postmenopausal women. Design: Longitudinal observational study. Setting: Community-dwelling volunteers. Patients: 226 healthy, normotensive postmenopausal women from the Baltimore Longitudinal Study of Aging with a mean (+/- SD) age of 64 +/- 10 years were followed for 5.7 +/- 5.3 years. Seventy-seven women used both estrogen and progestin, and 149 used neither. Measurements: Lifestyle variables, blood pressure, and traditional cardiovascular risk factors were measured at baseline and approximately every 2 years thereafter. Results: Systolic blood pressure at baseline was similar in HRT users and nonusers (133.9 +/- 16.0 mm Hg vs. 132.4 +/- 14.8 mm Hg). Over time, average systolic blood pressure increased less in HRT users than nonusers, independent of other cardiovascular risk factors, physical activity, and alcohol use. For example, HRT users who were 55 years of age at their first Baltimore Longitudinal Study of Aging visit experienced a 7.6-mm Hg average increase in systolic blood pressure over 10 years; in contrast, the average increase in nonusers was 18.7 mm Hg. The lesser increase in systolic blood pressure in HRT users was more evident at older age. Diastolic blood pressure, which did not change statistically over time in either group, was not associated with HRT. Conclusion: Postmenopausal women taking HRT have a smaller increase in systolic blood pressure over time than those not taking HRT. This difference is intensified at older ages.	NIA, Gerontol Res Ctr, Cardiovasc Sci Lab, NIH, Baltimore, MD 21224 USA; Johns Hopkins Univ, Sch Nursing, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University	Fleg, JL (corresponding author), NIA, Gerontol Res Ctr, Cardiovasc Sci Lab, NIH, 5600 Nathan Shock Dr, Baltimore, MD 21224 USA.		Lakatta, Edward G/AAL-1447-2020; Bos, Angelo Jose/A-5227-2017	Lakatta, Edward/0000-0002-4772-0035; Bos, Angelo Jose/0000-0003-4901-3155; SCUTERI, ANGELO/0000-0003-4784-5441; Talbot, Laura/0000-0002-0381-4486	NATIONAL INSTITUTE ON AGING [Z01AG000270] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; ANASTOS K, 1991, ANN INTERN MED, V115, P287, DOI 10.7326/0003-4819-115-4-287; BARRETTCONNOR E, 1991, ANN INTERN MED, V115, P455, DOI 10.7326/0003-4819-115-6-455; Best PJM, 1998, ANN INTERN MED, V128, P285, DOI 10.7326/0003-4819-128-4-199802150-00006; Brant Larry J., 1994, P373; BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; Cagnacci A, 1999, AM J PHYSIOL-HEART C, V276, pH1355, DOI 10.1152/ajpheart.1999.276.4.H1355; COLDITZ GA, 1987, NEW ENGL J MED, V316, P1105, DOI 10.1056/NEJM198704303161801; CRANE MG, 1971, ANN INTERN MED, V74, P13, DOI 10.7326/0003-4819-74-1-13; FISCHER GM, 1977, AM J PHYSIOL, V232, pH617, DOI 10.1152/ajpheart.1977.232.6.H617; GANGAR KF, 1991, LANCET, V338, P839; GORDON T, 1979, NATL HEART I FRAMING, P74; Grady D, 2000, ANN INTERN MED, V133, P999, DOI 10.7326/0003-4819-133-12-200012190-00016; Grodstein F, 2000, ANN INTERN MED, V133, P933, DOI 10.7326/0003-4819-133-12-200012190-00008; Herrington DM, 2000, NEW ENGL J MED, V343, P522, DOI 10.1056/NEJM200008243430801; HIMMELMANN A, 1994, J HUM HYPERTENS, V8, P485; HJORTLAND MC, 1976, AM J EPIDEMIOL, V103, P304, DOI 10.1093/oxfordjournals.aje.a112228; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; JETTE M, 1990, CLIN CARDIOL, V13, P555, DOI 10.1002/clc.4960130809; Kawano H, 1997, J AM COLL CARDIOL, V30, P914, DOI 10.1016/S0735-1097(97)00234-9; Lakatta EG, 1999, J AM GERIATR SOC, V47, P613, DOI 10.1111/j.1532-5415.1999.tb02579.x; Lesaffre E, 1998, BIOMETRICS, V54, P570, DOI 10.2307/3109764; Lind T, 1979, Br J Obstet Gynaecol, V86 Suppl 3, P1, DOI 10.1111/j.1471-0528.1979.tb16232.x; LIP GYH, 1994, J HUM HYPERTENS, V8, P491; MAGNESS RR, 1989, AM J PHYSIOL, V256, pE536, DOI 10.1152/ajpendo.1989.256.4.E536; Majmudar NG, 2000, J CLIN ENDOCR METAB, V85, P1577, DOI 10.1210/jc.85.4.1577; MARIGLIANO V, 1997, SENILEHYPERTENSION 9, P1; Matthews KA, 1996, AM J EPIDEMIOL, V143, P971; MATTHEWS KA, 1989, NEW ENGL J MED, V321, P641, DOI 10.1056/NEJM198909073211004; MILLER VT, 1995, JAMA-J AM MED ASSOC, V273, P199, DOI 10.1001/jama.1995.03520270033028; Miyagawa K, 1997, NAT MED, V3, P324, DOI 10.1038/nm0397-324; Morrell CH, 1997, AM STAT, V51, P338, DOI 10.2307/2685902; Pearson JD, 1997, J GERONTOL A-BIOL, V52, pM177, DOI 10.1093/gerona/52A.3.M177; PFEFFER RI, 1978, J CHRON DIS, V31, P389, DOI 10.1016/0021-9681(78)90003-6; Schunkert H, 1997, CIRCULATION, V95, P39, DOI 10.1161/01.CIR.95.1.39; Scuteri A, 1999, CIRCULATION, V100, P105; Seely EW, 1999, HYPERTENSION, V33, P1190, DOI 10.1161/01.HYP.33.5.1190; SHOCK NW, 1984, NORMAL HUMAN AGING B, V84, P2450; STAESSEN J, 1989, J HUM HYPERTENS, V3, P427; STAMLER J, 1976, JAMA-J AM MED ASSOC, V235, P2299, DOI 10.1001/jama.235.21.2299; UTIAN WH, 1978, MATURITAS, V1, P3, DOI 10.1016/0378-5122(78)90003-8; VANBERESTEYN ECH, 1989, AM J EPIDEMIOL, V129, P947, DOI 10.1093/oxfordjournals.aje.a115227; VARGAS R, 1993, BRIT J PHARMACOL, V109, P612, DOI 10.1111/j.1476-5381.1993.tb13616.x; VERBEKE G, 1998, LINEAR MIXED MODELS, P63; Verbrugge LM, 1996, J GERONTOL B-PSYCHOL, V51, pS30, DOI 10.1093/geronb/51B.1.S30; WEISS NS, 1972, AM J EPIDEMIOL, V96, P237, DOI 10.1093/oxfordjournals.aje.a121454; YONG LC, 1993, AM J EPIDEMIOL, V138, P973, DOI 10.1093/oxfordjournals.aje.a116817	47	72	77	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 21	2001	135	4					229	238		10.7326/0003-4819-135-4-200108210-00007	http://dx.doi.org/10.7326/0003-4819-135-4-200108210-00007			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465KE	11511137				2022-12-28	WOS:000170587500001
J	Henikoff, S; Ahmad, K; Malik, HS				Henikoff, S; Ahmad, K; Malik, HS			The centromere paradox: Stable inheritance with rapidly evolving DNA	SCIENCE			English	Review							ALPHA-SATELLITE DNA; CENP-A; MEIOTIC DRIVE; EPIGENETIC INHERITANCE; CHROMATIN ORGANIZATION; FUNCTIONAL-ANALYSIS; MISSING LINK; HISTONE H3; CHROMOSOME; PROTEIN	Every eukaryotic chromosome has a centromere, the locus responsible for poleward movement at mitosis and meiosis. Although conventional loci are specified by their DNA sequences, current evidence favors a chromatin-based inheritance mechanism for centromeres. The chromosome segregation machinery is highly conserved across at[ eukaryotes, but the DNA and protein components specific to centromeric chromatin are evolving rapidly. Incompatibilities between rapidly evolving centromeric components may be responsible for both the organization of centromeric regions and the reproductive isolation of emerging species.	Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Res Labs, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; Howard Hughes Medical Institute	Henikoff, S (corresponding author), Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Res Labs, 1100 Fairview Ave N, Seattle, WA 98109 USA.	steveh@fhcrc.org	Malik, Harmit S/I-5591-2019; Malik, Harmit S/E-8519-2012	Malik, Harmit S/0000-0001-6005-0016; Henikoff, Steven/0000-0002-7621-8685				Agudo M, 2000, CHROMOSOMA, V109, P190, DOI 10.1007/s004120050427; Ahmad K, 2001, J CELL BIOL, V153, P101, DOI 10.1083/jcb.153.1.101; BUCHWITZ B, UNPUB; Buchwitz BJ, 1999, NATURE, V401, P547, DOI 10.1038/44062; Buckler ES, 1999, GENETICS, V153, P415; Cambareri EB, 1998, MOL CELL BIOL, V18, P5465, DOI 10.1128/MCB.18.9.5465; CHARLESWORTH B, 1994, NATURE, V371, P215, DOI 10.1038/371215a0; Choo KHA, 2000, TRENDS CELL BIOL, V10, P182, DOI 10.1016/S0962-8924(00)01739-6; Choo KHA., 1997, CENTROMERE; Coyne JA, 1998, PHILOS T ROY SOC B, V353, P287, DOI 10.1098/rstb.1998.0210; Craig JM, 1999, EXP CELL RES, V246, P249, DOI 10.1006/excr.1998.4278; Csink AK, 1998, TRENDS GENET, V14, P200, DOI 10.1016/S0168-9525(98)01444-9; Dawe RK, 1996, P NATL ACAD SCI USA, V93, P8512, DOI 10.1073/pnas.93.16.8512; de Villena FPM, 2001, MAMM GENOME, V12, P331, DOI 10.1007/s003350040003; de Villena FPM, 2001, HUM GENET, V108, P31, DOI 10.1007/s004390000437; Depinet TW, 1997, HUM MOL GENET, V6, P1195, DOI 10.1093/hmg/6.8.1195; Dong FG, 1998, P NATL ACAD SCI USA, V95, P8135, DOI 10.1073/pnas.95.14.8135; DOVER GA, 1993, CURR OPIN GENET DEV, V3, P902, DOI 10.1016/0959-437X(93)90012-E; EARNSHAW WC, 1985, CHROMOSOMA, V91, P313, DOI 10.1007/BF00328227; Ekwall K, 1999, GENETICS, V153, P1153; Ekwall K, 1997, CELL, V91, P1021, DOI 10.1016/S0092-8674(00)80492-4; FISHEL B, 1988, MOL CELL BIOL, V8, P754, DOI 10.1128/MCB.8.2.754; Floridia G, 2000, EMBO REP, V1, P489; FRANK G, 1991, AM J OCCUP THER, V45, P252, DOI 10.5014/ajot.45.3.252; Grewal SIS, 1998, GENETICS, V150, P563; Haaf T, 1997, CHROMOSOMA, V106, P226, DOI 10.1007/s004120050243; Harrington JJ, 1997, NAT GENET, V15, P345, DOI 10.1038/ng0497-345; Henikoff S, 2000, P NATL ACAD SCI USA, V97, P716, DOI 10.1073/pnas.97.2.716; Higgins AW, 1999, CHROMOSOMA, V108, P256, DOI 10.1007/s004120050376; Howman EV, 2000, P NATL ACAD SCI USA, V97, P1148, DOI 10.1073/pnas.97.3.1148; HURST LD, 1991, GENETICS, V128, P841; Ikeno M, 1998, NAT BIOTECHNOL, V16, P431, DOI 10.1038/nbt0598-431; JACKSON V, 1988, BIOCHEMISTRY-US, V27, P2109, DOI 10.1021/bi00406a044; Jasencakova Z, 2001, CHROMOSOMA, V110, P83, DOI 10.1007/s004120100132; Kalitsis P, 1998, P NATL ACAD SCI USA, V95, P1136, DOI 10.1073/pnas.95.3.1136; Karpen GH, 1997, TRENDS GENET, V13, P489, DOI 10.1016/S0168-9525(97)01298-5; Kaszas E, 1998, GENETICS, V150, P1683; Keith KC, 1999, MOL CELL BIOL, V19, P6130; Laurie CC, 1997, GENETICS, V147, P937; Lo AWI, 2001, GENOME RES, V11, P448, DOI 10.1101/gr.GR-1676R; Lo AWI, 2001, EMBO J, V20, P2087, DOI 10.1093/emboj/20.8.2087; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Lyko F, 1999, BIOESSAYS, V21, P824; Malik HS, 2001, GENETICS, V157, P1293; Martienssen RA, 2001, SCIENCE, V293, P1070, DOI 10.1126/science.293.5532.1070; McKee BD, 1998, GENETICS, V149, P143; Meluh PB, 1998, CELL, V94, P607, DOI 10.1016/S0092-8674(00)81602-5; Moore LL, 2001, J CELL BIOL, V153, P1199, DOI 10.1083/jcb.153.6.1199; Murphy TD, 1998, CELL, V93, P317, DOI 10.1016/S0092-8674(00)81158-7; MURPHY TD, 1995, CELL, V82, P599, DOI 10.1016/0092-8674(95)90032-2; NOVITSKI E, 1955, J CELL COMPAR PHYSL, V45, P151, DOI 10.1002/jcp.1030450509; Oegema K, 2001, J CELL BIOL, V153, P1209, DOI 10.1083/jcb.153.6.1209; OKEEFE RT, 1992, J CELL BIOL, V116, P1095, DOI 10.1083/jcb.116.5.1095; Ortiz J, 1999, GENE DEV, V13, P1140, DOI 10.1101/gad.13.9.1140; PALMER DK, 1991, P NATL ACAD SCI USA, V88, P3734, DOI 10.1073/pnas.88.9.3734; PALMER DK, 1990, CHROMOSOMA, V100, P32, DOI 10.1007/BF00337600; Partridge JF, 2000, GENE DEV, V14, P783; PLATERO JS, UNPUB; Puechberty J, 1999, GENOMICS, V56, P274, DOI 10.1006/geno.1999.5742; Rhoades M. M., 1952, Heterosis., P66; Rhoades MM, 1942, GENETICS, V27, P0395; Saffery R, 2000, HUM MOL GENET, V9, P175, DOI 10.1093/hmg/9.2.175; Schmid KJ, 1999, GENETICS, V153, P1717; Shareef MM, 2001, MOL BIOL CELL, V12, P1671, DOI 10.1091/mbc.12.6.1671; Shelby RD, 1997, J CELL BIOL, V136, P501, DOI 10.1083/jcb.136.3.501; Shelby RD, 2000, J CELL BIOL, V151, P1113, DOI 10.1083/jcb.151.5.1113; Sheldon BC, 1999, CURR BIOL, V9, pR487, DOI 10.1016/S0960-9822(99)80303-0; STEINER NC, 1994, CELL, V79, P865, DOI 10.1016/0092-8674(94)90075-2; Sullivan BA, 1998, NAT GENET, V20, P227, DOI 10.1038/3024; Sullivan KF, 2001, CURR OPIN GENET DEV, V11, P182, DOI 10.1016/S0959-437X(00)00177-5; SULLIVAN KF, 1994, J CELL BIOL, V127, P581, DOI 10.1083/jcb.127.3.581; Sun XP, 1997, CELL, V91, P1007, DOI 10.1016/S0092-8674(00)80491-2; Taddei A, 2001, NAT CELL BIOL, V3, P114, DOI 10.1038/35055010; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; Tyler-Smith C, 1999, AM J HUM GENET, V64, P1440, DOI 10.1086/302380; Vafa O, 1999, CHROMOSOMA, V108, P367, DOI 10.1007/s004120050388; Vafa O, 1997, CURR BIOL, V7, P897, DOI 10.1016/S0960-9822(06)00381-2; Warburton PE, 2000, AM J HUM GENET, V66, P1794, DOI 10.1086/302924; Warburton PE, 1997, CURR BIOL, V7, P901, DOI 10.1016/S0960-9822(06)00382-4; Wickner RB, 1995, YEAST, V11, P1671, DOI 10.1002/yea.320111609; Willard HF, 1998, CURR OPIN GENET DEV, V8, P219, DOI 10.1016/S0959-437X(98)80144-5; WILLARD HF, 1990, TRENDS GENET, V6, P410, DOI 10.1016/0168-9525(90)90302-M; WINES DR, 1992, GENETICS, V131, P683; Winey M, 2001, NAT CELL BIOL, V3, pE23, DOI 10.1038/35050663; Yang JW, 2000, HUM MOL GENET, V9, P1891, DOI 10.1093/hmg/9.12.1891; Yoda K, 2000, P NATL ACAD SCI USA, V97, P7266, DOI 10.1073/pnas.130189697; Yucel JK, 2000, J CELL BIOL, V150, P1, DOI 10.1083/jcb.150.1.1; Zwick ME, 1999, GENETICS, V152, P1605	88	865	897	3	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2001	293	5532					1098	1102		10.1126/science.1062939	http://dx.doi.org/10.1126/science.1062939			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498581				2022-12-28	WOS:000170432600049
J	Liu, R; Liu, H; Chen, X; Kirby, M; Brown, PO; Zhao, KJ				Liu, R; Liu, H; Chen, X; Kirby, M; Brown, PO; Zhao, KJ			Regulation of CSF1 promoter by the SWI/SNF-like BAF complex	CELL			English	Article							RNA ADENOSINE-DEAMINASE; HANDED Z-DNA; FORMING SEQUENCES; NUCLEAR FACTOR-1; HUMAN GENOME; ZAB DOMAIN; CHROMATIN; TRANSCRIPTION; NUCLEOSOME; BINDING	The mammalian BAF complex regulates gene expression by modifying chromatin structure. In this report, we identify 80 genes activated and 2 genes repressed by the BAF complex in SW-13 cells. We find that prior binding of NFI/CTF to the NFI/CTF binding site in CSF1 promoter is required for the recruitment of the BAF complex and the BAF-dependent activation of the promoter. Furthermore, the activation of the CSF1 promoter requires Z-DNA-forming sequences that are converted to Z-DNA structure upon activation by the BAF complex. The BAF complex facilitates Z-DNA formation in a nucleosomal template in vitro. We propose a model in which the BAF complex promotes Z-DNA formation which, in turn, stabilizes the open chromatin structure at the CSF1 promoter.	NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Howard Hughes Medical Institute; Stanford University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Zhao, KJ (corresponding author), NHLBI, Lab Mol Immunol, NIH, Bldg 10, Bethesda, MD 20892 USA.							Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Cote J, 1995, METH MOL G, P108, DOI [10.1016/S1067-2389(06)80009-9, DOI 10.1016/S1067-2389(06)80009-9]; de la Serna IL, 2001, NAT GENET, V27, P187, DOI 10.1038/84826; DEVRIES E, 1987, EMBO J, V6, P161, DOI 10.1002/j.1460-2075.1987.tb04734.x; Di Croce L, 1999, MOL CELL, V4, P45, DOI 10.1016/S1097-2765(00)80186-0; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; Fry CJ, 2001, CURR BIOL, V11, pR185, DOI 10.1016/S0960-9822(01)00090-2; Fryer CJ, 1998, NATURE, V393, P88, DOI 10.1038/30032; Gao B, 1996, MOL CELL BIOL, V16, P5997; GARNER MM, 1987, J MOL BIOL, V196, P581, DOI 10.1016/0022-2836(87)90034-9; Gavin I, 2001, MOL CELL, V7, P97, DOI 10.1016/S1097-2765(01)00158-7; HAMADA H, 1982, NATURE, V298, P396, DOI 10.1038/298396a0; Havas K, 2000, CELL, V103, P1133, DOI 10.1016/S0092-8674(00)00215-4; Herbert A, 1999, GENETICA, V106, P37, DOI 10.1023/A:1003768526018; HERBERT A, 1995, P NATL ACAD SCI USA, V92, P7550, DOI 10.1073/pnas.92.16.7550; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Imbalzano AN, 1996, J BIOL CHEM, V271, P20726, DOI 10.1074/jbc.271.34.20726; IMBALZANO AN, 1994, NATURE, V370, P481, DOI 10.1038/370481a0; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Kadonaga JT, 1998, CELL, V92, P307, DOI 10.1016/S0092-8674(00)80924-1; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; KIM U, 1994, P NATL ACAD SCI USA, V91, P11457, DOI 10.1073/pnas.91.24.11457; Kim YG, 1999, J BIOL CHEM, V274, P19081, DOI 10.1074/jbc.274.27.19081; Kim YG, 2000, J BIOL CHEM, V275, P26828; Kingston RE, 1996, GENE DEV, V10, P905, DOI 10.1101/gad.10.8.905; Krebs JE, 1999, GENE DEV, V13, P1412, DOI 10.1101/gad.13.11.1412; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; Lorch Y, 1998, CELL, V94, P29, DOI 10.1016/S0092-8674(00)81218-0; Maas S, 2000, BIOESSAYS, V22, P790, DOI 10.1002/1521-1878(200009)22:9<790::AID-BIES4>3.0.CO;2-0; Muchardt C, 1999, J MOL BIOL, V293, P187, DOI 10.1006/jmbi.1999.2999; Peterson CL, 2000, CURR OPIN GENET DEV, V10, P187, DOI 10.1016/S0959-437X(00)00068-X; RAHMOUNI AR, 1989, SCIENCE, V246, P358, DOI 10.1126/science.2678475; RICH A, 1984, ANNU REV BIOCHEM, V53, P791, DOI 10.1146/annurev.bi.53.070184.004043; RUNKEL L, 1986, J MOL BIOL, V189, P487, DOI 10.1016/0022-2836(86)90319-0; Sawa H, 2000, MOL CELL, V6, P617, DOI 10.1016/S1097-2765(00)00060-5; Schnitzler G, 1998, CELL, V94, P17, DOI 10.1016/S0092-8674(00)81217-9; SCHROTH GP, 1992, J BIOL CHEM, V267, P11846; STANLEY ER, 1983, J CELL BIOCHEM, V21, P151, DOI 10.1002/jcb.240210206; Sudarsanam P, 2000, P NATL ACAD SCI USA, V97, P3364, DOI 10.1073/pnas.050407197; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; WANG AHJ, 1979, NATURE, V282, P680, DOI 10.1038/282680a0; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Whitehouse I, 1999, NATURE, V400, P784, DOI 10.1038/23506; WITTIG B, 1992, EMBO J, V11, P4653, DOI 10.1002/j.1460-2075.1992.tb05567.x; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	45	279	288	1	18	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 10	2001	106	3					309	318		10.1016/S0092-8674(01)00446-9	http://dx.doi.org/10.1016/S0092-8674(01)00446-9			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RJ	11509180	Bronze			2022-12-28	WOS:000170433300009
J	Miralda-Escude, J				Miralda-Escude, J			Cosmology - Probing matter at the lowest densities	SCIENCE			English	Editorial Material							IONIZED HELIUM; ALPHA FOREST; ABSORPTION		Ohio State Univ, Dept Astron, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Miralda-Escude, J (corresponding author), Ohio State Univ, Dept Astron, 174 W 18th Ave, Columbus, OH 43210 USA.	jordi@astronomy.ohio-state.edu	Miralda-Escudé, Jordi/HHN-5448-2022	Miralda-Escude, Jordi/0000-0002-2316-8370				Anderson SF, 1999, ASTRON J, V117, P56, DOI 10.1086/300698; BAHCALL JN, 1965, ASTROPHYS J, V142, P1677, DOI 10.1086/148460; Davidsen AF, 1996, NATURE, V380, P47, DOI 10.1038/380047a0; FARDAL MA, 1993, ASTROPHYS J, V415, P524, DOI 10.1086/173183; GUNN JE, 1965, ASTROPHYS J, V142, P1633, DOI 10.1086/148444; Heap SR, 2000, ASTROPHYS J, V534, P69, DOI 10.1086/308719; JAKOBSEN P, 1994, NATURE, V370, P35, DOI 10.1038/370035a0; Kriss GA, 2001, SCIENCE, V293, P1112, DOI 10.1126/science.1062693; LIN Z, 1993, ASTROPHYS J, V418, P28, DOI 10.1086/173367; Rauch M, 1998, ANNU REV ASTRON ASTR, V36, P267, DOI 10.1146/annurev.astro.36.1.267; Reimers D, 1997, ASTRON ASTROPHYS, V327, P890; ZUO L, 1992, MON NOT R ASTRON SOC, V258, P36, DOI 10.1093/mnras/258.1.36	12	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2001	293	5532					1055	1056		10.1126/science.1064216	http://dx.doi.org/10.1126/science.1064216			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498565				2022-12-28	WOS:000170432600033
J	Reik, W; Dean, W; Walter, J				Reik, W; Dean, W; Walter, J			Epigenetic reprogramming in mammalian development	SCIENCE			English	Review							H19 METHYLATION IMPRINT; EMBRYONIC GERM-CELLS; DE-NOVO METHYLATION; DNA METHYLATION; PREIMPLANTATION DEVELOPMENT; PATERNAL METHYLATION; CYTOSINE METHYLATION; MOUSE EMBRYO; CPG ISLAND; GENE	DNA methylation is a major epigenetic modification of the genome that regulates crucial aspects of its function. Genomic methylation patterns in somatic differentiated cells are generally stable and heritable. However, in mammals there are at least two developmental periods-in germ cells and in preimplantation embryos-in which methylation patterns are reprogrammed genome wide, generating cells with a broad developmental potential. Epigenetic reprogramming in germ cells is critical for imprinting; reprogramming in early embryos also affects imprinting. Reprogramming is Likely to have a crucial role in establishing nuclear totipotency in normal development and in cloned animals, and in the erasure of acquired epigenetic information. A role of reprogramming in stem cell differentiation is also envisaged.	Babraham Inst, Lab Dev Genet & Imprinting, Cambridge CB2 4AT, England; Univ Saarland, Fr Genet 8 2, D-66041 Saarbrucken, Germany	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Saarland University	Reik, W (corresponding author), Babraham Inst, Lab Dev Genet & Imprinting, Cambridge CB2 4AT, England.		Reik, Wolf/I-6794-2012	Reik, Wolf/0000-0003-0216-9881; Dean, Wendy/0000-0001-9441-5044				ALLEN ND, 1990, CELL, V61, P853, DOI 10.1016/0092-8674(90)90195-K; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Bhattacharya SK, 1999, NATURE, V397, P579, DOI 10.1038/17533; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; BRANDEIS M, 1993, EMBO J, V12, P3669, DOI 10.1002/j.1460-2075.1993.tb06041.x; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; Coffigny H, 1999, CYTOGENET CELL GENET, V87, P175, DOI 10.1159/000015460; Colman A, 1999, Cloning, V1, P185; Davis TL, 2000, HUM MOL GENET, V9, P2885, DOI 10.1093/hmg/9.19.2885; Dean W, 1998, DEVELOPMENT, V125, P2273; DEAN WL, COMMUNICATION; DUNCAN BK, 1980, NATURE, V287, P256; Eggan K, 2000, SCIENCE, V290, P1578, DOI 10.1126/science.290.5496.1578; El-Maarri O, 2001, NAT GENET, V27, P341, DOI 10.1038/85927; ENGLER P, 1991, CELL, V65, P939, DOI 10.1016/0092-8674(91)90546-B; Feil R, 1999, TRENDS GENET, V15, P431, DOI 10.1016/S0168-9525(99)01822-3; Ferguson-Smith AC, 2001, SCIENCE, V293, P1086, DOI 10.1126/science.1064020; Forne T, 1997, P NATL ACAD SCI USA, V94, P10243, DOI 10.1073/pnas.94.19.10243; Grossniklaus U, 2001, CURR OPIN PLANT BIOL, V4, P21, DOI 10.1016/S1369-5266(00)00130-8; HADCHOUEL M, 1987, NATURE, V329, P454, DOI 10.1038/329454a0; Hanel ML, 2001, MOL CELL BIOL, V21, P2384, DOI 10.1128/MCB.21.7.2384-2392.2001; Hendrich B, 1999, NATURE, V401, P301, DOI 10.1038/45843; HOLLIDAY R, 1975, SCIENCE, V187, P226, DOI 10.1126/science.1111098; Howell CY, 2001, CELL, V104, P829, DOI 10.1016/S0092-8674(01)00280-X; HOWLETT SK, 1991, DEVELOPMENT, V113, P119; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; JOST JP, COMMUNICATION; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; Kang YK, 2001, NAT GENET, V28, P173, DOI 10.1038/88903; Lane N.J., COMMUNICATION; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; MACLEOD D, 1994, GENE DEV, V8, P2282, DOI 10.1101/gad.8.19.2282; Macleod D, 1999, NAT GENET, V23, P139, DOI 10.1038/13767; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Mertineit C, 1998, DEVELOPMENT, V125, P889; MONK M, 1987, DEVELOPMENT, V99, P371; Moore T, 1997, P NATL ACAD SCI USA, V94, P12509, DOI 10.1073/pnas.94.23.12509; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; NEUMANN B, 1995, NAT GENET, V9, P12, DOI 10.1038/ng0195-12; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; Oakeley EJ, 1997, P NATL ACAD SCI USA, V94, P11721, DOI 10.1073/pnas.94.21.11721; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Olek A, 1997, NAT GENET, V17, P275, DOI 10.1038/ng1197-275; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Pickard B, 2001, MECH DEVELOP, V103, P35, DOI 10.1016/S0925-4773(01)00329-X; RAZIN A, 1980, SCIENCE, V210, P604, DOI 10.1126/science.6254144; REIK W, 1993, DEVELOPMENT, V119, P933; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Reik W, 2001, NAT GENET, V27, P255, DOI 10.1038/85804; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; RIGGS AD, 1975, CYTOGENET CELL GENET, V14, P9, DOI 10.1159/000130315; Robertson KD, 2000, NAT REV GENET, V1, P11, DOI 10.1038/35049533; ROMER I, 1997, CURR BIOL, V7, P277; Rougier N, 1998, GENE DEV, V12, P2108, DOI 10.1101/gad.12.14.2108; SANTOS F, COMMUNICATION; SAPIENZA C, 1989, DEVELOPMENT, V107, P165; Shibata H, 1998, GENOMICS, V49, P30, DOI 10.1006/geno.1998.5218; Siegfried Z, 1999, NAT GENET, V22, P203, DOI 10.1038/9727; SLEUTELS F, IN PRESS ADV GENET; Solter D, 2000, NAT REV GENET, V1, P199, DOI 10.1038/35042066; Stancheva I, 2000, GENE DEV, V14, P313; STANCHEVA I, COMMUNICATION; Surani MA, 1998, CELL, V93, P309, DOI 10.1016/S0092-8674(00)81156-3; Tada M, 1997, EMBO J, V16, P6510, DOI 10.1093/emboj/16.21.6510; Tada T, 1998, DEV GENES EVOL, V207, P551, DOI 10.1007/s004270050146; Thomassin H, 2001, EMBO J, V20, P1974, DOI 10.1093/emboj/20.8.1974; Tremblay KD, 1997, MOL CELL BIOL, V17, P4322, DOI 10.1128/MCB.17.8.4322; Ueda T, 2000, GENES CELLS, V5, P649, DOI 10.1046/j.1365-2443.2000.00351.x; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Walsh CP, 1999, GENE DEV, V13, P26, DOI 10.1101/gad.13.1.26; Warnecke PM, 1998, GENOMICS, V51, P182, DOI 10.1006/geno.1998.5371; Weber M, 2001, MECH DEVELOP, V101, P133, DOI 10.1016/S0925-4773(00)00573-6; Weiss A, 1996, CELL, V86, P709, DOI 10.1016/S0092-8674(00)80146-4; Wilmut I, 1998, REPROD FERT DEVELOP, V10, P639, DOI 10.1071/RD98047; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; YISRAELI J, 1986, CELL, V46, P409, DOI 10.1016/0092-8674(86)90661-6; Zhu B, 2001, P NATL ACAD SCI USA, V98, P5031, DOI 10.1073/pnas.091097298	82	2201	2365	11	475	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2001	293	5532					1089	1093		10.1126/science.1063443	http://dx.doi.org/10.1126/science.1063443			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498579				2022-12-28	WOS:000170432600047
J	Blisniuk, PM; Hacker, BR; Glodny, J; Ratschbacher, L; Bi, SW; Wu, ZH; McWilliams, MO; Calvert, A				Blisniuk, PM; Hacker, BR; Glodny, J; Ratschbacher, L; Bi, SW; Wu, ZH; McWilliams, MO; Calvert, A			Normal faulting in central Tibet since at least 13.5 Myr ago	NATURE			English	Article							EAST-WEST EXTENSION; SOUTHERN TIBET; ACTIVE TECTONICS; THAKKHOLA GRABEN; PLATEAU; DEFORMATION; MIOCENE; BENEATH; UPLIFT; CONVERGENCE	Tectonic models for the evolution of the Tibetan plateau interpret observed east-west thinning of the upper crust to be the result of either increased potential energy of elevated crust(1) or geodynamic processes that may be unrelated to plateau formation(2-6). A key piece of information needed to evaluate these models is the timing of deformation within the plateau. The onset of normal faulting has been estimated to have commenced in southern Tibet between about 14 Myr ago(7) and about 8 Myr ago(8) and, in central Tibet, about 4 Myr ago(9). Here, however, we report a minimum age of approximately 13.5 Myr for the onset of graben formation in central Tibet, based on mineralization ages determined with Rb-Sr and 40Ar-39Ar data that post-date a major graben-bounding normal fault. These data, along with evidence for prolonged activity of normal faulting in this and other Tibetan grabens, support models that relate normal faulting to processes occurring beneath the plateau. Thinning of the upper crust is most plausibly the result of potential-energy increases resulting from spatially and temporally heterogeneous changes in thermal structure and density distribution within the crust and upper mantle beneath Tibet. This is supported by recent geophysical and geological data(10-17), which indicate that spatial heterogeneity exists in both the Tibetan crust and lithospheric mantle.	Univ Potsdam, Inst Geowissensch, D-14415 Potsdam, Germany; Univ Calif Santa Barbara, Dept Geol Sci, Santa Barbara, CA 93106 USA; Geoforschungszentrum Potsdam, D-14473 Potsdam, Germany; Tech Univ Bergakad Freiberg, Inst Geol, D-09596 Freiberg, Germany; Chinese Acad Geol Sci, Inst Geomech, Beijing 100081, Peoples R China; Stanford Univ, Dept Geol & Environm Sci, Stanford, CA 94305 USA	University of Potsdam; University of California System; University of California Santa Barbara; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; Technical University Freiberg; Chinese Academy of Geological Sciences; Stanford University	Blisniuk, PM (corresponding author), Univ Potsdam, Inst Geowissensch, D-14415 Potsdam, Germany.	blisniuk@rz.uni-potsdam.de	Glodny, Johannes/P-7959-2017; McWilliams, Michael O/A-9548-2011	Glodny, Johannes/0000-0002-7812-5933; McWilliams, Michael O/0000-0002-4107-7069; Ratschbacher, Lothar/0000-0001-9960-2084				An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; ARMIJO R, 1989, J GEOPHYS RES-SOLID, V94, P2787, DOI 10.1029/JB094iB03p02787; COLEMAN M, 1995, NATURE, V374, P49, DOI 10.1038/374049a0; ENGLAND P, 1986, TECTONICS, V5, P1, DOI 10.1029/TC005i001p00001; ENGLAND P, 1989, J GEOPHYS RES-SOLID, V94, P17561, DOI 10.1029/JB094iB12p17561; Garzione CN, 2000, GEOLOGY, V28, P339, DOI 10.1130/0091-7613(2000)28<339:HTOTTP>2.0.CO;2; Hacker BR, 2000, SCIENCE, V287, P2463, DOI 10.1126/science.287.5462.2463; HARRISON TM, 1992, SCIENCE, V255, P1663, DOI 10.1126/science.255.5052.1663; HARRISON TM, 1995, TECTONICS, V14, P658, DOI 10.1029/95TC00608; HODGES KV, 1992, SCIENCE, V258, P1466, DOI 10.1126/science.258.5087.1466; Huang WC, 2000, J GEOPHYS RES-SOL EA, V105, P27979, DOI 10.1029/2000JB900339; Hurtado JM, 2001, GEOL SOC AM BULL, V113, P222, DOI 10.1130/0016-7606(2001)113<0222:NOTTGA>2.0.CO;2; KLOOTWIJK CT, 1985, EARTH PLANET SC LETT, V75, P167, DOI 10.1016/0012-821X(85)90099-8; Kosarev G, 1999, SCIENCE, V283, P1306, DOI 10.1126/science.283.5406.1306; Kroon D., 1991, Proceedings of the Ocean Drilling Program Scientific Results, V117, P257, DOI 10.2973/odp.proc.sr.117.126.1991; LOGATCHEV NA, 1987, TECTONOPHYSICS, V143, P225, DOI 10.1016/0040-1951(87)90092-8; McCaffrey R, 1998, GEOLOGY, V26, P691, DOI 10.1130/0091-7613(1998)026<0691:ROOCIT>2.3.CO;2; MOLNAR P, 1978, J GEOPHYS RES, V83, P5361, DOI 10.1029/JB083iB11p05361; MOLNAR P, 1989, GEOPHYS J INT, V99, P123, DOI 10.1111/j.1365-246X.1989.tb02020.x; Nelson KD, 1996, SCIENCE, V274, P1684, DOI 10.1126/science.274.5293.1684; Owens TJ, 1997, NATURE, V387, P37, DOI 10.1038/387037a0; QUADE J, 1989, NATURE, V342, P163, DOI 10.1038/342163a0; RATSCHBACHER L, 1994, J GEOPHYS RES-SOL EA, V99, P19917, DOI 10.1029/94JB00932; Rodgers AJ, 1998, J GEOPHYS RES-SOL EA, V103, P7137, DOI 10.1029/97JB03535; Wei WB, 2001, SCIENCE, V292, P716, DOI 10.1126/science.1010580; Williams H, 2001, GEOLOGY, V29, P339, DOI 10.1130/0091-7613(2001)029<0339:AACODI>2.0.CO;2; Yin A, 2000, ANNU REV EARTH PL SC, V28, P211, DOI 10.1146/annurev.earth.28.1.211; Yin A, 1999, GEOLOGY, V27, P787, DOI 10.1130/0091-7613(1999)027<0787:SLNEWE>2.3.CO;2; Zhang YQ, 1999, EPISODES, V22, P84; Zhao W, 2001, GEOPHYS J INT, V145, P486, DOI 10.1046/j.0956-540x.2001.01402.x	30	347	452	4	87	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 9	2001	412	6847					628	632		10.1038/35088045	http://dx.doi.org/10.1038/35088045			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460PP	11493918				2022-12-28	WOS:000170318000038
J	Gupta, S				Gupta, S			Avoiding ambiguity - Scientists sometimes use mathematics to give the illusion of certainty.	NATURE			English	Editorial Material									Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	Gupta, S (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.								0	6	6	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2001	412	6847					589	589		10.1038/35088152	http://dx.doi.org/10.1038/35088152			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460PP	11493898	Bronze			2022-12-28	WOS:000170318000020
J	Saurin, AJ; Shao, ZH; Erdjument-Bromage, H; Tempst, P; Kingston, RE				Saurin, AJ; Shao, ZH; Erdjument-Bromage, H; Tempst, P; Kingston, RE			A Drosophila Polycomb group complex includes Zeste and dTAFII proteins	NATURE			English	Article							HISTONE; CHROMATIN; BINDING; IDENTIFICATION; EXPRESSION; TRITHORAX; SITES; TAFS	A goal of modern biology is to identify the physical interactions that define 'functional modules'(1) of proteins that govern biological processes. One essential regulatory process is the maintenance of master regulatory genes, such as homeotic genes, in an appropriate 'on' or 'off' state for the lifetime of an organism. The Polycomb group (PcG) of genes maintain a repressed transcriptional state, and PcG proteins form large multiprotein complexes(2,3), but these complexes have not been described owing to inherent difficulties in purification. We previously fractionated a major PcG complex, PRC1, to 20-50% homogeneity from Drosophila embryos. Here, we identify 30 proteins in these preparations, then further fractionate the preparation and use western analyses to validate unanticipated connections. We show that the known PcG proteins Polycomb, Posterior sex combs, Polyhomeotic and dRING1 exist in robust association with the sequence-specific DNA-binding factor Zeste and with numerous TBP (TATA-binding-protein)-associated factors that are components of general transcription factor TFIID (dTAFIIs). Thus, in fly embryos, there is a direct physical connection between proteins that bind to specific regulatory sequences, PcG proteins, and proteins of the general transcription machinery.	Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Memorial Sloan Kettering Cancer Center	Kingston, RE (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	kingston@frodo.mgh.harvard.edu		Saurin, Andrew/0000-0001-5162-003X; Tempst, Paul/0000-0002-6680-3987; Erdjument-Bromage, Hediye/0000-0003-0224-3594				Albright SR, 2000, GENE, V242, P1, DOI 10.1016/S0378-1119(99)00495-3; BENSON M, 1988, EMBO J, V7, P3907, DOI 10.1002/j.1460-2075.1988.tb03277.x; DeRubertis F, 1996, NATURE, V384, P589; Erdjument-Bromage H, 1998, J CHROMATOGR A, V826, P167, DOI 10.1016/S0021-9673(98)00705-5; Fenyo D, 1998, ELECTROPHORESIS, V19, P998, DOI 10.1002/elps.1150190615; FRANKE A, 1992, EMBO J, V11, P2941, DOI 10.1002/j.1460-2075.1992.tb05364.x; Geromanos S, 2000, ANAL CHEM, V72, P777, DOI 10.1021/ac991071n; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hoffmann A, 1996, NATURE, V380, P356, DOI 10.1038/380356a0; Kal AJ, 2000, GENE DEV, V14, P1058; Kehle J, 1998, SCIENCE, V282, P1897, DOI 10.1126/science.282.5395.1897; Lessard J, 1998, BLOOD, V91, P1216, DOI 10.1182/blood.V91.4.1216; LOCKE J, 1988, GENETICS, V120, P181; MANN M, 1994, ANAL CHEM, V66, P4390, DOI 10.1021/ac00096a002; MANN M, 1993, BIOL MASS SPECTROM, V22, P338, DOI 10.1002/bms.1200220605; Mollaaghababa R, 2001, P NATL ACAD SCI USA, V98, P3958, DOI 10.1073/pnas.061497798; Nakatani Y, 1996, J BIOL CHEM, V271, P6575, DOI 10.1074/jbc.271.12.6575; Ng J, 2000, MOL CELL BIOL, V20, P3069, DOI 10.1128/MCB.20.9.3069-3078.2000; Orlando V, 1998, EMBO J, V17, P5141, DOI 10.1093/emboj/17.17.5141; Pennetta G, 1998, DEV GENES EVOL, V208, P531, DOI 10.1007/s004270050212; RASTELLI L, 1993, EMBO J, V12, P1513, DOI 10.1002/j.1460-2075.1993.tb05795.x; Satijn DPE, 1997, MOL CELL BIOL, V17, P4105, DOI 10.1128/MCB.17.7.4105; Schoen SW, 1997, BRAIN RES PROTOC, V1, P33, DOI 10.1016/S1385-299X(96)00006-2; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; SIMON J, 1995, CURR OPIN CELL BIOL, V7, P376, DOI 10.1016/0955-0674(95)80093-X; Tie F, 2001, DEVELOPMENT, V128, P275; Tsai CC, 1999, MOL CELL, V4, P175, DOI 10.1016/S1097-2765(00)80365-2; Tyler JK, 1996, MOL CELL BIOL, V16, P6149; Xie XL, 1996, NATURE, V380, P316, DOI 10.1038/380316a0	29	311	328	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 9	2001	412	6847					655	660		10.1038/35088096	http://dx.doi.org/10.1038/35088096			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460PP	11493925				2022-12-28	WOS:000170318000045
J	Tomioka, H; Iwamoto, E; Itakura, H; Hirai, K				Tomioka, H; Iwamoto, E; Itakura, H; Hirai, K			Generation and characterization of a fairly stable triplet carbene	NATURE			English	Article							TRIVALENT CARBON; SPECTROSCOPY	Most molecules are held together by covalent bonds-electron pairs jointly shared by the two atoms that are linked by the bond. Free radicals, in contrast, have at least one unpaired electron. In the case of carbon-based radicals, the carbon atom at the radical centre no longer makes four bonds with other atoms as it would do in its normal, tetravalent state. The presence of unpaired electrons renders such radicals highly reactive, so they normally occur only as transient intermediates during chemical reactions. But the discovery(1,2) by Gomberg in 1900 of triphenylmethyl, the first relatively stable free radical containing a central trivalent carbon atom, illustrated that radicals with suitable geometrical and electronic structures can be stable. Compounds containing a divalent carbon atom that uses only two of its four valence electrons for bonding are usually less stable than Gomberg-type radicals with trivalent carbon(3-5). Although the role of these so-called carbenes in chemical reactions has long been postulated, they were unambiguously identified only in the 1950s. More recently, stable carbenes have been prepared(6,7), but the singlet state of these molecules(6-12), with the two nonbonding valence electrons paired, means that they are not radicals. Carbenes in the second possible electronic state, the triplet state, are radicals: the two nonbonding electrons have parallel spins and occupy different orbitals(13,14). Here we report the preparation and characterization of a triplet carbene, whose half-life of 19 minutes at room temperature shows it to be significantly more stable than previously observed triplet carbenes(15-17).	Mie Univ, Fac Engn, Dept Chem Mat, Tsu, Mie 5148507, Japan	Mie University	Tomioka, H (corresponding author), Mie Univ, Fac Engn, Dept Chem Mat, Tsu, Mie 5148507, Japan.	tomioka@chem.mie-u.ac.jp						ARDUENGO AJ, 1991, J AM CHEM SOC, V113, P361, DOI 10.1021/ja00001a054; Arduengo AJ, 1999, ACCOUNTS CHEM RES, V32, P913, DOI 10.1021/ar980126p; ASTLES DJ, 1988, J ORG CHEM, V53, P6053, DOI 10.1021/jo00261a012; BANDON RW, 1962, J CHEM PHYS, V37, P1878; Bourissou D, 2000, CHEM REV, V100, P39, DOI 10.1021/cr940472u; CLOSS G, 1966, J CHEM PHYS, V44, P413, DOI 10.1063/1.1726482; DAGANI R, 1994, CHEM ENG NEWS, V72, P20, DOI 10.1021/cen-v072n018.p020; DOERING WV, 1954, J AM CHEM SOC, V76, P6162; GIBBONS WA, 1966, J AM CHEM SOC, V88, P172, DOI 10.1021/ja00953a037; Gomberg M, 1900, J AM CHEM SOC, V22, P757, DOI 10.1021/ja02049a006; Gomberg M, 1900, BER DTSCH CHEM GES, V33, P3150, DOI 10.1002/cber.19000330369; Heinemann C, 1996, J AM CHEM SOC, V118, P2023, DOI 10.1021/ja9523294; HINE J, 1950, J AM CHEM SOC, V72, P2438, DOI 10.1021/ja01162a024; Hirai K, 1999, J AM CHEM SOC, V121, P10213, DOI 10.1021/ja991387c; IGAU A, 1988, J AM CHEM SOC, V110, P6463, DOI 10.1021/ja00227a028; Itoh K, 1967, CHEM PHYS LETT, V1, P235, DOI 10.1016/0009-2614(67)85061-9; Iwamura H., 1990, ADV PHYS ORG CHEM, V26, P179, DOI DOI 10.1016/S0065-3160(08)60046-5; JONES M, 1975, CARBENES, V2, P159; KIRMSE W, 1971, CARBENE CHEMISTRY, P159; MORITANI I, 1966, TETRAHEDRON LETT, P373; MURRAY RW, 1962, J AM CHEM SOC, V84, P3213, DOI 10.1021/ja00875a054; REGITZ M, 1991, ANGEW CHEM INT EDIT, V30, P674, DOI 10.1002/anie.199106741; SANDER W, 1993, CHEM REV, V93, P1583, DOI 10.1021/cr00020a009; Staudinger H, 1912, BER DTSCH CHEM GES, V45, P501, DOI 10.1002/cber.19120450174; Takahashi Y, 2000, ANGEW CHEM INT EDIT, V39, P3478, DOI 10.1002/1521-3773(20001002)39:19<3478::AID-ANIE3478>3.0.CO;2-L; Tomioka H, 1997, ACCOUNTS CHEM RES, V30, P315, DOI 10.1021/ar9602157; Tomioka H, 1998, ADV CARBENE CHEM, P175; Tomioka H, 2000, ADV STR INT ORG MOL, V8, P83; WASSERMAN E, 1971, J AM CHEM SOC, V93, P6335, DOI 10.1021/ja00752a093	29	79	79	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 9	2001	412	6847					626	628		10.1038/35088038	http://dx.doi.org/10.1038/35088038			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460PP	11493917				2022-12-28	WOS:000170318000037
J	Zehr, JP; Waterbury, JB; Turner, PJ; Montoya, JP; Omoregie, E; Steward, GF; Hansen, A; Karl, DM				Zehr, JP; Waterbury, JB; Turner, PJ; Montoya, JP; Omoregie, E; Steward, GF; Hansen, A; Karl, DM			Unicellular cyanobacteria fix N-2 in the subtropical North Pacific Ocean	NATURE			English	Article							NITROGEN-FIXATION; ATLANTIC OCEAN; NIFH GENES; TRICHODESMIUM; SEA; MICROORGANISMS; PHYTOPLANKTON; VARIABILITY; EXPRESSION; STRAIN	Fixed nitrogen (N) often limits the growth of organisms in terrestrial and aquatic biomes(1,2), and N availability has been important in controlling the CO2 balance of modern and ancient oceans(3,4). The fixation of atmospheric dinitrogen gas (N-2) to ammonia is catalysed by nitrogenase and provides a fixed N for N-limited environments(2,5). The filamentous cyanobacterium Trichodesmium has been assumed to be the predominant oceanic N-2-fixing microorganism since the discovery of N-2 fixation in Trichodesmium in 1961 (ref. 6). Attention has recently focused on oceanic N-2 fixation because nitrogen availability is generally limiting in many oceans, and attempts to constrain the global atmosphere-ocean fluxes of CO2 are based on basin-scale N balances(7-9). Biogeochemical studies and models have suggested that total N-2-fixation rates may be substantially greater than previously believed(7,8) but cannot be reconciled with observed Trichodesmium abundances(8,9). It is curious that there are so few known N-2-fixing microorganisms in oligotrophic oceans when it is clearly ecologically advantageous. Here we show that there are unicellular cyanobacteria in the open ocean that are expressing nitrogenase, and are abundant enough to potentially have a significant role in N dynamics.	Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA; Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; Univ Hawaii, Sch Ocean & Earth Sci & Technol, Honolulu, HI 96822 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Woods Hole Oceanographic Institution; University System of Georgia; Georgia Institute of Technology; University of Hawaii System	Zehr, JP (corresponding author), Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA.		Zehr, Jonathan P/B-3513-2014; Karl, David/AFP-3837-2022; Montoya, Joseph/C-3115-2013; Steward, Grieg F./D-9768-2011	Zehr, Jonathan P/0000-0002-5691-5408; Montoya, Joseph/0000-0001-7197-4660; Steward, Grieg F./0000-0001-5988-0522; Karl, David/0000-0002-6660-6721; Omoregie, Enoma/0000-0002-7701-4182				Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; BRASS S, 1994, APPL ENVIRON MICROB, V60, P2575, DOI 10.1128/AEM.60.7.2575-2583.1994; Campbell L, 1997, DEEP-SEA RES PT I, V44, P167, DOI 10.1016/S0967-0637(96)00102-1; Chen YB, 1998, J BACTERIOL, V180, P3598, DOI 10.1128/JB.180.14.3598-3605.1998; DUGDALE RC, 1961, DEEP-SEA RES, V7, P298; Falkowski PG, 1997, NATURE, V387, P272, DOI 10.1038/387272a0; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; Haug GH, 1998, PALEOCEANOGRAPHY, V13, P427, DOI 10.1029/98PA01976; HAWSER SP, 1992, J APPL PHYCOL, V4, P79, DOI 10.1007/BF00003963; HOWARTH RW, 1988, LIMNOL OCEANOGR, V33, P688, DOI 10.4319/lo.1988.33.4_part_2.0688; Karl D, 1997, NATURE, V388, P533, DOI 10.1038/41474; Karl DM, 2000, TRENDS MICROBIOL, V8, P301, DOI 10.1016/S0966-842X(00)01774-1; Kolber ZS, 2000, NATURE, V407, P177, DOI 10.1038/35025044; Krieg NR, 1989, BERGEYS MANUAL SYSTE, V3, P1728; LETELIER RM, 1993, LIMNOL OCEANOGR, V38, P1420, DOI 10.4319/lo.1993.38.7.1420; Letelier RM, 1996, MAR ECOL PROG SER, V133, P263, DOI 10.3354/meps133263; Lin SJ, 1998, APPL ENVIRON MICROB, V64, P3052; Lipschultz F, 1996, BIOGEOCHEMISTRY, V35, P261, DOI 10.1007/BF02179830; Michaels AF, 1996, BIOGEOCHEMISTRY, V35, P181, DOI 10.1007/BF02179827; Neveux J, 1999, J GEOPHYS RES-OCEANS, V104, P3311, DOI 10.1029/98JC02000; PAERL HW, 1990, ADV MICROB ECOL, V11, P305; REDDY KJ, 1993, J BACTERIOL, V175, P1284, DOI 10.1128/JB.175.5.1284-1292.1993; VANDEPEER Y, 1994, COMPUT APPL BIOSCI, V10, P569; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Wasmund N, 2001, MAR ECOL PROG SER, V214, P1, DOI 10.3354/meps214001; Zani S, 2000, APPL ENVIRON MICROB, V66, P3119, DOI 10.1128/AEM.66.7.3119-3124.2000; Zehr JP, 1998, APPL ENVIRON MICROB, V64, P3444; Zehr JP, 2000, TRENDS MICROBIOL, V8, P68, DOI 10.1016/S0966-842X(99)01670-4	28	551	575	4	143	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2001	412	6847					635	638		10.1038/35088063	http://dx.doi.org/10.1038/35088063			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460PP	11493920				2022-12-28	WOS:000170318000040
J	Lee, PY; Alexander, KP; Hammill, BG; Pasquali, SK; Peterson, ED				Lee, PY; Alexander, KP; Hammill, BG; Pasquali, SK; Peterson, ED			Representation of elderly persons and women in published randomized trials of acute coronary syndromes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; THROMBOLYTIC THERAPY; CLINICAL-TRIALS; AGE; MORTALITY; OLDER	Context Elderly persons and women were underrepresented in randomized controlled trials (RCTs) prior to 1990. Since then, efforts have been made to correct these biases, but their effect is unclear. Objective To determine whether the percentage of elderly persons and women in published clinical trials of acute coronary syndromes has increased and how this enrollment compared with disease prevalence. Data Sources The MEDLINE and Cochrane databases were searched for English-language articles from January 1966 to March 2000 regarding myocardial infarction, unstable angina, or acute coronary syndromes. Additional data sources included meta-analyses, review articles, and cardiology textbooks. Estimates of community-based myocardial infarction rates came from the National Registry of Myocardial Infarction and the Worcester Heart Study. Study Selection Published RCTs of acute coronary syndrome patients were included and trials enrolling 50 patients or fewer, those without clinical end points, papers published in a language other than English, and unpublished manuscripts were excluded. Of 7645 studies identified, 593 RCTs were selected for review. Data Extraction The RCTs were abstracted by 2 of the authors for year of publication, source of support (ie, funding), pharmacotherapy, study phase, number of study sites, trial location, number of patients, mean age of the study population, and any age exclusion criteria for enrollment. Data Synthesis The number of published RCTs with explicit age exclusions has declined from 58% during 1966-1990 to 40% during 1991-2000. Trial enrollment of patients aged 75 years or older increased from 2% for studies published during 1966-1990 to 9% during 1991-2000, but remains well below their representation among all patients with myocardial infarction (37%) in the United States. Enrollment of women has risen from 20% for studies published between 1966-1990 to 25% during 1991-2000, but remains well below their proportion of all patients with myocardial infarction (43%) in the United States. Conclusions Attempts at making cardiovascular RCTs more inclusive appear to have had limited success; thus, women and elderly persons remain underrepresented in published trial literature relative to their disease prevalence. Because safety and efficacy can vary as a function of sex and age, these enrollment biases undermine efforts to provide evidence-based care to all cardiac patients.	Duke Univ, Med Ctr, Dept Med, Outcomes Res & Assessment Grp, Durham, NC 27710 USA; Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27710 USA	Duke University; Duke University	Peterson, ED (corresponding author), Duke Univ, Med Ctr, Dept Med, Outcomes Res & Assessment Grp, Box 3236, Durham, NC 27710 USA.		Peterson, Eric David/ABF-5033-2021		NIGMS NIH HHS [T35-GM-08679] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T35GM008679] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexander KP, 1998, J AM COLL CARDIOL, V32, P2023, DOI 10.1016/S0735-1097(98)00466-5; DOUGLAS PS, 1986, CIRCULATION, V74, P917, DOI 10.1161/01.CIR.74.5.917; Goldberg RJ, 1999, J AM COLL CARDIOL, V33, P1533, DOI 10.1016/S0735-1097(99)00040-6; Gurwitz JH, 1996, ANN INTERN MED, V124, P283, DOI 10.7326/0003-4819-124-3-199602010-00001; GURWITZ JH, 1992, JAMA-J AM MED ASSOC, V268, P1417, DOI 10.1001/jama.1992.03490110055029; Harris DJ, 2000, NEW ENGL J MED, V343, P475, DOI 10.1056/NEJM200008173430706; HEALY B, 1991, NEW ENGL J MED, V325, P274, DOI 10.1056/NEJM199107253250408; Hochman JS, 1999, NEW ENGL J MED, V341, P625, DOI 10.1056/NEJM199908263410901; Hutchins LF, 1999, NEW ENGL J MED, V341, P2061, DOI 10.1056/NEJM199912303412706; JECKER NS, 1991, JAMA-J AM MED ASSOC, V266, P3012, DOI 10.1001/jama.266.21.3012; KRUMHOLZ HM, 1995, CIRCULATION, V92, P2841, DOI 10.1161/01.CIR.92.10.2841; Krumholz HM, 1997, JAMA-J AM MED ASSOC, V277, P1683, DOI 10.1001/jama.277.21.1683; MACDONALD ET, 1982, DRUG TREATMENT ELDER, P217; National Institutes of Health, 1994, FED REGISTER, V59, P11146; *NIH, 1990, PUBL NIH; RICH MW, 1992, AM J MED, V92, P7, DOI 10.1016/0002-9343(92)90008-Y; Thiemann DR, 2000, CIRCULATION, V101, P2239, DOI 10.1161/01.CIR.101.19.2239; *US FDA, 1989, GUID STUD DRUGS LIK; Vaccarino V, 1999, NEW ENGL J MED, V341, P217, DOI 10.1056/NEJM199907223410401; VOGT TM, 1986, CONTROL CLIN TRIALS, V7, P118, DOI 10.1016/0197-2456(86)90028-0; [No title captured]	21	625	642	0	12	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2001	286	6					708	713		10.1001/jama.286.6.708	http://dx.doi.org/10.1001/jama.286.6.708			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459VE	11495621	Bronze			2022-12-28	WOS:000170271500027
J	Cole, BF; Gelber, RD; Gelber, S; Coates, AS; Goldhirsch, A				Cole, BF; Gelber, RD; Gelber, S; Coates, AS; Goldhirsch, A			Polychemotherapy for early breast cancer: an overview of the randomised clinical trials with quality-adjusted survival analysis	LANCET			English	Article							ADJUVANT CHEMOTHERAPY; METAANALYSIS	Background Overview analysis involving 18 000 women with breast cancer in 47 randomised trials showed that prolonged chemotherapy significantly reduces the risk of relapse and death compared with no chemotherapy. Here we express the size of the benefit in terms of quality-adjusted survival time gained. Methods We used the Q-TWIST method (Quality-adjusted Time Without Symptoms of disease and Toxicity of treatment) to provide treatment comparisons within 10 years' follow-up, incorporating differences in quality of life associated with times patients spend with chemotherapy toxic effects, after relapse, and without symptoms of relapse or toxicity. Findings Within 10 years' follow-up the benefit of increased relapse-free and overall survival for younger women (<50 years old) who received polychemotherapy balanced the burdens in terms of acute toxic side-effects, especially among women enrolled in trials that did not include tamoxifen. Overall, chemotherapy-treated younger women gained an average of 10.3 months of relapse-free survival and 5.4 months of overall survival within 10 years (p<0.0001 for both) compared with the no-chemotherapy group. Polychemotherapy provided more quality-adjusted time than control across nearly all values of utility weights for time spent undergoing chemotherapy and time after relapse. The range of benefit was from -0.6 to 10.3 months. For older women (50-69 years) overall, polychemotherapy also provided significant benefit compared with no chemotherapy but, compared with younger women, the size of benefit was less and the range of utility-weight values favouring polychemotherapy was smaller. Average gains for older women treated with polychemotherapy (with or without tamoxifen) were 6.8 months of relapse-free survival (p<0.0001) and 2.9 months of overall survival (p=0.0001) within 10 years. The range of quality-adjusted benefit was -3.1 to 6.8 months. For older women with oestrogen-receptor-poor tumours who did not receive tamoxifen (9% of the total), the benefit of polychemotherapy was significant and similar to that observed for younger women. Interpretation The benefits of adjuvant chemotherapy within 10 years outweigh the burdens especially for younger women (<50 years old) and among older women (50-69 years) to a lesser degree. Additional studies to compare the quality-adjusted survival of chemotherapy plus endocrine therapy versus endocrine therapy alone are required for younger patients with tumours that express steroid-hormone receptors.	Dartmouth Coll, Sch Med, Dartmouth Hitchcock Med Ctr, Lebanon, NH 03756 USA; Harvard Univ, Sch Publ Hlth, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Frontier Sci & Technol Res Fdn Inc, Boston, MA USA; Australian Canc Soc, Sydney, NSW, Australia; Univ Sydney, Sydney, NSW 2006, Australia; European Inst Oncol, Milan, Italy	Dartmouth College; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Frontier Science Foundation; University of Sydney; IRCCS European Institute of Oncology (IEO)	Cole, BF (corresponding author), Dartmouth Coll, Sch Med, Dartmouth Hitchcock Med Ctr, 7927 Rubin Bldg, Lebanon, NH 03756 USA.	bernard.cole@dartmouth.edu			NCI NIH HHS [CA-75362, CA-06516] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA006516] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABE O, 1992, LANCET, V339, P71; Abe O, 1998, LANCET, V352, P930; [Anonymous], 1992, Lancet, V339, P1; Clarke M, 1998, LANCET, V351, P1451; Coates AS, 1998, LANCET, V352, P1783, DOI 10.1016/S0140-6736(05)79861-5; COATES AS, 1992, INTRO NEW TREATMENTS; COLE BF, 1995, STAT MED, V14, P1771, DOI 10.1002/sim.4780141606; DAVIDSON N, 1999, P AN M AM SOC CLIN, V18, pA67; Gelber R D, 1995, Cancer J Sci Am, V1, P114; GELBER RD, 1991, ANN INTERN MED, V114, P621, DOI 10.7326/0003-4819-114-8-621; Gelber RD, 1996, LANCET, V347, P1066, DOI 10.1016/S0140-6736(96)90277-9; Gelber RD, 1998, RECENT RESULTS CANC, V152, P373; GELBER RD, 1992, MONOGR NATL CANC I, V11, P127; GELBER RD, 1995, QUALITY LIFE PHARMAC, P437; GLASZIOU PP, 1990, STAT MED, V9, P1259, DOI 10.1002/sim.4780091106; GOLDHIRSCH A, 1989, J CLIN ONCOL, V7, P36, DOI 10.1200/JCO.1989.7.1.36; GOLDHIRSCH A, 1995, ISRAEL J MED SCI, V31, P144; SIMES RJ, 1989, P AN M AM SOC CLIN, V8, P52; TANCINI G, 1983, J CLIN ONCOL, V1, P2, DOI 10.1200/JCO.1983.1.1.2; TORRANCE GW, 1987, J CHRON DIS, V40, P593, DOI 10.1016/0021-9681(87)90019-1; Weinstein MC, 1980, CLIN DECISION ANAL	21	99	102	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 28	2001	358	9278					277	286		10.1016/S0140-6736(01)05483-6	http://dx.doi.org/10.1016/S0140-6736(01)05483-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	457AF	11498214				2022-12-28	WOS:000170114400011
J	Lamas-Linares, A; Howell, JC; Bouwmeester, D				Lamas-Linares, A; Howell, JC; Bouwmeester, D			Stimulated emission of polarization-entangled photons	NATURE			English	Article							PARAMETRIC DOWN-CONVERSION; HORNE-ZEILINGER ENTANGLEMENT; QUANTUM CRYPTOGRAPHY; BELL INEQUALITIES; SQUEEZED STATES; VIOLATION; LIGHT; TELEPORTATION; INTERFERENCE; REALIZATION	Entangled photon pairs-discrete light quanta that exhibit nonclassical correlations-play a crucial role in quantum information science (for example, in demonstrations of quantum non-locality(1-7), quantum teleportation(8,9) and quantum cryptography (10-12,31)). At the macroscopic optical-field level non-classical correlations can also be important, as in the case of squeezed light(13), entangled light beams(14,15) and teleportation of continuous quantum variables(16). Here we use stimulated parametric down-conversion to study entangled states of light that bridge the gap between discrete and macroscopic optical quantum correlations. We demonstrate experimentally the onset of laser-like action for entangled photons, through the creation and amplification of the spin-1/2 and spin-1 singlet states consisting of two and four photons, respectively. This entanglement structure holds great promise in quantum information science where there is a strong demand for entangled states of increasing complexity.	Univ Oxford, Clarendon Lab, Ctr Quantum Computat, Oxford OX1 3PU, England	University of Oxford	Lamas-Linares, A (corresponding author), Univ Oxford, Clarendon Lab, Ctr Quantum Computat, Parks Rd, Oxford OX1 3PU, England.	a.lamas@qubit.org						ASPECT A, 1982, PHYS REV LETT, V49, P1804, DOI 10.1103/PhysRevLett.49.1804; Atature M, 1999, PHYS REV LETT, V83, P1323, DOI 10.1103/PhysRevLett.83.1323; Boschi D, 1998, PHYS REV LETT, V80, P1121, DOI 10.1103/PhysRevLett.80.1121; Bouwmeester D, 1997, NATURE, V390, P575, DOI 10.1038/37539; Bouwmeester D, 1999, PHYS REV LETT, V82, P1345, DOI 10.1103/PhysRevLett.82.1345; CLAUSER JF, 1978, REP PROG PHYS, V41, P1881, DOI 10.1088/0034-4885/41/12/002; Cregan RF, 1999, SCIENCE, V285, P1537, DOI 10.1126/science.285.5433.1537; De Martini F, 2001, Z NATURFORSCH A, V56, P61; De Martini F, 2000, OPT COMMUN, V179, P581, DOI 10.1016/S0030-4018(00)00611-8; EKERT AK, 1992, PHYS REV LETT, V69, P1293, DOI 10.1103/PhysRevLett.69.1293; Furusawa A, 1998, SCIENCE, V282, P706, DOI 10.1126/science.282.5389.706; HERZOG TJ, 1994, PHYS REV LETT, V72, P629, DOI 10.1103/PhysRevLett.72.629; Jennewein T, 2000, PHYS REV LETT, V84, P4729, DOI 10.1103/PhysRevLett.84.4729; Kim JS, 1999, APPL PHYS LETT, V74, P902, DOI 10.1063/1.123404; Knill E, 2001, NATURE, V409, P46, DOI 10.1038/35051009; Kok P, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.042304; KWIAT PG, 1995, PHYS REV LETT, V75, P4337, DOI 10.1103/PhysRevLett.75.4337; Milonni PW, 1996, PHYS REV A, V53, P4556, DOI 10.1103/PhysRevA.53.4556; Naik DS, 2000, PHYS REV LETT, V84, P4733, DOI 10.1103/PhysRevLett.84.4733; OU ZY, 1992, PHYS REV LETT, V68, P3663, DOI 10.1103/PhysRevLett.68.3663; OU ZY, 1988, PHYS REV LETT, V61, P50, DOI 10.1103/PhysRevLett.61.50; Ou ZY, 1999, PHYS REV LETT, V83, P959, DOI 10.1103/PhysRevLett.83.959; SHIH YH, 1988, PHYS REV LETT, V61, P2921, DOI 10.1103/PhysRevLett.61.2921; Simon C, 2000, PHYS REV LETT, V84, P2993, DOI 10.1103/PhysRevLett.84.2993; SLUSHER RE, 1985, PHYS REV LETT, V55, P2409, DOI 10.1103/PhysRevLett.55.2409; Tittel W, 2000, PHYS REV LETT, V84, P4737, DOI 10.1103/PhysRevLett.84.4737; Tittel W, 1998, PHYS REV LETT, V81, P3563, DOI 10.1103/PhysRevLett.81.3563; Weihs G, 1998, PHYS REV LETT, V81, P5039, DOI 10.1103/PhysRevLett.81.5039; WEINFURTER H, 2001, QUANTPH0103049; WU LA, 1986, PHYS REV LETT, V57, P2520, DOI 10.1103/PhysRevLett.57.2520	31	196	200	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2001	412	6850					887	890		10.1038/35091014	http://dx.doi.org/10.1038/35091014			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467EG	11528472	Green Submitted			2022-12-28	WOS:000170689000038
J	Jeruzalmi, D; Yurieva, O; Zhao, YX; Young, M; Stewart, J; Hingorani, M; O'Donnell, M; Kuriyan, J				Jeruzalmi, D; Yurieva, O; Zhao, YX; Young, M; Stewart, J; Hingorani, M; O'Donnell, M; Kuriyan, J			Mechanism of processivity clamp opening by the delta subunit wrench of the clamp loader complex of E-coli DNA polymerase III	CELL			English	Article							CELL NUCLEAR ANTIGEN; C-TERMINAL REGION; CRYSTAL-STRUCTURE; SLIDING CLAMP; ACCESSORY PROTEINS; BETA-CLAMP; HOLOENZYME; PEPTIDE; BINDING; DOMAIN	The dimeric ring-shaped sliding clamp of E. coli DNA polymerase III (beta subunit, homolog of eukaryotic PCNA) is loaded onto DNA by the clamp loader gamma complex (homolog of eukaryotic Replication Factor C, RFC). The delta subunit of the gamma complex binds to the beta ring and opens it. The crystal structure of a beta:delta complex shows that delta, which is structurally related to the delta' and gamma subunits of the gamma complex, is a molecular wrench that induces or traps a conformational change in beta such that one of its dimer interfaces is destabilized. Structural comparisons and molecular dynamics simulations suggest a spring-loaded mechanism in which the beta ring opens spontaneously once a dimer interface is perturbed by the delta wrench.	Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Kuriyan, J (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10021 USA.	kuriyan@rockefeller.edu	Young, Matthew/D-2033-2011; Young, Matthew/AAE-2632-2020	Young, Matthew/0000-0003-2921-3432; Young, Matthew/0000-0003-2921-3432; Zhao, Yanxiang/0000-0002-9408-9979; O'Donnell, Michael/0000-0001-9002-4214	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038839, R01GM045547] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM-45547, R01 GM-38839] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alley SC, 2000, BIOCHEMISTRY-US, V39, P3076, DOI 10.1021/bi992377r; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; CULLMANN G, 1995, MOL CELL BIOL, V15, P4661; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DONG ZM, 1993, J BIOL CHEM, V268, P11758; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FLORESROZAS H, 1994, P NATL ACAD SCI USA, V91, P8655, DOI 10.1073/pnas.91.18.8655; Guenther B, 1997, CELL, V91, P335, DOI 10.1016/S0092-8674(00)80417-1; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Hingorani MM, 2000, CURR BIOL, V10, pR25, DOI 10.1016/S0960-9822(99)00252-3; Hingorani MM, 1998, J BIOL CHEM, V273, P24550, DOI 10.1074/jbc.273.38.24550; HUANG CC, 1981, J BIOL CHEM, V256, P4087; JORGENSEN WL, 1981, J AM CHEM SOC, V103, P335, DOI 10.1021/ja00392a016; Kelman Z, 2000, J BIOL CHEM, V275, P7327, DOI 10.1074/jbc.275.10.7327; KELMAN Z, 1995, ANNU REV BIOCHEM, V64, P171, DOI 10.1146/annurev.bi.64.070195.001131; Kleywegt GJ, 1997, STRUCTURE, V5, P1557, DOI 10.1016/S0969-2126(97)00305-5; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P829, DOI 10.1107/S0907444996001783; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; Kornberg A., 1991, DNA REPLICATION; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; Leu FP, 2000, J BIOL CHEM, V275, P34609, DOI 10.1074/jbc.M005495200; Matsumiya S, 2001, PROTEIN SCI, V10, P17, DOI 10.1110/ps.36401; May AP, 2001, J BIOL CHEM, V276, P21991, DOI 10.1074/jbc.R100013200; MIRANKER A, 1991, NATURE, V349, P633, DOI 10.1038/349633a0; Moarefi I, 2000, J MOL BIOL, V296, P1215, DOI 10.1006/jmbi.1999.3511; NAKANISHI M, 1995, J BIOL CHEM, V270, P17060, DOI 10.1074/jbc.270.29.17060; NAKTINIS V, 1995, J BIOL CHEM, V270, P13358, DOI 10.1074/jbc.270.22.13358; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Neuwald AF, 1999, GENOME RES, V9, P27; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; ODONNELL M, 1993, NUCLEIC ACIDS RES, V21, P1, DOI 10.1093/nar/21.1.1; ONRUST R, 1991, J BIOL CHEM, V266, P21681; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PEARLMAN DA, 1995, AMBER 4 1; Shamoo Y, 1999, CELL, V99, P155, DOI 10.1016/S0092-8674(00)81647-5; Stewart J, 2001, J BIOL CHEM, V276, P19182, DOI 10.1074/jbc.M100592200; STILLMAN B, 1994, CELL, V78, P725, DOI 10.1016/S0092-8674(94)90362-X; STUKENBERG PT, 1991, J BIOL CHEM, V266, P11328; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Turner J, 1999, EMBO J, V18, P771, DOI 10.1093/emboj/18.3.771; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; WARBRICK E, 1995, CURR BIOL, V5, P275, DOI 10.1016/S0960-9822(95)00058-3; Yao N, 1996, GENES CELLS, V1, P101, DOI 10.1046/j.1365-2443.1996.07007.x; YOUNG MC, 1992, BIOCHEMISTRY-US, V31, P8675, DOI 10.1021/bi00152a001; Yu RC, 1998, NAT STRUCT BIOL, V5, P803, DOI 10.1038/1843	49	203	211	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 24	2001	106	4					417	428		10.1016/S0092-8674(01)00462-7	http://dx.doi.org/10.1016/S0092-8674(01)00462-7			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	466UU	11525728	Bronze			2022-12-28	WOS:000170665200006
J	Blatt, R				Blatt, R			Delicate information	NATURE			English	Article									Univ Innsbruck, Inst Expt Phys, A-6020 Innsbruck, Austria	University of Innsbruck	Blatt, R (corresponding author), Univ Innsbruck, Inst Expt Phys, Technikerstr 25, A-6020 Innsbruck, Austria.		Blatt, Rainer/H-9527-2014					Bennett CH, 2000, NATURE, V404, P247, DOI 10.1038/35005001; Steane A, 1998, REP PROG PHYS, V61, P117, DOI 10.1088/0034-4885/61/2/002; [No title captured]	3	4	4	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2001	412	6849					773	773		10.1038/35090662	http://dx.doi.org/10.1038/35090662			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465ET	11518945	Bronze			2022-12-28	WOS:000170577200019
J	Rupprecht, CE; Blass, L; Smith, K; Orciari, LA; Niezgoda, M; Whitfield, SG; Gibbons, RV; Guerra, M; Hanlon, CA				Rupprecht, CE; Blass, L; Smith, K; Orciari, LA; Niezgoda, M; Whitfield, SG; Gibbons, RV; Guerra, M; Hanlon, CA			Brief report: Human infection due to recombinant vaccinia-rabies glycoprotein virus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VACCINATION; GENE		Ctr Dis Control & Prevent, Rabies Sect, Atlanta, GA 30333 USA; Trumbull Mem Hosp, Warren, OH USA; Ohio Dept Hlth, Columbus, OH 43266 USA	Centers for Disease Control & Prevention - USA	Rupprecht, CE (corresponding author), Ctr Dis Control & Prevent, Rabies Sect, Mailstop G-33,1600 Clifton Rd NE, Atlanta, GA 30333 USA.		Rupprecht, Charles/AAI-1544-2020					ANILIONIS A, 1982, COMP IMMUNOL MICROB, V5, P27, DOI 10.1016/0147-9571(82)90011-X; BAER GM, 1988, REV INFECT DIS, V10, pS644; BALE SJ, 1993, SEMIN DERMATOL, V12, P202; BEHBEHANI AM, 1995, DIAGNOSTIC PROCEDURE, P511; Fearneyhough MG, 1998, J AM VET MED ASSOC, V212, P498; FENNER F, 1988, SMALLPOX ITS ERADICA, P149; Hanlon CA, 1997, VACCINE, V15, P140, DOI 10.1016/S0264-410X(96)00163-6; Hanlon CA, 1998, J WILDLIFE DIS, V34, P228, DOI 10.7589/0090-3558-34.2.228; Hanlon CA, 1998, EMERG INFECT DIS, P59, DOI DOI 10.1128/9781555816940.CH5; HRUBY DE, 1983, P NATL ACAD SCI-BIOL, V80, P3411, DOI 10.1073/pnas.80.11.3411; *IMM PRACT ADV COM, 1992, MMWR-MORBID MORTAL W, V41, P31; Immunization Practices Advisory Committee, 1991, MMWR-MORBID MORTAL W, V40, P1; KIENY MP, 1984, NATURE, V312, P163, DOI 10.1038/312163a0; McGuill MW, 1998, J AM VET MED ASSOC, V213, P1413; Meslin F X, 1994, Curr Top Microbiol Immunol, V187, P1; MOLLENHAUER HH, 1964, STAIN TECHNOL, V39, P111; PASTORET PP, 1988, VET REC, V123, P481, DOI 10.1136/vr.123.19.481; Smith J.S., 1991, P235; THOMAS I, 1990, J GEN VIROL, V71, P37, DOI 10.1099/0022-1317-71-1-37; WIKTOR TJ, 1984, P NATL ACAD SCI-BIOL, V81, P7194, DOI 10.1073/pnas.81.22.7194; 2000, MMWR MORB MORTAL WKL, V49, P31	21	125	139	0	3	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 23	2001	345	8					582	586		10.1056/NEJMoa010560	http://dx.doi.org/10.1056/NEJMoa010560			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464ZH	11529212				2022-12-28	WOS:000170562900005
J	Hart, A				Hart, A			Mann-Whitney test is not just a test of medians: differences in spread can be important	BRITISH MEDICAL JOURNAL			English	Article							INFLAMMATORY-BOWEL-DISEASE; ACCESS FOLLOW-UP; RANDOMIZED TRIAL				Hart, A (corresponding author), Univ Cent Lancashire, Fac Sci, Stat Grp, Preston PR1 2HE, Lancs, England.							Altman D.G., 1991, PRACTICAL STAT MED R; Barber JA, 2000, BRIT MED J, V320, P1730, DOI 10.1136/bmj.320.7251.1730; Carley SD, 2000, BMJ-BRIT MED J, V321, P20, DOI 10.1136/bmj.321.7252.20; Grande GE, 1999, BRIT MED J, V319, P1472, DOI 10.1136/bmj.319.7223.1472; Lux AL, 2000, BRIT MED J, V320, P1182, DOI 10.1136/bmj.320.7243.1182; MACLEOD U, 2000, BRIT MED J, V320, P142; Sprent P., 1998, DATA DRIVEN STAT MET; Thompson SG, 2000, BRIT MED J, V320, P1197, DOI 10.1136/bmj.320.7243.1197; Williams JG, 2000, BRIT MED J, V320, P544, DOI 10.1136/bmj.320.7234.544	9	203	208	1	11	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 18	2001	323	7309					391	393		10.1136/bmj.323.7309.391	http://dx.doi.org/10.1136/bmj.323.7309.391			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465GN	11509435	Green Published			2022-12-28	WOS:000170581400031
J	Betran, AP; de Onis, M; Lauer, JA; Villar, J				Betran, AP; de Onis, M; Lauer, JA; Villar, J			Ecological study of effect of breast feeding on infant mortality in Latin America	BMJ-BRITISH MEDICAL JOURNAL			English	Article							POTENTIAL INTERVENTIONS; DEVELOPING-COUNTRIES; CHILDHOOD PNEUMONIA; PROMOTION PROGRAM; DIARRHEAL; DISEASES; CHILDREN; RISK; PREVENTION	Objective To estimate the effect of exclusive breast feeding and partial breast feeding on infant mortality from diarrhoeal disease and acute respiratory infections in Latin America. Design Attributable fraction analysis of national data on infant mortality arid breast feeding. Setting Latin America and the Caribbean. Main outcome measures Mortality from diarrhoeal disease and acute respiratory infections and nationally representative breastfeeding rates. Results 55% of infant deaths from diarrhoeal disease and acute respiratory infections in Latin America are preventable by exclusive breast feeding among infants aged 0-3 months and partial breast feeding throughout the remainder of infancy. Among infants aged 0-3 months, 66% of deaths from these causes are preventable by exclusive breast feeding; among infants aged 4-11 months, 32% of such deaths are preventable by partial breast feeding. 13.9% of infant deaths from all causes are preventable by these breastfeeding patterns. The annual number of preventable deaths is about 52 000 for the region. Conclusions Exclusive breastfeeding of infants aged 0-3 months and partial breastfeeding throughout the remainder of infancy could substantially reduce infant mortality in Latin America. Interventions to promote breast feeding should target younger infants.	WHO, Reprod Hlth & Res, CH-1211 Geneva, Switzerland; WHO, Dept Nutr Hlth & Dev, CH-1211 Geneva, Switzerland; WHO, Global Programme Evidence Hlth Policy, CH-1211 Geneva, Switzerland; Univ Zaragoza, Fac Med, Dept Prevent Med & Publ Hlth, Zaragoza, Spain	World Health Organization; World Health Organization; World Health Organization; University of Zaragoza	Betran, AP (corresponding author), WHO, Reprod Hlth & Res, CH-1211 Geneva, Switzerland.	betrana@who.int	Betrán, Ana Pilar/G-2023-2010	Lauer, Jeremy A/0000-0003-0652-0691				Albernaz E, 1998, J Hum Lact, V14, P283, DOI 10.1177/089033449801400402; Amador Manuel, 1992, Food and Nutrition Bulletin, V14, P101; BARROS FC, 1986, PEDIATRICS, V78, P656; BROWN KH, 1989, PEDIATRICS, V83, P31; Carnes BA, 1996, POPUL DEV REV, V22, P231, DOI 10.2307/2137434; Castillo C, 1996, Bull Pan Am Health Organ, V30, P125; COLE P, 1971, BRIT J PREV SOC MED, V25, P242; FEACHEM RG, 1984, B WORLD HEALTH ORGAN, V62, P271; Garenne Michel, 1992, World Health Statistics Quarterly, V45, P180; Golding J, 1997, EARLY HUM DEV, V49, pS143, DOI 10.1016/S0378-3782(97)00060-1; Heligman L., 1980, J I ACTUARIES, V107, P49, DOI DOI 10.1017/S0020268100040257; HUFFMAN S, 1991, BREASTFEEDING SAVES; Kirkwood BR, 1995, B WORLD HEALTH ORGAN, V73, P793; Lopez A., 2000, 9 WHO GPE; MARTINES JC, 1994, J NUTR, V124, P1189, DOI 10.1093/jn/124.8.1189; Monteiro C., 1990, Health Policy and Planning, V5, P23, DOI 10.1093/heapol/5.1.23; Murray C., 1996, GLOBAL BURDEN DIS IN, V2; OUELLET BL, 1979, AM J EPIDEMIOL, V109, P451, DOI 10.1093/oxfordjournals.aje.a112703; *POP COUNC, 1990, STUD FAMILY PLANN, V21, P181; POPKIN BM, 1991, J BIOSOC SCI, V23, P5, DOI 10.1017/S0021932000019027; PUFFER RR, 1973, PATTERNS MORTALITY C; SACHDEV HPS, 1991, J PEDIATR GASTR NUTR, V12, P76, DOI 10.1097/00005176-199101000-00016; United Nations, 1995, WORLD POP PROSP; VALDES V, 1993, J TROP PEDIATRICS, V39, P142, DOI 10.1093/tropej/39.3.142; Victora Cesar G., 1996, Food and Nutrition Bulletin, V17, P390; Victora CG, 2000, LANCET, V355, P451, DOI 10.1016/S0140-6736(00)82011-5; VICTORA CG, 1992, ACTA PAEDIATR, V81, P7, DOI 10.1111/j.1651-2227.1992.tb12364.x; VICTORA CG, 1987, LANCET, V2, P319; Victora CG, 1999, AM J CLIN NUTR, V70, P309; VILLAR J, 1981, LANCET, V2, P621; WHO, 1996, WHONUT961; WHO UNICEF, 1989, PROT PROM SUPP BREAS; Yoon PW, 1996, AM J EPIDEMIOL, V143, P1142, DOI 10.1093/oxfordjournals.aje.a008692	33	69	80	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 11	2001	323	7308					303	306		10.1136/bmj.323.7308.303	http://dx.doi.org/10.1136/bmj.323.7308.303			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463HK	11498485	Green Published, Bronze			2022-12-28	WOS:000170470900016
J	Noda, S; Yokoyama, M; Imada, M; Chutinan, A; Mochizuki, M				Noda, S; Yokoyama, M; Imada, M; Chutinan, A; Mochizuki, M			Polarization mode control of two-dimensional photonic crystal laser by unit cell structure design	SCIENCE			English	Article							DEFECT	We demonstrate polarization mode selection in a two-dimensional (2D) photonic crystal laser by controlling the geometry of the unit cell structure. As the band diagram of the square-lattice photonic crystal is influenced by the unit cell structure, calculations reveal that changing the structure from a circular to an elliptical geometry should result in a strong modification of the electromagnetic field distributions at the band edges. Such a structural modification is expected to provide a mechanism for controlling the polarization modes of the emitted light. A square-lattice photonic crystal with the elliptical unit cell structure has been fabricated and integrated with a gain media. The observed coherent 2D lasing action with a single wavelength and controlled polarization is in good agreement with the predicted behavior.	Kyoto Univ, Dept Elect Sci & Engn, Sakyo Ku, Kyoto 6068501, Japan; Minolta Ltd, Res & Dev Headquarters, Osaka 5698503, Japan; JST, CREST, Kyoto 6068501, Japan	Kyoto University; Konica Minolta Inc.; Japan Science & Technology Agency (JST)	Noda, S (corresponding author), Kyoto Univ, Dept Elect Sci & Engn, Sakyo Ku, Yoshida Honmachi, Kyoto 6068501, Japan.	snoda@kuee.kyoto-u.ac.jp						Imada M, 1999, APPL PHYS LETT, V75, P316, DOI 10.1063/1.124361; IMADA M, UNPUB PHYS REV B; Joannopoulos JD, 1997, NATURE, V386, P143, DOI 10.1038/386143a0; JOHN S, 1991, PHYS TODAY, V44, P32, DOI 10.1063/1.881300; Meier M, 1999, APPL PHYS LETT, V74, P7, DOI 10.1063/1.123116; Noda S, 2000, NATURE, V407, P608, DOI 10.1038/35036532; Noda S, 2000, SCIENCE, V289, P604, DOI 10.1126/science.289.5479.604; Painter O, 1999, SCIENCE, V284, P1819, DOI 10.1126/science.284.5421.1819; UCHIYAMA S, 1986, IEEE J QUANTUM ELECT, V22, P302, DOI 10.1109/JQE.1986.1072955; Vats N, 1998, PHYS REV A, V58, P4168, DOI 10.1103/PhysRevA.58.4168; WU CM, 1992, IEEE PHOTONIC TECH L, V4, P960, DOI 10.1109/68.157115; YABLONOVITCH E, 1993, J OPT SOC AM B, V10, P283, DOI 10.1364/JOSAB.10.000283; YOKOYAMA M, UNPUB	13	516	551	8	151	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2001	293	5532					1123	1125		10.1126/science.1061738	http://dx.doi.org/10.1126/science.1061738			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498586				2022-12-28	WOS:000170432600055
J	Albrecht, MA; Bosch, RJ; Hammer, SM; Liou, SH; Kessler, H; Para, MF; Eron, J; Valdez, H; Dehlinger, M; Katzenstein, DA				Albrecht, MA; Bosch, RJ; Hammer, SM; Liou, SH; Kessler, H; Para, MF; Eron, J; Valdez, H; Dehlinger, M; Katzenstein, DA		AIDS Clin Trials Grp 364 Study Team	Nelfinavir, efavirenz, or both after the failure of nucleoside treatment of HIV infection.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMMUNODEFICIENCY-VIRUS INFECTION; PRIOR ANTIRETROVIRAL THERAPY; CD4 CELL COUNTS; COMBINATION THERAPY; CUBIC MILLIMETER; CONTROLLED TRIAL; DRUG-RESISTANCE; PLUS INDINAVIR; LAMIVUDINE; ZIDOVUDINE	Background: The optimal antiretroviral treatment for patients who have human immunodeficiency virus (HIV) viremia despite treatment with nucleoside reverse-transcriptase inhibitors (nucleoside analogues) remains uncertain. We studied treatment with regimens that combined two nucleoside analogues, at least one of which was new, with the protease inhibitor nelfinavir, the nonnucleoside reverse-transcriptase inhibitor efavirenz, or both. Methods: The study included 195 patients who had been treated with nucleoside analogues only, and had a plasma HIV type 1 (HIV-1) RNA level of at least 500 copies per milliliter. Patients were randomly assigned to receive, in addition to two nucleoside analogues, nelfinavir, efavirenz, or nelfinavir plus efavirenz. The primary end point was a plasma HIV-1 RNA level of less than 500 copies per milliliter at week 16. A secondary end point was the composite of the HIV-1 RNA levels measured at weeks 40 and 48. Results: At week 16 and at weeks 40 and 48, the proportions of patients in whom a plasma HIV-1 RNA level of less than 500 copies per milliliter was achieved were, respectively, 81 percent and 74 percent in the nelfinavir-plus-efavirenz group, 69 percent and 60 percent in the efavirenz group, and 64 percent and 35 percent in the nelfinavir group. Quadruple therapy resulted in a higher rate of viral suppression in both the short term (P=0.03) and the long term (P=0.001) than did triple therapy with nelfinavir. Triple therapy with efavirenz conferred a higher rate of long-term suppression than triple therapy with nelfinavir (P=0.004). Quadruple therapy also achieved a higher rate of virologic suppression than triple therapy with efavirenz (P=0.008). Conclusions: In HIV-infected patients previously treated with nucleoside analogues, treatment with nelfinavir plus efavirenz and at least one new nucleoside analogue achieves a higher rate of viral suppression than do regimens with nucleoside analogues and nelfinavir or efavirenz alone. (N Engl J Med 2001;345:398-407. Copyright (C) 2001 Massachusetts Medical Society.	Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Columbia Univ, Coll Phys & Surg, New York, NY USA; Rush Med Coll, Chicago, IL 60612 USA; Ohio State Univ, Coll Med & Publ Hlth, Columbus, OH 43210 USA; Univ N Carolina, Chapel Hill, NC USA; Case Western Reserve Univ, Sch Med, Cleveland, OH USA; NIAID, HIV Res Branch, Div AIDS, Bethesda, MD 20892 USA; Stanford Univ, Med Ctr, Stanford, CA 94305 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Columbia University; Rush University; University System of Ohio; Ohio State University; University of North Carolina; University of North Carolina Chapel Hill; Case Western Reserve University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Stanford University	Albrecht, MA (corresponding author), Beth Israel Deaconess Med Ctr, Div Infect Dis, 1 Deaconess Rd,Kennedy 6, Boston, MA 02215 USA.			katzenstein, david/0000-0002-8593-4560	NIAID NIH HHS [AI-27664, AI-25924] Funding Source: Medline; PHS HHS [U01 A127659] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI025924, U01AI027664] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Albrecht MA, 2000, AIDS RES HUM RETROV, V16, P1337, DOI 10.1089/08892220050140883; Carpenter CCJ, 1998, JAMA-J AM MED ASSOC, V280, P78, DOI 10.1001/jama.280.1.78; DeGruttola V, 2000, ANTIVIR THER, V5, P41; *DIV AIDS, 1996, DIV AIDS TABL GRAD S; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; HAAS DW, 1998, 38 INT C ANT AG CHEM, P441; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Hammer SM, 1996, NEW ENGL J MED, V335, P1081, DOI 10.1056/NEJM199610103351501; HAMMOND J, 1999, HUMAN RETROVIRUSES A, P542; HAUBRICH R, 2000, ANTIVIR THER S, V5, P69; Hirsch M, 1999, J INFECT DIS, V180, P659, DOI 10.1086/314948; Hirsch MS, 1998, JAMA-J AM MED ASSOC, V279, P1984, DOI 10.1001/jama.279.24.1984; Hogg RS, 1998, JAMA-J AM MED ASSOC, V279, P450, DOI 10.1001/jama.279.6.450; KATZENSTEIN D, 2001, 8 C RETR OPP INF CHI, P172; Katzenstein DA, 2000, AIDS RES HUM RETROV, V16, P1031, DOI 10.1089/08892220050075282; Kempf DJ, 1998, AIDS, V12, pF9, DOI 10.1097/00002030-199805000-00001; Montaner JSG, 1998, JAMA-J AM MED ASSOC, V279, P930, DOI 10.1001/jama.279.12.930; *NIH, 1998, MMWR-MORBID MORTAL W, V47, P1; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Starr SE, 1999, NEW ENGL J MED, V341, P1874, DOI 10.1056/NEJM199912163412502; Staszewski S, 1999, NEW ENGL J MED, V341, P1865, DOI 10.1056/NEJM199912163412501; STASZEWSKI S, 1999, 39 INT C ANT AG CHEM, P473; Winters MA, 1998, J VIROL, V72, P5303, DOI 10.1128/JVI.72.6.5303-5306.1998; ZAR JH, 1984, BIOSTAT ANAL, P390	24	105	106	0	4	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 9	2001	345	6					398	407		10.1056/NEJM200108093450602	http://dx.doi.org/10.1056/NEJM200108093450602			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460EJ	11496850	Green Published			2022-12-28	WOS:000170295000002
J	Schneider, EC; Leape, LL; Weissman, JS; Piana, RN; Gatsonis, C; Epstein, AM				Schneider, EC; Leape, LL; Weissman, JS; Piana, RN; Gatsonis, C; Epstein, AM			Racial differences in cardiac revascularization rates: Does "overuse" explain higher rates among white patients?	ANNALS OF INTERNAL MEDICINE			English	Article							BYPASS GRAFT-SURGERY; NEW-YORK-STATE; TRANSLUMINAL CORONARY ANGIOPLASTY; ARTERY DISEASE; CLUSTERED DATA; APPROPRIATENESS; ANGIOGRAPHY; UNDERUSE; ACCESS; RACE	Background: coronary artery bypass graft (CABG) surgery and percutaneous transluminal coronary angioplasty (PTCA) are well-established treatments for symptomatic coronary artery disease. Previous studies have documented racial differences in rates of use of these cardiac revascularization procedures. Other studies suggest that these procedures are overused: that is, they are done for patients with clinically inappropriate indications. Objective: To test the hypothesis that the higher rate of cardiac revascularization among white patients is associated with a higher prevalence of overuse (revascularization for clinically inappropriate indications) among white patients than among African-American patients. Design: Observational cohort study using Medicare claims and medical record review. Setting: 173 hospitals in five U.S. states. Participants: A stratified, weighted, random sample of 3960 Medicare beneficiaries who underwent coronary angiography during 1991 and 1992; 1692 of these patients underwent 1711 revascularization procedures within 90 days. Measurements: The proportion of CABG and PTCA procedures rated appropriate, uncertain, and inappropriate according to RAND criteria, and the multivariate odds of undergoing inappropriate revascularization among African-American patients and white patients. Results: After angiography, rates of PTCA (23% vs. 19%) and CABG surgery (29% vs. 17%) were significantly higher among white patients than among African-American patients. The respective rates of inappropriate PTCA and CABG surgery were 14% and 10%. Among the study states, rates of inappropriate use ranged from 4% to 24% for PTCA and 0% to 14% for CABG surgery. White patients were more likely than African-American patients to receive inappropriate PTCA (15% vs. 9%; different 6 percentage points [95% CI, -0.4 to 12.7 percentage points]), and difference by race was statistically significant among men (20% vs. 8%; difference, 12 percentage points [CI, 1.2 to 21.7 percentage points]). Rates of inappropriate CABG surgery did not differ by race (10% in both groups). Conclusions: Among a large and diverse sample of Medicare beneficiaries in five U.S. states, overuse of PTCA was greater among white men than among other groups, but this difference did not fully account for racial disparities in revascularization. Overuse of cardiac revascularization varied significantly by geographic region.	Harvard Univ, Sch Publ Hlth, Brigham & Womens Hosp, Boston, MA 02115 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; Brown Univ, Providence, RI 02912 USA	Harvard University; Brigham & Women's Hospital; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Brown University	Schneider, EC (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave, Boston, MA 02115 USA.			Schneider, Eric/0000-0002-1132-5084	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS007098] Funding Source: NIH RePORTER; AHRQ HHS [5-RO-HS07098-02S1] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		*AM HEART ASS, 2001, STAT ABSTR 2000 OLD; AYANIAN JZ, 1993, JAMA-J AM MED ASSOC, V269, P2642, DOI 10.1001/jama.269.20.2642; Ayanian JZ, 1998, NEW ENGL J MED, V338, P1896, DOI 10.1056/NEJM199806253382608; Berlin JA, 1999, BIOMETRICS, V55, P470, DOI 10.1111/j.0006-341X.1999.00470.x; Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P945; HAMM CW, 1994, NEW ENGL J MED, V331, P1037, DOI 10.1056/NEJM199410203311601; HANNAN EL, 1991, MED CARE, V29, P430, DOI 10.1097/00005650-199105000-00004; Hannan EL, 1999, MED CARE, V37, P68, DOI 10.1097/00005650-199901000-00010; HILBORNE LH, 1993, JAMA-J AM MED ASSOC, V269, P761, DOI 10.1001/jama.269.6.761; HILBORNE LH, 1991, PERCUTANEOUS TRANSLU; Leape LL, 1996, ANN INTERN MED, V125, P8, DOI 10.7326/0003-4819-125-1-199607010-00003; LEAPE LL, 1993, JAMA-J AM MED ASSOC, V269, P753, DOI 10.1001/jama.269.6.753; Leape LL, 1999, ANN INTERN MED, V130, P183, DOI 10.7326/0003-4819-130-3-199902020-00003; LEAPE LL, 1991, CORONARY ARTERY BYPA; MCBEAN AM, 1994, AM HEART J, V127, P287, DOI 10.1016/0002-8703(94)90115-5; MYERS WO, 1985, ANN THORAC SURG, V40, P245, DOI 10.1016/S0003-4975(10)60037-9; Neuhaus JM, 1998, BIOMETRICS, V54, P638, DOI 10.2307/3109770; PARISI AF, 1992, NEW ENGL J MED, V326, P10, DOI 10.1056/NEJM199201023260102; PARK RE, 1986, AM J PUBLIC HEALTH, V76, P766, DOI 10.2105/AJPH.76.7.766; PARSONNET V, 1989, CIRCULATION, V79, P3; PHELPS CE, 1993, NEW ENGL J MED, V329, P1241, DOI 10.1056/NEJM199310213291707; Schwartz LM, 1999, NEW ENGL J MED, V341, P279, DOI 10.1056/NEJM199907223410411; Shekelle PG, 1998, NEW ENGL J MED, V338, P1888, DOI 10.1056/NEJM199806253382607; *STAT CORP, 1999, STAT REL 6; WENNEKER MB, 1989, JAMA-J AM MED ASSOC, V261, P253, DOI 10.1001/jama.261.2.253; WHITTLE J, 1993, NEW ENGL J MED, V329, P621, DOI 10.1056/NEJM199308263290907; Williams DR, 1997, ANN EPIDEMIOL, V7, P322, DOI 10.1016/S1047-2797(97)00051-3; WINSLOW CM, 1988, JAMA-J AM MED ASSOC, V260, P505, DOI 10.1001/jama.260.4.505	28	127	127	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 4	2001	135	5					328	337		10.7326/0003-4819-135-5-200109040-00009	http://dx.doi.org/10.7326/0003-4819-135-5-200109040-00009			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	468WF	11529696				2022-12-28	WOS:000170780600003
J	Esler, WP; Wolfe, MS				Esler, WP; Wolfe, MS			Biomedicine - A portrait of Alzheimer secretases - New features and familiar faces	SCIENCE			English	Review							AMYLOID PRECURSOR PROTEIN; NECROSIS-FACTOR-ALPHA; DISEASE-ASSOCIATED PRESENILIN-1; BETA-PEPTIDE PRODUCTION; FURIN-LIKE CONVERTASE; C-TERMINAL FRAGMENTS; GAMMA-SECRETASE; TRANSMEMBRANE DOMAIN; DISINTEGRIN-METALLOPROTEASE; ENDOGENOUS PRESENILIN-1	The amyloid beta -peptide (A beta) is a principal component of the cerebral plaques found in the brains of patients with Alzeheimer's disease (AD). This insoluble 40- to 42-amino acid peptide is formed by the cleavage of the A beta precursor protein (APP). The three proteases that cleave APP, alpha-, beta-, and gamma -secretases, have been implicated in the etiology of AD. beta -Secretase is a membrane-anchored protein with clear homology to soluble aspartyl proteases, and alpha -secretase displays characteristics of certain membrane-tethered metalloproteases. gamma -Secretase is apparently an oligomeric complex that includes the presenilins, which may be the catalytic component of this protease. Identification of the alpha-, beta-, and gamma -secretases provides potential targets for designing new drugs to treat AD.	Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Wolfe, MS (corresponding author), Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA.	mwolfe@rics.bwh.harvard.edu						Annaert WG, 1999, J CELL BIOL, V147, P277, DOI 10.1083/jcb.147.2.277; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bennett BD, 2000, J BIOL CHEM, V275, P37712, DOI 10.1074/jbc.M005339200; Berezovska O, 2000, J NEUROCHEM, V75, P583, DOI 10.1046/j.1471-4159.2000.0750583.x; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Boyartchuk VL, 1997, SCIENCE, V275, P1796, DOI 10.1126/science.275.5307.1796; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; BUSCIGLIO J, 1993, P NATL ACAD SCI USA, V90, P2092, DOI 10.1073/pnas.90.5.2092; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; BUXBAUM JD, 1993, P NATL ACAD SCI USA, V90, P9195, DOI 10.1073/pnas.90.19.9195; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Capell A, 1998, J BIOL CHEM, V273, P3205, DOI 10.1074/jbc.273.6.3205; Capell A, 2000, NAT CELL BIOL, V2, P205, DOI 10.1038/35008626; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Duncan EA, 1998, J BIOL CHEM, V273, P17801, DOI 10.1074/jbc.273.28.17801; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; Esler WP, 2000, NAT CELL BIOL, V2, P428, DOI 10.1038/35017062; Farzan M, 2000, P NATL ACAD SCI USA, V97, P9712, DOI 10.1073/pnas.160115697; FELSENSTEIN KM, 1994, NEUROSCI LETT, V174, P173, DOI 10.1016/0304-3940(94)90014-0; Ghosh AK, 2000, J AM CHEM SOC, V122, P3522, DOI 10.1021/ja000300g; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; HARING R, 1994, BIOCHEM BIOPH RES CO, V203, P652, DOI 10.1006/bbrc.1994.2232; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; HILBICH C, 1991, J MOL BIOL, V218, P149, DOI 10.1016/0022-2836(91)90881-6; Hong L, 2000, SCIENCE, V290, P150, DOI 10.1126/science.290.5489.150; HUNG AY, 1993, J BIOL CHEM, V268, P22959; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; JACOBSEN JS, 1994, J BIOL CHEM, V269, P8376; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Kimberly WT, 2000, J BIOL CHEM, V275, P3173, DOI 10.1074/jbc.275.5.3173; Lah JJ, 2000, MOL CELL NEUROSCI, V16, P111, DOI 10.1006/mcne.2000.0861; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; LaPointe CF, 2000, J BIOL CHEM, V275, P1502, DOI 10.1074/jbc.275.2.1502; LEE RKK, 1995, P NATL ACAD SCI USA, V92, P8083, DOI 10.1073/pnas.92.17.8083; Leimer U, 1999, BIOCHEMISTRY-US, V38, P13602, DOI 10.1021/bi991453n; Lemere CA, 1996, NAT MED, V2, P1146, DOI 10.1038/nm1096-1146; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Lichtenthaler SF, 1997, BIOCHEMISTRY-US, V36, P15396, DOI 10.1021/bi971071m; Lichtenthaler SF, 1999, P NATL ACAD SCI USA, V96, P3053, DOI 10.1073/pnas.96.6.3053; Lin L, 1999, P NATL ACAD SCI USA, V96, P12108, DOI 10.1073/pnas.96.21.12108; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108; LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Maruyama K, 1996, BIOCHEM BIOPH RES CO, V227, P730, DOI 10.1006/bbrc.1996.1577; Maskos K, 1998, P NATL ACAD SCI USA, V95, P3408, DOI 10.1073/pnas.95.7.3408; Meziane H, 1998, P NATL ACAD SCI USA, V95, P12683, DOI 10.1073/pnas.95.21.12683; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; NITSCH RM, 1992, SCIENCE, V258, P304, DOI 10.1126/science.1411529; Parvathy S, 1998, BIOCHEMISTRY-US, V37, P1680, DOI 10.1021/bi972034y; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Podlisny MB, 1997, NEUROBIOL DIS, V3, P325, DOI 10.1006/nbdi.1997.0129; Ratovitski T, 1997, J BIOL CHEM, V272, P24536, DOI 10.1074/jbc.272.39.24536; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Ray WJ, 1999, P NATL ACAD SCI USA, V96, P3263, DOI 10.1073/pnas.96.6.3263; Ray WJ, 1999, J BIOL CHEM, V274, P36801, DOI 10.1074/jbc.274.51.36801; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Rudner DZ, 1999, P NATL ACAD SCI USA, V96, P14765, DOI 10.1073/pnas.96.26.14765; Saunders AJ, 1999, SCIENCE, V286; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Steiner H, 1999, BIOCHEMISTRY-US, V38, P14600, DOI 10.1021/bi9914210; Steiner H, 1998, J BIOL CHEM, V273, P32322, DOI 10.1074/jbc.273.48.32322; Steiner H, 1999, J BIOL CHEM, V274, P28669, DOI 10.1074/jbc.274.40.28669; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Tischer E, 1996, J BIOL CHEM, V271, P21914, DOI 10.1074/jbc.271.36.21914; Tomita T, 1997, P NATL ACAD SCI USA, V94, P2025, DOI 10.1073/pnas.94.5.2025; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wen CH, 1997, DEVELOPMENT, V124, P4759; WOLF BA, 1995, J BIOL CHEM, V270, P4916, DOI 10.1074/jbc.270.9.4916; Wolfe MS, 1999, BIOCHEMISTRY-US, V38, P4720, DOI 10.1021/bi982562p; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wong PC, 1997, NATURE, V387, P288, DOI 10.1038/387288a0; Xia WM, 2000, P NATL ACAD SCI USA, V97, P9299, DOI 10.1073/pnas.97.16.9299; Xia WM, 1997, P NATL ACAD SCI USA, V94, P8208, DOI 10.1073/pnas.94.15.8208; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yu G, 2000, J BIOL CHEM, V275, P27348; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; Yu G, 1998, J BIOL CHEM, V273, P16470, DOI 10.1074/jbc.273.26.16470; Zhang ZH, 2000, NAT CELL BIOL, V2, P463, DOI 10.1038/35017108	108	438	466	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2001	293	5534					1449	1454		10.1126/science.1064638	http://dx.doi.org/10.1126/science.1064638			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465XV	11520976				2022-12-28	WOS:000170616000033
J	Roca, AL; Georgiadis, N; Pecon-Slattery, J; O'Brien, SJ				Roca, AL; Georgiadis, N; Pecon-Slattery, J; O'Brien, SJ			Genetic evidence for two species of elephant in Africa	SCIENCE			English	Article							ALIGNMENT	Elephants from the tropical forests of Africa are morphologically distinct from savannah or bush elephants. Dart-biopsy samples from 195 free-ranging African elephants in 21 populations were examined for DNA sequence variation in four nuclear genes (1732 base pairs). Phylogenetic distinctions between African forest elephant and savannah elephant populations corresponded to 58% of the difference in the same genes between elephant genera Loxodonta (African) and Elephas (Asian). Large genetic distance, multiple genetically fixed nucleotide site differences, morphological and habitat distinctions, and extremely limited hybridization of gene flow between forest and savannah elephants support the recognition and conservation management of two African species: Loxodonta africana and Loxodonta cyclotis.	NCI, Lab Genom Divers, Frederick, MD 21702 USA; Mpala Res Ctr, Nanyuki, Kenya	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	O'Brien, SJ (corresponding author), NCI, Lab Genom Divers, Frederick, MD 21702 USA.	obrien@ncifcrf.gov	Pecon-Slattery, Jill/GXH-4494-2022; OBRIEN, STEPHEN/ABD-1346-2020	Roca, Alfred/0000-0001-9217-5593; OBRIEN, STEPHEN/0000-0001-7857-0757				ALLEN GM, 1937, P ACAD NAT SCI PHILA, V88, P15; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; [Anonymous], 2013, INS PESTS POT GLOB, DOI DOI 10.1016/B978-0-12-386895-4.00005-3; Avise John C., 1994, pi; AZZAROLI AUGUSTO, 1966, ECOLOGAE GEOL HELV, V59, P541; Backhaus D., 1958, Saugetierkundliche Mitteilungen, V6, P166; Barnes R., 1999, AFRICAN ELEPHANT DAT; Barnes RFW, 1999, MAMMAL REV, V29, P175, DOI 10.1046/j.1365-2907.1999.00044.x; Barriel V, 1999, CR ACAD SCI III-VIE, V322, P447, DOI 10.1016/S0764-4469(99)80093-6; BARTON NH, 1989, NATURE, V341, P497, DOI 10.1038/341497a0; Blumenbach, 1797, HDB NATURGESCHICHTE; Frade F, 1955, TRAITE ZOOL, VXVII, P715; Frade F., 1934, B SOC PORT SCI NAT, V11, P135; GEORGIADIS N, 1994, J HERED, V85, P100, DOI 10.1093/oxfordjournals.jhered.a111405; Groves Colin P., 2000, Elephant, V2, P4; Grubb Peter, 2000, Elephant, V2, P1; Johnson WE, 1997, J MOL EVOL, V44, pS98, DOI 10.1007/PL00000060; Karesh W., 1989, CONSERV BIOL, V1, P261; KINGDON J, 1979, E AFRICAN MAMMALS B, V3; KUMAR S, 2000, MEGA 2 MOL EVOLTUION; Lyons LA, 1997, NAT GENET, V15, P47, DOI 10.1038/ng0197-47; Maglio V.J., 1973, Transactions Am phil Soc, V63, P1, DOI 10.2307/1006229; MANTEL N, 1967, CANCER RES, V27, P209; Matschie P., 1900, SITZUNGSBERICHTE GES, V8, P189; Mayr W., 1969, PRINCIPLES SYSTEMATI; MORRISONSCOTT TCS, 1947, P ZOOL SOC LOND, V117, P505; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; OBRIEN SJ, 1991, SCIENCE, V251, P1187, DOI 10.1126/science.251.4998.1187; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Sikes S.K, 1971, NATURAL HIST AFRICAN; SWOFFORD DL, 1998, PAUP 4 OB2 PHYLOGENE; TAJIMA F, 1993, GENETICS, V135, P599; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wass P., 1995, KENYAS INDIGENOUS FO; White F., 1983, VEGETATION AFRICA DE	35	224	236	3	155	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2001	293	5534					1473	1477		10.1126/science.1059936	http://dx.doi.org/10.1126/science.1059936			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465XV	11520983	Green Submitted, Green Published			2022-12-28	WOS:000170616000040
J	McLoone, P				McLoone, P			Targeting deprived areas within small areas in Scotland: population study	BRITISH MEDICAL JOURNAL			English	Article									Univ Glasgow, MRC, Social & Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland	MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow	McLoone, P (corresponding author), Univ Glasgow, MRC, Social & Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland.		McLoone, Philip/H-2353-2017	McLoone, Philip/0000-0003-0002-8700				*CACI INF SERV, 1997, PAY CHECK REP CACIS; CARSTAIRS V, 1992, DEPRIVATION HLTH SCO; Holtermann S., 1975, SOCIAL TRENDS, V6, P33; SLOGGETT A, 1994, BRIT MED J, V309, P1470, DOI 10.1136/bmj.309.6967.1470; Townsend P., 1979, POVERTY UK SURVEY HO	5	25	25	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 18	2001	323	7309					374	375		10.1136/bmj.323.7309.374	http://dx.doi.org/10.1136/bmj.323.7309.374			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465GN	11509428	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000170581400019
J	Passera, L; Aron, S; Vargo, EL; Keller, L				Passera, L; Aron, S; Vargo, EL; Keller, L			Queen control of sex ratio in fire ants	SCIENCE			English	Article							SOLENOPSIS-INVICTA; EUSOCIAL HYMENOPTERA; KIN SELECTION; INVESTMENT RATIOS; WORKER CONFLICT; SOCIAL INSECTS; POPULATIONS; ALLOCATION; COLONIES; FORMICIDAE	The haptodiploid sex-determination system of ants gives rise to conflict between queens and workers over colony sex ratios, and the female-biased allocation ratios seen in many species suggest that workers often prevail in this conflict. We exchanged queens between male- and female-specialist colonies of the fire ant Solenopsis invicta. These exchanges quickly reversed the sex-ratio biases of adopting colonies. The sex ratio of queen-laid eggs differed strongly between male- and female-specialist colonies. These findings suggest that queens can force workers to raise mate sexuals by limiting the number of female brood and help to explain why sex investment ratios lie between the queen and worker equilibria in this and many other ant species.	Univ Lausanne, Inst Ecol, CH-1015 Lausanne, Switzerland; Univ Toulouse 3, Lab Ethol & Anim Cognit, CNRS, FRE 2382, F-31062 Toulouse, France; Free Univ Brussels, Unit Anim Communities, B-1050 Brussels, Belgium; N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA	University of Lausanne; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Libre de Bruxelles; Vrije Universiteit Brussel; University of North Carolina; North Carolina State University	Keller, L (corresponding author), Univ Lausanne, Inst Ecol, CH-1015 Lausanne, Switzerland.	Laurent.keller@ie-zea.unit.ch	Vargo, Edward/D-1097-2010; keller, laurent/AAI-7175-2020	Vargo, Edward/0000-0002-8712-1248; keller, laurent/0000-0002-5046-9953				ARON S, 1995, ANIM BEHAV, V49, P749, DOI 10.1016/0003-3472(95)80207-X; ARON S, 1994, J EVOLUTION BIOL, V7, P403, DOI 10.1046/j.1420-9101.1994.7040403.x; BOOMSMA JJ, 1989, AM NAT, V133, P517, DOI 10.1086/284933; Bourke A. F., 1995, SOCIAL EVOLUTION ANT; Bourke Andrew F.G., 1997, P203; BULMER MG, 1981, HEREDITY, V47, P197, DOI 10.1038/hdy.1981.76; Chapuisat M, 1997, P ROY SOC B-BIOL SCI, V264, P1255, DOI 10.1098/rspb.1997.0173; Chapuisat M, 1999, HEREDITY, V82, P473, DOI 10.1038/sj.hdy.6885340; Crozier R.H., 1996, EVOLUTION SOCIAL INS; FLETCHER DJC, 1983, SCIENCE, V219, P312, DOI 10.1126/science.219.4582.312; FLETCHER DJC, 1985, ANNU REV ENTOMOL, V30, P319, DOI 10.1146/annurev.en.30.010185.001535; Helms KR, 1999, EVOLUTION, V53, P1470, DOI 10.2307/2640893; Keller L, 1999, MG BEH ECOL, P153; Keller L, 1996, BEHAV ECOL, V7, P292, DOI 10.1093/beheco/7.3.292; Keller L, 1999, BIOSCIENCE, V49, P899, DOI 10.2307/1313649; Krieger MJB, 1997, MOL ECOL, V6, P997, DOI 10.1046/j.1365-294X.1997.00264.x; MARKIN GP, 1971, ANN ENTOMOL SOC AM, V64, P562, DOI 10.1093/aesa/64.3.562; NONACS P, 1986, Q REV BIOL, V61, P1, DOI 10.1086/414723; PAMILO P, 1982, AM NAT, V119, P638, DOI 10.1086/283940; PAMILO P, 1990, BEHAV ECOL SOCIOBIOL, V27, P31; Queller DC, 1998, BIOSCIENCE, V48, P165, DOI 10.2307/1313262; RATNIEKS FLW, 1992, J THEOR BIOL, V158, P33, DOI 10.1016/S0022-5193(05)80647-2; Reuter M, 2001, AM NAT, V158, P166, DOI 10.1086/321311; ROSS KG, 1985, BEHAV ECOL SOCIOBIOL, V17, P349, DOI 10.1007/BF00293212; ROSS KG, 1995, ANNU REV ECOL SYST, V26, P631, DOI 10.1146/annurev.es.26.110195.003215; Seger J, 1996, SCIENCE, V274, P941, DOI 10.1126/science.274.5289.941; Sundstrom L, 1996, SCIENCE, V274, P993, DOI 10.1126/science.274.5289.993; TRIVERS RL, 1976, SCIENCE, V191, P249, DOI 10.1126/science.1108197; TSCHINKEL WR, 1993, ECOL MONOGR, V63, P425, DOI 10.2307/2937154; Vargo EL, 1996, J EVOLUTION BIOL, V9, P783, DOI 10.1046/j.1420-9101.1996.9060783.x; VARGO EL, 1987, PHYSIOL ENTOMOL, V12, P109, DOI 10.1111/j.1365-3032.1987.tb00729.x	31	83	85	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2001	293	5533					1308	1310		10.1126/science.1062076	http://dx.doi.org/10.1126/science.1062076			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11509728	Green Published			2022-12-28	WOS:000170492600037
J	Hersbach, FMRJ; Bravenboer, B; Koolen, JJ				Hersbach, FMRJ; Bravenboer, B; Koolen, JJ			Hearty hormones	LANCET			English	Editorial Material							CUSHINGS-SYNDROME		Catharine Hosp, Dept Cardiol, NL-5602 ZA Eindhoven, Netherlands; Catharine Hosp, Dept Internal Med, NL-5602 ZA Eindhoven, Netherlands	Catharina Hospital; Catharina Hospital	Hersbach, FMRJ (corresponding author), Catharine Hosp, Dept Cardiol, POB 1350, NL-5602 ZA Eindhoven, Netherlands.							FALLO F, 1994, J HUM HYPERTENS, V8, P509; PLOTZ CM, 1952, AM J MED, V13, P597, DOI 10.1016/0002-9343(52)90027-2; ROSS EJ, 1982, LANCET, V2, P646; WELBOURN RB, 1971, BRIT J SURG, V58, P1, DOI 10.1002/bjs.1800580102; Younge PA, 1995, J ROY SOC MED, V88, P174	5	5	5	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 11	2001	358	9280					468	468		10.1016/S0140-6736(01)05626-4	http://dx.doi.org/10.1016/S0140-6736(01)05626-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463TB	11513912				2022-12-28	WOS:000170492400014
J	Knight, J				Knight, J			Drugs firms inflate research costs, watchdog says	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2001	412	6847					571	571		10.1038/35088181	http://dx.doi.org/10.1038/35088181			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460PP	11493879	Bronze			2022-12-28	WOS:000170318000003
J	Dang, CV				Dang, CV			Runner's anemia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PLASMA-VOLUME; EXERCISE	Macrocytic anemia occurring in patients with fatigue suggests numerous diagnoses, ranging from nutritional deficiencies to a myelodysplastic syndrome. A careful history-taking is critically important for recognition of runner's anemia, which is due to plasma volume expansion, with hemolysis from the pounding of feet on pavement, and hemoglobinuria. Gastrointestinal blood loss may also contribute to anemia in long-distance runners. Early recognition of runner's anemia in patients with a complex presentation of anemia is important in circumventing many diagnostic tests. Runner's anemia should be considered when, amidst a constellation of signs and symptoms, mild anemia is well tolerated by an avid runner.	Johns Hopkins Univ, Sch Med, Dept Med, Div Hematol, Baltimore, MD 21205 USA	Johns Hopkins University	Dang, CV (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Hematol, Ross Res Bldg,Room 1025,720 Rutland Ave, Baltimore, MD 21205 USA.		Dang, Chi/Y-3375-2019	Dang, Chi/0000-0002-4031-2522				DAVIDSON RJ, 1964, J CLIN PATHOL, V17, P536, DOI 10.1136/jcp.17.5.536; EICHNER ER, 1985, AM J MED, V78, P321, DOI 10.1016/0002-9343(85)90443-7; ERSLEV AJ, 1990, HEMATOLOGY, P653; FLEISCHER R, 1981, BERL KLIN WOCHENSCHR, V18, P691; Gilligan DR, 1943, J CLIN INVEST, V22, P859, DOI 10.1172/JCI101460; OSCAI LB, 1968, J APPL PHYSIOL, V24, P622, DOI 10.1152/jappl.1968.24.5.622; Roy BD, 2000, CAN J PHYSIOL PHARM, V78, P244, DOI 10.1139/cjpp-78-3-244; Shoemaker JK, 1998, MED SCI SPORT EXER, V30, P497, DOI 10.1097/00005768-199804000-00005; STEWART JG, 1984, ANN INTERN MED, V100, P843, DOI 10.7326/0003-4819-100-6-843	9	25	27	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2001	286	6					714	716		10.1001/jama.286.6.714	http://dx.doi.org/10.1001/jama.286.6.714			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459VE	11495622				2022-12-28	WOS:000170271500028
J	Vlot, AJ; van der Molen, AJ; Muls, MJ; Fijnheer, R				Vlot, AJ; van der Molen, AJ; Muls, MJ; Fijnheer, R			Antibodies that stop the adrenals in their tracks	LANCET			English	Editorial Material									Univ Utrecht, Med Ctr, Dept Hematol, NL-3584 CX Utrecht, Netherlands; Univ Utrecht, Med Ctr, Dept Radiol, NL-3584 CX Utrecht, Netherlands; Univ Utrecht, Med Ctr, Dept Endocrinol, NL-3584 CX Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University	Fijnheer, R (corresponding author), Univ Utrecht, Med Ctr, Dept Hematol, NL-3584 CX Utrecht, Netherlands.							ASHERSON RA, 1989, J RHEUMATOL, V16, P378; FOX B, 1976, J PATHOL, V119, P65, DOI 10.1002/path.1711190202; KOMESAROFF PA, 1991, J RHEUMATOL, V18, P88; Oelkers W, 1996, NEW ENGL J MED, V335, P1206, DOI 10.1056/NEJM199610173351607	4	5	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 4	2001	358	9279					382	382		10.1016/S0140-6736(01)05559-3	http://dx.doi.org/10.1016/S0140-6736(01)05559-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459DE	11502319				2022-12-28	WOS:000170235100014
J	Zhang, XM; Ramalho-Santos, M; McMahon, AP				Zhang, XM; Ramalho-Santos, M; McMahon, AP			Smoothened mutants reveal redundant roles for Shh and Ihh signaling including regulation of L/R asymmetry by the mouse node	CELL			English	Article							LEFT-RIGHT AXIS; SONIC-HEDGEHOG; SCLEROTOME INDUCTION; INDIAN HEDGEHOG; CARTILAGE DIFFERENTIATION; VERTEBRATE DEVELOPMENT; MAMMALIAN TOOTH; GENE; EXPRESSION; PROLIFERATION	Genetic analyses in Drosophila have demonstrated that the multipass membrane protein Smoothened (Smo) is essential for all Hedgehog signaling. We show that Smo acts epistatic to Ptc1 to mediate Shh and Ihh signaling in the early mouse embryo. Smo and Shh/Ihh compound mutants have identical phenotypes: embryos fail to turn, arresting at somite stages with a small, linear heart tube, an open gut and cyclopia. The absence of visible left/right (L/R) asymmetry led us to examine the pathways controlling L/R situs. We present evidence consistent with a model in which Hedgehog signaling within the node is required for activation of Gdf1, and induction of left-side determinants. Further, we demonstrate an absolute requirement for Hedgehog signaling in sclerotomal development and a role in cardiac morphogenesis.	Harvard Univ, Dept Mol & Cellular Biol, Biolabs, Cambridge, MA 02138 USA	Harvard University	McMahon, AP (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Biolabs, 16 Divin Ave, Cambridge, MA 02138 USA.		Ramalho-Santos, Miguel/L-9092-2018; McMahon, Andrew P/ABE-7520-2020	Ramalho-Santos, Miguel/0000-0003-0177-5556; 	NINDS NIH HHS [NS33642] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akiyama H, 1997, BIOCHEM BIOPH RES CO, V235, P142, DOI 10.1006/bbrc.1997.6750; Alcedo J, 2000, MOL CELL, V6, P457, DOI 10.1016/S1097-2765(00)00044-7; Apelqvist A, 1997, CURR BIOL, V7, P801, DOI 10.1016/S0960-9822(06)00340-X; Barresi MJF, 2000, DEVELOPMENT, V127, P2189; Bitgood MJ, 1996, CURR BIOL, V6, P298, DOI 10.1016/S0960-9822(02)00480-3; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Borycki AG, 2000, CURR TOP DEV BIOL, V48, P165; Borycki AG, 1999, DEVELOPMENT, V126, P4053; Borycki AG, 1998, DEVELOPMENT, V125, P777; Burdine RD, 2000, GENE DEV, V14, P763; Capdevila J, 2000, CELL, V101, P9, DOI 10.1016/S0092-8674(00)80619-4; Carpenter D, 1998, P NATL ACAD SCI USA, V95, P13630, DOI 10.1073/pnas.95.23.13630; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Chiang C, 1999, DEV BIOL, V205, P1, DOI 10.1006/dbio.1998.9103; Collignon J, 1996, NATURE, V381, P155, DOI 10.1038/381155a0; Cossu G, 1999, EMBO J, V18, P6867, DOI 10.1093/emboj/18.24.6867; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Dassule HR, 1998, DEV BIOL, V202, P215, DOI 10.1006/dbio.1998.8992; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; Dockter JL, 2000, CURR TOP DEV BIOL, V48, P77; Dutton R, 1999, J NEUROSCI, V19, P2601; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; FAN CM, 1994, CELL, V79, P1175, DOI 10.1016/0092-8674(94)90009-4; FAN CM, 1995, CELL, V81, P457, DOI 10.1016/0092-8674(95)90398-4; Gaio U, 1999, CURR BIOL, V9, P1339, DOI 10.1016/S0960-9822(00)80059-7; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hammerschmidt M, 1997, TRENDS GENET, V13, P14, DOI 10.1016/S0168-9525(96)10051-2; Hebrok M, 2000, DEVELOPMENT, V127, P4905; Hynes M, 2000, NAT NEUROSCI, V3, P41, DOI 10.1038/71114; Ingham PW, 2000, CURR BIOL, V10, P1315, DOI 10.1016/S0960-9822(00)00755-7; Karp SJ, 2000, DEVELOPMENT, V127, P543; Kos L, 1998, MECH DEVELOP, V70, P25, DOI 10.1016/S0925-4773(97)00168-8; Lassar AB, 1996, CURR OPIN NEUROBIOL, V6, P57, DOI 10.1016/S0959-4388(96)80009-2; LEVIN M, 1995, CELL, V82, P803, DOI 10.1016/0092-8674(95)90477-8; Litingtung Y, 1998, NAT GENET, V20, P58, DOI 10.1038/1717; Liu AM, 1998, MECH DEVELOP, V75, P107, DOI 10.1016/S0925-4773(98)00090-2; Lyons GE, 1996, CURR OPIN GENET DEV, V6, P454, DOI 10.1016/S0959-437X(96)80067-0; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; Marcelle C, 1999, DEV BIOL, V214, P277, DOI 10.1006/dbio.1999.9389; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; MASUYA H, 1995, GENE DEV, V9, P1645, DOI 10.1101/gad.9.13.1645; Meno C, 1997, GENES CELLS, V2, P513, DOI 10.1046/j.1365-2443.1997.1400338.x; Meno C, 1998, CELL, V94, P287, DOI 10.1016/S0092-8674(00)81472-5; Meyers EN, 1999, SCIENCE, V285, P403, DOI 10.1126/science.285.5426.403; Monkley SJ, 1996, DEVELOPMENT, V122, P3343; Murtaugh LC, 1999, GENE DEV, V13, P225, DOI 10.1101/gad.13.2.225; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; OBRIEN TX, 1993, P NATL ACAD SCI USA, V90, P5157, DOI 10.1073/pnas.90.11.5157; Parmantier E, 1999, NEURON, V23, P713, DOI 10.1016/S0896-6273(01)80030-1; PARR BA, 1995, NATURE, V374, P350, DOI 10.1038/374350a0; Pepicelli CV, 1998, CURR BIOL, V8, P1083, DOI 10.1016/S0960-9822(98)70446-4; Piedra ME, 1998, CELL, V94, P319, DOI 10.1016/S0092-8674(00)81475-0; Quirk J, 1997, COLD SPRING HARB SYM, V62, P217; Ramalho-Santos M, 2000, DEVELOPMENT, V127, P2763; Ramirez-Weber FA, 2000, MOL CELL, V6, P479, DOI 10.1016/S1097-2765(00)00046-0; Rankin CT, 2000, NAT GENET, V24, P262, DOI 10.1038/73472; Rowitch DH, 1999, J NEUROSCI, V19, P8954, DOI 10.1523/JNEUROSCI.19-20-08954.1999; Ryan AK, 1998, NATURE, V394, P545, DOI 10.1038/29004; Sarkar L, 2000, P NATL ACAD SCI USA, V97, P4520, DOI 10.1073/pnas.97.9.4520; Sato N, 1999, J CLIN INVEST, V104, P855, DOI 10.1172/JCI7691; Shen MM, 2000, TRENDS GENET, V16, P303, DOI 10.1016/S0168-9525(00)02006-0; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Strutt H, 2001, CURR BIOL, V11, P608, DOI 10.1016/S0960-9822(01)00179-8; Teillet MA, 1998, DEVELOPMENT, V125, P2019; Tsukui T, 1999, P NATL ACAD SCI USA, V96, P11376, DOI 10.1073/pnas.96.20.11376; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wallace VA, 1999, CURR BIOL, V9, P445, DOI 10.1016/S0960-9822(99)80195-X; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; WHITING J, 1991, GENE DEV, V5, P2048, DOI 10.1101/gad.5.11.2048; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Yan YT, 1999, GENE DEV, V13, P2527, DOI 10.1101/gad.13.19.2527; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3; Yoshioka H, 1998, CELL, V94, P299, DOI 10.1016/S0092-8674(00)81473-7; Zhang YD, 2000, DEVELOPMENT, V127, P1431; Zuniga A, 1999, NATURE, V401, P598, DOI 10.1038/44157	78	458	472	1	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 15	2001	105	6					781	792		10.1016/S0092-8674(01)00385-3	http://dx.doi.org/10.1016/S0092-8674(01)00385-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	444AE	11440720	Bronze			2022-12-28	WOS:000169375100011
